index,trialid,source_register,date_registration,date_enrollement,retrospective_registration,normed_spon_names,recruitment_status,phase,study_type,countries,public_title,study_category,intervention,intervention_list,target_enrollment,web_address,cross_registrations
0,ISRCTN18948812,ISRCTN,2014-04-09,2014-01-05,True,Covidien,Not Recruiting,Not Applicable,Interventional,United Kingdom,A post-market clinical study to evaluate the Kangarooâ„¢ ePump enteral feeding pump automated water flushes on water delivery and compliance,Not relevant,Not relevant,Not relevant,100,http://isrctn.com/ISRCTN18948812,None
1,NCT00223119,ClinicalTrials.gov,2005-09-13,2004-01-01,True,Covidien,Not Recruiting,Phase 4,Interventional,United States,Comparison of Absorbable Sutures in Perineal Laceration Repair,Not relevant,Not relevant,Not relevant,Not Available,http://clinicaltrials.gov/show/NCT00223119,None
2,NCT00223132,ClinicalTrials.gov,2005-09-13,2005-02-01,True,Covidien,Not Recruiting,Phase 4,Interventional,United States,Suture Granuloma in Body Contouring Surgery,Not relevant,Not relevant,Not relevant,Not Available,http://clinicaltrials.gov/show/NCT00223132,None
3,NCT00289523,ClinicalTrials.gov,2006-02-08,2006-01-01,True,Covidien,Not Recruiting,Not Applicable,Observational,United States,EEG Biomarkers for Predicting Response to Antidepressant Therapy,Not relevant,Not relevant,Not relevant,375,http://clinicaltrials.gov/show/NCT00289523,None
4,NCT00308984,ClinicalTrials.gov,2006-03-28,2006-01-01,True,Covidien,Not Recruiting,Not Applicable,Observational,United States,CARE--Childhood Awareness and Recall Evaluation,Not relevant,Not relevant,Not relevant,1784,http://clinicaltrials.gov/show/NCT00308984,None
5,NCT00450710,ClinicalTrials.gov,2007-03-21,2006-03-01,True,Covidien,Not Recruiting,Phase 4,Interventional,Brazil,Neuroendocrine Brake for Type 2 Diabetes Mellitus,Not relevant,Not relevant,Not relevant,40,http://clinicaltrials.gov/show/NCT00450710,None
6,NCT00456352,ClinicalTrials.gov,2007-04-02,2007-04-01,True,Covidien,Not Recruiting,Phase 4,Interventional,Brazil,Duodenal Exclusion for the Treatment of T2DM,Not relevant,Not relevant,Not relevant,37,http://clinicaltrials.gov/show/NCT00456352,None
7,NCT00596973,ClinicalTrials.gov,2007-11-28,2008-01-01,False,Covidien,Not Recruiting,Phase 4,Interventional,United States,Surgical Treatment of Type 2 Diabetes in Non-Morbidly Obese Patients,Not relevant,Not relevant,Not relevant,0,http://clinicaltrials.gov/show/NCT00596973,None
8,NCT00689130,ClinicalTrials.gov,2008-05-30,2008-05-01,True,Covidien,Not Recruiting,Not Applicable,Observational,"United States, Spain",ADVANCE: Assessment for Defining Variability in Anesthesia Through Novel Clinical EEG,Not relevant,Not relevant,Not relevant,120,http://clinicaltrials.gov/show/NCT00689130,None
9,NCT00832767,ClinicalTrials.gov,2009-01-29,2009-04-01,False,Covidien,Not Recruiting,Phase 4,Interventional,"United Kingdom, United States, Italy",SILSâ„¢ Port Laparoscopic Cholecystectomy Post Market Study,Not relevant,Not relevant,Not relevant,200,http://clinicaltrials.gov/show/NCT00832767,None
10,NCT01026025,ClinicalTrials.gov,2009-12-03,2011-01-01,False,Covidien,Not Recruiting,Not Applicable,Interventional,United States,Duet TRS Used in Pulmonary Resections,Not relevant,Not relevant,Not relevant,0,http://clinicaltrials.gov/show/NCT01026025,None
11,NCT01110109,ClinicalTrials.gov,2010-04-22,2010-04-01,True,Covidien,Not Recruiting,Not Applicable,Observational,United States,Removing Fluid Above Breathing Tubes in the Operating Room,Not relevant,Not relevant,Not relevant,48,http://clinicaltrials.gov/show/NCT01110109,None
12,NCT01241617,ClinicalTrials.gov,2010-07-30,2010-08-01,False,Covidien,Not Recruiting,Not Applicable,Interventional,Japan,ENDO GIA Stapler With Duet Tissue Reinforcement System (TRS) Used in Pulmonary Resections,Not relevant,Not relevant,Not relevant,100,http://clinicaltrials.gov/show/NCT01241617,None
13,NCT01483547,ClinicalTrials.gov,2011-11-25,2011-11-01,True,Fondazione IRCCS Istituto Neurologico Carlo Besta,Not Recruiting,Not Applicable,Observational,Italy,Reliability of BIS Monitoring in Neurosurgical Patients,Not relevant,Not relevant,Not relevant,405,http://clinicaltrials.gov/show/NCT01483547,None
14,NCT01531426,ClinicalTrials.gov,2012-02-06,2012-01-01,True,Charité University,Not Recruiting,Not Applicable,Observational,Germany,Cerebral Oxygenation in Cardiac Arrest and Hypothermia,Not relevant,Not relevant,Not relevant,94,http://clinicaltrials.gov/show/NCT01531426,None
15,NCT01720355,ClinicalTrials.gov,2012-10-31,2012-08-01,True,Covidien,Not Recruiting,Not Applicable,Observational,United States,Pulse Oximetry- Performance During Severe Signal Interference,Not relevant,Not relevant,Not relevant,17,http://clinicaltrials.gov/show/NCT01720355,None
16,NCT01747460,ClinicalTrials.gov,2012-11-27,2012-09-01,True,Covidien,Not Recruiting,Not Applicable,Observational,United States,Pulse Oximetry_Performance Testing- PCBA-1 (Printed Circuit Board Assembly),Not relevant,Not relevant,Not relevant,25,http://clinicaltrials.gov/show/NCT01747460,None
17,NCT01747473,ClinicalTrials.gov,2012-11-27,2012-11-01,True,Covidien,Not Recruiting,Not Applicable,Observational,United States,Pulse Oximetry_Performance During Severe Signal Interference - PCBA-1 (Printed Circuit Board Assembly),Not relevant,Not relevant,Not relevant,17,http://clinicaltrials.gov/show/NCT01747473,None
18,NCT01791569,ClinicalTrials.gov,2012-11-29,2012-09-01,True,Covidien,Not Recruiting,Not Applicable,Observational,United States,Pulse Oximetry- Evaluating Sensor Off- PCBA-1,Not relevant,Not relevant,Not relevant,20,http://clinicaltrials.gov/show/NCT01791569,None
19,NCT01791582,ClinicalTrials.gov,2012-11-29,2012-10-01,True,Covidien,Not Recruiting,Not Applicable,Observational,United States,Pulse Oximetry- Evaluating Resp Rate- PCBA-1,Not relevant,Not relevant,Not relevant,27,http://clinicaltrials.gov/show/NCT01791582,None
20,NCT01797250,ClinicalTrials.gov,2013-02-20,2013-05-01,False,Covidien,Not Recruiting,Not Applicable,Observational,United States,Pulse Oximetry_Performance Testing- PCBA-1 (Printed Circuit Board Assembly) NEO/PEDS,Not relevant,Not relevant,Not relevant,12,http://clinicaltrials.gov/show/NCT01797250,None
21,NCT01881269,ClinicalTrials.gov,2013-06-17,2013-06-01,True,Covidien,Not Recruiting,Not Applicable,Observational,United States,Respiration Rate Monitoring During Transitions,Not relevant,Not relevant,Not relevant,27,http://clinicaltrials.gov/show/NCT01881269,None
22,NCT02075346,ClinicalTrials.gov,2014-02-27,2013-11-01,True,Covidien,Not Recruiting,Not Applicable,Observational,United States,Bedside Respiratory Patient Monitoring System - Sensor Off Study,Not relevant,Not relevant,Not relevant,18,http://clinicaltrials.gov/show/NCT02075346,None
23,NCT02075398,ClinicalTrials.gov,2014-02-27,2013-12-01,True,Covidien,Not Recruiting,Not Applicable,Observational,United States,Nellcor Bedside Respiratory Patient Monitoring System With Respiration Rate Version 2.0,Not relevant,Not relevant,Not relevant,35,http://clinicaltrials.gov/show/NCT02075398,None
24,NCT02617355,ClinicalTrials.gov,2015-11-24,2011-10-01,True,Maisonneuve-Rosemont Hospital,Not Recruiting,Not Applicable,Interventional,No Country Given,Interference Between Surgical Magnetic Drapes and Pacemakers,Not relevant,Not relevant,Not relevant,47,https://clinicaltrials.gov/show/NCT02617355,None
25,NCT02658903,ClinicalTrials.gov,2015-11-20,2016-01-01,False,Oxys Medical AG,Recruiting,Phase 1,Interventional,Switzerland,Prevention of Catheter Associated Lower Urinary Infections Using the Oxys Indwelling Catheter,Not relevant,Not relevant,Not relevant,54,https://clinicaltrials.gov/show/NCT02658903,None
26,NCT02308995,ClinicalTrials.gov,2014-12-03,2014-12-01,True,Aljazeera Hospital,Recruiting,Phase 2,Interventional,Egypt,Barbed Sutures Versus Conventional Sutures in Laparoscopic Excision of Endometrioma,Not relevant,Not relevant,Not relevant,40,https://clinicaltrials.gov/show/NCT02308995,None
27,NCT02805322,ClinicalTrials.gov,2016-06-09,2016-04-01,True,ARC Devices,Not Recruiting,Phase 4,Interventional,Ireland,"Comparison of a Novel Non-Invasive, Non-Touch Infrared Thermometer With Routine Thermometry in Routine Clinical Practice",Not relevant,Not relevant,Not relevant,138,https://clinicaltrials.gov/show/NCT02805322,None
28,ISRCTN15554338,ISRCTN,2015-04-02,2006-01-08,True,Covidien,Not Recruiting,Not Applicable,Interventional,United Kingdom,Cathasept for prevention of catheter colonisation,Not relevant,Not relevant,Not relevant,140,http://isrctn.com/ISRCTN15554338,None
29,NCT02748629,ClinicalTrials.gov,2016-04-12,2015-03-01,True,"Regional Health Center in Kartuzy, Poland",Not Recruiting,Not Applicable,Interventional,Poland,ProGrip Mesh Repair vs Lichtenstein Operation,Not relevant,Not relevant,Not relevant,143,https://clinicaltrials.gov/show/NCT02748629,None
30,NCT02949856,ClinicalTrials.gov,2016-10-20,2016-10-01,True,Keimyung University Dongsan Medical Center,Not Recruiting,Not Applicable,Interventional,No Country Given,E-T Tube Cuff Pressure Change After Changing Position From Neutral to Hyperextension of Neck,Not relevant,Not relevant,Not relevant,50,https://clinicaltrials.gov/show/NCT02949856,None
31,ISRCTN13646289,ISRCTN,2016-12-21,2013-05-08,True,Covidien,Not Recruiting,Not Applicable,Interventional,Taiwan,Study of the effectiveness and safety of LigaSureâ„¢ in hysterectomy,Not relevant,Not relevant,Not relevant,72,http://isrctn.com/ISRCTN13646289,None
32,NCT01169311,ClinicalTrials.gov,2010-07-22,2010-07-01,True,Medtronic,Not Recruiting,Not Applicable,Interventional,United States,Safety and Performance of the Covidien EEA Hemorrhoid and Prolapse Stapling Set in a Hemorrhoidopexy Procedure,Not relevant,Not relevant,Not relevant,27,https://clinicaltrials.gov/show/NCT01169311,None
33,NCT01306877,ClinicalTrials.gov,2011-01-28,2011-01-01,True,Medtronic,Not Recruiting,Not Applicable,Interventional,United States,Comparison Study of Surgical Staplers for the Treatment of Hemorrhoids,Not relevant,Not relevant,Not relevant,149,https://clinicaltrials.gov/show/NCT01306877,None
34,NCT01664806,ClinicalTrials.gov,2012-08-10,2010-11-01,True,"University of Colorado, Denver",Not Recruiting,Phase 3,Interventional,United States,Laparoscopic Cholecystectomy And Capacitive Coupling - Coag Versus Blend Mode Causing Thermal Injury at Port Site Skin,Not relevant,Not relevant,Not relevant,40,https://clinicaltrials.gov/show/NCT01664806,None
35,NCT01706822,ClinicalTrials.gov,2012-10-11,2013-04-01,False,Medtronic,Not Recruiting,Phase 4,Interventional,United States,Radial Reload Laparoscopic LAR Case Series,Not relevant,Not relevant,Not relevant,8,https://clinicaltrials.gov/show/NCT01706822,None
36,NCT01717014,ClinicalTrials.gov,2012-10-26,2013-05-01,False,Medtronic,Not Recruiting,Not Applicable,Interventional,United States,Radial Reload Open LAR Case Series,Not relevant,Not relevant,Not relevant,8,https://clinicaltrials.gov/show/NCT01717014,None
37,NCT00489268,ClinicalTrials.gov,2007-06-19,2003-11-01,True,Covidien,Not Recruiting,Not Applicable,Interventional,"United States, Puerto Rico","Micro-Layer Ablation of Barrett's Metaplasia- A Two-Phase, Multi-Center Trial - Extension of Follow-up to 5 Years",Not relevant,Not relevant,Not relevant,102,https://clinicaltrials.gov/show/NCT00489268,None
38,NCT01455519,ClinicalTrials.gov,2011-10-11,2011-10-01,True,Shirley Ryan AbilityLab,Not Recruiting,Phase 4,Interventional,United States,True Functional Restoration and Analgesia in Non-Radicular Low Back Pain,Not relevant,Not relevant,Not relevant,51,https://clinicaltrials.gov/show/NCT01455519,None
39,NCT01765686,ClinicalTrials.gov,2012-12-13,2012-12-01,True,"National Cancer Centre, Singapore",Not Recruiting,Not Applicable,Interventional,Singapore,Comparing Harmonic Ultrasonic Scalpel to Small Jaw Bipolar Device in Thyroid Surgery,Not relevant,Not relevant,Not relevant,100,https://clinicaltrials.gov/show/NCT01765686,None
40,NCT02065453,ClinicalTrials.gov,2014-02-11,2012-01-01,True,St. Louis University,Not Recruiting,Not Applicable,Interventional,United States,Disposable Energy Sources and Operating Room Time for Laparoscopic Hysterectomy,Not relevant,Not relevant,Not relevant,52,https://clinicaltrials.gov/show/NCT02065453,None
41,NCT02822820,ClinicalTrials.gov,2016-06-24,2016-07-01,False,Ankara University,Not Recruiting,Not Applicable,Interventional,Turkey,The Comparison of Conventional and Advanced Bipolar Energy Modalities During Laparoscopic Staging Surgery of Gynecologic Cancers,Not relevant,Not relevant,Not relevant,68,https://clinicaltrials.gov/show/NCT02822820,None
42,NCT02886806,ClinicalTrials.gov,2016-08-29,2016-10-01,False,Erasme University Hospital,Not Recruiting,Phase 1,Interventional,Belgium,"Fully Automated Anesthesia, Analgesia and Fluid Management",Not relevant,Not relevant,Not relevant,13,https://clinicaltrials.gov/show/NCT02886806,None
43,NCT02698982,ClinicalTrials.gov,2016-02-12,2016-05-01,False,Erasme University Hospital,Not Recruiting,Not Applicable,Interventional,Belgium,Optimized Anesthesia to Reduce Postoperative Cognitive Impairment in the Elderly,Not relevant,Not relevant,Not relevant,41,https://clinicaltrials.gov/show/NCT02698982,None
44,IRCT2014022816773N1,IRCT,2014-04-19,2011-04-04,True,Yazd Shahid Sadoughi University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,compare of hemorrhoidectomy complications in conventional and ligasure technique,Not relevant,Not relevant,Not relevant,101,http://en.irct.ir/trial/15589,None
45,ACTRN12618000669291,ANZCTR,2018-04-24,2016-01-01,True,Lunguard Ltd,Not Recruiting,Not Applicable,Interventional,Israel,The efficacy of a novel peristaltic feeding tube (PFT) in reducing reflux and aspiration of gastric contents in mechanically ventilated patients.,Not relevant,Not relevant,Not relevant,20,http://www.anzctr.org.au/ACTRN12618000669291.aspx,None
46,ISRCTN16473881,ISRCTN,2018-07-19,2018-01-08,True,National Maternity Hospital,Recruiting,Not Applicable,Interventional,Ireland,Comparing different monitors for high-risk babies in the delivery room,Not relevant,Not relevant,Not relevant,100,http://isrctn.com/ISRCTN16473881,None
47,ISRCTN38642364,ISRCTN,2017-06-23,2014-09-28,True,Covidien,Not Recruiting,Not Applicable,Interventional,Netherlands,The efficacy and safety of a new radiofrequency ablation device for the treatment of Barrett's esophagus: a pilot study,Not relevant,Not relevant,Not relevant,30,http://isrctn.com/ISRCTN38642364,None
48,ISRCTN11028739,ISRCTN,2017-05-04,2017-04-17,True,National Maternity Hospital,Not Recruiting,Not Applicable,Observational,Ireland,Comparison of two different monitors (electrocardiogram and pulse oximeter versus pulse oximeter alone) for monitoring heart rate in newly born infants: A randomised study,Not relevant,Not relevant,Not relevant,100,http://isrctn.com/ISRCTN11028739,None
49,IRCT20180223038837N1,IRCT,2018-12-08,2018-10-23,True,Kermanshah University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Comparative study of radiofrequency ablation & foam sclerotherapy for treatment patients suffering from varicose veins,Not relevant,Not relevant,Not relevant,60,http://en.irct.ir/trial/32039,None
50,KCT0003331,CRIS,2018-11-09,2017-07-27,True,Chonnam National University Hospital,Recruiting,Phase 2,Interventional,South Korea,The effect of reinforced endotracheal tube on post-operative hoarseness undergoing thyroidectomy,Not relevant,Not relevant,Not relevant,140,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=12657,None
51,KCT0002700,CRIS,2018-02-23,2018-01-11,True,Konkuk University Medical Center,Recruiting,Not Applicable,Interventional,South Korea,Validity and Feasibility of Postoperative Management Without Chest Tube  Placement after Thoracoscopic Bullectomy for Spontaneous Pneumothorax.,Not relevant,Not relevant,Not relevant,120,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=11087,None
52,KCT0002336,CRIS,2017-05-23,2015-03-25,True,The Catholic University of Korea; St. Mary's Hospital,Not Recruiting,Not Applicable,Interventional,South Korea,A Prospective Randomized Comparison of two techniques for minimally invasive surgery in donor nephrectomy,Not relevant,Not relevant,Not relevant,52,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=7441,None
53,JPRN-UMIN000004030,JPRN,2010-08-11,2010-09-01,False,Covidien,Not Recruiting,Phase 3,Interventional,Japan,Randomized Trial between Buttressed Versus Nonbuttressed Stapling in Pulmonary Lobectomy,Not relevant,Not relevant,Not relevant,140,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004846,None
54,JPRN-UMIN000005451,JPRN,2011-04-16,2010-08-01,True,Osaka University Graduate School of Medicine,Not Recruiting,Not Applicable,Interventional,Japan,Randomized controlled trial of PICC catheters,Not relevant,Not relevant,Not relevant,40,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006464,None
55,JPRN-UMIN000007147,JPRN,2012-01-26,2012-02-01,False,Covidien,Not Recruiting,Not Applicable,Observational,Japan,Prospective Multi-Center Post Market Surveillance of the Efficacy and the Safety of the DuraSeal Dural Sealant System in a Craniotomy,Not relevant,Not relevant,Not relevant,140,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008394,None
56,JPRN-UMIN000021203,JPRN,2016-03-01,2016-03-01,False,Covidien,Not Recruiting,Not Applicable,Observational,Japan,NAVIGATE: Clinical Evaluation of superDimension Navigation System for Electromagnetic Navigation Bronchoscopy,Not relevant,Not relevant,Not relevant,180,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024177,None
57,JPRN-UMIN000023311,JPRN,2016-07-26,2016-07-26,False,Kansai Medical University,Recruiting,Phase 2,Interventional,Japan,Randomized control study of the usability of vessel sealing devices at the time of pancreatoduodenectomy,Not relevant,Not relevant,Not relevant,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026773,None
58,JPRN-UMIN000026993,JPRN,2017-04-21,2017-04-24,False,Covidien,Not Recruiting,Not Applicable,Interventional,"Japan,Asia(except Japan),North America,Europe",PRediction of Opioid-induced respiratory Depression In patients monitored by capnoGraphY (PRODIGY),Not relevant,Not relevant,Not relevant,1650,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030949,None
59,IRCT20120728010430N8,IRCT,2019-05-12,2015-08-01,True,Esfahan University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Investigating CPAP in Treatment of RDS,Not relevant,Not relevant,Not relevant,70,http://en.irct.ir/trial/38534,None
60,ISRCTN14884587,ISRCTN,2019-06-07,2015-09-17,True,Medela AG,Not Recruiting,Not Applicable,Interventional,Italy,"Testing a novel, self-contained chest drainage system (THOPAZ+) for post-operative cardiac drainage",Not relevant,Not relevant,Not relevant,120,http://isrctn.com/ISRCTN14884587,None
61,JPRN-UMIN000038838,JPRN,2019-12-10,2019-12-16,False,Covidien,Recruiting,Not Applicable,Observational,Japan,Post Market Surveillance of the VenaSeal(TM) Closure System,Not relevant,Not relevant,Not relevant,120,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044045,None
62,ACTRN12610000006044,ANZCTR,2010-01-06,2009-12-20,True,Yih Chun Ling Patricia,Recruiting,Not Applicable,Interventional,Hong Kong,Prospective randomized trial of single port laparoscopic cholecystectomy versus four ports laparoscopic cholecystectomy in patients with gallbladder stones,Not relevant,Not relevant,Not relevant,46,https://anzctr.org.au/ACTRN12610000006044.aspx,None
63,ACTRN12613000511730,ANZCTR,2013-05-08,2013-07-23,False,Covidien,Recruiting,Not Applicable,Interventional,"New Zealand, Belgium","ILLUMENATE Global (ProspectIve, SingLe-Arm, Global MuLti-Center Study to EvalUate TreatMent of Obstructive SupErficial Femoral Artery or Popliteal LesioNs With A Novel PacliTaxel-CoatEd Percutaneous Angioplasty Balloon)",Not relevant,Not relevant,Not relevant,370,https://anzctr.org.au/ACTRN12613000511730.aspx,None
64,ACTRN12614001069640,ANZCTR,2014-10-07,2016-06-05,False,University of Canterbury,Recruiting,Not Applicable,Interventional,New Zealand,"Optimising mechanical ventilation in Intensive Care Unit (ICU)

",Not relevant,Not relevant,Not relevant,300,https://anzctr.org.au/ACTRN12614001069640.aspx,None
65,ACTRN12615000883516,ANZCTR,2015-08-24,2016-01-02,False,Royal Brisbane & Women's Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,Australia,Biopatch (trademark) or Kendall (trademark) AMD Foam Disc to reduce the incidence of Central-Line-Associated Blood Stream Infection: A pilot randomized controlled trial,Not relevant,Not relevant,Not relevant,100,https://anzctr.org.au/ACTRN12615000883516.aspx,None
66,ACTRN12616000013460,ANZCTR,2016-01-12,2016-03-31,False,Queensland University of Technology,Not Recruiting,Not Applicable,Interventional,Australia,A randomised controlled trial of forced air warming for patients undergoing interventional cardiology procedures with sedation,Not relevant,Not relevant,Not relevant,140,https://anzctr.org.au/ACTRN12616000013460.aspx,None
67,NCT04246242,ClinicalTrials.gov,2020-01-27,2020-01-25,True,Xiangya Hospital of Central South University,Not Recruiting,Phase 4,Interventional,No Country Given,A Randomized Multicenter Controlled Clinical Trial of Arbidol in Patients With 2019 Novel Coronavirus (2019-nCoV),Drug,Umifenovir,Umifenovir,500,https://clinicaltrials.gov/show/NCT04246242,None
68,ChiCTR2000029953,ChiCTR,2020-02-17,2020-02-01,True,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,Construction and Analysis of Prognostic Predictive Model of Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,400,http://www.chictr.org.cn/showproj.aspx?proj=49217,None
69,ChiCTR2000029949,ChiCTR,2020-02-16,2020-02-16,False,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,A Medical Records Based Study for the Effectiveness of Extracorporeal Membrane Oxygenation in Patients with Severe Novel Coronavirus Pneumonia (COVID-19),Drug,Oxygen,Oxygen,40,http://www.chictr.org.cn/showproj.aspx?proj=49181,None
70,ChiCTR2000029947,ChiCTR,2020-02-16,2020-03-01,False,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,A Randomized Controlled Trial for Qingyi No. 4 Compound in the treatment of Convalescence Patients of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=49599,None
71,ChiCTR2000029941,ChiCTR,2020-02-16,2020-03-01,False,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for Traditional Chinese Medicine in the treatment for Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=49596,None
72,ChiCTR2000029939,ChiCTR,2020-02-16,2020-02-10,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Interventional,China,"A Single-blind, Randomized, Controlled Clinical Trial for Chloroquine Phosphate in the treatment of Novel Coronavirus Pneumonia 2019 (COVID-19)",Drug,Chloroquine,Chloroquine,100,http://www.chictr.org.cn/showproj.aspx?proj=49612,None
73,ChiCTR2000029935,ChiCTR,2020-02-16,2020-02-06,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Interventional,China,A Single-arm Clinical Trial for Chloroquine Phosphate in the treatment of Novel Coronavirus Pneumonia 2019 (COVID-19),Drug,Chloroquine,Chloroquine,100,http://www.chictr.org.cn/showproj.aspx?proj=49607,None
74,ChiCTR2000029907,ChiCTR,2020-02-16,2020-02-16,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Observational,China,Study for construction and assessment of early warning score of the clinical risk of novel coronavirus (COVID-19) infected patients,Clinical Presentation,No Intervention,No Intervention,1000,http://www.chictr.org.cn/showproj.aspx?proj=49587,None
75,ChiCTR2000029905,ChiCTR,2020-02-16,2020-02-10,True,Zhongnan Hospital of Wuhan University,Recruiting,Not Applicable,Observational,China,A medical records based study of novel coronavirus pneumonia (COVID-19) and influenza virus co-infection,Clinical Presentation,No Intervention,No Intervention,271,http://www.chictr.org.cn/showproj.aspx?proj=49595,None
76,ChiCTR2000029896,ChiCTR,2020-02-16,2020-01-31,True,Affiliated Hospital of Changchun University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Evaluate the effectiveness of Traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=49432,None
77,ChiCTR2000029883,ChiCTR,2020-02-16,2020-02-17,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,A comparative study on the sensitivity of nasopharyngeal and oropharyngeal swabbing for the detection of SARS-CoV-2 by real-time PCR,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,http://www.chictr.org.cn/showproj.aspx?proj=49549,None
78,ChiCTR2000029870,ChiCTR,2020-02-15,2020-02-15,False,Jiangsu Institute of Parasitic Diseases,Recruiting,Not Applicable,Diagnostic test,China,Evaluation of Rapid Diagnostic Kit (IgM/IgG) for Novel Coronavirus Pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,http://www.chictr.org.cn/showproj.aspx?proj=49563,None
79,ChiCTR2000029869,ChiCTR,2020-02-15,2020-02-10,True,Huangshi Hospital of Traditional Chinese Medicine,Not Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, controlled trial for integrated Chinese and western medicine in the treatment of ordinary novel coronavirus pneumonia (COVID-19) based on the ' Internal and External Relieving -Truncated Torsion' strategy",Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=49486,None
80,ChiCTR2000029867,ChiCTR,2020-02-15,2020-02-15,False,"Beijing You'an Hospital, Capital Medical University",Recruiting,Phase 4,Interventional,China,"The efficacy and safety of carrimycin treatment in patients with novel coronavirus pneumonia (COVID-19): a multicenter, randomized, open-label, controlled trial",Drug,Carrimycin vs. lopinavir/ritonavir,Carrimycin; lopinavir; ritonavir,520,http://www.chictr.org.cn/showproj.aspx?proj=49514,None
81,ChiCTR2000029855,ChiCTR,2020-02-15,2020-02-15,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,"A randomized, open and controlled clinical trial for traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,180,http://www.chictr.org.cn/showproj.aspx?proj=49543,None
82,ChiCTR2000029853,ChiCTR,2020-02-15,2020-02-16,False,People's Hospital of Guangshan County,Recruiting,Not Applicable,Interventional,China,"A randomized, open-label, controlled clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,Azvudine,20,http://www.chictr.org.cn/showproj.aspx?proj=49532,None
83,ChiCTR2000029850,ChiCTR,2020-02-15,2020-02-15,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,Study on convalescent plasma treatment for severe patients with novel coronavirus pneumonia (COVID-19),ATMP,Plasma,Plasma,20,http://www.chictr.org.cn/showproj.aspx?proj=49533,None
84,ChiCTR2000029849,ChiCTR,2020-02-15,2020-02-01,True,The First Affiliated Hospital of Zhengzhou University,Recruiting,Not Applicable,Interventional,China,Application of Regulating Intestinal Flora in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19),ATMP,Intestinal microbiome,Intestinal microbiome,60,http://www.chictr.org.cn/showproj.aspx?proj=49530,None
85,ChiCTR2000029839,ChiCTR,2020-02-15,2020-02-10,True,Ningbo First Hospital,Recruiting,Not Applicable,Observational,China,"An observational study on the clinical characteristics, treatment and outcome of novel coronavirus pneumonia (COVID-19)",Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=49439,None
86,ChiCTR2000029821,ChiCTR,2020-02-14,2020-02-14,False,Deyang Integrated Traditional Chinese and Western Medicine Hospital,Not Recruiting,Not Applicable,Prevention,China,Based on Delphi Method to Preliminarily Construct a Recommended Protocol for the Prevention of Novel Coronavirus Pneumonia (COVID-19) in Deyang Area by Using Chinese Medicine Technology and its Clinical Application Evaluation,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,400,http://www.chictr.org.cn/showproj.aspx?proj=49306,None
87,ChiCTR2000029819,ChiCTR,2020-02-14,2020-02-11,True,"Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University",Recruiting,Phase 4,Interventional,China,Ba-Bao-Dan in the adjuvant therapy of novel coronavirus pneumonia (COVID-19) patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://www.chictr.org.cn/showproj.aspx?proj=49490,None
88,ChiCTR2000029815,ChiCTR,2020-02-14,2020-02-01,True,Guangdong Provincial Hospital of Chinese Medicine,Recruiting,Not Applicable,Observational,China,Psychological survey of frontline medical staff in various regions of China during the epidemic of novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,No Intervention,800,http://www.chictr.org.cn/showproj.aspx?proj=49346,None
89,ChiCTR2000029814,ChiCTR,2020-02-14,2020-02-14,False,Children's Hospital of Fudan University,Recruiting,Not Applicable,Interventional,China,Clinical Trial for Integrated Chinese and Western Medicine in the Treatment of Children with Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,30,http://www.chictr.org.cn/showproj.aspx?proj=49387,None
90,ChiCTR2000029813,ChiCTR,2020-02-14,2020-02-14,False,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Interventional,China,Clinical Trial for Tanreqing Capsules in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,72,http://www.chictr.org.cn/showproj.aspx?proj=49425,None
91,ChiCTR2000029811,ChiCTR,2020-02-14,2020-02-20,False,"Guangzhou reborn health management consultation co., LTD",Not Recruiting,Not Applicable,Interventional,No Country Given,Clinical Study for Anti-aging Active Freeze-dried Powder Granules in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=49355,None
92,ChiCTR2000029810,ChiCTR,2020-02-14,2020-02-16,False,Shenzhen Second People's Hospital,Recruiting,Not Applicable,Diagnostic test,China,Clinical study of a novel high sensitivity nucleic acid assay for novel coronavirus pneumonia (COVID-19) based on CRISPR-cas protein,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,10000,http://www.chictr.org.cn/showproj.aspx?proj=49407,None
93,ChiCTR2000029806,ChiCTR,2020-02-14,2020-02-12,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Interventional,China,Immunomodulatory Therapy for Severe Novel Coronavirus Pneumonia (COVID-19),Drug,PD1 vs. thymosin,PD1; Thymosin,120,http://www.chictr.org.cn/showproj.aspx?proj=49161,None
94,ChiCTR2000029805,ChiCTR,2020-02-14,2020-02-12,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Observational,China,Analysis of clinical characteristics of severe novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=49188,None
95,ChiCTR2000029804,ChiCTR,2020-02-14,2020-02-12,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Prognosis,China,Clinical Application of ECMO in the Treatment of Patients with Very Serious Respiratory Failure due to novel Coronavirus Pneumonia (COVID-19),Drug,Oxygen,Oxygen,100,http://www.chictr.org.cn/showproj.aspx?proj=49178,None
96,ChiCTR2000029790,ChiCTR,2020-02-13,2020-02-17,False,Shanghai Pulmonary Hospital,Recruiting,Not Applicable,Interventional,China,Clinical study for the integration of traditional Chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=49453,None
97,ChiCTR2000029789,ChiCTR,2020-02-13,2020-02-15,False,The First Affiliated Hospital of He'nan University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Randomized controlled trial for TCM syndrome differentiation treatment impacting quality of life of post-discharge patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=49348,None
98,ChiCTR2000029788,ChiCTR,2020-02-13,2020-03-01,False,Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Traditional Chinese medicine cooperative therapy for patients with novel coronavirus pneumonia (COVID-19): a randomized controlled trial,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=49452,None
99,ChiCTR2000029782,ChiCTR,2020-02-13,2020-01-30,True,Zhejiang Provincial People's Hospital,Not Recruiting,Not Applicable,Observational,China,Clinical study for the changes in mental state of medical staff in the department of radiotherapy in a comprehensive tertiary hospital in Zhejiang Province during the epidemic of novel coronavirus infection (COVID-19),Other (psych),No Intervention,No Intervention,27,http://www.chictr.org.cn/showproj.aspx?proj=49445,None
100,ChiCTR2000029779,ChiCTR,2020-02-13,2020-02-14,False,Wuxi People's Hospital,Recruiting,Not Applicable,Diagnostic test,China,Study for the key issues of the diagnosis and treatment of novel coronavirus pneumonia (COVID-19) based on the medical imaging,Clinical Presentation,No Intervention,No Intervention,0,http://www.chictr.org.cn/showproj.aspx?proj=49378,None
101,ChiCTR2000029778,ChiCTR,2020-02-13,2020-02-14,False,Shanghai University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Clinical Study for Traditional Chinese Medicine Combined With Western Medicine in Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,600,http://www.chictr.org.cn/showproj.aspx?proj=49422,None
102,ChiCTR2000029777,ChiCTR,2020-02-13,2020-02-05,True,Huangshi Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, controlled trial for integrated chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19) based on the 'Truncated Torsion' strategy",Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,160,http://www.chictr.org.cn/showproj.aspx?proj=49380,None
103,ChiCTR2000029776,ChiCTR,2020-02-13,2020-02-11,True,The First Affiliated Hospital of Wenzhou Medical University,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled, multicenter trial for Polyinosinic-Polycytidylic Acid Injection in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Polyinosinic-polycytidylic acid,Polyinosinic-polycytidylic acid,40,http://www.chictr.org.cn/showproj.aspx?proj=49342,None
104,ChiCTR2000029769,ChiCTR,2020-02-13,2020-02-15,False,Enze Hospital of Taizhou Enze Medical Center (Group),Not Recruiting,Not Applicable,Interventional,China,Babaodan Capsule used for the adjuvant treatment of severe novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://www.chictr.org.cn/showproj.aspx?proj=49415,None
105,ChiCTR2000029768,ChiCTR,2020-02-13,2020-02-12,True,Zhongnan Hospital of Wuhan University,Recruiting,Not Applicable,Interventional,China,"A randomized, open, controlled trial for diammonium glycyrrhizinate enteric-coated capsules combined with vitamin C tablets in the treatment of common novel coronavirus pneumonia (COVID-19) in the basic of clinical standard antiviral treatment to evaluate the safety and efficiency",Drug,Diammonium glycyrrhizinate + Vitamin C,Diammonium glycyrrhizinate; Vitamin C,60,http://www.chictr.org.cn/showproj.aspx?proj=49131,None
106,ChiCTR2000029765,ChiCTR,2020-02-13,2020-02-10,True,The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital),Recruiting,Phase 4,Interventional,China,"A multicenter, randomized controlled trial for the efficacy and safety of tocilizumab in the treatment of new coronavirus pneumonia (COVID-19)",Drug,Tocilizumab,Tocilizumab,188,http://www.chictr.org.cn/showproj.aspx?proj=49409,None
107,ChiCTR2000029764,ChiCTR,2020-02-13,2020-02-16,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Observational,China,Imaging Features and Mechanisms of Novel Coronavirus Pneumonia (COVID-19): a Multicenter Study,Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=49388,None
108,ChiCTR2000029763,ChiCTR,2020-02-12,2020-02-13,False,China Academy of Chinese Medical Sciences; Zhongnan Hospital of Wuhan University,Recruiting,Not Applicable,Interventional,China,"The efficacy of traditional chinese medicine on Novel Coronavirus Pneumonia (COVID-19) patients treated in square cabin hospital: a prospective, randomized controlled trial",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,408,http://www.chictr.org.cn/showproj.aspx?proj=49408,None
109,ChiCTR2000029758,ChiCTR,2020-02-12,2020-02-03,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,Cohort Study of Novel Coronavirus Pneumonia (COVID-19) Critical Ill Patients,Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=49295,None
110,ChiCTR2000029756,ChiCTR,2020-02-12,2020-02-15,False,Renmin Hospital of Wuhan University,Recruiting,Not Applicable,Interventional,China,Clinical study of nebulized Xiyanping injection in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,238,http://www.chictr.org.cn/showproj.aspx?proj=49222,None
111,ChiCTR2000029754,ChiCTR,2020-02-12,2020-02-10,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,Study for the Effect of Novel Coronavirus Pneumonia (COVID-19) on the Health of Different People,Clinical Presentation,No Intervention,No Intervention,1500,http://www.chictr.org.cn/showproj.aspx?proj=49370,None
112,ChiCTR2000029751,ChiCTR,2020-02-12,2020-02-01,True,The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Clinical Study for Traditional Chinese Medicine in the Prevention and Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,350,http://www.chictr.org.cn/showproj.aspx?proj=49354,None
113,ChiCTR2000029747,ChiCTR,2020-02-11,2020-02-11,False,The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Effect evaluation and prognosis of Chinese medicine based on Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=49287,None
114,ChiCTR2000029742,ChiCTR,2020-02-11,2020-02-10,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A randomized, parallel controlled trial for the efficacy and safety of Sodium Aescinate Injection in the treatment of patients with pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,90,http://www.chictr.org.cn/showproj.aspx?proj=49297,None
115,ChiCTR2000029741,ChiCTR,2020-02-11,2020-02-12,False,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Phase 4,Interventional,China,"Efficacy of Chloroquine and Lopinavir/ Ritonavir in mild/general novel coronavirus (CoVID-19) infections: a prospective, open-label, multicenter randomized controlled clinical study",Drug,Lopinavir/ritonavir vs. chloroquine,Lopinavir/ritonavir; Chloroquine,112,http://www.chictr.org.cn/showproj.aspx?proj=49263,None
116,ChiCTR2000029739,ChiCTR,2020-02-11,2020-02-12,False,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Not Applicable,Interventional,China,"A Multicenter, Randomized, Parallel Controlled Clinical Study of Hydrogen-Oxygen Nebulizer to Improve the Symptoms of Patients With Novel Coronavirus Pneumonia (COVID-19)",Drug,Hydrogen + Oxygen vs Oxygen,Hydrogen; Oxygen,440,http://www.chictr.org.cn/showproj.aspx?proj=49283,None
117,ChiCTR2000029735,ChiCTR,2020-02-10,2020-01-26,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Risks of Death and Severe cases in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,500,http://www.chictr.org.cn/showproj.aspx?proj=49279,None
118,ChiCTR2000029734,ChiCTR,2020-02-10,2020-02-08,True,The First People's Hospital of Huaihua,Recruiting,Not Applicable,Observational,China,Epidemiological investigation and clinical characteristics analysis of novel coronavirus pneumonia (COVID-19),Clinical Presentation (Epidemiology),No Intervention,No Intervention,40,http://www.chictr.org.cn/showproj.aspx?proj=48868,None
119,ChiCTR2000029732,ChiCTR,2020-02-10,2020-02-10,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Observational,China,Impact of vitamin D deficiency on prognosis of patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,156,http://www.chictr.org.cn/showproj.aspx?proj=49302,None
120,ChiCTR2000029695,ChiCTR,2020-02-10,2020-03-01,False,Shenzhen Third People's Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,Early Detection of Novel Coronavirus Pneumonia (COVID-19) Based on a Novel High-Throughput Mass Spectrometry Analysis With Exhaled Breath,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,300,http://www.chictr.org.cn/showproj.aspx?proj=49219,None
121,ChiCTR2000029656,ChiCTR,2020-02-09,2020-02-14,False,Wuhan Pulmonary Hosptial,Not Recruiting,Not Applicable,Interventional,China,"A randomized, open-label study to evaluate the efficacy and safety of low-dose corticosteroids in hospitalized patients with novel coronavirus pneumonia (COVID-19)",Drug,Corticosteroids,Methylprednisolone,100,http://www.chictr.org.cn/showproj.aspx?proj=49086,None
122,ChiCTR2000029639,ChiCTR,2020-02-08,2020-02-10,False,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Interventional,China,"Study for Mental health and psychological status of doctors, nurses and patients in novel coronavirus pneumonia (COVID-19) designated hospital and effect of interventions",Other (psych),No Intervention,No Intervention,192,http://www.chictr.org.cn/showproj.aspx?proj=49187,None
123,ChiCTR2000029637,ChiCTR,2020-02-08,2020-02-07,True,Guangdong Provincial Hospital of Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,An observational study for Xin-Guan-1 formula  in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=49127,None
124,ChiCTR2000029636,ChiCTR,2020-02-08,2020-02-09,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,Efficacy and safety of aerosol inhalation of vMIP in the treatment of novel coronavirus pneumonia (COVID-19): a single arm clinical trial,ATMP,Vaccine,Vaccine,40,http://www.chictr.org.cn/showproj.aspx?proj=49215,None
125,ChiCTR2000029628,ChiCTR,2020-02-07,2020-02-07,False,Guangdong Provincial Hospital of Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,A clinical observational study for Xin-Guan-2 formula in the treatment of suspected novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=49155,None
126,ChiCTR2000029626,ChiCTR,2020-02-07,2020-02-17,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Basic Science,China,Immune Repertoire (TCR & BCR) Evaluation and Immunotherapy Research in Peripheral Blood of Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,20,http://www.chictr.org.cn/showproj.aspx?proj=49170,None
127,ChiCTR2000029625,ChiCTR,2020-02-07,2020-02-17,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Diagnostic test,China,Construction of Early Warning and Prediction System for Patients with Severe / Critical Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,80,http://www.chictr.org.cn/showproj.aspx?proj=49177,None
128,ChiCTR2000029624,ChiCTR,2020-02-07,2020-02-08,False,Shanghai Public Health Clinical Center,Not Recruiting,Not Applicable,Observational,China,A real world study for traditional Chinese Medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,500,http://www.chictr.org.cn/showproj.aspx?proj=49132,None
129,ChiCTR2000029621,ChiCTR,2020-02-07,2020-02-07,False,"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",Recruiting,Phase 4,Interventional,China,Clinical study of arbidol hydrochloride tablets in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Umifenovir,Umifenovir,380,http://www.chictr.org.cn/showproj.aspx?proj=49165,None
130,ChiCTR2000029609,ChiCTR,2020-02-06,2020-02-10,False,The Fifth Affiliated Hospital of Sun Yat-Sen University,Not Recruiting,Phase 4,Interventional,China,"A prospective, open-label, multiple-center study for the efficacy of chloroquine phosphate in patients with novel coronavirus pneumonia (COVID-19)",Drug,Chloroquine vs. lopinavir/ritonavir,Chloroquine; lopinavir; ritonavir,205,http://www.chictr.org.cn/showproj.aspx?proj=49145,None
131,ChiCTR2000029606,ChiCTR,2020-02-07,2020-01-25,True,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,Clinical Study for Human Menstrual Blood-Derived Stem Cells in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),ATMP,Cells (stem cells),Cells (stem cells),63,http://www.chictr.org.cn/showproj.aspx?proj=49146,None
132,ChiCTR2000029603,ChiCTR,2020-02-06,2020-02-06,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,"A Randomized, Open-Label, Multi-Centre Clinical Trial Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Confirmed Cases of Novel Coronavirus Pneumonia (COVID-19)",Drug,ASCO9 + Ritonavir vs. Lopinavir/ritonavir,ASC09; Ritonavir; Lopinavir/ritonavir,160,http://www.chictr.org.cn/showproj.aspx?proj=49075,None
133,ChiCTR2000029602,ChiCTR,2020-02-06,2020-02-01,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Clinical study for community based prevention and control strategy of novel coronavirus pneumonia (COVID-19) in the isolate suspected and confirmed population,Clinical Presentation (Epidemiology),No Intervention,No Intervention,600,http://www.chictr.org.cn/showproj.aspx?proj=48985,None
134,ChiCTR2000029601,ChiCTR,2020-02-06,2020-02-01,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Community based prevention and control for Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19) in the isolate suspected and confirmed population,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,400,http://www.chictr.org.cn/showproj.aspx?proj=48988,None
135,ChiCTR2000029600,ChiCTR,2020-02-06,2020-01-30,True,The Third People's Hospital of Shenzhen,Recruiting,Not Applicable,Interventional,China,Clinical study for safety and efficacy of Favipiravir in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Favipiravir + interferon alpha vs. interferon alpha + Lopinavir/ritonavir + interferon alpha vs. interferon alpha,Favipiravir; interferon alpha; Lopinavir/ritonavir,90,http://www.chictr.org.cn/showproj.aspx?proj=49042,None
136,ChiCTR2000029578,ChiCTR,2020-02-05,2020-02-06,False,Zhejiang Chinese Medical University,Recruiting,Not Applicable,Interventional,China,"Chinese medicine prevention and treatment program for novel coronavirus pneumonia (COVID-19): a perspective, sing-arm trial",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,1000,http://www.chictr.org.cn/showproj.aspx?proj=49080,None
137,ChiCTR2000029559,ChiCTR,2020-02-04,2020-01-31,True,Renmin Hospital of Wuhan University,Recruiting,Phase 4,Interventional,China,Therapeutic effect of hydroxychloroquine on novel coronavirus pneumonia (COVID-19),Drug,Hydroxychloroquine,Hydroxychloroquine,300,http://www.chictr.org.cn/showproj.aspx?proj=48880,None
138,ChiCTR2000029558,ChiCTR,2020-02-04,2020-01-29,True,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Recommendations of Integrated Traditional Chinese and Western Medicine for Diagnosis and Treatment of Novel Coronavirus Pneumonia (COVID-19) in Sichuan Province,Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=48792,None
139,ChiCTR2000029548,ChiCTR,2020-02-04,2020-02-04,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Interventional,China,"Randomized, open-label, controlled trial for evaluating of the efficacy and safety of Baloxavir Marboxil, Favipiravir, and Lopinavir-Ritonavir in the treatment of novel coronavirus pneumonia (COVID-19) patients",Drug,Baloxavir + Marboxil vs. Favipiravir vs. Lopinavir/ritonavir,Baloxavir; Marboxil; Favipiravir; Lopinavir/ritonavir,30,http://www.chictr.org.cn/showproj.aspx?proj=49015,None
140,ChiCTR2000029544,ChiCTR,2020-02-03,2020-02-04,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Interventional,China,"A randomized controlled trial for the efficacy and safety of Baloxavir Marboxil, Favipiravir tablets in novel coronavirus pneumonia (COVID-19) patients who are still positive on virus detection under the current antiviral therapy",Drug,Baloxavir + Marboxil vs. Favipiravir,Baloxavir; Marboxil; Favipiravir,30,http://www.chictr.org.cn/showproj.aspx?proj=49013,None
141,ChiCTR2000029542,ChiCTR,2020-02-03,2020-02-03,False,Sun Yat sen Memorial Hospital of Sun Yat sen University,Recruiting,Phase 4,Interventional,China,Study for the efficacy of chloroquine in patients with novel coronavirus pneumonia (COVID-19),Drug,Chloroquine,Chloroquine,20,http://www.chictr.org.cn/showproj.aspx?proj=48968,None
142,ChiCTR2000029541,ChiCTR,2020-02-03,2020-02-10,False,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"A randomised, open, controlled trial for darunavir/cobicistat or Lopinavir/ritonavir combined with thymosin a1 in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Darunavir + Cobicistat vs. Lopinavir/ritonavir,Darunavir; Cobicistat; Lopinavir/ritonavir,100,http://www.chictr.org.cn/showproj.aspx?proj=48992,None
143,ChiCTR2000029539,ChiCTR,2020-02-03,2020-02-04,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,"A randomized, open-label study to evaluate the efficacy and safety of Lopinavir-Ritonavir in patients with mild novel coronavirus pneumonia (COVID-19)",Drug,Lopinavir/ritonavir,Lopinavir; Ritonavir,328,http://www.chictr.org.cn/showproj.aspx?proj=48991,None
144,ChiCTR2000029518,ChiCTR,2020-02-03,2020-02-04,False,Zhejiang Chinese Medical University,Recruiting,Not Applicable,Interventional,China,"Chinese medicine prevention and treatment program for novel coronavirus pneumonia (COVID-19): a perspective, double-blind, placebo, randomised controlled trial",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,140,http://www.chictr.org.cn/showproj.aspx?proj=48860,None
145,ChiCTR2000029517,ChiCTR,2020-02-03,2020-02-04,False,Zhejiang Chinese Medical University,Recruiting,Not Applicable,Interventional,China,"Chinese medicine prevention and treatment program for suspected novel coronavirus pneumonia (COVID-19): a perspective, double-blind, placebo, randomised controlled trial",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=48861,None
146,ChiCTR2000029495,ChiCTR,2020-02-02,2020-02-03,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,"Traditional Chinese Medicine, Psychological Intervention and Investigation of Mental Health for Patients With Novel Coronavirus Pneumonia (COVID-19) in Convalescent Period",Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,90,http://www.chictr.org.cn/showproj.aspx?proj=48971,None
147,ChiCTR2000029493,ChiCTR,2020-02-02,2020-02-03,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,"Traditional Chinese Medicine for Pulmonary Fibrosis, Pulmonary Function and Quality of Life in Patients With Novel Coronavirus Pneumonia (COVID-19) in Convalescent Period: a Randomized Controlled Trial",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=48931,None
148,ChiCTR2000029487,ChiCTR,2020-02-02,2020-02-10,False,Wuhan Hospital of Integrated Traditional Chinese and Western Medicine,Not Recruiting,Not Applicable,Prevention,China,Clinical Study for Gu-Biao Jie-Du-Ling in Preventing of Novel Coronavirus Pneumonia (COVID-19) in Children,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=48965,None
149,ChiCTR2000029468,ChiCTR,2020-02-02,2020-02-01,True,"Institute of Emergency Medicine and Disaster Medicine Sichuan People's Hospital, Sichuan Academy of Medical Sciences",Not Recruiting,Not Applicable,Interventional,China,A real-world  study for lopinavir/ritonavir (LPV/r) and emtritabine (FTC) / Tenofovir alafenamide Fumarate tablets (TAF) regimen in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Lopinavir/ritonavir + emtricitabine + tenofovir vs. lopinavir/ritonavir,Lopinavir/ritonavir; Emtricitabine; Tenofovir,120,http://www.chictr.org.cn/showproj.aspx?proj=48919,None
150,ChiCTR2000029462,ChiCTR,2020-02-02,2020-02-01,True,The First Affiliated Hospital of He'nan University of Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,Study for clinical characteristics and distribution of TCM syndrome of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=48922,None
151,ChiCTR2000029461,ChiCTR,2020-02-02,2020-02-03,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,A Randomized Controlled Trial for Integrated Traditional Chinese Medicine and Western Medicine in the Treatment of Common Type Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=48927,None
152,ChiCTR2000029460,ChiCTR,2020-02-02,2020-02-02,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,The effect of shadowboxing for pulmonary function and quality of life in patients with novel coronavirus pneumonia (COVID-19) in rehabilitation period,Other (exercise),Exercise,Exercise,100,http://www.chictr.org.cn/showproj.aspx?proj=48930,None
153,ChiCTR2000029459,ChiCTR,2020-02-02,2020-02-03,False,"Xinhua Affiliated Hospital, Hubei University of Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine",Not Recruiting,Not Applicable,Interventional,China,The effect of pulmonary rehabilitation for pulmonary function and quality of life in patients with novel coronavirus pneumonia (COVID-19) in rehabilitation period,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,100,http://www.chictr.org.cn/showproj.aspx?proj=48929,None
154,ChiCTR2000029439,ChiCTR,2020-02-01,2020-02-02,False,Beijing Hospital of Traditional Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Not Recruiting,Not Applicable,Interventional,China,Combination of traditional Chinese medicine and western medicine in the treatment of common type novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=48904,None
155,ChiCTR2000029438,ChiCTR,2020-02-01,2020-02-04,False,Beijing Hospital of Traditional Chinese Medicine; Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Not Recruiting,Phase 4,Interventional,China,A randomized controlled trial of integrated TCM and Western Medicine in the treatment of severe novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=48911,None
156,ChiCTR2000029437,ChiCTR,2020-02-01,2020-02-03,False,Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Not Recruiting,Not Applicable,Observational,China,A single arm study for combination of traditional Chinese and Western Medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=48913,None
157,ChiCTR2000029436,ChiCTR,2020-02-01,2020-02-01,False,The First Hospital of He'nan University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,A single arm study for evaluation of integrated traditional Chinese and western medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=48884,None
158,ChiCTR2000029435,ChiCTR,2020-02-01,2020-02-01,False,Wuhan First Hospital,Not Recruiting,Not Applicable,Interventional,China,Randomized controlled trial for traditional Chinese medicine in the prevention of novel coronavirus pneumonia (COVID-19) in high risk population,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=48827,None
159,ChiCTR2000029432,ChiCTR,2020-02-01,2020-02-01,False,The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine,Not Recruiting,Phase 4,Interventional,China,A Real World Study for the Efficacy and Safety of Large Dose Tanreqing Injection in the Treatment of Patients with Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,72,http://www.chictr.org.cn/showproj.aspx?proj=48881,None
160,ChiCTR2000029431,ChiCTR,2020-02-01,2020-01-29,True,Affiliated Zhongshan Hospital of Dalian University,Recruiting,Not Applicable,Interventional,China,Clinical study for the remedy of M1 macrophages target in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,45,http://www.chictr.org.cn/showproj.aspx?proj=48907,None
161,ChiCTR2000029430,ChiCTR,2020-02-01,2020-02-03,False,Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Not Recruiting,Not Applicable,Observational,China,Study for the TCM syndrome characteristics of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,600,http://www.chictr.org.cn/showproj.aspx?proj=48902,None
162,ChiCTR2000029418,ChiCTR,2020-01-30,2020-02-03,False,Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Chinese Herbal medicine for Severe nevel coronavirus pneumonia (COVID-19): a Randomized Controlled Trial,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,42,http://www.chictr.org.cn/showproj.aspx?proj=48886,None
163,ChiCTR2000029400,ChiCTR,2020-01-29,2020-01-29,False,China Academy of Chinese Medical Sciences,Recruiting,Not Applicable,Interventional,China,Clinical Controlled Trial for Traditional Chinese Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=48824,None
164,ChiCTR2000029381,ChiCTR,2020-01-27,2020-01-24,True,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Phase 4,Interventional,China,A prospective comparative study for Xue-Bi-Jing injection in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,400,http://www.chictr.org.cn/showproj.aspx?proj=48768,None
165,ACTRN12619000250134,ANZCTR,2019-02-20,2020-04-03,False,Royal Prince Alfred Hopsital,Not Recruiting,Not Applicable,Interventional,Australia,A Pilot Study into a Pan-Enteric Capsule Endoscopy vs. Bidirectional Endoscopy In Patients With Iron Deficiency Anaemia.,Not relevant,Not relevant,Not relevant,50,https://anzctr.org.au/ACTRN12619000250134.aspx,None
166,IRCT20190809044488N1,IRCT,2020-01-13,2019-09-07,True,Boushehr University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,"Effects of using Forced Hot air system on physiological parameters, waking time and arterial blood gases in patients undergoing coronary artery bypass grafting surgery",Not relevant,Not relevant,Not relevant,102,http://en.irct.ir/trial/41571,None
167,ChiCTR2000030188,ChiCTR,2020-02-24,2020-02-15,True,Guangdong Provincial Hospital of Chinese Medicine - Zhuhai Hospital,Recruiting,Not Applicable,Interventional,China,Clinical Study on Syndrome Differentiation of TCM in Treating Severe and Critical novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=50025,None
168,ChiCTR2000030185,ChiCTR,2020-02-24,2020-02-24,False,West China Hospital of Sichuan University,Recruiting,Not Applicable,Diagnostic test,China,"The Value of Critical Care Ultrasound in Rapid Screening, Diagnosis, Evaluation of Effectiveness and Intensive Prevention of Novel Coronavirus Pneumonia (COVID-19)",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,40,http://www.chictr.org.cn/showproj.aspx?proj=50058,None
169,ChiCTR2000030179,ChiCTR,2020-02-24,2020-02-24,False,The First Affiliated Hospital of Nanchang University,Recruiting,Not Applicable,Interventional,China,Experimental study of novel coronavirus pneumonia rehabilitation plasma therapy severe novel coronavirus pneumonia (COVID-19),ATMP,Plasma,Plasma,100,http://www.chictr.org.cn/showproj.aspx?proj=50059,None
170,ChiCTR2000030173,ChiCTR,2020-02-24,2020-02-17,True,"Hunan yuanpin Cell Biotechnology Co., Ltd",Not Recruiting,Not Applicable,Interventional,China,Key techniques of umbilical cord mesenchymal stem cells for the treatment of novel coronavirus pneumonia (COVID-19) and clinical application demonstration,ATMP,Cells (mesenchymal),Cells (mesenchymal),60,http://www.chictr.org.cn/showproj.aspx?proj=49229,None
171,ChiCTR2000030170,ChiCTR,2020-02-24,2020-02-15,True,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Interventional,China,Study for safety and efficacy of Jakotinib hydrochloride tablets in the treatment severe and acute exacerbation patients of novel coronavirus pneumonia (COVID-19),Drug,Jakotinib,Jakotinib,16,http://www.chictr.org.cn/showproj.aspx?proj=50017,None
172,ChiCTR2000030167,ChiCTR,2020-02-24,2020-03-02,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,Clinical Trial for Recombinant Human Interleukin-2 in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Drug,Interleukin-2,Interleukin-2,80,http://www.chictr.org.cn/showproj.aspx?proj=49567,None
173,ChiCTR2000030166,ChiCTR,2020-02-24,2020-02-25,False,The Fifth Medical Center of PLA General Hospital,Not Recruiting,Not Applicable,Interventional,China,"Randomized, parallel control, open trial for Qing-Wen Bai-Du-Yin combined with antiviral therapy in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,20,http://www.chictr.org.cn/showproj.aspx?proj=49696,None
174,ChiCTR2000030165,ChiCTR,2020-02-24,2020-02-24,False,Tianjin University,Recruiting,Not Applicable,Interventional,China,Clinical study for ozonated autohemotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19),Drug,Ozone,Ozone,60,http://www.chictr.org.cn/showproj.aspx?proj=49947,None
175,ChiCTR2000030164,ChiCTR,2020-02-24,2020-02-24,False,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Not Recruiting,Not Applicable,Observational,China,A cross-sectional study of novel coronavirus pneumonia (COVID-19) patients in ICU,Clinical Presentation,No Intervention,No Intervention,10,http://www.chictr.org.cn/showproj.aspx?proj=49983,None
176,ChiCTR2000030138,ChiCTR,2020-02-24,2020-02-24,False,Chinese PLA General Hospital,Not Recruiting,Phase 2,Interventional,China,Clinical Trial for Human Mesenchymal Stem Cells in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),60,http://www.chictr.org.cn/showproj.aspx?proj=50004,None
177,ChiCTR2000030137,ChiCTR,2020-02-24,2020-02-24,False,The Second Affiliated Hospital of Xi'an Jiaotong University,Not Recruiting,Not Applicable,Observational,China,Humanistic Care in Healthcare Workers in Novel Coronavirus Pneumonia (COVID-19),Other,Humanistic Care,Humanistic Care,130,http://www.chictr.org.cn/showproj.aspx?proj=50007,None
178,ChiCTR2000030136,ChiCTR,2020-02-24,2020-02-24,False,The Second Affiliated Hospital of Xi'an Jiaotong University,Not Recruiting,Not Applicable,Interventional,China,Humanistic Care in Patients With Novel Coronavirus Pneumonia (COVID-19),Other,Humanistic Care,Humanistic Care,130,http://www.chictr.org.cn/showproj.aspx?proj=50005,None
179,ChiCTR2000030118,ChiCTR,2020-02-23,2020-02-24,False,Shenzhen National Medicine Inheritance Medical Research Institute co. LTD,Not Recruiting,Not Applicable,Interventional,China,A clinical study for ''Huo-Shen'' particles in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=49594,None
180,ChiCTR2000030117,ChiCTR,2020-02-23,2020-02-15,True,Shanghai Public Health Clinical Center,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open, parallel controlled trial for the evaluation of the effectiveness and safety of Xiyanping injection in the treatment of common type novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,348,http://www.chictr.org.cn/showproj.aspx?proj=49762,None
181,ChiCTR2000030116,ChiCTR,2020-02-23,2020-02-01,True,The First Affiliated Hospital of Nanchang University,Recruiting,Not Applicable,Interventional,China,Safety and effectiveness of human umbilical cord mesenchymal stem cells in the treatment of acute respiratory distress syndrome of severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),16,http://www.chictr.org.cn/showproj.aspx?proj=49901,None
182,ChiCTR2000030115,ChiCTR,2020-02-23,2020-02-27,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A clinical research for the changes of Blood cortisol ACTH level and adrenal morphology in blood cortisol to guide the application of individualized hormone in severe novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,No Intervention,50,http://www.chictr.org.cn/showproj.aspx?proj=49964,None
183,ChiCTR2000030113,ChiCTR,2020-02-23,2020-02-22,True,The Third People's Hospital of Shenzhen,Recruiting,Not Applicable,Interventional,No Country Given,Randomized controlled trial for safety and efficacy of Favipiravir in the treatment of novel coronavirus pneumonia (COVID-19) with poorly responsive ritonavir/ritonavir,Drug,Favipiravir vs. ritonavir,Favipiravir,30,http://www.chictr.org.cn/showproj.aspx?proj=49988,None
184,ChiCTR2000030102,ChiCTR,2020-02-23,2020-02-24,False,Tianjin Huanhu Hospital,Recruiting,Not Applicable,Interventional,China,A multicenter randomized controlled trial for ozone autohemotherapy in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Ozone,Ozone,180,http://www.chictr.org.cn/showproj.aspx?proj=49747,None
185,ChiCTR2000030096,ChiCTR,2020-02-23,2020-02-17,True,Peking University First Hospital,Not Recruiting,Not Applicable,Observational,China,Study for establishment of correlation between virological dynamics and clinical features in noveal coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,120,http://www.chictr.org.cn/showproj.aspx?proj=49794,None
186,ChiCTR2000030094,ChiCTR,2020-02-23,2020-03-01,False,Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,"Effects of novel coronavirus pneumonia (COVID-19) on menstruation, TCM body construction and psychological state for female at different ages",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=49970,None
187,ChiCTR2000030093,ChiCTR,2020-02-23,2020-03-01,False,The Second Hospital of Shanxi Medical University,Not Recruiting,Not Applicable,Interventional,China,Study for application of simplified cognitive-behavioral therapy for related emergency psychological stress reaction of medical providers working in the position of treatment and control of novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,Psychological,60,http://www.chictr.org.cn/showproj.aspx?proj=49932,None
188,ChiCTR2000030092,ChiCTR,2020-02-23,2020-02-12,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Assessment of cardiac function in patients with Novel Coronavirus Pneumonia (COVID-19) by echocardiography and its new techniques,Clinical Presentation,No Intervention,No Intervention,800,http://www.chictr.org.cn/showproj.aspx?proj=49880,None
189,ChiCTR2000030090,ChiCTR,2020-02-22,2020-02-22,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,A Prospective Randomized Controlled Trial for Home Exercise Prescription Intervention During Epidemic of Novel Coronary Pneumonia (COVID-19) in College Students,Other (exercise),Exercise,Exercise,400,http://www.chictr.org.cn/showproj.aspx?proj=49910,None
190,ChiCTR2000030089,ChiCTR,2020-02-22,2020-02-28,False,Shanghai Changzheng Hospital,Not Recruiting,Phase 4,Interventional,China,A clinical study for the efficacy and safety of Adalimumab Injection in the treatment of patients with severe novel coronavirus pneumonia (COVID-19),Drug,Adalimumab,Adalimumab,60,http://www.chictr.org.cn/showproj.aspx?proj=49889,None
191,ChiCTR2000030088,ChiCTR,2020-02-22,2020-03-01,False,The Sixth Medical Center of PLA General Hospital,Not Recruiting,Not Applicable,Interventional,China,Umbilical cord Wharton's Jelly derived mesenchymal stem cells in the treatment of severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),40,http://www.chictr.org.cn/showproj.aspx?proj=49902,None
192,ChiCTR2000030087,ChiCTR,2020-02-22,2020-02-12,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Clinical study for the diagnostic value of pulmonary ultrasound for novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,800,http://www.chictr.org.cn/showproj.aspx?proj=49919,None
193,ChiCTR2000030086,ChiCTR,2020-02-22,2020-02-24,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Study for the effects on medical providers' infection rate and mental health after performing different anesthesia schemes in cesarean section for novel coronavirus pneumonia (COVID-19) puerperae,Clinical Presentation,No Intervention,No Intervention,210,http://www.chictr.org.cn/showproj.aspx?proj=49934,None
194,ChiCTR2000030084,ChiCTR,2020-02-22,2020-02-24,False,The First Hospital of Shanxi Medical University,Recruiting,Not Applicable,Interventional,China,A multicenter study for efficacy of intelligent psychosomatic adjustment system intervention in the treatment of novel coronavirus pneumonia (COVID-19) patients with mild to moderate anxiety and depression,Other (psych),Psychological,Psychological,180,http://www.chictr.org.cn/showproj.aspx?proj=49952,None
195,ChiCTR2000030058,ChiCTR,2020-02-22,2020-03-10,False,Renmin Hospital of Wuhan University,Not Recruiting,Phase 3,Interventional,China,"A multicenter, randomized, double-blind, controlled clinical trial for leflunomide in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Leflunomide,Leflunomide,200,http://www.chictr.org.cn/showproj.aspx?proj=49831,None
196,ChiCTR2000030056,ChiCTR,2020-02-22,2020-02-23,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Study for the effect of early endotracheal intubation on the outcome of novel coronavirus pneumonia (COVID-19) patients,Other (physical),Endotracheal Intubation,Endotracheal Intubation,100,http://www.chictr.org.cn/showproj.aspx?proj=49904,None
197,ChiCTR2000030054,ChiCTR,2020-02-22,2020-02-22,False,Zhongshan Hospital Affiliated to Xiamen University,Not Recruiting,Not Applicable,Interventional,China,"A prospective, open label, randomized, control trial for chloroquine or hydroxychloroquine in patients with mild and common novel coronavirus pulmonary (COVIP-19)",Drug,Chloroquine + Hydroxychloroquine,Chloroquine; Hydroxychloroquine,100,http://www.chictr.org.cn/showproj.aspx?proj=49869,None
198,ChiCTR2000030046,ChiCTR,2020-02-21,2020-02-07,True,"The First People's Hospital of Jiangxia District, Wuhan (Union Jiangnan Hospital)",Recruiting,Not Applicable,Interventional,China,A single arm trial to evaluate the efficacy and safety of anti-2019-nCoV inactivated convalescent plasma in the treatment of novel coronavirus pneumonia patient (COVID-19),ATMP,Plasma,Plasma,10,http://www.chictr.org.cn/showproj.aspx?proj=49861,None
199,ChiCTR2000030043,ChiCTR,2020-02-21,2020-02-21,False,Peking University Third Hospital,Not Recruiting,Phase 4,Interventional,China,"Shen-Fu injection in the treatment of severe novel coronavirus pneumonia (COVID-19): a multicenter, randomized, open-label, controlled trial",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=49866,None
200,ChiCTR2000030041,ChiCTR,2020-02-21,2020-02-25,False,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"A single-arm, single-center clinical trial for Azivudine tablets in the treatment of adult novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,Azvudine,40,http://www.chictr.org.cn/showproj.aspx?proj=49891,None
201,ChiCTR2000030039,ChiCTR,2020-02-21,2020-05-31,False,Affiliated Hospital of Xuzhou Medical University,Recruiting,Not Applicable,Interventional,China,Clinical study for infusing convalescent plasma to treat patients with new coronavirus pneumonia (COVID-19),ATMP,Plasma,Plasma,90,http://www.chictr.org.cn/showproj.aspx?proj=49544,None
202,ChiCTR2000030034,ChiCTR,2020-02-21,2020-02-07,True,Tongde Hospital of Zhejiang Province,Recruiting,Not Applicable,Interventional,China,"Traditional Chinese Medicine in the treatment of novel coronavirus pneumonia (COVID-19): a multicentre, randomized controlled trial",Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,132,http://www.chictr.org.cn/showproj.aspx?proj=49647,None
203,ChiCTR2000030033,ChiCTR,2020-02-21,2020-02-24,False,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,A study for the intervention of Xiangxue antiviral oral solution and Wu-Zhi-Fang-Guan-Fang on close contacts of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,828,http://www.chictr.org.cn/showproj.aspx?proj=49703,None
204,ChiCTR2000030032,ChiCTR,2020-02-21,2020-02-10,True,Xi'an Chest Hospital,Recruiting,Not Applicable,Observational,China,Study on ultrasonographic manifestations of new type of novel coronavirus pneumonia (covid-19) in non-critical stage of pulmonary lesions,Clinical Presentation,No Intervention,No Intervention,20,http://www.chictr.org.cn/showproj.aspx?proj=49816,None
205,ChiCTR2000030030,ChiCTR,2020-02-20,2020-02-20,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,A medical records based study for acute kidney injury in novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,2000,http://www.chictr.org.cn/showproj.aspx?proj=49841,None
206,ChiCTR2000030029,ChiCTR,2020-02-21,2020-02-20,True,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Interventional,China,A multi-center study on the efficacy and safety of suramin sodium in adult patients with novel coronavirus pneumonia (COVID-19),Drug,Suramin,Suramin,20,http://www.chictr.org.cn/showproj.aspx?proj=49824,None
207,ChiCTR2000030027,ChiCTR,2020-02-20,2020-02-20,False,Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Traditional Chinese medicine cooperative therapy for patients with Novel coronavirus pneumonia (COVID-19) and its effect on spermatogenesis: a randomized controlled trial,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=49852,None
208,ChiCTR2000030021,ChiCTR,2020-02-20,2020-02-20,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,A medical records based analysis for the clinical characteristics of novel coronavirus pneumonia (COVID-19) in immunocompromised patients,Clinical Presentation,No Intervention,No Intervention,10,http://www.chictr.org.cn/showproj.aspx?proj=49690,None
209,ChiCTR2000030020,ChiCTR,2020-02-20,2020-02-06,True,"Second Hospital of University of South China, Hengyang",Recruiting,Not Applicable,Interventional,China,The clinical application and basic research related to mesenchymal stem cells to treat novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),20,http://www.chictr.org.cn/showproj.aspx?proj=49812,None
210,ChiCTR2000030019,ChiCTR,2020-02-20,2020-02-28,False,"Zhongshan Hospital, Fudan University",Not Recruiting,Not Applicable,Observational,China,"The COVID-19 Mobile Health Study (CMHS), a large-scale clinical observational registration study using nCapp",Clinical Presentation,No Intervention,No Intervention,600,http://www.chictr.org.cn/showproj.aspx?proj=49768,None
211,ChiCTR2000030017,ChiCTR,2020-02-20,2020-02-17,True,Renmin Hospital of Wuhan University,Recruiting,Not Applicable,Observational,China,Feature of Multiple Organs in Ultrasound Investigation for Clinical Management and Prognostic Evaluation of Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=49798,None
212,ChiCTR2000030016,ChiCTR,2020-02-19,2020-02-04,True,Guangxi Medical University,Recruiting,Phase 4,Interventional,China,Basic and clinical study of inhalation of inactivated mycobacterium vaccine in the treatment of Novel coronavirus pneumonia (COVID-19),ATMP,Vaccine,Vaccine,60,http://www.chictr.org.cn/showproj.aspx?proj=49799,None
213,ChiCTR2000030015,ChiCTR,2020-02-20,2020-02-19,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Basic Science,China,Study for the correlation between the incidence and outcome of novel coronary pneumonia (COVID-2019) and ovarian function in women,Clinical Presentation,No Intervention,No Intervention,300,http://www.chictr.org.cn/showproj.aspx?proj=49800,None
214,ChiCTR2000030012,ChiCTR,2020-02-19,2020-02-19,False,"The First People's Hospital of Chenzhou, Institute of Translational Medicine,University of South China",Not Recruiting,Not Applicable,Interventional,China,Development of anti-2019-nCoV therapeutic antibody from the recovered novel coronavirus pneumonia patients (COVID-19),ATMP,Antibody,Antibody,20,http://www.chictr.org.cn/showproj.aspx?proj=49718,None
215,ChiCTR2000030010,ChiCTR,2020-02-19,2020-02-19,False,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, parallel-controlled, trial to evaluate the efficacy and safety of anti-SARS-CoV-2 virus inactivated plasma in the treatment of severe novel coronavirus pneumonia patients (COVID-19)",ATMP,Plasma,Plasma,100,http://www.chictr.org.cn/showproj.aspx?proj=49777,None
216,ChiCTR2000030008,ChiCTR,2020-02-19,2020-02-12,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Observational,China,Correalation between anxiety as well as depression and gut microbiome among staff of hospital during the novel coronavirus pneumonia (COVID-19) outbreak,Other (psych),No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=49426,None
217,ChiCTR2000030007,ChiCTR,2020-02-19,2020-02-03,True,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,Multicenter randomized controlled trial for rhG-CSF in the treatment of novel coronavirus pneumonia (COVID-19),Drug,G-CSF,G-CSF,200,http://www.chictr.org.cn/showproj.aspx?proj=49619,None
218,ChiCTR2000030006,ChiCTR,2020-02-19,2020-02-19,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for the efficacy of ozonated autohemotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19),Drug,Ozone,Ozone,60,http://www.chictr.org.cn/showproj.aspx?proj=49737,None
219,ChiCTR2000030004,ChiCTR,2020-02-19,2020-02-20,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Observational,China,Effect of Novel Coronavirus Pneumonia (COVID-19) on the Mental Health of College Students,Other (psych),No Intervention,No Intervention,150000,http://www.chictr.org.cn/showproj.aspx?proj=49783,None
220,ChiCTR2000030003,ChiCTR,2020-02-19,2020-02-19,False,Hospital of Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Optimization Protocal of Integrated Traditional Chinese and Western Medicine in the Treatment for Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,480,http://www.chictr.org.cn/showproj.aspx?proj=49770,None
221,ChiCTR2000030002,ChiCTR,2020-02-19,2020-02-15,True,The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital),Recruiting,Phase 4,Interventional,China,Clinical study of novel NLRP Inflammasome inhibitor (Tranilast) in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Tranilast,Tranilast,60,http://www.chictr.org.cn/showproj.aspx?proj=49738,None
222,ChiCTR2000030001,ChiCTR,2020-02-19,2020-02-15,True,Health commission of Heilongjiang province,Recruiting,Phase 3,Interventional,China,"The efficacy and safety of Triazavirin for 2019 novel coronary pneumonia (COVID-19): a multicenter, randomized, double blinded, placebo-controlled trial",Drug,Triazavirin,Triazavirin,240,http://www.chictr.org.cn/showproj.aspx?proj=49723,None
223,ChiCTR2000030000,ChiCTR,2020-02-19,2020-02-16,True,The Ninth Hospital of Nanchang,Recruiting,Phase 4,Interventional,China,"An open, controlled clinical trial for evaluation of ganovo combined with ritonavir and integrated traditional Chinese and Western medicine in the treatment of novel coronavirus infection (COVID-19)",Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,50,http://www.chictr.org.cn/showproj.aspx?proj=49748,None
224,ChiCTR2000029999,ChiCTR,2020-02-19,2020-02-20,False,Shanghai 10th People's Hospital,Not Recruiting,Not Applicable,Interventional,China,A clinical study for probiotics in the regulation of intestinal function and microflora structure of novel coronavirus pneumonia (COVID-19),Supplement,Probiotics,Probiotics,60,http://www.chictr.org.cn/showproj.aspx?proj=49717,None
225,ChiCTR2000029996,ChiCTR,2020-02-20,2020-02-20,False,"Beijing Chaoyang Hospital, Capital Medical University",Recruiting,Phase 2,Interventional,China,"A randomized, open-label, controlled trial for the efficacy and safety of Farpiravir Tablets in the treatment of patients with novel coronavirus pneumonia (COVID-19)",Drug,Favipiravir,Favipiravir,60,http://www.chictr.org.cn/showproj.aspx?proj=49510,None
226,ChiCTR2000029995,ChiCTR,2020-02-19,2020-02-20,False,Shanghai General Hospital of Shanghai Jiaotong University,Recruiting,Not Applicable,Observational,China,Study on anxiety of different populations under novel coronavirus (COVID-19) infection,Other (psych),No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=49418,None
227,ChiCTR2000029994,ChiCTR,2020-02-18,2020-02-19,False,Shanghai University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Liu-Zi-Jue Qigong and Acupressure Therapy for Pulmonary Function and Quality of Life in Patient with Severe novel coronavirus pneumonia (COVID-19): A Randomized Controlled Trial,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=49309,None
228,ChiCTR2000029992,ChiCTR,2020-02-18,2020-02-17,True,Zhongshan Hospital Affiliated to Xiamen University,Not Recruiting,Phase 4,Interventional,China,"A prospective, randomized, open label, controlled trial for chloroquine and hydroxychloroquine in patients with severe novel coronavirus pneumonia (COVID-19)",Drug,Chloroquine + Hydroxychloroquine,Chloroquine; Hydroxychloroquine,100,http://www.chictr.org.cn/showproj.aspx?proj=49574,None
229,ChiCTR2000029990,ChiCTR,2020-02-18,2020-01-30,True,"Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences",Recruiting,Phase 1/Phase 2,Interventional,China,Clinical trials of mesenchymal stem cells for the treatment of pneumonitis caused by novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),120,http://www.chictr.org.cn/showproj.aspx?proj=49674,None
230,ChiCTR2000029989,ChiCTR,2020-02-18,2020-02-20,False,Chinese PLA General Hospital,Not Recruiting,Phase 4,Interventional,China,A randomized controlled Trial for therapeutic efficacy of Recombinant Human Interferon alpha 1b Eye Drops in the treatment of elderly with novel coronavirus pneumonia (COVID-19),Drug,Interferon alfa,Interferon alfa,300,http://www.chictr.org.cn/showproj.aspx?proj=49720,None
231,ChiCTR2000029988,ChiCTR,2020-02-18,2020-02-13,True,Zhongnan Hospital of Wuhan University,Recruiting,Phase 4,Interventional,China,Clinical Study of Chloroquine Phosphate in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19),Drug,Chloroquine,Chloroquine,80,http://www.chictr.org.cn/showproj.aspx?proj=49218,None
232,ChiCTR2000029985,ChiCTR,2020-02-18,2020-02-10,True,Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital,Recruiting,Not Applicable,Observational,China,Study for mental health status and influencing factors of nurses during epidemic prevention of novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,No Intervention,1853,http://www.chictr.org.cn/showproj.aspx?proj=49711,None
233,ChiCTR2000029981,ChiCTR,2020-02-18,2020-02-18,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Diagnostic test,China,Study for nucleic acid detection of novel coronavirus pneumonia (COVID-2019) in female vaginal secretions,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,60,http://www.chictr.org.cn/showproj.aspx?proj=49692,None
234,ChiCTR2000029978,ChiCTR,2020-02-18,2020-02-21,False,Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine,Not Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for the efficacy of Dao-Yin in the prevention and controlling novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,186,http://www.chictr.org.cn/showproj.aspx?proj=49702,None
235,ChiCTR2000029974,ChiCTR,2020-02-18,2020-02-09,True,"Qingdao East Sea Pharmaceutical Co., Ltd.",Recruiting,Not Applicable,Interventional,China,"A prospective, multicenter, open-label, randomized, parallel-controlled trial for probiotics to evaluate efficacy and safety in patients infected with 2019 novel coronavirus pneumonia (COVID-19)",Supplement,Probiotics,Probiotics,300,http://www.chictr.org.cn/showproj.aspx?proj=49321,None
236,ChiCTR2000029972,ChiCTR,2020-02-17,2020-02-17,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for the Efficacy of Ultra Short Wave Electrotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19),Other (physical),Ultra short wave electrotherapy,Ultra short wave electrotherapy,40,http://www.chictr.org.cn/showproj.aspx?proj=49664,None
237,ChiCTR2000029960,ChiCTR,2020-02-17,2020-02-28,False,The First Affiliated Hospital of Hu'nan University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Comparative study for integrate Chinese and conventional medicine the the treatment of novel coronavirus pneumonia (COVID-19) in Hu'nan province,Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=49639,None
238,ChiCTR2000029959,ChiCTR,2020-02-17,2020-01-25,True,"West China Second Hospital, Sichuan University",Recruiting,Not Applicable,Observational,China,Clinical observation and research of  Severe acute respiratory syndrome coronavirus 2(COVID-19) infection in perinatal newborns,Clinical Presentation,No Intervention,No Intervention,30,http://www.chictr.org.cn/showproj.aspx?proj=49636,None
239,ChiCTR2000029956,ChiCTR,2020-02-17,2020-02-18,False,Hospital of Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Chinese Medicine Promotes Rehabilitation Recommendations after 2019 Novel Coronavirus Infection (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=49618,None
240,ChiCTR2000029954,ChiCTR,2020-02-17,2020-04-30,False,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Phase 4,Interventional,China,"Efficacy and safety of honeysuckle oral liquid in the treatment of novel coronavirus pneumonia (COVID-19): a multicenter, randomized, controlled, open clinical trial",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=49402,None
241,ChiCTR2000029866,ChiCTR,2020-02-15,2020-02-17,False,Enze Hospital of Taizhou Enze Medical Center (Group),Recruiting,Not Applicable,Diagnostic test,China,Early warning prediction of patients with severe novel coronavirus pneumonia (COVID-19) based on multiomics,Genomics,No Intervention,No Intervention,120,http://www.chictr.org.cn/showproj.aspx?proj=49519,None
242,ChiCTR2000029851,ChiCTR,2020-02-15,2020-02-19,False,"Zhongshan Hospital, Fudan University",Recruiting,Phase 4,Interventional,China,"A multicenter, randomized controlled trial for the efficacy and safety of Alpha lipoic acid (iv) in the treatment of patients of severe novel coronavirus pneumonia (COVID-19)",Supplement,Alpha lipoic acid,Alpha lipoic acid,68,http://www.chictr.org.cn/showproj.aspx?proj=49534,None
243,ChiCTR2000029803,ChiCTR,2020-02-14,2020-02-20,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"A prospective, randomized, open-label, controlled clinical study to evaluate the preventive effect of hydroxychloroquine on close contacts after exposure to the Novel Coronavirus Pneumonia (COVID-19)",Drug,Hydroxychloroquine vs. Umeprevir,Hydroxychloroquine; Umeprevir,320,http://www.chictr.org.cn/showproj.aspx?proj=49428,None
244,ChiCTR2000029781,ChiCTR,2020-02-13,2020-02-14,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open and controlled trial for the efficacy and safety of Kang-Bing-Du granules in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,160,http://www.chictr.org.cn/showproj.aspx?proj=49138,None
245,ChiCTR2000029780,ChiCTR,2020-02-13,2020-02-14,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open, controlled trial for the efficacy and safety of Shen-Qi Fu-Zheng injection in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,160,http://www.chictr.org.cn/showproj.aspx?proj=49220,None
246,ChiCTR2000029740,ChiCTR,2020-02-11,2020-02-11,False,The First Hospital of Peking University,Recruiting,Phase 4,Interventional,China,Efficacy of therapeutic effects of hydroxycholoroquine in novel coronavirus pneumonia (COVID-19) patients(randomized open-label control clinical trial),Drug,Hydroxychloroquine,Hydroxychloroquine,78,http://www.chictr.org.cn/showproj.aspx?proj=49317,None
247,ChiCTR2000030442,ChiCTR,2020-03-02,2020-03-05,False,The Second Affiliated Hospital of Xi'an Jiaotong University,Not Recruiting,Not Applicable,Interventional,No Country Given,"Combination of Tocilizumab, IVIG and CRRT in severe patients with novel coronavirus pneumonia (COVID-19)",Drug (+ ATMP + Other (renal)),Tocilizumab + immunoglobulin + renal replacement therapy,Tocilizumab; Immunoglobulin; Renal replacement therapy,100,http://www.chictr.org.cn/showproj.aspx?proj=50380,None
248,ChiCTR2000030433,ChiCTR,2020-03-01,2020-03-01,False,The First Affiliated Hospital of Fujian Medical University,Not Recruiting,Phase 1,Interventional,China,Application of Rehabilitation and Lung Eight-segment Exercise in Home Rehabilitation of Survivors from novel coronavirus pneumonia (COVID-19),Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,80,http://www.chictr.org.cn/showproj.aspx?proj=50273,None
249,ChiCTR2000030432,ChiCTR,2020-03-01,2020-03-02,False,The First Affiliated Hospital of Fujian Medical University,Not Recruiting,Not Applicable,Interventional,China,Application of rehabilitation and Lung eight-segment exercise in front-line nurses in the prevention of novel coronavirus pneumonia (COVID-19) epidemic,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,80,http://www.chictr.org.cn/showproj.aspx?proj=50268,None
250,ChiCTR2000030424,ChiCTR,2020-03-01,2020-03-02,False,Henan Provincial People's Hospital,Not Recruiting,Not Applicable,Interventional,China,"A single-center, single-arm clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,Azvudine,30,http://www.chictr.org.cn/showproj.aspx?proj=50174,None
251,ChiCTR2000030420,ChiCTR,2020-03-01,2020-03-01,False,"Institute of Integrative Medicine of Dalian Medical University, Dalian, China",Not Recruiting,Not Applicable,Interventional,China,A Clinical Trial Study for the Influence of TCM Psychotherapy on Negative Emotion of Patients with Novel Coronavirus Pneumonia (COVID-19) Based on Network Platform,Other (psych),Psychological,Psychological,60,http://www.chictr.org.cn/showproj.aspx?proj=50286,None
252,ChiCTR2000030418,ChiCTR,2020-03-01,2020-03-01,False,The First Affiliated Hospital of Fujian Medical University,Recruiting,Not Applicable,Interventional,China,Application of rehabilitation lung exercise eight-segment exercise in patients with novel coronavirus pneumonia (COVID-19),Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,80,http://www.chictr.org.cn/showproj.aspx?proj=50341,None
253,ChiCTR2000030398,ChiCTR,2020-03-01,2020-02-27,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, placebo-controlled trial for evaluation of  the efficacy and safety of bismuth potassium citrate capsules in the treatment of patients with novel coronavirus pneumonia (COVID-19).",Drug,Bismuth potassium citrate,Bismuth potassium citrate,340,http://www.chictr.org.cn/showproj.aspx?proj=50173,None
254,ChiCTR2000030391,ChiCTR,2020-03-01,2020-03-01,False,Lishui Central Hospital,Not Recruiting,Not Applicable,Observational,China,A medical records based analysis for antiviral therapy effect on novel coronavirus pneumonia COVID-19 patients,Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=30796,None
255,ChiCTR2000030390,ChiCTR,2020-03-01,2020-01-01,True,Key Laboratory of Ministry of Industry and Information Technology of Biomedical Engineering and Translational Medicine,Recruiting,Not Applicable,Diagnostic test,China,Research and Development of Diagnostic Assistance Decision Support System for novel coronavirus pneumonia (COVID-19) Based on Big Data Technology,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,3000,http://www.chictr.org.cn/showproj.aspx?proj=50224,None
256,ChiCTR2000030389,ChiCTR,2020-03-01,2020-02-29,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,A Comparative Study for the Effectiveness of ''triple energizer treatment'' Method in Repairing Lung Injury in Patients with Novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=50278,None
257,ChiCTR2000030387,ChiCTR,2020-03-01,2020-03-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Clinical observation and research of multiple organs injury in severe patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,130,http://www.chictr.org.cn/showproj.aspx?proj=50329,None
258,ChiCTR2000030386,ChiCTR,2020-02-18,2020-03-01,False,Hunan University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Study for moxibustion in the preventing of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,1000,http://www.chictr.org.cn/showproj.aspx?proj=50323,None
259,ChiCTR2000030382,ChiCTR,2020-02-17,2020-03-01,False,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Construction and application of non-contact doctor-patient interactive diagnosis and treatment mode of moxibustion therapy for novel coronary pneumonia (COVID-19) based on mobile internet,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,50,http://www.chictr.org.cn/showproj.aspx?proj=50325,None
260,ChiCTR2000030363,ChiCTR,2020-02-29,2020-02-23,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,"Novel Coronavirus Infected Disease (COVID-19) in children: epidemiology, clinical features and treatment outcome",Clinical Presentation (Epidemiology),No Intervention,No Intervention,120,http://www.chictr.org.cn/showproj.aspx?proj=49984,None
261,ChiCTR2000030334,ChiCTR,2020-02-28,2020-02-19,True,Nanjing Second Hospital,Recruiting,Not Applicable,Diagnostic test,China,microRNA as a marker for early diagnosis of novel coronavirus infection (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,25,http://www.chictr.org.cn/showproj.aspx?proj=49491,None
262,ChiCTR2000030327,ChiCTR,2020-02-28,2020-01-21,True,The Second Affiliated hospital of Anhui Medical University,Recruiting,Not Applicable,Observational,China,Analysis of clinical characteristics of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=50214,None
263,ChiCTR2000030325,ChiCTR,2020-02-28,2020-02-28,False,"Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences",Not Recruiting,Not Applicable,Observational,China,A survey of mental health of first-line medical service providers and construction of crisis intervention model for novel coronavirus pneumonia (COVID-19) in Xiangyang,Other (psych),No Intervention,No Intervention,500,http://www.chictr.org.cn/showproj.aspx?proj=50227,None
264,ChiCTR2000030324,ChiCTR,2020-02-28,2020-02-28,False,"Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences",Not Recruiting,Not Applicable,Interventional,China,Traditional Chinese Medicine 'Zang-Fu Point-pressing' massage for children with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,40,http://www.chictr.org.cn/showproj.aspx?proj=50231,None
265,ChiCTR2000030322,ChiCTR,2020-02-28,2020-02-01,True,Xinyang Central Hospital,Recruiting,Not Applicable,Observational,China,Identification and Clinical Treatment of Severe novel coronavirus pneumonia (COVID-19) Patients,Clinical Presentation,No Intervention,No Intervention,210,http://www.chictr.org.cn/showproj.aspx?proj=50240,None
266,ChiCTR2000030317,ChiCTR,2020-02-28,2020-03-01,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,Clinical study for a new type of Gastroscope isolation mask for preventing and controlling the novel coronavirus pneumonia (COVID-19) Epidemic period,Other (physical),Gastroscope mask,Gastroscope mask,300,http://www.chictr.org.cn/showproj.aspx?proj=50247,None
267,ChiCTR2000030315,ChiCTR,2020-02-28,2020-01-01,True,Affiliated Hospital of Changchun University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Clinical Study for Traditional Chinese Medicine in the Prevention and Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=50255,None
268,ChiCTR2000030314,ChiCTR,2020-02-28,2020-02-28,False,"Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Sciences",Not Recruiting,Not Applicable,Interventional,No Country Given,Traditional Chinese medicine Ma-Xing-Shi-Gan-Tang and Sheng-Jiang-San in the treatment of children with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://www.chictr.org.cn/showproj.aspx?proj=50248,None
269,ChiCTR2000030305,ChiCTR,2020-02-28,2020-03-09,False,Li Caixia,Not Recruiting,Not Applicable,Observational,China,Multiomics study and emergency plan optimization of spleen strengthening clearing damp and stomach therapy combined with antiviral therapy for novel coronavirus pneumonia (COVID-19),Genomics,No Intervention,No Intervention,20,http://www.chictr.org.cn/showproj.aspx?proj=50223,None
270,ChiCTR2000030293,ChiCTR,2020-02-27,2020-03-01,False,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Observational,China,Clinical observation and research plan of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,No Intervention,300,http://www.chictr.org.cn/showproj.aspx?proj=50195,None
271,ChiCTR2000030290,ChiCTR,2020-02-27,2020-02-11,True,Xiamen University,Not Recruiting,Not Applicable,Observational,China,Health related quality of life and its influencing factors among front line nurses caring patients with new coronavirus pneumonia (COVID-19) from two hospitals in China,Other (psych),No Intervention,No Intervention,2000,http://www.chictr.org.cn/showproj.aspx?proj=50175,None
272,ChiCTR2000030283,ChiCTR,2020-02-27,2020-02-27,False,Xianning Central Hospital,Recruiting,Not Applicable,Observational,China,Correlation between imaging characteristics and laboratory tests of new coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=50119,None
273,ChiCTR2000030265,ChiCTR,2020-02-26,2020-02-24,True,The First Affiliated Hospital of Harbin Medical University,Not Recruiting,Not Applicable,Interventional,China,Study for continuous renal replacement therapy with adsorption filter in the treatment of the novel coronavirus pneumonia (COVID-19),Other (renal),Renal replacement therapy,Renal replacement therapy,30,http://www.chictr.org.cn/showproj.aspx?proj=49691,None
274,ChiCTR2000030264,ChiCTR,2020-02-26,2020-02-28,False,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,ICU healthcare personnel burnout investigation during the fight against novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,No Intervention,1000,http://www.chictr.org.cn/showproj.aspx?proj=50161,None
275,ChiCTR2000030263,ChiCTR,2020-02-26,2020-02-20,True,Beijing Geriatric Hospital,Not Recruiting,Not Applicable,Epidemiological research,China,Investigation and analysis of psychological status of hospital staff during the novel coronavirus pneumonia (COVID-19) epidemic,Other (psych),No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=50140,None
276,ChiCTR2000030261,ChiCTR,2020-02-26,2020-03-01,False,Wuxi Fifth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,A study for the key technology of mesenchymal stem cells exosomes atomization in the treatment of novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),26,http://www.chictr.org.cn/showproj.aspx?proj=49963,None
277,ChiCTR2000030260,ChiCTR,2020-02-26,2020-02-27,False,"Ganzi Hospital of West China Hospital, Sichuan University",Not Recruiting,Not Applicable,Interventional,China,Clinical study for individualized nutritional assessment and supportive treatment of novel coronavirus pneumonia (COVID-19) patients in Tibetan Plateau,Other (nutrition),Nutrition,Nutrition,20,http://www.chictr.org.cn/showproj.aspx?proj=50130,None
278,ChiCTR2000030258,ChiCTR,2020-02-26,2020-02-21,True,The Fourth Affiliated Hospital of Harbin Medical University,Not Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, controlled trial for efficacy and safety of hydrogen inhalation in the treatment of novel coronavirus pneumonia (COVID-19) patients",Drug,Hydrogen,Hydrogen,60,http://www.chictr.org.cn/showproj.aspx?proj=49887,None
279,ChiCTR2000030257,ChiCTR,2020-02-26,2020-03-09,False,Puren Hospital of Wuhan City,Not Recruiting,Not Applicable,Observational,China,The coagulation function of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=50006,None
280,ChiCTR2000030255,ChiCTR,2020-02-26,2020-03-01,False,Shanghai University of Traditional Chinese Medicine,Not Recruiting,Phase 4,Interventional,China,Efficacy and Safety of Jing-Yin Granule in the treatment of novel coronavirus pneumonia (COVID-19) wind-heat syndrome,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=50089,None
281,ChiCTR2000030253,ChiCTR,2020-02-26,2020-02-27,False,"Ganzi Hospital of West China Hospital, Sichuan University",Not Recruiting,Phase 1,Diagnostic test,China,Exploration and Research for a new method for detection of novel coronavirus (COVID-19) nucleic acid,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,30,http://www.chictr.org.cn/showproj.aspx?proj=50143,None
282,ChiCTR2000030226,ChiCTR,2020-02-26,2020-02-01,True,The Fourth Hospital of Hebei Medical University,Recruiting,Not Applicable,Observational,China,"The treatment status and risk factors related to prognosis of hospitalized patients with novel coronavirus pneumonia (COVID-19) in intensive care unit, Hebei, China: a descriptive study",Prognosis,No Intervention,No Intervention,40,http://www.chictr.org.cn/showproj.aspx?proj=49855,None
283,ChiCTR2000030225,ChiCTR,2020-02-26,2020-02-22,True,Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine,Not Recruiting,Not Applicable,Interventional,China,Clinical Reseach of Acupuncture in the treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,186,http://www.chictr.org.cn/showproj.aspx?proj=49945,None
284,ChiCTR2000030223,ChiCTR,2020-02-26,2020-02-20,True,No Sponsor Name Given,Recruiting,Not Applicable,Health services research,China,Quality of life among Chinese residents during and after novel coronavirus pneumonia (COVID19) outbreak: an online survey,Other (psych),No Intervention,No Intervention,5000,http://www.chictr.org.cn/showproj.aspx?proj=50026,None
285,ChiCTR2000030222,ChiCTR,2020-02-25,2020-02-21,True,The Thirteenth People's Hospital of Chongqing,Not Recruiting,Not Applicable,Observational,China,Cancelled due to lack of participants                                        Study for the Impact of Novel Coronavirus Pneumonia (COVID-19) to the Health of the elderly People,Not relevant,Not relevant,Not relevant,658,http://www.chictr.org.cn/showproj.aspx?proj=50048,None
286,ChiCTR2000030219,ChiCTR,2020-02-25,2020-01-21,True,The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Study for evaluation of integrated traditional Chinese and Western Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=50110,None
287,ChiCTR2000030218,ChiCTR,2020-02-25,2020-01-22,True,The Fifth People's Hospital of Ganzhou,Recruiting,Not Applicable,Interventional,China,Study of Pinavir / Ritonavir Tablets (Trade Name: Kelizhi) Combined with Xiyanping Injection for Novel Coronavirus Pneumonia (COVID-19),Drug,Lopinavir/ritonavir (+ Tradtional Medicine),Lopinavir; Ritonavir; Traditional Medicine,80,http://www.chictr.org.cn/showproj.aspx?proj=50115,None
288,ChiCTR2000030215,ChiCTR,2020-02-25,2020-02-26,False,"The First Affiliated Hospital of Nanchang University, Ten layers pulse Research Institute of traditional Chinese medicine, Nanchang University",Not Recruiting,Not Applicable,Interventional,China,Study for the efficacy of Kangguan No. 1-3 prescription in the treatment of novel coronavirus pneumonia (COVID19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=50107,None
289,ChiCTR2000030196,ChiCTR,2020-02-25,2020-02-20,True,Central South Hospital of Wuhan University,Not Recruiting,Phase 2,Interventional,China,"A multicenter, single arm, open label trial for the efficacy and safety of CMAB806 in the treatment of cytokine release syndrome of novel coronavirus pneumonia (COVID-19)",Drug,Tocilizumab,Tocilizumab,60,http://www.chictr.org.cn/showproj.aspx?proj=49883,None
290,ChiCTR2000030162,ChiCTR,2020-02-24,2020-03-01,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Interventional,No Country Given,Cancelled by the investigator                     Study for the water extract of soybean in the treatment of patients with novel coronavirus pneumonia (COVID-19),Not relevant,Not relevant,Not relevant,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=49570,None
291,ChiCTR2000030091,ChiCTR,2020-02-23,2020-02-22,True,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,A prospective randomized controlled trial for the home exercise prescription intervention in nursing students during epidemic of novel coronary pneumonia (COVID-19),Other (exercise),Exercise,Exercise,200,http://www.chictr.org.cn/showproj.aspx?proj=49914,None
292,ChiCTR2000030042,ChiCTR,2020-02-21,2020-02-21,False,Chongqing Liangjiang New Area First People's Hospital,Recruiting,Not Applicable,Observational,China,Cancelled due to lack of patient                                                                A Medical Records Based Study for Construction and Analysis of Diagnosis Predictive&,Not relevant,Not relevant,Not relevant,240,http://www.chictr.org.cn/showproj.aspx?proj=49899,None
293,ChiCTR2000030022,ChiCTR,2020-02-20,2020-02-22,False,The First Affiliated Hospital of Anhui Medical University,Not Recruiting,Phase 4,Interventional,China,"A parallel, randomized controlled clinical trial for the efficacy and safety of Pediatric Huatanzhike granules (containing ipecacuanha tincture) in the treatment of mild and moderate novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=49797,None
294,ChiCTR2000030013,ChiCTR,2020-02-19,2020-02-20,False,Chinese PLA General Hospital,Not Recruiting,Phase 4,Interventional,China,A prospective clinical study for recombinant human interferon alpha 1b spray in the prevention of novel coronavirus (COVID-19) infection in highly exposed medical staffs.,Drug,Interferon alfa,Interferon alfa,450,http://www.chictr.org.cn/showproj.aspx?proj=49796,None
295,ChiCTR2000029991,ChiCTR,2020-02-18,2020-02-18,False,The First Affiliated Hospital of Nanchang University,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, controlled trial for the safety and efficiency of Kesuting syrup and Keqing capsule in the treatment of mild and moderate novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,72,http://www.chictr.org.cn/showproj.aspx?proj=49666,None
296,ChiCTR2000029975,ChiCTR,2020-02-18,2020-02-24,False,The First Hospital of Jilin University,Not Recruiting,Phase 4,Interventional,China,Single arm study for exploration of chloroquine phosphate aerosol inhalation in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Chloroquine,Chloroquine,10,http://www.chictr.org.cn/showproj.aspx?proj=49592,None
297,ChiCTR2000029952,ChiCTR,2020-02-17,2020-02-17,False,Chongqing Three Gorges Central Hospital,Not Recruiting,Not Applicable,Observational,China,Cancelled due to lack of patient                         Medical records based study for epidemiological and clinical characteristics of 2019 novel coronavirus pneumonia (COVID-19) in Chongqing,Not relevant,Not relevant,Not relevant,0,http://www.chictr.org.cn/showproj.aspx?proj=49630,None
298,ChiCTR2000029900,ChiCTR,2020-02-16,2020-02-17,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,Research for Risks Associated with Novel Coronavirus Pneumonia (COVID-19) in the Hospital Workers and Nosocomial  Prevention and Control Strategy,Clinical Presentation,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=49377,None
299,ChiCTR2000029899,ChiCTR,2020-02-16,2020-02-17,False,Peking University Third Hospital,Recruiting,Phase 4,Interventional,China,"Evaluation the Efficacy and Safety of Hydroxychloroquine Sulfate in Comparison with Phosphate Chloroquine in Mild and Commen Patients with Novel Coronavirus Pneumonia (COVID-19): a Randomized, Open-label, Parallel, Controlled Trial",Drug,Hydroxychloroquine vs. Chloroquine,Chloroquine; Hydroxychloroquine,100,http://www.chictr.org.cn/showproj.aspx?proj=49536,None
300,ChiCTR2000029898,ChiCTR,2020-02-16,2020-02-17,False,Peking University Third Hospital,Recruiting,Phase 4,Interventional,China,"Evaluation the Efficacy and Safety of Hydroxychloroquine Sulfate in Comparison with Phosphate Chloroquine in Severe Patients with Novel Coronavirus Pneumonia (COVID-19): a Randomized, Open-Label, Parallel, Controlled Trial",Drug,Hydroxychloroquine vs. Chloroquine,Chloroquine; Hydroxychloroquine,100,http://www.chictr.org.cn/showproj.aspx?proj=49482,None
301,ChiCTR2000029829,ChiCTR,2020-02-15,2020-02-15,False,Chongqing Three Gorges Central Hospital,Not Recruiting,Not Applicable,Observational,China,Cancelled due to lack of patient                                 Medical records based study for Heart-type fatty acid-binding protein on prognosis of novel coronavirus pneumonia (COVID-19),Not relevant,Not relevant,Not relevant,40,http://www.chictr.org.cn/showproj.aspx?proj=49520,None
302,ChiCTR2000029762,ChiCTR,2020-02-12,2020-02-12,False,The First Affiliated Hospital of Chongqing Medical University,Not Recruiting,Phase 4,Interventional,China,Cancelled due to lack of patient                                                                              Clinical study for the effect and,Not relevant,Not relevant,Not relevant,60,http://www.chictr.org.cn/showproj.aspx?proj=49404,None
303,ChiCTR2000029761,ChiCTR,2020-02-12,2020-02-13,False,The First Affiliated Hospital of Chongqing Medical University,Recruiting,Phase 4,Interventional,China,Cancelled due to lack of patient                Clinical study on the safety and effectiveness of Hydroxychloroquine Sulfate tablets in the treatment of patients with novel coronavirus pneumonia (COVID-19),Not relevant,Not relevant,Not relevant,240,http://www.chictr.org.cn/showproj.aspx?proj=49400,None
304,ChiCTR2000029760,ChiCTR,2020-02-12,2020-02-12,False,The Second Affiliated Hospital of Chongqing Medical University,Not Recruiting,Phase 4,Interventional,China,Cancelled due to lack of patient                              A study for the efficacy of hydroxychloroquine for mild and moderate COVID-19 infectious diseases,Not relevant,Not relevant,Not relevant,240,http://www.chictr.org.cn/showproj.aspx?proj=49369,None
305,ChiCTR2000029759,ChiCTR,2020-02-12,2020-02-15,False,The Second Affiliated Hospital of Chongqing Medical University,Not Recruiting,Not Applicable,Interventional,China,"Retracted due to lack of patient                               A multicenter, randomized, open label, controlled trial for the efficacy and safety of ASC09/ Ritonavir compound tablets and Lopinavir/ Ritonavir (Kaletra) and Arbidol tablets in the treatm",Not relevant,Not relevant,Not relevant,60,http://www.chictr.org.cn/showproj.aspx?proj=49352,None
306,ChiCTR2000029755,ChiCTR,2020-02-12,2020-02-15,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A randomized, open, parallel-controlled clinical trial on the efficacy and safety of Jingyebaidu granules in treating novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=49301,None
307,ChiCTR2000029728,ChiCTR,2020-02-10,2020-02-15,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A Retrospective Study for Preventive Medication in Tongji Hospital During the Epidemic of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,500,http://www.chictr.org.cn/showproj.aspx?proj=49250,None
308,ChiCTR2000029387,ChiCTR,2020-01-29,2020-01-25,True,Chongqing Public Health Medical Center,Recruiting,Not Applicable,Interventional,China,"Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha and ribavirin plus lopinavir/ritonavir plus interferon-alphain in patients with mild to moderate novel coronavirus pneumonia",Drug,"Ribavirin + Interferon alfa
vs. lopinavir/ritonavir + interferon alfa
vs. ribavirin + interferon alfa vs. lopinavir/ritonavir",Ribavirin; Interferon alpha; Lopinavir; Ritonavir,108,http://www.chictr.org.cn/showproj.aspx?proj=48782,None
309,ChiCTR2000029386,ChiCTR,2020-01-29,2020-01-29,False,Chongqing Public Health Medical Center,Recruiting,Not Applicable,Interventional,China,Effectiveness of glucocorticoid therapy in patients with severe novel coronavirus pneumonia: a randomized controlled trial,Drug,Corticosteroids,Methylprednisolone,48,http://www.chictr.org.cn/showproj.aspx?proj=48777,None
310,ACTRN12618000468224,ANZCTR,2018-03-29,2017-08-29,True,Monash University Malaysia,Not Recruiting,Not Applicable,Observational,Malaysia,Assessing patient-ventilator interaction for patients with respiratory failure,Not relevant,Not relevant,Not relevant,60,https://anzctr.org.au/ACTRN12618000468224.aspx,None
311,ChiCTR2000030627,ChiCTR,2020-03-08,2020-02-01,True,The First Affiliated Hospital of Zhengzhou University,Recruiting,Not Applicable,Interventional,China,Study for using the healed novel coronavirus pneumonia (COVID-19) patients plasma in the treatment of severe critical cases,ATMP,Plasma,Plasma,30,http://www.chictr.org.cn/showproj.aspx?proj=50727,None
312,ChiCTR2000030593,ChiCTR,2020-03-08,2020-03-10,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Not Recruiting,Not Applicable,Observational,China,"Novel coronavirus pneumonia (COVID-19) antiviral related liver dysfunction: a multicenter, retrospective, observational study",Clinical Presentation,No Intervention,No Intervention,150,http://www.chictr.org.cn/showproj.aspx?proj=50228,None
313,ChiCTR2000030581,ChiCTR,2020-03-08,2020-02-02,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,The immediate psychological impact of novel coronavirus pneumonia (COVID-19) outbreak on medical students in anesthesiology and how the cope,Other (psych),No Intervention,No Intervention,192,http://www.chictr.org.cn/showproj.aspx?proj=50394,None
314,ChiCTR2000030579,ChiCTR,2020-03-08,2020-02-15,True,Shandong Provincial Hospital,Not Recruiting,Not Applicable,Observational,China,Risk Factors for Outcomes of Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=50692,None
315,ChiCTR2000030578,ChiCTR,2020-03-08,2020-03-07,True,Shandong Provincial Hospital,Not Recruiting,Not Applicable,Interventional,China,Clinical Prediction and Intervention of Pulmonary Function Impairment in Patients with Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,40,http://www.chictr.org.cn/showproj.aspx?proj=50690,None
316,ChiCTR2000030574,ChiCTR,2020-03-07,2020-03-08,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Research on peripheral immunity function monitoring and its clinical application in patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,500,http://www.chictr.org.cn/showproj.aspx?proj=49953,None
317,ChiCTR2000030564,ChiCTR,2020-03-07,2020-03-15,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Psychological Intervention of Children with Novel Coronavirus Disease (COVID-19),Other (psych),Psychological,Psychological,120,http://www.chictr.org.cn/showproj.aspx?proj=50653,None
318,ChiCTR2000030559,ChiCTR,2020-03-07,2020-03-07,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Observational,China,A medical records based study for the safety of artificial liver cluster nursing in critically ill patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,12,http://www.chictr.org.cn/showproj.aspx?proj=50583,None
319,ChiCTR2000030557,ChiCTR,2020-03-07,2020-03-10,False,The Third Affiliated Hospital of the Second Military Medical University,Recruiting,Not Applicable,Observational,China,"A retrospective study on virus typing, Hematological Immunology and case Review of novel coronavirus infected and convalescent patients (COVID-19)",Clinical Presentation,No Intervention,No Intervention,1030,http://www.chictr.org.cn/showproj.aspx?proj=50667,None
320,ChiCTR2000030556,ChiCTR,2020-03-07,2020-03-15,False,Anhui Cancer Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,Clinical study of nano-nose and its extended technology in diagnosis of novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,http://www.chictr.org.cn/showproj.aspx?proj=50672,None
321,ChiCTR2000030552,ChiCTR,2020-03-07,2020-03-08,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Critical ultrasound in evaluating cardiopulmonary function in critical patients infected with 2019 novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,70,http://www.chictr.org.cn/showproj.aspx?proj=49708,None
322,ChiCTR2000030544,ChiCTR,2020-03-06,2020-02-24,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Study for the risk factors of critically ill patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,1500,http://www.chictr.org.cn/showproj.aspx?proj=50134,None
323,ChiCTR2000030543,ChiCTR,2020-03-06,2020-02-14,True,Central Theater General Hospital of PLA,Recruiting,Not Applicable,Observational,China,Detection of coronavirus in simultaneously collecting tears and throat swab samples collected from the patients with novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,35,http://www.chictr.org.cn/showproj.aspx?proj=50541,None
324,ChiCTR2000030542,ChiCTR,2020-03-06,2020-03-09,False,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,"A clinical study about the diagnosis and prognosis evaluation of novel coronacirus pneumonia (COVID-19) based on viral genome, host genomic sequencing, relative cytokines and other laboratory indexes.",Genomics,No Intervention,No Intervention,600,http://www.chictr.org.cn/showproj.aspx?proj=50608,None
325,ChiCTR2000030541,ChiCTR,2020-03-06,2020-03-06,False,"Xiamen Medical College,Shijiazhuang Medical College",Not Recruiting,Not Applicable,Observational,China,Novel coronavirus pneumonia (COVID-19) epidemic survey of medical students in various provinces and municipalities throughout the country,Clinical Presentation,No Intervention,No Intervention,1300,http://www.chictr.org.cn/showproj.aspx?proj=50623,None
326,ChiCTR2000030540,ChiCTR,2020-03-06,2020-03-08,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Interventional,China,Research for the mechanism of improvement of novel coronavirus pneumonia (COVID-19) patients' pulmonary exudation by continuous renal replacement therapy,Other (renal),Renal replacement therapy,Renal replacement therapy,152,http://www.chictr.org.cn/showproj.aspx?proj=50658,None
327,ChiCTR2000030535,ChiCTR,2020-03-06,2020-02-20,True,Wuhan Red Cross Hospital,Recruiting,Phase 4,Interventional,China,Multi-Center Clinical Study on the Treatment of Patients with Novel Coronavirus Pneumonia (COVID-19) by Ebastine,Drug,Ebastine + Interferon alpha + Lopinavir vs. Interferon alpha + Lopinavir,Ebastine; interferon alpha; lopinavir,100,http://www.chictr.org.cn/showproj.aspx?proj=49790,None
328,ChiCTR2000030518,ChiCTR,2020-03-05,2020-02-29,True,The Second Affiliated Hospital of Wenzhou Medical University,Recruiting,Not Applicable,Interventional,China,"Zedoary Turmeric Oil for Injection in the treatment of Novel Coronavirus Pneumonia (COVID-19): a randomized, open, controlled trial",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=50586,None
329,ChiCTR2000030503,ChiCTR,2020-03-05,2020-01-20,True,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Interventional,China,Extracorporeal blood purification therapy using Li's Artifical Liver System for patients with severe novel coronavirus pneumonia (COVID19) patient,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=49632,None
330,ChiCTR2000030493,ChiCTR,2020-03-04,2020-03-04,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,"Survey for sleep, anxiety and depression status of Chinese residents during the outbreak of novel coronavirus infected disases (COVID-19)",Other (psych),No Intervention,No Intervention,1300,http://www.chictr.org.cn/showproj.aspx?proj=50547,None
331,ChiCTR2000030492,ChiCTR,2020-03-04,2020-03-04,False,The First Affiliated Hospital of Hu'nan University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,Retrospective study for integrate Chinese and conventional medicine  treatment of novel coronavirus pneumonia (COVID-19) in Hu'nan province,Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=50549,None
332,ChiCTR2000030491,ChiCTR,2020-03-04,2020-03-03,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,A medical records based study for Comparing Differences of Clinical Features and Outcomes of Novel Coronavirus Pneumonia (COVID-19) Patients between Sichuan Province and Wuhan City,Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=50552,None
333,ChiCTR2000030490,ChiCTR,2020-03-04,2020-02-01,True,Huo-Shen-Shan Hospital,Recruiting,Not Applicable,Interventional,No Country Given,To evaluate the efficacy and safety of diammonium glycyrrhizinate enteric-coated capsules combined with hydrogen-rich water in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Diammonium glycyrrhizinate + Hydrogen,Diammonium glycyrrhizinate; Hydrogen,100,http://www.chictr.org.cn/showproj.aspx?proj=50487,None
334,ChiCTR2000030489,ChiCTR,2020-03-04,2020-02-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Epidemiological research,China,Study for the route of ocular surface transmission of novel coronavirus pneumonia (COVID-19) infection and related eye diseases,Clinical Presentation,No Intervention,No Intervention,1000,http://www.chictr.org.cn/showproj.aspx?proj=50490,None
335,ChiCTR2000030487,ChiCTR,2020-03-04,2020-03-04,False,The First Affiliated Hospital of He'nan University of Chinese Medicine,Recruiting,Not Applicable,Interventional,China,"A single-center, single-arm clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,Azvudine,10,http://www.chictr.org.cn/showproj.aspx?proj=50507,None
336,ChiCTR2000030485,ChiCTR,2020-03-03,2020-03-03,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Study for timing of mechanical ventilation for critically ill patients with novel coronavirus pneumonia (COVID-19): A medical records based retrospective Cohort study,Other (physical),Mechanical ventilation,Mechanical ventilation,90,http://www.chictr.org.cn/showproj.aspx?proj=50459,None
337,ChiCTR2000030484,ChiCTR,2020-03-03,2020-02-02,True,Hubei Shiyan Taihe hospital,Not Recruiting,Not Applicable,Interventional,China,HUMSCs and Exosomes Treating Patients with Lung Injury following Novel Coronavirus Pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),90,http://www.chictr.org.cn/showproj.aspx?proj=50263,None
338,ChiCTR2000030482,ChiCTR,2020-03-03,2020-03-06,False,Peking University First Hospital,Not Recruiting,Not Applicable,Observational,China,"A Multicenter, Long- term Follow-up and Registration Study for Myocardial Injury and Prognosis of Novel coronavirus pneumonia (COVID-19)",Clinical Presentation,No Intervention,No Intervention,8000,http://www.chictr.org.cn/showproj.aspx?proj=50353,None
339,ChiCTR2000030481,ChiCTR,2020-03-03,2020-03-01,True,Zhongnan Hospital of Wuhan University,Recruiting,Phase 4,Interventional,China,The clinical value of corticosteroid therapy timing in the treatment of novel coronavirus pneumonia (COVID-19): a prospective randomized controlled trial,Drug,Corticosteroids,Corticosteroids,200,http://www.chictr.org.cn/showproj.aspx?proj=50453,None
340,ChiCTR2000030480,ChiCTR,2020-03-03,2020-03-03,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"Randomized, open, blank controlled trial for the efficacy and safety of recombinant human interferon alpha 1beta in the treatment of Wuhan patients with novel coronavirus pneumonia (COVID-19)",Drug,Interferon alfa,Interferon alfa,328,http://www.chictr.org.cn/showproj.aspx?proj=50470,None
341,ChiCTR2000030479,ChiCTR,2020-03-03,2020-02-26,True,"Affiliated Hospital of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine",Not Recruiting,Not Applicable,Interventional,China,Study for the Effectiveness and Safety of Yi-Qi Hua-shi Jie-Du-Fang in the Treatment of the Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=50450,None
342,ChiCTR2000030477,ChiCTR,2020-03-03,2020-03-04,False,Chinese Academy of Medical Sciences Peking Union Medical College Hospital,Not Recruiting,Not Applicable,Interventional,China,oXiris Membrane in Treating Critically Ill Hospitalized Adult Patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,19,http://www.chictr.org.cn/showproj.aspx?proj=50458,None
343,ChiCTR2000030475,ChiCTR,2020-03-03,2020-03-04,False,Chinese Academy of Medical Sciences Peking Union Medical College Hospital,Not Recruiting,Not Applicable,Interventional,China,Cytosorb in Treating Critically Ill Hospitalized Adult Patients with novel coronavirus pneumonia (COVID-19),Other (physical),Blood purification,Blood purification,19,http://www.chictr.org.cn/showproj.aspx?proj=50452,None
344,ChiCTR2000030472,ChiCTR,2020-03-03,2020-02-25,True,Shenyang Sixth People's Hospital,Recruiting,Not Applicable,Interventional,China,An open and controlled clinical study to evaluate the efficacy and safety of Ganovo combined with ritonavir in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,20,http://www.chictr.org.cn/showproj.aspx?proj=49753,None
345,ChiCTR2000030471,ChiCTR,2020-03-02,2020-03-02,False,Maoming People's Hospital,Recruiting,Phase 4,Interventional,China,Efficacy and safety of lipoic acid injection in reducing the risk of progression in common patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,394,http://www.chictr.org.cn/showproj.aspx?proj=50421,None
346,ChiCTR2000030469,ChiCTR,2020-03-02,2020-02-27,True,Shanghai University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,A randomized parallel controlled trial for LIUSHENWAN in Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,96,http://www.chictr.org.cn/showproj.aspx?proj=50082,None
347,ChiCTR2000030468,ChiCTR,2020-03-02,2020-02-28,True,Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Study for the key technique of integrative therapy of Novel Coronavirus Pneumonia (COVID-19): the TCM symptoms and treatment regulation,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,950,http://www.chictr.org.cn/showproj.aspx?proj=50390,None
348,ChiCTR2000030467,ChiCTR,2020-03-02,2020-03-01,True,"Dalian Medical University, Dalian, China.",Not Recruiting,Not Applicable,Interventional,China,A Randomized  Controlled Trial  for the Influence of TCM Psychotherapy on Negative Emotion of Patients with Novel Coronavirus Pneumonia (COVID-19) Based on Network Platform,Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=50378,None
349,ChiCTR2000030465,ChiCTR,2020-03-02,2020-03-02,False,The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Cancelled by the investigator                        Influence of nasal high-fow preoxygenation on video laryngoscope for emergency intubation in patients with critical novel coronavirus pneumonia (COVID-19),Not relevant,Not relevant,Not relevant,70,http://www.chictr.org.cn/showproj.aspx?proj=50388,None
350,ChiCTR2000030464,ChiCTR,2020-03-02,2020-03-03,False,"The Third Xiangya Hospital, Central South University",Recruiting,Not Applicable,Epidemiological research,No Country Given,Study for the clinical characteristics of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=50382,None
351,ChiCTR2000030453,ChiCTR,2020-03-02,2020-03-02,False,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Not Applicable,Observational,China,Clinical study for the effects of ACEIs/ARBs on the infection of novel coronavirus pneumonia (CoVID-19),Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,100,http://www.chictr.org.cn/showproj.aspx?proj=50381,None
352,ChiCTR2000030436,ChiCTR,2020-03-01,2020-03-06,False,Shanghai Sixth People's Hospital,Not Recruiting,Not Applicable,Observational,China,Application of flash glucose monitoring to evaluate the effect of blood glucose changes on prognosis in patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=50297,None
353,ChiCTR2000030312,ChiCTR,2020-02-28,2020-02-29,False,The First People's Hospital of Jiangxia District,Not Recruiting,Not Applicable,Interventional,China,"Cancelled, due to modify the protocol                                          A single-center, open-label and single arm trial to evaluate the efficacy and safety of anti-SARS-CoV-2 inactivated convalescent plasma in the treatment&",Not relevant,Not relevant,Not relevant,24,http://www.chictr.org.cn/showproj.aspx?proj=50258,None
354,ChiCTR2000030304,ChiCTR,2020-02-28,2020-03-10,False,The Third Affiliated Hospital of Sun Yat-Sen University,Not Recruiting,Not Applicable,Observational,China,Protective factors of mental resilience in first-line nurses with novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,No Intervention,300,http://www.chictr.org.cn/showproj.aspx?proj=49653,None
355,ChiCTR2000030163,ChiCTR,2020-02-24,2020-02-25,False,Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine,Not Recruiting,Not Applicable,Observational,China,A Medical Based Retrospective Real World Study for Assessment of Effectiveness of Comprehensive Traditional Chinese Medicine in the treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,256,http://www.chictr.org.cn/showproj.aspx?proj=50031,None
356,ChiCTR2000030014,ChiCTR,2020-02-20,2020-02-19,True,Wuhan Fourth Hospital,Not Recruiting,Not Applicable,Interventional,China,Cancelled due to lack of patient                               Effect of early pulmonary training on lung function and quality of life for novel coronavirus pneumonia (COVID-19) patients,Not relevant,Not relevant,Not relevant,300,http://www.chictr.org.cn/showproj.aspx?proj=49802,None
357,ChiCTR2000029993,ChiCTR,2020-02-18,2020-02-20,False,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Not Applicable,Interventional,China,A pilot study for Integrated Chinese and Western Medicine in the treatment of non-critical novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,40,http://www.chictr.org.cn/showproj.aspx?proj=49435,None
358,ChiCTR2000029958,ChiCTR,2020-02-17,2020-02-17,False,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,A medical records based study for the clinical characteristics of anesthesia novel coronavirus pneumonia (COVID-19) patients during perioperative period and assessment of infection and mental health of Anesthesiology Department,Clinical Presentation,No Intervention,No Intervention,260,http://www.chictr.org.cn/showproj.aspx?proj=49635,None
359,ChiCTR2000029757,ChiCTR,2020-02-12,2020-02-14,False,China-Japan Friendship Hospital,Recruiting,Not Applicable,Interventional,China,Convalescent plasma for the treatment of severe and critical novel coronavirus pneumonia (COVID-19): a prospective randomized controlled trial,ATMP,Plasma,Plasma,200,http://www.chictr.org.cn/showproj.aspx?proj=49081,None
360,ChiCTR2000029580,ChiCTR,2020-02-05,2020-01-31,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,"Severe novel coronavirus pneumonia (COVID-19) patients treated with ruxolitinib in combination with mesenchymal stem cells: a prospective, single blind, randomized controlled clinical trial",Drug (+ ATMP),Ruxolimab + Cells (mesenchymal),Ruxolimab; Cells (mesenchymal),70,http://www.chictr.org.cn/showproj.aspx?proj=49088,None
361,ChiCTR2000029579,ChiCTR,2020-02-05,2020-01-31,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,The investigation of cytokine expression profile of novel coronavirus pneumonia (COVID-19) and its clinical significance,Clinical Presentation,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=49045,None
362,ChiCTR2000029550,ChiCTR,2020-02-04,2020-01-29,True,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Recommendations for Diagnosis and Treatment of Influenza Patients in the Hospital of Chengdu University of Traditional Chinese Medicine Under the Raging of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=48775,None
363,ChiCTR2000029549,ChiCTR,2020-02-04,2020-02-03,True,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Recommendations of Integrated Traditional Chinese and Western Medicine for Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,400,http://www.chictr.org.cn/showproj.aspx?proj=49014,None
364,ChiCTR2000029308,ChiCTR,2020-01-23,2020-01-10,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Interventional,China,"A randomized, controlled open-label trial to evaluate the efficacy and safety of lopinavir-ritonavir in hospitalized patients with novel coronavirus pneumonia (COVID-19)",Drug,Lopinavir/ritonavir,lopinavir/ritonavir,160,http://www.chictr.org.cn/showproj.aspx?proj=48684,None
365,ChiCTR2000030902,ChiCTR,2020-03-16,2020-02-10,True,Jingzhou Mental Health Center,Recruiting,Not Applicable,Observational,China,Analysis for the mental health status of residents in Jingzhou during the outbreak of the novel coronavirus pneumonia (COVID-19) and corresponding influencing factors,Other (psych),No Intervention,No Intervention,1000,http://www.chictr.org.cn/showproj.aspx?proj=51130,None
366,ChiCTR2000030901,ChiCTR,2020-03-16,2020-03-09,True,The Chinese University of Hong Kong,Not Recruiting,Not Applicable,Observational,China,Retrospective analysis of epidemiology and transmission dynamics of patients confirmed with Coronavirus Disease (COVID-19) in Hong Kong,Clinical Presentation ,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=51064,None
367,ChiCTR2000030898,ChiCTR,2020-03-16,2020-01-27,True,The Affiliated Hospital to Changchun University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Evaluation on the effect of Chushifangyi prescription in preventing novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,1000,http://www.chictr.org.cn/showproj.aspx?proj=50780,None
368,ChiCTR2000030897,ChiCTR,2020-03-16,2020-02-10,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Interventional,China,Evaluation of the effect of taking Newgen beta-gluten probiotic composite powder to nutrition intervention of patients with novel coronavirus pneumonia (COVID-19),Supplement,Probiotics,Probiotics,20,http://www.chictr.org.cn/showproj.aspx?proj=50462,None
369,ChiCTR2000030896,ChiCTR,2020-03-16,2020-02-06,True,Zhengzhou People's Hospital,Recruiting,Not Applicable,Interventional,China,Clinical Application and Theoretical Discussion of Fu-Zheng Qing-Fei Thought in Treating Non-Critical Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,24,http://www.chictr.org.cn/showproj.aspx?proj=51028,None
370,ChiCTR2000030895,ChiCTR,2020-03-16,2020-03-14,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Retrospective and Prospective Study for Nosocomial infection in Stomatology Department under the Background of novel coronavirus pneumonia (COVID-19) epidemic period,Clinical Presentation,No Intervention,No Intervention,1000,http://www.chictr.org.cn/showproj.aspx?proj=51034,None
371,ChiCTR2000030893,ChiCTR,2020-03-16,2020-03-19,False,Zhengzhou People's Hospital,Not Recruiting,Not Applicable,Observational,China,Study for effects of crisis intervention based on positive psychology for medical staffs working in the novel coronavirus pneumonia (COVID-19) field,Other (psych),Psychological,Psychological,50,http://www.chictr.org.cn/showproj.aspx?proj=51073,None
372,ChiCTR2000030892,ChiCTR,2020-03-16,2020-03-06,True,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of Pirfenidone in the Treatment of Severe Post-Novel Coronavirus Pneumonia (COVID-19) Fibrosis: a prospective exploratory experimental medical study,Drug,Pirfenidone,Pirfenidone,40,http://www.chictr.org.cn/showproj.aspx?proj=51118,None
373,ChiCTR2000030883,ChiCTR,2020-03-16,2020-02-18,True,"Affiliated Hospital of Traditional Chinese Medicine, Southwest Medical University",Recruiting,Not Applicable,Observational,China,Clinical research and preparation development of qingfei detoxification decoction (mixture) for prevention and treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=50960,None
374,ChiCTR2000030866,ChiCTR,2020-03-16,2020-02-01,True,The First Hospital of Changsha,Recruiting,Not Applicable,Observational,China,"Open-label, observational study of human umbilical cord derived mesenchymal stem cells in the treatment of severe and critical patients with novel coronavirus pneumonia (COVID-19)",ATMP,Cells (mesenchymal),Cells (mesenchymal),30,http://www.chictr.org.cn/showproj.aspx?proj=50299,None
375,ChiCTR2000030865,ChiCTR,2020-03-16,2020-02-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Establishment of an early warning model for maternal and child vertical transmission of COVID-19 infection,Clinical Presentation,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=49933,None
376,ChiCTR2000030864,ChiCTR,2020-03-16,2020-02-01,True,Xiangyang First People's Hospital,Recruiting,Not Applicable,Interventional,China,Traditional Chinese Medicine for novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,50,http://www.chictr.org.cn/showproj.aspx?proj=50662,None
377,ChiCTR2000030863,ChiCTR,2020-03-16,2020-01-22,True,"Jinling Hospital, Medical School of Nanjing University",Recruiting,Not Applicable,Observational,China,Clinical and CT imaging Characteristics of novel coronavirus pneumonia (COVID-19): An Multicenter Cohort Study,Clinical Presentation,No Intervention,No Intervention,5000,http://www.chictr.org.cn/showproj.aspx?proj=50767,None
378,ChiCTR2000030862,ChiCTR,2020-03-16,2020-01-24,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Correlation analysis of blood eosinophil cell levels and clinical type category of novel coronavirus pneumonia (COVID-19): a medical records based retrospective study,Clinical Presentation,No Intervention,No Intervention,150,http://www.chictr.org.cn/showproj.aspx?proj=51107,None
379,ChiCTR2000030861,ChiCTR,2020-03-16,2019-02-27,True,The First Affiliated Hospital of the Guangzhou Medical University,Recruiting,Not Applicable,Health services research,No Country Given,Development and application of a new intelligent robot for novel coronavirus (2019-nCOV) oropharygeal sampling,Other (physical),Other,Other,90,http://www.chictr.org.cn/showproj.aspx?proj=51103,None
380,ChiCTR2000030860,ChiCTR,2020-03-16,2020-03-16,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,A medical records based study for investigation of dynamic profile of RT-PCR test for SARS-CoV-2 nucleic acid of novel coronavirus pneumonia (COVID-19) patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,http://www.chictr.org.cn/showproj.aspx?proj=51102,None
381,ChiCTR2000030859,ChiCTR,2020-03-16,2020-03-01,True,Wuhan Third Hospital,Not Recruiting,Not Applicable,Observational,China,A medical based analysis for influencing factors of death of novel coronavirus pneumonia (COVID-19) patients in Wuhan third hospital,Prognosis,No Intervention,No Intervention,1305,http://www.chictr.org.cn/showproj.aspx?proj=51025,None
382,ChiCTR2000030858,ChiCTR,2020-03-16,2020-02-06,True,Hubei Cancer Hospital,Recruiting,Not Applicable,Observational,China,"Clinical characteristics and outcomes of 483 mild patients with novel coronavirus pneumonia (COVID-19) in Wuhan, China during the outbreak: A single-center, retrospective study from the mobile cabin hospital",Clinical Presentation,No Intervention,No Intervention,483,http://www.chictr.org.cn/showproj.aspx?proj=51097,None
383,ChiCTR2000030857,ChiCTR,2020-03-16,2020-03-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Clinical study for bronchoscopic alveolar lavage in the treatment of critically trachea intubation patients with new coronavirus pneumonia (COVID-19),Other (physical),Bronchoscopic lavage,Bronchoscopic lavage,30,http://www.chictr.org.cn/showproj.aspx?proj=51040,None
384,ChiCTR2000030856,ChiCTR,2020-03-16,2020-02-15,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Diagnostic test,China,An artificial intelligence assistant system for suspected novel coronavirus pneumonia (COVID-19) based on chest CT,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,600,http://www.chictr.org.cn/showproj.aspx?proj=51091,None
385,ChiCTR2000030855,ChiCTR,2020-03-16,2020-02-01,True,Third Affiliated Hospital of Zunyi Medical University,Not Recruiting,Phase 1,Interventional,No Country Given,Study for the effect of external diaphragmatic pacing assisted invasive ventilation and weaning in patients with severe novel coronavirus pneumonia (COVID-19),Other (physical),Mechanical ventilation,Mechanical ventilation,200,http://www.chictr.org.cn/showproj.aspx?proj=51090,None
386,ChiCTR2000030854,ChiCTR,2020-03-16,2020-01-22,True,Li Lanjuan,Not Recruiting,Not Applicable,Observational,China,"A clinical multicenter study for the occurrence, development and prognosis of novel coronavirus pneumonia (COVID-19)",Clinical Presentation,No Intervention,No Intervention,237,http://www.chictr.org.cn/showproj.aspx?proj=51083,None
387,ChiCTR2000030853,ChiCTR,2020-03-16,2020-02-01,True,Third Affiliated Hospital of Zunyi Medical University,Not Recruiting,Not Applicable,Interventional,No Country Given,Evaluation of the protective effect of dexmedetomidine on patients with severe novel coronavirus pneumonia (COVID-19),Drug,Dexmedetomidine,Dexmedetomidine,200,http://www.chictr.org.cn/showproj.aspx?proj=51081,None
388,ChiCTR2000030852,ChiCTR,2020-03-16,2020-01-27,True,"Beijing An Zhen Hospital, Capital Medical University",Not Recruiting,Not Applicable,Observational,China,Factors associated with death in patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,150,http://www.chictr.org.cn/showproj.aspx?proj=51077,None
389,ChiCTR2000030850,ChiCTR,2020-03-15,2020-03-15,False,The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,Study for the physical and mental health status of medical workers under the novel coronavirus pneumonia (COVID-19) epidemic,Other (psych),No Intervention,No Intervention,226,http://www.chictr.org.cn/showproj.aspx?proj=51056,None
390,ChiCTR2000030849,ChiCTR,2020-03-15,2020-03-16,False,Zhengzhou People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Investigation on psychological status of novel coronavirus pneumonia (COVID-19) rehabilitation patients in Zhengzhou City and research on coping strategies,Other (psych),No Intervention,No Intervention,81,http://www.chictr.org.cn/showproj.aspx?proj=51086,None
391,ChiCTR2000030841,ChiCTR,2020-03-15,2020-02-17,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,Exploratory study for Immunoglobulin From Cured COVID-19 Patients in the Treatment of Acute Severe novel coronavirus pneuvirus (COVID-19),ATMP,Immunoglobulin,Immunoglobulin,10,http://www.chictr.org.cn/showproj.aspx?proj=51072,None
392,ChiCTR2000030839,ChiCTR,2020-03-15,2020-03-01,True,"Tongren Hospital, Shanghai Jiao Tong University School of Medicine",Not Recruiting,Not Applicable,Screening,China,Preliminary screening of novel coronavirus pneumonia (COVID-19) by special laboratory examination and CT imaging before surgery,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,http://www.chictr.org.cn/showproj.aspx?proj=50904,None
393,ChiCTR2000030838,ChiCTR,2020-03-15,2020-01-20,True,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Diagnostic test,China,Development of warning system with clinical differential diagnosis and prediction for severe type of novel coronavirus pneumonia (COVID-19) patients based on artificial intelligence and CT images,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,http://www.chictr.org.cn/showproj.aspx?proj=51071,None
394,ChiCTR2000030836,ChiCTR,2020-03-15,2020-02-01,True,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Not Recruiting,Phase 4,Interventional,China,Novel coronavirus pneumonia (COVID-19) combined with Chinese and Western medicine based on ''Internal and External Relieving -Truncated Torsion'' strategy,Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=51054,None
395,ChiCTR2000030835,ChiCTR,2020-03-15,2020-02-14,True,The First Affiliated Hospital of Xinxiang Medical University,Recruiting,Not Applicable,Interventional,China,Clinical study for the efficacy of Mesenchymal stem cells (MSC) in the treatment of severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),20,http://www.chictr.org.cn/showproj.aspx?proj=51050,None
396,ChiCTR2000030834,ChiCTR,2020-03-15,2020-03-16,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Epidemiological Characteristics and Antibody Levels of novel coronavirus pneumonia (COVID-19) of Pediatric Medical Staff working in Quarantine Area,Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,http://www.chictr.org.cn/showproj.aspx?proj=51047,None
397,ChiCTR2000030833,ChiCTR,2020-03-15,2020-03-22,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,Clinical validation and application of high-throughput novel coronavirus (2019-nCoV) screening detection kit,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,400,http://www.chictr.org.cn/showproj.aspx?proj=51035,None
398,ChiCTR2000030832,ChiCTR,2020-03-15,2020-03-16,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Interventional,No Country Given,Study for the pathogenesis and effective intervention of mood disorders caused by the novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,Psychological,800,http://www.chictr.org.cn/showproj.aspx?proj=51044,None
399,ChiCTR2000030831,ChiCTR,2020-03-15,2020-01-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,The analysis of related factors on improving oxygenation status by endotracheal intubation ventilation in severe patients suffered from novel coronavirus pneumonia (COVID-19): a single center and descriptive study in Wuhan,Prognosis,No Intervention,No Intervention,75,http://www.chictr.org.cn/showproj.aspx?proj=51036,None
400,ChiCTR2000030830,ChiCTR,2020-03-15,2020-01-01,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Observational,China,Development and application of novel coronavirus pneumonia (COVID-19) intelligent image classification system based on deep learning,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,150,http://www.chictr.org.cn/showproj.aspx?proj=51009,None
401,ChiCTR2000030819,ChiCTR,2020-03-15,2020-03-01,True,Wuhan Third Hospital,Not Recruiting,Not Applicable,Observational,China,"Retrospective analysis of digestive system symptoms in 600 cases of novel coronavirus pneumonia (COVID-19) in Guanggu district, Wuhan",Clinical Presentation,No Intervention,No Intervention,600,http://www.chictr.org.cn/showproj.aspx?proj=51039,None
402,ChiCTR2000030818,ChiCTR,2020-03-15,2020-01-31,True,"The First Affiliated Hospital, Henan Traditional Chinese Medicine University",Not Recruiting,Not Applicable,Observational,China,A medical records based study for the value of Lymphocyte subsets in the diagnose and treatment of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,10,http://www.chictr.org.cn/showproj.aspx?proj=51037,None
403,ChiCTR2000030816,ChiCTR,2020-03-15,2020-02-24,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Nutritional risk assessment and outcome prediction of critically ill novel coronavirus pneumonia (COVID-19) patients,Prognosis,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=51048,None
404,ChiCTR2000030814,ChiCTR,2020-03-15,2020-02-20,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A medical records based analysis of clinical evidence of human-to-human transmission of 2019 novel coronavirus pneumonia (COVID-19) by conjunctival route,Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=51042,None
405,ChiCTR2000030812,ChiCTR,2020-03-15,2020-01-31,True,Shanghai Ninth People's Hospital,Recruiting,Not Applicable,Observational,China,Study for the virus molecular evolution which driven the immune-pathological responses and the protection mechanisms of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,No Intervention,50,http://www.chictr.org.cn/showproj.aspx?proj=50947,None
406,ChiCTR2000030810,ChiCTR,2020-03-15,2020-02-23,True,Hubei Provincial Hospital of Integrated Chinese and Western Medicine,Recruiting,Phase 1,Interventional,China,Clinical observation and evaluation of traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19) in Hubei 672 Orthopaedics Hospital of Integrated Chinese&Western Medicine,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=50986,None
407,ChiCTR2000030809,ChiCTR,2020-03-15,2020-02-22,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,A medical records based study for clinical outcomes and follow-up of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,No Intervention,1000,http://www.chictr.org.cn/showproj.aspx?proj=51015,None
408,ChiCTR2000030807,ChiCTR,2020-03-15,2020-02-15,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Clinical characteristics and prognosis of cancer patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=51019,None
409,ChiCTR2000030806,ChiCTR,2020-03-15,2020-02-01,True,Wuhan Third Hospital,Recruiting,Not Applicable,Observational,China,Retrospective study for the efficacy of ulinastatin combined with ''clear lung detoxification soup'' in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,20,http://www.chictr.org.cn/showproj.aspx?proj=51029,None
410,ChiCTR2000030805,ChiCTR,2020-03-15,2020-02-15,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,No Country Given,Quantitative CT characteristic estimate the severity of novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,http://www.chictr.org.cn/showproj.aspx?proj=51026,None
411,ChiCTR2000030804,ChiCTR,2020-03-15,2020-02-01,True,Maoming People's Hospital,Recruiting,Phase 4,Interventional,China,Exocarpium Citri Grandis Relieves Symptoms of Novel Coronavirus Pneunomia (COVID-19): a Randomized Controlled Clinical Trial,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,128,http://www.chictr.org.cn/showproj.aspx?proj=51018,None
412,ChiCTR2000030803,ChiCTR,2020-03-15,2020-01-31,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,No Country Given,Collection and analysis of clinical data in severe and critically ill patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,400,http://www.chictr.org.cn/showproj.aspx?proj=51007,None
413,ChiCTR2000030802,ChiCTR,2020-03-15,2020-01-27,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A retrospective study of clinical drug therapy in patients with novel coronavirus pneumonia (COVID-19),Drug,Unspecified Drug,Unspecified Drug,2000,http://www.chictr.org.cn/showproj.aspx?proj=51004,None
414,ChiCTR2000030801,ChiCTR,2020-03-15,2020-01-23,True,The Third Hospital of Wuhan,Recruiting,Not Applicable,Observational,China,Analysis of risk factors affecting prognosis of elderly patients infected with novel coronavirus pneumonia (COVID-19): a single-center retrospective observational study,Prognosis,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=50998,None
415,ChiCTR2000030800,ChiCTR,2020-03-15,2020-02-01,True,Third Affiliated Hospital of Zunyi Medical University,Not Recruiting,Not Applicable,Diagnostic test,China,Cancelled by the investigator                Study on levels of inflammatory factors in peripheral blood of patients with novel coronavirus pneumonia (COVID-19) and their diagnostic and prognostic value,Not relevant,Not relevant,Not relevant,22,http://www.chictr.org.cn/showproj.aspx?proj=50997,None
416,ChiCTR2000030799,ChiCTR,2020-03-15,2020-01-20,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,Establishment and validation of Premonitory model of deterioration of the 2019 novel corona virus pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,1000,http://www.chictr.org.cn/showproj.aspx?proj=50995,None
417,ChiCTR2000030798,ChiCTR,2020-03-15,2020-02-10,True,Wuhan Third Hospital,Recruiting,Not Applicable,Observational,China,A medical records based study for clinical characteristics of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=50994,None
418,ChiCTR2000030797,ChiCTR,2020-03-15,2020-03-07,True,"Shanghai Fifth People's Hospital, Fudan University",Recruiting,Not Applicable,Observational,China,clinical study for hemodynamics and cardiac arrhythmia of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=50988,None
419,ChiCTR2000030796,ChiCTR,2020-03-15,2020-01-29,True,The Second Hospital of Hebei Medical University,Recruiting,Not Applicable,Observational,No Country Given,Clinical characteristics and treatment of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,500,http://www.chictr.org.cn/showproj.aspx?proj=50991,None
420,ChiCTR2000030795,ChiCTR,2020-03-15,2020-03-20,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A multicenter retrospective study of rheumatic  patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,90,http://www.chictr.org.cn/showproj.aspx?proj=50982,None
421,ChiCTR2000030784,ChiCTR,2020-03-14,2020-01-17,True,The People's Hospital of Guangxi Zhuang Autonomous Region,Recruiting,Not Applicable,Observational,China,A study for clinical characteristics of novel coronavirus pneumonia (COVID-19) patients follow-up in Guangxi,Clinical Presentation,No Intervention,No Intervention,150,http://www.chictr.org.cn/showproj.aspx?proj=50307,None
422,ChiCTR2000030779,ChiCTR,2020-03-14,2020-03-16,False,Shanghai Changzheng Hospital,Recruiting,Phase 4,Interventional,China,A clinical trial for Ulinastatin Injection in the treatment of patients with severe novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=50973,None
423,ChiCTR2000030778,ChiCTR,2020-03-14,2020-01-20,True,Ningbo First Hospital,Not Recruiting,Not Applicable,Observational,China,A medical records based study for epidemic and clinical features of novel coronavirus pneumonia (COVID-19) in Ningbo First Hospital,Clinical Presentation,No Intervention,No Intervention,40,http://www.chictr.org.cn/showproj.aspx?proj=50987,None
424,ChiCTR2000030773,ChiCTR,2020-03-14,2020-02-12,True,Huashan Hospital Affiliated to Fudan University,Recruiting,Not Applicable,Interventional,China,Application of blood purification in the treatment of novel coronavirus pneumonia (COVID-19),Other (physical),Blood purification,Blood purification,20,http://www.chictr.org.cn/showproj.aspx?proj=50934,None
425,ChiCTR2000030768,ChiCTR,2020-03-14,2020-02-01,True,Zhongnan Hospital of Wuhan University,Recruiting,Not Applicable,Epidemiological research,China,Study for the Psychological Status of Medical Staff of Otolaryngology Head and Neck Surgery in Hubei Province under the Epidemic of novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,No Intervention,450,http://www.chictr.org.cn/showproj.aspx?proj=50968,None
426,ChiCTR2000030764,ChiCTR,2020-03-13,2020-03-07,True,"Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine",Recruiting,Not Applicable,Observational,China,"Research for the influence of epidemic of novel coronavirus pneumonia (COVID-19) on sleep, psychological and chronic diseases among different populations",Clinical Presentation,No Intervention,No Intervention,2800,http://www.chictr.org.cn/showproj.aspx?proj=50852,None
427,ChiCTR2000030763,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Observational,China,A Medical Records Based analysis for Risk Factors for Outcomes After Respiratory Support in Patients with ARDS Due to Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=50921,None
428,ChiCTR2000030762,ChiCTR,2020-03-13,2019-12-01,True,The Second Affiliated Hospital of Guizhou University of traditional Chinese Medicine,Not Recruiting,Not Applicable,Epidemiological research,China,Diagnosis and treatment of novel coronavirus pneumonia (COVID-19) in common and severe cases based on the theory of ''Shi-Du-Yi (damp and plague)'',Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=50950,None
429,ChiCTR2000030761,ChiCTR,2020-03-13,2020-05-31,False,"Renji Hospital, Shanghai Jiaotong University School of Medicine",Not Recruiting,Not Applicable,Interventional,China,Continuous renal replacement therapy (CRRT) alleviating inflammatory response in severe patients with novel coronavirus pneumonia (COVID-19) associated with renal injury: A Prospective study,Other (renal),Renal replacement therapy,Renal replacement therapy,20,http://www.chictr.org.cn/showproj.aspx?proj=50956,None
430,ChiCTR2000030760,ChiCTR,2020-03-13,2020-03-13,False,Zhejiang Hospital,Not Recruiting,Not Applicable,Observational,China,"A medical records based study for clinical characteristics of 2019 novel coronavirus pneumonia (COVID-19) in Zhejiang province, China",Clinical Presentation,No Intervention,No Intervention,74,http://www.chictr.org.cn/showproj.aspx?proj=50955,None
431,ChiCTR2000030759,ChiCTR,2020-03-13,2020-02-15,True,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,Study for the therapeutic effect and mechanism of traditional Chinese medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,70,http://www.chictr.org.cn/showproj.aspx?proj=49284,None
432,ChiCTR2000030758,ChiCTR,2020-03-13,2020-03-10,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A medical records based study for sedation and Analgesia Usage in critically ill patients with novel coronavirus pneumonia (COVID-19),Drug,Unspecified sedation and analgesia,Unspecified (Sedation and analgesia),200,http://www.chictr.org.cn/showproj.aspx?proj=50590,None
433,ChiCTR2000030757,ChiCTR,2020-03-13,2020-03-13,False,Shenzhen-Peking University; The Hong Kong University of Science & Technology Medical Center,Not Recruiting,Not Applicable,Observational,China,Impact of Novel Coronavirus Pneumonia (COVID-19) Epidemic Period on the Management of investigator-initiated clinical trial and the resilience of medical service providers,Other (psych),No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=50648,None
434,ChiCTR2000030756,ChiCTR,2020-03-13,2020-02-20,True,Shenzhen Hospital of Southern Medical University,Recruiting,Not Applicable,Observational,China,Detection of SARS-CoV-2 in EPS / semen of patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation ,No Intervention,No Intervention,60,http://www.chictr.org.cn/showproj.aspx?proj=50705,None
435,ChiCTR2000030755,ChiCTR,2020-03-13,2020-03-15,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,"A medical records based study for characteristics, prognosis of ederly patients with Novel Coronavirus Pneumonia (COVID-19) in Wuhan area",Prognosis,No Intervention,No Intervention,400,http://www.chictr.org.cn/showproj.aspx?proj=50945,None
436,ChiCTR2000030754,ChiCTR,2020-03-13,2020-03-11,True,The Third Affiliated Hospital of Sun Yat-Sen University,Not Recruiting,Not Applicable,Diagnostic test,China,Medical records based study for the accuracy of SARS-CoV-2 IgM antibody screening for diagnosis of novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,30,http://www.chictr.org.cn/showproj.aspx?proj=50824,None
437,ChiCTR2000030753,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,No Status Given,Not Applicable,Observational,China,A medical records based analysis of the Incidence and Risk Factors of Ventilator-associated Pneumonia in ARDS Patients with Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=50901,None
438,ChiCTR2000030752,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Observational,China,A medical records based analysis for risk factors for death in patients with Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,500,http://www.chictr.org.cn/showproj.aspx?proj=50925,None
439,ChiCTR2000030751,ChiCTR,2020-03-13,2020-01-25,True,Affiliated Hospital of Inner Mongolia University for the Nationalities,Not Recruiting,Not Applicable,Interventional,China,Clinical Research for Traditional Mongolian Medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=50941,None
440,ChiCTR2000030747,ChiCTR,2020-03-13,2020-02-22,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,A prospective cohort  study for comprehensive treatment of Chinese medicine in the treatment of convalescent patients of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,1500,http://www.chictr.org.cn/showproj.aspx?proj=50000,None
441,ChiCTR2000030744,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Interventional,China,Clinical Application of ECMO(or Ultra-Protective Lung Mechanical Ventilation) in the Treatment of Patients with ARDS due to novel Coronavirus Pneumonia (COVID-19),Drug,Oxygen,Oxygen,30,http://www.chictr.org.cn/showproj.aspx?proj=50910,None
442,ChiCTR2000030742,ChiCTR,2020-03-13,2020-03-15,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,"Characteristics, prognosis, and treatments effectiveness of critically ill patients with Novel Coronavirus Pneumonia (COVID-19)",Clinical Presentation,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=50857,None
443,ChiCTR2000030741,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Observational,China,Observational Study for Prone Position Ventilation and Conventional Respiratory Support in ARDS Patients with  Novel Coronavirus Pneumonia (COVID-19),Other (physical),Mechanical ventilation,Mechanical ventilation,100,http://www.chictr.org.cn/showproj.aspx?proj=50907,None
444,ChiCTR2000030740,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Observational,China,Analysis of the incidence and risk factors of ARDS in patients with Novel Coronavirus Pneumonia (COVID-19).,Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=50900,None
445,ChiCTR2000030739,ChiCTR,2020-03-13,2020-02-01,True,Shandong Provincial Chest hospital,Recruiting,Not Applicable,Observational,China,Exploration of the Clinical Characteristics of Patients with Novel Coronavirus Pneumonia (COVID-19) and Its Differences from Patients with Severe Influenza A and MERS,Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=50896,None
446,ChiCTR2000030722,ChiCTR,2020-03-12,2020-03-09,True,Shanghai First People's Hospital,Not Recruiting,Not Applicable,Observational,China,Auscultatory characteristics of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,30,http://www.chictr.org.cn/showproj.aspx?proj=50338,None
447,ChiCTR2000030721,ChiCTR,2020-03-12,2020-03-16,False,Affiliated Hospital of Guangdong Medical University,Not Recruiting,Not Applicable,Diagnostic test,China,A comparative study for the sensitivity of induced sputum and throat swabs for the detection of SARS-CoV-2 by real-time PCR in patients with novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,http://www.chictr.org.cn/showproj.aspx?proj=50759,None
448,ChiCTR2000030720,ChiCTR,2020-03-11,2020-03-01,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Prognosis Investigation and Intervention Study on Patients with novel coronavirus pneumonia (COVID-19) in recovery period Based on Community Health Management,Prognosis,No Intervention,No Intervention,120,http://www.chictr.org.cn/showproj.aspx?proj=50793,None
449,ChiCTR2000030719,ChiCTR,2020-03-11,2020-03-01,True,Wuhan Hospital of Integrated Traditional Chinese and Western Medicine,Recruiting,Not Applicable,Observational,China,A retrospective cohort study for integrated traditional Chinese and western medicine in the treatment of 1071 patients with novel coronavirus pneumonia (COVID-19) in Wuhan,Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,1071,http://www.chictr.org.cn/showproj.aspx?proj=50867,None
450,ChiCTR2000030718,ChiCTR,2020-03-11,2020-02-12,True,Zhongnan Hospital of Wuhan University,Recruiting,Phase 4,Interventional,China,Randomized controlled trial for Chloroquine Phosphate in the Treatment of novel coronavirus pneumonia (COVID-19),Drug,Chloroquine,Chloroquine,80,http://www.chictr.org.cn/showproj.aspx?proj=50843,None
451,ChiCTR2000030717,ChiCTR,2020-03-11,2020-04-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A medical records based study for risk assessment and treatment timing of invasive fungal infection in novel coronavirus pneumonia (COVID-19) critical patients,Clinical Presentation,No Intervention,No Intervention,260,http://www.chictr.org.cn/showproj.aspx?proj=50860,None
452,ChiCTR2000030716,ChiCTR,2020-03-11,2020-03-05,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Shedding of SARS-CoV-2 in human semen and evaluation of reproductive health of novel coronavirus pneumonia (COVID-19) male patients,Clinical Presentation,No Intervention,No Intervention,150,http://www.chictr.org.cn/showproj.aspx?proj=50850,None
453,ChiCTR2000030708,ChiCTR,2020-03-11,2020-03-10,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,China,Cross sectional study of dialysis treatment and mental status under the outbreak of novel coronavirus pneumonia (COVID-2019) in China,Other (renal),Dialysis,Dialysis,1000,http://www.chictr.org.cn/showproj.aspx?proj=50083,None
454,ChiCTR2000030707,ChiCTR,2020-03-11,2020-03-20,False,"Ganzi Hospital of West China Hospital, Sichuan University",Not Recruiting,Not Applicable,Observational,China,Retrospective study on novel coronavirus pneumonia (COVID-19) in Tibetan Plateau,Clinical Presentation,No Intervention,No Intervention,78,http://www.chictr.org.cn/showproj.aspx?proj=50160,None
455,ChiCTR2000030706,ChiCTR,2020-03-11,2020-02-09,True,Affiliated Hospital of Zunyi Medical University,Recruiting,Not Applicable,Diagnostic test,China,Cancelled by the investigator                       Application of cas13a-mediated RNA detection in the assay of novel coronavirus nucleic acid (COVID-19),Not relevant,Not relevant,Not relevant,300,http://www.chictr.org.cn/showproj.aspx?proj=50001,None
456,ChiCTR2000030703,ChiCTR,2020-03-10,2020-03-10,False,Xiangya Hospital of Central South University,Recruiting,Not Applicable,Interventional,China,"A randomized, blinded, controlled, multicenter clinical trial to evaluate the efficacy and safety of Ixekizumab combined with conventional antiviral drugs in patients with novel coronavirus pneumonia (COVID-19)",Drug,"Ixekizumab + up to three of interferon-alfa, lopinavir/ritonavir, chloroquine, ribavirin, umifenovir",Ixekizumab; Interferon alpha; Lopinavir; Ritonavir; Chloroquine; Ribavirin; Umifenovir,40,http://www.chictr.org.cn/showproj.aspx?proj=50251,None
457,ChiCTR2000030702,ChiCTR,2020-03-10,2020-02-15,True,China-Japan Friendship Hospital,Recruiting,Not Applicable,Interventional,China,Plasma of the convalescent in the treatment of novel coronavirus pneumonia (COVID-19) common patient: a prospective clinical trial,ATMP,Plasma,Plasma,50,http://www.chictr.org.cn/showproj.aspx?proj=50537,None
458,ChiCTR2000030701,ChiCTR,2020-03-10,2020-03-10,False,The Third People's Hospital of Shenzhen,Not Recruiting,Not Applicable,Interventional,China,"A randomized, parallel controlled open-label trial for the efficacy and safety of Prolongin (Enoxaparin Sodium Injection) in the treatment of adult patients with novel coronavirus pneumonia (COVID-19)",Drug,Heparin,Heparin,60,http://www.chictr.org.cn/showproj.aspx?proj=50795,None
459,ChiCTR2000030700,ChiCTR,2020-03-10,2020-03-09,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Interventional,China,Study for the efficacy and safety of Prolongin (Enoxaparin Sodium Injection) in treatment of novel coronavirus pneumonia (COVID-19) adult common patients,Drug,Heparin,Heparin,60,http://www.chictr.org.cn/showproj.aspx?proj=50786,None
460,ChiCTR2000030697,ChiCTR,2020-03-10,2020-03-10,False,Ningbo First Hospital,Not Recruiting,Not Applicable,Observational,China,"A multi-center, open-label observation study for psychological status and intervention efficacy of doctors, nurses, patients and their families in novel coronavirus pneumonia (COVID-19) designated hospitals",Other (psych),Psychological,Psychological,1500,http://www.chictr.org.cn/showproj.aspx?proj=50781,None
461,ChiCTR2000030690,ChiCTR,2020-03-10,2020-02-10,True,The Third Affiliated Hospital of the Second Military Medical University,Recruiting,Not Applicable,Basic Science,China,Study for immune cell subsets in convalescent patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,30,http://www.chictr.org.cn/showproj.aspx?proj=50261,None
462,ChiCTR2000030687,ChiCTR,2020-03-09,2020-02-01,True,"Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology",Not Recruiting,Not Applicable,Basic Science,China,Novel coronavirus pneumonia (COVID-19) associated kidney injury in children,Clinical Presentation,No Intervention,No Intervention,120,http://www.chictr.org.cn/showproj.aspx?proj=50572,None
463,ChiCTR2000030686,ChiCTR,2020-03-09,2020-03-03,True,Peking University Third Hospital,Recruiting,Not Applicable,Observational,China,The effects of prevention and control measures on treatment and psychological status of cancer patients during the novel coronavirus pneumonia (COVID-19) outbreak,Other (psych),Psychological,Psychological,300,http://www.chictr.org.cn/showproj.aspx?proj=50714,None
464,ChiCTR2000030683,ChiCTR,2020-03-09,2020-03-09,False,The Sixth Affiliated Hospital of Sun Yat-Sen University,Not Recruiting,Not Applicable,Diagnostic test,China,The prediction value of prognosis of novel coronavirus pneumonia (COVID-19) in elderly patients by modified early warning score (MEWS): a medical records based retrospective observational study,Prognosis,No Intervention,No Intervention,234,http://www.chictr.org.cn/showproj.aspx?proj=50633,None
465,ChiCTR2000030681,ChiCTR,2020-03-09,2020-03-16,False,Liaocheng People's Hospital,Not Recruiting,Not Applicable,Interventional,China,An anaesthesia procedure and extubation strategy for reducing patient agitation and cough after extubation that can be used to prevent the spread of Novel Coronavirus Pneumonia (COVID-19) and other infectious viruses in the operating Room,Other (physical),Extubation,Extubation,240,http://www.chictr.org.cn/showproj.aspx?proj=50763,None
466,ChiCTR2000030679,ChiCTR,2020-03-09,2020-01-28,True,"Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology",Recruiting,Not Applicable,Observational,China,Cohort study of Novel Coronavirus Infected Diseases (COVID-19) in children,Clinical Presentation,No Intervention,No Intervention,500,http://www.chictr.org.cn/showproj.aspx?proj=50730,None
467,ChiCTR2000030619,ChiCTR,2020-03-08,2020-02-01,True,The First Affiliated Hospital of Bengbu Medical College,Not Recruiting,Not Applicable,Observational,China,A medical records based real world study for the characteristics and correlation mechanism of traditional Chinese medicine combined with western medicine in the treatment of patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,160,http://www.chictr.org.cn/showproj.aspx?proj=50656,None
468,ChiCTR2000030606,ChiCTR,2020-03-08,2020-03-09,False,"Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine",Not Recruiting,Not Applicable,Observational,China,Medical records based study for the correlation between Chinese medicine certificate and lung image of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=50713,None
469,ChiCTR2000030597,ChiCTR,2020-03-08,2020-03-09,False,China Academy of Chinese Medical Science,Not Recruiting,Not Applicable,Observational,China,Medical records based study for the correlation between Chinese medicine certificate and lung image of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,150,http://www.chictr.org.cn/showproj.aspx?proj=50702,None
470,ChiCTR2000030580,ChiCTR,2020-03-08,2020-02-01,True,Shanghai General Hospital,Recruiting,Phase 4,Interventional,China,Efficacy and safety of tozumab combined with adamumab(Qletli) in severe and critical patients with novel coronavirus pneumonia (COVID-19),Drug,Adamumab,Adamumab,60,http://www.chictr.org.cn/showproj.aspx?proj=50693,None
471,ChiCTR2000030558,ChiCTR,2020-03-07,2020-03-07,False,Guangzhou Panyu Central Hospital,No Status Given,Not Applicable,Epidemiological research,China,Cancelled by the investigator             Epidemiological research of novel coronavirus pneumonia (COVID-19) suspected cases based on virus nucleic acid test combined with low-dose chest CT screening in primary hospital,Not relevant,Not relevant,Not relevant,264,http://www.chictr.org.cn/showproj.aspx?proj=50678,None
472,ChiCTR2000030545,ChiCTR,2020-03-06,2020-02-04,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Phase 4,Interventional,China,"Efficacy and safety of honeysuckle oral liquid in the treatment of novel coronavirus pneumonia (COVID-19): a multicenter, randomized, controlled, open clinical trial",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=50126,None
473,ChiCTR2000030528,ChiCTR,2020-03-06,2020-03-06,False,The Second Clinical College of Guangzhou University of Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,Application of TCM Nursing Scheme in Patients with Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=50641,None
474,ChiCTR2000030509,ChiCTR,2020-03-05,2020-03-13,False,The First Affiliated Hospital of Harbin Medical University,Not Recruiting,Not Applicable,Interventional,China,Cancelled by the investigator           Clinical Study of NK Cells in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Not relevant,Not relevant,Not relevant,40,http://www.chictr.org.cn/showproj.aspx?proj=49956,None
475,ChiCTR2000030483,ChiCTR,2020-03-03,2020-03-01,True,The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine,Not Recruiting,Phase 1,Interventional,China,"Cancelled by the investigator         A multicentre, randomized, controlled trial for the Ba-Duan-Jin in the adjunctive treatment of patients with common type novel coronavirus pneumonia (COVID-19)",Not relevant,Not relevant,Not relevant,16,http://www.chictr.org.cn/showproj.aspx?proj=50495,None
476,ChiCTR2000030478,ChiCTR,2020-03-03,2020-02-26,True,"Affiliated Hospital of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine",Not Recruiting,Not Applicable,Interventional,China,Cancelled by the investigator                                    Study for the Effectiveness and Safety of Compound Yuxingcao Mixture in the Treatment of the Novel Coronavirus Pneumonia (COVID-19),Not relevant,Not relevant,Not relevant,120,http://www.chictr.org.cn/showproj.aspx?proj=50460,None
477,ChiCTR2000030476,ChiCTR,2020-03-03,2020-03-03,False,"Cancer Institute, Longhua Hospital, Shanghai University of Traditional Chinese Medicine",Recruiting,Not Applicable,Interventional,China,Study for meditation assists for the rehabilitation of patients with novel coronaviruse pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=50455,None
478,ChiCTR2000030466,ChiCTR,2020-03-02,2020-02-26,True,Chongqing Medical University,No Status Given,Not Applicable,Observational,China,Cancelled due to lack of patients                                       Investigation on Mental Health Status and Psychological Intervention of Hospitalized Patients with Novel Coronavirus Pneumonia (COVID-19),Not relevant,Not relevant,Not relevant,50,http://www.chictr.org.cn/showproj.aspx?proj=50387,None
479,ChiCTR2000030417,ChiCTR,2020-03-01,2020-03-01,False,Harbin Infectious Diseases Hospital,No Status Given,Not Applicable,Interventional,China,Cancelled by the investigator                               Efficacy and safety of chloroquine phosphate inhalation combined with standard therapy in the treatment of novel coronavirus pneumonia (COVID-19),Not relevant,Not relevant,Not relevant,30,http://www.chictr.org.cn/showproj.aspx?proj=50279,None
480,ChiCTR2000030388,ChiCTR,2020-03-01,2020-02-18,True,Jingzhou First People's Hospital,Recruiting,Not Applicable,Interventional,China,Efficacy and safety of Xue-Bi-Jing injection in the treatment of severe cases of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=50306,None
481,ChiCTR2000030381,ChiCTR,2020-02-29,2020-02-29,False,The First People's Hospital of Jiangxia District,Not Recruiting,Not Applicable,Interventional,China,"Cancelled by investigator           A randomized, open-label, controlled and single-center trial to evaluate the efficacy and safety of anti-SARS-CoV-2 inactivated convalescent plasma in the treatment of novel coronavirus pneumonia (COVID-19) patient",Not relevant,Not relevant,Not relevant,40,http://www.chictr.org.cn/showproj.aspx?proj=50290,None
482,ChiCTR2000030329,ChiCTR,2020-02-28,2020-03-05,False,The Second Affiliated Hospital of Xi'an Jiaotong University,Not Recruiting,Not Applicable,Interventional,China,Cancelled by the investigator                          Clinical trial for umbilical cord blood CIK and NK cells in the treatment of mild and general patients infected with novel coronavirus pneumonia (COVID-19),Not relevant,Not relevant,Not relevant,90,http://www.chictr.org.cn/showproj.aspx?proj=49779,None
483,ChiCTR2000030306,ChiCTR,2020-02-28,2020-03-19,False,Shenzhen University,No Status Given,Not Applicable,Observational,China,Cancelled by the investigator                               Mechanism of novel coronavirus pneumonia (COVID-19) virus with silent latent immune system induced by envelope protein and vaccine development,Not relevant,Not relevant,Not relevant,15,http://www.chictr.org.cn/showproj.aspx?proj=50222,None
484,ChiCTR2000030221,ChiCTR,2020-02-25,2020-01-31,True,Guangzhou Panyu Central Hospital,Recruiting,Not Applicable,Health services research,No Country Given,Cancelled by the investigator               Study for sleep status of medical staffs of hospitals administrating suspected cases of Novel Coronavirus Pneumonia (COVID-19),Not relevant,Not relevant,Not relevant,960,http://www.chictr.org.cn/showproj.aspx?proj=50071,None
485,ChiCTR2000030187,ChiCTR,2020-02-24,2020-02-25,False,Jingzhou First People's Hospital,Recruiting,Not Applicable,Interventional,China,Clinical study for Lopinavir and Ritonavir in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Lopinavir/ritonavir,lopinavir/ritonavir,60,http://www.chictr.org.cn/showproj.aspx?proj=50057,None
486,ChiCTR2000030135,ChiCTR,2020-02-24,2020-02-25,False,The Second Affiliated Hospital of Xi'an Jiaotong University,Not Recruiting,Not Applicable,Interventional,China,Cancelled by the investigator                  A randomized controlled trial for high-dose Vitamin C in the treatment of severe and critical novel coronavirus pneumonia (COVID-19) patients,Not relevant,Not relevant,Not relevant,39,http://www.chictr.org.cn/showproj.aspx?proj=50002,None
487,ChiCTR2000030114,ChiCTR,2020-02-23,2020-02-24,False,Peking University People's Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,"Lung ultrasound in the diagnosis, treatment and prognosis of pulmonary lesions of novel coronavirus pneumonia (COVID-19)",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,150,http://www.chictr.org.cn/showproj.aspx?proj=49987,None
488,ChiCTR2000030085,ChiCTR,2020-02-22,2020-02-22,False,Zunyi Medical University,No Status Given,Not Applicable,Diagnostic test,China,Cancelled by the investigator               Study for the false positive rate of IgM / IgG antibody test kit for novel coronavirus pneumonia (COVID-19) in different inpatients,Not relevant,Not relevant,Not relevant,400,http://www.chictr.org.cn/showproj.aspx?proj=49948,None
489,ChiCTR2000030082,ChiCTR,2020-02-22,2020-02-23,False,The First Affiliated Hospital of Nanchang University,No Status Given,Phase 4,Interventional,China,Cancelled by the investigator             Randomized controlled trial for the efficacy of dihydroartemisinine piperaquine in the treatment of mild/common novel coronavirus pneumonia (COVID-19),Not relevant,Not relevant,Not relevant,40,http://www.chictr.org.cn/showproj.aspx?proj=49915,None
490,ChiCTR2000030055,ChiCTR,2020-02-22,2020-02-10,True,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Phase 4,Prognosis,China,Multicenter study for the treatment of Dipyridamole with novel coronavirus pneumonia (COVID-19),Drug,Dipyridamole,Dipyridamole,460,http://www.chictr.org.cn/showproj.aspx?proj=49864,None
491,ChiCTR2000030031,ChiCTR,2020-02-21,2020-02-20,True,The Sixth Affiliated Hospital of Guangzhou Medical University (Qingyuan People's Hospital),No Status Given,Phase 4,Interventional,China,"Cancelled by the investigator                              A randomized, double-blind, parallel, controlled trial for comparison of phosphoric chloroquine combined with standard therapy and standard therapy in mild/common patients with novel coronavirus pneumonia (COV",Not relevant,Not relevant,Not relevant,120,http://www.chictr.org.cn/showproj.aspx?proj=49806,None
492,ChiCTR2000030005,ChiCTR,2020-02-19,2020-02-21,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,Nucleic acid analysis of novel coronavirus pneumonia (COVID-19) in morning sputum samples and pharyngeal swabs-a prospectively diagnostic test,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,http://www.chictr.org.cn/showproj.aspx?proj=49669,None
493,ChiCTR2000029984,ChiCTR,2020-02-18,2020-03-01,False,"Guangzhou reborn health management consultation co., LTD",Not Recruiting,Not Applicable,Interventional,No Country Given,Cancelled by the investigator              Study on the effect of human placenta biological preparation on the defense of immune function against novel coronavirus pneumonia (COVID-19),Not relevant,Not relevant,Not relevant,60,http://www.chictr.org.cn/showproj.aspx?proj=49712,None
494,ChiCTR2000029957,ChiCTR,2020-02-17,2020-02-24,False,The Second Affiliated Hospital of Xi'an Jiaotong University,Not Recruiting,Not Applicable,Observational,China,Cancelled by the investigator                         An observational study of high-dose Vitamin C in the treatment of severe and critical patients with novel coronavirus pneumonia (COVID-19),Not relevant,Not relevant,Not relevant,66,http://www.chictr.org.cn/showproj.aspx?proj=49633,None
495,ChiCTR2000029895,ChiCTR,2020-02-16,2020-02-16,False,Guangzhou Eighth People's Hospital,Recruiting,Phase 1/Phase 2,Interventional,China,Cancelled by investigator                Single arm study for the efficacy and safety of GD31 in patients with novel coronavirus pneumonia (COVID-19),Not relevant,Not relevant,Not relevant,160,http://www.chictr.org.cn/showproj.aspx?proj=49569,None
496,ChiCTR2000029837,ChiCTR,2020-02-15,2020-02-17,False,Jingzhou Central Hospital,Not Recruiting,Phase 4,Interventional,China,"Cancelled by the investigator          A randomized, double-blind, parallel, controlled trial for comparison of phosphoric chloroquine combined with standard therapy and standard therapy in mild/common patients with novel coronavirus pneumonia (COVID-19)",Not relevant,Not relevant,Not relevant,120,http://www.chictr.org.cn/showproj.aspx?proj=49495,None
497,ChiCTR2000029826,ChiCTR,2020-02-14,2020-02-17,False,Jingzhou Central Hospital,Not Recruiting,Phase 4,Interventional,China,"Cancelled by the investigator            A randomized, double-blind, parallel, controlled trial for comparison of phosphoric chloroquine combined with standard therapy and standard therapy in serious/critically ill patients with novel coronavirus pneumonia (COVID-19)",Not relevant,Not relevant,Not relevant,45,http://www.chictr.org.cn/showproj.aspx?proj=49481,None
498,ChiCTR2000029820,ChiCTR,2020-02-14,2020-02-01,True,wuhan asia,No Status Given,Not Applicable,Observational,China,Cancelled by investigator                                      A cox regression analysis of prognosis of novel coronavirus pneumonia (COVID-19),Not relevant,Not relevant,Not relevant,410,http://www.chictr.org.cn/showproj.aspx?proj=49492,None
499,ChiCTR2000029818,ChiCTR,2020-02-14,2020-02-20,False,"Guangzhou reborn health management consultation co., LTD",Not Recruiting,Not Applicable,Interventional,No Country Given,Cancelled by the investigator            Clinical Study for Umbilical Cord Blood Plasma in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),Not relevant,Not relevant,Not relevant,60,http://www.chictr.org.cn/showproj.aspx?proj=49382,None
500,ChiCTR2000029817,ChiCTR,2020-02-14,2020-02-20,False,"Guangzhou reborn health management consultation co., LTD",Not Recruiting,Not Applicable,Interventional,No Country Given,Cancelled by the investigator                    Clinical Study of Cord Blood NK Cells Combined with Cord Blood Mesenchymal Stem Cells in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),Not relevant,Not relevant,Not relevant,60,http://www.chictr.org.cn/showproj.aspx?proj=49384,None
501,ChiCTR2000029816,ChiCTR,2020-02-14,2020-02-20,False,"Guangzhou reborn health management consultation co., LTD",Not Recruiting,Not Applicable,Interventional,No Country Given,Cancelled by the investigator                      Clinical Study for Cord Blood Mesenchymal Stem Cells in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),Not relevant,Not relevant,Not relevant,60,http://www.chictr.org.cn/showproj.aspx?proj=49389,None
502,ChiCTR2000029812,ChiCTR,2020-02-14,2020-02-20,False,"Guangzhou reborn health management consultation co., LTD",Not Recruiting,Not Applicable,Interventional,No Country Given,Cancelled by the investigator               Clinical Study for Umbilical Cord Blood Mononuclear Cells in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19),Not relevant,Not relevant,Not relevant,60,http://www.chictr.org.cn/showproj.aspx?proj=49374,None
503,ChiCTR2000029770,ChiCTR,2020-02-13,2020-02-13,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,"Study for epidemiology, diagnosis and treatment of novel coronavirus pneumonia (COVID-19)",Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,http://www.chictr.org.cn/showproj.aspx?proj=49412,None
504,ChiCTR2000029592,ChiCTR,2020-02-05,2020-02-07,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Clinical Study of Arbidol Hydrochloride Using for Post-exposure Prophylaxis of 2019-nCoV in High-risk Population Including Medical Staff,Drug (Chemoprophylaxis),Umifenovir,Umifenovir,1000,http://www.chictr.org.cn/showproj.aspx?proj=49069,None
505,ChiCTR2000031163,ChiCTR,2020-03-23,2020-02-16,True,The People's Hospital of Guangxi Zhuang Autonomous Region,Not Recruiting,Not Applicable,Observational,China,The relationship between Vitamin D andnovel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,80,http://www.chictr.org.cn/showproj.aspx?proj=51390,None
506,ChiCTR2000031150,ChiCTR,2020-03-23,2020-04-01,False,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Health services research,China,Application of radiology in the prevention and control system of emergency respiratory infectious diseases,Other (radiology),Radiology,Radiology,150,http://www.chictr.org.cn/showproj.aspx?proj=51021,None
507,ChiCTR2000031140,ChiCTR,2020-03-22,2020-02-01,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Study for the impact on fetus and neonates of vertical transmission of 2019-nCoV,Clinical Presentation,No Intervention,No Intervention,300,http://www.chictr.org.cn/showproj.aspx?proj=50605,None
508,ChiCTR2000031139,ChiCTR,2020-03-22,2020-03-20,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Interventional,China,Safety and Effectiveness of Human embryonic stem cell-derived M cells (CAStem) for Pulmonary Fibrosis Correlated with novel coronavirus pneumonia (COVID-19),ATMP,Cells (stem cells),Cells (stem cells),20,http://www.chictr.org.cn/showproj.aspx?proj=51404,None
509,ChiCTR2000031138,ChiCTR,2020-03-22,2020-02-26,True,"The Third Xiangya Hospital, Central South University",Recruiting,Not Applicable,Interventional,China,Prospective exploratory clinical research on the efficacy and safety of pirfenidone capsules in the treatment of severe novel coronavirus pneumonia (COVID-19),Drug,Pirfenidone,Pirfenidone,40,http://www.chictr.org.cn/showproj.aspx?proj=51416,None
510,ChiCTR2000031115,ChiCTR,2020-03-22,2020-05-01,False,Zhengzhou People's Hospital,Recruiting,Not Applicable,Observational,China,A medical records based study of peripheral blood T lymphocyte subsets in patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,30,http://www.chictr.org.cn/showproj.aspx?proj=51032,None
511,ChiCTR2000031104,ChiCTR,2020-03-22,2020-02-05,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Observational,China,Study for metagenomics of patients with novel coronavirus pneumonia (COVID-19),Genomics,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=51185,None
512,ChiCTR2000031090,ChiCTR,2020-03-22,2020-03-23,False,Ningbo Kangning Hospital,Not Recruiting,Not Applicable,Interventional,China,Psychological Support for Diagnosed Patients with novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,Psychological,60,http://www.chictr.org.cn/showproj.aspx?proj=51148,None
513,ChiCTR2000031089,ChiCTR,2020-03-22,2020-03-13,True,Guangzhou Eighth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,A medical records based study for Tou-Jie-Qu-Wen Granules in the Treatment of mild and moderate patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=51136,None
514,ChiCTR2000031088,ChiCTR,2020-03-22,2020-02-09,True,Xiangyang First People's Hospital,Recruiting,Not Applicable,Observational,China,A prognosis study of novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,314,http://www.chictr.org.cn/showproj.aspx?proj=51132,None
515,ChiCTR2000031023,ChiCTR,2020-03-21,2020-03-16,True,Hu'nan Cancer Hospital,Recruiting,Not Applicable,Interventional,China,Perioperative immune prediction and intervention of tumor patients undergoing surgery during the novel coronavirus pneumonia (COVID-19) outbreak period,Prognosis,No Intervention,No Intervention,320,http://www.chictr.org.cn/showproj.aspx?proj=50984,None
516,ChiCTR2000031014,ChiCTR,2020-03-21,2020-03-19,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Not Recruiting,Not Applicable,Observational,China,A Study for SARS-COV-2 RNA Level in Blood and Excrement of Novel Coronavirus Pneumonia (COVID-19) Convalescent Patients,Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=51348,None
517,ChiCTR2000030996,ChiCTR,2020-03-20,2020-03-18,True,"Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine",Recruiting,Not Applicable,Interventional,China,Effect of Auricular point pressing on insomnia of novel coronavirus pneumonia (COVID-19) patients: a randomized controlled trial.,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=51349,None
518,ChiCTR2000030993,ChiCTR,2020-03-20,2020-03-12,True,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Diagnostic test,China,A medical records based study for the value of Upper Respiratory Tract Virus Detection in the assessment of rehabilitation of novel coronavirus pneumonia (COVID-19) patient,Prognosis,No Intervention,No Intervention,300,http://www.chictr.org.cn/showproj.aspx?proj=51342,None
519,ChiCTR2000030992,ChiCTR,2020-03-20,2020-03-10,True,"Changzheng Hospital, Naval Military Medical University, Shanghai",Recruiting,Not Applicable,Diagnostic test,No Country Given,A medical records based study for the diagnosis and prognosis prediction AI model of novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,http://www.chictr.org.cn/showproj.aspx?proj=51338,None
520,ChiCTR2000030989,ChiCTR,2020-03-20,2020-03-20,False,Beijing Normal University,Not Recruiting,Not Applicable,Interventional,China,Internet based Solution Focused Brief Therapy treating adolescent anxiety under the novel coronavirus pneumonia (COVID-19) outbreak: A randomized controlled trial,Other (psych),Psychological,Psychological,76,http://www.chictr.org.cn/showproj.aspx?proj=51331,None
521,ChiCTR2000030986,ChiCTR,2020-03-20,2020-03-20,False,Shenzhen Third People's Hospital,Recruiting,Not Applicable,Observational,China,Correlation of T lymphocytes level and clinical severity in novel coronavirus pneumonia (COVID-19) patients: a medical records based retrospective study,Clinical Presentation,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=51316,None
522,ChiCTR2000030985,ChiCTR,2020-03-20,2020-03-04,True,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,"Psychological Responses of Medical Staff during the Metaphase of novel coronavirus pneumonia (COVID-19) Outbreak in Hubei, China",Other (psych),No Intervention,No Intervention,1300,http://www.chictr.org.cn/showproj.aspx?proj=51311,None
523,ChiCTR2000030961,ChiCTR,2020-03-20,2020-01-01,True,"Changzheng Hospital, Naval Military Medical University, Shanghai",Recruiting,Not Applicable,Observational,No Country Given,"A Medical Records Based Retrospective Study for Clinical Characteristics, Treatments and Prognosis of Patients with Novel Coronavirus Pneumonia (COVID-19) in WuHan",Clinical Presentation,No Intervention,No Intervention,2000,http://www.chictr.org.cn/showproj.aspx?proj=51291,None
524,ChiCTR2000030952,ChiCTR,2020-03-19,2020-01-18,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Observational,China,Myocardial injury and arrythmias in the novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,No Intervention,93,http://www.chictr.org.cn/showproj.aspx?proj=51278,None
525,ChiCTR2000030951,ChiCTR,2020-03-19,2020-03-20,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,Developing and evaluating of artificial intelligence triage system for suspected novel coronavirus pneumonia (COVID-19): a retrospective study,Other (software),No Intervention,No Intervention,2500,http://www.chictr.org.cn/showproj.aspx?proj=51283,None
526,ChiCTR2000030950,ChiCTR,2020-03-19,2020-02-10,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Basic Science,China,Study for novel coronavirus pneumonia (COVID-19) patients etiology and immune response and guidance for vaccine design,Clinical Presentation,No Intervention,No Intervention,50,http://www.chictr.org.cn/showproj.aspx?proj=51272,None
527,ChiCTR2000030947,ChiCTR,2020-03-19,2020-02-11,True,"Beijing Chaoyang Hospital, Capital Medical University",Recruiting,Not Applicable,Observational,China,A medical records based study for clinical application of extracorporeal membrane oxygenation in the treatment of severe respiratory failure patients with novel coronavirus pneumonia (COVID-19),Drug,Oxygen,Oxygen,34,http://www.chictr.org.cn/showproj.aspx?proj=51267,None
528,ChiCTR2000030946,ChiCTR,2020-03-19,2020-02-10,True,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Phase 4,Interventional,China,Effects of different VTE prevention methods on the prognosis of hospitalized patients with novel coronavirus pneumonia (COVID-19),Drug,Heparin,Heparin,120,http://www.chictr.org.cn/showproj.aspx?proj=51265,None
529,ChiCTR2000030944,ChiCTR,2020-03-18,2020-09-01,False,The Second Affiliated Hospital of Nanchang University,Not Recruiting,Phase 1,Interventional,China,Clinical study of human NK cells and MSCs transplantation for severe novel coronavirus pneumonia (COVID-19),ATMP,"Cells, (mesenchymal/NK)",Cells (mesenchymal); Cells (NK),20,http://www.chictr.org.cn/showproj.aspx?proj=50199,None
530,ChiCTR2000030943,ChiCTR,2020-03-18,2020-03-31,False,Shandong Provincial Hospital,Not Recruiting,Not Applicable,Observational,China,Venous Thrombosis Risk of novel coronavirus pneumonia (COVID-19) Patients: A Prospective Study,Prognosis,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=50898,None
531,ChiCTR2000030942,ChiCTR,2020-03-18,2020-01-20,True,Shanghai Kongjiang Hospital,Not Recruiting,Not Applicable,Observational,China,Combined diagnostic value of novel coronavirus (2019-CoV) infection detected by NLR and CRP,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,191,http://www.chictr.org.cn/showproj.aspx?proj=50981,None
532,ChiCTR2000030941,ChiCTR,2020-03-18,2020-01-28,True,"Hu'nan Provincial People's Hospital, Hu'nan Normal University",Recruiting,Not Applicable,Observational,China,"A medical records based study for clinical features and prognosis of severe patients with novel coronavirus pneumonia (COVID-19) in Huanggan, Hubei in Huanggang.",Clinical Presentation,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=51000,None
533,ChiCTR2000030939,ChiCTR,2020-03-18,2020-03-16,True,PLA General Hospital,Recruiting,Not Applicable,Interventional,China,Preliminary evaluation of the safety and efficacy of oral LL-37 antiviral peptide (CAS001) in the treatment of novel coronavirus pneumonia (COVID-19),ATMP,Gene-derived protein,Gene-derived protein,10,http://www.chictr.org.cn/showproj.aspx?proj=51059,None
534,ChiCTR2000030934,ChiCTR,2020-03-18,2020-03-01,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Observational,China,A Platform for Rapid Immuno-detection and Emergency Vaccine Development of Novel Coronavirus (2019-COV),Other (software),No Intervention,No Intervention,90,http://www.chictr.org.cn/showproj.aspx?proj=51160,None
535,ChiCTR2000030933,ChiCTR,2020-03-18,2020-03-31,False,The First Affiliated Hospital of Nanchang University,Not Recruiting,Not Applicable,Interventional,China,Effectiveness of ''Liu-Zi-Jue'' combined with respiratory muscle training for respiratory function in novel coronavirus pneumonia (COVID-19) patients: a randomized controlled trial,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,108,http://www.chictr.org.cn/showproj.aspx?proj=51184,None
536,ChiCTR2000030932,ChiCTR,2020-03-18,2020-02-01,True,Anqing Municipal Hospital,Recruiting,Not Applicable,Observational,China,Correlation between virological negative conversion and clinical factors and prognosis in patients with novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=51230,None
537,ChiCTR2000030931,ChiCTR,2020-03-18,2020-03-23,False,HuiZhou Municipal Central Hospital,Not Recruiting,Not Applicable,Observational,China,A Medical Records Based Study for Clinical Characteristic and Outcomes of Hospitalized Patients With Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,60,http://www.chictr.org.cn/showproj.aspx?proj=51212,None
538,ChiCTR2000030929,ChiCTR,2020-03-17,2020-03-17,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, parallel-controlled trial to evaluate the efficacy and safety of anti-SARS-CoV-2 virus inactivated plasma in the treatment of severe novel coronavirus pneumonia (COVID-19)",ATMP,Plasma,Plasma,60,http://www.chictr.org.cn/showproj.aspx?proj=50696,None
539,ChiCTR2000030922,ChiCTR,2020-03-17,2020-02-26,True,Foshan First People's Hospital,Recruiting,Not Applicable,Interventional,China,"Prospective, open-label, controlled, multicenter cohort study of long-acting interferon plus ribavirin in patients with novel coronavirus pneumonia (COVID-19)",Drug,Interferon + Ribavirin vs. Umifenovir + Ribavirin,Interferon; Ribavirin; Umifenovir,30,http://www.chictr.org.cn/showproj.aspx?proj=51141,None
540,ChiCTR2000030920,ChiCTR,2020-03-17,2020-02-20,True,"Hwa Mei Hospital, University of Chinese Academy of Sciences",Recruiting,Not Applicable,Interventional,China,"Evaluation of the effect of taking tricholoma matsutake, cannabis sativa capsule and dendrobium candidum to nutrition intervention of patients with novel coronavirus pneumonia (COVID-19) during convalescence.",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=50476,None
541,ChiCTR2000030919,ChiCTR,2020-03-17,2020-03-20,False,Xiangya Hospital of Central South University,Not Recruiting,Not Applicable,Observational,China,An observational study for cardiac and pulmonary ultrasound and evaluation of treatment of severe patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,80,http://www.chictr.org.cn/showproj.aspx?proj=51149,None
542,ChiCTR2000030906,ChiCTR,2020-03-17,2020-03-10,True,Jiangsu Provincial Center for Disease Control and Prevention,Recruiting,Phase 1,Prevention,China,A phase I clinical trial for recombinant novel coronavirus (2019-COV) vaccine (adenoviral vector),ATMP,Adenovirus vector,Adenovirus vector,108,http://www.chictr.org.cn/showproj.aspx?proj=51154,None
543,ChiCTR2000030771,ChiCTR,2020-03-14,2020-03-01,True,The Second Xiangya Hospital of Central South University,Not Recruiting,Not Applicable,Diagnostic test,China,Screening and identification of peripheral blood biomarkers in patients with COVID-19 infection based on multiomics studies,Genomics,No Intervention,No Intervention,30,http://www.chictr.org.cn/showproj.aspx?proj=50961,None
544,ChiCTR2000030765,ChiCTR,2020-03-13,2019-12-01,True,The Second Affiliated Hospital of Guizhou University of traditional Chinese Medicine,Not Recruiting,Not Applicable,Epidemiological research,China,Cancelled by the investigator                 Clinical guidance of diagnose and treatment for novel coronavirus pneumonia (COVID-19) based on ''Shi-Du-Yi'',Not relevant,Not relevant,Not relevant,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=50964,None
545,ChiCTR2000030539,ChiCTR,2020-03-06,2020-03-06,False,Guangzhou Eighth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Study for clinical oral characteristics of patients with novel coronavirus pneumonia (COVID-19) and Effect of 3% hydrogen peroxide gargle on the Intraoral novel coronavirus,Drug,Hydrogen peroxide,Hydrogen peroxide,40,http://www.chictr.org.cn/showproj.aspx?proj=50660,None
546,ChiCTR2000030519,ChiCTR,2020-03-05,2020-03-06,False,Guangzhou Eighth People's Hospital,Not Recruiting,Not Applicable,Observational,China,Study for the clinical characteristics and digestive system damage of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,40,http://www.chictr.org.cn/showproj.aspx?proj=50604,None
547,ChiCTR2000030254,ChiCTR,2020-02-26,2020-02-20,True,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,"the Efficacy and Safety of Favipiravir for novel coronavirusâ€“infected pneumonia: A multicenter, randomized, open, positive, parallel-controlled clinical study",Drug,Favipiravir vs. Umifenovir,Favipiravir; Umifenovir,240,http://www.chictr.org.cn/showproj.aspx?proj=50137,None
548,ChiCTR2000030224,ChiCTR,2020-02-26,2020-02-26,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Interventional,China,Cancelled by the investigator                Clinical study of mesenchymal stem cells in treating severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),32,http://www.chictr.org.cn/showproj.aspx?proj=49968,None
549,ChiCTR2000030168,ChiCTR,2020-02-24,2020-02-29,False,"Affiliated Hospital of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine",Not Recruiting,Not Applicable,Observational,China,Cancelled by the investigator                   A real world study for Compound Houttuyniae Mixture for prevention of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,2000,http://www.chictr.org.cn/showproj.aspx?proj=49433,None
550,ChiCTR2000030095,ChiCTR,2020-02-23,2020-02-23,False,The First Affiliated Hospital of Nanchang University,Recruiting,Not Applicable,Observational,China,A medical records based study for optimization and evaluation of the comprehensive diagnosis and treatment of novel coronavirus pneumonia (COVID-19) and the assessment of risk factors for severe pneumonia,Clinical Presentation,No Intervention,No Intervention,94,http://www.chictr.org.cn/showproj.aspx?proj=49845,None
551,ChiCTR2000029955,ChiCTR,2020-02-17,2020-03-01,False,"West China Second Hospital, Sichuan University",Not Recruiting,Not Applicable,Diagnostic test,China,Evaluation of myocardial injury of novel coronavirus pneumonia (COVID-19) assessed by multimodal MRI imaging,Clinical Presentation,No Intervention,No Intervention,80,http://www.chictr.org.cn/showproj.aspx?proj=49531,None
552,ChiCTR2000029868,ChiCTR,2020-02-15,2020-02-11,True,"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",Not Recruiting,Phase 4,Interventional,China,"Hydroxychloroquine treating novel coronavirus pneumonia (COVID-19): a randomized controlled, open label, multicenter trial",Drug,Hydroxychloroquine,Hydroxychloroquine,360,http://www.chictr.org.cn/showproj.aspx?proj=49524,None
553,ChiCTR2000029830,ChiCTR,2020-02-15,2020-02-14,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Not Recruiting,Not Applicable,Observational,China,"A study for the psychological status, social support, and care needs of tumor patients admitted to a general hospital during the novel coronavirus pneumonia (COVID-19) outbreak",Other (psych),No Intervention,No Intervention,400,http://www.chictr.org.cn/showproj.aspx?proj=49511,None
554,ChiCTR2000029658,ChiCTR,2020-02-09,2020-02-10,False,Central Theater General Hospital of PLA,No Status Given,Not Applicable,Interventional,China,Nasal high-fow preoxygenation assisted fibre-optic bronchoscope intubation in patients with critical novel coronavirus pneumonia (COVID-19),Other (physical),Mechanical ventilation,Mechanical ventilation,60,http://www.chictr.org.cn/showproj.aspx?proj=49074,None
555,ChiCTR2000029573,ChiCTR,2020-02-05,2020-02-06,False,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, open, controlled clinical study to evaluate the efficacy and safety of recombinant cytokine gene-derived protein injection in combination with standard therapy in patients with novel coronavirus infection",ATMP,Gene-derived protein,Gene-derived protein,480,http://www.chictr.org.cn/showproj.aspx?proj=49065,None
556,ChiCTR2000029496,ChiCTR,2020-02-03,2020-01-29,True,The First Hospital of Changsha; The Second Xiangya Hospital of Central South University,Recruiting,Phase 4,Interventional,China,"A randomized, open label, parallel controlled trial of evaluating the efficacy of recombinant cytokine gene-derived protein injection for clearing novel coronavirus in patients with novel coronavirus pneumonia (COVID-19)",ATMP,Gene-derived protein,Gene-derived protein,90,http://www.chictr.org.cn/showproj.aspx?proj=48809,None
557,EUCTR2020-000890-25-FR,EU Clinical Trials Register,2020-03-10,2020-05-03,False,Fondation Méditerranée Infection (FMI) - IHU Méditerranée Infection,Authorised,Phase 3,Interventional,France,Hydroxychloroquine as a treatment for coronavirus disease COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,25,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000890-25,None
558,JPRN-UMIN000039686,JPRN,2020-03-06,2020-02-01,True,The Prince Charles Hospital,Recruiting,Not Applicable,Observational,"Japan, Australia, Asia, Europe",ExtraCorporeal Membrane Oxygenation for 2019 novel Coronavirus Acute Respiratory Disease,Drug,Oxygen,Oxygen,500,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045268,None
559,ChiCTR2000031366,ChiCTR,2020-03-29,2020-04-01,False,Chinese PLA General Hospital,Not Recruiting,Not Applicable,Observational,China,Causes of fever in outpatient outside Wuhan during novel coronavirus pneumonia pandemic: a medical records based retrospective analysis,Clinical Presentation,No Intervention,No Intervention,5000,http://www.chictr.org.cn/showproj.aspx?proj=51692,None
560,ChiCTR2000031365,ChiCTR,2020-03-29,2020-01-17,True,Westlake University,Recruiting,Not Applicable,Diagnostic test,China,To explore the pathogenesis and course prediction of novel coronavirus pneumonia (COVID-19) severe patients,Prognosis,No Intervention,No Intervention,0,http://www.chictr.org.cn/showproj.aspx?proj=51694,None
561,ChiCTR2000031361,ChiCTR,2020-03-28,2020-03-31,False,Hubei Maternal and Child Health Care Hospital,Not Recruiting,Not Applicable,Observational,China,Retrospective analysis of anesthesia management of emergency cesarean section in non-pneumonia hospital of Wuhan during pandemic of novel coronavirus pneumonia (COVID-19),Drug,Other,Other,2000,http://www.chictr.org.cn/showproj.aspx?proj=51385,None
562,ChiCTR2000031356,ChiCTR,2020-03-28,2020-04-12,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Study for the changes of the brain structure and function in healed patients of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,600,http://www.chictr.org.cn/showproj.aspx?proj=51499,None
563,ChiCTR2000031337,ChiCTR,2020-03-28,2020-03-18,True,Shandong Eye Institute,Recruiting,Not Applicable,Observational,China,"The relationship between habits of using eyes, degree of visual fatigue and myopia progression in students during the novel coronavirus pneumonia (COVID-19) pandemic",Clinical Presentation,No Intervention,No Intervention,400,http://www.chictr.org.cn/showproj.aspx?proj=51170,None
564,ChiCTR2000031336,ChiCTR,2020-03-28,2020-04-12,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,AI based prognostic evaluation of novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,1000,http://www.chictr.org.cn/showproj.aspx?proj=51517,None
565,ChiCTR2000031330,ChiCTR,2020-03-27,2020-03-18,True,Shandong Eye Institute,Recruiting,Not Applicable,Observational,China,Analysis for prevention and control effects of orthokeratology lens on myopia adolescents during the novel coronavirus pneumonia (COVID-19) pandemic situation,Other (device),Orthokeratology lens,Orthokeratology lens,160,http://www.chictr.org.cn/showproj.aspx?proj=51504,None
566,ChiCTR2000031329,ChiCTR,2020-03-27,2020-03-11,True,Guangdong Second Provincial General Hospital,Recruiting,Not Applicable,Observational,No Country Given,"Influence of novel coronavirus pneumonia (COVID-19) on disease activity, medical and mental condition of patients with rheumatic diseases",Clinical Presentation,No Intervention,No Intervention,120,http://www.chictr.org.cn/showproj.aspx?proj=51667,None
567,ChiCTR2000031328,ChiCTR,2020-03-27,2020-03-13,True,The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,The protective effect of sleep psychology and music therapy of novel coronavirus pneumonia (COVID-19) mild and moderate type patients,Other,Sleep aids,Sleep aids,60,http://www.chictr.org.cn/showproj.aspx?proj=51425,None
568,ChiCTR2000031324,ChiCTR,2020-03-27,2020-04-10,False,Nanjing University Medical College Affiliated Drum Tower Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,The investigation on medical adhesive-related skin injury caused by protective dressings of medical staffs during the period of novel coronavirus pneumonia (COVID-19),Other (device),No Intervention,No Intervention,300,http://www.chictr.org.cn/showproj.aspx?proj=51668,None
569,ChiCTR2000031319,ChiCTR,2020-03-27,2020-04-01,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe novel coronavirus pneumonia (COVID-19) patients,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,http://www.chictr.org.cn/showproj.aspx?proj=51647,None
570,ChiCTR2000031301,ChiCTR,2020-03-27,2020-02-01,True,China-Japan Union Hospital of Jilin Unversity,Not Recruiting,Not Applicable,Observational,China,A retrospective study of clinical characteristics and prognosis of novel coronavirus pneumonia (COVID-19) patients with myocardial injury,Prognosis,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=51603,None
571,ChiCTR2000031296,ChiCTR,2020-03-27,2020-01-14,True,Yichang Central People's Hospital,Not Recruiting,Not Applicable,Observational,China,A medical records based study for clinical features of novel coronavirus pneumonia (COVID-19) patients and risk factors of death,Clinical Presentation,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=51584,None
572,ChiCTR2000031293,ChiCTR,2020-03-27,2020-03-16,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Epidemiological study of novel coronavirus infection (COVID-19) in children at medium/low risk,Clinical Presentation (Epidemiology),No Intervention,No Intervention,240,http://www.chictr.org.cn/showproj.aspx?proj=51629,None
573,ChiCTR2000031272,ChiCTR,2020-03-26,2020-02-18,True,China European International Business School (CEIBS),Not Recruiting,Not Applicable,Interventional,China,The effectiveness of mindfulness intervention in improving people's psychological and physical well-being during novel coronavirus pneumonia (COVID-19) outbreak,Other (psych),Psychological,Psychological,110,http://www.chictr.org.cn/showproj.aspx?proj=51455,None
574,ChiCTR2000031271,ChiCTR,2020-03-26,2020-04-01,False,The Third Affiliated Hospital of Sun Yat-Sen University,Not Recruiting,Not Applicable,Interventional,China,Metabolic abnormalities and rearrangement reversal treatment of patient with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,80,http://www.chictr.org.cn/showproj.aspx?proj=51194,None
575,ChiCTR2000031252,ChiCTR,2020-03-25,2020-02-10,True,Chongqing Medical University,Not Recruiting,Not Applicable,Observational,China,Outcomes and infectivity of patients with asymptomatic novel coronavirus (COVID-19) infection,Clinical Presentation,No Intervention,No Intervention,60,http://www.chictr.org.cn/showproj.aspx?proj=51559,None
576,ChiCTR2000031247,ChiCTR,2020-03-25,2020-03-01,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Observational,No Country Given,Study on the mental state of medical staff  during the epidemic period of novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,No Intervention,500,http://www.chictr.org.cn/showproj.aspx?proj=51540,None
577,ChiCTR2000031246,ChiCTR,2020-03-25,2020-02-01,True,Chongqing Medical University,Not Recruiting,Not Applicable,Observational,China,Epidemiological survey of close contacts of novel coronavirus pneumonia (COVID-19),Clinical Presentation (Epidemiology),No Intervention,No Intervention,68,http://www.chictr.org.cn/showproj.aspx?proj=51535,None
578,ChiCTR2000031245,ChiCTR,2020-03-25,2020-01-25,True,Renmin Hospital of Wuhan University,Recruiting,Not Applicable,Observational,China,Epidemiologic and Clinical Characteristics of novel coronavirus pneumonia (COVID-19) in surgical patients: a medical records based retrospective study,Clinical Presentation (Epidemiology),No Intervention,No Intervention,2000,http://www.chictr.org.cn/showproj.aspx?proj=51518,None
579,ChiCTR2000031244,ChiCTR,2020-03-25,2020-03-25,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Shedding virus and functional prognosis in patients with novel coronavirus pneumonia (COVID-19): a medical records based study,Prognosis,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=51486,None
580,ChiCTR2000031227,ChiCTR,2020-03-25,2020-03-26,False,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,No Country Given,"Clinical features and prognosis of invasive echanicalventilation patients with novel coronavirus pneumonia (COVID-19) in Wuhan, China: a single-centered, retrospective, observational study",Other (physical),Mechanical ventilation,Mechanical ventilation,40,http://www.chictr.org.cn/showproj.aspx?proj=51473,None
581,ChiCTR2000031214,ChiCTR,2020-03-24,2020-03-31,False,Wuhan Third Hospital,Not Recruiting,Not Applicable,Observational,China,Clinical study on the correlation between novel coronavirus pneumonia (COVID-19) clinical rehabilitation assessment and prognosis,Prognosis,No Intervention,No Intervention,60,http://www.chictr.org.cn/showproj.aspx?proj=51509,None
582,ChiCTR2000031204,ChiCTR,2020-03-24,2020-01-30,True,"Beijing You'an Hospital, Capital Medical University",Recruiting,Phase 2,Interventional,China,"A multicenter, single-blind, randomized controlled clinical trial for chloroquine phosphate in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Chloroquine,Chloroquine,300,http://www.chictr.org.cn/showproj.aspx?proj=49420,None
583,ChiCTR2000031203,ChiCTR,2020-03-24,2020-03-16,True,Zhengzhou People's Hospital,Recruiting,Not Applicable,Interventional,China,Study for the effect of Moxibustion Guidance and Intervention based on internet for the discharged patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,28,http://www.chictr.org.cn/showproj.aspx?proj=51030,None
584,ChiCTR2000031198,ChiCTR,2020-03-23,2020-04-01,False,Nothern Jiangsu People's Hospital,Recruiting,Not Applicable,Observational,China,A medical records based study for clinical characteristics and risk factors of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,150,http://www.chictr.org.cn/showproj.aspx?proj=51488,None
585,ChiCTR2000031196,ChiCTR,2020-03-23,2020-01-10,True,The Fifth Medical Center of PLA General Hospital,Recruiting,Not Applicable,Interventional,China,Efficacy and optimization of antiviral therapy for novel coronavirus pneumonia (COVID-19) patients,Drug,Lopinavir/ritonavir + Interferon,Lopinavir/ritonavir; Interferon,90,http://www.chictr.org.cn/showproj.aspx?proj=51112,None
586,ChiCTR2000031187,ChiCTR,2020-03-23,2020-03-23,False,Wuhan Third Hospital; Tongren Hospital of Wuhan University,Not Recruiting,Not Applicable,Epidemiological research,China,A medical records based retrospective study for novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,1292,http://www.chictr.org.cn/showproj.aspx?proj=51442,None
587,ChiCTR2000031176,ChiCTR,2020-03-23,2020-02-20,True,Zhengzhou People's Hospital,Recruiting,Not Applicable,Observational,China,Study on home pharmaceutical care for chronic patients over the novel coronavirus pneumonia (COVID-19) epidemic,Other,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=51443,None
588,ChiCTR2000030988,ChiCTR,2020-03-20,2020-03-23,False,Guangdong Provincial Hospital of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,A RCT for Hua-Shi Bai-Du granules in patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,204,http://www.chictr.org.cn/showproj.aspx?proj=51317,None
589,ChiCTR2000030962,ChiCTR,2020-03-20,2020-03-01,True,Hospital of Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,"Clinical efficacy of TCM syndrome differentiation in the treatment of severe/critical type of novel coronavirus pneumonia (COVID-19): a prospective, observational, one-arm clinical study",Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=51254,None
590,ChiCTR2000030940,ChiCTR,2020-03-18,2020-02-01,True,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Study for ''Bai-Du Duan Fang'' application on the acupoint in the treatment of general type novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,76,http://www.chictr.org.cn/showproj.aspx?proj=51061,None
591,ChiCTR2000030938,ChiCTR,2020-03-18,2020-02-28,True,The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Recruiting,Not Applicable,Observational,China,Clinical investigation and reseach on TCM syndrome of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,160,http://www.chictr.org.cn/showproj.aspx?proj=51239,None
592,ChiCTR2000030937,ChiCTR,2020-03-18,2020-03-19,False,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Phase 4,Interventional,China,"A randomized, open-label, controlled trial for Gu-Shen Ding-Chuan-Wan in the treatment of patients with novel coronavirus pneumonia (COVID-19) at recovery phase with Fei-Pi-Qi-Xu Zhen",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,144,http://www.chictr.org.cn/showproj.aspx?proj=51240,None
593,ChiCTR2000030936,ChiCTR,2020-03-18,2020-03-10,True,Hospital of Chengdu University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,A real-world study for the Chinese medicines ''Xinguan 2'' and ''Xinguan 3'' in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,2840,http://www.chictr.org.cn/showproj.aspx?proj=51100,None
594,ChiCTR2000030923,ChiCTR,2020-03-17,2020-02-15,True,Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,The treatment and diagnosis plan of integrated traditional Chinese and Western medicine for novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,400,http://www.chictr.org.cn/showproj.aspx?proj=51139,None
595,ChiCTR2000030817,ChiCTR,2020-03-15,2020-02-28,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Multicenter clinical study of evaluation of multi-organ function in patients with novel coronavirus pneumonia (COVID-19) by ultrasound,Clinical Presentation,No Intervention,No Intervention,800,http://www.chictr.org.cn/showproj.aspx?proj=50631,None
596,ChiCTR2000030704,ChiCTR,2020-03-10,2020-02-10,True,The First People's Hospital of Jiangxia District,No Status Given,Phase 4,Interventional,China,Observation Of Clinical Efficacy And Safety Of Bufonis Venenum Injection In The Treatment Of Severe Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50,http://www.chictr.org.cn/showproj.aspx?proj=50778,None
597,ChiCTR2000030330,ChiCTR,2020-02-28,2020-02-28,False,The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital),No Status Given,Not Applicable,Observational,China,Cancelled by the investigator                               Clinical research of 6-minute walk training on motor function of novel coronavirus pneumonia (COVID-19),Other (exercise),Exercise,Exercise,10,http://www.chictr.org.cn/showproj.aspx?proj=50274,None
598,ChiCTR2000030288,ChiCTR,2020-02-27,2020-02-27,False,China Academy of Chinese Medical Sciences,Recruiting,Not Applicable,Interventional,China,Efficacy of Traditional Chinese Medicine in the Treatment of Novel Coronavirus Pneumonia (COVID-19): a Randomized Controlled Trial,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,204,http://www.chictr.org.cn/showproj.aspx?proj=50202,None
599,ChiCTR2000030256,ChiCTR,2020-02-26,2020-02-01,True,"Daping Hospital, Army Medical University",Not Recruiting,Not Applicable,Epidemiological research,China,"Epidemiological and clinical characteristics of COVID-19: a large-scale investigation in epicenter Wuhan, China",Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,http://www.chictr.org.cn/showproj.aspx?proj=50078,None
600,ChiCTR2000030198,ChiCTR,2020-02-25,2020-02-24,True,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,Clinical research of pulmonary rehabilitation in survivors due to severe or critial novel coronavirus pneumonia (COVID-19),Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,60,http://www.chictr.org.cn/showproj.aspx?proj=50066,None
601,ChiCTR2000030028,ChiCTR,2020-02-20,2020-02-24,False,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Interventional,China,Clinical comparative study of PD-1 mAb in the treatment of severe and critical patients with novel coronavirus pneumonia (COVID-19),Drug,PD1,PD1,40,http://www.chictr.org.cn/showproj.aspx?proj=49840,None
602,ChiCTR2000029982,ChiCTR,2020-02-18,2020-03-26,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Prediction of prognosis and antiviral effect of patients with neocoronavirus infected pneumonia based on Peripheral blood exosomal metabolomics analysis and radiomics in CT of lung and its mechanism,Genomics,No Intervention,No Intervention,150,http://www.chictr.org.cn/showproj.aspx?proj=49724,None
603,EUCTR2020-000919-69-NL,EU Clinical Trials Register,2020-03-17,2020-03-17,False,UMC Utrecht,Authorised,Phase 4,Interventional,Netherlands,Reducing health care workers absenteeism in Coronavirus 2019 pandemic nu enhancement of the immune system through vaccination with Bacillus Calmette-GuÃ©rin,ATMP,Vaccine,Vaccine,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000919-69,None
604,NCT04331860,ClinicalTrials.gov,2020-03-30,2020-03-30,False,RAD-AID International,Recruiting,Not Applicable,Observational,United States,COVID-19 Public Image Registry,Clinical Presentation,No Intervention,No Intervention,500000,https://clinicaltrials.gov/show/NCT04331860,None
605,ChiCTR2000031639,ChiCTR,2020-04-05,2020-03-27,True,Peking University Sixth Hospital,Not Recruiting,Not Applicable,Interventional,China,Effects of a single session internet-delivered cognitive behavioral therapy for Acute Insomnia during the pandemic of novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,Psychological,192,http://www.chictr.org.cn/showproj.aspx?proj=51119,None
606,ChiCTR2000031630,ChiCTR,2020-04-05,2020-02-17,True,Guangzhou Eighth People's Hospital,Recruiting,Not Applicable,Interventional,China,Clinical study for Celebrex in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Celecoxib,Celecoxib,60,http://www.chictr.org.cn/showproj.aspx?proj=50474,None
607,ChiCTR2000031627,ChiCTR,2020-04-05,2020-04-20,False,Second People's Hospital of Fuyang City,Not Recruiting,Not Applicable,Basic Science,China,Study for the Mechanism of the Relationship between Infection of novel coronavirus pneumonia (COVID-19) and Host Innate Immune,Clinical Presentation,No Intervention,No Intervention,60,http://www.chictr.org.cn/showproj.aspx?proj=51865,None
608,ChiCTR2000031589,ChiCTR,2020-04-05,2020-03-06,True,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,Investigation for the sleep quality in non-health care workers during the pandemic of novel coronavirus pneumonia (COVID-19),Other (psych),No Intervention,No Intervention,462,http://www.chictr.org.cn/showproj.aspx?proj=51969,None
609,ChiCTR2000031587,ChiCTR,2020-04-04,2020-01-27,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,"A paired clinical study for novel coronavirus pneumonia (COVID-19) patients with ordinary, severe, critical, and deceased patients in Tongji Hospital",Clinical Presentation,No Intervention,No Intervention,2000,http://www.chictr.org.cn/showproj.aspx?proj=51952,None
610,ChiCTR2000031540,ChiCTR,2020-04-03,2020-02-05,True,Affiliated Hospital of Zunyi Medical University,Recruiting,Phase 1,Interventional,China,Study for clinical effect of rehabilitation nursing program for patients with novel coronavirus pneumonia (COVID-19),Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,100,http://www.chictr.org.cn/showproj.aspx?proj=51684,None
611,ChiCTR2000031538,ChiCTR,2020-04-03,2020-04-03,False,"Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine",Not Recruiting,Not Applicable,Health services research,China,Assessment of mental health status of first-line dental emergency medical personnel during novel coronavirus pneumonia (COVID-19) pandemic,Other (psych),No Intervention,No Intervention,123,http://www.chictr.org.cn/showproj.aspx?proj=51938,None
612,ChiCTR2000031533,ChiCTR,2020-04-03,2020-04-10,False,Peking Union Medical College Hospital,Not Recruiting,Not Applicable,Health services research,China,Survey of psychological status and related factors of emergency medical staff in the country during the novel coronavirus pneumonia (COVID-19) pandemic,Other (psych),No Intervention,No Intervention,7000,http://www.chictr.org.cn/showproj.aspx?proj=51835,None
613,ChiCTR2000031504,ChiCTR,2020-04-03,2019-12-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A multi-center telephone follow-up study of disease management and infection in rheumatic patients during novel coronavirus pneumonia (COVID-19) pandemic in Hubei province,Clinical Presentation,No Intervention,No Intervention,2000,http://www.chictr.org.cn/showproj.aspx?proj=51781,None
614,ChiCTR2000031503,ChiCTR,2020-04-03,2020-04-01,True,Shanghai Sixth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Application of non-invasive multichannel cardiopulmonary monitoring cloud management platform in patients with Novel Coronavirus Pneumonia (COVID-19),Other (device),Cardiopulmonary monitoring,Cardiopulmonary monitoring,100,http://www.chictr.org.cn/showproj.aspx?proj=51911,None
615,ChiCTR2000031500,ChiCTR,2020-04-02,2020-03-05,True,Peking University First Hospital,Not Recruiting,Not Applicable,Health services research,China,Impact of measuring distance and cold outdoor environment on the screening of novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,58,http://www.chictr.org.cn/showproj.aspx?proj=51897,None
616,ChiCTR2000031499,ChiCTR,2020-04-02,2020-02-10,True,Shanghai Oriental Hospital,Not Recruiting,Not Applicable,Observational,China,Sleep quality of patients with novel coronavirus pneumonia (COVID-19) treated in mobile cabin hospital: a retrospective study,Other,Sleep aids,Sleep aids,55,http://www.chictr.org.cn/showproj.aspx?proj=51915,None
617,ChiCTR2000031494,ChiCTR,2020-04-02,2020-02-01,True,Huangshi Hospital of Traditional Chinese Medicine,Recruiting,Phase 1,Interventional,China,Clinical study for stem cells in the treatment of severe novel coronavirus pneumonia (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),36,http://www.chictr.org.cn/showproj.aspx?proj=51904,None
618,ChiCTR2000031465,ChiCTR,2020-04-02,2020-03-25,True,The First People's Hospital of Jiangxia District,Not Recruiting,Not Applicable,Diagnostic test,China,Novel coronavirus (2019-nCOV) IgG detection kit (magnetic particle chemiluminescence) clinical trial,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,http://www.chictr.org.cn/showproj.aspx?proj=51538,None
619,ChiCTR2000031454,ChiCTR,2020-04-01,2020-01-25,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Interventional,China,Clinical study for prevention and treatment of digestive tract lesions caused by novel coronavirus pneumonia (COVID-19),Drug,Rabeprazole + chloroquine vs. lopinavir + rabeprazole,Rabeprazole; chloroquine; lopinavir; rabeprazole,56,http://www.chictr.org.cn/showproj.aspx?proj=51693,None
620,ChiCTR2000031453,ChiCTR,2020-04-01,2020-04-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Phase 4,Interventional,China,"Efficacy and safety of Nintedanib esilate soft capsules in the treatment of pulmonary fibrosis in healed moderate to severe patients of novel coronavirus pneumonia (COVID-19): a single-center, randomized, placebo-controlled trial",Drug,Nintedanib,Nintedanib,80,http://www.chictr.org.cn/showproj.aspx?proj=51859,None
621,ChiCTR2000031439,ChiCTR,2020-04-01,2020-03-20,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,No Country Given,A medical records based study for novel coronavirus pneumonia (COVID-19) patients undergoing endotracheal intubation,Other (physical),Mechanical ventilation,Mechanical ventilation,Not Available,http://www.chictr.org.cn/showproj.aspx?proj=51837,None
622,ChiCTR2000031438,ChiCTR,2020-04-01,2020-04-01,False,Affiliated Hospital of Southwest Medical University,Not Recruiting,Not Applicable,Observational,China,Analysis of changes in high risk factors of cervical spondylosis during novel coronavirus pneumonia (COVID-19) pandemic,Clinical Presentation,No Intervention,No Intervention,820,http://www.chictr.org.cn/showproj.aspx?proj=51815,None
623,ChiCTR2000031432,ChiCTR,2020-03-31,2020-05-01,False,Nanjing University,Not Recruiting,Phase 1,Basic Science,China,A single center clinical study of evaluating the injection of microRNA2911 plasmid in healthy adults,ATMP,RNA Plasmid,RNA Plasmid,15,http://www.chictr.org.cn/showproj.aspx?proj=51646,None
624,ChiCTR2000031430,ChiCTR,2020-03-31,2020-03-20,True,The Fifth Medical Center of PLA General Hospital,Recruiting,Phase 2,Interventional,China,Clinical study of human umbilical cord mesenchymal stem cells in the treatment of novel coronavirus pneumonia (COVID-19) induced pulmonary fibrosis,ATMP,Cells (mesenchymal),Cells (mesenchymal),200,http://www.chictr.org.cn/showproj.aspx?proj=49254,None
625,ChiCTR2000031429,ChiCTR,2020-03-31,2020-04-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,"The Effects of novel coronavirus pneumonia (COVID-19) Risk Factors on Dynamic Changes of  Immunological, biochemical, and Metabolic Parameters: a Retrospective Observational Study",Clinical Presentation,No Intervention,No Intervention,2000,http://www.chictr.org.cn/showproj.aspx?proj=51816,None
626,ChiCTR2000031428,ChiCTR,2020-03-31,2020-02-05,True,Wuhan Asia Heart Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,Clinical application value of multiple tests for novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,http://www.chictr.org.cn/showproj.aspx?proj=51813,None
627,ChiCTR2000031427,ChiCTR,2020-03-31,2020-03-25,True,The First People's Hospital of Jiangxia District,Not Recruiting,Not Applicable,Diagnostic test,China,Novel coronavirus infection (COVID-19) IgM detection kit (magnetic particle chemiluminescence) clinical trial,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,http://www.chictr.org.cn/showproj.aspx?proj=51809,None
628,ChiCTR2000031376,ChiCTR,2020-03-29,2020-03-28,True,Peking University Third Hospital,Recruiting,Not Applicable,Observational,China,A medical records based study for safety and effectiveness analysis of data from novel coronavirus pneumonia (COVID-19) patients with conventional therapy,Drug,Unspecified Drug,Unspecified Drug,600,http://www.chictr.org.cn/showproj.aspx?proj=51724,None
629,ChiCTR2000031199,ChiCTR,2020-03-23,2020-02-04,True,Xiangya Hospital of Central South University,Recruiting,Not Applicable,Observational,China,A Medical Records Based Retrospective Study for Clinical Characteristics of severe Novel Coronavirus Pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,120,http://www.chictr.org.cn/showproj.aspx?proj=51478,None
630,ACTRN12620000443998,ANZCTR,2020-04-06,2020-01-05,True,Flinders Medical Centre,Not Recruiting,Not Applicable,Interventional,Australia,Home rehabilitation for people with COVID-19: Implementing telehealth approaches to care,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,58,https://anzctr.org.au/ACTRN12620000443998.aspx,None
631,ACTRN12620000444987,ANZCTR,2020-04-06,2020-07-04,False,South Metropolitan Health Service,Not Recruiting,Not Applicable,Observational,Australia,COVID-19 Research Response (ISARIC/WHO Clinical Characterisation Protocol for Severe Emerging Infections COVID-19 Research Response Trial),Clinical Presentation,No Intervention,No Intervention,100000,https://anzctr.org.au/ACTRN12620000444987.aspx,None
632,ACTRN12620000447954,ANZCTR,2020-04-06,2020-03-31,True,Royal Brisbane & Women's Hospital,Recruiting,Not Applicable,Interventional,Australia,Use of therapeutic drug monitoring (TDM) to optimise oral/enteral hydroxychloroquine dosing in critically ill patients with COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,150,https://anzctr.org.au/ACTRN12620000447954.aspx,None
633,ACTRN12620000438954,ANZCTR,2020-04-06,2020-04-20,False,Griffith University,Not Recruiting,Not Applicable,Observational,Australia,Utilizing lung ultrasound in COVID-19 patients in ICU â€“ comparison of management strategies on survival and time on ventilation.,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,60,https://anzctr.org.au/ACTRN12620000438954.aspx,None
634,ACTRN12620000449932,ANZCTR,2020-04-06,2020-10-04,False,University of Melbourne,Not Recruiting,Not Applicable,Observational,Australia,Maternal and neonatal outcomes from women infected with SARS-COV2 (COVID-19) during pregnancy,Clinical Presentation,No Intervention,No Intervention,200,https://anzctr.org.au/ACTRN12620000449932.aspx,None
635,ChiCTR2000031860,ChiCTR,2020-04-12,2020-04-27,False,Beijing Sports University,Not Recruiting,Not Applicable,Observational,China,Study for the exercise rehabilitation therapy for the dysfunction of cured discharged novel coronavirus pneumonia (COVID-19) patients,Other (exercise),Exercise,Exercise,150,http://www.chictr.org.cn/showproj.aspx?proj=52198,None
636,ChiCTR2000031836,ChiCTR,2020-04-11,2020-01-23,True,The First Affiliated Hospital of Yangtze University,Not Recruiting,Not Applicable,Observational,China,A Medical Records Based study for the Clinical Characteristics Of Hospitalized Novel Coronavirus Pneumonia (COVID-19) Patients With Acute Respiratory Distress Syndrome,Clinical Presentation,No Intervention,No Intervention,45,http://www.chictr.org.cn/showproj.aspx?proj=52213,None
637,ChiCTR2000031834,ChiCTR,2020-04-11,2020-04-20,False,Jiangsu Province Hospital,Not Recruiting,Not Applicable,Interventional,China,A clinical study for the effect of remote monitoring exercise rehabilitation on the discharged patients with novel coronavirus pneumonia (COVID-19),Telehealth,Telehealth,Telehealth,120,http://www.chictr.org.cn/showproj.aspx?proj=52216,None
638,ChiCTR2000031794,ChiCTR,2020-04-10,2020-04-08,True,Huanggang Central Hospital,Not Recruiting,Not Applicable,Observational,China,A medical records based retrospective study for analysis clinical characteristics and risk factors of death in patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,130,http://www.chictr.org.cn/showproj.aspx?proj=52193,None
639,ChiCTR2000031783,ChiCTR,2020-04-10,2020-03-24,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,Bolivia,Investigation for Prevention Awareness against COVID-19,Other,No Intervention,No Intervention,883,http://www.chictr.org.cn/showproj.aspx?proj=51832,None
640,ChiCTR2000031782,ChiCTR,2020-04-10,2020-04-13,False,The Second Xiangya Hospital of Central South University,Not Recruiting,Not Applicable,Observational,China,A questionnaire investigation of hydroxychloroquine for its potential protective effect against novel coronavirus infection (COVID-19),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,550,http://www.chictr.org.cn/showproj.aspx?proj=51934,None
641,ChiCTR2000031781,ChiCTR,2020-04-10,2020-04-09,True,Jiangsu Provincial Center for Disease Control and Prevention,Not Recruiting,Phase 2,Interventional,China,"A randomized, double-blinded, placebo-controlled phase II clinical trial for Recombinant Novel Coronavirus (2019-nCOV) Vaccine (Adenovirus Vector)",ATMP,Vaccine,Vaccine,500,http://www.chictr.org.cn/showproj.aspx?proj=52006,None
642,ChiCTR2000031779,ChiCTR,2020-04-10,2020-01-01,True,Shandong Provincial Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Effect of novel coronavirus pneumonia (COVID-19) upon male reproductive system,Clinical Presentation,No Intervention,No Intervention,50,http://www.chictr.org.cn/showproj.aspx?proj=52051,None
643,ChiCTR2000031772,ChiCTR,2020-04-09,2020-01-10,True,Fujian Provincial Maternity and Child Health Hospital,Recruiting,Not Applicable,Interventional,No Country Given,Impact of WeChat-based parenting education for children with autism spectrum disorder and their mothers during the epidemic of Coronavirus disease 2019 (COVID-19),Other,Health Education,Health Education,105,http://www.chictr.org.cn/showproj.aspx?proj=52165,None
644,ChiCTR2000031770,ChiCTR,2020-04-09,2020-01-22,True,Shanghai Jiao Tong University Affiliated Sixth People's Hospital,Not Recruiting,Not Applicable,Observational,China,Experiences in nursing care for patients with suspected novel coronavirus pneumonia (COVID-19) in Shanghai,Clinical Presentation,No Intervention,No Intervention,119,http://www.chictr.org.cn/showproj.aspx?proj=52148,None
645,ChiCTR2000031752,ChiCTR,2020-04-09,2020-01-01,True,The First Affiliated Hospital of Nanjing Medical University,Not Recruiting,Not Applicable,Observational,China,A medical records based observational study for myocardial injury and cardiac function in critically ill patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,75,http://www.chictr.org.cn/showproj.aspx?proj=52135,None
646,ChiCTR2000031751,ChiCTR,2020-04-08,2020-04-01,True,Wuhan Fourth Hospital,Recruiting,Not Applicable,Observational,China,Novel coronavirus pneumonia (COVID-2019) patients' prognosis and their influence on heart and lung function,Prognosis,No Intervention,No Intervention,60,http://www.chictr.org.cn/showproj.aspx?proj=52130,None
647,ChiCTR2000031735,ChiCTR,2020-04-08,2020-03-01,True,Huzhou Central Hospital,Not Recruiting,Not Applicable,Interventional,China,Clinical study for natural killer (NK) cells from umbilical cord blood in the treatment of novel coronavirus pneumonia (COVID-19),ATMP,Cells (NK),Cells (NK),20,http://www.chictr.org.cn/showproj.aspx?proj=50613,None
648,ChiCTR2000031705,ChiCTR,2020-04-07,2020-03-10,True,Shanghai Jiao Tong University Affiliated Sixth People's Hospital,Recruiting,Not Applicable,Observational,China,Study for early biological warning signals in patients with acute renal injury caused by novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=51793,None
649,ChiCTR2000031700,ChiCTR,2020-04-07,2020-04-21,False,Chinese PLA General Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,Development and clinical application of novel coronavirus pneumonia (COVID-19) antigen reagent,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,600,http://www.chictr.org.cn/showproj.aspx?proj=52052,None
650,ChiCTR2000031699,ChiCTR,2020-04-07,2020-02-01,True,Wenzhou Central Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,Study for immune antibody and multi-group function of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,No Intervention,33,http://www.chictr.org.cn/showproj.aspx?proj=51924,None
651,ChiCTR2000031675,ChiCTR,2020-04-06,2020-04-06,False,Women's Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Observational,China,A medical records based retrospective analysis of maternal and infant outcomes in Cesarean delivery in Hangzhou non pneumonia Hospital during pandemic of Novel coronovirus pneumonia(COVID-19),Clinical Presentation,No Intervention,No Intervention,2000,http://www.chictr.org.cn/showproj.aspx?proj=52037,None
652,ChiCTR2000030750,ChiCTR,2020-03-13,2020-03-01,True,Shenzhen Third People's Hospital,Not Recruiting,Phase 1/Phase 2,Interventional,China,A clinical study for effectiveness and safety evaluation for recombinant chimeric COVID-19 epitope DC vaccine in the treatment of novel coronavirus pneumonia,ATMP,Vaccine,Vaccine,120,http://www.chictr.org.cn/showproj.aspx?proj=50928,None
653,ChiCTR2000030494,ChiCTR,2020-03-05,2020-03-01,True,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Observational,China,Early risk stratification of the novel coronavirus infected diseases (COVID-19): a multicenter retrospective study  (ERS-COVID-19 study),Prognosis,No Intervention,No Intervention,600,http://www.chictr.org.cn/showproj.aspx?proj=50077,None
654,ChiCTR2000030331,ChiCTR,2020-02-28,2020-02-01,True,The First Affiliated Hospital Division of Life Sciences and Medicine University of Science and Technology of China,Recruiting,Not Applicable,Epidemiological research,China,Construction of a Bio information platform for novel coronavirus pneumonia (COVID-19) patients follow-up in Anhui,Clinical Presentation,No Intervention,No Intervention,498,http://www.chictr.org.cn/showproj.aspx?proj=50271,None
655,ChiCTR2000030328,ChiCTR,2020-02-28,2020-03-02,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Phase 4,Interventional,China,Cancelled by the investigator                            Clinical application of inhaled acetylcysteine solution in the treatment of novel coronavirus pneumonia (COVID-19),Drug,Acetylcysteine,Acetylcysteine,60,http://www.chictr.org.cn/showproj.aspx?proj=50241,None
656,EUCTR2020-001301-23-FR,EU Clinical Trials Register,2020-03-26,2020-10-04,False,Assistance Publique – Hôpitaux de Paris,Authorised,Phase 3,Interventional,France,Efficacy of Addition of Naproxen for COVID-19 Infection / Enacovid Study,Drug,Naproxen,Naproxen,584,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001301-23,None
657,EUCTR2020-001381-11-FR,EU Clinical Trials Register,2020-03-29,2020-08-04,False,Assistance Publique – Hôpitaux de Paris,Authorised,Phase 3,Interventional,France,COVID-19 - ACORES-2 study: ACE inhibitors or ARBs discontinuation for Clinical Outcome Risk reduction in patients hospitalized for the Endemic Severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection,Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,554,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001381-11,None
658,EUCTR2020-001442-19-ES,EU Clinical Trials Register,2020-04-03,2020-02-04,True,Institut de Recerca Hospital de la Santa Creu i Sant Pau,Authorised,Phase 2,Interventional,Spain,"Clinical trial of combined use of hydroxychloroquine, azithromycin, and tocilizumab for the treatment of COVID-19",Drug,Tocilizumab + hydroxychloroquine + azithromycin,Tocilizumab; hydroxychloroquine; azithromycin,276,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001442-19,None
659,EUCTR2020-001385-11-ES,EU Clinical Trials Register,2020-04-03,2020-03-28,True,Plan Nacional sobre el Sida (PNS),Authorised,Phase 3,Interventional,Spain,EPICOS - Experimental clinical trial for PreventIon or COronavirus in health Care professionalS,Drug (Chemoprophylaxis),Emtricitabine/tenofovir + hydroxychloroquine,Emtricitabine; tenofovir; hydroxychloroquine,4000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001385-11,None
660,EUCTR2020-001409-21-ES,EU Clinical Trials Register,2020-04-03,2020-01-04,True,Fundación para la Formación e Investigación Sanitarias de la Región de Murcia (FFIS),Authorised,Phase 2,Interventional,Spain,DEFIBROTIDE AS PREVENTION AND TREATMENT OF RESPIRATORY DISTRESS AND CYTOKINE RELEASE SYNDROME OF COVID-19,Drug,Defibrotide,Defibrotide,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001409-21,None
661,EUCTR2020-001492-33-FR,EU Clinical Trials Register,2020-04-01,2020-10-04,False,L'Hôpital Fondation Adolphe de Rothschild,Authorised,Phase 3,Interventional,France,Interest in the administration of Dornase alpha aerosol in Acute Respiratory Distress Syndrome secondary to respiratory infection by the coronavirus SRASCoV-2 / COVID-19,Drug,Dornase alfa,Dornase alfa,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001492-33,None
662,EUCTR2020-001194-69-ES,EU Clinical Trials Register,2020-04-07,2020-03-30,True,Félix Gutiérrez-Rodero,Authorised,Phase 3,Interventional,Spain,Pilot study to evaluate the efficacy and safety of mefloquine as prophylaxis in people exposed to the disease caused by the new SARS-CoV-2 coronavirus (COVID-19),Drug (Chemoprophylaxis),Mefloquine,Mefloquine,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001194-69,None
663,EUCTR2020-001565-37-ES,EU Clinical Trials Register,2020-04-07,2020-03-04,True,ISGlobal,Authorised,Phase 3,Interventional,Spain,Prevention of novel Coronavirus infection with hydroxychloroquine,Drug,Hydroxychloroquine,Hydroxychloroquine,440,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001565-37,None
664,EUCTR2020-001421-31-ES,EU Clinical Trials Register,2020-04-07,2020-06-04,False,Sociedad Espaola de Farmacia Hospitalaria,Authorised,Phase 4,Interventional,Spain,Clinical trial for evaluation of efficacy and safety of hydroxychloroquine chemoprophylaxis against SARS-CoV-2 (COVID-19) infection in healthcare professionals.,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1530,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001421-31,None
665,EUCTR2020-001606-33-ES,EU Clinical Trials Register,2020-04-07,2020-07-04,False,Instituto Investigacin Sanitario Biocruces Bizkaia,Authorised,Phase 3,Interventional,Spain,Randomized clinical trial to evaluate the efficacy of hydroxychloroquine associated or not with azithromycin as a treatment for COVID-19 infection,Drug,Hydroxychloroquine + azithromycin vs. hydroxychloroquine,Hydroxychloroquine; azithromycin,132,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001606-33,None
666,EUCTR2020-001307-16-ES,EU Clinical Trials Register,2020-04-08,2020-01-04,True,Fundación para la Investigación Biomédica Hospital Ramón y Cajal,Authorised,Phase 3,Interventional,Spain,Efficacy and Safety of corticoids in patients with adult respiratory distress syndrome (ARDS) secondary to coronavirus infection.,Drug,Corticosteroids,Methylprednisolone,104,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001307-16,None
667,NCT04337216,ClinicalTrials.gov,2020-04-01,2020-05-01,False,Virginia Commonwealth University,Not Recruiting,Phase 2,Interventional,United States,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in Patients With Severe COVID-19 Pneumonia and Systemic Hyper-inflammation,Drug,Mavrilimumab,Mavrilimumab,10,https://clinicaltrials.gov/show/NCT04337216,None
668,NCT04343677,ClinicalTrials.gov,2020-04-09,2020-04-01,True,United States Department of Defense,Not Recruiting,Phase 2,Interventional,United States,Military COVID-19 Hydroxychloroquine Pre-exposure and Post-exposure Prophylaxis Study,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1450,https://clinicaltrials.gov/show/NCT04343677,None
669,ACTRN12620000468921,ANZCTR,2020-04-14,2020-04-20,False,UNSW Sydney,Not Recruiting,Not Applicable,Interventional,Australia,Effect of a Brief Problem Management Intervention on Covid 19-Related Anxiety and Depression,Other (psych),Psychological,Psychological,140,https://anzctr.org.au/ACTRN12620000468921.aspx,None
670,ACTRN12620000472976,ANZCTR,2020-04-15,2020-04-27,False,Dr. Simon Joosten,Not Recruiting,Not Applicable,Interventional,Australia,Adapting the Decathlon Group EasybreatheÂ® snorkelling face mask for the safer administration of oxygen and/or continuous positive airway pressure and in the intra/interhospital transportation of patients with proven or suspected COVID 19 infection.,Other (device),Masks,Masks,100,https://anzctr.org.au/ACTRN12620000472976.aspx,None
671,ACTRN12620000479909,ANZCTR,2020-04-16,2020-01-05,True,The George Institute for Global Health,Not Recruiting,Not Applicable,Observational,"Germany, Italy, China, Australia, Spain, United States",Mental health and wellbeing on general population during the COVID-19 outbreak,Other (psych),No Intervention,No Intervention,3000,https://anzctr.org.au/ACTRN12620000479909.aspx,None
672,ACTRN12620000470998,ANZCTR,2020-04-14,2020-04-20,False,Firebrick Pharma Pty Ltd,Not Recruiting,Not Applicable,Interventional,Australia,Virucidal pilot study of NasodineÂ® Antiseptic Nasal Spray (povidone-iodine 0.5%) in people with COVID-19 and confirmed nasal shedding of SARS-CoV-2 virus.,Drug,Povidone Iodine,Povidone Iodine,20,https://anzctr.org.au/ACTRN12620000470998.aspx,None
673,ACTRN12620000478910,ANZCTR,2020-04-16,2020-01-06,True,Monash Health,Not Recruiting,Not Applicable,Interventional,Australia,Cord Blood Therapy to prevent progression of COVID-19 related pneumonia,ATMP,Cells (stem cells),Cells (stem cells),24,https://anzctr.org.au/ACTRN12620000478910.aspx,None
674,ACTRN12620000480987,ANZCTR,2020-04-16,2020-01-06,True,University of Auckland,Not Recruiting,Not Applicable,Interventional,New Zealand,Stress-reduction Using Probiotics to Promote Ongoing Resilience Throughout COVID-19 for Healthcare Workers (SUPPORT COVID-19 Healthcare Workers),Supplement,Probiotics,Probiotics,507,https://anzctr.org.au/ACTRN12620000480987.aspx,None
675,ChiCTR2000032098,ChiCTR,2020-04-19,2020-01-20,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Interventional,China,Danggui Shaoyao Powder in the synergistic treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=52477,None
676,ChiCTR2000032095,ChiCTR,2020-04-19,2020-03-18,True,The Third Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Observational,China,"Study for Healthy Behavior, Psychological Analysis and Psychological Reconstruction Strategies of Students Population Keeping in Home Under the Pandemic of Novel Coronavirus Pneumonia (COVID-19)",Other (psych),No Intervention,No Intervention,130,http://www.chictr.org.cn/showproj.aspx?proj=52565,None
677,ChiCTR2000032040,ChiCTR,2020-04-18,2020-04-01,True,Affiliated Hospital of Guangdong Medical University,Recruiting,Not Applicable,Observational,China,A medical records based study for the curative effect of combined traditional Chinese and western medicine in the treatment of severe novel coronavirus pneumonia (COVID-19),Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,30,http://www.chictr.org.cn/showproj.aspx?proj=52529,None
678,ChiCTR2000032013,ChiCTR,2020-04-17,2020-02-02,True,The Fourth Medical Center of PLA General Hospital,Not Recruiting,Not Applicable,Interventional,China,The prevention and treatment strategy of the protective respirator related facial pressure injuries among healthcare professionals fighting novel coronavirus pneumonia (COVID-19),Other (physical),Mechanical ventilation,Mechanical ventilation,8,http://www.chictr.org.cn/showproj.aspx?proj=52483,None
679,ChiCTR2000032011,ChiCTR,2020-04-17,2020-04-17,False,The Sixth Medical Center of PLA General Hospital,Not Recruiting,Not Applicable,Interventional,China,Effecacy and Safety of Hyperbaric Oxygen Therapy to patients with novel coronavirus pneumonia (COVID-19),Drug,Oxygen,Oxygen,45,http://www.chictr.org.cn/showproj.aspx?proj=52142,None
680,ChiCTR2000032010,ChiCTR,2020-04-17,2020-05-01,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,Novel coronavirus pneumonia (COVID-19) Intelligent Assistant Analysis System:A Multi-center Clinical Research,Clinical Presentation,No Intervention,No Intervention,3000,http://www.chictr.org.cn/showproj.aspx?proj=52479,None
681,ChiCTR2000032009,ChiCTR,2020-04-17,2020-02-08,True,"Renji Hospital, Shanghai Jiaotong University School of Medicine",Not Recruiting,Not Applicable,Observational,China,Clinical characteristics and risk factors of novel coronavirus pneumonia (COVID-19) patients with chronic liver disease,Clinical Presentation,No Intervention,No Intervention,30,http://www.chictr.org.cn/showproj.aspx?proj=52490,None
682,ChiCTR2000031982,ChiCTR,2020-04-16,2020-04-01,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Not Recruiting,Not Applicable,Observational,China,Clinical observation for the effect of Ke-Gan-Li-Yan oral liquid on the relief of laryngeal symptoms of novel coronavirus pneumonia (COVID-19) convalescence and suspected patients and other susceptible people,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,240,http://www.chictr.org.cn/showproj.aspx?proj=52341,None
683,ChiCTR2000031954,ChiCTR,2020-04-16,2020-04-15,True,"International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University",Recruiting,Not Applicable,Observational,China,Medical Records Based Study for Maternal and Perinatal Outcomes of Women with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,30,http://www.chictr.org.cn/showproj.aspx?proj=52365,None
684,ChiCTR2000031944,ChiCTR,2020-04-15,2020-04-16,False,China Academy of Chinese Medical Sciences,Recruiting,Not Applicable,Interventional,China,Efficacy of Chinese Herbal Tea in the Prevention of Novel Coronavirus Pneumonia (COVID-19): a Randomized Controlled Trial,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,2000,http://www.chictr.org.cn/showproj.aspx?proj=52414,None
685,ChiCTR2000031930,ChiCTR,2020-04-15,2020-01-31,True,Affiliated Hospital of Zunyi Medical University,Not Recruiting,Not Applicable,Observational,China,Analysis of clinical characteristics and therapeutic effect of 9 cases of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,9,http://www.chictr.org.cn/showproj.aspx?proj=51602,None
686,ChiCTR2000031888,ChiCTR,2020-04-13,2020-02-11,True,Guangzhou Eighth People's Hospital,Recruiting,Not Applicable,Interventional,China,A medical records based study for ''Guangdong Pneumonia NO.1'' in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=52106,None
687,ChiCTR2000031712,ChiCTR,2020-04-07,2020-04-01,True,The Chinese University of Hong Kong,Recruiting,Not Applicable,Observational,No Country Given,Study for investigation of contamination by novel coronavirus pneumonia (COVID-19) in the clinical environment,Other,Other,Other,60,http://www.chictr.org.cn/showproj.aspx?proj=51650,None
688,ChiCTR2000030300,ChiCTR,2020-02-28,2020-02-20,True,Nanjing Second Hospital,Recruiting,Phase 1,Interventional,China,Cancelled by the investigator             Umbilical cord mesenchymal stem cells (hucMSCs) in the treatment of high risk novel coronavirus pneumonia (COVID-19) patients,ATMP,Cells (mesenchymal),Cells (mesenchymal),9,http://www.chictr.org.cn/showproj.aspx?proj=50022,None
689,ChiCTR2000029976,ChiCTR,2020-02-18,2020-02-18,False,Shanghai University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,The effect of Gymnastic Qigong Yangfeifang on functional recovery and quality of life in patients with mild novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,160,http://www.chictr.org.cn/showproj.aspx?proj=49631,None
690,ChiCTR2000029434,ChiCTR,2020-02-01,2020-02-01,False,Hebei Yiling Hospital; Renmin Hospital of Wuhan University,Not Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled trial for Lian-Hua Qing-Wen Capsule /Granule in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,240,http://www.chictr.org.cn/showproj.aspx?proj=48889,None
691,ChiCTR2000029433,ChiCTR,2020-02-01,2020-02-01,False,Hebei Yiling Hospital; Renmin Hospital of Wuhan University,Not Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled trial for Lian-Hua Qing-Wen Capsule/Granule in the treatment of suspected novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,240,http://www.chictr.org.cn/showproj.aspx?proj=48898,None
692,EUCTR2020-001156-18-ES,EU Clinical Trials Register,2020-04-03,2020-03-27,True,Fundación para la investigación Biomédica Hospital Universitario La Paz (FIBHULP),Authorised,Phase 3,Interventional,Spain,Efficacy of different treatments in patients infected with COVID-19,Drug,"Dolquine, Azithromycin, Lopinavir/ritonavir",Dolquine; Azithromycin; Lopinavir/ritonavir,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001156-18,None
693,EUCTR2019-002688-89-ES,EU Clinical Trials Register,2019-07-26,2019-10-12,False,Histocell S.L.,Authorised,Phase 1/Phase 2,Interventional,Spain,"Clinical study to assess the safety and preliminary efficacy of HCR040, a drug based on mesenchymal stem cells, in patients with acute respiratory distress syndrome. (included patients COVID-19)",Not relevant,Not relevant,Not relevant,26,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-002688-89,None
694,EUCTR2020-001262-11-ES,EU Clinical Trials Register,2020-04-13,2020-09-04,True,Instituto de Investigación Sanitaria Fundación Jiménez Díaz,Authorised,Phase 4,Interventional,Spain,Clinical trial to assess the efficacy and safety of cyclosporin A treatment associated with standard treatment versus standard treatment only in hospitalized patients with confirmed coronavirus infection,Drug,Cyclosporine A vs. lopinavir/ritonavir + interferon beta + darunavir + spironolactone + tocilizumab + chloroquine,Cyclosporine; lopinavir/ritonavir; interferon beta; darunavir; spironolactone; tocilizumab; chloroquine,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001262-11,NCT04392531
695,EUCTR2020-001290-74-ES,EU Clinical Trials Register,2020-04-13,2020-11-04,False,Consorci Parc de Salut Mar (PSMAR),Authorised,Phase 3,Interventional,Spain,Efficacy and safety of sarilumab in the early treament of hospitalized patients with mild-moderate neumonia and COVID19 infection versus standard of care,Drug,Sarilumab vs. Hydroxychloroquine + Azithromycin,Sarilumab; Hydroxychloroquine; Azithromycin,216,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001290-74,None
696,EUCTR2020-001406-27-FR,EU Clinical Trials Register,2020-04-03,2020-07-04,False,"University Hospital, Montpellier",Authorised,Phase 3,Interventional,France,efficacy and safety of a bitherapy by hydroxychloroquine + azythromycin vs monotherapy by hydroxychoroquine in adult patients with documentated infection by covid19,Drug,Hydroxychloroquine vs. Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; Azithromycin,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001406-27,None
697,EUCTR2020-001321-31-ES,EU Clinical Trials Register,2020-04-13,2020-11-04,False,Hospital Universitario de Fuenlabrada,Authorised,Phase 2,Interventional,Spain,Clinical trial phase II to evaluate the efficacy of  3 types of treatment in patients with pneumonia by COVID-19,Drug,Hydroxychloroquine + baricitinib or imatinib or lopinavir/ritonavir,Hydroxychloroquine; baricitinib; imatinib; lopinavir/ritonavir,165,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001321-31,None
698,EUCTR2020-001437-12-ES,EU Clinical Trials Register,2020-04-13,2020-09-04,False,Vall d'Hebron Research Institute (VHIR),Authorised,Phase 4,Interventional,Spain,"Random, controlled, open, one-site clinical trial in adult patients with COVID-19 severe pneumonia treated with immunomodulatory drugs",Drug,"Cyclosporine, Tocilizumab",Cyclosporine; Tocilizumab,290,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001437-12,None
699,EUCTR2020-001689-12-ES,EU Clinical Trials Register,2020-04-13,2020-11-04,False,Montreal Heart Institute,Authorised,Phase 3,Interventional,Spain,COLCHICINA TEST IN THE SARS-COV2 CORONAVIRUS (COLCORONA-COVID-19),Drug,Colchicine,Colchicine,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001689-12,None
700,EUCTR2020-001379-34-ES,EU Clinical Trials Register,2020-04-14,2020-04-14,False,Instituto de Investigación Sanitaria INCLIVA,Authorised,Phase 4,Interventional,Spain,Sedation with sevoflurane versus propofol in patients with Acute Respiratory Distress Syndrome caused by COVID-19 infection,Drug,Sevoflurane vs. Propofol,Sevoflurane; Propofol,50,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001379-34,None
701,EUCTR2020-001511-25-ES,EU Clinical Trials Register,2020-04-15,2020-04-14,True,Fundación para la Formación e Investigación Sanitarias de la Región de Murcia (FFIS),Authorised,Phase 3,Interventional,Spain,Randomized open-blind controlled trial to study the benefit of Colchicine in Patients with COVID-19,Drug,Colchicine,Colchicine,102,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001511-25,None
702,EUCTR2020-001266-11-ES,EU Clinical Trials Register,2020-04-16,2020-04-16,False,Fundación Instituto de Investigación Sanitaria Fundación Jimenez Diaz,Authorised,Phase 2,Interventional,Spain,Clinical trial of administration of MSC to patients with respiratory distress type COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001266-11,None
703,IRCT20200310046736N1,IRCT,2020-04-01,2020-04-01,False,Ahvaz University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Comparison of The Therapeutic Effect of Convalescent Plasma and Plasma-derived Immunoglobulin-enriched solution on COVID-19 Patients,ATMP,Plasma,Plasma,45,http://en.irct.ir/trial/46424,None
704,IRCT20100228003449N30,IRCT,2020-03-22,2020-03-15,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Combination therapy in COVID 19,Drug,Hydroxychloroquine +  Oseltamivir + Lopinavir/ritonavir or Atazanavir/ritonavir ,Hydroxychloroquine; Oseltamivir; Lopinavir/ritonavir; Lopinavir/atazanavir,50,http://en.irct.ir/trial/46536,None
705,IRCT20100228003449N28,IRCT,2020-03-19,2020-03-15,True,Tehran University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Interferon in treatment of COVID-19,Drug,Interferon beta vs. hydroxychloroquine + oseltamivir + Lopinavir/ritonavir,Interferon beta; hydroxychloroquine; oseltamivir; lopinavir/ritonavir,30,http://en.irct.ir/trial/46538,None
706,IRCT20100228003449N27,IRCT,2020-03-16,2020-03-15,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Interferon ÃŸ in treatment  of COVID-19,Drug,Interferon beta vs. hydroxychloroquine + oseltamivir + Lopinavir/ritonavir,Interferon beta; hydroxychloroquine; oseltamivir; lopinavir/ritonavir,30,http://en.irct.ir/trial/46545,None
707,IRCT20200316046792N1,IRCT,2020-03-17,2020-03-16,True,Iran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of herbal syrup and solution in treatment of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,150,http://en.irct.ir/trial/46554,None
708,IRCT20151227025726N12,IRCT,2020-03-23,2020-03-03,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluting the therapeutic and adverse effects of Interferon beta 1-a in patients with novel Coronavirus(COVID-19),Drug,Interferon beta + hydroxychloroquine + osletamivir + lopinavir/ritonavir,Interferon beta; hydroxychloroquine; oseltamivir; lopinavir/ritonavir,20,http://en.irct.ir/trial/46561,None
709,IRCT20100228003449N29,IRCT,2020-03-19,2020-03-18,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,?Effect of sofosbuvir/ ledipasvir on COVID-19,Drug,Sofosbuvir + Ledipasvir vs. Hydroxychloroquine + Oseltamivir + Lopinavir/ritonavir,Sofosbuvir; Ledipasvir; Hydroxychloroquine; Oseltamivir; Lopinavir/ritonavir,50,http://en.irct.ir/trial/46567,None
710,IRCT20200317046797N1,IRCT,2020-04-03,2020-04-08,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Camostate mesylate on the outcome of Coronavirus (COVID-19)-induced pneumonia,Drug,Camostat Mesilate,Camostat Mesilate,40,http://en.irct.ir/trial/46573,None
711,IRCT20160625028622N1,IRCT,2020-03-22,2020-03-19,True,Qazvin University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,The effect of Noscapine  on clinical and pulmonary manifestations of COVID-19 patients,Drug,Noscapine,Noscapine,125,http://en.irct.ir/trial/46576,None
712,IRCT20120826010664N6,IRCT,2020-04-05,2020-03-29,True,Tehran University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of hydroxychloroquine on prevention of covid-19 virus,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,310,http://en.irct.ir/trial/46603,None
713,IRCT20131113015393N6,IRCT,2020-03-30,2020-02-28,True,Sabzevar University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of Benson Relaxation on Quality of Life and job stress  in nurses,Other (psych),Psychological,Psychological,62,http://en.irct.ir/trial/46609,None
714,IRCT20140528017891N8,IRCT,2020-03-28,2020-03-24,True,MOM Research and Innovation Center,Not Recruiting,Phase 3,Interventional,Iran,The effect of stem cell transplantation in the treatment of COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),10,http://en.irct.ir/trial/46623,None
715,IRCT20200321046828N1,IRCT,2020-03-26,2020-03-22,True,RNA Biotechnology,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Remedy of human coroviruse infection with genetic nanocomposit drug,Drug,Unspecified,Unspecified,30,http://en.irct.ir/trial/46624,None
716,IRCT20190727044343N1,IRCT,2020-04-05,2020-03-16,True,Mazandaran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,?Effect of febuxostat against coronavirus,Drug,Acetaminophen + Febuxostat vs.  Acetaminophen + Hydroxychloroquine,Febuxostat; Acetaminophen; Hydroxychloroquine,60,http://en.irct.ir/trial/46629,None
717,IRCT20140617018126N2,IRCT,2020-03-29,2020-04-03,False,Tabriz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Persian Medicine Products in Covid-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/46637,None
718,IRCT20150914024017N1,IRCT,2020-04-03,2020-03-27,True,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,ReciGen for treatment of Covid-19,Drug,Interferon beta,Interferon beta,40,http://en.irct.ir/trial/46665,None
719,IRCT20140911019125N6,IRCT,2020-04-04,2020-04-04,False,Kerman University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,The effect of dental pulp mesenchymal stem cells in treatment of  corona disease,ATMP,Cells (mesenchymal),Cells (mesenchymal),10,http://en.irct.ir/trial/46668,None
720,IRCT20160316027081N1,IRCT,2020-03-31,2020-03-23,True,Artesh University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of Licorice in COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,374,http://en.irct.ir/trial/46678,None
721,IRCT20151227025726N13,IRCT,2020-03-26,2020-03-11,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Evaluation the Efficacy and Safety of Tocilizumab in COVID-19,Drug,Tocilizumab + hydroxychloroquine + oseltamivir + lopinavir/ritonavir,Tocilizumab; hydroxychloroquine; oseltamivir; lopinavir/ritonavir,40,http://en.irct.ir/trial/46681,None
722,IRCT20160310026998N11,IRCT,2020-03-27,2020-03-20,True,Tabriz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of metformin in COVID-19  symptom improvement and death,Drug,Metformin,Metformin,200,http://en.irct.ir/trial/46690,None
723,IRCT20160310026998N10,IRCT,2020-03-26,2020-03-20,True,Tabriz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Study of the metformin effect on the survival and recovery rate of patients with COVID-19,Drug,Metformin,Metformin,200,http://en.irct.ir/trial/46693,None
724,IRCT20180610040049N3,IRCT,2020-03-29,2020-04-08,False,Arak University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of Trachyspermum copticum syrup on clinical manifestations of patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/46697,None
725,IRCT20200324046851N1,IRCT,2020-04-03,2020-03-29,True,Tabriz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effects of nano curcumin supplementation on the reduction of inflammation and mortality in patients with coronavirus 2019 admitted to ICU ward of imam Reza hospital in Tabriz,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,86,http://en.irct.ir/trial/46712,None
726,IRCT20200324046847N1,IRCT,2020-03-31,2020-03-28,True,Tehran University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Treatment of patients with Corona virus infection,Drug,Septimeb,Septimeb,30,http://en.irct.ir/trial/46720,None
727,IRCT20140907019073N4,IRCT,2020-03-29,2020-04-03,False,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effectiveness of Ipecac homeopathic remedy  in control of Clinical manifestations of COVID-19,Other,Homeopathy,Homeopathy,60,http://en.irct.ir/trial/46736,None
728,IRCT20200325046860N1,IRCT,2020-03-30,2020-03-15,True,Darmanara Co.,Recruiting,Not Applicable,Interventional,Iran,Convalescent Plasma therapy for COVID-19 Patients,ATMP,Plasma,Plasma,200,http://en.irct.ir/trial/46759,None
729,IRCT20101219005416N2,IRCT,2020-04-03,2020-03-24,True,Kerman University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of  the effect of traditional  Iranian medicine product on improvement of clinical menifestation of COVID -19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/46775,None
730,IRCT20200317046797N2,IRCT,2020-04-03,2020-04-08,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Fingolimod for treatment of COVID-19-induced cytokine storm,Drug,Fingolimod,Fingolimod,40,http://en.irct.ir/trial/46786,None
731,IRCT20200325046860N2,IRCT,2020-04-01,2020-03-28,True,Bagheiat-allah University of Medical Sciences,Not Recruiting,Phase 1,Interventional,Iran,Mesenchymal Stem Cell therapy in COVID19,ATMP,Cells (mesenchymal),Cells (mesenchymal),5,http://en.irct.ir/trial/46789,None
732,IRCT20170611034452N11,IRCT,2020-03-31,2020-03-30,True,Kerman University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Investigating the effectiveness of psychological interventions on mental health,Other (psych),Psychological,Psychological,60,http://en.irct.ir/trial/46803,None
733,IRCT20190917044805N2,IRCT,2020-03-31,2020-04-03,False,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effects of High-dose Vitamin C on COVID-19,Drug,Vitamin C,Vitamin C,60,http://en.irct.ir/trial/46804,None
734,IRCT20120225009124N4,IRCT,2020-04-02,2020-04-18,False,Gorgan University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Efficacy of dexamethasone, IV-IG and Interferone beta for treatment of patients with severe COVID-19",Drug (+ ATMP),"Intreventional: Dexamethason + Immunoglobulin vs. Dexamethason + Immunoglobulin + interferon beta

All Arms: Hydroxychloroquine + antiviral ",Dexamethason; Immunoglobulin; interferon beta; Hydroxychloroquine,105,http://en.irct.ir/trial/46810,None
735,IRCT20180802040678N4,IRCT,2020-04-01,2020-03-31,True,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effects of Losartan in patients with corona virus disease 2019,Drug,Losartan vs. amlodipine,Losartan; amlodipine,100,http://en.irct.ir/trial/46824,None
736,IRCT20150704023055N2,IRCT,2020-04-03,2020-03-24,True,Babol University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Hemoperfusion in patients with COVID-19,Other (device),Hemoperfusion,Hemoperfusion,10,http://en.irct.ir/trial/46837,None
737,IRCT20200319046819N1,IRCT,2020-04-04,2020-04-02,True,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,supplementation in COVID-19,Drug,Vitamin A + Vitamin D + Vitamin C + Vitamin B,Vitamin A; Vitamin D; Vitamin C; Vitamin B,60,http://en.irct.ir/trial/46838,None
738,JPRN-UMIN000039986,JPRN,2020-03-31,2020-03-28,True,Yokohama City University,Not Recruiting,Not Applicable,Other,Japan,Risk factors of death from coronavirus disease 2019,Prognosis,No Intervention,No Intervention,Not Available,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045582,None
739,JPRN-UMIN000040185,JPRN,2020-04-17,2020-04-17,False,Keio University School of Medicine,Recruiting,Not Applicable,Observational,Japan,Multicenter prospective cohort study evaluating outcome of COVID-19 in patients with hepatobiliary-pancreatic disease,Clinical Presentation,No Intervention,No Intervention,600,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045820,None
740,JPRN-UMIN000040188,JPRN,2020-04-17,2020-04-17,False,Yokohama City University,Not Recruiting,Not Applicable,Other,"Japan, North America",Chloroquine and hydroxychloroquine for treatment of COVID-19: systematic review of randomized and non-randomized controlled trial,Not relevant,Not relevant,Not relevant,Not Available,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045825,None
741,ACTRN12620000486921,ANZCTR,2020-04-17,2020-04-20,False,Royal North Shore Hospital,Not Recruiting,Not Applicable,Observational,Australia,"AUSTRALIAN CARDIOVASCULAR COVID-19 REGISTRY (AUS-COVID) 
",Clinical Presentation,No Intervention,No Intervention,865,https://anzctr.org.au/ACTRN12620000486921.aspx,None
742,ACTRN12620000492954,ANZCTR,2020-04-20,2020-01-05,True,University of New South Wales,Not Recruiting,Not Applicable,Interventional,Australia,A Facebook delivered physical activity focused group lifestyle intervention for older adults during the COVID-19 pandemic,Other (exercise),Exercise,Exercise,20,https://anzctr.org.au/ACTRN12620000492954.aspx,None
743,ACTRN12620000482965,ANZCTR,2020-04-17,2020-03-17,True,Juan Pedro Fuentes García,Not Recruiting,Not Applicable,Interventional,Spain,"Impact of high intensity interval training and aerobic training on stress, depression symptoms, anxiety and resilience in self-isolated people during the COVID-19 health emergency in Spain",Other (exercise),Exercise,Exercise,34,https://anzctr.org.au/ACTRN12620000482965.aspx,None
744,ACTRN12620000498998,ANZCTR,2020-04-20,2020-04-22,False,Tenon Hospital,Not Recruiting,Not Applicable,Observational,France,Retrospective Study on surgical outcomes among surgical patients during the COVID-19 (SARS-CoV-2) Pandemic,Clinical Presentation,No Intervention,No Intervention,700,https://anzctr.org.au/ACTRN12620000498998.aspx,None
745,ACTRN12620000493943,ANZCTR,2020-04-20,2020-07-04,False,Albury Wodonga Health,Recruiting,Not Applicable,Observational,Australia,Study evaluating Front-line health care workers serial blood COVID-19 antibody results in relation to symptom presentation,Clinical Presentation,No Intervention,No Intervention,50,https://anzctr.org.au/ACTRN12620000493943.aspx,None
746,ChiCTR2000032412,ChiCTR,2020-04-27,2020-05-15,False,Shanghai Public Health Clinical Center,Not Recruiting,Not Applicable,Observational,China,A medical records based retrospective study for the effectiveness and safety of Xi-Yan-Ping injection combined with conventional protocol in the treatment of common type novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,426,http://www.chictr.org.cn/showproj.aspx?proj=52988,None
747,ChiCTR2000032400,ChiCTR,2020-04-27,2020-01-01,True,"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",Recruiting,Not Applicable,Interventional,China,"the efficacy and safety of high dose intravenous vitamin C in the treatment of novel coronavirus pneumonia (COVID-19): a prospective, randomize, controlled trial",Drug,Vitamin C,Vitamin C,120,http://www.chictr.org.cn/showproj.aspx?proj=52958,None
748,ChiCTR2000032399,ChiCTR,2020-04-27,2020-04-20,True,Xiaogan Traditional Chinese Medicine Hospital,Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, double-blind, placebo-controlled trial for Xiaoyao capsule in the improvement of sleep mood disorder of convalescence patients of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=52942,None
749,ChiCTR2000032368,ChiCTR,2020-04-26,2020-04-15,True,China-Japan Friendship Hospital,Not Recruiting,Not Applicable,Health services research,China,Investigation on the mental health status and intervention of the medical staff of the national rescue medical team in hubei province during the pandemic of novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,Psychological,116,http://www.chictr.org.cn/showproj.aspx?proj=52933,None
750,ChiCTR2000032367,ChiCTR,2020-04-26,2020-02-19,True,Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine,Recruiting,Not Applicable,Interventional,China,Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19):  a randomized controlled trial,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,186,http://www.chictr.org.cn/showproj.aspx?proj=52972,None
751,ChiCTR2000032346,ChiCTR,2020-04-26,2020-04-21,True,The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,"Lingnan Fire-Needle Therapy Improves the Quality of Life in General Population Under the Pandemic of novel coronavirus pneumonia (COVID-19): A Prospective, Randomized Controlled Trial",Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=52692,None
752,ChiCTR2000032314,ChiCTR,2020-04-25,2020-03-01,True,West China Hospital of Sichuan University,Recruiting,Not Applicable,Interventional,China,A randomized clinical trial for the efficacy and safety of Aliskiren and Nifedipine in novel coronavirus pneumonia (COVID-19) patients with hypertension,Drug,Aliskiren vs. Nifedipine,Aliskiren; Nifedipine,242,http://www.chictr.org.cn/showproj.aspx?proj=52867,None
753,ChiCTR2000032313,ChiCTR,2020-04-25,2020-05-01,False,"Beijing University of Chinese Medicine, Third Affiliated Hospital",Not Recruiting,Not Applicable,Interventional,China,Study for efficacy and safety of Jie-Xing-Jun-Zi granules in the Treatment of convalescent patients of novel coronavious pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=52916,None
754,ChiCTR2000032242,ChiCTR,2020-04-24,2020-04-24,False,Mudanjiang Kang'an Hospital,Not Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, open, controlled trial for the efficacy and safety of oral kolimycin in the treatment of patients with new coronavirus pneumonia (CoVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,350,http://www.chictr.org.cn/showproj.aspx?proj=52824,None
755,ChiCTR2000032239,ChiCTR,2020-04-23,2020-01-29,True,The First People's Hospital of Jiangxia District,Recruiting,Not Applicable,Observational,China,A medical records based study for epidemiological characteristics of 88 patients with new coronavirus pneumonia (COVID-19) and its impact on severe disease,Clinical Presentation (Epidemiology),No Intervention,No Intervention,88,http://www.chictr.org.cn/showproj.aspx?proj=52507,None
756,ChiCTR2000032237,ChiCTR,2020-04-23,2020-04-01,True,Ezhou Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,No Country Given,"A multicenter, randomized, double-blind, placebo-controlled trial for Xiang-Sha-Liu-Jun Pill in the treatment of novel coronavirus pneumonia (COVID-19) decline in digestive function during convalescence",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=52699,None
757,ChiCTR2000032233,ChiCTR,2020-04-23,2020-04-23,False,Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Not Recruiting,Not Applicable,Observational,China,Clinical study for the potential impact of novel coronavirus pneumonia (COVID-19) on endocrine system,Clinical Presentation,No Intervention,No Intervention,28,http://www.chictr.org.cn/showproj.aspx?proj=52796,None
758,ChiCTR2000032214,ChiCTR,2020-04-23,2020-05-01,False,Hubei Hospital of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Screening of proprietary Chinese medicines in convalescent rehabilitation of novel coronavirus pneumonia (COVID-19) convalescent patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=52781,None
759,ChiCTR2000032213,ChiCTR,2020-04-23,2020-04-23,False,The First Affiliated Hospital of Chongqing Medical University,Recruiting,Not Applicable,Observational,China,A medical records based study for the impact of wearing medical masks on oxygen saturation in adult surgical patients after general anaesthesia during novel coronavirus pneumonia (COVID-19) pandemic,Other (device),Masks,Masks,151,http://www.chictr.org.cn/showproj.aspx?proj=52788,None
760,ChiCTR2000032205,ChiCTR,2020-04-23,2020-04-15,True,Wuhan Hospital Of Traditional Chinese and Western Medicine,Not Recruiting,Not Applicable,Interventional,China,"A multicenter randomized, double-blind, placebo-controlled trial for Sheng-Mai-Yin for improvement of the pulmonary heart function related symptoms of convalescence patients of new coronavirus pneumonia",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=52662,None
761,ChiCTR2000032162,ChiCTR,2020-04-21,2020-04-22,False,"Bayi Children's Hospital, Seventh Medical Centre, PLA General Hospital",Not Recruiting,Not Applicable,Observational,China,A medical records based study for ECMO in the rescue therapy of extremely critical novel coronavirus pneumonia (COVID-19) patients,Drug,Oxygen,Oxygen,80,http://www.chictr.org.cn/showproj.aspx?proj=52694,None
762,ChiCTR2000032161,ChiCTR,2020-04-21,2020-02-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,A retrospective study for evolution and clinical outcomes study of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,No Intervention,2000,http://www.chictr.org.cn/showproj.aspx?proj=52561,None
763,ISRCTN18348009,ISRCTN,2020-04-15,2020-04-16,False,University of Valladolid,Not Recruiting,Not Applicable,Observational,Spain,Occupational health and safety among health care personnel in a COVID-19 pandemic,Clinical Presentation,No Intervention,No Intervention,80,http://isrctn.com/ISRCTN18348009,None
764,ISRCTN51255782,ISRCTN,2020-04-14,2020-04-14,False,Labormedizinisches Zentrum Dr. Risch,Recruiting,Not Applicable,Observational,Liechtenstein,Can the Ava fertility tracker device detect early signs of COVID-19?,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,2170,http://isrctn.com/ISRCTN51255782,None
765,ISRCTN80453162,ISRCTN,2020-04-14,2020-09-04,False,University Hospitals Coventry and Warwickshire NHS Trust,Recruiting,Not Applicable,Observational,"Pitcairn, Korea, South, Liechtenstein, Algeria, Mozambique, Isle of Man, Cambodia, Sint Maarten (Dutch part), Bahrain, Guadeloupe, Turks and Caicos Islands, United Arab Emirates, Palau, Chile, Kazakhstan, Russian Federation, Zambia, Reunion, Barbados, Saint Vincent and the Grenadines, South Georgia and the South Sandwich Is, Moldova, Belarus, Czech Republic, Macao, Tunisia, Anguilla, Macedonia, Nicaragua, Sri Lanka, Azerbaijan, Bolivia, Israel, Heard Island and Mcdonald Islands, Solomon Islands, Marshall Islands, Burundi, Mayotte, United States Minor Outlying Islands, Hungary, Saint Helena, Bhutan, Norway, Curacao, Malaysia, Comoros, Gambia, Paraguay, Seychelles, Thailand, France, Somalia, Greenland, Turkey, Uzbekistan, Togo, Aruba, South Africa, Ukraine, Christmas Island, Haiti, Finland, Monaco, Bermuda, Cuba, Belize, Suriname, Tajikistan, Montserrat, Bahamas, Saint Barthelemy, Argentina, Kosovo, Qatar, Uganda, Bulgaria, Korea, North, Central African Republic, Liberia, India, Bosnia and Herzegovina, Germany, Cyprus, Venezuela, Netherlands, Yemen, Cocos (Keeling) Islands, Madagascar, Chad, Guinea, Croatia, Andorra, Guatemala, Pakistan, Benin, Slovakia, Guinea-Bissau, Hong Kong, Ireland, Puerto Rico, Svalbard and Jan Mayen, Martinique, Costa Rica, Saint Pierre and Miquelon, Iraq, Burkina Faso, Bonaire Saint Eustatius and Saba, Virgin Islands, British, Jersey, Singapore, Belgium, Bouvet Island, Maldives, Panama, Falkland Islands, Iran, Syria, Sweden, Taiwan, Ecuador, Jordan, Lesotho, Bangladesh, French Guiana, Faroe Islands, French Southern Territories, Rwanda, China, Tuvalu, Saint Lucia, Niger, Slovenia, United States, Eritrea, Honduras, Angola, Cayman Islands, Albania, San Marino, Poland, Canada, Swaziland, Nauru, Sierra Leone, Estonia, Laos, Sao Tome and Principe, South Sudan, Portugal, Mongolia, Nigeria, Philippines, Greece, Latvia, Tonga, Cameroon, Georgia, Democratic Republic of Congo, Fiji, Trinidad and Tobago, French Polynesia, Saint Kitts and Nevis, Netherlands Antilles, Palestinian Territory, Brunei, Niue, Holy See (Vatican City State), Lebanon, Morocco, Northern Mariana Islands, Equatorial Guinea, Mali, New Zealand, Botswana, Kyrgyzstan, Kuwait, Guernsey, Nepal, United Kingdom, Uruguay, Samoa, Austria, Malawi, Serbia, Spain, Tokelau, Zimbabwe, Ghana, Luxembourg, Myanmar, Mexico, Mauritania, Timor-Leste, Iceland, Cook Islands, Democratic Republic of Congo, Romania, Kenya, British Indian Ocean Territory, Antigua and Barbuda, Lithuania, Gibraltar, Ethiopia, Italy, Kiribati, Malta, Saudi Arabia, Brazil, Peru, Armenia, Antarctica, Australia, Vietnam, Mauritius, Norfolk Island, Japan, Tanzania, Western Sahara, Afghanistan, Guam, New Caledonia, Saint Martin (French part), Oman, Indonesia, Micronesia, Federated States of, Senegal, Switzerland, Namibia, Denmark, Djibouti, Libya, Cape Verde, Wallis and Futuna, Egypt, American Samoa, Colombia, Turkmenistan, Vanuatu, Virgin Islands, U.S., Jamaica, Papua New Guinea, Dominican Republic, Guyana, Montenegro, Dominica, El Salvador, Cote d'Ivoire, Gabon, Sudan, Grenada","The impact of the COVID-19 pandemic on the provision, practice, and outcomes of vascular surgery (COVER study)",Clinical Presentation,No Intervention,No Intervention,200,http://isrctn.com/ISRCTN80453162,None
766,EUCTR2020-001329-30-AT,EU Clinical Trials Register,2020-04-03,2020-09-04,False,Massachusetts General Hospital,Authorised,Phase 4,Interventional,"United States, China, Austria",Therapy with Inhaled Nitric Oxide for Patients Infected with Coronavirus Suffering form Lung Failure,Drug,Nitric oxide,Nitric oxide,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001329-30,None
767,EUCTR2020-001527-14-NL,EU Clinical Trials Register,2020-04-06,2020-04-21,False,Erasmus MC,Authorised,Phase 4,Interventional,Netherlands,COVID-19: addition of azithromycin to chloroquine treatment,Drug,Chloroquine + Azithromycin,Chloroquine; Azithromycin,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001527-14,None
768,EUCTR2017-001100-30-DE,EU Clinical Trials Register,2018-07-19,2018-10-24,False,Fachingen Heil- und Mineralbrunnen GmbH,Authorised,Phase 3,Interventional,Germany,"Investigation of efficacy and tolerability of the healing water Staatl. Fachingen STILL in patients for symptomatic treatment of heartburn in comparison to placebo
Adaption due to COVID-19",Not relevant,Not relevant,Not relevant,150,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2017-001100-30,None
769,EUCTR2020-001659-42-ES,EU Clinical Trials Register,2020-04-20,2020-04-18,True,Fundación para la Investigación Biomédica de Córdoba,Authorised,Phase 2,Interventional,Spain,Study of antithrombin as prophylaxis of acute respiratory disease in patients with COVID-19,Drug (Chemoprophylaxis),Antithrombin,Antithrombin,46,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001659-42,None
770,EUCTR2020-001440-26-ES,EU Clinical Trials Register,2020-04-20,2020-04-19,True,Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI),Authorised,Phase 3,Interventional,Spain,Study for the prevention of COVID-19 infection in healthcare personnel,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,184,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001440-26,None
771,EUCTR2020-001459-42-DK,EU Clinical Trials Register,2020-04-14,2020-04-22,False,Zealand University Hospital,Authorised,Phase 2,Interventional,Denmark,"Ruxolitinib Treatment in Patients with Severe COVID-19 Infection. A Danish Safety and Efficacy Study.
",Drug,Ruxolitinib,Ruxolitinib,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001459-42,None
772,EUCTR2020-001500-41-BE,EU Clinical Trials Register,2020-04-04,2020-03-04,True,"University Hospital, Ghent",Authorised,Phase 3,Interventional,Belgium,Treatment of COVID-19 patients with anti-interleukin drugs,Drug,Anakinra or tocilizumab or siltuximab,Anakinra; tocilizumab; siltuximab,342,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001500-41,None
773,NCT04372069,ClinicalTrials.gov,2020-04-29,2020-04-09,True,London Ambulance Service NHS Trust,Not Recruiting,Not Applicable,Observational,United Kingdom,London Ambulance Service Experience of COVID-19,Not relevant,Not relevant,Not relevant,40,https://clinicaltrials.gov/show/NCT04372069,None
774,ACTRN12620000512921,ANZCTR,2020-04-27,2020-04-29,False,Gold Coast University Hospital,Not Recruiting,Not Applicable,Observational,Australia,SARS-CoV2 in children presenting to hospital: A repeating point prevalence study during the COVID-19 pandemic in South East Queensland,Clinical Presentation (Epidemiology),No Intervention,No Intervention,400,https://anzctr.org.au/ACTRN12620000512921.aspx,None
775,ACTRN12620000516987,ANZCTR,2020-04-27,2020-02-06,True,University of Auckland,Not Recruiting,Not Applicable,Interventional,New Zealand,Testing a wellbeing app to support wellbeing during the Covid-19 pandemic,Other (psych),Psychological,Psychological,90,https://anzctr.org.au/ACTRN12620000516987.aspx,None
776,ACTRN12620000527965,ANZCTR,2020-04-29,2020-01-05,True,Hunter New England Local Health District,Not Recruiting,Not Applicable,Observational,Australia,Neonatal CoVID-19 Study to evaluate the population health impacts of COVID-19 in mothers and their newborn infants cared for in tertiary and non-tertiary hospitals in Australia.,Clinical Presentation,No Intervention,No Intervention,1000,https://anzctr.org.au/ACTRN12620000527965.aspx,None
777,ISRCTN13311119,ISRCTN,2020-04-24,2020-04-30,False,Eminentlabs GmbH,Recruiting,Phase 2,Interventional,India,START (Siddha Treatment Accelerating Recovery from SARS-CoV-2 Test) trial of Siddha treatment for patients with novel coronavirus infectious disease (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,116,http://isrctn.com/ISRCTN13311119,None
778,ChiCTR2000032632,ChiCTR,2020-05-04,2020-03-20,True,The First Affiliated Hospital of Xinjiang Medical University,Recruiting,Not Applicable,Interventional,China,The influence of COVID-19 pandemic on cardiovascular patients,Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=53190,None
779,ChiCTR2000032574,ChiCTR,2020-05-03,2020-01-01,True,Ganzhou People's Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,Diagnostic value of chest CT in outpatient for novel coronavirus pneumonia (COVID-19) compared to RT-PCR,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,248,http://www.chictr.org.cn/showproj.aspx?proj=53122,None
780,ChiCTR2000032573,ChiCTR,2020-05-03,2020-05-02,True,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,"A randomized, double-blind, controlled trial for Bu-Fei-Huo-Xue Capsule in the treatment of novel coronavirus pneumonia (COVID-19) convalescence patient with ''Fei-Pi-Qi-Xu zhen''",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=53225,None
781,ChiCTR2000032527,ChiCTR,2020-05-01,2020-05-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,"Developing and validating of clinical prediction model for novel coronavirus pneumonia (COVID-19) patients progressing to critical type, acute respiratory distress syndrome and death: a medical records based study",Prognosis,No Intervention,No Intervention,8500,http://www.chictr.org.cn/showproj.aspx?proj=53196,None
782,ChiCTR2000032514,ChiCTR,2020-05-01,2020-05-05,False,Zhongnan Hospital of Wuhan University,Not Recruiting,Not Applicable,Basic Science,China,Direct evidence of rectal cancer patient infected with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,13,http://www.chictr.org.cn/showproj.aspx?proj=53181,None
783,ChiCTR2000032487,ChiCTR,2020-04-29,2020-03-26,True,Shanghai Public Health Clinical Center,Not Recruiting,Phase 4,Interventional,China,Study for using sulfate in the prevention and control of novel coronavirus pneumonia (COVID-19) in high and low prevalence communities,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,2000,http://www.chictr.org.cn/showproj.aspx?proj=52394,None
784,ChiCTR2000032480,ChiCTR,2020-04-29,2020-04-29,False,China Academy of Chinese Medical Sciences,Not Recruiting,Not Applicable,Observational,China,Study on data management and diagnosis-treatment mode of TCM intervention for novel coronavirus pneumonia (COVID-19)  convalescence,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,1000,http://www.chictr.org.cn/showproj.aspx?proj=52698,None
785,ChiCTR2000032478,ChiCTR,2020-04-29,2020-02-03,True,"Guang'anmen Hospital, China Academy of Chinese Medical Sciences",Recruiting,Not Applicable,Observational,China,TCM Intervention study for novel coronavirus pneumonia (COVID-19) patient during home/designate-unit isolation based on community prevention and control,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,3000,http://www.chictr.org.cn/showproj.aspx?proj=52777,None
786,ChiCTR2000032476,ChiCTR,2020-04-29,2020-03-23,True,Xiangya Hospital of Central South University,Recruiting,Not Applicable,Observational,China,Analysis of clinical features of novel coronavirus  pneumonia (COVID-19): a medical records based study,Clinical Presentation,No Intervention,No Intervention,500,http://www.chictr.org.cn/showproj.aspx?proj=53094,None
787,ChiCTR2000032461,ChiCTR,2020-04-29,2020-05-06,False,Hospital of Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,A medical records based retrospective study for effect of applying individualized Chinese herbal medicine in treatment of patients with novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,500,http://www.chictr.org.cn/showproj.aspx?proj=52482,None
788,ChiCTR2000032460,ChiCTR,2020-04-29,2020-01-20,True,The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital),Not Recruiting,Not Applicable,Diagnostic test,China,Early warning model and new biomarker of severe novel coronavirus pneumonia (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,76,http://www.chictr.org.cn/showproj.aspx?proj=52875,None
789,ChiCTR2000032458,ChiCTR,2020-04-29,2020-02-29,True,Department of Science and Technology of Guizhou Province,Not Recruiting,Not Applicable,Observational,China,A medical records based retrospective study: Leukopenia is more common in asymptomatic patients less than 18 years old with novel coronavirus pneumonia (COVID-19) in convalescence,Clinical Presentation,No Intervention,No Intervention,25,http://www.chictr.org.cn/showproj.aspx?proj=52779,None
790,ChiCTR2000032457,ChiCTR,2020-04-29,2020-05-01,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Application of pulmonary rehabilitation exercise in the treatment of novel coronavirus pneumonia (COVID-19) patients during convalescence period.,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,60,http://www.chictr.org.cn/showproj.aspx?proj=52925,None
791,ChiCTR2000032456,ChiCTR,2020-04-29,2020-03-01,True,Shanghai Public Health Clinical Center,Not Recruiting,Not Applicable,Interventional,No Country Given,A Randomized Controlled Trial for the Effects of Low-Oxygen Consumption Instruction on the Prognosis of Patients with Novel Coronavirus Pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=53048,None
792,ChiCTR2000032455,ChiCTR,2020-04-29,2020-04-28,True,Ningxia Ning'an Hospital,Recruiting,Not Applicable,Interventional,China,A study for the mental health status of novel coronavirus pneumonia (COVID-19) convalescent patients and first-line medical staff and Isolate residents and Hospital staffand the intervention strategy of psychological crisis in Ningxia,Other (psych),No Intervention,No Intervention,140,http://www.chictr.org.cn/showproj.aspx?proj=53050,None
793,ChiCTR2000032135,ChiCTR,2020-04-20,2020-04-22,False,Shanghai Public Health Clinical Center,Not Recruiting,Phase 4,Interventional,China,Efficacy and Safety of ulinastatin in the Treatment of novel coronavirus pneumonia (COVID-19),Drug,Ulinastatin,Ulinastatin,50,http://www.chictr.org.cn/showproj.aspx?proj=52506,None
794,ChiCTR2000031896,ChiCTR,2020-04-14,2020-02-05,True,Fujian Provincial Hospital,Not Recruiting,Not Applicable,Observational,China,Study for the influence of novel coronavirus pneumonia (COVID-19) on mental health of Chinese public hospital stuffs,Other (psych),No Intervention,No Intervention,923,http://www.chictr.org.cn/showproj.aspx?proj=52332,None
795,ChiCTR2000031327,ChiCTR,2020-03-27,2020-04-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Clinical characteristics and death risk factors in severe novel coronavirus pneumonia (COVID-19) patients: a single-center respective analysis based on medical records,Clinical Presentation,No Intervention,No Intervention,120,http://www.chictr.org.cn/showproj.aspx?proj=51669,None
796,ChiCTR2000031174,ChiCTR,2020-03-23,2020-03-23,False,Shanghai Public Health Clinical Center,Not Recruiting,Not Applicable,Interventional,China,Effectiveness and safety of hydroxychloroquine sulfate in the preventive treatment of novel coronavirus pneumonia (COVID-19),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1000,http://www.chictr.org.cn/showproj.aspx?proj=51437,None
797,EUCTR2020-001723-13-FR,EU Clinical Trials Register,2020-04-08,2020-04-17,False,Groupe Hospitalier Paris Saint-Joseph,Authorised,Phase 3,Interventional,France,A randomized trial of efficacy and safety of an early OUTpatient treatment of COVID-19 in patients with risk factor for poor outcome : a strategy to prevent hospitalization : OUTCOV Study,Drug,"Azithromycin, Hydroxychloroquine, Lopinavir/Ritonavir",Azithromycin; Hydroxychloroquine; Lopinavir/Ritonavir,640,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001723-13,None
798,EUCTR2020-001717-20-ES,EU Clinical Trials Register,2020-04-27,2020-04-20,True,Fundación para la Investigación Biomédica de Córdoba,Authorised,Phase 2,Interventional,Spain,Prevention and treatment with Calcifediol of respiratory problems caused by COVID-19,Drug,Calcifediol,Calcifediol,1008,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001717-20,None
799,ACTRN12620000524998,ANZCTR,2020-04-28,2020-04-28,False,South Eastern Sydney Local Health District,Not Recruiting,Not Applicable,Interventional,Australia,Evaluation of a remote monitoring smartphone application and care model of COVID-19 patients in the community  (ReCOVER),Other (software),eHealth,eHealth,2000,https://anzctr.org.au/ACTRN12620000524998.aspx,None
800,ChiCTR2000032770,ChiCTR,2020-05-10,2020-01-29,True,Department of Science and Technology of Guizhou Province,Not Recruiting,Not Applicable,Observational,China,Asymptomatic novel coronavirus pneumonia (COVID-19) patients Have Longer Treatment Cycle Than Mild and Moderate Patients: a medical records based study,Clinical Presentation,No Intervention,No Intervention,52,http://www.chictr.org.cn/showproj.aspx?proj=53228,None
801,ChiCTR2000032769,ChiCTR,2020-05-09,2020-05-12,False,Beijing Ditan Hospital,Recruiting,Not Applicable,Interventional,China,"A randomized,double blinded, parallel  controlled clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)",Drug,Azvudine,Azvudine,342,http://www.chictr.org.cn/showproj.aspx?proj=53368,None
802,ChiCTR2000032768,ChiCTR,2020-05-09,2020-01-01,True,"The Third Xiangya Hospital, Central South University",Not Recruiting,Not Applicable,Observational,China,Correlation between novel coronavirus pneumonia (COVID-19) and mental health of breast cancer patients: a cross-sectional study in Hunan Province,Other (psych),No Intervention,No Intervention,309,http://www.chictr.org.cn/showproj.aspx?proj=53460,None
803,ChiCTR2000032767,ChiCTR,2020-05-09,2020-05-09,False,"Institute of Basic Research for Clinical Medicine, China Academy of Chinese Medical Sciences",Not Recruiting,Not Applicable,Observational,China,A Medical Records Based Study for Clinical Efficacy and Safety of ''clear lung detoxification soup'' in the treatment of Novel Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,782,http://www.chictr.org.cn/showproj.aspx?proj=53476,None
804,ChiCTR2000032743,ChiCTR,2020-05-09,2020-03-16,True,The First Affiliated Hospital of Dalian Medical University,Not Recruiting,Not Applicable,Observational,China,The effectiveness of diaphragmatic breathing relaxation training for improving sleep quality among nursing staff during the novel coronavirus pneumonia (COVID-19) pandemic: a before and after study,Other,Other,Other,151,http://www.chictr.org.cn/showproj.aspx?proj=53431,None
805,ChiCTR2000032737,ChiCTR,2020-05-08,2020-05-08,False,The First Affiliated Hospital of Guangdong Pharmaceutical University; Guangzhou Eighth People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Clinical trial for the washed microbiota transplantation in the treatment of novel coronavirus pneumonia (COVID-19) patients suspected with gut microbiota dysbiosis,Other,Washed microbiota transplantation,Washed microbiota transplantation,60,http://www.chictr.org.cn/showproj.aspx?proj=53458,None
806,ChiCTR2000032717,ChiCTR,2020-05-08,2020-02-12,True,Xi'an International Medical Center Hospital,Not Recruiting,Not Applicable,Interventional,China,Efficacy and safety of high-dose vitamin C combined with traditional Chinese medicine in the treatment of moderate and severe novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine + Vitamin C,Traditional Medicine; Vitamin C,40,http://www.chictr.org.cn/showproj.aspx?proj=53322,None
807,ChiCTR2000032716,ChiCTR,2020-05-08,2020-02-05,True,"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",Not Recruiting,Not Applicable,Interventional,China,High dose intravenous vitamin C might be used as an important rescue therapy for aggravation of severe and critical novel coronavirus pneumonia (COVID-19) patients,Drug,Vitamin C,Vitamin C,12,http://www.chictr.org.cn/showproj.aspx?proj=53389,None
808,ChiCTR2000032686,ChiCTR,2020-05-06,2020-05-04,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Study for the application of novel coronavirus pneumonia (COVID-19) intestinal tract toxicity in diagnosis and its prognostic effect,Prognosis,No Intervention,No Intervention,390,http://www.chictr.org.cn/showproj.aspx?proj=53153,None
809,ChiCTR2000032666,ChiCTR,2020-05-05,2020-04-01,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Follow-up study of pregnancy outcomes  of novel coronavirus pneumonia (COVID-19) complicated in the first and second trimester,Clinical Presentation,No Intervention,No Intervention,6,http://www.chictr.org.cn/showproj.aspx?proj=53285,None
810,ChiCTR2000032635,ChiCTR,2020-05-04,2020-05-06,False,Hubei Hospital of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Study for Screening of Chinese Patent Drugs in the Rehabilitation Treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=52671,None
811,ISRCTN68026880,ISRCTN,2020-04-30,2020-01-01,True,Imperial College London,Recruiting,Not Applicable,Observational,"Ecuador, Argentina, Mexico, Qatar, Uganda, Romania, United States, United Arab Emirates, Chile, India, Bosnia and Herzegovina, Germany, Russian Federation, Italy, Malta, Canada, Netherlands, Brazil, Estonia, Peru, Australia, Czech Republic, Portugal, Tunisia, Nigeria, Greece, Guatemala, Japan, Latvia, Israel, Ireland, Indonesia, Lebanon, Hungary, Colombia, Egypt, Thailand, Belgium, United Kingdom, Austria, South Africa, Spain","A global registry of women affected by COVID-19 in pregnancy and their babies, to guide treatment and prevention",Clinical Presentation,No Intervention,No Intervention,1000,http://isrctn.com/ISRCTN68026880,None
812,EUCTR2020-001700-42-FR,EU Clinical Trials Register,2020-04-11,2020-06-05,False,Assistance Publique – Hôpitaux de Paris,Authorised,Phase 2,Interventional,France,Efficacy of captopril  in Covid-19 patients suffering of pneumonia,Drug,Captopril,Captopril,230,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001700-42,None
813,EUCTR2020-001709-21-FR,EU Clinical Trials Register,2020-04-16,2020-04-29,False,CHU de Nancy,Authorised,Phase 4,Interventional,France,Low-molecular-weight heparin to prevent venous thromboembolism in COVID-19 patients : a randomized controlled trial of different doses,Drug,Heparin,Heparin,550,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001709-21,None
814,EUCTR2020-001768-27-FR,EU Clinical Trials Register,2020-04-16,2020-04-27,False,Centre Hospitalier de Versailles,Authorised,Phase 2,Interventional,France,"""STUDY OF THE EFFICIENCY OF NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE"" GERONIMO 19",ATMP,Immunoglobulin,Immunoglobulin,39,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001768-27,None
815,EUCTR2020-001598-66-FR,EU Clinical Trials Register,2020-04-16,2020-04-05,True,Centre Hospitalier de Versailles,Authorised,Phase 2,Interventional,France,CurosurfÂ® in Adult Acute Respiratory Distress Syndrome â€“ 1,Drug,Poractant alfa,Poractant alfa,20,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001598-66,None
816,EUCTR2020-001783-28-HU,EU Clinical Trials Register,2020-04-29,2020-06-05,False,National Korányi Institute of Pulmonology,Authorised,Phase 3,Interventional,Hungary,BCG vaccination against COVID-19 infection in Hungary,ATMP,Vaccine,Vaccine,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001783-28,None
817,NCT04380948,ClinicalTrials.gov,2020-05-06,2020-07-31,False,Washington University in St. Louis,Not Recruiting,Phase 1,Interventional,United States,"A Pilot Study Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Enhance Immune Clearance of SARS-CoV-2 (COVID-19)",Drug,NT-17,NT-17,30,https://clinicaltrials.gov/show/NCT04380948,None
818,ISRCTN87832712,ISRCTN,2020-05-05,2020-10-05,False,University of Ferrara,Recruiting,Not Applicable,Observational,Italy,Investigating the microorganisms found in the mouths of SARS-Cov-2 positive patients,Clinical Presentation,No Intervention,No Intervention,20,http://isrctn.com/ISRCTN87832712,None
819,ISRCTN97041334,ISRCTN,2020-05-04,2020-03-23,True,"University College, London",Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 social study: the effects of quarantine on mental health,Other (psych),No Intervention,No Intervention,1000000,http://isrctn.com/ISRCTN97041334,None
820,ChiCTR2000033003,ChiCTR,2020-05-17,2020-06-01,False,Beijing TIL Therapeutics,Not Recruiting,Not Applicable,Prevention,China,Novel coronavirus pneumonia (COVID-19) s-vax loaded autologous dendritic cell trial,ATMP,Cells (dendritic),Cells (dendritic),25,http://www.chictr.org.cn/showproj.aspx?proj=53790,None
821,ChiCTR2000032919,ChiCTR,2020-05-15,2020-05-08,True,Wuhan Third Hospital,Recruiting,Phase 4,Interventional,China,"A multicenter, randomized, double-blind, placebo-controlled trial for Lu-Dang-Shen oral liquid in the treatment of reduced digestion function of convalescent new coronavirus pneumonia (COVID-19) patient",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=53274,None
822,ChiCTR2000032915,ChiCTR,2020-05-15,2020-05-07,True,Hongqi Hospital Affiliated to Mudangjiang Medical University,Recruiting,Phase 4,Interventional,China,A randomized controlled trial for the efficacy and safety of artemisinin-pipequine tablets in the treatment of the mild and common type novel coronavirus pneumonia (COVID-19) patients whose nCoV Nucleic acid did not turn negative after treated by hydroxychloroquine and Abidor,Drug,Artemisinin/piperaquine,Artemisinin/piperaquine,240,http://www.chictr.org.cn/showproj.aspx?proj=53658,None
823,ChiCTR2000032895,ChiCTR,2020-05-15,2020-01-18,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Observational,China,"Epidemiological, clinical and prognosticated features of novel coronavirus pneumonia (COVID-19) in Zhuhai",Clinical Presentation,No Intervention,No Intervention,100,http://www.chictr.org.cn/showproj.aspx?proj=51841,None
824,ChiCTR2000032884,ChiCTR,2020-05-14,2020-03-16,True,The First Affiliated Hospital of Dalian Medical University,Not Recruiting,Not Applicable,Observational,China,The duration and influencing factors of medical staff wearing disposable protective equipment in the isolation area during novel coronavirus pneumonia (COVID-19): an epidemiological study,Other (device),Protective equiptment,Protective equiptment,176,http://www.chictr.org.cn/showproj.aspx?proj=53473,None
825,ChiCTR2000032842,ChiCTR,2020-05-13,2020-05-25,False,Southeast University,Not Recruiting,Not Applicable,Diagnostic test,No Country Given,Rapid Detection 2019-nCOV via Surface Plasamon Resonance,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,http://www.chictr.org.cn/showproj.aspx?proj=53621,None
826,ChiCTR2000030262,ChiCTR,2020-02-26,2020-02-11,True,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Interventional,China,Clinical study of novel coronavirus (SARS-Cov-2) infection treated with aerosol inhalation (IFN-? plus anti-inflammatory factor TFF2),Drug,Interferon kappa + trefoil factor 2 (a gene-derived protein),Interferon Kappa; Gene-derived protein (trefoil factor 2),140,http://www.chictr.org.cn/showproj.aspx?proj=50136,None
827,ChiCTR2000029638,ChiCTR,2020-02-08,2020-02-10,False,West China Hospital of Sichuan University,Recruiting,Not Applicable,Interventional,China,"A Multicenter, Randomized, Controlled trial for Recombinant Super-Compound Interferon (rSIFN-co) in the Treatment of 2019 Novel Coronavirus (2019-nCoV) Infected Pneumonia",Drug,Interferon,Interferon,100,http://www.chictr.org.cn/showproj.aspx?proj=49224,None
828,ChiCTR2000029605,ChiCTR,2020-02-06,2020-02-06,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A randomized, open-label, blank-controlled, multicenter trial for Shuang-Huang-Lian oral solution in the treatment of ovel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,400,http://www.chictr.org.cn/showproj.aspx?proj=49051,None
829,IRCT20200314046764N1,IRCT,2020-04-20,2020-04-26,False,Kermanshah University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Pirfenidine in SARS-COV2,Drug,"Interventional: Pirfenidine


Both Arms: Lopinavir/ritonavir + chloroquine + osiltamivir",Pirfenidine; Lopinavir/ritonavir; chloroquine; osiltamivir,40,http://en.irct.ir/trial/46533,None
830,IRCT20150303021315N17,IRCT,2020-04-12,2020-03-15,True,Aryogen Pharmed,Recruiting,Phase 3,Interventional,Iran,Tocilizumab in severe COVID-19,Drug,Tocilizumab,Tocilizumab,85,http://en.irct.ir/trial/46550,None
831,IRCT20200312046749N1,IRCT,2020-03-28,2020-03-27,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy of Tumor Necrosis Factor alpha inhibitor in COVID-19,Drug,TNF-alpha inhibitor,TNF-alpha inhibitor,80,http://en.irct.ir/trial/46551,None
832,IRCT20190727044343N2,IRCT,2020-04-19,2020-04-05,True,Mazandaran University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Atorvastatin effect on COVID-19,Drug,Atorvastatin,Atorvastatin,100,http://en.irct.ir/trial/46639,None
833,IRCT20171122037571N2,IRCT,2020-04-12,2020-03-20,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Remdesivir in treatment of COVID-19,Drug,Remdesivir + hydroxychloroquine or chloroquine + lopinavir/ritonavir or atazanavir,Remdesivir; hydroxychloroquine; chloroquine; lopinavir/ritonavir; atazanavir,120,http://en.irct.ir/trial/46660,None
834,IRCT20200324046850N2,IRCT,2020-03-29,2020-03-18,True,Abadan University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Comparison of the effect of Sofosbuvir + Daclatasvir (Sovodac) and Ribavirin in Covid-19,Drug,Daclatasvir/sofosbuvir vs. Ribavirin,Daclatasvir/sofosbuvir; Ribavirin,62,http://en.irct.ir/trial/46713,None
835,IRCT20200323046841N1,IRCT,2020-03-28,2020-03-28,False,Mashhad University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy evaluation of an herbal compound in COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/46715,None
836,IRCT20200322046833N1,IRCT,2020-04-03,2020-03-28,True,Center for Progress and Development of Iran,Not Recruiting,Phase 3,Interventional,Iran,Umifenovir effectiveness in the treatment of COVID-19,Drug,"Umifenovir

All Arms: Hydroxychloroquine + Atazanavir/Ritonavir",Umifenovir; Hydroxychloroquine; Atazanavir/Ritonavir,100,http://en.irct.ir/trial/46731,None
837,IRCT20190804044429N1,IRCT,2020-04-11,2020-03-25,True,Mazandaran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Interferon beta 1b in COVID-19,Drug,"Interventional: Interferon beta

Both Arms: Hydroxychloroquine + lopinavir/ritonavir",Interferon beta; Hydroxychloroquine; lopinavir/ritonavir,70,http://en.irct.ir/trial/46741,None
838,IRCT20160313027033N2,IRCT,2020-04-16,2020-04-02,True,Kerman University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,The effect of MCT Oil on COVID-19,Drug,Medium-chain triglycerides,Medium-chain triglycerides,120,http://en.irct.ir/trial/46762,None
839,IRCT20200204046369N1,IRCT,2020-04-08,2020-04-14,False,Shiraz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Methylprednisolone in treatment of COVID-19 patients,Drug,Corticosteroids,Methylprednisolone,48,http://en.irct.ir/trial/46776,None
840,IRCT20180712040449N2,IRCT,2020-04-01,2020-03-23,True,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of oral multi-herbal preparation on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,68,http://en.irct.ir/trial/46782,None
841,IRCT20130812014333N145,IRCT,2020-03-30,2020-04-08,False,Kermanshah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Comparative assessment of the efficacy and safety of add ontreatment with â€œSofosbuvir standard of care therapeutic regimenVelpatasvirâ€ to â€œstandard of caretherapeutic regimenâ€ in patients with COVID-19,Drug,Sofosbuvir/Velpatasvir with and without Hydroxychloroquine + lopinavir/ritonavir,Sofosbuvir/Velpatasvir; Hydroxychloroquine; lopinavir/ritonavir,80,http://en.irct.ir/trial/46790,None
842,IRCT20200325046859N1,IRCT,2020-04-02,2020-04-04,False,Mashhad University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,The efficacy of intravenous immunoglobulin (IVIg) in patients with severe COVID-19 who have not responded to standard three-drug protocol,ATMP,Plasma,Plasma,50,http://en.irct.ir/trial/46811,None
843,IRCT20161204031229N3,IRCT,2020-04-08,2020-03-30,True,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the Effect of Ticoplanin  in Patients With Coronavirus Disease,Drug,Teicoplanin with and without Hydroxychloroquine + lopinavir/ritonavir or atazanavir,Teicoplanin; Hydroxychloroquine; lopinavir/ritonavir; atazanavir,40,http://en.irct.ir/trial/46814,None
844,IRCT20130917014693N10,IRCT,2020-04-08,2020-04-07,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the effects of Hydroxychloroquine administration for COVID-19 prophylaxis,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,100,http://en.irct.ir/trial/46849,None
845,IRCT20180610040049N4,IRCT,2020-04-03,2020-04-07,False,Ghoum University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of Tanacetum parthenium (L) Sch syrup on clinical manifestations of patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/46850,None
846,IRCT20130812014333N147,IRCT,2020-04-22,2020-04-08,True,Kermanshah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,"Comparative assessment of the efficacy and safety of addon treatment with â€œSofosbuvir-Daclatasvirâ€, â€œLithiumâ€,and â€œTrifluoprazineâ€ to â€œstandard of care in three groups of patients with COVID-19",Drug,Hydroxychloroquine vs. Hydroxychloroquine + Sofosbuvir/Daclatasvir vs. Hydroxychloroquine + Lithium vs. Hydroxycholoquine + Trifluoprazine,Hydroxychloroquine; Sofosbuvir/Daclatasvir; Lithium; Trifluoprazine,80,http://en.irct.ir/trial/46853,None
847,IRCT20081019001369N2,IRCT,2020-04-07,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of berberine on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://en.irct.ir/trial/46868,None
848,IRCT20200402046923N1,IRCT,2020-04-09,2020-04-05,True,Tehran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,"Effect of herbal capsule, Viroherb, and herbal syrup, Fenugreek in treatment of COVID-19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,110,http://en.irct.ir/trial/46879,None
849,IRCT20200328046886N1,IRCT,2020-04-12,2020-03-05,True,Mazandaran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effectiveness of Sovodak (sofosbuvir+daclatasvir) in Covid-19 patients,Drug,Daclatasvir/sofosbuvir,Daclatasvir/sofosbuvir,48,http://en.irct.ir/trial/46885,None
850,IRCT20131215015805N2,IRCT,2020-05-04,2020-05-04,False,Shiraz University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,Assessment of effect of levamisole on pneumonia caused by COVID-19,Drug,Levamisole,Levamisole,50,http://en.irct.ir/trial/46887,None
851,IRCT20200404046933N1,IRCT,2020-04-12,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Evaluation the effect of licorice for treatment of coronavirus,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://en.irct.ir/trial/46893,None
852,IRCT20200404046937N1,IRCT,2020-04-09,2020-04-09,False,Ahvaz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluating the effect of Marshmallow and Licorice on COVID 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/46903,None
853,IRCT20080901001157N16,IRCT,2020-04-08,2020-03-30,True,HomaPharmed  Company,Recruiting,Phase 1/Phase 2,Interventional,Iran,Effect of IMFLUNA herbal compound on covid-19 pneumonia symptoms,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/46907,None
854,IRCT20200404046934N1,IRCT,2020-04-13,2020-03-10,True,Qom University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Investigation of the effect of Zufa syrup on clinical symptoms in the with suspected Corona (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,130,http://en.irct.ir/trial/46913,None
855,IRCT20200403046926N1,IRCT,2020-04-11,2020-04-08,True,Mazandaran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of SOVODAK in the treatment of COVID-19 patients,Drug,Daclatasvir/sofosbuvir + hydroxychloroquine vs. hydroxychloroquine,Daclatasvir/sofosbuvir; hydroxychloroquine,60,http://en.irct.ir/trial/46926,None
856,IRCT20151228025732N53,IRCT,2020-04-10,2020-04-20,False,Semnan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Therapeutic effects of plasma of recovered people from COVID-19 on hospitalized patients with this disease,ATMP,Plasma,Plasma,12,http://en.irct.ir/trial/46931,None
857,IRCT20130306012728N8,IRCT,2020-04-12,2020-04-20,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Post-exposure hydroxycloroquine prophylaxis for Covid 19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,500,http://en.irct.ir/trial/46932,None
858,IRCT20180429039463N2,IRCT,2020-04-10,2020-03-20,True,Torbate-Heidaria University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,"The Impact of Family-Based Empowerment Model on Stress, Anxiety and Satisfaction",Other (psych),Psychological,Psychological,30,http://en.irct.ir/trial/46933,None
859,IRCT20200404046935N1,IRCT,2020-04-20,2020-04-18,True,Mazandaran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,"Effect of herbal medicine containing Saatar, Hofarigon and Fennel on COVID-19 patients",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://en.irct.ir/trial/46940,None
860,IRCT20151227025726N14,IRCT,2020-04-10,2020-04-05,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the effects of Favipiravir in COVID-19 patients,Drug,Favipiravir vs. Lopinavir/ritonavir,Favipiravir; Lopinavir/ritonavir,84,http://en.irct.ir/trial/46942,None
861,IRCT20200405046958N1,IRCT,2020-04-14,2020-04-13,True,Mashhad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Prevention of Novel Coronavirus Disease by Hydroxychloroquine in cancer patients.,Drug,Hydroxychloroquine,Hydroxychloroquine,60,http://en.irct.ir/trial/46946,None
862,IRCT20200406046965N1,IRCT,2020-04-12,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,The effect of elderberry syrup against COVID-19 symptoms,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://en.irct.ir/trial/46958,None
863,IRCT20200405046960N1,IRCT,2020-04-08,2020-04-09,False,Ardabil University of Medical Sciences,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Efficacy of Kelofan syrup on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,15,http://en.irct.ir/trial/46961,None
864,IRCT20200318046812N2,IRCT,2020-04-08,2020-04-10,False,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,evaluation of Safety and efficacy of anti inflammatory regimens in COVID-19,Drug,Corticosteroids + naproxen + azithromycin + hydroxychloroquine vs. naproxen + azithromycin + hydroxychloroquine vs. hydroxychloroquine + Lopinavit/ritonavir,Prednisolone; naproxen; azithromycin; hydroxychloroquine; Lopinavit/ritonavir,906,http://en.irct.ir/trial/46968,None
865,IRCT20200317046797N4,IRCT,2020-04-14,2020-04-18,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Bromhexine Hydrochloride on patients with COVID-19,Drug,Bromhexine,Bromhexine,60,http://en.irct.ir/trial/46969,None
866,IRCT20200404046948N1,IRCT,2020-04-15,2020-04-13,True,Artesh University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Efficacy and safety of convalescent plasma in the treatment of COVID-19,ATMP,Plasma,Plasma,60,http://en.irct.ir/trial/46973,None
867,IRCT20180520039738N2,IRCT,2020-04-10,2020-04-07,True,Saveh University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation and comparison of the effectiveness of standard treatment with stand treatment plus Vitamin A in treatment in covid19 patients,Drug,Vitamin A,Vitamin A,140,http://en.irct.ir/trial/46974,None
868,IRCT20081019001369N4,IRCT,2020-04-11,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of minocycline on COVID-19,Drug,Minocycline,Minocycline,40,http://en.irct.ir/trial/46977,None
869,IRCT20081019001369N3,IRCT,2020-04-11,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of crocetin on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://en.irct.ir/trial/46978,None
870,IRCT20200408046992N1,IRCT,2020-04-14,2020-04-16,False,Birjand University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Trifluoperazine in treatment of COVID-19,Drug,Trifluoprazine + Hydroxychloroquine vs. Hydroxychloroquine,Trifluoprazine; hydroxychloroquine,70,http://en.irct.ir/trial/47006,None
871,IRCT20180129038542N1,IRCT,2020-04-13,2020-04-06,True,University of Baqiyatallah,Not Recruiting,Not Applicable,Interventional,Iran,Early tracheostomy in COVID-19,Other (physical),Mechanical ventilation,Mechanical ventilation,30,http://en.irct.ir/trial/47013,None
872,IRCT20200317046797N3,IRCT,2020-04-11,2020-04-20,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Intravenous immunoglobulin (IVIG) in the treatment of COVID-19-induced cytokine storm,ATMP,"Interventional: Immunoglobulin

Both Arms: hydroxychloroquine + ribavirin + lopinavir/ritonavir",Immunoglobulin; hydroxychloroquine; ribavirin; lopinavir/ritonavir,100,http://en.irct.ir/trial/47014,None
873,IRCT20200317046797N5,IRCT,2020-04-19,2020-04-20,False,Tabriz University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Treatment of COVID-19-induced cytokine storm by hemoperfusion,Other (device),Hemoperfusion,Hemoperfusion,10,http://en.irct.ir/trial/47015,None
874,IRCT20180923041093N5,IRCT,2020-04-10,2020-04-15,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation the efficacy of hot foot-bath on COVID-19,Procedure,Foot bath,Foot bath,60,http://en.irct.ir/trial/47018,None
875,IRCT20200406046968N1,IRCT,2020-04-14,2020-04-21,False,Tabriz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,The  effect of IL-6 inhibitor (Tocilizumab) on the prognosis of covid-19 patients with acute respiratory failure hospitalized in Imam Reza Hospital in Tabriz,Drug,Tocilizumab,Tocilizumab,10,http://en.irct.ir/trial/47021,None
876,IRCT20150808023559N20,IRCT,2020-04-11,2020-04-29,False,Ardabil University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Efficacy of hydroxychloroquine plus favipiravir drug regimen in comparison with hydroxychloroquine plus kaletra in  hospitalized patients with COVID-19,Drug,Favipravir + hydroxychloroquine vs. lopinavir/ritonavir + hydroxychloroquine,Favipravir; hydroxychloroquine; lopinavir/ritonavir,100,http://en.irct.ir/trial/47022,None
877,IRCT20130616013690N7,IRCT,2020-05-01,2020-05-02,False,Shiraz University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of interactive psycho-educational interventions on patients infected with COVID-19,Other (psych),Psychological,Psychological,50,http://en.irct.ir/trial/47034,None
878,IRCT20200410047009N1,IRCT,2020-04-26,2020-04-13,True,Iran University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,The effect of Naproxen in recovery and reducing mortality in patients with COVID-19,Drug,"Naproxen w/ and w/o Hydroxychloroquine, Oseltamivir, Lopinavir/ritonavir, chloroquine, ribavirin",Naproxen; Hydroxychloroquine; Oseltamivir; Lopinavir/ritonavir; chloroquine; ribavirin,101,http://en.irct.ir/trial/47052,None
879,IRCT20200408046990N1,IRCT,2020-04-18,2020-05-19,False,Mashhad University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of SinaCurcumin capsule efficacy as an supplement therapy for mild to moderate COVID-19 in Mashhad,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/47061,None
880,IRCT20200411047025N1,IRCT,2020-04-14,2020-04-18,False,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Intravenous vitamin c in Patients with COVID-19,Drug,Vitamin C + Hydroxychloroquine + Atazanavir/ritonavir vs. Hydroxychloroquine + Atazanavir/ritonavir,Vitamin C; Hydroxychloroquine; Atazanavir/ritonavir,110,http://en.irct.ir/trial/47078,None
881,IRCT20080901001165N46,IRCT,2020-04-15,2020-03-30,True,Center for Progress and Development of Iran,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Umifenovir in controlling the symptoms of patients with COVID-19,Drug,Umifenovir,Umifenovir,200,http://en.irct.ir/trial/47087,None
882,IRCT20200406046963N1,IRCT,2020-04-22,2020-03-30,True,Artesh University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficacy and safety of methylprednisolone pulse therapy in treatment of Covid-19 patients with Acute respiratory distress syndrome,Drug,Hydroxychloroquine + Corticosteroids vs. Hydroxychloroquine,Methylprednisolone; Hydroxychloroquine,40,http://en.irct.ir/trial/47088,None
883,IRCT20190122042450N4,IRCT,2020-04-16,2020-04-20,False,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of hydroxychloroquine to prevent coronavirus disease,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1000,http://en.irct.ir/trial/47090,None
884,IRCT20200411047030N1,IRCT,2020-04-17,2020-04-14,True,Mazandaran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of melatonin on the quality of sleep in COVID-19 patients,Drug,Melatonin + Hydroxychloroquine + Azithormycin vs. Hydroxychloroquine + Azithormycin,Melatonin; Hydroxychloroquine; azithormycin,82,http://en.irct.ir/trial/47099,None
885,IRCT20200406046968N2,IRCT,2020-04-22,2020-05-04,False,Tabriz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy of convalescent plasma transfusion of COVID-19 survivors on the treatment of respiratory failure of these patients,ATMP,Plasma,Plasma,30,http://en.irct.ir/trial/47115,None
886,IRCT20170207032444N3,IRCT,2020-04-17,2020-04-15,True,Esfahan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Thalidomide in COVID19,Drug,Thalidomide + Hydroxychloroquine + Methylprednisolone + Antibiotic + Diphenhydramine + Enoxaparin vs. Hydroxychloroquine + Methylprednisolone + Antibiotic + Diphenhydramine + Enoxaparin,Thalidomide; Hydroxychloroquine; Methylprednisolone; Antibiotic; Diphenhydramine; Enoxaparin,60,http://en.irct.ir/trial/47119,None
887,IRCT20200413047053N1,IRCT,2020-04-15,2020-04-20,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Evaluation the effect of asafoetida in the treatment of coronavirus infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/47139,None
888,IRCT20081019001369N5,IRCT,2020-04-26,2020-05-02,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of lithium carbonate  on COVID-19,Drug,Lithium,Lithium,40,http://en.irct.ir/trial/47141,None
889,IRCT20200408046988N1,IRCT,2020-04-29,2020-04-14,True,Gonabad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of the efficacy of melatonin tablets as auxiliary medication in accelerating the improvement of the COVID-19 symptoms and clinical findings,Drug,Melatonin + Hydroxychloroquine vs. Hydroxychloroquine,Melatonin; Hydroxychloroquine,60,http://en.irct.ir/trial/47142,None
890,IRCT20200413047062N1,IRCT,2020-05-04,2020-04-13,True,Islamic Azad University,Not Recruiting,Phase 3,Interventional,Iran,Effect of Atorvastatin in treatment of COVID-19 infection,Drug,Atorvastatin,Atorvastatin,76,http://en.irct.ir/trial/47146,None
891,IRCT20191125045492N2,IRCT,2020-04-18,2020-04-23,False,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of Ozone therapy in treatment of COVID-19,Drug,Ozone,Ozone,80,http://en.irct.ir/trial/47149,None
892,IRCT20200406046968N3,IRCT,2020-05-08,2020-04-29,True,Zist Daru Danesh Company,Recruiting,Phase 2,Interventional,Iran,effect of Interfron-beta1(zifron) on clinical improvement and prognosis of COVID-19 in Tabriz Imam-Reza hospital,Drug,Interferon beta + Hydroxycholoquine + Lopinavir/ritonavir vs. Hydroxycholoquine + Lopinavir/ritonavir,Interferon beta; Hydroxycholoquine; Lopinavir/ritonavir,60,http://en.irct.ir/trial/47152,None
893,IRCT20200413047063N1,IRCT,2020-05-04,2020-03-20,True,National Institute for Medical Research Development,Recruiting,Phase 1/Phase 2,Interventional,Iran,Placental Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection: A Phase 1-2 Clinical Trial,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,http://en.irct.ir/trial/47156,None
894,IRCT20200413047052N1,IRCT,2020-05-07,2020-05-04,True,Esfahan University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,"The effectiveness of educational-treatment package based on psychological flexibility in burnout, quality of working life, work-family conflict and mental health",Other (psych),Psychological,Psychological,60,http://en.irct.ir/trial/47160,None
895,IRCT20200414047070N1,IRCT,2020-04-21,2020-05-04,False,Fasa University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of ppd on recovery of covid disease 19,Drug,Tuberculin w/ and w/o Chloroquine + Lopinavir/ritonavir,Tuberculin; Chloroquine; Lopinavir/ritonavir,50,http://en.irct.ir/trial/47169,None
896,IRCT20170210032478N3,IRCT,2020-04-29,2020-04-18,True,National Research Institute of Tuberculosis and Lung Diseases,Recruiting,Phase 3,Interventional,Iran,Effect of  Formoterol in treatment of covid19,Drug,Formoterol,Formoterol,50,http://en.irct.ir/trial/47173,None
897,IRCT20200415047082N1,IRCT,2020-04-21,2020-05-04,False,Jahrom University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Effect evaluation of herbal supplementation from the combination of sugarcane, black myrobalan and mastic along with the treatment protocol of the Ministry of Health on the course of coronavirus disease",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,10,http://en.irct.ir/trial/47193,None
898,IRCT20200413047056N1,IRCT,2020-04-17,2020-04-18,False,Birjand University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Comparison between the efficacy of intravenous immunoglobulin and convalescent plasma in COVID-19,ATMP,Plasma vs. Immunoglobulin,Plasma; Immunoglobulin,15,http://en.irct.ir/trial/47212,None
899,IRCT20200418047116N1,IRCT,2020-05-04,2020-03-10,True,Gonabad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,The effect of Intravenous immunoglobulin on COVID-19 infection,ATMP,Immunoglobulin,Immunoglobulin,20,http://en.irct.ir/trial/47219,None
900,IRCT20200415047089N1,IRCT,2020-04-19,2020-04-18,True,Saveh University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of herbal drugs (Echinacea and Ginger) on Improvement of clinical symptoms and hospitalizations in suspected COVID-19 outpatient cases,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://en.irct.ir/trial/47234,None
901,IRCT20200415047092N1,IRCT,2020-04-20,2020-04-24,False,Tehran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of azithromycin in treatment of COVID19,Drug,Azithromycin +  Oseltamivir + Lopinavir/ritonavir or Atazanavir + Hydroxychloroquine vs. Oseltamivir + Lopinavir/ritonavir or Atazanavir + Hydroxychloroquine,Azithromycin; oseltamivir; lopinavir/ritonavir; atazanavir; hydroxychloroquine,110,http://en.irct.ir/trial/47244,None
902,IRCT20200416047104N1,IRCT,2020-04-23,2020-04-20,True,Shahre-kord University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of pomegranate tea on symptom relief of COVID-19 patients,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,66,http://en.irct.ir/trial/47251,None
903,IRCT20200417047113N1,IRCT,2020-04-24,2020-04-27,False,Middle East Gene Therapy Corporation,Recruiting,Phase 1/Phase 2,Interventional,Iran,Effect of NK cell therapy in COVID-19,ATMP,Cells (NK),Cells (NK),70,http://en.irct.ir/trial/47264,None
904,IRCT20200419047128N1,IRCT,2020-04-22,2020-05-04,False,Ahvaz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Tranilast in COVID19,Drug,Tranilast,Tranilast,60,http://en.irct.ir/trial/47265,None
905,IRCT20200416047099N1,IRCT,2020-04-21,2020-04-05,True,Shahid Beheshti University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Plasma therapy in patient with COVID-19,ATMP,Plasma,Plasma,10,http://en.irct.ir/trial/47266,None
906,IRCT20200418047122N1,IRCT,2020-05-03,2020-04-25,True,Esfahan University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Evaluation of the therapeutic effect of a combination drug including Apocynin, Niacin, and Tannin on COVID-19",Drug,Apocynin + Niacin + Tannin,Apocynin; Niacin; Tannin,80,http://en.irct.ir/trial/47268,None
907,IRCT20200418047121N2,IRCT,2020-05-05,2020-05-09,False,Kermanshah University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Stem cell therapy in COVID-19,ATMP,Cells (stem cells),Cells (stem cells),6,http://en.irct.ir/trial/47275,None
908,IRCT20140407017169N2,IRCT,2020-04-28,2020-04-30,False,Social Development and Health Promotion Research Center,Recruiting,Not Applicable,Interventional,Iran,Effect of natural from Tahini oil product on corona,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://en.irct.ir/trial/47295,None
909,IRCT20200329046892N1,IRCT,2020-05-02,2020-05-04,False,Rasht University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Trifluoperazine Effectiveness in Treatment of Coronavirus,Drug,Trifluoperazine,Trifluoperazine,70,http://en.irct.ir/trial/47300,None
910,IRCT20080901001165N48,IRCT,2020-04-22,2020-03-30,True,Niak Pharmaceutical Company,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy of Zofa (a herbal medicine) in symptom management of patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://en.irct.ir/trial/47318,None
911,IRCT20200420047147N1,IRCT,2020-04-23,2020-05-04,False,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,?Evaluation the effects of Sitagliptin administration in patients with COVID-19,Drug,Sitagliptin + Hydroxychloroquine + Lopinavir/ritonavir vs. Hydroxychloroquine + Lopinavir/ritonavir,Sitagliptin; Hydroxychloroquine; Lopinavir/ritonavir,84,http://en.irct.ir/trial/47334,None
912,IRCT20190618043923N4,IRCT,2020-05-04,2020-04-25,True,Tabriz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Ozone Autohemotherapy in Covid19,Drug,Ozone,Ozone,20,http://en.irct.ir/trial/47363,None
913,IRCT20200421047155N1,IRCT,2020-04-25,2020-04-29,False,Ardabil University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Efficacy of tenofovir in covid-19,Drug,Tenofovir vs. Hydroxychloroquine,Tenofovir vs. Hydroxychloroquine,86,http://en.irct.ir/trial/47387,None
914,IRCT20200419047128N2,IRCT,2020-04-24,2020-04-29,False,Ahvaz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Quercetin in COVID19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/47396,None
915,IRCT20080901001165N49,IRCT,2020-04-25,2020-03-30,True,Andisheh Salamat Sabalan Medicinal Plants Company,Recruiting,Not Applicable,Interventional,Iran,"Evaluation efficacy of a herbal combination (contains Glycyrrhiza glabra, Mentha pulegium and Urtica) in controlling symptoms in patients with COVID-19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/47401,None
916,IRCT20200422047168N1,IRCT,2020-04-29,2020-04-18,True,Ahvaz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Clinical trial study on the therapeutic effect of Tenofovir besides Kaletra and Chloroquinein in patients with Coronavirus disease 2019 (COVID-19),Drug,Tenofovir + Chloroquine + Lopinavir/ritonavir vs. Chloroquine + Lopinavir/ritonavir,Tenofovir; Chloroquine; Lopinavir/ritonavir,60,http://en.irct.ir/trial/47437,None
917,IRCT20200408046990N2,IRCT,2020-04-25,2020-04-29,False,Mashhad University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the colchicine tablet efficacy as an adjuvant therapy for patients with mild to moderate COVID-19,Drug,Colchicine,Colchicine,40,http://en.irct.ir/trial/47468,None
918,IRCT20180114038350N3,IRCT,2020-05-01,2020-05-04,False,Sanandaj University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Deferiprone on the improvement of symptoms of Coronavirus 2019 (COVID 19),Drug,Deferiprone,Deferiprone,80,http://en.irct.ir/trial/47475,None
919,IRCT20200426047206N1,IRCT,2020-04-28,2020-05-09,False,Hamedan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of NBS powder in treatment of patients with  COVID-19,Supplement (+ Drug),NBS Powder vs. Hydroxychloroquine + Lopinavir/ritonavir,NBS Powder; Hydroxychloroquine; Lopinavir/ritonavir,46,http://en.irct.ir/trial/47495,None
920,IRCT20120215009014N353,IRCT,2020-04-27,2020-05-14,False,Hamedan University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of plasma of patients recovered from covid-19 versus control group on treatment of covid-19,ATMP,Plasma,Plasma,100,http://en.irct.ir/trial/47501,None
921,IRCT20140305016852N4,IRCT,2020-05-04,2020-04-20,True,Sabzevar University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Comparison of three methods of treatment in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with and without coronavirus positive test,Drug,Vitamin D vs. Vitamin C,Vitamin D; Vitamin C,30,http://en.irct.ir/trial/47508,None
922,IRCT20180425039414N2,IRCT,2020-05-13,2020-04-20,True,Esfahan University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of zinc on the treatment and clinical course of patients with SARS-cov2 (COVID-19),Drug,Hydroxychloroqine + Zinc vs. Hydroxychloroquine,Hydroxychloroqine; Zinc,80,http://en.irct.ir/trial/47516,None
923,IRCT20200427047215N1,IRCT,2020-05-05,2020-05-08,False,Isfahan University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation effect of Indomethacin for Covid19 infection,Drug,Indomethacin,Indomethacin,60,http://en.irct.ir/trial/47520,None
924,IRCT20200426047212N1,IRCT,2020-05-02,2020-05-04,False,Shooshtar University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of of Inhalation of Thyme Oil in COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,48,http://en.irct.ir/trial/47572,None
925,IRCT20080901001165N50,IRCT,2020-05-01,2020-05-01,False,Sina Darou Laboratories Company,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Azithromycin inhaled spray in controlling the symptoms of patients with COVID-19,Drug,Azithromycin,Azithromycin,80,http://en.irct.ir/trial/47576,None
926,IRCT20080901001165N51,IRCT,2020-05-01,2020-05-01,False,Sina Darou Laboratories Company,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Hydroxychloroquine nasal spray in controlling the symptoms of patients with COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,80,http://en.irct.ir/trial/47577,None
927,IRCT20200418047121N1,IRCT,2020-05-01,2020-05-09,False,Kermanshah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,"Study the effectiveness of concomitant use of vitamin C, metformin, azithromycin and doxycycline on improving patients with COVID-19",Drug,Vitamin C + Metformin + Azithromycin + Doxycycline,Vitamin C; Metformin; Azithromycin; Doxycycline,40,http://en.irct.ir/trial/47578,None
928,IRCT20150808023559N21,IRCT,2020-05-09,2020-05-12,False,Ardabil University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,The Effect of Convalescent Plasma Therapy on  Patients with 19-COVID,ATMP,Plasma,Plasma,60,http://en.irct.ir/trial/47594,None
929,IRCT20200501047258N1,IRCT,2020-05-04,2020-05-04,False,Oroumia University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,effects of  convalescent plasma in COVID-19,ATMP,Plasma,Plasma,120,http://en.irct.ir/trial/47629,None
930,IRCT20131129015584N2,IRCT,2020-05-08,2020-04-04,True,Mazandaran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of herbal syrup on patients with corona,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,152,http://en.irct.ir/trial/47639,None
931,IRCT20080901001165N52,IRCT,2020-05-05,2020-04-20,True,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy of high dose of glucocorticoid in patients with moderate to severe pneumonia related to COVID-19,Drug,Corticosteroids,Methylprednisolone; Prednisone,50,http://en.irct.ir/trial/47641,None
932,IRCT20160706028815N5,IRCT,2020-05-05,2020-05-20,False,Sabzevar University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,The effect of addition of selenium to treatment regimen of hospitalized patients with corona on the outcome of disease compared with control group,Drug,Selenium,Selenium,40,http://en.irct.ir/trial/47682,None
933,IRCT20171213037866N2,IRCT,2020-05-07,2020-05-09,False,Semnan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of jujube product on Covid-19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,68,http://en.irct.ir/trial/47684,None
934,IRCT20200326046868N1,IRCT,2020-05-09,2020-05-21,False,Abadan University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,effect of propolis  in COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,88,http://en.irct.ir/trial/47934,None
935,IRCT20200508047346N1,IRCT,2020-05-13,2020-05-21,False,Kowsar Biotechnology Co.,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the effectiveness of rabbit antibody against coronavirus in patients,ATMP,Antibodies,Antibodies,124,http://en.irct.ir/trial/47953,None
936,IRCT20120215009014N354,IRCT,2020-05-12,2020-06-04,False,Hamedan University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,"Evaluating the effect of intravenous hydrocortisone, methylprednisolone, and dexamethasone in treatment of patients with moderate to severe acute respiratory distress syndrome caused by COVID-19",Drug,Corticosteroids,Hydrocortisone; Methylprednisolone; Dexamethasone,81,http://en.irct.ir/trial/48043,None
937,KCT0005005,CRIS,2020-05-11,2020-05-11,False,Daegu Catholic University Medical Center,Not Recruiting,Not Applicable,Observational,South Korea,Psychiatric Consultation for COVID-19 Patients,Other (psych),Psychological,Psychological,54,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16339,None
938,KCT0005003,CRIS,2020-05-11,2020-05-25,False,Gyeongsang National University Hospital,Not Recruiting,Phase 2,Interventional,South Korea,Clinical efficacy of Nafamostat for COVID-19 pneumonia,Drug,Nafamostat w/ or w/o Lopinavir / ritonavir + Hydroxychloroquine + Oxygen,Nafamostat; Lopinavir/ritonavir; Hydroxychloroquine; Oxygen,84,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16635,None
939,JPRN-UMIN000040193,JPRN,2020-04-18,2020-04-30,False,Osaka University Graduate School of Medicine,Not Recruiting,Not Applicable,Observational,Japan,"Evaluating the social function of people with dementia under the COVID-19 epidemic 
by the Japanese version of the social functioning in dementia scale",Other,No Intervention,No Intervention,300,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045831,None
940,JPRN-UMIN000040235,JPRN,2020-04-25,2020-04-23,True,Yuri Kumiai General Hospital,Recruiting,Not Applicable,Interventional,Japan,Examination of test accuracy of COVID-19 rapid antibody kit,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,20,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045901,None
941,JPRN-UMIN000040250,JPRN,2020-04-30,2020-05-08,False,Nihon University School of Medicine,Not Recruiting,Not Applicable,Observational,Japan,Changes of D-dimer in preventive period for COVID-19 for patients with chronic heart failure,Clinical Presentation,No Intervention,No Intervention,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045918,None
942,JPRN-UMIN000040278,JPRN,2020-05-08,2020-06-01,False,Nagasaki University,Not Recruiting,Not Applicable,Observational,Japan,Had COVID-19 Spread in Nagasaki Prefecture before the first confirmed case?,Clinical Presentation (Epidemiology),No Intervention,No Intervention,182,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045953,None
943,JPRN-UMIN000040286,JPRN,2020-05-11,2020-05-12,False,University of Tokyo,Not Recruiting,Not Applicable,Interventional,Japan,Study on risk perception and behavioral change related to COVID-19,Other (psych),No Intervention,No Intervention,1980,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045966,None
944,JPRN-UMIN000040295,JPRN,2020-05-02,2020-02-01,True,Japanese Red Cross Medical Center,Recruiting,Not Applicable,Observational,Japan,Prospective observational study on diagnosis and treatment of COVID-19,Clinical Presentation,No Intervention,No Intervention,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045974,None
945,JPRN-UMIN000040335,JPRN,2020-05-08,2020-05-08,False,Takasaki University of Health and Welfare,Not Recruiting,Not Applicable,Observational,Japan,Impacts of COVID-19 prevention life in community-dwelling older adults and support measures,Other,No Intervention,No Intervention,346,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045960,None
946,JPRN-UMIN000040401,JPRN,2020-05-15,2020-05-15,False,Tokyo Medical and Dental University,Recruiting,Not Applicable,Interventional,Japan,A feasibility study of remote rehabilitation using a wearable biological monitoring device in the patients with COVID-19,Other (device),Wearable,Wearable,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046104,None
947,ACTRN12620000575932,ANZCTR,2020-05-18,2020-03-05,True,Royal North Shore Hospital,Recruiting,Not Applicable,Observational,Australia,Prevalence of the loss of smell in patients with COVID-19: The SMELLY Study,Clinical Presentation,No Intervention,No Intervention,100,https://anzctr.org.au/ACTRN12620000575932.aspx,None
948,ACTRN12620000579998,ANZCTR,2020-05-19,2020-05-20,False,Mackay Hospital and Health Service,Not Recruiting,Not Applicable,Interventional,Australia,"In a simulation environment, is there a difference in time taken for consultant anaesthetists to perform spinal anaesthesia as compared to general anaesthesia on women, with suspected or confirmed COVID-19, who require emergency caesarean delivery?",Other,No Intervention,No Intervention,10,https://anzctr.org.au/ACTRN12620000579998.aspx,None
949,ISRCTN85216856,ISRCTN,2020-05-11,2020-10-05,False,Universidad Tecnológica Equinoccial,Recruiting,Phase 2/Phase 3,Interventional,Ecuador,Using blood plasma to develop passive immunity to coronavirus in Ecuador,ATMP,Plasma,Plasma,200,http://isrctn.com/ISRCTN85216856,None
950,ChiCTR2000033200,ChiCTR,2020-05-23,2020-01-01,True,The Fifth Medical Center of Chinese General Hospital,Recruiting,Not Applicable,Observational,China,The real-world study for the change of early breast cancer diagnosis and treatment mode under the pandemic of Coronavirus Disease 2019 (COVID-19),Other,No Intervention,No Intervention,10000,http://www.chictr.org.cn/showproj.aspx?proj=54056,None
951,ChiCTR2000033198,ChiCTR,2020-05-23,2020-05-25,False,"Beijing Friendship Hospital, Capital Medical University",Recruiting,Not Applicable,Observational,China,Status of management of surgery in Beijing during COVID-19,Health System,No Intervention,No Intervention,500,http://www.chictr.org.cn/showproj.aspx?proj=54015,None
952,ChiCTR2000033197,ChiCTR,2020-05-23,2020-05-13,True,Beijing Cancer Hospital Medical,Not Recruiting,Not Applicable,Observational,China,Investigation of Mental Status for in-patients with gastrointestinal malignancy  during the COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,65,http://www.chictr.org.cn/showproj.aspx?proj=53451,None
953,ChiCTR2000033190,ChiCTR,2020-05-23,2020-03-01,True,The First Hospital of Changsha,Not Recruiting,Not Applicable,Observational,China,The research Of novel coronavirus pneumonia (COVID-19) patients' immune status and severity of disease,ATMP,Immunoglobulin,Immunoglobulin,60,http://www.chictr.org.cn/showproj.aspx?proj=54062,None
954,ChiCTR2000033186,ChiCTR,2020-05-23,2020-02-01,True,The First Affiliated Hospital of Zhengzhou University,Recruiting,Not Applicable,Observational,China,A follow-up study about clinically diagnosed cases of novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,116,http://www.chictr.org.cn/showproj.aspx?proj=53927,None
955,ChiCTR2000033133,ChiCTR,2020-05-21,2020-02-12,True,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,"A randomized, open-label, blank-controlled, multicenter trial for Shuang-Huang-Lian oral solution in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=53925,None
956,ChiCTR2000033108,ChiCTR,2020-05-21,2020-05-20,True,Southern Medical University,Recruiting,Not Applicable,Observational,China,"Associations between suboptimal health status  and TraditChinese Medicine constitution of medical staff fighting the disease, recovered COVID-19 patients and the general public under the outbreak of novel coronavirus pneumonia: an epidemiological study",Clinical Presentation,No Intervention,No Intervention,600,http://www.chictr.org.cn/showproj.aspx?proj=54000,None
957,ChiCTR2000033107,ChiCTR,2020-05-21,2020-05-01,True,"Daping Hospital, Army Medical University",Not Recruiting,Not Applicable,Observational,China,Clinical characteristics and outcomes of novel coronavirus pneumonia (COVID-19) patients with pre-existing HBV infection,Clinical Presentation,No Intervention,No Intervention,72,http://www.chictr.org.cn/showproj.aspx?proj=54010,None
958,ChiCTR2000033104,ChiCTR,2020-05-21,2020-03-07,True,The Third People's Hospital of Hubei Province,Not Recruiting,Not Applicable,Diagnostic test,China,Clinical study for rapid detection of novel coronavirus pneumonia (COVID-19) nucleic acid,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,670,http://www.chictr.org.cn/showproj.aspx?proj=53845,None
959,ChiCTR2000033057,ChiCTR,2020-05-19,2020-02-25,True,The First Hospital of China Medical University,Recruiting,Not Applicable,Interventional,China,A randomized controlled trial for determination of the clinical effect of Internet-assisted pulmonary rehabilitation on patients with novel coronavirus pneumonia (COVID-19),Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,160,http://www.chictr.org.cn/showproj.aspx?proj=53529,None
960,ChiCTR2000033056,ChiCTR,2020-05-19,2020-01-29,True,Guizhou Provincial Jiangjunshan Hospital,Not Recruiting,Not Applicable,Interventional,China,Convalescent Plasma in the treatment of 6 COVID-19 Patients,ATMP,Plasma,Plasma,6,http://www.chictr.org.cn/showproj.aspx?proj=53859,None
961,ChiCTR2000033055,ChiCTR,2020-05-19,2020-05-20,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Novel coronavirus pneumonia (COVID-19) and Symptomatic Venous Thromboembolism: a Multicenter Retrospective Study,Clinical Presentation,No Intervention,No Intervention,300,http://www.chictr.org.cn/showproj.aspx?proj=53860,None
962,ChiCTR2000033054,ChiCTR,2020-05-19,2020-05-19,False,Wuhan Mental Health Center,Recruiting,Not Applicable,Observational,No Country Given,The investigation of psychosocial stress status in juveniles during the pandemic of the novel coronavirus pneumonia (COVID-19),Other (psych),Psychological,Psychological,800,http://www.chictr.org.cn/showproj.aspx?proj=53894,None
963,ChiCTR2000033053,ChiCTR,2020-05-19,2020-02-01,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Efficacy of Early Prone Positioning in Non-Mechanical Ventilation novel coronavirus pneumonia (COVID-19) Patients with Severe Hypoxia- a single-center prospective cohort study,Procedure,Positioning,Positioning,60,http://www.chictr.org.cn/showproj.aspx?proj=53886,None
964,ChiCTR2000033052,ChiCTR,2020-05-19,2020-03-16,True,Oscar Cano-Valderrama,Not Recruiting,Not Applicable,Observational,Spain,Acute Care Surgery during novel coronavirus pneumonia (COVID-19) pandemic in Spain,Other,No Intervention,No Intervention,400,http://www.chictr.org.cn/showproj.aspx?proj=53892,None
965,ChiCTR2000033050,ChiCTR,2020-05-18,2020-05-04,True,"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",Recruiting,Not Applicable,Observational,China,Effect of high dose intravenous vitamin C on moderate novel coronavirus pneumonia (COVID-19) patients: a medical records based retrospective study,Drug,Vitamin C,Vitamin C,110,http://www.chictr.org.cn/showproj.aspx?proj=53590,None
966,ChiCTR2000033049,ChiCTR,2020-05-18,2020-05-19,False,Hongqi Hospital Affiliated to Mudangjiang Medical University,Recruiting,Phase 4,Interventional,China,A clinical study for the efficacy and safety of artemisinin-pipequine tablets in the treatment of the untreated mild or common type novel coronavirus pneumonia (COVID-19) patients,Drug,Artemisinin/pipequine,Artemisinin/pipequine,160,http://www.chictr.org.cn/showproj.aspx?proj=53840,None
967,EUCTR2020-001614-38-BE,EU Clinical Trials Register,2020-04-06,2020-04-22,False,UZ Leuven,Authorised,Phase 2,Interventional,Belgium,"Covid-19: A randomized, open-label, adaptive, proof-of- concept clinical trial of new antiviral drug candidates against SARS-CoV-2.",Drug,Azithromycin,Azithromycin,282,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001614-38,None
968,NCT04404634,ClinicalTrials.gov,2020-05-22,2020-05-01,True,Yale University,Not Recruiting,Phase 2,Interventional,No Country Given,Convalescent Plasma To Limit COVID-19 Associated Complications,ATMP,Plasma,Plasma,300,https://clinicaltrials.gov/show/NCT04404634,None
969,ACTRN12620000602921,ANZCTR,2020-05-25,2020-05-29,False,The Australian and New Zealand Intensive Care Research Centre	,Not Recruiting,Not Applicable,Observational,Australia,Post-Intensive Care Nutrition Status in Patients with COVID-19,Clinical Presentation,No Intervention,No Intervention,200,https://anzctr.org.au/ACTRN12620000602921.aspx,None
970,ACTRN12620000617965,ANZCTR,2020-05-27,2020-04-30,True,"St. Vincent's Hospital, Sydney",Recruiting,Not Applicable,Observational,Australia,Multi-site audit of COVID-19 airway interventions,Other,No Intervention,No Intervention,100,https://anzctr.org.au/ACTRN12620000617965.aspx,None
971,ACTRN12620000593932,ANZCTR,2020-05-22,2020-01-08,True,Professor Julie Quinlivan,Not Recruiting,Not Applicable,Observational,Australia,Has the threat of SARS COVID-19 increased influenza vaccination rates in pregnant women?,Other,No Intervention,No Intervention,100,https://anzctr.org.au/ACTRN12620000593932.aspx,None
972,ACTRN12620000609954,ANZCTR,2020-05-25,2020-04-16,True,Alfred Health,Recruiting,Not Applicable,Observational,Australia,Covid-19 Biobank of clinical samples and data for use in research to help understand the immune characteristics of people who are diagnosed with COVID19.,Clinical Presentation,No Intervention,No Intervention,250,https://anzctr.org.au/ACTRN12620000609954.aspx,None
973,ChiCTR2000033433,ChiCTR,2020-05-31,2020-06-18,False,"International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University",Not Recruiting,Not Applicable,Interventional,China,Study for the Effect of Internet-based Cognitive Behavior Intervention on Perinatal Depression and Anxiety during the novel coronavirus pneumonia (COVID-19) pandemic,Other (psych),Psychological,Psychological,300,http://www.chictr.org.cn/showproj.aspx?proj=54482,None
974,ChiCTR2000033372,ChiCTR,2020-05-29,2020-03-12,True,Shandong University Qilu Hospital,Not Recruiting,Not Applicable,Interventional,China,Efficacy and safety of leflunomide for Refractory novel coronavirus pneumonia (COVID-19): A non-Randomized Controlled Study,Drug,Leflunomide,Leflunomide,30,http://www.chictr.org.cn/showproj.aspx?proj=54408,None
975,ChiCTR2000033364,ChiCTR,2020-05-29,2020-05-21,True,Shaanxi Traditional Chinese Medicine Hospital,Recruiting,Not Applicable,Observational,China,A correlation study between food intake and risk factors of PTSD after the COVID-19 of shift medical staff,Other (psych),No Intervention,No Intervention,300,http://www.chictr.org.cn/showproj.aspx?proj=54280,None
976,ChiCTR2000033347,ChiCTR,2020-05-28,2020-01-29,True,Affiliated Hospital of Zunyi Medical University,Not Recruiting,Not Applicable,Observational,China,Epidemiological and Clinical Characteristics of 20 Re-positive novel coronavirus pneumonia (COVID-19) Patients,Clinical Presentation,No Intervention,No Intervention,20,http://www.chictr.org.cn/showproj.aspx?proj=53976,None
977,ChiCTR2000033346,ChiCTR,2020-05-28,2020-02-29,True,Affiliated Hospital of Zunyi Medical University,Not Recruiting,Not Applicable,Observational,China,Erythrocyte Sedimentation Rate in novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,No Intervention,80,http://www.chictr.org.cn/showproj.aspx?proj=54388,None
978,ChiCTR2000033345,ChiCTR,2020-05-28,2020-05-29,False,The Affiliated Hospital to Changchun University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,Study for the effect of Traditional Chinese medicine in the prevention of novel coronavirus pneumonia (COVID-1) in the high risk area,Traditional Medicine (Drug),Tradtional Medicine,Tradtional Medicine,10000,http://www.chictr.org.cn/showproj.aspx?proj=54282,None
979,ChiCTR2000033342,ChiCTR,2020-05-28,2020-06-15,False,Children's Hospital of Fudan University,Not Recruiting,Not Applicable,Observational,China,The comprehensive evaluation of therapeutic drugs for pediatric novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Tradtional Medicine,Tradtional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=54371,None
980,ChiCTR2000033323,ChiCTR,2020-05-28,2020-05-11,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Interventional,Iraq,Severe Reluctant COVID-19 Patients Responding to Convalescent  Plasma; A case series,Drug,Plasma,Plasma,24,http://www.chictr.org.cn/showproj.aspx?proj=54346,None
981,ChiCTR2000033320,ChiCTR,2020-05-27,2020-01-21,True,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Study for Traditional Chinese Medicine in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=54321,None
982,ChiCTR2000033319,ChiCTR,2020-05-27,2020-06-01,False,The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital),Recruiting,Not Applicable,Observational,China,"A follow up research of exercise, cardiopulmonary and quality of Life for patients of novel coronavirus pneumonia (COVID-19)",Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,85,http://www.chictr.org.cn/showproj.aspx?proj=54327,None
983,ChiCTR2000033318,ChiCTR,2020-05-27,2020-02-18,True,Yueyang Hospital of Integrated Traditional Chinese Medicine and Western Medicine Affiliated to Shanghai University of Tranditional Medicine,Recruiting,Not Applicable,Interventional,China,Efficacy of Liu-zi-jue in Patients with 2019 Novel Coronavirus Pneumonia (COVID-19):  a randomized controlled trial,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,104,http://www.chictr.org.cn/showproj.aspx?proj=54326,None
984,ChiCTR2000033317,ChiCTR,2020-05-27,2020-05-25,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,China,Psychiatric admissions during the COVID-19 pandemic,Clinical Presentation,No Intervention,No Intervention,10000,http://www.chictr.org.cn/showproj.aspx?proj=54295,None
985,ChiCTR2000033286,ChiCTR,2020-05-26,2020-02-15,True,Xiangyang Central Hospital,Not Recruiting,Not Applicable,Interventional,China,"A Randomized, Double-blind, Placebo-controlled trial for determination of the Efficacy and Safety of Baicalein in Hospitalized Adult  Mild and Moderate Patients of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Tradtional Medicine,Tradtional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=54176,None
986,ChiCTR2000033284,ChiCTR,2020-05-26,2020-06-01,False,Guangzhou Women and Children's Medical Center,Not Recruiting,Not Applicable,Interventional,China,Study for the improvement of the quality of life of severe patients of novel coronavirus pneumonia (COVID-19) by the integrated Chinese medicine and Western medicine therapy,Traditional Medicine + Western Medicine,Traditional Medicine,Traditional Medicine,150,http://www.chictr.org.cn/showproj.aspx?proj=49590,None
987,ChiCTR2000033261,ChiCTR,2020-05-25,2020-02-15,True,Jiangsu People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Usefulness of abdominal massage and ST-36 (Zusanli) acupressure in improving appetite of novel coronavirus pneumonia (COVID-19) patients treated in makeshift hospital,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=54185,None
988,ChiCTR2000031539,ChiCTR,2020-04-03,2020-03-15,True,Wuhan Women and Children's Health Care Center,Not Recruiting,Not Applicable,Observational,China,A Medical Records Based Study for the Correlation between Angiotensin II Type 1 Receptor Blockers (ARBs) and  the Progression and Outcome of Novel Coronavirus Pneumonia (COVID-19),Drug,ARBs,ARBs,180,http://www.chictr.org.cn/showproj.aspx?proj=51893,None
989,ChiCTR2000029479,ChiCTR,2020-02-02,2020-01-30,True,Hospital of Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Research for Traditional Chinese Medicine Technology Prevention and Control of Novel Coronavirus Pneumonia  (COVID-19) in the Community Population,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,20000,http://www.chictr.org.cn/showproj.aspx?proj=48773,None
990,ISRCTN15254871,ISRCTN,2020-05-23,2020-05-18,True,Heim Pl National Pediatric Institute LaTRA Foundation,Recruiting,Not Applicable,Interventional,Hungary,Online parent training for reducing parenting stress during the coronavirus pandemic,Other (psych),Psychological,Psychological,300,http://isrctn.com/ISRCTN15254871,None
991,ISRCTN64783542,ISRCTN,2020-05-22,2020-01-03,True,Oxford University Hospitals NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,Investigating blood clotting changes in patients with COVID-19,Clinical Presentation,No Intervention,No Intervention,1000,http://isrctn.com/ISRCTN64783542,None
992,ISRCTN50212645,ISRCTN,2020-05-20,2020-01-06,True,"University College, London",Recruiting,Not Applicable,Interventional,United Kingdom,How effective are infection prevention and control measures that are informed by genetic analysis of coronavirus (rapid and standard) at preventing COVID-19 in NHS hospitals?,Genomics,Infection control,Infection control,2000,http://isrctn.com/ISRCTN50212645,None
993,ISRCTN44324934,ISRCTN,2020-05-18,2020-04-30,True,University of Bristol,Recruiting,Not Applicable,Observational,United Kingdom,"The symptoms, virology and immunity of COVID in healthcare workers",Clinical Presentation,No Intervention,No Intervention,135,http://isrctn.com/ISRCTN44324934,None
994,ISRCTN10077335,ISRCTN,2020-04-07,2020-03-19,True,LMU Klinikum,Not Recruiting,Not Applicable,Observational,Germany,Comparison of lung water in COVID-19 patients and other patients with acute respiratory failure,Clinical Presentation,No Intervention,No Intervention,25,http://isrctn.com/ISRCTN10077335,None
995,EUCTR2020-001573-78-FR,EU Clinical Trials Register,2020-04-14,2020-06-05,False,Revimmune,Authorised,Phase 2,Interventional,"France, United States",Recombinant InterLeukin-7 (CYT107) to Improve clinical outcomes in lymphopenic pAtients with COVID-19 infection,Drug,Interleukin-7,Interleukin-7,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001573-78,None
996,EUCTR2020-001754-21-FR,EU Clinical Trials Register,2020-04-17,2020-05-19,False,Assistance Publique – Hôpitaux de Marseille,Authorised,Phase 3,Interventional,France,An open prospective randomized therapeutic trial using ANAKINRA or TOCILIZUMAB alone or in combination with RUXOLITINIB in severe stage 2b and 3 COVID-19 disease,Drug,"Anakinra, Tocilizumab, Ruxolitinib",Anakinra; Tocilizumab; Ruxolitinib,150,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001754-21,None
997,EUCTR2020-001536-98-ES,EU Clinical Trials Register,2020-04-20,2020-04-18,True,Mútua Terrassa University Hospital,Not Recruiting,Phase 3,Interventional,Spain,"Prophylaxis of COVID-19 infection with hydroxychloroquine in healthcare
personnel with high risk of infection.",Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001536-98,None
998,EUCTR2020-001673-75-FR,EU Clinical Trials Register,2020-04-17,2020-06-05,False,ABIVAX,Authorised,Phase 2/Phase 3,Interventional,France,"Phase 2/3 study of ABX464, once daily oral capsule, in high risk patients infected by SARS-CoV-2 prior to COVID-19 associated respiratory distress.",Drug,ABX464,ABX464,1034,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001673-75,None
999,EUCTR2020-001497-30-FR,EU Clinical Trials Register,2020-04-28,2020-12-05,True,Alexion Pharmaceuticals,Authorised,Phase 3,Interventional,"Germany, Italy, France, United Kingdom, United States, Spain",ravulizumab for the treatment of patients with Coronavirus Disease 2019,Drug,Ravulizumab,Ravulizumab,270,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001497-30,None
1000,ACTRN12620000640909,ANZCTR,2020-06-01,2020-08-06,False,University of Melbourne,Not Recruiting,Not Applicable,Interventional,Australia,"A phase II, open label non-randomised clinical trial of the safety and efficacy of the CovidCare app to support self-monitoring for COVID-19 symptoms in self-isolation and to determine the impacts on mental health",Other (software),eHealth,eHealth,200,https://anzctr.org.au/ACTRN12620000640909.aspx,None
1001,ACTRN12620000635965,ANZCTR,2020-05-29,2020-05-06,True,South Western Sydney Local Health District,Not Recruiting,Not Applicable,Interventional,Australia,"Open label, prospective study for the Biofourmis Everion armband telemonitoring solution for patients during COVID-19 home isolation within South Western Sydney",Other (software),eHealth,eHealth,50,https://anzctr.org.au/ACTRN12620000635965.aspx,None
1002,ACTRN12620000641998,ANZCTR,2020-06-01,2020-03-06,True,University of Adelaide,Not Recruiting,Not Applicable,Observational,"Australia, United States",Ventricular Arrhythmias in Implantable Cardioverter Defibrillator Patients During the COVID-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,6000,https://anzctr.org.au/ACTRN12620000641998.aspx,None
1003,ACTRN12620000634976,ANZCTR,2020-05-29,2020-08-06,False,University of Auckland,Not Recruiting,Not Applicable,Interventional,New Zealand,Testing an Online Coping Skills Intervention for People Living with Chronic Illness During the Covid-19 Pandemic,Other (psych),Psychological,Psychological,46,https://anzctr.org.au/ACTRN12620000634976.aspx,None
1004,ACTRN12620000620921,ANZCTR,2020-05-28,2020-06-15,False,Rinaldo Bellomo,Not Recruiting,Not Applicable,Observational,"Germany, Italy, Canada, Belgium, United Kingdom, Australia","Angiotensin II Infusion in COVID-19-Associated Vasodilatory Shock: A multinational, multicentre registry",Clinical Presentation,No Intervention,No Intervention,315,https://anzctr.org.au/ACTRN12620000620921.aspx,None
1005,ChiCTR2000033627,ChiCTR,2020-06-07,2020-06-10,False,Rayak Hospital,Not Recruiting,Not Applicable,Interventional,Iraq,In vivo use of ivermectin (IVR) for treatment for corona virus infected patients: a randomized controlled trial,Drug,Ivermectin,Ivermectin,60,http://www.chictr.org.cn/showproj.aspx?proj=54707,None
1006,ChiCTR2000033609,ChiCTR,2020-06-07,2020-05-07,True,Yichang Central People's Hospital,Not Recruiting,Not Applicable,Observational,China,A medical records based study for nano short peptide nutrition intervention on the prognosis of patients with novel coronavirus pneumonia (COVID-19),Supplement,Peptides,Peptides,206,http://www.chictr.org.cn/showproj.aspx?proj=54788,None
1007,ChiCTR2000033580,ChiCTR,2020-06-06,2020-01-25,True,Yunnan CDC,Not Recruiting,Not Applicable,Observational,China,"Analysis of Characteristics of recurrent positive RT-PCR findings of recovered patients from novel coronavirus pneumonia (COVID-19) in Wuhan, China: a medical records based study",Clinical Presentation,No Intervention,No Intervention,758,http://www.chictr.org.cn/showproj.aspx?proj=54787,None
1008,ChiCTR2000033517,ChiCTR,2020-06-03,2020-06-05,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,China,Effectiveness of day care service on improving the physical and psychological well-being of people with dementia and easing the caregiving burden in COVID-19 pandemic,Other (psych),Psychological,Psychological,150,http://www.chictr.org.cn/showproj.aspx?proj=54668,None
1009,ChiCTR2000033514,ChiCTR,2020-06-03,2020-02-17,True,Xiangya Hospital of Central South University,Recruiting,Not Applicable,Observational,China,"A Survey Among Collage Students for Changes and impact factors of Lifestyle, Psychology and Weight During Keep Stay at Home for four months in the Pandemic of Novel Coronavirus Pneumonia (COVID-19)",Other,No Intervention,No Intervention,14000,http://www.chictr.org.cn/showproj.aspx?proj=54579,None
1010,ChiCTR2000033491,ChiCTR,2020-06-02,2020-02-11,True,Huo-Shen-Shan Hospital,Not Recruiting,Phase 4,Interventional,China,Oral Favipiravir for Patients with Delayed SARS-Cov-2 viral RNA Clearance,Drug,Favipiravir,Favipiravir,9,http://www.chictr.org.cn/showproj.aspx?proj=54278,None
1011,ISRCTN15571919,ISRCTN,2020-05-28,2020-05-05,True,University of York,Recruiting,Not Applicable,Observational,"Bangladesh, India, Pakistan","Investigating the impact of COVID-19 and its response, on people with severe mental illness in South Asia",Clinical Presentation,No Intervention,No Intervention,2000,http://isrctn.com/ISRCTN15571919,None
1012,ISRCTN11384058,ISRCTN,2020-05-26,2020-01-04,True,Policlinico San Martino Genoa,Recruiting,Not Applicable,Interventional,Italy,"A collaborative pilot study to monitor and optimise access to urgent surgery during the period of reduced resources in Genoa, Italy caused by the COVID-19 pandemic, using a bespoke referral process and the SWALIS 2020 model to prioritise surgery by clinical urgency and waiting time",Health System,No Intervention,No Intervention,300,http://isrctn.com/ISRCTN11384058,None
1013,ISRCTN77353041,ISRCTN,2020-04-07,2020-08-04,False,University of Zurich,Not Recruiting,Not Applicable,Observational,Switzerland,Cohort study for predicting severe disease courses in patients presenting for coronavirus testing to the University of Zurich COVID-19 Testing Center,Clinical Presentation,No Intervention,No Intervention,2000,http://isrctn.com/ISRCTN77353041,None
1014,EUCTR2020-001597-30-GB,EU Clinical Trials Register,2020-04-09,2020-05-29,False,4D Pharma,Authorised,Phase 2,Interventional,"United Kingdom, Ireland, United States, Italy",A study to test the effectiveness and safety of bacteria called Bifidobacterium breve in patients with COVID-19 infections,Drug,Bifidobacterium,Bifidobacterium,90,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001597-30,None
1015,EUCTR2020-001849-39-SE,EU Clinical Trials Register,2020-04-28,2020-05-18,False,Region Skåne,Authorised,Phase 2,Interventional,Sweden,Treatment of COVID-19 with the inhalation drug pulmozyme,Drug,Dornase alfa,Dornase alfa,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001849-39,None
1016,EUCTR2020-001951-42-PL,EU Clinical Trials Register,2020-04-29,2020-08-05,False,Nicolaus Copernicus University,Authorised,Phase 3,Interventional,"Poland, Canada, Spain, Italy",Amiodarone or Verapamil in COVID-19 hospitalized patients with symptoms: Randomized clinical trial,Drug,Amiodarone vs. Verapamil,Amiodarone; Verapamil,804,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001951-42,None
1017,EUCTR2015-002340-14-NL,EU Clinical Trials Register,2015-07-13,2015-09-16,False,UMC Utrecht,Authorised,Phase 4,Interventional,"Portugal, Czech Republic, Denmark, Croatia, Greece, New Zealand, Germany, Hungary, France, Ireland, Belgium, Netherlands, United Kingdom, Australia, Romania, Spain, Finland",Adaptive trial in severe pneumonia (REMAP-CAP),Not relevant,Not relevant,Not relevant,4000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2015-002340-14,None
1018,EUCTR2020-002130-33-BE,EU Clinical Trials Register,2020-05-06,2020-05-26,False,"University Hospital, Ghent",Authorised,Phase 2,Interventional,Belgium,ZilucoplanÂ® in patients with acute hypoxic respiratory failure due to COVID-19,Drug,Zilucoplan,Zilucoplan,81,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002130-33,None
1019,ISRCTN14447421,ISRCTN,2020-06-05,2020-03-06,True,"University College, London",Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 in care homes (VIVALDI),Clinical Presentation (Epidemiology),No Intervention,No Intervention,11000,http://isrctn.com/ISRCTN14447421,None
1020,ISRCTN15324611,ISRCTN,2020-06-01,2020-06-04,False,SingHealth,Not Recruiting,Not Applicable,Observational,Singapore,"A study to assess the usefulness of combination of Vitamin D, magnesium and Vitamin B12 in older COVID-19 patients",Drug,Vitamin D + Vitamin B + Magnesium,Vitamin D; Vitamin B; Magnesium,40,http://isrctn.com/ISRCTN15324611,None
1021,ChiCTR2000033872,ChiCTR,2020-06-15,2020-02-01,True,Chongqing General Hospital,Not Recruiting,Not Applicable,Observational,China,Serum protein marker in patients with novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,350,http://www.chictr.org.cn/showproj.aspx?proj=54781,None
1022,ChiCTR2000033830,ChiCTR,2020-06-14,2020-06-12,True,Shengjing Hospital of China Medical University,Not Recruiting,Not Applicable,Observational,China,Development and Application of a Low-Cost Ear-Contactless Stethoscope Powered by Raspberry Pi and Python,Other (device),Stethoscope,Stethoscope,12,http://www.chictr.org.cn/showproj.aspx?proj=54971,None
1023,ChiCTR2000033798,ChiCTR,2020-06-12,2020-06-12,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,The efficacy and safety of convalescent plasma therapy in novel coronavirus pneumonia (COVID-19): A medical records based retrospective cohort study,ATMP,Plasma,Plasma,150,http://www.chictr.org.cn/showproj.aspx?proj=55194,None
1024,ChiCTR2000033782,ChiCTR,2020-06-12,2020-06-18,False,"West China Hospital, Sichuan University",Not Recruiting,Not Applicable,Observational,China,A medical records based retrospective study of novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,No Intervention,1400,http://www.chictr.org.cn/showproj.aspx?proj=55039,None
1025,ChiCTR2000033781,ChiCTR,2020-06-12,2020-06-18,False,"West China Hospital, Sichuan University",Not Recruiting,Not Applicable,Observational,China,A medical records based study for predictors of novel coronavirus pneumonia (COVID-19) elderly patients,Clinical Presentation,No Intervention,No Intervention,114,http://www.chictr.org.cn/showproj.aspx?proj=55054,None
1026,ChiCTR2000033780,ChiCTR,2020-06-12,2020-06-11,True,Tianjin University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,A medical records based study for analysis of Tongue Features of novel coronavirus pneumonia (COVID-19) Patients,Clinical Presentation,No Intervention,No Intervention,500,http://www.chictr.org.cn/showproj.aspx?proj=55027,None
1027,ChiCTR2000033774,ChiCTR,2020-06-11,2020-03-02,True,Children's Hospital Affiliated to Zhejiang University School of Medicine,Not Recruiting,Phase 4,Interventional,China,Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets in Treating Pediatric novel coronavirus pneumonia (COVID-19),Drug,Bromhexine Hydrochloride,Bromhexine Hydrochloride,30,http://www.chictr.org.cn/showproj.aspx?proj=55097,None
1028,ChiCTR2000033745,ChiCTR,2020-06-11,2020-06-01,True,Maoming People's Hospital,Not Recruiting,Not Applicable,Observational,China,"Clinical study on the effect of Clarenicol oral liquid on the relief of pharyngeal symptoms of novel coronavirus pneumonia (COVID-19) in convalescence, suspected patients and other susceptible populations",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,240,http://www.chictr.org.cn/showproj.aspx?proj=55100,None
1029,ChiCTR2000033723,ChiCTR,2020-06-10,2020-06-09,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Not Recruiting,Not Applicable,Observational,China,A study for long-term prognosis in hospitalized novel coronavirus pneumonia (COVID-19) patients,Prognosis,No Intervention,No Intervention,2500,http://www.chictr.org.cn/showproj.aspx?proj=54977,None
1030,ChiCTR2000033720,ChiCTR,2020-06-10,2020-05-01,True,Dongguan People's Hospital,Not Recruiting,Not Applicable,Observational,China,"Clinical observation of the relieving effect of Clarenicol oral liquid on the throat symptoms of novel coronavirus pneumonia (COVID-19) in convalescence, suspected patients and other susceptible people",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,240,http://www.chictr.org.cn/showproj.aspx?proj=55040,None
1031,ChiCTR2000033719,ChiCTR,2020-06-10,2020-03-15,True,Hospital Universitario Ramón y Cajal,Not Recruiting,Not Applicable,Observational,Spain,Hip Fracture in elderly people during COVID-19 State of Alarm in Spain: reports from a specialized Center,Clinical Presentation,No Intervention,No Intervention,206,http://www.chictr.org.cn/showproj.aspx?proj=55044,None
1032,ChiCTR2000033705,ChiCTR,2020-06-10,2020-02-27,True,Xijing Hospital,Not Recruiting,Not Applicable,Observational,China,A medical records based study for the preliminary efficacy of Tocilizumab in the treatment of the patients with novel coronavirus pneumonia (COVID-19),Drug,Tocilizumab,Tocilizumab,61,http://www.chictr.org.cn/showproj.aspx?proj=54989,None
1033,EUCTR2020-001257-51-DK,EU Clinical Trials Register,2020-03-26,2020-04-15,False,"Rigshospitalet, Denmark",Not Recruiting,Phase 3,Interventional,Denmark,Hydroxychloroquine for prevention of COVID-19 in patients on chronic dialysis,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,568,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001257-51,None
1034,EUCTR2020-001363-85-DK,EU Clinical Trials Register,2020-04-17,2020-04-23,False,Odense University Hospital,Not Recruiting,Phase 3,Interventional,Denmark,Medication for prevention of Corona-virus for Danish nursing home residents,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,206,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001363-85,None
1035,EUCTR2020-001937-11-GB,EU Clinical Trials Register,2020-06-08,2020-04-30,True,"University College, London",Authorised,Phase 2,Interventional,United Kingdom,"The COVASE study:
Investigation of an approved nebulised human Dnase enzyme (Pulmozyme) to reduce hyperinflammation in hospitalised people with COVID-19",Drug,Dornase alfa,Dornase alfa,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001937-11,None
1036,IRCT20200128046294N2,IRCT,2020-03-14,2020-03-26,False,Digestive Disease Research Institute,Not Recruiting,Phase 3,Interventional,Iran,Study to Evaluate the Safety and Efficacy of Sofosbuvir/Daclatasvir in Participants with Moderate to Severe Coronavirus Disease (COVID-19),Drug,Sofosbuvir + Daclatasvir,Sofosbuvir; Daclatasvir,70,http://en.irct.ir/trial/46463,None
1037,IRCT20200314046774N1,IRCT,2020-06-12,2020-05-04,True,Ghoum University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,treatment of COVID-19 whit vitamin A,Drug,Vitamin A,Vitamin A,94,http://en.irct.ir/trial/46519,None
1038,IRCT20200324046850N3,IRCT,2020-03-30,2020-04-20,False,Abadan University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of naproxen on the healing process of patients with COVID-19,Drug,"Investigational: Naproxen

All Arms: Hydroxychloroquine + Lopinavir/Ritonavir",Naproxen; Hydroxychloroquine; Lopinavir/Ritonavi,80,http://en.irct.ir/trial/46718,None
1039,IRCT20180923041093N3,IRCT,2020-03-28,2020-04-02,False,Kerman University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Efficacy of the myrtle syrup in the treatment of novel corona,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,70,http://en.irct.ir/trial/46721,None
1040,IRCT20180923041093N4,IRCT,2020-03-28,2020-04-02,False,Kerman University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Efficacy of the barley-based remedy in the treatment of novel corona,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,70,http://en.irct.ir/trial/46728,None
1041,IRCT20200324046850N1,IRCT,2020-03-29,2020-06-06,False,Abadan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Comparison of vitamin D3 and N-acetylcysteine prescription in COVID-19 patients   and their effect on recovery process,Drug,Vitamin D vs. N-acetylcysteine vs. Vitamin D + N-acetylcysteine,Vitamin D; N-acetylcysteine,100,http://en.irct.ir/trial/46732,None
1042,IRCT20190810044500N5,IRCT,2020-05-18,2020-04-04,True,Yazd Shahid Sadoughi University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of colchicine in treatment of COVID-19,Drug,Colchicine,Colchicine,200,http://en.irct.ir/trial/46867,None
1043,IRCT20200404046947N1,IRCT,2020-04-15,2020-03-28,True,Tehran University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Effect of Methylprednisolone on treatment of COVID-19,Drug,Corticosteroids,Methylprednisolone,68,http://en.irct.ir/trial/46904,None
1044,IRCT20151228025732N52,IRCT,2020-04-09,2020-04-07,True,Semnan University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,A study on melatonin and Vitamin C and zinc efficacy in patients with COVID19,Drug,Melatonin + Vitamin C + Zinc,Melatonin; Vitamin C; Zinc,30,http://en.irct.ir/trial/46963,None
1045,IRCT20081027001411N3,IRCT,2020-06-01,2020-03-29,True,Tehran University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of Prednisolone on treatment of COVID-19,Drug,Corticosteroids,Prednisolone,60,http://en.irct.ir/trial/46975,None
1046,IRCT20091201002804N12,IRCT,2020-06-01,2020-04-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of surfactant on clinical outcome of patients with COVID-19,Drug,Surfactant,Surfactant,60,http://en.irct.ir/trial/46983,None
1047,IRCT20200217046526N1,IRCT,2020-04-13,2020-03-15,True,Iranian Academic Center for Education Culture and Research,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection,ATMP,Cells (mesenchymal),Cells (mesenchymal),6,http://en.irct.ir/trial/47030,None
1048,IRCT20200411047016N1,IRCT,2020-05-31,2020-04-05,True,Mazandaran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of Stopcivir syrup in patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,150,http://en.irct.ir/trial/47044,None
1049,IRCT20190727044343N3,IRCT,2020-06-12,2020-06-09,True,Mazandaran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,ANIF1 effect on COVID-19,Drug,ANIF1,ANIF1,60,http://en.irct.ir/trial/47062,None
1050,IRCT20200223046586N2,IRCT,2020-05-30,2020-05-18,True,Shahroud University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,web- based communication between nurse and family member,Telehealth,Telehealth,Telehealth,74,http://en.irct.ir/trial/47091,None
1051,IRCT20081019001369N6,IRCT,2020-05-17,2020-06-21,False,Mashhad University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Clinical trial of trans sodium crocetinate  against COVID-19,Drug,Trans Sodium Crocetinate,Trans Sodium Crocetinate,30,http://en.irct.ir/trial/47188,None
1052,IRCT20091012002582N21,IRCT,2020-05-18,2019-05-05,True,Tabriz University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Effect of intrapulmonary injection of processed serum derived from covid-19 patients in reduction of pulmonary complications,ATMP,Plasma,Plasma,30,http://en.irct.ir/trial/47197,None
1053,IRCT20200325046859N2,IRCT,2020-04-26,2020-04-22,True,Mashhad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,effects of the 2-drug diet (hydroxychloroquine + umifenovir(Arbidol)) compared with Hydroxy chlorquine on the of mortality rate in patients with moderate symptoms of COVID-19 infections,Drug,Umifenovir + Hydroxycholoquine vs. Hydroxychloroquine,Umifenovir; Hydroxycholoquine,100,http://en.irct.ir/trial/47200,None
1054,IRCT20190418043307N1,IRCT,2020-05-17,2020-04-26,True,Ilam University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of selenium on covid-19 disease,Drug,Selenium,Selenium,100,http://en.irct.ir/trial/47209,None
1055,IRCT20200411047019N1,IRCT,2020-05-18,2020-06-04,False,Shiraz University of Mdical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of BCG Vaccine on Preventing COVID-19,ATMP,Vaccine,Vaccine,500,http://en.irct.ir/trial/47279,None
1056,IRCT20150303021315N19,IRCT,2020-05-27,2020-06-06,False,CinnaGen Company,Recruiting,Phase 2,Interventional,Iran,"Pembrolizumab (CinnaGen Co, Iran) in COVID-19",Drug,Pembrolizumab,Pembrolizumab,62,http://en.irct.ir/trial/47335,None
1057,IRCT20200209046427N1,IRCT,2020-06-07,2020-05-30,True,Shahid Beheshti University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of bee products on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/47504,None
1058,IRCT20200428047228N1,IRCT,2020-05-16,2020-05-19,False,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficiency and safety of favipiravir + hydroxychloroquine drug regimen in comparison with hydroxychloroquine in hospitalized patients with covid-19,Drug,Favipiravir + Hydroxychloroquine vs. Hydroxychloroquine,Favipiravir; Hydroxychloroquine,50,http://en.irct.ir/trial/47559,None
1059,IRCT20200501047259N1,IRCT,2020-05-17,2020-05-09,True,Oroumia University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,IVIG and COVID19,ATMP,Immunoglobulin,Immunoglobulin,40,http://en.irct.ir/trial/47609,None
1060,IRCT20200115046144N2,IRCT,2020-05-21,2020-05-31,False,Semnan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effects of nokhod-ab on fatigue,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://en.irct.ir/trial/47645,None
1061,IRCT20131129015584N3,IRCT,2020-05-20,2020-05-04,True,Mazandaran University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,The effect of hot cupping on corona symptoms,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,68,http://en.irct.ir/trial/47665,None
1062,IRCT20150107020592N25,IRCT,2020-06-13,2020-03-20,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Prone position effectiveness in Non invasive ventilation of covid-19 patients undergoing respiratory failure,Procedure,Positioning,Positioning,30,http://en.irct.ir/trial/47666,None
1063,IRCT20200502047268N1,IRCT,2020-05-16,2020-05-21,False,Semnan University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Evaluation of the effect of GCSF injection in treatment of COVID-19 patients with lymphopenia,Drug,Granulocyte colony-stimulating factor,Granulocyte colony-stimulating factor,10,http://en.irct.ir/trial/47692,None
1064,IRCT20200503047280N1,IRCT,2020-06-02,2020-05-09,True,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Laris-Teucrium Polium L.and Laris-Hyssop combined herbal medicine on the prevention of covid-19 disease,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://en.irct.ir/trial/47704,None
1065,IRCT20200418047126N1,IRCT,2020-05-14,2020-05-04,True,Ardabil University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of colchicine  in treatment of coronavirus,Drug,Colchicine,Colchicine,100,http://en.irct.ir/trial/47707,None
1066,IRCT20200405046951N1,IRCT,2020-06-11,2020-05-21,True,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Vitamin A and COVID-19,Drug,Vitamin A,Vitamin A,120,http://en.irct.ir/trial/47722,None
1067,IRCT20170211032494N3,IRCT,2020-05-25,2020-05-27,False,Tehran University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Low dose whole lung irradiation for treatment of COVID-19 pneumonia,Other,Radiation,Radiation,10,http://en.irct.ir/trial/47735,None
1068,IRCT20081011001323N25,IRCT,2020-05-17,2020-05-21,False,Yasouj University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy  of  extract of  of Zingiber  cinnamomum  and  zataria multiflora    in covid-19 disease,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/47935,None
1069,IRCT20200421047150N1,IRCT,2020-05-14,2020-05-12,True,DEY Company,Recruiting,Phase 2/Phase 3,Interventional,Iran,Stem cell treatment for COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),90,http://en.irct.ir/trial/47964,None
1070,IRCT20180923041093N6,IRCT,2020-06-11,2020-05-13,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The efficacy of  barely-based traditional remedy on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/47974,None
1071,IRCT20200509047360N1,IRCT,2020-05-16,2020-05-03,True,Tehran University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,"The effect of cognitive-behavioral  intervention on improving COVID-19 fear symptoms, improving quality of life and improving mental health in patients with corona",Other (psych),Psychological,Psychological,60,http://en.irct.ir/trial/47979,None
1072,IRCT20140428017469N1,IRCT,2020-05-23,2020-06-13,False,Petroleum Industry Health Organization,Recruiting,Phase 3,Interventional,Iran,Polio Vaccine and COVID-19,ATMP,Vaccine,Vaccine,130000,http://en.irct.ir/trial/47989,None
1073,IRCT20200506047323N2,IRCT,2020-05-31,2020-05-21,True,Bandare-abbas University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effects of Licorice in treatment of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/47990,None
1074,IRCT20200509047373N1,IRCT,2020-05-23,2020-06-03,False,Health Medicine Chemistry Company,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation effect of Dinvl for Covid19 infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/48001,None
1075,IRCT20151227025726N15,IRCT,2020-05-18,2020-04-08,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluating the effects of Umifenovir (Arbidol) in COVID-19,Drug,Umifenovir,Umifenovir,100,http://en.irct.ir/trial/48018,None
1076,IRCT20150716023235N15,IRCT,2020-05-29,2020-05-21,True,Mashhad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,sex hormones in coronavirus,Drug,Hormones,Hormones,80,http://en.irct.ir/trial/48019,None
1077,IRCT20200510047383N1,IRCT,2020-05-15,2020-05-21,False,Arak University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Tocilizumab on outcomes of the severe COVID-19 patients,Drug,Tocilizumab,Tocilizumab,100,http://en.irct.ir/trial/48024,None
1078,IRCT20120215009014N355,IRCT,2020-05-18,2020-06-04,False,Hamedan University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Evaluating the effect of intravenous N-acetyl cysteine versus placebo in the treatment of patients with mild and moderate acute respiratory distress syndrome caused by COVID-19,Drug,N-acetylcysteine,N-acetylcysteine,92,http://en.irct.ir/trial/48039,None
1079,IRCT20090609002017N35,IRCT,2020-05-17,2020-05-19,False,Tabriz University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Assessment of boron-containing compounds  and Oleoylethanolamid  supplementation in the treatment of COVID-19,Drug,Boron vs. Oleoylethanolamid vs. Boron + Oleoylethanolamid,Boron; Oleoylethanolamid,40,http://en.irct.ir/trial/48058,None
1080,IRCT20080901001165N55,IRCT,2020-05-23,2020-05-13,True,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of N-Acetyl Cysteine (NAC) inhalation spray in controlling the symptoms of patients with COVID-19,Drug,N-acetylcysteine,N-acetylcysteine,72,http://en.irct.ir/trial/48061,None
1081,IRCT20080901001165N53,IRCT,2020-05-14,2020-05-14,False,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Interferon Beta1a nasal spray in controlling the symptoms of patients with COVID-19,Drug,Interferon beta,Interferon beta,100,http://en.irct.ir/trial/48066,None
1082,IRCT20200428047228N2,IRCT,2020-06-10,2020-05-19,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Hydroxychloroquine in comparison with hydroxychloroquine + azithromycin in  patients with covid-19,Drug,Hydroxychloroquine vs. Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,40,http://en.irct.ir/trial/48096,None
1083,IRCT20080901001165N60,IRCT,2020-05-28,2020-05-14,True,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy of Provita Capsule in controlling the symptoms of patients with COVID-19,Supplement,Nutritional Supplement,Nutritional Supplement,30,http://en.irct.ir/trial/48102,None
1084,IRCT20200506047323N1,IRCT,2020-05-23,2020-05-21,True,Bandare-abbas University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effects of Ginger in treatment COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,84,http://en.irct.ir/trial/48114,None
1085,IRCT20080901001165N56,IRCT,2020-05-23,2020-05-16,True,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,"Evaluation efficacy of ""Curcumin and Resveratrol"" capsule  in controlling symptoms in patients with COVID-19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/48116,None
1086,IRCT20200405046960N2,IRCT,2020-05-19,2020-05-17,True,Ardabil University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Efficacy of Kelofan syrup on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/48126,None
1087,IRCT20200516047462N1,IRCT,2020-05-17,2020-05-06,True,Kashan University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Intervention,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50,http://en.irct.ir/trial/48141,None
1088,IRCT20151227025726N17,IRCT,2020-05-31,2020-04-24,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Evolution of the efficacy and safety of Dexamethasone administration in COVID-19,Drug,Corticosteroids vs. Lopinavir/ritonavir,Dexamethasone; Lopinavir/ritonavir,48,http://en.irct.ir/trial/48153,None
1089,IRCT20200516047468N1,IRCT,2020-05-19,2020-04-08,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Investigation of the effect of intravenous vitamin C on definite patients with coronavirus pneumonia,Drug,Vitamin C,Vitamin C,50,http://en.irct.ir/trial/48176,None
1090,IRCT20150107020592N23,IRCT,2020-05-31,2020-03-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Plasmapheresis and plasma exchanges;usefulness in covid-19 critically ill patients,ATMP,Plasma,Plasma,15,http://en.irct.ir/trial/48185,None
1091,IRCT20160809029275N1,IRCT,2020-05-30,2020-06-14,False,Mashhad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,stem cell therapy in Covid-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,http://en.irct.ir/trial/48187,None
1092,IRCT20151226025699N3,IRCT,2020-05-20,2020-06-04,False,Sabzevar University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,The effect of omega-3 supplementation in COVID-19,Drug,Omega 3,Omega 3,50,http://en.irct.ir/trial/48213,None
1093,IRCT20180608040007N2,IRCT,2020-06-13,2020-04-28,True,Yazd Shahid Sadoughi University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of Auriculotherapy  in treatment of Covid 19,Other,Auriculotherapy,Auriculotherapy,70,http://en.irct.ir/trial/48218,None
1094,IRCT20200517047485N1,IRCT,2020-05-29,2020-06-20,False,Arak University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Comparison of combination therapies of COVID_19,Drug,Hydroxychloroquine + Atazanavir/ritonavir vs. Hydroxychloroquine + Lopinavir/ritonavir,Atazanavir/ritonavir; Hydroxychloroquine; Lopinavir/ritonavir,108,http://en.irct.ir/trial/48226,None
1095,IRCT20150107020592N22,IRCT,2020-05-25,2020-03-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Cyclosporin for the Prevention and Treatment of COVID-19 Disease,Drug,Cyclosporine,Cyclosporine,60,http://en.irct.ir/trial/48262,None
1096,IRCT20200518047497N1,IRCT,2020-05-21,2020-05-25,False,Tabriz University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of Laris - Hyssop combined herbal distilled on the improving clinical and paraclinical symptoms in patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/48289,None
1097,IRCT20200519047510N1,IRCT,2020-05-28,2020-06-05,False,Ahvaz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the anti-inflammatory effects of curcumin in the treatment of patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/48292,None
1098,IRCT20151227025726N18,IRCT,2020-06-10,2020-06-22,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Pentaglobin effect in critically ill patients with COVID-19,Drug,Cyclosporine vs. Lopinavir/ritonavir,Cyclosporine; Lopinavir/ritonavir,30,http://en.irct.ir/trial/48312,None
1099,IRCT20161206031256N3,IRCT,2020-06-02,2020-05-23,True,Mashhad University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Using interferon to treat COVID-19,Drug,Interferon beta,Interferon beta,76,http://en.irct.ir/trial/48329,None
1100,IRCT20160126026217N4,IRCT,2020-06-08,2020-06-21,False,Khoram-Abad University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Investigation of the effects of prone position on  cardiac and respiratory status in patients with Coronavirus,Procedure,Positioning,Positioning,74,http://en.irct.ir/trial/48403,None
1101,IRCT20200422047168N2,IRCT,2020-05-30,2020-05-30,False,Ahvaz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Clinical trial study of the therapeutic effect of Ivermectin, besides Kaletra and Chloroquinein in patients with Coronavirus disease 2019 (COVID-19)",Drug,Ivermectin + Lopinavir/ritonavir + Chloriquine vs. Lopinavir/ritonavir + Chloriquine,Ivermectin; Lopinavir/ritonavir; Chloriquine,60,http://en.irct.ir/trial/48444,None
1102,IRCT20200523047550N1,IRCT,2020-06-06,2020-04-20,True,Tehran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of Umifenovir in treatment of covid-19,Drug,Umifenovir + Hydroxychloroquine vs Hydroxychloroquine,Umifenovir; Hydroxychloroquine,50,http://en.irct.ir/trial/48495,None
1103,IRCT20160118026097N3,IRCT,2020-05-31,2020-03-20,True,Ghoum University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of interferon on the treatment of covid19 patients,Drug,Interferon beta,Interferon beta,60,http://en.irct.ir/trial/48517,None
1104,IRCT20150107020592N24,IRCT,2020-06-08,2020-03-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the effects of Oxycodone administration on pain control in patients with COVID-19,Drug,Oxycodone,Oxycodone,60,http://en.irct.ir/trial/48534,None
1105,IRCT20200518047497N2,IRCT,2020-06-06,2020-06-20,False,Zahravi Pharmaceutical Company,Not Recruiting,Phase 3,Interventional,Iran,Effect of Dinvl on improving of clinical and paraclinical symptoms in patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/48644,None
1106,IRCT20120703010178N20,IRCT,2020-06-13,2020-06-21,False,Persisgen Par Pharmaceutical Company,Not Recruiting,Phase 3,Interventional,Iran,effect of anakinra in treatment of COVID-19,Drug,Anakinra,Anakinra,30,http://en.irct.ir/trial/48702,None
1107,IRCT20200412047042N1,IRCT,2020-06-11,2020-06-19,False,Jahrom University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,"Evaluation the effect of raltegravir, and raltegravir/interferon beta combination on covid 19 patients",Drug,Hydroxychloroquine + Raltagravir vs. Hydroxychloroquine + Raltagravir + Interferon beta vs. Hydroxychloroquine,Raltagravir; Interferon beta; Hydroxychloroquine,60,http://en.irct.ir/trial/48749,None
1108,KCT0005105,CRIS,2020-06-10,2020-04-08,True,Koera University Guro Hospital,Recruiting,Phase 2,Interventional,South Korea,A Trial of Ciclesonide in Adults with Mild COVID-19,Drug,Ciclesonide,Ciclesonide,141,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16795,None
1109,KCT0005096,CRIS,2020-06-08,2019-11-29,True,Chungnam National University Hospital,Recruiting,Phase 2,Interventional,South Korea,The Efficacy of Gentamicin-impregnated collagen (CollatampÂ®) in the Loop Electrosurgical Excision Procedure,Not relevant,Not relevant,Not relevant,52,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16278,None
1110,JPRN-jRCTs031190227,JPRN,2020-02-27,2020-01-04,True,Tokue Yutaka,Not Recruiting,Phase 2,Interventional,Japan,Triple combination therapy in patients infected with COVID-19,Drug,Lopinavir/ritonavir + hydroxychloroquine (w/ and w/o oseltamivir),Lopinavir/Ritonavir; Hydroxychloroquine; Oseltamivir,50,https://jrct.niph.go.jp/latest-detail/jRCTs031190227,None
1111,JPRN-jRCTs032200044,JPRN,2020-06-03,2020-03-06,True,Wakabayashi Kenji,Recruiting,Phase 1/Phase 2,Interventional,Japan,Clinical safety and usefulness of the simple ventilator,Other (physical),Mechanical ventilation,Mechanical ventilation,10,https://jrct.niph.go.jp/latest-detail/jRCTs032200044,None
1112,JPRN-UMIN000039997,JPRN,2020-04-01,2020-04-01,False,Jichi Medical University,Recruiting,Not Applicable,Observational,Japan,"Prevention of COVID-19 infection in a medical institution 
and maintenance of medical system",Other,No Intervention,No Intervention,3700,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045600,None
1113,JPRN-UMIN000040219,JPRN,2020-04-22,2020-04-23,False,Yokohama City University,Not Recruiting,Not Applicable,Observational,Japan,A prospective cohort study to follow the health status of medical staff engage in COVID-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,30,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045877,None
1114,JPRN-UMIN000040341,JPRN,2020-05-09,2020-05-09,False,Takanawa Clinic,Not Recruiting,Not Applicable,Interventional,Japan,Immunological efficacy of Qing Fei Pai Du Tang for COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,15,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046023,None
1115,JPRN-UMIN000040353,JPRN,2020-05-11,2020-05-11,False,Oita San-ai Medical Center,Not Recruiting,Not Applicable,Observational,Japan,Examination in COVID-19 pandemic; Whether endoscopies really generate aerosol particles?,Other,Other,Other,90,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046029,None
1116,JPRN-UMIN000040407,JPRN,2020-05-15,2020-05-15,False,Takanawa Clinic,Not Recruiting,Not Applicable,Interventional,Japan,Immunological efficacy of Jinhua Qinggan Granule for COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,15,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046108,None
1117,JPRN-UMIN000040451,JPRN,2020-05-20,2020-05-22,False,St. Marianna University School of Medicine,Not Recruiting,Not Applicable,Other,"Japan,North America,Europe",COVID 19 - What Families Think and Do? A Survey for Families Visiting the Pediatric Emergency Department,Other,No Intervention,No Intervention,500,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046169,None
1118,JPRN-UMIN000040476,JPRN,2020-05-21,2020-05-21,False,Chiba University,Recruiting,Not Applicable,Observational,Japan,Clinical record investigation about ADHD children before and after the emergency declaration because of COVID19,Other,No Intervention,No Intervention,10,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046085,None
1119,JPRN-UMIN000040479,JPRN,2020-05-22,2020-05-22,False,Takanawa Clinic,Recruiting,Not Applicable,Interventional,Japan,Immunological efficacy of lactic acid bacteria for COVID-19,Drug,Lactic acid bacteria,Lactic acid bacteria,30,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046202,None
1120,JPRN-UMIN000040516,JPRN,2020-05-26,2023-03-31,False,Chiba University,Recruiting,Not Applicable,Observational,Japan,Usefulness of PCR testing for COVID-19 before gastrointestinal endoscopy and hospitalization,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046253,None
1121,JPRN-UMIN000040520,JPRN,2020-05-26,2020-05-13,True,Oita San-ai Medical Center,Not Recruiting,Not Applicable,Observational,Japan,Examination in COVID-19 pandemic; Whether endoscopies really generate aerosol particles?,Procedure,Endoscopy,Endoscopy,90,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046256,None
1122,JPRN-UMIN000040563,JPRN,2020-05-28,2020-05-18,True,Juntendo University,Recruiting,Not Applicable,Observational,Japan,Prospective observational study on cytokine removal effect of continuous hemodiafiltration in COVID-19,Other (device),Cytokine Adsorber,Cytokine Adsorber,20,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046299,None
1123,JPRN-UMIN000040614,JPRN,2020-06-01,2020-02-01,True,Japanese Red Cross Medical Center,Recruiting,Not Applicable,Observational,Japan,A retrospective study on the therapeutic effect of tocilizumab on COVID-19,Drug,Tocilizumab,Tocilizumab,20,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046354,None
1124,JPRN-UMIN000040616,JPRN,2020-06-01,2020-02-01,True,Japanese Red Cross Medical Center,Recruiting,Not Applicable,Observational,Japan,Retrospective study on clinical and pathological aspects of COVID-19,Clinical Presentation,No Intervention,No Intervention,5,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046355,None
1125,JPRN-UMIN000040617,JPRN,2020-06-01,2020-02-01,True,Japanese Red Cross Medical Center,Recruiting,Not Applicable,Observational,Japan,A retrospective study on serum markers in the diagnosis and differentiation of COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046356,None
1126,JPRN-UMIN000040679,JPRN,2020-06-09,2020-06-08,True,Gunma Prefectural Cancer Center,Not Recruiting,Not Applicable,Observational,Japan,prospective cohort study of COVID-19 antibody for medical stuff in hospital,Clinical Presentation (Epidemiology),No Intervention,No Intervention,50,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046429,None
1127,JPRN-UMIN000040683,JPRN,2020-06-08,2020-06-08,False,Keio University,Not Recruiting,Not Applicable,Observational,Japan,"Longitudinal study on work style change, health and well-being due to pandemic of novel coronavirus infection (COVID-19)",Other (psych),No Intervention,No Intervention,2000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046432,None
1128,JPRN-UMIN000040694,JPRN,2020-06-09,2020-06-10,False,Kinki Health Administration Center,Not Recruiting,Not Applicable,Interventional,Japan,SUrveillance of SARS-CoV-2 Virus Antibody in Health CarE and CloSe-Contact WorkerS,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046448,None
1129,ACTRN12620000500954,ANZCTR,2020-04-22,2020-01-05,True,Western Health,Not Recruiting,Not Applicable,Interventional,Australia,A reusable personalised ventilation hood: A phase 1 safety study of a new device (McMonty) in patients with suspected or confirmed COVID-19.,Other (device),Hood,Hood,20,https://anzctr.org.au/ACTRN12620000500954.aspx,None
1130,ACTRN12620000676910,ANZCTR,2020-06-15,2020-06-29,False,Monash Health,Not Recruiting,Phase 1/Phase 2,Interventional,Australia,Amnion cells for COVID-19 related respiratory failure,ATMP,Cells (amniotic epithelial),Cells (amniotic epithelial),40,https://anzctr.org.au/ACTRN12620000676910.aspx,None
1131,ISRCTN94091479,ISRCTN,2020-06-09,2020-06-15,False,"Tees, Esk and Wear Valleys NHS Foundation Trust",Recruiting,Not Applicable,Interventional,United Kingdom,Behavioural Activation in Social IsoLation (BASIL): Benefiting from activities to improve your mood while you are socially isolating,Other (psych),Psychological,Psychological,100,http://isrctn.com/ISRCTN94091479,None
1132,ISRCTN33578935,ISRCTN,2020-06-02,2020-01-06,True,Kimera Labs,Recruiting,Phase 2,Interventional,Germany,To study the treatment of COVID-19 with severe viral pneumonia by using purified stem cell exosomes,ATMP,Cells (mesenchymal),Cells (mesenchymal),64,http://isrctn.com/ISRCTN33578935,None
1133,ISRCTN21363594,ISRCTN,2020-05-18,2020-01-05,True,King Saud Medical City,Recruiting,Not Applicable,Interventional,"Saudi Arabia, Oman, United Arab Emirates",Therapeutic plasma exchange (removal of the non-cell portion of blood) in critically ill adult patients with serious SARS CoV-2 disease (COVID-19),ATMP,Plasma,Plasma,80,http://isrctn.com/ISRCTN21363594,None
1134,ISRCTN40092247,ISRCTN,2020-04-01,2020-03-20,True,University of Oxford,Recruiting,Not Applicable,Observational,United Kingdom,UKOSS: Pandemic COVID-19 in pregnancy,Clinical Presentation,No Intervention,No Intervention,500,http://isrctn.com/ISRCTN40092247,None
1135,ISRCTN16483855,ISRCTN,2019-08-05,2019-01-07,True,"University College, London",Recruiting,Not Applicable,Interventional,United Kingdom,"Inhale work package 3 â€“ rapid versus standard testing to diagnose lung infections in intensive care, including COVID-19 observational sub-study",Not relevant,Not relevant,Not relevant,466,http://isrctn.com/ISRCTN16483855,None
1136,ChiCTR2000033980,ChiCTR,2020-06-19,2020-06-10,True,The Second Affiliated Hospital of Chongqing Medical University,Not Recruiting,Not Applicable,Observational,China,"A follow-up study of novel coronavirus pneumonia (COVID-19) patients in Wanzhou District, Chongqing",Clinical Presentation,No Intervention,No Intervention,67,http://www.chictr.org.cn/showproj.aspx?proj=55355,None
1137,ChiCTR2000033960,ChiCTR,2020-06-19,2020-02-10,True,Maternal and Child Health Hospital of Hubei Province,Recruiting,Not Applicable,Observational,China,A multicenter clinical study: transmission of COVID-19 and impact on health and developmental outcomes among newborns of mothers with confirmed/suspected COVID-19,Clinical Presentation,No Intervention,No Intervention,90,http://www.chictr.org.cn/showproj.aspx?proj=55376,None
1138,ChiCTR2000033936,ChiCTR,2020-06-17,2020-06-16,True,No Sponsor Name Given,Recruiting,Not Applicable,Prevention,China,Psychological Preparedness towards Novel Coronavirus Precautionary Measures â€“ an online survey,Other (psych),No Intervention,No Intervention,1000,http://www.chictr.org.cn/showproj.aspx?proj=55291,None
1139,ChiCTR2000033919,ChiCTR,2020-06-17,2020-06-16,True,Tianjin Medical University General Hospital,Recruiting,Not Applicable,Observational,China,A medical records based study for the influence of novel coronavirus pneumonia (COVID-19) on the symptoms of patients with achalasia,Clinical Presentation,No Intervention,No Intervention,286,http://www.chictr.org.cn/showproj.aspx?proj=55301,None
1140,ChiCTR2000033899,ChiCTR,2020-06-16,2020-06-04,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Health services research,Pakistan,Impact of COVID-19 on Laboratory Professionals-Early Evidences from a Survey at a Clinical Chemistry Laboratory in a Developing Country,Other,No Intervention,No Intervention,64,http://www.chictr.org.cn/showproj.aspx?proj=55295,None
1141,ChiCTR2000031707,ChiCTR,2020-04-07,2020-03-01,True,Shanghai Oriental Hospital,Recruiting,Not Applicable,Observational,China,Study for sleep quality of medical teams members moved to Hubei for the fighting of novel coronavirus pneumonia (COVID-19) pandemic,Other (psych),No Intervention,No Intervention,47,http://www.chictr.org.cn/showproj.aspx?proj=52079,None
1142,EUCTR2020-001243-15-BE,EU Clinical Trials Register,2020-03-27,2020-03-26,True,UZ Leuven,Not Recruiting,Phase 2,Interventional,Belgium,"Covid-19: A randomized, open-label, adaptive, proof-of- concept clinical trial of new antiviral drug candidates against SARS-CoV-2.",Drug,Itraconazole,Itraconazole,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001243-15,None
1143,EUCTR2020-001889-10-GB,EU Clinical Trials Register,2020-05-15,2020-02-06,True,University of Oxford,Authorised,Phase 2,Interventional,United Kingdom,Treating COVID-19 infections with inhaled corticosteroids,Drug,Budesonide,Budesonide,478,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001889-10,None
1144,EUCTR2020-002120-37-GB,EU Clinical Trials Register,2020-06-08,2020-06-16,False,Thirty Respiratory Limited,Authorised,Phase 2/Phase 3,Interventional,"Germany, Italy, France, Netherlands, United Kingdom, United States, Spain","An open-label, adaptive randomized, controlled multicenter study to evaluate the efficacy and safety of RESP301+SOC vs SOC in hospitalized participants with COVID-19 requiring supplemental oxygen",Drug,Sodium Nitrite,Sodium Nitrite,300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002120-37,None
1145,EUCTR2020-002233-15-DE,EU Clinical Trials Register,2020-05-13,2020-06-17,False,Charité University,Authorised,Phase 2,Interventional,Germany,"A study to investigate the safety and efficacy of two approved drugs, niclosamide and camostat, administered alone and in combination and compared to placebo in COVID-19 patients",Drug,Niclosamide vs. Camostat Mesilate vs. Niclosamide + Camostat Mesilate,Niclosamide; Camostat Mesilate,72,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002233-15,None
1146,ACTRN12620000688987,ANZCTR,2020-06-19,2020-02-06,True,The Royal Melbourne Hospital,Not Recruiting,Not Applicable,Interventional,Australia,"Comparing the user seal check and fit test between two types of N95 respirators - the Halyard N95 Particulate Filter Respirators and the ProShieldÂ® N-95 masks
",Other (device),Mask,Mask,80,https://anzctr.org.au/ACTRN12620000688987.aspx,None
1147,ACTRN12620000692932,ANZCTR,2020-06-22,2020-06-24,False,University of Adelaide,Not Recruiting,Not Applicable,Observational,United States,Atrial Fibrillation in Patients with an Implantable Cardiac Device during the COVID-19 Pandemic,Other,No Intervention,No Intervention,10000,https://anzctr.org.au/ACTRN12620000692932.aspx,None
1148,ISRCTN13471603,ISRCTN,2020-06-17,2020-08-06,False,Cambridge University Hospitals NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,Management of patients with heart failure with preserved ejection fraction: what do patients and providers need and want?,Other,Other,Other,50,http://isrctn.com/ISRCTN13471603,None
1149,ISRCTN15475176,ISRCTN,2020-06-10,2020-05-24,True,King Saud Medical City,Recruiting,Not Applicable,Observational,Saudi Arabia,A Saudi Arabia based study into the impact of coronavirus infection on the nervous system,Clinical Presentation,No Intervention,No Intervention,1000,http://isrctn.com/ISRCTN15475176,None
1150,ChiCTR2000034164,ChiCTR,2020-06-27,2020-07-08,False,Chinese Academy of Sciences,Not Recruiting,Not Applicable,Interventional,China,Trauma Healing Project Based on Chinese Mind-Body Wisdom in the novel coronavirus pneumonia (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,340,http://www.chictr.org.cn/showproj.aspx?proj=55154,None
1151,ChiCTR2000034112,ChiCTR,2020-06-24,2020-06-25,False,Shulan (Hangzhou) Hospital; Center for Disease Control and Prevention of Guangxi Zhuang Autonomous Region,Not Recruiting,Phase 1,Prevention,China,"A Phase I clinical trial to evaluate the safety, tolerance and preliminary immunogenicity of different doses of a SARS-CoV-2 mRNA vaccine in population aged 18-59 years and 60 years and above",ATMP,Vaccine,Vaccine,168,http://www.chictr.org.cn/showproj.aspx?proj=55524,None
1152,ChiCTR2000034076,ChiCTR,2020-06-22,2020-05-23,True,Beijing TIL Therapeutics,Recruiting,Not Applicable,Interventional,China,Novel coronavirus pneumonia (COVID-19) loaded autologous dendritic cell trial,ATMP,Cells (dendritic),Cells (dendritic),25,http://www.chictr.org.cn/showproj.aspx?proj=55582,None
1153,ChiCTR2000029589,ChiCTR,2020-02-05,2020-02-06,False,Beijing Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,"A prospective, randomized,open, multi-center clinical trial evaluating  the efficiency and safety of Reduning injection  in the treatment of novel coronavirus pneumonia (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=49104,None
1154,EUCTR2020-001767-86-IE,EU Clinical Trials Register,2020-04-15,2020-06-25,False,University College Dublin,Authorised,Phase 2,Interventional,Ireland,trial comparing different doses of single-dose tocilizumab in adults with severe COVID-19 infection,Drug,Tocilizumab,Tocilizumab,90,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001767-86,None
1155,EUCTR2020-001777-71-GB,EU Clinical Trials Register,2020-04-30,2020-06-05,False,Guy's and St Thomas' NHS Foundation Trust,Authorised,Phase 4,Interventional,United Kingdom,Ruxolitinib therapy to Avoid Ventilation and improve outcome for deteriorating COVID-19 patients,Drug,Ruxolitinib,Ruxolitinib,59,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001777-71,None
1156,EUCTR2020-001501-24-IT,EU Clinical Trials Register,2020-06-24,2020-04-28,True,Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori,Authorised,Phase 2,Interventional,Italy,PROTECT: studio randomizzato con idrossiclorochina vs osservazione per la prevenzione e il trattamento precoce della malattia da coronavirus (COVID-19),Drug (+ Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,2300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001501-24,None
1157,EUCTR2020-001390-76-IT,EU Clinical Trials Register,2020-06-24,2020-04-27,True,IRCCS Istituto Nazionale per le Malattie Infettive “Lazzaro Spallanzani”,Authorised,Phase 3,Interventional,Italy,"A phase 3, randomized, open-labeled, multi-center study comparing clinical efficacy and safety of intravenous sarilumab plus standard of care compared to standard of care, in the treatment of patients with severe COVID-19 pneumonia .",Drug,Sarilumab,Sarilumab,171,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001390-76,None
1158,EUCTR2020-001528-32-IT,EU Clinical Trials Register,2020-06-24,2020-05-14,True,IRCCS Istituto Nazionale per le Malattie Infettive “Lazzaro Spallanzani”,Authorised,Phase 3,Interventional,Italy,Adaptive Randomized trial for therapy of COrona virus disease 2019 at home with oral antivirals,Drug,Lopinavir/ritonavir vs. Hydroxychloroquine vs. Darunavir vs. Favipiravir,Lopinavir/ritonavir; Hydroxychloroquine; Darunavir; Favipiravir,435,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001528-32,None
1159,EUCTR2020-001987-28-IT,EU Clinical Trials Register,2020-06-24,2020-06-05,True,IRCCS Ospedale San Raffaele,Authorised,Phase 3,Interventional,Italy,PRECOV: a randomized controlled clinical trial on the effects of hydroxychloroquine in the prevention of COVID-19 in healthcare workers at risk,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001987-28,None
1160,EUCTR2020-001921-30-IT,EU Clinical Trials Register,2020-06-26,2020-05-14,True,AOU di Modena,Authorised,Phase 3,Interventional,Italy,"Steroids and unfractionated heparin in critically-ill patients with pneumonia from COVID-19 infection. A multicenter, interventional, randomized, three arms study design.",Drug,"Corticosteroids, Heparin",Methylprednisolone; Heparin,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001921-30,None
1161,EUCTR2020-001795-15-IT,EU Clinical Trials Register,2020-06-26,2020-07-05,False,IRCCS Ospedale San Raffaele,Authorised,Phase 2,Interventional,Italy,Clinical study aimed to verify the efficacy and safety of mavrilimumab in COVID-19-associated pneumonia in patients who have signs of excessive inflammation,Drug,Mavrilimumab,Mavrilimumab,50,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001795-15,None
1162,EUCTR2020-001854-23-IT,EU Clinical Trials Register,2020-06-26,2020-04-27,True,Società Italiana di Malattie Infettive e Tropicali,Authorised,Phase 2/Phase 3,Interventional,Italy,A study with immunotherapy for Moderate COVID-19,Drug,Tocilizumab vs. Hydroxychloroquine vs. Siltuximab vs. Canakinumab vs. Sarilumab vs. Baricitinib vs. Methylprednisolone,Tocilizumab; Hydroxychloroquine; Siltuximab; Canakinumab; Sarilumab; Baricitinib; Methylprednisolone,1400,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001854-23,None
1163,ACTRN12620000702910,ANZCTR,2020-06-26,2020-06-29,False,Austin Health,Not Recruiting,Not Applicable,Observational,Australia,Fit testing of N95 filtering facepieces for anaesthetists and nurses treating COVID-19 patients,Other (device),Mask,Mask,60,https://anzctr.org.au/ACTRN12620000702910.aspx,None
1164,ISRCTN13990999,ISRCTN,2020-06-24,2020-03-04,True,IRCCS Don Calabria Ospedale Sacro Cuore,Not Recruiting,Not Applicable,Observational,Italy,A diagnostic study comparing different tests for the diagnosis of COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,400,http://isrctn.com/ISRCTN13990999,None
1165,ISRCTN12394803,ISRCTN,2020-06-22,2020-04-27,True,Imperial College London,Recruiting,Not Applicable,Observational,"Spain, Taiwan, Greece, Gambia, Latvia, Germany, Italy, France, Netherlands, Nepal, United Kingdom, Austria, Switzerland, Slovenia","DIAMONDS-SEARCH study: Designing new tests that can diagnose the causes of fever, including COVID-19",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,5000,http://isrctn.com/ISRCTN12394803,None
1166,ChiCTR2000034359,ChiCTR,2020-07-03,2020-10-01,False,Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Not Recruiting,Not Applicable,Health services research,China,Novel coronavirus pneumonia (COVID-19) Prevention and Control Strategy - Development of multi-layer Network Early Warning System,Health System,No Intervention,No Intervention,6000,http://www.chictr.org.cn/showproj.aspx?proj=56012,None
1167,ChiCTR2000034346,ChiCTR,2020-07-02,2020-04-10,True,Jianxing He,Not Recruiting,Not Applicable,Health services research,China,Survey for Surgery status of a designated Hospital for COVID-19 management in Guangzhou,Health System,No Intervention,No Intervention,3239,http://www.chictr.org.cn/showproj.aspx?proj=55654,None
1168,ChiCTR2000034287,ChiCTR,2020-07-01,2020-04-01,True,Guangdong Provincial Hospital of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Observational,China,Qualitative Study on Self-protection Experience of Medical Staff in the Isolation Area of Novel Coronavirus Pneumonia (COVID-19),Other,No Intervention,No Intervention,11,http://www.chictr.org.cn/showproj.aspx?proj=55339,None
1169,ChiCTR2000033105,ChiCTR,2020-05-21,2020-02-20,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Follow up study of convalescent patients of novel coronavirus pneumonia (COVID-19),ATMP,Plasma,Plasma,400,http://www.chictr.org.cn/showproj.aspx?proj=52816,None
1170,EUCTR2020-001271-33-FR,EU Clinical Trials Register,2020-03-24,2020-03-31,False,CHU Angers,Not Recruiting,Phase 3,Interventional,France,HYCOVID - Hydroxychloroquine versus placebo chez les patients ayant une infection COVID-19 Ã  risque dâ€™aggravation secondaire : Ã©tude prospective multicentrique randomisÃ©e en double aveugle,Drug,Hydroxychloroquine,Hydroxychloroquine,1300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001271-33,None
1171,EUCTR2020-001375-32-NL,EU Clinical Trials Register,2020-04-03,2020-03-04,False,University Medical Center Groningen,Authorised,Phase 2,Interventional,Netherlands,Early intervention with Tocilizumab in patients with COVID-19 and hypoxia,Drug,Tocilizumab,Tocilizumab,354,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001375-32,NL8504
1172,ISRCTN18077365,ISRCTN,2020-07-02,2020-05-25,True,Azienda Unita Sanitaria Locale Reggio Emilia,Recruiting,Not Applicable,Observational,Italy,Can the COVID-19 virus be detected in the smoke generated in minimally invasive surgery in patients with confirmed coronavirus infection?,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,20,http://isrctn.com/ISRCTN18077365,None
1173,ISRCTN54917435,ISRCTN,2020-06-15,2020-06-25,False,Uppsala County Council,Recruiting,Not Applicable,Interventional,Sweden,Could prone positioning increase lung function for patients with severe COVID-19 infection?,Procedure,Positioning,Positioning,240,http://isrctn.com/ISRCTN54917435,None
1174,ISRCTN69546370,ISRCTN,2020-06-02,2020-08-06,False,Imperial College London,Recruiting,Not Applicable,Observational,United Kingdom,Best available treatment study for inflammatory conditions associated with COVID-19,Clinical Presentation,No Intervention,No Intervention,1800,http://isrctn.com/ISRCTN69546370,None
1175,ChiCTR2000034588,ChiCTR,2020-07-11,2020-02-16,True,University Hospital of North Tees,Not Recruiting,Not Applicable,Observational,United Kingdom,An observational cohort study to evaluate volume and severity of emergency general surgery admissions during the COVID-19 pandemic: is there a â€œlockdownâ€ effect?,Health System,No Intervention,No Intervention,207,http://www.chictr.org.cn/showproj.aspx?proj=56245,None
1176,ChiCTR2000034563,ChiCTR,2020-07-10,2020-02-16,True,The Public and Health Clinic Centre of Chengdu,Recruiting,Not Applicable,Observational,China,Follow-up study on the recovery period of novel coronavirus pneumonia (COVID-19) patients,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,50,http://www.chictr.org.cn/showproj.aspx?proj=51931,None
1177,ChiCTR2000034537,ChiCTR,2020-07-09,2020-07-13,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,China,Psychological Preparedness towards Novel Coronavirus (COVID-19) among Old Age Home Staff - an online survey,Other (psych),No Intervention,No Intervention,500,http://www.chictr.org.cn/showproj.aspx?proj=56285,None
1178,ChiCTR2000034522,ChiCTR,2020-07-08,2020-05-15,True,"Health and Medical Research Fund, Hong Kong",Recruiting,Not Applicable,Observational,China,Hidden COVID-19 infection in Hong Kong,Clinical Presentation (Epidemiology),No Intervention,No Intervention,3000,http://www.chictr.org.cn/showproj.aspx?proj=53548,None
1179,ChiCTR2000034519,ChiCTR,2020-07-08,2020-07-30,False,Ophthalmic Center of People's Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,Exercise with a face mask might be dangerous during the period of COVID 2019: an optical coherence tomography angiography study in healthy young adults.,Other (device),Masks,Masks,30,http://www.chictr.org.cn/showproj.aspx?proj=56079,None
1180,ChiCTR2000031928,ChiCTR,2020-04-14,2020-06-01,False,The Chinese University of Hong Kong,Not Recruiting,Not Applicable,Observational,China,"Cancelled by the investigator                  Delineate the prevalence, risk factors, temporal distribution and epidemiological characteristics of hidden novel coronavirus (2019-nCoV) infection in the community",Clinical Presentation (Epidemiology),No Intervention,No Intervention,3000,http://www.chictr.org.cn/showproj.aspx?proj=52353,None
1181,IRCT20151113025025N3,IRCT,2020-03-29,2020-04-05,False,Tehran University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,Clinical Trial of renin-angiotensin-aldosterone system inhibitors with halting their administration and the effect on clinical outcomes of patients with coronavirus disease-2019 (COVID-19) referring to Sina and Imam-Khomeini Hospitals in 2020,Drug,RAAS inhibitors,RAAS inhibitors,60,http://en.irct.ir/trial/46531,None
1182,IRCT20200416047099N2,IRCT,2020-07-04,2020-06-21,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Plasma exchange in COVID-19 patients,ATMP,Plasma,Plasma,10,http://en.irct.ir/trial/47357,None
1183,IRCT20200428047229N1,IRCT,2020-06-27,2020-03-29,True,Esfahan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Medical Beer on COVID-19,Drug,Other,Other,60,http://en.irct.ir/trial/47530,None
1184,IRCT20200428047232N1,IRCT,2020-07-05,2020-05-09,True,Esfahan University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of Thalidomide in Covid 19 pneumonia,Drug,Thalidomide + Hydroxychloroquine vs. Hydroxychloroquine,Thalidomide; Hydroxychloroquine,60,http://en.irct.ir/trial/47637,None
1185,IRCT20200504047298N2,IRCT,2020-06-15,2020-07-10,False,Karaj University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Opuntia Cactus extract in patients with Covid-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,48,http://en.irct.ir/trial/47675,None
1186,IRCT20171105037262N4,IRCT,2020-06-18,2020-04-29,True,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Adalimumab effect on COVID-19,Drug,Adalimumab + Chloroquine vs. Chloroquine,Adalimumab; Chloroquine,100,http://en.irct.ir/trial/47696,None
1187,IRCT20200508047345N1,IRCT,2020-06-14,2020-06-21,False,Shiraz University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Combined effects of Extracts on  Covid-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://en.irct.ir/trial/47987,None
1188,IRCT20200511047396N1,IRCT,2020-05-16,2020-06-30,False,CinnaGen Company,Recruiting,Phase 3,Interventional,Iran,Efficacy evaluation of inhalation therapy (nasal spray) of Interferon Beta-1a in hospitalized Covid-19 patients,Drug,Interferon beta,Interferon beta,50,http://en.irct.ir/trial/48048,None
1189,IRCT20180425039414N3,IRCT,2020-06-17,2020-04-20,True,Esfahan University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of vitamin C and E in the treatment and clinical course of patients with SARS-cov2 (COVID-19),Drug,Vitamin C + Vitamin E + Hydroxychloroquine + Lopinavir/ritonavir vs. Hydroxychloroquine + Lopinavir/ritonavir,Vitamin C; Vitamin E; Hydroxychloroquine; Lopinavir/ritonavir,80,http://en.irct.ir/trial/48083,None
1190,IRCT20200510047385N1,IRCT,2020-07-07,2020-06-30,True,Tabriz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effects of SVF and exosome in covid-19 patients with acute respiratory distress syndrome,ATMP,Exosomes,Exosomes,60,http://en.irct.ir/trial/48099,None
1191,IRCT20200513047426N1,IRCT,2020-06-27,2020-06-21,True,Boushehr University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The prophylactic effect of oral hydroxy-chloroquine in close contacts of COVID-19 patients,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,500,http://en.irct.ir/trial/48236,None
1192,IRCT20110726007117N11,IRCT,2020-07-05,2020-06-21,True,Mashhad University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of vitamin D supplementation in novel corona virus 2019,Drug,Vitamin D,Vitamin D,210,http://en.irct.ir/trial/48287,None
1193,IRCT20200112046089N1,IRCT,2020-06-25,2020-06-14,True,Ahvaz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Resveratrol in COVID19,Drug,Resveratrol,Resveratrol,50,http://en.irct.ir/trial/48330,None
1194,IRCT20200330046899N1,IRCT,2020-06-17,2020-04-20,True,Kerman University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effectiveness of herbal capsule in  COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50,http://en.irct.ir/trial/48365,None
1195,IRCT20081027001411N4,IRCT,2020-07-09,2020-04-29,True,Tehran University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of TOCILIZUMAB (ACTEMRA) on treatment of COVID-19,Drug,Tocilizumab,Tocilizumab,40,http://en.irct.ir/trial/48396,None
1196,IRCT20200525047562N1,IRCT,2020-06-14,2020-05-25,True,High Educational and Research Institute of Transfusion Medicine,Recruiting,Phase 3,Interventional,Iran,Treatment of Covid-19 patients with convalescent plasma,ATMP,Plasma,Plasma,100,http://en.irct.ir/trial/48493,None
1197,IRCT20200317046797N6,IRCT,2020-06-18,2020-06-21,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Edaravone in COVID-19,Drug,Edaravone,Edaravone,30,http://en.irct.ir/trial/48500,None
1198,IRCT20200504047298N1,IRCT,2020-06-14,2020-06-14,False,Alborz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of Atazanavir/Ritonavirin treatment of COViD-19,Drug,Atazanavir/ritonavir vs. Lopinavir/ritonavir,Atazanavir/ritonavir; Lopinavir/ritonavir,100,http://en.irct.ir/trial/48640,None
1199,IRCT20200505047305N1,IRCT,2020-06-30,2020-06-06,True,Iran University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Grief counseling in family members of the COVID-19 victims,Other (psych),Psychological,Psychological,120,http://en.irct.ir/trial/48683,None
1200,IRCT20150107020592N29,IRCT,2020-06-21,2020-03-20,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Efficacy of Blood Purification Techniques on  COVID-19 Pneumonia,Other (physical),Blood purification,Blood purification,12,http://en.irct.ir/trial/48695,None
1201,IRCT20200607047675N1,IRCT,2020-06-15,2020-06-19,False,Mashhad University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effectiveness of traditional medicine combination based on the Ferula assa-foetida gum - Tragacanth in Participants with Moderate to Severe Coronavirus Disease (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://en.irct.ir/trial/48700,None
1202,IRCT20200608047686N1,IRCT,2020-06-30,2020-05-31,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,The role of metronidazole in COVID-19,Drug,Metronidazole,Metronidazole,30,http://en.irct.ir/trial/48717,None
1203,IRCT20150107020592N26,IRCT,2020-06-15,2020-03-20,True,Masih Daneshvari Hospital,Not Recruiting,Phase 3,Interventional,Iran,Favipiravir effectiveness in patients undergoing COVID19 Acute respiratory distress syndrome (ARDS),Drug,Favipiravir,Favipiravir,20,http://en.irct.ir/trial/48746,None
1204,IRCT20200609047707N1,IRCT,2020-06-24,2020-07-09,False,Esfarayen University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effective of Elman tablet on COVID-19 infection severity,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,90,http://en.irct.ir/trial/48764,None
1205,IRCT20200611047735N1,IRCT,2020-06-19,2020-07-05,False,Bandare-abbas University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Evaluation of the effect of nano micelles containing curcumin (Sina Ccurcumin) as a therapeutic supplement in patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://en.irct.ir/trial/48843,None
1206,IRCT20150107020592N27,IRCT,2020-06-15,2020-03-20,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of pentaglobin in the treatment of critically ill patients with COVID-19,ATMP,Immunoglobulin,Immunoglobulin,60,http://en.irct.ir/trial/48907,None
1207,IRCT20200515047456N1,IRCT,2020-06-28,2020-06-17,True,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The role of anticoagulant and thrombolitic in treatment of COVID patients,Drug,Heparin,Heparin,15,http://en.irct.ir/trial/48929,None
1208,IRCT20200611047727N1,IRCT,2020-06-24,2020-07-22,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,The Effect of Inspiratory muscle training in patients with COVID-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,40,http://en.irct.ir/trial/48941,None
1209,IRCT20150107020592N28,IRCT,2020-06-18,2020-03-20,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effectiveness of borage based solutions in cytokine's levels in covid-19 ARDS patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50,http://en.irct.ir/trial/48972,None
1210,IRCT20150107020592N30,IRCT,2020-07-10,2020-03-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Prophylactic  Favipiravir  for Healthcare Workers in COVID-19 Pandemic,Drug (Chemoprophylaxis),Favipiravir,Favipiravir,30,http://en.irct.ir/trial/48992,None
1211,IRCT20200404046937N3,IRCT,2020-06-25,2020-06-27,False,Ahvaz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,"Evaluating the effect of Phyllanthus Emblica, Rosa Damascene, Marshmallow and Honey on COVID 19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/49029,None
1212,IRCT20150725023332N3,IRCT,2020-06-27,2020-04-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of Bromelain and Montelukast  in Covid-19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/49112,None
1213,IRCT20180712040446N2,IRCT,2020-07-01,2020-06-30,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Investigating the effect of  sweet almond on symptoms of COVID 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/49120,None
1214,IRCT20190121042444N3,IRCT,2020-07-04,2020-02-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Considering the administration of Desferral supplementary and Vitamin C on the ferritin levels of Quid 19 patients,Drug,Deferoxamine + Vitamin C vs. Vitamin C,Deferoxamine; Vitamin C,78,http://en.irct.ir/trial/49132,None
1215,IRCT20111224008507N3,IRCT,2020-06-27,2020-05-21,True,Mazandaran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Ivermectin in the treatment of coronavirus infection,Drug,Ivermectin,Ivermectin,60,http://en.irct.ir/trial/49174,None
1216,IRCT20180519039711N6,IRCT,2020-06-29,2020-07-19,False,Arak University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Effect of mandala staining on anxiety in patients with COVID-19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/49186,None
1217,IRCT20200426047206N2,IRCT,2020-07-06,2020-07-22,False,Hamedan University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The efficacy and safety of mesenchymal stem cell transplantation in patients with COVID-19 pneumonia,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,http://en.irct.ir/trial/49385,None
1218,EUCTR2020-001325-31-NL,EU Clinical Trials Register,2020-04-07,2020-05-20,False,Radboud University Medical Centre,Authorised,Phase 2,Interventional,Netherlands,RDG-PET/CT imaging in COVID-19 patients.,Drug,Contrast agent,Contrast agent,10,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001325-31,None
1219,EUCTR2020-001270-29-GB,EU Clinical Trials Register,2020-03-30,2020-02-04,True,Sanofi,Not Recruiting,Phase 2/Phase 3,Interventional,"Czech Republic, Denmark, Germany, France, United Kingdom, Hungary",Hydroxychloroquine for COVID 19 in moderately to severely ill hospitalized patients,Drug,Hydroxychloroquine,Hydroxychloroquine,350,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001270-29,None
1220,EUCTR2020-001198-55-DK,EU Clinical Trials Register,2020-03-21,2020-03-04,True,Chronic Obstructive Pulmonary Disease Trial Network,Authorised,Phase 2,Interventional,Denmark,Early Treatment to Patients with Coronavirus (COVID),Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,226,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001198-55,None
1221,JPRN-jRCTs031190226,JPRN,2020-02-27,2020-03-14,False,Tokue Yutaka,Recruiting,Phase 2,Interventional,Japan,Favipiravir in patients infected with COVID-19,Drug,Favipiravir,Favipiravir,100,https://jrct.niph.go.jp/latest-detail/jRCTs031190226,None
1222,JPRN-jRCTs041200025,JPRN,2020-07-01,2020-01-07,True,Yuichiro Shindo,Recruiting,Phase 2,Interventional,Japan,Phase II trial of combination therapy with favipiravir and corticosteroids for COVID-19,Drug,Favipiravir + Corticosteroids,Favipiravir; Methylprednisolone,69,https://jrct.niph.go.jp/latest-detail/jRCTs041200025,None
1223,JPRN-UMIN000040409,JPRN,2020-07-01,2020-06-20,True,The Jikei University School of Medicine,Not Recruiting,Not Applicable,Observational,"Japan,South America,Europe","Study of International Clinical Data Collection, Doctor to Doctor Telemedicine, education, and AI platform against deterioration of COVID-19",Other,No Intervention,No Intervention,1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046113,None
1224,JPRN-UMIN000040733,JPRN,2020-06-22,2020-06-22,False,Kanagawa Dental University,Not Recruiting,Not Applicable,Interventional,Japan,A study on the prevalence of infection in dental institutions by measuring the antibody titer to COVID-19 of the staff members of Kanagawa Dental College Medical Center,Clinical Presentation (Epidemiology),No Intervention,No Intervention,300,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046461,None
1225,JPRN-UMIN000040816,JPRN,2020-06-17,2020-06-18,False,St. Marianna University School of Medicine,Not Recruiting,Not Applicable,Observational,Japan,Relationship between age and viral load in novel coronavirus patients,Clinical Presentation,No Intervention,No Intervention,30,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046573,None
1226,JPRN-UMIN000040838,JPRN,2020-07-01,2020-09-01,False,Hyogo College of Medicine,Not Recruiting,Not Applicable,Interventional,Japan,A seroprevalence study of COVID-19 in IBD patients,Clinical Presentation (Epidemiology),No Intervention,No Intervention,2000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046628,None
1227,NCT04471662,ClinicalTrials.gov,2020-07-13,2020-08-01,False,Tanta University,Not Recruiting,Phase 2,Interventional,No Country Given,Nelfinavir and Favipiravir Combination in Newly Diagnosed COVID19 Egyptian Patients,Drug,"Nelfinavir, Favipiravir",Nelfinavir; Favipiravir,50,https://clinicaltrials.gov/show/NCT04471662,None
1228,ACTRN12620000734965,ANZCTR,2020-07-13,2020-07-13,False,Monash Hospital,Not Recruiting,Not Applicable,Observational,"Ireland, Canada, Australia, United States",Lung ultrasound to predict invasive ventilation of patients with COVID-19 lung disease,Clinical Presentation,No Intervention,No Intervention,1000,https://anzctr.org.au/ACTRN12620000734965.aspx,None
1229,ACTRN12620000740998,ANZCTR,2020-07-16,2020-07-16,False,Royal Prince Alfred Hopsital,Not Recruiting,Not Applicable,Interventional,Australia,A Study of Lying Face Down to Help Improve Oxygen Levels of Adults Not Needing Ventilators in Intensive Care with COVID-19,Procedure,Positioning,Positioning,20,https://anzctr.org.au/ACTRN12620000740998.aspx,None
1230,ACTRN12620000731998,ANZCTR,2020-07-13,2020-01-09,True,Hunter New England Local Health District,Not Recruiting,Phase 1,Interventional,Australia,Will treating the overwhelming patient response with medications affect COVID-19 mortality?,Drug,Losartan,Losartan,36,https://anzctr.org.au/ACTRN12620000731998.aspx,None
1231,ACTRN12620000737932,ANZCTR,2020-07-14,2020-05-22,True,University of Southampton,Not Recruiting,Not Applicable,Interventional,United Kingdom,Nasal washout and gargling for healthcare staff in Care Homes during the COVID-19 pandemic: The Good-NIGHT COVID pilot study,Procedure,Gargling,Gargling,300,https://anzctr.org.au/ACTRN12620000737932.aspx,None
1232,ISRCTN55886926,ISRCTN,2020-06-01,2021-05-17,False,University of Cambridge,Recruiting,Not Applicable,Observational,United Kingdom,Investigation of COVID-19 symptoms and potential immunity in the general population,Clinical Presentation,No Intervention,No Intervention,90000,http://isrctn.com/ISRCTN55886926,None
1233,ChiCTR2000034798,ChiCTR,2020-07-19,2020-03-15,True,Azienda Sanitaria Locale 4 - Chiavarese,Not Recruiting,Not Applicable,Observational,Spain,Clinical features and prognostic factors for patients admitted for COVID-19 pneumonia,Clinical Presentation,No Intervention,No Intervention,309,http://www.chictr.org.cn/showproj.aspx?proj=55616,None
1234,ChiCTR2000034795,ChiCTR,2020-07-19,2020-01-28,True,Wuhan Hospital of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,The therapeutic efficacy of Xuan-Fei Bai-Du decoction in the treatment of novel coronavirus pneumonia (COVID-19): a pilot randomized controlled trial,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,42,http://www.chictr.org.cn/showproj.aspx?proj=56756,None
1235,ChiCTR2000034794,ChiCTR,2020-07-19,2020-05-01,True,Hubei Hospital of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,"Sancai granule improves lung and kidney function for patient with novel coronavirus pneumonia (COVID-19) in the recovery period: a randomized, parallel controlled trial",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.chictr.org.cn/showproj.aspx?proj=56771,None
1236,ChiCTR2000034784,ChiCTR,2020-07-19,2020-03-15,True,Azienda Sanitaria Locale 4 - Regione Liguria,Not Recruiting,Not Applicable,Observational,Spain,Management of acute respiratory failure due to Sars CoV2 with non invasive ventilatory support: a medical records based study,Other (physical),Mechanical ventilation,Mechanical ventilation,104,http://www.chictr.org.cn/showproj.aspx?proj=55391,None
1237,ChiCTR2000034781,ChiCTR,2020-07-18,2020-06-16,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Recruiting,Not Applicable,Observational,China,A follow-up study of long-term prognosis in patients with severe novel coronavirus pneumonia (COVID-19),Prognosis,No Intervention,No Intervention,280,http://www.chictr.org.cn/showproj.aspx?proj=56642,None
1238,ChiCTR2000034780,ChiCTR,2020-07-18,2020-07-16,True,China National Biotec Group Co. Ltd,Recruiting,Phase 3,Interventional,UAE,A Phase III clinical trial for inactivated novel coronavirus pneumonia (COVID-19) vaccine (Vero cells),ATMP,Vaccine,Vaccine,15000,http://www.chictr.org.cn/showproj.aspx?proj=56651,None
1239,ChiCTR2000034680,ChiCTR,2020-07-14,2020-09-01,False,"Beijing Tsinghua Chang Gung Hospital, Tsinghua University",Not Recruiting,Not Applicable,Observational,China,Development of early warning and rapid response system for patients with novel coronavirus pneumonia (COVID-19): a research protocol,Other,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=56364,None
1240,EUCTR2020-001504-42-FR,EU Clinical Trials Register,2020-04-20,2020-07-15,False,Inotrem,Authorised,Phase 2,Interventional,"France, United States, Belgium","A study evaluating the efficacy, safety and tolerability of Nangibotide in patients with Covid-19.",Drug,Nangibotide,Nangibotide,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001504-42,None
1241,EUCTR2020-001747-21-PT,EU Clinical Trials Register,2020-05-22,2020-06-07,False,Instituto de Saúde Pública da Universidade do Porto (ISPUP),Authorised,Phase 4,Interventional,Portugal,Efficacy and safety of Montelukast as add on treatment to the novel coronavirus pneumonia (COVID-19),Drug,Montelukast,Montelukast,160,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001747-21,None
1242,EUCTR2020-002106-68-GB,EU Clinical Trials Register,2020-07-07,2020-07-16,False,"University College, London",Authorised,Phase 2,Interventional,United Kingdom,FLARE: Favipiravir +/- Lopinavir: A RCT of Early antivirals,Drug,Favipiravir vs. Favipiravir + Lopinavir/ritonavir,Favipiravir; Lopinavir/ritonavir,240,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002106-68,None
1243,EUCTR2020-001808-42-ES,EU Clinical Trials Register,2020-07-10,2020-06-17,True,Pharmamel S.L.,Authorised,Phase 2,Interventional,Spain,"PHASE II CLINICAL TRIAL, SINGLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED TO EXPLORE THE EFFECTIVENESS AND SAFETY OF MELATONIN  IN PATIENTS WITH COVID-19 ENTERED INTO THE INTENSIVE CARE UNIT",Drug,Melatonin,Melatonin,18,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001808-42,None
1244,ISRCTN91495258,ISRCTN,2020-07-14,2018-01-01,True,Imperial College London,Recruiting,Not Applicable,Observational,"Malta, Italy, France, Netherlands, United Kingdom, Spain, Hungary",Investigating the impact of the coronavirus (COVID-19) pandemic on children presenting to emergency departments across Europe,Health System,No Intervention,No Intervention,2400000,http://isrctn.com/ISRCTN91495258,None
1245,ISRCTN10175886,ISRCTN,2020-07-14,2020-03-17,True,University Hospital Southampton NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,Coronavirus infection in immunosuppressed children,Clinical Presentation,No Intervention,No Intervention,400,http://isrctn.com/ISRCTN10175886,None
1246,ChiCTR2000034852,ChiCTR,2020-07-22,2020-07-15,True,The First Affiliated Hospital of Zhejiang University School of Medicine,Recruiting,Not Applicable,Observational,China,Management of endotracheal intubation in critically ill patients with novel coronavirus pneumonia (COVID-19) and clinical characteristics: a medical records based study,Other,No Intervention,No Intervention,14,http://www.chictr.org.cn/showproj.aspx?proj=56528,None
1247,ChiCTR2000034433,ChiCTR,2020-07-05,2020-05-27,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,The experiences of nurses hospitalized with novel coronavirus pneumonia (COVID-19) in China: a qualitative study Summary,Other,No Intervention,No Intervention,15,http://www.chictr.org.cn/showproj.aspx?proj=56104,None
1248,EUCTR2020-001765-37-ES,EU Clinical Trials Register,2020-04-13,2020-11-04,False,Institut Català d'Oncologia,Not Recruiting,Phase 2,Interventional,Spain,Pragmatic clinical trial of hydroxychloroquine in the treatment of oncohematological patients and health professionals with COVID-19 infection without radiological alteration.,Drug,Hydroxychloroquine,Hydroxychloroquine,103,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001765-37,None
1249,EUCTR2020-001707-16-ES,EU Clinical Trials Register,2020-07-22,2020-06-25,True,IIS Biodonostia,Authorised,Phase 3,Interventional,Spain,"PHASE III RANDOMIZED, UNICENTRIC OPEN, CONTROLLED CLINICAL TRIAL TO DEMONSTRATE THE EFFECTIVENESS OF TOCILIZUMAB AGAINST SYSTEMIC CORTICOTHERAPY IN PATIENTS ENTERED BY COVID-19 WITH BILATERAL PNEUMONIA AND BAD EVOLUTION",Drug,Tocilizumab vs. Corticosteroids,Tocilizumab; Methylprednisolone,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001707-16,None
1250,EUCTR2020-001890-56-ES,EU Clinical Trials Register,2020-07-22,2020-10-06,False,Universidad Catlica de Murcia (UCAM),Authorised,Phase 4,Interventional,Spain,Clinical trial to evaluate the efficacy and safety of gammaglobulins in COVID-19 treatment,ATMP,Immunoglobulin,Immunoglobulin,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001890-56,None
1251,EUCTR2020-001794-77-ES,EU Clinical Trials Register,2020-07-22,2020-10-06,False,Institut Català d'Oncologia Girona - Hospital Dr. Josep Trueta,Authorised,Phase 2,Interventional,Spain,Randomised clinical trial to test if silibinin administration can prevent the respiratory failure secondary to the COVID19 lung infection in oncologic patients.,Drug,Silibinin,Silibinin,92,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001794-77,None
1252,EUCTR2020-001929-31-ES,EU Clinical Trials Register,2020-07-22,2020-06-16,True,Fundación para la Investigación Biomédica Hospital Ramón y Cajal,Authorised,Phase 4,Interventional,Spain,Controlled trial on the usefulness of pioglitazone treatment in patients with type 2 diabetes mellitus and COVID-19.,Drug,Pioglitazone,Pioglitazone,76,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001929-31,None
1253,EUCTR2020-002186-34-ES,EU Clinical Trials Register,2020-07-22,2020-03-06,True,Vall d'Hebron Research Institute (VHIR),Authorised,Phase 4,Interventional,Spain,Efficacy of the early use of corticotherapy in CoV-2 infection to prevent the progression of acute respiratory distress syndrome (ARDS),Drug,Corticosteroids,Methylprednisolone,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002186-34,None
1254,EUCTR2020-002310-41-ES,EU Clinical Trials Register,2020-07-22,2020-06-15,True,IIS Fundación Jiménez Díaz,Authorised,Phase 2,Interventional,Spain,â€œMADRID-COVIDâ€,Drug,Metoprolol,Metoprolol,20,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002310-41,None
1255,EUCTR2020-002166-13-ES,EU Clinical Trials Register,2020-07-22,2020-09-07,False,Dr. Ramn Lleonart Bellfill; Dr. Xavier Corbella Virs,Authorised,Phase 2,Interventional,Spain,Investigating the Efficacy and Safety ICATIBANT For The Treatment of Patients with SARS-CoV-2 (COVID-19) Infection,Drug,Icatibant,Icatibant,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002166-13,None
1256,EUCTR2020-002449-41-ES,EU Clinical Trials Register,2020-07-22,2020-06-15,True,Antonio Antela Lopez,Authorised,Phase 3,Interventional,Spain,"Pilot trial on early treatment with hydroxychloroquine in patients with
COVID-19 who do not have hospital admission at diagnosis.",Drug,Hydroxychloroquine,Hydroxychloroquine,340,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002449-41,None
1257,EUCTR2020-002668-29-GB,EU Clinical Trials Register,2020-06-10,2020-06-25,False,"University College, London",Authorised,Phase 2,Interventional,United Kingdom,plasma exchange in severe COVID-19 infection,ATMP,Plasma,Plasma,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002668-29,None
1258,ACTRN12620000588998,ANZCTR,2020-05-21,2020-05-29,False,Grand Medical Pty Ltd,No Status Given,Phase 2,Interventional,Australia,The safety and efficacy of STC3141 in patient with COVID-19 Acute Respiratory Distress Syndrome,Drug,STC3141,STC3141,160,https://anzctr.org.au/ACTRN12620000588998.aspx,None
1259,ACTRN12620000566932,ANZCTR,2020-05-14,2020-05-10,True,University of Sydney,Not Recruiting,Phase 3,Interventional,Australia,Randomised clinical trial of interventions for the treatment of COVID-19 in the community setting for high risk older people.,Drug,Hydroxychloroquine,Hydroxychloroquine,400,https://anzctr.org.au/ACTRN12620000566932.aspx,None
1260,ACTRN12620000778987,ANZCTR,2020-07-30,2020-03-08,True,Sir Charles Gairdner Hospital,Not Recruiting,Not Applicable,Observational,Australia,Persistent lung and arterial inflammation following COVID-19 pneumonia,Clinical Presentation,No Intervention,No Intervention,30,https://anzctr.org.au/ACTRN12620000778987.aspx,None
1261,ISRCTN17301812,ISRCTN,2020-07-23,2020-07-24,False,University of Ferrara,Recruiting,Not Applicable,Observational,Italy,Search for antiviral antibodies in COVID-19 patients' eye secretions,Clinical Presentation,No Intervention,No Intervention,60,http://isrctn.com/ISRCTN17301812,None
1262,ISRCTN14990068,ISRCTN,2020-07-22,2020-07-27,False,University of Zurich,Recruiting,Not Applicable,Observational,Switzerland,"Zurich Coronavirus Cohort: an observational study to determine long-term clinical outcomes and immune responses after coronavirus infection (COVID-19), assess the influence of virus genetics, and examine the spread of the coronavirus in the population of the Canton of Zurich, Switzerland",Clinical Presentation,No Intervention,No Intervention,3200,http://isrctn.com/ISRCTN14990068,None
1263,ISRCTN10980107,ISRCTN,2020-07-22,2020-07-25,False,University of Leicester,Recruiting,Not Applicable,Observational,United Kingdom,Long-term follow up of adults hospitalised with COVID-19,Clinical Presentation,No Intervention,No Intervention,10000,http://isrctn.com/ISRCTN10980107,None
1264,ISRCTN89573163,ISRCTN,2020-07-15,2020-08-24,False,Cambridge University Hospitals NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,BEAT-CORONA: Building evidence to advance treatments for COVID-19,Clinical Presentation,No Intervention,No Intervention,10000,http://isrctn.com/ISRCTN89573163,None
1265,ChiCTR2000035060,ChiCTR,2020-07-29,2020-07-20,True,Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital),Not Recruiting,Not Applicable,Observational,China,Comprehensive mental and physical health assessment and intervention studies for novel coronavirus pneumonia (COVID-19) patients,Clinical Presentation,No Intervention,No Intervention,2000,http://www.chictr.org.cn/showproj.aspx?proj=57232,None
1266,ChiCTR2000029865,ChiCTR,2020-02-15,2020-02-20,False,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Descriptive study on the clinical characteristics and outcomes of novel coronavirus pneumonia (COVID-19) in cardiovascular patients,Prognosis,No Intervention,No Intervention,1200,http://www.chictr.org.cn/showproj.aspx?proj=49545,None
1267,EUCTR2020-002494-10-GB,EU Clinical Trials Register,2020-06-08,2020-07-17,False,Queen Mary University of London,Authorised,Phase 4,Interventional,United Kingdom,PERSONAL-COVIDBP,Drug,Amlodipine,Amlodipine,1000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002494-10,None
1268,EUCTR2020-002476-13-GB,EU Clinical Trials Register,2020-06-29,2020-07-24,False,Imperial College London,Authorised,Phase 2,Interventional,United Kingdom,A study to look at the safety and success of using Clazakizumab in patients who have kidney disease and COVID-19.,Drug,Clazakizumab,Clazakizumab,20,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002476-13,None
1269,EUCTR2020-002952-18-GB,EU Clinical Trials Register,2020-07-09,2020-07-21,False,Ashford and St. Peter's Hospitals NHS Foundation Trust,Authorised,Phase 2/Phase 3,Interventional,United Kingdom,DEFEAT-COVID Study,Drug,Leflunomide,Leflunomide,178,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002952-18,None
1270,EUCTR2020-002091-12-BG,EU Clinical Trials Register,2020-05-05,2020-05-15,False,Huvepharma EOOD,Authorised,Phase 2,Interventional,Bulgaria,Study of ivermectin against COVID-19,Drug,Ivermectin,Ivermectin,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002091-12,None
1271,ACTRN12620000787987,ANZCTR,2020-08-04,2020-09-30,False,UNSW Sydney,Not Recruiting,Not Applicable,Interventional,Australia,Effect of a Brief Problem Management Intervention on Anxiety and Depression Arising from COVID-19-Related Financial Stress,Other (psych),Psychological,Psychological,206,https://anzctr.org.au/ACTRN12620000787987.aspx,None
1272,ChiCTR2000035362,ChiCTR,2020-08-09,2020-08-17,False,"International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University",Not Recruiting,Not Applicable,Observational,China,Psychological health condition and effect of psychological couseling of infertile couples receiving ART during novel coronavirus pneumonia (COVID-19) pandemic,Other (psych),Psychological,Psychological,300,http://www.chictr.org.cn/showproj.aspx?proj=57875,None
1273,ChiCTR2000035342,ChiCTR,2020-08-09,2020-03-01,True,"Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Diagnostic test,China,Ultrafast Screening of novel coronavirus pneumonia (COVID-19) by Machine Learning Analysis of Exhaled NO,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,250,http://www.chictr.org.cn/showproj.aspx?proj=57431,None
1274,ChiCTR2000035213,ChiCTR,2020-08-03,2020-08-10,False,Peking University Third Hospital,Not Recruiting,Not Applicable,Health services research,No Country Given,"Evaluation of Knowledge, Attitude and Practice (KAP) of Pharmacists towards novel coronavirus pneumonia (COVID-19): A Cross-Sectional Study",Other,No Intervention,No Intervention,480,http://www.chictr.org.cn/showproj.aspx?proj=57283,None
1275,ChiCTR2000030259,ChiCTR,2020-02-26,2020-02-22,True,Shanghai Changzheng Hospital,Recruiting,Not Applicable,Interventional,China,"Evaluation Danoprevir sodium tablets combined with ritonavir in the treatment of novel coronavirus pneumonia (COVID-19): a randomized, open and controlled trial",Drug,Danoprevir + Ritonavir,Danoprevir; Ritonavir,60,http://www.chictr.org.cn/showproj.aspx?proj=49918,None
1276,ISRCTN60033461,ISRCTN,2020-07-31,2020-01-03,True,University of Oxford,Recruiting,Not Applicable,Observational,United Kingdom,Neonatal complications of coronavirus disease (COVID-19) study,Clinical Presentation,No Intervention,No Intervention,10000,http://isrctn.com/ISRCTN60033461,None
1277,ISRCTN21598625,ISRCTN,2020-07-30,2020-09-06,False,Swansea University,Not Recruiting,Not Applicable,Observational,United Kingdom,The impact of coronavirus on mental health and well-being in Wales,Other (psych),No Intervention,No Intervention,5500,http://isrctn.com/ISRCTN21598625,None
1278,ISRCTN17896927,ISRCTN,2020-07-27,2020-07-17,True,Yale University,Not Recruiting,Not Applicable,Interventional,United States,Encouraging behavior to reduce the spread of COVID-19,Other,Other,Other,3000,http://isrctn.com/ISRCTN17896927,None
1279,ISRCTN17072692,ISRCTN,2020-06-04,2020-06-16,False,Imperial College London,Recruiting,Phase 1,Interventional,United Kingdom,Clinical trial to assess the safety of a coronavirus vaccine in healthy men and women,ATMP,Vaccine,Vaccine,320,http://isrctn.com/ISRCTN17072692,None
1280,EUCTR2020-001417-21-BE,EU Clinical Trials Register,2020-04-01,2020-12-04,False,Institute of Tropical Medicine,Not Recruiting,Phase 2,Interventional,Belgium,An open label single center randomized controlled trial to evaluate the effect of hydroxychloroquine on viral shedding in mild COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,206,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001417-21,None
1281,EUCTR2020-002102-58-BE,EU Clinical Trials Register,2020-05-06,2020-12-06,False,CHU de Liege,Authorised,Phase 2,Interventional,Belgium,Therapy with stem cells for Patients with severe COVID-19 infection,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002102-58,None
1282,EUCTR2020-001770-30-BE,EU Clinical Trials Register,2020-04-15,2020-04-21,False,CHU Ambroise Paré,Not Recruiting,Phase 2,Interventional,Belgium,Experimental use of tocilizumab in COVID-19 related pneumonia.,Drug,Tocilizumab,Tocilizumab,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001770-30,None
1283,EUCTR2020-002574-27-FR,EU Clinical Trials Register,2020-06-15,2020-07-08,False,Nantes University Hospital,Authorised,Phase 1/Phase 2,Interventional,France,A study to evaluate the safety and efficacy of XAV-19 in patients with COVID-19 induced moderate pneumonia,Drug,XAV-19,XAV-19,368,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002574-27,None
1284,JPRN-jRCTs051200036,JPRN,2020-07-27,2020-07-27,False,Umemura Yutaka,Recruiting,Phase 2,Interventional,Japan,Efficacy  of nintedanib on severe COVID-19 pneumonia.,Drug,Nintedanib,Nintedanib,30,https://jrct.niph.go.jp/latest-detail/jRCTs051200036,None
1285,JPRN-UMIN000040333,JPRN,2020-05-08,2020-05-19,False,Kanagawa Physicians Association,Not Recruiting,Not Applicable,Observational,Japan,Fact-finding survey on subclinical infection of SARS-CoV-2 in Kanagawa Prefecture,Clinical Presentation,No Intervention,No Intervention,1500,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046025,None
1286,JPRN-UMIN000040602,JPRN,2020-06-01,2020-06-15,False,Federal University of São Carlos,Recruiting,Phase 2,Interventional,South America,Homeopathy for Covid-19 in primary care,Other,Homeopathy,Homeopathy,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046338,None
1287,JPRN-UMIN000040656,JPRN,2020-08-01,2020-08-01,False,Sapporo Medical University School of Medicine,Not Recruiting,Not Applicable,Observational,Japan,Multicenter registry study of Japanese patients with inflammatory bowel disease with COVID-19,Clinical Presentation,No Intervention,No Intervention,200,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046390,None
1288,JPRN-UMIN000041021,JPRN,2020-07-07,2020-07-13,False,Yokohama City University,Recruiting,Not Applicable,Observational,Japan,The association between the neutralizing activity and the amount of antibody in the convalescence stage of SARS-CoV-2 infection: A multicenter observational study,Clinical Presentation,No Intervention,No Intervention,140,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046800,None
1289,JPRN-UMIN000041073,JPRN,2020-07-12,2015-01-01,True,Shonan Kamakura General Hospital,Recruiting,Not Applicable,Observational,Japan,A study of changes in emergency department patient dynamics during the COVID-19 outbreak,Health System,No Intervention,No Intervention,100000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046864,None
1290,JPRN-UMIN000041102,JPRN,2020-07-14,2020-02-13,True,Osaka Saiseikai Nakatsu Hospital,Recruiting,Not Applicable,Observational,Japan,Reserch on patients with COVID-19 at Osaka Saiseikai Nakatsu Hospital,Clinical Presentation,No Intervention,No Intervention,1200,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045985,None
1291,JPRN-UMIN000041160,JPRN,2020-08-01,2020-08-27,False,St. Luke's International University Graduate School,Not Recruiting,Not Applicable,Interventional,Japan,Evaluation study of preventing exacerbations for home care patients with chronic diseases by using dual-monitoring-based telenursing system-a prospective longitudinal mixed methods study,Telehealth,Telehealth,Telehealth,42,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047000,None
1292,JPRN-UMIN000041186,JPRN,2020-07-23,2020-05-29,True,Keio University School of Medicine,Recruiting,Not Applicable,Observational,Japan,Survey of Coronavirus disease 2019(COVID-19),Clinical Presentation (Epidemiology),No Intervention,No Intervention,2000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047028,None
1293,JPRN-UMIN000041191,JPRN,2020-07-27,2020-07-28,False,Sapporo Medical University School of Medicine,Not Recruiting,Not Applicable,Observational,Japan,Questionnaire survey on anxiety and behavioral changes in Japanese patients with inflammatory bowel disease caused by the COVID-19 pandemic,Other (psych),No Intervention,No Intervention,2500,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047033,None
1294,JPRN-UMIN000041226,JPRN,2020-07-27,2020-07-08,True,Nippon Medical School,Recruiting,Not Applicable,Observational,Japan,Study of clinical characteristics of acute stroke with COVID-19,Clinical Presentation,No Intervention,No Intervention,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045903,None
1295,JPRN-UMIN000041301,JPRN,2020-08-04,2020-07-04,True,Tohoku University,Recruiting,Not Applicable,Observational,Japan,An observational study of the treatment of patients with mild and moderate COVID-19 (including suspected patients),Drug,Other,Other,1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047163,None
1296,ACTRN12620000786998,ANZCTR,2020-08-04,2020-08-24,False,University of Auckland,Not Recruiting,Not Applicable,Interventional,New Zealand,A Digital Companion for Loneliness During the COVID-19 Pandemic: A Feasibility Study,Other,Other,Other,30,https://anzctr.org.au/ACTRN12620000786998.aspx,None
1297,ACTRN12620000795998,ANZCTR,2020-08-07,2020-05-31,True,Monash University,Not Recruiting,Not Applicable,Interventional,Bangladesh,COVID-19 Health and wellbeing Trial in Bangladesh,Other (psych),Psychological,Psychological,2402,https://anzctr.org.au/ACTRN12620000795998.aspx,None
1298,ACTRN12620000799954,ANZCTR,2020-08-10,2020-08-25,False,Critical Care Research Group,Not Recruiting,Not Applicable,Observational,"Japan, Germany, Italy, Ireland, Hong Kong, Argentina, Brazil, South Africa, Australia, Spain, United States",Long-term Impact in Intensive Care Survivors of Coronavirus disease-19 (COVID-19),Clinical Presentation,No Intervention,No Intervention,200,https://anzctr.org.au/ACTRN12620000799954.aspx,None
1299,ACTRN12620000808943,ANZCTR,2020-08-11,2020-03-23,True,Maroondah Hospital,Recruiting,Not Applicable,Observational,Australia,A Patient Perspective Survey on Masking or De-Masking the Medical Staff amid COVID-19 Pandemic,Other,No Intervention,No Intervention,600,https://anzctr.org.au/ACTRN12620000808943.aspx,None
1300,ACTRN12620000811909,ANZCTR,2020-08-13,2020-09-30,False,UNSW Sydney,Not Recruiting,Not Applicable,Interventional,Australia,Effect of a Brief Mood Training Program on Anxiety and Depression Arising from COVID-19-Related Stress,Other (psych),Psychological,Psychological,240,https://anzctr.org.au/ACTRN12620000811909.aspx,None
1301,ChiCTR2000035691,ChiCTR,2020-08-16,2020-08-20,False,Hunan Provincial Center for Disease Control and Prevention,Not Recruiting,Phase 1,Prevention,China,"A randomized, double-blind, placebo-controlled phase I clinical trial for evaluation of the safety and tolerability of recombinant novel coronavirus vaccines (CHO cells) in healthy people aged 60 years and above",ATMP,Vaccine,Vaccine,50,http://www.chictr.org.cn/showproj.aspx?proj=58207,None
1302,ChiCTR2000035046,ChiCTR,2020-07-29,2020-02-04,True,920th Hospital of the PLA Joint Logistics Support Force,Recruiting,Not Applicable,Observational,China,Efficacy and outcomes of Lian-Hua Qing-Wen capsule in the treatment of novel coronavirus pneumonia (COVID-19): a medical records based retrospective study,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,147,http://www.chictr.org.cn/showproj.aspx?proj=57179,None
1303,ChiCTR2000032459,ChiCTR,2020-04-29,2020-04-29,False,Henan Provincial Center for Disease Control and Prevention,Recruiting,Phase 1/Phase 2,Interventional,China,A phase I/II clinical trial for inactivated novel coronavirus (2019-CoV) vaccine (Vero cells),ATMP,Vaccine,Vaccine,288,http://www.chictr.org.cn/showproj.aspx?proj=53003,None
1304,ChiCTR2000029822,ChiCTR,2020-02-14,2020-02-07,True,Nanjing Second Hospital,No Status Given,Not Applicable,Interventional,China,A randomized controlled trial for honeysuckle decoction in the treatment of patients with novel coronavirus (COVID-19) infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,110,http://www.chictr.org.cn/showproj.aspx?proj=49502,None
1305,ISRCTN15913068,ISRCTN,2020-08-07,2020-05-14,False,Revimmune,Recruiting,Phase 2,Interventional,United Kingdom,Study of investigational medicinal product CYT107 in patients with COVID-19 infection who have a low level of white blood cells in their blood (ILIAD 7 trial),Drug,CYT107,CYT107,48,http://isrctn.com/ISRCTN15913068,EUCTR2020-001786-36
1306,ISRCTN36352994,ISRCTN,2020-08-05,2019-01-01,True,Imperial College London,Recruiting,Not Applicable,Observational,United Kingdom,Sickness absence in NHS staff during the time of COVID-19,Health System,No Intervention,No Intervention,800000,http://isrctn.com/ISRCTN36352994,None
1307,ISRCTN58667920,ISRCTN,2020-08-04,2020-01-08,True,University of Leeds,Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 effects on the heart,Clinical Presentation,No Intervention,No Intervention,370,http://isrctn.com/ISRCTN58667920,None
1308,ISRCTN17782018,ISRCTN,2020-07-31,2020-05-08,True,Cardiff University,Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 cancer attitudes and behaviour study,Other,No Intervention,No Intervention,3535,http://isrctn.com/ISRCTN17782018,None
1309,ISRCTN16561225,ISRCTN,2020-07-27,2020-04-24,True,King's College London,Recruiting,Not Applicable,Observational,"Portugal, India, Ireland, Canada, Argentina, Netherlands, Brazil, Switzerland, United Kingdom, South Africa, Australia",CovPall: Improving palliative care for people affected by the COVID-19 pandemic by sharing learning â€“ the national and international response,Other,No Intervention,No Intervention,200,http://isrctn.com/ISRCTN16561225,None
1310,ISRCTN17717312,ISRCTN,2020-07-23,2020-07-30,False,Cambridge University Hospitals NHS Foundation Trust,Recruiting,Not Applicable,Observational,"Pitcairn, Korea, South, Liechtenstein, Algeria, Mozambique, Isle of Man, Cambodia, Sint Maarten (Dutch part), Bahrain, Guadeloupe, Turks and Caicos Islands, United Arab Emirates, Gabon, Palau, Chile, Kazakhstan, Russian Federation, Zambia, Reunion, Barbados, Saint Vincent and the Grenadines, South Georgia and the South Sandwich Is, Moldova, Belarus, Czech Republic, Anguilla, Macao, Tunisia, Bolivia, Macedonia, Nicaragua, Azerbaijan, Sri Lanka, Israel, Heard Island and Mcdonald Islands, Solomon Islands, Marshall Islands, Burundi, Bhutan, Mayotte, Hungary, Saint Helena, United States Minor Outlying Islands, Norway, Curacao, Malaysia, Comoros, Gambia, Paraguay, Seychelles, Thailand, France, Christmas Island, Greenland, Somalia, Aruba, Togo, Turkey, South Africa, Ukraine, Uzbekistan, Haiti, Finland, Monaco, Bermuda, Cuba, Belize, Suriname, Tajikistan, Bahamas, Montserrat, Saint Barthelemy, Argentina, Kosovo, Qatar, Uganda, Bulgaria, Korea, North, Central African Republic, Liberia, India, Bosnia and Herzegovina, Germany, Cyprus, Venezuela, Netherlands, Yemen, Cocos (Keeling) Islands, Madagascar, Chad, Guinea, Croatia, Andorra, Guatemala, Pakistan, Benin, Slovakia, Guinea-Bissau, Hong Kong, Ireland, Puerto Rico, Svalbard and Jan Mayen, Martinique, Costa Rica, Saint Pierre and Miquelon, Iraq, Burkina Faso, Bonaire Saint Eustatius and Saba, Virgin Islands, British, Jersey, Singapore, Belgium, Bouvet Island, Maldives, Panama, Falkland Islands, Bangladesh, Iran, Sweden, Syria, Ecuador, Jordan, Lesotho, Taiwan, French Guiana, China, Faroe Islands, French Southern Territories, Rwanda, Tuvalu, Saint Lucia, Niger, Slovenia, United States, Eritrea, Honduras, Angola, Cayman Islands, Albania, San Marino, Poland, Canada, Swaziland, Nauru, Sierra Leone, Estonia, Laos, Sao Tome and Principe, South Sudan, Portugal, Mongolia, Nigeria, Philippines, Greece, Latvia, Tonga, Cameroon, Democratic Republic of Congo, Georgia, Fiji, Trinidad and Tobago, French Polynesia, Saint Kitts and Nevis, Netherlands Antilles, Palestinian Territory, Niue, Holy See (Vatican City State), Lebanon, Botswana, Morocco, Equatorial Guinea, Mali, New Zealand, Northern Mariana Islands, Kyrgyzstan, Kuwait, Guernsey, Nepal, Uruguay, Austria, Samoa, Malawi, Serbia, Spain, Tokelau, Zimbabwe, Ghana, Luxembourg, Myanmar, Mexico, Mauritania, Timor-Leste, Iceland, Cook Islands, Democratic Republic of Congo, Romania, Kenya, British Indian Ocean Territory, Antigua and Barbuda, Aland Islands, Gibraltar, Ethiopia, Italy, Kiribati, Lithuania, Malta, Saudi Arabia, Brazil, Armenia, Peru, Antarctica, Australia, Vietnam, Mauritius, Norfolk Island, Japan, Tanzania, Western Sahara, Afghanistan, Guam, New Caledonia, Saint Martin (French part), Oman, Indonesia, Micronesia, Federated States of, Senegal, Switzerland, Namibia, Denmark, Djibouti, Libya, Cape Verde, Colombia, Egypt, American Samoa, Wallis and Futuna, Turkmenistan, Vanuatu, Virgin Islands, U.S., Jamaica, Papua New Guinea, Dominican Republic, Guyana, Montenegro, Dominica, El Salvador, Cote d'Ivoire, Brunei, Sudan, Grenada",CORONATION: Coronavirus (COVID-19) multinational observational registry,Clinical Presentation,No Intervention,No Intervention,10000,http://isrctn.com/ISRCTN17717312,None
1311,ISRCTN48734830,ISRCTN,2020-07-10,2020-03-08,True,Stockholm South General Hospital,Recruiting,Phase 4,Interventional,Sweden,Using the blood pressure medication losartan to improve outcomes for patients with SARS CoV-2,Drug,Losartan,Losartan,750,http://isrctn.com/ISRCTN48734830,None
1312,ISRCTN14025343,ISRCTN,2020-07-02,2020-04-16,True,IMDEA Food,Not Recruiting,Not Applicable,Observational,"Colombia, Chile, Italy, Brazil, Spain",Lifestyle modification of adolescents from different countries during confinement by Covid-19,Other,No Intervention,No Intervention,500,http://isrctn.com/ISRCTN14025343,None
1313,ISRCTN60400862,ISRCTN,2020-06-22,2020-05-15,True,Abbott,Not Recruiting,Not Applicable,Observational,United Kingdom,"Evaluation of a COVID-19 antibody test: What is the performance of the Panbioâ„¢ COVID-19 IgG/IgM rapid test device in fingerstick blood, venous whole blood, serum and plasma in adult participants?",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,206,http://isrctn.com/ISRCTN60400862,None
1314,ISRCTN16912075,ISRCTN,2020-04-06,2020-06-04,False,University of Warwick,Recruiting,Not Applicable,Interventional,United Kingdom,"RECOVERY Respiratory Support: Respiratory Strategies in patients with coronavirus COVID-19 â€“ CPAP, high-flow nasal oxygen, and standard care",Drug,Oxygen,Oxygen,4002,http://isrctn.com/ISRCTN16912075,None
1315,ISRCTN13694948,ISRCTN,2020-04-01,2020-02-04,True,"University Hospital, Bern",Recruiting,Not Applicable,Observational,"Sweden, Liechtenstein, Isle of Man, Luxembourg, French Southern Territories, Bulgaria, Slovenia, United States, Germany, Lithuania, Cyprus, Italy, Malta, Netherlands, Brazil, Australia, Czech Republic, Portugal, Croatia, Greece, Slovakia, Israel, Ireland, Switzerland, Lebanon, Denmark, Norway, New Zealand, France, Belgium, Turkey, United Kingdom, Austria, South Africa, Spain, Finland",Distress and resilience of healthcare professionals during the COVID-19 (coronavirus) pandemic,Other (psych),No Intervention,No Intervention,400,http://isrctn.com/ISRCTN13694948,None
1316,ISRCTN55201674,ISRCTN,2018-09-24,2018-06-08,True,Salford Royal NHS Foundation Trust,Not Recruiting,Not Applicable,Observational,United Kingdom,B-cells in stroke-associated infection,Not relevant,Not relevant,Not relevant,130,http://isrctn.com/ISRCTN55201674,None
1317,IRCT20180725040596N2,IRCT,2020-04-18,2020-04-29,False,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Arbidol in treatment of COVID-19,Drug,Umifenovir + Hydroxychloroquine vs. Lopinavir/ritonavir vs. Hydroxychloroquine,Umifenovir; Hydroxychloroquine; Lopinavir/ritonavir,100,http://en.irct.ir/trial/46897,None
1318,IRCT20200408046987N1,IRCT,2020-04-27,2020-05-04,False,Chistasazan Notash Fartak Company Limited.,Not Recruiting,Phase 3,Interventional,Iran,Dose-Finding Study of Ivermectin in the Treatment of COVID-19,Drug,Ivermectin,Ivermectin,125,http://en.irct.ir/trial/47012,None
1319,IRCT20200404046937N2,IRCT,2020-04-13,2020-04-13,False,Ahvaz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluating the effect of Phyllanthus Emblica on COVID 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/47016,None
1320,IRCT20200414047076N1,IRCT,2020-08-01,2020-04-18,True,Esfahan University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Evaluate the efficacy of hydroxychloroquine in the prevention of SARS-COV2 infection in high risk health care workers,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,160,http://en.irct.ir/trial/47286,None
1321,IRCT20170922036314N4,IRCT,2020-06-22,2020-07-10,False,Mashhad University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,"The effects of self-care cellphone application on stress, anxiety and depression among admitted patients with COVID-19",Other (psych),Psychological,Psychological,112,http://en.irct.ir/trial/47383,None
1322,IRCT20200503047281N1,IRCT,2020-07-25,2020-09-22,False,Yazd Shahid Sadoughi University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Evaluation of Convalescent Plasma Therapy for COVID-19 Patients,ATMP,Plasma,Plasma,40,http://en.irct.ir/trial/47632,None
1323,IRCT20200505047318N1,IRCT,2020-08-06,2020-03-20,True,Qazvin University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of finasterid on COVID-19 treatment,Drug,Finasterid + Hydroxychloroquine + Ceftriaxone vs. Hydroxychloroquine + Ceftriaxone,Finasterid; Hydroxychloroquine; Ceftriaxone,80,http://en.irct.ir/trial/48007,None
1324,IRCT20110907007511N4,IRCT,2020-07-25,2020-05-16,True,Gorgan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Lavender syrup on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://en.irct.ir/trial/48013,None
1325,IRCT20200511047399N1,IRCT,2020-07-23,2020-02-20,True,Tehran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of omega-3 on diabetic patients with Covid-19,Drug,Omega 3,Omega 3,30,http://en.irct.ir/trial/48045,None
1326,IRCT20200522047545N1,IRCT,2020-08-05,2020-07-31,True,Tabriz University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,"Evaluation of herbal compound containing Anacyclus pyrethrum, Senna, Ferrula asafoetida and Terminalia chebula in COVID19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://en.irct.ir/trial/48351,None
1327,IRCT20200522047542N1,IRCT,2020-08-04,2020-07-18,True,Mashhad University of Medical Sciences,Recruiting,Phase 1,Interventional,Iran,Effect of Corton on olfactory dysfunction in COVID-19 patients,Drug,Corticosteroids,Mometasone,70,http://en.irct.ir/trial/48379,None
1328,IRCT20080901001165N58,IRCT,2020-05-27,2020-04-29,True,Bagheiat-allah University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Investigating the efficacy and safety of Plasmapheresis in patients with Moderate to severe COVID-19,ATMP,Plasma,Plasma,100,http://en.irct.ir/trial/48394,None
1329,IRCT20200525047570N1,IRCT,2020-07-30,2020-07-31,False,Tabriz University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,"A comparative study of the effects of Tocilizumab?, interferon-gamma and vitamin C on the recovery of critically ill Covid-19 patients and cytokine storm",Drug,Tocilizumab vs. Interferon gamma + Vitamine C,Tocilizumab; Interferon gamma; Vitamine C,60,http://en.irct.ir/trial/48583,None
1330,IRCT20200607047682N1,IRCT,2020-07-27,2020-06-09,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Clinical trial of Annual SZ drug in Covid-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/48727,None
1331,IRCT20200610047722N1,IRCT,2020-07-07,2020-06-21,True,Hossein Nik Tale,Not Recruiting,Not Applicable,Interventional,Iran,?Effect of Allicin derivatives capsule in treatment of patients with new Coronavirus,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://en.irct.ir/trial/48869,None
1332,IRCT20190602043787N3,IRCT,2020-07-20,2020-07-22,False,Mashhad University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Ivermectin effect in the treatment of patients with covid-19,Drug,Ivermectin vs. Hydroxychloroquine,Ivermectin; Hydroxychloroquine,40,http://en.irct.ir/trial/49180,None
1333,IRCT20190624043993N3,IRCT,2020-07-23,2020-08-22,False,Kermanshah University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The evaluation of isotretinoineffects on treatment of COVID-19 infections,Drug,Isotretinoin,Isotretinoin,50,http://en.irct.ir/trial/49257,None
1334,IRCT20190624043993N2,IRCT,2020-07-12,2020-08-22,False,Kermanshah University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of ivermectin effects on Covid-19,Drug,Ivermectin,Ivermectin,50,http://en.irct.ir/trial/49280,None
1335,IRCT20200105046009N4,IRCT,2020-07-18,2020-06-30,True,Babol University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,management of the  pulmonary diseases based on Persian medicine in patients infected with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/49365,None
1336,IRCT20200506047323N3,IRCT,2020-07-22,2020-07-25,False,Bandare-abbas University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effects of Favipiravir and Lopinavir/Ritonavir in treatment COVID-19,Drug,Favipiravir + Lopinavir/ritonavir vs Lopinavir/ritonavir,Favipiravir; Lopinavir/ritonavir,60,http://en.irct.ir/trial/49463,None
1337,IRCT20200705048013N1,IRCT,2020-07-19,2020-02-20,True,Karaj University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of Pentoxifylline in patients with Covid-19,Drug,Pentoxifylline vs. Vitamin D + Hydroxychloroquine,Pentoxifylline; Vitamin D; Hydroxychloroquine,150,http://en.irct.ir/trial/49525,None
1338,IRCT20190406043175N3,IRCT,2020-07-12,2020-08-22,False,Mashhad University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,The effect of diet based on traditional medicine on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/49530,None
1339,IRCT20170117032025N7,IRCT,2020-07-12,2020-07-11,True,Hamedan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effectiveness of Mouthwashes in Early Reducing the mouth Viral Load Among COVID-19 Patients,Drug,Povidone Iodine,Povidone Iodine,60,http://en.irct.ir/trial/49534,None
1340,IRCT20190415043279N6,IRCT,2020-07-24,2020-07-10,True,Sanandaj University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Afsantin on COVID 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/49544,None
1341,IRCT20200426047206N3,IRCT,2020-07-21,2020-07-22,False,Hamedan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of Cyclosporine in prognosis and clinical improvement in patients with COVID-19,Drug,Cyclosporine,Cyclosporine,48,http://en.irct.ir/trial/49579,None
1342,IRCT20200408046990N3,IRCT,2020-07-16,2020-07-21,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,"Evaluation of atorvastatin tablet as an adjuvant treatment for patients with mild to moderate COVID-19 in Qaem Hospital, Mashhad",Drug,Atorvostatin,Atorvostatin,40,http://en.irct.ir/trial/49629,None
1343,IRCT20151227025726N20,IRCT,2020-07-26,2020-07-09,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluating the effects of intravenous immunoglobulin (IVIG) in COVID-19 patients,ATMP,Immunoglobulin,Immunoglobulin,80,http://en.irct.ir/trial/49638,None
1344,IRCT20101020004976N6,IRCT,2020-07-18,2020-05-14,True,Mashhad University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of  LactocareÂ® synbiotic on the prevention of COVID-19 infection in the staff of emergency department,Supplement,Probiotics,Probiotics,80,http://en.irct.ir/trial/49670,None
1345,IRCT20180513039641N2,IRCT,2020-07-27,2020-07-26,True,Ghoum University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Determination of dandelion capsule on patient with Covid-19 virus,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/49803,None
1346,IRCT20200506047323N4,IRCT,2020-08-01,2020-08-10,False,Bandare-abbas University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Desferal in COVID-19,Drug,Deferoxamine vs. Hydroxychloroquine,Deferoxamine; Hydroxychloroquine,60,http://en.irct.ir/trial/49881,None
1347,IRCT20200723048178N1,IRCT,2020-07-28,2020-07-28,False,Shaheed Zulfiqar Ali Bhutto Medical University,Recruiting,Not Applicable,Interventional,Pakistan,nimesulide in COVID-19 infection,Drug,Nimesulide,Nimesulide,60,http://en.irct.ir/trial/49901,None
1348,IRCT20160131026298N4,IRCT,2020-08-04,2020-04-20,True,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of the effectiveness of Cyclotide complex herbal syrup in preventing COVID-19 virus in exposed individuals,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/49925,None
1349,IRCT20200404046937N4,IRCT,2020-08-06,2020-07-30,True,Ahvaz University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Evaluating the effect of Ivermectin on covid 19 patients,Drug,Ivermectin,Ivermectin,60,http://en.irct.ir/trial/49935,None
1350,KCT0005307,CRIS,2020-08-11,2020-09-30,False,Dong-A University Hospital,Recruiting,Phase 2,Interventional,South Korea,AN OPEN LABEL PHYSICIAN INITIATED 28 DAY PHASE 2A STUDY OF IFENPRODIL ON LUNG FUNCTION IN CONFIRMED COVID-19 INFECTED PATIENTS WITH SEVERE PNEUMONIA,Drug,Ifenprodil,Ifenprodil,40,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=17062,None
1351,KCT0005226,CRIS,2020-07-13,2020-03-23,True,"Yonsei University Health System, Gangnam Severance Hospital",Not Recruiting,Not Applicable,Observational,South Korea,Clinical characteristics and disease progression in early-stage COVID-19 patients in South Korea,Clinical Presentation,No Intervention,No Intervention,293,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16997,None
1352,EUCTR2020-001333-13-FR,EU Clinical Trials Register,2020-04-02,2020-09-04,False,Groupe Hospitalier Paris Saint-Joseph,Not Recruiting,Phase 3,Interventional,France,Dexamethasone associated with hydroxychloroquine vs. hydroxychloroquine alone for the early treatment of severe ARDS caused by COVID-19 : a randomized controlled trial,Drug,Dexamethasone + hydroxychloroquine vs. hydroxychloroquine,Dexamethasone; hydroxychloroquine,122,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001333-13,None
1353,EUCTR2020-002038-33-FI,EU Clinical Trials Register,2020-06-26,2020-07-16,False,Porin Kaupunki,Authorised,Phase 2,Interventional,Finland,Trial of hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting,Drug,Hydroxychloroquine,Hydroxychloroquine,600,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002038-33,None
1354,EUCTR2020-002458-25-IT,EU Clinical Trials Register,2020-08-10,2020-06-23,True,IRCCS Ospedale San Raffaele,Authorised,Phase 2,Interventional,Italy,"Clinical study for the treatment with Interferon-ÃŸ-1a (IFNÃŸ-1a) of COVID-19 patients: randomized, controlled, open label",Drug,Interferon beta,Interferon beta,126,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002458-25,None
1355,EUCTR2020-002283-32-IT,EU Clinical Trials Register,2020-08-10,2020-12-06,False,IRCCS Don Calabria Ospedale Sacro Cuore,Authorised,Phase 2,Interventional,"Spain, Italy","Randomized, Double-blind, Multi Centre Phase II, Dose Finding Clinical Trial on Ivermectin for the early Treatment of COVID-19",Drug,Ivermectin,Ivermectin,122,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002283-32,None
1356,EUCTR2020-001739-28-BE,EU Clinical Trials Register,2020-04-10,2020-05-20,False,UZ Leuven,Authorised,Phase 2,Interventional,Belgium,"A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19.

",Drug,"Aprotinin, Heparin, Anakinra, Nadroparin",Aprotinin; Heparin; Anakinra; Nadroparin,210,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001739-28,None
1357,ACTRN12618000245291,ANZCTR,2018-02-15,2018-04-06,False,Queensland University of Technology,Not Recruiting,Not Applicable,Interventional,Australia,Autologous skin cell suspension in partial thickness paediatric burns: The BRACS Randomised Trial.,Not relevant,Not relevant,Not relevant,84,https://anzctr.org.au/ACTRN12618000245291.aspx,None
1358,ACTRN12620000816954,ANZCTR,2020-08-14,2020-08-17,False,Atossa Therapeutics Inc,Not Recruiting,Phase 1,Interventional,Australia,"A Double-blinded, Randomised, and Placebo-controlled Safety Study of AT-301 Nasal Spray in Healthy Adults",Drug,AT-301,AT-301,32,https://anzctr.org.au/ACTRN12620000816954.aspx,None
1359,ISRCTN12154994,ISRCTN,2020-08-14,2020-06-29,True,Aga Khan University Hospital,Recruiting,Not Applicable,Observational,Kenya,Investigating the impact of coronavirus infection (COVID-19) on cardiovascular injury using multiple imaging methods,Clinical Presentation,No Intervention,No Intervention,50,http://isrctn.com/ISRCTN12154994,None
1360,ISRCTN15634328,ISRCTN,2020-08-13,2020-02-06,True,Abbott,Recruiting,Not Applicable,Observational,United Kingdom,"
                Coronavirus (COVID-19) antibody response in healthcare staff: What proportion of healthcare staff have COVID-19 antibodies? How long do the antibodies last? Do the antibodies protect against recurring infection?

",Clinical Presentation (Epidemiology),No Intervention,No Intervention,2000,http://isrctn.com/ISRCTN15634328,None
1361,ISRCTN40302986,ISRCTN,2020-05-26,2020-06-22,False,Lagos University Teaching Hospital,Recruiting,Phase 3,Interventional,Nigeria,Does ivermectin cure and/or prevent COVID-19?,Drug (+ Chemoprophylaxis),Ivermectin,Ivermectin,45,http://isrctn.com/ISRCTN40302986,None
1362,ISRCTN20867558,ISRCTN,2020-05-04,2020-08-15,False,University of Southampton,Recruiting,Not Applicable,Observational,United Kingdom,Survive and Thrive: exploring the wellbeing of doctors in a post-COVID-19 era,Other (psych),No Intervention,No Intervention,350,http://isrctn.com/ISRCTN20867558,None
1363,ChiCTR2000035907,ChiCTR,2020-08-19,2020-01-31,True,West China Hospital of Sichuan University,Not Recruiting,Not Applicable,Observational,China,The Efficacy of Early Prone or Lateral Positioning in Severe COVID-19 Patients: a Single-Center Prospective Cohort Study,Procedure,Positioning,Positioning,197,http://www.chictr.org.cn/showproj.aspx?proj=57893,None
1364,NCT04525118,ClinicalTrials.gov,2020-07-29,2020-09-01,False,Boston Children's Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Wide Scale Monitoring for Acute Respiratory Infection Using a Mobile-based Study Platform,Other (software),eHealth,eHealth,100000,https://clinicaltrials.gov/show/NCT04525118,None
1365,ACTRN12620000840987,ANZCTR,2020-08-26,2020-05-05,True,Royal Perth Hospital,Recruiting,Phase 1,Interventional,Australia,Mesenchymal stromal cell (MSC) therapy for COVID-19 pneumonia,ATMP,Cells (mesenchymal),Cells (mesenchymal),10,https://anzctr.org.au/ACTRN12620000840987.aspx,None
1366,ACTRN12620000854932,ANZCTR,2020-08-27,2020-08-18,True,"St. Vincents Hospital, Sydney",Recruiting,Not Applicable,Observational,Australia,"ADAPT-C Sub-Study: Community-based cohort of people tested for COVID-19
",Clinical Presentation,No Intervention,No Intervention,150,https://anzctr.org.au/ACTRN12620000854932.aspx,None
1367,ACTRN12620000843954,ANZCTR,2020-08-26,2020-01-09,True,Peter MacCallum Cancer Centre,Not Recruiting,Phase 3,Interventional,Australia,"C-SMART.
COVID-19 Prevention and Treatment in Cancer. Arm 1 : Prevention in patients not infected with COVID-19.",Drug,"Interferon alpha, lenzilumab, selinexor",Interferon alpha; lenzilumab; selinexor,1914,https://anzctr.org.au/ACTRN12620000843954.aspx,None
1368,ACTRN12620000842965,ANZCTR,2020-08-26,2020-01-09,True,Peter MacCallum Cancer Centre,Not Recruiting,Phase 3,Interventional,Australia,"C-SMART.
COVID-19 Prevention and Treatment in Cancer. 
Arm 2 : Post-exposure prevention in patients recently exposed to COVID-19",Drug,"Interferon alpha, lenzilumab, selinexor",Interferon alpha; lenzilumab; selinexor,170,https://anzctr.org.au/ACTRN12620000842965.aspx,None
1369,ACTRN12620000841976,ANZCTR,2020-08-26,2020-01-09,True,Peter MacCallum Cancer Centre,Not Recruiting,Phase 3,Interventional,Australia,"C-SMART.
COVID-19 Prevention and Treatment in Cancer. 
Arm 3: treatment among cancer patients with moderate COVID-19 infection.",Drug,"Interferon alpha, lenzilumab, selinexor",Interferon alpha; lenzilumab; selinexor,126,https://anzctr.org.au/ACTRN12620000841976.aspx,None
1370,ACTRN12620000844943,ANZCTR,2020-08-26,2020-01-09,True,Peter MacCallum Cancer Centre,Not Recruiting,Phase 3,Interventional,Australia,"C-SMART.
COVID-19 Prevention and Treatment in Cancer
Arm 4: treatment among cancer patients with severe COVID-19 infection.",Drug,"Interferon alpha, lenzilumab, selinexor",Interferon alpha; lenzilumab; selinexor,72,https://anzctr.org.au/ACTRN12620000844943.aspx,None
1371,ISRCTN93266696,ISRCTN,2020-06-11,2020-05-20,True,Queen Mary University of London,Recruiting,Not Applicable,Observational,United Kingdom,Studying the immune response and long-term morbidity of COVID-19 infection in pregnancy,Clinical Presentation,No Intervention,No Intervention,200,http://isrctn.com/ISRCTN93266696,None
1372,ISRCTN10666798,ISRCTN,2020-04-23,2020-03-18,True,North Bristol NHS Trust,Recruiting,Not Applicable,Observational,"United Kingdom, Ireland",The COVID-19 Emergency Response Assessment Study: a survey of the psychological health of frontline doctors in the UK and Ireland during the coronavirus pandemic,Other (psych),No Intervention,No Intervention,6000,http://isrctn.com/ISRCTN10666798,None
1373,ISRCTN72343080,ISRCTN,2011-06-10,2011-06-14,False,Covidien,Not Recruiting,Not Applicable,Interventional,"Sweden, Germany, Italy, France, Poland, Belgium",Aneurysm Embolization System (AES) for treatment of intracranial aneurysms,Not relevant,Not relevant,Not relevant,63,http://isrctn.com/ISRCTN72343080,None
1374,ChiCTR2000035985,ChiCTR,2020-08-21,2020-10-01,False,ShuGuang Hospital,Not Recruiting,Not Applicable,Diagnostic test,China,A clinical study based on novel Coronavirus intelligent robot for nasopharyngeal swab sampling,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,550,http://www.chictr.org.cn/showproj.aspx?proj=59191,None
1375,ChiCTR2000035633,ChiCTR,2020-08-15,2020-11-13,False,Shanghai Public Health Clinical Center,Not Recruiting,Not Applicable,Interventional,China,"Clinical study of safety, tolerance, and pharmacokinetics of nebulizer (INF-K + anti-inflammatory factor TFF2) in healthy volunteers and exploration of PK/PD fitting modeling in clinical trials of Novel Coronavirus Pneumonia (COVID-19) patients",Drug,Interferon kappa + TFF2,Interferon kappa; TFF2,32,http://www.chictr.org.cn/showproj.aspx?proj=57741,None
1376,ChiCTR2000032165,ChiCTR,2020-04-21,2020-04-25,False,Hubei Hospital of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,"A multicenter, randomized, double-blind, parallel-controlled trial for Qi-Mai-Fei-Luo-Ping Mixture in the improvement of lung function of novel coronavirus pneumonia (COVID-19) in the convalescent period",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,160,http://www.chictr.org.cn/showproj.aspx?proj=52679,None
1377,EUCTR2020-001408-41-DE,EU Clinical Trials Register,2020-04-07,2020-04-21,True,"University Hospital, Freiburg",Not Recruiting,Phase 2,Interventional,Germany,Evaluation of efficacy and safety of an tocilizumab treatment in patients with severe COVID-19 pneumonia,Drug,Tocilizumab,Tocilizumab,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001408-41,DRKS00021238
1378,ACTRN12620000876998,ANZCTR,2020-09-03,2020-08-14,True,University of New South Wales,Recruiting,Not Applicable,Interventional,Australia,The Building Educatorsâ€™ Skills in Adolescent Mental Health (BEAM) study: A cluster randomised-controlled trial of an adolescent mental health training program for secondary school Educators,Other (psych),Psychological,Psychological,234,https://anzctr.org.au/ACTRN12620000876998.aspx,None
1379,ACTRN12620000869976,ANZCTR,2020-08-31,2020-04-27,True,Westmead Hospital,Not Recruiting,Not Applicable,Observational,Australia,Management of early breast cancer during the COVID-19 pandemic: Single institution experience,Other,No Intervention,No Intervention,150,https://anzctr.org.au/ACTRN12620000869976.aspx,None
1380,ISRCTN89159899,ISRCTN,2020-08-21,2020-04-14,True,Liverpool School of Tropical Medicine,Recruiting,Not Applicable,Observational,United Kingdom,Evaluation of a rapid COVID-19 test (FASTER),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,400,http://isrctn.com/ISRCTN89159899,None
1381,ISRCTN33260034,ISRCTN,2020-08-20,2020-10-20,True,University of Oxford,Recruiting,Phase 2,Interventional,United Kingdom,Adalimumab for coronavirus in community care,Drug,Adalimumab,Adalimumab,750,http://isrctn.com/ISRCTN33260034,EUCTR2020-003628-18
1382,ISRCTN14226970,ISRCTN,2020-07-20,2020-04-06,True,University of Oxford,Recruiting,Not Applicable,Observational,United Kingdom,Rapid community testing for COVID-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,2000,http://isrctn.com/ISRCTN14226970,None
1383,ISRCTN99248812,ISRCTN,2020-05-29,2020-05-30,False,University of Oxford,Not Recruiting,Not Applicable,Interventional,United Kingdom,Peer support training for adolescents during the COVID-19 outbreak,Other (psych),Psychological,Psychological,100,http://isrctn.com/ISRCTN99248812,None
1384,EUCTR2020-002394-94-BE,EU Clinical Trials Register,2020-06-04,2020-06-22,False,Dr. De Backer Wilfried BV,Authorised,Phase 2,Interventional,Belgium,"Pulsed, inhaled nitric oxide (iNO) for the treatment of patients with mild or
moderate corona virus disease (COVID-19)",Drug,Nitric oxide,Nitric oxide,6,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002394-94,None
1385,JPRN-JapicCTI-205238,JPRN,2020-03-27,2020-03-31,False,"FUJIFILM Toyama Chemical Co., Ltd.",Not Recruiting,Phase 3,Interventional,Japan,Phase 3 Clinical Study of Favipiravir in Patients with COVID-19 Non-Severe Pneumonia,Drug,Favipiravir,Favipiravir,96,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205238,None
1386,JPRN-JapicCTI-205416,JPRN,2020-08-19,2020-01-09,True,"Rohto Pharmaceutical Co., Ltd.",Not Recruiting,Phase 1,Interventional,Japan,An Exploratory Study of ADR-001 in Patients with Severe Pneumonia caused by SARS-CoV-2 infection (COVID-19),Drug,ADR-001,ADR-001,6,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205416,None
1387,JPRN-jRCT1032200025,JPRN,2020-05-01,2020-01-05,True,Watanabe Yoshiyuki,Not Recruiting,Not Applicable,Observational,Japan,new SARS-CoV-2 detection system (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://jrct.niph.go.jp/latest-detail/jRCT1032200025,None
1388,JPRN-jRCT2071200023,JPRN,2020-07-21,2020-07-22,False,Miyazaki Taiga,Recruiting,Phase 1/Phase 2,Interventional,Japan,Evaluation of Nelfinavir for asymptomatic and mild COVID-19,Drug,Nelfinavir,Nelfinavir,120,https://jrct.niph.go.jp/latest-detail/jRCT2071200023,None
1389,JPRN-jRCTs021200020,JPRN,2020-08-25,2020-08-25,False,Takayama Takayama Shin,Recruiting,Phase 3,Interventional,Japan,Study of the additional effect of Kampo medicine on common cold symptoms in COVID-19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,150,https://jrct.niph.go.jp/latest-detail/jRCTs021200020,None
1390,JPRN-jRCTs041190120,JPRN,2020-03-02,2020-02-03,True,Doi Yohei,Not Recruiting,Phase 2,Interventional,Japan,Favipiravir for SARS-CoV-infected patients,Drug,Favipiravir,Favipiravir,86,https://jrct.niph.go.jp/latest-detail/jRCTs041190120,None
1391,JPRN-UMIN000040453,JPRN,2020-05-25,2020-05-25,False,Daini Osaka Police Hospital,Recruiting,Not Applicable,Observational,Japan,Corona virus disease 2019 (COVID-19) antibody seroprevalence of the medical staff in the hospital with cluster of COVID-19.,Clinical Presentation (Epidemiology),No Intervention,No Intervention,2500,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046159,None
1392,JPRN-UMIN000040598,JPRN,2020-06-01,2020-01-01,True,Toho University Faculty of Medicine,Recruiting,Not Applicable,Observational,Japan,Clinical Outcomes of COVID-19 Infection in Hospitalized Patients with Cardiovascular Diseases and/or Risk Factors: CLAVIS-COVID,Clinical Presentation,No Intervention,No Intervention,1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046132,None
1393,JPRN-UMIN000040837,JPRN,2020-06-24,2020-05-27,True,Tokyo Dental College Ichikawa General Hospital,Not Recruiting,Not Applicable,Interventional,Japan,A Randomized Controlled trial Investigating the Effectiveness of VR(Virtual Reality)-based Cognitive Behavioral Therapy (VR-CBT) for Adult Depression in the Covid-19 Pandemic,Other (psych),Psychological,Psychological,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046623,None
1394,JPRN-UMIN000041276,JPRN,2020-09-01,2020-09-01,False,National Hospital Organization Tokyo Medical Center,Not Recruiting,Not Applicable,Observational,Japan,Post-Intensive Care outcomeS of patients with COronaVIrus Disease 2019; PICS-COVID study,Clinical Presentation,No Intervention,No Intervention,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047140,None
1395,JPRN-UMIN000041402,JPRN,2020-09-01,2020-09-01,False,Okayama University,Not Recruiting,Not Applicable,Observational,Japan,Investigation for clinical utility of diagnostic reagents for COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,300,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047146,None
1396,JPRN-UMIN000041430,JPRN,2020-08-16,2020-07-30,True,Airlangga University,Recruiting,Not Applicable,Other,Asia(except Japan),Benefit and Harm of Angiotensin Converting Enzyme Inhibitor and Angiotensin Receptor Blocker in COVID-19 Patients: A Review Protocol of Systematic Review and Meta-Analysis,Not relevant,Not relevant,Not relevant,Not Available,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046347,None
1397,JPRN-UMIN000041450,JPRN,2020-08-20,2020-05-12,True,Hiroshima University,Recruiting,Not Applicable,Observational,Japan,Epidemiological survey of COVID-19 patients in Japan,Clinical Presentation (Epidemiology),No Intervention,No Intervention,10000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047316,None
1398,JPRN-UMIN000041557,JPRN,2020-09-01,2020-09-01,False,Tohoku University,Not Recruiting,Not Applicable,Observational,Japan,Study to establish effective measures for COVID-19 in psychiatric medical institutes,Other (psych),No Intervention,No Intervention,150,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047450,None
1399,JPRN-UMIN000041579,JPRN,2020-08-28,2020-06-01,True,Fukuoka Children's Hospital,Not Recruiting,Not Applicable,Observational,Japan,"A multicenter, retrospective longitudinal observational study about Quarantine and social Isolation for COVID-19 and its impact on Kawasaki disease",Other,"Quarantine, Social Isolation",Quarantine; Social Isolation,4500,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047464,None
1400,IRCT20200402046917N1,IRCT,2020-08-31,2020-08-22,True,Semnan University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,therapeutic effect of Rosa Damascena extract in treatment of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,20,http://en.irct.ir/trial/46938,None
1401,IRCT20170128032241N3,IRCT,2020-08-17,2020-05-21,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation the Efficacy of CURCUDEN 35 in Patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,20,http://en.irct.ir/trial/47031,None
1402,IRCT20200409047007N1,IRCT,2020-04-12,2020-04-13,False,Mashhad University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Effect of COVID 19 survivors plasma in COVID 19 patients with ARDS,ATMP,Plasma,Plasma,64,http://en.irct.ir/trial/47058,None
1403,IRCT20200418047119N1,IRCT,2020-09-01,2020-08-31,True,Kermanshah University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of curcumin in treatment of respiratory syndrome of corona,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,42,http://en.irct.ir/trial/47231,None
1404,IRCT20151222025660N2,IRCT,2020-05-04,2020-04-13,True,Arak University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The prophylactic effect of Hydroxychloroquine on Novel Corona virus,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,90,http://en.irct.ir/trial/47319,None
1405,IRCT20200514047445N1,IRCT,2020-08-10,2020-08-05,True,Bandare-abbas University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of curcumin in improving patients with covid -19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/48275,None
1406,IRCT20190131042569N5,IRCT,2020-08-23,2020-06-29,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,The effect of nebulizing Peppermint extract and Rose extract on percentage of blood oxygen saturation in patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/48311,None
1407,IRCT20200527047581N1,IRCT,2020-08-23,2020-06-05,True,Kashan University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of  oral health care and mouth rinse in treatment of Covid-19,Drug,Chlorhexidine + povidone iodine,Chlorhexidine; Povidone Iodine,200,http://en.irct.ir/trial/48447,None
1408,IRCT20200616047792N1,IRCT,2020-08-03,2020-08-18,False,Ahvaz University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,A study of therapeutic effect of blood ozone therapy of severe Covid-19 patients,Drug,Ozone,Ozone,60,http://en.irct.ir/trial/48978,None
1409,IRCT20200616047799N1,IRCT,2020-08-23,2020-06-30,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Photobiomodulation anti-inflammatory effect in COVID-19,Other (device),Low-Level Laser Therapy,Low-Level Laser Therapy,40,http://en.irct.ir/trial/49012,None
1410,IRCT20090304001739N3,IRCT,2020-09-01,2020-04-02,True,Khoram-Abad University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Evaluation of slow release mucoadhesive paste ofâ€ MUCODENTOL â€œ in oral vestibule on symptoms of COVID-19 disease  in hospital staff,Other,Mucodentol,Mucodentol,1600,http://en.irct.ir/trial/49065,None
1411,IRCT20200623047897N1,IRCT,2020-08-16,2020-05-21,True,Iran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Efficacy of N-acetylcysteine in patients with COVID-19,Drug,"N-acetylcysteine, Lopinavir/ritonavir, hydroxychloroquine, atazanavir",N-acetylcysteineN-acetylcysteine; Lopinavir/ritonavir; hydroxychloroquine; atazanavir,60,http://en.irct.ir/trial/49277,None
1412,IRCT20200509047364N1,IRCT,2020-08-09,2020-06-21,True,Bandare-abbas University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of erythropoietin on COVID-19,Drug,"Erythropoietin + Standard Treatment (Hydroxychloroquine, Chloroquine, Lopinavir/Rionavir, Atazanavir) vs. Standard Treatment",Erythropoietin; Hydroxychloroquine; Chloroquine; Lopinavir/Rionavir; Atazanavir,20,http://en.irct.ir/trial/49282,None
1413,IRCT20200630047962N1,IRCT,2020-08-21,2020-08-07,True,Tehran University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,The effect of progressive muscle relaxation on covid-19 anxiety in pregnant women,Other (psych),Psychological,Psychological,126,http://en.irct.ir/trial/49309,None
1414,IRCT20200705048011N1,IRCT,2020-08-16,2020-08-22,False,Sabzevar University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Garlic and cinnamon on the treatment of patients with corona,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,45,http://en.irct.ir/trial/49481,None
1415,IRCT20190312043030N2,IRCT,2020-08-19,2020-06-29,True,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,"The effect of selenium, vitamin C and methylprednisolone combination on mortality and morbidity of Covid-19 patients.",Drug,Corticosteroids + selenium + methylprednisolone + Lopinavir/ritonavir + hydroxychloroquine vs. Lopinavir/ritonavir + hydroxychloroquine ,Methylprednisolone; Selenium; Methylprednisolone; Lopinavir/ritonavir; Hydroxychloroquine ,40,http://en.irct.ir/trial/49508,None
1416,IRCT20170716035126N4,IRCT,2020-08-26,2020-07-10,True,Ardabil University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The efficacy of methylprednisolone mini pulse on the treatment of COVID-19 patients admitted to intensive care unit,Drug,Corticosteroids,Methylprednisolone,60,http://en.irct.ir/trial/49519,None
1417,IRCT20200711048076N1,IRCT,2020-09-05,2020-05-21,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of mucodentol on covid-19 symptoms,Other,Mucodentol,Mucodentol,600,http://en.irct.ir/trial/49555,None
1418,IRCT20200509047364N2,IRCT,2020-08-17,2020-06-21,True,Bandare-abbas University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Famotidine and COVID-19,Drug,Famotidine + Hydroxychloroquine/Chloroquine + Lopinavir/Atazanavir/Ritonavir vs. Hydroxychloroquine/Chloroquine + Lopinavir/Atazanavir/Ritonavir,Famotidine; Hydroxychloroquine; Chloroquine; Lopinavir/ritonavir; Atazanavir/ritonavir,20,http://en.irct.ir/trial/49657,None
1419,IRCT20200718048129N1,IRCT,2020-08-11,2020-08-22,False,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effectiveness of Hydroxychloroquine and Clarithromycin in dyspnea and caugh caused by COVID-19 in recovery phase,Drug,Hydroxychloroquine vs. Clarithromycin,Hydroxychloroquine; Clarithromycin,45,http://en.irct.ir/trial/49729,None
1420,IRCT20200725048199N1,IRCT,2020-08-11,2020-08-10,True,Dezfoul University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Shalomin on the treatment and improvement of symptoms in patients with Covid 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,146,http://en.irct.ir/trial/49853,None
1421,IRCT20160808029264N9,IRCT,2020-08-15,2020-09-20,False,Semnan University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Effects of chest physiotherapy in COVID-19 patients with respiratory infection,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,44,http://en.irct.ir/trial/49890,None
1422,IRCT20190831044653N5,IRCT,2020-08-24,2020-08-20,True,Bojnourd University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,?The effect of Atorvastatin therapy in COVID-19,Drug,Atorvastatin + Hydroxychloroquine + Lopinavir/ritonavir vs. Hydroxychloroquine + Lopinavir/ritonavir,Atorvastatin; Hydroxychloroquine; Lopinavir/ritonavir,160,http://en.irct.ir/trial/49893,None
1423,IRCT20200730048253N1,IRCT,2020-08-08,2020-08-22,False,Ahvaz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluating the effectiveness of intravenous ozonized saline in COVID-19 disease,Drug,"Ozone + Standard Treatment (Hydroxychloroquine, Chloroquine, Lopinavir/Rionavir, Atazanavir, Corticosteroids, Anticoagulants) vs. Standard Treatment (Hydroxychloroquine, Chloroquine, Lopinavir/Rionavir, Atazanavir, Corticosteroids, Anticoagulants)",Ozone; Hydroxychloroquine; Chloroquine; Lopinavir/Rionavir; Atazanavir; Corticosteroids; Anticoagulants,60,http://en.irct.ir/trial/50031,None
1424,IRCT20091012002582N22,IRCT,2020-08-08,2020-08-22,False,Tabriz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of hemoperfusion on short term outcome of critical ill COVID-19,Other (device),Blood filter,Blood filter,160,http://en.irct.ir/trial/50079,None
1425,IRCT20101219005416N3,IRCT,2020-08-26,2020-08-10,True,Kerman University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of traditional medicine protocol included Astraglus gossypinus  with  Ferula assa capsule on improvement of  COVID-19 outpatients symptoms,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://en.irct.ir/trial/50101,None
1426,IRCT20200806048318N1,IRCT,2020-08-20,2020-09-22,False,Esfahan University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of herbal tea on improving respiratory symptoms in patients with Covid-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/50227,None
1427,IRCT20200506047323N5,IRCT,2020-08-14,2020-08-22,False,Bandare-abbas University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Melatonin in COVID-19,Drug,Melatonin + Hydroxychloroquine vs. Hydroxychloroquine,Melatonin; Hydroxychloroquine,60,http://en.irct.ir/trial/50239,None
1428,IRCT20090701002113N2,IRCT,2020-08-25,2020-08-15,True,Shiraz University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Methylene Blue in COVID-19,Drug,Methylene Blue + Corticosteroids + Lopinavir/ritonavir vs. Corticosteroids + Lopinavir/ritonavir,Methylene Blue; Corticosteroids; Lopinavir/ritonavir,260,http://en.irct.ir/trial/50275,None
1429,IRCT20180922041089N4,IRCT,2020-08-23,2020-04-19,True,Tehran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of oral Ivermectin on patients with COVID-19,Drug,Ivermectin + Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Azithromycin,Ivermectin; Hydroxychloroquine; Azithromycin,130,http://en.irct.ir/trial/50305,None
1430,IRCT20161108030776N3,IRCT,2020-08-26,2020-09-05,False,Kerman University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of donkey milk on the new corona virus infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,110,http://en.irct.ir/trial/50341,None
1431,ACTRN12620000421932,ANZCTR,2020-03-30,2020-05-03,False,Extracorporeal Life Support Organisation,Recruiting,Not Applicable,Observational,"Sweden, China, Luxembourg, Argentina, Mexico, Qatar, United States, United Arab Emirates, Kenya, Chile, India, Germany, Italy, Saudi Arabia, Poland, Canada, Netherlands, Brazil, Estonia, Australia, Vietnam, Tunisia, Croatia, Philippines, Japan, Hong Kong, Ireland, Indonesia, Switzerland, Lebanon, South Korea, Colombia, Egypt, Thailand, Morocco, Singapore, Kuwait, Belgium, Turkey, United Kingdom, Austria, South Africa, Ukraine, Zimbabwe, Spain",COVID-19 Critical Care Consortium Observational Study Incorporating the Extracorporeal Membrane Oxygenation for 2019 Novel Coronavirus Acute Respiratory Disease (ECMOCARD),Drug,Oxygen,Oxygen,10000,https://anzctr.org.au/ACTRN12620000421932.aspx,None
1432,ACTRN12620000448943,ANZCTR,2020-04-06,2020-06-20,False,Deakin University,Recruiting,Not Applicable,Interventional,Australia,Expressive Writing To Combat Distress Associated With The COVID-19 Pandemic In People With Inflammatory Bowel Disease,Other (psych),Psychological,Psychological,154,https://anzctr.org.au/ACTRN12620000448943.aspx,None
1433,ACTRN12620000477921,ANZCTR,2020-04-16,2020-04-23,False,Dr. Michael Soares,Not Recruiting,Not Applicable,Interventional,Australia,The design of an updated iron lung ventilator which can be easily built and used by people with minimal training in situations such as COVID-19 where skilled doctors or normal ventilators are unavailable.,Other (physical),Mechanical ventilation,Mechanical ventilation,1,https://anzctr.org.au/ACTRN12620000477921.aspx,None
1434,ACTRN12620000454976,ANZCTR,2020-04-08,2020-02-07,True,Austin Health,Recruiting,Phase 1/Phase 2,Interventional,Australia,Can intravenous high dose zinc improve clinical outcomes in patients with COVID-19 infection?,Drug,Zinc,Zinc,160,https://anzctr.org.au/ACTRN12620000454976.aspx,None
1435,ACTRN12620000487910,ANZCTR,2020-04-20,2020-07-04,False,Albury Wodonga Health,Recruiting,Not Applicable,Observational,Australia,Study evaluating Coronavirus (COVID-19) nasal/oral swab results compared to blood antibody results in COVID-19 clinic patients.,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,https://anzctr.org.au/ACTRN12620000487910.aspx,None
1436,ACTRN12620000473965,ANZCTR,2020-04-15,2020-08-18,False,University of Queensland,Recruiting,Phase 3,Interventional,Australia,Reducing acute severe respiratory events in health care workers during the Covid-19 pandemic with OM85,Drug (Chemoprophylaxis),OM85,OM85,1000,https://anzctr.org.au/ACTRN12620000473965.aspx,None
1437,ACTRN12620000517976,ANZCTR,2020-04-27,2020-09-07,False,"St. Vincents Hospital, Melbourne",Recruiting,Phase 3,Interventional,Australia,COVID-19: Can Nebulised HepArin Reduce Time to Extubation in SARS-CoV-2 patients requiring mechanical ventilation (CHARTER Study),Drug,Heparin,Heparin,206,https://anzctr.org.au/ACTRN12620000517976.aspx,None
1438,ACTRN12620000580976,ANZCTR,2020-05-19,2020-10-19,False,QIMR Berghofer Medical Research Institute,Not Recruiting,Phase 1/Phase 2,Interventional,Australia,Tocilizumab for tReatment Of COVID-19 in intensive cARe patients (â€œTROCARâ€),Drug,Tocilizumab,Tocilizumab,150,https://anzctr.org.au/ACTRN12620000580976.aspx,None
1439,ACTRN12620000612910,ANZCTR,2020-05-25,2020-01-06,True,Cynata Therapeutics Limited,Recruiting,Phase 1/Phase 2,Interventional,Australia,The MEND (MEseNchymal coviD-19) Trial: a pilot study to investigate early efficacy of mesenchymal stem cells in adults with COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),24,https://anzctr.org.au/ACTRN12620000612910.aspx,None
1440,ACTRN12620000590965,ANZCTR,2020-05-21,2020-05-26,False,The Royal Melbourne Hospital,Recruiting,Not Applicable,Observational,Australia,Psychological impact of COVID-19 pandemic on perioperative staff at the Royal Melbourne Hospital â€“ a longitudinal study,Other (psych),Psychological,Psychological,90,https://anzctr.org.au/ACTRN12620000590965.aspx,None
1441,ACTRN12620000698976,ANZCTR,2020-06-23,2020-10-06,False,Royal Prince Alfred Hopsital,Recruiting,Not Applicable,Interventional,Australia,Maintaining the health of people with and without COVID-19 during isolation,Other,Other,Other,40,https://anzctr.org.au/ACTRN12620000698976.aspx,None
1442,ACTRN12620000707965,ANZCTR,2020-06-29,2020-06-30,False,Accelagen Pty Ltd,No Status Given,Phase 3,Interventional,Australia,"A Placebo-Controlled Study to Evaluate the effect of the recombinant Bacillus Calmetteâ€“GuÃ©rin (BCG) vaccine VPM1002 on the Incidence or Disease Severity of SARS-COV-2/COVID-19 Among High-Risk Participants in Australia
",ATMP,Vaccine,Vaccine,3468,https://anzctr.org.au/ACTRN12620000707965.aspx,None
1443,ACTRN12620000817943,ANZCTR,2020-08-14,2020-08-22,False,Accelagen Pty Ltd,Recruiting,Phase 1/Phase 2,Interventional,Australia,"A Phase 1/2 randomized, placebo-controlled, multi-centre study to evaluate the safety and immunogenicity of COVID-19 Vaccine in Healthy Adults",ATMP,Vaccine,Vaccine,280,https://anzctr.org.au/ACTRN12620000817943.aspx,None
1444,ACTRN12620000779976,ANZCTR,2020-07-30,2020-06-08,True,Dr. Sarah Egan,Recruiting,Not Applicable,Interventional,"United Kingdom, Australia",The effect of Cognitive behaviour therapy on adult mental health during the COVID-19 pandemic.,Other (psych),Psychological,Psychological,100,https://anzctr.org.au/ACTRN12620000779976.aspx,None
1445,ACTRN12620000860965,ANZCTR,2020-08-28,2020-01-09,True,Wesley Medical Research,Not Recruiting,Not Applicable,Interventional,Australia,A research study to determine the effect of a smartphone application (app) on management of patients with heart failure in isolation due to COVID-19,Other (software),eHealth,eHealth,400,https://anzctr.org.au/ACTRN12620000860965.aspx,None
1446,ISRCTN74727214,ISRCTN,2020-08-10,2020-06-15,True,Sultan Qaboos University,Not Recruiting,Not Applicable,Interventional,Oman,Effect of the anti-inflammatory test drug anakinra in patients with coronavirus (COVID-19) requiring oxygen support,Drug,Anakinra,Anakinra,75,http://isrctn.com/ISRCTN74727214,None
1447,ISRCTN67000769,ISRCTN,2020-07-20,2019-05-28,True,UMC Utrecht,Recruiting,Not Applicable,Interventional,"Portugal, Croatia, New Zealand, Germany, Hungary, France, Ireland, Canada, Belgium, Netherlands, Saudi Arabia, United States, United Kingdom, Australia, Spain, Finland",An international platform trial for severely ill patients with community-acquired pneumonia or COVID-19,Drug (+ ATMP),"COVID Portion of Trial: Lopinavir/ritonavir, Hydroxychloroquine, interferon beta, Anakinra, Tocilizumab, Sarilumab, Plasma, Heparin, Vitamin C, Simvastatin",Lopinavir/ritonavir; Hydroxychloroquine; interferon beta; Anakinra; Tocilizumab; Sarilumab; Plasma; Heparin; Vitamin C; Simvastatin,1000,http://isrctn.com/ISRCTN67000769,None
1448,ISRCTN18274006,ISRCTN,2019-07-29,2018-09-25,True,ACCORD (UK),Recruiting,Not Applicable,Observational,United Kingdom,Understanding cognitive decline after stroke and the impact of COVID-19,Not relevant,Not relevant,Not relevant,2000,http://isrctn.com/ISRCTN18274006,None
1449,ChiCTR2000034825,ChiCTR,2020-07-21,2020-07-20,True,Jiangsu Provincial Center for Disease Control and Prevention,Not Recruiting,Phase 1,Interventional,China,A Phase I clinical trial of novel coronavirus pneumonia (COVID-19) mRNA Vaccine (BNT162b1) in China,ATMP,Vaccine,Vaccine,144,http://www.chictr.org.cn/showproj.aspx?proj=56834,None
1450,ChiCTR2000031672,ChiCTR,2020-04-06,2020-04-01,True,Beijing University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Development and application of TCM body regulating protection scheme for the convalescent population of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,150,http://www.chictr.org.cn/showproj.aspx?proj=51940,None
1451,ACTRN12620000474954,ANZCTR,2020-04-15,2020-04-28,False,Sir Charles Gairdner Hospital,Not Recruiting,Not Applicable,Observational,Australia,Airway Pressure Release Ventilation for mechanically ventilated patients with COVID-19 in Western Australian Intensive Care Units: an observational study,Other (physical),Mechanical ventilation,Mechanical ventilation,100,https://anzctr.org.au/ACTRN12620000474954.aspx,None
1452,ACTRN12620000571976,ANZCTR,2020-05-15,2020-04-06,True,UNSW Sydney,Not Recruiting,Phase 1,Interventional,Australia,"Evaluation of Shift, a smartphone application for Junior Medical Officers in New South Wales during the COVID-19 epidemic.",Other (psych),Psychological,Psychological,75,https://anzctr.org.au/ACTRN12620000571976.aspx,None
1453,ACTRN12620000909921,ANZCTR,2020-09-14,2020-09-28,False,University of Otago,Not Recruiting,Not Applicable,Observational,New Zealand,The March 15 Study: Examining the impacts and recovery from the March 15 2019 Christchurch Mosque attacks in people most directly exposed and their adult family members,Not relevant,Not relevant,Not relevant,600,https://anzctr.org.au/ACTRN12620000909921.aspx,None
1454,ACTRN12620000921987,ANZCTR,2020-09-17,2020-09-23,False,La Trobe University,Not Recruiting,Not Applicable,Observational,Australia,Sources of a Resilient Mindset in Health Professionals During COVID-19: The SOAR Study,Other (psych),No Intervention,No Intervention,20,https://anzctr.org.au/ACTRN12620000921987.aspx,None
1455,ACTRN12620000857909,ANZCTR,2020-08-28,2020-03-27,True,Monash University,Not Recruiting,Not Applicable,Observational,Australia,The impact of work loss during the COVID-19 pandemic on health and employment.,Other,No Intervention,No Intervention,1829,https://anzctr.org.au/ACTRN12620000857909.aspx,None
1456,ACTRN12620000922976,ANZCTR,2020-09-17,2020-05-29,True,Telethon Kids Institute,Not Recruiting,Not Applicable,Observational,Australia,DETECT Schools Study: Understanding the impact of COVID-19 in Western Australian Schools,Clinical Presentation (Epidemiology),No Intervention,No Intervention,30000,https://anzctr.org.au/ACTRN12620000922976.aspx,None
1457,ISRCTN95933274,ISRCTN,2020-09-09,2020-06-30,True,National Dental Centre of Singapore,Recruiting,Not Applicable,Interventional,Singapore,Efficacy of mouth-rinses in reducing SARS CoV-2 viral load in the saliva of COVID-19 positive patients,Drug,povidone-iodine vs. chlorhexidine gluconate vs. cetylpyridinium chloride,povidone-iodine; chlorhexidine gluconate; cetylpyridinium chloride,68,http://isrctn.com/ISRCTN95933274,None
1458,ISRCTN44152751,ISRCTN,2020-05-04,2020-11-05,False,Norwegian Institute of Public Health,Not Recruiting,Not Applicable,Interventional,Norway,School opening in Norway during the COVID-19 pandemic,Other,Other,Other,116750,http://isrctn.com/ISRCTN44152751,None
1459,ISRCTN86534580,ISRCTN,2020-03-22,2020-03-25,True,University of Oxford,Recruiting,Phase 3,Interventional,United Kingdom,PRINCIPLE: A trial evaluating treatments for suspected COVID-19 in people aged 50 years and above with pre-existing conditions and those aged 65 years and above,Drug,Hydroxychloroquine,Hydroxychloroquine,3000,http://isrctn.com/ISRCTN86534580,EUCTR2020-001209-22
1460,ChiCTR2000031955,ChiCTR,2020-04-16,2020-04-01,True,Beijing University of Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Study for prevention of novel coronavirus pneumonia (COVID-19) in high risk population by Chinese medicine,Clinical Presentation (Epidemiology),No Intervention,No Intervention,3808,http://www.chictr.org.cn/showproj.aspx?proj=52364,None
1461,EUCTR2020-002314-40-AT,EU Clinical Trials Register,2020-07-15,2020-09-14,False,Medical University of Vienna,Authorised,Phase 2,Interventional,Austria,A Pilot study to investigate the cardiac effect and pharmacokinetics of potential combination treatments for COVID-19,Drug,Lopinavir/ritonavir vs. Ribavirin,Lopinavir/ritonavir; Ribavirin,16,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002314-40,None
1462,EUCTR2020-002027-10-SE,EU Clinical Trials Register,2020-04-24,2020-07-13,False,University Hospital of Umeå,Authorised,Phase 2,Interventional,Sweden,"A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19)",Drug,Enzalutamide,Enzalutamide,600,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002027-10,None
1463,ACTRN12620000878976,ANZCTR,2020-09-03,2020-09-17,False,University of Melbourne,Not Recruiting,Not Applicable,Observational,Australia,A Collaborative Maternity and Newborn Dashboard for the COVID-19 Pandemic,Other,No Intervention,No Intervention,180000,https://anzctr.org.au/ACTRN12620000878976.aspx,None
1464,ISRCTN10373531,ISRCTN,2020-09-15,2019-01-01,True,Academic Hospital Maastricht,Not Recruiting,Not Applicable,Observational,Netherlands,The ability of the steep ramp test to measure and monitor aerobic capacity,Not relevant,Not relevant,Not relevant,50,http://isrctn.com/ISRCTN10373531,None
1465,ISRCTN34160010,ISRCTN,2020-09-14,2020-01-06,True,North-Western State Medical University,Not Recruiting,Not Applicable,Interventional,Russian Federation,A low-intervention study of pre-exposure prophylaxis (PrEP) in healthy volunteers at high risk of coronavirus (SARS-CoV-2) infection.,Drug (Chemoprophylaxis),inosine-glutathione + potassium chloride,inosine-glutathione; potassium chloride,100,http://isrctn.com/ISRCTN34160010,None
1466,ISRCTN21086382,ISRCTN,2020-09-14,2020-04-26,True,University of Oxford,Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 infection survey of the UK general population,Clinical Presentation (Epidemiology),No Intervention,No Intervention,500000,http://isrctn.com/ISRCTN21086382,None
1467,ISRCTN10378358,ISRCTN,2020-07-08,2020-01-11,True,University of Portsmouth,Recruiting,Not Applicable,Interventional,United Kingdom,"Reducing the risk of COVID-19 spread in hospitals, by stopping droplets from spreading",Other (device),Rubber dam,Rubber dam,400,http://isrctn.com/ISRCTN10378358,None
1468,ChiCTR2000036982,ChiCTR,2020-08-26,2020-06-22,True,Hospital of Sestri Levante,Recruiting,Not Applicable,Observational,Italy,Long term follow up of patients with COVID 19,Clinical Presentation,No Intervention,No Intervention,250,http://www.chictr.org.cn/showproj.aspx?proj=59893,None
1469,ChiCTR2000031501,ChiCTR,2020-04-02,2020-03-17,True,Eastern Theater General Hospital,No Status Given,Not Applicable,Interventional,China,"The efficacy  of convalescent plasma in patients with critical novel coronavirus pneumonia (COVID-19): a pragmatic, prospective cohort study",ATMP,Plasma,Plasma,20,http://www.chictr.org.cn/showproj.aspx?proj=50254,None
1470,ChiCTR2000029572,ChiCTR,2020-02-05,2020-02-05,False,Xiangyang First People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Withdraw       Safety and efficacy of umbilical cord blood mononuclear cells in the treatment of severe and critically novel coronavirus pneumonia(COVID-19): a randomized controlled clinical trial,ATMP,Cells (mononuclear),Cells (mononuclear),30,http://www.chictr.org.cn/showproj.aspx?proj=41760,None
1471,ChiCTR2000029569,ChiCTR,2020-02-04,2020-02-05,False,Xiangyang First People's Hospital,Not Recruiting,Not Applicable,Interventional,China,Withdraw           Safety and efficacy of umbilical cord blood mononuclear cells conditioned medium in the treatment of severe and critically novel coronavirus pneumonia (COVID-19): a randomized controlled trial,ATMP,Cells (mononuclear),Cells (mononuclear),30,http://www.chictr.org.cn/showproj.aspx?proj=49062,None
1472,EUCTR2020-001530-35-ES,EU Clinical Trials Register,2020-04-13,2020-09-04,False,Fundación para la Investigación Biomédica Hospital Universitario La Paz (FIBHULP),Authorised,Phase 4,Interventional,Spain,Clinical trial to avoid infection by SARS-CoV-2 in high-risk population. COVID-19,Drug,Melatonin,Melatonin,450,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001530-35,None
1473,EUCTR2020-001622-64-ES,EU Clinical Trials Register,2020-04-20,2020-04-19,True,Dr. Ana Pueyo Bastida,Authorised,Phase 4,Interventional,Spain,OUTPATIENT TREATMENT OF COVID-19 WITH EARLY PULMONARY CORTICOSTEROIDS AS AN OPPORTUNITY TO MODIFY THE COURSE OF THE DISEASE,Drug,Corticosteroids,Prednisone,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001622-64,None
1474,EUCTR2020-001722-66-ES,EU Clinical Trials Register,2020-04-27,2020-04-23,True,Fundació Clínic per a la Recerca Biomèdica,Authorised,Phase 2,Interventional,Spain,Plasma turnover in patients with COVID-19 disease and invasive mechanical ventilation,ATMP,Plasma,Plasma,116,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001722-66,None
1475,EUCTR2020-001505-22-ES,EU Clinical Trials Register,2020-04-27,2020-04-23,True,Banc de Sang i Teixits,Authorised,Phase 1/Phase 2,Interventional,Spain,Efficacy and safety evaluation of umbilical cord mesenchymal stem cells for the treatment of patients with respiratory failure due to coronavirus (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001505-22,None
1476,EUCTR2020-001541-39-ES,EU Clinical Trials Register,2020-04-27,2020-04-24,True,Fundación para la Investigación Biomédica de Córdoba,Authorised,Phase 2,Interventional,Spain,Pilot study of bevacizumab as a treatment for respiratory distress in patients with COVID-19,Drug,Bevacizumab,Bevacizumab,22,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001541-39,None
1477,EUCTR2020-001618-39-ES,EU Clinical Trials Register,2020-04-27,2020-04-24,True,Oryzon Genomics S. A.,Authorised,Phase 2,Interventional,Spain,Study to evaluate the efficacy and tolerability of treatment with vafidemstat in combination with standard of care treatment to prevent Acute Respiratory Distress Syndrome in adult severely ill patients with COVID-19.,Drug,Vafidemstat,Vafidemstat,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001618-39,None
1478,EUCTR2020-000705-86-ES,EU Clinical Trials Register,2020-05-05,2020-04-26,True,Vall d'Hebron University Hospital,Authorised,Phase 4,Interventional,Spain,Control of inflammatory parameters with fish oil in parenteral nutrition,Supplement,Fish oil,Fish oil,117,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-000705-86,None
1479,EUCTR2020-001825-29-ES,EU Clinical Trials Register,2020-05-05,2020-04-28,True,Navarrabiomed - Fundación Miguel Servet,Authorised,Phase 2/Phase 3,Interventional,Spain,CLINICAL TRIAL OF THE USE OF ANAKINRA (ANTI IL-1) IN CYTOKINE STORM SYNDROME (CSS) SECONDARY TO COVID-19,Drug,Anakinra vs. Hydoxychloroquine + Azithromycin + Lopinavir/ritonavir,Anakinra; Hydoxychloroquine; Azithromycin; Lopinavir/ritonavir,180,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001825-29,None
1480,EUCTR2020-001697-30-ES,EU Clinical Trials Register,2020-05-07,2020-04-23,True,Navarrabiomed - Fundación Miguel Servet,Authorised,Phase 3,Interventional,Spain,PRE-EXPOSURE PROPHYLAXIS WITH HYDROXYCHLOROQUINE IN SANITARIES HIGHLY EXPOSED TO COVID-19. (COVIDNA),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001697-30,None
1481,EUCTR2020-001376-15-DE,EU Clinical Trials Register,2020-04-06,2020-05-13,False,Vakzine Projekt Management GmbH,Not Recruiting,Phase 3,Interventional,Germany,A study to investigate whether vaccination with VPM1002 can reduce the sick days of healthcare professionals during the SARS-CoV-2 pandemic,ATMP,Vaccine,Vaccine,1200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001376-15,None
1482,EUCTR2020-002299-11-HU,EU Clinical Trials Register,2020-06-02,2020-09-17,False,SigmaDrugs Research Ltd.,Authorised,Phase 2,Interventional,Hungary,"A randomized, double-blind, placebo-controlled, adaptive-design study to assess the safety and efficacy of daily 200 mg fluvoxamine as add-on therapy to standard of care in moderate severity COVID-19 patients",Drug,Fluvoxamine,Fluvoxamine,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002299-11,None
1483,EUCTR2020-002728-35-HU,EU Clinical Trials Register,2020-08-13,2020-09-17,False,Hungarian Ministry of Innovation and Technology,Authorised,Phase 3,Interventional,Hungary,Clinical trial of Favipiravir treatment of patients with COVID-19,Drug,Favipiravir,Favipiravir,150,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002728-35,None
1484,EUCTR2020-001645-40-IT,EU Clinical Trials Register,2020-09-22,2020-06-05,True,Dompe Farmaceutici,Authorised,Phase 2/Phase 3,Interventional,Italy,Reparixin in COVID-19 pneumonia,Drug,Reparixin,Reparixin,159,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001645-40,None
1485,EUCTR2020-003470-47-NL,EU Clinical Trials Register,2020-09-26,2020-08-27,True,UMC Utrecht,Authorised,Phase 4,Interventional,Netherlands,Investigation IN VULNERABLE ELDERLY to evaluate the reduction of respiratory infections during the coronapandemie by training of the immuunsystem through a BCG vaccination,ATMP,Vaccine,Vaccine,5200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003470-47,None
1486,EUCTR2020-001686-36-FR,EU Clinical Trials Register,2020-04-14,2020-04-23,False,Assistance Publique – Hôpitaux de Marseille,Authorised,Phase 2,Interventional,France,"A double-blind, randomized study versus placebo of avdoralimab (IPH5401), an anti-C5aR antibody, in patients with COVID-19 induced pneumonia",Drug,Avdoralimab,Avdoralimab,168,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001686-36,None
1487,ACTRN12620000834954,ANZCTR,2020-08-24,2020-09-16,False,"CytoAgents, Inc",Not Recruiting,Phase 1,Interventional,Australia,"A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses of GP1681 in Healthy Adult Participants",Drug,GP1681,GP1681,24,https://anzctr.org.au/ACTRN12620000834954.aspx,None
1488,ACTRN12620000977976,ANZCTR,2020-09-30,2020-01-11,True,Woolcock Institute of Medical Research,Not Recruiting,Not Applicable,Observational,Australia,National Asthma Treatment Survey in Australian adults,Other,No Intervention,No Intervention,8000,https://anzctr.org.au/ACTRN12620000977976.aspx,None
1489,ACTRN12620000975998,ANZCTR,2020-09-30,2020-05-10,True,Bolton Clarke,Not Recruiting,Not Applicable,Interventional,Australia,Feasibility and acceptability of a volunteer-peer telephone support programme - A COVID-19 response,Other (psych),Psychological,Psychological,100,https://anzctr.org.au/ACTRN12620000975998.aspx,None
1490,ISRCTN57085639,ISRCTN,2020-09-24,2020-08-05,True,University Hospital Southampton NHS Foundation Trust,Recruiting,Phase 2,Interventional,United Kingdom,A platform to investigate the safety and effectiveness of several new medicines for the treatment of COVID-19 in hospitalised patients,Drug,"Bemcentinib,  MEDI3506,  Acalabrutinib,  Zilucoplan ",Bemcentinib;  MEDI3506;  Acalabrutinib;  Zilucoplan ,1800,http://isrctn.com/ISRCTN57085639,EUCTR2020-001736-95
1491,ISRCTN53038326,ISRCTN,2020-09-23,2020-06-22,False,University Hospitals Coventry and Warwickshire NHS Trust,Recruiting,Phase 2,Interventional,United Kingdom,IMU838 and oseltamivir in the treatment of COVID-19,Drug,Vidofludimus calcium + Oseltamivir vs. Oseltamivir,Vidofludimus calcium; Oseltamivir,120,http://isrctn.com/ISRCTN53038326,EUCTR2020-001805-21
1492,ISRCTN45176516,ISRCTN,2020-09-21,2020-09-23,False,Royal Devon and Exeter NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,Impact of biologic therapy on SARS-CoV-2 infection and immunity in patients with inflammatory bowel disease,Drug,"Infliximab, Vedolizumab",Infliximab; Vedolizumab,6970,http://isrctn.com/ISRCTN45176516,None
1493,JPRN-jRCT2031200120,JPRN,2020-09-16,2020-09-16,False,Yamaoka Kunihiro,Recruiting,Phase 2,Interventional,Japan,double-blind study in COvid-19 patients with iveRmectin,Drug,Ivermectin,Ivermectin,240,https://jrct.niph.go.jp/latest-detail/jRCT2031200120,None
1494,JPRN-jRCTs031190269,JPRN,2020-03-27,2020-03-04,True,Sugiyama Haruhito,Not Recruiting,Phase 2,Interventional,Japan,"A multicenter, open-label, randomized controlled phase II study to evaluate the efficacy and safety of inhaled ciclesonide for asymptomatic and mild patients with COVID-19",Drug,Ciclesonide,Ciclesonide,90,https://jrct.niph.go.jp/latest-detail/jRCTs031190269,None
1495,JPRN-jRCTs031200124,JPRN,2020-09-17,2020-09-17,False,Kutsuna Satoshi,Recruiting,Not Applicable,Interventional,Japan,COVIPLA-R,ATMP,Plasma,Plasma,59,https://jrct.niph.go.jp/latest-detail/jRCTs031200124,None
1496,JPRN-jRCTs032200131,JPRN,2020-09-28,2020-09-28,False,Izumi Shinnyuu,Recruiting,Phase 2,Interventional,Japan,PMX-DHP for COVID-19,Procedure,PMX-DHP,PMX-DHP,30,https://jrct.niph.go.jp/latest-detail/jRCTs032200131,None
1497,JPRN-jRCTs051200060,JPRN,2020-09-25,2020-09-25,False,Kakeya Hiroshi,Not Recruiting,Phase 1,Interventional,Japan,Prohylaxis with hydroxichloroquine aiming at prevention of COVID-19 for medical care workers,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,500,https://jrct.niph.go.jp/latest-detail/jRCTs051200060,None
1498,JPRN-UMIN000039873,JPRN,2020-03-19,2020-03-19,False,National Center for Global Health and Medicine,Recruiting,Not Applicable,Observational,Japan,COVID-19 Registry,Clinical Presentation,No Intervention,No Intervention,99999,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045453,None
1499,JPRN-UMIN000040931,JPRN,2020-06-28,2020-07-10,False,Yokohama City University,Recruiting,Not Applicable,Observational,Japan,The association between the neutralizing activity and the amount of antibody in early stages of SARS-CoV-2 infection: A multicenter observational study,Clinical Presentation,No Intervention,No Intervention,150,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046736,None
1500,JPRN-UMIN000041168,JPRN,2020-08-01,2020-08-01,False,The Japanese Respiratory Society,Recruiting,Not Applicable,Observational,Japan,A study of the COVID-19 sequlae,Clinical Presentation,No Intervention,No Intervention,1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046991,None
1501,JPRN-UMIN000041387,JPRN,2020-08-11,2020-08-17,False,Dokkyo Medical University,Recruiting,Not Applicable,Observational,Japan,Japan COVID-19 Study of the psychosocial impacts of the postponement/cancellation of reproductive medicine,Other (psych),No Intervention,No Intervention,1100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047141,None
1502,JPRN-UMIN000041458,JPRN,2020-10-01,2020-07-01,True,Okayama University,Not Recruiting,Not Applicable,Interventional,Japan,Research on the maintenance and improvement of physical and mental functions of elderly people under the self-restraint caused by COVID-19 by using a remote system to connect their homes,Other (psych),Psychological,Psychological,40,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047327,None
1503,JPRN-UMIN000041526,JPRN,2020-08-25,2020-09-01,False,Jobu Hospital for Respiratory Diseases,Not Recruiting,Not Applicable,Observational,Japan,How does the COVID-19 quarantine affect physical activity levels?,Other (exercise),No Intervention,No Intervention,400,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047400,None
1504,JPRN-UMIN000041705,JPRN,2020-09-07,2020-09-07,False,"EA Pharma Co.,Ltd.",Not Recruiting,Not Applicable,Observational,Japan,A survey of the impact of COVID-19 on the prescription and other conditions of patients with gastrointestinal diseases,Other,No Intervention,No Intervention,1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047583,None
1505,JPRN-UMIN000041893,JPRN,2020-09-24,2020-09-24,False,Japanese Association for Acute Medicine,Recruiting,Not Applicable,Observational,Japan,Assessment of the prediction models to alleviate burden of infectious disease in the emergency department-COVID-19(AMABIE-COVID-19),Health System,No Intervention,No Intervention,784,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046668,None
1506,EUCTR2020-001264-28-DE,EU Clinical Trials Register,2020-04-27,2020-05-28,False,Immunic AG,Authorised,Phase 2/Phase 3,Interventional,"Greece, Bosnia and Herzegovina, Russian Federation, Germany, Macedonia, the former Yugoslav Republic of, Romania, United States, Moldova, Republic of, Ukraine, Bulgaria, Hungary",A study to investigate whether the experimental medication IMU-838 is safe and effective when it is given to Covid-19 patients in addition to their normal treatment,Drug,Vidofludimus calcium,Vidofludimus calcium,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001264-28,None
1507,EUCTR2020-001498-63-BE,EU Clinical Trials Register,2020-05-03,2020-05-18,False,Biophytis S.A.,Authorised,Phase 2,Interventional,"France, Belgium, Brazil, United Kingdom, United States","Testing the Efficacy and Safety of BIO101, for the Prevention of Respiratory Deterioration, in Patients with COVID-19 Pneumonia (COVA study)",Drug,BIO101,BIO101,465,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001498-63,None
1508,EUCTR2020-001327-13-AT,EU Clinical Trials Register,2020-03-30,2020-04-21,False,Medical University of Vienna,Authorised,Phase 2,Interventional,Austria,"A SINGLE-BLINDED RANDOMIZED, PLACEBO-CONTROLLED PHASE II TRIAL OF PROPHYLACTIC TREATMENT WITH ORAL AZITHROMYCIN VERSUS PLACEBO IN CANCER PATIENTS UNDERGOING ANTINEOPLASTIC TREATMENT DURING THE COVID-19 PANDEMIC",Drug,Azithromycin,Azithromycin,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001327-13,None
1509,EUCTR2020-002110-41-GB,EU Clinical Trials Register,2020-05-29,2020-06-18,False,Cancer Research UK,Authorised,Phase 2/Phase 3,Interventional,United Kingdom,A clinical study in a community setting to see whether use of camostat reduces the worsening of COVID-19.,Drug,Camostat Mesilate,Camostat Mesilate,389,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002110-41,None
1510,IRCT20170117032004N3,IRCT,2020-03-29,2020-04-03,False,Tabriz University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Effect of vitamin A in patients with COVID19,Drug,Vitamin A,Vitamin A,30,http://en.irct.ir/trial/46564,None
1511,IRCT20200318046812N1,IRCT,2020-04-01,2020-04-01,False,Iran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Comparison of the safety and efficacy of Favipiravir and kaletra in COVID-19,Drug,Favipiravir + hydroxychloroquine vs. Lopinavir/ritonavir + hydroxychloroquine,Favipiravir; hydroxychloroquine; Lopinavir/ritonavir,324,http://en.irct.ir/trial/46783,None
1512,IRCT20190810044500N7,IRCT,2020-09-19,2020-04-08,True,Yazd Shahid Sadoughi University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Evaluation of Levamisole efficacy in treatment of Covid-19,Drug,Levamisole,Levamisole,50,http://en.irct.ir/trial/46826,None
1513,IRCT20151228025732N51,IRCT,2020-04-08,2020-03-18,True,Semnan University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,"Effect of Algomed, Menta longifolia, Chamomile, Althaea rosea, Malva sylvestris supplements on the Severity and Consequences of Coronavirus 19 disease (COVID-19)",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/46828,None
1514,IRCT20190717044241N2,IRCT,2020-04-22,2020-04-20,True,Barakat Pharmaceutical Group,Recruiting,Phase 1,Interventional,Iran,Cell therapy in patients with COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),5,http://en.irct.ir/trial/47110,None
1515,IRCT20081019001369N7,IRCT,2020-09-27,2020-10-22,False,Mashhad University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Clinical trial of trans sodium crocetinate against COVID-19,Drug,Sodium crocetinate,Sodium crocetinate,30,http://en.irct.ir/trial/47441,None
1516,IRCT20200504047295N1,IRCT,2020-09-16,2020-08-10,True,Ahvaz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effectiveness of Shallomin syrup on patients affected by COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,90,http://en.irct.ir/trial/47661,None
1517,IRCT20160118026097N4,IRCT,2020-09-13,2020-03-29,True,Ghoum University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of dexamethasone in the treatment of high-risk covid19 patients,Drug,Corticosteroids,Dexamethasone,60,http://en.irct.ir/trial/48310,None
1518,IRCT20160118026097N5,IRCT,2020-09-19,2020-03-29,True,Ghoum University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of plasmapheresis in the treatment of high-risk covid patients in Qom province,Procedure (+ Drug),Plasmapheresis vs. Hydroxychloroquine or chloroquine and lopinavir/ritonavir or atazanavir/ritonavir,Plasmapheresis; Hydroxychloroquine; Chloroquine; Lopinavir/ritonavir; Atazanavir/ritonavir,60,http://en.irct.ir/trial/48401,None
1519,IRCT20190226042851N1,IRCT,2020-10-05,2020-08-22,True,Ahvaz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of nano-based inhalation solution to relieve shortness of breath in COVID-19 patients,Drug,"Deionized water + Silver (and Interferon beta, dexamethasone, corticosteroids, heparin)","Deionized water; Silver; Interferon beta; Dexamethasone, Heparin",40,http://en.irct.ir/trial/48462,None
1520,IRCT20180624040213N2,IRCT,2020-09-14,2020-07-21,True,Babol University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Montelukast in COVID-19,Drug,Montelukast,Montelukast,114,http://en.irct.ir/trial/49420,None
1521,IRCT20200504047298N3,IRCT,2020-09-09,2020-08-22,True,Karaj University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Diphenhydramine Compound in Covid-19,Drug,Diphenhydramine,Diphenhydramine,120,http://en.irct.ir/trial/49696,None
1522,IRCT20200727048217N1,IRCT,2020-09-13,2020-08-22,True,Shahroud University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of ethanol and DMSO in prophylaxis and treatment of COVID-19,Drug,Ethanol + Dimethyl Sulfoxide,Ethanol; Dimethyl Sulfoxide,610,http://en.irct.ir/trial/49924,None
1523,IRCT20200802048266N1,IRCT,2020-09-22,2020-11-19,False,Ahvaz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of MMR vaccine in preventing Covid disease 19,ATMP,Vaccine,Vaccine,323,http://en.irct.ir/trial/50035,None
1524,IRCT20131112015390N5,IRCT,2020-09-26,2020-05-21,True,Oroumia University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,"Effects of guided imagery on anxiety, muscle pain and vial signs in patients with COVID-19",Other,Other,Other,110,http://en.irct.ir/trial/50268,None
1525,IRCT20200317046797N7,IRCT,2020-09-14,2020-04-20,True,Tabriz University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,The efficacy of bromhexine hydrochloride in the prevention of COVID-19 disease,Drug (Chemoprophylaxis),Bromhexine hydorchloride,Bromhexine hydorchloride,3500,http://en.irct.ir/trial/50556,None
1526,IRCT20200831048568N1,IRCT,2020-09-11,2020-09-10,True,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Efficacy of sofosbuvir and daclatasvir in ambulatory patients with coronavirus disease,Drug,Sofosbuvir/daclatasvir,Sofosbuvir/daclatasvir,2000,http://en.irct.ir/trial/50601,None
1527,IRCT20181203041832N1,IRCT,2020-10-05,2020-09-22,True,Oroumia University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,The effectiveness of online mindfulness training on mental health and quality of work life of nurses fighting on the frontlines against COVID-19,Other (psych),Psychological,Psychological,36,http://en.irct.ir/trial/50750,None
1528,IRCT20200902048598N1,IRCT,2020-09-28,2020-09-22,True,Hamedan University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Evaluation of the effect of education in the prevention of covid-19,Other,Other,Other,200,http://en.irct.ir/trial/50796,None
1529,IRCT20140911019125N8,IRCT,2020-09-26,2020-09-10,True,Kerman University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of dental pulp mesenchymal stem cells in treatment of corona disease,ATMP,Cells (mesenchymal),Cells (mesenchymal),120,http://en.irct.ir/trial/50848,None
1530,IRCT20200913048701N1,IRCT,2020-09-22,2020-09-22,False,Iran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of effects of eucalyptus tablets on the process of covid 19 disease,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50,http://en.irct.ir/trial/50912,None
1531,IRCT20200907048644N1,IRCT,2020-10-04,2020-09-22,True,Zahedan University of Medical Sciences,Recruiting,Phase 1,Interventional,Iran,Celecoxib effects on  COVID-19 patients,Drug,Celecoxib,Celecoxib,60,http://en.irct.ir/trial/50932,None
1532,IRCT20200913048708N1,IRCT,2020-10-01,2020-10-31,False,Mazandaran University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Efficacy and safety of Chlorpromazine  in the treatment of COVID-19 patients,Drug,Chlorpormazine + Atazanavir/ritonavior vs. Atazanavir/ritonavior,Chlorpormazine; Atazanavir/ritonavior,60,http://en.irct.ir/trial/50959,None
1533,IRCT20131115015405N4,IRCT,2020-10-03,2020-07-22,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of fluvoxamine on cytokine in COVID-19 patients,Drug,Fluvoxamine,Fluvoxamine,40,http://en.irct.ir/trial/50977,None
1534,IRCT20131125015536N13,IRCT,2020-10-03,2020-05-21,True,Tehran University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Assessment of the effect of nanocurcumin supplement in patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,48,http://en.irct.ir/trial/51310,None
1535,IRCT20201001048893N1,IRCT,2020-10-03,2020-03-10,True,Shiraz University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Effect of Online Psycho-educational Interventions on Psychological Health of Patients with COVID-19,Other (psych),Psychological,Psychological,50,http://en.irct.ir/trial/51328,None
1536,ISRCTN32891583,ISRCTN,2020-10-02,2020-10-15,False,Diponegoro University,Recruiting,Not Applicable,Observational,Indonesia,Investigating the COVID-19 mucosal immunity of children in Indonesia,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,http://isrctn.com/ISRCTN32891583,None
1537,ISRCTN14707226,ISRCTN,2020-10-02,2020-09-10,True,Nuffield Health,Recruiting,Not Applicable,Observational,United Kingdom,Evaluating a new model of rehabilitation for individuals recovering from COVID-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,500,http://isrctn.com/ISRCTN14707226,None
1538,ISRCTN18395399,ISRCTN,2020-09-30,2020-04-24,True,King's College London,Recruiting,Not Applicable,Observational,United Kingdom,The psychosocial impact of the COVID-19 pandemic on NHS affiliated staff â€“ monitoring the response to the pandemic and the evaluation of local and national staff support programmes,Other (psych),No Intervention,No Intervention,20000,http://isrctn.com/ISRCTN18395399,None
1539,ISRCTN59449699,ISRCTN,2020-08-07,2020-09-28,False,North Bristol NHS Trust,Recruiting,Not Applicable,Observational,United Kingdom,Visualising blood vessel disease in the eye in COVID-19,Clinical Presentation,No Intervention,No Intervention,30,http://isrctn.com/ISRCTN59449699,None
1540,ChiCTR2000030522,ChiCTR,2020-03-06,2020-03-09,False,Affiliated Hospital of Chengdu University of Traditional Chinese Medicine,Not Recruiting,Not Applicable,Interventional,China,Canceled by the investigator                                       Efficacy and safety of Ma-Xing-Gan-Shi decoction in the treatment of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.chictr.org.cn/showproj.aspx?proj=44213,None
1541,EUCTR2020-001610-38-DK,EU Clinical Trials Register,2020-04-07,2020-09-16,False,Slagelse Hospital,Authorised,Phase 4,Interventional,Denmark,Irbesartan and Oseltamivir treatment of COVID-19 infection.,Drug,Irbesartan + Oseltamivir,Irbesartan; Oseltamivir,80,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001610-38,None
1542,EUCTR2020-001498-63-GB,EU Clinical Trials Register,2020-06-09,2020-01-10,True,Biophytis S.A.,Authorised,Phase 2,Interventional,"France, Belgium, Brazil, United Kingdom, United States","Testing the Efficacy and Safety of BIO101, for the Prevention of Respiratory Deterioration, in Patients with COVID-19 Pneumonia (COVA study)",Drug,BIO101,BIO101,465,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001498-63,None
1543,EUCTR2020-001608-40-DE,EU Clinical Trials Register,2020-04-14,2020-07-15,False,Zhejiang Hisun Pharmaceutical Co. Ltd.,Authorised,Phase 3,Interventional,"China, Germany","A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase III Clinical Study Evaluating the Efficacy and Safety of Favipiravir in the Treatment of Adult Patients with COVID-19-Moderate Typ",Drug,Favipiravir,Favipiravir,256,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001608-40,None
1544,ACTRN12620001048976,ANZCTR,2020-10-15,2020-02-11,True,Gilead Sciences,Not Recruiting,Phase 1,Interventional,"New Zealand, Germany, Puerto Rico, United States","A Phase 1 Open-Label, Parallel-Group, Single-Dose Study to
Evaluate the Pharmacokinetics of Remdesivir and Metabolites in
Participants with Normal Renal Function and Renal Impairment",Not relevant,Not relevant,Not relevant,80,https://anzctr.org.au/ACTRN12620001048976.aspx,None
1545,ISRCTN18428598,ISRCTN,2020-10-08,2020-01-01,True,Education Endowment Foundation,Recruiting,Not Applicable,Interventional,United Kingdom,Does the Flexible Phonics programme lead to improved reading outcomes for children in Reception when taught in addition to existing phonics programmes/practice?,Not relevant,Not relevant,Not relevant,2875,http://isrctn.com/ISRCTN18428598,None
1546,ISRCTN10197987,ISRCTN,2020-10-05,2020-08-09,True,Hamad Medical Corporation,Recruiting,Not Applicable,Interventional,Qatar,The possible beneficial role of the regular use of potent mouthwash solutions in the treatment of COVID-19,Drug,Chlorhexidine gluconate + Hydrogen peroxide,Chlorhexidine gluconate; Hydrogen peroxide,100,http://isrctn.com/ISRCTN10197987,None
1547,ISRCTN14602359,ISRCTN,2020-08-12,2020-01-10,True,University of Bristol,Recruiting,Not Applicable,Interventional,United Kingdom,COVID-19 Germ Defence: a website to improve infection control during the COVID-19 pandemic,Other,Other,Other,6822,http://isrctn.com/ISRCTN14602359,None
1548,ISRCTN43900695,ISRCTN,2020-04-08,2020-08-17,False,Northumbria University,Recruiting,Not Applicable,Interventional,United Kingdom,Testing an early online intervention for the treatment of disturbed sleep during the COVID-19 pandemic,Other,Sleep aids,Sleep aids,60,http://isrctn.com/ISRCTN43900695,None
1549,EUCTR2020-003349-12-IE,EU Clinical Trials Register,2020-08-14,2020-09-10,False,National University of Ireland Galway,Authorised,Phase 2,Interventional,Ireland,This is a proof of principle / feasibility study aiming to evaluate the effect of nebulised unfractionated heparin on procoagulant markers related to acute respiratory distress syndrome in patients invasively ventilated for Covid 19 lung disease.,Drug,Heparin,Heparin,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003349-12,None
1550,EUCTR2020-004928-42-HU,EU Clinical Trials Register,2020-10-12,2020-12-10,False,Hungarian Ministry of Innovation and Technology,Authorised,Phase 3,Interventional,Hungary,Clinical trail of remdesivir in Covid-19 patinets,Drug,Remdesivir,Remdesivir,2000,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004928-42,None
1551,EUCTR2020-001420-34-DK,EU Clinical Trials Register,2020-04-01,2020-04-14,False,Aarhus University,Authorised,Phase 2,Interventional,Denmark,Senicapoc treatment of COVID-19 positive patients in intensive care,Drug,Senicapoc,Senicapoc,46,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001420-34,None
1552,ISRCTN21447815,ISRCTN,2020-10-16,2020-09-19,True,North Bristol NHS Trust,Recruiting,Not Applicable,Observational,United Kingdom,Studying aerosol emission of the COVID-19 virus in healthcare settings,Clinical Presentation,No Intervention,No Intervention,600,http://isrctn.com/ISRCTN21447815,None
1553,ISRCTN12107048,ISRCTN,2020-05-28,2020-08-06,False,University of Cambridge,Recruiting,Not Applicable,Interventional,United Kingdom,Supporting weight management during COVID-19,Other (exercise),Exercise,Exercise,360,http://isrctn.com/ISRCTN12107048,None
1554,ISRCTN10437835,ISRCTN,2020-05-21,2020-01-02,True,Fundación Pública Urxencias Sanitarias de Galicia,Recruiting,Not Applicable,Observational,Spain,Survival of patients suffering an out-of-hospital cardiac arrest treated by emergency services in Spain during the COVID-19 pandemic and 1 year later,Health System,No Intervention,No Intervention,4000,http://isrctn.com/ISRCTN10437835,None
1555,ISRCTN14966673,ISRCTN,2020-03-18,2020-03-20,False,University Hospital Southampton NHS Foundation Trust,Recruiting,Not Applicable,Interventional,United Kingdom,Does point-of-care testing for coronavirus in hospital improve patient care compared to laboratory testing?,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,http://isrctn.com/ISRCTN14966673,None
1556,EUCTR2020-001010-38-NO,EU Clinical Trials Register,2020-03-16,2020-03-23,False,Akershus University Hospital,Not Recruiting,Phase 4,Interventional,Norway,NORWEGIAN CORONAVIRUS DISEASE 2019 [NO-COVID-19] STUDY: A TRIAL TO EVALUATE THE ANTIVIRAL EFFECT OF CHLOROQUINE IN ADULT PATIENTS WITH SARS-COV-2 INFECTION,Drug,Hydroxychloroquine,Hydroxychloroquine,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001010-38,None
1557,EUCTR2020-001867-94-FR,EU Clinical Trials Register,2020-04-20,2020-10-15,False,CHU Caen,Authorised,Phase 3,Interventional,France,Effet du tenofovir/emtricitabine en cure courte sur la clairance virale chez des patients infectÃ©s par le SARS-CoV2 (COVID-19) non hospitalisÃ©s,Drug,Tenofovir + Emtricitabine,Tenofovir; Emtricitabine,180,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001867-94,None
1558,EUCTR2020-001244-26-AT,EU Clinical Trials Register,2020-03-31,2020-11-04,False,Medical University of Vienna,Authorised,Phase 2,Interventional,Austria,COVID-19: Efficacy of solnatide to treat pulmonary permeability oedema in SARS-Cov-2 positive patients with moderate-to-severe ARDS - a pilot-trial.,Drug,Solnatide,Solnatide,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001244-26,None
1559,EUCTR2020-001504-42-BE,EU Clinical Trials Register,2020-05-03,2020-12-06,False,Inotrem,Authorised,Phase 2,Interventional,"France, United States, Belgium","A study evaluating the efficacy, safety and tolerability of Nangibotide in patients with Covid-19.",Drug,Nangibotide,Nangibotide,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001504-42,None
1560,EUCTR2020-001558-23-IT,EU Clinical Trials Register,2020-06-26,2020-09-04,False,Azienda Sanitaria Unica Regionale (ASUR),Authorised,Phase 3,Interventional,Italy,Hydroxychloroquine sulfate early administration in symptomatic out of hospital COVID-19 positive patients. Hydro-Stop-COVID19 Trial,Drug,Hydroxychloroquine,Hydroxychloroquine,216,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001558-23,None
1561,EUCTR2020-001745-40-IT,EU Clinical Trials Register,2020-06-24,2020-04-23,True,ASST Fatebenefratelli Sacco,Authorised,Phase 2,Interventional,Italy,PILOT STUDY ON THE USE OF SARILUMAB IN PATIENTS WITH COVID-19 INFECTION,Drug,Sarilumab,Sarilumab,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001745-40,None
1562,EUCTR2020-001732-10-DE,EU Clinical Trials Register,2020-04-27,2020-05-28,False,Philipps University Marburg,Authorised,Phase 2,Interventional,Germany,"Ruxolitinib for treatment of Covid-19 Patienten with acute respiratory
distress syndrome",Drug,Ruxolitinib,Ruxolitinib,15,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001732-10,None
1563,ACTRN12620000457943,ANZCTR,2020-04-08,2020-04-14,False,Medical Research Institute of New Zealand,No Status Given,Phase 2,Interventional,New Zealand,Hydroxychloroquine for the Community-Based Treatment of COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,70,https://anzctr.org.au/ACTRN12620000457943.aspx,None
1564,ACTRN12620000557932,ANZCTR,2020-05-11,2020-07-09,False,Dr Karin Ried,Recruiting,Not Applicable,Interventional,"Australia, Turkey","International ALLIANCE Study of Therapies to prevent progression of COVID-19, a randomized trial",Drug,Hydroxychloroquine + Azithromycin + Zinc + Vitamin D + Vitamin B + Vitamin C vs. Hydroxychloroquine + Azithromycin + Zinc + Vitamin D + Vitamin B,Hydroxychloroquine; Azithromycin; Zinc; Vitamin D; Vitamin B; Vitamin C,200,https://anzctr.org.au/ACTRN12620000557932.aspx,None
1565,ACTRN12620001114932,ANZCTR,2020-10-28,2020-02-11,True,Royal Brisbane & Women's Hospital,Not Recruiting,Not Applicable,Observational,Australia,Morbidity Post COVID-19 - Investigation and call to action,Clinical Presentation,No Intervention,No Intervention,200,https://anzctr.org.au/ACTRN12620001114932.aspx,None
1566,ISRCTN12890382,ISRCTN,2020-10-23,2020-02-11,True,University of Oxford,Recruiting,Not Applicable,Interventional,United Kingdom,Child anxiety treatment in the context of COVID-19,Other (psych),Psychological,Psychological,560,http://isrctn.com/ISRCTN12890382,None
1567,ISRCTN13773960,ISRCTN,2020-10-22,2018-01-03,True,Imperial College London,Recruiting,Not Applicable,Observational,United Kingdom,Schools Transmission Study (COVID-19 and scarlet fever),Clinical Presentation (Epidemiology),No Intervention,No Intervention,344,http://isrctn.com/ISRCTN13773960,None
1568,ISRCTN45562523,ISRCTN,2020-10-19,2020-01-03,True,Health Protection Scotland,Not Recruiting,Not Applicable,Observational,United Kingdom,Development of a risk prediction model for people with diabetes and COVID-19 in Scotland,Clinical Presentation (Epidemiology),No Intervention,No Intervention,5782649,http://isrctn.com/ISRCTN45562523,None
1569,ISRCTN13177364,ISRCTN,2020-09-09,2020-01-11,True,University of Exeter,Recruiting,Not Applicable,Interventional,United Kingdom,"The development, testing and evaluation of a COVID-19 fundamental nursing care protocol",Health System,Other,Other,1080,http://isrctn.com/ISRCTN13177364,None
1570,ISRCTN13447477,ISRCTN,2020-05-22,2020-04-11,True,Royal Surrey County Hospital NHS Foundation Trust,Recruiting,Not Applicable,Interventional,United Kingdom,A pilot study of the ability of povidone-iodine (PVP-I) 0.5% aqueous solution oral/nasal spray and mouthwash to kill the SARS-CoV-2 virus in people with COVID-19,Drug,Povidone Iodine,Povidone Iodine,22,http://isrctn.com/ISRCTN13447477,None
1571,ISRCTN83971151,ISRCTN,2020-03-25,2020-03-26,True,World Health Organization,Recruiting,Phase 3,Interventional,"Iran, Argentina, Qatar, Kenya, Honduras, India, Germany, Italy, Saudi Arabia, Canada, Brazil, Peru, Philippines, Israel, Ireland, Indonesia, Lebanon, Switzerland, Norway, Malaysia, Thailand, South Africa, Spain",Public health emergency SOLIDARITY trial of treatments for COVID-19 infection in hospitalized patients,Drug,Remdesivir vs. chloroquine/hydroxychloroquine vs. lopinavir/ritonavir vs. interferon beta,Remdesivir; chlorquine; hydroxychloroquine; lopinavir/ritonavir; interferon beta,10000,http://isrctn.com/ISRCTN83971151,EUCTR2020-001366-11; NCT04330690; PER-010-20; IRCT20200405046953N1; NCT04321616; EUCTR2020-000982-18; CTRI/2020/04/024773; LBCTR2020043495; EUCTR2020-002060-31; EUCTR2020-001549-38; NCT04575064; NCT04647669
1572,EUCTR2020-003486-19-GB,EU Clinical Trials Register,2020-08-14,2020-08-10,True,University of Dundee,Authorised,Phase 2,Interventional,United Kingdom,SFX-01 treatment for Acute Respiratory Infections (STAR-Covid19),Drug,Sulforadex,Sulforadex,300,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003486-19,None
1573,EUCTR2020-003689-37-FR,EU Clinical Trials Register,2020-10-01,2020-10-27,False,CHU de Nantes,Authorised,Phase 2,Interventional,France,"REmimazolam infusion in the context of Hypnotic Shortage in the Critical care Unit during the pandemic of COVID-19. The non-randomized, non-controlled, pilot, open, mono-centric REHSCU study.",Drug,Remimazolam,Remimazolam,30,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003689-37,None
1574,EUCTR2020-002677-95-IT,EU Clinical Trials Register,2020-08-10,2020-08-25,False,RedHill Biopharma Limited,Authorised,Phase 2/Phase 3,Interventional,"Russian Federation, Italy, Mexico, Brazil, United Kingdom, United States",A clinical trial using opaganib in adult patients hospitalised with severe pneumonia due to COVID-19,Drug,Opaganib,Opaganib,270,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002677-95,None
1575,JPRN-jRCT2021200018,JPRN,2020-08-18,2020-07-10,True,Harigae Hideo,Recruiting,Phase 2,Interventional,Japan,An exploratory Phase II investigator-initiated clinical trial of the efficacy and safety of TM5614 in patients with novel coronavirus  pneumonia,Drug,TM5614,TM5614,30,https://jrct.niph.go.jp/latest-detail/jRCT2021200018,None
1576,JPRN-jRCT2071200041,JPRN,2020-10-12,2020-01-11,True,Kita Toshihiro,Not Recruiting,Phase 2,Interventional,Japan,Therapeutic development of adrenomedullin for severe pneumonia caused by COVID-19,Drug,Adrenomedullin,Adrenomedullin,40,https://jrct.niph.go.jp/latest-detail/jRCT2071200041,None
1577,JPRN-jRCTs031200026,JPRN,2020-05-01,2020-11-06,False,Kyoji Moriya,Recruiting,Phase 3,Interventional,Japan,Combination therapy of Favipiravir and Nafamostat Mesilate in Patients with COVID-19 Pneumonia,Drug,Favipiravir + Nafamostat Mesilate,Favipiravir; Nafamostat Mesilate,160,https://jrct.niph.go.jp/latest-detail/jRCTs031200026,None
1578,JPRN-jRCTs031200150,JPRN,2020-10-14,2020-10-14,False,Namiki Takao,Recruiting,Phase 3,Interventional,Japan,Prophylactic study for COVID-19 with Kampo medicines,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,6000,https://jrct.niph.go.jp/latest-detail/jRCTs031200150,None
1579,JPRN-jRCTs051200049,JPRN,2020-08-26,2020-01-09,True,Iwahori Kota,Recruiting,Phase 2,Interventional,Japan,Therapeutic drug development program for COVID-19,Drug,Demethylchlortetracycline + Favipiravir,Demethylchlortetracycline; Favipiravir,30,https://jrct.niph.go.jp/latest-detail/jRCTs051200049,None
1580,JPRN-jRCTs052200053,JPRN,2020-09-07,2020-07-09,True,Fukushima Norihide,Recruiting,Phase 3,Interventional,Japan,Specified clinical trial for ECMO system for COVID-19 resipiratory failure,Drug,Oxygen,Oxygen,50,https://jrct.niph.go.jp/latest-detail/jRCTs052200053,None
1581,JPRN-jRCTs061200002,JPRN,2020-05-20,2020-05-20,False,Eiki Ichihara,Recruiting,Phase 2,Interventional,Japan,Teprenone for preventing aggravation of COVID-19,Drug,Teprenone,Teprenone,100,https://jrct.niph.go.jp/latest-detail/jRCTs061200002,None
1582,JPRN-jRCTs071200048,JPRN,2020-10-29,2020-10-29,False,Izumikawa Koichi,Recruiting,Phase 2,Interventional,Japan,Exploratory examination of Efficacy and safety of functional food included 5-aminolevulinic phosphoric acid/sodium ferrous citrate on COVID-19,Drug,5-aminolevulinic phosphoric acid + sodium ferrous citrate,5-aminolevulinic phosphoric acid; sodium ferrous citrate,50,https://jrct.niph.go.jp/latest-detail/jRCTs071200048,None
1583,JPRN-UMIN000040162,JPRN,2020-04-15,2020-04-14,True,University of Tokyo,Not Recruiting,Not Applicable,Observational,"Japan, Asia(except Japan), North America, South America, Australia, Europe, Africa",Multicenter observational study to examine the efficacy of protection during endoscopy examination for Covid-19 infection,Other,No Intervention,No Intervention,1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045790,None
1584,JPRN-UMIN000040211,JPRN,2020-04-21,2020-05-01,False,Kanagawa Cardiovascular and Respiratory Center,Not Recruiting,Not Applicable,Observational,Japan,"A Multicenter, Retrospective Study to Evaluate the Efficacy of Systemic Gluco-corticoid Against COVID-19",Drug,Corticosteroids,Corticosteroids,500,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045861,None
1585,JPRN-UMIN000040405,JPRN,2020-05-18,2020-05-18,False,Japanese Society of Intensive Care Medicine,Not Recruiting,Not Applicable,Observational,"Japan, Asia(except Japan), North America, South America, Australia, Europe, Africa",International survey to investigate the implementation of ICU daily care for COVID-19,Health System,No Intervention,No Intervention,200,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046103,None
1586,JPRN-UMIN000040587,JPRN,2020-06-01,2020-06-01,False,Yokohama City University,Not Recruiting,Not Applicable,Observational,Japan,"The analysis of COVID-19 in saliva, gastric fluid and intestinal fluid on gastrointestinal endoscopy",Clinical Presentation,No Intervention,No Intervention,500,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046321,None
1587,JPRN-UMIN000041227,JPRN,2020-07-28,2020-09-01,False,Yokohama City University,Not Recruiting,Not Applicable,Observational,Japan,Immune responses in the convalescence stage of COVID-19 patients,Clinical Presentation,No Intervention,No Intervention,700,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047079,None
1588,JPRN-UMIN000041427,JPRN,2020-08-16,2020-07-16,True,Airlangga University,Not Recruiting,Not Applicable,Other,Asia(except Japan),Prognostic role of simple coagulation profiles in predicting in-hospital mortality of COVID-19 patients: a meta-analysis,Prognosis,No Intervention,No Intervention,Not Available,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047297,None
1589,JPRN-UMIN000041769,JPRN,2020-10-01,2020-10-23,False,Yokohama City University,Recruiting,Not Applicable,Observational,Japan,Antibody acquisition and maintenance in childlen with COVID-19: Prospective observational study,Clinical Presentation (Epidemiology),No Intervention,No Intervention,50,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047674,None
1590,JPRN-UMIN000041990,JPRN,2020-10-02,2020-09-29,True,Kobe University,Not Recruiting,Not Applicable,Interventional,Japan,Intervention to promote exercise behavior among older adults under the epidemic of COVID-19,Other (exercise),Exercise,Exercise,300,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047925,None
1591,JPRN-UMIN000042034,JPRN,2020-10-07,2020-09-09,True,St. Marianna University School of Medicine,Not Recruiting,Not Applicable,Interventional,Japan,About preventive measures against covid-19 infection in sports,Other,No Intervention,No Intervention,5,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047574,None
1592,JPRN-UMIN000042052,JPRN,2020-10-30,2020-04-01,True,Universitas Indonesia,Not Recruiting,Not Applicable,Observational,Asia(except Japan),Orthopaedic Surgery in The Pandemic Era,Health System,No Intervention,No Intervention,35,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047986,None
1593,JPRN-UMIN000042061,JPRN,2020-10-09,2020-09-25,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,Japan,&quot;Study of resistance to COVID-19 of medical staff&quot; -(Pilot Study)-,Clinical Presentation (Epidemiology),No Intervention,No Intervention,165,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047878,None
1594,JPRN-UMIN000042106,JPRN,2020-10-15,2020-09-01,True,Nagoya University,Recruiting,Not Applicable,Observational,Japan,The impact of COVID19 pandemic-related activity restriction on the outcomes of chronic obstructive lung disease,Other,No Intervention,No Intervention,150,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048052,None
1595,JPRN-UMIN000042142,JPRN,2020-10-17,2020-05-19,True,Chiba University,Not Recruiting,Not Applicable,Other,Japan,cohort survey of healthcare workers with COVID-19 infection,Clinical Presentation (Epidemiology),No Intervention,No Intervention,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047872,None
1596,JPRN-UMIN000042211,JPRN,2020-10-23,2020-08-15,True,Uji-Tokushukai Medical Center,Not Recruiting,Not Applicable,Observational,Japan,The impact of COVID-19 pandemic on colorectal cancer therapy,Other,No Intervention,No Intervention,123,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048176,None
1597,JPRN-UMIN000042235,JPRN,2020-10-26,2020-11-01,False,Kuwana City Medical Center,Recruiting,Not Applicable,Observational,Japan,Venous Thromboembolism in Patients with COVID-19 in Japan Study,Clinical Presentation,No Intervention,No Intervention,200,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048031,None
1598,ACTRN12620001029987,ANZCTR,2020-10-09,2020-01-11,True,Planet Innovation,Not Recruiting,Not Applicable,Observational,Australia,Negative predictive value of the FebriDx host response point-of-care test in patients presenting to a single Australian Emergency Department with suspected COVID-19.,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,300,https://anzctr.org.au/ACTRN12620001029987.aspx,None
1599,ACTRN12620000982910,ANZCTR,2020-09-30,2020-05-10,True,Neuroscience Trials Australia,Not Recruiting,Phase 3,Interventional,Australia,A randomized double-blind placebo-controlled trial of oral ivermectin for outpatient treatment of those at high risk for hospitalization due to COVID-19,Drug,Ivermectin,Ivermectin,400,https://anzctr.org.au/ACTRN12620000982910.aspx,None
1600,ACTRN12620001104943,ANZCTR,2020-10-26,2020-12-11,False,Linear Clinical Research Ltd,Not Recruiting,Phase 1,Interventional,Australia,A Single Dose Study to Determine the Safety and Tolerability of Intranasal REVTx-99 in Healthy Adult Volunteers,Drug,REVTx-99,REVTx-99,32,https://anzctr.org.au/ACTRN12620001104943.aspx,None
1601,ISRCTN13539303,ISRCTN,2020-10-30,2020-08-06,True,Pregistry LLC,Recruiting,Not Applicable,Observational,"Pitcairn, Korea, South, Liechtenstein, Algeria, Mozambique, Isle of Man, Cambodia, Sint Maarten (Dutch part), Bahrain, Guadeloupe, Turks and Caicos Islands, United Arab Emirates, Gabon, Palau, Chile, Kazakhstan, Russian Federation, Zambia, Reunion, Barbados, Saint Vincent and the Grenadines, South Georgia and the South Sandwich Is, Moldova, Belarus, Czech Republic, Anguilla, Macao, Tunisia, Bolivia, Macedonia, Nicaragua, Azerbaijan, Sri Lanka, Israel, Heard Island and Mcdonald Islands, Solomon Islands, Marshall Islands, Burundi, Bhutan, Mayotte, Hungary, Saint Helena, United States Minor Outlying Islands, Norway, Curacao, Malaysia, Comoros, Gambia, Paraguay, Seychelles, Thailand, France, Christmas Island, Greenland, Somalia, Aruba, Togo, Turkey, South Africa, Ukraine, Uzbekistan, Haiti, Finland, Monaco, Bermuda, Cuba, Belize, Suriname, Tajikistan, Bahamas, Montserrat, Saint Barthelemy, Argentina, Kosovo, Qatar, Uganda, Bulgaria, Korea, North, Central African Republic, Liberia, India, Bosnia and Herzegovina, Germany, Cyprus, Venezuela, Netherlands, Yemen, Cocos (Keeling) Islands, Madagascar, Chad, Guinea, Croatia, Andorra, Guatemala, Pakistan, Benin, Slovakia, Guinea-Bissau, Hong Kong, Ireland, Puerto Rico, Svalbard and Jan Mayen, Martinique, Costa Rica, Saint Pierre and Miquelon, Iraq, Burkina Faso, Bonaire Saint Eustatius and Saba, Virgin Islands, British, Jersey, Singapore, Belgium, Bouvet Island, Maldives, Panama, Falkland Islands, Bangladesh, Iran, Sweden, Syria, Ecuador, Jordan, Lesotho, Taiwan, French Guiana, China, Faroe Islands, French Southern Territories, Rwanda, Tuvalu, Saint Lucia, Niger, Slovenia, United States, Eritrea, Honduras, Angola, Cayman Islands, Albania, San Marino, Poland, Canada, Swaziland, Nauru, Sierra Leone, Estonia, Laos, Sao Tome and Principe, South Sudan, Portugal, Mongolia, Nigeria, Philippines, Greece, Latvia, Tonga, Cameroon, Democratic Republic of Congo, Georgia, Fiji, Trinidad and Tobago, French Polynesia, Saint Kitts and Nevis, Netherlands Antilles, Palestinian Territory, Niue, Holy See (Vatican City State), Lebanon, Botswana, Morocco, Equatorial Guinea, Mali, New Zealand, Northern Mariana Islands, Kyrgyzstan, Kuwait, Guernsey, Nepal, United Kingdom, Uruguay, Austria, Samoa, Malawi, Serbia, Spain, Tokelau, Zimbabwe, Ghana, Luxembourg, Myanmar, Mexico, Mauritania, Timor-Leste, Iceland, Cook Islands, Democratic Republic of Congo, Romania, Kenya, British Indian Ocean Territory, Antigua and Barbuda, Aland Islands, Gibraltar, Ethiopia, Italy, Kiribati, Lithuania, Malta, Saudi Arabia, Brazil, Armenia, Peru, Antarctica, Australia, Vietnam, Mauritius, Norfolk Island, Japan, Tanzania, Western Sahara, Afghanistan, Guam, New Caledonia, Saint Martin (French part), Oman, Indonesia, Micronesia, Federated States of, Senegal, Switzerland, Namibia, Denmark, Djibouti, Libya, Cape Verde, Colombia, Egypt, American Samoa, Wallis and Futuna, Turkmenistan, Vanuatu, Virgin Islands, U.S., Jamaica, Papua New Guinea, Dominican Republic, Guyana, Montenegro, Dominica, El Salvador, Cote d'Ivoire, Brunei, Sudan, Grenada",An international registry of coronavirus exposure in pregnancy,Clinical Presentation,No Intervention,No Intervention,25000,http://isrctn.com/ISRCTN13539303,None
1602,ISRCTN13235264,ISRCTN,2020-10-20,2020-10-20,False,University of Manchester,Recruiting,Not Applicable,Observational,United Kingdom,Identifying acceptable support strategies for parents of children with obsessive-compulsive disorder,Not relevant,Not relevant,Not relevant,95,http://isrctn.com/ISRCTN13235264,None
1603,ISRCTN13455972,ISRCTN,2020-08-04,2020-04-08,True,Department of Health and Social Care,Not Recruiting,Not Applicable,Interventional,United Kingdom,Evaluation of coronavirus self-isolation interventions,Other,Self-isolation,Self-isolation,10000,http://isrctn.com/ISRCTN13455972,None
1604,ISRCTN18181860,ISRCTN,2020-07-13,2020-01-04,True,Swiss School of Public Health,Recruiting,Not Applicable,Observational,Switzerland,Corona Immunitas: a nationwide program of antibody studies of SARS-CoV-2 in the Swiss population,Clinical Presentation (Epidemiology),No Intervention,No Intervention,25000,http://isrctn.com/ISRCTN18181860,None
1605,ChiCTR2000039715,ChiCTR,2020-11-06,2020-11-17,False,Jiangsu Provincial Center for Disease Control and Prevention,Not Recruiting,Phase 2,Interventional,China,A Phase II Clinical Trial of Influenza virus Vector COVID-19 Vaccine for intranasal Spray (DelNS1-2019-nCoV-RBD-OPT1),ATMP,Vaccine,Vaccine,720,http://www.chictr.org.cn/showproj.aspx?proj=63754,None
1606,ChiCTR2000039640,ChiCTR,2020-11-04,2020-11-30,False,Beijing Tsinghua Chang Gung Hospital,Recruiting,Not Applicable,Interventional,China,Application of an intelligent mobile isolation operating cabin preventing COVID-19 infection,Other,Other,Other,10,http://www.chictr.org.cn/showproj.aspx?proj=61895,None
1607,ChiCTR2000039593,ChiCTR,2020-11-02,2020-03-11,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Diagnostic test,China,A clinical trial of a new pharyngeal exposure device for pharyngeal swab operation and its effect of testing novel coronavirus pneumonia (COVID-19) infection,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,0,http://www.chictr.org.cn/showproj.aspx?proj=63496,None
1608,ChiCTR2000039592,ChiCTR,2020-11-02,2020-06-01,True,Xiangya Nursing School of Central South University,Not Recruiting,Not Applicable,Interventional,China,Effect of Group Otago Exercise Program on Cognitive Frailty in the Nursing Home: a Randomised Controlled Trial,Other (exercise),Exercise,Exercise,62,http://www.chictr.org.cn/showproj.aspx?proj=62882,None
1609,ChiCTR2000039462,ChiCTR,2020-10-28,2020-10-27,True,Jiangsu Provincial Center for Disease Control and Prevention,Not Recruiting,Phase 2,Prevention,China,A phase II clinical trial for inactivated SARS-CoV-2 (COVID-19) Vaccine (Vero Cells),ATMP,Vaccine,Vaccine,1000,http://www.chictr.org.cn/showproj.aspx?proj=63353,None
1610,ChiCTR2000039212,ChiCTR,2020-10-22,2020-10-28,False,Shulan (Hangzhou) Hospital,Not Recruiting,Phase 1,Prevention,China,"A Phase Ib clinical trial to evaluate the safety, tolerance and preliminary immunogenicity of different doses of a novel coronavirus pneumonia (COVID-19) mRNA vaccine in population aged 18-59 years",ATMP,Vaccine,Vaccine,120,http://www.chictr.org.cn/showproj.aspx?proj=63183,None
1611,ChiCTR2000039079,ChiCTR,2020-10-16,2020-01-13,True,"Ningcheng Center Hospital,",Recruiting,Not Applicable,Observational,No Country Given,Stress and neuropsychiatric symptoms/disorders (i.e. functional brain diseases): COVID-19 as a source of stress,Other (psych),Psychological,Psychological,400,http://www.chictr.org.cn/showproj.aspx?proj=62482,None
1612,ChiCTR2000039000,ChiCTR,2020-10-13,2020-09-02,True,China National Biotec Group Co. Ltd,Recruiting,Phase 3,Interventional,Morocco,A Phase III clinical trial for inactivated novel coronavirus pneumonia (COVID-19) vaccine (Vero cells),ATMP,Vaccine,Vaccine,600,http://www.chictr.org.cn/showproj.aspx?proj=62581,None
1613,ChiCTR2000038943,ChiCTR,2020-10-10,2020-01-17,True,Xiangya Hospital of Central South University,Recruiting,Not Applicable,Observational,China,Outcomes of and Prognosis Factors for COVID-19 Patients: An Observational Study,Prognosis,No Intervention,No Intervention,233,http://www.chictr.org.cn/showproj.aspx?proj=61717,None
1614,ChiCTR2000038866,ChiCTR,2020-10-07,2020-10-15,False,Sun Yat-Sen University,Not Recruiting,Not Applicable,Interventional,China,A mHealth-based randomized controlled trial for improving mental health among people living with HIV during the COVID-19 outbreak,Other (psych),Psychological,Psychological,120,http://www.chictr.org.cn/showproj.aspx?proj=61662,None
1615,ChiCTR2000038864,ChiCTR,2020-10-07,2020-10-19,False,No Sponsor Name Given,Recruiting,Not Applicable,Observational,China,"Study on the risk perception, mental health, and behavioural responses of university students in Hong Kong in COVID-19 pandemic",Other (psych),No Intervention,No Intervention,600,http://www.chictr.org.cn/showproj.aspx?proj=62357,None
1616,ChiCTR2000038827,ChiCTR,2020-10-05,2020-11-02,False,The Hong Kong Jockey Club Charities Trust,Not Recruiting,Not Applicable,Interventional,China,Online multicomponent health intervention to support children with special education needs (SEN) and their families during COVID-19 pandemic,Other (software),eHealth,eHealth,1500,http://www.chictr.org.cn/showproj.aspx?proj=61884,None
1617,ChiCTR2000038740,ChiCTR,2020-09-30,2020-08-01,True,"Beijing University of Chinese Medicine, Third Affiliated Hospital",Not Recruiting,Not Applicable,Interventional,China,Study on Traditional Chinese Medicine Intervention Program for the Sequela of novel coronavirus pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.chictr.org.cn/showproj.aspx?proj=62250,None
1618,ChiCTR2000038739,ChiCTR,2020-09-30,2020-08-01,True,"Beijing University of Chinese Medicine, Third Affiliated Hospital",Not Recruiting,Not Applicable,Observational,China,Analysis on the Distribution of TCM Syndromes in convalescent novel coronavirus pneumonia (COVID-19) patients,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,800,http://www.chictr.org.cn/showproj.aspx?proj=62287,None
1619,ChiCTR2000038471,ChiCTR,2020-09-23,2020-09-25,False,The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital),Recruiting,Not Applicable,Observational,China,A study of neurological damage in patients recovering from novel coronavirus pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,160,http://www.chictr.org.cn/showproj.aspx?proj=61958,None
1620,ChiCTR2000037782,ChiCTR,2020-09-01,2020-09-01,False,Jiangsu Provincial Center for Disease Control and Prevention,Not Recruiting,Phase 1,Interventional,China,A Phase I Clinical Trial of Influenza virus Vector COVID-19 Vaccine for intranasal Spray (DelNS1-2019-nCoV-RBD-OPT1),ATMP,Vaccine,Vaccine,60,http://www.chictr.org.cn/showproj.aspx?proj=55421,None
1621,ChiCTR2000037524,ChiCTR,2020-08-29,2020-08-29,False,Chinese Academy of Medical Sciences,Not Recruiting,Not Applicable,Interventional,China,Effects of an online mindfulness-based intervention on quality of life and psychological symptoms in novel coronavirus pneumonia (COVID-19) patients in China: a randomized controlled trial,Other (psych),Psychological,Psychological,1600,http://www.chictr.org.cn/showproj.aspx?proj=60034,None
1622,ChiCTR2000037518,ChiCTR,2020-08-28,2020-08-28,False,West China Hospital of Sichuan University,Not Recruiting,Phase 1,Interventional,China,"Randomized double blind, placebo controlled phase I trial for anti novel coronavirus pneumonia (COVID-19) recombinant vaccine (Sf9)",ATMP,Vaccine,Vaccine,168,http://www.chictr.org.cn/showproj.aspx?proj=60581,None
1623,ChiCTR2000037342,ChiCTR,2020-08-28,2020-10-01,False,Shanghai Traditional Chinese Medicine Hospital,Recruiting,Not Applicable,Observational,China,A medical records based research on the establishment of a precise treatment system for novel coronavirus pneumonia (COVID-19) from the perspective of ''damp-and-heat epidemic'',Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=60400,None
1624,ChiCTR2000037078,ChiCTR,2020-08-26,2020-10-01,False,Shanghai First People's Hospital,Recruiting,Not Applicable,Observational,China,The technical specification of precise drug therapy and the systematic study of novel Coronavirus inactivation procedure for biological samples,Clinical Presentation,No Intervention,No Intervention,200,http://www.chictr.org.cn/showproj.aspx?proj=60149,None
1625,ChiCTR2000036871,ChiCTR,2020-08-25,2020-09-01,False,Beijing Hospital of Traditional Chinese Medicine,Not Recruiting,Phase 4,Interventional,Pakistan,"Multi-center, Randomized, Double Blind and Placebo Controlled Clinical Trial on the Efficacy and Safety of Jinhua Qinggan Granules (JHQG) for the Treatment of COVID-19 Patients.",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.chictr.org.cn/showproj.aspx?proj=55984,None
1626,ChiCTR2000036849,ChiCTR,2020-08-25,2020-10-01,False,Huashan Hospital; Fudan Universtiy,Not Recruiting,Not Applicable,Diagnostic test,China,Establishment of imaging diagnostic models for novel coronavirus pneumonia (COVID-19) and related brain injury based on artificial intelligence,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,2000,http://www.chictr.org.cn/showproj.aspx?proj=59903,None
1627,ChiCTR2000036661,ChiCTR,2020-08-24,2020-10-30,False,Shanghai Public Health Clinical Center,Not Recruiting,Not Applicable,Diagnostic test,China,Application of IL-18/IL-18BP in diagnosis and treatment of novel coronavirus pneumonia (COVID-19),Drug,IL-18BP,IL-18BP,30,http://www.chictr.org.cn/showproj.aspx?proj=59797,None
1628,ChiCTR2000036333,ChiCTR,2020-08-22,2020-02-01,True,The Second Xiangya Hospital of Central South University,Not Recruiting,Not Applicable,Interventional,China,Using Mindfulness to Reduce Anxiety and Depression of Patient with Fever Undergoing Screening in an Isolation Ward During novel coronavirus pneumonia (COVID-19) pandemic,Other (psych),Psychological,Psychological,51,http://www.chictr.org.cn/showproj.aspx?proj=57115,None
1629,ChiCTR2000036217,ChiCTR,2020-08-21,2020-10-01,False,Shanghai Public Health Clinical Center,Not Recruiting,Not Applicable,Diagnostic test,China,Multi-center study on intelligent accurate diagnosis and critical illness prediction of novel coronavirus pneumonia (COVID-19) with multimodal imaging,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,http://www.chictr.org.cn/showproj.aspx?proj=59358,None
1630,IRCT20100623004251N13,IRCT,2020-04-04,2019-10-23,True,Iran University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Comparison of the Effect of Types of Orthosis and Back School Program on Physical Fitness and Respiratory Capacity of Elderly with Thoracic Kyphosis,Not relevant,Not relevant,Not relevant,60,http://en.irct.ir/trial/42393,None
1631,IRCT20200324046850N5,IRCT,2020-04-04,2020-10-17,False,Abadan University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effectiveness of vitamin C on the improvement process of patients with COVID-19,Drug,Vitamin C w or w/o Hydroxychloroquine or Chloroquine + Lopinavir/Ritonavir,Vitamin C; Hydroxychloroquine; Chloroquine; Lopinavir/Ritonavir,400,http://en.irct.ir/trial/46751,None
1632,IRCT20200414047072N1,IRCT,2020-04-28,2020-04-14,True,Hilton Pharma Pvt. Ltd.,Recruiting,Not Applicable,Interventional,Pakistan,Use of Convalescent Plasma in the treatment of COVID-19,ATMP,Plasma,Plasma,357,http://en.irct.ir/trial/47163,None
1633,IRCT20080901001165N59,IRCT,2020-05-27,2020-05-25,True,Niwasha Company,Not Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Niwasha mouthwash in controlling the symptoms of patients with COVID-19,Drug,Mouthwash,Mouthwash,80,http://en.irct.ir/trial/47477,None
1634,IRCT20200328046885N1,IRCT,2020-10-12,2020-07-19,True,Iran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Comparison of the effectiveness of two treatment regimens in patients with COVID-19,Drug,Hydroxychloroquine + Sofosbuvir/daclatsivir vs. Hydroxychloroquine + lopinavir/ritonavir,Hydroxychloroquine; Sofosbuvir/daclatsivir; Lopinavir/ritonavir,300,http://en.irct.ir/trial/47565,None
1635,IRCT20170731035423N2,IRCT,2020-06-12,2020-05-21,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of the combination of BCc1 & Hep-S on hospitalized COVID-19 patients,Drug,BCc1 vs. Hep-S vs. BCc1 + Hep-S,BCc1; Hep-S,120,http://en.irct.ir/trial/48049,None
1636,IRCT20200531047619N1,IRCT,2020-10-18,2020-08-21,True,Iran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of Tofacitinib in covid-19 patients,Drug,Tofacitinib,Tofacitinib,10,http://en.irct.ir/trial/48766,None
1637,IRCT20200516047462N2,IRCT,2020-07-17,2020-07-08,True,Kashan University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,The effect of hyoscyamus niger with propolis on covid-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,90,http://en.irct.ir/trial/49628,None
1638,IRCT20200802048267N1,IRCT,2020-10-20,2020-08-22,True,Esfahan University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Propolis supplementation AND Coronavirus,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/50162,None
1639,IRCT20200816048422N1,IRCT,2020-10-16,2020-06-25,True,Ahvaz University of Medical Sciences,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Efficacy of Daclatasvir+Sofosbuvir in patients with severe acute respiratory syndrome coronavirus (SARS-COVID-19),Drug,Sofosbuvir/daclatsivir,Sofosbuvir/daclatsivir,70,http://en.irct.ir/trial/50363,None
1640,IRCT20150808023559N23,IRCT,2020-10-11,2020-09-20,True,Ardabil University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effectiveness of favipiravir in comparison with Tenofovir Alafenamid in patients with COVID-19,Drug,Favipiravir vs. Tenofovir alafenamid,Favipiravir; Tenofovir alafenamid,100,http://en.irct.ir/trial/50405,None
1641,IRCT20200825048514N1,IRCT,2020-10-10,2020-05-04,True,Yazd Shahid Sadoughi University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Effect of ÃŸ-interferon and methylprednisolone in COVID-19,Drug,Interferon beta + Lopinavir/ritonavir + naproxen + hydroxychloroquine + corticosteroids vs. Interferon beta + Lopinavir/ritonavir + naproxen + hydroxychloroquine ,Interferon beta; Lopinavir/ritonavir; naproxen; hydroxychloroquine; methylprednisolone,60,http://en.irct.ir/trial/50543,None
1642,IRCT20200328046886N2,IRCT,2020-10-12,2020-08-22,True,Mazandaran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficacy and safety of Atazanavir/Ritonavir plus Hydroxychloroquine regimen in patients with moderate COVID-19,Drug,Hydroxychloroquine + Atazanavir/ritonavir vs. Hydroxychlroquine + Lopinavir/ritonavir,Atazanavir/ritonavir; Hydroxychlroquine; Lopinavir/ritonavir,120,http://en.irct.ir/trial/50980,None
1643,IRCT20080901001165N63,IRCT,2020-10-22,2020-07-22,True,Bagheiat-allah University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Investigating the efficacy and safety of Myrtus nasal spray in controlling the symptoms of patients with mild  COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://en.irct.ir/trial/51157,None
1644,IRCT20100228003449N31,IRCT,2020-10-08,2020-09-26,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Corticosteroids in COVID-19,Drug,Corticosteroids,Dexamethasone,119,http://en.irct.ir/trial/51163,None
1645,IRCT20200923048815N1,IRCT,2020-10-15,2020-10-22,False,Esfahan University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of synbiotic on inflammatory markers and clinical manifestations in patients with C0VID-19,Supplement,Probiotics,Probiotics,80,http://en.irct.ir/trial/51166,None
1646,IRCT20200922048804N1,IRCT,2020-10-06,2020-08-05,True,Tehran University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Melatonin in COVID-19,Drug,Melatonin,Melatonin,20,http://en.irct.ir/trial/51177,None
1647,IRCT20200404046937N5,IRCT,2020-10-14,2020-09-27,True,Ahvaz University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Effect of remdesivir in COVID-19,Drug,Remdesivir,Remdesivir,50,http://en.irct.ir/trial/51178,None
1648,IRCT20200928048867N1,IRCT,2020-10-22,2020-10-01,True,Mashhad University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Evaluation of short term outcomes of liver transplantation from COVID-19 positive deceased donors,Clinical Presentation,No Intervention,No Intervention,10,http://en.irct.ir/trial/51319,None
1649,IRCT20201003048904N1,IRCT,2020-10-11,2020-10-11,False,Boushehr University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of Blood Transfusion in Covid-19,Procedure,Blood transfusion,Blood transfusion,40,http://en.irct.ir/trial/51364,None
1650,IRCT20201003048905N1,IRCT,2020-10-07,2020-05-23,True,Larestan University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Effect of spiritual care based on Ghalbe Salim on anxiety related to COVID-19 (corona phobia),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,14,http://en.irct.ir/trial/51394,None
1651,IRCT20201004048922N1,IRCT,2020-10-10,2020-10-11,False,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effectiveness of intravenous infusion of human COVID-19 hyperimmune plasma with specific antibody titer in hospitalized patients with Covid-19: a randomized clinical trial,ATMP,Plasma,Plasma,75,http://en.irct.ir/trial/51443,None
1652,IRCT20201005048936N1,IRCT,2020-10-26,2020-10-31,False,Dr. Abidi Pharmacutical Co.,Recruiting,Phase 3,Interventional,Iran,The evaluation of efficacy of Favipiravir in patients with mild to moderate COVID-19,Drug,Favipiravir vs. Hydroxychloroquine,Favipiravir; Hydroxychloroquine,126,http://en.irct.ir/trial/51499,None
1653,IRCT20181208041886N1,IRCT,2020-10-18,2020-10-22,False,Esfahan University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Levamizole in treatment of COVID19.,Drug,Levamizole,Levamizole,60,http://en.irct.ir/trial/51501,None
1654,IRCT20200128046294N3,IRCT,2020-10-22,2020-10-24,False,Tehran University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Safety of Sofosbuvir /Daclatasvir in outpatients with COVID-19,Drug,Sofosbuvir/daclatsivir,Sofosbuvir/daclatsivir,50,http://en.irct.ir/trial/51585,None
1655,IRCT20200930048892N1,IRCT,2020-10-18,2020-10-20,False,Shiraz University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,evaluation the effect of virtual pulmonary rehabilitaion on covid 19 patients,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,70,http://en.irct.ir/trial/51595,None
1656,EUCTR2020-002122-82-DE,EU Clinical Trials Register,2020-05-07,2020-12-06,False,"University Hospital, Erlangen",Authorised,Phase 2,Interventional,Germany,Clinical study for the Evaluation of efficacy and safety of a Treatment with Plasma gained from patients who recovered from COVID-19 infection and given to patients who are currently suffering from a severe COVID-19 infection,ATMP,Plasma,Plasma,58,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002122-82,None
1657,EUCTR2020-001936-86-DE,EU Clinical Trials Register,2020-08-20,2020-10-19,False,Hannover Medical School,Authorised,Phase 2,Interventional,Germany,Clinical trial to evaluate superiority of anti-SARS-CoV-2 convalescent plasma versus standard-of-care in hospitalized patients with mild COVID-19,ATMP,Plasma,Plasma,340,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001936-86,None
1658,EUCTR2020-001782-37-SK,EU Clinical Trials Register,2020-06-15,2020-07-11,False,NPO Petrovax,Authorised,Phase 2/Phase 3,Interventional,"Slovakia, Russian Federation, Italy, France, Poland, Brazil, Romania","A multi-centre, adaptive, randomized, double-blind, placebo-controlled comparative clinical study of the safety and efficacy of 12 mg PolyoxidoniumÂ®, lyophilizate solution for injections (NPO Petrovax Pharm LLC, Russia) in patients with coronavirus disease (COVID-19).",Drug,Azoximer bromide,Azoximer bromide,464,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001782-37,None
1659,ACTRN12620000445976,ANZCTR,2020-04-06,2020-07-28,False,University of Melbourne,Recruiting,Phase 3,Interventional,"New Zealand, Australia, India","Australasian COVID-19 Trial (ASCOT). A multi-centre randomised clinical trial to assess clinical, virological and immunological outcomes in patients with SARS-CoV-2 infection (COVID-19).",Drug,Lopinavir/ritonavir + hydroxychloroquine vs. lopinavir/ritonavir vs. hydroxychloroquine,Lopinavir/ritonavir; hydroxychloroquine,2500,https://anzctr.org.au/ACTRN12620000445976.aspx,None
1660,ACTRN12620001193965,ANZCTR,2020-11-10,2020-05-29,True,Epworth HealthCare,Recruiting,Not Applicable,Observational,Australia,"The adequacy of user seal checking for N95 respirators compared to formal fit testing, a multicentred observational study",Other (device),Masks,Masks,150,https://anzctr.org.au/ACTRN12620001193965.aspx,None
1661,ACTRN12620001167954,ANZCTR,2020-11-06,2020-11-27,False,Melanoma Institute Australia,Not Recruiting,Not Applicable,Observational,Australia,Melanoma Patientsâ€™ and Cliniciansâ€™ Satisfaction with Telehealth During COVID-19,Telehealth,No Intervention,No Intervention,100,https://anzctr.org.au/ACTRN12620001167954.aspx,None
1662,ISRCTN25647404,ISRCTN,2020-11-09,2020-09-20,True,Cardiff University,Recruiting,Not Applicable,Interventional,United Kingdom,Measurement of the effect of mouthwash against COVID-19,Drug,Cetylperidium chloride vs. povidone iodine vs. Cetylperidium chloride,Cetylperidium chloride; povidone iodine; Cetylperidium chlorid,104,http://isrctn.com/ISRCTN25647404,None
1663,ISRCTN63911163,ISRCTN,2020-11-05,2020-05-15,True,University of Birmingham,Recruiting,Not Applicable,Observational,United Kingdom,Analysis of the immunological response to coronavirus infection,Clinical Presentation,No Intervention,No Intervention,600,http://isrctn.com/ISRCTN63911163,None
1664,ISRCTN79623250,ISRCTN,2020-11-04,2020-04-30,True,Coventry University,Not Recruiting,Not Applicable,Interventional,United Kingdom,The digital Hope programme for people living with cancer during COVID-19,Other (psych),Psychological,Psychological,40,http://isrctn.com/ISRCTN79623250,None
1665,ISRCTN16865246,ISRCTN,2020-11-02,2020-10-22,True,University of Concepción,Recruiting,Not Applicable,Observational,Chile,One year follow-ups of Chilean patients with COVID-19,Clinical Presentation,No Intervention,No Intervention,250,http://isrctn.com/ISRCTN16865246,None
1666,ISRCTN13953727,ISRCTN,2020-11-02,2020-01-10,True,Imperial College London,Recruiting,Not Applicable,Observational,United Kingdom,Assessing patientsâ€™ risk of COVID-19 severe infection: developing a risk prediction score,Clinical Presentation,No Intervention,No Intervention,2870,http://isrctn.com/ISRCTN13953727,None
1667,ISRCTN66141262,ISRCTN,2020-10-22,2020-01-01,True,NHS Greater Glasgow and Clyde,Recruiting,Not Applicable,Observational,United Kingdom,"ASTERIX: An observational study to identify sub-groups of COVID-19 patients based on their demographic, clinical and laboratory profile, and to determine if these sub-groups can be used to predict severity of disease and response to therapy",Clinical Presentation,No Intervention,No Intervention,600,http://isrctn.com/ISRCTN66141262,None
1668,ISRCTN82901740,ISRCTN,2020-10-13,2020-11-16,False,University of Bristol,Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 testing and infection control in schools,Clinical Presentation (Epidemiology),No Intervention,No Intervention,6000,http://isrctn.com/ISRCTN82901740,None
1669,ISRCTN51287266,ISRCTN,2019-12-06,2019-12-13,False,St. George's University Hospitals NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,Aspergillosis in patients with severe influenza or coronavirus infection,Not relevant,Not relevant,Not relevant,180,http://isrctn.com/ISRCTN51287266,None
1670,ISRCTN75313566,ISRCTN,2017-06-27,2017-09-25,False,University of Manchester,Recruiting,Not Applicable,Interventional,United Kingdom,PRedSS: Prednisolone in early diffuse systemic sclerosis,Not relevant,Not relevant,Not relevant,72,http://isrctn.com/ISRCTN75313566,None
1671,EUCTR2020-001891-14-ES,EU Clinical Trials Register,2020-05-05,2020-04-05,True,Fundación Neumosur,Authorised,Phase 2,Interventional,Spain,"Impact of the use of low molecular weight heparins (LMWH), at prophylactic versus intermediate doses, on SARS-CoV2 infection (COVID-19)",Drug,Heparin,Heparin,140,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001891-14,None
1672,EUCTR2020-002032-69-ES,EU Clinical Trials Register,2020-05-05,2020-04-05,True,Fundación para la Investigación Biomédica Hospital Ramón y Cajal,Authorised,Phase 2,Interventional,Spain,Clinical trial on the efficacy of tocilizumab in modifying the inflammatory parameters of patients with COVID-19,Drug,Tocilizumab,Tocilizumab,78,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002032-69,None
1673,EUCTR2020-001603-16-ES,EU Clinical Trials Register,2020-05-08,2020-06-05,False,Instituto de Investigación Marqués de Valdecilla (IDIVAL),Authorised,Phase 3,Interventional,Spain,Ensayo clÃ­nico aleatorizado para investigar la eficacia de la administraciÃ³n anticipada de la colchicina en pacientes mayores de 70 aÃ±os y de alto riesgo en tener complicaciones pulmonares como neumonÃ­a asociada al coronavirus.,Drug,Colchicine,Colchicine,1024,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001603-16,None
1674,EUCTR2020-001994-66-ES,EU Clinical Trials Register,2020-05-08,2020-06-05,False,Fundació Assistencial Mútua Terrassa,Authorised,Phase 3,Interventional,Spain,Study of the efficacy of ivermectin in the treatment and prevention of COVID-19,Drug,Ivermectin,Ivermectin,266,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001994-66,None
1675,EUCTR2020-001934-37-ES,EU Clinical Trials Register,2020-05-08,2020-07-05,False,Instituto de Investigación Marqués de Valdecilla (IDIVAL),Authorised,Phase 4,Interventional,Spain,USE OF CORTICOSTEROIDS IN PATIENTS WITH SARS-COV2 CORONAVIRUS INFECTION,Drug,Corticosteroids,Methylprednisolone,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001934-37,None
1676,EUCTR2020-002123-11-ES,EU Clinical Trials Register,2020-05-08,2020-07-05,False,Tatiana Cobo-Ibáñez,Authorised,Phase 4,Interventional,Spain,CLINICAL STUDY IN WHICH PATIENTS ARE RANDOMIZED TO RECEIVE HYDROXYCHLOROQUINE VS. CYCLOSPORINE - HYDROXYCHLOROQUINE TO COMPARE THEIR EFFICACY IN THE TREATMENT OF COVID-19 PNEUMONIA.,Drug,Hydroxychloroquine vs. Hydroxychloroquine + Cyclosporine,Hydroxychloroquine; Cyclosporine,280,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002123-11,None
1677,EUCTR2020-001474-29-ES,EU Clinical Trials Register,2020-05-08,2020-07-05,False,Clínica Universidad de Navarra,Authorised,Phase 2,Interventional,Spain,Pilot study to evaluate the potential of ivermectin to reduce COVID-19 transmission,Drug,Ivermectin,Ivermectin,24,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001474-29,None
1678,EUCTR2020-002472-12-NL,EU Clinical Trials Register,2020-05-14,2020-11-06,False,Radboud University Medical Centre,Authorised,Phase 4,Interventional,Netherlands,Lanadelumab for treatment of COVID-19 disease,Drug,Lanadelumab,Lanadelumab,80,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002472-12,None
1679,EUCTR2020-001903-17-ES,EU Clinical Trials Register,2020-05-15,2020-10-06,False,Hospital Universitario de Móstoles,Authorised,Phase 3,Interventional,Spain,Effects of Tocilizumab  and its combination with Vitamin D to treat the increased defensive response in COVID-19,Drug,Tocilizumab + Vitamin D,Tocilizumab; Vitamin D,120,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001903-17,None
1680,EUCTR2020-002114-40-FR,EU Clinical Trials Register,2020-06-17,2020-07-30,False,Assistance Publique – Hôpitaux de Paris,Authorised,Phase 3,Interventional,France,Nintedanib for the treatment of pulmonary fibrosis induced by Covid-19,Drug,Nintedanib,Nintedanib,250,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002114-40,None
1681,EUCTR2020-001852-16-NL,EU Clinical Trials Register,2020-07-14,2020-07-14,False,Máxima Medisch Centrum,Authorised,Phase 2,Interventional,Netherlands,Iodine treatment Coronavirus infection,Drug,Potassium Iodine,Potassium Iodine,224,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001852-16,None
1682,EUCTR2020-001857-31-DE,EU Clinical Trials Register,2020-07-21,2020-09-11,False,Pluristem Ltd.,Authorised,Phase 2,Interventional,"Israel, Bulgaria, Germany",A clinical study to test if a drug called PLX-PAD is both safe and can help in the treatment of COVID-19 patients,Drug,Emiplacel,Emiplacel,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001857-31,None
1683,EUCTR2020-002497-27-CZ,EU Clinical Trials Register,2020-10-22,2020-10-27,False,Thomayer Hospital,Authorised,Phase 4,Interventional,Czech Republic,"A randomized, open-label, phase IV monocentric study evaluating the clinical effect of oral immunomodulatory therapy with IMUNORÂ® in patients with moderate COVID-19 disease",Drug,IMUNOR,IMUNOR,30,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002497-27,None
1684,EUCTR2020-001623-13-GR,EU Clinical Trials Register,2020-04-22,2020-05-20,False,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.,Authorised,Phase 2,Interventional,Greece,Triiodothyronine for the treatment of critically ill patients with COVID-19 infection (Thy-Support Study),Drug,Triiodothyronine,Triiodothyronine,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001623-13,None
1685,EUCTR2020-002225-29-FR,EU Clinical Trials Register,2020-04-30,2020-12-11,False,GCS Ramsay Sant pour l'Enseignement et la Recherche,Authorised,Phase 2,Interventional,France,Evaluation of the effects of bradykinin antagonists on pulmonary manifestations of COVID-19 infections.,Drug,Icatibant Acetate vs. C1 Estrerase Inhibitor,Icatibant Acetate; C1 Estrerase Inhibitor,45,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002225-29,None
1686,EUCTR2020-001236-10-NL,EU Clinical Trials Register,2020-03-31,2020-03-31,True,UMC Amsterdam,Authorised,Phase 2,Interventional,Netherlands,Countering Lung Damage in COVID-19 infection: the CounterCovid Study,Drug,Imatinib,Imatinib,386,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001236-10,NL8491
1687,ACTRN12620000554965,ANZCTR,2020-05-11,2020-05-14,False,St. Vincent's Health Network,Recruiting,Not Applicable,Observational,Australia,"ADAPT - COVID-19 Study - A prospective, observational cohort study at St Vincentâ€™s Hospital Sydney",Clinical Presentation,No Intervention,No Intervention,300,https://anzctr.org.au/ACTRN12620000554965.aspx,None
1688,ISRCTN16842454,ISRCTN,2020-11-10,2020-05-19,True,Ministry of Research and Technology/National Research and Innovation Agency (Indonesia),Recruiting,Not Applicable,Interventional,Indonesia,Effectiveness and safety of plasma convalescent therapy in patients with COVID-19,ATMP,Plasma,Plasma,5,http://isrctn.com/ISRCTN16842454,None
1689,ISRCTN56609224,ISRCTN,2020-09-21,2020-01-06,True,Public Health England,Recruiting,Not Applicable,Observational,United Kingdom,Evaluating home antibody test kits for the detection of coronavirus (COVID-19) antibodies,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,3000,http://isrctn.com/ISRCTN56609224,None
1690,EUCTR2020-001467-82-NL,EU Clinical Trials Register,2020-04-28,2020-10-23,False,Leiden University Medical Center,Authorised,Phase 2,Interventional,Netherlands,Investigation of the antiviral effect of Voclosporine on COVID-19 in renal transplant patients,Drug,Voclosporin,Voclosporin,30,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001467-82,None
1691,EUCTR2020-004743-83-GB,EU Clinical Trials Register,2020-10-26,2020-09-11,True,Synairgen Research Limited,Authorised,Phase 3,Interventional,"Argentina, Mexico, Moldova, Republic of, Romania, Chile, India, Russian Federation, Germany, Italy, Poland, Canada, Netherlands, Brazil, Peru, Portugal, Israel, United States, Colombia, France, Belgium, Turkey, United Kingdom, South Africa, Ukraine, Serbia, Spain",A trial of an inhaled antiviral drug to treat or prevent severe respiratory difficulties in patients hospitalised with moderate COVID-19,Drug,Interferon beta,Interferon beta,900,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004743-83,None
1692,ACTRN12620001265965,ANZCTR,2020-11-25,2020-03-30,True,Hospital Regional de Alta Especialidad Dr. Juan Graham Casasús,Not Recruiting,Not Applicable,Observational,Mexico,Epidemiology and clinical features in patients with COVID-19 in Mexican Southeast: A retrospective analysis,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,https://anzctr.org.au/ACTRN12620001265965.aspx,None
1693,ACTRN12620001279910,ANZCTR,2020-11-26,2021-01-02,False,Royal Prince Alfred Hopsital,Not Recruiting,Not Applicable,Observational,Australia,"Investigating the safety, satisfaction and efficacy of pulmonary tele rehabilitation for people with respiratory conditions, including patients recovering from COVID-19.


",Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,100,https://anzctr.org.au/ACTRN12620001279910.aspx,None
1694,ACTRN12620001269921,ANZCTR,2020-11-25,2020-11-27,False,Bendigo Health,Not Recruiting,Not Applicable,Observational,Australia,The Loddon Mallee Healthcare Worker COVID-19 Study,Other,No Intervention,No Intervention,4000,https://anzctr.org.au/ACTRN12620001269921.aspx,None
1695,ACTRN12620001249943,ANZCTR,2020-11-20,2020-01-12,True,Aegros Ltd.,Not Recruiting,Phase 1/Phase 2,Interventional,Australia,"Intravenous immunoglobulin rich in neutralising antibodies to SARS-CoV-2 as a passive
immunity modality in healthy individuals at risk of infection with COVID-19: an open label,
active control Phase 1/2 Study",ATMP,Immunoglobulin,Immunoglobulin,30,https://anzctr.org.au/ACTRN12620001249943.aspx,None
1696,ISRCTN63459073,ISRCTN,2020-11-19,2019-01-04,True,University of Porto,Recruiting,Not Applicable,Observational,Portugal,"COVID-19 pandemic effects on depression, anxiety and help-seeking attitudes in college students",Other (psych),No Intervention,No Intervention,500,http://isrctn.com/ISRCTN63459073,None
1697,ISRCTN12792822,ISRCTN,2020-11-18,2020-11-21,False,Population Council - Kenya,Recruiting,Not Applicable,Interventional,Kenya,Cash transfers to stimulate school re-enrollment among vulnerable adolescent girls in urban informal settlements as Kenya responds to COVID-19,Other,Other,Other,1700,http://isrctn.com/ISRCTN12792822,None
1698,ISRCTN90437126,ISRCTN,2020-11-17,2020-09-15,True,Federal University of Pernambuco,Recruiting,Phase 3,Interventional,Brazil,Study on the effects of using ivermectin to prevent COVID-19 in an adult population in Brazil,Drug (Chemoprophylaxis),Ivermectin,Ivermectin,800,http://isrctn.com/ISRCTN90437126,None
1699,ISRCTN40292537,ISRCTN,2020-11-17,2020-01-04,True,ACCORD (UK),Recruiting,Not Applicable,Observational,United Kingdom,Early Pandemic Evaluation and Enhanced Surveillance of the coronavirus COVID-19 (EAVE II),Clinical Presentation (Epidemiology),No Intervention,No Intervention,5400000,http://isrctn.com/ISRCTN40292537,None
1700,ISRCTN14810048,ISRCTN,2020-11-17,2020-03-25,True,LMU Klinikum,Not Recruiting,Not Applicable,Observational,Germany,AspCOVID-19 study: fungal infection of the airways in severe COVID-19 pneumonia,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,32,http://isrctn.com/ISRCTN14810048,None
1701,ISRCTN68675756,ISRCTN,2020-07-01,2020-10-02,False,Bengbu Medical College,Not Recruiting,Not Applicable,Interventional,China,Psychological intervention to improve the mental health of patients with COVID-19,Other (psych),Psychological,Psychological,93,http://isrctn.com/ISRCTN68675756,None
1702,ISRCTN55218215,ISRCTN,2019-07-05,2019-01-02,True,University of Stirling,Recruiting,Not Applicable,Interventional,United Kingdom,Trial of financial incentives for preventing postpartum return to smoking,Not relevant,Not relevant,Not relevant,900,http://isrctn.com/ISRCTN55218215,None
1703,EUCTR2020-001546-19-BE,EU Clinical Trials Register,2020-04-09,2020-04-21,False,Argenx BV,Not Recruiting,Phase 1/Phase 2,Interventional,Belgium,A First-in-Human Study in Adult Subjects Hospitalized with Covid-19 to Investigate a new product called ARGX-117,Drug,ARGX-117,ARGX-117,6,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001546-19,None
1704,EUCTR2020-001319-26-ES,EU Clinical Trials Register,2020-05-14,2020-05-14,False,Instituto de Investigación Sanitaria Fundación Jiménez Díaz,Authorised,Phase 3,Interventional,Spain,Clinical trial to assess the prognostic repercussions of rosuvastatin treatment in patients discharged after hospitalization for COVID-19 Positive.,Drug,Rosuvastatin,Rosuvastatin,1080,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001319-26,None
1705,EUCTR2020-001995-13-ES,EU Clinical Trials Register,2020-05-21,2020-05-15,True,Fundación SEIMC-GESIDA,Authorised,Phase 2,Interventional,Spain,Clinical trial to evaluate the efficacy and safety of tocilizumab for treating patients with COVID-19 pneumonia: the BREATH-19 Study,Drug,Tocilizumab,Tocilizumab,500,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001995-13,None
1706,EUCTR2020-002274-28-ES,EU Clinical Trials Register,2020-05-21,2020-05-19,True,Fundación para la Investigación y la Innovación Biosanitaria del Principado de Asturias (FINBA),Authorised,Phase 4,Interventional,Spain,Evaluation of the likely beneficial effects of vitamin D on infection with coronavirus.,Drug,Vitamin D,Vitamin D,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002274-28,None
1707,EUCTR2020-001704-42-ES,EU Clinical Trials Register,2020-05-21,2020-05-15,True,Instituto de Investigación Marqués de Valdecilla (IDIVAL),Authorised,Phase 4,Interventional,Spain,Controlled and randomised trial to assess the safety and efficacy of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in hospital healthcare personnel (Sanitarios sin COVID-19).,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,450,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001704-42,None
1708,EUCTR2020-002287-31-ES,EU Clinical Trials Register,2020-05-25,2020-05-22,True,Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS),Authorised,Phase 3,Interventional,Spain,COVID 19 prevention in nursing homes,Drug,Hydroxychloroquine,Hydroxychloroquine,1930,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002287-31,None
1709,EUCTR2020-002037-15-ES,EU Clinical Trials Register,2020-05-26,2020-05-25,True,Cristina Avendaño-Solá,Authorised,Phase 2,Interventional,Spain,"Multicenter, randomized, open-label study to evaluate the efficacy and safety of SOC + Sarilumab versus Standard of Care for the Early Treatment of COVID-19-pneumonia in Hospitalized Patients",Drug,Sarilumab,Sarilumab,200,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002037-15,None
1710,EUCTR2020-001960-28-ES,EU Clinical Trials Register,2020-05-26,2020-05-25,True,Investigation Institute Bioaraba,Authorised,Phase 4,Interventional,Spain,Efficacy of vitamin D treatment in patients diagnosed with pneumonia who require hospital admission and have vitamin D deficiency and a positive diagnosis for SARS-Cov-2 (COVID-19),Drug,Vitamin D,Vitamin D,108,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001960-28,None
1711,EUCTR2020-001841-38-ES,EU Clinical Trials Register,2020-05-26,2020-05-25,True,Sociedad Española de Cardiología,Authorised,Phase 3,Interventional,Spain,"Colchicine for the Treatment of Hyperinflammation associated with Pneumonia due to COVID-19
",Drug,Colchicine,Colchicine,240,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001841-38,None
1712,EUCTR2020-002456-21-NL,EU Clinical Trials Register,2020-05-26,2020-05-28,False,Radboud University Medical Centre,Not Recruiting,Phase 4,Interventional,Netherlands,Boosting the BCG-induced immunity response by addition of bisphosphonate or MMR vaccine: a possible preventive approach against the coronavirus (BCG-PLUS),ATMP,Vaccine,Vaccine,100,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002456-21,None
1713,EUCTR2020-001605-23-ES,EU Clinical Trials Register,2020-05-31,2020-05-29,True,Basque Health Service,Authorised,Phase 4,Interventional,Spain,Effectiveness of the combined treatment with hydroxycloroquine and azithromycin vs lopinavir/ritonavir + hydroxycloroquine in hospitalized patients with confirmed COVID-19 infection,Drug,Hydroxychloroquine + Azithromycin vs. Lopinavir/ritonavir + Hydroxychloroquine,Hydroxychloroquine; Azithromycin; Lopinavir/ritonavir,108,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001605-23,None
1714,EUCTR2020-002312-43-ES,EU Clinical Trials Register,2020-05-31,2020-05-28,True,Hospital Universitario Severo Ochoa,Authorised,Phase 3,Interventional,Spain,"Clinical trial,  randomized, open-label, to evaluate the efficacy of  high-dose vitamin D  in patients with COVID-19 pneumonia",Drug,Vitamin D,Vitamin D,82,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002312-43,None
1715,EUCTR2020-001671-32-ES,EU Clinical Trials Register,2020-05-31,2020-05-28,False,"Staidson (Beijing) Biopharmaceuticals Co., Ltd; Beijing Defengrui Biological Technology Co., Ltd.",Authorised,Phase 2,Interventional,Spain,"A clinical trial to investigate the efficacy and safety of a new compound for the treatment of COVID-19, called BDB-001. Patients in the trial will be randomly allocated to either the new treatment or the conventional treatment and will be aware of which treatment they are receiving",Drug,BDB-001,BDB-001,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001671-32,CTRI/2020/08/027109
1716,EUCTR2020-002009-25-CZ,EU Clinical Trials Register,2020-06-04,2020-01-10,True,"University Hospital, Pilsen",Authorised,Phase 2,Interventional,Czech Republic,The efficacy and safety of Eftilagimod Alpha Treatment in COVID-19 disease (EAT COVID trial),Drug,Eftilagimod Alpha,Eftilagimod Alpha,104,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002009-25,None
1717,EUCTR2020-001971-33-ES,EU Clinical Trials Register,2020-07-22,2020-02-06,True,Carmen Hidalgo,Authorised,Phase 3,Interventional,Spain,"Pragmatic study ""CORIVER"": Ivermectin as antiviral treatment for patients infected by SARS-COV2 (COVID19)",Drug,Ivermectin vs. Hydroxychloroquine + Azithormycin,Ivermectin; Hydroxychloroquine; Azithormycin,45,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001971-33,None
1718,EUCTR2020-002234-32-BE,EU Clinical Trials Register,2020-10-26,,False,"University Hospital, Bern",Authorised,Phase 3,Interventional,Belgium,Efficacy and Safety of Edoxaban and or Colchicine for patients with SARS-CoV-2 infection managed in the out of hospital setting (COVID 19),Drug,Endoxaban vs. Colchicine vs. Endoxaban + Colchicine,Endoxaban; Colchicine,420,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002234-32,None
1719,EUCTR2020-004682-39-CZ,EU Clinical Trials Register,2020-11-13,2020-11-16,False,Thomayer Hospital,Authorised,Phase 4,Interventional,Czech Republic,"Pilot, open-label, monocentric study evaluating safety and clinical effect of application of NORMOSANGÂ® in patients with COVID-19 disease",Drug,Normosang,Normosang,8,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004682-39,None
1720,EUCTR2020-001206-35-DE,EU Clinical Trials Register,2020-04-09,2020-04-14,False,Medical University Innsbruck,Authorised,Phase 4,Interventional,"Austria, Germany",Discontinuation of ACE inhibitors in patients with COVID-19 infection,Drug,ACE inhibitors,ACE inhibitors,798,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001206-35,None
1721,EUCTR2020-002322-85-SE,EU Clinical Trials Register,2020-05-14,2020-02-07,True,Kancera AB,Authorised,Phase 2,Interventional,Sweden,"KAND567 Versus Placebo in Subjects Hospitalized with COVID-19. A Phase II, Randomized, 2-Arm Parallel-Group, Double-blind Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacokinetics.",Drug,KAND567,KAND567,40,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002322-85,None
1722,EUCTR2020-003936-25-IT,EU Clinical Trials Register,2020-11-23,2020-10-31,True,Dompe Farmaceutici,Authorised,Phase 2/Phase 3,Interventional,Italy,Trial to study efficacy and safety of two doses of raloxifene in adult paucisymptomatic COVID-19 patients,Drug,Raloxifene,Raloxifene,150,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003936-25,None
1723,EUCTR2020-003904-15-DK,EU Clinical Trials Register,2020-08-11,2020-08-27,False,University of Southern Denmark,Authorised,Phase 3,Interventional,Denmark,BCG vaccine for seniors to prevent infections during the COVID-19 pandemic.,ATMP,Vaccine,Vaccine,1900,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003904-15,None
1724,EUCTR2020-001784-88-FI,EU Clinical Trials Register,2020-04-17,2020-04-29,False,University of Helsinki,Authorised,Phase 3,Interventional,Finland,"A clinical study to evaluate the efficacy of different anti-viral drugs in
SARS-CoV-2 infected patients (COVID-19)",Drug,"Oxiklorin, Hydroxychloroquine, Remdesivir","Oxiklorin, Hydroxychloroquine, Remdesivir",582,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001784-88,None
1725,DRKS00022729,German Clinical Trials Register,2020-07-30,2020-07-15,True,"University Hospital Carl Gustav Carus, Dresden",Recruiting,Not Applicable,Observational,Germany,SARS-CoV-2 Surveillance in Day Care Centers (COVID-19),Clinical Presentation (Epidemiology),No Intervention,No Intervention,750,http://www.drks.de/DRKS00022729,None
1726,DRKS00021439,German Clinical Trials Register,2020-04-20,2020-04-20,False,"University Hospital, Freiburg",Recruiting,Not Applicable,Observational,Germany,COVID-19 associated brainstem encephalitis - is SARS-CoV-2 a neurotropic agent?,Clinical Presentation,No Intervention,No Intervention,70,http://www.drks.de/DRKS00021439,None
1727,DRKS00021443,German Clinical Trials Register,2020-04-28,2020-04-23,True,University of Oldenburg,Recruiting,Not Applicable,Observational,Germany,Feasibility and usability of video-based physical therapy for older people in the context of the COVID-19 pandemic,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,30,http://www.drks.de/DRKS00021443,None
1728,DRKS00021447,German Clinical Trials Register,2020-04-27,2020-01-05,True,Charité University,Not Recruiting,Phase 2,Interventional,Germany,CytoResc - CytoSorb Rescue for COVID-19 Cytokine Storm,Other (device),Cytokine Adsorber,Cytokine Adsorber,100,http://www.drks.de/DRKS00021447,None
1729,DRKS00021416,German Clinical Trials Register,2020-04-30,2020-04-29,True,Klinik fur Ophthalmologie,Recruiting,Not Applicable,Observational,Germany,SARS-CoV-2 in tears in patients with COVID-19,Clinical Presentation,No Intervention,No Intervention,30,http://www.drks.de/DRKS00021416,None
1730,DRKS00021420,German Clinical Trials Register,2020-04-16,2020-01-04,True,Technische Universität München,Recruiting,Phase 1,Interventional,Germany,Observational clinical trial for the evaluation of an automated nasal and pharyngeal swab exam to test COVID-19 patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,30,http://www.drks.de/DRKS00021420,None
1731,DRKS00021424,German Clinical Trials Register,2020-06-12,2020-02-04,True,German Cancer Research Center (DKFZ),Not Recruiting,Not Applicable,Observational,Germany,Explorative Study of the Association of Oropharyngeal Microbiota Profiles with SARS-CoV-2 Infection and COVID-19 disease,Clinical Presentation,No Intervention,No Intervention,360,http://www.drks.de/DRKS00021424,None
1732,DRKS00022761,German Clinical Trials Register,2020-07-30,2020-02-08,True,University of Saarlandes,Not Recruiting,Not Applicable,Observational,Germany,Fear learning during pandemic fear: how COVID-19 perception affects classical fear conditioning,Other,No Intervention,No Intervention,120,http://www.drks.de/DRKS00022761,None
1733,DRKS00021432,German Clinical Trials Register,2020-05-04,2020-04-20,True,University of Oldenburg,Recruiting,Not Applicable,Observational,Germany,Limitations of social life in the context of the COVID-19 pandemic - Effects on physical performance and health-related quality of life of older people,Other (psych),No Intervention,No Intervention,100,http://www.drks.de/DRKS00021432,None
1734,DRKS00021468,German Clinical Trials Register,2020-06-04,2020-05-06,True,"University Hospital, Cologne",Not Recruiting,Not Applicable,Observational,Germany,Exploring immunological control mechanisms of SARS-CoV-2 (COVID-19),Clinical Presentation,No Intervention,No Intervention,2000,http://www.drks.de/DRKS00021468,None
1735,DRKS00022790,German Clinical Trials Register,2020-08-04,2020-08-22,False,Martin Luther University Halle-Wittenberg,Not Recruiting,Not Applicable,Observational,Germany,Risk prEdiction of indoor SporTs And cultuRe events for the Transmission of COVID-19,Other,No Intervention,No Intervention,4000,http://www.drks.de/DRKS00022790,None
1736,DRKS00021399,German Clinical Trials Register,2020-04-20,2020-12-04,False,Dortmund Hospital,Recruiting,Not Applicable,Observational,Germany,Prospective gas chromatographic and spectrometric analysis of the exhalation of healthy test persons and of SARS-CoV2 infected patients as well as  of patients suffering from COVID-19 at the Klinikum Dortmund,Clinical Presentation,No Intervention,No Intervention,450,http://www.drks.de/DRKS00021399,None
1737,DRKS00021395,German Clinical Trials Register,2020-04-17,2020-04-20,False,"University Hospital, Freiburg",Not Recruiting,Not Applicable,Observational,Germany,The effects of the COVID-19 pandemic on mental health,Other (psych),No Intervention,No Intervention,60,http://www.drks.de/DRKS00021395,None
1738,DRKS00021516,German Clinical Trials Register,2020-04-22,2020-04-22,False,Kantonsspital Aarau,Recruiting,Not Applicable,Observational,Switzerland,Dysosmia and Dysgeusia in COVID-19 patients,Clinical Presentation,No Intervention,No Intervention,100,http://www.drks.de/DRKS00021516,None
1739,DRKS00021521,German Clinical Trials Register,2020-04-22,2020-04-22,False,Zentrum fur Infektionskrankheiten,Recruiting,Not Applicable,Observational,Germany,Prevalence of COVID-19 in Children in Baden-WÃ¼rttemberg,Clinical Presentation (Epidemiology),No Intervention,No Intervention,2000,http://www.drks.de/DRKS00021521,None
1740,DRKS00021523,German Clinical Trials Register,2020-04-27,2020-04-28,False,"University Hospital, Freiburg",Not Recruiting,Not Applicable,Observational,Germany,The influence of proton pump inhibitor therapy on the clinical course of COVID-19,Drug,Proton pump inhibitor,Proton pump inhibitor,200,http://www.drks.de/DRKS00021523,None
1741,DRKS00021522,German Clinical Trials Register,2020-04-22,2020-04-21,True,"University Hospital, Freiburg",Recruiting,Not Applicable,Observational,Germany,Local and systemic markers of inflammation and circadian rhythmicity in COVID-19 disease and their role in the prediction of clinical outcome,Clinical Presentation,No Intervention,No Intervention,50,http://www.drks.de/DRKS00021522,None
1742,DRKS00021527,German Clinical Trials Register,2020-04-24,2020-04-14,True,"University Hospital, Leipzig",Not Recruiting,Not Applicable,Interventional,Germany,Evaluation of online support during the coronavirus (COVID-19) pandemic: a group chat program in the psychiatric outpatient clinic of the Leipzig University Hospital,Other (psych),Psychological,Psychological,100,http://www.drks.de/DRKS00021527,None
1743,DRKS00019207,German Clinical Trials Register,2019-12-23,2019-12-17,True,Charité University,Recruiting,Not Applicable,Interventional,Germany,EPICS-14: Point of Care Influenzascreening and SARS-CoV-2 (COVID-19) testing in the Emergency Department,Not relevant,Not relevant,Not relevant,3000,http://www.drks.de/DRKS00019207,None
1744,DRKS00021506,German Clinical Trials Register,2020-04-22,2020-03-18,True,"University Hospital Carl Gustav Carus, Dresden",Recruiting,Not Applicable,Observational,Germany,Registry of hospitalized pediatric Patients mit SARS-CoV-2 infection (COVID-19),Clinical Presentation,No Intervention,No Intervention,1000,http://www.drks.de/DRKS00021506,None
1745,DRKS00021514,German Clinical Trials Register,2020-04-24,2020-04-26,False,Forschung in der Operativen Medizin (IFOM),Not Recruiting,Not Applicable,Observational,Germany,Database for diagnosis and therapy of COVID-19 infected patients,Clinical Presentation,No Intervention,No Intervention,150,http://www.drks.de/DRKS00021514,None
1746,DRKS00022845,German Clinical Trials Register,2020-09-01,2020-06-19,True,LMU Klinikum,Recruiting,Not Applicable,Observational,Germany,Neurological rehabilitation outcome of the treatment of patients with COVID-19 disease,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,500,http://www.drks.de/DRKS00022845,None
1747,DRKS00021574,German Clinical Trials Register,2020-05-19,2020-08-04,False,"University Hospital, Frankfurt",Recruiting,Not Applicable,Observational,Germany,Investigation of the predictive value of coagulation parameters for the course of disease in COVID-19 patients,Clinical Presentation,No Intervention,No Intervention,1000,http://www.drks.de/DRKS00021574,None
1748,DRKS00021573,German Clinical Trials Register,2020-04-27,2020-04-30,False,"University Hospital, Heidelberg",Not Recruiting,Phase 1,Interventional,Germany,"Impact of pantoprazole on absorption and disposition of hydroxychloroquine, a drug used in Covid-19",Drug,Proton pump inhibitor + Hydoxychloroquine + Midazolam + Yohimbine vs. Hydoxychloroquine + Midazolam + Yohimbine,Proton pump inhibitor; Hydoxychloroquine; Midazolam; Yohimbine,24,http://www.drks.de/DRKS00021573,None
1749,DRKS00021575,German Clinical Trials Register,2020-04-29,2020-05-16,False,"University Hospital, Halle (Saale)",Recruiting,Not Applicable,Observational,Germany,Covid-19 HOspitalized patients RegisTry,Clinical Presentation,No Intervention,No Intervention,500,http://www.drks.de/DRKS00021575,None
1750,DRKS00021578,German Clinical Trials Register,2020-04-28,2020-04-24,True,Universität Konstanz Lehrstuhl,Not Recruiting,Not Applicable,Observational,Germany,Validation of new detection methods for SARS CoV-2 in suspected COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,300,http://www.drks.de/DRKS00021578,None
1751,DRKS00007246,German Clinical Trials Register,2015-04-24,2011-12-31,True,Covidien,Not Recruiting,Not Applicable,Interventional,Germany,"Prospective, Controlled, Multi-Center, Open, Single Arm Study for the Treatment of Subjects Presenting De Novo Occluded/Stenotic or Re-occluded/Restenotic Lesions of the Superficial Femoral or Popliteal Arteries Using a Paclitaxel-Coated Percutaneous Angioplasty Catheter",Not relevant,Not relevant,Not relevant,80,http://www.drks.de/DRKS00007246,None
1752,DRKS00021537,German Clinical Trials Register,2020-04-30,2020-04-17,True,Stuttgart Hospital,Recruiting,Not Applicable,Observational,Germany,Long term Analysis and Evaluation of morphologic and clinical Parameters in COVID-19 Patients: prospective development of a practical risk score,Clinical Presentation,No Intervention,No Intervention,150,http://www.drks.de/DRKS00021537,None
1753,DRKS00022868,German Clinical Trials Register,2020-08-20,2020-01-09,True,"University Hospital, Freiburg",Not Recruiting,Not Applicable,Observational,Germany,Impact of the COVID-19 pandemic and the political measures to contain its spread on children with disabilities and chronic illnesses and their families,Clinical Presentation (Epidemiology),No Intervention,No Intervention,800,http://www.drks.de/DRKS00022868,None
1754,DRKS00022871,German Clinical Trials Register,2020-10-01,2020-10-13,False,Hannover Medical School,Recruiting,Not Applicable,Observational,Germany,"Clinical, molecular and functional biomarkers for PROgnosis, pathomechanisms and treatment strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)",Clinical Presentation,No Intervention,No Intervention,400,http://www.drks.de/DRKS00022871,None
1755,DRKS00022874,German Clinical Trials Register,2020-08-20,2020-07-13,True,Hannover Medical School,Recruiting,Not Applicable,Observational,Germany,Retinal Microangiopathy in Patients after Covid-19 Disease,Clinical Presentation,No Intervention,No Intervention,66,http://www.drks.de/DRKS00022874,None
1756,DRKS00021585,German Clinical Trials Register,2020-04-29,2020-04-24,True,Vivantes Humboldt Klinikum,Recruiting,Not Applicable,Interventional,Germany,Lung Ultrasound in Covid-19 Pneumonia,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,220,http://www.drks.de/DRKS00021585,None
1757,DRKS00021588,German Clinical Trials Register,2020-05-04,2020-08-05,False,"University Hospital, Erlangen",Recruiting,Not Applicable,Interventional,Germany,Naturalistic evaluation of an Internet-based psychological training program for mental strain associated with the coronavirus / COVID-19 pandemic,Other (psych),Psychological,Psychological,1000,http://www.drks.de/DRKS00021588,None
1758,DRKS00021581,German Clinical Trials Register,2020-04-27,2020-04-27,False,LMU Klinikum,Recruiting,Not Applicable,Observational,Germany,Alterations in  inflammatory and coagulation variables in COVID-19 patients,Clinical Presentation,No Intervention,No Intervention,100,http://www.drks.de/DRKS00021581,None
1759,DRKS00021582,German Clinical Trials Register,2020-05-12,2020-05-31,False,Heidelberg University,Not Recruiting,Not Applicable,Interventional,"Germany, France, Mexico, United Kingdom, United States, Spain","A short, animated video to improve COVID-19 hygiene uptake: an online randomized experiment with 20,000 participants",Other,Other,Other,20000,http://www.drks.de/DRKS00021582,None
1760,DRKS00021591,German Clinical Trials Register,2020-04-27,2020-03-05,True,Bundeswehrkrankenhaus Berlin,Not Recruiting,Not Applicable,Observational,Germany,Identification of predictive biomarkers for severe progression of COVID-19,Clinical Presentation,No Intervention,No Intervention,100,http://www.drks.de/DRKS00021591,None
1761,DRKS00003600,German Clinical Trials Register,2012-03-19,2011-03-30,True,Central Institute of Mental Health Mannheim,Recruiting,Not Applicable,Observational,Germany,"Epigenetic effects of exposure to pre-, peri- and postnatal stress assessed in early infancy (subproject 1 of ""PrÃ¤-, peri- und pOstnatal Stress in human and non-human offspring: Epigenetic Impact on DepressiON (POSEIDON)"") / DIAbetes Mellitus - Obstetric and Neonatal Distress: Epigenetic Effects (DiaMOND E2)",Not relevant,Not relevant,Not relevant,400,http://www.drks.de/DRKS00003600,None
1762,DRKS00022500,German Clinical Trials Register,2020-08-21,2020-08-25,False,LMU Klinikum,Recruiting,Not Applicable,Observational,Germany,"Online survey on clinical care, health problems and psychosocial stress during the corona pandemic in children and adolescents with chronic inflammatory bowel disease (IBD) (COVID19-CED-PÃ„D)",Other (psych),No Intervention,No Intervention,300,http://www.drks.de/DRKS00022500,None
1763,DRKS00022504,German Clinical Trials Register,2020-08-06,2020-10-08,False,"University Hospital, Rostock",Recruiting,Not Applicable,Observational,Germany,"Prospective Study initiated by University Hospital Rostock concerning COVID-19 in mothers, nursery and school teachers of children in Rostock",Clinical Presentation (Epidemiology),No Intervention,No Intervention,600,http://www.drks.de/DRKS00022504,None
1764,DRKS00022533,German Clinical Trials Register,2020-08-19,2020-01-12,True,Charité University,Not Recruiting,Not Applicable,Observational,Germany,Pilot study to investigate the SmartPointer system in the context of domestic life with older people in need of support,Not relevant,Not relevant,Not relevant,117,http://www.drks.de/DRKS00022533,None
1765,DRKS00022534,German Clinical Trials Register,2020-11-04,2020-09-16,True,Charité University,Recruiting,Not Applicable,Observational,Germany,Requirements analysis for a robotic assistive system to support and promote the autonomy of people with neuromuscular diseases,Not relevant,Not relevant,Not relevant,15,http://www.drks.de/DRKS00022534,None
1766,DRKS00021206,German Clinical Trials Register,2020-03-30,2020-03-26,True,"University Hospital, Freiburg",Recruiting,Not Applicable,Observational,Germany,COVID-19 Registry Freiburg,Clinical Presentation,No Intervention,No Intervention,400,http://www.drks.de/DRKS00021206,None
1767,DRKS00022536,German Clinical Trials Register,2020-10-21,2020-06-24,True,"Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kinder- und Jugendalters",Recruiting,Not Applicable,Observational,Germany,Trends in suicide rates during the Covid-19 pandemic quarantine,Other (psych),No Intervention,No Intervention,500,http://www.drks.de/DRKS00022536,None
1768,DRKS00021208,German Clinical Trials Register,2020-03-31,2020-03-04,True,Vorstand der Deutschen Gesellschaft for Perinatale Medizin (DGPM),Recruiting,Not Applicable,Observational,Germany,COVID-19 related obstetric and neonatal outcome study (CRONOS),Clinical Presentation,No Intervention,No Intervention,100,http://www.drks.de/DRKS00021208,None
1769,DRKS00021214,German Clinical Trials Register,2020-04-01,2020-07-04,False,"University Hospital, Schleswig-Holstein",Recruiting,Not Applicable,Interventional,Germany,Improvement of the nutritional status regarding nicotinamide (vitamin B3) and the course of COVID-19 disease,Drug,Vitamin B3,Vitamin B3,1300,http://www.drks.de/DRKS00021214,None
1770,DRKS00022506,German Clinical Trials Register,2020-07-22,2020-04-16,True,"University Hospital, Würzburg",Recruiting,Not Applicable,Observational,Germany,Birth in Times of COVID-19,Clinical Presentation,No Intervention,No Intervention,300,http://www.drks.de/DRKS00022506,None
1771,DRKS00022507,German Clinical Trials Register,2020-07-22,2020-04-30,True,"University Hospital, Würzburg",Recruiting,Not Applicable,Observational,Germany,Patients with Breast Cancer in Times of COVID-19,Clinical Presentation,No Intervention,No Intervention,200,http://www.drks.de/DRKS00022507,None
1772,DRKS00021247,German Clinical Trials Register,2020-07-08,2020-04-18,True,"University Hospital, Freiburg",Recruiting,Not Applicable,Observational,Germany,"Prospective, multicentre evaluation of psychological distress in obstetric patients during pre-, and postnatal isolation in inpatient setting in the context of the SARS-CoV-2-Pandemic (COVID-19)",Other (psych),No Intervention,No Intervention,100,http://www.drks.de/DRKS00021247,None
1773,DRKS00021255,German Clinical Trials Register,2020-04-28,2020-01-05,True,Witten/Herdecke University,Not Recruiting,Not Applicable,Observational,Germany,Point-of-care coagulation testing in patients suffering from COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,20,http://www.drks.de/DRKS00021255,None
1774,DRKS00021254,German Clinical Trials Register,2020-04-03,2020-05-04,False,Universitätsklinikum Schleswig-Holstein,Not Recruiting,Not Applicable,Observational,Germany,"Investigation of the influence of the new coronavirus pandemic (COVID-19) on pain, mood and everyday life of patients with painful polyneuropathy",Other (psych),No Intervention,No Intervention,50,http://www.drks.de/DRKS00021254,None
1775,DRKS00022549,German Clinical Trials Register,2020-07-29,2020-09-04,False,"University Hospital Carl Gustav Carus, Dresden",Recruiting,Not Applicable,Observational,Germany,"Assessment of disease progression, infection chains and seroprevalence of Covid-19 infections in Saxony",Clinical Presentation (Epidemiology),No Intervention,No Intervention,250,http://www.drks.de/DRKS00022549,None
1776,DRKS00022553,German Clinical Trials Register,2020-09-14,2020-01-10,True,"University Hospital, Hamburg-Eppendorf",Recruiting,Phase 4,Interventional,Germany,Psychodiagnostic Screening in U-Examinations,Other (psych),No Intervention,No Intervention,5670,http://www.drks.de/DRKS00022553,None
1777,DRKS00021226,German Clinical Trials Register,2020-05-04,2020-07-05,False,"University Hospital, Heidelberg",Not Recruiting,Not Applicable,Observational,Germany,"PROTEGO: PRospective Observational cohort Trial Evaluating correlation of clinical findings, symptoms and disease development of German in- or Outpatients infected with SARS-CoV-2 - a CHIR-Net Student-Initiated German Medical Audit trial COVID-19 study (CHIR-Net SIGMA study group)",Clinical Presentation,No Intervention,No Intervention,500,http://www.drks.de/DRKS00021226,None
1778,DRKS00021225,German Clinical Trials Register,2020-04-01,2020-02-04,True,LMU Klinikum,Recruiting,Not Applicable,Observational,Germany,COVID-19 Registry of the LMU Munich,Clinical Presentation,No Intervention,No Intervention,1500,http://www.drks.de/DRKS00021225,None
1779,DRKS00021220,German Clinical Trials Register,2020-04-01,2020-04-17,False,"University Hospital, Heidelberg",Recruiting,Not Applicable,Observational,Germany,Evaluation of the performance of novel rapid diagnostics for COVID-19 at point-of-care,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,5000,http://www.drks.de/DRKS00021220,None
1780,DRKS00021229,German Clinical Trials Register,2020-07-27,2020-03-27,True,Witten/Herdecke University,Recruiting,Not Applicable,Observational,Germany,CoronaKids - Epidemiological data acquisition SARS-CoV2/Covid-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,900,http://www.drks.de/DRKS00021229,None
1781,DRKS00022564,German Clinical Trials Register,2020-09-07,2020-01-09,True,"University Hospital Carl Gustav Carus, Dresden",Recruiting,Not Applicable,Observational,Germany,Registry of SARS-CoV2-seroprevalence and Transmission of Covid-19 infections in common households,Clinical Presentation (Epidemiology),No Intervention,No Intervention,250,http://www.drks.de/DRKS00022564,None
1782,DRKS00021231,German Clinical Trials Register,2020-04-02,2020-03-04,True,Paracelsus Medical University ,Recruiting,Not Applicable,Observational,"Austria, Germany",Accompanying monitoring of primary care in GP practices during the COVID-19 pandemic,Health System,No Intervention,No Intervention,2000,http://www.drks.de/DRKS00021231,None
1783,DRKS00022498,German Clinical Trials Register,2020-07-23,2020-01-08,True,"University Hospital, Jena",Not Recruiting,Not Applicable,Observational,Germany,The state of health of ambulatory patients after COVID-19 disease,Clinical Presentation,No Intervention,No Intervention,1000,http://www.drks.de/DRKS00022498,None
1784,DRKS00021166,German Clinical Trials Register,2020-03-27,2020-03-30,False,"University Hospital, Leipzig",Not Recruiting,Not Applicable,Observational,Germany,Development of a test to measure the immune response in patients with Covid-19,Clinical Presentation,No Intervention,No Intervention,60,http://www.drks.de/DRKS00021166,None
1785,DRKS00021161,German Clinical Trials Register,2020-04-07,2020-02-15,True,Abteilung für Krankenhaushygiene,Recruiting,Not Applicable,Observational,Germany,Demographic and epidemiological characteristics of Covid-19 disease in Helios-Hospital and determinants of clinical course,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,http://www.drks.de/DRKS00021161,None
1786,DRKS00022496,German Clinical Trials Register,2020-07-20,2020-01-08,True,"University Hospital, Essen",Not Recruiting,Not Applicable,Observational,Germany,Study in times of Corona protection measures. An online survey of medical students in the summer semester 2020 (COVID-19),Other (psych),Psychological,Psychological,1000,http://www.drks.de/DRKS00022496,None
1787,DRKS00021164,German Clinical Trials Register,2020-03-27,2020-03-16,True,Universität Duisburg-Essen,Not Recruiting,Not Applicable,Observational,Germany,Psychological distress of the COVID-19 pandemic: A comparison between cancer patients and healthy controls,Other (psych),No Intervention,No Intervention,220,http://www.drks.de/DRKS00021164,None
1788,DRKS00022495,German Clinical Trials Register,2020-08-25,2020-01-08,True,Hannover Medical School,Recruiting,Not Applicable,Observational,"Austria, Germany",Prospective validation of a proteomic urine test for early and accurate prognosis of critical course complications in patients with SARS-CoV-2 infection,Prognosis,No Intervention,No Intervention,1000,http://www.drks.de/DRKS00022495,None
1789,DRKS00021145,German Clinical Trials Register,2020-04-08,2020-03-16,True,Deutsches Zentrum für Infektionsforschung (DZIF) e. V.,Recruiting,Not Applicable,Observational,"Portugal, Germany, Italy, France, Ireland, Belgium, United Kingdom, Iceland, Austria, Switzerland, Spain","Lean European Open Survey on 
SARS-CoV-2 (COVID-19)",Clinical Presentation,No Intervention,No Intervention,20000,http://www.drks.de/DRKS00021145,None
1790,DRKS00022475,German Clinical Trials Register,2020-07-27,2020-03-08,True,"University Hospital, Frankfurt",Recruiting,Not Applicable,Observational,Germany,"COVID19 Chronic Morbidity: Follow-up of patients with COVID19 and non-COVID19 pneumonia with respect to clinical status, pulmonary function and radiologic findings",Clinical Presentation,No Intervention,No Intervention,500,http://www.drks.de/DRKS00022475,None
1791,DRKS00022479,German Clinical Trials Register,2020-07-16,2020-07-26,False,Katholisches Klinikum Bochum,Not Recruiting,Not Applicable,Observational,Germany,Covid-19 safe anesthetic gas measurement with the AnaConDaS system,Other,Other,Other,14,http://www.drks.de/DRKS00022479,None
1792,DRKS00022473,German Clinical Trials Register,2020-08-27,2020-05-29,True,"University Hospital, Freiburg",Recruiting,Not Applicable,Observational,Germany,Palliative care expertise as an integral part of pandemic management (COVID-19),Health System,No Intervention,No Intervention,30,http://www.drks.de/DRKS00022473,None
1793,DRKS00021152,German Clinical Trials Register,2020-04-07,2020-05-04,False,Hannover Medical School,Not Recruiting,Not Applicable,Observational,Germany,COVID-19 Contact Study - Immunoreaction after possible SARS-CoV-2 / COVID-19 contact,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,http://www.drks.de/DRKS00021152,None
1794,DRKS00021153,German Clinical Trials Register,2020-04-06,2020-07-04,False,Leuphana Universität Lüneburg,Recruiting,Not Applicable,Interventional,Germany,get.calm and move.on â€“ tackling worries and finding strength for the crisis (COVID-19) in 10 steps,Other (psych),Psychological,Psychological,352,http://www.drks.de/DRKS00021153,None
1795,DRKS00022484,German Clinical Trials Register,2020-07-17,2020-09-04,False,"University Hospital, Regensburg",Recruiting,Not Applicable,Interventional,Germany,Clinical pilot study on the effects of a hydrogen peroxide mouthrinse on the intraoral viral load of SARS-CoV-2 (COVID-19),Drug,Hydrogen peroxide,Hydrogen peroxide,50,http://www.drks.de/DRKS00022484,None
1796,DRKS00021186,German Clinical Trials Register,2020-03-26,2020-03-26,False,KKH Bergstraße Abteilung,Recruiting,Not Applicable,Observational,Germany,"prospective observational study to evaluate transpulmonary pressure, end expiratory lung volume and intraabdominal pressure in mechanical ventilated patients with Covid-19",Clinical Presentation,No Intervention,No Intervention,45,http://www.drks.de/DRKS00021186,None
1797,DRKS00021301,German Clinical Trials Register,2020-04-16,2020-04-06,True,Universität Duisburg-Essen,Recruiting,Not Applicable,Interventional,Germany,An e-Mental Health Intervention to Support burdened People in Times of the COVID-19 pandemic: CoPE It,Other (psych),Psychological,Psychological,240,http://www.drks.de/DRKS00021301,None
1798,DRKS00021305,German Clinical Trials Register,2020-06-26,2020-04-13,True,"University Hospital, Freiburg",Recruiting,Not Applicable,Observational,"Australia, Liechtenstein, New Zealand, Germany, France, United States, United Kingdom, Uruguay, Austria, Switzerland, Spain",COVID-19 Symptom Tracker,Clinical Presentation,No Intervention,No Intervention,100000,http://www.drks.de/DRKS00021305,None
1799,DRKS00021306,German Clinical Trials Register,2020-04-14,2020-03-31,True,"University Hospital, Bonn",Not Recruiting,Not Applicable,Observational,Germany,Covid-19 Case-Cluster-Study,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1400,http://www.drks.de/DRKS00021306,None
1800,DRKS00021289,German Clinical Trials Register,2020-04-14,2020-03-31,True,Performa Nord,Not Recruiting,Not Applicable,Observational,Germany,Study on SARS-CoV-2-Serology (COVID-19) in Bremen's public sector,Clinical Presentation (Epidemiology),No Intervention,No Intervention,100,http://www.drks.de/DRKS00021289,None
1801,DRKS00021295,German Clinical Trials Register,2020-05-04,2020-06-04,False,Nierenzentrum Heidelberg e.V.,Recruiting,Not Applicable,Observational,Germany,Clinical characteristics of renal patients with COVID-19 infection,Clinical Presentation,No Intervention,No Intervention,100,http://www.drks.de/DRKS00021295,None
1802,DRKS00021297,German Clinical Trials Register,2020-05-04,2020-06-04,False,Nierenzentrum Heidelberg e.V.,Recruiting,Not Applicable,Observational,Germany,Clinical and immunological predictors of SARS-CoV-2 infection and Covid-19 diseases in patients with renal diseases and healthy persons,Clinical Presentation,No Intervention,No Intervention,100,http://www.drks.de/DRKS00021297,None
1803,DRKS00021268,German Clinical Trials Register,2020-04-09,2020-04-20,False,"University Hospital, Erlangen",Recruiting,Not Applicable,Observational,"Turkey, Germany",VOICE: Online-Survey on distress and mental resources of medical health care workers during Covid-19-pandemic,Other (psych),No Intervention,No Intervention,5000,http://www.drks.de/DRKS00021268,None
1804,DRKS00021276,German Clinical Trials Register,2020-04-06,2020-04-13,False,"University Hospital, Rostock",Not Recruiting,Not Applicable,Observational,Germany,Dynamics of regional lung aeration non-invasive determined by electrical impedance tomography in patients with COVID 19,Clinical Presentation,No Intervention,No Intervention,24,http://www.drks.de/DRKS00021276,None
1805,DRKS00021270,German Clinical Trials Register,2020-04-15,2020-04-14,True,Krankenhaus Reinbek St. Adolf-Stift,Not Recruiting,Not Applicable,Observational,Germany,Prospective molecular biological and serological examination for the detection of SARS-CoV-2 (COVID-19) in employees of a hospital of regular care in Germany,Clinical Presentation,No Intervention,No Intervention,900,http://www.drks.de/DRKS00021270,None
1806,DRKS00021273,German Clinical Trials Register,2020-04-20,2020-04-25,False,Goethe University Frankfurt,Recruiting,Not Applicable,Interventional,"Chile, Germany, Italy, France, Singapore, Argentina, Brazil, Austria, Spain",Effects of digital home exercise programs on physical and mental well-being during the COVID-19 pandemic: a multi-center trial,Other (exercise),Exercise,Exercise,544,http://www.drks.de/DRKS00021273,None
1807,DRKS00022305,German Clinical Trials Register,2020-07-31,2020-03-08,True,LMU Klinikum,Not Recruiting,Not Applicable,Interventional,Germany,Evaluation of the Patient-Doctor-Relationship during the COVID-19 pandemia,Other,No Intervention,No Intervention,500,http://www.drks.de/DRKS00022305,None
1808,DRKS00022335,German Clinical Trials Register,2020-07-08,2020-01-07,True,Helmholtz-Zentrum for Infektionsforschung GmbH,Recruiting,Not Applicable,Observational,Germany,Multi-local and serial cross-sectional prevalence study on antibodies against SARS-CoV-2 (COVID-19) in Germany,Clinical Presentation (Epidemiology),No Intervention,No Intervention,60000,http://www.drks.de/DRKS00022335,None
1809,DRKS00022337,German Clinical Trials Register,2020-06-29,2020-06-29,False,Chemo Group,Recruiting,Not Applicable,Observational,Chile,Analytical study of the profile of pro-inflammatory and pro-resolution factors in non-obese males with pulmonary symptomatology resulting from SARS Covid-19 verified with PCR blood analysis.,Clinical Presentation,No Intervention,No Intervention,20,http://www.drks.de/DRKS00022337,None
1810,DRKS00022259,German Clinical Trials Register,2020-07-10,2020-06-22,True,Pius-Hospital Oldenburg,Recruiting,Not Applicable,Observational,Germany,"Prevalence of SARS-CoV-2 Infections in the employees of the Pius-Hospital Oldenburg, confirmed through virus antibody testing - COVID-19",Clinical Presentation (Epidemiology),No Intervention,No Intervention,1250,http://www.drks.de/DRKS00022259,None
1811,DRKS00023584,German Clinical Trials Register,2020-11-17,2020-11-23,False,"University Hospital, Heidelberg",Not Recruiting,Not Applicable,Observational,Germany,What can we learn from the implementation of a novel point-of-care Antigen-Based SARS-CoV-2 Rapid Diagnostic Test to Screen Incoming Patients in a large University Hospital? (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,44,http://www.drks.de/DRKS00023584,None
1812,DRKS00022251,German Clinical Trials Register,2020-07-07,2020-07-07,False,"University Hospital, Düsseldorf",Recruiting,Not Applicable,Observational,Germany,Medical education with virtual patient encounters only in times of Covid-19 â€“ studentsâ€˜ and staff perceptions,Other,No Intervention,No Intervention,20,http://www.drks.de/DRKS00022251,None
1813,DRKS00023595,German Clinical Trials Register,2020-11-19,2020-01-12,True,Interdisziplinäres Zentrum für Palliativmedizin,Not Recruiting,Not Applicable,Observational,Germany,"COVID-19: National strategy for palliative care during times of a pandemic - generalst palliative care in hospitals (AP 4 PallPan, qualitative part)",Health System,No Intervention,No Intervention,30,http://www.drks.de/DRKS00023595,None
1814,DRKS00023561,German Clinical Trials Register,2020-11-13,2020-11-20,False,Ernst von Bergmann Klinikum,Recruiting,Not Applicable,Observational,Germany,Covid19 Antibody prevalence and sustainability. A retrospective longitudinal monocentered observational study in Covid 19 PCR positive hospitalworkers.,Clinical Presentation (Epidemiology),No Intervention,No Intervention,207,http://www.drks.de/DRKS00023561,None
1815,DRKS00022292,German Clinical Trials Register,2020-06-26,2020-01-06,True,"University Hospital, Freiburg",Recruiting,Not Applicable,Observational,Germany,Serological screening and metabolic analysis for evaluation of the immune response to SARS-CoV2 (COVID-19),Clinical Presentation,No Intervention,No Intervention,250,http://www.drks.de/DRKS00022292,None
1816,DRKS00022294,German Clinical Trials Register,2020-09-14,2020-06-22,True,Klinikum Aschaffenburg-Alzenau gemeinnutzige GmbH,Recruiting,Not Applicable,Observational,Germany,"TASC-3B (Trace element ATORG Study COVID-19 in Berlin, Bavaria, and Baden-WÃ¼rttemberg): Characterization of COVID-19 infections using parameters of the immune system and trace element status",Clinical Presentation,No Intervention,No Intervention,300,http://www.drks.de/DRKS00022294,None
1817,DRKS00022277,German Clinical Trials Register,2020-07-30,2020-04-15,True,"University Hospital, Mainz",Recruiting,Not Applicable,Observational,"Germany, Italy, Belgium, Netherlands, United Kingdom",COvid-19 REgistry on THROMBOSIS complications associated with hospitalization,Clinical Presentation,No Intervention,No Intervention,5000,http://www.drks.de/DRKS00022277,None
1818,DRKS00022280,German Clinical Trials Register,2020-07-13,2020-07-16,False,Humboldt University of Berlin,Not Recruiting,Not Applicable,Observational,Germany,Impact of the COVID-19 Pandemic on Symptoms of Anxiety Disorders,Other (psych),No Intervention,No Intervention,110,http://www.drks.de/DRKS00022280,None
1819,DRKS00005743,German Clinical Trials Register,2014-05-21,2014-05-21,False,Helios St.Elisabeth Klinik Oberhausen,Not Recruiting,Not Applicable,Interventional,Germany,Mesh fixation during intraperitoneal onlay mesh (IPOM) using either spiral tacks or vicryl sutures - a randomised clinical trial,Not relevant,Not relevant,Not relevant,80,http://www.drks.de/DRKS00005743,None
1820,DRKS00022406,German Clinical Trials Register,2020-10-06,2020-02-10,True,R-Biopharm AG,Recruiting,Not Applicable,Observational,Germany,Trial for collection of blood samples from healed Covid-19 patients - research and development of in-vitro diagnostics,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,http://www.drks.de/DRKS00022406,None
1821,DRKS00022416,German Clinical Trials Register,2020-07-20,2020-05-13,True,"University Hospital, Jena",Not Recruiting,Not Applicable,Observational,Germany,Seroprevalence of SARS-CoV-2 antibodies in a quarantined community after a COVID-19 outbreak-the CoNAN study,Clinical Presentation (Epidemiology),No Intervention,No Intervention,800,http://www.drks.de/DRKS00022416,None
1822,DRKS00022418,German Clinical Trials Register,2020-07-14,2020-05-07,True,"NEXTCLINIC IVF Zentren Prof. Zech, Bregenz",Recruiting,Not Applicable,Observational,Austria,Extent and spread of SARS-CoV-2 (COVID-19) infections in the first acute phase in the area of ??Vorarlberg,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,http://www.drks.de/DRKS00022418,None
1823,DRKS00022424,German Clinical Trials Register,2020-07-09,2020-09-07,False,"University Hospital, Leipzig",Not Recruiting,Not Applicable,Observational,Germany,Psychosocial functioning and lifestyle changes of German university students during the coronavirus (COVID-19) pandemic: An online survey,Other (psych),No Intervention,No Intervention,10000,http://www.drks.de/DRKS00022424,None
1824,DRKS00022403,German Clinical Trials Register,2020-07-15,2020-05-18,True,Technische Universität München,Recruiting,Not Applicable,Observational,Germany,SARS-CoV-2 serology in HIV PrEP users during the COVID-19 pandemic: THE PREP-CO STUDY,Clinical Presentation (Epidemiology),No Intervention,No Intervention,300,http://www.drks.de/DRKS00022403,None
1825,DRKS00022402,German Clinical Trials Register,2020-07-09,2020-05-15,True,"University Hospital, Würzburg",Recruiting,Not Applicable,Observational,Germany,Prospective collection of data and biomaterial of COVID-19 at the location WÃ¼rzburg,Clinical Presentation,No Intervention,No Intervention,400,http://www.drks.de/DRKS00022402,None
1826,DRKS00022455,German Clinical Trials Register,2020-07-23,2020-05-18,True,"University Hospital Carl Gustav Carus, Dresden",Not Recruiting,Not Applicable,Observational,Germany,Prospective SARS-CoV-2 seroprevalence study of schoolchildren after the lockdown March 2020 (COVID-19),Clinical Presentation (Epidemiology),No Intervention,No Intervention,600,http://www.drks.de/DRKS00022455,None
1827,DRKS00021134,German Clinical Trials Register,2020-03-19,2020-03-20,False,"University Hospital, Leipzig",Not Recruiting,Not Applicable,Observational,Germany,Identification of host cell respiratory tract cell gene expression and epigenetic pattern after human SARS-CoV-2 infection (COVID-19),Genomics,No Intervention,No Intervention,60,http://www.drks.de/DRKS00021134,None
1828,DRKS00022463,German Clinical Trials Register,2020-07-17,2020-08-30,False,"University Hospital, Mainz",Not Recruiting,Not Applicable,Observational,Germany,Mental recilience in relatives of inpatient palliative care patients during the Corona pandemic (COVID-19),Other (psych),No Intervention,No Intervention,100,http://www.drks.de/DRKS00022463,None
1829,DRKS00022432,German Clinical Trials Register,2020-07-20,2020-05-19,True,"University Hospital, Jena",Not Recruiting,Not Applicable,Observational,Germany,Survey of the seroprevalence and infection status of SARS-CoV-2 among employees of the University Hospital Jena (COVID-19),Clinical Presentation (Epidemiology),No Intervention,No Intervention,300,http://www.drks.de/DRKS00022432,None
1830,DRKS00022434,German Clinical Trials Register,2020-08-07,2020-08-06,True,Katholisches Klinikum Bochum,Recruiting,Not Applicable,Observational,Germany,CorKid (COVID19/ SARS-CoV-2 seroconversion in kids),Clinical Presentation (Epidemiology),No Intervention,No Intervention,3000,http://www.drks.de/DRKS00022434,None
1831,DRKS00022433,German Clinical Trials Register,2020-07-10,2020-01-08,True,University of Oldenburg,Recruiting,Not Applicable,Observational,Germany,Limitations of social life in the context of the COVID-19 pandemic - Effects on physical performance and health-related quality of life of older people (part B),Other (psych),No Intervention,No Intervention,2000,http://www.drks.de/DRKS00022433,None
1832,DRKS00022438,German Clinical Trials Register,2020-07-10,2020-06-26,True,University of Oldenburg,Recruiting,Not Applicable,Observational,Germany,Limitations of social life in the context of the COVID-19 pandemic - Effects on physical performance and health-related quality of life of older people (part C),Other (psych),No Intervention,No Intervention,300,http://www.drks.de/DRKS00022438,None
1833,DRKS00022448,German Clinical Trials Register,2020-07-22,2020-07-16,True,Steirische Akademie fur Allgemeinmedizin,Recruiting,Not Applicable,Observational,Austria,COVID-19 in primary care: assessment of risk factors and predictors for severe courses (PrimeRisk C-19),Clinical Presentation,No Intervention,No Intervention,300,http://www.drks.de/DRKS00022448,None
1834,DRKS00022371,German Clinical Trials Register,2020-07-06,2020-05-28,True,"University Hospital, Heidelberg",Not Recruiting,Not Applicable,Observational,Liberia,"Knowledge, Attitudes and Practices (KAP) Study on COVID-19 in Maryland, Liberia",Other,No Intervention,No Intervention,500,http://www.drks.de/DRKS00022371,None
1835,DRKS00022387,German Clinical Trials Register,2020-07-09,2020-12-06,False,A-AGG-psychotherapeutische Ambulanz,Recruiting,Not Applicable,Observational,Austria,Effects of the Covid 19 crisis on the experiences of psychiatric patients in the combination setting of group and individual psychotherapy treatment,Other (psych),No Intervention,No Intervention,450,http://www.drks.de/DRKS00022387,None
1836,DRKS00022380,German Clinical Trials Register,2020-07-07,2020-12-07,False,LMU Klinikum,Recruiting,Not Applicable,Observational,Germany,Clinical translational and epidemiological research project on SARS coronavirus 2 infection in during the COVID 19 pandemic children in Bavaria,Clinical Presentation (Epidemiology),No Intervention,No Intervention,14000,http://www.drks.de/DRKS00022380,None
1837,DRKS00022359,German Clinical Trials Register,2020-07-17,2020-06-29,True,DB Fernverkehr AG,Recruiting,Not Applicable,Observational,Germany,Study by DB Fernverkehr AG on corona infections and corona immunity of its employees (COVID-19),Clinical Presentation (Epidemiology),No Intervention,No Intervention,1050,http://www.drks.de/DRKS00022359,None
1838,DRKS00022395,German Clinical Trials Register,2020-08-27,2020-04-20,True,"University Hospital, Essen",Not Recruiting,Not Applicable,Observational,Germany,The influence of the Covid-19-pandemic on pain and pain related disability in chronic pain patients â€“ an explorative study,Other,No Intervention,No Intervention,197,http://www.drks.de/DRKS00022395,None
1839,DRKS00005847,German Clinical Trials Register,2014-04-25,2014-02-27,True,Covidien,Not Recruiting,Phase 4,Interventional,Germany,EverFlexâ„¢ Self-expanding Peripheral Stent With Entrustâ„¢ Delivery System Clinical Study,Not relevant,Not relevant,Not relevant,30,http://www.drks.de/DRKS00005847,None
1840,DRKS00017593,German Clinical Trials Register,2019-07-26,2019-02-08,True,"University Hospital, Frankfurt",Recruiting,Not Applicable,Observational,Germany,Feasibility study of a mobile device for the prevention of sepsis in patients with solid tumors after chemotherapy and patients with infectiose diseases (COVID-19),Not relevant,Not relevant,Not relevant,50,http://www.drks.de/DRKS00017593,None
1841,DRKS00023418,German Clinical Trials Register,2020-10-28,2020-06-05,True,University of Lübeck,Recruiting,Not Applicable,Observational,Germany,ELISA - LÃ¼bEcker longitudinal study on Infections with SARS-CoV-2 (COVID-19),Clinical Presentation (Epidemiology),No Intervention,No Intervention,3000,http://www.drks.de/DRKS00023418,None
1842,DRKS00023435,German Clinical Trials Register,2020-10-27,2020-11-16,False,"University Hospital, Bonn",Not Recruiting,Not Applicable,Observational,Germany,SARS-CoV-2 in Air (COVID-19),Clinical Presentation,No Intervention,No Intervention,15,http://www.drks.de/DRKS00023435,None
1843,DRKS00023430,German Clinical Trials Register,2020-11-10,2020-11-15,False,"University Hospital, Düsseldorf",Not Recruiting,Not Applicable,Observational,Germany,Evaluation of the use of video consultation in rheumatology in the context of the COVID-19 pandemic,Telehealth,No Intervention,No Intervention,300,http://www.drks.de/DRKS00023430,None
1844,DRKS00023406,German Clinical Trials Register,2020-11-09,2020-11-15,False,"University Hospital, Cologne",Not Recruiting,Not Applicable,Interventional,Germany,Intubation with VieScope vs. Videolaryngoskopy in complete personal protecion gear in asimulated COVID-19-Patient - A randomized controll trail,Procedure,Intubation,Intubation,35,http://www.drks.de/DRKS00023406,None
1845,DRKS00023322,German Clinical Trials Register,2020-10-19,2020-09-04,True,LMU Klinikum,Recruiting,Not Applicable,Observational,Germany,Identification of biomarkers for prognosis of morbidity and mortality of SARS-CoV-2 (COVID-19) patients,Prognosis,No Intervention,No Intervention,100,http://www.drks.de/DRKS00023322,None
1846,DRKS00023334,German Clinical Trials Register,2020-10-30,2020-09-14,True,"University Hospital, Jena",Recruiting,Not Applicable,Observational,Germany,SARS-CoViD-Endotheliitis Study via Retinal Vascular Analysis (COVID-19),Clinical Presentation,No Intervention,No Intervention,30,http://www.drks.de/DRKS00023334,None
1847,DRKS00022057,German Clinical Trials Register,2020-06-05,2020-05-31,True,"University Hospital, Tübingen",Not Recruiting,Not Applicable,Observational,Germany,Traumatological emergency consultations during the COVID-19 pandemic 2020,Health System,No Intervention,No Intervention,25000,http://www.drks.de/DRKS00022057,None
1848,DRKS00022054,German Clinical Trials Register,2020-06-02,2020-05-05,True,"University Hospital, Heidelberg",Recruiting,Not Applicable,Observational,Germany,CovidCare 1 â€“ Surveillance and care for confirmed and suspected patients with COVID-19 in general practice: an observational study,Clinical Presentation,No Intervention,No Intervention,400,http://www.drks.de/DRKS00022054,None
1849,DRKS00023385,German Clinical Trials Register,2020-11-06,2020-02-10,True,Charité University,Recruiting,Not Applicable,Observational,Germany,"Prospective cohort study on the incidence
of SARS-CoV-2-infections (COVID-19) in professional orchestra musicians and choir singers",Clinical Presentation (Epidemiology),No Intervention,No Intervention,2500,http://www.drks.de/DRKS00023385,None
1850,DRKS00023393,German Clinical Trials Register,2020-10-26,2020-05-04,True,University of Lübeck,Recruiting,Not Applicable,Observational,Germany,Handling and coping with the corona pandemic (Covid-19) and its physical and psychological effects,Other (psych),No Intervention,No Intervention,5000,http://www.drks.de/DRKS00023393,None
1851,DRKS00022067,German Clinical Trials Register,2020-06-12,2020-06-25,False,MSB Medical School Berlin,Not Recruiting,Not Applicable,Interventional,Germany,An intensive longitudinal study on habit formation of hand washing behavior during the COVID-19 pandemic,Procedure,Hand washing,Hand washing,134,http://www.drks.de/DRKS00022067,None
1852,DRKS00022035,German Clinical Trials Register,2020-06-25,2020-05-18,True,Thüringer Hausärzteverband,Recruiting,Not Applicable,Observational,Germany,"COVID-19 in inpatient care facilities (nursing homes) in Thuringia - it hit us hard! A structured retrospective review of primary care, the work of nurses and the course of infections",Health System,No Intervention,No Intervention,100,http://www.drks.de/DRKS00022035,None
1853,DRKS00022032,German Clinical Trials Register,2020-06-30,2020-05-27,True,"University Hospital, Leipzig",Not Recruiting,Not Applicable,Observational,Germany,Study on the Evaluation of the Infectious Process of SARS-CoV-2 in Teachers and Students in Saxony (COVID-19),Clinical Presentation (Epidemiology),No Intervention,No Intervention,4000,http://www.drks.de/DRKS00022032,None
1854,DRKS00023364,German Clinical Trials Register,2020-10-19,2020-06-20,True,"University Hospital, Leipzig",Recruiting,Not Applicable,Observational,Germany,Seroprevalence of SARS CoV-2 infections/Covid-19 in blood donors and patients of the University Hospitals in Leipzig,Clinical Presentation (Epidemiology),No Intervention,No Intervention,2000,http://www.drks.de/DRKS00023364,None
1855,DRKS00022071,German Clinical Trials Register,2020-05-29,2020-03-06,True,"University Hospital, Leipzig",Not Recruiting,Not Applicable,Observational,Germany,Psychosocial functioning and stress factors of psychiatric patients during the COVID-19 pandemic: Telephone survey of patients in the psychiatric outpatient clinic of the Leipzig University Hospital,Other (psych),No Intervention,No Intervention,150,http://www.drks.de/DRKS00022071,None
1856,DRKS00022083,German Clinical Trials Register,2020-06-09,2020-05-20,True,Landesklinikum Neunkirchen,Recruiting,Not Applicable,Interventional,Austria,Evaluation of three commercially available rapid assays for detection of IgG and/or IGM antibodies to SARS-CoV-2 (COVID-19) for assessment of contact personsâ€™ immune status and termination of quarantine and self-isolation â€“ a prospective pilot study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,70,http://www.drks.de/DRKS00022083,None
1857,DRKS00022082,German Clinical Trials Register,2020-06-15,2020-06-16,False,"University Hospital, Bonn",Not Recruiting,Not Applicable,Observational,Germany,Effects of COVID-19 on lung function and gas exchange,Clinical Presentation,No Intervention,No Intervention,124,http://www.drks.de/DRKS00022082,None
1858,DRKS00022088,German Clinical Trials Register,2020-06-03,2020-02-06,True,"University Hospital, Erlangen",Recruiting,Not Applicable,Observational,Germany,"Prevalence of SARS-CoV-2 (COVID-19) in pregnancy and at delivery in Franconia, Germany",Clinical Presentation (Epidemiology),No Intervention,No Intervention,2550,http://www.drks.de/DRKS00022088,None
1859,DRKS00004377,German Clinical Trials Register,2012-09-14,2012-12-09,False,Herford Hospital,Not Recruiting,Not Applicable,Interventional,Germany,Comparison of the multiport system with a single port system in patients undergoing SILS-cholezystectomy,Not relevant,Not relevant,Not relevant,42,http://www.drks.de/DRKS00004377,None
1860,DRKS00023500,German Clinical Trials Register,2020-11-05,2020-06-18,True,"University Hospital, Frankfurt",Not Recruiting,Not Applicable,Interventional,Germany,"Rapidly applicable surveillance process for COVID-19 
in day care centers with dual swabs",Clinical Presentation (Epidemiology),No Intervention,No Intervention,1250,http://www.drks.de/DRKS00023500,None
1861,DRKS00023507,German Clinical Trials Register,2020-11-27,2020-11-29,False,Institute of Virology,Recruiting,Not Applicable,Observational,Germany,SARS-CoV-2 Surveillance in childcare facilities,Clinical Presentation (Epidemiology),No Intervention,No Intervention,120,http://www.drks.de/DRKS00023507,None
1862,DRKS00022224,German Clinical Trials Register,2020-06-17,2020-06-17,False,"University Hospital, Heidelberg",Recruiting,Not Applicable,Observational,Germany,Ambulatory healthcare models and processes  during the ongoing SARS-CoV-2 pandemic (COVID-19),Other (psych),Psychological,Psychological,1000,http://www.drks.de/DRKS00022224,None
1863,DRKS00022226,German Clinical Trials Register,2020-07-06,2020-01-07,True,SLK-Kliniken Heilbronn GmbH,Recruiting,Not Applicable,Observational,Germany,SLKovid: Seroprevalence of SARS-CoV-2 in employees of a clinic with COVID-centre (COVID-19),Clinical Presentation (Epidemiology),No Intervention,No Intervention,5000,http://www.drks.de/DRKS00022226,None
1864,DRKS00023558,German Clinical Trials Register,2020-11-16,2020-11-22,False,Arbeitsmedizinischer Dienst der BG BAU GmbH,Not Recruiting,Not Applicable,Observational,Germany,COVID-19 Infection Rate in the Construction- and Cleaning Industry,Clinical Presentation (Epidemiology),No Intervention,No Intervention,3000,http://www.drks.de/DRKS00023558,None
1865,DRKS00023525,German Clinical Trials Register,2020-11-10,2020-01-12,True,"University Hospital, Cologne",Not Recruiting,Not Applicable,Observational,Germany,"TEMPO - Telemedical psychiatry and psychotherapy for children and adolescents during the Covid-19 pandemic: feasibility, acceptance, satisfaction and pandemic-specific mental stress",Other (psych),Psychological,Psychological,300,http://www.drks.de/DRKS00023525,None
1866,DRKS00022203,German Clinical Trials Register,2020-06-15,2020-06-20,False,Pharco Corporate,Recruiting,Phase 2/Phase 3,Interventional,Egypt,"Efficacy & Safety of Sofosbuvir/Daclatasvir treatment in COVID-19: A randomized, controlled study",Drug,Sofosbuvir + Daclatasvir vs. Hydroxychloroquine,Sofosbuvir; Daclatasvir; Hydroxychloroquine,90,http://www.drks.de/DRKS00022203,None
1867,DRKS00022147,German Clinical Trials Register,2020-07-13,2020-02-03,True,Technische Universität München,Recruiting,Not Applicable,Observational,Germany,Consequences of the COVID-19 pandemic for surgical patient treatment in a tertiary care center in Munich,Health System,No Intervention,No Intervention,500,http://www.drks.de/DRKS00022147,None
1868,DRKS00023447,German Clinical Trials Register,2020-11-03,2020-06-11,True,LMU Klinikum,Not Recruiting,Not Applicable,Observational,Germany,Sars-CoV-2 Infection (Covid-19) During Pregnancy: Effects on Mother and Child,Clinical Presentation,No Intervention,No Intervention,30,http://www.drks.de/DRKS00023447,None
1869,DRKS00022185,German Clinical Trials Register,2020-06-16,2020-04-29,True,Orthopadische Universitatsklinik,Recruiting,Not Applicable,Observational,Germany,Data evaluation of an online symptom and risk detection application for Covid 19 research,Other (software),eHealth,eHealth,10000,http://www.drks.de/DRKS00022185,None
1870,DRKS00022188,German Clinical Trials Register,2020-06-15,2020-01-07,True,Bundeswehrkrankenhaus Ulm,Not Recruiting,Not Applicable,Observational,Germany,Influence of the Covid-19 pandemic on the patient mix in German emergency departments,Health System,No Intervention,No Intervention,500000,http://www.drks.de/DRKS00022188,None
1871,DRKS00022157,German Clinical Trials Register,2020-08-03,2020-10-08,False,Sauerlandpraxis Medebach,Not Recruiting,Not Applicable,Observational,Germany,Physical and Psychological Impact of the COVID-19 Pandemic in Germany- a Survey of General Practitioners,Other,No Intervention,No Intervention,500,http://www.drks.de/DRKS00022157,None
1872,DRKS00023499,German Clinical Trials Register,2020-11-03,2020-03-11,True,Heidelberg University,Recruiting,Not Applicable,Observational,Germany,Effects of COVID-19 on levels of stress and anxiety in dental students,Other (psych),No Intervention,No Intervention,100,http://www.drks.de/DRKS00023499,None
1873,DRKS00022166,German Clinical Trials Register,2020-06-15,2020-05-18,True,Paracelsus Medical University ,Recruiting,Not Applicable,Observational,Austria,Scientific guidance for risk-control and prevention of COVID-19 in professional soccer-players in Austria,Health System,No Intervention,No Intervention,250,http://www.drks.de/DRKS00022166,None
1874,DRKS00023113,German Clinical Trials Register,2020-09-22,2020-09-30,False,"University Hospital, Bonn",Not Recruiting,Not Applicable,Observational,Germany,COVID-19 Study on natural protection against SARS-CoV2 reinfections,Clinical Presentation,No Intervention,No Intervention,1250,http://www.drks.de/DRKS00023113,None
1875,DRKS00023117,German Clinical Trials Register,2020-09-21,2020-01-03,True,Charité University,Recruiting,Not Applicable,Observational,Germany,COVID-NA: Changes in emergency department utilitzation during the COVID-19 pandemic,Health System,No Intervention,No Intervention,1000000,http://www.drks.de/DRKS00023117,None
1876,DRKS00023180,German Clinical Trials Register,2020-10-01,2020-04-28,True,Klinik Bad Reichenhall,Recruiting,Not Applicable,Observational,Germany,Effects of pulmonary rehabilitation in patients with COVID-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,100,http://www.drks.de/DRKS00023180,None
1877,DRKS00023184,German Clinical Trials Register,2020-10-07,2020-09-20,True,Arbeitsgemeinschaft Intensivmedizin (AIM) Arnsberg,Recruiting,Not Applicable,Interventional,Germany,Impact of personal protective equipment (PPE) during a simulated cardiac arrest in times of the COVID-19 pandemic,Other,Other,Other,400,http://www.drks.de/DRKS00023184,None
1878,DRKS00023171,German Clinical Trials Register,2020-10-26,2020-02-11,True,BKK Verkehrsbau Union GmbH,Not Recruiting,Not Applicable,Interventional,Germany,Virtual Assisted Living,Other,Other,Other,207,http://www.drks.de/DRKS00023171,None
1879,DRKS00023312,German Clinical Trials Register,2020-10-13,2020-10-25,False,"University Hospital, Essen",Recruiting,Not Applicable,Observational,Germany,Investigation of COVID-19 associated neurological comorbidities,Clinical Presentation,No Intervention,No Intervention,250,http://www.drks.de/DRKS00023312,None
1880,DRKS00005132,German Clinical Trials Register,2013-07-08,2009-03-25,True,"University Hospital, Tübingen",Not Recruiting,Not Applicable,Interventional,Germany,Nasal high - flow - oxygen therapy in patients with hypoxic respiratory failure: Effect on functional and subjective respiratory parameters compared to conventional O2 therapy and non-invasive ventilation (NIV),Not relevant,Not relevant,Not relevant,14,http://www.drks.de/DRKS00005132,None
1881,DRKS00000302,German Clinical Trials Register,2009-12-23,2010-05-01,False,Gummersbach District Hospital,Not Recruiting,Not Applicable,Interventional,Germany,Conventional laparoscopic versus needleskopic versus single-port cholecystectomy - a randomised clinical trial,Not relevant,Not relevant,Not relevant,90,http://www.drks.de/DRKS00000302,None
1882,DRKS00006420,German Clinical Trials Register,2014-11-21,2012-05-31,True,Maya Medical,Recruiting,Phase 2,Interventional,"New Zealand, Germany, Italy, Luxembourg, Belgium, Netherlands",Rapid Renal Sympathetic Denervation for Resistant Hypertension Using the OneShotâ„¢ Ablation System,Not relevant,Not relevant,Not relevant,50,http://www.drks.de/DRKS00006420,None
1883,DRKS00023001,German Clinical Trials Register,2020-09-14,2020-09-15,False,Leipzig University,Recruiting,Not Applicable,Observational,Germany,Coronary heart disease management during the Corona Pandemic (COVID-19),Health System,No Intervention,No Intervention,400,http://www.drks.de/DRKS00023001,None
1884,DRKS00023014,German Clinical Trials Register,2020-09-11,2020-09-20,False,IGES Institut,Not Recruiting,Not Applicable,Observational,Germany,Outpatient treatment of COVID-19: Impact of comorbidities on hospital admissions and other treatment decisions,Health System,No Intervention,No Intervention,500,http://www.drks.de/DRKS00023014,None
1885,DRKS00023012,German Clinical Trials Register,2020-10-27,2020-01-06,True,St. Marien Hospital Siegen,Recruiting,Not Applicable,Observational,Germany,SARS-CoV-2 (COVID-19) registry for oncological and hematological patients in Germany,Clinical Presentation (Epidemiology),No Intervention,No Intervention,170,http://www.drks.de/DRKS00023012,None
1886,DRKS00023069,German Clinical Trials Register,2020-10-05,2020-10-26,False,"University Hosapital, Tübingen",Not Recruiting,Not Applicable,Observational,Germany,"Lessons-Learned - Developing a strategy for outpatient care during a pandemic in Baden-WÃ¼rttemberg, Germany. Patient characteristics and clinical course of infections with SARS-CoV-2.",Clinical Presentation,No Intervention,No Intervention,2000,http://www.drks.de/DRKS00023069,None
1887,DRKS00023086,German Clinical Trials Register,2020-10-09,2020-10-15,False,"University Hospital, Homburg",Not Recruiting,Not Applicable,Observational,Germany,Analysis of the SARS-CoV-2 specific immune response in persons with SARS-CoV-2 infection (COVID-19),Clinical Presentation,No Intervention,No Intervention,190,http://www.drks.de/DRKS00023086,None
1888,DRKS00023087,German Clinical Trials Register,2020-09-15,2020-09-21,False,"University Hospital, Rostock",Not Recruiting,Not Applicable,Observational,"Austria, Switzerland, Germany",Survey about SARS-CoV2 / Covid-19,Other,No Intervention,No Intervention,1000,http://www.drks.de/DRKS00023087,None
1889,DRKS00023091,German Clinical Trials Register,2020-09-24,2020-09-16,True,Hessian Ministry for Social Affairs and Integration,Recruiting,Not Applicable,Interventional,Germany,"Early detection of SARS-CoV-2 (COVID-19) in schools in the state of Hesse, Germany",Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,http://www.drks.de/DRKS00023091,None
1890,DRKS00023092,German Clinical Trials Register,2020-09-17,2020-09-19,False,Central Institute of Mental Health Mannheim,Not Recruiting,Not Applicable,Observational,Germany,"Does dealing with the worldwide COVID-19-pandemic and alcohol stimuli trigger craving for alcohol for people with Alcohol Use Disorder?
A comparative Eye-Tracking study",Other,No Intervention,No Intervention,30,http://www.drks.de/DRKS00023092,None
1891,DRKS00021813,German Clinical Trials Register,2020-06-29,2020-06-29,False,Kliniken Nordoberpfalz AG,Not Recruiting,Not Applicable,Observational,Germany,Antibody assesement for COVID-19 prevalence two months after outbreak in the hot spot Region of Tirschenreuth / Bavaria,Clinical Presentation (Epidemiology),No Intervention,No Intervention,2500,http://www.drks.de/DRKS00021813,None
1892,DRKS00021812,German Clinical Trials Register,2020-06-12,2020-12-10,False,Paracelsus Medical University ,Not Recruiting,Not Applicable,Observational,Germany,"Ability to mentalize in old age. Resilience, risk and transgenerational transmission.",Not relevant,Not relevant,Not relevant,88,http://www.drks.de/DRKS00021812,None
1893,DRKS00021815,German Clinical Trials Register,2020-06-05,2020-07-28,False,Kassenärztliche Vereinigung Thüringen,Recruiting,Not Applicable,Observational,Germany,Investigation of the immune status against SARS-CoV-2 of medical professionals in Doctor's Practices in Thuringia (COVID-19 research project),Clinical Presentation (Epidemiology),No Intervention,No Intervention,10000,http://www.drks.de/DRKS00021815,None
1894,DRKS00021823,German Clinical Trials Register,2020-05-28,2020-05-29,False,"Klinik for Ansthesiologie, Intensivmedizin und Schmerztherapie",Not Recruiting,Not Applicable,Observational,Germany,"Survival and risk factors in Covid-19 and influenza, a retrospective analysis",Clinical Presentation,No Intervention,No Intervention,18000,http://www.drks.de/DRKS00021823,None
1895,DRKS00021810,German Clinical Trials Register,2020-05-27,2020-03-18,True,"University Hospital, Heidelberg",Recruiting,Not Applicable,Observational,Germany,The role of immune-reactions in patients with COVID-19,Clinical Presentation,No Intervention,No Intervention,1000,http://www.drks.de/DRKS00021810,None
1896,DRKS00021909,German Clinical Trials Register,2020-07-02,2020-05-27,True,Landessportverband Baden-Worttemberg e. V. (LSV),Recruiting,Not Applicable,Observational,Germany,Prevalence of SARS-CoV2 in scholars: Comparison of boarding and private school (COVID-19),Clinical Presentation (Epidemiology),No Intervention,No Intervention,60,http://www.drks.de/DRKS00021909,None
1897,DRKS00022926,German Clinical Trials Register,2020-08-21,2020-03-22,True,"University Hospital, Heidelberg",Not Recruiting,Not Applicable,Observational,Germany,Evaluation of the course of COVID-19 and perceptions among those tested positive â€“ a survey based study,Clinical Presentation,No Intervention,No Intervention,1000,http://www.drks.de/DRKS00022926,None
1898,DRKS00022925,German Clinical Trials Register,2020-09-24,2020-10-15,False,"University Hospital, Freiburg",Not Recruiting,Not Applicable,Observational,Germany,"Role, challenges and opportunities of catholic pastoral care as part of 'spiritual care' in the end-of-life setting and under COVID-19 pandemic conditions",Other,Other,Other,30,http://www.drks.de/DRKS00022925,None
1899,DRKS00021604,German Clinical Trials Register,2020-07-01,2020-05-18,True,Zollernalb Klinikum Balingen,Recruiting,Not Applicable,Observational,Germany,Pulmonary embolism and/or deep vein thrombosis in COVID-19 patients.,Clinical Presentation,No Intervention,No Intervention,100,http://www.drks.de/DRKS00021604,None
1900,DRKS00021605,German Clinical Trials Register,2020-04-28,2020-04-27,True,Klinikum Konstanz II. Medizin,Recruiting,Not Applicable,Observational,Germany,"COVID-19 in an academic teaching hospital in Konstanz/Germany - evaluation of the ""double rule out - single rule in"" concept (DURO-SIN)",Prognosis,No Intervention,No Intervention,200,http://www.drks.de/DRKS00021605,None
1901,DRKS00021611,German Clinical Trials Register,2020-05-12,2020-05-15,False,"Ortenauklinikum, Betriebsstelle Lahr",Recruiting,Not Applicable,Observational,Germany,Hypernatremia in critically ill patients with Covid-19,Clinical Presentation,No Intervention,No Intervention,33,http://www.drks.de/DRKS00021611,None
1902,DRKS00022941,German Clinical Trials Register,2020-08-28,2020-06-15,True,"St. Vincenz Hospital, Datteln",Recruiting,Not Applicable,Observational,Germany,"""COVID-19: Hotspot hospital?- Epidemiological analysis time shifted antibody tests of hospital employees",Clinical Presentation (Epidemiology),No Intervention,No Intervention,3000,http://www.drks.de/DRKS00022941,None
1903,DRKS00021612,German Clinical Trials Register,2020-04-30,2020-03-30,True,Technische Universität München,Recruiting,Not Applicable,Observational,Germany,CORRECT: COvid (Covid-19) Registry REChts der Isar intensive care Trial,Clinical Presentation,No Intervention,No Intervention,500,http://www.drks.de/DRKS00021612,None
1904,DRKS00022909,German Clinical Trials Register,2020-08-31,2020-09-15,False,Charité University,Not Recruiting,Not Applicable,Observational,Germany,Health realted self-help strategies during the COVID-19 pandemic - an online-based cross-sectional study,Other (psych),No Intervention,No Intervention,2000,http://www.drks.de/DRKS00022909,None
1905,DRKS00021638,German Clinical Trials Register,2020-05-11,2020-04-17,True,"University Hospital, Cologne",Not Recruiting,Not Applicable,Observational,Germany,Retrospective analysis of the relationship between invasive ventilation (considering COVID-19) and a Comprehensive Geriatric Assessment (CGA),Other (physical),Mechanical ventilation,Mechanical ventilation,1276,http://www.drks.de/DRKS00021638,None
1906,DRKS00021649,German Clinical Trials Register,2020-06-30,2020-04-24,True,"University Hospital, Würzburg",Recruiting,Not Applicable,Observational,Germany,SARS-CoV-2 exposure and psychological well-being of health care workers in a German Department of Anesthesiology during the COVID-19 pandemic,Other (psych),No Intervention,No Intervention,100,http://www.drks.de/DRKS00021649,None
1907,DRKS00021653,German Clinical Trials Register,2020-06-05,2020-04-21,True,Gesellschaft for Klinische Studien,Recruiting,Not Applicable,Observational,Germany,"Retrospective examination of the course of a Covid-19 infection
in patients with inflammatory bowel disease",Clinical Presentation,No Intervention,No Intervention,500,http://www.drks.de/DRKS00021653,None
1908,DRKS00022958,German Clinical Trials Register,2020-10-07,2021-04-01,False,University of Osnabruck,Not Recruiting,Not Applicable,Interventional,Germany,Covid-19-associated research on hand eczema in the health sector â€“ Part 2,Other,No Intervention,No Intervention,35,http://www.drks.de/DRKS00022958,None
1909,DRKS00021630,German Clinical Trials Register,2020-05-06,2020-08-05,False,"University Hospital, Schleswig-Holstein",Not Recruiting,Not Applicable,Observational,Germany,Detection of a delayed Treatment of urgent ophthalmologic Treatment during the SARS-CoV-2 pandemic (COVID-19),Health System,No Intervention,No Intervention,30,http://www.drks.de/DRKS00021630,None
1910,DRKS00022964,German Clinical Trials Register,2020-09-07,2020-07-16,True,"University Hospital, Würzburg",Recruiting,Not Applicable,Observational,Germany,"Investigation of clinical characteristics, management and outcome of ARDS patients: a Germany-wide register study 
DIVI ECMO COVID-19 Register",Clinical Presentation,No Intervention,No Intervention,100,http://www.drks.de/DRKS00022964,None
1911,DRKS00020352,German Clinical Trials Register,2020-01-13,2020-01-27,False,University of Greifswald,Not Recruiting,Not Applicable,Observational,Germany,Prospective data acquisition of patients presenting in the specialised CRPS outpatient clinic of the Unfallkrankenhaus Berlin for the assessment of the Budapest criteria,Not relevant,Not relevant,Not relevant,200,http://www.drks.de/DRKS00020352,None
1912,DRKS00021688,German Clinical Trials Register,2020-05-13,2020-01-03,True,Charité University,Recruiting,Not Applicable,Observational,Germany,Analysis of the Pathophysiology and Pathology of Corona Virus Disease 2019 (Pa-COVID-19),Clinical Presentation,No Intervention,No Intervention,1500,http://www.drks.de/DRKS00021688,None
1913,DRKS00021680,German Clinical Trials Register,2020-05-12,2020-06-05,False,"University Hospital, Freiburg",Recruiting,Not Applicable,Observational,Germany,Quality assurance of cochlear implant rehabilitation in times of the COVID-19 pandemic (Corona),Other,Other,Other,100,http://www.drks.de/DRKS00021680,None
1914,DRKS00021699,German Clinical Trials Register,2020-05-11,2020-12-05,False,"University Hospital, Freiburg",Not Recruiting,Not Applicable,Observational,Germany,lnfluence of the COVID-19-pandemic on the treatment of ENT patients,Clinical Presentation,No Intervention,No Intervention,20000,http://www.drks.de/DRKS00021699,None
1915,DRKS00021698,German Clinical Trials Register,2020-05-19,2020-07-04,False,LMU Klinikum,Recruiting,Not Applicable,Observational,Germany,Prospective COVID-19 Cohort Munich,Clinical Presentation (Epidemiology),No Intervention,No Intervention,6000,http://www.drks.de/DRKS00021698,None
1916,DRKS00021658,German Clinical Trials Register,2020-05-05,2020-01-03,True,"University Hospital, Freiburg",Not Recruiting,Not Applicable,Observational,Germany,Incidence and risk factors for acute kidney injury in COVID-19,Clinical Presentation,No Intervention,No Intervention,100,http://www.drks.de/DRKS00021658,None
1917,DRKS00021664,German Clinical Trials Register,2020-05-14,2020-05-20,False,"University Hospital, Freiburg",Not Recruiting,Not Applicable,Observational,Germany,Influence of COVID-19 Infection on sensory organs in othorynolaryngology,Clinical Presentation,No Intervention,No Intervention,100,http://www.drks.de/DRKS00021664,None
1918,DRKS00021675,German Clinical Trials Register,2020-05-08,2020-07-05,False,"University Hospital, Essen",Recruiting,Not Applicable,Observational,Germany,Sorting the wheat form the chaff â€“ COVID-19 in the Emergency department,Clinical Presentation,No Intervention,No Intervention,340,http://www.drks.de/DRKS00021675,None
1919,DRKS00021677,German Clinical Trials Register,2020-05-11,2020-01-07,True,BG University Hospital Bergmannsheil Bochum,Not Recruiting,Not Applicable,Observational,Germany,COVID-19 associated neuropathy and myopathy in Germany.,Clinical Presentation,No Intervention,No Intervention,200,http://www.drks.de/DRKS00021677,None
1920,DRKS00021676,German Clinical Trials Register,2020-05-08,2020-02-04,True,"University Hospital, Rostock",Not Recruiting,Not Applicable,Observational,Germany,Communication in times of the corona virus pandemic (COVID-19),Other (psych),No Intervention,No Intervention,200,http://www.drks.de/DRKS00021676,None
1921,DRKS00021671,German Clinical Trials Register,2020-05-06,2020-03-04,True,"University Hospital, Heidelberg",Recruiting,Not Applicable,Observational,Germany,Neuroendocrine mechanisms Social isolation and psychobiological stress during the Covid-19 pandemic,Other (psych),No Intervention,No Intervention,200,http://www.drks.de/DRKS00021671,None
1922,DRKS00021727,German Clinical Trials Register,2020-05-12,2020-12-05,False,"University Hospital, Freiburg",Not Recruiting,Not Applicable,Observational,Germany,Incidence and long-term course of subclinical and clinical myocardial damage as well as pulmonary vascular and structural changes in patients with COVID-19,Clinical Presentation,No Intervention,No Intervention,100,http://www.drks.de/DRKS00021727,None
1923,DRKS00021729,German Clinical Trials Register,2020-05-25,2020-12-05,False,Helios Universitätsklinikum Wuppertal,Not Recruiting,Not Applicable,Observational,Germany,A prospective trial on the prevalence and the variation over time of SARS-CoV-2 antibodies in hospital health care workers (COVID-19),Clinical Presentation (Epidemiology),No Intervention,No Intervention,300,http://www.drks.de/DRKS00021729,None
1924,DRKS00021732,German Clinical Trials Register,2020-06-10,2020-06-30,True,Klinikum St. Georg gGmbH,Recruiting,Not Applicable,Interventional,Germany,"Treatment of Sars-CoV2 infections (Covid-19) with valsartan vs placebo, a three-armed randomized, partly blinded trial",Drug,Valsartan,Valsartan,300,http://www.drks.de/DRKS00021732,EUCTR2020-001431-27
1925,DRKS00021705,German Clinical Trials Register,2020-08-03,2020-01-08,True,"University Hospital, Leipzig",Not Recruiting,Not Applicable,Observational,Germany,Precalence study on ICU Treatment of COVID-19 patients in Northern and Western Saxony in the first half of 2020 - PraeCoSa,Clinical Presentation (Epidemiology),No Intervention,No Intervention,100,http://www.drks.de/DRKS00021705,None
1926,DRKS00021706,German Clinical Trials Register,2020-05-15,2020-05-25,False,"University Hospital, Leipzig",Not Recruiting,Not Applicable,Interventional,Germany,Evaluation of online support during the coronavirus (COVID-19) pandemic: Online cognitive behavioral therapy for obsessive-compulsive disorder (OCD NET program),Other (psych),Psychological,Psychological,40,http://www.drks.de/DRKS00021706,None
1927,DRKS00021709,German Clinical Trials Register,2020-05-18,2020-03-07,True,"University Hospital, Heidelberg",Recruiting,Not Applicable,Observational,Germany,Serial cross-sectional seroprevalence study of SARS-CoV-2 infection during and after the COVID-19 epidemic in Heidelberg and the Rhein-Neckar region,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1500,http://www.drks.de/DRKS00021709,None
1928,DRKS00021757,German Clinical Trials Register,2020-05-19,2020-05-22,False,Humboldt University of Berlin,Not Recruiting,Not Applicable,Observational,Germany,Impact of the COVID-19 Pandemic on Symptoms of Obessive Compulsive Disorder,Other (psych),No Intervention,No Intervention,70,http://www.drks.de/DRKS00021757,None
1929,DRKS00021763,German Clinical Trials Register,2020-05-29,2020-02-06,True,"University Hospital, Freiburg",Not Recruiting,Not Applicable,Observational,Germany,Influence of the Corona regulation on the physical activity of hospital staff - COVID-19,Other (exercise),No Intervention,No Intervention,175,http://www.drks.de/DRKS00021763,None
1930,DRKS00021772,German Clinical Trials Register,2020-05-18,2020-03-25,True,"University Hospital, Würzburg",Recruiting,Not Applicable,Observational,Germany,Covid-19 related Obstetric Anaesthesia Longitudinal Assessment-Registry,Clinical Presentation,No Intervention,No Intervention,Not Available,http://www.drks.de/DRKS00021772,None
1931,DRKS00021775,German Clinical Trials Register,2020-06-10,2020-05-31,True,"University Hospital, Freiburg",Recruiting,Not Applicable,Observational,Germany,COVID-19 treatment outcomes at the University Medical Center Freiburg,Clinical Presentation,No Intervention,No Intervention,400,http://www.drks.de/DRKS00021775,None
1932,DRKS00021740,German Clinical Trials Register,2020-05-15,2020-05-04,True,"University Hospital, RWTH Aachen",Recruiting,Not Applicable,Observational,Germany,CoViD-19 imaging register study Aachen,Clinical Presentation,No Intervention,No Intervention,100,http://www.drks.de/DRKS00021740,None
1933,DRKS00021752,German Clinical Trials Register,2020-05-28,2020-05-29,False,MUC Research GmbH,Not Recruiting,Not Applicable,Observational,Germany,Study platform ArcHIV - Substudy on SARS-CoV-2 (COVID-19) IgG antibody prevalence in an HIV cohort,Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,http://www.drks.de/DRKS00021752,None
1934,DRKS00021756,German Clinical Trials Register,2020-10-28,2020-12-05,False,"University Hospital, Düsseldorf",Recruiting,Not Applicable,Observational,Germany,Psychological coping with the COVID-19-pandemic,Other (psych),No Intervention,No Intervention,9000,http://www.drks.de/DRKS00021756,None
1935,DRKS00021788,German Clinical Trials Register,2020-07-14,2020-10-06,False,"University Hospital, Essen",Recruiting,Not Applicable,Observational,Germany,Infection rate of Covid-19 among medical staff in GP practices in North Rhine-Westphalia (Germany),Clinical Presentation (Epidemiology),No Intervention,No Intervention,900,http://www.drks.de/DRKS00021788,None
1936,DRKS00021780,German Clinical Trials Register,2020-06-29,2020-04-19,True,"Rheumazentrum Ruhrgebiet, Herne",Recruiting,Not Applicable,Observational,Germany,Collection of clinical data in patients with inflammatory rheumatic disease during the pandemic with the SARS-CoV-2 virus - COVID-19,Clinical Presentation,No Intervention,No Intervention,1521,http://www.drks.de/DRKS00021780,None
1937,DRKS00021791,German Clinical Trials Register,2020-05-28,2020-08-04,False,"University Hosapital, Tübingen",Not Recruiting,Not Applicable,Observational,Germany,The Impact of quarantine and social distancing on mental health in the context of the Covid-19 pandemic,Other (psych),No Intervention,No Intervention,Not Available,http://www.drks.de/DRKS00021791,None
1938,DRKS00014593,German Clinical Trials Register,2018-05-14,2018-05-15,False,Robert-Bosch-Hospital,Not Recruiting,Phase 3,Interventional,Germany,Relieving Distressed Caregivers: A Pragmatic Trial.,Not relevant,Not relevant,Not relevant,504,http://www.drks.de/DRKS00014593,None
1939,ChiCTR2000038537,ChiCTR,2020-09-23,2020-02-01,True,University of Sulaimani,Not Recruiting,Not Applicable,Observational,Iraq,Large vessel thrombosis in patients with COVID-19,Clinical Presentation,No Intervention,No Intervention,7,http://www.chictr.org.cn/showproj.aspx?proj=60821,None
1940,ChiCTR2000038160,ChiCTR,2020-09-11,2020-09-11,False,Zhongnan Hospital of Wuhan University,Recruiting,Not Applicable,Observational,China,The efficacy and safety of ambroxol hydrochloride in the treatment of novel coronavirus pneumonia (COVID-19): a retrospective medical based study,Drug,Ambroxol hydrochloride,Ambroxol hydrochloride,1200,http://www.chictr.org.cn/showproj.aspx?proj=61045,None
1941,ChiCTR2000038152,ChiCTR,2020-09-11,2020-09-14,False,Huashan Hospital Affiliated to Fudan University,Recruiting,Phase 1,Interventional,China,"A Single-center, Randomized, Double-blind, Placebo-controlled, Dose Ranging Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of INO-4800, Administered Intradermally Followed by Electroporation in Healthy Volunteers",ATMP,Vaccine,Vaccine,45,http://www.chictr.org.cn/showproj.aspx?proj=59326,None
1942,ChiCTR2000038134,ChiCTR,2020-09-11,2020-09-01,True,The Second Affiliated Hospital of Chongqing Medical University,Recruiting,Not Applicable,Observational,China,Half-year follow-up of novel coronavirus pneumonia (COVID-19) rehabilitated patients in Chongqing Municipality,Clinical Presentation,No Intervention,No Intervention,40,http://www.chictr.org.cn/showproj.aspx?proj=61155,None
1943,ChiCTR2000034796,ChiCTR,2020-07-19,2020-01-18,True,"Ruijin Hospital, Shanghai Jiao Tong University School of Medicine",Recruiting,Not Applicable,Observational,China,the efficacy and safety of heparin in the treatment of novel coronavirus pneumonia (COVID-19): a retrospective single center clinical trial,Drug,Heparin,Heparin,160,http://www.chictr.org.cn/showproj.aspx?proj=55775,None
1944,SLCTR/2020/011,SLCTR,2020-05-04,2020-05-04,False,University of Kelaniya,Not Recruiting,Phase 4,Interventional,Sri Lanka,"Hydroxychloroquine for Post-Exposure Prophylaxis of COVID-19 among naval personnel: a placebo-controlled, randomized, clinical trial",Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,0,https://slctr.lk/trials/slctr-2020-011,None
1945,IRCT20160131026298N2,IRCT,2020-04-20,2020-03-10,True,Bagheiat-allah University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,The effect of PHR spray on patients with coronavirus-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,64,http://en.irct.ir/trial/46733,None
1946,IRCT20160131026298N3,IRCT,2020-04-30,2020-05-04,False,Bagheiat-allah University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,"Evaluation of the effect of Iranian medicine product, Algro, on patients with coronavirus 19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/47019,None
1947,IRCT20200415047080N2,IRCT,2020-11-07,2020-04-04,True,Tehran University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of the effectiveness of TAC cocktail in critically ill patients with Covid 19 induced pneumonia,Drug,Thiamine + Vitamin C + Corticosteroids,Thiamine; Vitamin C; Methlyprednisolone,30,http://en.irct.ir/trial/47186,None
1948,IRCT20140312016968N2,IRCT,2020-11-01,2020-04-21,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Study of the effects of grapefruit extract on COVID-19,Supplement,Grapefruit extract,Grapefruit extract,20,http://en.irct.ir/trial/47381,None
1949,IRCT20121216011763N46,IRCT,2020-05-04,2020-05-04,False,Esfahan University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of curcumin-piperine in patients with coronavirus (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://en.irct.ir/trial/47529,None
1950,IRCT20200415047080N1,IRCT,2020-11-02,2020-09-22,True,Tehran University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effectiveness of Tissue plasminogen activator (TPA) for treatment of ARDS induced by Covid-19,ATMP,Tissue plasminogen activator,Tissue plasminogen activator,30,http://en.irct.ir/trial/47982,None
1951,IRCT20200608047686N2,IRCT,2020-11-19,2020-10-17,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,The role of hemoperfusion in COVID-19,Other (device),Blood filter,Blood filter,40,http://en.irct.ir/trial/48933,None
1952,IRCT20151227025726N24,IRCT,2020-11-25,2020-07-10,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of the efficacy and safety of bromhexine administration in COVID-19,Drug,Bromhexine,Bromhexine,100,http://en.irct.ir/trial/49043,None
1953,IRCT20200624047908N1,IRCT,2020-07-05,2020-07-13,False,Abadan University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of sofosbuvir/daclatasvir  in COVID-19 patients,Drug,Sofosbuvir + Daclatasvir + Lopinavir/ritonavir vs. Lopinavir/ritonavir,Sofosbuvir; Daclatasvir; Lopinavir/ritonavir,1000,http://en.irct.ir/trial/49198,None
1954,IRCT20130428013151N2,IRCT,2020-10-28,2020-04-25,True,Khoram-Abad University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,Evaluation of the effect of mucodentol on people with coronavirus,Drug,Mucodentol,Mucodentol,200,http://en.irct.ir/trial/49356,None
1955,IRCT20200506047323N6,IRCT,2020-11-17,2020-11-15,True,Bandare-abbas University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Ivermectin in treatment of COVID-19,Drug,Ivermectin + Hydroxycholoroquine vs. Hydroxychloroquine,Ivermectin; Hydroxychloroquine,120,http://en.irct.ir/trial/49501,None
1956,IRCT20180103038199N3,IRCT,2020-08-30,2020-10-22,False,Mashhad University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,effects of two products containing Noscapine on COVID-19,Drug,Noscapine,Noscapine,120,http://en.irct.ir/trial/49775,None
1957,IRCT20191211045691N1,IRCT,2020-07-28,2020-07-30,False,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficacy and safety of inhaled magnesium sulfate in combination with standard treatment in Covid-19 patients,Drug,Magnesium sulfate,Magnesium sulfate,100,http://en.irct.ir/trial/49879,None
1958,IRCT20160131026298N5,IRCT,2020-08-23,2020-09-22,False,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of the effect of SINA anti-flu natural product on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/49886,None
1959,IRCT20160131026298N6,IRCT,2020-09-08,2020-11-05,False,Bagheiat-allah University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of the effectiveness of Nigel-7 capsule and black seed mixture on corona,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://en.irct.ir/trial/50246,None
1960,IRCT20160919029870N3,IRCT,2020-11-24,2020-03-20,True,Ghoum University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,The effect of selenium in patients with Covid-19,Drug,Selenium,Selenium,80,http://en.irct.ir/trial/50425,None
1961,IRCT20200711048077N1,IRCT,2020-11-16,2020-11-21,False,Mashhad University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Evaluation of respiratory Tele-rehabilitation in patient with COVID-19,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,60,http://en.irct.ir/trial/50721,None
1962,IRCT20200818048444N1,IRCT,2020-09-15,2020-09-22,False,Tabriz University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Verification of the efficacy of Bromhexine-hydrochloride in treatment of patients with COVID19 disease,Drug,Bromhexine hydorchloride,Bromhexine hydorchloride,1300,http://en.irct.ir/trial/50780,None
1963,IRCT20200408046987N2,IRCT,2020-11-07,2020-10-16,True,Akam Tejarat Fartak Farasoo,Recruiting,Phase 2/Phase 3,Interventional,Iran,Determination the therapeutic effect of Ivermectin and Sovodak on patients infected with COVID-19,Drug,Ivermectin + Sofosbuvir/daclatsivir,Ivermectin; Sofosbuvir/daclatsivir,150,http://en.irct.ir/trial/51007,None
1964,IRCT20200921048786N1,IRCT,2020-11-11,2020-09-22,True,Dezfoul University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the effect of interferon beta-1b in the treatment of COVID-19,Drug,Interferon beta,Interferon beta,82,http://en.irct.ir/trial/51086,None
1965,IRCT20200921048794N1,IRCT,2020-11-19,2020-11-20,False,Hamedan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Evaluation of the Effects of L-carnitine Supplementation on Patients with COVID-19,Drug,L-carnitine,L-carnitine,96,http://en.irct.ir/trial/51120,None
1966,IRCT20151227025726N23,IRCT,2020-11-10,2020-08-06,True,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluating the effects of Adalimumab in patients with acute respiratory distress syndrome caused by COVID-19,Drug,Adalimumab,Adalimumab,60,http://en.irct.ir/trial/51473,None
1967,IRCT20181030041504N1,IRCT,2020-11-08,2020-10-07,True,Sirjan Faculty of Medical Science,Not Recruiting,Phase 3,Interventional,Iran,"Evaluation of the combined effect of Hesperidin,Artemisinin- Artemisia annua, Noscapine, N-acetylcysteine, Resveratrol supplements and high dose of vitamin C on treatment, clinical symptoms of non-hospitalization and hospitalization patients with symptomatic COVID-19",Supplement,Artemisinin; Vitamin C; Noscapine; Hesperdin; Resveratrik; N-acetylcysteine,Artemisinin; Vitamin C; Noscapine; Hesperdin; Resveratrik; N-acetylcysteine,100,http://en.irct.ir/trial/51482,None
1968,IRCT20200428047229N3,IRCT,2020-11-25,2020-09-08,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of cupping on respiratory symptoms of COVID-19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,72,http://en.irct.ir/trial/51516,None
1969,IRCT20201012049010N1,IRCT,2020-11-12,2020-07-22,True,Qazvin University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,The effect of balloon-blowing on dyspnea and oxygenation in non-critical adult covid-19 patients.,Other,Other,Other,90,http://en.irct.ir/trial/51591,None
1970,IRCT20200426047206N4,IRCT,2020-11-01,2020-10-22,True,Hamedan University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,Effect of Melatonin in treatment of COVID-19,Drug,Melatonin,Melatonin,60,http://en.irct.ir/trial/51687,None
1971,IRCT20150825023753N17,IRCT,2020-11-01,2020-04-13,True,Shiraz University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Evaluation of the effect of ghamz with needle on improvement of respiratory symptoms of COVID-19 patients admitted to hospital,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,18,http://en.irct.ir/trial/51709,None
1972,IRCT20201015049030N1,IRCT,2020-11-07,2020-09-11,True,Tehran University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Effect of  Dexamethasone on treatment of COVID-19,Drug,Corticosteroids,Dexamethasone,200,http://en.irct.ir/trial/51736,None
1973,IRCT20201020049088N1,IRCT,2020-11-15,2020-11-05,True,Kerman University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,The effects of aromatherapy on the anxiety and sleep quality of the patients with COVID-19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/51748,None
1974,IRCT20201016049048N1,IRCT,2020-11-04,2020-11-07,False,Shiraz University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Effect of Iranian Borage on the management of Covid-19 symptoms,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/51767,None
1975,IRCT20201015049036N1,IRCT,2020-11-27,2020-09-12,True,Dezfoul University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,Efficacy of Date Palm Leaf Extract (Phoenix dactylifera) in Patients with COVID-19 Hospitalized in Ganjavian Hospital in Dezful,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://en.irct.ir/trial/51772,None
1976,IRCT20181208041886N2,IRCT,2020-10-29,2020-11-21,False,Exir Danesh Asia Pharmaceutical Co.,Recruiting,Not Applicable,Interventional,Iran,Aftogel and COVID-19 PCR test,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://en.irct.ir/trial/51774,None
1977,IRCT20200720048139N1,IRCT,2020-11-09,2020-11-21,False,Islamic Azad University,Recruiting,Phase 2,Interventional,Iran,Investigating effect of Spirulina dietary supplementation on COVID-19 disease outcomes in patients admitted to Intensive Care Units,Drug,Spirulina,Spirulina,138,http://en.irct.ir/trial/51784,None
1978,IRCT20200404046936N4,IRCT,2020-11-01,2020-12-21,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,RF ablation vs EVLA in lower limb varicosis,Not relevant,Not relevant,Not relevant,1090,http://en.irct.ir/trial/51802,None
1979,IRCT20201024049134N1,IRCT,2020-11-02,2020-11-15,False,Babol University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,Efficacy of Arbidol in treatment of COVID-19,Drug,Umifenovir,Umifenovir,100,http://en.irct.ir/trial/51847,None
1980,IRCT20200927048848N2,IRCT,2020-11-04,2020-10-31,True,Mashhad University of Medical Sciences,Recruiting,Phase 3,Interventional,Iran,squalene and COVID-19,Drug,Squalene vs. Hydroxychloroquine + Lopinavir/ritonavir,Squalene; Hydroxychloroquine; Lopinavir/ritonavir,15,http://en.irct.ir/trial/51922,None
1981,IRCT20170809035597N2,IRCT,2020-11-16,2020-08-17,True,Iran University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Efficacy and safety of  pentoxifylline in treatment and recovery of patients with COVID-19,Drug,Pentoxifylline + Hydroxychloroquine + Sofosbuvir/daclatasvir vs. Hydroxychloroquine + Sofosbuvir/daclatasvir,Pentoxifylline; Hydroxychloroquine; Sofosbuvir/daclatasvir,86,http://en.irct.ir/trial/51927,None
1982,IRCT20191211045691N2,IRCT,2020-11-02,2020-09-14,True,Yazd Shahid Sadoughi University of Medical Sciences,Not Recruiting,Phase 3,Interventional,Iran,Evaluation of the efficacy and safety of Doxycycline in combination with standard treatment in Covid-19 patients,Drug,Doxycycline,Doxycycline,60,http://en.irct.ir/trial/51951,None
1983,IRCT20190713044192N2,IRCT,2020-11-21,2020-11-21,False,Tehran University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,The effect of the online child birth preparation classes on pregnant women during COVID_19  pandemic,Other,Other,Other,100,http://en.irct.ir/trial/52153,None
1984,IRCT20170315033086N7,IRCT,2020-11-12,2020-11-21,False,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,An Investigation of the impact of Faramir on the clinical symptoms in patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,128,http://en.irct.ir/trial/52223,None
1985,IRCT20190804044429N4,IRCT,2020-11-25,2020-11-10,True,Mazandaran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,pentoxifyliine in COVID-19,Drug,Pentoxyfylline + Hydroxychloroquine + Lopinavir/ritonavir vs. Hydroxychloroquine + Lopinavir/ritonavir,Pentoxyfylline; Hydroxychloroquine; Lopinavir/ritonavir,60,http://en.irct.ir/trial/52284,None
1986,LBCTR2020043459,LBCTR,2020-04-16,2020-04-14,True,Hôtel-Dieu de France Hospital,Not Recruiting,Not Applicable,Observational,Lebanon,The effect of confinement on the mental health of individuals during the COVID-19 pandemic: an online survey,Other (psych),No Intervention,No Intervention,500,https://lbctr.moph.gov.lb/Trials/Details/3459,None
1987,PACTR202004801273802,PACTR,2020-04-02,2020-04-20,False,Lagos State Government,Recruiting,Phase 3,Interventional,Nigeria,"Lagos COVID-19 Chloroquine Treatment Trial (LACCTT)
",Drug,Chloroquine vs. Hydroxychloroquine,Chloroquine; Hydroxychloroquine,800,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10928,None
1988,PACTR202004693933092,PACTR,2020-04-12,2020-04-15,False,Misr University for Science and Technology,Not Recruiting,Not Applicable,Interventional,Egypt,Effectiveness of Measles Vaccine in Health Care Professionals During COVID-19 Outbreak (Randomized Controlled Trial),ATMP,Vaccine,Vaccine,200,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10953,None
1989,PACTR202004761408382,PACTR,2020-04-13,2020-01-05,True,International Centre for Ethnomedicine and Drug Development and Neimeth International Pharmaceuticals Plc.,Not Recruiting,Not Applicable,Interventional,Nigeria,"Efficacy and safety of IHP Detox Tea (a special blend of Andrographis paniculata, Garcinia kola and Psidium guajava) for treatment of Corona virus disease 2019 (COVID-19): a pilot randomized trial",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,72,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10957,None
1990,PACTR202005599385499,PACTR,2020-04-16,2020-04-20,False,Cairo University,Not Recruiting,Phase 2,Interventional,Egypt,Folic acid: A new suggested prevention and treatment of COVID-19 infection.,Drug,Folic Acid,Folic Acid,60,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10971,None
1991,PACTR202004893013257,PACTR,2020-04-21,2020-04-25,False,Dr. Birgit Whitman,Not Recruiting,Phase 3,Interventional,Ghana,Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19,Drug,Hydroxychloroquine + Lopinavir/ritonavir vs. Hydroxychloroquine vs. Lopinavir/ritonavir,Hydroxychloroquine; Lopinavir/ritonavir,6400,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10981,None
1992,PACTR202005681895696,PACTR,2020-04-26,2020-01-10,True,University of Oxford,Recruiting,Phase 1,Interventional,Kenya,A study to determine if a new vaccine safely generates good immune responses to protect adults in Kenya from Coronavirus Disease,ATMP,Vaccine,Vaccine,400,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10988,None
1993,PACTR202009786901147,PACTR,2020-05-07,2020-01-10,True,Dr. William Schilling,Not Recruiting,Phase 3,Interventional,Kenya,Hydroxychloroquine for prevention of COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1600,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11019,None
1994,PACTR202006473370201,PACTR,2020-05-12,2020-04-30,True,London School of Hygiene and Tropical Medicine,Not Recruiting,Phase 3,Interventional,"Pakistan, Nigeria",Coronavirus Response - Active Support for Hospitalised COVID-19 patients,Drug,Aspirin vs. Losartan vs. Simvastatin vs. Aspirin + Losartan vs. Aspirin + Simvastatin vs. Lostartan + Simvastatin vs. Aspirin + Losartan + Simvastatin,Aspirin; Losartan; Simvastatin,10000,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11037,None
1995,PACTR202007653923168,PACTR,2020-05-13,2020-01-08,True,Kenyatta University Teaching Referral and Research Hospital,Not Recruiting,Phase 3,Interventional,Kenya,A clinical trial comparing use of convalescent plasma therapy plus standard treatment to standard treatment alone in patients with severe COVID-19 infection,ATMP,Plasma,Plasma,206,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11047,None
1996,PACTR202005622389003,PACTR,2020-05-14,2020-01-06,True,Universite Cheikh Anta Diop ,Not Recruiting,Phase 3,Interventional,Senegal,"Hydroxychloroquine, Azithromycine and Zinc for the treatment of SARS-Cov2 infection in Senegal. COVID-19",Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,384,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11053,None
1997,PACTR202006717277937,PACTR,2020-05-25,2020-01-10,True,Awolola Eniola Oladejo,Not Recruiting,Not Applicable,Interventional,Nigeria,Effect of Interferential Therapy on SARS-CoV-2. COVID-19,Other,Inferential Therapy,Inferential Therapy,48,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11088,None
1998,PACTR202006899597082,PACTR,2020-05-29,2020-04-29,True,Malagasy Government,Not Recruiting,Phase 2,Interventional,Madagascar,Efficacy of a new COVID-19 treatment,Drug,Artesunate vs. Artesunate + Vitamin C,Artesunate; Vitamin C,60,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11103,None
1999,PACTR202007589336711,PACTR,2020-06-04,2020-07-13,False,Caleb Ademola Omuwa Gbiri,Not Recruiting,Not Applicable,Interventional,Nigeria,"Physiotherapy as a Complimentary treatment in Reducing Viral-Load, Complications, Death, Expedite Discharge and Improve Quality of Life, Exercise Endurance and Capacity in Stroke Survivors with COVID-19: A Clinical-Controlled Study",Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,30,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11115,None
2000,PACTR202010519682638,PACTR,2020-06-12,2020-08-27,False,National Institute for Pharmaceutical Research and Development (NIPRD),Not Recruiting,Phase 3,Interventional,Nigeria,Efficay of two hydroxychloroquine based drug combination regimens in comparison to standard of care  in The Treatment of Hospitalized COVID-19 Patients,Drug,Hydroxychloroquine vs. Lopinavir/ritonavir,Hydroxychloroquine; Lopinavir/ritonavir,210,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12147,None
2001,PACTR202006537901307,PACTR,2020-06-15,2020-07-20,False,Drugs for Neglected Diseases initiative (DNDi),Recruiting,Phase 3,Interventional,"Kenya, Guinea, Equatorial Guinea, Cote d'Ivoire, Cameroon, Ghana, Burkina Faso, Mozambique, Ethiopia, Tanzania, Democratic Republic of the Congo, Uganda, Sudan","An open-label, multicentre, randomised, adaptive platform trial of the safety and efficacy of several therapies, including antiviral therapies, versus control in mild/moderate cases of COVID-19",Drug,Lopinavir/ritonavir vs. Hydroxychloroquine,Lopinavir/ritonavir; Hydroxychloroquine,3000,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12150,None
2002,PACTR202007606032743,PACTR,2020-06-19,2020-06-15,True,Dr. Tarek Ismail,Recruiting,Not Applicable,Interventional,Egypt,Nebulized heparin in patients with mainly moderate coronavirus disease 2019: Randomized controlled trial. COVID-19,Drug,Heparin,Heparin,100,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12158,None
2003,PACTR202006922165132,PACTR,2020-06-22,2020-06-24,False,University of Oxford,Recruiting,Phase 1,Interventional,South Africa,COVID-19 vaccine (ChAdOx1 nCoV-19) trial in South African Adults with and without HIV-infection,ATMP,Vaccine,Vaccine,2000,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12166,None
2004,PACTR202006760881890,PACTR,2020-06-23,2020-01-08,True,Lagos State Government,Recruiting,Phase 2,Interventional,Nigeria,Lagos Covid-19 Convalescent Plasma Trial (LACCPT),ATMP,Plasma,Plasma,100,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12168,None
2005,PACTR202006883882711,PACTR,2020-06-30,2020-01-07,True,Dar Al Fouad Hospital,Not Recruiting,Phase 3,Interventional,Egypt,"Effectiveness of Measles, Mumps and Rubella Vaccine in Health Care Professionals for COVID-19",ATMP,Vaccine,Vaccine,200,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12175,None
2006,PACTR202007720062393,PACTR,2020-07-02,2020-07-20,False,Inserm-ANRS,Not Recruiting,Phase 2,Interventional,Cote d'Ivoire,Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial (INTENSE-COV),Drug,Lopinavir/ritonavir vs. Lopinavir/ritonavir + Telmisartan vs. Lopinavir/ritonavir + Atorvastatin,Lopinavir/ritonavir; Telmisartan; Atorvastatin,294,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12183,None
2007,PACTR202007611764617,PACTR,2020-07-06,2020-01-09,True,Lagos State Government,Not Recruiting,Phase 3,Interventional,Nigeria,Lagos COVID-19 Black Seed Oil Trial (LACBSOT),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12192,None
2008,PACTR202007700757139,PACTR,2020-07-07,2020-07-13,False,Cytel Inc,Not Recruiting,Phase 2,Interventional,South Africa,TOGETHER 3 Trial. COVID-19,Drug,Lopinavir/ritonavir vs. Vitamin C,Lopinavir/ritonavir; Vitamin C,420,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12194,None
2009,PACTR202008485004797,PACTR,2020-07-17,2020-03-08,True,Desmond Tutu Health Foundation,Not Recruiting,Not Applicable,Interventional,South Africa,TRACE - Transmission of Covid-19 in Crowded Environments,Clinical Presentation (Epidemiology),No Intervention,No Intervention,720,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12214,None
2010,PACTR202009726132275,PACTR,2020-08-25,2020-07-30,True,Novavax,Recruiting,Phase 2,Interventional,South Africa,A Study Looking at the Safety and Effectiveness of a COVID-19 Vaccine Plus Adjuvant in South African Adults,ATMP,Vaccine,Vaccine,2904,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12319,None
2011,PACTR202009769021840,PACTR,2020-08-31,2020-09-15,False,Aga Khan University,Not Recruiting,Phase 2,Interventional,Kenya,Whole-lung low dose radiation therapy (LDRT) in the treatment of severe COVID-19 pneumonia,Other,Radiation,Radiation,20,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12333,None
2012,PACTR202009642148520,PACTR,2020-09-02,2020-01-11,True,Liverpool School of Tropical Medicine,Not Recruiting,Phase 3,Interventional,"Kenya, Burkina Faso",Malaria as a risk factor for COVID-19 in western Kenya and Burkina Faso,Clinical Presentation,No Intervention,No Intervention,142,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12343,None
2013,PACTR202010537777617,PACTR,2020-09-13,2020-01-11,True,EMSKE Phytochem,Not Recruiting,Phase 2,Interventional,Kenya,FLAVOCOV Distributed Clinical Trial. COVID-19,Drug,Diosmin + hesperidin,Diosmin; hesperidin,200,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=12365,None
2014,PACTR202009483194545,PACTR,2020-09-20,2020-10-15,False,University of Lome,Not Recruiting,Phase 2,Interventional,Togo,Evaluation of phytopharmaceuticals to improve the prognosis of Covid-19 disease in Togo.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,250,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13381,None
2015,PACTR202010729372570,PACTR,2020-09-25,2020-05-10,True,Government of Uganda; Makerere University,Not Recruiting,Phase 3,Interventional,Uganda,The COVID-19 Community Engagement Study,Other,No Intervention,No Intervention,800,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13392,None
2016,PACTR202010690466874,PACTR,2020-10-01,2020-01-11,True,Kwame Nkrumah University of Science and Technology,Not Recruiting,Phase 2,Interventional,Ghana,KNUST COVID-19 CLINICAL TRIAL,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,20,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13403,None
2017,PACTR202010781639956,PACTR,2020-10-07,2020-09-21,True,Drugs for Neglected Diseases Initiative (DNDi),Recruiting,Phase 3,Interventional,"Kenya, Equatorial Guinea, Ghana, Mozambique, Ethiopia, Democratic Republic of the Congo, Sudan","The impact of COVID-19 treatment on the type, strength and duration of antibody and cellular immune responses in SARS-CoV-2 patients in sub-Saharan Africa
Ancillary Study of the ANTICOV Study:
An open-label, multicentre, randomised, adaptive platform trial of the safety and efficacy of several therapies, including antiviral therapies, versus control in mild / moderate cases of COVID-19",Drug,Hydroxychloroquine vs. Lopinavir/ritonavir vs. Paracetamol,Hydroxychloroquine; Lopinavir/ritonavir; Paracetamol,1000,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13420,None
2018,PACTR202010472402152,PACTR,2020-10-07,2020-12-10,False,MRC Unit The Gambia at LSHTM,Not Recruiting,Not Applicable,Interventional,Gambia,COVADIS study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1100,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13421,None
2019,PACTR202010718451278,PACTR,2020-10-14,2020-02-11,True,Drugs for Neglected Diseases Initiative (DNDi),Not Recruiting,Phase 3,Interventional,"Mozambique, Kenya, Equatorial Guinea, Ghana","Factors affecting transmission of SARS-CoV-2 in Households of SARS-CoV-2 patients in Sub-Saharan Africa Ancillary study of the ANTICOV Study: An open-label, multicentre, randomised, adaptive platform trial of the safety and efficacy of several therapies, including antiviral therapies, versus control in mild / moderate cases of COVID-19",Drug,Hydroxychloroquine vs. Lopinavir/ritonavir vs. Paracetamol,Hydroxychloroquine; Lopinavir/ritonavir; Paracetamol,2800,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13432,None
2020,PACTR202011523101903,PACTR,2020-11-02,2020-01-12,True,No Sponsor Name Given,Not Recruiting,Phase 3,Interventional,Kenya,"Study of Recombinant Protein Vaccine with Adjuvant against COVID-19 in Adults 18 Years of Age and Older.
",ATMP,Vaccine,Vaccine,34520,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=13475,None
2021,RPCEC00000306,RPCEC,2020-04-13,2020-03-27,True,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Recruiting,Phase 1/Phase 2,Interventional,Cuba,CIGB 2020 in contacts and SARS-CoV-2 infection suspects,ATMP,Vaccine,Vaccine,80,https://rpcec.sld.cu/en/trials/RPCEC00000306-En,None
2022,RPCEC00000307,RPCEC,2020-04-14,2020-10-04,False,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Recruiting,Phase 2,Interventional,Cuba,ESPERANZA study,Drug,Interferon alpha,Interferon alpha,120,https://rpcec.sld.cu/en/trials/RPCEC00000307-En,None
2023,RPCEC00000308,RPCEC,2020-05-03,2020-04-05,True,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Not Recruiting,Phase 1,Interventional,Cuba,Pharmacodynamics of the Nasalferon in healthy volunteers.,Drug,Nasalferon,Nasalferon,30,https://rpcec.sld.cu/en/trials/RPCEC00000308-En,None
2024,RPCEC00000309,RPCEC,2020-05-05,2020-05-20,False,Colima State Health Service ,Recruiting,Phase 1/Phase 2,Interventional,Mexico,Therapy for COVID-19-Phase I-II,Drug,Homeostec + Paracetamol,Homeostec; Paracetamol,100,https://rpcec.sld.cu/en/trials/RPCEC00000309-En,None
2025,RPCEC00000310,RPCEC,2020-05-05,2020-03-04,True,Centro Nacional de Biopreparados (BioCen),Recruiting,Not Applicable,Observational,Cuba,Biomodulina T - IM- covid-19 - older adultos - Phase IV clinical trial,Drug,Biomodulin T,Biomodulin T,0,https://rpcec.sld.cu/en/trials/RPCEC00000310-En,None
2026,RPCEC00000311,RPCEC,2020-05-12,2020-03-28,True,Center of Molecular Immunology (CIM),Recruiting,Not Applicable,Interventional,Cuba,Treatment of SARS CoV-2 pneumonia with the anti-CD6 monoclonal antibody itolizumab,Drug,Itolizumab,Itolizumab,80,https://rpcec.sld.cu/en/trials/RPCEC00000311-En,None
2027,RPCEC00000312,RPCEC,2020-05-13,2020-04-29,True,Cuban Ministry of Public Health,Recruiting,Not Applicable,Observational,Cuba,PrevengHo-Vir Homeoprohylaxis COVID-2019,Other,Homeopathy,Homeopathy,180,https://rpcec.sld.cu/en/trials/RPCEC00000312-En,None
2028,RPCEC00000313,RPCEC,2020-05-14,2020-03-31,True,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Not Recruiting,Not Applicable,Interventional,Cuba,CIGB-258 at COVID-19,Drug,CIGB-258,CIGB-258,16,https://rpcec.sld.cu/en/trials/RPCEC00000313-En,None
2029,RPCEC00000314,RPCEC,2020-05-22,2020-04-24,True,Finlay Vaccine Institute (IFV),Recruiting,Not Applicable,Interventional,Cuba,VA-MENGOC-BC to stimulate the innate response against SARS-CoV-2,ATMP,Vaccine,Vaccine,115000,https://rpcec.sld.cu/en/trials/RPCEC00000314-En,None
2030,RPCEC00000315,RPCEC,2020-05-22,2020-05-19,True,Finlay Vaccine Institute (IFV),Recruiting,Not Applicable,Interventional,Cuba,Evaluation of the synergistic effect of  sequential administration of two immunostimulant products: Immuno-1 and Immuno-2 for the stimulation of the immune response in older adults. Exploratory study,Drug,Immunostimulants,Immunostimulants,60,https://rpcec.sld.cu/en/trials/RPCEC00000315-En,None
2031,RPCEC00000316,RPCEC,2020-05-28,2020-03-07,True,Centro Nacional de Biopreparados (BioCen),Not Recruiting,Not Applicable,Interventional,Cuba,Exploratory study of BMT EV to stimulate immune response in patients with CKD-5 on iterated hemodialysis,Drug,Biomodulin T,Biomodulin T,20,https://rpcec.sld.cu/en/trials/RPCEC00000316-En,None
2032,RPCEC00000317,RPCEC,2020-05-28,2020-01-06,True,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Not Recruiting,Phase 1/Phase 2,Interventional,Cuba,ATENEA-Co-300 study,Drug,CIGB-300,CIGB-300,20,https://rpcec.sld.cu/en/trials/RPCEC00000317-En,None
2033,RPCEC00000318,RPCEC,2020-05-29,2020-11-03,False,National Board of Science and Technology of the Ministry of Public Health (MINSAP),Recruiting,Not Applicable,Observational,Cuba,Heberon Alfa R in COVID-19,Drug,Interferon alpha,Interferon alpha,0,https://rpcec.sld.cu/en/trials/RPCEC00000318-En,None
2034,RPCEC00000319,RPCEC,2020-05-29,2020-04-13,True,Centro Nacional de Biopreparados (BioCen),Not Recruiting,Not Applicable,Observational,Cuba,Biomodulina T - IM - covid-19 - older adult,Drug,Biomodulin T,Biomodulin T,160,https://rpcec.sld.cu/en/trials/RPCEC00000319-En,None
2035,RPCEC00000320,RPCEC,2020-06-05,2020-08-06,False,National Center for Scientific Research (CNIC),Not Recruiting,Not Applicable,Interventional,Cuba,Rectal Ozone in the COVID-19 treatment,Drug,Ozone,Ozone,32,https://rpcec.sld.cu/en/trials/RPCEC00000320-En,None
2036,RPCEC00000321,RPCEC,2020-06-22,2020-04-27,True,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Recruiting,Not Applicable,Interventional,Cuba,VIDA study,Drug,CIGB-258 Peptide,CIGB-258 Peptide,0,https://rpcec.sld.cu/en/trials/RPCEC00000321-En,None
2037,RPCEC00000322,RPCEC,2020-07-03,2020-05-05,True,Dr. José Manuel Ballester Santovenia Institute of Hematology and Immunology,Recruiting,Not Applicable,Interventional,Cuba,Stem cells in patients with lung lesions (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://rpcec.sld.cu/en/trials/RPCEC00000322-En,None
2038,RPCEC00000323,RPCEC,2020-07-03,2020-05-05,True,Dr. José Manuel Ballester Santovenia Institute of Hematology and Immunology,Recruiting,Not Applicable,Observational,Cuba,PLASMA TREATMENT TO ASYMPTOMATIC PATIENT WITH COVID-19 INFECTION,ATMP,Plasma,Plasma,0,https://rpcec.sld.cu/en/trials/RPCEC00000323-En,None
2039,RPCEC00000330,RPCEC,2020-08-11,2020-11-08,False,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Not Recruiting,Phase 2,Interventional,Mexico,DALIA Study,Drug,CIGB-258 Peptide,CIGB-258 Peptide,60,https://rpcec.sld.cu/en/trials/RPCEC00000330-En,None
2040,RPCEC00000332,RPCEC,2020-08-13,2020-08-24,False,Finlay Vaccine Institute (IFV),Recruiting,Phase 1/Phase 2,Interventional,Cuba,SOBERANA 01,ATMP,Vaccine,Vaccine,676,https://rpcec.sld.cu/en/trials/RPCEC00000332-En,None
2041,RPCEC00000334,RPCEC,2020-09-10,2020-09-14,False,Centro Nacional de Biopreparados (BioCen),Recruiting,Not Applicable,Interventional,Cuba,Biomodulin T in older adult for protection in events of local transmission of COVID-19,Drug,Biomodulin T,Biomodulin T,0,https://rpcec.sld.cu/en/trials/RPCEC00000334-En,None
2042,RPCEC00000335,RPCEC,2020-09-19,2020-09-26,False,Centro Nacional de Biopreparados (BioCen),Recruiting,Not Applicable,Interventional,Cuba,BIOMODULINA T in a long-lived population at high risk of COVID-19 infection,Drug,Biomodulin T,Biomodulin T,0,https://rpcec.sld.cu/en/trials/RPCEC00000335-En,None
2043,RPCEC00000337,RPCEC,2020-10-01,2020-12-10,False,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Not Recruiting,Phase 1/Phase 2,Interventional,Cuba,OLIVO Study,Drug,Interferon alpha,Interferon alpha,80,https://rpcec.sld.cu/en/trials/RPCEC00000337-En,None
2044,RPCEC00000338,RPCEC,2020-10-17,2020-10-19,False,Finlay Vaccine Institute (IFV),Not Recruiting,Phase 1,Interventional,Cuba,SOBERANA 01A,ATMP,Vaccine,Vaccine,60,https://rpcec.sld.cu/en/trials/RPCEC00000338-En,None
2045,RPCEC00000340,RPCEC,2020-10-27,2020-02-11,True,Finlay Vaccine Institute (IFV),Not Recruiting,Phase 1,Interventional,Cuba,SOBERANA 02,ATMP,Vaccine,Vaccine,40,https://rpcec.sld.cu/en/trials/RPCEC00000340-En,None
2046,RPCEC00000341,RPCEC,2020-10-27,2020-08-15,True,National Center for Scientific Research (CNIC),Not Recruiting,Not Applicable,Observational,Cuba,Prevalence of positive evolutive PCR in patients with COVID 19 treated with rectal ozone therapy: observational study prospective cohort.,Drug,Ozone,Ozone,200,https://rpcec.sld.cu/en/trials/RPCEC00000341-En,None
2047,RPCEC00000342,RPCEC,2020-11-06,2020-08-06,True,National Center for Scientific Research (CNIC),Not Recruiting,Not Applicable,Observational,Cuba,Observational study of the benefits of rectal ozonotherapy and BIOPLA as complemetary theraphy in convalescent patients with SARS-COV 2,Drug,Ozone,Ozone,40,https://rpcec.sld.cu/en/trials/RPCEC00000342-En,None
2048,RPCEC00000344,RPCEC,2020-11-24,2020-03-19,True,Center for Technological Applications and Nuclear Development (CEADEN),Not Recruiting,Not Applicable,Observational,Cuba,Curmeric-Prevention-COVID-19-Health Workers-University Hospital General Calixto Garcia,Drug (Chemoprophylaxis),Curmeric,Curmeric,199,https://rpcec.sld.cu/en/trials/RPCEC00000344-En,None
2049,RPCEC00000345,RPCEC,2020-11-26,2020-07-12,True,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Not Recruiting,Phase 1/Phase 2,Interventional,Cuba,MAMBISA Study,ATMP,Vaccine,Vaccine,88,https://rpcec.sld.cu/en/trials/RPCEC00000345-En,None
2050,RPCEC00000346,RPCEC,2020-11-26,2020-07-12,True,"Center for Genetic Engineering and Biotechnology (CIGB), Havana",Not Recruiting,Phase 1/Phase 2,Interventional,Cuba,ABDALA Clinical Study,ATMP,Vaccine,Vaccine,0,https://rpcec.sld.cu/en/trials/RPCEC00000346-En,None
2051,TCTR20201124002,TCTR,2020-11-14,2020-01-12,True,Srinakharinwirot University,Not Recruiting,Not Applicable,Observational,Thailand,Effect of medical mask on maternal oxygen saturation and fetal non-stress test during late third trimester of pregnancy in the COVID-19 era,Other (device),Masks,Masks,70,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=7050,None
2052,TCTR20201027002,TCTR,2020-10-26,2020-04-10,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,Turkey,Effect of dexamethasone or ibuprofen-acetaminophen combination for pain management in symptomatic apical periodontitis during COVID-19 outbreak: a retrospective cohort study,Drug,Corticosteroids vs. ibuprofen + acetaminophen,Corticosteroids; Ibuprofen; Acetaminophen,50,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6971,None
2053,TCTR20201015003,TCTR,2020-08-10,2020-01-10,True,Ratchadapiseksompotch Fund,Recruiting,Phase 4,Interventional,Thailand,Clinical outcomes and safety of preoperative non-preserved steroid eye drop in trabeculectomy: A randomised controlled trial,Not relevant,Not relevant,Not relevant,162,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6630,None
2054,TCTR20200901001,TCTR,2020-08-28,2020-07-18,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,Thailand,"Impact of COVID-19 pandemic era on the outcome, morbidity, and mortality of Acute Care Surgery patients",Clinical Presentation,No Intervention,No Intervention,61,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6728,None
2055,TCTR20200828001,TCTR,2020-05-29,2020-09-15,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,Thailand,Seroprevalence of COVID-19 in Thailand,Clinical Presentation (Epidemiology),No Intervention,No Intervention,400,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6327,None
2056,TCTR20200822003,TCTR,2020-05-23,2020-07-07,False,HRH Princess Chulabhorn College of Medical Science,Recruiting,Not Applicable,Observational,Thailand,Herd immunity level to COVID-19 as an indicator of the epidemic progression in Thailand,Clinical Presentation (Epidemiology),No Intervention,No Intervention,15000,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6299,None
2057,TCTR20200822002,TCTR,2020-08-21,2020-08-21,False,Faculty of Medicine,Recruiting,Not Applicable,Observational,Thailand,Use of emergency medical services: experience 100 days after first case  of COVID-19,Health System,No Intervention,No Intervention,545,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6692,None
2058,TCTR20200820006,TCTR,2020-08-20,2020-08-20,False,Faculty of Medicine,Recruiting,Not Applicable,Observational,Thailand,Response time of motorlance in COVID-19 pandemic,Health System,No Intervention,No Intervention,871,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6682,None
2059,TCTR20200819003,TCTR,2020-08-15,2020-09-15,False,Mahidol University,Not Recruiting,Phase 2,Interventional,Thailand,"Efficacy and feasibility of an audio-based mindfulness intervention in reducing anxiety, depression and stress among people with the risk of anxiety and depression during the coronavirus disease 2019 (COVID-19) pandemic in Thailand",Other (psych),Psychological,Psychological,70,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6659,None
2060,TCTR20200709002,TCTR,2020-07-02,2020-06-21,True,Mahidol University,Recruiting,Not Applicable,Observational,Thailand,Impact of the COVID-19 lockdown on dry eye,Other,No Intervention,No Intervention,144,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6466,None
2061,TCTR20200708001,TCTR,2020-06-28,2020-10-06,False,Chulalongkorn University,Not Recruiting,Not Applicable,Observational,Thailand,SARS-CoV-2 RNA shedding in recovered COVID-19 cases and the presence of antibodies against SARS-CoV-2 in recovered COVID-19 cases and contacts,Clinical Presentation (Epidemiology),No Intervention,No Intervention,239,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6446,None
2062,TCTR20200601002,TCTR,2020-05-28,2020-01-06,True,Self-sponsored,Recruiting,Not Applicable,Interventional,Malaysia,"A Randomized Controlled Trial on Effectiveness of Mental Health & Psychosocial Support Module (MHPSS) in Reduction of Depression, Anxiety and Stress among Healthcare Workers during COVID-19 Pandemic in Jerantut, Pahang",Other (psych),Psychological,Psychological,110,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6322,None
2063,TCTR20200527001,TCTR,2020-05-22,2020-03-13,True,King Chulalongkorn Memorial Hospital,Not Recruiting,Not Applicable,Observational,Thailand,Endotoxin and circulating bacteriome in severe COVID-19 patients,Clinical Presentation,No Intervention,No Intervention,19,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6293,None
2064,TCTR20200514001,TCTR,2020-05-12,2020-01-06,True,Siriraj Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,Thailand,An Investigation of the Efficacy and Safety of Favipiravir in COVID-19 Patients without Pneumonia Ã¢?? An open-label randomized controlled study Ã¢??,Drug,Favipiravir,Favipiravir,96,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6236,None
2065,TCTR20200426002,TCTR,2020-04-24,2020-08-04,False,Chulalongkorn University,Recruiting,Not Applicable,Observational,Thailand,Chula Covid-19 Rapid Test for Pandemic Control,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6132,None
2066,TCTR20200425001,TCTR,2020-04-25,2020-04-21,True,Pharmacoepidemiology and Statistics Research Center (PESRC),Recruiting,Not Applicable,Observational,Thailand,Mental Health Circumstances Among Healthcare Workers and General Public Under the Pandemic Situation of COVID-19,Other (psych),No Intervention,No Intervention,2500,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6136,None
2067,TCTR20200409006,TCTR,2020-04-03,2020-01-05,True,King Chulalongkorn Memorial Hospital,Not Recruiting,Not Applicable,Interventional,Thailand,Efficacy of HA330 Hemoperfusion in Critically Ill Patients with Severe COVID-19,Other (device),HA330,HA330,206,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6016,None
2068,TCTR20200405001,TCTR,2020-04-05,2020-03-19,True,Chulalongkorn University,Recruiting,Not Applicable,Observational,Thailand,Use of Covid-19 Rapid Test for Hospital Care: GI Procedure,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,40,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6023,None
2069,TCTR20200404004,TCTR,2020-03-31,2020-04-27,False,Health Systems Research Institute (HSRI),Not Recruiting,Phase 4,Interventional,Thailand,Comparative effectiveness of Chloroquine and Vitamin C prophylaxis in household contacts of confirmed COVID-19 patients,Drug,Chloroquine + Vitamin C,Chloroquine; Vitamin C,400,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=5995,None
2070,TCTR20200401002,TCTR,2020-03-31,2020-01-05,True,Wellcome Trust,Not Recruiting,Not Applicable,Observational,"Thailand, Malaysia, United Kingdom, Italy","Social, ethical and behavioural aspects of the novel coronavirus pandemic",Other,No Intervention,No Intervention,2640,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=5997,None
2071,TCTR20200324001,TCTR,2020-03-21,2020-03-24,False,Study Group for Efficiency and Quality of Emergency Departments and Non-Scheduled Activities Departm,Not Recruiting,Not Applicable,Observational,France,Covid-19 preparedness among Emergency Departments: a cross-sectional study in France.,Health System,No Intervention,No Intervention,650,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=5976,None
2072,TCTR20200321001,TCTR,2020-03-20,2020-03-20,False,Study Group for Efficiency and Quality of Emergency Departments and Non-Scheduled Activities Departm,Not Recruiting,Not Applicable,Observational,France,ED Response against Covid-19 pandemic,Other,No Intervention,No Intervention,5000,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=5975,None
2073,PER-013-20,REPEC,2020-06-25,2020-01-06,True,Seguro Social de Salud,Recruiting,Phase 2,Interventional,Peru,CONVALESCENT PLASMA AS TREATMENT FOR COVID-19,ATMP,Plasma,Plasma,192,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=013-20,None
2074,PER-031-20,REPEC,2020-07-27,2020-06-07,True,Oncosalud,Not Recruiting,Phase 2,Interventional,Peru,PHASE 2 STUDY OF EFFICACY AND SAFETY OF PLASMA FROM CONVALESCENT PATIENTS WITH COVID-19 IN PATIENTS WITH MODERATE DISEASE (AUNA 20-01),ATMP,Plasma,Plasma,50,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=031-20,None
2075,PER-032-20,REPEC,2020-07-23,2020-07-22,True,"Kiniksa Pharmaceuticals, Ltd.",Recruiting,Phase 2,Interventional,"United Kindgdom, Chile, Italy, Ireland, Peru, United States, South Africa","A PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MAVRILIMUMAB (KPL-301) TREATMENT IN ADULT SUBJECTS HOSPITALIZED WITH SEVERE COVID-19 PNEUMONIA AND HYPER-INFLAMMATION",Drug,Mavrilimumab,Mavrilimumab,115,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=032-20,None
2076,PER-034-20,REPEC,2020-07-17,2020-09-07,False,Universidad Peruana Cayetano Heredia,Recruiting,Phase 2,Interventional,Peru,RANDOMIZED PHASE IIA CLINICAL TRIAL TO COMPARE THE EFFICACY OF IVERMECTIN VERSUS PLACEBO TO OBTAIN NEGATIVE PCR RESULTS IN PATIENTS WITH EARLY PHASE COVID-19,Drug,Ivermectin,Ivermectin,68,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=034-20,None
2077,PER-050-20,REPEC,2020-09-17,2020-09-28,False,"Telios Pharma, Inc.",Not Recruiting,Phase 2,Interventional,"Denmark, Philippines, Germany, Russian Federation, Italy, France, Argentina, Brazil, Romania, Peru, United States, Ukraine, Spain, Hungary","â€œA PHASE 1/2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF TL-895 WITH STANDARD AVAILABLE TREATMENT VERSUS STANDARD AVAILABLE TREATMENT FOR THE TREATMENT OF COVID-19 IN PATIENTS WITH CANCERâ€",Drug,TL-895,TL-895,30,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=050-20,None
2078,PER-054-20,REPEC,2020-08-20,2020-10-09,False,CureVac AG,Recruiting,Phase 2,Interventional,"Peru, Brazil, Panama","COVID-19: A PHASE 2A, PARTIALLY OBSERVER-BLIND, MULTICENTER, CONTROLLED, DOSE-CONFIRMATION CLINICAL TRIAL TO EVALUATE THE SAFETY, REACTOGENICITY AND IMMUNOGENICITY OF THE INVESTIGATIONAL SARS-COV-2 MRNA VACCINE CVNCOV IN ADULTS >60 YEARS OF AGE AND 18 TO 60 YEARS OF AGE",ATMP,Vaccine,Vaccine,270,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=054-20,None
2079,PER-060-20,REPEC,2020-09-21,2020-07-09,True,Marina de Guerra del Peru,Recruiting,Phase 2,Interventional,Peru,"RANDOMIZED PHASE 2 CLINICAL TRIAL TO EVALUATE SAFETY AND EFFICACY OF THE USE OF PLASMA FROM CONVALESCENT PATIENTS WITH THE NEW CORONAVIRUS DISEASE (COVID-19) FOR THE EXPERIMENTAL TREATMENT  OF PATIENTS HOSPITALIZED IN THE CENTRO MEDICO NAVAL ""CIRUJANO MAYOR SANTIAGO TAVARA""
""",ATMP,Plasma,Plasma,100,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=060-20,None
2080,PER-064-20,REPEC,2020-09-29,2020-01-10,True,Universidad Peruana Cayetano Heredia,Recruiting,Phase 2,Interventional,Peru,LACTOFERRIN FOR PREVENTION OF COVID-19 IN HEALTH CARE PERSONNEL.,Drug (Chemoprophylaxis),Lactoferrin,Lactoferrin,336,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=064-20,None
2081,PER-067-20,REPEC,2020-10-29,2020-09-18,True,Oncotelic Inc.,Not Recruiting,Phase 2,Interventional,Argentina,"A DOUBLE BLIND, RANDOMIZED, PLACEBO CONTROLLED, MULTI CENTER STUDY OF OT 101 IN HOSPITALIZED COVID 19 SUBJECTS",Drug,Trabedersen,Trabedersen,48,https://www.ins.gob.pe/ensayosclinicos/rpec/recuperarECPBNuevoEN.asp?numec=067-20,None
2082,JPRN-JapicCTI-205270,JPRN,2020-04-23,2020-05-25,False,"Chugai Pharmaceutical Co., Ltd.",Not Recruiting,Phase 3,Interventional,Japan,A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia in Japan,Drug,Tocilizumab,Tocilizumab,10,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205270,None
2083,JPRN-JapicCTI-205465,JPRN,2020-08-27,2020-10-30,False,Human Life CORD Japan Inc.,Not Recruiting,Phase 1,Interventional,Japan,Umbilical cord-derived mesenchymal stromal cells therapy for SARS-CoV-2 infection (COVID-19) related Acute Respiratory Distress Syndrome,ATMP,Cells (mesenchymal),Cells (mesenchymal),12,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205465,None
2084,JPRN-jRCT1051200078,JPRN,2020-11-24,2020-11-24,False,Matsuyama Akifumi,Recruiting,Phase 2,Interventional,Japan,Study on reduction of salivary virus by povidone iodine on COVID-19,Drug,Povidone iodine,Povidone iodine,440,https://jrct.niph.go.jp/latest-detail/jRCT1051200078,None
2085,JPRN-jRCT1052200041,JPRN,2020-07-31,2020-07-30,True,Sawa Yoshiki,Not Recruiting,Not Applicable,Observational,Japan,Exploratory study of severity index for COVID-19 patients,Clinical Presentation,No Intervention,No Intervention,40,https://jrct.niph.go.jp/latest-detail/jRCT1052200041,None
2086,JPRN-jRCT2031200180,JPRN,2020-11-04,2020-11-24,False,Taniguchi Masaki,Not Recruiting,Phase 2/Phase 3,Interventional,Japan,A Phase II/III Study of Sargramostim,Drug,Sargramostim,Sargramostim,60,https://jrct.niph.go.jp/latest-detail/jRCT2031200180,None
2087,JPRN-jRCT2051200085,JPRN,2020-11-12,2020-11-25,False,Tomono Kazunori,Recruiting,Phase 1/Phase 2,Interventional,Japan,Phase I / II study of intracutaneous inoculation of COVID-19 DNA vaccine (AG0302-COVID19),ATMP,Vaccine,Vaccine,30,https://jrct.niph.go.jp/latest-detail/jRCT2051200085,None
2088,JPRN-jRCTs031200196,JPRN,2020-11-11,2020-11-11,False,Tsushima Kenji,Recruiting,Phase 2/Phase 3,Interventional,Japan,"Combination therapy of favipiravir, camostat mesilate and inhaled ciclesonide for COVID-19 pneumonia",Drug,Favipiravir + Camostat mesilate + ciclesonide,Favipiravir; Camostat mesilate; ciclesonide,100,https://jrct.niph.go.jp/latest-detail/jRCTs031200196,None
2089,JPRN-UMIN000040289,JPRN,2020-05-01,2020-05-01,False,Tokyo Women's Medical University,Not Recruiting,Not Applicable,Observational,Japan,Simulation study of tracheal intubation through an aerosol-box assuming COVID-19,Other (physical),Endotracheal Intubation,Endotracheal Intubation,30,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045947,None
2090,JPRN-UMIN000040349,JPRN,2020-05-11,2020-05-10,True,Haga Red Cross Hospital,Recruiting,Not Applicable,Observational,Japan,Psychological and physical effects of self-isolation on Japanese school-aged children related to COVID19 epidemic,Other (psych),No Intervention,No Intervention,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046043,None
2091,JPRN-UMIN000040386,JPRN,2020-07-01,2020-06-01,True,Nagasaki University,Recruiting,Not Applicable,Observational,Japan,Evaluation of COVID-19 antigen test in COVID-19 suspected cases,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,300,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046087,None
2092,JPRN-UMIN000040402,JPRN,2020-07-01,2020-06-16,True,Nagasaki University,Not Recruiting,Not Applicable,Observational,Japan,Verification of operating characteristic of COVID-19 antibody test,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046105,None
2093,JPRN-UMIN000040539,JPRN,2020-07-01,2020-07-01,False,Tokyo Medical and Dental University,Not Recruiting,Not Applicable,Observational,Japan,Study for medical support using smart devise for IBD patients under the novel coronavirus prevalence.,Other (device),Smart device,Smart device,2000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046274,None
2094,JPRN-UMIN000040744,JPRN,2020-06-16,2020-06-22,False,Yokohama City University,Not Recruiting,Not Applicable,Interventional,Japan,Clinical study to evaluate the efficiency of specific antibody against SARS-CoV-2 for the purpose of its social implementation,Clinical Presentation (Epidemiology),No Intervention,No Intervention,5000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046508,None
2095,JPRN-UMIN000041421,JPRN,2020-08-14,2020-08-14,False,Kanazawa University,Not Recruiting,Not Applicable,Interventional,Japan,Detecting Exacerbation Early Signs of SARS-CoV-2 infection by Fitbit: Pilot Study,Other (device),Biosensors,Biosensors,30,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047290,None
2096,JPRN-UMIN000041428,JPRN,2020-08-16,2020-05-05,True,Airlangga University,Not Recruiting,Not Applicable,Other,Asia(except Japan),Elevated fibrinogen and fibrin degradation product were associated with poor outcome in COVID-19 patients,Clinical Presentation,No Intervention,No Intervention,2000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046671,None
2097,JPRN-UMIN000042076,JPRN,2020-10-11,2020-10-11,False,Airlangga University,Not Recruiting,Not Applicable,Other,Asia(except Japan),Association of calcium channel blocker use with COVID-19 clinical outcome: a metaanalysis,Not relevant,Not relevant,Not relevant,1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048016,None
2098,JPRN-UMIN000042214,JPRN,2020-10-22,2020-11-15,False,Wakayama Medical University,Not Recruiting,Not Applicable,Observational,Japan,Relationships between physical activity during hospitalization and physical capacity after discharge from hospital in patients with COVID-19: a prospective observational study,Other (exercise),Exercise,Exercise,40,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048185,None
2099,JPRN-UMIN000042248,JPRN,2020-11-11,2020-07-10,True,Yokohama City University,Recruiting,Not Applicable,Observational,Japan,The relationship between COVID-19 Infection and new onset and prognosis of vasospastic angina: Multi-center prospective study,Clinical Presentation,No Intervention,No Intervention,300,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048215,None
2100,JPRN-UMIN000042299,JPRN,2020-11-02,2020-11-02,False,Keio University,Not Recruiting,Not Applicable,Observational,Japan,Infrastructure research for understanding the actual situation and pathophysiology of long-term complications of Coronavirus disease 2019 (COVID-19),Clinical Presentation,No Intervention,No Intervention,2000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048241,None
2101,JPRN-UMIN000042384,JPRN,2020-11-16,2020-11-16,False,Jinseikai Kohnan Hospital,Not Recruiting,Not Applicable,Interventional,Japan,Verification of stress relief by introducing online visits to the restrictions on visits of COVID-19,Other (psych),No Intervention,No Intervention,100,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048379,None
2102,JPRN-UMIN000042424,JPRN,2020-11-11,2020-11-11,False,Airlangga University,Not Recruiting,Not Applicable,Other,Asia(except Japan),Prevalence of Right Ventricular Dysfunction and Its Association with COVID-19 Clinical Outcome: A Meta-Analysis,Clinical Presentation,No Intervention,No Intervention,1000,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048431,None
2103,JPRN-UMIN000042453,JPRN,2020-11-16,2020-04-01,True,Indonesia University,Not Recruiting,Not Applicable,Observational,Asia(except Japan),"Does emergency Orthopaedic surgery in the pandemic era increase the risk of developing COVID-19? A combined analysis of retrospective and prospective study at a national tertiary hospital in Jakarta, Indonesia",Other,No Intervention,No Intervention,14,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048463,None
2104,JPRN-UMIN000042477,JPRN,2020-11-17,2020-11-17,False,Yokohama City University,Recruiting,Not Applicable,Interventional,Japan,Prospective research for early detection of COVID-19 pneumonia using mobile CT vehicle at specialized accommodation facilities,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,150,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048432,None
2105,JPRN-UMIN000042489,JPRN,2020-11-18,2020-04-08,True,I.M. Sechenov First Moscow State Medical University,Not Recruiting,Not Applicable,Observational,Europe,Antiinflammatory and anticoagulative agents in COVID-19 pneumonia treatment,Drug,Enoxaparin + Corticosteroids,Dexamethasone; Enoxaparin,157,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048499,None
2106,JPRN-UMIN000042522,JPRN,2020-11-24,2020-11-24,False,Nagoya University Hospital,Recruiting,Not Applicable,Observational,Japan,"An observational study for hospitalized patients with community-acquired, hospital-acquired, and ventilator-associated pneumonia",Clinical Presentation,No Intervention,No Intervention,1500,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048542,None
2107,KCT0005634,CRIS,2020-11-27,2020-05-20,True,Koera University Guro Hospital,Not Recruiting,Not Applicable,Observational,South Korea,EFFECTIVENESS OF COVID-19 SCREENING IN PATIENTS BEFORE SURGERY,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1500,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=18110,None
2108,CTRI/2015/03/005657,CTRI,2015-03-27,2015-03-30,False,Covidien,Not Recruiting,Not Applicable,Observational,India,Observational and Minimal Interventional Study Designed to Collect Data During Planned Surgery,Not relevant,Not relevant,Not relevant,75,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=11463,None
2109,CTRI/2017/02/007820,CTRI,2017-02-09,2014-11-25,True,Kasturba Medical College,Not Recruiting,Not Applicable,Interventional,India,Is Lightweight Polyester Mesh a better alternative for inguinal hernia repair?,Not relevant,Not relevant,Not relevant,96,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=16467,None
2110,CTRI/2020/03/024402,CTRI,2020-03-31,2020-08-04,False,Dr. Remesh Bhasi,Not Recruiting,Phase 3,Interventional,India,"Hydroxy Chloroquine, in open labelled, Randomised intervention for prevention of new infection and adverse outcomes following COVID-19 infection -A Tertiary Hospital based study",Drug,Hydroxychloroquine,Hydroxychloroquine,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42638,None
2111,CTRI/2020/04/024442,CTRI,2020-04-01,2020-08-04,False,Max Super Speciality Hospital (Devki Devi Foundation),Not Recruiting,Not Applicable,Observational,India,Screening for symptoms of COVID-19,Clinical Presentation,No Intervention,No Intervention,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42687,None
2112,CTRI/2020/04/024413,CTRI,2020-04-01,2020-09-04,False,K M Amran Hossain,No Status Given,Not Applicable,Observational,Bangladesh,"Knowledge, attitude and fear of COVID-19 in Bangladesh",Other (psych),No Intervention,No Intervention,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42718,None
2113,CTRI/2020/04/024473,CTRI,2020-04-03,2020-04-15,False,Discovery the Critical Care Research Network,Not Recruiting,Not Applicable,Observational,"United Kingdom, India, United States, Italy",Viral Infection and Respiratory illness Universal Study,Clinical Presentation,No Intervention,No Intervention,50000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42684,None
2114,CTRI/2020/04/024482,CTRI,2020-04-07,2020-07-04,False,Zifo RnD Solutions,Not Recruiting,Not Applicable,Observational,India,A pan-india non-interventional virtual registry evaluating the prophylactic efficacy of different regimens against SARS-CoV2 infection (COVID-2019) in asymptomatic health care workers,Drug (Chemoprophylaxis),Unspecified,Unspecified,10000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42777,None
2115,CTRI/2020/04/024479,CTRI,2020-04-07,2020-04-13,False,Command Hospital Airforce,Not Recruiting,Not Applicable,Interventional,India,Study of the effect of Hydroxychloroquine in addition to standard therapy in COVID-19 patients,Drug,Chloroquine,Chloroquine,32,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42713,None
2116,CTRI/2020/04/024636,CTRI,2020-04-15,2020-01-05,True,DACH Jaipur,Not Recruiting,Not Applicable,Observational,India,Assessment of Objective clinical scoring system to rule out COVID-19 with high sensitivity,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42961,None
2117,CTRI/2020/04/024659,CTRI,2020-04-15,2020-04-27,False,SSV Phytopharmaceuticals,Not Recruiting,Phase 3,Interventional,India,Study of Shreepad Shree Vallabh SSV Formulation to improve immunity in quarantine patients of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42967,None
2118,CTRI/2020/04/024697,CTRI,2020-04-17,2020-04-17,False,Caring Mahajan Imaging,Not Recruiting,Not Applicable,Observational,India,COVID-19 Data-bank Project,Clinical Presentation,No Intervention,No Intervention,100000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42835,None
2119,CTRI/2020/04/024731,CTRI,2020-04-20,2020-04-24,False,Parul University,Not Recruiting,Phase 3,Interventional,India,Study to Evaluate Preventive Effect of Ayurveda and Homeopathy Treatment in COVID 19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42912,None
2120,CTRI/2020/04/024729,CTRI,2020-04-20,2020-04-21,False,All India Institute of Medical Sciences,Not Recruiting,Phase 2,Interventional,India,"Topical Chloroquine Nasal Drops in Early Stage Covid 19-
Impact on Viral load and cure rates
",Drug,Chloroquine,Chloroquine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42933,None
2121,CTRI/2020/04/024772,CTRI,2020-04-21,2020-04-28,False,Max Super Speciality Hospital (Devki Devi Foundation),Not Recruiting,Not Applicable,Observational,India,Comparison of suspected or negative cases with confirmed cases of COVID-19 at Max Hospital,Clinical Presentation,No Intervention,No Intervention,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43079,None
2122,CTRI/2020/04/024747,CTRI,2020-04-21,2020-01-05,True,GSL Medical College,Not Recruiting,Not Applicable,Interventional,India,EFFECTIVENESS TO MANAGE COVID 19 PANDEMIC BY  TEACHING  VENTILATORY MANAGEMENT TO NON-ANAESTHESIOLOGY RESIDENTS,Other,Other,Other,26,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43115,None
2123,CTRI/2020/04/024775,CTRI,2020-04-21,2020-04-22,False,Indian Council Of Medical Research,Not Recruiting,Phase 2,Interventional,India,Study to assess the efficacy and safety of convalescent plasma in moderate COVID-19 disease.,ATMP,Plasma,Plasma,452,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43149,None
2124,CTRI/2020/04/024749,CTRI,2020-04-21,2020-04-21,False,Serum Institute of India Pvt Ltd,Not Recruiting,Phase 3,Interventional,India,Study to Evaluate the Efficacy of Recombinant BCG VPM1002 in Reducing Infection Incidence and Disease Severity of SARS-COV-2/COVID-19 Among High-Risk Subjects,ATMP,Vaccine,Vaccine,5946,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42972,None
2125,CTRI/2020/04/024806,CTRI,2020-04-22,2020-04-26,False,All India Institute of Medical Sciences,Recruiting,Phase 2,Interventional,India,Imatinib in COVID-19 infection,Drug,Imatinib,Imatinib,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42843,None
2126,CTRI/2020/04/024804,CTRI,2020-04-22,2020-11-05,False,International Stemcell Services Ltd,Recruiting,Phase 1/Phase 2,Interventional,India,Evaluation of safety and efficacy of convalescent plasma in COVID-19 patients,ATMP,Plasma,Plasma,24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42849,None
2127,CTRI/2020/04/024776,CTRI,2020-04-22,2020-04-23,False,Dr. Mahesh Mahich,Recruiting,Not Applicable,Interventional,India,"Novel Artificial Intelligence Algorithm to screen COVID-19 Patients from X-Ray , CT-Scan of Thorax and Voice Sampling through Android App and storage through Cloud",Other (software),eHealth,eHealth,1650,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43160,None
2128,CTRI/2020/04/024784,CTRI,2020-04-22,2020-04-24,False,Dr. Sameer Malhotra,Not Recruiting,Not Applicable,Observational,India,ANXIETY AND DEPRESSION DURING COVID-19 IN INDIA,Other (psych),No Intervention,No Intervention,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42939,None
2129,CTRI/2020/04/024805,CTRI,2020-04-22,2020-04-24,False,Sanjay Gandhi Postgraduate Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Impact of Covid-19 pandemic on practice pattern of Indian urologists,Health System,No Intervention,No Intervention,160,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42979,None
2130,CTRI/2020/04/024833,CTRI,2020-04-24,2020-01-05,True,Dr. Narayanan Parameswaran,Not Recruiting,Not Applicable,Interventional,India,BCG-Denmark versus no-BCG for COVID 19 prevention,ATMP,Vaccine,Vaccine,1826,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43105,None
2131,CTRI/2020/04/024857,CTRI,2020-04-25,2020-04-05,True,Welling Healthcare Private Limited,Not Recruiting,Phase 1/Phase 2,Interventional,India,Proving the efficacy of  Homeopathic treatment in prevention and cure of COVID-19.,Other,Homeopathy,Homeopathy,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43212,None
2132,CTRI/2020/04/024859,CTRI,2020-04-25,2020-04-25,False,Max Super Speciality Hospital (Devki Devi Foundation),Not Recruiting,Not Applicable,Observational,India,To Study the Clinical characteristics and treatment Outcome of COVID-19 Patients admitted in hospitals of Max Healthcare (SCOPe Study),Clinical Presentation,No Intervention,No Intervention,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43232,None
2133,CTRI/2020/04/024858,CTRI,2020-04-25,2020-04-25,False,Max Super Speciality Hospital (Devki Devi Foundation),Not Recruiting,Not Applicable,Interventional,India,"Ã¢??To study the effectiveness of Ivermectin with standard of care treatment
versus standard of care treatment for COVID 19 cases. A Pilot Study",Drug,Ivermectin,Ivermectin,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43236,None
2134,CTRI/2020/04/024882,CTRI,2020-04-27,2020-04-28,False,"Ministry of Ayush, Government of India",Not Recruiting,Phase 3,Interventional,India,A study to assess the effectiveness of Ayurvedic formulation in addition to standard of care in COVID-19 positive patients in a tertiary hospital.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42899,None
2135,CTRI/2020/04/024904,CTRI,2020-04-28,2020-11-05,False,Director General Armed Forces Medical Services,Not Recruiting,Phase 3,Interventional,India,Treatment of COVID19 : A randomised controlled trial,Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43130,None
2136,CTRI/2020/04/024883,CTRI,2020-04-28,2020-04-29,False,Pankajakasthuri Herbal Research Foundation,Not Recruiting,Phase 4,Interventional,India,Clinical research on safety and efficacy of ZingiVir-H as an add on therapy in COVID-19 patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,112,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43168,None
2137,CTRI/2020/04/024914,CTRI,2020-04-29,2020-08-05,False,Dr. Sulagna Bhattacharjee,Not Recruiting,Not Applicable,Observational,India,Characteristics of seriously ill COVID-19 patients admitted to a tertiary care centre,Clinical Presentation,No Intervention,No Intervention,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43323,None
2138,CTRI/2020/04/024915,CTRI,2020-04-29,2020-09-05,False,Max Super Speciality Hospital (Devki Devi Foundation),Not Recruiting,Phase 2,Interventional,India,"A Phase II, Open Label, Randomized Controlled Trial to Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications",ATMP,Plasma,Plasma,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43332,None
2139,CTRI/2020/04/024948,CTRI,2020-04-30,2020-05-15,False,Lady Hardinge Medical College,Not Recruiting,Phase 2,Interventional,India,"A clinical Trial to Study the Effects of Hydroxychloroquine, Ciclesonide and Ivermectin in treatment of moderate COVID-19 illness",Drug,Hydroxychloroquine vs. Ciclesonide vs. Ivermectin,Hydroxychloroquine; Ciclesonide; Ivermectin,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43364,None
2140,CTRI/2020/04/024949,CTRI,2020-04-30,2020-05-15,False,Lady Hardinge Medical College,Recruiting,Phase 2,Interventional,India,A study to evaluate the effect of Oral Niclosamide in mild and very mild COVID-19 cases,Drug,Niclosamide,Niclosamide,48,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43400,None
2141,CTRI/2020/04/024947,CTRI,2020-04-30,2020-08-05,False,Dr. Priti Katre,Not Recruiting,Phase 3,Interventional,India,Clinical trial on effects of homeopathic medicine made from cadamba on COVID-19,Other,Homeopathy,Homeopathy,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43259,None
2142,CTRI/2020/05/024967,CTRI,2020-05-01,2020-11-05,False,MiLab LifeSciences,Not Recruiting,Phase 4,Interventional,India,Herbal product Clinical trial on COVID-19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,42,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43338,None
2143,CTRI/2020/05/024959,CTRI,2020-05-01,2020-01-05,True,Biocon Limited,Not Recruiting,Phase 2,Interventional,India,Efficacy and Safety of Itolizumab in COVID-19 Complications,Drug,Itolizumab,Itolizumab,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42878,None
2144,CTRI/2020/05/024969,CTRI,2020-05-01,2020-10-15,False,Naiminath Homoeopathic Medical College Hospital and Research Centre,Not Recruiting,Phase 2/Phase 3,Interventional,India,Homoeopathy as adjuvant in management of Covid-19 infection,Other,Homeopathy,Homeopathy,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43393,None
2145,CTRI/2020/05/024962,CTRI,2020-05-01,2020-05-05,False,Win medicare,Not Recruiting,Not Applicable,Interventional,India,The use of topical Povidone Iodine (PVP-I) oropharyngeal and intranasal application during the current coronavirus pandemic as a potential measure to reduce viral transmission,Drug,Povidone Iodine,Povidone Iodine,96,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43237,None
2146,CTRI/2020/05/024981,CTRI,2020-05-02,2020-05-15,False,Dabur India Ltd,Not Recruiting,Not Applicable,Interventional,India,Clinical study on Dabur Chyawanprash as a preventive remedy in pandemic of Covid-19.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43374,None
2147,CTRI/2020/05/024982,CTRI,2020-05-02,2020-05-15,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Effects of using hydroxychloroquine and azithromycin in the treatment of confirmed COVID-19 positive patients,Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43432,None
2148,CTRI/2020/05/024983,CTRI,2020-05-02,2020-05-05,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,"Usage of topical lignocaine to decrease the gag reflex
while sampling for Covid-19: Does it affect the yield of

specimen?",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43204,None
2149,CTRI/2020/05/024984,CTRI,2020-05-03,2020-12-05,False,Sanjay Gandhi Postgraduate Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,How has the spread of COVID 19 disease affected the teaching and training of postgraduate students who are studying anaesthesiology,Other,No Intervention,No Intervention,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43425,None
2150,CTRI/2020/05/025010,CTRI,2020-05-04,2020-04-05,True,Indian Council Of Medical Research,Not Recruiting,Not Applicable,Observational,India,Hydroxychloroquine prophylaxis in Covid 19 infection,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,2000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43269,None
2151,CTRI/2020/05/024989,CTRI,2020-05-04,2020-11-05,False,Asian HealthCare Foundation,Not Recruiting,Not Applicable,Observational,India,Mechanism of Covid 19 infection in Humans,Clinical Presentation,No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43377,None
2152,CTRI/2020/05/024986,CTRI,2020-05-04,2020-05-13,False,Central Council for Research in Homoeopathy,Not Recruiting,Not Applicable,Interventional,India,HOMOEOPATHY IN PREVENTION OF COVID-19,Other,Homeopathy,Homeopathy,10000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43455,None
2153,CTRI/2020/05/024985,CTRI,2020-05-04,2020-05-13,False,Sanjay Gandhi Postgraduate Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Attempting to pass a breathing tube in a model of human body using two different preventive device as a precautionary measure in the times of COVID,Procedure,No Intervention,No Intervention,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43462,None
2154,CTRI/2020/05/025013,CTRI,2020-05-05,2020-06-05,False,Haffkine Institute for Training Research and Testing,Not Recruiting,Phase 2,Interventional,India,Evaluation of BCG as potential therapy for COVID-19,ATMP,Vaccine,Vaccine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42858,None
2155,CTRI/2020/05/025022,CTRI,2020-05-05,2020-06-05,False,All India Institute of Medical Sciences,Not Recruiting,Phase 2,Interventional,India,Hydroxychloroquine in patients with mild COVID-19 illness with risk factors for severe disease,Drug,Hydroxychloroquine,Hydroxychloroquine,166,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43183,None
2156,CTRI/2020/05/025067,CTRI,2020-05-06,2020-06-15,False,George Institute for Global Health India,Recruiting,Not Applicable,Interventional,India,A randomized controlled trial of hydroxychloroquine prophylaxis for Healthcare Workers exposed to COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,6950,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43019,None
2157,CTRI/2020/05/025041,CTRI,2020-05-06,2020-06-05,False,Max Super Speciality Hospital (Devki Devi Foundation),Not Recruiting,Not Applicable,Observational,India,Radiographic findings and their temporal changes in COVID-19 positive patient: A Prospective study,Clinical Presentation,No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43277,None
2158,CTRI/2020/05/025049,CTRI,2020-05-06,2020-08-05,False,Sai Nidan Homeopathy Clinic,Not Recruiting,Phase 2/Phase 3,Interventional,India,A CLINICAL TRIAL TO STUDY THE EFFICACY OF HOMOEOPATHIC MEDICINE IN PREVENTION AND CURE OF CORONA VIRUS DISEASE 19,Other,Homeopathy,Homeopathy,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43313,None
2159,CTRI/2020/05/025069,CTRI,2020-05-07,2020-05-16,False,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Phase 3/Phase 4,Interventional,India,Ayurvedic Interventions in prevention of COVID-19 infection-A survey study,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,9200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43522,None
2160,CTRI/2020/05/025070,CTRI,2020-05-07,2020-09-05,False,Max Super Speciality Hospital (Devki Devi Foundation),Not Recruiting,Not Applicable,Observational,India,An Observational study to identify the issues and challenges in cancer patients on active treatment during the COVID-19 Pandemic and the resulting Lockdown,Clinical Presentation,No Intervention,No Intervention,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43343,None
2161,CTRI/2020/05/025068,CTRI,2020-05-07,2020-05-27,False,Christian Medical College Vellore,Not Recruiting,Phase 3,Interventional,India,Can a medicine help in curing viral infection,Drug,Ivermectin,Ivermectin,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43449,None
2162,CTRI/2020/05/025071,CTRI,2020-05-08,2020-05-16,False,All India Institute of Medical Sciences,Not Recruiting,Phase 3,Interventional,India,Clinical trial evaluating two ventilator settings in Corona virus related severe lung diseases ( known as ARDS),Other (physical),Mechanical ventilation,Mechanical ventilation,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43447,None
2163,CTRI/2020/05/025088,CTRI,2020-05-09,2020-05-20,False,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Phase 1/Phase 2,Interventional,India,Study of GUDUCHI TABLET on healthy individuals to prevent covid 19.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43555,None
2164,CTRI/2020/05/025089,CTRI,2020-05-09,2020-05-18,False,Sanjay Gandhi Postgraduate Institute of Medical Sciences,Recruiting,Not Applicable,Observational,India,Effect of Hydroxychloroquine on QTc Interval,Drug,Hydroxychloroquine,Hydroxychloroquine,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43506,None
2165,CTRI/2020/05/025093,CTRI,2020-05-11,2020-05-18,False,"Ministry of Ayush, Government of India",Not Recruiting,Phase 2/Phase 3,Interventional,India,Study of effect of Yashtimadhu tablet for the prevention of COVID -19 on healthy individuals.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43539,None
2166,CTRI/2020/05/025092,CTRI,2020-05-11,2020-05-28,False,Science and Engineering Research Board (SERB),Not Recruiting,Not Applicable,Observational,India,Outcomes of viral infection in hematology patients,Clinical Presentation,No Intervention,No Intervention,250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43608,None
2167,CTRI/2020/05/025091,CTRI,2020-05-11,2020-05-20,False,Siddha Central Research Institute,Not Recruiting,Not Applicable,Observational,India,Knowledge status of public about COVID 19 disease prevention and control  in Tamil Nadu,Other,No Intervention,No Intervention,549,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43622,None
2168,CTRI/2020/05/025114,CTRI,2020-05-12,2020-05-20,False,Glenmark Pharmaceuticals Ltd,Not Recruiting,Phase 3,Interventional,India,A Clinical Study on Favipiravir Compared to Standard Supportive Care in Patients With Mild to Moderate COVID-19.,Drug,Favipiravir,Favipiravir,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43504,None
2169,CTRI/2020/05/025156,CTRI,2020-05-13,2020-05-18,False,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Phase 3/Phase 4,Interventional,India,Effect of Ayurveda intervention AYUSH-64 add-on therapy for patients with COVID-19 infection (Stage I),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43590,None
2170,CTRI/2020/05/025163,CTRI,2020-05-13,2020-05-20,False,University of Birmingham,Not Recruiting,Not Applicable,Observational,"Philippines, Pakistan, Benin, India, Italy, France, Zambia, Mexico, Rwanda, United Kingdom, South Africa, Spain, United States",Surgery Outcomes in COVID patients,Clinical Presentation,No Intervention,No Intervention,3000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43610,None
2171,CTRI/2020/05/025160,CTRI,2020-05-13,2020-05-25,False,University of Birmingham,Not Recruiting,Not Applicable,Observational,"United Arab Emirates, Nigeria, Philippines, Pakistan, Ghana, Benin, India, Italy, France, Zambia, Canada, Mexico, Rwanda, United Kingdom, South Africa, Australia, Spain, United States",Outcomes Of Cancer Surgery During COVID-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,7000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43628,None
2172,CTRI/2020/05/025162,CTRI,2020-05-13,2020-05-26,False,Jawaharlal Institute of Postgraduate Medical Education and Research,Recruiting,Not Applicable,Interventional,India,Effect of pranayama and meditation on psychological well-being of healthcare workers during COVID-19 pandemic.,Other (psych),Psychological,Psychological,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43650,None
2173,CTRI/2020/05/025161,CTRI,2020-05-13,2020-05-16,False,Ms Shukla Ashar Impex Pvt Ltd,Not Recruiting,Phase 2,Interventional,India,To study the Effectiveness of herbal formulation - Aayudh Advance as a supplementary treatment for the Corona Virus 2019 (Covid-19) infected patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43442,None
2174,CTRI/2020/05/025166,CTRI,2020-05-14,2020-05-19,False,"Ministry of Ayush, Government of India",Not Recruiting,Phase 2/Phase 3,Interventional,India,Study of ASHWAGANDHA TABLET on healthy individuals to prevent covid 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43553,None
2175,CTRI/2020/05/025178,CTRI,2020-05-14,2020-05-18,False,All India Institute of Ayurveda,Not Recruiting,Phase 2,Interventional,India,Evaluation of the Immuno-Stimulatory Potential (Shareera Bala) of an Ayurveda Management Protocol in Cohort of Quarantined Delhi Police under Covid-19 Care Centers- An Exploratory Clinical Study,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,140,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43557,None
2176,CTRI/2020/05/025167,CTRI,2020-05-14,2020-05-17,False,Intas Pharmaceuticals Ltd,Recruiting,Phase 2,Interventional,India,Evaluation of Efficacy and Safety of Thymoquinone compared to Best supportive care in Patients with COVID-19,Drug,Thymoquinone,Thymoquinone,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43378,None
2177,CTRI/2020/05/025171,CTRI,2020-05-14,2020-05-16,False,All India Institute of Ayurveda,Not Recruiting,Phase 2,Interventional,India,Ayurveda protocol & COVID-19 exposed individuals: Clinical trial of an Ayurveda Intervention,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43487,None
2178,CTRI/2020/05/025184,CTRI,2020-05-15,2020-05-19,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,"United Arab Emirates, India, United States",Psychological impact of COVID Ã¢?? 19 Pandemic,Other (psych),No Intervention,No Intervention,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43600,None
2179,CTRI/2020/05/025194,CTRI,2020-05-15,2020-05-22,False,Narrain Shree,Not Recruiting,Not Applicable,Observational,India,Mental status of public during lockdown COVID-19,Other (psych),No Intervention,No Intervention,280,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43664,None
2180,CTRI/2020/05/025182,CTRI,2020-05-15,2020-05-22,False,Central Council for Research in Siddha,Not Recruiting,Not Applicable,Observational,India,Siddha interventions prevention to front line workers,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,366,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43680,None
2181,CTRI/2020/05/025213,CTRI,2020-05-15,2020-05-23,False,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Not Applicable,Interventional,India,Ayurveda formulation for COVID-19 prevention,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,1500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43698,None
2182,CTRI/2020/05/025205,CTRI,2020-05-15,2020-05-24,False,Central Council for Research in Homoeopathy,Not Recruiting,Phase 2/Phase 3,Interventional,India,Arsenicum album Ã¢?? 30 as prophylactic for Covid-19,Other,Homeopathy,Homeopathy,33000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43721,None
2183,CTRI/2020/05/025214,CTRI,2020-05-15,2020-05-24,False,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,India,To observe the effect of Ayurvedic medicine for the treatment of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43727,None
2184,CTRI/2020/05/025183,CTRI,2020-05-15,2020-05-18,False,Indian Council of Medical Research,Not Recruiting,Not Applicable,Observational,India,Questionnaire based study of drugs taken by healthcare workers to prevent COVID 19,Other,No Intervention,No Intervention,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43241,None
2185,CTRI/2020/05/025212,CTRI,2020-05-15,2020-05-25,False,Dr. Jai Prakash Agarwal,Not Recruiting,Not Applicable,Observational,India,"Assessing Stress levels among the Health Care Workers during and after Outbreak of
COVID-19",Other (psych),No Intervention,No Intervention,350,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43757,None
2186,CTRI/2020/05/025209,CTRI,2020-05-15,2020-05-20,False,Council of Scientific and Industrial Research,Recruiting,Phase 2,Interventional,India,A clinical trial for validating therapeutic efficacy of convalescent plasma in severe COVID-19 disease,ATMP,Plasma,Plasma,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43251,None
2187,CTRI/2020/05/025216,CTRI,2020-05-16,2020-05-26,False,Rohit Walia,Not Recruiting,Not Applicable,Observational,India,HCQ POCKET ECG Ambulatory Telemetry  Study,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43755,None
2188,CTRI/2020/05/025215,CTRI,2020-05-16,2020-05-25,False,Dean,Not Recruiting,Phase 1/Phase 2,Interventional,India,"Effectiveness of Siddha medicine, Kabasura kudineer and vitamin c-zinc supplementation in the management of Mild COVID 19 patients.",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43769,None
2189,CTRI/2020/05/025217,CTRI,2020-05-17,2020-05-29,False,Dr. Bhawna Sirohi,Recruiting,Not Applicable,Observational,India,COVID-19 and cancer chemotherapy,Clinical Presentation,No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43015,None
2190,CTRI/2020/05/025220,CTRI,2020-05-17,2020-05-20,False,Hiba Siddiqui,Not Recruiting,Not Applicable,Observational,India,"To study the effect of COVID-19 pandemic and Psychological Well-being of Healthcare Professionals and Support Staff in Max Super Speciality Hospital, Saket in New Delhi, India.",Other (psych),No Intervention,No Intervention,1300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43619,None
2191,CTRI/2020/05/025219,CTRI,2020-05-17,2020-05-26,False,Dr. Ramandeep Singh Arora,Not Recruiting,Not Applicable,Observational,India,To find out what has happened to the treatment and care of children suffering with cancer in India during the lockdown from the COVID-19 pandemic,Clinical Presentation,No Intervention,No Intervention,1250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43750,None
2192,CTRI/2020/05/025221,CTRI,2020-05-17,2020-05-26,False,Dr. Ramandep Arora,Not Recruiting,Not Applicable,Observational,India,Create registry of Childhood Cancer patients in India with COVID 19 to provide guidelines for prevention and treatment,Clinical Presentation,No Intervention,No Intervention,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43753,None
2193,CTRI/2020/05/025218,CTRI,2020-05-17,2020-05-25,False,Tata Memorial Centre,Not Recruiting,Not Applicable,Observational,India,A survey for challenges faced by the Investigators during COVID-19 pandemic in the conduct of Clinical Trials at Tata Memorial Centre.,Health System,No Intervention,No Intervention,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43772,None
2194,CTRI/2020/05/025222,CTRI,2020-05-18,2020-01-06,True,Shree Dhootapapeshwar Limited,Not Recruiting,Phase 4,Interventional,India,Efficacy of Tablet AOIM - Z in Prevention of  COVID - 19   in High Risk Healthy Police Personnel,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,275,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43803,None
2195,CTRI/2020/05/025224,CTRI,2020-05-18,2020-05-24,False,R D Gardi Medical College,Not Recruiting,Phase 2,Interventional,India,Study to efficacy of Ivermectin in patients of COVID-19,Drug,Ivermectin,Ivermectin,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43728,None
2196,CTRI/2020/05/025242,CTRI,2020-05-19,2020-05-25,False,Indian Council of Medical Research,Not Recruiting,Not Applicable,Interventional,India,Hydroxychloroquine of pharmacokinetics in healthcare workers,Drug,Hydroxychloroquine,Hydroxychloroquine,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43057,None
2197,CTRI/2020/05/025243,CTRI,2020-05-19,2020-05-19,False,Medanta Institute of Education and Research,Not Recruiting,Not Applicable,Observational,India,A study on salivary samples and nasopharyngeal samples in diagnosis of COVID-19 Disease Patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43615,None
2198,CTRI/2020/05/025238,CTRI,2020-05-19,2020-05-20,False,Veena Nayak,Not Recruiting,Not Applicable,Observational,India,Emotional Impact of Isolation during COVID 19 among college students and staff,Other (psych),No Intervention,No Intervention,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43623,None
2199,CTRI/2020/05/025272,CTRI,2020-05-20,2020-05-30,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Interventional,India,"A study to assess the efficacy of Homoeopathic medicine in the prevention of Covid-19 
",Other,Homeopathy,Homeopathy,800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43790,None
2200,CTRI/2020/05/025254,CTRI,2020-05-20,2020-05-29,False,Central Council for Research in Unani Medicine,Not Recruiting,Phase 3,Interventional,India,To Study effectiveness and outcomes of Unani Medicine prophylactic interventions on population at risk of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43630,None
2201,CTRI/2020/05/025276,CTRI,2020-05-20,2020-05-29,False,Ch Brahm Prakash Ayurved Charak Sansthan,Not Recruiting,Phase 3,Interventional,India,effect of Ayurvedic intervention in COVID-19 positive cases,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43892,None
2202,CTRI/2020/05/025273,CTRI,2020-05-20,2020-05-29,False,Patanjali Research Institute,Not Recruiting,Not Applicable,Interventional,India,Impact of effect of Ayurvedic treatment on novel Corona virus disease,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43900,None
2203,CTRI/2020/05/025275,CTRI,2020-05-20,2020-05-30,False,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Phase 3,Interventional,India,Role of Chyawanprash in the prevention of COVID-19 in health care workers,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43917,None
2204,CTRI/2020/05/025274,CTRI,2020-05-20,2020-05-30,False,"Post Graduate Institute of Medical Education & Research, Chandigarh",Not Recruiting,Not Applicable,Observational,India,Impact of remote audio-visual surveillance of doffing process during COVID 19 pandemic on the safety of health care workers,Other,Other,Other,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43921,None
2205,CTRI/2020/05/025271,CTRI,2020-05-20,2020-05-31,False,Cadila Pharnmaceuticals,Recruiting,Phase 3,Interventional,India,"Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill",Drug,Mycobacterium,Mycobacterium,480,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43206,None
2206,CTRI/2020/05/025248,CTRI,2020-05-20,2020-06-15,False,Dr. Rahul Taneja,Not Recruiting,Not Applicable,Interventional,India,COVID-19 telephonic counseling model for addressing mental health concerns in different populations during corona outbreak in India,Telehealth,Telehealth,Telehealth,128,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43479,None
2207,CTRI/2020/05/025247,CTRI,2020-05-20,2020-05-26,False,Dr. Amit Patel,Not Recruiting,Not Applicable,Observational,India,"To Study Clinical Characteristics, Treatment Outcome of Coronavirus (COVID-19) Patients",Clinical Presentation,No Intervention,No Intervention,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43762,None
2208,CTRI/2020/05/025293,CTRI,2020-05-21,2020-05-27,False,Shri BM Patil Medical College Hospital and Research Center,Recruiting,Not Applicable,Observational,India,Difficulties faced by pregnant women during the Covid 19 Pandemic and lockdown,Clinical Presentation,No Intervention,No Intervention,250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43824,None
2209,CTRI/2020/05/025289,CTRI,2020-05-21,2020-06-15,False,P Vamsavardhana Reddy,Not Recruiting,Not Applicable,Observational,India,An observational study on QT interval changes with Hydroxychloroquine used as prophylaxis in COVID exposure risk individuals,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43612,None
2210,CTRI/2020/05/025291,CTRI,2020-05-21,2020-05-24,False,Maulana Azad Medical College,Not Recruiting,Not Applicable,Observational,India,Corona virus in tears,Clinical Presentation,No Intervention,No Intervention,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43654,None
2211,CTRI/2020/05/025297,CTRI,2020-05-21,2020-05-31,False,Abdul Haque M Quraishi,Not Recruiting,Not Applicable,Observational,India,Spectrum of injuries during COVID-19 Lock down at a major trauma centre in Central India,Other,No Intervention,No Intervention,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43911,None
2212,CTRI/2020/05/025290,CTRI,2020-05-21,2020-05-31,False,Dr. Gautam Sharma,Not Recruiting,Not Applicable,Observational,India,Psychological distress among health care workers due to COVID-19 outbreak,Other (psych),No Intervention,No Intervention,10000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43671,None
2213,CTRI/2020/05/025277,CTRI,2020-05-21,2020-05-31,False,Cadila Pharnmaceuticals,Recruiting,Phase 3,Interventional,India,Clinical Trial of Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19,Drug,Mycobacterium,Mycobacterium,4000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43176,None
2214,CTRI/2020/05/025299,CTRI,2020-05-21,2020-01-06,True,Wockhardt Ltd,Not Recruiting,Phase 2,Interventional,India,Convalescent Plasma treatment trial in COVID 19 patients,ATMP,Plasma,Plasma,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43752,None
2215,CTRI/2020/05/025298,CTRI,2020-05-21,2020-05-25,False,Central Council for Research in Siddha,Not Recruiting,Not Applicable,Interventional,India,Siddha Intervention Population Study.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,21500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43761,None
2216,CTRI/2020/05/025320,CTRI,2020-05-22,2020-05-22,False,Government Yoga And Naturopathy Medical College Chennai,Recruiting,Phase 3/Phase 4,Interventional,India,Effect of Yoga & Naturopathy in patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,658,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43576,None
2217,CTRI/2020/05/025317,CTRI,2020-05-22,2020-05-26,False,Ms Gelnova Laboratories India Pvt Ltd,Not Recruiting,Phase 4,Interventional,India,SURVEY OF MOUTH-DISSOLVING TURMERIC LOZENGES IN HEALTHCARE WORKERS,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43754,None
2218,CTRI/2020/05/025319,CTRI,2020-05-22,2020-01-06,True,Sanjay Gandhi Postgraduate Institute of Medical Sciences,Recruiting,Phase 3,Interventional,India,Trial of antihypertensive losartan for additional benefit in treating COVID 19 infection.,Drug,Losartan,Losartan,186,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42751,None
2219,CTRI/2020/05/025331,CTRI,2020-05-23,2020-05-24,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Home based prehabilitation via telemedicine in lung cancer patients during COVID 19,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43339,None
2220,CTRI/2020/05/025327,CTRI,2020-05-23,2020-09-06,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,To study some blood tests which would help predict severity and outcome in children with cancers having the novel corona virus infection.,Prognosis,No Intervention,No Intervention,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43914,None
2221,CTRI/2020/05/025326,CTRI,2020-05-23,2020-05-31,False,Shree Bharadi Ayurvedic,Not Recruiting,Phase 2,Interventional,India,Tablet PINAK given as treatment  to COVID positive patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43951,None
2222,CTRI/2020/05/025328,CTRI,2020-05-23,2020-01-06,True,Apollo Hospitals,Not Recruiting,Phase 2,Interventional,India,Study to Assess the Safety and Efficacy of Convalescent Plasma on outcome of COVID-19 Associated Complications,ATMP,Plasma,Plasma,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43703,None
2223,CTRI/2020/05/025338,CTRI,2020-05-24,2020-02-06,True,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,India,Evaluation of Efficacy and Safety of Ayurveda Intervention (Ayush -64) in the management of COVID-19 infection (Asymptomatic &Mild to Moderate symptoms,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44033,None
2224,CTRI/2020/05/025342,CTRI,2020-05-24,2020-06-15,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,mask use in covid in medical personnel - a survey,Other,No Intervention,No Intervention,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44039,None
2225,CTRI/2020/05/025336,CTRI,2020-05-24,2020-01-06,True,Tata Memorial Centre,Not Recruiting,Phase 3,Interventional,India,Randomized Controlled Trial Of Resveretrol-Copper Or Sodium-Copper-Chlorophyllin Vs Standard Treatment In Mild Covid-19 infection,Drug,Copper,Copper,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43934,None
2226,CTRI/2020/05/025334,CTRI,2020-05-24,2020-05-30,False,Health Solutions,Not Recruiting,Phase 2,Interventional,India,Protect and prevent onset of COVID like infections in Health Care Workers and High risk person.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43935,None
2227,CTRI/2020/05/025337,CTRI,2020-05-24,2020-01-06,True,Tata Memorial Centre,Not Recruiting,Phase 2,Interventional,India,Randomized Controlled Trial Of Resveretrol-Copper OR Sodium-Copper-Chlorophyllin Versus Standard Treatment In Severe Covid-19,Drug,Copper,Copper,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43940,None
2228,CTRI/2020/05/025335,CTRI,2020-05-24,2020-06-20,False,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Phase 3,Interventional,India,"Efficacy of AYUSH-64 (a polyherbal formulation) in COVID - 19 Cases
",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43949,None
2229,CTRI/2020/05/025339,CTRI,2020-05-24,2020-02-06,True,Kasturba Medical College,Not Recruiting,Not Applicable,Observational,India,Treatment and economical problems faced due to non COVID patients admitted in severe acute respiratory illness (SARI) ICU based on SARI criteria,Other,No Intervention,No Intervention,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43959,None
2230,CTRI/2020/05/025341,CTRI,2020-05-24,2020-02-06,True,No Sponsor Name Given,Recruiting,Not Applicable,Interventional,India,A study to know the effect of Ayurvedic Kwath(Kiratiktadi Kwath) & Ashwagandha Churna along with yoga exercises in the treatment of COVID-19 Positive patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44013,None
2231,CTRI/2020/05/025343,CTRI,2020-05-25,2020-05-30,False,Health Solutions,Not Recruiting,Phase 2/Phase 3,Interventional,India,Study results of Ayurvedic treatment on COVID patients using proprietary herbal formulation SUVED and whole colostrum REIMMUGEN.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43919,None
2232,CTRI/2020/05/025345,CTRI,2020-05-25,2020-05-06,True,Acculi Labs Pvt Ltd,Recruiting,Not Applicable,Observational,India,Detailed Organ System Analysis of Asymptomatic COVID19 patients using noninvasive mobile tool,Other (software),eHealth,eHealth,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43948,None
2233,CTRI/2020/05/025347,CTRI,2020-05-25,2020-01-06,True,Kasturba Medical College,Not Recruiting,Not Applicable,Observational,India,Psychological impact of COVID-19 pandemic on health care workers,Other (psych),No Intervention,No Intervention,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43958,None
2234,CTRI/2020/05/025348,CTRI,2020-05-25,2020-01-06,True,Apurv Barche,Not Recruiting,Not Applicable,Observational,India,Medical students preference and perspective for online teaching during lockdown period,Other,No Intervention,No Intervention,800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43979,None
2235,CTRI/2020/05/025344,CTRI,2020-05-25,2020-08-06,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Effects of the corona virus disease on mental health of Anaesthesiologists working at different parts of India.,Other (psych),No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44024,None
2236,CTRI/2020/05/025346,CTRI,2020-05-25,2020-01-06,True,Government of Tamil Nadu,Not Recruiting,Not Applicable,Interventional,India,A Clinical Trial to Assess the Safety and Efficacy of Convalescent Plasma in Severe Covid-19 patients.,ATMP,Plasma,Plasma,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43005,None
2237,CTRI/2020/05/025350,CTRI,2020-05-26,2020-05-31,False,R D Gardi Medical College,Not Recruiting,Phase 2,Interventional,India,Study to assess safety and efficacy of Inj Sepsivac in patients of Covid-19,Drug,Sepsivac,Sepsivac,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43559,None
2238,CTRI/2020/05/025370,CTRI,2020-05-27,2020-04-06,True,Ayurved University,Not Recruiting,Not Applicable,Interventional,India,Evaluation of Role of Ayurvedic Drug- Guduchi Ghan Vati in the treatment of COVID-19 related illness,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44064,None
2239,CTRI/2020/05/025385,CTRI,2020-05-27,2020-01-06,True,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Not Applicable,Interventional,India,Research study to evaluate the impact of Selected Ayurvedic interventions in containment zone,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43953,None
2240,CTRI/2020/05/025369,CTRI,2020-05-27,2020-05-30,False,Medanta Institute of Education and Research,Recruiting,Phase 3,Interventional,India,A study on treatment of COVID-19 patients with study drug along with standard of care,Drug,Tocilizumab,Tocilizumab,180,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43485,None
2241,CTRI/2020/05/025371,CTRI,2020-05-27,2020-02-06,True,Entrepreneurship Development Center Venture Center,Not Recruiting,Not Applicable,Observational,India,Retrospective Assessment of Treatments of Hospitalized COVID19 Patients.,Clinical Presentation,No Intervention,No Intervention,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44023,None
2242,CTRI/2020/05/025425,CTRI,2020-05-28,2020-02-06,True,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Phase 3/Phase 4,Interventional,India,Ayurvedic intervention (Chyawanprash) in the prevention of COVID-19 pandemic  among Health Care Personnel,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44043,None
2243,CTRI/2020/05/025424,CTRI,2020-05-28,2020-04-06,True,Christian Medical College Vellore,Not Recruiting,Not Applicable,Observational,India,Clinical features and outcome of COVID-19 and non-COVID respiratory infection,Clinical Presentation,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44074,None
2244,CTRI/2020/05/025398,CTRI,2020-05-28,2020-05-28,False,No Sponsor Name Given,Recruiting,Not Applicable,Interventional,India,Study to find out the results of Ayurvedic Kwath & Ashwagandha churna with Yoga exercises to prevent our health workers against corona virus infection.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43831,None
2245,CTRI/2020/05/025397,CTRI,2020-05-28,2020-05-06,True,Sun Pharmaceutical Industries Limited,Not Recruiting,Phase 2,Interventional,India,A study to evaluate the effect and safety of a phytopharmaceutical drug in treatment of Coronavirus infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,210,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43702,None
2246,CTRI/2020/05/025423,CTRI,2020-05-28,2020-01-06,True,Indian Council of Medical Research,Not Recruiting,Not Applicable,Observational,India,Pregnancy and COVID-19 Registry,Clinical Presentation,No Intervention,No Intervention,2000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43519,None
2247,CTRI/2020/05/025429,CTRI,2020-05-29,2020-10-06,False,Central Council for Research in Ayurvedic Sciences,Recruiting,Phase 2/Phase 3,Interventional,India,effect of Ashwagandha (Withania somnifera) as a prophylactic measure among high risk population (Health Care Workers/Containment Zone Population) exposed to COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44058,None
2248,CTRI/2020/05/025430,CTRI,2020-05-29,2020-03-06,True,Dabur India Ltd,Not Recruiting,Not Applicable,Observational,India,EFFECT OF AYURVEDA IMMUNO-MODULATOR DRUGS on HEALTH OF CORONA WARRIORS,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44060,None
2249,CTRI/2020/05/025431,CTRI,2020-05-29,2020-08-06,False,Dr. Jagannath Dixit,Not Recruiting,Not Applicable,Observational,India,"A study to find our proportion of Covid 19 cases, need for hospital beds and utility of lockdown at Aurangabad",Health System,No Intervention,No Intervention,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44128,None
2250,CTRI/2020/05/025428,CTRI,2020-05-29,2020-05-29,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,"COVID -19 Pandemic and Lockdown : Impact on Parents Stress level, Infant care and follow-up",Other (psych),No Intervention,No Intervention,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43890,None
2251,CTRI/2020/05/025427,CTRI,2020-05-29,2020-05-30,False,Majumdar Shaw Medical Center,Not Recruiting,Not Applicable,Observational,India,Clinical Characteristics and Outcomes of  Patients Admitted with Severe Acute Respiratory Illness,Clinical Presentation,No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43933,None
2252,CTRI/2020/05/025434,CTRI,2020-05-29,2020-05-31,False,Pankajakasthuri Herbal Research Foundation,Recruiting,Phase 4,Interventional,India,A clinical trial to evaluate the Medicinal effects of ZingiVir-H as Anti-Viral therapy in COVID-19 patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,135,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43957,None
2253,CTRI/2020/05/025466,CTRI,2020-05-29,2020-03-07,True,Norwich Clinical Services PvtLtd,Not Recruiting,Not Applicable,Observational,India,A study to estimate drug levels in health care workers on COVID infection prophylaxis,Clinical Presentation,No Intervention,No Intervention,24,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43209,None
2254,CTRI/2020/05/025433,CTRI,2020-05-29,2020-01-06,True,Dr. Freston Marc Sirur,Not Recruiting,Not Applicable,Observational,India,Respiratory emergencies during the COVID-19 Pandemic.,Clinical Presentation,No Intervention,No Intervention,700,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43743,None
2255,CTRI/2020/05/025483,CTRI,2020-05-30,2020-02-06,True,Apex Laboratories Pvt Ltd,Not Recruiting,Phase 3/Phase 4,Interventional,India,Use of Clevira in COVID19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44041,None
2256,CTRI/2020/05/025485,CTRI,2020-05-30,2020-06-29,False,Central Council for Research in Ayurvedic Sciences,Recruiting,Phase 2/Phase 3,Interventional,India,the effect of Guduchi (Tinospora cordifolia) as a prophylactic measure among high risk population (Health Care Workers/Containment Zone Population) exposed to COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44052,None
2257,CTRI/2020/05/025484,CTRI,2020-05-30,2020-03-06,True,Central Council for Research in Ayurvedic Sciences,Recruiting,Phase 2/Phase 3,Interventional,India,study on the effect of Chyavanprash Lehyam as a prophylactic measure among high risk population (Health Care Workers/Containment Zone Population) exposed to COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44055,None
2258,CTRI/2020/05/025486,CTRI,2020-05-30,2020-10-06,False,Prajna P Nayak,Not Recruiting,Not Applicable,Observational,India,Dental studentsÃ¢?? perceptions and concerns regarding the current COVID-19 pandemics,Other (psych),No Intervention,No Intervention,750,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44071,None
2259,CTRI/2020/05/025487,CTRI,2020-05-30,2020-04-06,True,National AgriFood Biotechnology Institute (NABI),Not Recruiting,Not Applicable,Observational,India,Development of Smell based test for identifying COVID-19 infection.,Clinical Presentation,No Intervention,No Intervention,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43586,None
2260,CTRI/2020/05/025490,CTRI,2020-05-31,2020-07-06,False,Siddhartha Hospital,Recruiting,Phase 2/Phase 3,Interventional,India,A Clinical trial to study the efficacy of pH based Integrated  SARS Cov-2 Immunity in Human Subjects.,Clinical Presentation,No Intervention,No Intervention,110,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44042,None
2261,CTRI/2020/05/025488,CTRI,2020-05-31,2020-03-06,True,National Institute of Ayurveda,Not Recruiting,Phase 2/Phase 3,Interventional,India,Clinical study on Guduchi Ghana Vati as a preventive remedy in pandemic of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,12000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44062,None
2262,CTRI/2020/05/025491,CTRI,2020-05-31,2020-08-06,False,Life Force Foundation Trust,Recruiting,Phase 2,Interventional,India,The efficacy of Homeopathic medicines in the prevention of COVID-19 in Quarantined or Exposed Individuals,Other,Homeopathy,Homeopathy,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44065,None
2263,CTRI/2020/05/025489,CTRI,2020-05-31,2020-01-06,True,All India Institute of Medical Sciences,Recruiting,Not Applicable,Interventional,India,To compare two intubation scopes for securing the airway during COVID pandemic in patients undergoing surgery,Other (device),Intubation scope,Intubation scope,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43376,None
2264,CTRI/2020/05/025492,CTRI,2020-05-31,2020-06-15,False,JIPMER Intramural fund,Not Recruiting,Not Applicable,Interventional,India,Impact of tele-consultation for following up newborns during COVID-19 pandemic,Telehealth,Telehealth,Telehealth,2978,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43382,None
2265,CTRI/2020/05/025493,CTRI,2020-05-31,2020-06-15,False,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Not Applicable,Observational,India,"Effect of Ayurvedic medicine in the Prophylaxis for COVID-19 of Police personnel Dept of AYUSH, TS  & CCRAS- NIIMH, Hyderabad.",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,1500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44177,None
2266,CTRI/2020/05/025494,CTRI,2020-05-31,2020-10-06,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,"Mental impact of SARS Covid-19 disease outbreaks among suspects coming to AIIMS Rishikesh, their close contacts, and associated healthcare providers",Other (psych),No Intervention,No Intervention,3000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44179,None
2267,CTRI/2020/05/025496,CTRI,2020-05-31,2020-08-06,False,Life Force Foundation Trust,Recruiting,Phase 1,Interventional,India,Study to observe safety of CNV01 homeopathy preparation in healthy volunteers,Other,Homeopathy,Homeopathy,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44192,None
2268,CTRI/2020/05/025495,CTRI,2020-05-31,2020-10-06,False,Tata Consultancy Services India,Not Recruiting,Not Applicable,Observational,India,"Screening of healthcare workers,  Doctors and Nurses  working in Covid-19 wards using a continous wearable watch device",Other (device),Biosensors,Biosensors,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44209,None
2269,CTRI/2020/05/025497,CTRI,2020-05-31,2020-06-14,False,Dr. Abhishek Pandey,Not Recruiting,Not Applicable,Observational,India,"Knowledge, attitudes, and practices towards COVID-19 among Indian residents during the period of the COVID-19 outbreak",Other,No Intervention,No Intervention,480,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44257,None
2270,CTRI/2020/06/025523,CTRI,2020-06-01,2020-08-06,False,NCI Jhajjar,Not Recruiting,Not Applicable,Interventional,India,The effect of meditation on well-being of SARS-Cov-2 infected patients.,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,84,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43396,None
2271,CTRI/2020/06/025526,CTRI,2020-06-01,2020-10-06,False,Ayurved University,Not Recruiting,Not Applicable,Observational,India,To observe the impact of Ayurveda Kwath in Healthy and Suspected persons for COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44182,None
2272,CTRI/2020/06/025522,CTRI,2020-06-01,2020-02-06,True,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Comparison of two devices for intubation in COVID simulated scenario in mannequin,Other (device),Intubation,Intubation,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43438,None
2273,CTRI/2020/06/025527,CTRI,2020-06-01,2020-01-06,True,Vopec Pharmaceuticals Pvt Ltd,Not Recruiting,Phase 4,Interventional,India,Clinical trial on Immunity and antiviral for quarantine patients of COVID-19,Clinical Presentation,No Intervention,No Intervention,42,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43968,None
2274,CTRI/2020/06/025557,CTRI,2020-06-02,2020-11-06,False,"Ministry of Ayush, Government of India",Recruiting,Phase 2,Interventional,India,A clinical study of  Ayurvedic formulations  in the treatment  of Mild to Moderate COVID-19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,420,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43812,None
2275,CTRI/2020/06/025530,CTRI,2020-06-02,2020-06-18,False,Cancer Aid Society,Not Recruiting,Not Applicable,Interventional,India,Using Homeopathic Combinations for Prevention and Treatment of Viral Fevers including COVID19,Other,Homeopathy,Homeopathy,10000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43305,None
2276,CTRI/2020/06/025556,CTRI,2020-06-02,2020-06-15,False,Natural Solutions,Not Recruiting,Not Applicable,Interventional,India,A clinical trial to know the effect of VirulinaÃ‚Â® along with standard treatment in covid 19 positive patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44144,None
2277,CTRI/2020/06/025558,CTRI,2020-06-02,2020-06-15,False,Aarogya Homoeopathic Medical College and Hospital,Not Recruiting,Phase 4,Interventional,India,Homoeopathic Medicines Bryonia alba 30C as a Prophylaxis for COVID-19,Other,Homeopathy,Homeopathy,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43411,None
2278,CTRI/2020/06/025560,CTRI,2020-06-02,2020-04-06,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,Difficulty in doing usual work after wearing personal protective equipment.,Other,No Intervention,No Intervention,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43710,None
2279,CTRI/2020/06/025529,CTRI,2020-06-02,2020-10-06,False,Kazi Md Amran Hossain,No Status Given,Not Applicable,Observational,Bangladesh,"Knowledge, Practice and mental health status of Spinal injured people",Other (psych),No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44243,None
2280,CTRI/2020/06/025575,CTRI,2020-06-03,2020-06-15,False,All India Institute of Medical Sciences,Recruiting,Phase 3/Phase 4,Interventional,India,Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised control trial,Drug,Hydroxychloroquine + Ribavirin vs. Lopinavir/Ritonavir,Hydroxychloroquine + Ribavirin; Lopinavir/ritonavir,175,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43076,None
2281,CTRI/2020/06/025588,CTRI,2020-06-03,2020-08-06,False,Hinduja Hospital,Not Recruiting,Not Applicable,Observational,India,"Data of patients with Corona virus disease admitted to the ICU at P.D. Hinduja Hospital, Mumbai.",Clinical Presentation,No Intervention,No Intervention,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43851,None
2282,CTRI/2020/06/025590,CTRI,2020-06-03,2020-08-06,False,Dalmia Centre for Research and Development,Not Recruiting,Phase 3,Interventional,India,A clinical trial to evaluate safety and efficacy of polyherbal capsule Astha-15 used as an add on therapy with standard care of therapy as an immunity booster in the suspected and COVID-19 diagnosed patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44121,None
2283,CTRI/2020/06/025589,CTRI,2020-06-03,2020-06-15,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,comparison of two different  laryngoscopes using COVID barrier box,Other (device),Barrier,Barrier,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44164,None
2284,CTRI/2020/06/025561,CTRI,2020-06-03,2020-06-15,False,Central Council for Research in Ayurvedic Sciences,Recruiting,Not Applicable,Observational,India,"Effect of Ayurvedic medicine in the Prophylaxis for COVID-19 of AYUSH healthcare workers , Dept of AYUSH, TS  & CCRAS- NIIMH, Hyderabad.

",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44244,None
2285,CTRI/2020/06/025613,CTRI,2020-06-04,2020-06-15,False,Rohit Walia,Not Recruiting,Phase 4,Interventional,India,Melatonin Immune Boost COVID 19 Study,Drug,Melatonin,Melatonin,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44346,None
2286,CTRI/2020/06/025593,CTRI,2020-06-04,2020-12-06,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,A study to determine relative efficacy of hydroxy-chloroquine prophylaxis to healthcare-professionals for Covid-19 mitigation,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,3000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44173,None
2287,CTRI/2020/06/025637,CTRI,2020-06-05,2020-06-22,False,ABVMC RC VIDISHA,Not Recruiting,Not Applicable,Interventional,India,"As the present outbreak of novel coronavirus in Indian scenario we want to study about the prophylactic study in Distric Hospital, Vidisha.",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43550,None
2288,CTRI/2020/06/025625,CTRI,2020-06-05,2020-11-05,False,Eminentlabs Business Solutions Pvt Ltd,Recruiting,Phase 2,Interventional,India,Study of the effect of Siddha Treatment in addition to standard therapy in COVID-19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,86,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43345,None
2289,CTRI/2020/06/025664,CTRI,2020-06-05,2020-06-15,False,Dr. Reddy's Laboratories Limited,Recruiting,Phase 2,Interventional,India,Phase II study to evaluate the Safety and Efficacy of 2-Deoxy-D-Glucose in COVID -19 patients,Drug,2-Deoxy-D-Glucose,2-Deoxy-D-Glucose,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44369,None
2290,CTRI/2020/06/025634,CTRI,2020-06-05,2020-06-15,False,Dr. Kanika Batra Modi,Not Recruiting,Not Applicable,Observational,India,To assess the  postoperative outcomes after implementation of the protocol in patients undergoing surgery for gynaecological malignancies in the COVID-19 pandemic,Clinical Presentation,No Intervention,No Intervention,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43893,None
2291,CTRI/2020/06/025650,CTRI,2020-06-05,2020-06-15,False,"Ministry of Ayush, Government of India",Not Recruiting,Phase 2,Interventional,India,To assess the safety and outcome of herbal medicine in prevention of COVID-19 infection among high risk population,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,4000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44412,None
2292,CTRI/2020/06/025673,CTRI,2020-06-06,2020-07-30,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,A study on association between tobacco and COVID 19 to help policy makers,Clinical Presentation,No Intervention,No Intervention,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44398,None
2293,CTRI/2020/06/025672,CTRI,2020-06-06,2020-06-15,False,"Ministry of Ayush, Government of India",Not Recruiting,Phase 2/Phase 3,Interventional,India,To evaluate the effect of herbal medicine in prevention and management of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44415,None
2294,CTRI/2020/06/025671,CTRI,2020-06-06,2020-06-15,False,Dr. Giridhara Kaje,Not Recruiting,Phase 3,Interventional,India,A clinical trial to evaluate the medicinal efficacy of Ayurvedic Tablet Bhoumya and Tablet Saathmya in COVID-19 positive Patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44425,None
2295,CTRI/2020/06/025675,CTRI,2020-06-06,2020-06-15,False,Imperial Clinical Research Services,Not Recruiting,Not Applicable,Observational,India,This study has been conducted to collect the Cough and breathing sound of COVID-19 positive and COVID-19 negative patients for analysis of early indication of COVID-19 in humans.,Clinical Presentation,No Intervention,No Intervention,600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44427,None
2296,CTRI/2020/06/025674,CTRI,2020-06-06,2020-06-16,False,Diabetes Research Society,Not Recruiting,Not Applicable,Observational,India,Oral Fluid Sars-CoV-2 Ab Rapid test,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44431,None
2297,CTRI/2020/06/025703,CTRI,2020-06-08,2020-06-17,False,Dr. Sameer Malhotra,Not Recruiting,Not Applicable,Observational,"United Arab Emirates, New Zealand, India, Singapore, United Kingdom, Australia, United States","Knowledge, Attitude, Feelings and Behavior in Adolescents during COVID-19",Other,No Intervention,No Intervention,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44358,None
2298,CTRI/2020/06/025702,CTRI,2020-06-08,2020-06-15,False,Jagdale Industries Pvt Ltd,Not Recruiting,Phase 3/Phase 4,Interventional,India,"Clinical Trial On Mildly Symptomatic Covid -19 Patients And Health Care Workers Posted To Covid Wards

",Other (nutrition),Nutrition,Nutrition,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44376,None
2299,CTRI/2020/06/025704,CTRI,2020-06-08,2020-01-07,True,Bharat Serums and Vaccines ltd,Recruiting,Phase 3,Interventional,India,Ulinastatin for COVID-19 in patients with breathlessness,Drug,Ulinastatin + Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Azithromycin,Ulinastatin; Hydroxychloroquine; Azithromycin,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44170,None
2300,CTRI/2020/06/025714,CTRI,2020-06-08,2020-02-06,True,Government Yoga And Naturopathy Medical College Chennai,Not Recruiting,Phase 3/Phase 4,Interventional,India,Holistic Health Management through Yoga and Naturopathy for Frontline COVID Health Care Providers Ã¢?? The H2M trial,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44020,None
2301,CTRI/2020/06/025763,CTRI,2020-06-09,2020-07-17,False,National Institute of Siddha,Not Recruiting,Phase 2/Phase 3,Interventional,India,A Randomized controlled Clinical Trial to determine the efficacy of Siddha drugs in COVID 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44340,None
2302,CTRI/2020/06/025764,CTRI,2020-06-09,2020-06-22,False,Department of Psychiatry,Not Recruiting,Not Applicable,Observational,India,"Assessment of depression, anxiety and coping strategies among Health care workers working in dedicated COVID-19 hospitals",Other (psych),No Intervention,No Intervention,93,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44405,None
2303,CTRI/2020/06/025766,CTRI,2020-06-09,2020-11-06,False,Dr. Jagdeep Kakadia,Not Recruiting,Not Applicable,Interventional,India,A study of 254nm UVC ray therapy in pharynx for asymptomatic to mild cases of Corona Virus Disease,Other,Ultraviolet Therapy,Ultraviolet Therapy,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44171,None
2304,CTRI/2020/06/025760,CTRI,2020-06-09,2020-06-17,False,Dr. N Babu,Not Recruiting,Phase 3,Interventional,India,A clinical trial to study the effect of drug named Sofosbuvir in hospitalized patients with COVID 19.,Drug,Sofosbuvir + Hydroxychloroquine vs. Hydroxychloroquine,Sofosbuvir; Hydroxychloroquine,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44441,None
2305,CTRI/2020/06/025768,CTRI,2020-06-09,2020-07-20,False,National Institute of Siddha,Recruiting,Phase 2/Phase 3,Interventional,India,An open label Randomized Controlled Clinical trial to Evaluate the Safety and Efficacy of selected Siddha formulations in patients diagnosed with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44445,None
2306,CTRI/2020/06/025761,CTRI,2020-06-09,2020-06-15,False,National Institute of Siddha,Not Recruiting,Not Applicable,Observational,India,"Population based cross sectional study for COVID 19 prophylaxis with
Polyherbal Siddha formulation Kabasura Kudineer / Nilavembu kudineer in containment zones and non
containment zones during 2020 pandemic in Tamil Nadu, South India",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,10000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44258,None
2307,CTRI/2020/06/025762,CTRI,2020-06-09,2020-06-15,False,National Institute of Siddha,Not Recruiting,Phase 3,Interventional,India,"An Open-Label Randomized Controlled, Proof-of-Concept (PoC) Study to
Evaluate the Safety and Efficacy of selected Siddha formulations in patients
diagnosed with COVID-19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44259,None
2308,CTRI/2020/06/025769,CTRI,2020-06-09,2020-06-15,False,National Institute of Siddha,Recruiting,Phase 2/Phase 3,Interventional,India,"A prophylactic interventional study to determine the possible protective effect of Siddha Polyherbal formulation Kabasura Kudineer against the COVID 19 on
intermittent, month-long consumption by public with close contacts to COVID patients and frontline workers in Tamil Nadu, India",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44260,None
2309,CTRI/2020/06/025801,CTRI,2020-06-10,2020-06-19,False,The Himalaya Drug Company,Not Recruiting,Phase 2/Phase 3,Interventional,India,Role of Herbal Immunomodulators   in mild COVID-19 confirmed cases,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44293,None
2310,CTRI/2020/06/025796,CTRI,2020-06-10,2020-06-15,False,Vaidhya Tushar Trivedi,Not Recruiting,Not Applicable,Interventional,India,Effect of aragwadhadi kwath (kadha in Hindi) in treatment of mild corona virus disease,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44181,None
2311,CTRI/2020/06/025798,CTRI,2020-06-10,2020-06-18,False,No Sponsor Name Given,Not Recruiting,Phase 4,Interventional,India,A Clinical trial to establish the appropriate line of management of Non Muscle Invasive Bladder Cancers who have had their intravesical BCG therapy interrupted,ATMP,Vaccine,Vaccine,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44460,None
2312,CTRI/2020/06/025779,CTRI,2020-06-10,2020-06-17,False,Ayurved University,Not Recruiting,Not Applicable,Interventional,India,Study of AYUSH KWATH in quarantine persons,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44463,None
2313,CTRI/2020/06/025802,CTRI,2020-06-10,2020-06-17,False,Max Super Speciality Hospital (Devki Devi Foundation),Not Recruiting,Not Applicable,Observational,India,COVID-19 and liver injury in patients with or without underlying liver disease: A multi-centre retrospective-prospective observational study,Clinical Presentation,No Intervention,No Intervention,314,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44476,None
2314,CTRI/2020/06/025799,CTRI,2020-06-10,2020-06-17,False,Cipla Ltd,Not Recruiting,Phase 3,Interventional,India,"A study of Favipiravir in patients with mild to moderate coronavirus disease (COVID-19)
",Drug,Favipiravir,Favipiravir,156,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44480,None
2315,CTRI/2020/06/025800,CTRI,2020-06-10,2020-06-22,False,National Health Mission Uttar Pradesh,Not Recruiting,Phase 2,Interventional,India,Role of Ayurveda in Covid 19 management.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44485,None
2316,CTRI/2020/06/025797,CTRI,2020-06-10,2020-06-13,False,Dr. Anuja Pandit,Not Recruiting,Not Applicable,Observational,India,Quality of Life During COVID-19 Lockdown,Other (psych),No Intervention,No Intervention,54,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43759,None
2317,CTRI/2020/06/025804,CTRI,2020-06-11,2020-06-20,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Effectiveness of lying face down in improving the outcome of COVID-19 patients,Procedure,Positioning,Positioning,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44572,None
2318,CTRI/2020/06/025803,CTRI,2020-06-11,2020-06-18,False,"Institute of Liver and Biliary Sciences, India",Recruiting,Phase 3,Interventional,India,Effect of convalescent plasma in COVID-19 patients,ATMP,Plasma,Plasma,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44478,None
2319,CTRI/2020/06/025848,CTRI,2020-06-12,2020-06-21,False,TNMC BYL Nair Hospital,Not Recruiting,Not Applicable,Observational,India,Clinical Analysis of Patients Hospitalized Due To Covid-19,Clinical Presentation,No Intervention,No Intervention,1500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44593,None
2320,CTRI/2020/06/025849,CTRI,2020-06-12,2020-06-15,False,Dr. Reddy's Laboratories Limited,Not Recruiting,Phase 2,Interventional,India,Study to Evaluate the Safety and Efficacy of a Combination of Nitazoxanide and Hydroxychloroquine Versus Hydroxychloroquine Alone in COVID-19 Patients,Drug,Nitazoxanide + Hydroxycholorquine vs. Hydroxychloroquine,Nitazoxanide; Hydroxycholorquine,158,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44408,None
2321,CTRI/2020/06/025852,CTRI,2020-06-12,2020-06-14,False,Intramural,Not Recruiting,Phase 1/Phase 2,Interventional,India,RNB in UPUMS SAIFAI,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44204,None
2322,CTRI/2020/06/025853,CTRI,2020-06-12,2020-06-17,False,ESIC PGIMSR,Not Recruiting,Not Applicable,Observational,India,Mental Health of children during Covid-19 Pandemic,Other (psych),No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44466,None
2323,CTRI/2020/06/025850,CTRI,2020-06-12,2020-06-20,False,Dr. Monika Arora,Not Recruiting,Not Applicable,Observational,India,Studying tobacco use and quitting behaviour due to the coronavirus lockdown in India.,Other,No Intervention,No Intervention,800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44518,None
2324,CTRI/2020/06/025844,CTRI,2020-06-12,2020-06-22,False,Central Council for Research in Homoeopathy,Not Recruiting,Phase 2/Phase 3,Interventional,India,Pre-Identified Homoeopathic Medicines In Asymptomatic Covid -19 Individuals Receiving Standard Treatment Protocol,Other,Homeopathy,Homeopathy,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43760,None
2325,CTRI/2020/06/025854,CTRI,2020-06-13,2020-06-25,False,Indian Council of Medical Research,Not Recruiting,Not Applicable,Interventional,India,BCG vaccination against COVID-19,ATMP,Vaccine,Vaccine,1450,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44078,None
2326,CTRI/2020/06/025856,CTRI,2020-06-13,2020-06-25,False,Directorate of Indian Medicine and Homeopathy,Not Recruiting,Phase 2,Interventional,India,Evaluation of siddha regimen in the management of covid 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44606,None
2327,CTRI/2020/06/025855,CTRI,2020-06-13,2020-06-15,False,Institute for Postgraduate Teaching & Research in Ayurveda,Not Recruiting,Phase 2,Interventional,India,Effect of AYUSH 64 in COVID 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44386,None
2328,CTRI/2020/06/025858,CTRI,2020-06-13,2020-06-22,False,Dr. Amarja Ashok Havaldar,Not Recruiting,Not Applicable,Observational,India,Observational study on suspected COVID 19 patients admitted to ICU,Clinical Presentation,No Intervention,No Intervention,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44652,None
2329,CTRI/2020/06/025857,CTRI,2020-06-13,2020-06-23,False,Kazi Md Amran Hossain,No Status Given,Not Applicable,Observational,Bangladesh,Follow-up of COVID-19 Positive Patients,Clinical Presentation,No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44663,None
2330,CTRI/2020/06/025861,CTRI,2020-06-14,2020-06-20,False,"Department of Ayush, Uttarakhand",Recruiting,Phase 3,Interventional,India,Scientific evaluation of Immuno-modulatory effects of AYUSH INTERVENTIONS on normal healthy and high-risk individuals in context with COVID-19 pandemic: An open level study,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44072,None
2331,CTRI/2020/06/025862,CTRI,2020-06-14,2020-06-13,True,No Sponsor Name Given,Recruiting,Phase 1,Interventional,India,Low Dose Radiation Therapy for COVID-19,Other,Radiation,Radiation,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43858,None
2332,CTRI/2020/06/025874,CTRI,2020-06-15,2020-06-24,False,Dean Government Theni Medical College,Not Recruiting,Phase 2,Interventional,India,To observe the effect of Siddha formulation Kabasura kudineer in COVID 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44684,None
2333,CTRI/2020/06/025927,CTRI,2020-06-16,2020-06-20,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Comparison of C-MAC and Mc-GRATH laryngoscopes for intubation in COVID scenario.,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43316,None
2334,CTRI/2020/06/025928,CTRI,2020-06-16,2020-06-30,False,Dr. Sumita Shankar,Recruiting,Not Applicable,Interventional,India,Local application of Povidone Iodine solution in nose and oral gargle for house hold contacts of COVID19 cases,Drug,Povidone Iodine,Povidone Iodine,204,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44664,None
2335,CTRI/2020/06/025917,CTRI,2020-06-16,2020-06-28,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Psychological assessment of the health care-workers amid COVID-19 working at a tertiary care teaching hospital of the central India and impact of tele-counselling on their psychological problems,Other (psych),Psychological,Psychological,25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44505,None
2336,CTRI/2020/06/025957,CTRI,2020-06-17,2020-06-29,False,Glenmark Pharmaceuticals Ltd,Recruiting,Phase 3,Interventional,India,A Clinical Study on Favipiravir and Umifenovir Compared to Favipiravir alone in Hospitalized Patients with Moderate COVID-19.,Drug,Favipiravir + Umifenovir vs. Favipiravir,Favipiravir; Umifenovir,158,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44709,None
2337,CTRI/2020/06/025977,CTRI,2020-06-18,2020-06-22,False,Ms Shukla Ashar Impex Pvt Ltd,Recruiting,Phase 2,Interventional,India,Clinical Study to Study Safety and Efficacy of herbal formulation - Aayudh Advance,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44449,None
2338,CTRI/2020/06/025996,CTRI,2020-06-19,2020-06-27,False,Bansi Gir Gaushala,Not Recruiting,Not Applicable,Interventional,India,"A study to evaluate the effect of a combination Giloy Gomutra Capsules, Asthi Churna and Kamdhenu Asava in COVID-19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44622,None
2339,CTRI/2020/06/025998,CTRI,2020-06-20,2020-06-30,False,Uttar Pradesh University of Medical Sciences,Not Recruiting,Phase 3,Interventional,India,Efficacy of An Ayurvedic Preparation Raj Nirwan Bati (RNB) on symptomatic COVID-19 Patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44707,None
2340,CTRI/2020/06/026000,CTRI,2020-06-21,2020-06-26,False,Seth GS Medical College; KEM Hospital,Recruiting,Not Applicable,Observational,India,COVID-19 in kidney transplant recipient,Clinical Presentation,No Intervention,No Intervention,75,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44567,None
2341,CTRI/2020/06/026001,CTRI,2020-06-21,2020-06-25,False,All India Institute of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,India,Ivermectin in COVID,Drug,Ivermectin,Ivermectin,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44196,None
2342,CTRI/2020/06/025999,CTRI,2020-06-21,2020-06-27,False,BVG Life Sciences Ltd,Not Recruiting,Phase 2,Interventional,India,Clinical trial of ShatPlus as an immunomodulator in adult Covid 19 positive patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44764,None
2343,CTRI/2020/06/026005,CTRI,2020-06-21,2020-06-22,False,National Centre for Biological Sciences,Not Recruiting,Not Applicable,Observational,India,Pooled testing for COVID,Clinical Presentation (Epidemiology),No Intervention,No Intervention,321,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44520,None
2344,CTRI/2020/06/026002,CTRI,2020-06-21,2020-01-07,True,National Institute of Ayurveda,Not Recruiting,Phase 2,Interventional,India,Study of use of Ayurveda Intervention (Ayush-64) in COVID 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44799,None
2345,CTRI/2020/06/026039,CTRI,2020-06-22,2020-06-15,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,CANCER care in COVID-19 ERAÃ¢?? A survey proposed to study the treatment preference and perspectives of patients with blood cancer in a highly specialized cancer care hospital in India during COVID-19 ERA.,Clinical Presentation,No Intervention,No Intervention,213,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43815,None
2346,CTRI/2020/06/026044,CTRI,2020-06-22,2020-04-07,True,Asian HealthCare Foundation,Not Recruiting,Not Applicable,Observational,India,Oral Fluid Sars-CoV-2 Ab Rapid test,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44919,None
2347,CTRI/2020/06/026045,CTRI,2020-06-22,2020-01-07,True,Father Muller Homoeopathic Medical College,Not Recruiting,Phase 3,Interventional,India,A study to improve the resistance against Covid 19 illness with the help of Homoeopathic remedies.,Other,Homeopathy,Homeopathy,800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44677,None
2348,CTRI/2020/06/026055,CTRI,2020-06-23,2020-06-26,False,"Ministry of Ayush, Government of India",Not Recruiting,Phase 3,Interventional,India,An interventional study to access the effect of Ayurvedic medicine ASA-20 as a prohylaxis in high risk population exposed to COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44306,None
2349,CTRI/2020/06/026056,CTRI,2020-06-23,2020-06-26,False,"Ministry of Ayush, Government of India",Not Recruiting,Phase 3,Interventional,India,An interventional study to access the effect of Homoeopathic medicine Arsenicum album 30 C as a prohylaxis in high risk population exposed to COVID-19.,Other,Homeopathy,Homeopathy,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44130,None
2350,CTRI/2020/06/026047,CTRI,2020-06-23,2020-01-07,True,Swet Nisha,Not Recruiting,Not Applicable,Observational,India,Dental education and coronavirus,Other,No Intervention,No Intervention,25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44913,None
2351,CTRI/2020/06/026087,CTRI,2020-06-23,2020-08-07,False,Cadila Healthcare Ltd,Not Recruiting,Phase 2,Interventional,India,"Phase II, randomized, controlled, open-label study of
Pegylated IFN alfa-2b with SARS-CoV-2",Drug,Interferon alpha,Interferon alpha,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43775,None
2352,CTRI/2020/06/026118,CTRI,2020-06-24,2020-01-08,True,Dr. Rajlaxmi Sarangi,Not Recruiting,Not Applicable,Observational,India,"Antiphospholipid Antibody (APLA) level in COVID-19 Cases.
",Clinical Presentation,No Intervention,No Intervention,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44829,None
2353,CTRI/2020/06/026123,CTRI,2020-06-24,2020-06-25,False,Dr. Sushant Meshram,Not Recruiting,Phase 2,Interventional,India,Plasma therapy in corona patients(Severe COVID-19).,ATMP,Plasma,Plasma,472,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44667,None
2354,CTRI/2020/06/026120,CTRI,2020-06-24,2020-03-07,True,Maulana Azad Medical College,Not Recruiting,Not Applicable,Observational,India,"Validation of Rapid Test kit for Antibody (IgG, IgM) detection against COVID19.",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44931,None
2355,CTRI/2020/06/026119,CTRI,2020-06-24,2020-06-30,False,Swami Vivekaanand Homoeopathic Medical College And Hospital,Not Recruiting,Not Applicable,Interventional,India,"Efficacy of Arsenic Album 30C and 200C potency in mild case of COVID-19 positive . (Isolation ward of Sir T General Hospital, Bhavnagar) patients: A randomized controlled study.",Other,Homeopathy,Homeopathy,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44218,None
2356,CTRI/2020/06/026121,CTRI,2020-06-24,2020-04-07,True,Sanjay Gandhi Postgraduate Institute of Medical Sciences,Recruiting,Not Applicable,Observational,India,To Understand Knowledge and Compliance of Hydroxychloroquine Prophylaxis among Health Care Workers during COVID-19 pandemic,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,175,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45006,None
2357,CTRI/2020/06/026147,CTRI,2020-06-25,2020-10-06,False,All India Institute of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,India,Ayurveda and Yoga trial for preventing COVID 19 among quarantined individuals exposed to COVID 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,604,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43778,None
2358,CTRI/2020/06/026151,CTRI,2020-06-25,2020-10-06,False,All India Institute of Medical Sciences,Not Recruiting,Phase 2,Interventional,India,Ayurveda and Yoga trial for preventing COVID 19 among healthcare workers,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,452,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43770,None
2359,CTRI/2020/06/026161,CTRI,2020-06-26,2020-09-21,False,AYUSHCSIR,Not Recruiting,Not Applicable,Interventional,India,Drug Trial to Evaluate Efficacy and Safety of an Ayurvedic Formulation II [Sanshamani Vati Plus] as Adjunct Treatment to Standard of Care for the management of Mild to Moderate COVID-19 Patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,140,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44832,None
2360,CTRI/2020/06/026152,CTRI,2020-06-26,2020-06-26,False,Seth GS Medical College; KEM Hospital,Not Recruiting,Not Applicable,Observational,India,COVID-19 in dialysis patients,Clinical Presentation,No Intervention,No Intervention,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43879,None
2361,CTRI/2020/06/026181,CTRI,2020-06-26,2020-04-07,True,Haoma Wellness Center,Not Recruiting,Phase 3/Phase 4,Interventional,India,Herbal Steaminhaler clinical trial on  COVID patients,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44976,None
2362,CTRI/2020/06/026190,CTRI,2020-06-26,2020-07-14,False,Prof Jaya Chakravarty,Not Recruiting,Phase 2,Interventional,India,A Trial of Shirashadi Kasai in patients with Covid-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,160,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45005,None
2363,CTRI/2020/06/026188,CTRI,2020-06-26,2020-06-07,True,Kalinga Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Psychological Assessment of adult COVID-19 patients,Other (psych),No Intervention,No Intervention,240,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45024,None
2364,CTRI/2020/06/026187,CTRI,2020-06-26,2020-05-07,True,Mr Ghanshyam Goti,Not Recruiting,Phase 2,Interventional,India,Clinical trial of herbal supplement as an immunomodulator in adult Covid 19 positive patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45027,None
2365,CTRI/2020/06/026189,CTRI,2020-06-26,2020-01-08,True,Suraksha Pharma Private Limited,Not Recruiting,Phase 2,Interventional,India,"To Compare the safety and efficacy of Vitamin D, with Magnesium in mild to moderate Covid 19 patients",Drug,Vitamin D + Magnesium,Vitamin D; Magnesium,210,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45029,None
2366,CTRI/2020/06/026184,CTRI,2020-06-26,2020-06-07,True,Kalinga Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Mental Health of Health Care Workers during COVID-19 pandemics,Other (psych),No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45031,None
2367,CTRI/2020/06/026191,CTRI,2020-06-27,2020-01-08,True,Suraksha Pharma Private Limited,Not Recruiting,Phase 2,Interventional,India,"To study the safety and efficacy   of Vitamin D3, Vitamin K2-7 & magnesium ,  in prevention of COVID 19 infection in health care professional (HCP)",Drug (Chemoprophylaxis),Vitamin D + Magnesium + Vitamin K,Vitamin D; Magnesium; Vitamin K,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45075,None
2368,CTRI/2020/06/026192,CTRI,2020-06-28,2020-07-13,False,Vicore Pharma AB,Not Recruiting,Phase 2,Interventional,"United Kingdom, India, Ukraine, Russian Federation",The study of C21 in hospitalised subjects with COVID-19 infection not requiring mechanical ventilation,Drug,Compound 21,Compound 21,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44815,None
2369,CTRI/2020/06/026195,CTRI,2020-06-28,2020-08-07,False,Central Council for Research in Homoeopathy,Not Recruiting,Phase 2/Phase 3,Interventional,India,Homoeopathy as an add-on in treatment of COVID-19,Other,Homeopathy,Homeopathy,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45129,None
2370,CTRI/2020/06/026198,CTRI,2020-06-28,2020-10-07,False,Pgmier Chandigarh,Not Recruiting,Not Applicable,Observational,India,Conscious posture therapy and covid 19 hypoxemia,Other,Conscious posture therapy,Conscious posture therapy,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43651,None
2371,CTRI/2020/06/026196,CTRI,2020-06-28,2020-08-15,False,University of Birmingham,Not Recruiting,Phase 3/Phase 4,Interventional,"Nigeria, Benin, Ghana, India, Italy, Mexico, Rwanda, United Kingdom, South Africa",Prevention of Respiratory Complications In At Surgery in COVID-19 Pandemic,Drug,"Lopinavir/ritonavir, Hydroxychloroquine",Lopinavir/ritonavir; Hydroxychloroquine,6400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43482,None
2372,CTRI/2020/06/026193,CTRI,2020-06-28,2020-07-30,False,Maulana Azad Medical College,Recruiting,Not Applicable,Interventional,India,A study of drug Lithium on patients of Covid 19 disease,Drug,Lithium + Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44766,None
2373,CTRI/2020/06/026197,CTRI,2020-06-28,2020-06-07,True,"Ministry of Ayush, Government of India",Not Recruiting,Phase 3/Phase 4,Interventional,India,Validation of Classical Ayurvedic formulations in treatment of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45052,None
2374,CTRI/2020/06/026228,CTRI,2020-06-29,2020-06-29,False,Acerta Pharma B.V.,Not Recruiting,Phase 2,Interventional,"Sweden, Japan, India, Germany, Russian Federation, Italy, France, Turkey, Brazil, Spain",Study in Hospitalized COVID-19 patients with Acalabrutinib along with the Best Supportive Care versus Best Supportive Care,Drug,Acalabrutinib,Acalabrutinib,140,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44554,None
2375,CTRI/2020/06/026222,CTRI,2020-06-29,2020-06-29,False,Virchow Biotech Private Limited,Not Recruiting,Phase 2,Interventional,India,Intravenous Immunoglobulin Therapy in the treatment of Moderate Pneumonia in COVID-19 patients,ATMP,Immunoglobulin,Immunoglobulin,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44299,None
2376,CTRI/2020/06/026227,CTRI,2020-06-29,2020-07-07,False,Central Council for Research in Unani Medicine,Not Recruiting,Phase 3,Interventional,India,"A Study on Unani regimen 
for prevention of high/moderate risk population of COVID 19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44584,None
2377,CTRI/2020/06/026229,CTRI,2020-06-29,2020-10-07,False,Dr. Namrata Joshi,Recruiting,Phase 2,Interventional,India,A clinical trial of Ayurveda formulations in COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45105,None
2378,CTRI/2020/06/026220,CTRI,2020-06-29,2020-07-17,False,Sun Pharmaceutical Industries Limited,Not Recruiting,Phase 2,Interventional,India,A study to evaluate the efficacy and safety of Nafamostat Mesilate in treatment of Coronavirus infection,Drug,Nafamostat Mesilate,Nafamostat Mesilate,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44350,None
2379,CTRI/2020/06/026232,CTRI,2020-06-29,2020-10-07,False,DVFM,Not Recruiting,Phase 3,Interventional,India,Ivermectin in the prevention of covid-19,Drug,Ivermectin,Ivermectin,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45156,None
2380,CTRI/2020/06/026231,CTRI,2020-06-29,2020-07-15,False,"Ministry of Ayush, Government of India",Not Recruiting,Not Applicable,Interventional,India,"To study effect of ayurvedic treatment for prevention and management of asymptomatic, mild and moderate cases of COVID-19.",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,160,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44497,None
2381,CTRI/2020/06/026221,CTRI,2020-06-29,2020-01-07,True,"Directorate of AYUSH, Government of Madhya Pradesh",Not Recruiting,Phase 2,Interventional,India,Intervention of Ayurvedic Medicine (Arogya Kashayam) in Covid-19 positive cases (Asymptomatic and Mild Symptomatic),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44542,None
2382,CTRI/2020/06/026250,CTRI,2020-06-30,2020-07-15,False,Dr. Jyotirmayee Bahinipati,Not Recruiting,Not Applicable,Observational,India,Correlation of urinary porphyrin and biochemical markers with the severity of symptoms of COVID-19 cases.,Clinical Presentation,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45057,None
2383,CTRI/2020/06/026256,CTRI,2020-06-30,2020-10-07,False,Topiwala National Medical College; BYL Nair Charitable Hospital,Not Recruiting,Not Applicable,Observational,India,Resveratrol and copper for the treatment of COVID-19 pnuemonia.,Drug,Resveratrol + Copper,Resveratrol; Copper,230,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45115,None
2384,CTRI/2020/06/026262,CTRI,2020-06-30,2020-01-07,True,Bhaktivedanta Hospital and Research Institute,Not Recruiting,Not Applicable,Interventional,India,"Single Center,Study on Evaluation of use of,Ã¢??AYURCOVÃ¢?? as add on therapy for Treatment of SARS-CoV-2 Infection in COVID-19 Patients,at Tertiary Care Center.",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43889,None
2385,CTRI/2020/07/026301,CTRI,2020-07-01,2020-08-07,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Role of Yoga in deStressing HCWs in COVID-19 : A RCT,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44651,None
2386,CTRI/2020/07/026299,CTRI,2020-07-01,2020-07-13,False,Department of Psychiatry,Recruiting,Not Applicable,Observational,India,Impact of Corona virus pandemic and lockdown on people with mental illness and their caregivers,Other (psych),No Intervention,No Intervention,804,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45163,None
2387,CTRI/2020/07/026298,CTRI,2020-07-01,2020-07-15,False,Shri Lal Bahadur Shastri Government Medical College,Not Recruiting,Not Applicable,Observational,India,The impact of COVID-19 pandemic in frontline health care professionals,Other,No Intervention,No Intervention,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43722,None
2388,CTRI/2020/07/026337,CTRI,2020-07-02,2020-11-07,False,AVP Research Foundation,Not Recruiting,Phase 2/Phase 3,Interventional,India,The Covid-19 Study with Ayurveda add-on to ICMR Guideline,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,36,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44863,None
2389,CTRI/2020/07/026338,CTRI,2020-07-02,2020-07-13,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Interventional,India,Study to assess the Health care workersÃ¢?? knowledge of the Medical cause of death certification for COVID-19 related deaths in cancer patients,Other,No Intervention,No Intervention,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45181,None
2390,CTRI/2020/07/026340,CTRI,2020-07-02,2020-11-07,False,Ramen Goel,Not Recruiting,Not Applicable,Interventional,India,To study the role of Zinc combined with standard treatment for COVID-19,Drug,Zinc,Zinc,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44929,None
2391,CTRI/2020/07/026339,CTRI,2020-07-02,2020-07-15,False,Tata Memorial Centre,Recruiting,Not Applicable,Observational,India,Understanding COVID and cancer,Clinical Presentation,No Intervention,No Intervention,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44951,None
2392,CTRI/2020/07/026330,CTRI,2020-07-02,2020-11-07,False,Dr. Arun Kumar,Not Recruiting,Not Applicable,Observational,India,"Illness Wellness Scale is a new scale which is being developed to assess the physical performance status of all patients, whether or not suffering from COVID infection, requiring surgical intervention or care.",Other,No Intervention,No Intervention,210,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45213,None
2393,CTRI/2020/07/026331,CTRI,2020-07-02,2020-06-07,True,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Survey on Convalescent Plasma (CVP) for COVID-19,ATMP,Plasma,Plasma,2200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45017,None
2394,CTRI/2020/07/026351,CTRI,2020-07-03,2020-07-14,False,PurplAS IT Services Pvt Ltd,Not Recruiting,Not Applicable,Observational,India,"Software for COVID19 Detection from Chest X-Ray, CT or Ultrasonography",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45151,None
2395,CTRI/2020/07/026343,CTRI,2020-07-03,2020-11-07,False,Ayurved Rasayani,Not Recruiting,Not Applicable,Interventional,India,Ayurvedic Rasayana treatment as an addon therapy to improve the results in management of coronavirus disease,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45204,None
2396,CTRI/2020/07/026349,CTRI,2020-07-03,2020-04-07,True,Anant Mohan,Recruiting,Phase 3,Interventional,India,Effect of awake proning in patients with COVID-19 related respiratory failure,Procedure,Positioning,Positioning,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42918,None
2397,CTRI/2020/07/026350,CTRI,2020-07-03,2020-07-15,False,Dr. Suvarna Jyothi Kantipudi,Not Recruiting,Not Applicable,Observational,India,Stress and coping among healthcare workers during COVID-19 outbreak,Other (psych),No Intervention,No Intervention,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44198,None
2398,CTRI/2020/07/026355,CTRI,2020-07-04,2020-07-14,False,Ayurved University,Not Recruiting,Not Applicable,Interventional,India,"Evaluation Of The Efficacy of AYUSH KWATH in The Prevention  of COVID-19 

",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45327,None
2399,CTRI/2020/07/026354,CTRI,2020-07-04,2020-07-13,False,Bisleri Charitable Trust,Not Recruiting,Phase 1/Phase 2,Interventional,India,Clinical trial of ozone therapy  in mild to moderate Covid-19 subjects.,Drug,Ozone,Ozone,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45173,None
2400,CTRI/2020/07/026353,CTRI,2020-07-04,2020-12-07,False,Bansi Gir Gaushala,Not Recruiting,Not Applicable,Interventional,India,"A study to evaluate the effect of a combination Giloy Gomutra Capsules, Asthi Churna and Kamdhenu Asava in COVID-19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45266,None
2401,CTRI/2020/07/026352,CTRI,2020-07-04,2020-07-13,False,Cadila Healthcare Ltd,Not Recruiting,Phase 1/Phase 2,Interventional,India,Novel Corona Virus-2019-nCov vaccine by intradermal route in healthy subjects.,ATMP,Vaccine,Vaccine,1048,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45306,None
2402,CTRI/2020/07/026367,CTRI,2020-07-05,2020-07-15,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,"United Kingdom, India, United States","An international multi-centre appraisal of the management of acute 
CHOLEcystitis during the COVID-19 pandemic: The CHOLECOVID audit.",Other,No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45324,None
2403,CTRI/2020/07/026369,CTRI,2020-07-05,2020-07-14,False,Capital Health Services India Pvt Ltd,Not Recruiting,Not Applicable,Observational,India,Evaluation of the performance of rapid diagnostic kit (COVIDAG-SP) in the detection of COVID-19 virus antigen,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44880,None
2404,CTRI/2020/07/026370,CTRI,2020-07-05,2020-07-14,False,Capital Health Services India Pvt Ltd,Not Recruiting,Not Applicable,Observational,India,Evaluation of the performance of rapid diagnostic kit (COVIDAB-SP) in the detection of COVID-19 virus antibody,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,2000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45185,None
2405,CTRI/2020/07/026368,CTRI,2020-07-05,2020-07-13,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,Spread of corona virus disease and factors affecting it in Pune city.,Clinical Presentation (Epidemiology),No Intervention,No Intervention,700,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45232,None
2406,CTRI/2020/07/026371,CTRI,2020-07-05,2020-07-13,False,Sriveda Sattva Private Limited Sri Sri Tattva,Not Recruiting,Phase 3/Phase 4,Interventional,India,"Kabasura Kudineer, Shakti drops and Turmeric plus in the management of COVID-19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45272,None
2407,CTRI/2020/07/026389,CTRI,2020-07-06,2020-01-08,True,Centre for Health Research and Development Society for Applied Studies,Recruiting,Not Applicable,Observational,India,Effect of Corona virus infection and lockdown on access to health services and on mental health among urban and peri-urban low- to mid-socioeconomic neighborhoods in South Delhi,Other (psych),No Intervention,No Intervention,450,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44395,None
2408,CTRI/2020/07/026424,CTRI,2020-07-08,2020-07-14,False,Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University,Not Recruiting,Not Applicable,Observational,India,An Observational Study on Health issues during covid 19 lock down,Other,No Intervention,No Intervention,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45337,None
2409,CTRI/2020/07/026431,CTRI,2020-07-08,2020-01-09,True,KVG Dental College Hospital,Not Recruiting,Phase 1/Phase 2,Interventional,India,A clinical trial to find out the effectiveness of traditional awareness method and anticipatory guidance through motivational interviewing.,Other,Other,Other,700,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45340,None
2410,CTRI/2020/07/026433,CTRI,2020-07-08,2020-07-15,False,Ayush Govt of Gujarat,Not Recruiting,Not Applicable,Interventional,India,Effect of Ayurveda medicinein Covid-19 mild symptoms,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45252,None
2411,CTRI/2020/07/026463,CTRI,2020-07-09,2020-10-07,False,Radhika Ayurveda Research and Development,Recruiting,Not Applicable,Interventional,India,Clinical study to evaluate efficacy and safety of GanjhuVir syrup and tablet in Covid-19 positive patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43844,None
2412,CTRI/2020/07/026462,CTRI,2020-07-09,2020-07-20,False,Central Council for Research in Unani Medicine,Not Recruiting,Phase 3,Interventional,India,A study to observe and assess the safety and efficacy of Unani regimen in preventing the progression of severity of asymptomatic mild to moderate symptomatic cases.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,124,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44637,None
2413,CTRI/2020/07/026445,CTRI,2020-07-09,2020-07-18,False,Tina Purayil,Not Recruiting,Not Applicable,Observational,India,Types of dental emergencies during Covid epidemic,Health System,No Intervention,No Intervention,380,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45445,None
2414,CTRI/2020/07/026451,CTRI,2020-07-09,2020-07-13,False,InnoDx Solutions Pvt Ltd,Not Recruiting,Not Applicable,Observational,India,"Observational Study of Sensitivity and Specificity of COVID-19 Screening and
Diagnostics in COVID-19 Infected Individuals.
",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44483,None
2415,CTRI/2020/07/026471,CTRI,2020-07-10,2020-07-20,False,The Directorate of Indian Medicine and Homoeopathy,Not Recruiting,Phase 2,Interventional,India,A clinical trial to study the effect and safety of the Siddha medicines in patients with Corona Virus disease,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45318,None
2416,CTRI/2020/07/026469,CTRI,2020-07-10,2020-07-14,False,HealthCubed India Pvt Ltd,Not Recruiting,Phase 4,Interventional,India,Rapid diagnostic test for the detection of COVID-19 antibodies,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45336,None
2417,CTRI/2020/07/026468,CTRI,2020-07-10,2020-09-18,False,AYUSHCSIR,Recruiting,Not Applicable,Interventional,India,"Drug Trial to Evaluate Efficacy and Safety of an Ayurvedic Formulation as Adjunct Treatment to Standard of Care for the management of Mild to Moderate COVID-19 Patients 
",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,140,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44844,None
2418,CTRI/2020/07/026470,CTRI,2020-07-10,2020-07-15,False,Almaa Siddha Multispeciality Hospital Pvt Ltd,Not Recruiting,Phase 2,Interventional,India,Safety and Effectiveness of  Siddha Sastric Medicines for the Management of Covid-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45363,None
2419,CTRI/2020/07/026472,CTRI,2020-07-10,2020-07-16,False,Kasturba Medical College,Not Recruiting,Not Applicable,Observational,India,Epidemiology and outcomes of COVID-19 in Udupi,Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45392,None
2420,CTRI/2020/07/026499,CTRI,2020-07-10,2020-07-20,False,Capital Health Services India Pvt Ltd,Not Recruiting,Not Applicable,Observational,India,Evaluation of the performance of India Health FoundationÃ¢??s (IHFÃ¢??s) RT PCR kit for detection of COVID-19 virus (SARS-CoV-2) antigens,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45406,None
2421,CTRI/2020/07/026473,CTRI,2020-07-10,2020-07-18,False,P Kalyana Chakravarthy,Not Recruiting,Not Applicable,Observational,India,Views of Indian dental students on international dental higher education after Covid-19,Other,No Intervention,No Intervention,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45448,None
2422,CTRI/2020/07/026474,CTRI,2020-07-10,2020-07-19,False,Dr. Souvik Maitra,Not Recruiting,Not Applicable,Observational,India,Effect of insulins (a chemical in our body which decreases blood sugar) sugar lowering effect in COVID-19 patients,Clinical Presentation,No Intervention,No Intervention,125,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45474,None
2423,CTRI/2020/07/026510,CTRI,2020-07-12,2020-07-17,False,Hindu Mission Hospital,Not Recruiting,Not Applicable,Observational,India,"Clinical presentation, Management, Treatment and Outcome of  COVID patients",Clinical Presentation,No Intervention,No Intervention,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45415,None
2424,CTRI/2020/07/026509,CTRI,2020-07-12,2020-07-20,False,Persisten Foundation,Not Recruiting,Not Applicable,Observational,India,Serosurvey for antibodies against SARS-CoV-2 in Pune city,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1520,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45476,None
2425,CTRI/2020/07/026508,CTRI,2020-07-12,2020-07-20,False,"National Centre For Cell Science, Pune",Not Recruiting,Not Applicable,Observational,India,Genome Sequencing of COVID-19 virus,Genomics,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44266,None
2426,CTRI/2020/07/026514,CTRI,2020-07-13,2020-07-22,False,Tata Memorial Centre,Not Recruiting,Phase 2,Interventional,India,Randomized Controlled Trial Of Resveretrol-Copper OR Sodium-Copper-Chlorophyllin Versus Standard Treatment In Severe Covid-19 Cancer Patients.,Drug,Resveratrol + Copper; Sodium-Copper-Chlorophyllin,Resveratrol; Copper; Sodium-Copper-Chlorophyllin,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45580,None
2427,CTRI/2020/07/026515,CTRI,2020-07-13,2020-07-22,False,Tata Memorial Centre,Not Recruiting,Phase 3,Interventional,India,Randomized Controlled Trial Of Resveretrol-Copper Or Sodium-Copper-Chlorophyllin Vs Standard Treatment In Mild Covid-19 infection with Cancer Patients.,Drug,Resveratrol + Copper; Sodium-Copper-Chlorophyllin,Resveratrol; Copper; Sodium-Copper-Chlorophyllin,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45584,None
2428,CTRI/2020/07/026532,CTRI,2020-07-13,2020-07-14,False,Dr. Souvik Maitra,Not Recruiting,Not Applicable,Interventional,India,Comparison to two different position to relieve difficulty in breathing in COVID- 19 patients,Procedure,Positioning,Positioning,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44354,None
2429,CTRI/2020/07/026534,CTRI,2020-07-13,2020-07-20,False,"Indian Institute of Technology, Bombay",Not Recruiting,Phase 3,Interventional,India,Study of antiviral nutraceutical PICOVRID in COVID 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45137,None
2430,CTRI/2020/07/026533,CTRI,2020-07-13,2020-07-19,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,Study to observe cancer directed treatment during COVID-19 pandemic situation.,Other,No Intervention,No Intervention,10000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45172,None
2431,CTRI/2020/07/026529,CTRI,2020-07-13,2020-07-20,False,Dr. Abhay Vispute Shantaram,Not Recruiting,Phase 2/Phase 3,Interventional,India,A Study to evaluate the safety and efficacy of Eflornithine against the standard of care in human adult hospitalized COVID-19 patients,Drug,Eflomithine,Eflomithine,18,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45475,None
2432,CTRI/2020/07/026516,CTRI,2020-07-13,2020-07-25,False,Dr. Sukena Susnerwala,Not Recruiting,Not Applicable,Observational,India,Clinical manifestations in neonates born to Covid 19 positive mothers.,Clinical Presentation,No Intervention,No Intervention,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44982,None
2433,CTRI/2020/07/026528,CTRI,2020-07-13,2020-08-13,False,Aparna Abhay Raut,Not Recruiting,Not Applicable,Interventional,India,Herbal formulation for immunity boosting during pandemic,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45269,None
2434,CTRI/2020/07/026530,CTRI,2020-07-13,2020-01-08,True,SASTRA Deemed University,Not Recruiting,Phase 2/Phase 3,Interventional,India,Ayurvedic formulations for the prevention of COVID-19 infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45532,None
2435,CTRI/2020/07/026535,CTRI,2020-07-13,2020-07-20,False,Dr. Bharat S Mody,Not Recruiting,Not Applicable,Interventional,India,A clinical study to observe the effects of 8.4% Sodium Bicarbonate impregnated steam inhalation on Covid-19 infected patients,Drug,Sodium bicarbonate,Sodium bicarbonate,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45535,None
2436,CTRI/2020/07/026576,CTRI,2020-07-14,2020-07-25,False,Dr. Swathi Pai,Not Recruiting,Not Applicable,Observational,India,Influence of Lockdown on dental professionals,Health System,No Intervention,No Intervention,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45573,None
2437,CTRI/2020/07/026560,CTRI,2020-07-14,2020-07-21,False,Nisarga Biotech Pvt Ltd,Not Recruiting,Phase 3,Interventional,India,Neem Prophylaxis for Subjects Coming in Contact with COVID-19 Patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45385,None
2438,CTRI/2020/07/026574,CTRI,2020-07-14,2020-07-20,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,"To assess the seriousness  in COVID-19 patients with the blood test report.
",Clinical Presentation,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45396,None
2439,CTRI/2020/07/026571,CTRI,2020-07-14,2020-07-21,False,Hassan Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,"Pattern of ocular surface involvement in COVID-19 patients in Hassan,Karnataka.",Clinical Presentation,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45426,None
2440,CTRI/2020/07/026575,CTRI,2020-07-14,2020-07-20,False,Parul University,Not Recruiting,Phase 2,Interventional,India,Sahadevi Choorna for COVID 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,48,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45500,None
2441,CTRI/2020/07/026570,CTRI,2020-07-14,2020-07-15,False,AMAI Charitable Trust Pune,Not Recruiting,Not Applicable,Interventional,India,Safety and efficacy of Ayurvedic Capsule in mild to moderate COVID-19 infection.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45007,None
2442,CTRI/2020/07/026559,CTRI,2020-07-14,2020-07-21,False,Deepika Chenna,Not Recruiting,Not Applicable,Observational,India,Survey about knowledge towards blood donation during COVID 19 pandemic,Other,No Intervention,No Intervention,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45544,None
2443,CTRI/2020/07/026579,CTRI,2020-07-14,2020-07-24,False,The Himalaya Drug Company,Not Recruiting,Phase 3,Interventional,India,Role of Herbal Immunomodulators in in Boosting the Immunity among healthcare workers assigned to COVID-19 wards,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45034,None
2444,CTRI/2020/07/026568,CTRI,2020-07-14,2020-07-15,False,Ayurved Rasayani,Not Recruiting,Not Applicable,Interventional,India,Ayurveda Rasayan therapy for reducing risk of COVID infection in high risk individuals with comorbidities,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45035,None
2445,CTRI/2020/07/026611,CTRI,2020-07-15,2020-07-24,False,Sanjay Gandhi Postgraduate Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Surgical Outcomes in COVID-19 Patients (SOVID),Clinical Presentation,No Intervention,No Intervention,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44568,None
2446,CTRI/2020/07/026612,CTRI,2020-07-15,2020-07-24,False,Sanjay Gandhi Postgraduate Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Psycho-social Problems among COVID Infection Survivors,Other (psych),No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45100,None
2447,CTRI/2020/07/026602,CTRI,2020-07-15,2020-07-24,False,Deenanath Mangeshkar Hospital Research Centre,Not Recruiting,Phase 2,Interventional,India,Study of an Ayurveda regimen in COVID Positive patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,72,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45628,None
2448,CTRI/2020/07/026608,CTRI,2020-07-15,2020-07-27,False,Dr. Ananthakumar P K,Not Recruiting,Not Applicable,Interventional,India,A clinical trial to study the effects of two drugs methylprednisolone and dexamethasone in patients with severe COVID-19,Drug,Corticosteroids,Dexamethasone; Methylprednisolone,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45638,None
2449,CTRI/2020/07/026610,CTRI,2020-07-15,2020-07-28,False,Cancer Institute (WIA),Not Recruiting,Not Applicable,Observational,India,General anaesthesia with aerosol box during COVID pandemic,Other (Device),Aerosol box,Aerosol box,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45643,None
2450,CTRI/2020/07/026609,CTRI,2020-07-15,2020-07-24,False,Sanjay Gandhi Postgraduate Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Yoganidra benefits on COVID health care workers,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45139,None
2451,CTRI/2020/07/026607,CTRI,2020-07-15,2020-07-22,False,CSIR National Aerospace Laboratories,Not Recruiting,Phase 2,Interventional,India,Evaluation of Non Invasive Ventilator,Other (physical),Mechanical ventilation,Mechanical ventilation,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43998,None
2452,CTRI/2020/07/026601,CTRI,2020-07-15,2020-07-21,False,Aarti Foundation Mumbai and Kutchhi Jain Foundation Mumbai,Not Recruiting,Phase 2/Phase 3,Interventional,India,A study to check effect of an Ayurvedic treatment on corona positive patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45564,None
2453,CTRI/2020/07/026630,CTRI,2020-07-16,2020-07-22,False,Mr Ghanshyam Goti,Recruiting,Phase 2,Interventional,India,Clinical trial of ACT 12 tablet and ACT 13 dry syrup in Covid 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45581,None
2454,CTRI/2020/07/026632,CTRI,2020-07-16,2020-07-27,False,Government Siddha Medical College,Not Recruiting,Phase 2,Interventional,India,Siddha Treatment for COVID 19- a Pilot Study,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45680,None
2455,CTRI/2020/07/026631,CTRI,2020-07-16,2020-07-19,False,Kumarans Fertility Centre,Not Recruiting,Not Applicable,Interventional,India,Uses of herbal combination by taking it in hot water  in  covid 19 positive patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45494,None
2456,CTRI/2020/07/026658,CTRI,2020-07-17,2020-07-18,False,Dr. Ankita Sangle,Not Recruiting,Not Applicable,Observational,India,Teleophthalmology experience during COVIDÃ¢??19 lockdown.,Telehealth,No Intervention,No Intervention,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45350,None
2457,CTRI/2020/07/026667,CTRI,2020-07-17,2020-07-17,False,"Ministry of Ayush, Government of India",Not Recruiting,Not Applicable,Interventional,India,: Efficacy of Pranayama on Positivity rate in People exposed to Covid-19 Patients and mental status,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44342,None
2458,CTRI/2020/07/026633,CTRI,2020-07-17,2020-07-25,False,Uttara Adhunik Medical College and Hospital,No Status Given,Not Applicable,Observational,Bangladesh,Mental state of the Bangladeshi physiotherapist amid COVID-19 pandemic.,Other (psych),No Intervention,No Intervention,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45666,None
2459,CTRI/2020/07/026659,CTRI,2020-07-17,2020-07-25,False,Dr. Deeksha Karkada,Not Recruiting,Not Applicable,Observational,India,COVID-19 related study among dental patients in Udupi District,Clinical Presentation (Epidemiology),No Intervention,No Intervention,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45431,None
2460,CTRI/2020/07/026664,CTRI,2020-07-17,2020-07-20,False,Natesh Prabu,Not Recruiting,Not Applicable,Observational,India,"To find the frequency of misting ""fogging""of protective spectacles and comparison of various techniques to reduce misting of spectacles while working in intensive care unit during COVID 19 pandemic",Other (Device),Protective Eye Wear,Protective Eye Wear,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44690,None
2461,CTRI/2020/07/026660,CTRI,2020-07-17,2020-07-27,False,Tata Memorial Hospital,Not Recruiting,Not Applicable,Observational,India,A study to measure the mental stress of the upcoming primary caregivers of children cancer patients diagnosed with Covid-19 illness,Other (psych),No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45715,None
2462,CTRI/2020/07/026669,CTRI,2020-07-18,2020-03-08,True,Z V M Unani Medical College,Not Recruiting,Not Applicable,Interventional,India,Unani Herbal tablets for mild cases od Covid 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45623,None
2463,CTRI/2020/07/026673,CTRI,2020-07-18,2020-05-08,True,"Ministry of Ayush, Government of India",Not Recruiting,Phase 2/Phase 3,Interventional,India,Siddha formulations for the prevention of COVID-19 infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45673,None
2464,CTRI/2020/07/026668,CTRI,2020-07-18,2020-05-08,True,Indian Council of Medical Research,Not Recruiting,Not Applicable,Interventional,India,To study the effect of BCG vaccine in Reducing the Incidence and severity of COVID-19 in the high-risk population,ATMP,Vaccine,Vaccine,800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45677,None
2465,CTRI/2020/07/026670,CTRI,2020-07-18,2020-07-28,False,All India Institute of Ayurveda,Not Recruiting,Not Applicable,Interventional,India,Role of immune boosting kit in covid disease,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45713,None
2466,CTRI/2020/07/026671,CTRI,2020-07-18,2020-07-27,False,Bisleri Charitable Trust,Not Recruiting,Not Applicable,Interventional,India,Ozone Therapy for Covid 19 patients,Drug,Ozone,Ozone,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45728,None
2467,CTRI/2020/07/026672,CTRI,2020-07-18,2020-07-28,False,Tata Memorial Hospital,Not Recruiting,Not Applicable,Observational,"Algeria, Mozambique, Cambodia, Bahrain, United Arab Emirates, Palau, Chile, Kazakhstan, Russian Federation, Zambia, Barbados, Saint Vincent and the Grenadines, Belarus, Czech Republic, Tunisia, Bolivia, Nicaragua, Sri Lanka, Azerbaijan, United Republic of Tanzania, Israel, Solomon Islands, Marshall Islands, Burundi, Bhutan, Hungary, Norway, Malaysia, Comoros, Gambia, Paraguay, Seychelles, Thailand, France, Somalia, Turkey, Uzbekistan, Togo, South Africa, Ukraine, Haiti, Finland, Monaco, Cuba, Belize, Suriname, Tajikistan, Bahamas, Serbia , Argentina, Qatar, Uganda, Bulgaria, Central African Republic, Liberia, Venezuela (Bolivarian Republic of), India, Bosnia and Herzegovina, Germany, Cyprus, Netherlands, Yemen, Madagascar, Chad, The former Yugoslav Republic of Macedonia, Guinea, Croatia, Andorra, Guatemala, Pakistan, Benin, Slovakia, Guinea-Bissau, Hong Kong, Ireland, Democratic People's Republic of Korea, Libyan Arab Jamahiriya, Costa Rica, Iraq, Other, Burkina Faso, Singapore, Belgium, Maldives, Panama, Lao People's Democratic Republic, Bangladesh, Taiwan, Sweden, Ecuador, Jordan, Lesotho, China, Rwanda, Tuvalu, Saint Lucia, Niger, Slovenia, United States, Eritrea, Honduras, Angola, Albania, Republic of Korea, San Marino, Poland, Canada, Swaziland, Nauru, Sierra Leone, Estonia, Sao Tome and Principe, Portugal, Mongolia, Nigeria, Philippines, Greece, Latvia, Tonga, Cameroon, Democratic Republic of Congo, Georgia, Fiji, Trinidad and Tobago, Saint Kitts and Nevis, Niue, Lebanon, Botswana, Morocco, Equatorial Guinea, Mali, New Zealand, Kyrgyzstan, Micronesia (Federated States of), Kuwait, Nepal, United Kingdom, Uruguay, Austria, Samoa, Malawi, Spain, Zimbabwe, Brunei Darussalam, Ghana, Luxembourg, Myanmar, Mexico, Mauritania, Timor-Leste, Iceland, Cook Islands, Romania, Kenya, Antigua and Barbuda, Lithuania, Ethiopia, Italy, Democratic Republic of the Congo, Kiribati, Malta, Saudi Arabia, Brazil, Armenia, Peru, Australia, Republic of Moldova, Vietnam, Mauritius, Japan, Tanzania, Afghanistan, Iran, Senegal, Oman, Indonesia, Switzerland, Namibia, Denmark, Djibouti, Syrian Arab Republic, Cape Verde, Colombia, Egypt, Turkmenistan, Vanuatu, Jamaica, Papua New Guinea, Dominican Republic, Guyana, Montenegro, Dominica, El Salvador, Cote d'Ivoire, Gabon, Sudan, Grenada",Mental health affected by COVID-19,Other (psych),No Intervention,No Intervention,2000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45764,None
2468,CTRI/2020/07/026676,CTRI,2020-07-19,2020-03-08,True,Dr. Harini Atturu,Not Recruiting,Not Applicable,Observational,India,Psychological Impact of COVID 19 on Pregnant women,Other (psych),No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44603,None
2469,CTRI/2020/07/026674,CTRI,2020-07-19,2020-07-27,False,Suraj Ayurveda Clinic and Research Center,Not Recruiting,Phase 1,Interventional,India,Effect of Ayurveda Spice Mix Tablet for the Prevention of COVID-19 infection in people exposed to Covid 19 and in high risk patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,130,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45712,None
2470,CTRI/2020/07/026675,CTRI,2020-07-19,2020-07-27,False,Suraj Ayurveda Clinic and Research Center,Not Recruiting,Phase 1/Phase 2,Interventional,India,Efficacy of Ayurveda treatment Protocol with Tulsimmune Tablet in Covid 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,76,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45731,None
2471,CTRI/2020/07/026677,CTRI,2020-07-19,2020-03-08,True,Gnaneswar Atturu,Not Recruiting,Not Applicable,Observational,India,Role of cough and voice analysis using artificial intelligence in the management of COVID 19 patients,Clinical Presentation,No Intervention,No Intervention,250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45780,None
2472,CTRI/2020/07/026678,CTRI,2020-07-19,2020-07-30,False,Chengalpattu Medical College,Recruiting,Not Applicable,Observational,India,what are the clinical effects in newborns born to mothers exposed to COVID-19 viral infection.,Clinical Presentation,No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45786,None
2473,CTRI/2020/07/026705,CTRI,2020-07-20,2020-07-28,False,Central Council for Research in Ayurveda and Siddha,Not Recruiting,Phase 1,Interventional,India,Efficacy and safety of AYUSH 64 tablets in treating mild to moderate Covid 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45088,None
2474,CTRI/2020/07/026698,CTRI,2020-07-20,2020-05-19,True,Self-sponsored,Not Recruiting,Not Applicable,Observational,India,COVID 19 and changes in the heart,Clinical Presentation,No Intervention,No Intervention,3000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43604,None
2475,CTRI/2020/07/026700,CTRI,2020-07-20,2020-07-27,False,Ayurved Rasayani,Not Recruiting,Not Applicable,Interventional,India,Ayurvedic Rasayana therapies,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45207,None
2476,CTRI/2020/07/026701,CTRI,2020-07-20,2020-07-23,False,Narayana Health,Not Recruiting,Not Applicable,Observational,India,"Scanning of Lungs, Heart and blood vessels by two different techniques using ultrasound in COVID-19 patients",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44985,None
2477,CTRI/2020/07/026714,CTRI,2020-07-21,2020-03-08,True,Dr. Harini Atturu,Not Recruiting,Not Applicable,Observational,India,Psychological Impact of COVID 19 on Healthcare Workers,Other (psych),No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44848,None
2478,CTRI/2020/07/026728,CTRI,2020-07-21,2020-01-08,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,"Knowledge,Attitude,and Practice towards COVID-19 among Kerala Residents during the outbreak period:an online cross sectional survey.",Other,No Intervention,No Intervention,140,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45408,None
2479,CTRI/2020/07/026715,CTRI,2020-07-21,2020-07-31,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Structured online training program on specific COVID-19 Airway Management,Other,No Intervention,No Intervention,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45798,None
2480,CTRI/2020/07/026757,CTRI,2020-07-23,2020-07-31,False,"Ministry of Ayush, Government of India",Not Recruiting,Phase 3,Interventional,India,An interventional study to access the effect of Homoeopathic medicine in positive cases of COVID-19.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45824,None
2481,CTRI/2020/07/026758,CTRI,2020-07-23,2020-10-08,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,Knowledge Attitude and Practice of Nurses towards Hand hygiene in COVID-19 care units,Other,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45877,None
2482,CTRI/2020/07/026759,CTRI,2020-07-23,2020-03-08,True,Ortho Clinical Diagnostics,Not Recruiting,Not Applicable,Observational,India,Detection of Antibodies to COVID-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,175,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45882,None
2483,CTRI/2020/07/026755,CTRI,2020-07-23,2020-07-27,False,RUHS College of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Clinical severity and outcome among covid-19 infected patients in respect to viral load and immune & inflammatory response.,Clinical Presentation,No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44619,None
2484,CTRI/2020/07/026747,CTRI,2020-07-23,2020-07-24,False,Sami Labs Limited,Not Recruiting,Not Applicable,Observational,India,In this study selenium levels would be determined in both normal volunteers as well as patients suffering from COVID-19.,Clinical Presentation,No Intervention,No Intervention,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45446,None
2485,CTRI/2020/07/026756,CTRI,2020-07-23,2020-07-28,False,All India Institute of Ayurveda,Not Recruiting,Not Applicable,Interventional,India,Ayurveda strength and immunity enhancing protocol and immunity in health care workers : Clinical trial of an Ayurveda Intervention,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,425,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45755,None
2486,CTRI/2020/07/026791,CTRI,2020-07-25,2020-01-08,True,Dr. Deepti Siddharthan,Recruiting,Phase 2/Phase 3,Interventional,India,Statin and Aspirin in SARS-CoV-2 infection,Drug,"Atorvostatin, Aspirin",Atorvostatin; Aspirin,800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44814,None
2487,CTRI/2020/07/026798,CTRI,2020-07-25,2020-03-08,True,Dr. Ridhima Sharma,Not Recruiting,Not Applicable,Observational,India,"Depression, Anxiety and 
 Stress among healthcare workers during the curved 19 pandemic",Other (psych),No Intervention,No Intervention,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45852,None
2488,CTRI/2020/07/026796,CTRI,2020-07-25,2020-03-08,True,National Institute of Nutrition,Not Recruiting,Not Applicable,Interventional,India,A trial to evaluate the effect of cotton face-masks and other behavioral factors on COVID-19 risk in rural Telangana,Other (device),Masks,Masks,10000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45868,None
2489,CTRI/2020/07/026792,CTRI,2020-07-25,2020-07-30,False,Niyaz Khan,Not Recruiting,Not Applicable,Observational,India,Affect in surgical care in children due to COVID 19 in India: a  online survey of surgeons,Other,No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45616,None
2490,CTRI/2020/07/026789,CTRI,2020-07-25,2020-07-31,False,MGC Pharmaceuticals,Not Recruiting,Phase 2,Interventional,India,A clinical study to see effect of  ArtemiC in patients with COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45111,None
2491,CTRI/2020/07/026797,CTRI,2020-07-25,2020-02-08,True,New Civil Hospital Surat,Not Recruiting,Not Applicable,Observational,India,An observational study of lying down flat on chest in treatment of corona patient who breath on their own and on oxygen therapy.,Procedure,Positioning,Positioning,111,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45903,None
2492,CTRI/2020/07/026790,CTRI,2020-07-25,2020-03-08,True,Dr. Ankit Agarwal,Not Recruiting,Not Applicable,Interventional,India,This is the comparative study between two protective boxes which can be used by the doctors while managing critical COVID 19 patients in addition to personal protective equipment.,Other (device),Protective Boxes,Protective Boxes,21,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45143,None
2493,CTRI/2020/07/026800,CTRI,2020-07-25,2020-03-08,True,"Max Superspeciality Hospital, Vaishali",Recruiting,Not Applicable,Observational,India,A study to campare various blood investigations  in  COVID-19 positive patients.,Clinical Presentation,No Intervention,No Intervention,72,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45937,None
2494,CTRI/2020/07/026799,CTRI,2020-07-25,2020-04-08,True,Sri Devaraj Urs Academy of Higher Education and Research,Recruiting,Phase 2/Phase 3,Interventional,India,Yoga for Nurses (COVID-19),Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45964,None
2495,CTRI/2020/07/026793,CTRI,2020-07-25,2020-07-31,False,Ionisation Filtration Industries,Not Recruiting,Phase 2,Interventional,India,Panchgavya Therapy in prophylaxis and as an adjuvant therapy in management of Covid 19.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45721,None
2496,CTRI/2020/07/026788,CTRI,2020-07-25,2020-08-17,False,Department of Psychiatry,Not Recruiting,Not Applicable,Observational,India,A Qualitative study regarding stress and coping in Front-line Health Care Doctors at a tertiary-care hospital.,Other (psych),No Intervention,No Intervention,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44768,None
2497,CTRI/2020/07/026794,CTRI,2020-07-25,2020-03-08,True,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Vitamin-D levels in COVID-19 Patients and their relationship with other bone metabolism markers,Clinical Presentation,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45802,None
2498,CTRI/2020/07/026836,CTRI,2020-07-27,2020-10-08,False,Manipal Academy of Higher Education,Not Recruiting,Not Applicable,Observational,India,Effect of COVID - 19 pandemic researchers,Other,No Intervention,No Intervention,1850,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45113,None
2499,CTRI/2020/07/026831,CTRI,2020-07-27,2020-01-08,True,George Institute for Global Health India,Not Recruiting,Phase 3,Interventional,India,"Controlled evaluation of Angiotensin Receptor Blockers for COVID-19
Respiratory Disease
",Drug,ARBs,ARBs,605,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44605,None
2500,CTRI/2020/07/026820,CTRI,2020-07-27,2020-09-08,False,Rohit Walia,Not Recruiting,Phase 4,Interventional,India,Curcumin for COVID-19 Pre Exposure Prophylaxis,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45936,None
2501,CTRI/2020/07/026834,CTRI,2020-07-27,2020-07-08,True,Director,Not Recruiting,Not Applicable,Interventional,India,REaCHing to you with listening ears; A friendly telephonic interaction Program for the DDU-GKY members,Other (psych),Psychological,Psychological,1480,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45953,None
2502,CTRI/2020/07/026837,CTRI,2020-07-27,2020-04-08,True,Ortho Clinical Diagnostics,Not Recruiting,Not Applicable,Observational,India,Antibody response to COVID-19 in health care workers,Clinical Presentation,No Intervention,No Intervention,45,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45957,None
2503,CTRI/2020/07/026840,CTRI,2020-07-27,2020-07-28,False,"Directorate of AYUSH, Government of Madhya Pradesh",Not Recruiting,Not Applicable,Interventional,India,A study to assess the effectiveness of Ayurvedic formulation Guduchi Ghan vati in Covid-19 cases,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45981,None
2504,CTRI/2020/07/026821,CTRI,2020-07-27,2020-08-24,False,GCS Medical College Hospital and Research Centre,Not Recruiting,Not Applicable,Observational,India,"Study of skin, hair and nail changes after COVID 19 illness.",Clinical Presentation,No Intervention,No Intervention,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45989,None
2505,CTRI/2020/07/026839,CTRI,2020-07-27,2020-05-08,True,Shreepad Shree Vallabh SSV Phytopharmaceuticals,Not Recruiting,Phase 3,Interventional,India,Study of Shreepad Shree Vallabh SSV Formulation in management of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45994,None
2506,CTRI/2020/07/026835,CTRI,2020-07-27,2020-07-27,False,All India Institute of Medical Sciences,Not Recruiting,Phase 3/Phase 4,Interventional,India,Comparison of two different types of simple non-invasive oxygen therapy devices in coronavirus lung infection,Drug,Oxygen,Oxygen,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44539,None
2507,CTRI/2020/07/026832,CTRI,2020-07-27,2020-07-13,True,Vishweshwairiah Technological University,Not Recruiting,Not Applicable,Observational,India,Artificial intelligence and machine learning for Covid 19,Other (software),Machine Learning,Machine Learning,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44797,None
2508,CTRI/2020/07/026841,CTRI,2020-07-28,2020-03-08,True,Dr. Sarang Phadke,Not Recruiting,Phase 2,Interventional,India,"A clinical trial to study the effects of an Ayurvedic medicine, Haldi 30 ( Turmeric extract ) drops in patients with Corona virus infection.",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,260,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45659,None
2509,CTRI/2020/07/026902,CTRI,2020-07-29,2020-05-08,True,GCS Medical College Hospital and Research Centre,Not Recruiting,Not Applicable,Observational,India,Effect of CRP blood test in management of COVID 19 patients,Clinical Presentation,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45977,None
2510,CTRI/2020/07/026925,CTRI,2020-07-30,2020-07-31,False,Sterling Multispeciality Hosptal and Ayurved Rugnalay,Not Recruiting,Phase 3/Phase 4,Interventional,India,"to see the effect of twakadi(tea made up of dalcheeni, tulasi pepper, clove, etc)tea on police worker who have a duty in covid 19 pandemic",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45587,None
2511,CTRI/2020/07/026922,CTRI,2020-07-30,2020-04-08,True,"State Plan Management Unit, National Health Mission, Uttar Pradesh",Not Recruiting,Not Applicable,Interventional,India,Ayurvedic intervention in COVID-19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45909,None
2512,CTRI/2020/07/026954,CTRI,2020-07-31,2020-10-08,False,GCS Medical College Hospital and Research Centre,Not Recruiting,Not Applicable,Observational,India,Study of blood tests findings in patients of COVID 19 in a tertiary care centre,Clinical Presentation,No Intervention,No Intervention,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46080,None
2513,CTRI/2020/07/026955,CTRI,2020-07-31,2020-08-15,False,Dr. Arpit Prajapati,Not Recruiting,Not Applicable,Observational,India,"What are risk factors associated with disease severity and length of hospital stay in patients admitted with COVID-19 in GCS Medical College, Hospital & Research Centre, Ahmedabad?",Clinical Presentation,No Intervention,No Intervention,910,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46111,None
2514,CTRI/2020/07/026943,CTRI,2020-07-31,2020-03-08,True,Dr. Shruthi Acharya,Not Recruiting,Not Applicable,Observational,India,Effects of revised COVID19 specific infection control protocol on the well being of dental professionals,Other,Other,Other,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44582,None
2515,CTRI/2020/07/026953,CTRI,2020-07-31,2020-03-08,True,"Ministry of Ayush, Government of India",Not Recruiting,Phase 3/Phase 4,Interventional,India,COMPARISON OF THREE HOMOEOPATHIC DRUGS FOR COVID 19 IMMUNE BOOSTERS AGAINST STANDARD TREATMENT,Other,Homeopathy,Homeopathy,704,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45668,None
2516,CTRI/2020/07/026952,CTRI,2020-07-31,2020-01-08,True,SDM College of Ayurveda and Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,India,"Survey and Management 
 of depression, Anxiety and Stress due to COVID-19 fear",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45683,None
2517,CTRI/2020/07/026942,CTRI,2020-07-31,2020-03-08,True,Nivedita Hegde,Not Recruiting,Not Applicable,Observational,India,Study of COVID 19 suspected pregnant women,Clinical Presentation,No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45698,None
2518,CTRI/2020/07/026926,CTRI,2020-07-31,2020-07-31,False,Forum for Ethical Review Committees in Asia and the Western Pacific,Not Recruiting,Not Applicable,Observational,"Malaysia, Philippines, Sri Lanka, Thailand, India, Singapore, Nepal, Indonesia",Ethics of Behavioral Interventions during the Covid 19,Other,No Intervention,No Intervention,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45456,None
2519,CTRI/2020/08/026956,CTRI,2020-08-01,2020-10-08,False,Principal Investigator,Not Recruiting,Not Applicable,Observational,India,Telemedicine effectiveness during COVID-19,Telehealth,Telehealth,Telehealth,463,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46136,None
2520,CTRI/2020/08/026957,CTRI,2020-08-02,2020-07-08,True,Corival Lifesciences Private Limited,Recruiting,Phase 3/Phase 4,Interventional,India,A Clinical trial to evaluate the effect of a combination of treatment of Reginmune capsule and Immunofree tablets in the treatment of mild to moderate COVID-19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45825,None
2521,CTRI/2020/08/026980,CTRI,2020-08-04,2020-10-08,False,Rashtriyakamdhenu Ayog,Not Recruiting,Phase 3,Interventional,India,"Effect  Ayurveda decoctions, tablet and Panchagavya on COVID 19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,180,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46082,None
2522,CTRI/2020/08/026964,CTRI,2020-08-04,2020-09-08,False,New Civil Hospital Surat,Not Recruiting,Not Applicable,Observational,India,An observational study of effect of positioning on either side on oxygen level in corona patient.,Procedure,Positioning,Positioning,167,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46100,None
2523,CTRI/2020/08/026977,CTRI,2020-08-04,2020-10-08,False,Poonam Joshi,Not Recruiting,Not Applicable,Interventional,India,Comparison of two online learning method of resuscitation training.,Other,Other,Other,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44057,None
2524,CTRI/2020/08/026962,CTRI,2020-08-04,2020-01-09,True,Anitha S S,Not Recruiting,Not Applicable,Observational,India,"Incubation period of COVID-19 cases admitted in North Kerala, India",Clinical Presentation,No Intervention,No Intervention,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46133,None
2525,CTRI/2020/08/026985,CTRI,2020-08-04,2020-08-14,False,Chettinad Hospital and Research Institute,Not Recruiting,Phase 2,Interventional,India,"Assessment of safety and efficacy of Kabasura
Kudineer in mild to moderate COVID-19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,126,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46168,None
2526,CTRI/2020/08/026983,CTRI,2020-08-04,2020-08-17,False,Kasturba Medical College,Not Recruiting,Not Applicable,Observational,India,Point of care ultrasound study in patients with respiratory illness during COVID-19,Clinical Presentation,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45679,None
2527,CTRI/2020/08/026978,CTRI,2020-08-04,2020-08-19,False,Nepal Health Research Council,No Status Given,Not Applicable,Interventional,Nepal,Effectiveness of Ayurvedic Formulation for COVID 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44435,None
2528,CTRI/2020/08/027007,CTRI,2020-08-05,2020-07-31,True,"Ministry of Ayush, Government of India",Not Recruiting,Phase 3,Interventional,India,An interventional study to access the effect of Ayurvedic medicine in positive cases of COVID-19.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45827,None
2529,CTRI/2020/08/027008,CTRI,2020-08-05,2020-08-17,False,NIRMA University,Not Recruiting,Not Applicable,Observational,India,Advantage of Artificial Intelligence to detect COVID 19 using Chest X-Ray.,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46099,None
2530,CTRI/2020/08/026999,CTRI,2020-08-05,2020-10-08,False,"Indian Medicine and Homeopathy Department, Chennai",Not Recruiting,Phase 2,Interventional,India,Evaluate the Efficacy of Siddha Treatment in Patients with Novel Coronavirus Infectious Disease (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46134,None
2531,CTRI/2020/08/027005,CTRI,2020-08-05,2020-12-08,False,Homoeocon Foundation,Not Recruiting,Phase 2,Interventional,India,Investigation of effect of homoeopathic remedy as add on therapy to standard of care (regular treatment) in adult patients with moderate to severe COVID-19,Other,Homeopathy,Homeopathy,96,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46189,None
2532,CTRI/2020/08/027000,CTRI,2020-08-05,2020-08-14,False,Central Council for Research in Homoeopathy,Recruiting,Not Applicable,Observational,India,Retrospective cohort study in COVID 19 recovered patients,Clinical Presentation,No Intervention,No Intervention,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45722,None
2533,CTRI/2020/08/026998,CTRI,2020-08-05,2020-08-14,False,Dr. Varalakshmi Chandra Sekaran,Not Recruiting,Not Applicable,Observational,India,Youth experiences during COVID-19 pandemic,Other,No Intervention,No Intervention,540,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46243,None
2534,CTRI/2020/08/027009,CTRI,2020-08-05,2020-08-15,False,Sriveda Sattva Private Limited Sri Sri Tattva,Not Recruiting,Phase 3/Phase 4,Interventional,India,"Use of Herbal Medicine like Tulasi,Amruth(Giloy), Turmeric,Ashwagandha for Improving the Immunity among Health care workers.",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46269,None
2535,CTRI/2020/08/027001,CTRI,2020-08-05,2020-08-20,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,association of cardiac markers with severity of covid 19,Clinical Presentation,No Intervention,No Intervention,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45531,None
2536,CTRI/2020/08/027033,CTRI,2020-08-07,2020-07-08,True,Government Siddha Medical College,Not Recruiting,Phase 2,Interventional,India,SARS-COV-2 and COVID-19 - A Randomized controlled trail (unblinded),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46096,None
2537,CTRI/2020/08/027032,CTRI,2020-08-07,2020-11-08,False,Sonalika Social Development Society,Not Recruiting,Not Applicable,Interventional,India,A clinical study to assess the effects of MEDITATION (MINDFUL HAPPINESS) as an additional therapy in asymptomatic and mildly symptomatic covid-19 confirmed cases,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45920,None
2538,CTRI/2020/08/027034,CTRI,2020-08-07,2020-08-15,False,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Not Applicable,Observational,India,An observational study of Guduchi Extract Tablet,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46193,None
2539,CTRI/2020/08/027038,CTRI,2020-08-07,2020-08-20,False,SN Medical College,Not Recruiting,Phase 3,Interventional,India,Study  to assess effects of nano ozonised hydrogen peroxide nebulisation on results of RT-PCR for novel corona Virus thus infectivity and clinical course among mild to moderate sick COVID-19 Patients,Drug,Hydrogen Peroxide,Hydrogen Peroxide,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46197,None
2540,CTRI/2020/08/027035,CTRI,2020-08-07,2020-08-19,False,Dr. Divya Jain,Not Recruiting,Not Applicable,Interventional,India,A randomized trial to evaluate effect of mediatation on Stress and Anxiety due to COVID-19 in healthy adult population,Other (psych),Psychological,Psychological,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46262,None
2541,CTRI/2020/08/027036,CTRI,2020-08-07,2020-08-19,False,Dr. Divya Jain,Not Recruiting,Not Applicable,Observational,India,Retrospective Analysis of 245 COVID-19 Cases from a Government Teaching Hospital of North India,Clinical Presentation,No Intervention,No Intervention,245,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46280,None
2542,CTRI/2020/08/027037,CTRI,2020-08-07,2020-08-17,False,Sri Devaraj Urs Academy of Higher Education and Research,Recruiting,Phase 3,Interventional,India,Effect of Yoga for COVID-19 patients in addition to regular treatment,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46324,None
2543,CTRI/2020/08/027040,CTRI,2020-08-08,2020-12-08,False,"Ministry of Ayush, Government of India",Not Recruiting,Phase 3,Interventional,India,An interventional study to access the effect of Ayurvedic medicine in positive cases of COVID-19.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45846,None
2544,CTRI/2020/08/027047,CTRI,2020-08-09,2020-08-31,False,Mrs Prima Jenevive Jyothi DSouza,Not Recruiting,Not Applicable,Observational,India,Nursing students perception of out of the classroom learning during the period of COVID-19,Other,No Intervention,No Intervention,380,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46338,None
2545,CTRI/2020/08/027048,CTRI,2020-08-09,2020-08-17,False,Sri Devaraj Urs Academy of Higher Education and Research,Recruiting,Phase 3,Interventional,India,Yoga for Police personnel,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46344,None
2546,CTRI/2020/08/027049,CTRI,2020-08-09,2020-08-20,False,Manipal Medical College,Not Recruiting,Not Applicable,Observational,India,Study of families who travelled from another place and had COVID-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,19,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46361,None
2547,CTRI/2020/08/027051,CTRI,2020-08-09,2020-10-08,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Survey of challenges faced by pain and palliative physicians working in cancer set up during corona virus disease time,Health System,No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44061,None
2548,CTRI/2020/08/027050,CTRI,2020-08-09,2020-08-20,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,Assessment of PPE usage pattern and the associated Surgeon Discomfort and Fatigue Study.,Other,Personal Protective Equiptment,Personal Protective Equiptment,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46415,None
2549,CTRI/2020/08/027045,CTRI,2020-08-09,2020-08-17,False,Dr. Ashish Agarwal,Not Recruiting,Phase 2,Interventional,India,A clinical study to evaluate efficacy and safety of Camphora tablets in Covid positive patients,Other,Homeopathy,Homeopathy,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46226,None
2550,CTRI/2020/08/027043,CTRI,2020-08-09,2020-10-08,False,Neurogen Brain and Spine Institute,Not Recruiting,Phase 1,Interventional,India,Mesenchymal Stem Cell Therapy For Covid 19,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43175,None
2551,CTRI/2020/08/027046,CTRI,2020-08-09,2020-08-20,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,A survey to analyze the understanding about the use of face mask among the general public during COVID 19,Other,No Intervention,No Intervention,697,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46254,None
2552,CTRI/2020/08/027041,CTRI,2020-08-09,2020-08-14,False,Venkat Pharma,Not Recruiting,Phase 3/Phase 4,Interventional,India,Clinical trial on COVID 19 patients to Improve Immunity,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46258,None
2553,CTRI/2020/08/027042,CTRI,2020-08-09,2020-01-09,True,Anitha S S,Not Recruiting,Not Applicable,Observational,India,"Secondary attack rate of COVID 19, Kerala",Clinical Presentation (Epidemiology),No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46277,None
2554,CTRI/2020/08/027044,CTRI,2020-08-09,2020-08-14,False,Shri Krishna Ayush University,Not Recruiting,Phase 2/Phase 3,Interventional,India,To observe the outcome of Classical Ayurvedic medicine for the treatment of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44249,None
2555,CTRI/2020/08/027082,CTRI,2020-08-10,2020-08-18,False,Prabhleen Kaur Sibal,Not Recruiting,Not Applicable,Observational,India,To assess the fear and readiness of medical workers to work in the health care set up in the state of Karnataka during COVID-19 illness after the lock down is over.,Health System,No Intervention,No Intervention,600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46351,None
2556,CTRI/2020/08/027078,CTRI,2020-08-10,2020-08-17,False,Tata Memorial Hospital,Not Recruiting,Not Applicable,Observational,India,Establishment of surveillance system for individuals diagnosed with COVID-19.,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45924,None
2557,CTRI/2020/08/027079,CTRI,2020-08-10,2020-08-17,False,Dr. Swathy Moorthy,Not Recruiting,Not Applicable,Observational,India,study of lab investigations among hospitalized COVID-19 patients,Clinical Presentation,No Intervention,No Intervention,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46185,None
2558,CTRI/2020/08/027084,CTRI,2020-08-10,2020-08-20,False,Leaf BioLab - Leaf Research Institute,Not Recruiting,Not Applicable,Interventional,India,Evaluate the medicinal effects of both Ayurveda combinations Bio-Immune as Anti-viral and Covalix Vaccoil as alternate to Vaccine of COVID-19 on exposed individuals and Covid19 contact.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,61000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44420,None
2559,CTRI/2020/08/027061,CTRI,2020-08-10,2020-08-13,False,Dr. Rahul Pandit,Not Recruiting,Not Applicable,Interventional,India,Investigator Initiated Study to see the safety and efficacy of adding Thymosin Alpha to existing standard of care in severe COVID patients.,Drug,Thymosin alpha,Thymosin alpha,15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45729,None
2560,CTRI/2020/08/027080,CTRI,2020-08-10,2020-08-15,False,"GCS Medical College, Hospital & Research Centre",Not Recruiting,Phase 3/Phase 4,Interventional,India,Benefit of positioning in COVID-19 patient on Bipap mechnical support,Procedure,Positioning,Positioning,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46272,None
2561,CTRI/2020/08/027081,CTRI,2020-08-10,2020-08-17,False,"GCS Medical College, Hospital & Research Centre",Not Recruiting,Phase 3/Phase 4,Interventional,India,Comparision of two barrier devices for placement of tube into trachea(windpipe)in COVID19 patients,Other (device),Barrier devices,Barrier devices,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46289,None
2562,CTRI/2020/08/027083,CTRI,2020-08-10,2020-08-18,False,Bansi Gir Gaushala,Not Recruiting,Not Applicable,Observational,India,"Giloy Gomutra Capsule, Asthi churna aur Kamdhenu Asava ka vaishvik mahamari Covid-19 par logo ka anubhav aur Chikitsakiya prabhava ka Ankalan",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46331,None
2563,CTRI/2020/08/027085,CTRI,2020-08-11,2020-08-17,False,Germkill India,Not Recruiting,Not Applicable,Interventional,India,Safety and efficacy of citrobioShield product in improving immunity in COVID 19 patients via inhalation.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46278,None
2564,CTRI/2020/08/027094,CTRI,2020-08-11,2020-01-09,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,Role of Digital communication in COVID 19 isolation facilities an observation study,Other,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43763,None
2565,CTRI/2020/08/027102,CTRI,2020-08-13,2020-08-15,False,Dr. Krishna Kishore C,Not Recruiting,Phase 2,Interventional,India,Colchichine use for preventing COVID infection in haemodialysis patients,Drug,Colchicine,Colchicine,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45658,None
2566,CTRI/2020/08/027106,CTRI,2020-08-13,2020-08-20,False,Natural Supplemets LLC,Recruiting,Not Applicable,Interventional,India,"TO EVALUATE EFFICACY AND SAFETY OF Ã¢??VIRACIDEÃ¢?? 
IN THE MANAGEMENT OF CORONA VIRUS DISEASE 2019 (COVID-19)
",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44639,None
2567,CTRI/2020/08/027104,CTRI,2020-08-13,2020-08-13,False,Seth GS Medical College,Not Recruiting,Not Applicable,Observational,India,"CROSS SECTIONAL RETROSPECTIVE ANALYSIS OF CLINICAL SIGN OF breathlessness in sitting and supine position  IN
COVID-19 PATIENTS",Clinical Presentation,No Intervention,No Intervention,45,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45464,None
2568,CTRI/2020/08/027118,CTRI,2020-08-13,2020-08-22,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,Personal Experience During COVID - 19 Pandemic,Other,No Intervention,No Intervention,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46509,None
2569,CTRI/2020/08/027112,CTRI,2020-08-13,2020-08-18,False,Vardhman Mahavir Medical College; Safdarjung Hospital,Not Recruiting,Not Applicable,Observational,India,Effect of N95 mask in our body study in high volume center,Other (device),Masks,Masks,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46270,None
2570,CTRI/2020/08/027110,CTRI,2020-08-13,2020-08-22,False,Vardhman Mahavir Medical College; Safdarjung Hospital,Not Recruiting,Not Applicable,Observational,India,"The role of  markers(nlr,il-6,d-dimer) in COVID-19 patients and itÃ¢??s co-relationship with oxygenation ,a retrospective  observational study in Tertiary  care covid ICU",Clinical Presentation,No Intervention,No Intervention,250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46271,None
2571,CTRI/2020/08/027103,CTRI,2020-08-13,2020-08-19,False,BioEra Life Sciences,Not Recruiting,Not Applicable,Observational,India,Novel Safe Transport Medium and Rapid RNA Extraction Method for COVID-19,Other,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46285,None
2572,CTRI/2020/08/027120,CTRI,2020-08-13,2020-08-20,False,Amulya Herbs,Recruiting,Phase 3/Phase 4,Interventional,India,A clinical trial to know the efficacy and safety of herbal product Virowin in combination with Energy-Z capsule in treating mild to moderate COVID-19 patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46319,None
2573,CTRI/2020/08/027166,CTRI,2020-08-14,2020-08-18,False,GCS Medical College Hospital and Research Centre,Not Recruiting,Not Applicable,Observational,India,"Study of stress, depression and anxiety in healthcare workers doing COVID duty",Other (psych),No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46395,None
2574,CTRI/2020/08/027163,CTRI,2020-08-14,2020-08-23,False,Central Council for Research in Ayurvedic Sciences,Recruiting,Phase 2/Phase 3,Interventional,India,Ashwagandha in the prevention of COVID-19 in Health Care workers,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46406,None
2575,CTRI/2020/08/027165,CTRI,2020-08-14,2020-01-09,True,"University of California, San Francisco",Not Recruiting,Not Applicable,Observational,"Sweden, Algeria, Argentina, Mexico, Iceland, United States, Chile, India, Germany, Italy, Canada, Brazil, Australia, Czech Republic, Iran, Denmark, Norway, Egypt, New Zealand, France, Belgium, United Kingdom, Austria, Finland",COVID-19 Global Rheumatology Alliance,Other,No Intervention,No Intervention,3000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46228,None
2576,CTRI/2020/08/027162,CTRI,2020-08-14,2020-08-20,False,Themis Medicare,Not Recruiting,Phase 2,Interventional,India,A clinical study to understand the effect of Inosine Pranobex in Covid-19 patients when used along with the standard of Care in Covid patients.,Drug,Inosine Pranobex,Inosine Pranobex,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46240,None
2577,CTRI/2020/08/027168,CTRI,2020-08-14,2020-08-21,False,SRV Hospital,Recruiting,Not Applicable,Interventional,India,Clinical trial study to investigate safety and efficacy of ImmunoSEB and ProbioSEB,Supplement,Nutritional Supplement,Nutritional Supplement,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45750,None
2578,CTRI/2020/08/027164,CTRI,2020-08-14,2020-08-17,False,Indian Council of Medical Research,Not Recruiting,Not Applicable,Observational,India,National Clinical Registry of COVID 19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,10000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46320,None
2579,CTRI/2020/08/027170,CTRI,2020-08-15,2020-08-24,False,Serum Institute of India Pvt Ltd,Not Recruiting,Phase 2/Phase 3,Interventional,India,Study to check the safety and immune response of a COVID-19 vaccine in healthy Indian adults.,ATMP,Vaccine,Vaccine,1600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46186,None
2580,CTRI/2020/08/027169,CTRI,2020-08-15,2020-08-25,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,"Disease Profile of Covid-19 in patients admitted at AIIMS, Rishikesh",Clinical Presentation,No Intervention,No Intervention,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46255,None
2581,CTRI/2020/08/027171,CTRI,2020-08-15,2020-08-25,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Measurement of renal biomarker in COVID-19 associated acute renal failure,Clinical Presentation,No Intervention,No Intervention,75,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46527,None
2582,CTRI/2020/08/027175,CTRI,2020-08-15,2020-08-30,False,Government,Not Recruiting,Not Applicable,Observational,India,Clinical profile of neonates born to mothers with COVID-19,Clinical Presentation,No Intervention,No Intervention,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44760,None
2583,CTRI/2020/08/027174,CTRI,2020-08-15,2020-08-20,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Psychological Impact of COVID 19 on frontline health care workers,Other (psych),No Intervention,No Intervention,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45547,None
2584,CTRI/2020/08/027173,CTRI,2020-08-15,2020-08-15,False,Shrideevi Kori,Not Recruiting,Not Applicable,Observational,India,Necessary measures taken for covid positive pregnant women during pandemic.,Other,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46063,None
2585,CTRI/2020/08/027172,CTRI,2020-08-15,2020-08-16,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,Clinical Profile and Outcome of Neonates Born to Mothers with COVID in a Tertiary Care Centre,Clinical Presentation,No Intervention,No Intervention,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46077,None
2586,CTRI/2020/08/027192,CTRI,2020-08-17,2020-08-22,False,Dr. Rashi Agarwal,Not Recruiting,Not Applicable,Observational,India,"to assess the impact of COVID-19 pandemic on the delivery of radiation therapy in delhi national
capital region, india",Health System,No Intervention,No Intervention,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45344,None
2587,CTRI/2020/08/027193,CTRI,2020-08-17,2020-08-31,False,Department of Psychiatry,Not Recruiting,Not Applicable,Observational,India,Impact of COVID -19 situation on people staying and discharged from a psychiatric rehabilitation centre,Other (psych),No Intervention,No Intervention,54,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46646,None
2588,CTRI/2020/08/027189,CTRI,2020-08-17,2020-08-20,False,Department of Radiodiagnosis,Not Recruiting,Not Applicable,Observational,India,Role of chest CT scan in covid19 patients: A study in a dedicated covid hospital of odisha,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46430,None
2589,CTRI/2020/08/027224,CTRI,2020-08-18,2020-08-25,False,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,India,To observe the effect of Ayurvedic medicine (Ashwagandha and Shunti) for the treatment of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46608,None
2590,CTRI/2020/08/027225,CTRI,2020-08-18,2020-08-28,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Ivermectin as a possible treatment for COVID-19,Drug,Ivermectin,Ivermectin,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46660,None
2591,CTRI/2020/08/027226,CTRI,2020-08-18,2020-08-28,False,Jai Prakash Agarwal,Recruiting,Not Applicable,Observational,India,Study of Radiotherapy practice during Corona Pandemic,Other,Radiation,Radiation,2500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46685,None
2592,CTRI/2020/08/027218,CTRI,2020-08-18,2020-01-09,True,Eunice Kennedy Shriver National Institute of Child Health and Human Development,Not Recruiting,Not Applicable,Observational,"Bangladesh, Kenya, Guatemala, Pakistan, India, Democratic Republic of the Congo, Zambia",COVID-19 prevalence during pregnancy and pregnancy outcomes in low resource settings,Clinical Presentation (Epidemiology),No Intervention,No Intervention,16000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45967,None
2593,CTRI/2020/08/027210,CTRI,2020-08-18,2020-08-19,False,Tata Memorial Centre,Not Recruiting,Not Applicable,Observational,India,A backdated comparison of patients operated before the COVID-19 pandemic versus those operated during the COVID_19 pandemic.,Health System,No Intervention,No Intervention,3000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46279,None
2594,CTRI/2020/08/027222,CTRI,2020-08-18,2020-08-24,False,Hamdard Laboratories,Not Recruiting,Phase 2,Interventional,India,Unani formulations for prevention of COVID-19 infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46308,None
2595,CTRI/2020/08/027244,CTRI,2020-08-19,2020-08-29,False,Dr. Subhashish Nath,Not Recruiting,Not Applicable,Observational,India,Behavioural and emotional difficulties of school going children during COVID times,Other (psych),No Intervention,No Intervention,3500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46157,None
2596,CTRI/2020/08/027247,CTRI,2020-08-19,2020-08-20,False,Dr. Roopak Dubey,Not Recruiting,Not Applicable,Observational,India,Lower morbidity and mortality in COVID-19 patients admitted in a dedicated COVID Hospital of Odisha - A Radiological perspective,Clinical Presentation,No Intervention,No Intervention,1500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46417,None
2597,CTRI/2020/08/027243,CTRI,2020-08-19,2020-11-09,False,T Gayathri,Not Recruiting,Not Applicable,Observational,India,Identifying the factors that alters the recovery time of the COVID-19 patients.,Clinical Presentation,No Intervention,No Intervention,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46500,None
2598,CTRI/2020/08/027246,CTRI,2020-08-19,2020-01-09,True,GCS Medical College Hospital and Research Centre,Not Recruiting,Not Applicable,Observational,India,Role of Tocilizumab in COVID-19 Pneumonia patients,Drug,Tocilizumab,Tocilizumab,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46546,None
2599,CTRI/2020/08/027275,CTRI,2020-08-20,2020-08-20,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,"The study of occurrence , distribution and control measures of COVID-19 among police personnel during pandemic in Pune city , Maharashtra",Other,Other,Other,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46386,None
2600,CTRI/2020/08/027281,CTRI,2020-08-20,2020-08-31,False,GCS Medical College Hospital and Research Centre,Not Recruiting,Not Applicable,Observational,India,Assessing the fear and worries associated with covid-19 in out-patient population of a hospital,Other (psych),No Intervention,No Intervention,250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46396,None
2601,CTRI/2020/08/027282,CTRI,2020-08-20,2020-08-31,False,Department of Community Medicine,Not Recruiting,Phase 3,Interventional,India,Prophylactic Ivermectin in COVID 19 Contacts,Drug (Chemoprophylaxis),Ivermectin,Ivermectin,180,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46676,None
2602,CTRI/2020/08/027284,CTRI,2020-08-20,2020-08-28,False,Dyuthi Biosciences Private Limited,Not Recruiting,Not Applicable,Interventional,India,A study to evaluate the efficacy and safety of Aceinavir combined with supportive Standard of Care (SoC) in hospitalized patients with moderate coronavirus disease (COVID-19),Drug,Aceinavir,Aceinavir,44,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46679,None
2603,CTRI/2020/08/027285,CTRI,2020-08-20,2020-08-21,False,All India Institute of Medical Sciences,Recruiting,Not Applicable,Observational,India,Safety of convalescent plasma (CVP) drawn from mild symptomatic COVID-19 patients.,ATMP,Plasma,Plasma,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45050,None
2604,CTRI/2020/08/027283,CTRI,2020-08-20,2020-08-24,False,Dr. Vishwa Santhosha Bharathi,Not Recruiting,Phase 2/Phase 3,Interventional,India,A clinical trial to evaluate the medicinal efficacy and safety of Ayurvedic kit in COVID-19 positive Patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46591,None
2605,CTRI/2020/08/027301,CTRI,2020-08-21,2020-08-26,False,GCS Medical College Hospital and Research Centre,Not Recruiting,Not Applicable,Observational,India,Assessment of anxiety related to excessive internate search regarding covid-19 pandemic in medical students and para-medical staff.,Other (psych),No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46394,None
2606,CTRI/2020/08/027316,CTRI,2020-08-21,2020-08-28,False,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Phase 3/Phase 4,Interventional,India,The effect of Ayurvedic intervention (Ayurveda Raksha Kit) as a preventive measure in the Pandemic of COVID-19 - A community based study,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46680,None
2607,CTRI/2020/08/027299,CTRI,2020-08-21,2020-08-31,False,Dr. Rushi Patel,Not Recruiting,Not Applicable,Observational,India,"A study to find out possible causes of mortality amongst the Covid-19 patients that are admitted in GCS Medical College, Ahmedabad",Clinical Presentation,No Intervention,No Intervention,600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46175,None
2608,CTRI/2020/08/027286,CTRI,2020-08-21,2020-08-22,False,Government Institute of Medical Sceinces,Recruiting,Phase 2,Interventional,India,Effectiveness of Siddha Medicines Kabasura Kudineer and Nilavembu Kudineer in the Management of Smptomatic COVID 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46511,None
2609,CTRI/2020/08/027300,CTRI,2020-08-21,2020-01-09,True,Prof RK Dhamija,Not Recruiting,Not Applicable,Interventional,India,Efficacy and feasibility of Teleneurorehabilitation in Persons with Parkinsons Disease,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44285,None
2610,CTRI/2020/08/027324,CTRI,2020-08-23,2020-01-09,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Interventional,India,"Study to assess the usefulness, effectiveness and feasibility for future use of the consultations done using telephone/whatsapp in rheumatic diseases during CoVID-19 pandemic",Telehealth,Telehealth,Telehealth,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46339,None
2611,CTRI/2020/08/027323,CTRI,2020-08-23,2020-08-26,False,Innowear Technologies,Not Recruiting,Not Applicable,Observational,India,A survey to collect vital parameters and symptoms of participants at risk of COVID19,Clinical Presentation,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46086,None
2612,CTRI/2020/08/027345,CTRI,2020-08-24,2020-08-31,False,Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences,Not Recruiting,Phase 3,Interventional,India,Re-purposing of Anti HCV drugs for the treatment of COVID-19 diseasr,Drug,Daclatasvir + Sofosbuvir vs. Ledipasvir + Sofosbuvir,Daclatasvir; Sofosbuvir; Ledipasvir,175,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45932,None
2613,CTRI/2020/08/027346,CTRI,2020-08-24,2020-08-25,False,Shri Dhanwantry Ayurevdic College and Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,India,To assess the clinical efficacy of Ayurvedic interventions in managing asymptomatic to mild cases of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46229,None
2614,CTRI/2020/08/027359,CTRI,2020-08-24,2020-09-15,False,Bhaikaka University,Not Recruiting,Not Applicable,Interventional,India,"A study regarding knowledge, attitude and practice about immunity boosting measures for prevention of COVID-19 infection among healthcare workers at tertiary care hospital",Other,Other,Other,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46829,None
2615,CTRI/2020/08/027396,CTRI,2020-08-26,2020-03-09,True,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Mental health of pregnant women Covid-19 pandemic,Other (psych),No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46853,None
2616,CTRI/2020/08/027394,CTRI,2020-08-26,2020-02-09,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Interventional,India,Assessment of response of ivermectin on virological clearance in COVID 19 patients,Drug,Ivermectin,Ivermectin,56,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46873,None
2617,CTRI/2020/08/027403,CTRI,2020-08-26,2020-07-09,True,Maulana Azad Medical College; Lok Nayak Hospital,Not Recruiting,Not Applicable,Observational,India,A retrospective assessment of risk factors for COVID- 19 in health care workers,Clinical Presentation,No Intervention,No Intervention,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46923,None
2618,CTRI/2020/08/027397,CTRI,2020-08-26,2020-03-09,True,Indian Administrative Service,Recruiting,Phase 2,Interventional,India,Role of Siddha medicine in the management of Covid-19 positive patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46165,None
2619,CTRI/2020/08/027407,CTRI,2020-08-26,2020-08-31,False,GCS Medical College Hospital and Research Centre,Not Recruiting,Not Applicable,Observational,India,COVID-19 with Hypertension is responsible for death of patients.,Clinical Presentation,No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46707,None
2620,CTRI/2020/08/027395,CTRI,2020-08-26,2020-01-09,True,Dr. Swathy Moorthy,Not Recruiting,Not Applicable,Observational,India,Study of Radiological Imaging in COVID Patients,Clinical Presentation,No Intervention,No Intervention,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46716,None
2621,CTRI/2020/08/027393,CTRI,2020-08-26,2020-08-28,False,Narasimman Swamiathan,Not Recruiting,Not Applicable,Observational,India,Physiotherapy Practices for patients with COVID-19- A National Survey,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46249,None
2622,CTRI/2020/08/027420,CTRI,2020-08-27,2020-06-09,True,Jayanti Gupta,Recruiting,Not Applicable,Observational,India,A Survey to Assess the Impact of the COVID-19 Pandemic and Resultant Lockdown Measures on Ongoing Clinical Trials in India,Other,Other,Other,130,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46472,None
2623,CTRI/2020/08/027418,CTRI,2020-08-27,2020-09-15,False,Manipal Academy of Higher Education,Not Recruiting,Not Applicable,Observational,India,Offline versus online presentation:  Benefits & Challenges during Covid pandemic .,Telehealth,No Intervention,No Intervention,225,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46745,None
2624,CTRI/2020/08/027419,CTRI,2020-08-27,2020-07-09,True,Muljibhai Patel Society for Research in NephroUrology,Not Recruiting,Not Applicable,Observational,India,Realtion of Catalytic iron and Hepcidin with Poor Outcomes in COVID-19 patients,Clinical Presentation,No Intervention,No Intervention,49,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46503,None
2625,CTRI/2020/08/027435,CTRI,2020-08-27,2020-08-30,False,Dr. Viswanathan P,Not Recruiting,Not Applicable,Observational,India,COVID-19 severity in Elderly people aged more than 60years,Clinical Presentation,No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46530,None
2626,CTRI/2020/08/027458,CTRI,2020-08-28,2020-08-31,False,Dr. Vaasanthi,Not Recruiting,Not Applicable,Observational,India,laboratory predictors and covid,Clinical Presentation,No Intervention,No Intervention,850,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46665,None
2627,CTRI/2020/08/027460,CTRI,2020-08-28,2020-08-31,False,Priyadarshini Varadaraj,Not Recruiting,Not Applicable,Observational,India,Oxygen requirement in COVID patients.,Clinical Presentation,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46545,None
2628,CTRI/2020/08/027459,CTRI,2020-08-28,2020-01-09,True,Dr. Aiswarya M Nair,Not Recruiting,Not Applicable,Observational,India,To study about the outcome of COVID-19 on Diabetes patients,Clinical Presentation,No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46552,None
2629,CTRI/2020/08/027465,CTRI,2020-08-29,2020-04-09,True,Government of West Bengal,Recruiting,Phase 1/Phase 2,Interventional,India,Nasal Wash and Gargle to Mitigate COVID-19,Drug,Mouthwash,Mouthwash,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45634,None
2630,CTRI/2020/08/027466,CTRI,2020-08-29,2020-08-31,False,Tata Memorial Hospital,Not Recruiting,Not Applicable,Observational,"India, Germany, France, Ireland, United States",Outcomes of liver and pancreatic caner surgery during the COVID-19 pandemic,Health System,No Intervention,No Intervention,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46198,None
2631,CTRI/2020/08/027501,CTRI,2020-08-31,2020-10-09,False,NatureCeuticals Sdn Bhd,Not Recruiting,Not Applicable,Interventional,India,A study to assess aspects of safety and efficacy of NuvastaticÃ¢?Â¢ (C5OSEW5050ESA) as an immunomodulator supportive treatment to the standard care of treatment in Covid 19 patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,10,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44303,None
2632,CTRI/2020/08/027494,CTRI,2020-08-31,2020-06-09,True,All India Institute of Ayurveda,Not Recruiting,Not Applicable,Observational,India,To identify the pathogenesis of COVID-19 at different stages with the help of Ayurveda,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,75,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46900,None
2633,CTRI/2020/08/027475,CTRI,2020-08-31,2020-01-09,True,Cadila Pharnmaceuticals,Recruiting,Phase 3,Interventional,India,A Randomized Controlled Trial Of An Immunomodulator Mycobacterium w In Mild To Moderate Covid-19 Pneumonia,Drug,Mycobacterium,Mycobacterium,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45627,None
2634,CTRI/2020/08/027502,CTRI,2020-08-31,2020-10-09,False,Dr. Souvik Maitra,Not Recruiting,Not Applicable,Interventional,India,Comparison two types of artificial respiration in severe COVID-19 patients,Other (physical),Mechanical ventilation,Mechanical ventilation,216,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44862,None
2635,CTRI/2020/08/027477,CTRI,2020-08-31,2020-03-09,True,Dhanvantari Clinic Ayurveda Health Care and Research Center,Not Recruiting,Phase 2,Interventional,India,Evaluation of safety and efficacy of T-AYU-HM Premium and Onion steam vaporization/nebulization in Covid-19 patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46654,None
2636,CTRI/2020/08/027499,CTRI,2020-08-31,2020-05-09,True,Indian Administrative Service,Recruiting,Phase 2,Interventional,India,Role of siddha medicine in the management of covid -19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46927,None
2637,CTRI/2020/08/027468,CTRI,2020-08-31,2020-01-09,True,Dr. Mayank Goyal,Not Recruiting,Not Applicable,Observational,India,"HRCT chest imaging in pediartic, adult and geriatric patients with COVID-19 infection",Clinical Presentation,No Intervention,No Intervention,900,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46446,None
2638,CTRI/2020/08/027500,CTRI,2020-08-31,2020-08-31,False,Kalinga Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Study for predicting hypoxemia in COVID 19 patients on the basis of HRCT thorax findings with correlating the CT findings with SpO2 levels.,Clinical Presentation,No Intervention,No Intervention,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46721,None
2639,CTRI/2020/08/027492,CTRI,2020-08-31,2020-06-09,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,"Mental health status, adjustment strategies due  to covid19 pandemic and related factors",Other (psych),No Intervention,No Intervention,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46983,None
2640,CTRI/2020/08/027490,CTRI,2020-08-31,2020-10-09,False,University of Liverpool,Not Recruiting,Not Applicable,Observational,India,Neurological manifestations of COVID-19,Clinical Presentation,No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47009,None
2641,CTRI/2020/08/027491,CTRI,2020-08-31,2020-06-09,True,District Administration,Not Recruiting,Phase 2,Interventional,India,benefits of Siddha medicines in covid-19 positive patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46256,None
2642,CTRI/2020/08/027503,CTRI,2020-08-31,2021-06-15,False,Dr. Souvik Maitra,Not Recruiting,Not Applicable,Interventional,India,Effect of blood thinning medicine in COVID-19 infection,Drug,Aspirin,Aspirin,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44980,None
2643,CTRI/2020/08/027467,CTRI,2020-08-31,2020-08-31,False,Uttar Pradesh University of Medical Sciences,Not Recruiting,Phase 3,Interventional,India,Effect of Allo-vedic Preparation Raj Nirwan Bati (RNB) on Severe COVID-19 Patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46524,None
2644,CTRI/2020/08/027470,CTRI,2020-08-31,2020-01-09,True,"Max Super Speciality Hospital, Saket",Not Recruiting,Not Applicable,Observational,India,Anaesthesia practices and safety of caregivers during the covid 19 pandemic.,Health System,No Intervention,No Intervention,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45806,None
2645,CTRI/2020/08/027471,CTRI,2020-08-31,2020-01-09,True,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Association of COVID-19 severity with blood group antigens.,Clinical Presentation,No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45049,None
2646,CTRI/2020/09/027516,CTRI,2020-09-01,2020-07-09,True,Dr. Niraj Mahajan,Not Recruiting,Not Applicable,Observational,India,Coronavirus infection among healthcare workers,Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46986,None
2647,CTRI/2020/09/027517,CTRI,2020-09-01,2020-07-09,True,C Research Foundation,Not Recruiting,Not Applicable,Observational,India,Management of cardiac disease during COVID 19 pandemic and impact among cardiologist in Tamil Nadu,Health System,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47025,None
2648,CTRI/2020/09/027535,CTRI,2020-09-01,2020-08-09,True,CSIR Central Drug Research Institute,Recruiting,Phase 3,Interventional,India,"Efficacy and safety study of antiviral Umifenovir therapy in non-severe COVID-
19 patients.",Drug,Umifenovir,Umifenovir,132,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45236,None
2649,CTRI/2020/09/027518,CTRI,2020-09-01,2020-09-13,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Compare marker abnormalities in COVID positive and negative cancer patients,Clinical Presentation,No Intervention,No Intervention,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47089,None
2650,CTRI/2020/09/027548,CTRI,2020-09-02,2020-12-09,False,Jagdale Industries Pvt Ltd,Not Recruiting,Not Applicable,Interventional,India,Effects of health drink additional to standard of care treatment in COVID 19 patients.,Supplement,Nutritional Supplement,Nutritional Supplement,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47125,None
2651,CTRI/2020/09/027560,CTRI,2020-09-02,2020-09-15,False,Dr. Kalyan Banerjee; Dr. Kushal Banerjee,Not Recruiting,Not Applicable,Observational,"United Arab Emirates, Norway, Sweden, Thailand, India, Germany, Italy, Hong Kong, China, Belgium, Canada, Singapore, United Kingdom, Switzerland, Australia, United States","Identifying homeopathy medicines in use for protection against
COVID-19, calculating the number of COVID-19 cases or cases with COVID-19 like symptoms in these homeopathy users and identifying some general features like age, gender and location in them.",Other,Homeopathy,Homeopathy,6500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47165,None
2652,CTRI/2020/09/027558,CTRI,2020-09-02,2020-10-09,False,Swet Nisha,Not Recruiting,Not Applicable,Observational,India,Dental Students Health and Well being During Covid-19 Pandemic.,Other (psych),No Intervention,No Intervention,480,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44917,None
2653,CTRI/2020/09/027544,CTRI,2020-09-02,2020-10-09,False,Swet Nisha,Not Recruiting,Not Applicable,Observational,India,Covid 19 and Professional course students quality of life,Other (psych),No Intervention,No Intervention,636,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47068,None
2654,CTRI/2020/09/027562,CTRI,2020-09-03,2020-01-10,True,Maulana Azad Medical College; Lok Nayak Hospital,Not Recruiting,Not Applicable,Observational,India,Effect of prone positioning with HFNC on oxygenation and overall outcomes in severe COVID-19 patients.,Procedure,Positioning,Positioning,92,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47154,None
2655,CTRI/2020/09/027572,CTRI,2020-09-03,2020-09-14,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,"""Effect of comorbidities in the outcome of COVID-19 patients, a study in tertiary care centre ICU in IndiaÃ¢??",Clinical Presentation,No Intervention,No Intervention,350,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46643,None
2656,CTRI/2020/09/027596,CTRI,2020-09-04,2020-09-14,False,C Research Foundation,Not Recruiting,Not Applicable,Observational,India,Behavioral changes during COVID 19 among cricket players in India,Other,No Intervention,No Intervention,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47171,None
2657,CTRI/2020/09/027616,CTRI,2020-09-05,2021-01-13,False,Rajiv Gandhi University of Health Sciences,Not Recruiting,Phase 1,Interventional,India,Oral medicine trial for COVID 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47155,None
2658,CTRI/2020/09/027615,CTRI,2020-09-05,2020-11-09,False,Dr. Vishal Narwane,Not Recruiting,Not Applicable,Interventional,India,Clinical trial of homeopathic medicine arsenic album as add on therapy in hospitalized patients admitted with Covid 19 disease.,Other,Homeopathy,Homeopathy,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46648,None
2659,CTRI/2020/09/027613,CTRI,2020-09-05,2020-09-15,False,Cardiological Society of India,Not Recruiting,Not Applicable,Observational,India,"Pattern of acute MI admissions in India during COVID-19 era: a  Cardiological Society of India  study
",Health System,No Intervention,No Intervention,30000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46158,None
2660,CTRI/2020/09/027617,CTRI,2020-09-05,2020-09-14,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Effect of COVID-19 positivity on pregnancy characteristics and pregnancy on infectivity potential of COVID-19,Clinical Presentation,No Intervention,No Intervention,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47239,None
2661,CTRI/2020/09/027618,CTRI,2020-09-05,2020-09-14,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Identification of SARS-CoV-2 in female genital tract and breast milk in confirmed cases of COVID-19,Clinical Presentation,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47248,None
2662,CTRI/2020/09/027614,CTRI,2020-09-05,2020-08-24,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,Effectiveness of training programme on hand hygiene among laundry staff,Other,Other,Other,14,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46274,None
2663,CTRI/2020/09/027622,CTRI,2020-09-07,2020-08-09,True,Dr. Shikha seth,Not Recruiting,Not Applicable,Interventional,India,Role of female sex hormone in COVID 19 patients,Clinical Presentation,No Intervention,No Intervention,64,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46908,None
2664,CTRI/2020/09/027661,CTRI,2020-09-08,2020-09-15,False,Central Ayurveda Research Institute for Hepatobiliary Disorders,Not Recruiting,Phase 3/Phase 4,Interventional,India,Preventive Study among COVID 19 frontline warriors and their families,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,3000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47273,None
2665,CTRI/2020/09/027674,CTRI,2020-09-08,2020-08-09,True,Bharat Biotech International Limited,Recruiting,Phase 1/Phase 2,Interventional,India,"A Phase 1, Followed by a Phase 2, vaccine given Randomly in subjects in different sites
to Evaluate the Safety, side effects, and resistance of the Virus Vaccine, BBV152D Administered between the layers of the skin(intradermal) in Healthy Volunteers.",ATMP,Vaccine,Vaccine,124,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46312,None
2666,CTRI/2020/09/027684,CTRI,2020-09-09,2020-09-15,False,SGT University,Recruiting,Not Applicable,Interventional,India,"Protective effect of re-vaccination with
BCG against COVID-19 in healthcare workers Ã¢?? A Pilot Study
",ATMP,Vaccine,Vaccine,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47179,None
2667,CTRI/2020/09/027681,CTRI,2020-09-09,2020-01-10,True,University of Birmingham,Recruiting,Not Applicable,Observational,"Bangladesh, Sweden, Ecuador, Jordan, Algeria, Ghana, Mozambique, Panama, Argentina, Mexico, Rwanda, United Kingdom, Bahrain, Qatar, Bulgaria, Romania, United States, Kenya, United Arab Emirates, Venezuela (Bolivarian Republic of), India, Germany, Republic of Korea, Italy, Poland, Saudi Arabia, Canada, Zambia, Brazil, Estonia, Peru, Australia, Samoa, Portugal, Nigeria, Nicaragua, Greece, Guatemala, Japan, Benin, Cameroon, Georgia, Pakistan, Philippines, Ireland, Senegal, Oman, Indonesia, Hungary, Namibia, Denmark, Norway, Iraq, Colombia, Morocco, Egypt, Mali, Paraguay, New Zealand, Kuwait, Singapore, Belgium, Somalia, Montenegro, Nepal, Turkey, Uruguay, Austria, South Africa, Malawi, Spain, Finland",Determining The Best Time For Surgery After COVID-19 Infection,Other,No Intervention,No Intervention,45000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46744,None
2668,CTRI/2020/09/027687,CTRI,2020-09-09,2020-09-16,False,Dr. Shobha,Not Recruiting,Not Applicable,Interventional,India,"Assessment of effect of steam inhalation, saline gargling and povidone Iodine gargling on reduction of symptoms and prevention of spread of COVID 19",Drug,Povidone iodine,Povidone iodine,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47280,None
2669,CTRI/2020/09/027683,CTRI,2020-09-09,2020-09-15,False,Dr. Meenakshi Wadhwani,Not Recruiting,Not Applicable,Observational,India,Online survey on Dry eye symptoms in health care workers and children during COVID 19 pandemic,Other,No Intervention,No Intervention,330,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47026,None
2670,CTRI/2020/09/027685,CTRI,2020-09-09,2020-09-16,False,Chirayu Medical College and Hospital,Not Recruiting,Not Applicable,Interventional,India,Clinical Study to Investigate Safety and Efficacy of ImmunoSEB and ProbioSEB,Supplement,Nutritional Supplement,Nutritional Supplement,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47321,None
2671,CTRI/2020/09/027686,CTRI,2020-09-09,2020-09-20,False,GCS Medical College Hospital and Research Centre,Not Recruiting,Not Applicable,Observational,India,To determine whether diabetes in COVID-19 patients is associated with more complications.,Clinical Presentation,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47332,None
2672,CTRI/2020/09/027689,CTRI,2020-09-09,2020-09-18,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,Assessing the impact of COVID-19 pandemic on Cancer related care in a tertiary cancer hospital of Varanasi district.,Health System,No Intervention,No Intervention,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47353,None
2673,CTRI/2020/09/027741,CTRI,2020-09-10,2020-09-15,False,Cadila Pharnmaceuticals,Recruiting,Not Applicable,Interventional,India,Role of heat killed Mycobacterium w (Sepsivac) in Corona virus disease 2019 (COVID-19),Drug,Mycobacterium,Mycobacterium,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47197,None
2674,CTRI/2020/09/027719,CTRI,2020-09-10,2020-09-20,False,Institute of Post Graduate Medical Education and Research,Not Recruiting,Not Applicable,Observational,India,Satisfaction of medical students with online learning,Other,No Intervention,No Intervention,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47277,None
2675,CTRI/2020/09/027691,CTRI,2020-09-10,2020-09-17,False,Sonde Health,Not Recruiting,Not Applicable,Observational,India,Improving real-time COVID-19 monitoring through smartphone voice analysis,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,350,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46833,None
2676,CTRI/2020/09/027775,CTRI,2020-09-11,2020-09-19,False,Genecell Co LTD,Not Recruiting,Phase 2,Interventional,India,Efficacy and safety clinical study of ES16001 as an adjunct in COVID positive patients.,Drug,ES16001,ES16001,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47367,None
2677,CTRI/2020/09/027769,CTRI,2020-09-11,2020-09-22,False,Centre for Dental Education and Research,Not Recruiting,Not Applicable,Observational,India,Views regarding dental facilities and the manner in which patients wants to use dental facilities during COVID 19 in a hospital setting.,Health System,No Intervention,No Intervention,375,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47390,None
2678,CTRI/2020/09/027786,CTRI,2020-09-14,2020-01-10,True,Government of Tamil Nadu,Not Recruiting,Not Applicable,Interventional,India,Ayurvedic Management of Covid 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46950,None
2679,CTRI/2020/09/027785,CTRI,2020-09-14,2020-09-21,False,Serum Institute of India Pvt Ltd,Recruiting,Not Applicable,Observational,India,Case Control study to check the effect of Measles vaccine in prevention of COVID-19,ATMP,Vaccine,Vaccine,548,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47016,None
2680,CTRI/2020/09/027787,CTRI,2020-09-14,2020-01-10,True,Dr. Ashish Kumar Kannaujia,Not Recruiting,Not Applicable,Observational,India,Effect of wearing N 95 mask along with surgical mask in health care workers in covid era,Other (device),Masks,Masks,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47329,None
2681,CTRI/2020/09/027782,CTRI,2020-09-14,2020-09-23,False,Dr. Aalap Prajapati,Not Recruiting,Not Applicable,Observational,India,Dental practices in COVID-19,Health System,No Intervention,No Intervention,1600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47085,None
2682,CTRI/2020/09/027817,CTRI,2020-09-15,2020-09-18,False,Bioved Pharmaceuticals Pvt Ltd,Recruiting,Phase 3,Interventional,India,A Phase III Clinical Study to assess the Safety and Efficacy of Ayurvedic Tablets combined with the current available medicine and its impact on lab parameters in Subjects with Uncomplicated Moderate COVID-19 infection.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,180,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46041,None
2683,CTRI/2020/09/027841,CTRI,2020-09-16,2020-09-22,False,Sami Sabinsa Group Limited,Not Recruiting,Not Applicable,Interventional,India,"In this study IMMUACTIVE would be compared with an inert substance, as a supplement in treatment of COVID-19 patients.",Supplement,Nutritional Supplement,Nutritional Supplement,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47174,None
2684,CTRI/2020/09/027829,CTRI,2020-09-16,2020-09-20,False,Saint Lukes Mid America Heart Institute,Not Recruiting,Phase 3,Interventional,"India, Argentina, Mexico, Brazil, United States",DARE-19 (Dapagliflozin in Respiratory failure in patients with COVID-19),Drug,Dapagliflozin,Dapagliflozin,900,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45521,None
2685,CTRI/2020/09/027842,CTRI,2020-09-16,2020-01-10,True,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Effect of Teleyoga on health care workers involved in Covid 19 duty,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47591,None
2686,CTRI/2020/09/027882,CTRI,2020-09-17,2020-09-28,False,Patanjali Research Institute,Not Recruiting,Not Applicable,Interventional,India,A Clinical Trial to Evaluate the effect of an Ayurvedic Regimen administered in (COVID Ã¢?? 19) Patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47632,None
2687,CTRI/2020/09/027881,CTRI,2020-09-17,2020-09-17,False,Public Health Department,Not Recruiting,Not Applicable,Observational,India,An observational multi-center study on COVID 19 disease to study on HERD immunity,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46661,None
2688,CTRI/2020/09/027862,CTRI,2020-09-17,2020-09-28,False,Nowrosjee Wadia Maternity Hospital,Not Recruiting,Not Applicable,Observational,India,Study on placenta of women with coronavirus disease 2019 (COVID-19),Clinical Presentation,No Intervention,No Intervention,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47505,None
2689,CTRI/2020/09/027908,CTRI,2020-09-18,2020-09-28,False,Malabar Cancer Centre,Not Recruiting,Not Applicable,Observational,India,STRESS AND COPING AMONG HEALTH WORKERS DURING COVID,Other (psych),Psychological,Psychological,600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47619,None
2690,CTRI/2020/09/027904,CTRI,2020-09-18,2020-02-10,True,Dr. M Christopher,Not Recruiting,Not Applicable,Interventional,India,Autologous whole blood injection as treatment for Covid-19 infection,ATMP,Whole blood,Whole blood,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47392,None
2691,CTRI/2020/09/027903,CTRI,2020-09-18,2020-09-22,False,Intas Pharmaceuticals Ltd,Recruiting,Phase 2,Interventional,India,Testing the efficacy and safety of a blood product COVID-19 Hyper-Immuneglobulin (Human) Solution in Participants with Active COVID-19,ATMP,Immunoglobulin,Immunoglobulin,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47147,None
2692,CTRI/2020/09/027910,CTRI,2020-09-18,2020-10-15,False,All India Institute of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,India,Transcendental Meditation (TM) to reduce stress and improve immunity of health care providers during COVID-19 pandemic,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45292,None
2693,CTRI/2020/09/027907,CTRI,2020-09-18,2020-01-10,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,Stress of Doctors in Covid era,Other (psych),No Intervention,No Intervention,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47598,None
2694,CTRI/2020/09/027914,CTRI,2020-09-19,2020-09-22,False,Dabur India Ltd,Recruiting,Phase 2/Phase 3,Interventional,India,"Evaluation of efficacy of Fixed Ayurvedic Regimen of Giloy Ki Ghan Vati,Tulsi Tablets,Kalmegh Tablets and Dabur Chyawanprash in COVID-19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,72,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47442,None
2695,CTRI/2020/09/027917,CTRI,2020-09-21,2020-09-30,False,All India Institute of Ayurveda,Not Recruiting,Not Applicable,Observational,India,Surveillance of Bala Vriddhikara Bhava (FACTORS RESPONSIBLE FOR HOST IMMUNITY) in COVID-19 subjects,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47662,None
2696,CTRI/2020/09/027915,CTRI,2020-09-21,2020-01-10,True,"Ministry of Ayush, Government of India",Not Recruiting,Not Applicable,Interventional,India,Tele-yoga for prevention and management of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,136,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46754,None
2697,CTRI/2020/09/027941,CTRI,2020-09-21,2020-09-26,False,Biocon Limited,Not Recruiting,Phase 4,Interventional,India,Single arm study of Itolizumab in the treatment of COVID 19 complication.,Drug,Itolizumab,Itolizumab,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46023,None
2698,CTRI/2020/09/027938,CTRI,2020-09-21,2020-09-25,False,Particle Life Sciences,Not Recruiting,Phase 3,Interventional,India,Study of Particle Life Sciences Formulation in management of COVID-19,Drug,Particle Life Sciences Formulation vs. Hydroxychloroquine + Azithromycin,Particle Life Sciences Formulation; Hydroxychloroquine; Azithromycin,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47586,None
2699,CTRI/2020/09/027916,CTRI,2020-09-21,2020-01-10,True,Government of Tamil Nadu,Not Recruiting,Not Applicable,Interventional,India,Covid19 Post Treatment Restorative Healthcare,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47333,None
2700,CTRI/2020/09/027974,CTRI,2020-09-22,2020-10-15,False,Central Council for Research in Ayurvedic Sciences,Not Recruiting,Phase 2,Interventional,India,Clinical Evaluation of Chyawanprash for the prevention of COVID-19 among Health Care Personnel .,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47658,None
2701,CTRI/2020/09/027944,CTRI,2020-09-22,2020-09-22,False,Public Health Department,Not Recruiting,Phase 3,Interventional,India,"An open label, prospective comparative study to evaluate the proposed therapy in adults with mild symptomatic COVID-19 patients receiving the standard treatment of COVID infection.",Drug,Ivermectin + Cefixime + Montelukast + Ascoril syrup vs. Vitamins + Antacids,Ivermectin; Cefixime; Montelukast; Ascoril syrup; Vitamins; Antacids,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46392,None
2702,CTRI/2020/09/027975,CTRI,2020-09-22,2020-02-10,True,HopeAyurvedic Medicine Pvt Ltd,Not Recruiting,Phase 3,Interventional,India,Utility of Medihope as an addon therapy for Covid 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,880,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47748,None
2703,CTRI/2020/09/027993,CTRI,2020-09-23,2020-09-30,False,Dr. Chhaya Verma,Not Recruiting,Not Applicable,Observational,India,Assessment of effect of COVID-19 on fatigue and exercise capacity in patients with Covid-19 treated at a government tertiary care hospital.,Clinical Presentation,No Intervention,No Intervention,75,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47645,None
2704,CTRI/2020/09/027992,CTRI,2020-09-23,2020-09-25,False,Dr. Om Shrivastava,Not Recruiting,Not Applicable,Interventional,India,Investigator Initiated  Study to Evaluate the Effectiveness and Safety of Thymosin ÃŽÂ±-1 (TÃŽÂ±1) in Moderate COVID-19 Patients,Drug,Thymosin,Thymosin,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46389,None
2705,CTRI/2020/09/028045,CTRI,2020-09-24,2020-09-28,False,Poonam Joshi,Not Recruiting,Not Applicable,Interventional,India,Online learning programme for providing cardiopulmonary resuscitation among Nurses,Other,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44046,None
2706,CTRI/2020/09/028044,CTRI,2020-09-24,2020-09-30,False,Windlas Biotech Private Limited,Recruiting,Phase 4,Interventional,India,Phase IV study to evaluate the safety and efficacy of Artemisinin- a herbal supplement on COVID-19 subjects,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47432,None
2707,CTRI/2020/09/028043,CTRI,2020-09-24,2020-09-21,True,"Ministry of Ayush, Government of India",Not Recruiting,Phase 4,Interventional,India,"Clinical study to assess role of Vasa Ghana, Guduchi Ghana and Vasa-Guduchi
Ghana in therapeutic management of symptoms in Covid19",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47443,None
2708,CTRI/2020/09/028040,CTRI,2020-09-24,2020-05-10,True,Child Trust Medical Research Foundation,Not Recruiting,Not Applicable,Observational,India,Seroprevalence of COVID 19 in children,Clinical Presentation (Epidemiology),No Intervention,No Intervention,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47809,None
2709,CTRI/2020/09/028046,CTRI,2020-09-24,2020-05-10,True,Central Council for Research in Homoeopathy,Not Recruiting,Not Applicable,Interventional,India,Homoeopathy management for covid 19 patients,Other,Homeopathy,Homeopathy,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45038,None
2710,CTRI/2020/09/028049,CTRI,2020-09-25,2020-10-20,False,Rohit Arora,Not Recruiting,Not Applicable,Observational,India,Evaluation of Atypical imaging features on HRCT CHEST.,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46447,None
2711,CTRI/2020/09/028050,CTRI,2020-09-25,2020-02-10,True,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Intubation and ventilatory support in COVID patients: observational study from a tertiary care ICU.,Other (physical),Mechanical ventilation,Mechanical ventilation,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47764,None
2712,CTRI/2020/09/028090,CTRI,2020-09-28,2020-07-10,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,Social factors related to COVID 19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47924,None
2713,CTRI/2020/09/028069,CTRI,2020-09-28,2020-01-10,True,Sri Ramachandra Institute of Higher Education Research Institute,Not Recruiting,Not Applicable,Observational,India,Variation in biochemical parameters in COVID-19 infection,Clinical Presentation,No Intervention,No Intervention,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47703,None
2714,CTRI/2020/09/028085,CTRI,2020-09-28,2020-05-10,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,"Coping methods of stress  among frontline Healthcare workers 

",Other (psych),No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47774,None
2715,CTRI/2020/09/028087,CTRI,2020-09-28,2020-10-20,False,KIMS Hospital,Not Recruiting,Not Applicable,Observational,India,Evaluation of severity of chest CT findings in covid 19 patients with pre-existing illness,Clinical Presentation,No Intervention,No Intervention,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47816,None
2716,CTRI/2020/09/028086,CTRI,2020-09-28,2020-08-10,True,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Effect of 12-weeks of Online Sudarshan Kriya Yoga practice on Burnout and Health Parameters among COVID-19 Frontline Warriors.,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,43,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47819,None
2717,CTRI/2020/09/028088,CTRI,2020-09-28,2020-10-31,False,Vivek Chauhan,Not Recruiting,Not Applicable,Interventional,India,"Open Label Randomized trial of Colchicine, Aspirin and Montelukast in Covid-19",Drug,Colchicine + Aspirin + Montelukast,Colchicine; Aspirin; Montelukast,34,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47829,None
2718,CTRI/2020/09/028089,CTRI,2020-09-28,2020-05-10,True,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Role of self sampling in COVID 19 patients,Other,Other,Other,1350,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47832,None
2719,CTRI/2020/09/028083,CTRI,2020-09-28,2020-01-10,True,Sri Ramachandra Institute of Higher Education Research Institute,Not Recruiting,Not Applicable,Observational,India,Effect of poor sleep hygiene and screen time usage on sleep,Other (psych),No Intervention,No Intervention,330,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47599,None
2720,CTRI/2020/09/028131,CTRI,2020-09-29,2020-02-10,True,Ambrosia Food Farm Co,Recruiting,Not Applicable,Interventional,India,A study of Cordyceps Capsules as an Add-On Therapy in patients with moderate COVID 19 Infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46887,None
2721,CTRI/2020/09/028122,CTRI,2020-09-29,2020-06-10,True,"Ministry of Ayush, Government of India",Not Recruiting,Phase 3,Interventional,India,Homoeopathy in the prevention of COVID-19,Other,Homeopathy,Homeopathy,15992,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47851,None
2722,CTRI/2020/09/028132,CTRI,2020-09-29,2020-05-10,True,Central Council for Research in Homoeopathy,Not Recruiting,Not Applicable,Observational,India,A cross sectional study to assess the impact of COVID-19 on patints with non communicable disease at AYUSH LSD clinics,Clinical Presentation,No Intervention,No Intervention,450,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47860,None
2723,CTRI/2020/09/028133,CTRI,2020-09-29,2020-05-10,True,LK Wellness,Recruiting,Not Applicable,Interventional,India,Oral VIRAHALT (Novel Immunomodulatory Herbal combination) Compared to standard of care in Subjects with Moderate to Severe COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47866,None
2724,CTRI/2020/09/028153,CTRI,2020-09-30,2020-05-10,True,National Institute of Homoeopathy,Not Recruiting,Not Applicable,Observational,India,A survey is to study the prophylactic effect of Homoeopathic medicine namely Arsenicum album 30 against COVID 19 infection in Madurai tamilnadu,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,10000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47878,None
2725,CTRI/2020/09/028158,CTRI,2020-09-30,2020-05-10,True,LK Wellness,Recruiting,Not Applicable,Interventional,India,Oral VIRANORM (Ayurvedic Proprietary Medicine) Compared to Placebo in Subjects with Asymptomatic or Mild COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,250,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47896,None
2726,CTRI/2020/09/028162,CTRI,2020-09-30,2020-01-10,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,"Macedonia, Nigeria, Egypt, Pakistan, Japan, Ghana, India, Russian Federation, Italy, France, Argentina, Mexico, Brazil, United Kingdom, Indonesia, Spain, United States","A prospective cohort study of the effects of COVID-19
in pregnancy and the neonatal period",Clinical Presentation,No Intervention,No Intervention,1500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46374,None
2727,CTRI/2020/09/028157,CTRI,2020-09-30,2020-10-10,False,Punjab Institute of Medical Sciences ,Not Recruiting,Not Applicable,Observational,India,Perspective of MBBS Students towards Teaching through Onscreen Classes,Other,No Intervention,No Intervention,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47423,None
2728,CTRI/2020/09/028156,CTRI,2020-09-30,2020-04-10,True,Predible Health Private Limited,Not Recruiting,Not Applicable,Observational,India,Comparative Study of Artificial Intelligence and Radiologists in Assessing Severity of COVID19 Patient Images,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47790,None
2729,CTRI/2020/09/028165,CTRI,2020-09-30,2020-05-10,True,Mohammad Anwar Hossain,No Status Given,Not Applicable,Observational,Bangladesh,A cross sectional study to identify the symptoms that are presenting by COVID-19 suffering people in Bangladesh,Clinical Presentation,No Intervention,No Intervention,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47824,None
2730,CTRI/2020/09/028164,CTRI,2020-09-30,2021-04-10,False,National Institute of Homoeopathy,Not Recruiting,Not Applicable,Interventional,India,A clinical trail to know the efficacy of Homoeopathic medicine as an adjuvant therapy to Standard treatment in COVID-19 patients,Other,Homeopathy,Homeopathy,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47843,None
2731,CTRI/2020/10/028195,CTRI,2020-10-01,2020-08-10,True,"Ministry of Ayush, Government of India",Not Recruiting,Not Applicable,Interventional,India,The role of Yogic breathing techniques in progression and recovery from COVID-19.,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,72,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47893,None
2732,CTRI/2020/10/028196,CTRI,2020-10-01,2020-10-10,False,K M Amran Hossain,No Status Given,Not Applicable,Observational,Bangladesh,Coping with COVID Pandemic,Other (psych),No Intervention,No Intervention,3000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47979,None
2733,CTRI/2020/10/028192,CTRI,2020-10-01,2020-04-10,True,National Institute of Homoeopathy,Not Recruiting,Not Applicable,Observational,India,A survey to assess the effectiveness of Arsenicum Album 30C as a Prophylactic medicine against COVID 19 infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,15000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47846,None
2734,CTRI/2020/10/028179,CTRI,2020-10-01,2020-07-10,True,Mohammad Anwar Hossain,No Status Given,Not Applicable,Interventional,Bangladesh,An experimental study to find out the impact of post COVID physiotherapy and rehabilitation in Bangladesh,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47847,None
2735,CTRI/2020/10/028230,CTRI,2020-10-05,2020-12-10,False,Government of India AYUSH EMR scheme,Not Recruiting,Phase 2,Interventional,India,clinical trial of Pippali Rasayana and Nagaradi Kashaya Ghana Vati combination as an adjuvant treatment with ICMR guided medicines in Covid-19 positive mildly symptomatic cases,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47188,None
2736,CTRI/2020/10/028233,CTRI,2020-10-05,2020-10-10,False,"Ministry of Ayush, Government of India",Not Recruiting,Not Applicable,Interventional,India,Study on use of Homoeopathy Medicines in Treatment of Covid 19 cases,Other,Homeopathy,Homeopathy,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47982,None
2737,CTRI/2020/10/028231,CTRI,2020-10-05,2020-12-10,False,Dr. Kapil G Zirpe,Recruiting,Not Applicable,Interventional,India,Proof of Concept Study of Ketoji (Liquid) for its Effectiveness in Treatment and Management of COVID-19 Patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,15,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47237,None
2738,CTRI/2020/10/028234,CTRI,2020-10-05,2020-12-10,False,Medical College Kolkata,Not Recruiting,Phase 4,Interventional,India,Study to compare the effect of different antiviral medicines in  COVID-19 infected sick children,Drug,Hydroxychloroquine + Zinc + Vitamins vs. Doxycycline + Zinc + Vitamins vs. + Zinc + Vitamins,Hydroxychloroquine; Zinc; Vitamins,45,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47844,None
2739,CTRI/2020/10/028232,CTRI,2020-10-05,2020-10-14,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Psychological effect of coronavirus disease 2019 on pregnant women,Other (psych),No Intervention,No Intervention,25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48105,None
2740,CTRI/2020/10/028254,CTRI,2020-10-06,2020-08-10,True,Shashikala Bhat,Not Recruiting,Not Applicable,Observational,India,Ã¢??Retrospective Study of Pregnancy with COVID-19Ã¢??,Clinical Presentation,No Intervention,No Intervention,44,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47156,None
2741,CTRI/2020/10/028253,CTRI,2020-10-06,2020-10-10,False,Dr. Abhijit R Lodha,Not Recruiting,Phase 2,Interventional,India,A clinical trial to test the effectiveness of thalidomide in reducing immune dysfunction in covid-19 disease.,Drug,Thalidomide,Thalidomide,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47986,None
2742,CTRI/2020/10/028257,CTRI,2020-10-06,2020-10-10,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,Psychological Impacts Of The COVID-19 Pandemic On Medical Students In India: A Web-Based Cross-Sectional Study,Other (psych),No Intervention,No Intervention,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48025,None
2743,CTRI/2020/10/028256,CTRI,2020-10-06,2020-10-13,False,Tata Memorial Hospital Research Administrative Council,Not Recruiting,Not Applicable,Interventional,India,A study to know whether we can supervise cancer patients infected with COVID-19 from without admission in hospitals. We will test how much helpful is a software called Datos health along with pulse oximeter and thermometer in this supervision by doctors.,Other (software),eHealth,eHealth,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48118,None
2744,CTRI/2020/10/028250,CTRI,2020-10-06,2020-10-14,False,Indian Council of Medical Research,Not Recruiting,Phase 2,Interventional,India,A study to evaluate the effects of stem cells in patients with Acute Respiratory Distress syndrome caused by Pneumonia due to COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48119,None
2745,CTRI/2020/10/028251,CTRI,2020-10-06,2020-10-15,False,Pediatric Cardiac Society of India,Not Recruiting,Not Applicable,Observational,India,COVID-19 and Children with congenital heart disease,Clinical Presentation,No Intervention,No Intervention,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47097,None
2746,CTRI/2020/10/028280,CTRI,2020-10-07,2020-10-15,False,"Directorate of AYUSH, Government of NCT of Delhi",Not Recruiting,Not Applicable,Interventional,India,A Study to Evaluate Efficacy of Selected Homoeopathic Medicines in Prevention of COVID-19,Other,Homeopathy,Homeopathy,18000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48199,None
2747,CTRI/2020/10/028277,CTRI,2020-10-07,2020-12-10,False,Gufic Biosciences,Not Recruiting,Phase 3,Interventional,India,"A study to assess the safety and effectiveness of Thymosin ÃŽÂ±-1 (TÃŽÂ±1) used for the treatment of Moderate to severe COVID 19 Patients.

",Drug,Thymosin,Thymosin,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47691,None
2748,CTRI/2020/10/028278,CTRI,2020-10-07,2020-12-10,False,Kalluri Satya Srividya,Not Recruiting,Not Applicable,Observational,India,"The Knowledge, Attitude And Practices related to COVID-19 in Patients Presenting to Glaucoma Clinic and the Reasons for seeking Glaucoma care",Other,No Intervention,No Intervention,246,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47232,None
2749,CTRI/2020/10/028279,CTRI,2020-10-07,2020-12-10,False,Central Council for Research in Homoeopathy,Not Recruiting,Not Applicable,Interventional,India,Standard of care with homoeopathy as adjuvant in COVID19,Other,Homeopathy,Homeopathy,128,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48085,None
2750,CTRI/2020/10/028295,CTRI,2020-10-08,2020-10-25,False,Dr. Neetha Shenoy,Not Recruiting,Not Applicable,Observational,India,Perception Of Dentists On Infection Control Measures During Novel Corona Virus (COVID-19) Pandemic,Other,No Intervention,No Intervention,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48202,None
2751,CTRI/2020/10/028296,CTRI,2020-10-08,2020-10-21,False,Dr. Mathangi Kumar,Not Recruiting,Not Applicable,Observational,India,Impact of the COVID-19 pandemic on graduating dental interns: A studentÃ¢??s perspective,Health System,No Intervention,No Intervention,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46970,None
2752,CTRI/2020/10/028297,CTRI,2020-10-08,2020-10-26,False,Dept of Health and Family Welfare Government of West Bengal,Not Recruiting,Phase 2,Interventional,India,Cotrimoxazole in hospitalised patients with moderate to early-severe COVID-19 infection,Drug,Cotrimoxazole,Cotrimoxazole,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48268,None
2753,CTRI/2020/10/028333,CTRI,2020-10-09,2020-10-13,False,Shri Sarveshwar Seva Sahkari Samstha,Not Recruiting,Phase 3/Phase 4,Interventional,India,"Prospective on evaluation of use of , Ã¢??AyurCoro3Ã¢?? as an add on medication  for the treatment purpose in COVID-19 patients",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48137,None
2754,CTRI/2020/10/028335,CTRI,2020-10-09,2020-12-10,False,Piramal Enterprises Limited,Not Recruiting,Phase 3,Interventional,India,A clinical study to assess the efficacy and safety of Tinefcon in patients with moderate COVID-19 infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45359,None
2755,CTRI/2020/10/028324,CTRI,2020-10-09,2020-09-10,True,Bhaktivedanta Hospital and Research Institute,Not Recruiting,Not Applicable,Interventional,India,"Evaluation of use of , Ã¢??study medication Ã¢??for prophylaxis in frontline health care workers involved in treating COVID-19 patients",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47697,None
2756,CTRI/2020/10/028326,CTRI,2020-10-09,2020-10-20,False,Manashi Chakrabarti Foundation,Not Recruiting,Not Applicable,Interventional,India,Assessment of memory cells response to Mycobacterium Indicus Pranii vaccination,ATMP,Vaccine,Vaccine,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48214,None
2757,CTRI/2020/10/028325,CTRI,2020-10-09,2020-10-19,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Comparison of Tocilizumab Vs Itolizumab in covid 19 patient.,Drug,Tocilizumab vs. Itolizumab,Tocilizumab; Itolizumab,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48319,None
2758,CTRI/2020/10/028339,CTRI,2020-10-12,2020-01-11,True,Government Medical College and Hospital Chandigarh,Not Recruiting,Not Applicable,Observational,India,"To study the relationship between spirituality,hope, distress and ability to bounce back from stress among family members of recovered COVID-19 patients",Other (psych),No Intervention,No Intervention,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47879,None
2759,CTRI/2020/10/028340,CTRI,2020-10-12,2020-10-20,False,NCI Jhajjar,Not Recruiting,Not Applicable,Observational,India,Clinical characteristics and laboratory parameters of COVID-19 patients on oxygen,Clinical Presentation,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46861,None
2760,CTRI/2020/10/028364,CTRI,2020-10-12,2020-10-19,False,Vedicinals India Pvt Ltd,Not Recruiting,Phase 2,Interventional,India,"A clinical trial to evaluate the effectiveness and safety of Vedicinals-9-a Herbal Formulation in Mild to Moderate COVID-19
Patients.",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,124,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48152,None
2761,CTRI/2020/10/028363,CTRI,2020-10-12,2020-01-11,True,Dr. Nipa Singh,Not Recruiting,Not Applicable,Observational,India,The barriers encountered by health-service providers while giving healthcare to patients admitted to COVID hospitals of Odisha,Health System,No Intervention,No Intervention,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48039,None
2762,CTRI/2020/10/028360,CTRI,2020-10-12,2020-10-19,False,Seth GS Medical College; KEM Hospital,Not Recruiting,Not Applicable,Observational,India,"Psychiatric sequelae in COVID-19 infection recovered resident doctors and
interns of a tertiary health care hospital.
",Other (psych),No Intervention,No Intervention,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48352,None
2763,CTRI/2020/10/028361,CTRI,2020-10-12,2020-10-19,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Endothelial Dysfunction in Severe COVID 19 disease,Clinical Presentation,No Intervention,No Intervention,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48356,None
2764,CTRI/2020/10/028362,CTRI,2020-10-12,2020-10-15,False,Dr. Anuja Santosh Kulkarni,Not Recruiting,Not Applicable,Interventional,India,Study to assess the efficacy of deep breathing Pranayama technique in  addition to conventional allopathic treatment in management of COVID19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,278,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48109,None
2765,CTRI/2020/10/028376,CTRI,2020-10-13,2020-10-22,False,Arber Biosciences Pte Ltd,Not Recruiting,Not Applicable,Interventional,India,A Clinical Study to evaluate the safety and efficacy of CoviToneÃ¢?Â¢ in Mild to moderate Covid patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48426,None
2766,CTRI/2020/10/028372,CTRI,2020-10-13,2020-10-22,False,Anant Mohan,Not Recruiting,Not Applicable,Observational,India,Evaluation of Respiratory profile and radiological changes in patients after recovery from COVID-19,Clinical Presentation,No Intervention,No Intervention,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48321,None
2767,CTRI/2020/10/028373,CTRI,2020-10-13,2020-10-30,False,Dr. Leena Sequira,Not Recruiting,Not Applicable,Observational,India,"""Experiences among nurses caring patients with COVID 19""",Health System,No Intervention,No Intervention,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48335,None
2768,CTRI/2020/10/028384,CTRI,2020-10-13,2020-10-16,False,CROM Clinical Research & Medical Tourism,Not Recruiting,Not Applicable,Observational,India,A population based survey on COVID-19 infection in Goa state among both urban and rural population.,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48092,None
2769,CTRI/2020/10/028412,CTRI,2020-10-14,2020-10-30,False,Manipal Academy of Higher Education,Not Recruiting,Not Applicable,Observational,India,school teachers experience in online teaching during this COVID-19 situation,Other,No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48163,None
2770,CTRI/2020/10/028422,CTRI,2020-10-15,2020-10-24,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Effect of COVID 19 on lymphocyte and eosinophil count,Clinical Presentation,No Intervention,No Intervention,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47424,None
2771,CTRI/2020/10/028414,CTRI,2020-10-15,2020-02-11,True,"Ministry of Ayush, Government of India",Not Recruiting,Phase 2,Interventional,India,Clinical study of an Ayurveda formulation containing Gold and Indian Gooseberry along with Tulasi juice as an add on therapy in standard care of COVID 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48010,None
2772,CTRI/2020/10/028423,CTRI,2020-10-15,2020-10-28,False,PNB Vesper Life Science Pvt Ltd,Recruiting,Phase 2,Interventional,India,A clinical study to see the effects and safety of PNB-001 in patients with moderate COVID-19 infection,Drug,PNB-001,PNB-001,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47514,None
2773,CTRI/2020/10/028424,CTRI,2020-10-15,2020-10-30,False,"Ministry of Ayush, Government of India",Not Recruiting,Phase 3,Interventional,India,Clinical study to evaluate the effect of Ayurveda intervention as a prophylaxis for COVID-19 in Healthcare workers,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48294,None
2774,CTRI/2020/10/028439,CTRI,2020-10-16,2020-10-16,False,Manisha Arthur,Not Recruiting,Not Applicable,Observational,India,Secondary attack rate of COVID-19 and risk factors for transmission,Clinical Presentation,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44034,None
2775,CTRI/2020/10/028437,CTRI,2020-10-16,2020-02-11,True,"Ministry of Ayush, Government of India",Not Recruiting,Phase 3,Interventional,India,Effect of Ayurvedic Treatment Regimen in COVID-19 Patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,380,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47956,None
2776,CTRI/2020/10/028432,CTRI,2020-10-16,2020-10-16,False,All India Institute of Ayurveda,Not Recruiting,Not Applicable,Observational,India,Mental health of COVID 19 patients during outbreak,Other (psych),No Intervention,No Intervention,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48231,None
2777,CTRI/2020/10/028438,CTRI,2020-10-16,2020-01-12,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,Perspective of cancer patient in COVID-19 pandemic,Other,No Intervention,No Intervention,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48532,None
2778,CTRI/2020/10/028436,CTRI,2020-10-16,2020-10-25,False,Dr. Amarja Havaldar,Not Recruiting,Not Applicable,Observational,India,This study is designed to look at certain blood parameters like biomarkers for predicting the outcome of COVID patients,Clinical Presentation,No Intervention,No Intervention,130,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47604,None
2779,CTRI/2020/10/028472,CTRI,2020-10-19,2020-10-29,False,Sparsh Foundation,Not Recruiting,Not Applicable,Interventional,India,Study of Edaravone as adjunctive treatment in COVID,Drug,Edaravone,Edaravone,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47524,None
2780,CTRI/2020/10/028470,CTRI,2020-10-19,2020-10-26,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,"Relation of lung disease and smoking with the severity of COVID-19 in a district hospital of Pune city, Maharashtra",Clinical Presentation,No Intervention,No Intervention,489,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47547,None
2781,CTRI/2020/10/028471,CTRI,2020-10-19,2020-02-11,True,NGR Vishnu Sri,Not Recruiting,Not Applicable,Interventional,India,"Effect of the drug Ã¢??ImmuneÃ¢??- an Ayurveda medication in COVID-19 patients
",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48593,None
2782,CTRI/2020/10/028486,CTRI,2020-10-20,2020-02-11,True,Pragya Jain Shrimal,Not Recruiting,Phase 1,Interventional,India,Yoga for COVID-19 Patients with mild symptoms,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48223,None
2783,CTRI/2020/10/028489,CTRI,2020-10-20,2020-10-26,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,To study the relationship of COVID-19 severity with blood vessels,Clinical Presentation,No Intervention,No Intervention,75,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48502,None
2784,CTRI/2020/10/028488,CTRI,2020-10-20,2020-10-26,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Role of blood cellular mechanism in severity of COVID-19,Clinical Presentation,No Intervention,No Intervention,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48575,None
2785,CTRI/2020/10/028485,CTRI,2020-10-20,2020-02-11,True,Pragya Jain Shrimal,Not Recruiting,Phase 1,Interventional,India,Yoga for COVID-19 healthcare workers,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48619,None
2786,CTRI/2020/10/028487,CTRI,2020-10-20,2020-10-30,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,To Study the safety of Remdesivir in COVID-19 Patients.,Drug,Remdesivir,Remdesivir,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48636,None
2787,CTRI/2020/10/028523,CTRI,2020-10-21,2020-10-30,False,Parumkhswami Medical College; Shree Krishna Hospital,Not Recruiting,Not Applicable,Observational,India,Hematological and biochemical abnormalities parameters in the severity of COVID-19,Clinical Presentation,No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48500,None
2788,CTRI/2020/10/028525,CTRI,2020-10-21,2020-10-31,False,Nandakrishna B,Not Recruiting,Not Applicable,Observational,India,A study of association of chest x ray with clinical severity in hospitalised covid19 patients,Clinical Presentation,No Intervention,No Intervention,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48521,None
2789,CTRI/2020/10/028524,CTRI,2020-10-21,2020-01-12,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,"Impact of Covid-19 on mental health among health care workers.
",Other (psych),No Intervention,No Intervention,632,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48550,None
2790,CTRI/2020/10/028520,CTRI,2020-10-21,2020-10-26,False,Dr. Divya Karanth,Not Recruiting,Not Applicable,Observational,India,Challenges faced by PG students in conducting research,Other,No Intervention,No Intervention,800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48305,None
2791,CTRI/2020/10/028571,CTRI,2020-10-22,2020-10-30,False,Tata Memorial Centre,Not Recruiting,Not Applicable,Observational,India,Treatment and followup outcomes of gynecological cancer patients treated with radiation therapy during lockdown phase of COVID pandemic,Other,Other,Other,1500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47944,None
2792,CTRI/2020/10/028569,CTRI,2020-10-22,2020-10-26,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,Challenges for healthcare workers with infection control practices during COVID-19 pandemic,Health System,No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47444,None
2793,CTRI/2020/10/028568,CTRI,2020-10-22,2020-10-26,False,RV New Vision Healthcare Pvt Ltd,Not Recruiting,Phase 2,Interventional,India,"Evaluate Safety 
and Efficacy of RV Forte Capsule as an immunomodulator in adult 
Covid 19 positive patients",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45761,None
2794,CTRI/2020/10/028566,CTRI,2020-10-22,2020-02-11,True,Pragya Jain Shrimal,Not Recruiting,Phase 1,Interventional,India,Yoga for COVID-19 asymptomatic patients,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48585,None
2795,CTRI/2020/10/028537,CTRI,2020-10-22,2020-10-22,False,Shree Baidyanath Ayurved Bhawan Pvt Ltd,Not Recruiting,Phase 2,Interventional,India,Clinical trial of Ayurvedic Medicines in Patients with Asymptomatic and/or Mild Symptoms of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48342,None
2796,CTRI/2020/10/028570,CTRI,2020-10-22,2020-05-11,True,"Ministry of Ayush, Government of India",Not Recruiting,Phase 2/Phase 3,Interventional,India,To study the effect of Vyaghradi Kashay tablet on COVID-19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48600,None
2797,CTRI/2020/10/028567,CTRI,2020-10-22,2020-01-11,True,Seth GS Medical College; KEM Hospital,Not Recruiting,Not Applicable,Observational,India,Red cell antibody profile in Covid-19,Clinical Presentation,No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46310,None
2798,CTRI/2020/10/028539,CTRI,2020-10-22,2020-10-28,False,Maulana Azad Medical College; Lok Nayak Hospital,Not Recruiting,Not Applicable,Observational,India,High-flow nasal cannula oxygen in adult patients of COVID-19 admitted to intensive care units.,Other (device),Nasal cannula,Nasal cannula,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48627,None
2799,CTRI/2020/10/028597,CTRI,2020-10-23,2020-06-11,True,Harshamitra Superspecialty Cancer Centre and Research Institute,Not Recruiting,Phase 2,Interventional,India,Low dose lung X-ray therapy for COVID-19,Other,Radiation,Radiation,61,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48730,None
2800,CTRI/2020/10/028598,CTRI,2020-10-23,2020-02-11,True,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Assessment of SARS CoV-2 seroprevalence and clinical profiling of COVID Unsuspected patients attending Otorhinolaryngology Department at AIIMS Jodhpur.,Clinical Presentation (Epidemiology),No Intervention,No Intervention,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47989,None
2801,CTRI/2020/10/028602,CTRI,2020-10-23,2020-03-11,True,BerGenBio ASA,Not Recruiting,Phase 2,Interventional,"South Africa, India",Phase II Study of Bemcentinib for the Treatment of COVID-19 in Hospitalised Patients,Drug,Bemcentinib,Bemcentinib,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48797,None
2802,CTRI/2020/10/028600,CTRI,2020-10-23,2020-05-11,True,"Government Medical College, Kannur",Not Recruiting,Not Applicable,Observational,India,Knowledge Attitude and Practice of Hand hygiene among Nursing Assistants and Trolley workers in a COVID-19 care units,Other,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46239,None
2803,CTRI/2020/10/028581,CTRI,2020-10-23,2020-10-23,False,Dr. Tushar Patel,Not Recruiting,Not Applicable,Interventional,India,Clinical trial to study the effect of Budesonide taken through inhalation in mild COVID cases,Drug,Budesonide,Budesonide,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47042,None
2804,CTRI/2020/10/028580,CTRI,2020-10-23,2020-10-26,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Interventional,India,Effectiveness of an online training module with lectures and videos regarding maternal and newborn care during COVID 19 pandemic on the knowledge and acceptability among nursing students,Other,Other,Other,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48581,None
2805,CTRI/2020/10/028637,CTRI,2020-10-26,2020-04-11,True,All India Institute of Medical Sciences,Not Recruiting,Phase 3/Phase 4,Interventional,India,Best Larnyngoscopes for tracheal intubation in covid patient with intubation box,Other (device),Larnyngoscopes,Larnyngoscopes,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44357,None
2806,CTRI/2020/10/028635,CTRI,2020-10-26,2020-02-11,True,NRI Academy of Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,India,use of VIRUNIL an Ayurvedic medicie as a supportive treatment in management of COVID-19.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,150,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48783,None
2807,CTRI/2020/10/028634,CTRI,2020-10-26,2020-02-11,True,Rajendra Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Impact of high flow oxygen therapy on outcomes of COVID-19 patients,Drug,Oxygen,Oxygen,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48823,None
2808,CTRI/2020/10/028639,CTRI,2020-10-26,2020-10-26,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,"Trends of Symptoms in Patients Under Institutional Isolation in COVID-19 Pandemic in India-An Observational studyÃ¢??
",Clinical Presentation,No Intervention,No Intervention,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44503,None
2809,CTRI/2020/10/028636,CTRI,2020-10-26,2020-01-11,True,Christian Medical College Vellore,Not Recruiting,Not Applicable,Observational,India,Covid 19 infection during pregnancy and its effect on the mother and baby,Clinical Presentation,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48380,None
2810,CTRI/2020/10/028648,CTRI,2020-10-27,2020-02-11,True,Dr. Aditi Chaturvedi,Not Recruiting,Not Applicable,Observational,India,To assess the overall effect of COVID-19 on intent of treatment and staging of cancer,Other,No Intervention,No Intervention,350,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46401,None
2811,CTRI/2020/10/028649,CTRI,2020-10-27,2020-10-31,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,Surgery complications rates in pre and post COVID era,Other,No Intervention,No Intervention,888,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48029,None
2812,CTRI/2020/10/028657,CTRI,2020-10-27,2020-10-30,False,Department of pharmacology,Not Recruiting,Not Applicable,Observational,India,Remdesivir effect in the treatment of corona,Drug,Remdesivir,Remdesivir,275,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47817,None
2813,CTRI/2020/10/028672,CTRI,2020-10-27,2020-11-30,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,A survey to know effect of Corona pandemic on medical postgraduate studentÃ¢??s mental stress and their attitude to choose anaesthesiology as a career.,Other,No Intervention,No Intervention,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48895,None
2814,CTRI/2020/10/028696,CTRI,2020-10-28,2020-10-29,False,Dr. Girijanandan D Menon,Not Recruiting,Not Applicable,Observational,India,online survey among anaesthesiologists about method of assessing breathing tube before administering anaesthesia duirng Covid 19 pandemic,Other,No Intervention,No Intervention,392,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48669,None
2815,CTRI/2020/10/028695,CTRI,2020-10-28,2020-05-11,True,No Sponsor Name Given,Not Recruiting,Phase 4,Interventional,India,Can Vitamin C reduces COVID-19 symptoms,Drug,Vitamin C,Vitamin C,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43749,None
2816,CTRI/2020/10/028774,CTRI,2020-10-29,2020-10-30,False,SD Biosensor,Not Recruiting,Not Applicable,Observational,India,Clinical evaluation of STANDARD Q COVID-19 Ag Test,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48412,None
2817,CTRI/2020/10/028744,CTRI,2020-10-29,2020-11-20,False,Anuradha Yadav,Not Recruiting,Not Applicable,Observational,India,"effect of COVID-19on physical activity, screen time and emotional wellbeing on medical students",Other (psych),No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48499,None
2818,CTRI/2020/11/028799,CTRI,2020-11-02,2020-02-11,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Interventional,India,The study of psychological interventions either individually or in groups and comparing its effect in reduction of  psychological distress  in covid-19 positive patients.,Other (psych),Psychological,Psychological,55,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45864,None
2819,CTRI/2020/11/028813,CTRI,2020-11-02,2020-10-11,True,PGIMER,Not Recruiting,Not Applicable,Observational,India,Evaluation of antibody and cytokine detection in tears of COVID-19 patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48182,None
2820,CTRI/2020/11/028811,CTRI,2020-11-02,2020-07-11,True,Apollo Hospitals,Not Recruiting,Not Applicable,Interventional,India,Role of Physiotherapist in enhancing functional aerobic capacity in pulmonary rehabilitation in Covid-19 Patients.,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48960,None
2821,CTRI/2020/11/028800,CTRI,2020-11-02,2020-11-13,False,Government Institute of Medical Sceinces,Not Recruiting,Not Applicable,Observational,India,Side effects of drugs used in ICU,Drug,Unspecified,Unspecified,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49028,None
2822,CTRI/2020/11/028779,CTRI,2020-11-02,2020-05-11,True,Biological E. Limited,Not Recruiting,Phase 1,Interventional,India,Effect of SARS-CoV-2 Equine Antiserum Immunoglobulin (Purified F(ab)2 fragment) in hospitalised COVID-19 patients with moderate disease.,ATMP,Immunoglobulin,Immunoglobulin,72,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48578,None
2823,CTRI/2020/11/028836,CTRI,2020-11-03,2020-11-15,False,Aparna,Not Recruiting,Not Applicable,Observational,India,Correlating the Clinical and CT Severity of COVID-19 patients with the Inflammatory markers and Co-morbidities,Clinical Presentation,No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48390,None
2824,CTRI/2020/11/028846,CTRI,2020-11-03,2020-11-11,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,"A study on knowledge, attitude and behavior of healthcare workers on practices required to prevent COVID - 19",Other,No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48947,None
2825,CTRI/2020/11/028827,CTRI,2020-11-03,2020-04-11,True,Central Council for Research in Yoga and Naturopathy,Not Recruiting,Not Applicable,Interventional,India,Yoga program on COVID 19 patients,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,86,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46946,None
2826,CTRI/2020/11/028843,CTRI,2020-11-03,2020-09-11,True,Safdarjung Hospital,Not Recruiting,Not Applicable,Observational,India,Outcomes of Nutrition scores on serious COVID patients,Clinical Presentation,No Intervention,No Intervention,78,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49036,None
2827,CTRI/2020/11/028848,CTRI,2020-11-03,2020-11-16,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,Lifestyle and psychological changes during COVID 19 lockdown among undergraduate students in Chennai,Other (psych),No Intervention,No Intervention,526,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49115,None
2828,CTRI/2020/11/028859,CTRI,2020-11-03,2020-11-11,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Cancer Services during COVID-19 Pandemic Ã¢?? Importance of a symptoms based screening strategy,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49144,None
2829,CTRI/2020/11/028905,CTRI,2020-11-04,2020-12-11,False,"Ministry of Ayush, Government of India",Not Recruiting,Phase 1/Phase 2,Interventional,India,An academic trial to study the prophylactic activity of Vishasura Kudineer(VSK)in healthcare workers exposed/non-exposed to COVID-19 patients.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48668,None
2830,CTRI/2020/11/028903,CTRI,2020-11-04,2020-09-11,True,Dr. Jeyaram,Not Recruiting,Not Applicable,Interventional,India,Telephonic intervention for people tested positive for Covid,Telehealth,Telehealth,Telehealth,0,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48964,None
2831,CTRI/2020/11/028897,CTRI,2020-11-04,2020-11-16,False,Bhargava Phytolab Pvt Ltd,Not Recruiting,Phase 3,Interventional,India,"To Evaluate the Efficacy and Safety of ANT-V Syrup to show antiviral action of upper respiratory
tract like common cold and act as an immune booster to fight against infection, flu, fever, sore
throat, nasal and chest congestion Breathlessness in COVID-19 patients.",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48480,None
2832,CTRI/2020/11/028885,CTRI,2020-11-04,2020-09-11,True,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Frailty assessment for COVID-19 severity,Clinical Presentation,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47990,None
2833,CTRI/2020/11/028938,CTRI,2020-11-05,2020-11-19,False,Manju Mathew,Not Recruiting,Not Applicable,Observational,India,Ultrasonography in Covid19 patients with a focus on possible clinical diagnosis and management decisions,Clinical Presentation,No Intervention,No Intervention,44,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48595,None
2834,CTRI/2020/11/028967,CTRI,2020-11-06,2020-11-15,False,Kalinga Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Seroprevalence of COVID-19 antibodies,Clinical Presentation (Epidemiology),No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47399,None
2835,CTRI/2020/11/028954,CTRI,2020-11-06,2020-10-11,True,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Psychological burden in COVID19,Other (psych),No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48686,None
2836,CTRI/2020/11/028969,CTRI,2020-11-06,2020-11-16,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,Effect Of COVID-19 on breast cancer treatment and its outcome,Health System,No Intervention,No Intervention,900,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49266,None
2837,CTRI/2020/11/028959,CTRI,2020-11-06,2020-06-11,True,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Effect of recombinant erythropoietin in covid-19 patients.,Drug,recombinant erythropoietin,recombinant erythropoietin,40,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48272,None
2838,CTRI/2020/11/028976,CTRI,2020-11-09,2020-11-11,False,Bharat Biotech International Limited,Recruiting,Phase 3,Interventional,India,"A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, Immunogenicity,and Lot-to-Lot consistency of BBV152, a Whole virion Inactivated Vaccine in Adults greater than or equal to 18 Years of Age.",ATMP,Vaccine,Vaccine,25800,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48057,None
2839,CTRI/2020/11/029025,CTRI,2020-11-10,2020-11-15,False,Pankajakasthuri Herbal Research Foundation,Recruiting,Not Applicable,Interventional,India,An open label observational study on post covid complications and radiological pattern changes on those patients treated with ZingiVir H .,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49174,None
2840,CTRI/2020/11/029035,CTRI,2020-11-10,2020-11-15,False,Nadia Rose,Recruiting,Not Applicable,Observational,India,Compare oxygen saturation from pulse oximetry and ABG in COVID-19 patients in ICU/HDU,Clinical Presentation,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48696,None
2841,CTRI/2020/11/029004,CTRI,2020-11-10,2020-11-16,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,RADIOLOGICAL AND LABORATORY TESTS CORELATION WITH CLINCIAL SEVERITY OF COVID19,Clinical Presentation,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48969,None
2842,CTRI/2020/11/029026,CTRI,2020-11-10,2020-11-16,False,Fluid Research Grant,Not Recruiting,Not Applicable,Observational,India,Long term lung problem of children who were affected by corona virus.,Clinical Presentation,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49243,None
2843,CTRI/2020/11/029006,CTRI,2020-11-10,2020-11-20,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,"Survey of Knowledge, Attitudes and Practices towards Covid-19 Pandemic",Other,No Intervention,No Intervention,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49299,None
2844,CTRI/2020/11/029029,CTRI,2020-11-10,2020-12-11,False,Dr. Maya Prasad,Not Recruiting,Not Applicable,Observational,India,"A pilot study to determine health concerns developed during COVID-19 pandemic in childhood cancer survivors and siblings of Tata Memorial Hospital, who are now grown up adults.",Health System,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48282,None
2845,CTRI/2020/11/029008,CTRI,2020-11-10,2020-11-20,False,Dr. Meenakshi Garg,Not Recruiting,Not Applicable,Observational,India,"To study the overall impact of consumption of non-alcoholic beverages on working from home adults, pre and during COVID times",Other,No Intervention,No Intervention,295,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49069,None
2846,CTRI/2020/11/029007,CTRI,2020-11-10,2020-11-17,False,Maulana Azad Medical College,Not Recruiting,Not Applicable,Observational,India,Signs and symptoms and outcome of babies less than 28 days age admitted during pandemic in a only COVID-19 hospital in north India,Clinical Presentation,No Intervention,No Intervention,1000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49326,None
2847,CTRI/2020/11/029009,CTRI,2020-11-10,2020-11-20,False,Dr. Meenakshi Garg,Not Recruiting,Not Applicable,Observational,India,"An online survey to compare the diet and physical activity management before and during COVID and how it is affected by education, occupation and income in people with diabetes belonging to middle and upper socioeconomic classes",Other,No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49077,None
2848,CTRI/2020/11/029012,CTRI,2020-11-10,2020-11-20,False,Dr. Meenakshi Garg,Not Recruiting,Not Applicable,Observational,India,"To assess the impact of COVID-19 on the Diet, lifestyle and physical activity of IT employees (20-30 years)",Other,No Intervention,No Intervention,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49084,None
2849,CTRI/2020/11/029032,CTRI,2020-11-10,2020-11-16,False,Biological E. Limited,Recruiting,Phase 1/Phase 2,Interventional,India,Biological EÃ¢??s novel Covid-19 vaccine of SARS-CoV-2 for protection against Covid-19 disease.,ATMP,Vaccine,Vaccine,360,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48329,None
2850,CTRI/2020/11/029030,CTRI,2020-11-10,2020-11-19,False,Dr. Dhiren Gupta,Not Recruiting,Not Applicable,Observational,India,Multicentric observational study on Pediatric Multisystem Inflammatory Syndrome (PMIS) related to Covid-19,Clinical Presentation,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48102,None
2851,CTRI/2020/11/029036,CTRI,2020-11-10,2020-11-16,False,Raktim Swarnakar,Not Recruiting,Not Applicable,Observational,India,A study to identify the rehabilitation need in post-discharge COVID-19 survivors,Other (physio),No Intervention,No Intervention,384,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46058,None
2852,CTRI/2020/11/029037,CTRI,2020-11-10,2020-11-18,False,Canary Health Technologies,Not Recruiting,Not Applicable,Observational,India,"The performance of a novel ultra-rapid diagnostic test in the detection of COVID 19, an observational and case controlled study.",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,750,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48368,None
2853,CTRI/2020/11/029060,CTRI,2020-11-11,2020-12-21,False,Vedaghosh Amara,Not Recruiting,Not Applicable,Observational,India,"High chloride level, anaemia and severity of COVID-19",Clinical Presentation,No Intervention,No Intervention,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49411,None
2854,CTRI/2020/11/029059,CTRI,2020-11-11,2020-11-20,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,Blood Glucose Management in Diabetic COVID19 Patients,Other,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48971,None
2855,CTRI/2020/11/029040,CTRI,2020-11-11,2020-11-15,False,Government Medical College and Hospital,Not Recruiting,Not Applicable,Observational,India,Effect of corona virus disease on  the mental state of  anesthesiologists in India,Other (psych),No Intervention,No Intervention,383,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44640,None
2856,CTRI/2020/11/029038,CTRI,2020-11-11,2020-10-19,True,Alchem Phytoceuticals,Not Recruiting,Phase 3,Interventional,India,"Can combination of Haldi, Pomegranate and Zinger extract tablets help in reducing duration of hospital stay of mild to moderate COVID-19 patients.",Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48233,None
2857,CTRI/2020/11/029041,CTRI,2020-11-11,2020-11-20,False,Dr. Meenakshi Garg,Not Recruiting,Not Applicable,Observational,India,A study to assess the overall dietary practices among young and middle-aged adults pre and during COVID times,Other,No Intervention,No Intervention,317,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49076,None
2858,CTRI/2020/11/029042,CTRI,2020-11-11,2020-11-20,False,Dr. Meenakshi Garg,Not Recruiting,Not Applicable,Observational,India,Measurement of nutritional and health status of Beedi workers before and during COVID times.,Other,No Intervention,No Intervention,160,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49098,None
2859,CTRI/2020/11/029061,CTRI,2020-11-11,2020-11-29,False,ICH HC Madras Medical College Chennai,Not Recruiting,Not Applicable,Observational,India,Multisystemic inflammatory  syndrome  in  children (MIS-C) in COVID pandemic,Clinical Presentation,No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49371,None
2860,CTRI/2020/11/029058,CTRI,2020-11-11,2020-11-20,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Interventional,India,Study to assess the impact of COVID 19 infection on pulmonary function tests in children,Clinical Presentation,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49392,None
2861,CTRI/2020/11/029063,CTRI,2020-11-12,2020-12-11,False,Uttar Pradesh University of Medical Sciences,Not Recruiting,Phase 3,Interventional,India,To study the effect of povidone iodine gargle and nasal drops on disease transmissibility in SARS-CoV-2 infected patients,Drug,Povidone iodine,Povidone iodine,32,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48939,None
2862,CTRI/2020/11/029067,CTRI,2020-11-12,2020-11-15,False,Columbia Asia Hospital,Not Recruiting,Not Applicable,Observational,India,A study to look out outcomes of treated COVID-19 patients admitted to a private hospital in Bangalore,Clinical Presentation,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47660,None
2863,CTRI/2020/11/029068,CTRI,2020-11-12,2020-11-17,False,Dr. Vijaysinh Parmar,Not Recruiting,Not Applicable,Observational,India,study of heart injury by laboratory investigation  in corona positive patients.,Clinical Presentation,No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48973,None
2864,CTRI/2020/11/029070,CTRI,2020-11-12,2020-11-20,False,Dr. Meenakshi Garg,Not Recruiting,Not Applicable,Observational,India,"To study the Influence of Food habits, Physical activity and knowledge of pregnant mothers on the problems faced in pregnancy, type of delivery and Birth weight of newborn during COVID-19 times.",Other,No Intervention,No Intervention,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49261,None
2865,CTRI/2020/11/029084,CTRI,2020-11-12,2020-11-21,False,Dr. Cynthia Amrutha Sukumar,Not Recruiting,Not Applicable,Observational,India,Covid-19 risk factors among health care workers,Clinical Presentation (Epidemiology),No Intervention,No Intervention,172,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49352,None
2866,CTRI/2020/11/029124,CTRI,2020-11-13,2020-11-21,False,Rachana,Not Recruiting,Not Applicable,Observational,India,"Effect of COVID-19 on exercise pattern, diet pattern and weight change in athletes",Other,No Intervention,No Intervention,336,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49435,None
2867,CTRI/2020/11/029130,CTRI,2020-11-16,2020-11-16,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,The lying in prone position effect on oxygen saturation in patients in early stage and not intubated having mild to moderate Lung Disease with COVID-19,Procedure,Positioning,Positioning,48,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49155,None
2868,CTRI/2020/11/029143,CTRI,2020-11-16,2020-01-12,True,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Impact of COVID 19 on Guillain-BarrÃƒÂ© Syndrome in India,Clinical Presentation,No Intervention,No Intervention,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47626,None
2869,CTRI/2020/11/029142,CTRI,2020-11-16,2020-01-12,True,Manipal Academy of Higher Education,Not Recruiting,Not Applicable,Observational,India,Effect of COVID19 work from home on musculoskeletal disorders.,Other,No Intervention,No Intervention,498,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49439,None
2870,CTRI/2020/11/029141,CTRI,2020-11-16,2020-01-12,True,Shikha Dixit,Not Recruiting,Not Applicable,Observational,India,"Sero-surveillance for Dengue, Chikungunya and COVID",Clinical Presentation (Epidemiology),No Intervention,No Intervention,5000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49486,None
2871,CTRI/2020/11/029144,CTRI,2020-11-16,2020-11-20,False,Bhargavi Bhaskar Hegde and  Sakshi Srivastava and Sunanda Banerjee,Not Recruiting,Not Applicable,Observational,India,Effect of work from home on stress level and nutritional status of IT professionals during COVID-19 pandemic,Other (psych),No Intervention,No Intervention,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49306,None
2872,CTRI/2020/11/029146,CTRI,2020-11-16,2020-11-23,False,JFD Limited,Not Recruiting,Not Applicable,Interventional,India,Use of a new breathing device for covid 19 patients,Other (physical),Mechanical ventilation,Mechanical ventilation,240,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48879,None
2873,CTRI/2020/11/029170,CTRI,2020-11-17,2020-11-20,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Lignocaine nebulisation in covid pneumonia,Drug,Lignocaine,Lignocaine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49412,None
2874,CTRI/2020/11/029148,CTRI,2020-11-17,2020-11-20,False,SRM Medical College Hospital and Research Centre,Not Recruiting,Not Applicable,Observational,India,Difficulties encountered with respiration while providing analgesia for surgeries to patients who had recovered from Covid-19 infection,Other,No Intervention,No Intervention,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49160,None
2875,CTRI/2020/11/029188,CTRI,2020-11-17,2020-11-17,False,Sri Ramachandra Institute of Higher Education Research Institute,Not Recruiting,Not Applicable,Observational,India,Quality  of life in post covid  affected patients,Other (psych),No Intervention,No Intervention,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47149,None
2876,CTRI/2020/11/029174,CTRI,2020-11-17,2020-11-30,False,Tata Memorial Hospital,Not Recruiting,Not Applicable,Observational,India,Impact of COVID 19 on domestic responsibilities in physicians,Other,No Intervention,No Intervention,2000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48433,None
2877,CTRI/2020/11/029159,CTRI,2020-11-17,2020-11-20,False,Government Medical College and Hospital Chandigarh,Not Recruiting,Not Applicable,Observational,India,"Study to evaluate the knowledge, attitude and mental health  of in-hospital front-line warriors of operation theatre",Other (psych),No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44643,None
2878,CTRI/2020/11/029173,CTRI,2020-11-17,2020-01-12,True,Kasturba Medical College,Not Recruiting,Not Applicable,Observational,India,What does Covid 19 do to patients with long standing Kidney disease and the impact of treatment on their course in hospital - a tertiary care hospital study,Clinical Presentation,No Intervention,No Intervention,62,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49522,None
2879,CTRI/2020/11/029172,CTRI,2020-11-17,2020-11-23,False,Jasmine Tamak,Not Recruiting,Not Applicable,Observational,India,Effect of the globally spread Covid-19 on the diet and lifestyle of adults (25-60 years),Other,No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49271,None
2880,CTRI/2020/11/029166,CTRI,2020-11-17,2020-01-12,True,Dr. Sant Prabhudasji,Not Recruiting,Phase 3,Interventional,India,Curaneum 20 for Covid 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46785,None
2881,CTRI/2020/11/029171,CTRI,2020-11-17,2020-11-22,False,Alfa F Rodrigues Krithika Rai,Not Recruiting,Not Applicable,Observational,India,Mothers view on the impact of increased screen time on the overall health of school going children during COVID-19,Other,No Intervention,No Intervention,261,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49097,None
2882,CTRI/2020/11/029200,CTRI,2020-11-18,2020-11-25,False,Department of Anaesthesiology,Not Recruiting,Not Applicable,Observational,India,Psychological effect of COVID 19 on Positive female patient,Other (psych),No Intervention,No Intervention,25,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49556,None
2883,CTRI/2020/11/029233,CTRI,2020-11-19,2020-12-15,False,Naveen Naik B,Not Recruiting,Not Applicable,Interventional,India,An observation and comparison of the efficacy and relative satisfaction of Health Care Workers while being monitored by the  standard BUDDY technique versus the Remote Audio Visual Doffing Surveillance (RADS) of the doffing process during the COVID 19 Pandemic,Other (psych),No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49177,None
2884,CTRI/2020/11/029221,CTRI,2020-11-19,2020-11-24,False,P Vaishnavi Yadav,Not Recruiting,Not Applicable,Observational,India,"Measurement of Quality of food intake, mental health status, and safety measures followed by the hospital support staff during COVID-19.",Other,No Intervention,No Intervention,354,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49250,None
2885,CTRI/2020/11/029235,CTRI,2020-11-19,2020-11-23,False,Reshma Mariam Santhosh,Not Recruiting,Not Applicable,Observational,India,"Impact of COVID-19 on screen time, physical activity, sleep pattern and food intake among students of 18-23 years.",Other,No Intervention,No Intervention,478,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49267,None
2886,CTRI/2020/11/029232,CTRI,2020-11-19,2020-11-25,False,No Sponsor Name Given,Not Recruiting,Phase 3,Interventional,India,Role Of Montelukast In Management Of COVID 19,Drug,Montelukast,Montelukast,90,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49293,None
2887,CTRI/2020/11/029230,CTRI,2020-11-19,2020-11-20,False,No Sponsor Name Given,Not Recruiting,Phase 3,Interventional,India,ROLE OF VITAMIN C IN MANAGEMENT OF COVID 19,Drug,Vitamin C,Vitamin C,80,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49295,None
2888,CTRI/2020/11/029236,CTRI,2020-11-19,2020-01-12,True,Bhabha Atomic Research Centre Hospital,Recruiting,Not Applicable,Observational,India,Patient satisfaction with psychiatry services during the pandemic,Other,No Intervention,No Intervention,347,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48376,None
2889,CTRI/2020/11/029263,CTRI,2020-11-20,2020-11-30,False,Glenmark Pharmaceuticals Ltd,Not Recruiting,Phase 4,Interventional,India,A clinical study on Favipiravir in mild to moderate COVID-19 patients,Drug,Favipiravir,Favipiravir,1200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=46353,None
2890,CTRI/2020/11/029265,CTRI,2020-11-20,2020-11-30,False,"Ministry of Ayush, Government of India",Recruiting,Phase 3,Interventional,India,Preventive trial of Homoeopathic medicines in COVID-19,Drug,Homeopathy,Homeopathy,20000,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48401,None
2891,CTRI/2020/11/029264,CTRI,2020-11-20,2020-01-12,True,Sri Ramachandra Institute of Higher Education Research Institute,Not Recruiting,Not Applicable,Observational,India,To study the long term ill effects of  covid 19 infection in old age people,Clinical Presentation,No Intervention,No Intervention,400,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47176,None
2892,CTRI/2020/11/029266,CTRI,2020-11-20,2020-04-12,True,Vishal Shanbhag,Not Recruiting,Not Applicable,Observational,India,Response of patients and chest x-ray improvement after Remdesivir,Drug,Remdesivir,Remdesivir,126,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49576,None
2893,CTRI/2020/11/029289,CTRI,2020-11-23,2020-11-25,False,Arul Anandar College,Not Recruiting,Phase 2/Phase 3,Interventional,India,A clinical trial of Siddha drugs M V kashayam (Internally) for the management   and  treatment of COVID 19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,130,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48077,None
2894,CTRI/2020/11/029297,CTRI,2020-11-23,2020-01-12,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,Changing Trends in Presentation of Trauma Patients during Nationwide lockdown for COVID 19,Health System,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=47331,None
2895,CTRI/2020/11/029305,CTRI,2020-11-24,2020-11-25,False,Self-sponsored,Not Recruiting,Not Applicable,Interventional,India,Clarithromycin in Post Covid 19 parenchymal organizing pneumonia,Drug,Clarithromycin,Clarithromycin,120,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48195,None
2896,CTRI/2020/11/029328,CTRI,2020-11-24,2020-11-30,False,Indus Biotech Private Limited,Not Recruiting,Phase 2,Interventional,India,A phase II study to evaluate safety and effectiveness of IND02 Capsules in patients who are hospitalized SARS-CoV2 positive patients with mild to moderate COVID-19 at COVID management centres offering Ayurvedic care.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,118,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49552,None
2897,CTRI/2020/11/029335,CTRI,2020-11-24,2020-02-12,True,Muskaan Chichra,Not Recruiting,Not Applicable,Observational,India,Apprehensions and Challenges faced by dentists during Covid 19 pandemic,Other,No Intervention,No Intervention,189,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49555,None
2898,CTRI/2020/11/029356,CTRI,2020-11-25,2020-11-25,False,BLDEDU,Not Recruiting,Phase 2,Interventional,India,A clinical study to compare high flow nasal oxygen and non invasive ventilation in patients with covid-19.,Other (physical),Mechanical ventilation,Mechanical ventilation,82,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49432,None
2899,CTRI/2020/11/029346,CTRI,2020-11-25,2020-11-26,False,LV Prasad Eye Institute,Not Recruiting,Not Applicable,Interventional,India,Spectrum of eye infections in COVID-19 affected individuals,Clinical Presentation,No Intervention,No Intervention,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48444,None
2900,CTRI/2020/11/029350,CTRI,2020-11-25,2020-01-12,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,"Assessing the knowledge and precautions taken by dentists and dental auxiliaries(operating, non-operating) in dental office during the pandemic of Corona virus (COVID-19)",Other,No Intervention,No Intervention,108,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49535,None
2901,CTRI/2020/11/029376,CTRI,2020-11-25,2020-06-05,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,An online study to assess the disposal of Personal protective equipments at home amid COVID 19 Pandemic in India,Other,No Intervention,No Intervention,500,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49632,None
2902,CTRI/2020/11/029396,CTRI,2020-11-26,2020-01-12,True,Myself Health Check Ltd,Not Recruiting,Not Applicable,Interventional,India,Safety of an aerosol having as its active ingredient 8.4 % sodium bicarbonate and xylitol 5% when administered to the nasopharynx and oropharynx,Drug,Xylitol + Sodium bicarbonate,Xylitol; Sodium bicarbonate,325,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49442,None
2903,CTRI/2020/11/029399,CTRI,2020-11-26,2020-10-12,True,Central Council for Research in Homoeopathy,Not Recruiting,Phase 1,Interventional,India,Develop homeopathic Nosodes for Immunity Against COVID 19.,Other,Homeopathy,Homeopathy,20,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49714,None
2904,CTRI/2020/11/029393,CTRI,2020-11-26,2020-11-30,False,Lilavati Hospital,Not Recruiting,Not Applicable,Observational,India,Eye Diseases associated with COVID-19,Clinical Presentation,No Intervention,No Intervention,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48183,None
2905,CTRI/2020/11/029398,CTRI,2020-11-26,2020-07-12,True,Kasturba Medical College,Not Recruiting,Not Applicable,Observational,India,Palliative Care in COVID-19,Other,No Intervention,No Intervention,50,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49741,None
2906,CTRI/2020/11/029377,CTRI,2020-11-26,2020-12-15,False,Centre for Health Research and Development Society for Applied Studies,Not Recruiting,Not Applicable,Observational,India,Formative research for management of serious infections in infants less than 2 months of age during COVID pandemic,Other,No Intervention,No Intervention,70,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49498,None
2907,CTRI/2020/11/029414,CTRI,2020-11-26,2020-12-14,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,India,COVID WITH AKI,Clinical Presentation,No Intervention,No Intervention,100,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49245,None
2908,CTRI/2020/11/029388,CTRI,2020-11-26,2020-11-27,False,Vitrobio SAS,Not Recruiting,Not Applicable,Interventional,India,Pirdal Nasal Spray in preventing symptomatic manifestation of disease in Covid-19 proven cases,Drug,Pirdal,Pirdal,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49529,None
2909,CTRI/2020/11/029394,CTRI,2020-11-26,2020-01-12,True,Dr. Pradipkumar R Atodaria,Not Recruiting,Not Applicable,Observational,India,Precautionary measure during surgical process during COVID-19 pandemic around the globe,Other (device),Barrier,Barrier,30,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=48280,None
2910,CTRI/2020/11/029390,CTRI,2020-11-26,2020-11-28,False,Smt NHL Municipal Medical College,Not Recruiting,Not Applicable,Observational,India,A study of clinical profile of children with  COVID 19 INFECTION admitted at tertiary care hospital,Clinical Presentation,No Intervention,No Intervention,200,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49606,None
2911,CTRI/2020/11/029444,CTRI,2020-11-27,2020-03-12,True,Shri Vishwavati Ayurved Chikitsalaya and Research Centre,Not Recruiting,Phase 3/Phase 4,Interventional,India,A clinical trial to study effect of Madhav Rasayan tablets in COVID 19 patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49712,None
2912,CTRI/2020/11/029437,CTRI,2020-11-27,2020-12-15,False,Medanta Institute of Education and Research,Not Recruiting,Not Applicable,Observational,India,"A study to evaluate post COVID-19 lung damage.


",Clinical Presentation,No Intervention,No Intervention,300,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49744,None
2913,CTRI/2020/11/029438,CTRI,2020-11-27,2021-04-01,False,Christian Medical College Vellore,Not Recruiting,Not Applicable,Observational,India,Reinfection with SARS-COV-2 and associated factors,Clinical Presentation (Epidemiology),No Intervention,No Intervention,600,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=49809,None
2914,ACTRN12620000788976,ANZCTR,2020-08-05,2021-04-01,False,Mucpharm Pty Ltd,Recruiting,Phase 1,Interventional,Australia,Safety and efficacy of intranasal delivery of BromAcÂ® (Bromelain & Acetylcysteine) in swab positive SARS-CoV-2 COVID-19 patients,Drug,Bromelain + Acetylcysteine,Bromelain; Acetylcysteine,40,https://anzctr.org.au/ACTRN12620000788976.aspx,None
2915,ISRCTN11811602,ISRCTN,2020-11-23,2020-01-11,True,University of Leicester,Recruiting,Not Applicable,Observational,United Kingdom,UK-REACH: United Kingdom research study into ethnicity and COVID-19 outcomes in healthcare workers,Clinical Presentation,No Intervention,No Intervention,1530180,http://isrctn.com/ISRCTN11811602,None
2916,ISRCTN11466448,ISRCTN,2020-11-23,2020-11-30,False,University Hospitals Coventry and Warwickshire NHS Trust,Recruiting,Not Applicable,Interventional,United Kingdom,A randomized trial to assess the effects of physical and mental health rehabilitation for people recovering from COVID-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,535,http://isrctn.com/ISRCTN11466448,None
2917,ISRCTN11946807,ISRCTN,2020-11-23,2020-11-13,True,University of Bristol,Recruiting,Not Applicable,Observational,United Kingdom,Characterisation of COVID-19 long-term immunity,Clinical Presentation,No Intervention,No Intervention,250,http://isrctn.com/ISRCTN11946807,None
2918,ISRCTN11970082,ISRCTN,2020-11-20,2020-08-16,True,"Indian Institute of Technology, Madras",Recruiting,Not Applicable,Interventional,India,Effect of the drug indomethacin in the treatment of COVID-19 patients,Drug,Indomethacin,Indomethacin,250,http://isrctn.com/ISRCTN11970082,None
2919,ISRCTN31062548,ISRCTN,2020-09-07,2020-09-14,True,NHS Greater Glasgow and Clyde,Recruiting,Phase 2,Interventional,United Kingdom,"GETAFIX (Glasgow Early Treatment Arm Favipiravir) â€“ a study to compare the effectiveness of adding the antiviral drug favipiravir to standard care in COVID-19 patients, compared with standard care alone",Drug,Favipiravir,Favipiravir,302,http://isrctn.com/ISRCTN31062548,EUCTR2020-001904-41
2920,ISRCTN93382525,ISRCTN,2020-08-03,2020-12-10,False,South London and Maudsley NHS Foundation Trust,Recruiting,Not Applicable,Interventional,United Kingdom,STAR (Study of Trauma And Recovery): a trial of trauma-focused psychological therapy for psychosis,Not relevant,Not relevant,Not relevant,300,http://isrctn.com/ISRCTN93382525,None
2921,ISRCTN17898730,ISRCTN,2020-04-23,2020-07-04,False,Psychosocial Innovation Network,Recruiting,Not Applicable,Interventional,Serbia,Expressive writing for the reduction of psychological difficulties during the COVID-19 pandemic,Other (psych),Psychological,Psychological,150,http://isrctn.com/ISRCTN17898730,None
2922,EUCTR2020-002504-39-DE,EU Clinical Trials Register,2020-08-14,2020-10-11,False,"University Hospital, Hamburg-Eppendorf",Authorised,Phase 3,Interventional,Germany,Hamburg Edoxaban foR anticoagulation in COvid-19 study,Drug,Edoxaban,Edoxaban,172,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002504-39,None
2923,EUCTR2020-004695-18-DE,EU Clinical Trials Register,2020-10-15,2020-02-12,True,Heinrich-Heine University,Authorised,Phase 2,Interventional,Germany,Plasma from Covid 19 recovered patients or camostat as a therapy for early SARS-CoV-2 infection in high risk individuals,ATMP,Plasma,Plasma,994,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004695-18,None
2924,EUCTR2020-002119-23-IT,EU Clinical Trials Register,2020-09-22,2020-11-16,False,Istituto Europeo di Oncologia,Authorised,Phase 2,Interventional,Italy,prevention of complications from COVID-19 in cancer patients under active treatment,Clinical Presentation,No Intervention,No Intervention,80,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002119-23,None
2925,EUCTR2020-003872-42-IT,EU Clinical Trials Register,2020-11-23,2020-06-11,True,Istituto di Farmacologia Traslazionale (IFT),Authorised,Phase 2,Interventional,Italy,Antiviral and Immunomodulatory Interferon-Beta in high-risk COVID-19 patients,Drug,Interferon beta,Interferon beta,60,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003872-42,None
2926,EUCTR2020-004408-32-GR,EU Clinical Trials Register,2020-10-01,2020-10-23,False,Amyndas Pharmaceuticals S.A.,Authorised,Phase 2,Interventional,Greece,Clinical trial of the investigational drug AMY-101 for the treatment of patients with severe COVID-19.,Drug,AMY-101,AMY-101,62,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-004408-32,None
2927,EUCTR2020-001391-15-IE,EU Clinical Trials Register,2020-03-31,2020-04-24,False,Royal College of Surgeons Ireland,Authorised,Phase 2,Interventional,Ireland,"A randomized double-blind placebo-controlled, pilot trial of intravenous plasma-purified alpha-1 antitrypsin for severe COVID-19 illness.",ATMP,Alpha-1-proteinase inhibitor,Alpha-1-proteinase inhibitor,36,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001391-15,None
2928,ChiCTR2000038609,ChiCTR,2020-09-26,2020-05-01,True,"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Follow-up Study on Pulmonary Function and Lung Radiographic Changes in Rehabilitating COVID-19 Patients After Discharge,Clinical Presentation,No Intervention,No Intervention,300,http://www.chictr.org.cn/showproj.aspx?proj=62070,None
2929,ChiCTR2000038256,ChiCTR,2020-09-15,2020-09-07,True,North Sichuan Medical College,Recruiting,Not Applicable,Interventional,China,Motion Modelling for Sedentary Behavior during the novel coronavirus pneumonia (COVID-19) pandemic: 10-min High Intensity Interval Training (HIIT) with Music Therapy (MT),Other,No Intervention,No Intervention,118,http://www.chictr.org.cn/showproj.aspx?proj=61345,None
2930,ChiCTR2000038255,ChiCTR,2020-09-15,2020-05-25,True,Beijing Normal University,Recruiting,Not Applicable,Interventional,China,Establishment of psychological assistance system for the bereaved during the COVID-19 pandemic,Other (psych),Psychological,Psychological,300,http://www.chictr.org.cn/showproj.aspx?proj=61390,None
2931,ChiCTR2000030782,ChiCTR,2020-03-14,2020-02-01,True,Cangzhou People's Hospital,Recruiting,Not Applicable,Observational,No Country Given,"Canceled by the investigator                                    The value of CD4 / CD8 cells, CRP / ALB and APCHEII in novel coronavirus pneumonia (COVID-19)",Prognosis,No Intervention,No Intervention,20,http://www.chictr.org.cn/showproj.aspx?proj=50976,None
2932,RBR-2ss28r,REBEC,2018-06-20,2018-01-07,True,Instituto Federal do Paraná,Not Recruiting,Not Applicable,Observational,Brazil,"Associations Among Bed Bath, Sleep and Body Temperature in Intensive Care Patients",Not relevant,Not relevant,Not relevant,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/5913,None
2933,RBR-8bn3y2,REBEC,2018-07-26,2014-01-04,True,Instituto Nacional de Rehabilitacion,Not Recruiting,Not Applicable,Interventional,Mexico,Effect of Blocking a nerve in the neck and arm on inflammation in shoulder surgery. Comparative study,Not relevant,Not relevant,Not relevant,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/2012,None
2934,RBR-6m69fc,REBEC,2020-04-02,2020-01-04,True,University of Sevilla,Recruiting,Not Applicable,Interventional,Spain,"Therapeutic Pulmonary Telerehabilitation Protocol in patients affected by COVID-19, confined in their homes",Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9664,None
2935,RBR-9pgwfc,REBEC,2020-04-09,2020-07-04,False,Hospital Universitário Bettina Ferro de Souza,Recruiting,Not Applicable,Observational,"Portugal, Colombia, Chile, France, Canada, Brazil, United Kingdom, United States, Spain",Psychological effects of social isolation in the coronavirus pandemic,Other (psych),No Intervention,No Intervention,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9694,None
2936,RBR-9ktwx6,REBEC,2020-04-09,2020-03-30,True,Socidade Brasileira de Reumatologia,Recruiting,Not Applicable,Observational,Brazil,Effect of the use of Chloroquine and Hydroxychloroquine as a possible protector for Infection with the New Corona Virus 2019 in patients with Rheumatic Diseases,Drug,Hydroxychloroquine or Chloroquine,Hydroxychloroquine; Chloroquine,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9646,None
2937,RBR-8969zg,REBEC,2020-04-13,2020-04-14,False,University de São Paulo,Not Recruiting,Not Applicable,Interventional,Brazil,Treatment of 2019-nCoV Pneumonia with N-acetylcysteine,Drug,N-acetylcysteine,N-acetylcysteine,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9718,None
2938,RBR-658khm,REBEC,2020-04-22,2020-01-04,True,Centro Medico Mazzei,Recruiting,Not Applicable,Interventional,Brazil,"Telemedicine in the Covid-19 pandemic in Brazil
in a medical clinic in the supplementary health sector in SÃ£o Paulo, Brazil",Telehealth,Telehealth,Telehealth,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9688,None
2939,RBR-6w5tbk,REBEC,2020-04-29,2020-04-30,False,Hospital Universitário de Brasília,Not Recruiting,Not Applicable,Interventional,Brazil,Effects of tests for covid-19 on the preservation of the healthcare workforce during pandemia in Brazil,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9810,None
2940,RBR-5s2mqg,REBEC,2020-05-05,2020-04-27,True,"University of Campinas, Brazil",Recruiting,Phase 2/Phase 3,Interventional,Brazil,The effect of an inhibitor of pulmonary inflammation in patients with Covid-19,Drug,Icatibant acetate,Icatibant acetate,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9693,None
2941,RBR-3k4wxb,REBEC,2020-05-05,2020-01-05,True,Hospital Santo António,Not Recruiting,Phase 2,Interventional,Brazil,"Evaluation of the use of Hydroxychlorochine in Chinese flu
",Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9773,None
2942,RBR-4vm3yy,REBEC,2020-05-15,2020-04-19,True,Instituto Estadual de Hematologia Arthur Siqueira Cavalcanti,Recruiting,Not Applicable,Interventional,Brazil,Effect of convalescent plasma in patients with severe COVI-19,ATMP,Plasma,Plasma,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9901,None
2943,RBR-62y3h7,REBEC,2020-05-18,2020-01-05,True,Faculdade de Medicina de Botucatu,Recruiting,Not Applicable,Observational,Brazil,"Acute impairment of renal function in COVID-19: study on incidence, risk factors and mortality",Clinical Presentation,No Intervention,No Intervention,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9809,None
2944,RBR-2dxyx4,REBEC,2020-06-02,2020-04-06,True,Hospital Universitário Clementino Fraga Filho,Not Recruiting,Not Applicable,Interventional,Brazil,Mechanical ventilator for use in patients with respiratory failure due to Covid-19 (VExCO),Other (physical),Mechanical ventilation,Mechanical ventilation,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10001,None
2945,RBR-43hbks,REBEC,2020-06-03,2020-04-21,True,Universidade Federal de São Paulo,Recruiting,Not Applicable,Observational,Brazil,Evaluation with ultrasound on the bedside in serious patients with COVID-19,Other,No Intervention,No Intervention,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9922,None
2946,RBR-949z6v,REBEC,2020-05-06,2020-05-30,False,Faculdade de Medicina de Ribeirão Preto,Recruiting,Phase 2,Interventional,Brazil,Full versus prophylactic anticoagulation for the treatment of severe forms of Covid-19:,Drug,Heparin,Heparin,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9870,None
2947,RBR-876qb5,REBEC,2020-06-08,2020-05-27,True,Hospital das Clínicas de Ribeirão Preto,Recruiting,Phase 1/Phase 2,Interventional,Brazil,Treatment of severe cases of Covid-19 with Eculizumab,Drug,Eculizumab,Eculizumab,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9903,None
2948,RBR-4qjzh7,REBEC,2020-06-08,2020-04-17,True,Universidade Federal de São Paulo,Not Recruiting,Not Applicable,Observational,Brazil,Study of vascular complications in critically ill patients with coronavirus,Clinical Presentation,No Intervention,No Intervention,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9924,None
2949,RBR-3zdynp,REBEC,2020-06-23,2020-03-16,True,Victor Côrtes Pourchet de Carvalho,Recruiting,Phase 4,Interventional,Brazil,Using Tocilizumab in critically ill patients with COVID-19.,Drug,Tocilizumab,Tocilizumab,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9995,None
2950,RBR-33ytqc,REBEC,2020-06-24,2020-05-13,True,Socidade Brasileira de Reumatologia,Recruiting,Not Applicable,Observational,Brazil,Evaluation of COVID-19 in patients with Chronic Inflammatory Rheumatic Diseases.,Clinical Presentation,No Intervention,No Intervention,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9999,None
2951,RBR-4wnx2q,REBEC,2020-06-26,2020-06-06,True,Universidade Estadual do Centro Oeste,Recruiting,Not Applicable,Interventional,Brazil,Pulmonary rehabilitation in individuals affected by Covid-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10123,None
2952,RBR-5kkpg6,REBEC,2020-06-28,2020-06-29,False,Federal University of Pernambuco,Not Recruiting,Not Applicable,Interventional,Brazil,"Effect of eating habits and exposure to light on sleep, emotion, memory and headache in college students during the COVID-19 pandemic",Other,No Intervention,No Intervention,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10110,None
2953,RBR-7jqpnw,REBEC,2020-06-29,2020-01-07,True,University of Pernambuco,Not Recruiting,Phase 3,Interventional,Brazil,"Effect of COVID-19 convalescent plasma produced by HEMOPE: A randomized study, with a comparative group in several centers",ATMP,Plasma,Plasma,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10116,None
2954,RBR-3rywwg,REBEC,2020-07-10,2020-01-06,True,Faculdade de Medicina de São José do Rio Preto (FAMERP),Recruiting,Phase 2,Interventional,Brazil,"A clinical, randomized study to evaluate the efficacy and safety of Naproxen compared to placebo in combination with Azithromycin or Levofloxacin in patients with Severe Acute Respiratory Syndrome during the Covid-19 pandemic",Drug,"Naproxen, Amoxacillin or Clavulanate, Azithromycin or Levofloxacin, Oseltamivir",Naproxen; Amoxacillin; Clavulanate; Azithromycin; Levofloxacin; Oseltamivir,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9819,None
2955,RBR-7jrxqm,REBEC,2020-07-10,2020-01-06,True,Universidade do Estado da Bahia,Recruiting,Not Applicable,Interventional,Brazil,Effect of a special nutritional oral supplement use on inflammation in patients with COVID-19,Supplement,Nutritional Supplement,Nutritional Supplement,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9944,None
2956,RBR-6xqcr4,REBEC,2020-07-10,2020-01-07,True,Federal University of Paraíba,Recruiting,Not Applicable,Observational,Brazil,Assessment cardiorespiratory  in recovered Covid-19 patients,Clinical Presentation,No Intervention,No Intervention,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10193,None
2957,RBR-45kf9p,REBEC,2020-07-13,2020-06-29,True,University de São Paulo,Recruiting,Not Applicable,Interventional,Brazil,CoV-Hep study : Comparative study between different anti-coagulation strategies in continuous hemodialysis in COVID-19 patients,Drug,Sodium Citrate vs. Heparin,Sodium Citrate; Heparin,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9913,None
2958,RBR-7drpyr,REBEC,2020-07-13,2020-06-20,True,"University of Campinas, Brazil",Not Recruiting,Not Applicable,Interventional,Brazil,Effect of two covers to prevent injuries caused to professionals working in the health area due to the use of personal protective equipment,Other (device),Barrier devices,Barrier devices,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10034,None
2959,RBR-62zdkk,REBEC,2020-07-17,2020-12-06,False,Hospital Universitário de Brasília,Recruiting,Not Applicable,Observational,Brazil,Evaluation of immunity in the evolution of the severe or mild form of COVID-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10139,None
2960,RBR-8hmb2r,REBEC,2020-07-27,2020-03-08,True,Instituto Nacional de Infectologia Evandro Chagas/Fundacao Oswaldo Cruz (INI/Fiocruz),Not Recruiting,Not Applicable,Observational,Brazil,Studying the progression and the consequences of the new Coronavirus in Brazil,Clinical Presentation,No Intervention,No Intervention,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10287,None
2961,RBR-5ysj54,REBEC,2020-07-27,2020-07-15,True,Universidade Federal do Rio de Janeiro,Not Recruiting,Phase 2/Phase 3,Interventional,Brazil,BCG vaccine use to prevent COVID-19 in health care workers,ATMP,Vaccine,Vaccine,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10111,None
2962,RBR-7nky44,REBEC,2020-07-28,2020-01-07,True,Universidade Estadual do Oeste do Paraná,Recruiting,Not Applicable,Observational,Brazil,Novel Coronavirus infection among health workers,Clinical Presentation (Epidemiology),No Intervention,No Intervention,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10252,None
2963,RBR-3g5f9f,REBEC,2020-07-29,2020-08-28,False,Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein,Not Recruiting,Not Applicable,Interventional,Brazil,"Educational intervention by cell phone to increase informed choices at childbirth, in the context of the Covid-19 pandemic.",Other,Other,Other,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10283,None
2964,RBR-8jyhxh,REBEC,2020-07-30,2020-11-04,False,Hospital das Clínicas de Ribeirão Preto,Recruiting,Phase 2/Phase 3,Interventional,Brazil,Clinical trial for the treatment of COVID-19 with Chloroquine and Colchicine,Drug,Hydroxychloroquine + Colchicine,Hydroxychloroquine; Colchicine,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10257,None
2965,RBR-7w5zhr,REBEC,2020-07-30,2020-03-30,True,University de São Paulo,Recruiting,Not Applicable,Observational,Brazil,Frailty and negative consequences in adults hospitalized for COVID-19,Clinical Presentation,No Intervention,No Intervention,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10018,None
2966,RBR-7dsxsv,REBEC,2020-08-04,2020-02-03,True,Diagnosticos da America Sociedade Anonima (DASA),Recruiting,Not Applicable,Observational,Brazil,"Software to evaluate clinical, epidemiological data and chest computed tomography to predict which patients with COVID-19 will develop a severe form of the disease.",Prognosis,No Intervention,No Intervention,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10171,None
2967,RBR-564y4n,REBEC,2020-08-06,2020-05-20,True,Instituto de Assistência Médica ao Servidor Público Estadual (IAMSPE),Recruiting,Not Applicable,Observational,Brazil,"Evaluation of muscle weakness, function and quality of life after Intensive Care Unit discharge in survivors of COVID-19",Clinical Presentation,No Intervention,No Intervention,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10119,None
2968,RBR-2w7ghc,REBEC,2020-08-07,2020-07-20,True,Maria do Rosario Toscano von Flach - Salvador,Recruiting,Not Applicable,Interventional,Brazil,"Online meditation as an aid in reducing symptoms of Depression, Anxiety and Psychological Stress in Resident Physicians
during COVID-19 pandemic in Brazil",Other (psych),Psychological,Psychological,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10234,None
2969,RBR-2f9k8p,REBEC,2020-08-07,2020-06-18,True,University de São Paulo,Recruiting,Not Applicable,Observational,Brazil,Profile of hospitalized patients with Covid-19 and repercussions of physiotherapy,Clinical Presentation,No Intervention,No Intervention,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10262,None
2970,RBR-7d7ngw,REBEC,2020-08-07,2020-07-15,True,Hospital Geral Roberto Santos,Recruiting,Phase 2/Phase 3,Interventional,Brazil,Early prone position in patients on spontaneous ventilation,Procedure,Positioning,Positioning,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10240,None
2971,RBR-2k66ft,REBEC,2020-08-10,2020-08-20,False,Rodrigo S Biondi ,Not Recruiting,Not Applicable,Interventional,Brazil,"Randomized,  study to evaluate early prone position in patients with COVID-19
",Procedure,Positioning,Positioning,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10094,None
2972,RBR-9y32yy,REBEC,2020-05-24,2020-01-07,True,Sao Paulo State University (Universidade Estadual Paulista),Not Recruiting,Not Applicable,Interventional,Brazil,Acute and chronic cardiovascular and respiratory changes in COVID-19 hospitalized patients and the effect of physical rehabilitation supervised by telecommunication,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9959,None
2973,RBR-4vy54v,REBEC,2020-08-11,2020-07-15,True,Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (FAPERGS),Not Recruiting,Not Applicable,Interventional,Brazil,On-Line Collectives in Mental Health: Transdisciplinary Action for Groups Vulnerable to COVID-19,Other (psych),Psychological,Psychological,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10103,None
2974,RBR-4pfygr,REBEC,2020-08-13,2020-07-27,True,Cryopraxis,Not Recruiting,Phase 1/Phase 2,Interventional,Brazil,"Clinical study to assess the safety and tolerability of administration, directly into a vein, of human umbilical cord and placental blood plasma (PlasmacordÂ®) in patients with Severe acute respiratory syndrome resulting from Sars-Cov-2 infection (fever, cough headache, muscle aches and difficulty breathing)",ATMP,Cells (stem cells),Cells (stem cells),Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10300,None
2975,RBR-8j9kqy,REBEC,2020-08-13,2020-02-06,True,Faculdade de Medicina de Botucatu,Recruiting,Not Applicable,Observational,Brazil,"Evaluation of symptoms, respiratory, pulmonary image and inflammation in patients who have been hospitalized for coronavirus infection in the period of a year, multicentric study (fenix)",Clinical Presentation,No Intervention,No Intervention,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10019,None
2976,RBR-3rdhgm,REBEC,2020-05-14,2020-01-05,True,Faculdade de Medicina de Botucatu,Recruiting,Not Applicable,Interventional,Brazil,The role of early dialysis in the evolution of patients with COVID19,Other (device),Dialysis,Dialysis,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9733,None
2977,RBR-9xs978,REBEC,2020-08-24,2020-06-17,True,Hospital Universitario Walter Cantidio,Recruiting,Phase 1/Phase 2,Interventional,Brazil,Telehealth for patients with dementia at the Hospital UniversitÃ¡rio Walter Cantidio-UFC,Telehealth,Telehealth,Telehealth,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10125,None
2978,RBR-2z3f7k,REBEC,2020-05-04,2020-04-29,True,"Federal Institute of Education, Science and Technology of Rio de Janeiro",Recruiting,Not Applicable,Interventional,Brazil,"Artificial ventilation setting in patients infected with COVID-19
",Other (physical),Mechanical ventilation,Mechanical ventilation,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9725,None
2979,RBR-2kjm6y,REBEC,2020-08-26,2020-05-22,True,Blade Therapeutics,Recruiting,Phase 2,Interventional,"United States, Brazil",A phase 2 randomized double-blind placebo-controlled study to evaluate safety of BLD-2660 and its activity against COVID-19 virus in hospitalized subjects recently diagnosed with COVID-19 in comparison to standard of care treatment,Drug,BLD-2660,BLD-2660,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10389,None
2980,RBR-72bg24,REBEC,2020-08-27,2020-08-31,False,Instituto de Tecnologia do Paraná,Not Recruiting,Not Applicable,Interventional,Brazil,SARS-CoV-2 quick analysis in breath device,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10429,None
2981,RBR-3fz9yr,REBEC,2020-08-31,2020-10-06,False,Paulo Roberto Slud Brofman,Not Recruiting,Not Applicable,Interventional,Brazil,Use of mesenchymal cells for the treatment of patients with respiratory syndrome caused by new coronavirus,ATMP,Cells (mesenchymal),Cells (mesenchymal),Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10204,None
2982,RBR-5vpyh4,REBEC,2020-07-06,2020-08-28,False,"Pesquisador - Belo Horizonte, MG, Brazil",Recruiting,Phase 2,Interventional,Brazil,Use of Anti-IL-17 in patients with Covid-19 associated pneumonia,Drug,Anti-IL-17,Anti-IL-17,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9729,None
2983,RBR-2fvjjm,REBEC,2020-08-11,2020-08-18,False,Universidade Federal de Minas Gerais,Recruiting,Not Applicable,Interventional,Brazil,Hyperbaric Oxygen Therapy for hospitalized patients with Covid-19,Drug,Oxygen,Oxygen,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10039,None
2984,RBR-35vwq9,REBEC,2020-09-07,2020-08-15,True,Centro de Referência do Idoso da Zona Norte,Recruiting,Not Applicable,Observational,Brazil,Telephone orientation on the health of elderly during COVID-19 pandemic,Telehealth,Telehealth,Telehealth,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10166,None
2985,RBR-4scq8h,REBEC,2020-09-09,2020-07-09,True,Universidad Federico Henríquez y Carvajal,Recruiting,Not Applicable,Observational,Dominican Republic,Periodontal problems in covid-positive but asymptomatic patients,Clinical Presentation,No Intervention,No Intervention,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10447,None
2986,RBR-65qxs2,REBEC,2020-09-17,2020-01-07,True,Hospital Universitário de Brasília,Recruiting,Not Applicable,Observational,Brazil,"Effects of COVID-19 on pregnancy, childbirth, puerperium, neonatal period and child development: prospective, multicenter cohort study",Clinical Presentation,No Intervention,No Intervention,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10065,None
2987,RBR-5d4dj5,REBEC,2020-09-17,2020-03-14,True,University de São Paulo,Not Recruiting,Not Applicable,Observational,Brazil,Group of patients admitted to the emergency department with COVID-19,Clinical Presentation,No Intervention,No Intervention,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10496,None
2988,RBR-9rnkbs,REBEC,2020-09-22,2020-01-09,True,Pontificia Universidade Catolica do Rio Grande do Sul,Recruiting,Not Applicable,Interventional,Brazil,Effectiveness of an equipment to reduce the dispersion of particles in emergency dental care during the Covid-19 pandemic,Other,Other,Other,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10530,None
2989,RBR-8nfx26,REBEC,2020-09-22,2020-10-10,False,Brazilian National Council for Scientific and Technological Development (CNPq),Not Recruiting,Phase 2,Interventional,Brazil,Effect of Inhaled Nitric Oxide for the treatment of COVID-19,Drug,Nitric Oxide,Nitric Oxide,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10112,None
2990,RBR-97nt6j,REBEC,2020-09-24,2020-09-25,False,Associação Brasileira de Ozonioterapia (ABOZ),Not Recruiting,Phase 1/Phase 2,Interventional,Brazil,Multicenter Study of the Integrative and Complementary Practice of the Use of Ozone Gas in Outpatients with Covid-19,Drug,Ozone,Ozone,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10463,None
2991,RBR-5v3k5d,REBEC,2020-10-02,2020-05-07,True,Sociedade Brasileira de Ozonioterapia Médica (SOBOM),Recruiting,Phase 3,Interventional,Brazil,Study of the use of ozone therapy adjunct to the treatment of Covid-19 infections,Drug,Ozone,Ozone,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10467,None
2992,RBR-8h7q82,REBEC,2020-10-02,2020-01-05,True,Universidade Federal de Roraima,Not Recruiting,Phase 2,Interventional,Brazil,"The effect of chloroquine, hydroxychloroquine OR ivermectin in patients with severe manifestations of coronavirus",Drug,Chloroquine vs. Hydroxychloroquine vs. Ivermectin,Chloroquine; Hydroxychloroquine; Ivermectin,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10560,None
2993,RBR-2xxrrq,REBEC,2020-10-02,2020-08-13,True,Universidade Federal de  São Paulo,Not Recruiting,Not Applicable,Interventional,Brazil,The effect of cardiac massage training in patients with cardiac arrest with COVID-19 positioned in the ventral position.,Procedure,Cardiac massage,Cardiac massage,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10408,None
2994,RBR-63hzd3,REBEC,2020-10-06,2020-01-05,True,Associação EvangA(c)lica Beneficente de Minas Gerais,Recruiting,Not Applicable,Observational,Brazil,Consequences of COVID-19 in dialytic patients,Clinical Presentation,No Intervention,No Intervention,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9799,None
2995,RBR-825p57,REBEC,2020-10-08,2020-09-20,True,Federal University of São Carlos,Recruiting,Not Applicable,Interventional,Brazil,Telerehabilitation for elderly people with Alzheimer's disease and their caregivers,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/9943,None
2996,RBR-4nr86m,REBEC,2020-08-24,2020-08-06,True,Universidade Federal do Rio de Janeiro,Recruiting,Phase 2,Interventional,Brazil,Effects of Nitazoxanide Administration to Patients in the Initial Phase of COVID-19,Drug,Nitazoxanide,Nitazoxanide,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10311,None
2997,RBR-58ftdj,REBEC,2020-10-28,2020-10-08,True,University de São Paulo,Recruiting,Not Applicable,Interventional,Brazil,"Evaluation of the Effectiveness of an Oral Antiseptic in Improving the Clinical Status, Decreasing Viral Load and Its Prolonged Action in Patients with COVID-19",Drug,Mouthwash,Mouthwash,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10239,None
2998,RBR-9b6kvp,REBEC,2020-10-29,2020-02-11,True,Universidade Federal do Rio Grande,Not Recruiting,Not Applicable,Interventional,Brazil,"Effect of a Cloth Mask Physical Exercise session on Cardiovascular health, Feeling and Exercise Effort, Oxygen Quantity and Jumping Performance: Recommendation for Physical Mask Exercise during and after the COVID-19 global outbreak",Other (device),Masks,Masks,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10606,None
2999,RBR-4kjqtg,REBEC,2020-08-05,2020-05-08,True,Universidade Federal de Goias,Recruiting,Phase 2,Interventional,Brazil,Testing of BCG vaccine against COVID-19,ATMP,Vaccine,Vaccine,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10338,None
3000,RBR-8x8g36,REBEC,2020-10-29,2020-01-11,True,Instituto Federal do Paraná,Not Recruiting,Phase 3,Interventional,Brazil,Effectiveness of a mouthwash and toothpaste containing PHTALOX in controlling symptoms of COVID-19 and flu,Drug,Mouthwash,Mouthwash,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10682,None
3001,RBR-5d7hkv,REBEC,2020-11-03,2020-11-09,False,Escola de Educação Física e Esporte de Ribeirão Preto,Recruiting,Not Applicable,Interventional,Brazil,Effect of Moderate Physical Training on a bicycle associated with altitude simulation on the health status of people recovered from COVID-19 (AEROBI-COVID),Other (exercise),Exercise,Exercise,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10638,None
3002,RBR-2fvw6v,REBEC,2020-11-16,2021-05-04,False,Universidade Federal de Alfenas,Not Recruiting,Not Applicable,Interventional,Brazil,"Analysis of motor response time, electromyography and muscle strength in volunteers from the group at risk for covid-19 submitted to a home exercise protocol: randomized controlled clinical trial, cross over

",Other (exercise),Exercise,Exercise,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10450,None
3003,RBR-2z5t7z,REBEC,2020-11-16,2020-04-10,True,Anhembi Morumbi,Recruiting,Phase 1,Interventional,Brazil,Light on COVID-19,Other (device),infrared LED,infrared LED,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10620,None
3004,RBR-4jh63b,REBEC,2020-11-19,2020-11-23,False,StemCorp,Recruiting,Phase 1/Phase 2,Interventional,Brazil,Evaluation of stem cells treatment in Covid-19 patients,ATMP,Cells (mesenchymal),Cells (mesenchymal),Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10602,None
3005,RBR-5p8nzk6,REBEC,2020-11-25,2020-03-11,True,Universidade Federal de Santa Catarina,Recruiting,Not Applicable,Observational,Brazil,Treatment of COVID-19 sequelae with physical exercises,Other (exercise),Exercise,Exercise,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10748,None
3006,RBR-8tygcz7,REBEC,2020-12-01,2020-11-16,True,Universidade Estadual de Londrina,Recruiting,Not Applicable,Observational,Brazil,"Determination of the effectiveness of a mouthwash and nasal spray in clinical improvement, decrease in the number of viruses and their prolonged action in patients with Covid-19",Drug,Mouthwash,Mouthwash,Not Available,http://ensaiosclinicos.gov.br/xml_ictrp/downloadxmlictrp/10702,None
3007,NCT00571389,ClinicalTrials.gov,2007-12-10,2007-11-01,True,"BioCytics, Inc.",Recruiting,Not Applicable,Observational,United States,Isolation and Culture of Immune Cells and Circulating Tumor Cells From Peripheral Blood and Leukapheresis Products,Not relevant,Not relevant,Not relevant,1000,https://clinicaltrials.gov/show/NCT00571389,None
3008,NCT01306084,ClinicalTrials.gov,2011-02-26,2011-03-05,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Not Applicable,Observational,United States,Viral Infections in Healthy and Immunocompromised Hosts,Not relevant,Not relevant,Not relevant,1000,https://clinicaltrials.gov/show/NCT01306084,None
3009,NCT01520506,ClinicalTrials.gov,2012-01-25,2012-05-01,False,Medtronic,Not Recruiting,Not Applicable,Interventional,"New Zealand, Germany, Italy, Luxembourg, Belgium, Netherlands",Rapid Renal Sympathetic Denervation for Resistant Hypertension,Not relevant,Not relevant,Not relevant,50,https://clinicaltrials.gov/show/NCT01520506,None
3010,NCT02047305,ClinicalTrials.gov,2014-01-24,2009-01-01,True,Covidien,Not Recruiting,Not Applicable,Interventional,China,Radiofrequency Ablation for Patients With Esophageal Squamous Cell Neoplasia,Not relevant,Not relevant,Not relevant,96,https://clinicaltrials.gov/show/NCT02047305,None
3011,NCT02470416,ClinicalTrials.gov,2015-06-02,2015-10-01,False,Western Sydney Local Health District,Not Recruiting,Not Applicable,Interventional,Australia,Prevalence of Small Bowel Polyps in Patients With Sporadic Duodenal Adenomas,Not relevant,Not relevant,Not relevant,177,https://clinicaltrials.gov/show/NCT02470416,None
3012,NCT02586415,ClinicalTrials.gov,2015-10-21,2016-04-01,False,Gregory W Albers,Not Recruiting,Not Applicable,Interventional,United States,Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3,Not relevant,Not relevant,Not relevant,182,https://clinicaltrials.gov/show/NCT02586415,None
3013,NCT02731079,ClinicalTrials.gov,2016-03-30,2018-01-22,False,William Beaumont Army Medical Center,Recruiting,Not Applicable,Interventional,United States,Sleeve Gastrectomy Outcomes With Different Stapling Devices,Not relevant,Not relevant,Not relevant,150,https://clinicaltrials.gov/show/NCT02731079,None
3014,NCT02765191,ClinicalTrials.gov,2016-05-02,2016-04-01,True,Uppsala University,Recruiting,Not Applicable,Interventional,Sweden,MR-Evaluation of Renal Function In Septic Patients,Not relevant,Not relevant,Not relevant,20,https://clinicaltrials.gov/show/NCT02765191,None
3015,NCT02788903,ClinicalTrials.gov,2016-05-27,2016-03-01,True,Milton S. Hershey Medical Center,Not Recruiting,Not Applicable,Observational,No Country Given,A Patient-Centered PaTH to Addressing Diabetes,Not relevant,Not relevant,Not relevant,2000000,https://clinicaltrials.gov/show/NCT02788903,None
3016,NCT03024021,ClinicalTrials.gov,2016-12-21,2016-09-01,True,Tepecik Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,Cerebral Oxymetry and Neurological Outcome in Therapeutic Hypothermia,Not relevant,Not relevant,Not relevant,100,https://clinicaltrials.gov/show/NCT03024021,None
3017,NCT03042143,ClinicalTrials.gov,2017-02-01,2019-01-07,True,Belfast Health and Social Care Trust,Recruiting,Phase 1/Phase 2,Interventional,United Kingdom,Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration (REALIST) (COVID-19),Not relevant,Not relevant,Not relevant,75,https://clinicaltrials.gov/show/NCT03042143,EUCTR2017-000584-33
3018,NCT03147534,ClinicalTrials.gov,2017-04-19,2017-02-01,True,ARC Devices,Not Recruiting,Not Applicable,Interventional,Canada,Comparison of Thermometry in Canada for Pediatrics,Not relevant,Not relevant,Not relevant,89,https://clinicaltrials.gov/show/NCT03147534,None
3019,NCT03183570,ClinicalTrials.gov,2017-05-08,2017-11-08,False,Stanford University,Recruiting,Phase 1,Interventional,United States,"Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT",Not relevant,Not relevant,Not relevant,30,https://clinicaltrials.gov/show/NCT03183570,None
3020,NCT03226886,ClinicalTrials.gov,2017-07-06,2012-02-05,True,Royal Marsden NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,TRACERx Renal CAPTURE Sub-study,Not relevant,Not relevant,Not relevant,360,https://clinicaltrials.gov/show/NCT03226886,None
3021,NCT03305341,ClinicalTrials.gov,2017-10-04,2020-07-18,False,Dr. Han Xu,Not Recruiting,Phase 1,Interventional,United States,Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologics,Not relevant,Not relevant,Not relevant,20,https://clinicaltrials.gov/show/NCT03305341,None
3022,NCT03331445,ClinicalTrials.gov,2017-10-25,2017-10-24,True,Chris Miller,Recruiting,Phase 2,Interventional,Canada,Inhaled Gaseous Nitric Oxide (gNO) Antimicrobial Treatment of Difficult Bacterial and Viral Lung (COVID-19) Infections,Not relevant,Not relevant,Not relevant,20,https://clinicaltrials.gov/show/NCT03331445,None
3023,NCT03348670,ClinicalTrials.gov,2017-11-15,2020-07-20,False,Dr. Han Xu,Not Recruiting,Phase 1,Interventional,United States,Discovery Stage (Proof-of-concept) COVID-19 Antigen Presentation Therapeutic Biologics (COVID-19--AP),Not relevant,Not relevant,Not relevant,20,https://clinicaltrials.gov/show/NCT03348670,None
3024,NCT03368911,ClinicalTrials.gov,2017-11-30,2017-12-01,False,Chonnam National University Hospital,Not Recruiting,Not Applicable,Interventional,South Korea,The Effect of Reinforced Endotracheal Tube on Post-operative Hoarseness Undergoing Thyroidectomy,Not relevant,Not relevant,Not relevant,140,https://clinicaltrials.gov/show/NCT03368911,None
3025,NCT03376854,ClinicalTrials.gov,2017-12-07,2018-05-01,False,"University of Maryland, Baltimore",Recruiting,Phase 2,Interventional,United States,Pilot RCT of Therapeutic Hypothermia Plus Neuromuscular Blockade in COVID-19 Patients With ARDS,Not relevant,Not relevant,Not relevant,20,https://clinicaltrials.gov/show/NCT03376854,None
3026,NCT03452774,ClinicalTrials.gov,2018-02-13,2018-01-01,True,"Massive Bio, Inc.",Recruiting,Not Applicable,Observational,United States,SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry,Not relevant,Not relevant,Not relevant,1500,https://clinicaltrials.gov/show/NCT03452774,None
3027,NCT03527329,ClinicalTrials.gov,2018-05-03,2014-03-01,True,Dr. Negrin University Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Perioperative Hypothermia in Patients Submitted to Transurethral Resection,Not relevant,Not relevant,Not relevant,300,https://clinicaltrials.gov/show/NCT03527329,None
3028,NCT03630887,ClinicalTrials.gov,2018-08-08,2018-08-14,False,Dr. Negrin University Hospital,Not Recruiting,Not Applicable,Interventional,Spain,Prevention of Perioperative Hypothermia in Patients Submitted to Transurethral Resection,Not relevant,Not relevant,Not relevant,297,https://clinicaltrials.gov/show/NCT03630887,None
3029,NCT03680274,ClinicalTrials.gov,2018-09-19,2018-11-08,False,University of Sherbrooke,Recruiting,Phase 3,Interventional,Canada,Lessening Organ Dysfunction With VITamin C,Not relevant,Not relevant,Not relevant,800,https://clinicaltrials.gov/show/NCT03680274,None
3030,NCT03808922,ClinicalTrials.gov,2019-01-16,2019-05-23,True,"Ansun Biopharma, Inc.",Recruiting,Phase 3,Interventional,"Denmark, Taiwan, South Korea, France, China, United States, Australia",Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study,Not relevant,Not relevant,Not relevant,250,https://clinicaltrials.gov/show/NCT03808922,EUCTR2018-004318-16
3031,NCT03891420,ClinicalTrials.gov,2019-03-15,2020-04-09,False,BioCryst Pharmaceuticals,Recruiting,Phase 1,Interventional,Brazil,"A Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19",Not relevant,Not relevant,Not relevant,132,https://clinicaltrials.gov/show/NCT03891420,None
3032,NCT03907891,ClinicalTrials.gov,2019-04-03,2019-08-01,False,"University of Illinois, Chicago",Recruiting,Not Applicable,Interventional,United States,Reducing Hopelessness Through Improved Physical Activity in Adults With Heart Disease: With COVID-19 Considerations,Not relevant,Not relevant,Not relevant,225,https://clinicaltrials.gov/show/NCT03907891,None
3033,NCT04025580,ClinicalTrials.gov,2019-07-18,2019-10-02,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Phase 2,Interventional,United States,Systems Analyses of the Immune Response to the Seasonal Influenza Vaccine,Not relevant,Not relevant,Not relevant,300,https://clinicaltrials.gov/show/NCT04025580,None
3034,NCT04061382,ClinicalTrials.gov,2019-07-30,2019-10-15,True,University of Oxford,Recruiting,Not Applicable,Observational,United Kingdom,Sero-epidemiological Survey of England in 2019/2020,Not relevant,Not relevant,Not relevant,3500,https://clinicaltrials.gov/show/NCT04061382,ISRCTN11952463
3035,NCT04107402,ClinicalTrials.gov,2019-04-11,2019-03-15,True,"University Clinic, UCLouvain",Recruiting,Not Applicable,Interventional,Belgium,PLatelets Acetyl-CoA Carboxylase Phosphorylation State in SEPtic Shock,Not relevant,Not relevant,Not relevant,150,https://clinicaltrials.gov/show/NCT04107402,None
3036,NCT04148430,ClinicalTrials.gov,2019-10-30,2019-10-30,False,Memorial Sloan Kettering Cancer Center,Recruiting,Phase 2,Interventional,United States,A Study of Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy,Not relevant,Not relevant,Not relevant,90,https://clinicaltrials.gov/show/NCT04148430,None
3037,NCT04160975,ClinicalTrials.gov,2019-11-08,2019-12-20,False,Harvard University,Recruiting,Not Applicable,Interventional,United States,Persuasion in Medicine: Experimental Evidence on Sender and Signal Effects,Not relevant,Not relevant,Not relevant,3350,https://clinicaltrials.gov/show/NCT04160975,None
3038,NCT04177927,ClinicalTrials.gov,2019-11-20,2019-07-01,True,Istanbul Medeniyet University,Recruiting,Not Applicable,Interventional,Turkey,Endtidalcarbondioxide Monitoring,Not relevant,Not relevant,Not relevant,60,https://clinicaltrials.gov/show/NCT04177927,None
3039,NCT04233268,ClinicalTrials.gov,2020-01-15,2020-04-06,False,Cambridge University Hospitals NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,RASCALS: Rapid Assay for Sick Children With Acute Lung Infection Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,250,https://clinicaltrials.gov/show/NCT04233268,None
3040,NCT04244591,ClinicalTrials.gov,2020-01-23,2020-01-26,False,Peking Union Medical College Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,China,Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure,Drug,Corticosteroids,Methylprednisolone,80,https://clinicaltrials.gov/show/NCT04244591,None
3041,NCT04245631,ClinicalTrials.gov,2020-01-26,2020-01-01,True,Beijing Ditan Hospital,Recruiting,Not Applicable,Observational,China,"Development of a Simple, Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://clinicaltrials.gov/show/NCT04245631,None
3042,NCT04251767,ClinicalTrials.gov,2020-01-30,2020-02-05,False,The Second Hospital of Nanjing Medical University,Not Recruiting,Not Applicable,Interventional,China,Washed Microbiota Transplantation for Patients With 2019-nCoV Infection,ATMP,Intestinal microbiome,Intestinal microbiome,0,https://clinicaltrials.gov/show/NCT04251767,None
3043,NCT04251871,ClinicalTrials.gov,2020-01-28,2020-01-22,True,Beijing 302 Hospital,Recruiting,Not Applicable,Interventional,China,Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,150,https://clinicaltrials.gov/show/NCT04251871,None
3044,NCT04252118,ClinicalTrials.gov,2020-01-27,2020-01-27,False,Beijing 302 Hospital,Recruiting,Phase 1,Interventional,China,Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04252118,None
3045,NCT04252274,ClinicalTrials.gov,2020-01-29,2020-01-30,False,Shanghai Public Health Clinical Center,Recruiting,Phase 3,Interventional,China,Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19,Drug,Darunavir + Cobicistat,Darunavir; Cobicistat,30,https://clinicaltrials.gov/show/NCT04252274,None
3046,NCT04252664,ClinicalTrials.gov,2020-01-31,2020-02-12,False,Capital Medical University,Not Recruiting,Phase 3,Interventional,China,A Trial of Remdesivir in Adults With Mild and Moderate COVID-19,Drug,Remdesivir,Remdesivir,308,https://clinicaltrials.gov/show/NCT04252664,None
3047,NCT04252820,ClinicalTrials.gov,2020-01-31,2020-03-01,False,Dr. Negrin University Hospital,Not Recruiting,Not Applicable,Interventional,Spain,Prevention of Perioperative Hypothermia in Transurethral Resection Under Spinal Anaesthesia,Not relevant,Not relevant,Not relevant,215,https://clinicaltrials.gov/show/NCT04252820,None
3048,NCT04252885,ClinicalTrials.gov,2020-01-30,2020-01-28,True,Guangzhou Eighth People's Hospital,Not Recruiting,Phase 4,Interventional,China,The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection,Drug,Lopinavir/ritonavir vs. umifenovir,Lopinavir/ritonavir; Umifenovir,86,https://clinicaltrials.gov/show/NCT04252885,None
3049,NCT04254874,ClinicalTrials.gov,2020-02-02,2020-02-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia",Drug,Interferon + Umifenovir vs. Umifenovir,Interferon; Umifenovir,100,https://clinicaltrials.gov/show/NCT04254874,None
3050,NCT04255017,ClinicalTrials.gov,2020-02-02,2020-02-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,"A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia",Drug,Umeprevir vs. Oseltamivir vs. lopinavir/ritonavir,Umeprevir; Oseltamivir; Lopinavir/ritonavir,400,https://clinicaltrials.gov/show/NCT04255017,None
3051,NCT04255940,ClinicalTrials.gov,2020-02-03,2020-01-20,True,Qilu Hospital of Shandong University,Recruiting,Not Applicable,Observational,China,2019-nCoV Outbreak and Cardiovascular Diseases,Clinical Presentation,No Intervention,No Intervention,12000,https://clinicaltrials.gov/show/NCT04255940,None
3052,NCT04256395,ClinicalTrials.gov,2020-02-01,2020-02-01,False,Beijing Tsinghua Chang Gung Hospital,Not Recruiting,Not Applicable,Observational,China,Efficacy of a Self-test and Self-alert Mobile Applet in Detecting Susceptible Infection of COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,102456,https://clinicaltrials.gov/show/NCT04256395,None
3053,NCT04257656,ClinicalTrials.gov,2020-01-31,2020-02-06,False,Capital Medical University,Not Recruiting,Phase 3,Interventional,China,A Trial of Remdesivir in Adults With Severe COVID-19,Drug,Remdesivir,Remdesivir,237,https://clinicaltrials.gov/show/NCT04257656,None
3054,NCT04259892,ClinicalTrials.gov,2020-02-05,2020-02-04,True,INSERM,Recruiting,Not Applicable,Observational,"France, French Guiana",Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19.,Clinical Presentation,No Intervention,No Intervention,345,https://clinicaltrials.gov/show/NCT04259892,None
3055,NCT04260308,ClinicalTrials.gov,2020-02-03,2020-02-03,False,Huazhong University of Science and Technology,Recruiting,Not Applicable,Observational,China,A Survey of Psychological Status of Medical Workers and Residents in the Context of 2019 Novel Coronavirus Pneumonia,Other (psych),No Intervention,No Intervention,30000,https://clinicaltrials.gov/show/NCT04260308,None
3056,NCT04260594,ClinicalTrials.gov,2020-02-06,2020-02-07,False,Jieming QU,Not Recruiting,Phase 4,Interventional,No Country Given,Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus,Drug,Umifenovir,Umifenovir,380,https://clinicaltrials.gov/show/NCT04260594,None
3057,NCT04261270,ClinicalTrials.gov,2020-02-04,2020-02-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 3,Interventional,China,"A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia",Drug,ASCO9F + Ritonavir vs. Ritonavir + Oseltamivir vs. Oseltamivir,ASCO9F; Ritonavir; Oseltamivir,60,https://clinicaltrials.gov/show/NCT04261270,None
3058,NCT04261426,ClinicalTrials.gov,2020-02-06,2020-02-10,False,Peking Union Medical College Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia,ATMP,Immunoglobulin,Immunoglobulin,80,https://clinicaltrials.gov/show/NCT04261426,None
3059,NCT04261517,ClinicalTrials.gov,2020-02-06,2020-02-06,False,Shanghai Public Health Clinical Center,Not Recruiting,Phase 3,Interventional,China,Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,30,https://clinicaltrials.gov/show/NCT04261517,None
3060,NCT04261907,ClinicalTrials.gov,2020-02-06,2020-02-07,False,The First Affiliated Hospital of Zhejiang University,Not Recruiting,Not Applicable,Interventional,No Country Given,Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection,Drug,SC09 + ritonavir vs. lopinavir/ritonavir,ASC09; lopinavir/ritonavir,160,https://clinicaltrials.gov/show/NCT04261907,None
3061,NCT04262921,ClinicalTrials.gov,2020-02-06,2020-02-08,False,INSERM,Recruiting,Not Applicable,Observational,France,French COVID Cohort,Clinical Presentation,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04262921,None
3062,NCT04263402,ClinicalTrials.gov,2020-02-02,2020-02-01,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 4,Interventional,China,The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia,Drug,Corticosteroids,Methylprednisolone,100,https://clinicaltrials.gov/show/NCT04263402,None
3063,NCT04264533,ClinicalTrials.gov,2020-02-04,2020-02-14,False,ZhiYong Peng,Not Recruiting,Phase 2,Interventional,China,Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia,Drug,Vitamin C,Vitamin C,56,https://clinicaltrials.gov/show/NCT04264533,None
3064,NCT04264858,ClinicalTrials.gov,2020-02-08,2020-03-17,False,"Wuhan Union Hospital, China",Not Recruiting,Not Applicable,Interventional,China,Treatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured Patients,ATMP,Immunoglobulin,Immunoglobulin,10,https://clinicaltrials.gov/show/NCT04264858,None
3065,NCT04268537,ClinicalTrials.gov,2020-02-08,2020-02-10,False,"Southeast University, China",Not Recruiting,Phase 2,Interventional,No Country Given,Immunoregulatory Therapy for 2019-nCoV,Drug,PD1 vs. thymosin,PD1; Thymosin,120,https://clinicaltrials.gov/show/NCT04268537,None
3066,NCT04269525,ClinicalTrials.gov,2020-02-07,2020-02-06,True,ZhiYong Peng,Recruiting,Phase 2,Interventional,China,Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia,ATMP,Cells (mesenchymal),Cells (mesenchymal),16,https://clinicaltrials.gov/show/NCT04269525,None
3067,NCT04270383,ClinicalTrials.gov,2020-02-11,2020-02-15,False,Beijing Children's Hospital,Not Recruiting,Not Applicable,Observational,China,Clinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04270383,None
3068,NCT04272710,ClinicalTrials.gov,2020-02-12,2020-01-25,True,Chongqing Medical University,Not Recruiting,Not Applicable,Observational,China,Prognositc Factors in COVID-19 Patients Complicated With Hypertension,Drug,ACE inhibitors,ACE inhibitors,0,https://clinicaltrials.gov/show/NCT04272710,None
3069,NCT04273321,ClinicalTrials.gov,2020-02-15,2020-02-14,True,"Beijing Chaoyang Hospital, Capital Medical University",Not Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of Corticosteroids in COVID-19,Drug,Corticosteroids,Methylprednisolone,86,https://clinicaltrials.gov/show/NCT04273321,None
3070,NCT04273529,ClinicalTrials.gov,2020-02-14,2020-02-20,False,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Phase 2,Interventional,No Country Given,The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia,Drug,Thalidomide,Thalidomide,100,https://clinicaltrials.gov/show/NCT04273529,None
3071,NCT04273581,ClinicalTrials.gov,2020-02-14,2020-02-18,False,The First Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Phase 2,Interventional,No Country Given,The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19,Drug,Thalidomide + Corticosteroids,Thalidomide; Methylprednisolone,40,https://clinicaltrials.gov/show/NCT04273581,None
3072,NCT04273646,ClinicalTrials.gov,2020-02-14,2020-04-20,False,"Wuhan Union Hospital, China",Not Recruiting,Not Applicable,Interventional,China,Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),48,https://clinicaltrials.gov/show/NCT04273646,None
3073,NCT04273763,ClinicalTrials.gov,2020-02-14,2020-02-16,False,The Second Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19),Drug,Bromhexine + Umifenovir + Interferon alpha vs. Umifenovir + interferon alpha,Bromhexine; Umifenovir; interferon alpha,18,https://clinicaltrials.gov/show/NCT04273763,None
3074,NCT04274322,ClinicalTrials.gov,2020-02-16,2020-02-19,False,Peking University Third Hospital,Not Recruiting,Not Applicable,Observational,China,Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool,Other (nutrition),Nutrition,Nutrition,117,https://clinicaltrials.gov/show/NCT04274322,None
3075,NCT04275245,ClinicalTrials.gov,2020-02-06,2020-02-03,True,Tang-Du Hospital,Recruiting,Phase 1/Phase 2,Interventional,China,Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia,Drug,Mepolizumab,Mepolizumab,20,https://clinicaltrials.gov/show/NCT04275245,None
3076,NCT04275388,ClinicalTrials.gov,2020-02-17,2020-05-15,False,Jiangxi Qingfeng Pharmaceutical Co. Ltd.,Not Recruiting,Not Applicable,Observational,No Country Given,Xiyanping Injection for the Treatment of New Coronavirus Infected Pneumonia,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,426,https://clinicaltrials.gov/show/NCT04275388,None
3077,NCT04275414,ClinicalTrials.gov,2020-02-14,2020-02-15,False,Qilu Hospital of Shandong University,Not Recruiting,Phase 2,Interventional,"China, Italy",Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia,Drug,Bevacizumab,Bevacizumab,27,https://clinicaltrials.gov/show/NCT04275414,None
3078,NCT04275947,ClinicalTrials.gov,2020-02-17,2020-02-14,True,Chinese Alliance Against Lung Cancer,Recruiting,Not Applicable,Observational,China,The COVID-19 Mobile Health Study (CMHS),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,450,https://clinicaltrials.gov/show/NCT04275947,None
3079,NCT04276688,ClinicalTrials.gov,2020-02-11,2020-02-10,True,University of Hong Kong,Not Recruiting,Phase 2,Interventional,Hong Kong,"Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment",Drug,Lopinavir/ritonavir + Ribavirin + Interferon beta,Lopinavir/ritonavir; Ribavirin; Interferon beta,127,https://clinicaltrials.gov/show/NCT04276688,None
3080,NCT04276896,ClinicalTrials.gov,2020-02-17,2020-03-24,False,Shenzhen Geno-Immune Medical Institute,Recruiting,Phase 1/Phase 2,Interventional,China,Immunity and Safety of Covid-19 Synthetic Minigene Vaccine,ATMP,Vaccine,Vaccine,100,https://clinicaltrials.gov/show/NCT04276896,None
3081,NCT04276987,ClinicalTrials.gov,2020-02-16,2020-02-15,True,Ruijin Hospital,Not Recruiting,Phase 1,Interventional,China,A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia,ATMP,Cells (mesenchymal),Cells (mesenchymal),24,https://clinicaltrials.gov/show/NCT04276987,None
3082,NCT04278404,ClinicalTrials.gov,2020-02-18,2020-03-05,False,Duke University,Recruiting,Not Applicable,Observational,"United States, Canada","Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)",Drug,Other,Other,5000,https://clinicaltrials.gov/show/NCT04278404,None
3083,NCT04278963,ClinicalTrials.gov,2020-02-19,2020-02-27,False,China Academy of Chinese Medical Sciences,Not Recruiting,Phase 2/Phase 3,Interventional,China,Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,https://clinicaltrials.gov/show/NCT04278963,None
3084,NCT04279197,ClinicalTrials.gov,2020-02-15,2020-04-23,False,ShuGuang Hospital,Recruiting,Phase 2,Interventional,China,Treatment of Pulmonary Fibrosis Due to COVID-19 With Fuzheng Huayu,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,160,https://clinicaltrials.gov/show/NCT04279197,None
3085,NCT04279782,ClinicalTrials.gov,2020-02-15,2020-01-20,True,The Third Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Observational,China,Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04279782,None
3086,NCT04279795,ClinicalTrials.gov,2020-02-19,2020-01-20,True,The Third Affiliated Hospital of Sun Yat-Sen University,Recruiting,Not Applicable,Observational,China,Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04279795,None
3087,NCT04279899,ClinicalTrials.gov,2020-02-18,2020-02-01,True,Children's Hospital of Fudan University,Recruiting,Not Applicable,Observational,China,The Investigation of the Neonates With or With Risk of COVID-19,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04279899,None
3088,NCT04280224,ClinicalTrials.gov,2020-02-13,2020-02-15,False,Xinxiang Medical University,Recruiting,Phase 1,Interventional,China,NK Cells Treatment for COVID-19,ATMP,Cells (NK),Cells (NK),30,https://clinicaltrials.gov/show/NCT04280224,None
3089,NCT04280588,ClinicalTrials.gov,2020-02-20,2020-02-22,False,The First Affiliated Hospital of Fujian Medical University,Not Recruiting,Phase 2,Interventional,China,Fingolimod in COVID-19,Drug,Fingolimod,Fingolimod,0,https://clinicaltrials.gov/show/NCT04280588,None
3090,NCT04280913,ClinicalTrials.gov,2020-02-20,2020-02-22,False,Guangzhou Institute of Respiratory Disease,Not Recruiting,Not Applicable,Observational,China,Clinical Outcomes of Patients With COVID19,Clinical Presentation,No Intervention,No Intervention,0,https://clinicaltrials.gov/show/NCT04280913,None
3091,NCT04281693,ClinicalTrials.gov,2020-02-20,2020-02-01,True,Affiliated Hospital to Academy of Military Medical Sciences,Not Recruiting,Not Applicable,Interventional,China,A New Screening Strategy for 2019 Novel Coronavirus Infection,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,230,https://clinicaltrials.gov/show/NCT04281693,None
3092,NCT04282902,ClinicalTrials.gov,2020-02-10,2020-02-04,False,Huilan Zhang,Recruiting,Phase 3,Interventional,China,A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection,Drug,Pirfenidone,Pirfenidone,294,https://clinicaltrials.gov/show/NCT04282902,ChiCTR2000030333
3093,NCT04283396,ClinicalTrials.gov,2020-02-13,2020-02-21,False,"Wuhan Union Hospital, China",Recruiting,Not Applicable,Observational,China,Study for Novel Coronavirus Pneumonia (NCP),Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04283396,None
3094,NCT04284046,ClinicalTrials.gov,2020-02-22,2020-01-31,True,Shanghai General Hospital of Shanghai Jiaotong University,Not Recruiting,Not Applicable,Observational,China,CT Scores Predict Mortality in 2019-nCoV Pneumonia,Prognosis,No Intervention,No Intervention,39,https://clinicaltrials.gov/show/NCT04284046,None
3095,NCT04285190,ClinicalTrials.gov,2020-02-19,2020-02-26,False,"Tasly Pharmaceuticals, Inc.",Not Recruiting,Not Applicable,Interventional,No Country Given,The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,0,https://clinicaltrials.gov/show/NCT04285190,None
3096,NCT04285801,ClinicalTrials.gov,2020-02-24,2020-02-14,True,Chinese University of Hong Kong,Not Recruiting,Not Applicable,Observational,Hong Kong,Critically Ill Patients With COVID-19 in Hong Kong: a Multicentre Observational Cohort Study,Clinical Presentation,No Intervention,No Intervention,8,https://clinicaltrials.gov/show/NCT04285801,None
3097,NCT04286503,ClinicalTrials.gov,2020-02-25,2020-02-23,True,"Beijing You'an Hospital, Capital Medical University",Not Recruiting,Phase 4,Interventional,No Country Given,The Clinical Study of Carrimycin on Treatment Patients With COVID-19,Drug,Carrimycin vs. lopinavir/ritonavir or Umifenovir or chloroquine,Carrimycin; lopinavir; ritonavir; Umifenovir; chloroquine,520,https://clinicaltrials.gov/show/NCT04286503,None
3098,NCT04287686,ClinicalTrials.gov,2020-02-21,2020-02-01,True,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Not Applicable,Interventional,China,Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19,Drug,ACE enzyme,ACE enzyme,0,https://clinicaltrials.gov/show/NCT04287686,None
3099,NCT04288102,ClinicalTrials.gov,2020-02-24,2020-03-05,False,Beijing 302 Hospital,Not Recruiting,Phase 2,Interventional,China,Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),100,https://clinicaltrials.gov/show/NCT04288102,None
3100,NCT04288713,ClinicalTrials.gov,2020-02-27,2019-10-01,True,Hudson Medical,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Eculizumab (Soliris) in Covid-19 Infected Patients,Drug,Eculizumab,Eculizumab,Not Available,https://clinicaltrials.gov/show/NCT04288713,None
3101,NCT04290780,ClinicalTrials.gov,2020-02-27,2020-03-09,False,Hospices Civils de Lyon,Recruiting,Not Applicable,Observational,France,COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04290780,None
3102,NCT04290858,ClinicalTrials.gov,2020-02-27,2020-03-01,False,Xijing Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 Infection,Drug,Nitric oxide,Nitric oxide,0,https://clinicaltrials.gov/show/NCT04290858,None
3103,NCT04290871,ClinicalTrials.gov,2020-02-27,2020-03-23,False,Xijing Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19.,Drug,Nitric oxide,Nitric oxide,0,https://clinicaltrials.gov/show/NCT04290871,None
3104,NCT04291053,ClinicalTrials.gov,2020-02-27,2020-04-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,The Efficacy and Safety of Huai er in the Adjuvant Treatment of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,550,https://clinicaltrials.gov/show/NCT04291053,None
3105,NCT04291729,ClinicalTrials.gov,2020-02-27,2020-02-17,True,The Ninth Hospital of Nanchang,Not Recruiting,Phase 4,Interventional,China,Evaluation of Ganovo (Danoprevir ) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,Drug,Danoprevir + Ritonavir (w/ or w/o Interferon),Danoprevir; Ritonavir; Interferon,11,https://clinicaltrials.gov/show/NCT04291729,None
3106,NCT04292327,ClinicalTrials.gov,2020-02-23,2020-01-01,True,Fujian Provincial Hospital,Not Recruiting,Not Applicable,Observational,China,Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus,Clinical Presentation,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04292327,None
3107,NCT04292340,ClinicalTrials.gov,2020-02-25,2020-02-01,True,Shanghai Public Health Clinical Center,Recruiting,Not Applicable,Observational,China,Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19,ATMP,Plasma,Plasma,15,https://clinicaltrials.gov/show/NCT04292340,None
3108,NCT04292730,ClinicalTrials.gov,2020-02-28,2020-03-15,True,Gilead Sciences,Not Recruiting,Phase 3,Interventional,"Taiwan, Sweden, South Korea, Japan, Germany, Italy, France, Hong Kong, China, Singapore, Netherlands, Iran, United Kingdom, United States, Switzerland, Spain",Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment,Drug,Remdesivir,Remdesivir,1113,https://clinicaltrials.gov/show/NCT04292730,EUCTR2020-000842-32; ISRCTN85762140
3109,NCT04292899,ClinicalTrials.gov,2020-02-28,2020-03-06,True,Gilead Sciences,Not Recruiting,Phase 3,Interventional,"Taiwan, Sweden, South Korea, Japan, Germany, Italy, France, Hong Kong, China, Singapore, Netherlands, United Kingdom, United States, Switzerland, Spain",Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Severe Coronavirus Disease (COVID-19),Drug,Remdesivir,Remdesivir,4891,https://clinicaltrials.gov/show/NCT04292899,EUCTR2020-000841-15; ISRCTN15874265
3110,NCT04292964,ClinicalTrials.gov,2020-03-01,2020-03-01,False,Chongqing Medical University,Not Recruiting,Not Applicable,Observational,China,Prognostic Factors of Patients With COVID-19,Prognosis,No Intervention,No Intervention,201,https://clinicaltrials.gov/show/NCT04292964,None
3111,NCT04293692,ClinicalTrials.gov,2020-02-24,2020-02-24,False,Puren Hospital Affiliated to Wuhan University of Science and Technology,Not Recruiting,Not Applicable,Interventional,China,Therapy for Pneumonia Patients iInfected by 2019 Novel Coronavirus,ATMP,Cells (mesenchymal),Cells (mesenchymal),0,https://clinicaltrials.gov/show/NCT04293692,None
3112,NCT04293887,ClinicalTrials.gov,2020-02-15,2020-03-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Phase 1,Interventional,No Country Given,Efficacy and Safety of IFN-a2ÃŸ in the Treatment of Novel Coronavirus Patients,Drug,Interferon alfa,Interferon alfa,328,https://clinicaltrials.gov/show/NCT04293887,None
3113,NCT04295551,ClinicalTrials.gov,2020-03-03,2020-03-14,False,Jiangxi Qingfeng Pharmaceutical Co. Ltd.,Not Recruiting,Not Applicable,Interventional,No Country Given,Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,80,https://clinicaltrials.gov/show/NCT04295551,None
3114,NCT04296643,ClinicalTrials.gov,2020-03-03,2020-04-01,False,McMaster University,Recruiting,Not Applicable,Interventional,"Canada, Israel",Medical Masks vs N95 Respirators for COVID-19,Other (device),Masks,Masks,576,https://clinicaltrials.gov/show/NCT04296643,None
3115,NCT04298060,ClinicalTrials.gov,2020-02-28,2020-07-01,False,"Ansun Biopharma, Inc.",Not Recruiting,Phase 2,Interventional,China,DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19),Drug,DAS181,DAS181,280,https://clinicaltrials.gov/show/NCT04298060,None
3116,NCT04298814,ClinicalTrials.gov,2020-02-26,2020-08-07,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,Safety Related Factors of Endotracheal Intubation in Patients With Severe Covid-19 Pneumonia,Other (physical),Endotracheal Intubation,Endotracheal Intubation,0,https://clinicaltrials.gov/show/NCT04298814,None
3117,NCT04299152,ClinicalTrials.gov,2020-02-28,2020-11-10,False,Tianhe Stem Cell Biotechnologies Inc.,Not Recruiting,Phase 2,Interventional,No Country Given,Stem Cell Educator Therapy Treat the Viral Inflammation in COVID-19,ATMP,Cells (stem cells),Cells (stem cells),20,https://clinicaltrials.gov/show/NCT04299152,None
3118,NCT04299711,ClinicalTrials.gov,2020-03-04,2020-10-15,False,University of Macau,Not Recruiting,Not Applicable,Observational,No Country Given,Mental Health and Its Correlates Among Chinese Adolescents Exposed to the Novel Coronavirus Disease 2019,Other (psych),No Intervention,No Intervention,3428,https://clinicaltrials.gov/show/NCT04299711,None
3119,NCT04299724,ClinicalTrials.gov,2020-03-05,2020-02-15,True,Shenzhen Geno-Immune Medical Institute,Recruiting,Phase 1,Interventional,China,Safety and Immunity of Covid-19 aAPC Vaccine,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04299724,None
3120,NCT04302519,ClinicalTrials.gov,2020-02-27,2020-03-05,False,"CAR-T (Shanghai) Biotechnology Co., Ltd.",Not Recruiting,Phase 1,Interventional,No Country Given,Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells,ATMP,Cells (mesenchymal),Cells (mesenchymal),24,https://clinicaltrials.gov/show/NCT04302519,None
3121,NCT04302688,ClinicalTrials.gov,2020-03-07,2019-12-10,True,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Observational,China,Accurate Classification System for Patients With COVID-19 Pneumonitis,Prognosis,No Intervention,No Intervention,669,https://clinicaltrials.gov/show/NCT04302688,None
3122,NCT04302766,ClinicalTrials.gov,2020-03-02,2019-08-12,True,U.S. Army Medical Research and Development Command,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Expanded Access Remdesivir (RDV; GS-5734â„¢),Drug,Remdesivir,Remdesivir,Not Available,https://clinicaltrials.gov/show/NCT04302766,None
3123,NCT04303299,ClinicalTrials.gov,2020-02-24,2020-08-19,False,Rajavithi Hospital,Recruiting,Phase 3,Interventional,Thailand,"Favipiravir, Protease Inhibitors, Oseltamivir -Gpo, Hydroxychloroquine for Treatment of COVID-19",Drug,"Various Combinations of: Oseltamivir, Chloroquine, Lopipinavir/Ritonavir, Darunavir/ritonavir, Favipiravir",Oseltamivir; Hydroxychloroquine; Lopinavir; Ritonavir; Darunavir; Favipiravir,320,https://clinicaltrials.gov/show/NCT04303299,None
3124,NCT04303507,ClinicalTrials.gov,2020-03-06,2020-04-29,True,University of Oxford,Recruiting,Not Applicable,Interventional,"Thailand, Pakistan, Italy, United Kingdom, Lao People's Democratic Republic, Indonesia",Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting,Drug,Chloroquine or Hydroxychloroquine,Chloroquine; hydroxychloroquine,40000,https://clinicaltrials.gov/show/NCT04303507,EUCTR2020-001441-39; ISRCTN10207947
3125,NCT04304053,ClinicalTrials.gov,2020-03-05,2020-03-18,True,Fundació Lluita contra la SIDA,Not Recruiting,Phase 3,Interventional,Spain,Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention,Drug (Chemoprophylaxis),Darunavir + cobicistat + hydroxychloroquine,Darunavir; cobicistat; hydroxychloroquine,2300,https://clinicaltrials.gov/show/NCT04304053,EUCTR2020-001031-27
3126,NCT04304313,ClinicalTrials.gov,2020-02-14,2020-02-09,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Phase 3,Interventional,China,A Pilot Study of Sildenafil in COVID-19,Drug,Sildenafil,Sildenafil,10,https://clinicaltrials.gov/show/NCT04304313,None
3127,NCT04305106,ClinicalTrials.gov,2020-03-09,2020-03-17,False,Qilu Hospital of Shandong University,Recruiting,Not Applicable,Interventional,China,Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT,Drug,Bevacizumab,Bevacizumab,140,https://clinicaltrials.gov/show/NCT04305106,None
3128,NCT04305457,ClinicalTrials.gov,2020-03-09,2020-03-21,False,Massachusetts General Hospital,Recruiting,Phase 2,Interventional,United States,Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19,Drug,Nitric oxide,Nitric oxide,70,https://clinicaltrials.gov/show/NCT04305457,None
3129,NCT04305574,ClinicalTrials.gov,2020-03-08,2020-03-07,True,Jean Liu,Not Recruiting,Not Applicable,Observational,Singapore,Social Media Use During COVID-19,Other,No Intervention,No Intervention,1145,https://clinicaltrials.gov/show/NCT04305574,None
3130,NCT04306055,ClinicalTrials.gov,2020-03-08,2020-03-13,False,Guangzhou Blood Center,Not Recruiting,Not Applicable,Interventional,China,Blood Donor Recruitment During Epidemic of COVID-19,Other,No Intervention,No Intervention,19491,https://clinicaltrials.gov/show/NCT04306055,None
3131,NCT04306393,ClinicalTrials.gov,2020-03-10,2020-03-21,True,Massachusetts General Hospital,Recruiting,Phase 2,Interventional,United States,Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19,Drug,Nitric oxide,Nitric oxide,200,https://clinicaltrials.gov/show/NCT04306393,EUCTR2020-001490-68
3132,NCT04306497,ClinicalTrials.gov,2020-03-01,2020-01-22,True,"Jiangsu Famous Medical Technology Co., Ltd.",Not Recruiting,Not Applicable,Observational,China,TCM Differentiation and Treatment Protocol of COVID-19,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,340,https://clinicaltrials.gov/show/NCT04306497,None
3133,NCT04306705,ClinicalTrials.gov,2020-03-08,2020-02-20,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19,Drug,Tocilizumab,Tocilizumab,120,https://clinicaltrials.gov/show/NCT04306705,None
3134,NCT04307459,ClinicalTrials.gov,2020-03-10,2020-03-19,False,University of Milan,Recruiting,Not Applicable,Observational,Italy,Acute Respiratory Failure and COVID-19 in Real Life,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04307459,None
3135,NCT04307693,ClinicalTrials.gov,2020-03-10,2020-03-11,False,Asan Medical Center,Not Recruiting,Phase 2,Interventional,South Korea,Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19),Drug,Lopinavir/ritonavir vs. hydroxychloroquine,Lopinavir/ritonavir; Hydroxychloroquine,65,https://clinicaltrials.gov/show/NCT04307693,None
3136,NCT04308187,ClinicalTrials.gov,2020-03-12,2020-03-11,True,"University Hospital, Clermont-Ferrand",Not Recruiting,Not Applicable,Observational,France,Influence of the COvid-19 Epidemic on STRESS,Other (psych),No Intervention,No Intervention,50000,https://clinicaltrials.gov/show/NCT04308187,None
3137,NCT04308317,ClinicalTrials.gov,2020-03-04,2020-03-05,False,Henan Provincial People's Hospital,Recruiting,Phase 4,Interventional,China,Tetrandrine Tablets Used in the Treatment of COVID-19,Drug,Tetrandrine,Tetrandrine,60,https://clinicaltrials.gov/show/NCT04308317,None
3138,NCT04308668,ClinicalTrials.gov,2020-03-11,2020-03-17,False,University of Minnesota,Not Recruiting,Phase 3,Interventional,"United States, Canada",Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1309,https://clinicaltrials.gov/show/NCT04308668,None
3139,NCT04310228,ClinicalTrials.gov,2020-03-09,2020-03-08,False,Peking University First Hospital,Recruiting,Not Applicable,Interventional,China,Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019,Drug,Favipiravir + tocilizumab vs. favipiravir vs. tocilizumab,Favipiravir; tocilizumab,150,https://clinicaltrials.gov/show/NCT04310228,ChiCTR2000030894
3140,NCT04310865,ClinicalTrials.gov,2020-03-15,2020-11-01,False,Zhong Wang,Not Recruiting,Phase 2/Phase 3,Interventional,China,Yinhu Qingwen Granula for the Treatment of Severe CoVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,116,https://clinicaltrials.gov/show/NCT04310865,None
3141,NCT04311177,ClinicalTrials.gov,2020-03-13,2020-04-09,False,University of Minnesota,Not Recruiting,Phase 2,Interventional,United States,Losartan for Patients With COVID-19 Not Requiring Hospitalization,Drug,ARB (Losartan),ARB (Losartan),580,https://clinicaltrials.gov/show/NCT04311177,None
3142,NCT04311398,ClinicalTrials.gov,2020-03-14,2020-05-13,False,Huashan Hospital,Not Recruiting,Not Applicable,Observational,China,Development and Verification of a New Coronavirus Multiplex Nucleic Acid Detection System,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04311398,None
3143,NCT04311697,ClinicalTrials.gov,2020-03-14,2020-05-15,False,"NeuroRx, Inc.",Recruiting,Phase 2,Interventional,"United States, Israel",Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure,Drug,Aviptadil,Aviptadil,165,https://clinicaltrials.gov/show/NCT04311697,None
3144,NCT04312100,ClinicalTrials.gov,2020-03-13,2020-02-01,True,Henan Provincial People's Hospital,Recruiting,Not Applicable,Observational,China,Sequential Oxygen Therapy Strategy for Patients With COVID-19,Drug,Oxygen,Oxygen,30,https://clinicaltrials.gov/show/NCT04312100,None
3145,NCT04312243,ClinicalTrials.gov,2020-03-15,2020-04-07,False,Massachusetts General Hospital,Recruiting,Phase 2,Interventional,United States,NO Prevention of COVID-19 for Healthcare Providers,Drug,Nitric oxide,Nitric oxide,470,https://clinicaltrials.gov/show/NCT04312243,None
3146,NCT04312464,ClinicalTrials.gov,2020-03-04,2020-01-01,True,"Wuhan Union Hospital, China",Recruiting,Not Applicable,Observational,China,Myocardial Damage in COVID-19,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04312464,None
3147,NCT04312997,ClinicalTrials.gov,2020-03-16,2020-06-16,False,"Pulmotect, Inc.",Recruiting,Phase 2,Interventional,United States,The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection,Drug,"PUL-042, unspecified immunomodulatory drug",PUL-042 (unspecified immunomodulatory drug),100,https://clinicaltrials.gov/show/NCT04312997,None
3148,NCT04313023,ClinicalTrials.gov,2020-03-16,2020-06-09,False,"Pulmotect, Inc.",Recruiting,Phase 2,Interventional,United States,The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2,Drug,"PUL-042, unspecified immunomodulatory drug",PUL-042 (unspecified immunomodulatory drug),200,https://clinicaltrials.gov/show/NCT04313023,None
3149,NCT04313127,ClinicalTrials.gov,2020-03-15,2020-03-16,False,CanSino Biologics Inc.,Not Recruiting,Phase 1,Interventional,China,Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults,ATMP,Adenovirus vector,Adenovirus vector,108,https://clinicaltrials.gov/show/NCT04313127,None
3150,NCT04313322,ClinicalTrials.gov,2020-03-15,2020-03-16,False,Stem Cells Arabia,Recruiting,Phase 1,Interventional,Jordan,Treatment of COVID-19 Patients Using Wharton's Jelly-Mesenchymal Stem Cells,ATMP,Cells (mesenchymal),Cells (mesenchymal),5,https://clinicaltrials.gov/show/NCT04313322,None
3151,NCT04313946,ClinicalTrials.gov,2020-03-17,2020-03-18,False,Professor Adrian Covic,Recruiting,Not Applicable,Observational,"Romania, United Kingdom, Italy",Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04313946,None
3152,NCT04314232,ClinicalTrials.gov,2020-03-17,2020-03-18,False,"University Hospital, Akershus",Recruiting,Not Applicable,Observational,Norway,Mechanisms for Covid-19 Disease Complications,Prognosis,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04314232,None
3153,NCT04314271,ClinicalTrials.gov,2020-03-16,2020-03-20,False,Xiangya Hospital of Central South University,Recruiting,Not Applicable,Observational,China,The Observational Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus Pneumonia,Clinical Presentation,No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04314271,None
3154,NCT04314817,ClinicalTrials.gov,2020-03-17,2020-03-17,False,Groupe Hospitalier Pitié Salpêtrière,Recruiting,Not Applicable,Observational,France,Adverse Events Related to Treatments Used Against Coronavirus Disease 2019,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,1000,https://clinicaltrials.gov/show/NCT04314817,None
3155,NCT04315298,ClinicalTrials.gov,2020-03-15,2020-03-18,False,Regeneron Pharmaceuticals,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19,Drug,Sarilumab,Sarilumab,1912,https://clinicaltrials.gov/show/NCT04315298,None
3156,NCT04315480,ClinicalTrials.gov,2020-03-14,2020-03-12,True,Universit Politecnica delle Marche,Not Recruiting,Phase 2,Interventional,Italy,Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis,Drug,Tocilizumab,Tocilizumab,38,https://clinicaltrials.gov/show/NCT04315480,None
3157,NCT04315870,ClinicalTrials.gov,2020-03-18,2020-01-01,True,Federico II University,Recruiting,Not Applicable,Observational,Italy,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy.,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04315870,None
3158,NCT04315896,ClinicalTrials.gov,2020-03-18,2020-04-14,False,"National Institute of Respiratory Diseases, Mexico",Not Recruiting,Phase 3,Interventional,Mexico,Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial),Drug,Hydroxychloroquine,Hydroxychloroquine,500,https://clinicaltrials.gov/show/NCT04315896,None
3159,NCT04315948,ClinicalTrials.gov,2020-03-13,2020-03-22,True,INSERM,Recruiting,Phase 3,Interventional,"Luxembourg, France, Austria, Belgium",Trial of Treatments for COVID-19 in Hospitalized Adults,Drug,Remdesivir vs. Lopinavir/ritonavir vs. Lopinavir/ritonavir + Interferon beta vs. Hydroxychloroquine,Remdesivir; Lopinavir/ritonavir; Interferon beta; Hydroxychloroquine,3100,https://clinicaltrials.gov/show/NCT04315948,EUCTR2020-000936-23
3160,NCT04315987,ClinicalTrials.gov,2020-03-18,2020-06-01,False,Azidus Brasil,Not Recruiting,Phase 2,Interventional,Brazil,NestaCellÂ® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia,ATMP,Cells (mesenchymal),Cells (mesenchymal),90,https://clinicaltrials.gov/show/NCT04315987,None
3161,NCT04316299,ClinicalTrials.gov,2020-03-17,2020-02-26,True,Zhenhua Zen,Not Recruiting,Not Applicable,Observational,China,Acute Kidney Injury in Patients Hospitalized With COVID-19,Clinical Presentation,No Intervention,No Intervention,287,https://clinicaltrials.gov/show/NCT04316299,None
3162,NCT04316377,ClinicalTrials.gov,2020-03-13,2020-03-25,False,"University Hospital, Akershus",Not Recruiting,Phase 4,Interventional,Norway,Norwegian Coronavirus Disease 2019 Study,Drug,Hydroxychloroquine,Hydroxychloroquine,53,https://clinicaltrials.gov/show/NCT04316377,None
3163,NCT04316728,ClinicalTrials.gov,2020-03-14,2020-03-01,True,"Centro Studi Internazionali, Italy",Not Recruiting,Not Applicable,Interventional,Italy,Clinical Performance of the VivaDiag â„¢ COVID-19 lgM / IgG Rapid Test in Early Detecting the Infection of COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04316728,None
3164,NCT04316884,ClinicalTrials.gov,2020-03-13,2020-03-12,True,Uppsala University,Recruiting,Not Applicable,Observational,Sweden,Mechanisms for Organ Dysfunction in Covid-19,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04316884,None
3165,NCT04317040,ClinicalTrials.gov,2020-03-19,2020-04-08,False,"OncoImmune, Inc.",Not Recruiting,Phase 3,Interventional,United States,CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment,ATMP,Gene-derived protein,Gene-derived protein,243,https://clinicaltrials.gov/show/NCT04317040,None
3166,NCT04317092,ClinicalTrials.gov,2020-03-19,2020-03-19,True,National Cancer Institute,Not Recruiting,Phase 2,Interventional,Italy,Tocilizumab in COVID-19 Pneumonia (TOCIVID-19),Drug,Tocilizumab,Tocilizumab,400,https://clinicaltrials.gov/show/NCT04317092,EUCTR2020-001110-38
3167,NCT04318015,ClinicalTrials.gov,2020-03-19,2020-04-14,False,"National Institute of Respiratory Diseases, Mexico",Recruiting,Phase 3,Interventional,Mexico,Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,400,https://clinicaltrials.gov/show/NCT04318015,None
3168,NCT04318301,ClinicalTrials.gov,2020-03-20,2020-03-21,False,Zhenhua Zen,Not Recruiting,Not Applicable,Observational,China,Hypertension in Patients Hospitalized With COVID-19,Clinical Presentation,No Intervention,No Intervention,275,https://clinicaltrials.gov/show/NCT04318301,None
3169,NCT04318314,ClinicalTrials.gov,2020-03-17,2020-03-18,False,"University College, London",Recruiting,Not Applicable,Observational,United Kingdom,COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2,Clinical Presentation,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04318314,None
3170,NCT04318366,ClinicalTrials.gov,2020-03-19,2020-03-19,False,Universita Vita-Salute San Raffaele,Recruiting,Not Applicable,Observational,Italy,"COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor",Prognosis,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04318366,None
3171,NCT04318418,ClinicalTrials.gov,2020-03-19,2020-03-23,False,Neuromed IRCCS,Not Recruiting,Not Applicable,Observational,Italy,"ACE Inhibitors, Angiotensin II Type-I Receptor Blockers and Severity of COVID-19",Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,3400,https://clinicaltrials.gov/show/NCT04318418,None
3172,NCT04318431,ClinicalTrials.gov,2020-03-20,2020-04-14,False,Centre Hospitalier Intercommunal Creteil,Not Recruiting,Not Applicable,Interventional,France,Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children,Clinical Presentation (Epidemiology),No Intervention,No Intervention,605,https://clinicaltrials.gov/show/NCT04318431,None
3173,NCT04318444,ClinicalTrials.gov,2020-03-20,2020-03-29,False,Columbia University,Recruiting,Phase 2/Phase 3,Interventional,United States,Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1600,https://clinicaltrials.gov/show/NCT04318444,None
3174,NCT04319016,ClinicalTrials.gov,2020-03-20,2020-01-01,True,Federico II University,Recruiting,Not Applicable,Observational,Italy,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04319016,None
3175,NCT04319172,ClinicalTrials.gov,2020-03-20,2020-03-12,True,Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI),Recruiting,Not Applicable,Observational,Spain,Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04319172,None
3176,NCT04319211,ClinicalTrials.gov,2020-03-20,2020-03-25,False,Istanbul University-Cerrahpasa,Not Recruiting,Not Applicable,Observational,Turkey,"Effects of Social Isolation From Coronavirus; on Physical Activity, Quality of Life and Stress",Other,Social Isolation,Social Isolation,200,https://clinicaltrials.gov/show/NCT04319211,None
3177,NCT04319315,ClinicalTrials.gov,2020-03-16,2020-03-11,True,Assiut University,Recruiting,Not Applicable,Observational,Egypt,Social Media Effect on Knowledge Dissemination During COVID-19 Virus Outbreak,Other,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04319315,None
3178,NCT04319445,ClinicalTrials.gov,2020-03-20,2020-03-22,False,Wake Forest University,Recruiting,Not Applicable,Interventional,United States,Mindfulness During COVID-19,Other (psych),Psychological,Psychological,200,https://clinicaltrials.gov/show/NCT04319445,None
3179,NCT04319731,ClinicalTrials.gov,2020-03-22,2020-03-20,True,University of Utah,Recruiting,Phase 1,Interventional,United States,A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure,ATMP,Human Amniotic Fluid,Human Amniotic Fluid,10,https://clinicaltrials.gov/show/NCT04319731,None
3180,NCT04319900,ClinicalTrials.gov,2020-03-20,2020-03-05,False,"Beijing Chaoyang Hospital, Capital Medical University",Recruiting,Phase 2/Phase 3,Interventional,China,Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia,Drug,Chloroquine + Favipiravir vs. Favipiravir,Chloroquine; favipiravir,150,https://clinicaltrials.gov/show/NCT04319900,ChiCTR2000030987
3181,NCT04320017,ClinicalTrials.gov,2020-03-20,2020-03-20,False,Groupe Hospitalier Pitié Salpêtrière,Recruiting,Not Applicable,Observational,France,Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04320017,None
3182,NCT04320056,ClinicalTrials.gov,2020-03-19,2020-04-20,False,Laval University,Recruiting,Not Applicable,Interventional,Canada,Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19),Drug,Oxygen,Oxygen,216,https://clinicaltrials.gov/show/NCT04320056,None
3183,NCT04320238,ClinicalTrials.gov,2020-03-21,2020-01-21,True,Shanghai Jiaotong University,Recruiting,Phase 3,Interventional,China,Experimental Trial of rhIFNa Nasal Drops to Prevent 2019-nCOV in Medical Staff,Drug,Interferon Alpha vs. Interferon Alpha + Thymosin Alpha,Interferon alpha; Thymosin alpha,2944,https://clinicaltrials.gov/show/NCT04320238,None
3184,NCT04320277,ClinicalTrials.gov,2020-03-20,2020-05-16,False,Hospital of Prato,Not Recruiting,Phase 2/Phase 3,Interventional,Italy,"Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study.",Drug,Baricitinib,Baricitinib,200,https://clinicaltrials.gov/show/NCT04320277,None
3185,NCT04320472,ClinicalTrials.gov,2020-03-22,2020-03-23,False,Ictal Group,Not Recruiting,Not Applicable,Observational,"Colombia, Egypt, France, Mexico, Brazil, United States, Spain",Acute Encephalopathy in Critically Ill Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04320472,None
3186,NCT04320511,ClinicalTrials.gov,2020-03-23,2020-06-24,False,William Beaumont Hospitals,Recruiting,Not Applicable,Observational,United States,Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2,Clinical Presentation,No Intervention,No Intervention,25,https://clinicaltrials.gov/show/NCT04320511,None
3187,NCT04320615,ClinicalTrials.gov,2020-03-23,2020-04-03,True,Roche,Not Recruiting,Phase 3,Interventional,"Denmark, Germany, Italy, France, Canada, Netherlands, United Kingdom, United States, Spain",A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia,Drug,Tocilizumab,Tocilizumab,450,https://clinicaltrials.gov/show/NCT04320615,EUCTR2020-001154-22
3188,NCT04320732,ClinicalTrials.gov,2020-03-23,2020-03-27,False,Oslo University Hospital,Recruiting,Not Applicable,Observational,Norway,Risk Factors for Community- and Workplace Transmission of COVID-19,Clinical Presentation,No Intervention,No Intervention,250000,https://clinicaltrials.gov/show/NCT04320732,None
3189,NCT04320862,ClinicalTrials.gov,2020-03-23,2020-04-03,False,Duke University,Recruiting,Not Applicable,Observational,United States,COVID-19 Pandemic Response Network,Clinical Presentation (Epidemiology),No Intervention,No Intervention,200000,https://clinicaltrials.gov/show/NCT04320862,None
3190,NCT04320953,ClinicalTrials.gov,2020-03-21,2020-03-16,True,Changhai Hospital,Not Recruiting,Not Applicable,Interventional,China,Non-contact Endoscopy at Covid-19 Outbreak,Other (device),Non-contact Endoscopy,Non-contact Endoscopy,5,https://clinicaltrials.gov/show/NCT04320953,None
3191,NCT04321096,ClinicalTrials.gov,2020-03-23,2020-04-04,True,Aarhus University,Recruiting,Phase 1/Phase 2,Interventional,Denmark,The Impact of Camostat Mesilate on COVID-19 Infection,Drug,Camostat Mesilate,Camostat Mesilate,580,https://clinicaltrials.gov/show/NCT04321096,EUCTR2020-001200-42
3192,NCT04321174,ClinicalTrials.gov,2020-03-18,2020-04-17,False,Darrell Tan,Recruiting,Phase 3,Interventional,Canada,COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir,Drug,Lopinavir/ritonavir,Lopinavir/ritonavir,1220,https://clinicaltrials.gov/show/NCT04321174,None
3193,NCT04321265,ClinicalTrials.gov,2020-03-19,2020-03-19,False,Heinrich-Heine University,Recruiting,Not Applicable,Observational,"France, Denmark, Germany, Norway",Outcomes and Prognostic Factors in COVID-19,Prognosis,No Intervention,No Intervention,4000,https://clinicaltrials.gov/show/NCT04321265,None
3194,NCT04321278,ClinicalTrials.gov,2020-03-23,2020-03-28,False,Hospital Israelita Albert Einstein,Not Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II),Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; azithromycin,440,https://clinicaltrials.gov/show/NCT04321278,None
3195,NCT04321369,ClinicalTrials.gov,2020-03-23,2020-03-09,True,Dr. Deneen Vojta,Not Recruiting,Not Applicable,Observational,United States,Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,533,https://clinicaltrials.gov/show/NCT04321369,None
3196,NCT04321421,ClinicalTrials.gov,2020-03-23,2020-03-17,True,Foundation IRCCS San Matteo Hospital,Not Recruiting,Not Applicable,Interventional,Italy,Hyperimmune Plasma for Critical Patients With COVID-19,ATMP,Plasma,Plasma,49,https://clinicaltrials.gov/show/NCT04321421,None
3197,NCT04321811,ClinicalTrials.gov,2020-03-23,2020-03-21,True,xCures,Recruiting,Not Applicable,Observational,United States,"Behavior, Environment And Treatments for Covid-19",Clinical Presentation,No Intervention,No Intervention,100000,https://clinicaltrials.gov/show/NCT04321811,None
3198,NCT04321928,ClinicalTrials.gov,2020-03-20,2020-04-01,False,University of Pecs,Recruiting,Not Applicable,Interventional,Hungary,Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary,Other,Health Education,Health Education,7576,https://clinicaltrials.gov/show/NCT04321928,None
3199,NCT04321993,ClinicalTrials.gov,2020-03-24,2020-04-17,False,Lisa Barrett,Recruiting,Phase 2,Interventional,Canada,Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients,Drug,Lopinavir/ritonavir vs. hydroxychloroquine vs. baricitinib vs. sarilumab,lopinavir/ritonavir; hydroxychloroquine; sarilumab,800,https://clinicaltrials.gov/show/NCT04321993,None
3200,NCT04322123,ClinicalTrials.gov,2020-03-24,2020-04-01,True,Hospital do Coração,Not Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19),Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; azithromycin,630,https://clinicaltrials.gov/show/NCT04322123,RBR-9d8z6m
3201,NCT04322188,ClinicalTrials.gov,2020-03-24,2020-03-19,True,A.O. Ospedale Papa Giovanni XXIII,Not Recruiting,Not Applicable,Observational,Italy,An Observational Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications,Drug,Siltuximab,Siltuximab,220,https://clinicaltrials.gov/show/NCT04322188,None
3202,NCT04322279,ClinicalTrials.gov,2020-03-24,2020-03-09,True,INSERM,Recruiting,Not Applicable,Observational,"France, French Guiana",Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. COVID19.,Clinical Presentation (Epidemiology),No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04322279,None
3203,NCT04322344,ClinicalTrials.gov,2020-03-23,2020-03-23,False,University of Catanzaro,Recruiting,Phase 2/Phase 3,Interventional,Italy,Escin in Patients With Covid-19 Infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,https://clinicaltrials.gov/show/NCT04322344,None
3204,NCT04322396,ClinicalTrials.gov,2020-03-23,2020-04-06,False,Chronic Obstructive Pulmonary Disease Trial Network,Recruiting,Phase 2,Interventional,Denmark,Proactive Prophylaxis With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine + Azithromycin,Hydroxychloroquine; azithromycin,226,https://clinicaltrials.gov/show/NCT04322396,None
3205,NCT04322487,ClinicalTrials.gov,2020-03-23,2020-04-08,False,Catholic University of the Sacred Heart,Recruiting,Not Applicable,Observational,Italy,"Simple, Safe, Same: Lung Ultrasound for COVID-19",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04322487,None
3206,NCT04322513,ClinicalTrials.gov,2020-03-23,2020-03-24,False,University of Catanzaro,Recruiting,Not Applicable,Observational,Italy,Biomarkers for Identification of COVID-19 Infection,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,110,https://clinicaltrials.gov/show/NCT04322513,None
3207,NCT04322565,ClinicalTrials.gov,2020-03-24,2020-04-20,True,AOU di Parma,Recruiting,Phase 2,Interventional,Italy,Colchicine Counteracting Inflammation in COVID-19 Pneumonia,Drug,Colchicine,Colchicine,310,https://clinicaltrials.gov/show/NCT04322565,EUCTR2020-001258-23
3208,NCT04322682,ClinicalTrials.gov,2020-03-23,2020-03-23,True,Montreal Heart Institute,Recruiting,Phase 3,Interventional,"Canada, Brazil, United States, South Africa, Spain",Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA),Drug,Colchicine,Colchicine,6000,https://clinicaltrials.gov/show/NCT04322682,EUCTR2020-001689-12
3209,NCT04322773,ClinicalTrials.gov,2020-03-24,2020-04-05,True,Marius Henriksen,Not Recruiting,Phase 2,Interventional,Denmark,Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure,Drug,Tocilizumab vs. sarilumab,Tocilizumab; sarilumab,20,https://clinicaltrials.gov/show/NCT04322773,EUCTR2020-001275-32
3210,NCT04322786,ClinicalTrials.gov,2020-03-23,1998-01-01,True,"University College, London",Not Recruiting,Not Applicable,Observational,No Country Given,"The Use of Angiotensin Converting Enzyme Inhibitors and Incident Respiratory Infections, Are They Harmful or Protective?",Drug,ACE inhibitors,ACE inhibitors,1302508,https://clinicaltrials.gov/show/NCT04322786,None
3211,NCT04323228,ClinicalTrials.gov,2020-03-23,2020-09-01,False,King Saud University,Recruiting,Phase 2/Phase 3,Interventional,Saudi Arabia,Anti-inflammatory/Antioxidant Oral Nutrition Supplementation in COVID-19,Supplement,Oral nutrition supplement,Oral nutrition supplement,40,https://clinicaltrials.gov/show/NCT04323228,None
3212,NCT04323332,ClinicalTrials.gov,2020-03-08,2020-03-01,True,"Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine",Not Recruiting,Phase 3,Interventional,China,Traditional Chinese Medicine for Severe COVID-19,Traditional Medicine (Unspecified),Traditional Medicine,Traditional Medicine,50,https://clinicaltrials.gov/show/NCT04323332,None
3213,NCT04323345,ClinicalTrials.gov,2020-03-23,2020-04-15,False,Misr University for Science and Technology,Recruiting,Phase 3,Interventional,Egypt,Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,1000,https://clinicaltrials.gov/show/NCT04323345,None
3214,NCT04323514,ClinicalTrials.gov,2020-03-18,2020-03-13,True,University of Palermo,Recruiting,Not Applicable,Interventional,Italy,Use of Ascorbic Acid in Patients With COVID 19,Drug,Vitamin C,Vitamin C,500,https://clinicaltrials.gov/show/NCT04323514,None
3215,NCT04323592,ClinicalTrials.gov,2020-03-19,2020-03-23,False,University of Trieste,Not Recruiting,Not Applicable,Observational,Italy,Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome,Drug,Corticosteroids,Methylprednisolone,173,https://clinicaltrials.gov/show/NCT04323592,None
3216,NCT04323631,ClinicalTrials.gov,2020-03-25,2020-04-30,False,Rambam Health Care Campus,Not Recruiting,Phase 1,Interventional,No Country Given,Hydroxychloroquine for the Treatment of Patients With Mild to Moderate COVID-19 to Prevent Progression to Severe Infection or Death,Drug,Hydroxychloroquine,Hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04323631,None
3217,NCT04323644,ClinicalTrials.gov,2020-03-25,2020-01-01,True,University of Birmingham,Recruiting,Not Applicable,Observational,Spain,Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg),Other (surgery),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04323644,None
3218,NCT04323761,ClinicalTrials.gov,2020-03-24,2020-09-15,True,Gilead Sciences,Not Recruiting,Not Applicable,Expanded Access,"Iceland, Czech Republic, Slovenia, Romania, Germany, Lithuania, Cyprus, Italy, Poland, Canada, Netherlands, Estonia, Australia, Portugal, Greece, Slovakia, Israel, Ireland, United States, Switzerland, Hungary, Denmark, France, Belgium, United Kingdom, Austria, Spain",Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19),Drug,Remdesivir,Remdesivir,Not Available,https://clinicaltrials.gov/show/NCT04323761,EUCTR2020-001453-49
3219,NCT04323787,ClinicalTrials.gov,2020-03-24,2020-03-30,False,Mayo Clinic,Recruiting,Not Applicable,Observational,United States,Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry,Clinical Presentation,No Intervention,No Intervention,50000,https://clinicaltrials.gov/show/NCT04323787,None
3220,NCT04323800,ClinicalTrials.gov,2020-03-24,2020-06-10,False,Johns Hopkins University,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma to Stem Coronavirus (CSSC-001),ATMP,Plasma,Plasma,500,https://clinicaltrials.gov/show/NCT04323800,None
3221,NCT04323839,ClinicalTrials.gov,2020-03-24,2020-03-20,True,"University of California, San Francisco",Recruiting,Not Applicable,Observational,United States,COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY),Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04323839,None
3222,NCT04323878,ClinicalTrials.gov,2020-03-25,2020-06-01,False,Mario Negri Institute for Pharmacological Research,Recruiting,Not Applicable,Observational,Italy,Early CPAP in COVID-19 Patients With Respiratory Failure. A Prospective Cohort Study.,Other (physical),Mechanical ventilation,Mechanical ventilation,3000,https://clinicaltrials.gov/show/NCT04323878,None
3223,NCT04324047,ClinicalTrials.gov,2020-03-25,2020-03-27,True,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Observational,France,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients,Drug,Unspecified Drug,Unspecified Drug,1000,https://clinicaltrials.gov/show/NCT04324047,EUCTR2020-001246-18
3224,NCT04324073,ClinicalTrials.gov,2020-03-25,2020-03-27,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2/Phase 3,Interventional,France,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI,Drug,Sarilumab,Sarilumab,239,https://clinicaltrials.gov/show/NCT04324073,EUCTR2020-001246-18
3225,NCT04324190,ClinicalTrials.gov,2020-03-26,2020-04-08,False,Gunther Meinlschmidt,Recruiting,Not Applicable,Interventional,Germany,DIgital Online SuPport for COVID-19 StrEss,Other (psych),Psychological,Psychological,600,https://clinicaltrials.gov/show/NCT04324190,None
3226,NCT04324463,ClinicalTrials.gov,2020-03-25,2020-04-21,False,Population Health Research Institute,Recruiting,Phase 3,Interventional,"United Arab Emirates, Ecuador, Colombia, Philippines, Egypt, Chile, Pakistan, India, Russian Federation, Saudi Arabia, Canada, Brazil",Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial,Drug,Chloroquine + azithromycin,Chloroquine; azithromycin,4000,https://clinicaltrials.gov/show/NCT04324463,None
3227,NCT04324489,ClinicalTrials.gov,2020-03-25,2020-03-06,True,Renmin Hospital of Wuhan University,Not Recruiting,Not Applicable,Interventional,China,DAS181 for Severe COVID-19: Compassionate Use,Drug,DAS181,DAS181,4,https://clinicaltrials.gov/show/NCT04324489,None
3228,NCT04324528,ClinicalTrials.gov,2020-03-25,2020-03-27,True,Dr. Alexander Supady,Recruiting,Not Applicable,Interventional,Germany,Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation,Drug,Oxygen,Oxygen,30,https://clinicaltrials.gov/show/NCT04324528,DRKS00021300
3229,NCT04324606,ClinicalTrials.gov,2020-03-20,2020-04-23,True,University of Oxford,Not Recruiting,Phase 1/Phase 2,Interventional,United Kingdom,A Study of a Candidate COVID-19 Vaccine (COV001),ATMP,Vaccine,Vaccine,1090,https://clinicaltrials.gov/show/NCT04324606,EUCTR2020-001072-15; ISRCTN15281137
3230,NCT04324684,ClinicalTrials.gov,2020-03-25,2020-03-31,False,Catholic University of the Sacred Heart,Not Recruiting,Not Applicable,Observational,Italy,Prognostic Factors Keeping Track for COVID-19 Pneumonia,Prognosis,No Intervention,No Intervention,198,https://clinicaltrials.gov/show/NCT04324684,None
3231,NCT04324736,ClinicalTrials.gov,2020-03-25,2020-03-10,True,Nantes University Hospital,Not Recruiting,Not Applicable,Observational,France,"""COVID-19 and Diabetes Outcomes""",Clinical Presentation,No Intervention,No Intervention,5309,https://clinicaltrials.gov/show/NCT04324736,None
3232,NCT04324866,ClinicalTrials.gov,2020-03-24,2020-04-01,False,Universita di Verona,Not Recruiting,Not Applicable,Observational,No Country Given,Prevalence and Incidence of COVID-19 Infection in Patients With Chronic Plaque Psoriasis on Immunosuppressant Therapy,Clinical Presentation (Epidemiology),No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04324866,None
3233,NCT04324996,ClinicalTrials.gov,2020-03-25,2020-02-21,True,Chongqing Public Health Medical Center,Recruiting,Phase 1/Phase 2,Interventional,China,A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19,ATMP,Cells (NK),Cells (NK),90,https://clinicaltrials.gov/show/NCT04324996,None
3234,NCT04325048,ClinicalTrials.gov,2020-03-25,2020-04-01,False,Cordio Medical,Not Recruiting,Not Applicable,Observational,No Country Given,Clinical Evaluation of Cordio Application in Adult COVID-19 Virus Positive Patients,Other (software),eHealth,eHealth,5000,https://clinicaltrials.gov/show/NCT04325048,None
3235,NCT04325061,ClinicalTrials.gov,2020-03-25,2020-04-03,True,Dr. Negrin University Hospital,Not Recruiting,Phase 4,Interventional,Spain,Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19,Drug,Corticosteroids,Dexamethasone,200,https://clinicaltrials.gov/show/NCT04325061,EUCTR2020-001278-31
3236,NCT04325412,ClinicalTrials.gov,2020-03-25,2020-03-23,True,UMC Utrecht,Recruiting,Not Applicable,Observational,Netherlands,Cardiac complicAtions in Patients With SARS Corona vIrus 2 (COVID-19) regisTrY,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04325412,None
3237,NCT04325633,ClinicalTrials.gov,2020-03-26,2020-04-13,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy of Addition of Naproxen in the Treatment of Critically Ill Patients Hospitalized for COVID-19 Infection,Drug,Naproxen,Naproxen,584,https://clinicaltrials.gov/show/NCT04325633,None
3238,NCT04325646,ClinicalTrials.gov,2020-03-26,2020-03-13,True,Institut Pasteur,Recruiting,Not Applicable,Observational,France,Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France,Clinical Presentation (Epidemiology),No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04325646,None
3239,NCT04325672,ClinicalTrials.gov,2020-03-26,2020-04-01,False,Mayo Clinic,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma to Limit Coronavirus Associated Complications,ATMP,Plasma,Plasma,0,https://clinicaltrials.gov/show/NCT04325672,None
3240,NCT04325867,ClinicalTrials.gov,2020-03-21,2020-03-31,False,Professor Adrian Covic,Recruiting,Not Applicable,Interventional,Romania,Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19,Other,Other,Other,200,https://clinicaltrials.gov/show/NCT04325867,None
3241,NCT04325893,ClinicalTrials.gov,2020-03-25,2020-04-01,False,"University Hospital, Angers",Not Recruiting,Phase 3,Interventional,"Monaco, France",Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease,Drug,Hydroxychloroquine,Hydroxychloroquine,259,https://clinicaltrials.gov/show/NCT04325893,None
3242,NCT04325906,ClinicalTrials.gov,2020-03-26,2020-04-02,False,Rush University Medical Center,Recruiting,Not Applicable,Interventional,United States,Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS,Other (device),Nasal cannula,Nasal cannula,346,https://clinicaltrials.gov/show/NCT04325906,None
3243,NCT04325919,ClinicalTrials.gov,2020-03-24,2020-02-24,True,Chinese University of Hong Kong,Recruiting,Not Applicable,Observational,Hong Kong,Coronavirus Disease 2019 (COVID-19) Study of Hospitalized Patients in Hong Kong,Clinical Presentation,No Intervention,No Intervention,170,https://clinicaltrials.gov/show/NCT04325919,None
3244,NCT04326036,ClinicalTrials.gov,2020-03-26,2020-03-25,True,"Black Tie Medical, Inc.",Recruiting,Phase 1,Interventional,United States,Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection,ATMP,Stromal Vascular Fraction,Stromal Vascular Fraction,10,https://clinicaltrials.gov/show/NCT04326036,None
3245,NCT04326075,ClinicalTrials.gov,2020-03-26,2020-10-01,False,Mario Negri Institute for Pharmacological Research,Not Recruiting,Not Applicable,Interventional,Italy,Early CPAP in COVID-19 Patients With Respiratory Failure.,Other (physical),Mechanical ventilation,Mechanical ventilation,900,https://clinicaltrials.gov/show/NCT04326075,None
3246,NCT04326114,ClinicalTrials.gov,2020-03-26,2020-07-26,False,Complutense University of Madrid,Not Recruiting,Not Applicable,Interventional,No Country Given,Effectiveness and Safety of Respiratory Training in the Prevention and Severity of COVID-19,Other (training),Other,Other,240,https://clinicaltrials.gov/show/NCT04326114,None
3247,NCT04326309,ClinicalTrials.gov,2020-03-26,2020-03-25,True,HealthMode Inc.,Recruiting,Not Applicable,Observational,United States,Audio Data Collection for Identification and Classification of Coughing,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,https://clinicaltrials.gov/show/NCT04326309,None
3248,NCT04326387,ClinicalTrials.gov,2020-03-26,2020-04-06,False,University of Cambridge,Recruiting,Not Applicable,Observational,United Kingdom,Evaluation of Novel Diagnostic Tests for COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04326387,None
3249,NCT04326426,ClinicalTrials.gov,2020-03-26,2020-04-13,False,Vanda Pharmaceuticals,Recruiting,Phase 3,Interventional,United States,ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection,Drug,Tradipitant,Tradipitant,300,https://clinicaltrials.gov/show/NCT04326426,None
3250,NCT04326452,ClinicalTrials.gov,2020-03-25,2020-03-27,False,TMC HealthCare,Recruiting,Not Applicable,Interventional,United States,Treating COVID-19 With a Bidirectional Oxygenation Valve,Other (device),Bidirectional Oxygenation Valve,Bidirectional Oxygenation Valve,30,https://clinicaltrials.gov/show/NCT04326452,None
3251,NCT04326725,ClinicalTrials.gov,2020-03-26,2020-03-20,True,Istinye University,Not Recruiting,Not Applicable,Observational,Turkey,Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia,Drug (Chemoprophylaxis),Hydroxychloroquine + Zinc + Vitamin C,Hydroxychloroquine; Zinc; Vitamin C,80,https://clinicaltrials.gov/show/NCT04326725,None
3252,NCT04326790,ClinicalTrials.gov,2020-03-26,2020-04-03,True,National and Kapodistrian University of Athens,Recruiting,Phase 2,Interventional,Gibraltar,The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention,Drug,Colchicine,Colchicine,180,https://clinicaltrials.gov/show/NCT04326790,EUCTR2020-001455-40
3253,NCT04327180,ClinicalTrials.gov,2020-03-25,2020-03-30,False,"University Hospital, Lille",Recruiting,Not Applicable,Observational,France,PREdiction of DIagnosed Covid-19 infecTion in IUC Patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,https://clinicaltrials.gov/show/NCT04327180,None
3254,NCT04327206,ClinicalTrials.gov,2020-03-25,2020-03-30,True,Murdoch Childrens Research Institute,Recruiting,Phase 3,Interventional,"United Kingdom, Australia, Netherlands, Spain",BCG Vaccination to Protect Healthcare Workers Against COVID-19,ATMP,Vaccine,Vaccine,10078,https://clinicaltrials.gov/show/NCT04327206,EUCTR2020-002503-19
3255,NCT04327349,ClinicalTrials.gov,2020-03-24,2020-03-28,True,Mazandaran University of Medical Sciences,Recruiting,Not Applicable,Interventional,Iran,Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial,ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04327349,IRCT20181104041551N1
3256,NCT04327388,ClinicalTrials.gov,2020-03-26,2020-03-28,True,Sanofi,Not Recruiting,Phase 3,Interventional,"Chile, Japan, Germany, Israel, Italy, Russian Federation, France, Canada, Argentina, Brazil, Spain",Sarilumab COVID-19,Drug,Sarilumab,Sarilumab,420,https://clinicaltrials.gov/show/NCT04327388,EUCTR2020-001162-12
3257,NCT04327401,ClinicalTrials.gov,2020-03-26,2020-04-13,False,Hospital Sírio-Libanês,Not Recruiting,Phase 3,Interventional,Brazil,COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III,Drug,Dexamethasone,Dexamethasone,299,https://clinicaltrials.gov/show/NCT04327401,None
3258,NCT04327479,ClinicalTrials.gov,2020-03-26,2020-03-26,False,"University Hospital, Essen",Recruiting,Not Applicable,Observational,Germany,Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection,Clinical Presentation,No Intervention,No Intervention,728,https://clinicaltrials.gov/show/NCT04327479,None
3259,NCT04327531,ClinicalTrials.gov,2020-03-27,2020-03-26,True,Kanuni Sultan Suleyman Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,"Evaluation of Covid 19 Knowledge Anxiety and Expectation Levels of Turkish Physicians, Survey Study",Other (psych),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04327531,None
3260,NCT04327570,ClinicalTrials.gov,2020-03-26,2020-03-27,False,UZ Leuven,Recruiting,Not Applicable,Observational,Belgium,In-depth Immunological Investigation of COVID-19.,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04327570,None
3261,NCT04327674,ClinicalTrials.gov,2020-03-27,2020-03-14,True,Aarhus University,Recruiting,Not Applicable,Observational,Denmark,The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,375,https://clinicaltrials.gov/show/NCT04327674,None
3262,NCT04327804,ClinicalTrials.gov,2020-03-26,2020-03-25,True,Dr. Deneen Vojta,Recruiting,Not Applicable,Observational,United States,A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,120,https://clinicaltrials.gov/show/NCT04327804,None
3263,NCT04328012,ClinicalTrials.gov,2020-03-27,2020-04-06,False,Bassett Healthcare,Recruiting,Phase 2/Phase 3,Interventional,United States,COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2,Drug,Lopinavir/ritonavir vs. hydroxychloroquine vs. ARB (Losartan),Lopinavir/ritonavir; Hydroxychloroquine; ARB (Losartan),4000,https://clinicaltrials.gov/show/NCT04328012,None
3264,NCT04328129,ClinicalTrials.gov,2020-03-23,2020-03-23,False,Institut Pasteur,Recruiting,Not Applicable,Interventional,"New Caledonia, French Guiana, Guadeloupe",Household Transmission Investigation Study for COVID-19 in Tropical Regions,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1300,https://clinicaltrials.gov/show/NCT04328129,None
3265,NCT04328272,ClinicalTrials.gov,2020-03-25,2020-03-28,False,Dr. Umar Farooq,Not Recruiting,Phase 3,Interventional,Pakistan,Effectiveness of Hydroxychloroquine in Covid-19 Patients,Drug,Hydroxychloroquine vs. Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,75,https://clinicaltrials.gov/show/NCT04328272,None
3266,NCT04328285,ClinicalTrials.gov,2020-03-25,2020-04-14,True,CHU de Saint Etienne,Not Recruiting,Phase 3,Interventional,France,Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1200,https://clinicaltrials.gov/show/NCT04328285,EUCTR2020-001188-96
3267,NCT04328441,ClinicalTrials.gov,2020-03-27,2020-03-25,True,UMC Utrecht,Not Recruiting,Phase 3,Interventional,Netherlands,Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine,ATMP,Vaccine,Vaccine,1500,https://clinicaltrials.gov/show/NCT04328441,None
3268,NCT04328454,ClinicalTrials.gov,2020-03-27,2020-01-30,True,Shanghai 10th People's Hospital,Recruiting,Not Applicable,Observational,China,Clinical Characteristics and Prognostic Factors of Patients With COVID-19,Prognosis,No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04328454,None
3269,NCT04328467,ClinicalTrials.gov,2020-03-27,2020-04-06,False,University of Minnesota,Not Recruiting,Phase 3,Interventional,United States,Pre-exposure Prophylaxis for SARS-Coronavirus-2,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1500,https://clinicaltrials.gov/show/NCT04328467,None
3270,NCT04328480,ClinicalTrials.gov,2020-03-30,2020-04-17,False,Estudios Clínicos Latino América,Recruiting,Phase 3,Interventional,Argentina,The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients.,Drug,Colchicine,Colchicine,2500,https://clinicaltrials.gov/show/NCT04328480,None
3271,NCT04328493,ClinicalTrials.gov,2020-03-27,2020-04-07,False,University of Oxford,Recruiting,Phase 2,Interventional,Vietnam,The Vietnam Chloroquine Treatment on COVID-19,Drug,Chloroquine,Chloroquine,250,https://clinicaltrials.gov/show/NCT04328493,None
3272,NCT04328961,ClinicalTrials.gov,2020-03-23,2020-03-31,False,University of Washington,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP),Drug (Chemoprophylaxis),Hydroxychloroquine vs. Vitamin C,Hydroxychloroquine; Vitamin C,829,https://clinicaltrials.gov/show/NCT04328961,None
3273,NCT04329507,ClinicalTrials.gov,2020-03-26,2020-03-25,True,NHS Lothian,Recruiting,Not Applicable,Observational,United Kingdom,Non-invasive Detection of Pneumonia in Context of Covid-19 Using Gas Chromatography - Ion Mobility Spectrometry (GC-IMS),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04329507,None
3274,NCT04329533,ClinicalTrials.gov,2020-03-26,2020-04-13,False,University of Arizona,Not Recruiting,Not Applicable,Interventional,United States,Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic,Other (psych),Psychological,Psychological,101,https://clinicaltrials.gov/show/NCT04329533,None
3275,NCT04329546,ClinicalTrials.gov,2020-03-29,2020-03-27,True,"University Hospital, Geneva",Recruiting,Not Applicable,Observational,Switzerland,Understanding COVID-19,Clinical Presentation,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04329546,None
3276,NCT04329559,ClinicalTrials.gov,2020-03-29,2020-03-30,False,Hepatopancreatobiliary Surgery Institute of Gansu Province,Recruiting,Not Applicable,Observational,China,COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04329559,None
3277,NCT04329572,ClinicalTrials.gov,2020-03-29,2020-04-23,False,Azidus Brasil,Not Recruiting,Phase 1,Interventional,Brazil,Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Hospitalized Patients With Moderate to Severe COVID-19,Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,400,https://clinicaltrials.gov/show/NCT04329572,None
3278,NCT04329611,ClinicalTrials.gov,2020-03-29,2020-04-13,False,Dr. Michael Hill,Not Recruiting,Phase 3,Interventional,Canada,ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease,Drug,Hydroxychloroquine,Hydroxychloroquine,148,https://clinicaltrials.gov/show/NCT04329611,None
3279,NCT04329650,ClinicalTrials.gov,2020-03-31,2020-04-15,True,Judit Pich Martínez,Recruiting,Phase 2,Interventional,Spain,Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia,Drug,Siltuximab vs. Corticosteroids,Siltuximab; Methylprednisolone,200,https://clinicaltrials.gov/show/NCT04329650,EUCTR2020-001413-20
3280,NCT04329832,ClinicalTrials.gov,2020-03-30,2020-03-30,False,"Intermountain Health Care, Inc.",Not Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19,Drug,Hydroxychloroquine vs. Azithromycin,Hydroxychloroquine; azithromycin,85,https://clinicaltrials.gov/show/NCT04329832,None
3281,NCT04330144,ClinicalTrials.gov,2020-03-30,2020-04-01,True,Gangnam Severance Hospital,Not Recruiting,Phase 3,Interventional,No Country Given,Hydroxychloroquine as Post Exposure Prophylaxis for SARS-CoV-2(HOPE Trial),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,2486,https://clinicaltrials.gov/show/NCT04330144,KCT0004907
3282,NCT04330261,ClinicalTrials.gov,2020-03-30,2020-03-18,True,University of Calgary,Recruiting,Not Applicable,Observational,Canada,Clinical Characteristics and Outcomes of Pediatric COVID-19,Clinical Presentation,No Intervention,No Intervention,12500,https://clinicaltrials.gov/show/NCT04330261,None
3283,NCT04330300,ClinicalTrials.gov,2020-03-30,2020-04-30,False,"National University of Ireland, Galway",Not Recruiting,Phase 4,Interventional,Ireland,Coronavirus (COVID-19) ACEi/ARB Investigation,Drug,ACE inhibitors or ARBs vs. Calcium Channel Blockers or Thiazide/Thiazide-like diuretics ,ACE inhibitors; ARBs; Calcium Channel Blockers; Thiazide/Thiazide-like diuretics ,2414,https://clinicaltrials.gov/show/NCT04330300,None
3284,NCT04330495,ClinicalTrials.gov,2020-03-31,2020-04-06,True,Instituto de Investigacin Marqus de Valdecilla,Not Recruiting,Phase 4,Interventional,No Country Given,"Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection",Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,800,https://clinicaltrials.gov/show/NCT04330495,EUCTR2020-001357-52
3285,NCT04330521,ClinicalTrials.gov,2020-03-30,2020-04-08,False,Stanford University,Recruiting,Not Applicable,Observational,United States,Impact of the Coronavirus (COVID-19) on Patients With Cancer,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04330521,None
3286,NCT04330586,ClinicalTrials.gov,2020-03-31,2020-04-01,False,Korea University Guro Hospital,Recruiting,Phase 2,Interventional,South Korea,A Trial of Ciclesonide in Adults With Mild-to-moderate COVID-19,Drug,Ciclesonide + hydroxychloroquine vs. hydroxychloroquine,Ciclesonide; hydroxychloroquine ,94,https://clinicaltrials.gov/show/NCT04330586,None
3287,NCT04330599,ClinicalTrials.gov,2020-03-31,2020-05-01,False,Queen Mary University of London,Recruiting,Not Applicable,Observational,United Kingdom,Longitudinal Population-based Observational Study of COVID-19 in the UK Population,Clinical Presentation,No Intervention,No Intervention,12000,https://clinicaltrials.gov/show/NCT04330599,None
3288,NCT04331054,ClinicalTrials.gov,2020-03-29,2020-04-13,True,Assistance Publique – Hôpitaux de Paris,Recruiting,Phase 3,Interventional,France,Protective Role of Inhaled Steroids for Covid-19 Infection,Drug,Corticosteroids + formoterol,Budesonide; formoterol,436,https://clinicaltrials.gov/show/NCT04331054,EUCTR2020-001306-35
3289,NCT04331106,ClinicalTrials.gov,2020-03-27,2020-03-27,False,Charité University,Recruiting,Not Applicable,Observational,Germany,Survey of the Anxiety Associated With the COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,7500,https://clinicaltrials.gov/show/NCT04331106,None
3290,NCT04331171,ClinicalTrials.gov,2020-03-30,2020-03-17,True,Weprom,Recruiting,Not Applicable,Observational,France,Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients' Triage,Other (device),Other,Other,12000000,https://clinicaltrials.gov/show/NCT04331171,None
3291,NCT04331366,ClinicalTrials.gov,2020-03-31,2020-04-08,False,Emory University,Not Recruiting,Not Applicable,Interventional,United States,Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19,Other (device),Bidirectional Oxygenation Valve,Bidirectional Oxygenation Valve,2,https://clinicaltrials.gov/show/NCT04331366,None
3292,NCT04331470,ClinicalTrials.gov,2020-03-30,2020-04-04,True,Fasa University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19,Drug,Levamisole + budesonide/formoterol + lopinavir/ritonavir + hydroxychloroquine,Levamisole; budesonide; formoterol; Lopinavir/ritonavir; hydroxychloroquine,30,https://clinicaltrials.gov/show/NCT04331470,IRCT20200324046852N1
3293,NCT04331509,ClinicalTrials.gov,2020-03-31,2020-03-23,True,King's College London,Recruiting,Not Applicable,Observational,"United Kingdom, United States",COVID-19 Symptom Tracker,Clinical Presentation,No Intervention,No Intervention,10000000,https://clinicaltrials.gov/show/NCT04331509,None
3294,NCT04331574,ClinicalTrials.gov,2020-03-30,2020-03-10,True,Società Italiana dell'Ipertensione Arteriosa-Lega Italiana,Recruiting,Not Applicable,Observational,Italy,Renin-Angiotensin System Inhibitors and COVID-19,Drug,ACE Inhibitors or ARBs,ACE Inhibitors; ARBs,2000,https://clinicaltrials.gov/show/NCT04331574,None
3295,NCT04331600,ClinicalTrials.gov,2020-03-30,2020-04-16,True,Wroclaw Medical University,Recruiting,Phase 4,Interventional,Poland,Chloroquine as Antiviral Treatment in Coronavirus Infection 2020,Drug,Chloroquine,Chloroquine,400,https://clinicaltrials.gov/show/NCT04331600,EUCTR2020-001469-35
3296,NCT04331613,ClinicalTrials.gov,2020-02-06,2020-01-27,True,Chinese Academy of Sciences,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS,ATMP,Cells (IMRC),Cells (IMRC),9,https://clinicaltrials.gov/show/NCT04331613,None
3297,NCT04331665,ClinicalTrials.gov,2020-04-01,2020-04-20,False,"University Health Network, Toronto",Not Recruiting,Not Applicable,Interventional,Canada,Study of the Efficacy and Safety of Ruxolitinib to Treat COVID-19 Pneumonia,Drug,Ruxolitinib,Ruxolitinib,64,https://clinicaltrials.gov/show/NCT04331665,None
3298,NCT04331795,ClinicalTrials.gov,2020-04-01,2020-04-04,False,University of Chicago,Not Recruiting,Phase 2,Interventional,United States,"Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis",Drug,Tocilizumab,Tocilizumab,32,https://clinicaltrials.gov/show/NCT04331795,None
3299,NCT04331808,ClinicalTrials.gov,2020-03-31,2020-03-30,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI),Drug,Tocilizumab,Tocilizumab,228,https://clinicaltrials.gov/show/NCT04331808,EUCTR2020-001246-18
3300,NCT04331834,ClinicalTrials.gov,2020-04-01,2020-04-03,False,Barcelona Institute for Global Health,Not Recruiting,Phase 3,Interventional,Spain,Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,440,https://clinicaltrials.gov/show/NCT04331834,None
3301,NCT04331886,ClinicalTrials.gov,2020-03-31,2020-04-13,False,"Target PharmaSolutions, Inc.",Recruiting,Not Applicable,Observational,United States,An Observational Study of Patients With Coronavirus Disease 2019,Clinical Presentation,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04331886,None
3302,NCT04331899,ClinicalTrials.gov,2020-03-27,2020-04-24,False,Stanford University,Not Recruiting,Phase 2,Interventional,United States,Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19,Drug,Interferon lambda,Interferon lambda,120,https://clinicaltrials.gov/show/NCT04331899,None
3303,NCT04332016,ClinicalTrials.gov,2020-03-30,2020-04-02,False,"University Hospital, Bordeaux",Recruiting,Not Applicable,Observational,France,COVID-19 Biological Samples Collection,Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04332016,None
3304,NCT04332081,ClinicalTrials.gov,2020-03-30,2020-04-06,False,NYU Langone Health,Not Recruiting,Not Applicable,Interventional,United States,Hyperbaric Oxygen for COVID-19 Patients,Drug,Oxygen,Oxygen,20,https://clinicaltrials.gov/show/NCT04332081,None
3305,NCT04332094,ClinicalTrials.gov,2020-03-31,2020-04-02,False,Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau,Recruiting,Phase 2,Interventional,Spain,"Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19",Drug,Hydroxychloroquine + Azithromycin + Tocilizumab,Hydroxychloroquine; azithromycin; tocilizumab,276,https://clinicaltrials.gov/show/NCT04332094,None
3306,NCT04332380,ClinicalTrials.gov,2020-03-30,2020-05-01,False,Del Rosario University,Not Recruiting,Phase 2,Interventional,Colombia,Convalescent Plasma for Patients With COVID-19: A Pilot Study,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04332380,None
3307,NCT04332666,ClinicalTrials.gov,2020-03-27,2020-09-30,False,Erasme University Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,"Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial",Drug,Angiotensin (1-7),Angiotensin (1-7),60,https://clinicaltrials.gov/show/NCT04332666,None
3308,NCT04332835,ClinicalTrials.gov,2020-03-31,2020-08-08,False,Del Rosario University,Not Recruiting,Phase 2/Phase 3,Interventional,Colombia,"Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study",ATMP (+ Drug),Plasma + Hydroxychloroquine vs. Hydroxychloroquine,Plasma; Hydroxychloroquine,92,https://clinicaltrials.gov/show/NCT04332835,None
3309,NCT04332913,ClinicalTrials.gov,2020-03-26,2020-04-01,False,University of L'Aquila,Recruiting,Not Applicable,Observational,Italy,Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related Pneumonia,Drug,Tocilizumab,Tocilizumab,30,https://clinicaltrials.gov/show/NCT04332913,None
3310,NCT04332991,ClinicalTrials.gov,2020-03-31,2020-04-02,False,Massachusetts General Hospital,Not Recruiting,Phase 3,Interventional,United States,Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease,Drug,Hydroxychloroquine,Hydroxychloroquine,479,https://clinicaltrials.gov/show/NCT04332991,None
3311,NCT04333225,ClinicalTrials.gov,2020-04-01,2020-04-03,False,Baylor Research Institute,Not Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,228,https://clinicaltrials.gov/show/NCT04333225,None
3312,NCT04333251,ClinicalTrials.gov,2020-03-27,2020-04-01,False,Baylor Research Institute,Not Recruiting,Phase 1,Interventional,No Country Given,Study Testing Convalescent Plasma vs Best Supportive Care,ATMP,Plasma,Plasma,115,https://clinicaltrials.gov/show/NCT04333251,None
3313,NCT04333355,ClinicalTrials.gov,2020-03-31,2020-05-08,False,Hospital San Jose Tec de Monterrey,Recruiting,Phase 1,Interventional,Mexico,Safety in Convalescent Plasma Transfusion to COVID-19,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04333355,None
3314,NCT04333407,ClinicalTrials.gov,2020-04-01,2020-04-03,False,Imperial College London,Recruiting,Not Applicable,Interventional,United Kingdom,Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.,Drug,Aspirin + clopidogrel + rivaroxaban + atorvastatin + omeprazole,Aspirin; clopidogrel; rivaroxaban; atorvastatin; omeprazole,3170,https://clinicaltrials.gov/show/NCT04333407,None
3315,NCT04333550,ClinicalTrials.gov,2020-04-01,2020-04-01,False,Kermanshah University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Application of Desferal to Treat COVID-19,Drug,Deferoxamine,Deferoxamine,50,https://clinicaltrials.gov/show/NCT04333550,None
3316,NCT04333589,ClinicalTrials.gov,2020-04-01,2020-04-01,False,Peking University First Hospital,Recruiting,Not Applicable,Interventional,China,Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive,Drug,Favipiravir,Favipiravir,210,https://clinicaltrials.gov/show/NCT04333589,None
3317,NCT04333628,ClinicalTrials.gov,2020-04-01,2020-06-01,False,"HaEmek Medical Center, Israel",Not Recruiting,Phase 2/Phase 3,Interventional,Israel,Chloroquine for Mild Symptomatic and Asymptomatic COVID-19,Drug,Chloroquine,Chloroquine,5,https://clinicaltrials.gov/show/NCT04333628,None
3318,NCT04333654,ClinicalTrials.gov,2020-04-01,2020-04-12,False,Sanofi,Not Recruiting,Phase 1,Interventional,"France, United States, Belgium, Netherlands",Hydroxychloroquine in Outpatient Adults With COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,8,https://clinicaltrials.gov/show/NCT04333654,None
3319,NCT04333693,ClinicalTrials.gov,2020-03-31,2020-04-01,False,Spanish Society for Angiology and Vascular Surgery,Not Recruiting,Not Applicable,Observational,Spain,Outcomes of Vascular Surgery in COVID-19 Infection: National Cohort Study,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04333693,None
3320,NCT04333732,ClinicalTrials.gov,2020-03-31,2020-09-04,True,Washington University in St. Louis,Recruiting,Phase 3,Interventional,"Ghana, Ireland, Canada, Zambia, Netherlands, United Kingdom, Uganda, United States, South Africa, Australia, Zimbabwe",CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION,Drug (Chemoprophylaxis),Chloroquine/hydroxychloroquine,Chloroquine; hydroxychloroquine,30000,https://clinicaltrials.gov/show/NCT04333732,ISRCTN99916292
3321,NCT04333849,ClinicalTrials.gov,2020-04-01,2020-03-25,True,"University Hospital, Angers",Not Recruiting,Not Applicable,Observational,France,Telephony Or Videophony for Isolated elDerly in Maine-Et-Loire 49 During COVID-19,Other,Other,Other,132,https://clinicaltrials.gov/show/NCT04333849,None
3322,NCT04333862,ClinicalTrials.gov,2020-04-01,2020-03-19,True,"University Hospital, Bern",Recruiting,Not Applicable,Observational,Switzerland,Assessment of Covid-19 Infection Rates in Healthcare Workers Using a Desynchronization Strategy,Health System,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04333862,None
3323,NCT04333953,ClinicalTrials.gov,2020-03-31,2020-04-01,False,University of Missouri-Columbia,Recruiting,Not Applicable,Observational,United States,COVID-19 in Patients With HIV,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04333953,None
3324,NCT04334005,ClinicalTrials.gov,2020-03-29,2020-04-10,False,University of Granada,Not Recruiting,Not Applicable,Interventional,Spain,Vitamin D on Prevention and Treatment of COVID-19,Drug,Vitamin D,Vitamin D,200,https://clinicaltrials.gov/show/NCT04334005,None
3325,NCT04334044,ClinicalTrials.gov,2020-04-01,2020-04-15,False,Grupo Cooperativo Hemopatías Malignas,Recruiting,Phase 1/Phase 2,Interventional,Mexico,Treatment of SARS Caused by COVID-19 With Ruxolitinib,Drug,Ruxolitinib,Ruxolitinib,20,https://clinicaltrials.gov/show/NCT04334044,None
3326,NCT04334148,ClinicalTrials.gov,2020-04-02,2020-04-22,False,Adrian Hernandez,Not Recruiting,Phase 3,Interventional,United States,Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1363,https://clinicaltrials.gov/show/NCT04334148,None
3327,NCT04334252,ClinicalTrials.gov,2020-04-02,2020-04-17,False,Jessa Hospital,Recruiting,Not Applicable,Observational,Belgium,Descriptive Study Regarding Ambulant Screening During COVID-19 Pandemia,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,5000,https://clinicaltrials.gov/show/NCT04334252,None
3328,NCT04334265,ClinicalTrials.gov,2020-04-01,2020-04-01,False,Peking University First Hospital,Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,750,https://clinicaltrials.gov/show/NCT04334265,None
3329,NCT04334291,ClinicalTrials.gov,2020-04-01,2020-03-23,True,Iván J. Núñez Gil,Recruiting,Not Applicable,Observational,Spain,"International COVID19 Clinical Evaluation Registry,",Clinical Presentation,No Intervention,No Intervention,6000,https://clinicaltrials.gov/show/NCT04334291,None
3330,NCT04334382,ClinicalTrials.gov,2020-04-02,2020-04-02,False,"Intermountain Health Care, Inc.",Recruiting,Phase 3,Interventional,United States,Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19,Drug,Hydroxychloroquine vs. azithromycin,Hydroxychloroquine; azithromycin,1550,https://clinicaltrials.gov/show/NCT04334382,None
3331,NCT04334434,ClinicalTrials.gov,2020-04-02,2020-08-20,False,Kubra Koce,Not Recruiting,Not Applicable,Interventional,Turkey,Telerehabilitation in Individuals Over 65 Years of Age Having Social Isolation Due to Coronavirus (Covid-19),Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,30,https://clinicaltrials.gov/show/NCT04334434,None
3332,NCT04334460,ClinicalTrials.gov,2020-04-02,2020-05-04,False,Blade Therapeutics,Not Recruiting,Phase 2,Interventional,"United States, Brazil",Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects,Drug,BLD-2660,BLD-2660,120,https://clinicaltrials.gov/show/NCT04334460,None
3333,NCT04334512,ClinicalTrials.gov,2020-04-02,2020-06-22,False,ProgenaBiome,Recruiting,Phase 2,Interventional,United States,A Study of Quintuple Therapy to Treat COVID-19 Infection,Drug,Hydroxychloroquine + azithromycin + vitamin C + vitamin D + zinc,Hydroxychloroquine; azithromycin; vitamin C; vitamin D; zinc,600,https://clinicaltrials.gov/show/NCT04334512,None
3334,NCT04334629,ClinicalTrials.gov,2020-04-02,2020-05-26,False,King's College London,Recruiting,Phase 4,Interventional,United Kingdom,LIBERATE Trial in COVID-19,Drug,Ibuprofen,Ibuprofen,230,https://clinicaltrials.gov/show/NCT04334629,None
3335,NCT04334850,ClinicalTrials.gov,2020-04-02,2020-04-20,True,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Interventional,France,Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia,Other,Other,Other,194,https://clinicaltrials.gov/show/NCT04334850,EUCTR2020-001324-33
3336,NCT04334876,ClinicalTrials.gov,2020-04-02,2020-04-01,True,Indiana University,Not Recruiting,Not Applicable,Observational,No Country Given,Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,340,https://clinicaltrials.gov/show/NCT04334876,None
3337,NCT04334928,ClinicalTrials.gov,2020-04-02,2020-04-15,False,Plan Nacional sobre el Sida (PNS),Recruiting,Phase 3,Interventional,Spain,Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel,Drug,Emtricitabine/tenofovir disoproxil + hydroxychloroquine vs. hydroxychloroquine vs. Emtricitabine/tenofovir disoproxil,Emtricitabine/tenofovir disoproxil; hydroxychloroquine,4000,https://clinicaltrials.gov/show/NCT04334928,None
3338,NCT04334967,ClinicalTrials.gov,2020-04-02,2020-03-30,True,Providence Health & Services,Not Recruiting,Phase 4,Interventional,United States,Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care,Drug,Hydroxychloroquine vs. Vitamin C,Hydroxychloroquine; Vitamin C,13,https://clinicaltrials.gov/show/NCT04334967,None
3339,NCT04334980,ClinicalTrials.gov,2020-03-31,2020-10-01,False,Symvivo Corporation,Recruiting,Phase 1,Interventional,"United States, Canada, Australia","Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19",ATMP,Vaccine,Vaccine,12,https://clinicaltrials.gov/show/NCT04334980,None
3340,NCT04335019,ClinicalTrials.gov,2020-04-02,2020-04-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,No Country Given,Interest of the Use of Pulmonary Ultrasound in the Referral of Patients With or Suspected COVID-19 +,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,300,https://clinicaltrials.gov/show/NCT04335019,None
3341,NCT04335032,ClinicalTrials.gov,2020-04-01,2020-11-09,False,S.L.A. Pharma AG,Not Recruiting,Phase 3,Interventional,No Country Given,EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2),Drug,Eicosapentaenoic acid,Eicosapentaenoic acid,284,https://clinicaltrials.gov/show/NCT04335032,None
3342,NCT04335071,ClinicalTrials.gov,2020-04-02,2020-04-26,False,"University Hospital, Bern",Not Recruiting,Phase 2,Interventional,Switzerland,Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19),Drug,Tocilizumab,Tocilizumab,5,https://clinicaltrials.gov/show/NCT04335071,None
3343,NCT04335084,ClinicalTrials.gov,2020-04-02,2020-06-22,False,ProgenaBiome,Recruiting,Phase 2,Interventional,United States,"A Study of Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection",Drug,Hydroxychloroquine + vitamin C + vitamin D + zinc,Hydroxychloroquine; vitamin C; vitamin D; zinc,600,https://clinicaltrials.gov/show/NCT04335084,None
3344,NCT04335097,ClinicalTrials.gov,2020-04-01,2020-04-22,False,Lars Wik,Recruiting,Not Applicable,Interventional,Norway,Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home Isolation,Other (device),Biosensors,Biosensors,214,https://clinicaltrials.gov/show/NCT04335097,None
3345,NCT04335123,ClinicalTrials.gov,2020-03-31,2020-04-04,False,University of Kansas Medical Center,Not Recruiting,Phase 1,Interventional,United States,Study of Open Label Losartan in COVID-19,Drug,ARB (Losartan),ARB (Losartan),34,https://clinicaltrials.gov/show/NCT04335123,None
3346,NCT04335136,ClinicalTrials.gov,2020-04-01,2020-04-30,True,Apeiron Biologics,Recruiting,Phase 2,Interventional,"Denmark, Russian Federation, Germany, United States, United Kingdom, Austria",Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19,Drug,ACE enzyme,ACE enzyme,200,https://clinicaltrials.gov/show/NCT04335136,EUCTR2020-001172-15
3347,NCT04335162,ClinicalTrials.gov,2020-04-03,2020-02-28,True,CHU de Nice,Recruiting,Not Applicable,Observational,France,Cardiovascular Complications and COVID-19 (CovCardioVasc-Study),Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04335162,None
3348,NCT04335188,ClinicalTrials.gov,2020-03-31,2020-04-06,False,IHF GmbH - Institut for Herzinfarktforschung,Recruiting,Not Applicable,Observational,Germany,COVID-19 Registry Rhineland-Palatinate (Germany),Clinical Presentation,No Intervention,No Intervention,4000,https://clinicaltrials.gov/show/NCT04335188,None
3349,NCT04335201,ClinicalTrials.gov,2020-03-31,2020-04-06,True,IRCCS Ospedale San Raffaele,Not Recruiting,Phase 2,Interventional,No Country Given,Defibrotide in COVID-19 Pneumonia,Drug,Defibrotide,Defibrotide,50,https://clinicaltrials.gov/show/NCT04335201,EUCTR2020-001513-20
3350,NCT04335279,ClinicalTrials.gov,2020-04-01,2020-04-09,False,Lady Davis Institute,Not Recruiting,Not Applicable,Interventional,Canada,Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program,Other (psych),Psychological,Psychological,172,https://clinicaltrials.gov/show/NCT04335279,None
3351,NCT04335305,ClinicalTrials.gov,2020-03-31,2020-04-09,True,MedSIR,Recruiting,Phase 2,Interventional,Spain,Checkpoint Blockade in COVID-19 Pandemic,Drug,Tocilizumab + Pembrolizumab,Tocilizumab; pembrolizumab,24,https://clinicaltrials.gov/show/NCT04335305,EUCTR2020-001160-28
3352,NCT04335630,ClinicalTrials.gov,2020-04-02,2020-03-30,True,Memorial Hermann Health System,Recruiting,Not Applicable,Observational,United States,Cardiovascular Manifestations of COVID-19,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04335630,None
3353,NCT04335747,ClinicalTrials.gov,2020-04-03,2020-04-23,False,Salome Kristensen,Recruiting,Not Applicable,Observational,Denmark,COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases,Clinical Presentation,No Intervention,No Intervention,333,https://clinicaltrials.gov/show/NCT04335747,None
3354,NCT04335773,ClinicalTrials.gov,2020-04-03,2020-04-03,False,"University Hospital, Akershus",Recruiting,Not Applicable,Observational,Norway,"COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology",Clinical Presentation,No Intervention,No Intervention,350,https://clinicaltrials.gov/show/NCT04335773,None
3355,NCT04335786,ClinicalTrials.gov,2020-04-02,2020-04-17,True,Radboud University,Recruiting,Phase 4,Interventional,Netherlands,Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease,Drug,Valsartan,Valsartan,651,https://clinicaltrials.gov/show/NCT04335786,EUCTR2020-001320-34
3356,NCT04335851,ClinicalTrials.gov,2020-04-02,2020-04-06,False,Biruni University,Not Recruiting,Not Applicable,Interventional,Turkey,Video-Based Exercises and Well-Being During Social Isolation,Other (exercise),Exercise,Exercise,68,https://clinicaltrials.gov/show/NCT04335851,None
3357,NCT04336215,ClinicalTrials.gov,2020-04-02,2020-04-07,False,Rutgers University,Recruiting,Not Applicable,Observational,United States,Rutgers COVID-19 Cohort Study,Clinical Presentation,No Intervention,No Intervention,750,https://clinicaltrials.gov/show/NCT04336215,None
3358,NCT04336254,ClinicalTrials.gov,2020-03-28,2020-04-06,False,Renmin Hospital of Wuhan University,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04336254,None
3359,NCT04336332,ClinicalTrials.gov,2020-03-31,2020-04-01,False,Rutgers University,Recruiting,Phase 2,Interventional,United States,Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19,Drug,Hydroxychloroquine + azithromycin vs. hydroxychloroquine,Hydroxychloroquine; azithromycin,160,https://clinicaltrials.gov/show/NCT04336332,None
3360,NCT04336345,ClinicalTrials.gov,2020-04-02,2020-04-01,True,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,Not Recruiting,Not Applicable,Observational,Mexico,Outcomes of Patients With COVID-19 in the Intensive Care Unit,Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04336345,None
3361,NCT04336384,ClinicalTrials.gov,2020-03-30,2020-03-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Impact of Covid-19 in Congenital Heart Disease,Clinical Presentation,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04336384,None
3362,NCT04336410,ClinicalTrials.gov,2020-04-03,2020-04-03,False,Inovio Pharmaceuticals,Not Recruiting,Phase 1,Interventional,United States,"Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers",Drug,INO-4800,INO-4800,120,https://clinicaltrials.gov/show/NCT04336410,None
3363,NCT04336462,ClinicalTrials.gov,2020-03-25,2020-02-15,True,Shanghai Asclepius Meditec Inc.,Recruiting,Not Applicable,Interventional,China,Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19,Drug,Hydrogen + Oxygen vs Oxygen,Hydrogen; oxygen,100,https://clinicaltrials.gov/show/NCT04336462,None
3364,NCT04336657,ClinicalTrials.gov,2020-04-03,2020-04-01,True,Assiut University,Recruiting,Not Applicable,Observational,Egypt,Corona-Like Illness: Did we Got it Before WHO Announcement of the Disease?,Clinical Presentation (Epidemiology),No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04336657,None
3365,NCT04336748,ClinicalTrials.gov,2020-04-04,2020-04-01,True,Medical University of Vienna,Not Recruiting,Phase 3,Interventional,No Country Given,HCQ for Primary Prophylaxis Against COVID19 in Health-care Workers,Drug,Hydroxychloroquine,Hydroxychloroquine,440,https://clinicaltrials.gov/show/NCT04336748,None
3366,NCT04336761,ClinicalTrials.gov,2020-04-03,2020-04-15,False,"University Hospital, Lille",Recruiting,Not Applicable,Observational,France,Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France,Clinical Presentation (Epidemiology),No Intervention,No Intervention,914,https://clinicaltrials.gov/show/NCT04336761,None
3367,NCT04336774,ClinicalTrials.gov,2020-04-03,2020-07-01,False,Duke University,Not Recruiting,Not Applicable,Interventional,United States,CAPTION AI to Minimize Risk of COVID Exposure,Other (software),Other,Other,0,https://clinicaltrials.gov/show/NCT04336774,None
3368,NCT04336787,ClinicalTrials.gov,2020-04-03,2020-04-12,False,Istanbul Kültür University,Not Recruiting,Not Applicable,Observational,Turkey,"Physical Activity Level, Stress Level, Sleep Quality in Pregnant Women During Covid-19 Quarantine",Other (psych),No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04336787,None
3369,NCT04336904,ClinicalTrials.gov,2020-04-03,2020-03-25,True,Giuliano Rizzardini,Not Recruiting,Phase 3,Interventional,Italy,Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19,Drug,Favipiravir,Favipiravir,100,https://clinicaltrials.gov/show/NCT04336904,None
3370,NCT04336956,ClinicalTrials.gov,2020-03-30,2020-04-07,False,Centre Hospitalier Intercommunal Creteil,Recruiting,Not Applicable,Observational,France,Covid-19 Pediatric Observatory,Clinical Presentation,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04336956,None
3371,NCT04337008,ClinicalTrials.gov,2020-04-03,2020-04-03,False,Assistance Publique – Hôpitaux de Marseille,Recruiting,Not Applicable,Interventional,France,Renin Angiotensin System - CoronaVirus,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04337008,None
3372,NCT04337047,ClinicalTrials.gov,2020-04-03,2020-03-31,True,Wefight,Not Recruiting,Not Applicable,Observational,France,Distress in Crisis Situations During COVID-19,Other (psych),No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04337047,None
3373,NCT04337151,ClinicalTrials.gov,2020-04-03,2020-04-01,True,Royal National Orthopaedic Hospital NHS Trust,Recruiting,Not Applicable,Observational,United Kingdom,Blood Titanium Analysis of Patients With MAGEC Spine Rods in the COVID-19 Environment,Other,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04337151,None
3374,NCT04337190,ClinicalTrials.gov,2020-04-03,2020-04-03,False,"University Hospital, Angers",Recruiting,Not Applicable,Observational,France,Impact of Angiotensin II Receptor Blockers Treatment in Patients With COVID 19 (COVID-ARA2),Drug,ARBs,ARBs,100,https://clinicaltrials.gov/show/NCT04337190,None
3375,NCT04337320,ClinicalTrials.gov,2020-04-05,2020-03-15,True,Kanuni Sultan Suleyman Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,"Maternal And Neonatal Outcome of Pregnant Patients With COVID-19 in Istanbul, Turkey: A Single-Center, Retrospective, Descriptive Study",Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04337320,None
3376,NCT04337346,ClinicalTrials.gov,2020-04-05,2020-04-05,False,Kanuni Sultan Suleyman Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,Evaluation of Covid 19 Anxiety in Endometriosis Patients,Other (psych),No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04337346,None
3377,NCT04337359,ClinicalTrials.gov,2020-04-03,2020-04-05,False,Novartis Pharmaceuticals,Not Recruiting,Not Applicable,Expanded Access,"Indonesia, Italy",Ruxolitinib Managed Access Program (MAP) for Patients Diagnosed With Severe/Very Severe COVID-19 Illness,Drug,Ruxolitinib,Ruxolitinib,Not Available,https://clinicaltrials.gov/show/NCT04337359,None
3378,NCT04337489,ClinicalTrials.gov,2020-04-01,2020-07-28,False,Imperial College London,Not Recruiting,Not Applicable,Observational,No Country Given,Remote Monitoring Use In Cases Of Suspected COVID-19 (Coronavirus),Other (device),Wearable,Wearable,200,https://clinicaltrials.gov/show/NCT04337489,None
3379,NCT04337502,ClinicalTrials.gov,2020-04-06,2019-12-23,True,Maastricht University,Not Recruiting,Not Applicable,Observational,China,Clinical and Radiomic Model of COVID-19,Other (software),Other,Other,300,https://clinicaltrials.gov/show/NCT04337502,None
3380,NCT04337541,ClinicalTrials.gov,2020-04-02,2020-04-02,False,"Rigshospitalet, Denmark",Not Recruiting,Not Applicable,Interventional,Denmark,Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System,Other (device),Masks,Masks,6000,https://clinicaltrials.gov/show/NCT04337541,None
3381,NCT04337762,ClinicalTrials.gov,2020-04-06,2020-04-06,False,Beat COVID LLC,Recruiting,Not Applicable,Observational,United States,Beat COVID-19 - Observational Trial,Clinical Presentation,No Intervention,No Intervention,100000,https://clinicaltrials.gov/show/NCT04337762,None
3382,NCT04337788,ClinicalTrials.gov,2020-04-03,2020-05-01,False,"University Hospital, Limoges",Not Recruiting,Not Applicable,Interventional,No Country Given,Gerontological Telemonitoring of Older Adults Living in Nursing Homes With COVID-19 Disease,Telehealth,Telehealth,Telehealth,200,https://clinicaltrials.gov/show/NCT04337788,None
3383,NCT04337918,ClinicalTrials.gov,2020-04-06,2020-05-08,False,Sanotize Research and Development corp.,Recruiting,Phase 2,Interventional,Canada,Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection,Drug,Nitric oxide,Nitric oxide,200,https://clinicaltrials.gov/show/NCT04337918,None
3384,NCT04337983,ClinicalTrials.gov,2020-03-30,2020-03-13,True,Bicetre Hospital,Recruiting,Not Applicable,Observational,France,Hemodynamic Characteristics of Patients With SARS-CoV-2,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04337983,None
3385,NCT04337996,ClinicalTrials.gov,2020-04-01,2020-07-13,False,Tourcoing Hospital,Recruiting,Not Applicable,Interventional,France,Dynamic Evaluation of COVID-19 Diagnostic Tests,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,165,https://clinicaltrials.gov/show/NCT04337996,None
3386,NCT04338009,ClinicalTrials.gov,2020-04-01,2020-03-31,True,University of Pennsylvania,Recruiting,Not Applicable,Interventional,United States,Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019,Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,152,https://clinicaltrials.gov/show/NCT04338009,None
3387,NCT04338074,ClinicalTrials.gov,2020-04-06,2020-06-01,False,University of Alabama at Birmingham,Recruiting,Phase 2,Interventional,United States,TXA and Corona Virus 2019 (COVID19) in Outpatients,Drug,Tranexamic acid,Tranexamic acid,100,https://clinicaltrials.gov/show/NCT04338074,None
3388,NCT04338100,ClinicalTrials.gov,2020-03-31,2020-04-06,False,"University Hospital, Angers",Not Recruiting,Not Applicable,Observational,No Country Given,Point Of Care UltraSonography for Risk-stratification of COVID-19 Patients,Prognosis,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04338100,None
3389,NCT04338126,ClinicalTrials.gov,2020-04-06,2021-09-30,False,University of Alabama at Birmingham,Not Recruiting,Phase 2,Interventional,United States,Tranexamic Acid (TXA) and Corona Virus 2019 (COVID19) in Inpatients,Drug,Tranexamic acid,Tranexamic acid,60,https://clinicaltrials.gov/show/NCT04338126,None
3390,NCT04338347,ClinicalTrials.gov,2020-03-31,2019-01-10,True,Capricor Inc.,Not Recruiting,Not Applicable,Expanded Access,United States,CAP-1002 in Severe COVID-19 Disease,ATMP,Cells (allogeneic cardiosphere-derived),Cells (allogeneic cardiosphere-derived),Not Available,https://clinicaltrials.gov/show/NCT04338347,None
3391,NCT04338360,ClinicalTrials.gov,2020-04-03,2019-01-10,True,Mayo Clinic,Not Recruiting,Not Applicable,Expanded Access,United States,Expanded Access to Convalescent Plasma for the Treatment of Patients With COVID-19,ATMP,Plasma,Plasma,Not Available,https://clinicaltrials.gov/show/NCT04338360,None
3392,NCT04338568,ClinicalTrials.gov,2020-04-04,2020-04-16,False,Hasselt University,Recruiting,Not Applicable,Interventional,Belgium,Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://clinicaltrials.gov/show/NCT04338568,None
3393,NCT04338672,ClinicalTrials.gov,2020-04-04,2020-04-05,False,Sheba Medical Center,Recruiting,Not Applicable,Observational,Israel,The Impact of the Covid-19 Outbreak on Emergency Room Attendances of Surgical Patients,Health System,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04338672,None
3394,NCT04338698,ClinicalTrials.gov,2020-04-04,2020-04-22,False,Shehnoor Azhar,Recruiting,Phase 3,Interventional,Pakistan,"Hydroxychloroquine, Oseltamivir and Azithromycin for the Treatment of COVID-19 Infection: An RCT",Drug,"Monotherapy and all Combinations of: Hydroxychloroquine, oseltamivir, and azithromycin",Hydroxychloroquine; osletamivir; azithromycin,500,https://clinicaltrials.gov/show/NCT04338698,None
3395,NCT04338802,ClinicalTrials.gov,2020-04-01,2020-04-02,False,Huilan Zhang,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe COVID -19,Drug,Nintedanib,Nintedanib,96,https://clinicaltrials.gov/show/NCT04338802,None
3396,NCT04338828,ClinicalTrials.gov,2020-04-05,2020-04-18,False,Massachusetts General Hospital,Recruiting,Phase 2,Interventional,United States,Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED,Drug,Nitric oxide,Nitric oxide,260,https://clinicaltrials.gov/show/NCT04338828,None
3397,NCT04338906,ClinicalTrials.gov,2020-04-03,2020-06-01,False,Heinrich-Heine University,Not Recruiting,Phase 4,Interventional,No Country Given,Combination Therapy With Camostat Mesilate + Hydroxychloroquine for COVID-19,Drug,Camostat Mesilate + hydroxychloroquine vs. hydroxychloroquine,Camostat Mesilate; hydroxychloroquine,334,https://clinicaltrials.gov/show/NCT04338906,None
3398,NCT04338932,ClinicalTrials.gov,2020-04-07,2020-04-17,False,Jessa Hospital,Not Recruiting,Not Applicable,Observational,Belgium,COVID-19 and Deep Venous Thrombosis,Clinical Presentation,No Intervention,No Intervention,12,https://clinicaltrials.gov/show/NCT04338932,None
3399,NCT04338945,ClinicalTrials.gov,2020-04-07,2020-03-15,True,Piazza della Vittoria 14 Studio Medico - Ginecologia e Ostetricia,Not Recruiting,Not Applicable,Observational,Italy,Impact of Pandemic COVID-19 on Surgical Specialities Residents in Italy,Other,No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04338945,None
3400,NCT04338958,ClinicalTrials.gov,2020-04-07,2020-04-22,True,University of Jena,Recruiting,Phase 2,Interventional,Germany,Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation,Drug,Ruxolitinib,Ruxolitinib,200,https://clinicaltrials.gov/show/NCT04338958,EUCTR2020-001481-11
3401,NCT04339322,ClinicalTrials.gov,2020-04-07,2020-05-01,False,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,Characteristics and Outcome of Coronavirus Disease 2019 (COVID-19) in Egypt,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04339322,None
3402,NCT04339387,ClinicalTrials.gov,2020-04-06,2020-03-01,True,Brigham and Women's Hospital,Not Recruiting,Not Applicable,Observational,United States,COVID-19 Risk Stratification,Prognosis,No Intervention,No Intervention,1326,https://clinicaltrials.gov/show/NCT04339387,None
3403,NCT04339608,ClinicalTrials.gov,2020-04-07,2020-04-02,True,Max Healthcare Insititute Limited,Recruiting,Not Applicable,Observational,India,Max COVID19- Study,Clinical Presentation,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04339608,None
3404,NCT04339634,ClinicalTrials.gov,2020-04-07,2020-04-07,False,Tabula Rasa HealthCare,Not Recruiting,Not Applicable,Observational,United States,Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy,Clinical Presentation,No Intervention,No Intervention,12123,https://clinicaltrials.gov/show/NCT04339634,None
3405,NCT04339660,ClinicalTrials.gov,2020-04-02,2020-02-01,True,Puren Hospital Affiliated to Wuhan University of Science and Technology,Recruiting,Phase 1/Phase 2,Interventional,China,Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04339660,None
3406,NCT04339686,ClinicalTrials.gov,2020-04-08,2020-04-20,False,Poitiers University Hospital,Recruiting,Not Applicable,Observational,France,Multicentric Retrospective Observational Study of Thoracic Scanner Performance in COVID Screening.,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,56000,https://clinicaltrials.gov/show/NCT04339686,None
3407,NCT04339712,ClinicalTrials.gov,2020-04-01,2020-04-02,True,Hellenic Institute for the Study of Sepsis,Recruiting,Phase 2,Interventional,Greece,Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction,Drug,Anakinra or Tocilizumab,Anakinra; Tocilizumab,40,https://clinicaltrials.gov/show/NCT04339712,EUCTR2020-001039-29
3408,NCT04339790,ClinicalTrials.gov,2020-04-08,2020-04-07,True,National Institute of Mental Health (NIMH),Not Recruiting,Not Applicable,Observational,United States,Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers,Other (psych),No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04339790,None
3409,NCT04339816,ClinicalTrials.gov,2020-04-06,2020-05-13,True,Frantisek Duska,Not Recruiting,Phase 3,Interventional,Czech Republic,Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial,Drug,Hydroxychloroquine + azithromycin vs. hydroxychloroquine,Hydroxychloroquine; azithromycin,3,https://clinicaltrials.gov/show/NCT04339816,EUCTR2020-001456-18
3410,NCT04339998,ClinicalTrials.gov,2020-04-06,2020-04-15,False,University of Minnesota,Recruiting,Not Applicable,Observational,United States,Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,https://clinicaltrials.gov/show/NCT04339998,None
3411,NCT04340050,ClinicalTrials.gov,2020-04-07,2020-04-10,False,University of Chicago,Not Recruiting,Phase 1,Interventional,United States,COVID-19 Convalescent Plasma,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04340050,None
3412,NCT04340219,ClinicalTrials.gov,2020-03-31,2020-03-30,True,"University Hospital, Ghent",Not Recruiting,Not Applicable,Observational,Belgium,"Oncology-patient-reported Anxiety, Mood, and QoL During the COVID-19 Pandemic",Other (psych),No Intervention,No Intervention,394,https://clinicaltrials.gov/show/NCT04340219,None
3413,NCT04340232,ClinicalTrials.gov,2020-04-03,2020-11-01,False,"University of Colorado, Denver",Not Recruiting,Phase 2/Phase 3,Interventional,United States,Safety and Efficacy of Baricitinib for COVID-19,Drug,Baricitinib,Baricitinib,80,https://clinicaltrials.gov/show/NCT04340232,None
3414,NCT04340349,ClinicalTrials.gov,2020-04-02,2020-05-11,False,Instituto Nacional de Rehabilitacion,Recruiting,Phase 1,Interventional,Mexico,Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals,Drug (Chemoprophylaxis),Hydroxychloroquine + bromhexine vs. bromhexine,Hydroxychloroquine; bromhexine,140,https://clinicaltrials.gov/show/NCT04340349,None
3415,NCT04340414,ClinicalTrials.gov,2020-03-03,2020-02-20,True,Peking Union Medical College Hospital,Recruiting,Not Applicable,Interventional,China,Safety and Effectiveness of Low-flow ECMO Driving by CVVH Machine in Severe NCP,Drug,Oxygen,Oxygen,10,https://clinicaltrials.gov/show/NCT04340414,None
3416,NCT04340466,ClinicalTrials.gov,2020-04-07,2020-04-03,True,CHU de Nimes,Recruiting,Not Applicable,Observational,France,French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study,Clinical Presentation,No Intervention,No Intervention,220,https://clinicaltrials.gov/show/NCT04340466,None
3417,NCT04340479,ClinicalTrials.gov,2020-04-06,2020-07-30,False,"University of Colorado, Denver",Recruiting,Not Applicable,Observational,United States,The Use of Ultrasound in Establishing COVID-19 Infection as Part of a Trauma Evaluation,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,20,https://clinicaltrials.gov/show/NCT04340479,None
3418,NCT04340557,ClinicalTrials.gov,2020-04-06,2020-03-27,True,Sharp HealthCare,Recruiting,Phase 4,Interventional,United States,Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection,Drug,Losartan,Losartan,200,https://clinicaltrials.gov/show/NCT04340557,None
3419,NCT04340921,ClinicalTrials.gov,2020-04-03,2020-05-14,False,Barts & The London NHS Trust,Recruiting,Not Applicable,Observational,United Kingdom,The Role of Adaptive Immunity in COVID-19 Associated Myocardial Injury,Clinical Presentation,No Intervention,No Intervention,140,https://clinicaltrials.gov/show/NCT04340921,None
3420,NCT04341012,ClinicalTrials.gov,2020-04-07,2019-09-10,True,Mayo Clinic,Recruiting,Not Applicable,Observational,United States,Breath Analysis Based Disease Biomarkers of COVID-19 and Other Diseases,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,120,https://clinicaltrials.gov/show/NCT04341012,None
3421,NCT04341038,ClinicalTrials.gov,2020-04-07,2020-04-01,False,Hospital Universitari de Bellvitge,Recruiting,Phase 3,Interventional,Spain,Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury,Drug,Tacrolimus + Corticosteroids,Tacrolimus; Methylprednisolone,84,https://clinicaltrials.gov/show/NCT04341038,EUCTR2020-001445-39
3422,NCT04341103,ClinicalTrials.gov,2020-03-16,2020-04-01,False,CareDx,Not Recruiting,Not Applicable,Observational,No Country Given,AlloSure Guided Immuno-Optimization for COVID-19: An Early Experience,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04341103,None
3423,NCT04341142,ClinicalTrials.gov,2020-04-08,2020-04-09,False,Hospices Civils de Lyon,Recruiting,Not Applicable,Interventional,France,Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,550,https://clinicaltrials.gov/show/NCT04341142,None
3424,NCT04341168,ClinicalTrials.gov,2020-04-03,2020-04-01,True,"University Hospital, Cologne",Not Recruiting,Not Applicable,Observational,Germany,"Clinical and Immunological Characterisation of COVID-19 in Children, Adolescents and Adults",Clinical Presentation,No Intervention,No Intervention,160,https://clinicaltrials.gov/show/NCT04341168,None
3425,NCT04341207,ClinicalTrials.gov,2020-04-08,2020-04-03,True,Institut Gustave Roussy,Recruiting,Phase 2,Interventional,France,Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; Azithromycin,1000,https://clinicaltrials.gov/show/NCT04341207,EUCTR2020-001250-21
3426,NCT04341285,ClinicalTrials.gov,2020-03-30,2020-08-01,False,"University Hospital, Tübingen",Not Recruiting,Not Applicable,Interventional,Germany,Early Versus Late ECMO Therapy in COVID-19 Induced ARDS (ECMO-VID),Drug,Oxygen,Oxygen,200,https://clinicaltrials.gov/show/NCT04341285,None
3427,NCT04341389,ClinicalTrials.gov,2020-04-07,2020-04-12,False,"Insitute of Biotechnology, Academy of Military Medical Sciences, PLA of China",Not Recruiting,Phase 2,Interventional,China,A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector),ATMP,Vaccine,Vaccine,508,https://clinicaltrials.gov/show/NCT04341389,None
3428,NCT04341415,ClinicalTrials.gov,2020-04-07,2020-04-09,False,Fondation Ophtalmologique Adolphe de Rothschild,Recruiting,Not Applicable,Interventional,France,Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome,Procedure,Auricular neuromodulation,Auricular neuromodulation,60,https://clinicaltrials.gov/show/NCT04341415,None
3429,NCT04341480,ClinicalTrials.gov,2020-04-07,2020-07-01,False,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,The Safety of Chemotherapy for Patients With Gynecological Malignancy in High-risk Region of COVID-19,Clinical Presentation,No Intervention,No Intervention,305,https://clinicaltrials.gov/show/NCT04341480,None
3430,NCT04341493,ClinicalTrials.gov,2020-04-07,2020-04-06,True,Hugo Mendieta Zeron,Recruiting,Phase 4,Interventional,Mexico,Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19,Drug,Hydroxychloroquine vs. Nitazoxanide,Hydroxychloroquine; nitazoxanide,86,https://clinicaltrials.gov/show/NCT04341493,None
3431,NCT04341506,ClinicalTrials.gov,2020-04-07,2020-09-08,False,Northwestern Medicine,Recruiting,Not Applicable,Observational,United States,Non-contact ECG Sensor System for COVID19,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04341506,None
3432,NCT04341519,ClinicalTrials.gov,2020-04-07,2020-04-06,True,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Observational,France,"Psychological Burden in ICU Survivors of Severe COVID-19 Pneumonia, Their Relatives and Their Healthcare Providers",Other (psych),No Intervention,No Intervention,1464,https://clinicaltrials.gov/show/NCT04341519,None
3433,NCT04341584,ClinicalTrials.gov,2020-04-07,2020-04-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,No Country Given,CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 Infection,Drug,Anakinra,Anakinra,240,https://clinicaltrials.gov/show/NCT04341584,EUCTR2020-001246-18
3434,NCT04341610,ClinicalTrials.gov,2020-04-07,2020-04-20,False,"Rigshospitalet, Denmark",Not Recruiting,Phase 1/Phase 2,Interventional,Denmark,ASC Therapy for Patients With Severe Respiratory COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),0,https://clinicaltrials.gov/show/NCT04341610,None
3435,NCT04341675,ClinicalTrials.gov,2020-04-05,2020-04-24,False,University of Cincinnati,Recruiting,Phase 2,Interventional,United States,Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia,Drug,Sirolimus,Sirolimus,30,https://clinicaltrials.gov/show/NCT04341675,None
3436,NCT04341688,ClinicalTrials.gov,2020-04-06,2020-08-01,False,Aga Khan University,Not Recruiting,Not Applicable,Interventional,No Country Given,A Clinical Trial of Gargling Agents in Reducing Intraoral Viral Load Among COVID-19 Patients,Drug,Mouthwash,Mouthwash,50,https://clinicaltrials.gov/show/NCT04341688,None
3437,NCT04341714,ClinicalTrials.gov,2020-04-08,2020-03-16,True,Pierre and Marie Curie University,Recruiting,Not Applicable,Observational,France,Efficiency and Satisfaction With Telephone Consultation in Neuro-urology: Experience of the COVID-19 Pandemic,Telehealth,Telehealth,Telehealth,450,https://clinicaltrials.gov/show/NCT04341714,None
3438,NCT04341766,ClinicalTrials.gov,2020-04-01,2020-03-31,True,Centre Hospitalier Intercommunal Creteil,Not Recruiting,Not Applicable,Observational,France,Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid (Coronavirus Disease) 19,Clinical Presentation,No Intervention,No Intervention,106,https://clinicaltrials.gov/show/NCT04341766,None
3439,NCT04341792,ClinicalTrials.gov,2020-04-07,2020-04-11,False,"University Hospital, Lille",Recruiting,Not Applicable,Observational,France,Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04341792,None
3440,NCT04341870,ClinicalTrials.gov,2020-04-06,2020-04-11,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2/Phase 3,Interventional,France,"Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO",Drug,Sarilumab + Azithromycin + Hydroxychloroquine vs. Sarilumab,Sarilumab; azithromycin; hydroxychloroquine,27,https://clinicaltrials.gov/show/NCT04341870,EUCTR2020-001246-18
3441,NCT04341922,ClinicalTrials.gov,2020-04-07,2020-05-09,False,Karolinska Institutet,Not Recruiting,Not Applicable,Interventional,Sweden,A Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic,Other (psych),Psychological,Psychological,670,https://clinicaltrials.gov/show/NCT04341922,None
3442,NCT04341935,ClinicalTrials.gov,2020-04-06,2021-01-30,False,University of Miami,Not Recruiting,Phase 4,Interventional,United States,Effects of DPP4 Inhibition on COVID-19,Drug,Linagliptin,Linagliptin,20,https://clinicaltrials.gov/show/NCT04341935,None
3443,NCT04342104,ClinicalTrials.gov,2020-04-08,2020-04-01,True,Hospital General Universitario Morales Meseguer,Recruiting,Not Applicable,Observational,Spain,NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04342104,None
3444,NCT04342156,ClinicalTrials.gov,2020-04-08,2020-04-01,True,Tan Tock Seng Hospital,Not Recruiting,Phase 3,Interventional,No Country Given,Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04342156,None
3445,NCT04342169,ClinicalTrials.gov,2020-04-07,2020-04-04,True,University of Utah,Recruiting,Phase 2,Interventional,United States,University of Utah COVID-19 Hydrochloroquine Trial,Drug,Hydroxychloroquine,Hydroxychloroquine,400,https://clinicaltrials.gov/show/NCT04342169,None
3446,NCT04342182,ClinicalTrials.gov,2020-03-31,2020-04-08,False,Erasmus Medical Center,Not Recruiting,Phase 2/Phase 3,Interventional,Netherlands,Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study),ATMP,Plasma,Plasma,426,https://clinicaltrials.gov/show/NCT04342182,None
3447,NCT04342195,ClinicalTrials.gov,2020-04-08,2020-03-25,True,Columbia University,Recruiting,Not Applicable,Observational,United States,Acquiring Convalescent Specimens for COVID-19 Antibodies,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04342195,None
3448,NCT04342208,ClinicalTrials.gov,2020-04-07,2020-04-10,False,Istanbul University-Cerrahpasa,Not Recruiting,Not Applicable,Observational,No Country Given,Evaluate the Working Environments of Individuals Working From Home During Covid-19 Outbreak,Other,Other,Other,500,https://clinicaltrials.gov/show/NCT04342208,None
3449,NCT04342637,ClinicalTrials.gov,2020-04-07,2020-04-10,False,Al-Azhar University,Not Recruiting,Not Applicable,Observational,"Egypt, United States, Iran",COVID-19 Endoscopy Survey,Other,Other,Other,163,https://clinicaltrials.gov/show/NCT04342637,None
3450,NCT04342650,ClinicalTrials.gov,2020-04-04,2020-04-08,False,Fundação de Medicina Tropical Dr. Heitor Vieira Dourado,Not Recruiting,Phase 2,Interventional,Brazil,Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection,Drug,Chloroquine,Chloroquine,152,https://clinicaltrials.gov/show/NCT04342650,None
3451,NCT04342663,ClinicalTrials.gov,2020-04-08,2020-04-10,False,Washington University in St. Louis,Not Recruiting,Phase 2,Interventional,United States,"A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection",Drug,Fluvoxamine,Fluvoxamine,152,https://clinicaltrials.gov/show/NCT04342663,None
3452,NCT04342689,ClinicalTrials.gov,2020-04-08,2020-06-03,False,Yale University,Recruiting,Phase 3,Interventional,United States,The Role of Resistant Starch in COVID-19 Infection,Supplement,Resistant Potato Starch,Resistant Potato Starch,1500,https://clinicaltrials.gov/show/NCT04342689,None
3453,NCT04342702,ClinicalTrials.gov,2020-04-04,2020-03-16,True,The Second Affiliated Hospital of Wenzhou Medical University,Not Recruiting,Not Applicable,Observational,China,A Study on the Prospective Cohort Library of COVID-19 in Southeran,Clinical Presentation,No Intervention,No Intervention,504,https://clinicaltrials.gov/show/NCT04342702,None
3454,NCT04342728,ClinicalTrials.gov,2020-04-08,2020-04-08,False,The Cleveland Clinic,Recruiting,Not Applicable,Interventional,United States,Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation,Drug,Zinc + Vitamin C vs Zinc vs. Vitamin C,Zinc; vitamin C,520,https://clinicaltrials.gov/show/NCT04342728,None
3455,NCT04342806,ClinicalTrials.gov,2020-04-08,2020-04-10,False,Duke University,Recruiting,Not Applicable,Observational,United States,"Healthcare Worker Exposure Response and Outcomes (HERO) Registry Study, COVID-19",Clinical Presentation,No Intervention,No Intervention,100000,https://clinicaltrials.gov/show/NCT04342806,None
3456,NCT04342884,ClinicalTrials.gov,2020-04-08,2020-04-08,False,Wake Forest University,Recruiting,Not Applicable,Observational,United States,COVID-19 Community Research Partnership,Clinical Presentation,No Intervention,No Intervention,150000,https://clinicaltrials.gov/show/NCT04342884,None
3457,NCT04342897,ClinicalTrials.gov,2020-04-10,2020-04-20,False,Eli Lilly and Company,Not Recruiting,Phase 2,Interventional,United States,A Study of LY3127804 in Participants With COVID-19,Drug,LY3127804,LY3127804,95,https://clinicaltrials.gov/show/NCT04342897,None
3458,NCT04343001,ClinicalTrials.gov,2020-04-08,2020-10-01,False,London School of Hygiene and Tropical Medicine,Not Recruiting,Phase 3,Interventional,"Pakistan, Nigeria",Coronavirus Response - Active Support for Hospitalised Covid-19 Patients,Drug,"Monotherapy and all Combinations of: ARB (Losartan), simvastatin, and aspirin",ARB (Losartan); simvastatin; aspirin,0,https://clinicaltrials.gov/show/NCT04343001,None
3459,NCT04343092,ClinicalTrials.gov,2020-04-05,2020-04-18,False,University of Baghdad,Not Recruiting,Phase 1,Interventional,Iraq,Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management,Drug,Ivermectin + hydroxychloroquine vs. hydroxychloroquine,Ivermectin; hydroxychloroquine,16,https://clinicaltrials.gov/show/NCT04343092,None
3460,NCT04343144,ClinicalTrials.gov,2020-04-09,2020-04-15,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,"Trial Evaluating Efficacy and Safety of Nivolumab (OptivoÂ®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort.",Drug,Nivolumab,Nivolumab,92,https://clinicaltrials.gov/show/NCT04343144,EUCTR2020-001246-18
3461,NCT04343183,ClinicalTrials.gov,2020-04-07,2020-04-01,True,Ochsner Health System,Not Recruiting,Not Applicable,Interventional,United States,Hyperbaric Oxygen Therapy (HBOT) as a Treatment for COVID-19 (COVID-19) Infection,Drug,Oxygen,Oxygen,48,https://clinicaltrials.gov/show/NCT04343183,None
3462,NCT04343248,ClinicalTrials.gov,2020-04-08,2020-05-12,False,Romark Laboratories L.C.,Recruiting,Phase 3,Interventional,United States,Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF),Drug (Chemoprophylaxis),Nitazoxanide,Nitazoxanide,800,https://clinicaltrials.gov/show/NCT04343248,None
3463,NCT04343261,ClinicalTrials.gov,2020-04-08,2020-04-10,False,Saint Francis Care,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma in the Treatment of COVID 19,ATMP,Plasma,Plasma,48,https://clinicaltrials.gov/show/NCT04343261,None
3464,NCT04343339,ClinicalTrials.gov,2020-04-08,2020-04-08,False,"University Hospital, Montpellier",Not Recruiting,Not Applicable,Observational,France,Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment,Other (psych),No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04343339,None
3465,NCT04343404,ClinicalTrials.gov,2020-04-08,2020-04-01,True,"University Hospital, Strasbourg",Not Recruiting,Not Applicable,Observational,France,Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19,Drug,Oxygen,Oxygen,100,https://clinicaltrials.gov/show/NCT04343404,None
3466,NCT04343651,ClinicalTrials.gov,2020-03-31,2020-04-01,False,"CytoDyn, Inc.",Not Recruiting,Phase 2,Interventional,United States,Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19,Drug,Leronlimab,Leronlimab,86,https://clinicaltrials.gov/show/NCT04343651,None
3467,NCT04343664,ClinicalTrials.gov,2020-04-09,2020-08-01,False,Tjhin Wiguna,Not Recruiting,Not Applicable,Observational,Indonesia,Mental Health Assessment Among Community Member During the Covid-19 Pandemic in Indonesia,Other (psych),No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04343664,None
3468,NCT04343690,ClinicalTrials.gov,2020-04-09,2020-03-27,True,Duke University,Not Recruiting,Not Applicable,Interventional,United States,COPING With COVID-19( CWC-19),Other (psych),Psychological,Psychological,0,https://clinicaltrials.gov/show/NCT04343690,None
3469,NCT04343729,ClinicalTrials.gov,2020-04-09,2020-04-18,False,Fundação de Medicina Tropical Dr. Heitor Vieira Dourado,Not Recruiting,Phase 2,Interventional,Brazil,Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19,Drug,Corticosteroids,Methylprednisolone,416,https://clinicaltrials.gov/show/NCT04343729,None
3470,NCT04343742,ClinicalTrials.gov,2020-04-07,2020-04-01,True,Genesis Foundation,Recruiting,Not Applicable,Observational,Colombia,Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19,Drug,Chlorine dioxide,Chlorine dioxide,20,https://clinicaltrials.gov/show/NCT04343742,None
3471,NCT04343768,ClinicalTrials.gov,2020-04-08,2020-04-09,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2,Interventional,Iran,"An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial",Drug,Hydroxychloroquine + Lopinavir/ritonavir + interferon beta 1a vs. hydroxychloroquine + Lopinavir/ritonavir + interferon beta 1b vs. hydroxychloroquine + Lopinavir/ritonavir,Hydroxychloroquine; Lopinavir/ritonavir; interferon beta,60,https://clinicaltrials.gov/show/NCT04343768,None
3472,NCT04343781,ClinicalTrials.gov,2020-04-09,2020-03-22,True,"University Hospital, Angers",Not Recruiting,Not Applicable,Observational,France,National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19,Clinical Presentation,No Intervention,No Intervention,353,https://clinicaltrials.gov/show/NCT04343781,None
3473,NCT04343794,ClinicalTrials.gov,2020-02-20,2020-04-01,False,University of Hong Kong,Recruiting,Not Applicable,Interventional,Hong Kong,Using BiovitalsÂ® Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19,Other (device),Biosensors,Biosensors,200,https://clinicaltrials.gov/show/NCT04343794,None
3474,NCT04343898,ClinicalTrials.gov,2020-04-09,2020-04-01,True,Brigham and Women's Hospital,Not Recruiting,Not Applicable,Observational,United States,Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,5220,https://clinicaltrials.gov/show/NCT04343898,None
3475,NCT04343963,ClinicalTrials.gov,2020-04-09,2020-04-04,True,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,Recruiting,Phase 2/Phase 3,Interventional,Mexico,Pyridostigmine in Severe SARS-CoV-2 Infection,Drug,Pyridostigmine,Pyridostigmine,436,https://clinicaltrials.gov/show/NCT04343963,None
3476,NCT04343989,ClinicalTrials.gov,2020-04-09,2020-03-31,True,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,Drug,Clazakizumab,Clazakizumab,90,https://clinicaltrials.gov/show/NCT04343989,None
3477,NCT04344002,ClinicalTrials.gov,2020-04-09,2020-04-21,False,Spanish Lung Cancer Group,Recruiting,Not Applicable,Observational,Spain,LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID),Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04344002,None
3478,NCT04344015,ClinicalTrials.gov,2020-04-09,2020-04-13,False,Thomas Jefferson University,Recruiting,Not Applicable,Interventional,United States,COVID-19 Plasma Collection,ATMP,Plasma,Plasma,2000,https://clinicaltrials.gov/show/NCT04344015,None
3479,NCT04344041,ClinicalTrials.gov,2020-04-09,2020-04-15,True,"University Hospital, Angers",Recruiting,Phase 3,Interventional,France,COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial),Drug,Vitamin D,Vitamin D,260,https://clinicaltrials.gov/show/NCT04344041,EUCTR2020-001602-34
3480,NCT04344080,ClinicalTrials.gov,2020-04-09,2020-04-01,False,"University Hospital, Hamburg-Eppendorf",Recruiting,Not Applicable,Interventional,Germany,Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19,Other (device),Cytokine Adsorber,Cytokine Adsorber,24,https://clinicaltrials.gov/show/NCT04344080,DRKS00021199
3481,NCT04344106,ClinicalTrials.gov,2020-04-08,2020-04-01,True,ELHARRAR Xavier,Recruiting,Not Applicable,Interventional,France,Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study,Procedure,Positioning,Positioning,25,https://clinicaltrials.gov/show/NCT04344106,None
3482,NCT04344119,ClinicalTrials.gov,2020-04-09,2020-04-09,False,CHU de Nice,Recruiting,Not Applicable,Observational,France,Assessment of Chilbains Occuring During Covid-19 Infection,Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04344119,None
3483,NCT04344145,ClinicalTrials.gov,2020-04-09,2020-04-16,False,Université Libre de Bruxelles,Not Recruiting,Not Applicable,Observational,Belgium,Exhaustion and Needs in Frontline COVID-19 Healthcare Workers: Cross-sectional Study in a Belgian Population,Other (psych),No Intervention,No Intervention,693,https://clinicaltrials.gov/show/NCT04344145,None
3484,NCT04344171,ClinicalTrials.gov,2020-04-10,2020-03-30,True,ClarData,Recruiting,Not Applicable,Observational,"Germany, Romania",CovidDB: The Covid-19 Inpatient Database,Clinical Presentation,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04344171,None
3485,NCT04344197,ClinicalTrials.gov,2020-04-09,2020-04-02,True,University of Rome Tor Vergata,Recruiting,Not Applicable,Observational,Italy,"Surgery During Covid-19: The Role of Asymptomatic Patients, a Survey",Clinical Presentation,No Intervention,No Intervention,1200,https://clinicaltrials.gov/show/NCT04344197,None
3486,NCT04344210,ClinicalTrials.gov,2020-04-07,2020-04-17,False,Federal University of Rio Grande do Sul,Not Recruiting,Not Applicable,Interventional,Brazil,Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus,Telehealth,Telehealth,Telehealth,149,https://clinicaltrials.gov/show/NCT04344210,None
3487,NCT04344236,ClinicalTrials.gov,2020-04-08,2020-04-09,False,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19,Drug,Povidone Iodine,Povidone Iodine,48,https://clinicaltrials.gov/show/NCT04344236,None
3488,NCT04344249,ClinicalTrials.gov,2020-04-08,2020-04-10,False,Nantes University Hospital,Recruiting,Not Applicable,Observational,France,Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,850,https://clinicaltrials.gov/show/NCT04344249,None
3489,NCT04344288,ClinicalTrials.gov,2020-04-10,2020-04-21,True,Hospices Civils de Lyon,Not Recruiting,Phase 2,Interventional,France,Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection,Drug,Corticosteroids,Prednisone,11,https://clinicaltrials.gov/show/NCT04344288,EUCTR2020-001553-48
3490,NCT04344327,ClinicalTrials.gov,2020-04-09,2020-04-10,False,French Cardiology Society,Not Recruiting,Not Applicable,Observational,France,Early Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCF,Clinical Presentation,No Intervention,No Intervention,2878,https://clinicaltrials.gov/show/NCT04344327,None
3491,NCT04344379,ClinicalTrials.gov,2020-03-27,2020-04-17,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 3,Interventional,France,Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus,Drug (Chemoprophylaxis),Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,122,https://clinicaltrials.gov/show/NCT04344379,EUCTR2020-001273-73
3492,NCT04344431,ClinicalTrials.gov,2020-04-09,2020-04-14,False,Direction Centrale du Service de Sant des Armes,Recruiting,Phase 2/Phase 3,Interventional,France,Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19),Drug,Oxygen,Oxygen,100,https://clinicaltrials.gov/show/NCT04344431,None
3493,NCT04344444,ClinicalTrials.gov,2020-04-10,2020-04-13,False,LCMC Health,Not Recruiting,Phase 3,Interventional,United States,Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; Azithromycin,600,https://clinicaltrials.gov/show/NCT04344444,None
3494,NCT04344457,ClinicalTrials.gov,2020-04-08,2020-04-16,False,"Perseverance Research Center, LLC",Recruiting,Phase 1/Phase 2,Interventional,United States,"Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19",Drug,Hydroxychloroquine + Indomethacin + Azithromycin,Hydroxychloroquine; Indomethacin; Azithromycin,80,https://clinicaltrials.gov/show/NCT04344457,None
3495,NCT04344509,ClinicalTrials.gov,2020-04-10,2020-06-01,False,Poitiers University Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Microbial Etiology of Ventilator-associated Pneumonia in COVID-19 Infected Patients,Clinical Presentation,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04344509,None
3496,NCT04344535,ClinicalTrials.gov,2020-04-10,2020-04-08,True,Stony Brook University,Recruiting,Phase 1/Phase 2,Interventional,United States,Convalescent Plasma vs. Standard Plasma for COVID-19,ATMP,Plasma,Plasma,500,https://clinicaltrials.gov/show/NCT04344535,None
3497,NCT04344548,ClinicalTrials.gov,2020-04-10,2020-04-13,False,National University of Colombia,Not Recruiting,Phase 1/Phase 2,Interventional,Colombia,Phase I / II Clinical Study of Immunotherapy Based on Adoptive Cell Transfer as a Therapeutic Alternative for Patients With COVID-19 in Colombia,ATMP,Cells (NK),Cells (NK),10,https://clinicaltrials.gov/show/NCT04344548,None
3498,NCT04344561,ClinicalTrials.gov,2020-04-10,2020-05-25,False,Johns Hopkins University,Recruiting,Not Applicable,Interventional,United States,Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation,Procedure,Positioning,Positioning,70,https://clinicaltrials.gov/show/NCT04344561,None
3499,NCT04344600,ClinicalTrials.gov,2020-04-10,2020-05-29,False,Johns Hopkins University,Recruiting,Phase 2,Interventional,United States,Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection,Drug,Interferon lambda,Interferon lambda,164,https://clinicaltrials.gov/show/NCT04344600,None
3500,NCT04344665,ClinicalTrials.gov,2020-04-09,2020-04-23,False,Population Health Research Institute,Not Recruiting,Not Applicable,Interventional,Canada,Post Discharge After Surgery Virtual Care With Remote Automated Monitoring Technology (PVC-RAM) Trial,Telehealth,Telehealth,Telehealth,905,https://clinicaltrials.gov/show/NCT04344665,None
3501,NCT04344730,ClinicalTrials.gov,2020-04-09,2020-04-10,True,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Interventional,France,Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia,Drug,"Dexamethasone, Oxygen",Dexamethasone; Oxygen,550,https://clinicaltrials.gov/show/NCT04344730,EUCTR2020-001457-43
3502,NCT04344756,ClinicalTrials.gov,2020-04-09,2020-04-20,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,"Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort",Drug,Tinzaparin or Heparin,Tinzaparin; Heparin,808,https://clinicaltrials.gov/show/NCT04344756,EUCTR2020-001246-18
3503,NCT04344782,ClinicalTrials.gov,2020-04-09,2020-04-15,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,No Country Given,"Trial Evaluating Efficacy and Safety of Bevacizumab (AvastinÂ®/ZeribevÂ®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort",Drug,Bevacizumab,Bevacizumab,130,https://clinicaltrials.gov/show/NCT04344782,EUCTR2020-001246-18
3504,NCT04344834,ClinicalTrials.gov,2020-04-11,2020-05-01,False,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,Impact of Covid-19 on Egyptian Health Care Workers and General Population Mental Health,Other (psych),No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04344834,None
3505,NCT04344912,ClinicalTrials.gov,2020-04-10,2020-03-20,True,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Observational,France,Impact of COVID19 Outbreak in Cardiac Acute Care,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04344912,None
3506,NCT04344925,ClinicalTrials.gov,2020-04-03,2020-04-18,False,Lawson Health Research Institute,Recruiting,Not Applicable,Observational,Canada,Non Invasive Positive Pressure Ventilation to Minimize Aerosolization for COVID 19,Other (device),Masks,Masks,50,https://clinicaltrials.gov/show/NCT04344925,None
3507,NCT04344938,ClinicalTrials.gov,2020-04-10,2020-04-01,True,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,Covid 19 Pandemic. Emerging Legal and Ehical Disputes Over Patient Confidentiality,Other,No Intervention,No Intervention,874,https://clinicaltrials.gov/show/NCT04344938,None
3508,NCT04344951,ClinicalTrials.gov,2020-04-06,2020-04-06,True,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.,Recruiting,Phase 2,Interventional,Greece,"Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial",Drug,Chloroquine,Chloroquine,60,https://clinicaltrials.gov/show/NCT04344951,EUCTR2020-001345-38
3509,NCT04344964,ClinicalTrials.gov,2020-04-10,2020-04-15,False,Austin Health,Not Recruiting,Not Applicable,Observational,Australia,Endoscopy-related Phone Consultation During the COVID-19 Outbreak,Telehealth,Telehealth,Telehealth,186,https://clinicaltrials.gov/show/NCT04344964,None
3510,NCT04345159,ClinicalTrials.gov,2020-04-10,2020-04-17,False,Fondation Ophtalmologique Adolphe de Rothschild,Not Recruiting,Not Applicable,Observational,France,Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease,Clinical Presentation,No Intervention,No Intervention,572,https://clinicaltrials.gov/show/NCT04345159,None
3511,NCT04345276,ClinicalTrials.gov,2020-04-10,2020-03-18,False,Huo-Shen-Shan Hospital,Not Recruiting,Phase 4,Interventional,China,Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection,Drug,Danoprevir + Ritonavir,Danoprevir; Ritonavir,10,https://clinicaltrials.gov/show/NCT04345276,ChiCTR2000031734
3512,NCT04345289,ClinicalTrials.gov,2020-04-10,2020-05-01,True,Thomas Benfield,Recruiting,Phase 3,Interventional,Denmark,Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia,Drug (+ ATMP),Plamsa vs. Sarilumab vs. Hydroxychloroquine vs. Baricitinib,Plamsa; Sarilumab; Hydroxychloroquine; Baricitinib,1100,https://clinicaltrials.gov/show/NCT04345289,EUCTR2020-001367-88
3513,NCT04345315,ClinicalTrials.gov,2020-04-10,2020-03-27,True,Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori,Recruiting,Not Applicable,Observational,Italy,"Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent.",Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04345315,None
3514,NCT04345406,ClinicalTrials.gov,2020-04-11,2020-04-15,False,Tanta University,Not Recruiting,Phase 3,Interventional,Egypt,Angiotensin Converting Enzyme Inhibitors in Treatment of Covid 19,Drug,ACE inhibitors,ACE inhibitors,60,https://clinicaltrials.gov/show/NCT04345406,None
3515,NCT04345445,ClinicalTrials.gov,2020-04-08,2020-04-15,False,University of Malaya,Not Recruiting,Phase 3,Interventional,Malaysia,Study to Evaluate the Efficacy and Safety of Tocilizumab Versus Corticosteroids in Hospitalised COVID-19 Patients With High Risk of Progression,Drug,Tocilizumab vs. Corticosteroids,Tocilizumab; Methylprednisolone,310,https://clinicaltrials.gov/show/NCT04345445,None
3516,NCT04345510,ClinicalTrials.gov,2020-04-12,2020-04-20,False,German Cancer Research Center (DKFZ),Not Recruiting,Not Applicable,Observational,No Country Given,Testing for COVID-19 Infection in Asymptomatic Persons,Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04345510,None
3517,NCT04345523,ClinicalTrials.gov,2020-04-02,2020-04-03,False,Cristina Avendaño-Solá,Recruiting,Phase 2,Interventional,Spain,Convalescent Plasma Therapy vs. SOC for the Treatment of COVID19 in Hospitalized Patients,ATMP,Plasma,Plasma,278,https://clinicaltrials.gov/show/NCT04345523,None
3518,NCT04345536,ClinicalTrials.gov,2020-04-05,2020-03-15,True,Oslo University Hospital,Recruiting,Not Applicable,Observational,Norway,Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University Hospital,Clinical Presentation,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04345536,None
3519,NCT04345549,ClinicalTrials.gov,2020-04-10,2020-02-26,True,Aarogyam UK,Not Recruiting,Not Applicable,Interventional,United Kingdom,Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,18,https://clinicaltrials.gov/show/NCT04345549,None
3520,NCT04345601,ClinicalTrials.gov,2020-04-10,2020-12-01,False,Baylor University,Not Recruiting,Phase 1,Interventional,United States,Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease),ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04345601,None
3521,NCT04345614,ClinicalTrials.gov,2020-04-07,2020-04-08,False,"CalciMedica, Inc.",Recruiting,Phase 2,Interventional,"United States, Puerto Rico",A Study of Auxora in Patients With Severe COVID-19 Pneumonia,Drug,CM4620-Injectable Emulsion,CM4620-Injectable Emulsion,400,https://clinicaltrials.gov/show/NCT04345614,None
3522,NCT04345640,ClinicalTrials.gov,2020-04-10,2020-04-10,False,"Institute of Liver and Biliary Sciences, India",Recruiting,Not Applicable,Observational,India,The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver.,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04345640,None
3523,NCT04345653,ClinicalTrials.gov,2020-04-08,2020-04-14,False,Hackensack Meridian Health,Not Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,44,https://clinicaltrials.gov/show/NCT04345653,None
3524,NCT04345679,ClinicalTrials.gov,2020-04-11,2020-04-14,False,Orthosera Kft.,Not Recruiting,Phase 1,Interventional,No Country Given,Anti COVID-19 Convalescent Plasma Therapy,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04345679,None
3525,NCT04345692,ClinicalTrials.gov,2020-04-09,2020-03-26,True,Queen's Medical Centre,Not Recruiting,Phase 3,Interventional,United States,A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients,Drug,Hydroxychloroquine,Hydroxychloroquine,17,https://clinicaltrials.gov/show/NCT04345692,None
3526,NCT04345848,ClinicalTrials.gov,2020-04-07,2020-04-28,False,"University Hospital, Geneva",Recruiting,Phase 3,Interventional,Switzerland,Preventing COVID-19 Complications With Low- and High-dose Anticoagulation,Drug,Heparin,Heparin,200,https://clinicaltrials.gov/show/NCT04345848,None
3527,NCT04345861,ClinicalTrials.gov,2020-04-05,2020-04-11,False,"University Hospital, Montpellier",Not Recruiting,Phase 2/Phase 3,Interventional,France,Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial),Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; azithormycin,7,https://clinicaltrials.gov/show/NCT04345861,None
3528,NCT04345887,ClinicalTrials.gov,2020-04-10,2020-04-21,False,Istanbul University-Cerrahpasa,Not Recruiting,Phase 4,Interventional,Turkey,Spironolactone in Covid-19 Induced ARDS,Drug,Spironolactone,Spironolactone,60,https://clinicaltrials.gov/show/NCT04345887,None
3529,NCT04345991,ClinicalTrials.gov,2020-04-10,2020-04-15,True,Assistance Publique – Hôpitaux de Paris,Recruiting,Phase 2,Interventional,France,"Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort",ATMP,Plasma,Plasma,120,https://clinicaltrials.gov/show/NCT04345991,EUCTR2020-001246-18
3530,NCT04346017,ClinicalTrials.gov,2020-04-13,2020-03-20,True,Francis Corazza,Recruiting,Not Applicable,Interventional,Belgium,Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04346017,None
3531,NCT04346043,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Ain Shams University,Not Recruiting,Not Applicable,Observational,Egypt,To Access the Egyptian COVID-19 Whole Genome by NGS and Compare to the International Worldwide Database,Genomics,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04346043,None
3532,NCT04346056,ClinicalTrials.gov,2020-04-13,2020-04-14,False,Ain Shams University,Recruiting,Not Applicable,Observational,Egypt,Retrospective Study on Severe Respiratory Illness to Access the Presence of COVID-19,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04346056,None
3533,NCT04346082,ClinicalTrials.gov,2020-04-07,2020-08-01,False,Chinese University of Hong Kong,Not Recruiting,Not Applicable,Interventional,Hong Kong,Feasibility of Online Based Mindfulness Interventions During COVID-19 Outbreak,Other (psych),Psychological,Psychological,30,https://clinicaltrials.gov/show/NCT04346082,None
3534,NCT04346121,ClinicalTrials.gov,2020-04-10,2020-04-28,False,Nantes University Hospital,Not Recruiting,Not Applicable,Observational,France,Non-COVID Patient-safety Incidents Reported by General Practitioners in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study.cRisis,Other,No Intervention,No Intervention,132,https://clinicaltrials.gov/show/NCT04346121,None
3535,NCT04346147,ClinicalTrials.gov,2020-04-07,2020-04-13,False,Hospital Universitario de Fuenlabrada,Recruiting,Phase 2,Interventional,Spain,Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19,Drug,"Lopinavir/ritonavir vs. Imatinib vs. Baricitinib

All in comibination with Hydroxychloroquine ",Hydroxychloroquine; Lopinavir/ritonavir; Imatinib; Baricitinib,165,https://clinicaltrials.gov/show/NCT04346147,None
3536,NCT04346160,ClinicalTrials.gov,2020-04-10,2020-04-14,False,D'Annunzio University of Chieti–Pescara,Not Recruiting,Not Applicable,Observational,Italy,"A Study to Assess the Virus RNA, and miRNA Levels Related to Viral Infection, and Inflammatory Response in Tears of Patients Affected by COVID-19 Disease",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,25,https://clinicaltrials.gov/show/NCT04346160,None
3537,NCT04346186,ClinicalTrials.gov,2020-04-11,2020-04-15,False,"Copenhagen University Hospital, Herlev Hospital",Recruiting,Not Applicable,Observational,Denmark,COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,30000,https://clinicaltrials.gov/show/NCT04346186,None
3538,NCT04346212,ClinicalTrials.gov,2020-04-10,2020-04-14,False,Hospital de Mataró,Recruiting,Not Applicable,Observational,Spain,Oropharyngeal Dysphagia in Patients With COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,300,https://clinicaltrials.gov/show/NCT04346212,None
3539,NCT04346264,ClinicalTrials.gov,2020-04-13,2020-04-27,False,Ludwig Boltzmann Institute for Lung Health,Recruiting,Not Applicable,Observational,Austria,CoVid-19 - Infection and Antibody Formation in the Viennese Population,Clinical Presentation (Epidemiology),No Intervention,No Intervention,5500,https://clinicaltrials.gov/show/NCT04346264,None
3540,NCT04346277,ClinicalTrials.gov,2020-04-13,2020-04-27,False,Implicit Bioscience,Not Recruiting,Not Applicable,Expanded Access,Italy,Compassionate Use Open-Label Anti-CD14 Treatment in Patients With SARS-CoV-2 (COVID-19),Drug,IC14,IC14,Not Available,https://clinicaltrials.gov/show/NCT04346277,None
3541,NCT04346329,ClinicalTrials.gov,2020-04-10,2020-04-20,False,National University of Colombia,Not Recruiting,Phase 3,Interventional,Colombia,Immune Monitoring of Prophylactic Effect of Hydroxychloroquine in Healthcare Providers Highly Exposed to COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,86,https://clinicaltrials.gov/show/NCT04346329,None
3542,NCT04346342,ClinicalTrials.gov,2020-04-09,2020-03-06,True,UMC Amsterdam,Not Recruiting,Not Applicable,Observational,Netherlands,PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID),Other (physical),Mechanical ventilation,Mechanical ventilation,1122,https://clinicaltrials.gov/show/NCT04346342,None
3543,NCT04346355,ClinicalTrials.gov,2020-04-12,2020-03-31,True,Azienda Unita Sanitaria Locale Reggio Emilia,Not Recruiting,Phase 2,Interventional,Italy,Efficacy of Early Administration of Tocilizumab in COVID-19 Patients,Drug,Tocilizumab,Tocilizumab,126,https://clinicaltrials.gov/show/NCT04346355,EUCTR2020-001386-37
3544,NCT04346368,ClinicalTrials.gov,2020-03-23,2020-04-01,False,Guangzhou Institute of Respiratory Disease,Not Recruiting,Phase 1/Phase 2,Interventional,China,Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04346368,None
3545,NCT04346420,ClinicalTrials.gov,2020-04-08,2020-04-09,False,"University Clinic, UCLouvain",Not Recruiting,Not Applicable,Interventional,Belgium,Impact of the Double-Trunk Mask on Oxygenation Titration in COVID-19,Other (device),Masks,Masks,12,https://clinicaltrials.gov/show/NCT04346420,None
3546,NCT04346446,ClinicalTrials.gov,2020-04-14,2020-04-20,True,"Institute of Liver and Biliary Sciences, India",Not Recruiting,Phase 2,Interventional,India,Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients,ATMP,Plasma,Plasma,29,https://clinicaltrials.gov/show/NCT04346446,CTRI/2020/04/024706
3547,NCT04346589,ClinicalTrials.gov,2020-04-09,2020-04-15,False,A.O. Ospedale Papa Giovanni XXIII,Recruiting,Not Applicable,Interventional,Italy,Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04346589,None
3548,NCT04346602,ClinicalTrials.gov,2020-04-06,2020-02-01,True,Jilin University,Recruiting,Not Applicable,Observational,China,A Study on the Clinical and Psychological Characteristics of Patients With COVID-2019,Clinical Presentation,No Intervention,No Intervention,132,https://clinicaltrials.gov/show/NCT04346602,None
3549,NCT04346615,ClinicalTrials.gov,2020-04-09,2020-04-25,False,"Biohaven Pharmaceuticals, Inc.",Recruiting,Phase 2/Phase 3,Interventional,United States,Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen,Drug,Vazegepant,Vazegepant,120,https://clinicaltrials.gov/show/NCT04346615,None
3550,NCT04346628,ClinicalTrials.gov,2020-04-10,2020-07-12,False,Stanford University,Recruiting,Phase 2,Interventional,United States,Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19,Drug,Favipiravir,Favipiravir,120,https://clinicaltrials.gov/show/NCT04346628,None
3551,NCT04346667,ClinicalTrials.gov,2020-04-13,2020-04-14,False,"Government of Punjab, Specialized Healthcare and Medical Education Department",Recruiting,Phase 4,Interventional,Pakistan,Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Chloroquine ,Hydroxychloroquine; chloroquine ,400,https://clinicaltrials.gov/show/NCT04346667,None
3552,NCT04346693,ClinicalTrials.gov,2020-04-08,2020-04-08,False,Burnasyan Federal Medical Biophysical Center,Not Recruiting,Phase 3,Interventional,Russian Federation,An Open Randomized Study of Dalargin Effectiveness in Patients With Severe and Critical Manifestations of SARS-COVID-19,Drug,Dalargin + Hydroxychloroquine + azithromycin + / - tocilizumab vs. Hydroxychloroquine + azithromycin + / - tocilizumab,Dalargin; Hydroxychloroquine; azithromycin; tocilizumab,320,https://clinicaltrials.gov/show/NCT04346693,None
3553,NCT04346797,ClinicalTrials.gov,2020-04-06,2020-04-16,True,Assistance Publique – Hôpitaux de Paris,Recruiting,Phase 2,Interventional,France,"CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort",Drug,Eculizumab,Eculizumab,120,https://clinicaltrials.gov/show/NCT04346797,EUCTR2020-001246-18
3554,NCT04346810,ClinicalTrials.gov,2020-04-08,2020-04-15,False,Hôpital Raymond-Poincaré,Not Recruiting,Not Applicable,Observational,No Country Given,Burnout Among Caregivers Facing COVID-19 Health Crisis at a Non-conventional Intensive Care Unit Compared to a Conventional Intensive Care Unit,Other (psych),No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04346810,None
3555,NCT04346927,ClinicalTrials.gov,2020-04-13,2020-08-10,False,Yasemin Çırak,Not Recruiting,Not Applicable,Interventional,No Country Given,Telerehabilitation for Patients Diagnosed With Coronavirus,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,30,https://clinicaltrials.gov/show/NCT04346927,None
3556,NCT04346953,ClinicalTrials.gov,2020-04-13,2020-08-20,False,Istinye University,Not Recruiting,Not Applicable,Interventional,No Country Given,Video-Based Exercise for Individuals With Social Isolation Due to Coronavirus (COVID-19),Other (exercise),Exercise,Exercise,128,https://clinicaltrials.gov/show/NCT04346953,None
3557,NCT04347031,ClinicalTrials.gov,2020-04-07,2020-04-08,False,Burnasyan Federal Medical Biophysical Center,Not Recruiting,Phase 2/Phase 3,Interventional,Russian Federation,A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19,Drug,"Mefloquine, Hydroxychloroquine, Azithormycin, Tocilizumab",Mefloquine; Hydroxychloroquine; Azithormycin; Tocilizumab,320,https://clinicaltrials.gov/show/NCT04347031,None
3558,NCT04347070,ClinicalTrials.gov,2020-04-10,2017-04-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Implementation of Physiotherapy on COVID-19 Patients in ICU,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,150,https://clinicaltrials.gov/show/NCT04347070,None
3559,NCT04347226,ClinicalTrials.gov,2020-04-02,2020-04-16,False,Matthew Dallos,Recruiting,Phase 2,Interventional,United States,Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19,Drug,Anti-Interleukin-8,Anti-Interleukin-8,138,https://clinicaltrials.gov/show/NCT04347226,None
3560,NCT04347239,ClinicalTrials.gov,2020-04-13,2020-04-15,False,"CytoDyn, Inc.",Recruiting,Phase 2,Interventional,United States,Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19),Drug,Leronlimab,Leronlimab,390,https://clinicaltrials.gov/show/NCT04347239,None
3561,NCT04347278,ClinicalTrials.gov,2020-04-03,2020-04-22,False,Instituto de Investigacin Marqus de Valdecilla,Recruiting,Not Applicable,Observational,Spain,Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry,Drug,Unspecified,Unspecified,1000,https://clinicaltrials.gov/show/NCT04347278,None
3562,NCT04347369,ClinicalTrials.gov,2020-03-18,2020-01-17,True,Xinqiao Hospital of Chongqing,Recruiting,Not Applicable,Observational,China,A Retrospective Study of Neural Network Model to Dynamically Quantificate the Severity in COVID-19 Disease,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04347369,None
3563,NCT04347382,ClinicalTrials.gov,2020-04-11,2020-04-30,False,Sohaib Ashraf,Not Recruiting,Phase 3,Interventional,Pakistan,Honey & Nigella Sativa Trial Against COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,313,https://clinicaltrials.gov/show/NCT04347382,None
3564,NCT04347408,ClinicalTrials.gov,2020-04-07,2020-05-06,False,"Queen's University, Belfast",Recruiting,Not Applicable,Observational,United Kingdom,Seroprevalence of SARS-Cov-2 Antibodies in Children,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,https://clinicaltrials.gov/show/NCT04347408,None
3565,NCT04347460,ClinicalTrials.gov,2020-04-08,2020-03-27,True,Technische Universität München,Recruiting,Not Applicable,Observational,Germany,Establishing a COVID-19 Prospective Cohort for Identification of Secondary HLH,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04347460,None
3566,NCT04347512,ClinicalTrials.gov,2020-04-11,2020-06-02,False,"University Hospital, Strasbourg",Not Recruiting,Phase 3,Interventional,No Country Given,EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRA,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Azithromycin; Hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04347512,None
3567,NCT04347538,ClinicalTrials.gov,2020-04-11,2020-05-01,False,Vanderbilt University,Not Recruiting,Not Applicable,Interventional,United States,Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19,Procedure,Saline Nasal Irrigation,Saline Nasal Irrigation,90,https://clinicaltrials.gov/show/NCT04347538,None
3568,NCT04347681,ClinicalTrials.gov,2020-04-08,2020-04-18,False,King Fahad Specialist Hospital,Recruiting,Phase 2,Interventional,Saudi Arabia,Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19,ATMP,Plasma,Plasma,575,https://clinicaltrials.gov/show/NCT04347681,None
3569,NCT04347694,ClinicalTrials.gov,2020-04-12,2020-04-11,True,Medical University of Vienna,Recruiting,Not Applicable,Observational,Austria,Study to Determine the Immunization Status Among Nephrological Health Care Personnel Against SARS-CoV-2 in a Single Center Over the Course of 12 Months During the Worldwide COVID-19 Pandemic.,Clinical Presentation,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04347694,None
3570,NCT04347798,ClinicalTrials.gov,2020-04-13,2020-09-01,False,University of Alberta,Recruiting,Not Applicable,Observational,Canada,IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT,Drug,Hydroxychloroquine or Chloroquine,Hydroxychloroquine; Chloroquine,500,https://clinicaltrials.gov/show/NCT04347798,None
3571,NCT04347824,ClinicalTrials.gov,2020-04-09,2020-04-27,False,"University Hospital, Göttingen",Recruiting,Not Applicable,Observational,Germany,Predict Adverse Events by Covid-19 Nephritis,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04347824,None
3572,NCT04347850,ClinicalTrials.gov,2020-04-09,2020-02-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,A Cohort of Patients With Possible or Confirmed SARS-CoV-2 (COVID-19),Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04347850,None
3573,NCT04347876,ClinicalTrials.gov,2020-04-14,2020-04-11,True,Assiut University,Recruiting,Not Applicable,Observational,Egypt,Outcome of COVID-19 Cases Based on Tuberculin Test: Can Previous BCG Alter the Prognosis?,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04347876,None
3574,NCT04347889,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Stony Brook University,Not Recruiting,Phase 2,Interventional,No Country Given,Preventing COVID-19 in Healthcare Workers With HCQ: A RCT,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Vitamin C,Hydroxychloroquine; Vitamin C,0,https://clinicaltrials.gov/show/NCT04347889,None
3575,NCT04347915,ClinicalTrials.gov,2020-04-14,2020-05-06,False,Bukwang Pharmaceutical,Recruiting,Phase 2,Interventional,South Korea,The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19,Drug,Clevudine vs. Hydroxychloroquine,Clevudine; Hydroxychloroquine,60,https://clinicaltrials.gov/show/NCT04347915,None
3576,NCT04347928,ClinicalTrials.gov,2020-04-08,2020-04-20,False,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,France,Respiratory and Hemodynamic Changes Induced in Mechanically Ventilated Patients for COVID-19,Clinical Presentation,No Intervention,No Intervention,15,https://clinicaltrials.gov/show/NCT04347928,None
3577,NCT04347941,ClinicalTrials.gov,2020-04-08,2020-07-11,False,University College Hospital Galway,Recruiting,Not Applicable,Interventional,Ireland,Awake Prone Positioning to Reduce Invasive VEntilation in COVID-19 Induced Acute Respiratory failurE,Procedure,Positioning,Positioning,200,https://clinicaltrials.gov/show/NCT04347941,None
3578,NCT04347954,ClinicalTrials.gov,2020-04-13,2020-08-15,False,Stanford University,Recruiting,Phase 1/Phase 2,Interventional,United States,PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19),Drug,Povidone Iodine,Povidone Iodine,45,https://clinicaltrials.gov/show/NCT04347954,None
3579,NCT04347980,ClinicalTrials.gov,2020-04-09,2020-04-01,True,Centre Chirurgical Marie Lannelongue,Recruiting,Phase 3,Interventional,France,Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19,Drug,Dexamethasone + Hydroxychloroquine vs. Hydroxychloroquine,Dexamethasone; Hydroxychloroquine,122,https://clinicaltrials.gov/show/NCT04347980,None
3580,NCT04347993,ClinicalTrials.gov,2020-04-13,2020-03-27,True,Hackensack Meridian Health,Recruiting,Not Applicable,Observational,United States,"A Prospective ""Universal"" Observational Database for COVID-19",Clinical Presentation,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04347993,None
3581,NCT04348071,ClinicalTrials.gov,2020-04-13,2020-11-01,False,"University of Colorado, Denver",Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Safety and Efficacy of Ruxolitinib for COVID-19,Drug,Ruxolitinib,Ruxolitinib,80,https://clinicaltrials.gov/show/NCT04348071,None
3582,NCT04348214,ClinicalTrials.gov,2020-04-13,2020-04-22,False,Ain Shams University,Recruiting,Not Applicable,Observational,Egypt,Screening & Risk Assessment of Healthcare Workers & Infection Control in University & COVID-19 Quarantine Hospitals,Clinical Presentation,No Intervention,No Intervention,3000,https://clinicaltrials.gov/show/NCT04348214,None
3583,NCT04348227,ClinicalTrials.gov,2020-04-10,2019-01-01,True,Hôpital Universitaire Fattouma Bourguiba,Not Recruiting,Not Applicable,Observational,Tunisia,How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country's ICU?,Clinical Presentation,No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04348227,None
3584,NCT04348305,ClinicalTrials.gov,2020-04-11,2020-04-17,True,Scandinavian Critical Care Trials Group,Not Recruiting,Phase 3,Interventional,Denmark,Hydrocortisone for COVID-19 and Severe Hypoxia,Drug,Corticosteroids,Hydrocortisone,1000,https://clinicaltrials.gov/show/NCT04348305,EUCTR2020-001395-15
3585,NCT04348370,ClinicalTrials.gov,2020-03-30,2020-04-20,False,Texas A&M University,Recruiting,Phase 4,Interventional,United States,BCG Vaccine for Health Care Workers as Defense Against COVID 19,ATMP,Vaccine,Vaccine,1800,https://clinicaltrials.gov/show/NCT04348370,None
3586,NCT04348383,ClinicalTrials.gov,2020-04-08,2020-04-08,False,Fundación para la Formación e Investigación Sanitarias de la Región de Murcia (FFIS),Recruiting,Phase 2,Interventional,Spain,Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19.,Drug,Defibrotide,Defibrotide,120,https://clinicaltrials.gov/show/NCT04348383,None
3587,NCT04348396,ClinicalTrials.gov,2020-04-10,2020-04-03,True,Istituto Nazionale di Ricovero e Cura per Anziani,Recruiting,Not Applicable,Observational,Italy,Clinical and Biological Predictors of COVID-19 Disease in Older Patients,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04348396,None
3588,NCT04348409,ClinicalTrials.gov,2020-04-03,2020-05-25,False,Azidus Brasil,Recruiting,Not Applicable,Interventional,Brazil,Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19,Drug,Nitazoxanide,Nitazoxanide,50,https://clinicaltrials.gov/show/NCT04348409,None
3589,NCT04348422,ClinicalTrials.gov,2020-04-13,2020-05-01,False,Assaf-Harofeh Medical Center,Recruiting,Not Applicable,Observational,Israel,Evaluating the Immune Response for COVID-19,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04348422,None
3590,NCT04348435,ClinicalTrials.gov,2020-04-14,2020-05-14,False,Hope Biosciences,Recruiting,Phase 2,Interventional,United States,"A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19",ATMP,Cells (mesenchymal),Cells (mesenchymal),100,https://clinicaltrials.gov/show/NCT04348435,None
3591,NCT04348448,ClinicalTrials.gov,2020-04-13,2020-04-01,True,AUSL Romagna Rimini,Not Recruiting,Not Applicable,Observational,No Country Given,"Observational Study, Use of Canakinumab Administered Subcutaneously in the Treatment COVID-19 Pneumonia",Drug,Canakinumab,Canakinumab,100,https://clinicaltrials.gov/show/NCT04348448,None
3592,NCT04348461,ClinicalTrials.gov,2020-04-10,2020-04-06,True,Instituto de Investigación Sanitaria Fundación Jiménez Díaz,Not Recruiting,Phase 2,Interventional,No Country Given,BAttLe Against COVID-19 Using MesenchYmal Stromal Cells,ATMP,Cells (mesenchymal),Cells (mesenchymal),100,https://clinicaltrials.gov/show/NCT04348461,None
3593,NCT04348474,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Azidus Brasil,Not Recruiting,Phase 1,Interventional,Brazil,Efficacy and Safety of Hydroxychloroquine and Azithromycin for the Treatment of Ambulatory Patients With Mild COVID-19,Drug,Hydroxychloroquine + Azithromycin ,Hydroxychloroquine; Azithromycin ,200,https://clinicaltrials.gov/show/NCT04348474,None
3594,NCT04348500,ClinicalTrials.gov,2020-04-13,2020-04-24,False,Cedars-Sinai Medical Center,Not Recruiting,Phase 2,Interventional,United States,Clazakizumab (Anti-IL- 6 Monoclonal) Compared to Placebo for COVID19 Disease,Drug,Clazakizumab,Clazakizumab,17,https://clinicaltrials.gov/show/NCT04348500,None
3595,NCT04348513,ClinicalTrials.gov,2020-04-09,2020-05-29,False,Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.,Recruiting,Phase 2,Interventional,Greece,Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection,Drug,Triiodothyronine,Triiodothyronine,60,https://clinicaltrials.gov/show/NCT04348513,None
3596,NCT04348552,ClinicalTrials.gov,2020-04-13,2020-04-28,False,Nantes University Hospital,Recruiting,Not Applicable,Observational,France,Non-COVID Patient-safety Incidents Reported by Primary Care Professionals in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study,Other,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04348552,None
3597,NCT04348656,ClinicalTrials.gov,2020-04-13,2020-05-14,False,Hamilton Health Sciences Corporation,Recruiting,Phase 3,Interventional,"United States, Canada",CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1),ATMP,Plasma,Plasma,1200,https://clinicaltrials.gov/show/NCT04348656,None
3598,NCT04348695,ClinicalTrials.gov,2020-04-13,2020-04-12,False,Fundación de Investigación HM Hospita​les​,Recruiting,Phase 2,Interventional,Spain,Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19.,Drug,Ruxolitinib + Simvastatin,Ruxolitinib; Simvastatin,94,https://clinicaltrials.gov/show/NCT04348695,EUCTR2020-001405-23
3599,NCT04348877,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Ain Shams University,Not Recruiting,Not Applicable,Interventional,Egypt,Plasma Rich Antibodies From Recovered Patients From COVID19,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04348877,None
3600,NCT04348929,ClinicalTrials.gov,2020-04-10,2020-04-16,False,CHU de Nancy,Recruiting,Not Applicable,Interventional,France,Birth Experience During COVID-19 Confinement,Clinical Presentation,No Intervention,No Intervention,927,https://clinicaltrials.gov/show/NCT04348929,None
3601,NCT04348942,ClinicalTrials.gov,2020-04-13,2020-05-29,False,ObvioHealth,Not Recruiting,Not Applicable,Observational,United States,"A COVID-19 Symptom, Exposure and Immune Response Registry",Clinical Presentation,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04348942,None
3602,NCT04349098,ClinicalTrials.gov,2020-04-14,2020-04-17,True,Karyopharm Therapeutics Inc,Recruiting,Phase 2,Interventional,"Israel, France, United Kingdom, Austria, United States, Spain",Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection,Drug,Selinexor,Selinexor,230,https://clinicaltrials.gov/show/NCT04349098,EUCTR2020-001411-25
3603,NCT04349202,ClinicalTrials.gov,2020-04-13,2020-04-10,True,William Beaumont Hospitals,Recruiting,Not Applicable,Observational,United States,Beaumont Health Large-scale Automated Serologic Testing for COVID-19,Clinical Presentation,No Intervention,No Intervention,56000,https://clinicaltrials.gov/show/NCT04349202,None
3604,NCT04349228,ClinicalTrials.gov,2020-04-14,2020-04-28,False,Abderrahmane Mami Hospital,Not Recruiting,Phase 3,Interventional,Tunisia,Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04349228,None
3605,NCT04349241,ClinicalTrials.gov,2020-04-13,2020-04-18,False,Ain Shams University,Not Recruiting,Phase 3,Interventional,Egypt,Efficacy and Safety of Favipiravir in Management of COVID-19,Drug,Favipiravir,Favipiravir,100,https://clinicaltrials.gov/show/NCT04349241,None
3606,NCT04349371,ClinicalTrials.gov,2020-04-12,2020-04-01,True,Columbia University,Recruiting,Phase 2,Interventional,United States,Saved From COVID-19,Drug (Chemoprophylaxis),Chloroquine,Chloroquine,350,https://clinicaltrials.gov/show/NCT04349371,None
3607,NCT04349410,ClinicalTrials.gov,2020-04-11,2020-04-11,False,The Camelot Foundation,Not Recruiting,Phase 2/Phase 3,Interventional,United States,The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol,Drug (+ ATMP),Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Doxycycline vs. Hydroxychloroquine + Clindamycin vs. Hydroxychloroquine  + Clindamycin + Primaquine vs. Remdesivir vs. Tocilizumab vs. Corticosteroids vs. Interferon alpha vs. Losartan vs. Plasma,Hydroxychloroquine;  Azithromycin;  Doxycycline; Clindamycin; Primaquine; Remdesivir; Tocilizumab; Corticosteroids; Interferon alpha; Losartan; Plasma,1800,https://clinicaltrials.gov/show/NCT04349410,None
3608,NCT04349540,ClinicalTrials.gov,2020-04-14,2020-04-15,False,Great Ormond Street Hospital for Children NHS Foundation Trust,Not Recruiting,Not Applicable,Observational,United Kingdom,Role of Immune and Inflammatory Response in Recipients of Allogeneic Haematopoietic Stem Cell Transplantation (SCT) Affected by Severe COVID19,Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04349540,None
3609,NCT04349592,ClinicalTrials.gov,2020-04-12,2020-04-14,False,Hamad Medical Corporation,Recruiting,Not Applicable,Interventional,Qatar,Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; Azithromycin,456,https://clinicaltrials.gov/show/NCT04349592,None
3610,NCT04349618,ClinicalTrials.gov,2020-04-08,2020-04-14,False,Hospices Civils de Lyon,Not Recruiting,Not Applicable,Interventional,France,Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 Pneumonia,Other (physical),Mechanical ventilation,Mechanical ventilation,200,https://clinicaltrials.gov/show/NCT04349618,None
3611,NCT04349631,ClinicalTrials.gov,2020-04-06,2020-04-22,False,Hope Biosciences,Not Recruiting,Phase 2,Interventional,United States,A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),56,https://clinicaltrials.gov/show/NCT04349631,None
3612,NCT04349982,ClinicalTrials.gov,2020-04-10,2020-04-08,True,Medical University of Graz,Recruiting,Not Applicable,Observational,Austria,ICU Trial in Critical Ill COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04349982,None
3613,NCT04350086,ClinicalTrials.gov,2020-04-13,2020-04-20,False,"University Hospital, Limoges",Not Recruiting,Phase 4,Interventional,France,Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection,Drug,Dexmedetomidine,Dexmedetomidine,0,https://clinicaltrials.gov/show/NCT04350086,None
3614,NCT04350099,ClinicalTrials.gov,2020-04-11,2020-04-15,False,"University Hospital, Limoges",Not Recruiting,Not Applicable,Observational,France,Emotional Burden of Healthcare Professionals and Covid Infection 19,Other (psych),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04350099,None
3615,NCT04350281,ClinicalTrials.gov,2020-04-13,2020-04-09,True,University of Hong Kong,Not Recruiting,Phase 2,Interventional,Hong Kong,Double Therapy With IFN-beta 1b and Hydroxychloroquine,Drug,Interferon beta + Hydroxychloroquine vs. Hydroxychloroquine,Interferon beta; Hydroxychloroquine,60,https://clinicaltrials.gov/show/NCT04350281,None
3616,NCT04350320,ClinicalTrials.gov,2020-04-14,2020-04-30,False,Fundación para la Formación e Investigación Sanitarias de la Región de Murcia (FFIS),Recruiting,Phase 3,Interventional,Spain,Trial to Study the Benefit of Colchicine in Patients With COVID-19,Drug,Colchicine,Colchicine,102,https://clinicaltrials.gov/show/NCT04350320,None
3617,NCT04350450,ClinicalTrials.gov,2020-04-14,2020-04-01,True,Montefiore Medical Center,Not Recruiting,Phase 2,Interventional,United States,Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore,Drug,Hydroxychloroquine,Hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04350450,None
3618,NCT04350476,ClinicalTrials.gov,2020-04-14,2020-04-17,False,Vivek Reddy,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Remote Monitoring,Clinical Presentation,No Intervention,No Intervention,0,https://clinicaltrials.gov/show/NCT04350476,None
3619,NCT04350580,ClinicalTrials.gov,2020-04-08,2020-04-11,True,Centre Hospitalier St. Anne,Recruiting,Phase 3,Interventional,France,Polyvalent Immunoglobulin in COVID-19 Related ARds,ATMP,Immunoglobulin,Immunoglobulin,138,https://clinicaltrials.gov/show/NCT04350580,EUCTR2020-001570-30
3620,NCT04350593,ClinicalTrials.gov,2020-04-14,2020-04-22,True,Saint Luke's Health System,Recruiting,Phase 3,Interventional,"United States, Brazil",Dapagliflozin in Respiratory Failure in Patients With COVID-19,Drug,Dapagliflozin,Dapagliflozin,900,https://clinicaltrials.gov/show/NCT04350593,EUCTR2020-001473-79
3621,NCT04350671,ClinicalTrials.gov,2020-04-14,2020-04-15,False,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,Interferon Beta 1a in Hospitalized COVID-19 Patients,Drug,Interferon beta + Lopinavir/Ritonavir + Hydroxychlroquine vs. Lopinavir/Ritonavir + Hydroxychloroquine,Interferon beta; Lopinavir/Ritonavir; Hydroxychloroquine,40,https://clinicaltrials.gov/show/NCT04350671,None
3622,NCT04350684,ClinicalTrials.gov,2020-04-14,2020-04-15,False,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 4,Interventional,Iran,Umifenovir in Hospitalized COVID-19 Patients,Drug,Umifenovir + Interferon beta + Lopinavir/Ritonavir + Hydroxychloroquine vs. Interferon beta + Lopinavir/Ritonavir + Hydroxycholroquine,Umifenovir; Interferon beta; Lopinavir/Ritonavir; Hydroxychloroquine,40,https://clinicaltrials.gov/show/NCT04350684,None
3623,NCT04350710,ClinicalTrials.gov,2020-04-09,2020-03-18,True,"University Hospital, Angers",Recruiting,Not Applicable,Observational,France,Description of Respiratory Mechanics in Patients With SARS-CoV-2 Associated ARDS,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04350710,None
3624,NCT04350723,ClinicalTrials.gov,2020-04-14,2020-06-10,False,St. Joseph's Healthcare Hamilton,Recruiting,Not Applicable,Interventional,"Saudi Arabia, Canada",Awake Prone Position in Hypoxemic Patients With Coronavirus Disease 19 (COVI-PRONE): A Randomized Clinical Trial,Procedure,Positioning,Positioning,350,https://clinicaltrials.gov/show/NCT04350723,None
3625,NCT04350736,ClinicalTrials.gov,2020-04-14,2020-04-23,False,Theravance Biopharma,Not Recruiting,Phase 1,Interventional,United Kingdom,"First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19",Drug,TD-0903,TD-0903,54,https://clinicaltrials.gov/show/NCT04350736,None
3626,NCT04350931,ClinicalTrials.gov,2020-04-13,2020-04-20,False,Ain Shams University,Not Recruiting,Phase 3,Interventional,Egypt,Application of BCG Vaccine for Immune-prophylaxis Among Egyptian Healthcare Workers During the Pandemic of COVID-19,ATMP,Vaccine,Vaccine,900,https://clinicaltrials.gov/show/NCT04350931,None
3627,NCT04351139,ClinicalTrials.gov,2020-04-15,2020-05-06,False,Hospices Civils de Lyon,Recruiting,Not Applicable,Observational,France,Impact of the COVID-19 Pandemic in Gynecological Oncology,Clinical Presentation,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04351139,None
3628,NCT04351152,ClinicalTrials.gov,2020-04-15,2020-04-30,False,"Humanigen, Inc.",Recruiting,Phase 3,Interventional,United States,Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19,Drug,Lenzilumab,Lenzilumab,300,https://clinicaltrials.gov/show/NCT04351152,None
3629,NCT04351191,ClinicalTrials.gov,2020-04-14,2020-04-15,False,"Government of Punjab, Specialized Healthcare and Medical Education Department",Recruiting,Phase 4,Interventional,Pakistan,PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Chloroquine ,Hydroxychloroquine; Chloroquine ,400,https://clinicaltrials.gov/show/NCT04351191,None
3630,NCT04351295,ClinicalTrials.gov,2020-04-15,2020-04-20,False,Tanta University,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Efficacy of Faviprevir in COVID-19 Treatment,Drug,Favipiravir,Favipiravir,90,https://clinicaltrials.gov/show/NCT04351295,None
3631,NCT04351347,ClinicalTrials.gov,2020-04-15,2020-06-16,False,Tanta University,Recruiting,Phase 2/Phase 3,Interventional,Egypt,The Efficacy of Ivermectin and Nitazoxanide in COVID-19 Treatment,Drug,Chloroquine + Nitazoxanide vs. Chloroquine + Ivermectin vs. Chloroquine ,Chloroquine; Nitazoxanide; Ivermectin,300,https://clinicaltrials.gov/show/NCT04351347,None
3632,NCT04351490,ClinicalTrials.gov,2020-04-14,2020-04-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Interventional,No Country Given,Impact of Zinc and Vitamin D3 Supplementation on the Survival of Aged Patients Infected With COVID-19,Drug,Zinv + Vitamin D,Zinc; Vitamin D,3140,https://clinicaltrials.gov/show/NCT04351490,None
3633,NCT04351503,ClinicalTrials.gov,2020-04-15,2020-04-09,True,"University Hospital, Basel",Recruiting,Not Applicable,Observational,Switzerland,A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04351503,None
3634,NCT04351516,ClinicalTrials.gov,2020-04-15,2020-04-21,True,"University Hospital, Tübingen",Not Recruiting,Phase 2/Phase 3,Interventional,Germany,Test and Treat COVID 65plus+,Drug,Hydroxychloroquine,Hydroxychloroquine,350,https://clinicaltrials.gov/show/NCT04351516,EUCTR2020-001482-37
3635,NCT04351529,ClinicalTrials.gov,2020-04-16,2020-04-01,True,Arbeitsgemeinschaft medikamentoese Tumortherapie (AGMT),Recruiting,Not Applicable,Observational,Austria,Austrian COVID-19 Registry,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04351529,None
3636,NCT04351542,ClinicalTrials.gov,2020-04-14,2020-03-06,True,Aarogyam UK,Not Recruiting,Not Applicable,Interventional,United Kingdom,Ayurveda for Flu Like Illness During Covid-19 Outbreak,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,32,https://clinicaltrials.gov/show/NCT04351542,None
3637,NCT04351568,ClinicalTrials.gov,2020-04-14,2020-04-01,True,Assiut University,Recruiting,Not Applicable,Observational,Egypt,Professional and Ethical Challenges of Social Media Usage in Providing Healthcare Services During the Period of 19 Covid Pandemics;,Other,No Intervention,No Intervention,874,https://clinicaltrials.gov/show/NCT04351568,None
3638,NCT04351581,ClinicalTrials.gov,2020-04-14,2020-05-18,True,"Copenhagen University Hospital, Gentofte",Recruiting,Not Applicable,Interventional,Denmark,Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With COVID-19,Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,215,https://clinicaltrials.gov/show/NCT04351581,EUCTR2020-001544-26
3639,NCT04351620,ClinicalTrials.gov,2020-04-14,2020-04-01,True,University of Chicago,Recruiting,Phase 1,Interventional,United States,High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,20,https://clinicaltrials.gov/show/NCT04351620,None
3640,NCT04351646,ClinicalTrials.gov,2020-04-07,2020-04-15,False,"St. George's, University of London",Not Recruiting,Not Applicable,Observational,United Kingdom,Diagnostics of COVID-19/DARTS (Development and Assessment of Rapid Testing for SARS-CoV-2 Outbreak),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,https://clinicaltrials.gov/show/NCT04351646,None
3641,NCT04351659,ClinicalTrials.gov,2020-04-16,2020-04-14,True,KK Women's and Children's Hospital,Recruiting,Not Applicable,Observational,Singapore,Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19,ATMP,Plasma,Plasma,8,https://clinicaltrials.gov/show/NCT04351659,None
3642,NCT04351711,ClinicalTrials.gov,2020-04-10,2020-04-09,True,CHU de Nimes,Recruiting,Not Applicable,Observational,France,Immunological Profiling of Patients With COVID-19 in Respiratory Distress,Clinical Presentation,No Intervention,No Intervention,130,https://clinicaltrials.gov/show/NCT04351711,None
3643,NCT04351724,ClinicalTrials.gov,2020-04-10,2020-04-16,True,Medical University of Vienna,Recruiting,Phase 2/Phase 3,Interventional,Austria,Austrian CoronaVirus Adaptive Clinical Trial (COVID-19),Drug,"Chloroquine or Hydroxychloroquine vs. lopinavir/ritonavir

Substudies: Rovaroxaban, Clazakizumab, Candesartan",Chloroquine; Hydroxychloroquine; Lopinavir/Ritonavir; Rovaroxaban; Clazakizumab; Candesartan,500,https://clinicaltrials.gov/show/NCT04351724,EUCTR2020-001302-30
3644,NCT04351763,ClinicalTrials.gov,2020-04-14,2020-04-27,False,Nicolaus Copernicus University,Recruiting,Phase 2/Phase 3,Interventional,Poland,Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms,Drug,Amiodarone or Verapamil,Amiodarone; Verapamil,804,https://clinicaltrials.gov/show/NCT04351763,None
3645,NCT04351789,ClinicalTrials.gov,2020-04-11,2020-05-01,False,"Copenhagen University Hospital, Hvidovre",Recruiting,Not Applicable,Interventional,Denmark,Impact of a Minimal Psychoeducational Intervention on Anxiety Among Hospitalized COVID-19 Patients in Denmark,Other (psych),Psychological,Psychological,66,https://clinicaltrials.gov/show/NCT04351789,None
3646,NCT04351906,ClinicalTrials.gov,2020-04-09,2020-05-03,False,University of Giessen,Recruiting,Not Applicable,Interventional,Germany,Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome,Other (device),ECCO2R,ECCO2R,20,https://clinicaltrials.gov/show/NCT04351906,None
3647,NCT04351919,ClinicalTrials.gov,2020-04-15,2020-05-05,False,Abderrahmane Mami Hospital,Not Recruiting,Phase 4,Interventional,Tunisia,Assessment of Efficacy and Safety of HCQ and Antibiotics Administrated to Patients COVID19(+),Drug,Hydroxychloroquein + Azithromycin,Hydroxychloroquine; Azithromycin,0,https://clinicaltrials.gov/show/NCT04351919,None
3648,NCT04352348,ClinicalTrials.gov,2020-03-31,2020-03-31,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Interventional,France,Cohort of Patients Infected With SARS-CoV2 (COVID-19) or Suspected of Being,Prognosis,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04352348,None
3649,NCT04352400,ClinicalTrials.gov,2020-04-03,2020-04-01,True,University Hospital Padova,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Efficacy of Nafamostat in Covid-19 Patients (RACONA Study),Drug,Nafamostat,Nafamostat,256,https://clinicaltrials.gov/show/NCT04352400,None
3650,NCT04352465,ClinicalTrials.gov,2020-04-15,2020-05-01,False,Azidus Brasil,Not Recruiting,Phase 1/Phase 2,Interventional,Brazil,Efficacy and Safety of MTX-loaded Nanoparticles to Treat Severe COVID-19 Patients,Drug,Methotrexate,Methotrexate,42,https://clinicaltrials.gov/show/NCT04352465,None
3651,NCT04352491,ClinicalTrials.gov,2020-04-14,2020-04-24,False,"Institute of Liver and Biliary Sciences, India",Not Recruiting,Not Applicable,Observational,India,An Online Survey to Understand Feelings Related to COVID-19 Among ILBS Patients With Liver Disease,Other (psych),No Intervention,No Intervention,347,https://clinicaltrials.gov/show/NCT04352491,None
3652,NCT04352517,ClinicalTrials.gov,2020-04-10,2020-03-16,True,University of Extremadura,Recruiting,Not Applicable,Observational,"Chile, Uruguay, Brazil",Influence Physical Activity Psychological Responses COVID-19 Pandemic,Other (exercise),Exercise,Exercise,3500,https://clinicaltrials.gov/show/NCT04352517,None
3653,NCT04352556,ClinicalTrials.gov,2020-04-09,2020-04-07,True,Ospedale di Circolo e Fondazione Macchi,Recruiting,Not Applicable,Observational,Italy,COVID19-hematological Malignancies: the Italian Hematology Alliance,Clinical Presentation,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04352556,None
3654,NCT04352582,ClinicalTrials.gov,2020-04-13,2020-04-14,False,"University Hospital, Geneva",Not Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 and Vaccination Attitudes,Other,No Intervention,No Intervention,1194,https://clinicaltrials.gov/show/NCT04352582,None
3655,NCT04352608,ClinicalTrials.gov,2020-04-14,2020-04-16,False,"Sinovac Research and Development Co., Ltd.",Not Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19),ATMP,Vaccine,Vaccine,744,https://clinicaltrials.gov/show/NCT04352608,None
3656,NCT04352634,ClinicalTrials.gov,2020-04-08,2020-04-26,False,University of Chile,Recruiting,Not Applicable,Observational,"Argentina, Mexico, Czech Republic, Chile, Germany, Italy, Venezuela, Saudi Arabia, Netherlands, Armenia, Australia, Tunisia, Bolivia, Nigeria, Guatemala, Puerto Rico, United States, Lebanon, Costa Rica, Turkey, Spain",The Covid-19 HEalth caRe wOrkErS (HEROES) Study,Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04352634,None
3657,NCT04352699,ClinicalTrials.gov,2020-04-14,2020-03-15,True,CHU de Nice,Not Recruiting,Not Applicable,Observational,France,Outcomes of Urological Surgery During Periods of Social COVID-19 Containemnt: is it Reasonable to Limit Access to Surgical Care for All?,Clinical Presentation,No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04352699,None
3658,NCT04352751,ClinicalTrials.gov,2020-04-16,2020-05-01,False,Hilton Pharma,Recruiting,Not Applicable,Interventional,Pakistan,Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020,ATMP,Plasma,Plasma,2000,https://clinicaltrials.gov/show/NCT04352751,None
3659,NCT04352764,ClinicalTrials.gov,2020-04-16,2020-03-27,True,Texas Cardiac Arrhythmia Research Foundation,Recruiting,Not Applicable,Observational,United States,ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,5000,https://clinicaltrials.gov/show/NCT04352764,None
3660,NCT04352803,ClinicalTrials.gov,2020-04-16,2020-04-01,True,Regeneris Medical,Not Recruiting,Phase 1,Interventional,No Country Given,Adipose Mesenchymal Cells for Abatement of SARS-CoV-2 Respiratory Compromise in COVID-19 Disease,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04352803,None
3661,NCT04352842,ClinicalTrials.gov,2020-04-16,2020-01-21,True,RenJi Hospital,Not Recruiting,Not Applicable,Observational,China,Echocardiographic Manifestation in Patient With COVID-19 (EARLY-MYO COVID-19),Clinical Presentation,No Intervention,No Intervention,51,https://clinicaltrials.gov/show/NCT04352842,None
3662,NCT04352933,ClinicalTrials.gov,2020-04-07,2020-05-11,True,Cambridge University Hospitals NHS Foundation Trust,Recruiting,Phase 3,Interventional,United Kingdom,PROLIFIC ChemoprophylaxisTrial (COVID-19),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1000,https://clinicaltrials.gov/show/NCT04352933,EUCTR2020-001331-26
3663,NCT04352946,ClinicalTrials.gov,2020-04-16,2020-04-24,False,GeoSentinel Foundation,Not Recruiting,Phase 3,Interventional,United States,HEalth Care Worker pROphylaxis Against COVID-19: The HERO Trial,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,374,https://clinicaltrials.gov/show/NCT04352946,None
3664,NCT04352959,ClinicalTrials.gov,2020-04-15,2020-04-27,False,Claude Bernard University,Recruiting,Not Applicable,Interventional,France,COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses,Drug,Bêta-cyclodextrin + citrox,Bêta-cyclodextrin; citrox,206,https://clinicaltrials.gov/show/NCT04352959,None
3665,NCT04352985,ClinicalTrials.gov,2020-04-15,2020-05-01,False,Spectral Diagnostics (US) Inc.,Not Recruiting,Not Applicable,Expanded Access,United States,Evaluating the Use of Polymyxin B Cartridge Hemoperfusion for Patients With Septic Shock and COVID 19,Other (device),Hemoperfusion,Hemoperfusion,Not Available,https://clinicaltrials.gov/show/NCT04352985,None
3666,NCT04353037,ClinicalTrials.gov,2020-04-09,2020-04-07,True,UnitedHealth Group,Recruiting,Phase 2,Interventional,United States,PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine,Drug,Hydroxychloroquine,Hydroxychloroquine,850,https://clinicaltrials.gov/show/NCT04353037,None
3667,NCT04353128,ClinicalTrials.gov,2020-04-16,2020-04-20,False,Instituto de Investigación Hospital Universitario La Paz,Recruiting,Phase 2/Phase 3,Interventional,Spain,Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.,Drug (Chemoprophylaxis),Melatonin,Melatonin,450,https://clinicaltrials.gov/show/NCT04353128,None
3668,NCT04353141,ClinicalTrials.gov,2020-04-16,2020-04-28,False,KU Leuven,Recruiting,Not Applicable,Observational,"United Kingdom, Belgium, Italy",International Lung UltraSound Analysis (ILUSA) Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1850,https://clinicaltrials.gov/show/NCT04353141,None
3669,NCT04353154,ClinicalTrials.gov,2020-04-15,2020-04-15,False,Ottawa Heart Institute Research Corporation,Not Recruiting,Not Applicable,Observational,No Country Given,The RAPID COVID TRIAGE Algorithm,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,20,https://clinicaltrials.gov/show/NCT04353154,None
3670,NCT04353180,ClinicalTrials.gov,2020-04-10,2020-10-01,False,Kafrelsheikh University,Not Recruiting,Phase 3,Interventional,Egypt,Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 (Randomized),Drug,Isotretinoin,Isotretinoin,1000,https://clinicaltrials.gov/show/NCT04353180,None
3671,NCT04353206,ClinicalTrials.gov,2020-04-16,2020-06-27,False,Noah Merin,Recruiting,Phase 1,Interventional,United States,Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04353206,None
3672,NCT04353245,ClinicalTrials.gov,2020-04-15,2020-06-01,False,University of São Paulo General Hospital,Not Recruiting,Not Applicable,Observational,Brazil,Study of Biomarkers in the Long-term Impact of Coronavirus Infection in the Cardiorespiratory System,Clinical Presentation,No Intervention,No Intervention,130,https://clinicaltrials.gov/show/NCT04353245,None
3673,NCT04353271,ClinicalTrials.gov,2020-03-25,2020-04-17,False,University of South Alabama,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Trial of Hydroxychloroquine In Covid-19 Kinetics,Drug,Hydroxychloroquine,Hydroxychloroquine,58,https://clinicaltrials.gov/show/NCT04353271,None
3674,NCT04353284,ClinicalTrials.gov,2020-04-16,2020-06-19,False,Yale University,Recruiting,Phase 2,Interventional,United States,Camostat Mesylate in COVID-19 Outpatients,Drug,Camostat Mesilate,Camostat Mesilate,114,https://clinicaltrials.gov/show/NCT04353284,None
3675,NCT04353323,ClinicalTrials.gov,2020-04-15,2020-05-25,False,"University Hospital, Limoges",Not Recruiting,Not Applicable,Observational,France,COVID 19-Caregivers IGg Seroconversion,Clinical Presentation (Epidemiology),No Intervention,No Intervention,130,https://clinicaltrials.gov/show/NCT04353323,None
3676,NCT04353401,ClinicalTrials.gov,2020-04-15,2020-08-03,False,Vanda Pharmaceuticals,Recruiting,Not Applicable,Observational,United States,WGS Analysis of COVID-19 Positive Patients,Genomics,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04353401,None
3677,NCT04353518,ClinicalTrials.gov,2020-04-16,2020-04-30,False,Cadila Pharnmaceuticals,Not Recruiting,Phase 3,Interventional,No Country Given,Clinical Trial to Evaluate Mycobacterium w in Preventing COVID-19 in Subjects at Risk of Getting Infected With COVID-19,Drug,Mycobacterium,Mycobacterium,4000,https://clinicaltrials.gov/show/NCT04353518,None
3678,NCT04353531,ClinicalTrials.gov,2020-03-23,2020-05-20,False,Rush University Medical Center,Recruiting,Not Applicable,Observational,United States,Investigate the Aerosol Particle Distribution During Aerosol Generating Procedures,Other,No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04353531,None
3679,NCT04353583,ClinicalTrials.gov,2020-04-06,2020-04-21,False,University of Giessen,Recruiting,Not Applicable,Observational,Germany,Renal Outcome in Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04353583,None
3680,NCT04353596,ClinicalTrials.gov,2020-04-14,2020-04-15,True,Medical University Innsbruck,Recruiting,Phase 4,Interventional,"Austria, Germany",Stopping ACE-inhibitors in COVID-19,Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,208,https://clinicaltrials.gov/show/NCT04353596,EUCTR2020-001206-35
3681,NCT04353609,ClinicalTrials.gov,2020-04-15,2020-04-18,False,"University Hospital, Lille",Recruiting,Not Applicable,Observational,France,"Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases",Clinical Presentation,No Intervention,No Intervention,13770,https://clinicaltrials.gov/show/NCT04353609,None
3682,NCT04353674,ClinicalTrials.gov,2020-04-07,2020-04-28,False,Lawson Health Research Institute,Recruiting,Not Applicable,Interventional,Canada,Modulation of Hyperinflammation in COVID-19,Other (device),Dialysis,Dialysis,40,https://clinicaltrials.gov/show/NCT04353674,None
3683,NCT04354155,ClinicalTrials.gov,2020-04-13,2020-06-02,False,Neil Goldenberg,Recruiting,Phase 2,Interventional,United States,COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial,Drug,Heparin,Heparin,38,https://clinicaltrials.gov/show/NCT04354155,None
3684,NCT04354259,ClinicalTrials.gov,2020-04-16,2020-05-13,False,"University Health Network, Toronto",Recruiting,Phase 2,Interventional,Canada,Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19,Drug,Interferon lambda,Interferon lambda,140,https://clinicaltrials.gov/show/NCT04354259,None
3685,NCT04354272,ClinicalTrials.gov,2020-04-10,2020-04-13,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,No Country Given,Evaluation of Dental Emergency Treatments During COVID19 Crisis,Clinical Presentation (Epidemiology),No Intervention,No Intervention,840,https://clinicaltrials.gov/show/NCT04354272,None
3686,NCT04354389,ClinicalTrials.gov,2020-04-15,2020-07-25,False,"Ansun Biopharma, Inc.",Not Recruiting,Phase 2/Phase 3,Interventional,Italy,DAS181 for STOP COVID-19,Drug,DAS181,DAS181,0,https://clinicaltrials.gov/show/NCT04354389,None
3687,NCT04354428,ClinicalTrials.gov,2020-04-16,2020-04-16,False,University of Washington,Not Recruiting,Phase 2/Phase 3,Interventional,United States,Treatment for COVID-19 in High-Risk Adult Outpatients,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine vs. Vitamin C + Folic Acid,Azithromycin; Hydroxychloroquine; Vitamin C; Folic Acid,300,https://clinicaltrials.gov/show/NCT04354428,None
3688,NCT04354441,ClinicalTrials.gov,2020-04-14,2020-05-01,False,Sir Mortimer B. Davis - Jewish General Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women,Drug,Hydroxychloroquine,Hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04354441,None
3689,NCT04354519,ClinicalTrials.gov,2020-04-06,2020-03-14,True,Swansea University,Recruiting,Not Applicable,Observational,United Kingdom,The United Kingdom Multiple Sclerosis Register Covid-19 Substudy,Clinical Presentation,No Intervention,No Intervention,3000,https://clinicaltrials.gov/show/NCT04354519,None
3690,NCT04354558,ClinicalTrials.gov,2020-04-06,2020-07-01,False,CHU de Amiens,Recruiting,Not Applicable,Observational,France,French Single Centre Experience of Critically Ill Patients With Covid 19,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04354558,None
3691,NCT04354584,ClinicalTrials.gov,2020-04-13,2020-04-06,True,"Copenhagen University Hospital, Hvidovre",Recruiting,Not Applicable,Observational,Denmark,Compartmental Inflammation in Mechanically Ventilated Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04354584,None
3692,NCT04354597,ClinicalTrials.gov,2020-04-09,2020-05-01,False,King Hussein Cancer Center,Not Recruiting,Not Applicable,Interventional,Jordan,Hydroxychloroquine and Azithromycin as Prophylaxis for Healthcare Workers Dealing With COVID19 Patients,Drug (Chemoprophylaxis),Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,200,https://clinicaltrials.gov/show/NCT04354597,None
3693,NCT04354610,ClinicalTrials.gov,2020-04-14,2020-04-27,False,CHU de Nancy,Recruiting,Not Applicable,Interventional,France,Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection,Clinical Presentation,No Intervention,No Intervention,57,https://clinicaltrials.gov/show/NCT04354610,None
3694,NCT04354701,ClinicalTrials.gov,2020-04-16,2020-03-17,True,Vanderbilt-Ingram Cancer Center,Recruiting,Not Applicable,Observational,United States,COVID-19 and Cancer Consortium Registry,Clinical Presentation,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04354701,None
3695,NCT04354714,ClinicalTrials.gov,2020-04-16,2020-06-30,False,Washington University in St. Louis,Not Recruiting,Phase 2,Interventional,United States,Ruxolitinib to Combat COVID-19,Drug,Ruxolitinib,Ruxolitinib,0,https://clinicaltrials.gov/show/NCT04354714,None
3696,NCT04354753,ClinicalTrials.gov,2020-04-17,2020-03-28,True,Aarogyam UK,Not Recruiting,Not Applicable,Observational,United Kingdom,AiM COVID for Covid 19 Tracking and Prediction,Clinical Presentation (Epidemiology),No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04354753,None
3697,NCT04354766,ClinicalTrials.gov,2020-04-17,2020-04-29,False,Hospices Civils de Lyon,Recruiting,Not Applicable,Observational,France,COVID-19 : Neutralizing Human Monoclonal Antibodies Against SARS-Cov-2,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04354766,None
3698,NCT04354779,ClinicalTrials.gov,2020-04-17,2020-05-11,False,AUVA,Not Recruiting,Not Applicable,Observational,Austria,Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel.,Clinical Presentation (Epidemiology),No Intervention,No Intervention,3301,https://clinicaltrials.gov/show/NCT04354779,None
3699,NCT04354792,ClinicalTrials.gov,2020-04-16,2020-05-01,False,Kasr El Aini Hospital,Not Recruiting,Not Applicable,Observational,Egypt,Asymptomatic COVID-19 Infection Among Healthcare Workers,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,https://clinicaltrials.gov/show/NCT04354792,None
3700,NCT04354805,ClinicalTrials.gov,2020-04-17,2020-08-01,False,Cairo University,Not Recruiting,Phase 2/Phase 3,Interventional,Egypt,Administration of Chlorpromazine as a Treatment for COVID-19,Drug,Chlorpromazine,Chlorpromazine,100,https://clinicaltrials.gov/show/NCT04354805,None
3701,NCT04354818,ClinicalTrials.gov,2020-04-16,2020-05-11,False,Kirby Institute,Recruiting,Not Applicable,Observational,Australia,Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA),Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04354818,None
3702,NCT04354831,ClinicalTrials.gov,2020-04-14,2020-05-11,False,Medical College of Wisconsin,Recruiting,Phase 2,Interventional,United States,A Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19 Infection,ATMP,Plasma,Plasma,131,https://clinicaltrials.gov/show/NCT04354831,None
3703,NCT04354857,ClinicalTrials.gov,2020-04-17,2020-03-27,True,CHU de Nimes,Recruiting,Not Applicable,Observational,France,Qualitative and Quantitative Evaluation of Anosmia Over Time in Clinically Symptomatic Patients Tested for COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,454,https://clinicaltrials.gov/show/NCT04354857,None
3704,NCT04354870,ClinicalTrials.gov,2020-04-16,2020-04-03,True,NYU Langone Health,Not Recruiting,Phase 2,Interventional,United States,COVID-19 PrEP HCW HCQ Study,Drug,Hydroxychloroquine,Hydroxychloroquine,130,https://clinicaltrials.gov/show/NCT04354870,None
3705,NCT04355026,ClinicalTrials.gov,2020-04-15,2020-04-10,True,Celje General Hospital,Recruiting,Phase 4,Interventional,Slovenia,Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia,Drug,Bromhexine + Hydroxychloroquine vs. Hydroxychloroquine,Bromhexine; Hydroxychloroquine,90,https://clinicaltrials.gov/show/NCT04355026,None
3706,NCT04355052,ClinicalTrials.gov,2020-04-16,2020-04-11,True,Sheba Medical Center,Recruiting,Phase 3,Interventional,Israel,"Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to ""no Treatment"" in SARS CoV 2 Virus",Drug,Camostat Mesilate + Hydroxychloroquine vs. Hydroxychloroquine + Azithromycin,Camostat Mesilate; Hydroxychloroquine; Azithromycin,250,https://clinicaltrials.gov/show/NCT04355052,None
3707,NCT04355143,ClinicalTrials.gov,2020-04-14,2020-05-01,False,"University of California, Los Angeles",Recruiting,Phase 2,Interventional,United States,Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19),Drug,Colchicine,Colchicine,150,https://clinicaltrials.gov/show/NCT04355143,None
3708,NCT04355234,ClinicalTrials.gov,2020-04-17,2020-05-04,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Interventional,France,"Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns",Clinical Presentation (Epidemiology),No Intervention,No Intervention,2200,https://clinicaltrials.gov/show/NCT04355234,None
3709,NCT04355247,ClinicalTrials.gov,2020-04-17,2020-04-14,True,Auxilio Mutuo Cancer Center,Recruiting,Phase 2,Interventional,Puerto Rico,Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm,Drug (Chemoprophylaxis),Corticosteroids,Methylprednisolone,20,https://clinicaltrials.gov/show/NCT04355247,None
3710,NCT04355338,ClinicalTrials.gov,2020-04-17,2020-10-25,False,Butantan Institute,Recruiting,Not Applicable,Observational,Brazil,Assessment of Incidence of SARS-CoV-2 Infection and COVID-19 in Brazil (AVISA),Clinical Presentation (Epidemiology),No Intervention,No Intervention,4100,https://clinicaltrials.gov/show/NCT04355338,None
3711,NCT04355351,ClinicalTrials.gov,2020-04-17,2020-05-05,False,CHU de Nice,Recruiting,Not Applicable,Interventional,France,Study of Immune Response During SARS-CoV-2 Infection - (COVID-19),Clinical Presentation,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04355351,None
3712,NCT04355429,ClinicalTrials.gov,2020-04-17,2020-05-05,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,Efficacy of Captopril in Covid-19 Patients With Severe Acute Respiratory Syndrome (SARS) CoV-2 Pneumonia (CAPTOCOVID),Drug,Captopril,Captopril,230,https://clinicaltrials.gov/show/NCT04355429,None
3713,NCT04355442,ClinicalTrials.gov,2020-04-16,2020-04-01,True,"University Hospital, Montpellier",Not Recruiting,Not Applicable,Observational,France,Evolution of Facial Trauma During COVID Containment Measures,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04355442,None
3714,NCT04355481,ClinicalTrials.gov,2020-04-17,2020-04-17,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Observational,France,Dissemination of SARS-COV-2 (COVID-19) in the Environment of Infected Patients Admitted to Intensive Care Unit,Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04355481,None
3715,NCT04355494,ClinicalTrials.gov,2020-04-17,2020-04-17,False,Alexion Pharmaceuticals,Not Recruiting,Not Applicable,Expanded Access,"France, United States",SOLIRISÂ® (Eculizumab) Treatment of Participants With COVID-19,Drug,Eculizumab,Eculizumab,Not Available,https://clinicaltrials.gov/show/NCT04355494,None
3716,NCT04355507,ClinicalTrials.gov,2020-04-17,2020-04-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,Computed Tomography for COVID-19 Diagnosis,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,10000,https://clinicaltrials.gov/show/NCT04355507,None
3717,NCT04355533,ClinicalTrials.gov,2020-04-17,2020-07-29,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Interventional,France,Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1920,https://clinicaltrials.gov/show/NCT04355533,None
3718,NCT04355611,ClinicalTrials.gov,2020-04-17,2020-04-20,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Observational,France,Epidemiological Characteristics of COVID-19 in Patients With MS or NMO,Clinical Presentation (Epidemiology),No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04355611,None
3719,NCT04355624,ClinicalTrials.gov,2020-04-17,2020-04-15,True,CHU de Nice,Recruiting,Not Applicable,Observational,France,Kidney Involvement in COVID-19 Disease (COVKID),Clinical Presentation,No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04355624,None
3720,NCT04355637,ClinicalTrials.gov,2020-04-15,2020-04-21,True,Sara Varea,Recruiting,Phase 4,Interventional,Spain,Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia,Drug,Corticosteroids,Budesonide,300,https://clinicaltrials.gov/show/NCT04355637,EUCTR2020-001616-18
3721,NCT04355702,ClinicalTrials.gov,2020-04-17,2020-03-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Covid-19 in Lupus Patients,Clinical Presentation,No Intervention,No Intervention,130,https://clinicaltrials.gov/show/NCT04355702,None
3722,NCT04355715,ClinicalTrials.gov,2020-04-17,2019-04-01,True,"University Hospital, Montpellier",Not Recruiting,Not Applicable,Observational,France,Combination of Chest Scanography and Nasal Viral Detection Test to Detect COVID-19 Positive Patients Before Surgical Intervention in a University Hospital During Coronavirus Pandemia,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04355715,None
3723,NCT04355728,ClinicalTrials.gov,2020-04-13,2020-04-25,False,Camillo Ricordi,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Use of UC-MSCs for COVID-19 Patients,ATMP,Cells (mesenchymal),Cells (mesenchymal),24,https://clinicaltrials.gov/show/NCT04355728,None
3724,NCT04355741,ClinicalTrials.gov,2020-04-15,2020-04-20,False,University Nova de Lisboa,Not Recruiting,Not Applicable,Observational,Portugal,"Gut Microbiota, ""Spark and Flame"" of COVID-19 Disease",Clinical Presentation,No Intervention,No Intervention,115,https://clinicaltrials.gov/show/NCT04355741,None
3725,NCT04355754,ClinicalTrials.gov,2020-04-16,2020-04-15,True,Medical University of Gdańsk,Recruiting,Not Applicable,Interventional,Poland,Ventil Device Usefulness in Mechanically Ventilated ICU Patients,Other (physical),Mechanical ventilation,Mechanical ventilation,40,https://clinicaltrials.gov/show/NCT04355754,None
3726,NCT04355793,ClinicalTrials.gov,2020-04-18,2020-11-01,False,Incyte Corporation,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Expanded Access Program of Ruxolitinib for the Emergency Treatment of Cytokine Storm From COVID-19 Infection,Drug,Ruxolitinib,Ruxolitinib,Not Available,https://clinicaltrials.gov/show/NCT04355793,None
3727,NCT04355871,ClinicalTrials.gov,2020-04-19,2020-03-18,True,Fundación SEIMC-GESIDA,Not Recruiting,Not Applicable,Observational,Spain,Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain,Clinical Presentation,No Intervention,No Intervention,4035,https://clinicaltrials.gov/show/NCT04355871,None
3728,NCT04355884,ClinicalTrials.gov,2020-04-19,2020-04-20,False,University of Hong Kong,Not Recruiting,Not Applicable,Observational,Hong Kong,Opportunistic Screening for Asymptomatic Left Ventricular Dysfunction in Coronavirus Disease 2019 (COVID19) Survivors,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04355884,None
3729,NCT04355897,ClinicalTrials.gov,2020-04-15,2020-04-28,False,The Christ Hospital,Recruiting,Phase 1,Interventional,United States,CoVID-19 Plasma in Treatment of COVID-19 Patients,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04355897,None
3730,NCT04355936,ClinicalTrials.gov,2020-04-17,2020-05-19,False,Laboratorio Elea,Recruiting,Phase 4,Interventional,Argentina,Telmisartan for Treatment of COVID-19 Patients,Drug,Telmisartan,Telmisartan,400,https://clinicaltrials.gov/show/NCT04355936,None
3731,NCT04356144,ClinicalTrials.gov,2020-04-15,2020-04-15,False,Medical University of Vienna,Recruiting,Not Applicable,Observational,Austria,Thrombomodulin-modified Thrombin Generation Assay (TGA-TM) in Patients With Critical Infections,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,60,https://clinicaltrials.gov/show/NCT04356144,None
3732,NCT04356365,ClinicalTrials.gov,2020-04-21,2020-03-31,True,University of Oslo,Not Recruiting,Not Applicable,Observational,Norway,The Mental Health Status of the General Population During the COVID-19 Pandemic and Its Association With Adherence to Government-initiated Non-pharmacological Epidemiological Interventions (NPI's),Other (psych),No Intervention,No Intervention,10084,https://clinicaltrials.gov/show/NCT04356365,None
3733,NCT04356417,ClinicalTrials.gov,2020-04-17,2020-04-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,Long-term Use of Drugs That Could Prevent the Risk of Serious COVID-19 Infections or Make it Worse,Drug,Synthetic anti-malarials,Synthetic anti-malarials,6000000,https://clinicaltrials.gov/show/NCT04356417,None
3734,NCT04356443,ClinicalTrials.gov,2020-04-16,2020-04-15,True,Massachusetts General Hospital,Recruiting,Not Applicable,Observational,United States,Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection,Other (device),Respiratory Monitor,Respiratory Monitor,500,https://clinicaltrials.gov/show/NCT04356443,None
3735,NCT04356482,ClinicalTrials.gov,2020-04-17,2020-05-20,False,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado,Recruiting,Phase 1/Phase 2,Interventional,Mexico,CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19,ATMP,Plasma,Plasma,90,https://clinicaltrials.gov/show/NCT04356482,None
3736,NCT04356508,ClinicalTrials.gov,2020-04-10,2020-04-14,False,Dr. Gerry Gin Wai Kwok,Not Recruiting,Phase 2,Interventional,No Country Given,COVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1,Drug,Nivolumab,Nivolumab,15,https://clinicaltrials.gov/show/NCT04356508,None
3737,NCT04356534,ClinicalTrials.gov,2020-04-15,2020-04-19,False,Royal College of Surgeons in Ireland - Medical University of Bahrain,Not Recruiting,Not Applicable,Interventional,Bahrain,Convalescent Plasma Trial in COVID -19 Patients,ATMP,Plasma,Plasma,40,https://clinicaltrials.gov/show/NCT04356534,None
3738,NCT04356560,ClinicalTrials.gov,2020-04-13,2020-03-23,True,"Rigshospitalet, Denmark",Recruiting,Not Applicable,Observational,Denmark,COVID-19 Surveillance of Patients and Healthcare Workers in a Hospital Department,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,300,https://clinicaltrials.gov/show/NCT04356560,None
3739,NCT04356586,ClinicalTrials.gov,2020-04-17,2020-05-04,False,Sciensano,Not Recruiting,Not Applicable,Observational,Belgium,Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms,Clinical Presentation,No Intervention,No Intervention,287,https://clinicaltrials.gov/show/NCT04356586,None
3740,NCT04356677,ClinicalTrials.gov,2020-04-20,2020-11-01,False,"Bausch Health Americas, Inc.",Not Recruiting,Phase 1,Interventional,No Country Given,Study to Evaluate the Safety and Efficacy of VIRAZOLEÂ® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19,Drug,Ribavirin,Ribavirin,50,https://clinicaltrials.gov/show/NCT04356677,None
3741,NCT04356690,ClinicalTrials.gov,2020-04-17,2020-05-08,False,Boston Medical Center,Recruiting,Phase 2,Interventional,United States,Etoposide in Patients With COVID-19 Infection,Drug,Etoposide,Etoposide,64,https://clinicaltrials.gov/show/NCT04356690,None
3742,NCT04356833,ClinicalTrials.gov,2020-04-14,2020-04-22,True,"University College, London",Recruiting,Phase 2,Interventional,United Kingdom,Nebulised Rt-PA for ARDS Due to COVID-19,Drug,Recombinant Tissue-Plasminogen Activator,Recombinant Tissue-Plasminogen Activator,24,https://clinicaltrials.gov/show/NCT04356833,EUCTR2020-001640-26
3743,NCT04356885,ClinicalTrials.gov,2020-04-19,2020-04-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,COVID-19 and Psychotic Symptoms in France,Clinical Presentation,No Intervention,No Intervention,600,https://clinicaltrials.gov/show/NCT04356885,None
3744,NCT04356937,ClinicalTrials.gov,2020-04-19,2020-04-20,False,Massachusetts General Hospital,Not Recruiting,Phase 3,Interventional,United States,Efficacy of Tocilizumab on Patients With COVID-19,Drug,Tocilizumab,Tocilizumab,243,https://clinicaltrials.gov/show/NCT04356937,None
3745,NCT04357028,ClinicalTrials.gov,2020-04-19,2020-07-13,False,Kasr El Aini Hospital,Recruiting,Phase 3,Interventional,Egypt,Measles Vaccine in HCW,ATMP,Vaccine,Vaccine,200,https://clinicaltrials.gov/show/NCT04357028,None
3746,NCT04357041,ClinicalTrials.gov,2020-04-17,2020-04-17,False,Illinois Institute of Technology,Not Recruiting,Not Applicable,Observational,United States,"COVID-19 Survey Study on Dietary Intake, Physical Activity and Overall Well-being",Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04357041,None
3747,NCT04357106,ClinicalTrials.gov,2020-04-14,2020-04-13,True,Centro de Hematologia y Medicina Interna,Recruiting,Phase 2,Interventional,Mexico,COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04357106,None
3748,NCT04357275,ClinicalTrials.gov,2020-04-15,2020-03-13,True,University of Zurich,Recruiting,Not Applicable,Observational,Switzerland,The RIsk Stratification in COVID-19 Patients in the ICU Registry,Clinical Presentation,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04357275,None
3749,NCT04357314,ClinicalTrials.gov,2020-04-19,2020-03-01,True,French Cardiology Society,Not Recruiting,Not Applicable,Observational,France,Myocardial Infarction Rates Overview During COVID-19 Pandemic In France: MODIF Study,Clinical Presentation,No Intervention,No Intervention,6332,https://clinicaltrials.gov/show/NCT04357314,None
3750,NCT04357327,ClinicalTrials.gov,2020-04-15,2020-04-16,False,Università degli Studi dell'Insubria,Not Recruiting,Not Applicable,Interventional,Italy,Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,122,https://clinicaltrials.gov/show/NCT04357327,None
3751,NCT04357340,ClinicalTrials.gov,2020-04-13,2020-04-02,True,Tehran University of Medical Sciences,Not Recruiting,Not Applicable,Interventional,Iran,The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,40,https://clinicaltrials.gov/show/NCT04357340,None
3752,NCT04357366,ClinicalTrials.gov,2020-04-20,2020-04-15,True,Hellenic Institute for the Study of Sepsis,Recruiting,Phase 2,Interventional,Greece,suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE),Drug,Anakinra + trimethoprim/sulfamethoxazole,Anakinra; trimethoprim; sulfamethoxazole,500,https://clinicaltrials.gov/show/NCT04357366,EUCTR2020-001466-11
3753,NCT04357418,ClinicalTrials.gov,2020-04-16,2020-04-01,True,Centre Hospitalier de Ville-Evrard,Not Recruiting,Not Applicable,Observational,France,Psychological Outcome of COVID-19 Lockdown on Psychiatric Hospital Staff and Close Relatives,Other (psych),No Intervention,No Intervention,187,https://clinicaltrials.gov/show/NCT04357418,None
3754,NCT04357431,ClinicalTrials.gov,2020-04-21,2020-04-22,False,Assiut University,Not Recruiting,Not Applicable,Observational,Egypt,COVID-19 Among Egyptian Health Care Providers,Other,No Intervention,No Intervention,565,https://clinicaltrials.gov/show/NCT04357431,None
3755,NCT04357444,ClinicalTrials.gov,2020-04-10,2020-10-23,True,Assistance Publique – Hôpitaux de Paris,Recruiting,Phase 2,Interventional,France,Low Dose of IL-2 In Acute Respiratory DistrEss Syndrome Related to COVID-19,Drug,ILT101,ILT101,30,https://clinicaltrials.gov/show/NCT04357444,EUCTR2020-001571-32
3756,NCT04357457,ClinicalTrials.gov,2020-04-20,2020-09-03,True,Assistance Publique – Hôpitaux de Paris,Recruiting,Phase 3,Interventional,France,Efficacy of Intravenous Almitrine in Reducing the Need for Mechanical Ventilation in Patients With Hypoxemic Acute Respiratory Failure Due to Covid-19-related Pneumonia,Drug,Almitrine,Almitrine,212,https://clinicaltrials.gov/show/NCT04357457,EUCTR2020-001909-22
3757,NCT04357496,ClinicalTrials.gov,2020-04-20,2020-12-20,False,Centogene,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 Epidemic Response Study,Clinical Presentation,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04357496,None
3758,NCT04357535,ClinicalTrials.gov,2020-04-19,2020-05-10,False,Hakeam Abdulaziz Hakeam,Not Recruiting,Not Applicable,Observational,Saudi Arabia,Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives,Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,314,https://clinicaltrials.gov/show/NCT04357535,None
3759,NCT04357574,ClinicalTrials.gov,2020-04-20,2020-04-14,True,Duke University,Recruiting,Not Applicable,Observational,United States,Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19,Telehealth,Telehealth,Telehealth,1000,https://clinicaltrials.gov/show/NCT04357574,None
3760,NCT04357613,ClinicalTrials.gov,2020-04-20,2020-09-01,False,Versailles Hospital,Not Recruiting,Phase 2,Interventional,France,IMATINIB IN COVID-19 DISEASE IN AGED PATIENTS.,Drug,Imatinib,Imatinib,99,https://clinicaltrials.gov/show/NCT04357613,None
3761,NCT04357639,ClinicalTrials.gov,2020-04-20,2020-05-28,False,Centre Hospitalier Intercommunal Creteil,Recruiting,Not Applicable,Observational,France,Impact of Long-term Protease Inhibitors in Patients Living With HIV on the Incidence of COVID-19 ( COVIP ),Clinical Presentation,No Intervention,No Intervention,1040,https://clinicaltrials.gov/show/NCT04357639,None
3762,NCT04357730,ClinicalTrials.gov,2020-04-18,2020-05-14,False,Denver Health and Hospital Authority,Recruiting,Phase 2,Interventional,United States,Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection,Drug,Alteplase,Alteplase,60,https://clinicaltrials.gov/show/NCT04357730,None
3763,NCT04357769,ClinicalTrials.gov,2020-04-16,2020-04-10,True,Federico II University,Recruiting,Not Applicable,Observational,Italy,COVID-19 Pandemic Burden in Severe Mental Disease Patients,Other (psych),No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04357769,None
3764,NCT04357782,ClinicalTrials.gov,2020-04-17,2020-04-16,True,Veteran Affairs Medical Center,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation,Drug,Vitamin C,Vitamin C,20,https://clinicaltrials.gov/show/NCT04357782,None
3765,NCT04357808,ClinicalTrials.gov,2020-04-14,2020-04-13,True,Maria del Rosario Garcia de Vicuña Pinedo,Not Recruiting,Phase 2,Interventional,Spain,Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID),Drug,Sarilumab,Sarilumab,30,https://clinicaltrials.gov/show/NCT04357808,EUCTR2020-001634-36
3766,NCT04357834,ClinicalTrials.gov,2020-04-17,2020-05-01,False,"University Hospital, Bern",Recruiting,Not Applicable,Observational,Switzerland,WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories,Other (device),Smartwatch,Smartwatch,100,https://clinicaltrials.gov/show/NCT04357834,None
3767,NCT04357847,ClinicalTrials.gov,2020-04-09,2020-04-09,False,"University Hospital, Rouen",Recruiting,Not Applicable,Observational,France,Assessment of Endothelial and Haemostatic Changes During Severe SARS-CoV-2 Infection,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04357847,None
3768,NCT04357860,ClinicalTrials.gov,2020-04-20,2020-04-27,True,Maimonides Biomedical Research Institute of Cordoba,Not Recruiting,Phase 2,Interventional,Spain,Clinical Trial of Sarilumab in Adults With COVID-19,Drug,Sarilumab,Sarilumab,120,https://clinicaltrials.gov/show/NCT04357860,EUCTR2020-001531-27
3769,NCT04357886,ClinicalTrials.gov,2020-04-20,2020-05-01,False,Istanbul University-Cerrahpasa,Not Recruiting,Not Applicable,Observational,Turkey,Comparison of New Coronavirus (COVID-19) Awareness in Individuals of Different Age Groups: Analysis of Turkey,Other,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04357886,None
3770,NCT04357977,ClinicalTrials.gov,2020-04-20,2020-04-01,True,"Kaligia Biosciences, LLC",Not Recruiting,Not Applicable,Observational,United States,A Human Clinical Study to Collect Calibration and Performance Data for the RBA-2 Device,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,300,https://clinicaltrials.gov/show/NCT04357977,None
3771,NCT04357990,ClinicalTrials.gov,2020-04-20,2020-09-04,False,Kerecis Ltd.,Recruiting,Not Applicable,Interventional,Iceland,Viruxal Oral and Nasal Spray for Treating the Symptoms of COVID-19,Drug,Omega 3,Omega 3,128,https://clinicaltrials.gov/show/NCT04357990,None
3772,NCT04358003,ClinicalTrials.gov,2020-04-20,2020-05-20,False,Marker Therapeutics AG,Recruiting,Not Applicable,Interventional,United States,Plasma Adsorption in Patients With Confirmed COVID-19,Other (device),Plasma Adsorption Cartridge,Plasma Adsorption Cartridge,2000,https://clinicaltrials.gov/show/NCT04358003,None
3773,NCT04358029,ClinicalTrials.gov,2020-04-20,2020-04-09,True,Vivek Reddy,Recruiting,Not Applicable,Observational,United States,Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19),Clinical Presentation,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04358029,None
3774,NCT04358042,ClinicalTrials.gov,2020-04-08,2020-04-24,False,Nantes University Hospital,Recruiting,Not Applicable,Observational,France,PSYCHIATRIC Disorders and Covid-19,Other (psych),No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04358042,None
3775,NCT04358068,ClinicalTrials.gov,2020-04-20,2020-05-01,False,National Institute of Allergy and Infectious Diseases (NIAID),Not Recruiting,Phase 2,Interventional,"United States, Puerto Rico",Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19,Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,20,https://clinicaltrials.gov/show/NCT04358068,None
3776,NCT04358081,ClinicalTrials.gov,2020-04-08,2020-05-01,False,Novartis Pharmaceuticals,Not Recruiting,Phase 3,Interventional,United States,Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Azithromycin; Hydroxychloroquine,20,https://clinicaltrials.gov/show/NCT04358081,None
3777,NCT04358211,ClinicalTrials.gov,2020-04-17,2020-05-01,False,Dr. Nakhle Saba,Not Recruiting,Not Applicable,Expanded Access,United States,Expanded Access to Convalescent Plasma to Treat and Prevent Pulmonary Complications Associated With COVID-19,ATMP,Plasma,Plasma,Not Available,https://clinicaltrials.gov/show/NCT04358211,None
3778,NCT04358380,ClinicalTrials.gov,2020-04-18,2020-04-15,True,Austral University,Recruiting,Not Applicable,Observational,Argentina,Liver Injury in Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,320,https://clinicaltrials.gov/show/NCT04358380,None
3779,NCT04358406,ClinicalTrials.gov,2020-04-16,2020-07-30,False,BioAegis Therapeutics Inc.,Recruiting,Phase 2,Interventional,Spain,Rhu-pGSN for Severe Covid-19 Pneumonia,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04358406,None
3780,NCT04358510,ClinicalTrials.gov,2020-04-20,2020-04-01,True,Dascena,Not Recruiting,Not Applicable,Observational,United States,COVID-19 Mortality Prediction Model,Prognosis,No Intervention,No Intervention,114,https://clinicaltrials.gov/show/NCT04358510,None
3781,NCT04358536,ClinicalTrials.gov,2020-04-20,2020-04-01,True,Dascena,Not Recruiting,Not Applicable,Observational,United States,Classification of COVID-19 Infection in Posteroanterior Chest X-rays,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,230,https://clinicaltrials.gov/show/NCT04358536,None
3782,NCT04358549,ClinicalTrials.gov,2020-04-16,2020-04-17,False,"Fujifilm Pharmaceuticals U.S.A., Inc.",Not Recruiting,Phase 2,Interventional,United States,Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19,Drug,Favipiravir,Favipiravir,50,https://clinicaltrials.gov/show/NCT04358549,None
3783,NCT04358588,ClinicalTrials.gov,2020-04-21,2014-02-01,True,Bellerophon,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Pulsed Inhaled Nitric Oxide for the Treatment of Patients With Mild or Moderate COVID-19,Drug,Nitric oxide,Nitric oxide,Not Available,https://clinicaltrials.gov/show/NCT04358588,None
3784,NCT04358614,ClinicalTrials.gov,2020-04-19,2020-03-16,True,Fabrizio Cantini,Not Recruiting,Phase 2/Phase 3,Interventional,Italy,Baricitinib Therapy in COVID-19,Drug,Baricitinib,Baricitinib,12,https://clinicaltrials.gov/show/NCT04358614,None
3785,NCT04358627,ClinicalTrials.gov,2020-04-15,2020-04-15,False,Hospital Clinic of Barcelona,Not Recruiting,Not Applicable,Observational,No Country Given,Dexmedetomidine to Improve Outcomes of ARDS in Critical Care COVID-19 Patients,Drug,Dexmedetomidine,Dexmedetomidine,80,https://clinicaltrials.gov/show/NCT04358627,None
3786,NCT04358640,ClinicalTrials.gov,2020-04-21,2020-04-09,True,CHU de Nimes,Recruiting,Not Applicable,Observational,France,Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey,Other (psych),No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04358640,None
3787,NCT04358783,ClinicalTrials.gov,2020-04-21,2020-04-27,False,Hospital Universitario Dr. Jose E. Gonzalez,Recruiting,Phase 2,Interventional,Mexico,Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia,ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04358783,None
3788,NCT04358809,ClinicalTrials.gov,2020-04-21,2020-04-30,False,Cadila Pharnmaceuticals,Not Recruiting,Phase 3,Interventional,No Country Given,"Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill",Drug,Mycobacterium,Mycobacterium,480,https://clinicaltrials.gov/show/NCT04358809,None
3789,NCT04358835,ClinicalTrials.gov,2020-04-16,2020-09-01,False,Johns Hopkins University,Not Recruiting,Not Applicable,Interventional,No Country Given,Keto-diet for Intubated Critical Care COVID-19,Other (nutrition),Nutrition,Nutrition,0,https://clinicaltrials.gov/show/NCT04358835,None
3790,NCT04358926,ClinicalTrials.gov,2020-04-21,2020-04-30,False,Assaf-Harofeh Medical Center,Not Recruiting,Not Applicable,Interventional,Israel,Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19),Drug,Oxygen,Oxygen,30,https://clinicaltrials.gov/show/NCT04358926,None
3791,NCT04358939,ClinicalTrials.gov,2020-04-16,2020-04-27,False,CHU de Tours,Recruiting,Not Applicable,Interventional,France,Prone Position in Patients on High-flow Nasal Oxygen Therapy for COVID-19 (HIGH-PRONE-COVID-19),Procedure,Positioning,Positioning,404,https://clinicaltrials.gov/show/NCT04358939,None
3792,NCT04358952,ClinicalTrials.gov,2020-04-09,2020-04-04,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Observational,France,Myocardial Involvement of Severe Acute Respiratory Syndrome-Cov-2 (Covid19) Infected Patients,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04358952,None
3793,NCT04359095,ClinicalTrials.gov,2020-04-15,2020-08-18,False,National University of Colombia,Recruiting,Phase 2/Phase 3,Interventional,Colombia,Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Lopinavir/Ritonavir vs. Hydroxychloroquine,Hydroxychloroquine; Azithromycin; Lopinavir/Ritonavir,1200,https://clinicaltrials.gov/show/NCT04359095,None
3794,NCT04359121,ClinicalTrials.gov,2020-04-21,2020-04-15,True,Medical University of Graz,Recruiting,Not Applicable,Observational,Austria,COVID-19 and the Developement of Phobic Fears of Disease,Other (psych),No Intervention,No Intervention,600,https://clinicaltrials.gov/show/NCT04359121,None
3795,NCT04359212,ClinicalTrials.gov,2020-04-21,2020-05-01,False,Quovadis Associazione,Not Recruiting,Not Applicable,Observational,Italy,Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19,Drug,Heparin or Fondaparinux,Heparin; Fondaparinux,90,https://clinicaltrials.gov/show/NCT04359212,None
3796,NCT04359225,ClinicalTrials.gov,2020-04-16,2020-06-30,False,NHS Greater Glasgow and Clyde,Not Recruiting,Not Applicable,Interventional,United Kingdom,A Comparison of 3D and 2D Telemedicine During Covid 19,Telehealth,Telehealth,Telehealth,80,https://clinicaltrials.gov/show/NCT04359225,None
3797,NCT04359251,ClinicalTrials.gov,2020-04-13,2020-03-05,True,"Southeast University, China",Not Recruiting,Not Applicable,Interventional,China,Different PEEP Settings of COVID-19 Induced ARDS,Other (physical),Mechanical ventilation,Mechanical ventilation,20,https://clinicaltrials.gov/show/NCT04359251,None
3798,NCT04359264,ClinicalTrials.gov,2020-04-16,2020-04-20,False,"St. Michael's Hospital, Toronto",Not Recruiting,Not Applicable,Interventional,Canada,Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled Trial,Other,Other,Other,392,https://clinicaltrials.gov/show/NCT04359264,None
3799,NCT04359277,ClinicalTrials.gov,2020-04-20,2020-04-21,False,NYU Langone Health,Not Recruiting,Phase 3,Interventional,United States,A Randomized Trial of Anticoagulation Strategies in COVID-19,Drug,"Enoxaparin, Heparin",Enoxaparin; Heparin,77,https://clinicaltrials.gov/show/NCT04359277,None
3800,NCT04359290,ClinicalTrials.gov,2020-04-15,2020-07-01,False,Philipps University Marburg Medical Center,Not Recruiting,Phase 2,Interventional,Germany,Ruxolitinib for Treatment of Covid-19 Induced Lung Injury ARDS,Drug,Ruxolitinib,Ruxolitinib,15,https://clinicaltrials.gov/show/NCT04359290,None
3801,NCT04359303,ClinicalTrials.gov,2020-04-09,2020-07-01,False,Javier Hidalgo Tallón,Not Recruiting,Phase 3,Interventional,Spain,Indirect Endovenous Systemic Ozone for New Coronavirus Disease (COVID19) in Non-intubated Patients,Drug,Ozone,Ozone,50,https://clinicaltrials.gov/show/NCT04359303,None
3802,NCT04359316,ClinicalTrials.gov,2020-04-18,2020-04-20,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 4,Interventional,Iran,Azithromycin in Hospitalized COVID-19 Patients,Drug,Azithromycin vs. Hydroxychloroquine,Azithromycin; Hydroxychloroquine,40,https://clinicaltrials.gov/show/NCT04359316,None
3803,NCT04359329,ClinicalTrials.gov,2020-04-21,2020-04-20,True,Sharon Nachman,Recruiting,Phase 2,Interventional,United States,Estrogen Patch for COVID-19 Symptoms,Drug,Estradiol,Estradiol,110,https://clinicaltrials.gov/show/NCT04359329,None
3804,NCT04359407,ClinicalTrials.gov,2020-04-20,2020-04-27,False,Walid Habre,Recruiting,Not Applicable,Observational,Switzerland,Prone Positioning and Regional Ventilation in Mechanically Ventilated COVID-19 Patients,Procedure,Positioning,Positioning,16,https://clinicaltrials.gov/show/NCT04359407,None
3805,NCT04359459,ClinicalTrials.gov,2020-04-20,2020-06-01,False,University Medical Center Groningen,Not Recruiting,Not Applicable,Observational,No Country Given,Nasal Epithelial Genetic and Single Cell RNA COVID-19 Study,Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04359459,None
3806,NCT04359511,ClinicalTrials.gov,2020-04-20,2020-06-01,False,CHU de Tours,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy and Safety of Corticosteroids in Oxygen-dependent Patients With COVID-19 Pneumonia,Drug,Corticosteroids,Prednisone; Hydrocortisone,210,https://clinicaltrials.gov/show/NCT04359511,None
3807,NCT04359537,ClinicalTrials.gov,2020-04-20,2020-05-01,False,Shaheed Zulfiqar Ali Bhutto Medical University,Recruiting,Phase 2,Interventional,Pakistan,Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,200,https://clinicaltrials.gov/show/NCT04359537,None
3808,NCT04359602,ClinicalTrials.gov,2020-04-21,2020-04-08,True,"University of California, Los Angeles",Recruiting,Not Applicable,Observational,United States,COVID-19 Recovered Volunteer Research Participant Pool Registry,Other,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04359602,None
3809,NCT04359615,ClinicalTrials.gov,2020-04-18,2020-04-20,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 4,Interventional,Iran,Favipiravir in Hospitalized COVID-19 Patients,Drug,Favipiravir + Hydroxychloroquine vs. Hydroxychloroquine,Favipiravir; Hydroxychloroquine,40,https://clinicaltrials.gov/show/NCT04359615,None
3810,NCT04359654,ClinicalTrials.gov,2020-04-21,2020-06-16,False,"University College, London",Recruiting,Phase 2,Interventional,United Kingdom,Nebulised Dornase Alfa for Treatment of COVID-19,Drug,Dornase alfa,Dornase alfa,50,https://clinicaltrials.gov/show/NCT04359654,None
3811,NCT04359667,ClinicalTrials.gov,2020-04-16,2020-06-16,False,"University Hospital for Infectious Diseases, Croatia",Recruiting,Not Applicable,Observational,Croatia,Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19 Pneumonia Treated With Tocilizumab,Drug,Tocilizumab,Tocilizumab,30,https://clinicaltrials.gov/show/NCT04359667,None
3812,NCT04359680,ClinicalTrials.gov,2020-04-20,2020-05-13,False,Romark Laboratories L.C.,Recruiting,Phase 3,Interventional,United States,Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection,Drug (Chemoprophylaxis),Nitazoxanide,Nitazoxanide,4000,https://clinicaltrials.gov/show/NCT04359680,None
3813,NCT04359693,ClinicalTrials.gov,2020-04-21,2020-04-22,False,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,France,Impact of COVID-19 Infection on the Incidence of Ventilator-acquired Infections,Clinical Presentation,No Intervention,No Intervention,1576,https://clinicaltrials.gov/show/NCT04359693,None
3814,NCT04359706,ClinicalTrials.gov,2020-04-21,2020-05-08,False,"University Hospital, Lille",Recruiting,Not Applicable,Observational,France,Bacterial and Fungal Microbiota of Patients With Severe Viral Pneumonia With COVID-19,Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04359706,None
3815,NCT04359810,ClinicalTrials.gov,2020-04-21,2020-04-21,False,Max R. O'Donnell,Recruiting,Phase 2,Interventional,"United States, Brazil",Plasma Therapy of COVID-19 in Severely Ill Patients,ATMP,Plasma,Plasma,219,https://clinicaltrials.gov/show/NCT04359810,None
3816,NCT04359836,ClinicalTrials.gov,2020-04-20,2020-04-16,True,ProgenaBiome,Recruiting,Not Applicable,Observational,United States,A Study to Explore the Role of Gut Flora in COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04359836,None
3817,NCT04359849,ClinicalTrials.gov,2020-04-20,2020-05-01,False,Portsmouth Hospitals NHS Trust,Recruiting,Not Applicable,Observational,United Kingdom,Sequencing and Tracking of Phylogeny in COVID-19 Study,Genomics,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04359849,None
3818,NCT04359862,ClinicalTrials.gov,2020-04-21,2020-04-16,True,Fundación para la Investigación del Hospital Clínico de la Comunidad Valenciana (INCLIVA),Recruiting,Phase 4,Interventional,Spain,Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection,Drug,Sevoflurane vs. Propofol,Sevoflurane; Propofol,50,https://clinicaltrials.gov/show/NCT04359862,None
3819,NCT04359875,ClinicalTrials.gov,2020-04-18,2020-04-01,True,CHU de Tours,Not Recruiting,Not Applicable,Interventional,France,A Phone-call With a Student/General Practitioner Team to Impact Morbidity of Chronic Patients During COVID-19 Containment,Telehealth,Telehealth,Telehealth,22000,https://clinicaltrials.gov/show/NCT04359875,None
3820,NCT04359901,ClinicalTrials.gov,2020-04-20,2020-04-10,True,Westyn Branch-Elliman,Recruiting,Phase 2,Interventional,United States,Sarilumab for Patients With Moderate COVID-19 Disease,Drug,Sarilumab,Sarilumab,120,https://clinicaltrials.gov/show/NCT04359901,None
3821,NCT04359914,ClinicalTrials.gov,2020-04-19,2020-04-15,True,University of Rostock,Recruiting,Not Applicable,Observational,Germany,Neurocognitive Impairment in Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04359914,None
3822,NCT04359927,ClinicalTrials.gov,2020-04-21,2020-04-20,True,Hospital Clinic of Barcelona,Recruiting,Not Applicable,Observational,Spain,Long-term Effects of Coronavirus Disease 2019 on the Cardiovascular System: CV COVID-19 Registry,Clinical Presentation,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04359927,None
3823,NCT04359953,ClinicalTrials.gov,2020-04-17,2020-04-25,True,"University Hospital, Strasbourg",Recruiting,Phase 3,Interventional,France,"Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19",Drug,Hydroxychloroquine + Telmisartan + Azithromycin,Hydroxychloroquine; Telmisartan; Azithromycin,1600,https://clinicaltrials.gov/show/NCT04359953,EUCTR2020-001303-16
3824,NCT04359992,ClinicalTrials.gov,2020-04-16,2020-04-17,False,"University Hospital, Strasbourg",Not Recruiting,Not Applicable,Observational,No Country Given,Study of Hemostasis in Case of Severe COVID-19,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04359992,None
3825,NCT04360122,ClinicalTrials.gov,2020-04-15,2020-05-20,False,Ain Shams University,Not Recruiting,Phase 3,Interventional,Egypt,Levamisole and Isoprinosine in Immune-prophylaxis of Egyptian Healthcare Workers Facing COVID-19,Drug (Chemoprophylaxis),Levamisole + Isoprinosine vs. Levamisole vs. Isoprinosine,Levamisole; Isoprinosine,100,https://clinicaltrials.gov/show/NCT04360122,None
3826,NCT04360278,ClinicalTrials.gov,2020-04-22,2020-04-21,True,National Institutes of Health Clinical Center (CC),Recruiting,Not Applicable,Observational,United States,Plasma Collection From Convalescent and/or Immunized Donors for the Treatment of COVID-19,ATMP,Plasma,Plasma,1500,https://clinicaltrials.gov/show/NCT04360278,None
3827,NCT04360356,ClinicalTrials.gov,2020-04-19,2020-05-01,False,Tanta University,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Ivermectin and Nitazoxanide Combination Therapy for COVID-19,Drug,Ivermectin + Nitazoxanide,Ivermectin; Nitazoxanide,100,https://clinicaltrials.gov/show/NCT04360356,None
3828,NCT04360486,ClinicalTrials.gov,2020-04-20,2020-06-01,False,U.S. Army Medical Research and Development Command,Not Recruiting,Not Applicable,Expanded Access,"Djibouti, Iraq, Japan, Germany, Kuwait, Afghanistan, Guam, United States",Treatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP),ATMP,Plasma,Plasma,Not Available,https://clinicaltrials.gov/show/NCT04360486,None
3829,NCT04360538,ClinicalTrials.gov,2020-04-16,2020-04-08,True,University of Chicago,Recruiting,Not Applicable,Observational,United States,Long Term Outcomes of Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04360538,None
3830,NCT04360551,ClinicalTrials.gov,2020-04-21,2020-07-01,False,University of Hawaii,Recruiting,Phase 2,Interventional,United States,Pilot Clinical Trial of the Safety and Efficacy of Telmisartan for the Mitigation of Pulmonary and Cardiac Complications in COVID-19 Patients,Drug,Telmisartan,Telmisartan,40,https://clinicaltrials.gov/show/NCT04360551,None
3831,NCT04360707,ClinicalTrials.gov,2020-04-22,2020-04-08,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Solid Organ Transplant Recipients With SARS-CoV-2 French Registry,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04360707,None
3832,NCT04360733,ClinicalTrials.gov,2020-04-22,2020-04-20,True,University of Bonn,Recruiting,Not Applicable,Observational,Germany,Precision Immunology to Determine the Immune Response in Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04360733,None
3833,NCT04360759,ClinicalTrials.gov,2020-04-22,2020-05-01,False,University of Cape Town,Not Recruiting,Phase 3,Interventional,South Africa,Chloroquine Outpatient Treatment Evaluation for HIV-Covid-19,Drug,Chloroquine or hydroxychloroquine,Chloroquine; hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04360759,None
3834,NCT04360811,ClinicalTrials.gov,2020-04-22,2020-04-17,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Interventional,France,"Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,3600,https://clinicaltrials.gov/show/NCT04360811,None
3835,NCT04360824,ClinicalTrials.gov,2020-04-13,2020-05-06,False,University of Iowa,Recruiting,Phase 4,Interventional,United States,Covid-19 Associated Coagulopathy,Drug,Enoxaparin,Enoxaparin,170,https://clinicaltrials.gov/show/NCT04360824,None
3836,NCT04360837,ClinicalTrials.gov,2020-04-22,2020-05-06,False,Szeged University,Recruiting,Not Applicable,Interventional,Hungary,PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,10,https://clinicaltrials.gov/show/NCT04360837,None
3837,NCT04360850,ClinicalTrials.gov,2020-04-21,2020-04-24,False,University of Washington,Recruiting,Not Applicable,Observational,United States,Use of Telehealth Technology by Mental Health Care Professionals in Times of COVID-19 Pandemic,Telehealth,Telehealth,Telehealth,10000,https://clinicaltrials.gov/show/NCT04360850,None
3838,NCT04360863,ClinicalTrials.gov,2020-04-22,2020-04-24,False,University of Hong Kong,Recruiting,Not Applicable,Observational,Hong Kong,The Impact of COVID-19 Pandemic on the Smoking Behaviour of Young Smokers and the Youth Quitline Service in Hong Kong,Other,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04360863,None
3839,NCT04360876,ClinicalTrials.gov,2020-04-22,2020-09-01,False,"University of Colorado, Denver",Not Recruiting,Phase 2,Interventional,No Country Given,Targeted Steroids for ARDS Due to COVID-19 Pneumonia: A Pilot Randomized Clinical Trial,Drug,Corticosteroids,Dexamethasone,0,https://clinicaltrials.gov/show/NCT04360876,None
3840,NCT04360954,ClinicalTrials.gov,2020-04-20,2020-04-23,False,Washington University in St. Louis,Not Recruiting,Not Applicable,Observational,United States,Evaluation of Antibody Tests for COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,461,https://clinicaltrials.gov/show/NCT04360954,None
3841,NCT04360980,ClinicalTrials.gov,2020-04-22,2020-03-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Phase 2,Interventional,Iran,The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection,Drug,Colchicine,Colchicine,80,https://clinicaltrials.gov/show/NCT04360980,None
3842,NCT04361019,ClinicalTrials.gov,2020-04-22,2020-04-16,True,Basque Country University,Recruiting,Not Applicable,Observational,Spain,Physical Activity in University Students Around COVID-19 Confinement,Other (exercise),No Intervention,No Intervention,25000,https://clinicaltrials.gov/show/NCT04361019,None
3843,NCT04361032,ClinicalTrials.gov,2020-04-22,2020-09-04,False,Abderrahmane Mami Hospital,Not Recruiting,Phase 3,Interventional,Tunisia,"Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia",Drug,Tocilizumab,Tocilizumab,260,https://clinicaltrials.gov/show/NCT04361032,None
3844,NCT04361123,ClinicalTrials.gov,2020-04-22,2020-05-06,False,Dr. Michael Runyon,Recruiting,Not Applicable,Observational,United States,Atrium COVID-19 Syndromic and Serologic Surveillance,Clinical Presentation (Epidemiology),No Intervention,No Intervention,450000,https://clinicaltrials.gov/show/NCT04361123,None
3845,NCT04361214,ClinicalTrials.gov,2020-04-22,2020-05-05,False,University of Chicago,Recruiting,Phase 1,Interventional,United States,Leflunomide in Mild COVID-19 Patients,Drug,Leflunomide,Leflunomide,20,https://clinicaltrials.gov/show/NCT04361214,None
3846,NCT04361253,ClinicalTrials.gov,2020-04-23,2020-04-30,False,Brigham and Women's Hospital,Recruiting,Phase 3,Interventional,United States,Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy,ATMP,Plasma,Plasma,220,https://clinicaltrials.gov/show/NCT04361253,None
3847,NCT04361318,ClinicalTrials.gov,2020-04-18,2020-05-01,False,Tanta University,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Hydroxychloroquine and Nitazoxanide Combination Therapy for COVID-19,Drug,Hydroxychloroquine + Nitazoxanide,Hydroxychloroquine; Nitazoxanide,100,https://clinicaltrials.gov/show/NCT04361318,None
3848,NCT04361344,ClinicalTrials.gov,2020-04-16,2020-05-19,False,Centre Hospitalier de Pau,Recruiting,Not Applicable,Interventional,France,Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection,Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04361344,None
3849,NCT04361422,ClinicalTrials.gov,2020-04-21,2020-12-01,False,Tanta University,Not Recruiting,Phase 3,Interventional,No Country Given,Isotretinoin in Treatment of COVID-19,Drug,Isotretinoin,Isotretinoin,300,https://clinicaltrials.gov/show/NCT04361422,None
3850,NCT04361435,ClinicalTrials.gov,2020-04-12,2020-05-01,False,St. Justine's Hospital,Not Recruiting,Not Applicable,Interventional,No Country Given,Lung Recruitment Device for COVID-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,50,https://clinicaltrials.gov/show/NCT04361435,None
3851,NCT04361448,ClinicalTrials.gov,2020-04-20,2020-04-20,False,Jessa Hospital,Not Recruiting,Not Applicable,Interventional,Belgium,Performance of 3 Sampling Methods for the Detection of SARS-CoV-2 (COVID-19) With Real-time Reverse Transcriptase PCR,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,30,https://clinicaltrials.gov/show/NCT04361448,None
3852,NCT04361461,ClinicalTrials.gov,2020-04-22,2020-04-30,False,Apsen Farmaceutica S.A.,Not Recruiting,Phase 3,Interventional,Brazil,Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19),Drug,Hydroxychloroquine + Azythromycin vs. Hydroxychloroquine,Hydroxychloroquine; Azithormycin,0,https://clinicaltrials.gov/show/NCT04361461,None
3853,NCT04361474,ClinicalTrials.gov,2020-04-22,2020-05-18,True,Fondation Ophtalmologique Adolphe de Rothschild,Not Recruiting,Phase 3,Interventional,France,Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity,Drug,Corticosteroids,Budesonide,120,https://clinicaltrials.gov/show/NCT04361474,EUCTR2020-001667-85
3854,NCT04361500,ClinicalTrials.gov,2020-04-22,2020-04-15,True,Hannover Medical School,Recruiting,Not Applicable,Observational,Germany,Registry of COVID-19 Patients Treated With the Seraph 100 Microbind Affinity Blood Filter,Other (device),Blood filter,Blood filter,100,https://clinicaltrials.gov/show/NCT04361500,None
3855,NCT04361526,ClinicalTrials.gov,2020-04-21,2020-04-17,True,Manuel Castella,Recruiting,Not Applicable,Interventional,Spain,Pilot Study on Cytokine Filtration in COVID-19 ARDS,Other (device),Cytokine Adsorber,Cytokine Adsorber,40,https://clinicaltrials.gov/show/NCT04361526,None
3856,NCT04361552,ClinicalTrials.gov,2020-04-07,2020-04-07,False,Emory University,Not Recruiting,Phase 3,Interventional,United States,Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection),Drug,Tocilizumab,Tocilizumab,0,https://clinicaltrials.gov/show/NCT04361552,None
3857,NCT04361565,ClinicalTrials.gov,2020-04-22,2020-03-20,True,CHU de Nice,Recruiting,Not Applicable,Observational,France,Frequency and Clinical Evolution of Olfactory and Taste Disorders in COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04361565,None
3858,NCT04361591,ClinicalTrials.gov,2020-04-22,2020-03-01,True,Hospital Clinic of Barcelona,Recruiting,Not Applicable,Observational,Spain,COVID-19 in Liver Transplant Recipients,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04361591,None
3859,NCT04361604,ClinicalTrials.gov,2020-04-20,2020-04-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,Clinical Characterisation Protocol for COVID-19 in People Living With HIV,Clinical Presentation,No Intervention,No Intervention,270,https://clinicaltrials.gov/show/NCT04361604,None
3860,NCT04361643,ClinicalTrials.gov,2020-04-23,2020-10-27,False,Hospital Universitario Getafe,Not Recruiting,Phase 4,Interventional,Spain,Low-dose Lenalidomide for Non-severe COVID-19 Treatment Trial,Drug,Lenalidomide,Lenalidomide,120,https://clinicaltrials.gov/show/NCT04361643,None
3861,NCT04361786,ClinicalTrials.gov,2020-04-17,2020-04-01,True,"University Hospital, Montpellier",Not Recruiting,Not Applicable,Observational,France,Acral Cutaneous Thrombotic Vasculopathy and Covid-19 Infection,Clinical Presentation,No Intervention,No Intervention,10,https://clinicaltrials.gov/show/NCT04361786,None
3862,NCT04361838,ClinicalTrials.gov,2020-04-16,2020-06-01,False,Kansas City Heart Rhythm Institute,Recruiting,Not Applicable,Interventional,United States,The COVID-19 ICU PRAYER Study,Other,Other,Other,1000,https://clinicaltrials.gov/show/NCT04361838,None
3863,NCT04361877,ClinicalTrials.gov,2020-04-20,2020-03-30,True,LMU Klinikum,Recruiting,Not Applicable,Observational,Germany,Cardiovascular Prevention During COVID-19 Pandemic Lockdown in Young Adults (COLA Trial),Clinical Presentation,No Intervention,No Intervention,1900,https://clinicaltrials.gov/show/NCT04361877,None
3864,NCT04361903,ClinicalTrials.gov,2020-04-14,2020-04-25,False,Azienda Unita Sanitaria Locale Toscana Nord Ovest,Not Recruiting,Not Applicable,Observational,No Country Given,Ruxolitinib for the Treatment of Acute Respiratory Distress Syndrome in Patients With COVID-19 Infection,Drug,Ruxolitinib,Ruxolitinib,13,https://clinicaltrials.gov/show/NCT04361903,None
3865,NCT04361916,ClinicalTrials.gov,2020-04-14,2020-04-21,False,Mario Negri Institute for Pharmacological Research,Not Recruiting,Not Applicable,Interventional,Italy,Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino),Other,Other,Other,37,https://clinicaltrials.gov/show/NCT04361916,None
3866,NCT04361942,ClinicalTrials.gov,2020-04-17,2020-05-01,True,Red de Terapia Celular,Recruiting,Phase 2,Interventional,Spain,Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV),ATMP,Cells (mesenchymal),Cells (mesenchymal),24,https://clinicaltrials.gov/show/NCT04361942,EUCTR2020-001682-36
3867,NCT04361981,ClinicalTrials.gov,2020-04-23,2020-04-01,True,Sociedad Española de Angiología y Cirugía Vascular (SEACV),Not Recruiting,Not Applicable,Observational,Spain,Influence of COVID-19 Infection in Thromboembolic Venous Disease: National Cohort Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://clinicaltrials.gov/show/NCT04361981,None
3868,NCT04362059,ClinicalTrials.gov,2020-04-20,2020-06-18,True,University Hospital Southampton NHS Foundation Trust,Recruiting,Not Applicable,Interventional,United Kingdom,A Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19,Drug,Bovactant,Bovactant,24,https://clinicaltrials.gov/show/NCT04362059,EUCTR2020-001886-35
3870,NCT04362085,ClinicalTrials.gov,2020-04-20,2020-05-11,False,"St. Michael's Hospital, Toronto",Recruiting,Phase 3,Interventional,Canada,Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care,Drug,Heparin,Heparin,462,https://clinicaltrials.gov/show/NCT04362085,None
3871,NCT04362111,ClinicalTrials.gov,2020-04-21,2020-07-29,False,University of Alabama at Birmingham,Recruiting,Phase 3,Interventional,United States,Early Treatment of Cytokine Storm Syndrome in Covid-19,Drug,Anakinra,Anakinra,30,https://clinicaltrials.gov/show/NCT04362111,None
3872,NCT04362124,ClinicalTrials.gov,2020-04-21,2020-08-01,False,University of Antioquia,Not Recruiting,Phase 3,Interventional,Colombia,Performance Evaluation of BCG Vaccination in Healthcare Personnel to Reduce the Severity of COVID-19 Infection.,ATMP,Vaccine,Vaccine,0,https://clinicaltrials.gov/show/NCT04362124,None
3873,NCT04362150,ClinicalTrials.gov,2020-04-23,2020-04-21,True,"University of California, San Francisco",Not Recruiting,Not Applicable,Observational,United States,Long-term Impact of Infection With Novel Coronavirus (COVID-19),Clinical Presentation,No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04362150,None
3874,NCT04362189,ClinicalTrials.gov,2020-04-21,2020-06-30,False,Hope Biosciences,Not Recruiting,Phase 2,Interventional,United States,Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),100,https://clinicaltrials.gov/show/NCT04362189,None
3875,NCT04362267,ClinicalTrials.gov,2020-04-23,2020-06-15,False,"University Hospital, Lille",Recruiting,Not Applicable,Observational,France,Longitudinal Study of Covid-19 Infection Among HCW in a French University Hospital,Clinical Presentation (Epidemiology),No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04362267,None
3876,NCT04362319,ClinicalTrials.gov,2020-04-23,2020-05-15,False,University of Malaya,Not Recruiting,Not Applicable,Observational,Malaysia,Burnout and Medical Errors in the Anaesthesiology Fraternity During Covid-19 Pandemic,Other (psych),No Intervention,No Intervention,85,https://clinicaltrials.gov/show/NCT04362319,None
3877,NCT04362332,ClinicalTrials.gov,2020-04-20,2020-04-14,True,UMC Utrecht,Not Recruiting,Phase 4,Interventional,Netherlands,"Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19",Drug,Chloroquine vs. hydroxychloroquine,Chloroquine; hydroxychloroquine,25,https://clinicaltrials.gov/show/NCT04362332,None
3878,NCT04362345,ClinicalTrials.gov,2020-04-20,2020-04-09,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04362345,None
3879,NCT04362358,ClinicalTrials.gov,2020-04-21,2020-05-01,False,"University Hospital, Strasbourg",Not Recruiting,Not Applicable,Interventional,No Country Given,Online Cognitive Behavioral Therapy (CBT) for Stress Disorders in Health Workers Involved in the Care of Patients During the Covid-19 Epidemic,Other (psych),Psychological,Psychological,120,https://clinicaltrials.gov/show/NCT04362358,None
3880,NCT04362865,ClinicalTrials.gov,2020-04-24,2020-04-27,False,National Cancer Institute (NCI),Recruiting,Not Applicable,Observational,United States,Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,180,https://clinicaltrials.gov/show/NCT04362865,None
3881,NCT04362930,ClinicalTrials.gov,2020-04-24,2020-04-27,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Observational,France,Cohort of Patients With Covid-19 Presenting Neurological or Psychiatric Disorders (CoCo-Neurosciences),Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04362930,None
3882,NCT04362943,ClinicalTrials.gov,2020-04-22,2020-04-20,True,Complejo Hospitalario Universitario de Albacete,Recruiting,Not Applicable,Observational,Spain,Clinical-epidemiological Characterization of COVID-19 Disease in Hospitalized Older Adults,Drug,Baricitinib or Anakinra,Baricitinib; Anakinra,576,https://clinicaltrials.gov/show/NCT04362943,None
3883,NCT04362956,ClinicalTrials.gov,2020-04-21,2020-07-10,False,Fundación Infant,Recruiting,Not Applicable,Observational,Argentina,Clinical and Immunologic Impact of Perinatal SARS-CoV-2 (COVID-19) Infection,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04362956,None
3884,NCT04362969,ClinicalTrials.gov,2020-04-23,2020-05-01,False,"Hospital San Carlos, Madrid",Not Recruiting,Not Applicable,Observational,Ecuador,"COVID-EC Study: Clinical Characteristics of Patients With COVID-19 in Guayaquil, Ecuador",Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04362969,None
3885,NCT04363008,ClinicalTrials.gov,2020-04-21,2020-03-30,True,University of British Columbia,Recruiting,Not Applicable,Observational,Canada,COVID 19 Biomarkers,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,150,https://clinicaltrials.gov/show/NCT04363008,None
3886,NCT04363034,ClinicalTrials.gov,2020-04-23,2020-07-06,False,University of Arkansas,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Arkansas Expanded Access COVID-19 Convalescent Plasma Treatment Program,ATMP,Plasma,Plasma,Not Available,https://clinicaltrials.gov/show/NCT04363034,None
3887,NCT04363047,ClinicalTrials.gov,2020-04-20,2020-10-01,False,University of Manchester,Recruiting,Not Applicable,Observational,United Kingdom,"Immune Cells in Inflammatory Arthritis With Coronaviruses, Including COVID-19",Clinical Presentation,No Intervention,No Intervention,125,https://clinicaltrials.gov/show/NCT04363047,None
3888,NCT04363060,ClinicalTrials.gov,2020-04-23,2020-04-30,False,Nantes University Hospital,Not Recruiting,Phase 3,Interventional,France,Azithromycin+Amoxicillin/Clavulanate vs Amoxicillin/Clavulanate in COVID19 Patients With Pneumonia in Non-intensive Unit,Drug,Azithromycin + Amoxicillin/Clavulanate vs. Amoxicillin/Clavulanate,Azithromycin; Amoxicillin/Clavulanate,104,https://clinicaltrials.gov/show/NCT04363060,None
3889,NCT04363099,ClinicalTrials.gov,2020-04-23,2020-03-01,True,Maison de Santé Pluridisciplinaire de Creil,Recruiting,Not Applicable,Observational,France,Multicentre Observational Study on Management COVID 19 Positive Outpatients in a French Cluster.,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04363099,None
3890,NCT04363177,ClinicalTrials.gov,2020-04-21,2020-11-01,False,Karolinska Institutet,Not Recruiting,Not Applicable,Interventional,"Sweden, Hong Kong, China",Global Mental Health of Urban Mothers,Other (psych),Psychological,Psychological,200,https://clinicaltrials.gov/show/NCT04363177,None
3891,NCT04363203,ClinicalTrials.gov,2020-04-23,2020-04-30,False,Dr. Salomeh Keyhani,Not Recruiting,Phase 3,Interventional,United States,VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL),Drug,Hydroxychloroquine vs. Azithromycin,Hydroxychloroquine; Azithromycin,300,https://clinicaltrials.gov/show/NCT04363203,None
3892,NCT04363216,ClinicalTrials.gov,2020-04-23,2020-05-01,False,Thomas Jefferson University,Not Recruiting,Phase 2,Interventional,No Country Given,Pharmacologic Ascorbic Acid as an Activator of Lymphocyte Signaling for COVID-19 Treatment,Drug,Vitamin C,Vitamin C,66,https://clinicaltrials.gov/show/NCT04363216,None
3893,NCT04363229,ClinicalTrials.gov,2020-04-23,2020-07-01,False,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,Psychological Impact of COVID19 Among Doctors in Assiut University Hospitals,Other (psych),No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04363229,None
3894,NCT04363268,ClinicalTrials.gov,2020-04-23,2020-04-20,True,Medable Inc.,Recruiting,Not Applicable,Observational,United States,ACCESS A Master Digital Surveillance Protocol for COVID-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000000,https://clinicaltrials.gov/show/NCT04363268,None
3895,NCT04363333,ClinicalTrials.gov,2020-04-19,2020-04-27,False,Koç University,Not Recruiting,Not Applicable,Observational,Turkey,Obstructive Sleep Apnea & Covid-19 Outcomes,Clinical Presentation,No Intervention,No Intervention,320,https://clinicaltrials.gov/show/NCT04363333,None
3896,NCT04363346,ClinicalTrials.gov,2020-04-23,2020-05-14,False,University of Minnesota,Recruiting,Phase 1,Interventional,United States,Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia,Drug,FT516,FT516,12,https://clinicaltrials.gov/show/NCT04363346,None
3897,NCT04363372,ClinicalTrials.gov,2020-04-24,2020-06-01,False,4D Pharma,Recruiting,Phase 2,Interventional,United Kingdom,A Study for Efficacy and Safety of Live Biotherapeutic MRx4DP0004 to Treat COVID-19,Drug,MRx-4DP0004,MRx-4DP0004,90,https://clinicaltrials.gov/show/NCT04363372,None
3898,NCT04363385,ClinicalTrials.gov,2020-04-21,2020-05-31,False,Centre Hospitalier Intercommunal Creteil,Recruiting,Not Applicable,Interventional,France,Collection of Biological Samples With Clinical Characterization of Covid-19 Patients,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04363385,None
3899,NCT04363437,ClinicalTrials.gov,2020-04-23,2020-04-26,False,Maimonides Medical Center,Recruiting,Phase 2,Interventional,United States,COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19,Drug,Colchicine,Colchicine,70,https://clinicaltrials.gov/show/NCT04363437,None
3900,NCT04363450,ClinicalTrials.gov,2020-04-23,2020-04-27,False,Louisiana State University Health Sciences Center in New Orleans,Recruiting,Phase 3,Interventional,United States,Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1700,https://clinicaltrials.gov/show/NCT04363450,None
3901,NCT04363463,ClinicalTrials.gov,2020-04-22,2020-08-28,False,Centre Hospitalier Régional d'Orleans,Recruiting,Not Applicable,Interventional,France,Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory Distress,Procedure,Positioning,Positioning,400,https://clinicaltrials.gov/show/NCT04363463,None
3902,NCT04363489,ClinicalTrials.gov,2020-04-23,2020-08-01,False,King's College London,Not Recruiting,Not Applicable,Observational,No Country Given,The CEDiD Study (COVID-19 Early Diagnosis in Doctors and Healthcare Workers),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,60,https://clinicaltrials.gov/show/NCT04363489,None
3903,NCT04363502,ClinicalTrials.gov,2020-04-23,2020-05-07,False,Johns Hopkins University,Recruiting,Phase 2,Interventional,United States,Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,Drug,Clazakizumab,Clazakizumab,30,https://clinicaltrials.gov/show/NCT04363502,None
3904,NCT04363528,ClinicalTrials.gov,2020-04-23,2020-04-24,False,Versailles Hospital,Recruiting,Not Applicable,Interventional,France,Incidence of Deep Vein Thrombosis at Doppler Echo in Covid-19 Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04363528,None
3905,NCT04363541,ClinicalTrials.gov,2020-04-23,2020-08-27,False,Instituto Nacional de Perinatología,Recruiting,Not Applicable,Interventional,Mexico,Local Thermotherapy for Patients With Mild-to-moderate COVID-19,Other (device),Heating pad,Heating pad,274,https://clinicaltrials.gov/show/NCT04363541,None
3906,NCT04363606,ClinicalTrials.gov,2020-04-24,2020-05-27,False,CHU de Saint Etienne,Recruiting,Not Applicable,Interventional,France,Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability,Clinical Presentation,No Intervention,No Intervention,82,https://clinicaltrials.gov/show/NCT04363606,None
3907,NCT04363671,ClinicalTrials.gov,2020-04-21,2020-05-01,False,Hôpital Cochin,Not Recruiting,Not Applicable,Observational,France,Adolescents and Health Professionals Faced With the Necessity for Changing to Remote Care During the COVID-19 Outbreak Quarantine (AdoPro-Cov19),Other (psych),No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04363671,None
3908,NCT04363736,ClinicalTrials.gov,2020-04-21,2020-05-05,False,Roche,Not Recruiting,Phase 2,Interventional,United States,A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia,Drug,Tocilizumab,Tocilizumab,100,https://clinicaltrials.gov/show/NCT04363736,None
3909,NCT04363749,ClinicalTrials.gov,2020-04-20,2020-04-27,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 Infection: Exploration of Respiratory Control Center Abnormalities,Other,Other,Other,30,https://clinicaltrials.gov/show/NCT04363749,None
3910,NCT04363788,ClinicalTrials.gov,2020-04-23,2020-02-28,True,Lazarski University,Not Recruiting,Not Applicable,Observational,Poland,Needle Stick Injuries in Emergency Medical Service Practice,Procedure,Double Gloves,Double Gloves,300,https://clinicaltrials.gov/show/NCT04363788,None
3911,NCT04363814,ClinicalTrials.gov,2020-04-19,2020-06-10,False,Inmunotek S.L.,Recruiting,Phase 3,Interventional,Dominican Republic,Clinical Impact of BACTEK-R in Subject With Mild Pneumonia Due to COVID-19 Infection,Drug,Bactek-R,Bactek-R,100,https://clinicaltrials.gov/show/NCT04363814,None
3912,NCT04363827,ClinicalTrials.gov,2020-04-24,2020-05-14,False,Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori,Recruiting,Phase 2,Interventional,Italy,Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19),Drug (+ Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,2300,https://clinicaltrials.gov/show/NCT04363827,None
3913,NCT04363840,ClinicalTrials.gov,2020-04-24,2020-05-01,False,Louisiana State University Health Sciences Center in New Orleans,Not Recruiting,Phase 2,Interventional,No Country Given,"The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 Hospitalizations",Drug,Aspirin + Vitamin D vs. Aspirin,Aspirin; Vitamin D,1080,https://clinicaltrials.gov/show/NCT04363840,None
3914,NCT04363853,ClinicalTrials.gov,2020-04-17,2020-06-01,False,Instituto Nacional de Cancerología,Not Recruiting,Phase 2,Interventional,Mexico,Tocilizumab Treatment in Patients With COVID-19,Drug,Tocilizumab,Tocilizumab,200,https://clinicaltrials.gov/show/NCT04363853,None
3915,NCT04363866,ClinicalTrials.gov,2020-04-24,2020-08-01,False,Oregon Health and Science University,Not Recruiting,Phase 2,Interventional,United States,Assessing Hydroxychloroquine in Patients With SARS-CoV-2 (COVID-19),Drug,Hydroxychloroquine,Hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04363866,None
3916,NCT04364009,ClinicalTrials.gov,2020-04-17,2020-04-27,True,CHU de Tours,Not Recruiting,Phase 3,Interventional,France,Anakinra for COVID-19 Respiratory Symptoms,Drug,Anakinra,Anakinra,71,https://clinicaltrials.gov/show/NCT04364009,EUCTR2020-001734-36
3917,NCT04364022,ClinicalTrials.gov,2020-04-23,2020-04-23,False,Calmy Alexandra,Recruiting,Phase 3,Interventional,Switzerland,Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Lopinavir/Ritonavir,Hydroxychloroquine; Lopinavir/Ritonavir,300,https://clinicaltrials.gov/show/NCT04364022,None
3918,NCT04364594,ClinicalTrials.gov,2020-04-22,2020-03-26,True,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Not Recruiting,Not Applicable,Interventional,Italy,COVID-19 Search in Conjunctival Cells,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://clinicaltrials.gov/show/NCT04364594,None
3919,NCT04364698,ClinicalTrials.gov,2020-04-24,2020-05-07,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Observational,France,Observational Cohort of COVID-19 Patients at Raymond-Poincare,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04364698,None
3920,NCT04364711,ClinicalTrials.gov,2020-04-20,2020-05-01,False,UMC Utrecht,Not Recruiting,Not Applicable,Observational,No Country Given,EuRopean Study of MAjor Infectious Disease Syndromes Related to COVID-19,Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04364711,None
3921,NCT04364737,ClinicalTrials.gov,2020-04-22,2020-04-17,True,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients,ATMP,Plasma,Plasma,300,https://clinicaltrials.gov/show/NCT04364737,None
3922,NCT04364763,ClinicalTrials.gov,2020-04-20,2020-08-05,False,"Renibus Therapuetics, Inc.",Recruiting,Phase 2,Interventional,United States,A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study),Drug,Stannous protoporphyrin,Stannous protoporphyrin,252,https://clinicaltrials.gov/show/NCT04364763,None
3923,NCT04364802,ClinicalTrials.gov,2020-04-25,2020-04-29,False,Alexandra Kejner,Recruiting,Phase 2,Interventional,United States,COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients,Drug,Povidone Iodine,Povidone Iodine,300,https://clinicaltrials.gov/show/NCT04364802,None
3924,NCT04364815,ClinicalTrials.gov,2020-04-22,2020-12-01,False,University of the Philippines,Not Recruiting,Phase 3,Interventional,Philippines,The University of the Philippines Hydroxychloroquine PEP Against COVID-19 Trial,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04364815,None
3925,NCT04364828,ClinicalTrials.gov,2020-04-22,2021-01-01,False,"University Hospital, Tübingen",Not Recruiting,Not Applicable,Interventional,No Country Given,NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease Progression,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,https://clinicaltrials.gov/show/NCT04364828,None
3926,NCT04364893,ClinicalTrials.gov,2020-04-07,2020-04-09,False,D'Or Institute for Research and Education,Recruiting,Not Applicable,Interventional,Brazil,Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19,Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,700,https://clinicaltrials.gov/show/NCT04364893,None
3927,NCT04364984,ClinicalTrials.gov,2020-04-23,2020-04-01,True,Medical Practice Prof D. Ivanov,Recruiting,Not Applicable,Observational,Ukraine,"ARB, ACEi, DRi in COVID-19",Drug,ACE inhibitors,ACE inhibitors,10,https://clinicaltrials.gov/show/NCT04364984,None
3928,NCT04365101,ClinicalTrials.gov,2020-04-22,2020-05-13,False,Celularity Incorporated,Recruiting,Phase 1/Phase 2,Interventional,United States,Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19,ATMP,Cells (NK),Cells (NK),86,https://clinicaltrials.gov/show/NCT04365101,None
3929,NCT04365127,ClinicalTrials.gov,2020-04-24,2020-04-27,False,Sara Ghandehari,Not Recruiting,Phase 1,Interventional,United States,Progesterone for the Treatment of COVID-19 in Hospitalized Men,Drug,Progesterone,Progesterone,40,https://clinicaltrials.gov/show/NCT04365127,None
3930,NCT04365153,ClinicalTrials.gov,2020-04-24,2020-04-24,False,The Cleveland Clinic,Not Recruiting,Phase 2,Interventional,United States,Canakinumab in Covid-19 Cardiac Injury (The Three C Study),Drug,Canakinumab,Canakinumab,45,https://clinicaltrials.gov/show/NCT04365153,None
3931,NCT04365166,ClinicalTrials.gov,2020-04-19,2020-04-21,False,Direction Centrale du Service de Sant des Armes,Recruiting,Not Applicable,Observational,France,Study of Clinical and Immune Severity Profiles of Patients Infected With SARS-Cov2 (COVID-19),Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04365166,None
3932,NCT04365231,ClinicalTrials.gov,2020-04-23,2020-04-01,True,"Hospital St. Joseph, Marseille",Not Recruiting,Phase 3,Interventional,France,Hydroxychloroquine Azithromycin COVID-19 Pregnancy Trial,Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,0,https://clinicaltrials.gov/show/NCT04365231,None
3933,NCT04365309,ClinicalTrials.gov,2020-04-24,2020-02-10,True,Xijing Hospital,Recruiting,Phase 2/Phase 3,Interventional,China,Protective Effect of Aspirin on COVID-19 Patients,Drug,Aspirin,Aspirin,128,https://clinicaltrials.gov/show/NCT04365309,None
3934,NCT04365322,ClinicalTrials.gov,2020-04-25,2020-04-20,True,CHU de Besançon,Recruiting,Not Applicable,Observational,France,Study of Specific Viral Immune Responses Induced by SARS-CoV-2 (COVID-19),Clinical Presentation,No Intervention,No Intervention,160,https://clinicaltrials.gov/show/NCT04365322,None
3935,NCT04365335,ClinicalTrials.gov,2020-04-24,2020-04-25,False,Direction Centrale du Service de Sant des Armes,Not Recruiting,Not Applicable,Observational,France,Stress Biomarkers Leading to Professional Burnout Among People Involved in a Mobile Intensive Care Unit During the COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04365335,None
3936,NCT04365348,ClinicalTrials.gov,2020-04-25,2020-04-27,False,University of Hong Kong,Recruiting,Not Applicable,Observational,Hong Kong,The Psychological Impact of COVID-19 Outbreak on COVID-19 Survivors and Their Families,Other (psych),No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04365348,None
3937,NCT04365361,ClinicalTrials.gov,2020-04-25,2020-04-26,False,University of Hong Kong,Recruiting,Not Applicable,Observational,Hong Kong,The Psychological Impact of the COVID-19 on Students.,Other (psych),No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04365361,None
3938,NCT04365439,ClinicalTrials.gov,2020-04-18,2020-04-27,False,Enos Bernasconi,Not Recruiting,Not Applicable,Interventional,No Country Given,Convalescent Plasma for COVID-19,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04365439,None
3939,NCT04365517,ClinicalTrials.gov,2020-04-14,2020-12-29,False,University of Milan,Not Recruiting,Phase 3,Interventional,Italy,The Effect of Sitagliptin Treatment in COVID-19 Positive Diabetic Patients,Drug,Sitagliptin,Sitagliptin,170,https://clinicaltrials.gov/show/NCT04365517,None
3940,NCT04365530,ClinicalTrials.gov,2020-04-26,2020-04-01,True,Groupe Hospitalier Paris Saint-Joseph,Recruiting,Not Applicable,Observational,France,Become of Patients Infected or Suspected of Being Infected by Covid-19 and Supported by the GHPSJ and the Establishments of the Paris Plaisance Hospital City,Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04365530,None
3941,NCT04365582,ClinicalTrials.gov,2020-04-23,2020-05-07,False,Groupe Hospitalier Paris Saint-Joseph,Not Recruiting,Phase 3,Interventional,France,OUTpatient Treatment of COVID-19 in Patients With Risk Factor for Poor Outcome,Drug,Hydroxychloroquine vs. Azithromycin vs. Lopinavir/ritonavir,Hydroxychloroquine; Azithromycin; Lopinavir/ritonavir,640,https://clinicaltrials.gov/show/NCT04365582,None
3942,NCT04365595,ClinicalTrials.gov,2020-04-24,2020-06-03,False,University of Zurich,Recruiting,Not Applicable,Observational,Switzerland,SARS-CoV-2 Associated Respiratory Failure Recovery (COVID-19 CAir),Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04365595,None
3943,NCT04365608,ClinicalTrials.gov,2020-04-24,2020-03-20,True,Lazarski University,Recruiting,Not Applicable,Interventional,Poland,Prehospital Intubation of COVID-19 Patient With Personal Protective Equipment,Other (physical),Mechanical ventilation,Mechanical ventilation,90,https://clinicaltrials.gov/show/NCT04365608,None
3944,NCT04365634,ClinicalTrials.gov,2020-04-25,2020-02-02,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Not Recruiting,Not Applicable,Observational,China,A Single-center Retrospective Study to Find Prediction Factors Related to Mortality of COVID-19 Patients.,Clinical Presentation,No Intervention,No Intervention,306,https://clinicaltrials.gov/show/NCT04365634,None
3945,NCT04365699,ClinicalTrials.gov,2020-04-25,2020-04-08,True,NYU Langone Health,Recruiting,Phase 2,Interventional,United States,Cardiovascular Effects of COVID-19,Drug,AT-001,AT-001,500,https://clinicaltrials.gov/show/NCT04365699,None
3946,NCT04365725,ClinicalTrials.gov,2020-04-25,2020-05-05,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Observational,France,"Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections",Drug,Remdesivir,Remdesivir,200,https://clinicaltrials.gov/show/NCT04365725,None
3947,NCT04365738,ClinicalTrials.gov,2020-04-26,2020-03-11,True,Istanbul Bilgi University,Not Recruiting,Not Applicable,Interventional,Turkey,Pulmonary Rehabilitation in Post-Acute Period of COVID-19 Infection,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,270,https://clinicaltrials.gov/show/NCT04365738,None
3948,NCT04365764,ClinicalTrials.gov,2020-04-25,2020-03-14,True,Groupe Hospitalier Pitié Salpêtrière,Recruiting,Not Applicable,Observational,France,Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study,Drug,Unspecified Drug,Unspecified Drug,400,https://clinicaltrials.gov/show/NCT04365764,None
3949,NCT04365816,ClinicalTrials.gov,2020-04-24,2020-04-30,False,"University Hospital, Grenoble",Not Recruiting,Not Applicable,Observational,France,NutriCovid30 : Nutritional Evaluation for Covid-19 Infection at D30,Clinical Presentation,No Intervention,No Intervention,403,https://clinicaltrials.gov/show/NCT04365816,None
3950,NCT04365881,ClinicalTrials.gov,2020-04-26,2020-03-31,True,Modum Bad,Not Recruiting,Not Applicable,Observational,Norway,Loneliness During the NPIs for the COVID-19 Pandemic in Norway: Risk Factors and Associations With Psychopathology,Other (psych),No Intervention,No Intervention,10084,https://clinicaltrials.gov/show/NCT04365881,None
3951,NCT04365959,ClinicalTrials.gov,2020-04-21,2020-03-20,True,University of Milano Bicocca,Not Recruiting,Not Applicable,Observational,Italy,The Prone Position in Covid-19 Affected Patients,Procedure,Positioning,Positioning,56,https://clinicaltrials.gov/show/NCT04365959,None
3952,NCT04365972,ClinicalTrials.gov,2020-04-24,2020-04-23,True,Tel Aviv University,Not Recruiting,Not Applicable,Interventional,Israel,Attention Bias Modification for Reducing Health Anxiety During the Coronavirus Pandemic,Other (psych),Psychological,Psychological,20,https://clinicaltrials.gov/show/NCT04365972,None
3953,NCT04365985,ClinicalTrials.gov,2020-04-26,2020-04-29,False,William Beaumont Hospitals,Recruiting,Phase 2,Interventional,United States,Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19,Drug,"Ketamine, Naltrexone",Ketamine; Naltrexone,500,https://clinicaltrials.gov/show/NCT04365985,None
3954,NCT04366024,ClinicalTrials.gov,2020-04-21,2020-01-17,True,Xinqiao Hospital of Chongqing,Recruiting,Not Applicable,Observational,China,A Novel Nomogram to Predict Severity of COVID-19,Prognosis,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04366024,None
3955,NCT04366050,ClinicalTrials.gov,2020-04-24,2020-05-11,False,"University of California, San Diego",Recruiting,Phase 2,Interventional,United States,Ramipril for the Treatment of COVID-19,Drug,Ramipril,Ramipril,560,https://clinicaltrials.gov/show/NCT04366050,None
3956,NCT04366063,ClinicalTrials.gov,2020-04-20,2020-04-05,False,Royan Institute,Recruiting,Phase 2/Phase 3,Interventional,Iran,Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome,ATMP,Cells (mesenchymal),Cells (mesenchymal),60,https://clinicaltrials.gov/show/NCT04366063,IRCT20200217046526N2
3957,NCT04366089,ClinicalTrials.gov,2020-04-22,2020-03-26,True,Dr. Roberto Poscia,Recruiting,Phase 2,Interventional,Italy,Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora,Drug,Oxygen + Ozone,Oxygen; Ozone,152,https://clinicaltrials.gov/show/NCT04366089,None
3958,NCT04366115,ClinicalTrials.gov,2020-04-26,2020-11-01,False,AVM Biotechnology LLC,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDS,Drug,AVM0703,AVM0703,8,https://clinicaltrials.gov/show/NCT04366115,None
3959,NCT04366141,ClinicalTrials.gov,2020-04-24,2020-05-01,False,University of British Columbia,Recruiting,Not Applicable,Interventional,Canada,COVID-19 (Coronavirus Disease 2019) Intubation Barrier Box,Other (device),Barrier,Barrier,120,https://clinicaltrials.gov/show/NCT04366141,None
3960,NCT04366167,ClinicalTrials.gov,2020-04-24,2020-04-18,True,Barts & The London NHS Trust,Recruiting,Not Applicable,Observational,United Kingdom,Patient Recovery From Heart Surgery During the Covid-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04366167,None
3961,NCT04366180,ClinicalTrials.gov,2020-04-27,2020-04-24,True,Biosearch S.A.,Recruiting,Not Applicable,Interventional,Spain,Evaluation of the Probiotic Lactobacillus Coryniformis K8 on COVID-19 Prevention in Healthcare Workers,Supplement,Probiotics,Probiotics,314,https://clinicaltrials.gov/show/NCT04366180,None
3962,NCT04366206,ClinicalTrials.gov,2020-04-19,2020-03-14,True,Centre Hospitalier Intercommunal Robert Ballanger,Recruiting,Not Applicable,Observational,France,Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est,Clinical Presentation,No Intervention,No Intervention,143,https://clinicaltrials.gov/show/NCT04366206,None
3963,NCT04366219,ClinicalTrials.gov,2020-04-27,2020-06-01,False,Centre Hospitalier le Mans,Not Recruiting,Not Applicable,Observational,No Country Given,"Impact of Confinement and Preventive Measures in Period of SARS-COV2 Infection on Clinical Features, Diagnostic and Therapeutic Management and Prognosis of Patients With Lung Cancer: an Ambispective Study Extended Over 2 Time Periods.",Other,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04366219,None
3964,NCT04366232,ClinicalTrials.gov,2020-04-27,2020-08-19,True,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer,Not Recruiting,Phase 2,Interventional,France,Efficacy of Intravenous Anakinra and Ruxolitinib During COVID-19 Inflammation (JAKINCOV),Drug,Anakinra + Ruxolitinib vs. Anakinra,Anakinra; Ruxolitinib,2,https://clinicaltrials.gov/show/NCT04366232,EUCTR2020-001963-10
3965,NCT04366245,ClinicalTrials.gov,2020-04-22,2020-04-23,False,Andalusian Network for Design and Translation of Advanced Therapies,Recruiting,Phase 1/Phase 2,Interventional,Spain,Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection,ATMP,Plasma,Plasma,72,https://clinicaltrials.gov/show/NCT04366245,None
3966,NCT04366271,ClinicalTrials.gov,2020-04-23,2020-05-07,True,Hospital Infantil Universitario Niño Jesús,Recruiting,Phase 2,Interventional,Spain,Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),106,https://clinicaltrials.gov/show/NCT04366271,EUCTR2020-001450-22
3967,NCT04366297,ClinicalTrials.gov,2020-04-23,2020-01-12,True,Lazarski University,Not Recruiting,Not Applicable,Interventional,Poland,Intravascular Access of COVID-19 Patient Under Personal Protective Equipment,Other (device),Intraosseous/Intravenous access device,Intraosseous/Intravenous access device,41,https://clinicaltrials.gov/show/NCT04366297,None
3968,NCT04366323,ClinicalTrials.gov,2020-04-22,2020-04-27,True,Andalusian Network for Design and Translation of Advanced Therapies,Not Recruiting,Phase 1/Phase 2,Interventional,Spain,Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),26,https://clinicaltrials.gov/show/NCT04366323,EUCTR2020-001364-29
3969,NCT04366739,ClinicalTrials.gov,2020-04-24,2020-04-29,False,Centre Hospitalier St. Anne,Not Recruiting,Phase 3,Interventional,France,Repurposing of Chlorpromazine in Covid-19 Treatment,Drug,Chlorpromazine,Chlorpromazine,40,https://clinicaltrials.gov/show/NCT04366739,None
3970,NCT04366752,ClinicalTrials.gov,2020-04-27,2020-04-22,True,CHU de Amiens,Recruiting,Not Applicable,Observational,France,Thrombo Embolic Events in Critical Care Patients With Covid-19 Serious Acute Pneumopathy,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04366752,None
3971,NCT04366765,ClinicalTrials.gov,2020-04-06,2020-03-19,True,"University Hospital, Basel",Recruiting,Not Applicable,Observational,Switzerland,COVID-19 Survival - The COVIVA Study,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04366765,None
3972,NCT04366778,ClinicalTrials.gov,2020-04-23,2020-05-01,False,Hospices Civils de Lyon,Recruiting,Not Applicable,Observational,France,Thrombosis and Covid-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,325,https://clinicaltrials.gov/show/NCT04366778,None
3973,NCT04366791,ClinicalTrials.gov,2020-04-24,2020-04-23,True,Emory University,Recruiting,Phase 1/Phase 2,Interventional,United States,Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19,Other,Radiation,Radiation,10,https://clinicaltrials.gov/show/NCT04366791,None
3974,NCT04366817,ClinicalTrials.gov,2020-04-20,2020-04-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,Psychological Impact of the Lockdown on Patients Giving Birth During the COVID-19 Epidemic Short Title : Isolement and Childbirth: Psychological Impact,Other (psych),No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04366817,None
3975,NCT04366830,ClinicalTrials.gov,2020-04-24,2020-04-01,True,Mesoblast International,Not Recruiting,Not Applicable,Expanded Access,United States,"Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection",ATMP,Cells (mesenchymal),Cells (mesenchymal),Not Available,https://clinicaltrials.gov/show/NCT04366830,None
3976,NCT04366856,ClinicalTrials.gov,2020-04-26,2020-06-26,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Interventional,France,PROne Positioning in coVID-19 Oxygeno-dependent Patients in Spontaneous Ventilation (PROVID Study),Procedure,Positioning,Positioning,500,https://clinicaltrials.gov/show/NCT04366856,None
3977,NCT04366882,ClinicalTrials.gov,2020-04-22,2020-04-14,True,Jessa Hospital,Recruiting,Not Applicable,Interventional,Belgium,Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,45,https://clinicaltrials.gov/show/NCT04366882,None
3978,NCT04366908,ClinicalTrials.gov,2020-04-25,2020-04-28,False,Maimonides Biomedical Research Institute of Cordoba,Not Recruiting,Phase 2,Interventional,No Country Given,Prevention and Treatment With Calcifediol of COVID-19 Induced Acute Respiratory Syndrome,Drug,Calcifediol,Calcifediol,1008,https://clinicaltrials.gov/show/NCT04366908,None
3979,NCT04366921,ClinicalTrials.gov,2020-04-17,2020-04-10,True,Academic Hospital Maastricht,Recruiting,Not Applicable,Observational,"Sweden, Czech Republic, Germany, Lithuania, Italy, Russian Federation, Poland, Netherlands, Portugal, Greece, Israel, Switzerland, Hungary, Denmark, France, Belgium, United Kingdom, Austria, Spain",European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID-19 Patients in ECMO,Drug,Oxygen,Oxygen,150,https://clinicaltrials.gov/show/NCT04366921,None
3980,NCT04366934,ClinicalTrials.gov,2020-04-22,2020-05-04,False,Institut Pasteur,Recruiting,Not Applicable,Observational,France,Study of the Pathogenesis of Olfactory Disorders in COVID-19,Clinical Presentation,No Intervention,No Intervention,24,https://clinicaltrials.gov/show/NCT04366934,None
3981,NCT04366947,ClinicalTrials.gov,2020-04-23,2020-04-14,True,Lazarski University,Not Recruiting,Not Applicable,Interventional,Poland,Intravascular Access in Suspected/Confirmed COVID-19 Patient,Other (device),Intraosseous/Intravenous access device,Intraosseous/Intravenous access device,60,https://clinicaltrials.gov/show/NCT04366947,None
3982,NCT04366960,ClinicalTrials.gov,2020-04-24,2020-05-14,True,Niguarda Hospital,Recruiting,Phase 3,Interventional,Italy,Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients,Drug,Enoxaparin,Enoxaparin,2712,https://clinicaltrials.gov/show/NCT04366960,EUCTR2020-001708-41
3983,NCT04366986,ClinicalTrials.gov,2020-04-23,2020-06-23,False,Pregistry,Recruiting,Not Applicable,Observational,United States,International Registry of Coronavirus (COVID-19) Exposure in Pregnancy,Clinical Presentation,No Intervention,No Intervention,25000,https://clinicaltrials.gov/show/NCT04366986,None
3984,NCT04367064,ClinicalTrials.gov,2020-04-26,2020-04-25,True,Max Healthcare Insititute Limited,Recruiting,Not Applicable,Observational,India,To Study the Clinical Characteristics and Treatment Outcome of COVID-19 Patients Admitted in Hospitals of Max Healthcare (SCOPe Study),Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04367064,None
3985,NCT04367077,ClinicalTrials.gov,2020-04-27,2020-04-28,False,"Athersys, Inc",Recruiting,Phase 2/Phase 3,Interventional,United States,MultiStem Administration for COVID-19 Induced ARDS (MACoVIA),ATMP,Cells (stem cells),Cells (stem cells),400,https://clinicaltrials.gov/show/NCT04367077,None
3986,NCT04367129,ClinicalTrials.gov,2020-04-16,2020-04-14,True,"University Hospital, Ferrara",Recruiting,Not Applicable,Observational,Italy,Electrocardiogram Analysis in COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04367129,None
3987,NCT04367142,ClinicalTrials.gov,2020-04-27,2020-09-01,False,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Rapid Detection of COVID-19 by Portable and Connected Biosensor,Other (device),Biosensors,Biosensors,200,https://clinicaltrials.gov/show/NCT04367142,None
3988,NCT04367168,ClinicalTrials.gov,2020-04-24,2020-05-27,False,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,Recruiting,Phase 2,Interventional,Mexico,Colchicine Twice Daily During 10 Days as an Option for the Treatment of Symptoms Induced by Inflammation in Patients With Mild and Severe Coronavirus Disease,Drug,Colchicine,Colchicine,174,https://clinicaltrials.gov/show/NCT04367168,None
3989,NCT04367207,ClinicalTrials.gov,2020-04-27,2020-05-01,False,University of Cape Town,Recruiting,Not Applicable,Observational,South Africa,African Covid-19 Critical Care Outcomes Study,Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04367207,None
3990,NCT04367337,ClinicalTrials.gov,2020-04-28,2020-03-25,True,"University of Social Sciences and Humanities, Warsaw",Not Recruiting,Not Applicable,Observational,"Portugal, Malaysia, Gambia, Germany, Israel, Italy, France, Poland, China, Canada, Singapore, Switzerland, Australia, Romania",Health Behavior Change During COVID-19 Pandemic,Other,No Intervention,No Intervention,6079,https://clinicaltrials.gov/show/NCT04367337,None
3991,NCT04367350,ClinicalTrials.gov,2020-04-28,2020-03-20,True,"University Hospital, Tübingen",Recruiting,Not Applicable,Observational,Germany,Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04367350,None
3992,NCT04367363,ClinicalTrials.gov,2020-04-17,2020-03-17,True,Jean Liu,Not Recruiting,Not Applicable,Observational,Singapore,Social Media and COVID-19,Other,No Intervention,No Intervention,151,https://clinicaltrials.gov/show/NCT04367363,None
3993,NCT04367402,ClinicalTrials.gov,2020-04-17,2020-03-30,True,Azienda Ospedaliera San Paolo,Recruiting,Not Applicable,Observational,Italy,"COST (COvid STudio) ACTION: Study for the Evaluation of Specific Antibodies Anti Covid-19 Linked to Covid-19 Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in Patients (COST ACTION)",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,600,https://clinicaltrials.gov/show/NCT04367402,None
3994,NCT04367545,ClinicalTrials.gov,2020-04-27,2020-04-16,True,"University Hospital, Rouen",Not Recruiting,Not Applicable,Interventional,France,Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,130,https://clinicaltrials.gov/show/NCT04367545,None
3995,NCT04367636,ClinicalTrials.gov,2020-04-20,2020-04-20,False,University of Ghent,Not Recruiting,Not Applicable,Interventional,Belgium,The Effects of Attention Training on Emotion Regulation and Stress Related Complaints During COVID-19,Other (psych),Psychological,Psychological,100,https://clinicaltrials.gov/show/NCT04367636,None
3996,NCT04367662,ClinicalTrials.gov,2020-04-16,2020-04-09,True,"University Hospital, Rouen",Not Recruiting,Not Applicable,Interventional,France,Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19,Clinical Presentation,No Intervention,No Intervention,99,https://clinicaltrials.gov/show/NCT04367662,None
3997,NCT04367714,ClinicalTrials.gov,2020-04-27,2020-03-15,True,Region Midtjylland,Recruiting,Not Applicable,Observational,Denmark,Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04367714,None
3998,NCT04367740,ClinicalTrials.gov,2020-04-27,2020-04-28,False,"University of North Carolina, Chapel Hill",Recruiting,Not Applicable,Observational,United States,"ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,10000,https://clinicaltrials.gov/show/NCT04367740,None
3999,NCT04367792,ClinicalTrials.gov,2020-04-27,2020-04-23,True,A.O. Ospedale Papa Giovanni XXIII,Not Recruiting,Not Applicable,Observational,Italy,Cardiac Injury in COVID-19: a Pathology Study,Clinical Presentation,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04367792,None
4000,NCT04367805,ClinicalTrials.gov,2020-04-27,2020-04-27,False,CHU de Amiens,Recruiting,Not Applicable,Observational,France,COVID-19 Infection in Patients With Hepatocellular Carcinoma,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://clinicaltrials.gov/show/NCT04367805,None
4001,NCT04367831,ClinicalTrials.gov,2020-04-27,2020-05-02,False,Columbia University,Recruiting,Phase 4,Interventional,United States,Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19,Drug,Enoxaparin,Enoxaparin,100,https://clinicaltrials.gov/show/NCT04367831,None
4002,NCT04367857,ClinicalTrials.gov,2020-04-28,2020-04-18,True,Columbia University,Recruiting,Not Applicable,Observational,United States,ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04367857,None
4003,NCT04367870,ClinicalTrials.gov,2020-04-28,2020-05-23,False,UNICANCER,Recruiting,Not Applicable,Observational,France,COVID-19 Detection Test in Oncology,Clinical Presentation (Epidemiology),No Intervention,No Intervention,2500,https://clinicaltrials.gov/show/NCT04367870,None
4004,NCT04367883,ClinicalTrials.gov,2020-04-28,2020-03-01,True,Consorci Sanitari de Terrassa,Recruiting,Not Applicable,Observational,Spain,"Influenza Vaccination, ACEI and ARB in the Evolution of SARS-Covid19 Infection",Drug (+ ATMP),ACE inhibitors or ARBs + Flu Vaccination,ACE inhibitors; ARBs; Flu Vaccination,2574,https://clinicaltrials.gov/show/NCT04367883,None
4005,NCT04367896,ClinicalTrials.gov,2020-04-27,2020-03-24,True,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Not Recruiting,Not Applicable,Observational,Italy,COVID-19 OUTBREAK AND SOLID ORGAN TRANSPLANTATION (SOT) : AN INTERNATIONAL WEB-BASED SURVEY,Clinical Presentation,No Intervention,No Intervention,1819,https://clinicaltrials.gov/show/NCT04367896,None
4006,NCT04368013,ClinicalTrials.gov,2020-04-27,2020-04-28,False,Johan Normark,Not Recruiting,Not Applicable,Interventional,Sweden,"Host-pathogen Interactions, Immune Response, and Clinical Prognosis at COVID-19 - the CoVUm Trial",Prognosis,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04368013,None
4007,NCT04368026,ClinicalTrials.gov,2020-04-27,2020-03-30,True,Jagiellonian University,Recruiting,Not Applicable,Observational,Poland,SARS-CoV-2 (COVID-19) and Surgery,Health System,No Intervention,No Intervention,350,https://clinicaltrials.gov/show/NCT04368026,None
4008,NCT04368065,ClinicalTrials.gov,2020-04-28,2020-04-02,True,Iqvia Pty Ltd,Recruiting,Not Applicable,Observational,"United Kingdom, United States",COVID-19 Active Research Experience (CARE),Clinical Presentation,No Intervention,No Intervention,100000,https://clinicaltrials.gov/show/NCT04368065,None
4009,NCT04368143,ClinicalTrials.gov,2020-04-27,2020-04-01,True,Institute of Tropical Medicine,Recruiting,Not Applicable,Observational,Belgium,COVID-19 Immune Repertoire Sequencing,Genomics,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04368143,None
4010,NCT04368156,ClinicalTrials.gov,2020-04-20,2020-04-20,False,Carlos Tornero,Recruiting,Not Applicable,Interventional,Spain,Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms,Other (device),Vagus nerve stimulation,Vagus nerve stimulation,90,https://clinicaltrials.gov/show/NCT04368156,None
4011,NCT04368208,ClinicalTrials.gov,2020-04-28,2020-04-29,False,Poitiers University Hospital,Recruiting,Not Applicable,Observational,France,Impact of Giving Birth During the Covid 19 Pandemia on Postnatal Women's Depression,Other (psych),No Intervention,No Intervention,900,https://clinicaltrials.gov/show/NCT04368208,None
4012,NCT04368221,ClinicalTrials.gov,2020-04-24,2020-05-04,False,Rennes University Hospital,Not Recruiting,Not Applicable,Observational,France,Characterization of Fungal Infections in COVID-19 Infected and Mechanically Ventilated Patients in ICU,Clinical Presentation,No Intervention,No Intervention,576,https://clinicaltrials.gov/show/NCT04368221,None
4013,NCT04368234,ClinicalTrials.gov,2020-04-27,2020-04-18,True,Duke University,Recruiting,Not Applicable,Observational,United States,Duke COVID-19 Shared Data and Specimen Repository,Clinical Presentation,No Intervention,No Intervention,100000,https://clinicaltrials.gov/show/NCT04368234,None
4014,NCT04368260,ClinicalTrials.gov,2020-04-24,2020-04-24,False,University of Virginia,Recruiting,Not Applicable,Interventional,United States,Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,40,https://clinicaltrials.gov/show/NCT04368260,None
4015,NCT04368299,ClinicalTrials.gov,2020-04-25,2020-05-01,False,Chinese University of Hong Kong,Recruiting,Not Applicable,Interventional,Hong Kong,Telemedicine for Follow-up of Systemic Lupus Erythematosus,Telehealth,Telehealth,Telehealth,150,https://clinicaltrials.gov/show/NCT04368299,None
4016,NCT04368312,ClinicalTrials.gov,2020-04-09,2020-05-06,False,"University Hospital, Essen",Not Recruiting,Not Applicable,Observational,No Country Given,Psychological Impairment Due to Covid-19,Other (psych),No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04368312,None
4017,NCT04368351,ClinicalTrials.gov,2020-04-27,2020-03-01,True,University of Roma La Sapienza,Not Recruiting,Not Applicable,Observational,Italy,Bacteriotherapy in the Treatment of COVID-19,Drug,Bacteriotherapy + Azithromycin + Hydroxychloroquine vs. Azithromycin + Hydrixychloroquine,Bacteriotherapy; Azithromycin; Hydroxychloroquine,70,https://clinicaltrials.gov/show/NCT04368351,None
4018,NCT04368377,ClinicalTrials.gov,2020-04-23,2020-04-06,True,University of Milan,Not Recruiting,Phase 2,Interventional,Italy,Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19,Drug,Tirofiban + Clopidogrel + Aspirin + Fondaparinux,Tirofiban; Clopidogrel; Aspirin; Fondaparinux,5,https://clinicaltrials.gov/show/NCT04368377,None
4019,NCT04368390,ClinicalTrials.gov,2020-04-28,2020-04-03,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Neuroradiolological Analysis of COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04368390,None
4020,NCT04368637,ClinicalTrials.gov,2020-04-26,2020-05-03,False,Jordan Collaborating Cardiology Group,Recruiting,Not Applicable,Observational,Jordan,Acute Cardiovascular Events Triggered by COVID-19-Related Stress,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04368637,None
4021,NCT04368676,ClinicalTrials.gov,2020-04-26,2020-06-25,False,Lawson Health Research Institute,Recruiting,Phase 1,Interventional,Canada,Breath Regulation and Yogic Exercise An Online Therapy for Calm and Happiness,Traditional Medicine (other),Traditional Medicine,Traditional Medicine,60,https://clinicaltrials.gov/show/NCT04368676,None
4022,NCT04368728,ClinicalTrials.gov,2020-04-27,2020-04-29,True,Biontech SE,Recruiting,Phase 2/Phase 3,Interventional,"Germany, Argentina, Turkey, Brazil, United States, South Africa","Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals",ATMP,Vaccine,Vaccine,43998,https://clinicaltrials.gov/show/NCT04368728,EUCTR2020-002641-42
4023,NCT04368793,ClinicalTrials.gov,2020-04-23,2020-04-06,True,China-Japan Friendship Hospital,Recruiting,Not Applicable,Observational,China,Clinical Effects of Internet Assisted Pulmonary Rehabilitation of COVID-2019 Pneumonia Patients After Discharge,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,200,https://clinicaltrials.gov/show/NCT04368793,None
4024,NCT04368832,ClinicalTrials.gov,2020-04-22,2020-04-25,False,CHU de Nancy,Not Recruiting,Not Applicable,Observational,France,imPROving prenaTal carE During ConfinemenT,Other,No Intervention,No Intervention,108,https://clinicaltrials.gov/show/NCT04368832,None
4025,NCT04368845,ClinicalTrials.gov,2020-04-20,2020-05-11,False,Clinical Exercise Physiology and Rehabilitation Reasearch Laboratory,Recruiting,Not Applicable,Interventional,Greece,Telerehabilitation in Patients With COVID-19 After Hospitalization. The ATHLOS Study,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,100,https://clinicaltrials.gov/show/NCT04368845,None
4026,NCT04368871,ClinicalTrials.gov,2020-04-29,2020-04-28,True,Max Healthcare Insititute Limited,Recruiting,Not Applicable,Observational,India,Radiographic Findings and Their Temporal Changes in COVID-19 Positive Changes Patients: A Prospective Study,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04368871,None
4027,NCT04368884,ClinicalTrials.gov,2020-04-29,2020-04-22,True,Max Healthcare Insititute Limited,Recruiting,Not Applicable,Observational,India,Assess the Seroconversion Status of Health Care Workers Suspected or Confirmed Cases of COVID-19 Patients,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04368884,None
4028,NCT04368897,ClinicalTrials.gov,2020-04-27,2020-05-01,False,"Applied Biology, Inc.",Recruiting,Not Applicable,Observational,Spain,In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04368897,None
4029,NCT04368923,ClinicalTrials.gov,2020-04-24,2020-03-15,True,Cairo University,Not Recruiting,Not Applicable,Interventional,Egypt,Management of Covid-19 Patients During Home Isolation,Drug,Oxygen,Oxygen,60,https://clinicaltrials.gov/show/NCT04368923,None
4030,NCT04368975,ClinicalTrials.gov,2020-04-27,2020-03-12,True,Hospital Clinic of Barcelona,Recruiting,Not Applicable,Observational,Spain,ARDS Caused by COVID-19,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04368975,None
4031,NCT04368988,ClinicalTrials.gov,2020-04-24,2020-05-25,False,Novavax,Not Recruiting,Phase 1/Phase 2,Interventional,"United States, Australia",Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant,ATMP,Vaccine,Vaccine,1419,https://clinicaltrials.gov/show/NCT04368988,None
4032,NCT04369066,ClinicalTrials.gov,2020-04-27,2020-04-28,False,Institut Curie,Recruiting,Not Applicable,Interventional,France,"COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur",Clinical Presentation,No Intervention,No Intervention,2800,https://clinicaltrials.gov/show/NCT04369066,None
4033,NCT04369274,ClinicalTrials.gov,2020-04-23,2020-05-01,False,Massachusetts General Hospital,Not Recruiting,Not Applicable,Interventional,No Country Given,Repeated Measures Trial of Temporary Automated Manual Ventilation Versus Noninvasive Oxygenation or Conventional Vent,Other (physical),Mechanical ventilation,Mechanical ventilation,30,https://clinicaltrials.gov/show/NCT04369274,None
4034,NCT04369300,ClinicalTrials.gov,2020-04-28,2020-04-24,True,Max Healthcare Insititute Limited,Recruiting,Not Applicable,Observational,India,Anxiety And Depression During COVID-19 IN INDIA,Other (psych),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04369300,None
4035,NCT04369365,ClinicalTrials.gov,2020-04-27,2020-04-27,False,Dr. Matthias Preusser,Recruiting,Phase 2,Interventional,Austria,"A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic",Drug (Chemoprophylaxis),Azithromycin,Azithromycin,200,https://clinicaltrials.gov/show/NCT04369365,None
4036,NCT04369378,ClinicalTrials.gov,2020-04-24,2020-08-19,False,Lake Erie College of Osteopathic Medicine,Recruiting,Not Applicable,Interventional,United States,Effectiveness of Using a Meditation App in Reducing Anxiety and Improving Well-being During the Covid-19 Pandemic,Other (psych),Psychological,Psychological,200,https://clinicaltrials.gov/show/NCT04369378,None
4037,NCT04369456,ClinicalTrials.gov,2020-04-27,2020-04-22,True,CHU de Nice,Recruiting,Not Applicable,Interventional,France,Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients,Clinical Presentation,No Intervention,No Intervention,115,https://clinicaltrials.gov/show/NCT04369456,None
4038,NCT04369690,ClinicalTrials.gov,2020-04-20,2020-04-03,True,University of Ottawa,Recruiting,Not Applicable,Observational,Canada,"The Psychological, Social, and Economic Impacts of COVID-19",Other (psych),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04369690,None
4039,NCT04369742,ClinicalTrials.gov,2020-04-25,2020-04-15,True,NYU Langone Health,Not Recruiting,Phase 2,Interventional,United States,Treating COVID-19 With Hydroxychloroquine (TEACH),Drug,Hydroxychloroquine,Hydroxychloroquine,626,https://clinicaltrials.gov/show/NCT04369742,None
4040,NCT04369794,ClinicalTrials.gov,2020-04-27,2020-08-10,False,"University of Campinas, Brazil",Recruiting,Phase 4,Interventional,Brazil,"COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement",ATMP,Vaccine,Vaccine,1000,https://clinicaltrials.gov/show/NCT04369794,None
4041,NCT04369807,ClinicalTrials.gov,2020-04-22,2020-04-21,True,Perspectum,Recruiting,Not Applicable,Observational,United Kingdom,Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection,Clinical Presentation,No Intervention,No Intervention,507,https://clinicaltrials.gov/show/NCT04369807,None
4042,NCT04369820,ClinicalTrials.gov,2020-04-29,2020-03-31,True,Assistance Publique – Hôpitaux de Marseille,Recruiting,Not Applicable,Interventional,France,C5a Receptor Expression - COVID-19 (C5-COV),Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04369820,None
4043,NCT04369859,ClinicalTrials.gov,2020-04-29,2020-04-23,True,Assistance Publique – Hôpitaux de Marseille,Recruiting,Not Applicable,Observational,France,Obstetric and Perinatal Outcomes of Women With COVID-19,Clinical Presentation,No Intervention,No Intervention,1300,https://clinicaltrials.gov/show/NCT04369859,None
4044,NCT04369989,ClinicalTrials.gov,2020-04-28,2020-04-14,True,OSF Healthcare System,Recruiting,Not Applicable,Observational,United States,Observational Study of COVID-19 Treatment Efficacy,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04369989,None
4045,NCT04370015,ClinicalTrials.gov,2020-04-27,2020-05-15,False,"Services Institute of Medical Sciences, Pakistan",Not Recruiting,Not Applicable,Interventional,No Country Given,Hydroxychloroquine Chemoprophylaxis for COVID-19 Infection in High-risk Healthcare Workers.,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,374,https://clinicaltrials.gov/show/NCT04370015,None
4046,NCT04370171,ClinicalTrials.gov,2020-04-27,2020-05-04,False,"University Hospital, Strasbourg",Not Recruiting,Not Applicable,Observational,France,Management of Diabetic Patients With Telemedicine in the Context of the Covid-19 Epidemic,Telehealth,Telehealth,Telehealth,610,https://clinicaltrials.gov/show/NCT04370171,None
4047,NCT04370197,ClinicalTrials.gov,2020-04-29,2020-03-03,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Covid-19 Epidemic on Acute Stroke Management,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04370197,None
4048,NCT04370210,ClinicalTrials.gov,2020-04-29,2020-05-04,False,Centre Hospitalier René Dubos,Not Recruiting,Not Applicable,Observational,France,Sleep Quality During COVID-19 Containment in Children Whether or Not Usually Followed in Child Psychiatry,Other (psych),No Intervention,No Intervention,247,https://clinicaltrials.gov/show/NCT04370210,None
4049,NCT04370223,ClinicalTrials.gov,2020-04-27,2020-05-25,False,Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta,Not Recruiting,Phase 3,Interventional,Spain,Ozone Auto-hemotherapy for COVID-19 Pneumonia,Drug,Ozone,Ozone,208,https://clinicaltrials.gov/show/NCT04370223,None
4050,NCT04370236,ClinicalTrials.gov,2020-04-29,2020-10-21,False,"Inmune Bio, Inc.",Recruiting,Phase 2/Phase 3,Interventional,United States,INB03 for the Treatment of Pulmonary Complications From COVID-19,Drug,XPro1595,XPro1595,366,https://clinicaltrials.gov/show/NCT04370236,None
4051,NCT04370249,ClinicalTrials.gov,2020-04-28,2020-04-09,True,Nantes University Hospital,Recruiting,Not Applicable,Observational,France,Construction of a Composite Clinical-echo Score Predictive of a Risk of Short-term Aggravation of Respiratory Impairment in Patients Suspected of Covid-19,Clinical Presentation,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04370249,None
4052,NCT04370275,ClinicalTrials.gov,2020-04-29,2020-04-23,True,Latisana Hospital,Recruiting,Not Applicable,Observational,Italy,Accuracy of Lung Ultrasound in the Diagnosis of covid19 Pneumonia,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,235,https://clinicaltrials.gov/show/NCT04370275,None
4053,NCT04370288,ClinicalTrials.gov,2020-04-29,2020-04-19,False,Mashhad University of Medical Sciences,Recruiting,Phase 1,Interventional,Iran,Clinical Application of Methylene Blue for Treatment of Covid-19 Patients,Drug,Methylene blue + Vitamin C + N-acetyl cysteine,Methylene blue; Vitamin C; N-acetyl cysteine,20,https://clinicaltrials.gov/show/NCT04370288,IRCT20191228045924N1
4054,NCT04370678,ClinicalTrials.gov,2020-04-24,2020-04-17,True,Region Zealand,Not Recruiting,Not Applicable,Observational,Denmark,Changes in Preference for Surgery of Patients Signed up for Arthroscopic Procedures,Other,No Intervention,No Intervention,79,https://clinicaltrials.gov/show/NCT04370678,None
4055,NCT04370808,ClinicalTrials.gov,2020-04-26,2020-06-01,False,University of Lisbon,Not Recruiting,Not Applicable,Observational,Portugal,VITACOV: Vitamin D Polymorphisms and Severity of COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04370808,None
4056,NCT04370821,ClinicalTrials.gov,2020-04-27,2020-05-09,False,Villanova University,Recruiting,Not Applicable,Observational,United States,"COVID-19 CHAMPS Study of Healthcare, First Responder and Service Workers",Other (psych),No Intervention,No Intervention,20000,https://clinicaltrials.gov/show/NCT04370821,None
4057,NCT04370834,ClinicalTrials.gov,2020-04-30,2020-05-28,False,National Cancer Institute (NCI),Not Recruiting,Phase 2,Interventional,United States,Tocilizumab for Patients With Cancer and COVID-19 Disease,Drug,Tocilizumab,Tocilizumab,217,https://clinicaltrials.gov/show/NCT04370834,None
4058,NCT04370886,ClinicalTrials.gov,2020-04-28,2020-04-30,False,Guangzhou Blood Center,Not Recruiting,Not Applicable,Interventional,China,Recruit Blood Donors Via SMS During Epidemic of COVID-19,Other,No Intervention,No Intervention,456517,https://clinicaltrials.gov/show/NCT04370886,None
4059,NCT04370938,ClinicalTrials.gov,2020-04-29,2020-04-29,False,University of Pittsburgh,Recruiting,Not Applicable,Interventional,United States,Provider Burnout During COVID-19,Other (psych),Psychological,Psychological,250,https://clinicaltrials.gov/show/NCT04370938,None
4060,NCT04371029,ClinicalTrials.gov,2020-04-28,2020-04-28,False,"University Hospital, Bordeaux",Recruiting,Not Applicable,Interventional,France,Impact of Neck Inspiratory Muscle Activation During Sleep in ICU Patients After a COVID 19 ARDS,Other,Polysomnography,Polysomnography,25,https://clinicaltrials.gov/show/NCT04371029,None
4061,NCT04371107,ClinicalTrials.gov,2020-04-27,2020-04-29,False,CHU de Amiens,Not Recruiting,Phase 3,Interventional,France,Proactive Care of Ambulatory COVID19 Patients,Drug,Azithromycin,Azithromycin,64,https://clinicaltrials.gov/show/NCT04371107,None
4062,NCT04371250,ClinicalTrials.gov,2020-04-22,2020-04-30,False,Erasme University Hospital,Not Recruiting,Not Applicable,Observational,Belgium,Study of Resilience and Loneliness in Youth (18 - 25 Years Old) During the COVID-19 Pandemic Lock-down Measures.,Other (psych),No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04371250,None
4063,NCT04371289,ClinicalTrials.gov,2020-04-28,2020-04-01,True,Istituto Auxologico Italiano,Not Recruiting,Not Applicable,Observational,Italy,Predictors of Cardiovascular Risk in Covid-19 Patients During Acute Disease and at Short Term Follow-up,Clinical Presentation,No Intervention,No Intervention,5500,https://clinicaltrials.gov/show/NCT04371289,None
4064,NCT04371302,ClinicalTrials.gov,2020-04-29,2020-05-01,False,University of Malaya,Not Recruiting,Not Applicable,Observational,No Country Given,Nursing Perspective on Burnout and Medical Errors in the Intensive Care Unit During Covid-19 Pandemic,Other (psych),No Intervention,No Intervention,145,https://clinicaltrials.gov/show/NCT04371302,None
4065,NCT04371315,ClinicalTrials.gov,2020-04-24,2020-04-27,False,St. Jude Children's Research Hospital,Recruiting,Not Applicable,Observational,United States,"Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children",Clinical Presentation,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04371315,None
4066,NCT04371328,ClinicalTrials.gov,2020-04-29,2020-03-13,True,"University Hospital, Toulouse",Not Recruiting,Not Applicable,Observational,France,Emergency Management in a Dedicated Respiratory Unit of Patients With a Possible COVID-19 Infection,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1860,https://clinicaltrials.gov/show/NCT04371328,None
4067,NCT04371354,ClinicalTrials.gov,2020-04-28,2020-04-27,True,Fundación Miguel Servet,Recruiting,Not Applicable,Observational,Spain,Outcomes of Covid-19 Protective Measures in Endoscopy,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04371354,None
4068,NCT04371367,ClinicalTrials.gov,2020-04-29,2020-04-27,True,Assistance Publique – Hôpitaux de Marseille,Recruiting,Phase 2,Interventional,France,"Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE )",Drug,Avdoralimab,Avdoralimab,168,https://clinicaltrials.gov/show/NCT04371367,None
4069,NCT04371393,ClinicalTrials.gov,2020-04-28,2020-04-30,False,Icahn School of Medicine at Mount Sinai,Recruiting,Phase 3,Interventional,United States,MSCs in COVID-19 ARDS,ATMP,Cells (mesenchymal),Cells (mesenchymal),300,https://clinicaltrials.gov/show/NCT04371393,None
4070,NCT04371406,ClinicalTrials.gov,2020-04-29,2020-04-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients,Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,0,https://clinicaltrials.gov/show/NCT04371406,None
4071,NCT04371419,ClinicalTrials.gov,2020-04-28,2020-05-13,False,"National Bureau of Economic Research, Inc.",Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Health Messaging to Underserved Communities,Other,Health Education,Health Education,15475,https://clinicaltrials.gov/show/NCT04371419,None
4072,NCT04371471,ClinicalTrials.gov,2020-04-30,2020-03-01,True,Groupe Hospitalier La Rochelle,Not Recruiting,Not Applicable,Observational,France,Covid-19 Pandemic Triage Score,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://clinicaltrials.gov/show/NCT04371471,None
4073,NCT04371510,ClinicalTrials.gov,2020-04-28,2020-04-22,True,CHU de Nice,Recruiting,Not Applicable,Interventional,France,Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients,Clinical Presentation,No Intervention,No Intervention,115,https://clinicaltrials.gov/show/NCT04371510,None
4074,NCT04371523,ClinicalTrials.gov,2020-04-28,2020-05-01,False,St. Joseph's Healthcare Hamilton,Not Recruiting,Phase 3,Interventional,Canada,Hydroxychloroquine to Prevent COVID-19 Disease Amongst Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1100,https://clinicaltrials.gov/show/NCT04371523,None
4075,NCT04371562,ClinicalTrials.gov,2020-04-30,2020-03-01,True,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Not Recruiting,Not Applicable,Observational,Italy,Predicting Death and ICU Admission in COVID-19 Patients in ED,Prognosis,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04371562,None
4076,NCT04371601,ClinicalTrials.gov,2020-03-25,2020-03-01,True,Fuzhou General Hospital,Not Recruiting,Phase 1,Interventional,China,Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019,ATMP (+ Drug),Cells (mesenchymal) + Oseltamivir + Oxygen + Hormones vs. Oseltamivir + Oxygen + Hormones,Cells (mesenchymal); Oseltamivir; Oxygen; Hormones,60,https://clinicaltrials.gov/show/NCT04371601,None
4077,NCT04371679,ClinicalTrials.gov,2020-04-30,2020-04-01,True,Hasselt University,Recruiting,Not Applicable,Observational,Belgium,Changes in Cardiac and Pulmonary Hemodynamics as Predictor of Outcome in Hospitalized COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04371679,None
4078,NCT04371692,ClinicalTrials.gov,2020-04-28,2020-04-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Prevalence of COVID-19 Infection Among HCW in a French University Hospital,Clinical Presentation (Epidemiology),No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04371692,None
4079,NCT04371744,ClinicalTrials.gov,2020-04-30,2020-04-17,True,Assistance Publique – Hôpitaux de Marseille,Not Recruiting,Not Applicable,Observational,France,QT-Logs : Artificial Intelligence for QT Interval Analysis of ECG From Smartwatches in Patient Receiving Treatment for Covid-19,Other (software),Other,Other,100,https://clinicaltrials.gov/show/NCT04371744,None
4080,NCT04371822,ClinicalTrials.gov,2020-04-29,2020-08-01,False,Kafrelsheikh University,Not Recruiting,Phase 1,Interventional,Egypt,Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 Infected Patients,Drug,"SnPP Protoporphyrin, Porphyrin",SnPP Protoporphyrin; Porphyrin,56,https://clinicaltrials.gov/show/NCT04371822,None
4081,NCT04371835,ClinicalTrials.gov,2020-04-28,2020-08-12,False,Kirby Institute,Recruiting,Not Applicable,Observational,Nigeria,COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings,Clinical Presentation,No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04371835,None
4082,NCT04371848,ClinicalTrials.gov,2020-04-22,2020-04-16,True,Laval University,Not Recruiting,Not Applicable,Observational,Canada,Impact of the COVID-19 Pandemic on Diet Quality and Food Insecurity: a NutriQuÃ©bec Sub-study,Other (nutrition),No Intervention,No Intervention,2465,https://clinicaltrials.gov/show/NCT04371848,None
4083,NCT04371926,ClinicalTrials.gov,2020-04-29,2020-06-01,False,Texas Cardiac Arrhythmia Research Foundation,Not Recruiting,Not Applicable,Interventional,No Country Given,Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04371926,None
4084,NCT04371952,ClinicalTrials.gov,2020-04-27,2020-06-01,False,Nantes University Hospital,Not Recruiting,Phase 3,Interventional,France,DYNAMIC Study (DoxycYcliNe AMbulatoIre COVID-19),Drug,Doxycycline,Doxycycline,330,https://clinicaltrials.gov/show/NCT04371952,None
4085,NCT04371965,ClinicalTrials.gov,2020-04-29,2020-09-01,False,Poitiers University Hospital,Not Recruiting,Phase 2,Interventional,France,"Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With COVID-19",Drug,Povidone Iodine,Povidone Iodine,24,https://clinicaltrials.gov/show/NCT04371965,None
4086,NCT04371978,ClinicalTrials.gov,2020-04-30,2020-10-01,False,Rabin Medical Center,Recruiting,Phase 3,Interventional,Israel,Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients With Established COVID-19,Drug,Linagliptin,Linagliptin,100,https://clinicaltrials.gov/show/NCT04371978,None
4087,NCT04372004,ClinicalTrials.gov,2020-04-29,2020-05-08,False,Texas Cardiac Arrhythmia Research Foundation,Recruiting,Phase 1,Interventional,United States,Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04372004,None
4088,NCT04372017,ClinicalTrials.gov,2020-04-25,2020-05-14,False,Sanford Health,Not Recruiting,Phase 3,Interventional,United States,Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1,https://clinicaltrials.gov/show/NCT04372017,None
4089,NCT04372030,ClinicalTrials.gov,2020-04-22,2020-05-01,False,UCLouvain,Not Recruiting,Not Applicable,Interventional,No Country Given,Health Care Use During the Covid19 Crisis,Health System,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04372030,None
4090,NCT04372043,ClinicalTrials.gov,2020-04-29,2020-04-30,False,Saint-Joseph University,Not Recruiting,Not Applicable,Observational,Lebanon,Evaluation of the Sleep Hygiene in the Lebanese Population During the COVID-19 Confinement Period.,Other (psych),No Intervention,No Intervention,1200,https://clinicaltrials.gov/show/NCT04372043,None
4091,NCT04372056,ClinicalTrials.gov,2020-04-29,2020-05-06,False,Oslo University Hospital,Recruiting,Not Applicable,Observational,Norway,The COVID-ICU Healthcare Professional Study,Other,No Intervention,No Intervention,2200,https://clinicaltrials.gov/show/NCT04372056,None
4092,NCT04372082,ClinicalTrials.gov,2020-04-30,2020-05-01,False,"University Hospital, Lille",Not Recruiting,Phase 3,Interventional,No Country Given,Hydroxychloroquine or Diltiazem-Niclosamide for the Treatment of COVID-19,Drug,Hydroxychloroquine vs. Diltiazem/Niclosamide,Hydroxychloroquine; Diltiazem/Niclosamide,480,https://clinicaltrials.gov/show/NCT04372082,None
4093,NCT04372186,ClinicalTrials.gov,2020-04-29,2020-05-14,True,"Genentech, Inc.",Not Recruiting,Phase 3,Interventional,"Kenya, Mexico, Brazil, Peru, United States, South Africa",A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia,Drug,Tocilizumab,Tocilizumab,379,https://clinicaltrials.gov/show/NCT04372186,PER-027-20
4094,NCT04372199,ClinicalTrials.gov,2020-04-29,2020-04-29,False,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Recruiting,Not Applicable,Observational,Italy,SEVERITY SCORE FOR COVID-19 PNEUMONIA,Clinical Presentation,No Intervention,No Intervention,248,https://clinicaltrials.gov/show/NCT04372199,None
4095,NCT04372368,ClinicalTrials.gov,2020-04-29,2019-06-19,True,"University of Colorado, Denver",Not Recruiting,Not Applicable,Expanded Access,United States,Convalescent Plasma for the Treatment of Patients With COVID-19,ATMP,Plasma,Plasma,Not Available,https://clinicaltrials.gov/show/NCT04372368,None
4096,NCT04372472,ClinicalTrials.gov,2020-04-29,2020-04-07,True,"Cytovale, Inc.",Not Recruiting,Not Applicable,Observational,United States,SQuISH-COVID: A Pilot Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,300,https://clinicaltrials.gov/show/NCT04372472,None
4097,NCT04372576,ClinicalTrials.gov,2020-04-29,2020-04-16,True,Semmelweis University,Recruiting,Not Applicable,Observational,Hungary,Epidemiology and Outcome of Ventilator-associated Pneumonia Among Critically Ill COVID-19 Patients,Clinical Presentation (Epidemiology),No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04372576,None
4098,NCT04372589,ClinicalTrials.gov,2020-04-24,2020-05-20,False,University of Manitoba,Recruiting,Phase 2/Phase 3,Interventional,"United States, Canada, Mexico, Brazil",Antithrombotic Therapy to Ameliorate Complications of COVID-19 ( ATTACC ),Drug,Heparin,Heparin,3000,https://clinicaltrials.gov/show/NCT04372589,None
4099,NCT04372602,ClinicalTrials.gov,2020-04-30,2020-10-12,False,Washington University in St. Louis,Recruiting,Phase 2,Interventional,United States,Duvelisib to Combat COVID-19,Drug,Duvelisib,Duvelisib,28,https://clinicaltrials.gov/show/NCT04372602,None
4100,NCT04372628,ClinicalTrials.gov,2020-04-30,2020-06-01,False,Vanderbilt University,Recruiting,Phase 2,Interventional,United States,Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19,Drug,Hydroxychloroquein vs. Lopinavir/ritonavir,Hydroxychloroquein; Lopinavir/ritonavir,600,https://clinicaltrials.gov/show/NCT04372628,None
4101,NCT04372680,ClinicalTrials.gov,2020-04-30,2020-04-22,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Interventional,France,WeanINg From Mechanical Ventilation for ARDS CovId-19 Patients Guided by Combined Thoracic UltraSound,Other (physical),Mechanical ventilation,Mechanical ventilation,200,https://clinicaltrials.gov/show/NCT04372680,None
4102,NCT04372693,ClinicalTrials.gov,2020-04-27,2020-09-01,False,Cairo University,Recruiting,Not Applicable,Interventional,Egypt,Unplanned Shifting to Online Distance Learning: Nursing Students' Perception and Achievement,Other,Other,Other,180,https://clinicaltrials.gov/show/NCT04372693,None
4103,NCT04372979,ClinicalTrials.gov,2020-04-24,2020-09-14,False,Direction Centrale du Service de Sant des Armes,Recruiting,Phase 3,Interventional,France,Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients.,ATMP,Plasma,Plasma,80,https://clinicaltrials.gov/show/NCT04372979,None
4104,NCT04373005,ClinicalTrials.gov,2020-04-30,2020-05-11,False,"University Health Network, Toronto",Not Recruiting,Not Applicable,Observational,Canada,Screening of Cancer Patients to Assess Impact of COVID-19,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04373005,None
4105,NCT04373044,ClinicalTrials.gov,2020-04-17,2020-05-01,False,University of Southern California,Recruiting,Phase 2,Interventional,United States,"Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19",Drug,Baricitinib + one of Hydroxychloroquine or Lopinavir/ritonavir or Remdesivir,Baricitinib; Hydroxychloroquine; Lopinavir/ritonavir; Remdesivir,144,https://clinicaltrials.gov/show/NCT04373044,None
4106,NCT04373096,ClinicalTrials.gov,2020-04-30,2020-06-01,False,"University Health Network, Toronto",Not Recruiting,Not Applicable,Interventional,No Country Given,Enhanced Hood PPE to Minimize COVID-19 Transmission to Front-line Health Care Workers,Other (device),Hood,Hood,42,https://clinicaltrials.gov/show/NCT04373096,None
4107,NCT04373109,ClinicalTrials.gov,2020-04-16,2020-04-16,False,Jeremia Held,Not Recruiting,Not Applicable,Observational,Switzerland,Stroke Rehabilitation Outcome During COVID-19 Lockdown,Clinical Presentation,No Intervention,No Intervention,36,https://clinicaltrials.gov/show/NCT04373109,None
4108,NCT04373135,ClinicalTrials.gov,2020-04-30,2020-05-08,False,"University of California, Los Angeles",Not Recruiting,Not Applicable,Interventional,United States,"Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19",Other,Other,Other,2500,https://clinicaltrials.gov/show/NCT04373135,None
4109,NCT04373148,ClinicalTrials.gov,2020-04-30,2020-04-08,True,Stanford University,Recruiting,Not Applicable,Observational,United States,"Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19",Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04373148,None
4110,NCT04373161,ClinicalTrials.gov,2020-04-30,2020-03-20,True,Swedish Hospital,Not Recruiting,Not Applicable,Interventional,United States,Home Pulse Oximeter Use in Patients With COVID-19,Other (device),Biosensors,Biosensors,209,https://clinicaltrials.gov/show/NCT04373161,None
4111,NCT04373200,ClinicalTrials.gov,2020-04-22,2020-05-25,False,Rennes University Hospital,Recruiting,Not Applicable,Interventional,France,Human Ab Response & immunoMONItoring of COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,75,https://clinicaltrials.gov/show/NCT04373200,None
4112,NCT04373213,ClinicalTrials.gov,2020-04-30,2020-05-05,False,Erzincan University,Not Recruiting,Not Applicable,Observational,Turkey,Evaluation of the Fluid Response of SARS-CoV-2 (COVID-19) Patients in Intensive Care; Pleth Variability Index,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,30,https://clinicaltrials.gov/show/NCT04373213,None
4113,NCT04373291,ClinicalTrials.gov,2020-05-01,2020-05-18,True,Bandim Health Project,Recruiting,Phase 3,Interventional,Denmark,Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic,ATMP,Vaccine,Vaccine,1500,https://clinicaltrials.gov/show/NCT04373291,EUCTR2020-001888-90
4114,NCT04373382,ClinicalTrials.gov,2020-04-30,2020-07-27,False,"Mount Sinai Hospital, Canada",Not Recruiting,Not Applicable,Interventional,Canada,Peer Champion Support for Hospital Staff During and After the COVID-19 Pandemic,Other (psych),Psychological,Psychological,882,https://clinicaltrials.gov/show/NCT04373382,None
4115,NCT04373460,ClinicalTrials.gov,2020-04-30,2020-06-03,False,Johns Hopkins University,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma to Limit SARS-CoV-2 Associated Complications,ATMP,Plasma,Plasma,1344,https://clinicaltrials.gov/show/NCT04373460,None
4116,NCT04373486,ClinicalTrials.gov,2020-04-30,2020-03-03,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Incidence of Acute Pulmonary Embolism in Covid-19 Patients on CT Angiography and Relationship to D-dimer Levels,Clinical Presentation (Epidemiology),No Intervention,No Intervention,160,https://clinicaltrials.gov/show/NCT04373486,None
4117,NCT04373707,ClinicalTrials.gov,2020-05-01,2020-05-13,False,CHU de Nancy,Recruiting,Phase 4,Interventional,France,Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19,Drug,Heparin,Heparin,602,https://clinicaltrials.gov/show/NCT04373707,None
4118,NCT04373733,ClinicalTrials.gov,2020-05-01,2020-05-01,True,Chelsea and Westminster Hospital NHS Foundation Trust,Recruiting,Phase 3,Interventional,United Kingdom,Early Intervention in COVID-19: Favipiravir Verses Standard Care,Drug,Favipiravir vs. Hydroxychloroquine + Azithromycin + Zinc,Favipiravir; Hydroxychloroquine; Azithromycin; Zinc,450,https://clinicaltrials.gov/show/NCT04373733,EUCTR2020-001449-38
4119,NCT04373798,ClinicalTrials.gov,2020-05-01,2020-05-04,False,Henning Bliddal,Recruiting,Not Applicable,Observational,Denmark,C-reactive Protein Levels Among Individuals With COVID-19,Clinical Presentation,No Intervention,No Intervention,3000,https://clinicaltrials.gov/show/NCT04373798,None
4120,NCT04373811,ClinicalTrials.gov,2020-04-26,2020-04-16,True,Groupe Hospitalier Paris Saint-Joseph,Not Recruiting,Not Applicable,Observational,France,One-Year Quality of Life and Functional Prognosis of COVID-19 Patients in Post-ICU Setting,Prognosis,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04373811,None
4121,NCT04373824,ClinicalTrials.gov,2020-04-26,2020-04-25,True,Max Healthcare Insititute Limited,Recruiting,Not Applicable,Interventional,India,Max Ivermectin- COVID 19 Study Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study,Drug,Ivermectin,Ivermectin,50,https://clinicaltrials.gov/show/NCT04373824,None
4122,NCT04373889,ClinicalTrials.gov,2020-04-13,2020-04-22,False,Sciensano,Not Recruiting,Not Applicable,Observational,Belgium,COVID-19 Among Healthcare Workers in Belgian Hospitals,Clinical Presentation (Epidemiology),No Intervention,No Intervention,850,https://clinicaltrials.gov/show/NCT04373889,None
4123,NCT04374019,ClinicalTrials.gov,2020-05-01,2020-05-01,False,Susanne Arnold,Recruiting,Phase 2,Interventional,United States,Novel Agents for Treatment of High-risk COVID-19 Positive Patients,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Ivermectin vs. Hydroxychloroquine vs. Camostat Mesilate,Azithromycin; Hydroxychloroquine; Ivermectin; Camostat Mesilate,240,https://clinicaltrials.gov/show/NCT04374019,None
4124,NCT04374032,ClinicalTrials.gov,2020-04-30,2020-05-01,False,Bosnalijek D.D,Not Recruiting,Phase 2/Phase 3,Interventional,Bosnia and Herzegovina,Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection,Drug,Metenkefalin + Tridecactide,Metenkefalin; Tridecactide,120,https://clinicaltrials.gov/show/NCT04374032,None
4125,NCT04374045,ClinicalTrials.gov,2020-04-30,2020-04-30,False,CHU de Saint Etienne,Recruiting,Not Applicable,Observational,France,Testing for Dysautonomia in Patients Hospitalized for SARS-CoV-2 Infection (COVID-19) : COVIDANS Study,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04374045,None
4126,NCT04374058,ClinicalTrials.gov,2020-05-01,2020-03-20,True,Dialisis Madariaga,Not Recruiting,Not Applicable,Observational,Argentina,Less Frequency Hemodialysis and COVID-19,Other,Other,Other,50,https://clinicaltrials.gov/show/NCT04374058,None
4127,NCT04374071,ClinicalTrials.gov,2020-04-30,2020-03-12,True,Henry Ford Health System,Not Recruiting,Not Applicable,Observational,United States,Early Short Course Corticosteroids in COVID-19,Drug,Corticosteroids,Methylprednisolone,250,https://clinicaltrials.gov/show/NCT04374071,None
4128,NCT04374084,ClinicalTrials.gov,2020-04-20,2020-05-10,False,"Guang'anmen Hospital, China Academy of Chinese Medical Sciences",Recruiting,Not Applicable,Interventional,China,Moxibustion Plus Cupping in Convalescent Patients With COVID-19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,60,https://clinicaltrials.gov/show/NCT04374084,None
4129,NCT04374097,ClinicalTrials.gov,2020-05-02,2020-03-31,True,University of Oslo,Not Recruiting,Not Applicable,Observational,Norway,Level and Predictors of Trauma-symptoms Among Health Workers and Public Service Providers During the COVID-19 Outbreak,Other (psych),No Intervention,No Intervention,1778,https://clinicaltrials.gov/show/NCT04374097,None
4130,NCT04374110,ClinicalTrials.gov,2020-04-22,2020-05-05,False,"Institute of Cardiology, Warsaw",Recruiting,Not Applicable,Observational,Poland,Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04374110,None
4131,NCT04374123,ClinicalTrials.gov,2020-04-20,2020-04-20,False,Instituto Ecuatoriano de Enfermedades Digestivas,Not Recruiting,Not Applicable,Observational,Ecuador,COVID-19 Serology Screening and Strict Protocol in the Endoscopy Unit,Clinical Presentation (Epidemiology),No Intervention,No Intervention,111,https://clinicaltrials.gov/show/NCT04374123,None
4132,NCT04374149,ClinicalTrials.gov,2020-04-20,2020-04-30,False,Prisma Health-Upstate,Not Recruiting,Phase 2,Interventional,United States,Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS,ATMP (+ Drug),Plasma vs. Plasma + Ruxolitinib,Plasma; Ruxolitinib,20,https://clinicaltrials.gov/show/NCT04374149,None
4133,NCT04374370,ClinicalTrials.gov,2020-05-01,2017-03-20,True,AdventHealth,Not Recruiting,Not Applicable,Expanded Access,United States,SARSCoV2 (COVID-19) Convalescent Plasma (CP) Expanded Access Protocol (EAP),ATMP,Plasma,Plasma,Not Available,https://clinicaltrials.gov/show/NCT04374370,None
4134,NCT04374422,ClinicalTrials.gov,2020-04-29,2020-04-10,True,Acibadem University,Not Recruiting,Not Applicable,Observational,Turkey,COVID-19 Pandemic and Female Sexual Behavior,Other,No Intervention,No Intervention,58,https://clinicaltrials.gov/show/NCT04374422,None
4135,NCT04374461,ClinicalTrials.gov,2020-05-01,2020-05-01,True,Memorial Sloan Kettering Cancer Center,Recruiting,Phase 2,Interventional,United States,A Study of N-acetylcysteine in Patients With COVID-19 Infection,Drug,N-acetylcysteine,N-acetylcysteine,84,https://clinicaltrials.gov/show/NCT04374461,CTRI/2020/06/026194
4136,NCT04374474,ClinicalTrials.gov,2020-04-29,2021-01-10,False,Lawson Health Research Institute,Not Recruiting,Phase 4,Interventional,Canada,Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19),Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,0,https://clinicaltrials.gov/show/NCT04374474,None
4137,NCT04374487,ClinicalTrials.gov,2020-04-29,2020-05-09,False,Max Healthcare Insititute Limited,Not Recruiting,Phase 2,Interventional,India,Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04374487,None
4138,NCT04374513,ClinicalTrials.gov,2020-05-02,2020-05-02,False,Damanhour University,Recruiting,Not Applicable,Observational,Egypt,Community Pharmacists Behaviour During Covid-19,Health System,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04374513,None
4139,NCT04374526,ClinicalTrials.gov,2020-05-02,2020-05-27,False,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Recruiting,Phase 2/Phase 3,Interventional,Italy,Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression.,ATMP,Plasma,Plasma,182,https://clinicaltrials.gov/show/NCT04374526,None
4140,NCT04374539,ClinicalTrials.gov,2020-05-02,2020-04-29,True,Fundació Clínic per a la Recerca Biomèdica,Recruiting,Phase 2,Interventional,Spain,Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial,ATMP,Plasma,Plasma,116,https://clinicaltrials.gov/show/NCT04374539,None
4141,NCT04374552,ClinicalTrials.gov,2020-05-02,2020-05-05,False,Rutgers University,Not Recruiting,Phase 2,Interventional,United States,Asymptomatic COVID-19 Trial,Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,0,https://clinicaltrials.gov/show/NCT04374552,None
4142,NCT04374565,ClinicalTrials.gov,2020-04-27,2020-05-05,False,University of Virginia,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia,ATMP,Plasma,Plasma,29,https://clinicaltrials.gov/show/NCT04374565,None
4143,NCT04374591,ClinicalTrials.gov,2020-05-02,2020-08-01,False,Mansoura University,Not Recruiting,Not Applicable,Interventional,Egypt,The Role of Sodium Bicarbonate as Adjuvant Treatment of Computed Tomography Identified COVID-19 Pneumonia,Drug,Sodium Bicarbonate,Sodium Bicarbonate,180,https://clinicaltrials.gov/show/NCT04374591,None
4144,NCT04374617,ClinicalTrials.gov,2020-05-02,2020-04-01,True,Vall d'Hebron Research Institute (VHIR),Not Recruiting,Not Applicable,Observational,Spain,Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19,Clinical Presentation,No Intervention,No Intervention,230,https://clinicaltrials.gov/show/NCT04374617,None
4145,NCT04374643,ClinicalTrials.gov,2020-04-30,2020-04-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Descriptive Study of the PSYchological Impact of CONFinement Measures in the General Population,Other (psych),No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04374643,None
4146,NCT04374656,ClinicalTrials.gov,2020-05-01,2020-05-18,False,Johns Hopkins University,Recruiting,Not Applicable,Observational,United States,Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic,Clinical Presentation (Epidemiology),No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04374656,None
4147,NCT04374695,ClinicalTrials.gov,2020-05-03,2020-05-01,True,Versailles Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,"Renin-Angiotensin-Aldosterone System Inhibitors, Hypertension, and COVID-19",Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,700,https://clinicaltrials.gov/show/NCT04374695,None
4148,NCT04374786,ClinicalTrials.gov,2020-05-01,2020-05-15,False,University of Arizona,Recruiting,Not Applicable,Interventional,United States,Effects of Mobile App in House Staff Health and Well-being During COVID-19 Pandemic,Other (psych),Psychological,Psychological,328,https://clinicaltrials.gov/show/NCT04374786,None
4149,NCT04374838,ClinicalTrials.gov,2020-05-01,2020-05-15,False,South Egypt Cancer Institute,Recruiting,Not Applicable,Observational,Egypt,Effect of COVID-19 Pandemic on Pediatric Cancer Care,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04374838,None
4150,NCT04374903,ClinicalTrials.gov,2020-05-03,2020-05-01,True,King Hussein Cancer Center,Not Recruiting,Not Applicable,Interventional,Jordan,Hydroxychloroquine in Combination With Azithromycin or Sirolimus for Treating COVID-19 Patients,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Sirolimus,Azithromycin; Hydroxychloroquine; Sirolimus,58,https://clinicaltrials.gov/show/NCT04374903,None
4151,NCT04374942,ClinicalTrials.gov,2020-04-30,2020-04-30,True,Megan Landes,Recruiting,Phase 3,Interventional,Canada,Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus?,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,988,https://clinicaltrials.gov/show/NCT04374942,ISRCTN14326006
4152,NCT04375046,ClinicalTrials.gov,2020-05-01,2020-09-01,False,Kafrelsheikh University,Not Recruiting,Phase 1,Interventional,No Country Given,Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP Could be Promising COVID-19 Infection- and Lung Injury Preventing Drug Better Than Recombinant Human ACE2,Drug,ACE enzyme,ACE enzyme,24,https://clinicaltrials.gov/show/NCT04375046,None
4153,NCT04375098,ClinicalTrials.gov,2020-05-03,2020-05-04,False,Pontificia Universidad Católica de Chile,Not Recruiting,Phase 2,Interventional,Chile,Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection,ATMP,Plasma,Plasma,58,https://clinicaltrials.gov/show/NCT04375098,None
4154,NCT04375124,ClinicalTrials.gov,2020-05-01,2020-04-25,True,Kanuni Sultan Suleyman Training and Research Hospital,Recruiting,Not Applicable,Interventional,Turkey,Treatment of Angiotensin Peptide (1-7) for COVID-19,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04375124,None
4155,NCT04375137,ClinicalTrials.gov,2020-05-03,2020-04-20,True,Shahid Beheshti University of Medical Sciences,Recruiting,Not Applicable,Observational,Iran,Correlation Between Oxidative Stress Status and COVID-19 Severity,Clinical Presentation,No Intervention,No Intervention,90,https://clinicaltrials.gov/show/NCT04375137,None
4156,NCT04375176,ClinicalTrials.gov,2020-05-03,2020-04-27,True,Università degli Studi dell'Insubria,Recruiting,Not Applicable,Observational,Italy,Monocytes and NK Cells Activity in Covid-19 Patients,Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04375176,None
4157,NCT04375202,ClinicalTrials.gov,2020-04-29,2020-04-18,False,University of Perugia,Recruiting,Phase 2,Interventional,Italy,Colchicine in COVID-19: a Pilot Study,Drug,Colchicine,Colchicine,308,https://clinicaltrials.gov/show/NCT04375202,EUCTR2020-001475-33
4158,NCT04375397,ClinicalTrials.gov,2020-05-04,2020-06-06,False,AbbVie,Recruiting,Phase 2,Interventional,United States,Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury,Drug,Ibrutinib,Ibrutinib,46,https://clinicaltrials.gov/show/NCT04375397,None
4159,NCT04375410,ClinicalTrials.gov,2020-04-30,2020-04-22,True,Vendsyssel Hospital,Recruiting,Not Applicable,Observational,Denmark,Consequences of Intensified Handwash and Hand Disinfection Among Children During the COVID19 Pandemic,Procedure,Hand washing,Hand washing,7000,https://clinicaltrials.gov/show/NCT04375410,None
4160,NCT04375501,ClinicalTrials.gov,2020-05-04,2020-02-01,True,Barts & The London NHS Trust,Not Recruiting,Not Applicable,Observational,United Kingdom,A Study of Outcomes in Patients With Fractured Neck of Femur During the COVID-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,442,https://clinicaltrials.gov/show/NCT04375501,None
4161,NCT04375644,ClinicalTrials.gov,2020-05-04,2020-05-11,False,Hospices Civils de Lyon,Not Recruiting,Not Applicable,Observational,France,Impact of the COVID-19 Pandemic on the Quality of Psychological Life (COVID-PRO-IMPACT),Other (psych),No Intervention,No Intervention,1800,https://clinicaltrials.gov/show/NCT04375644,None
4162,NCT04375670,ClinicalTrials.gov,2020-04-28,2020-05-11,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Observational,France,COVID19-FOIE National Observatory,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04375670,None
4163,NCT04375709,ClinicalTrials.gov,2020-05-04,2020-03-15,True,Kantonsspital Winterthur (KSW),Recruiting,Not Applicable,Observational,Switzerland,Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19);,Other (exercise),Exercise,Exercise,60,https://clinicaltrials.gov/show/NCT04375709,None
4164,NCT04375735,ClinicalTrials.gov,2020-04-22,2020-07-01,False,Lawson Health Research Institute,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,London's Exogenous Surfactant Study for COVID19,Drug,Bovine Lipid Extract Surfactant,Bovine Lipid Extract Surfactant,20,https://clinicaltrials.gov/show/NCT04375735,None
4165,NCT04375748,ClinicalTrials.gov,2020-04-21,2020-04-15,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Observational,"France, RÃ©union, Martinique, Mayotte",Hospital Registry of Acute Myocarditis: Evolution of the Proportion of Positive SARS-COV-2 (COVID19) Cases,Clinical Presentation (Epidemiology),No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04375748,None
4166,NCT04375761,ClinicalTrials.gov,2020-04-30,2020-05-01,False,National Institute of Allergy and Infectious Diseases (NIAID),Not Recruiting,Not Applicable,Observational,United States,COVID-19: Human Epidemiology and Response to SARS-CoV-2,Clinical Presentation (Epidemiology),No Intervention,No Intervention,5605,https://clinicaltrials.gov/show/NCT04375761,None
4167,NCT04375774,ClinicalTrials.gov,2020-04-17,2020-05-01,False,"University Clinic, UCLouvain",Recruiting,Not Applicable,Interventional,Belgium,Verification of Alternative Do-it-yourself Equipment Respirators for the COVID-19 Personal Protective Equipment (PPE),Other (device),Masks,Masks,10,https://clinicaltrials.gov/show/NCT04375774,None
4168,NCT04376034,ClinicalTrials.gov,2020-04-19,2020-04-16,True,West Virginia University,Recruiting,Phase 3,Interventional,United States,Convalescent Plasma Collection and Treatment in Pediatrics and Adults,ATMP,Plasma,Plasma,240,https://clinicaltrials.gov/show/NCT04376034,None
4169,NCT04376398,ClinicalTrials.gov,2020-05-04,2020-04-06,True,"University Clinic, UCLouvain",Not Recruiting,Not Applicable,Observational,Belgium,Survey: COVID-19 Patients Managed in the Operating Theatre of Belgian Hospitals,Health System,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04376398,None
4170,NCT04376476,ClinicalTrials.gov,2020-04-28,2020-05-05,False,Hospices Civils de Lyon,Recruiting,Not Applicable,Interventional,France,Host-pathogen Interactions During SARS-CoV-2 Infection,Clinical Presentation,No Intervention,No Intervention,450,https://clinicaltrials.gov/show/NCT04376476,None
4171,NCT04376515,ClinicalTrials.gov,2020-03-31,2020-03-20,True,"University of California, Irvine",Not Recruiting,Not Applicable,Interventional,United States,Harnessing Online Peer Education Online Support Intervention for COVID-19 (HOPE COVID-19),Other (psych),Psychological,Psychological,300,https://clinicaltrials.gov/show/NCT04376515,None
4172,NCT04376580,ClinicalTrials.gov,2020-04-30,2020-04-30,False,Tiva Group,Recruiting,Not Applicable,Observational,Argentina,Use of the Nasal Cannula During COVID-19,Other (device),Nasal cannula,Nasal cannula,100,https://clinicaltrials.gov/show/NCT04376580,None
4173,NCT04376593,ClinicalTrials.gov,2020-05-03,2020-05-01,True,"University of California, Davis",Recruiting,Phase 1,Interventional,United States,PET/CT Imaging in COVID-19 Patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,10,https://clinicaltrials.gov/show/NCT04376593,None
4174,NCT04376658,ClinicalTrials.gov,2020-05-04,2020-06-15,False,Hospital Moinhos de Vento,Not Recruiting,Not Applicable,Observational,No Country Given,Quality of Life and Patient-centered Outcomes After Hospitalization for COVID-19,Other,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04376658,None
4175,NCT04376710,ClinicalTrials.gov,2020-05-04,2020-07-01,False,"University of Colorado, Denver",Not Recruiting,Not Applicable,Observational,United States,Surgical Telemedicine in the COVID-19 Pandemic Era,Telehealth,Telehealth,Telehealth,180,https://clinicaltrials.gov/show/NCT04376710,None
4176,NCT04376775,ClinicalTrials.gov,2020-05-04,2020-05-11,False,"University Hospital, Bordeaux",Not Recruiting,Not Applicable,Observational,France,Assessment of the Impact of COVID-19 on Transplant Patients and on Patients Awaiting Transplantation,Clinical Presentation,No Intervention,No Intervention,3602,https://clinicaltrials.gov/show/NCT04376775,None
4177,NCT04376788,ClinicalTrials.gov,2020-05-01,2020-05-20,False,Ain Shams University,Recruiting,Phase 2,Interventional,Egypt,Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19,ATMP (+ Drug),Plasma + Methylene Blue,Plasma; Methylene Blue,15,https://clinicaltrials.gov/show/NCT04376788,None
4178,NCT04376814,ClinicalTrials.gov,2020-05-03,2020-03-29,True,Baqiyatallah Medical Sciences University,Not Recruiting,Not Applicable,Interventional,Iran,Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19,Drug,Favipiravir + Hydroxychloroquine vs. Lopinavir/ritonavir + Hydroxychloroquine,Favipiravir; Hydroxychloroquine; Lopinavir/ritonavir,40,https://clinicaltrials.gov/show/NCT04376814,None
4179,NCT04376840,ClinicalTrials.gov,2020-05-04,2020-05-28,False,CHU de Reims,Recruiting,Not Applicable,Interventional,France,Prevalence of Long-term Respiratory Complications of Severe SARS-CoV-2 Pneumonia - COVID-19,Clinical Presentation,No Intervention,No Intervention,270,https://clinicaltrials.gov/show/NCT04376840,None
4180,NCT04376853,ClinicalTrials.gov,2020-04-20,2020-04-15,True,"University Hospital, Heidelberg",Recruiting,Not Applicable,Observational,Germany,CoronaWatch - Early Detection of Cardiovascular Risks in COVID-19 Via SmartWatch,Other (device),Biosensors,Biosensors,50,https://clinicaltrials.gov/show/NCT04376853,None
4181,NCT04376879,ClinicalTrials.gov,2020-05-04,2020-05-16,False,CHU de Nancy,Recruiting,Not Applicable,Observational,France,Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19),Prognosis,No Intervention,No Intervention,384,https://clinicaltrials.gov/show/NCT04376879,None
4182,NCT04376905,ClinicalTrials.gov,2020-04-16,2020-04-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Extra Vascular Lung Water and Pulmonary Permeability in Critically Ill Patients With SARS-CoV-2 (COVID-19),Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04376905,None
4183,NCT04376944,ClinicalTrials.gov,2020-05-04,2020-04-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Barrier Measures to Limit Covid-19.Nosocomial Transmission: a Cross-sectional Evaluation,Other,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04376944,None
4184,NCT04376996,ClinicalTrials.gov,2020-05-04,2020-04-20,True,University of Ljubljana,Recruiting,Not Applicable,Observational,Slovenia,Slovenian National COVID-19 Prevalence Study,Clinical Presentation (Epidemiology),No Intervention,No Intervention,3000,https://clinicaltrials.gov/show/NCT04376996,None
4185,NCT04377035,ClinicalTrials.gov,2020-05-01,2020-03-31,True,"Copenhagen University Hospital, Gentofte",Recruiting,Not Applicable,Observational,Denmark,The Role of Ultrasound in COVID-19,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04377035,None
4186,NCT04377074,ClinicalTrials.gov,2020-05-04,2020-03-31,True,University of Oslo,Not Recruiting,Not Applicable,Observational,Norway,Parental Stress During the COVID-19 Pandemic and Its Association With Depression and Anxiety,Other (psych),No Intervention,No Intervention,2880,https://clinicaltrials.gov/show/NCT04377074,None
4187,NCT04377165,ClinicalTrials.gov,2020-05-04,2020-05-06,False,University of Queensland,Not Recruiting,Not Applicable,Interventional,No Country Given,Innovative Tool to Limit Spread of SARS-CoV-2 (COVID 19) in Residential Aged Care Facilities,Other,Other,Other,34,https://clinicaltrials.gov/show/NCT04377165,None
4188,NCT04377308,ClinicalTrials.gov,2020-04-18,2020-05-01,False,University of Toledo,Recruiting,Phase 4,Interventional,United States,Fluoxetine to Reduce Intubation and Death After COVID19 Infection,Drug,Fluoxetine,Fluoxetine,2000,https://clinicaltrials.gov/show/NCT04377308,None
4189,NCT04377334,ClinicalTrials.gov,2020-04-16,2020-10-01,False,"University Hospital, Tübingen",Not Recruiting,Phase 2,Interventional,Germany,Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS),ATMP,Cells (mesenchymal),Cells (mesenchymal),40,https://clinicaltrials.gov/show/NCT04377334,None
4190,NCT04377412,ClinicalTrials.gov,2020-05-02,2020-05-01,True,"Zelazna Medical Centre, LLC",Recruiting,Not Applicable,Observational,"Norway, Sweden, Taiwan, Albania, Germany, Israel, Italy, France, Hong Kong, Lebanon, Poland, United States, Australia, Czech Republic, Spain",Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,8500,https://clinicaltrials.gov/show/NCT04377412,None
4191,NCT04377425,ClinicalTrials.gov,2020-04-29,2020-05-07,False,Aarhus University Hospital,Not Recruiting,Not Applicable,Observational,Denmark,COVID-19 Prevalence and Cognitive Deficits in Neurological Patients,Clinical Presentation,No Intervention,No Intervention,0,https://clinicaltrials.gov/show/NCT04377425,None
4192,NCT04377464,ClinicalTrials.gov,2020-05-04,2020-05-05,False,Chinese University of Hong Kong,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 - Quality of Life After Infection,Other,Other,Other,200,https://clinicaltrials.gov/show/NCT04377464,None
4193,NCT04377477,ClinicalTrials.gov,2020-05-04,2020-05-10,False,Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia,Recruiting,Not Applicable,Interventional,Italy,COVID-19 Pneumonitis Low Dose Lung Radiotherapy (COLOR-19),Other,Radiation,Radiation,30,https://clinicaltrials.gov/show/NCT04377477,None
4194,NCT04377490,ClinicalTrials.gov,2020-05-05,2020-05-04,True,CHU de Amiens,Recruiting,Not Applicable,Observational,France,Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04377490,None
4195,NCT04377503,ClinicalTrials.gov,2020-05-02,2020-05-01,True,Hospital Sao Domingos,Not Recruiting,Phase 2,Interventional,No Country Given,Tocilizumab Versus Methylprednisolone in the Cytokine Release Syndrome of Patients With COVID-19,Drug,Tocilizumab vs. Corticosteroids,Tocilizumab; Methylprednisolone,40,https://clinicaltrials.gov/show/NCT04377503,None
4196,NCT04377568,ClinicalTrials.gov,2020-04-30,2020-10-07,False,The Hospital for Sick Children,Recruiting,Phase 2,Interventional,Canada,Efficacy of Human Coronavirus-immune Convalescent Plasma for the Treatment of COVID-19 Disease in Hospitalized Children,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04377568,None
4197,NCT04377581,ClinicalTrials.gov,2020-04-30,2020-04-09,True,Milton S. Hershey Medical Center,Not Recruiting,Not Applicable,Observational,United States,"COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior",Other,No Intervention,No Intervention,18251,https://clinicaltrials.gov/show/NCT04377581,None
4198,NCT04377607,ClinicalTrials.gov,2020-05-04,2020-11-01,False,Nevsehir Public Hospital,Recruiting,Not Applicable,Observational,Turkey,Haemoglobin Concentration on COVID-19,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04377607,None
4199,NCT04377620,ClinicalTrials.gov,2020-05-04,2020-05-24,False,Incyte Corporation,Recruiting,Phase 3,Interventional,"United States, Russian Federation",Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT),Drug,Ruxolitinib,Ruxolitinib,500,https://clinicaltrials.gov/show/NCT04377620,None
4200,NCT04377646,ClinicalTrials.gov,2020-05-01,2020-05-04,False,Military Hospital of Tunis,Not Recruiting,Phase 3,Interventional,Tunisia,A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers,Drug (Chemoprophylaxis),Hydroxychloroquine + Zinc,Hydroxychloroquine + Zinc,660,https://clinicaltrials.gov/show/NCT04377646,None
4201,NCT04377659,ClinicalTrials.gov,2020-05-04,2020-05-01,True,Memorial Sloan Kettering Cancer Center,Not Recruiting,Phase 2,Interventional,United States,Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection,Drug,Tocilizumab,Tocilizumab,9,https://clinicaltrials.gov/show/NCT04377659,None
4202,NCT04377672,ClinicalTrials.gov,2020-05-04,2020-05-28,False,Johns Hopkins University,Recruiting,Phase 1,Interventional,United States,Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19),ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04377672,None
4203,NCT04377685,ClinicalTrials.gov,2020-05-05,2020-03-01,True,CHU de Saint Etienne,Recruiting,Not Applicable,Observational,France,Prediction of Clinical Course in COVID19 Patients,Prognosis,No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04377685,None
4204,NCT04377711,ClinicalTrials.gov,2020-05-05,2020-06-08,False,Covis Pharma,Recruiting,Phase 3,Interventional,United States,A Study of the Safety and Efficacy of Ciclesonide in the Treatment of Non-hospitalized COVID-19 Patients,Drug,Ciclesonide,Ciclesonide,400,https://clinicaltrials.gov/show/NCT04377711,None
4205,NCT04377724,ClinicalTrials.gov,2020-05-05,2020-04-27,True,Jörg Goldhahn,Not Recruiting,Not Applicable,Observational,Switzerland,Spread and Course of COVID-19 Infections,Clinical Presentation (Epidemiology),No Intervention,No Intervention,3000,https://clinicaltrials.gov/show/NCT04377724,None
4206,NCT04377737,ClinicalTrials.gov,2020-05-04,2020-05-15,False,Fondation Lenval,Not Recruiting,Not Applicable,Interventional,France,Incidence of Covid-19 in School Children,Clinical Presentation (Epidemiology),No Intervention,No Intervention,0,https://clinicaltrials.gov/show/NCT04377737,None
4207,NCT04377750,ClinicalTrials.gov,2020-04-23,2020-04-08,True,Hadassah Medical Organization,Recruiting,Phase 4,Interventional,Israel,The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation,Drug,Tocilizumab,Tocilizumab,500,https://clinicaltrials.gov/show/NCT04377750,None
4208,NCT04377763,ClinicalTrials.gov,2020-05-05,2020-07-15,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Observational,France,Developement and Evaluation of Serological Assays for COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,https://clinicaltrials.gov/show/NCT04377763,None
4209,NCT04377776,ClinicalTrials.gov,2020-05-05,2020-05-04,True,IRCCS Ospedale San Raffaele,Not Recruiting,Not Applicable,Observational,Italy,"Observational Study Concerning COVID-19 Infection in Transplanted Kidney, Pancreas or Pancreatic Islet Patients",Clinical Presentation,No Intervention,No Intervention,644,https://clinicaltrials.gov/show/NCT04377776,None
4210,NCT04377789,ClinicalTrials.gov,2020-05-01,2020-03-20,True,Kanuni Sultan Suleyman Training and Research Hospital,Recruiting,Not Applicable,Interventional,Turkey,Effect of Quercetin on Prophylaxis and Treatment of COVID-19,Drug (Chemoprophylaxis),Quercetin,Quercetin,50,https://clinicaltrials.gov/show/NCT04377789,None
4211,NCT04377802,ClinicalTrials.gov,2020-05-04,2020-05-17,False,King Fahad Specialist Hospital,Not Recruiting,Not Applicable,Interventional,Saudi Arabia,Safe Return to Regular Clinical Operation After COVID-19 Pandemic,Health System,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04377802,None
4212,NCT04377815,ClinicalTrials.gov,2020-04-24,2020-04-23,True,"University College, London",Recruiting,Not Applicable,Observational,United Kingdom,Finding Out if COVID-19 Infection Can be pREdicted by ChAnges in Smell and/or Taste,Prognosis,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04377815,None
4213,NCT04377997,ClinicalTrials.gov,2020-05-01,2020-05-15,False,Massachusetts General Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19,Drug,Enoxaparin,Enoxaparin,300,https://clinicaltrials.gov/show/NCT04377997,None
4214,NCT04378244,ClinicalTrials.gov,2020-05-04,2021-01-12,False,Aveni Foundation,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19,Other,Gene Therapy,Gene Therapy,18,https://clinicaltrials.gov/show/NCT04378244,None
4215,NCT04378257,ClinicalTrials.gov,2020-05-02,2020-06-01,False,Sultan Qaboos University,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy of Therapist Guided e-Therapy Versus Self-Help Therapy on Psychological Distress Among Individuals in Oman During COVID-19 Pandemic,Other (psych),Psychological,Psychological,70,https://clinicaltrials.gov/show/NCT04378257,None
4216,NCT04378582,ClinicalTrials.gov,2020-05-05,2020-05-07,False,University of São Paulo General Hospital,Not Recruiting,Not Applicable,Observational,Brazil,Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU,Clinical Presentation,No Intervention,No Intervention,1589,https://clinicaltrials.gov/show/NCT04378582,None
4217,NCT04378595,ClinicalTrials.gov,2020-05-05,2020-04-10,True,"University of Texas, Austin",Recruiting,Not Applicable,Observational,United States,Assessing Pediatric Food Insecurity During the COVID-19 Pandemic in Austin,Other,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04378595,None
4218,NCT04378686,ClinicalTrials.gov,2020-05-05,2020-04-23,True,UZ Leuven,Recruiting,Not Applicable,Observational,Belgium,Serological Testing for COVID-19 (SARS-CoV-2) in ESKD,Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04378686,None
4219,NCT04378712,ClinicalTrials.gov,2020-04-29,2020-01-21,True,Guangzhou Institute of Respiratory Disease,Not Recruiting,Not Applicable,Interventional,China,Hydrogen/Oxygen Mixed Gas Inhalation for Coronavirus Disease 2019 (COVID-19),Drug,Hydrogen + Oxygen,Hydrogen; Oxygen,90,https://clinicaltrials.gov/show/NCT04378712,None
4220,NCT04378738,ClinicalTrials.gov,2020-05-01,2020-05-01,False,Acibadem University,Recruiting,Not Applicable,Interventional,Turkey,Social Media and Covid19 Pandemic,Other,No Intervention,No Intervention,212,https://clinicaltrials.gov/show/NCT04378738,None
4221,NCT04378777,ClinicalTrials.gov,2020-05-01,2020-05-01,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Not Applicable,Observational,United States,Immunophenotyping Assessment in a COVID-19 Cohort,Genomics,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04378777,None
4222,NCT04378803,ClinicalTrials.gov,2020-05-04,2020-05-13,False,University of Miami,Not Recruiting,Not Applicable,Interventional,United States,Mindfulness Training for Seniors,Other (psych),Psychological,Psychological,53,https://clinicaltrials.gov/show/NCT04378803,None
4223,NCT04378829,ClinicalTrials.gov,2020-05-03,2020-09-12,False,Konya Training and Research Hospital,Recruiting,Not Applicable,Observational,Turkey,"Platelet Count, Platelet, Mean Platelet Volume and Platelet Distribution Width in COVID-19",Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04378829,None
4224,NCT04378842,ClinicalTrials.gov,2020-05-05,2020-05-18,False,"University Hospital, Lille",Recruiting,Not Applicable,Observational,France,COVID-19 and ICU-acquired MDR Bacteria,Clinical Presentation,No Intervention,No Intervention,690,https://clinicaltrials.gov/show/NCT04378842,None
4225,NCT04378881,ClinicalTrials.gov,2020-05-05,2020-06-01,False,Tabula Rasa HealthCare,Not Recruiting,Not Applicable,Observational,United States,Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations,Other,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04378881,None
4226,NCT04378920,ClinicalTrials.gov,2020-05-05,2020-04-14,True,Institut de Cancérologie Strasbourg Europe (ICANS),Recruiting,Phase 1/Phase 2,Interventional,France,"A Study of Liposomal Trans Crocetin, LEAF-4L6715, in Patients With Acute Respiratory Distress Syndrome Due to COVID-19, Sepsis or Other Causes",Drug,Trans Crocetin,Trans Crocetin,90,https://clinicaltrials.gov/show/NCT04378920,None
4227,NCT04379037,ClinicalTrials.gov,2020-05-05,2020-06-27,False,Nemechek Technologies,Recruiting,Not Applicable,Interventional,Argentina,Vagus Nerve Stimulation ARDS Prevention Trial for COVID-19 Hospitalized Patients,Other (device),Vagus nerve stimulation,Vagus nerve stimulation,50,https://clinicaltrials.gov/show/NCT04379037,None
4228,NCT04379063,ClinicalTrials.gov,2020-05-05,2020-05-13,False,Jon Bailey,Not Recruiting,Not Applicable,Observational,Canada,COVID-19 Pandemic Short Interval National Survey Gauging Psychological Distress,Other (psych),No Intervention,No Intervention,342,https://clinicaltrials.gov/show/NCT04379063,None
4229,NCT04379076,ClinicalTrials.gov,2020-05-05,2020-05-14,False,Revimmune,Recruiting,Phase 2,Interventional,United Kingdom,InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort,Drug,CYT107,CYT107,48,https://clinicaltrials.gov/show/NCT04379076,None
4230,NCT04379089,ClinicalTrials.gov,2020-04-30,2020-04-29,True,University of Pittsburgh,Recruiting,Not Applicable,Observational,United States,Neurologic Manifestations of COVID 19 in Children,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04379089,None
4231,NCT04379154,ClinicalTrials.gov,2020-04-28,2020-04-14,True,Hôpital Foch,Recruiting,Not Applicable,Interventional,France,Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-COV-2 (COVID-19),Other,Other,Other,60,https://clinicaltrials.gov/show/NCT04379154,None
4232,NCT04379232,ClinicalTrials.gov,2020-05-04,2020-03-19,True,Hospices Civils de Lyon,Not Recruiting,Not Applicable,Observational,France,Surgical Activity During the Covid-19 Pandemic: Results for 112 Patients in a French Tertiary Care Center,Clinical Presentation,No Intervention,No Intervention,112,https://clinicaltrials.gov/show/NCT04379232,None
4233,NCT04379245,ClinicalTrials.gov,2020-05-04,2020-04-30,True,Hospices Civils de Lyon,Not Recruiting,Not Applicable,Observational,France,COVID-19 Infection in Patients Infected With HIV and/or on PrEP,Clinical Presentation,No Intervention,No Intervention,4200,https://clinicaltrials.gov/show/NCT04379245,None
4234,NCT04379258,ClinicalTrials.gov,2020-04-22,2020-05-11,False,Hospital Universitario Getafe,Not Recruiting,Not Applicable,Observational,No Country Given,Analysis of Mortality of Critically Ill Patients With COVID-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,650,https://clinicaltrials.gov/show/NCT04379258,None
4235,NCT04379271,ClinicalTrials.gov,2020-05-01,2020-06-11,True,Immunic AG,Recruiting,Phase 2/Phase 3,Interventional,"Germany, Bulgaria","A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19)",Drug,Vidofludimus calcium,Vidofludimus calcium,230,https://clinicaltrials.gov/show/NCT04379271,EUCTR2020-001264-28
4236,NCT04379284,ClinicalTrials.gov,2020-05-04,2020-05-08,False,Mayo Clinic,Recruiting,Not Applicable,Observational,United States,Risks of COVID19 in the Pregnant Population,Clinical Presentation (Epidemiology),No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04379284,None
4237,NCT04379297,ClinicalTrials.gov,2020-05-06,2020-04-10,True,Luxembourg Institute of Health,Not Recruiting,Not Applicable,Observational,Luxembourg,COvid-19 National Survey for Assessing VIral Spread by Nonaffected CarriErs (CON-VINCE),Clinical Presentation (Epidemiology),No Intervention,No Intervention,1800,https://clinicaltrials.gov/show/NCT04379297,None
4238,NCT04379310,ClinicalTrials.gov,2020-05-04,2020-05-01,True,Nisantasi University,Not Recruiting,Not Applicable,Observational,Turkey,Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019),Drug,"ACE Inhibitors, Calcium Channel Blockers",ACE Inhibitors; Calcium Channel Blockers,54,https://clinicaltrials.gov/show/NCT04379310,None
4239,NCT04379336,ClinicalTrials.gov,2020-05-04,2020-05-04,False,TASK Applied Science,Recruiting,Phase 3,Interventional,South Africa,BCG Vaccination for Healthcare Workers in COVID-19 Pandemic,ATMP,Vaccine,Vaccine,500,https://clinicaltrials.gov/show/NCT04379336,None
4240,NCT04379375,ClinicalTrials.gov,2020-05-04,2020-07-27,False,Medical College of Wisconsin,Not Recruiting,Not Applicable,Interventional,United States,Nudges to Improve Health Behaviors That Limit COVID-19 Spread,Other,Other,Other,45,https://clinicaltrials.gov/show/NCT04379375,None
4241,NCT04379440,ClinicalTrials.gov,2020-05-03,2020-04-25,True,Raffaele Antonelli Incalzi,Recruiting,Not Applicable,Observational,Italy,Geriatric Population COVID-19 Observational Study (GEROCOVIDobs),Clinical Presentation (Epidemiology),No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04379440,None
4242,NCT04379453,ClinicalTrials.gov,2020-04-27,2020-04-27,False,Hospital Israelita Albert Einstein,Recruiting,Not Applicable,Interventional,Brazil,Robot Assisted Percutaneous Cardiovascular Intervention as a Strategy to Reduce or Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses,Procedure,Percutaneous Cardiovascular Intervention,Percutaneous Cardiovascular Intervention,10,https://clinicaltrials.gov/show/NCT04379453,None
4243,NCT04379466,ClinicalTrials.gov,2020-05-04,2020-05-05,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Observational,France,Effector and Regulatory T Cell Receptor Repertoire Analyses in Patients Affected by COVID-19,Clinical Presentation,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04379466,None
4244,NCT04379479,ClinicalTrials.gov,2020-05-01,2020-05-01,False,"National Polytechnic Institute, Mexico",Not Recruiting,Phase 2,Interventional,Mexico,Clinical Effect of Dialyzable Leukocyte Extract in Suspected or Confirmed Cases of COVID-19 (FUTURE-T),Drug,Dialyzable Leukocyte,Dialyzable Leukocyte,562,https://clinicaltrials.gov/show/NCT04379479,None
4245,NCT04379492,ClinicalTrials.gov,2020-05-05,2020-05-05,False,Memorial Sloan Kettering Cancer Center,Not Recruiting,Phase 2,Interventional,United States,A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,0,https://clinicaltrials.gov/show/NCT04379492,None
4246,NCT04379518,ClinicalTrials.gov,2020-05-06,2020-09-04,False,Roswell Park Cancer Institute,Recruiting,Phase 1/Phase 2,Interventional,United States,Rintatolimod and IFN Alpha-2b for the Treatment of Mild or Moderate COVID-19 Infection in Cancer Patients,Drug,Interferon alfa + Rintatolimod,Interferon alfa; Rintatolimod,44,https://clinicaltrials.gov/show/NCT04379518,None
4247,NCT04379531,ClinicalTrials.gov,2020-04-30,2020-04-25,True,Department of Health Care of Moscow,Not Recruiting,Not Applicable,Interventional,Russian Federation,LDCT in COVID-19 Pneumonia: a Prospective Moscow Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,230,https://clinicaltrials.gov/show/NCT04379531,None
4248,NCT04379544,ClinicalTrials.gov,2020-05-04,2020-04-23,True,University of Pennsylvania,Recruiting,Not Applicable,Observational,United States,Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19,Prognosis,No Intervention,No Intervention,105,https://clinicaltrials.gov/show/NCT04379544,None
4249,NCT04379661,ClinicalTrials.gov,2020-05-05,2020-04-03,True,Columbia University,Not Recruiting,Not Applicable,Interventional,United States,SUNLIGHT Study: Online Support Groups for MS to Address COVID-19,Other,Other,Other,32,https://clinicaltrials.gov/show/NCT04379661,None
4250,NCT04380376,ClinicalTrials.gov,2020-05-06,2020-04-30,True,"Federal State Budgetary Institution, Pulmonology Scientific Research Institute",Recruiting,Phase 2,Interventional,Russian Federation,Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia,Drug,Melphalan,Melphalan,60,https://clinicaltrials.gov/show/NCT04380376,None
4251,NCT04380402,ClinicalTrials.gov,2020-05-01,2020-05-20,False,Mount Auburn Hospital,Not Recruiting,Phase 2,Interventional,No Country Given,Atorvastatin as Adjunctive Therapy in COVID-19,Drug,Atorvastatin,Atorvastatin,300,https://clinicaltrials.gov/show/NCT04380402,None
4252,NCT04380519,ClinicalTrials.gov,2020-05-06,2020-04-23,True,"R-Pharm International, LLC",Not Recruiting,Phase 2/Phase 3,Interventional,Russian Federation,Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19),Drug,RPH -104 vs. Olokizumab,RPH -104; Olokizumab,372,https://clinicaltrials.gov/show/NCT04380519,None
4253,NCT04380532,ClinicalTrials.gov,2020-04-29,2020-05-15,False,Immunitor LLC,Not Recruiting,Phase 1/Phase 2,Interventional,"Canada, Mongolia",Tableted COVID-19 Therapeutic Vaccine,ATMP,Vaccine,Vaccine,20,https://clinicaltrials.gov/show/NCT04380532,None
4254,NCT04380662,ClinicalTrials.gov,2020-05-07,2020-06-30,False,"University Hospital, Grenoble",Not Recruiting,Not Applicable,Observational,France,Risk Factors Worsening COVID19 for Out-patient With Home Monitoring,Clinical Presentation,No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04380662,None
4255,NCT04380701,ClinicalTrials.gov,2020-05-06,2020-04-23,True,Biontech SE,Recruiting,Phase 1/Phase 2,Interventional,Germany,A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults,ATMP,Vaccine,Vaccine,456,https://clinicaltrials.gov/show/NCT04380701,EUCTR2020-001038-36
4256,NCT04380714,ClinicalTrials.gov,2020-05-07,2020-05-01,True,"University Hospital, Montpellier",Not Recruiting,Not Applicable,Observational,France,Changes in the Consumption of Psychoactive Substances During Containment Linked to COVID-19,Clinical Presentation,No Intervention,No Intervention,700,https://clinicaltrials.gov/show/NCT04380714,None
4257,NCT04380727,ClinicalTrials.gov,2020-04-28,2020-03-20,True,CHU de Nancy,Not Recruiting,Not Applicable,Observational,France,Almitrine and COVID-19 Related Hypoxemia,Clinical Presentation,No Intervention,No Intervention,17,https://clinicaltrials.gov/show/NCT04380727,None
4258,NCT04380766,ClinicalTrials.gov,2020-04-21,2019-01-01,True,Fondazione Policlinico Universitario Agostino Gemelli IRCCS,Not Recruiting,Not Applicable,Observational,Italy,Covid-19 Pandemic and Pancreatic Surgery in Italy,Clinical Presentation,No Intervention,No Intervention,730,https://clinicaltrials.gov/show/NCT04380766,None
4259,NCT04380818,ClinicalTrials.gov,2020-05-04,2020-06-05,False,Grupo de Investigación Clínica en Oncología Radioterapia (GICOR),Recruiting,Not Applicable,Interventional,Spain,Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19,Other (+ Drug),"Radiation with or without hydroxychloroquine, lopinavir/ritonavir, azithromycin, cortocosteroids, Heparin, oxygen",Radiation; hydroxychloroquine; lopinavir/ritonavir; azithromycin; methylprednisolone; dexamethasone; prednisone; Heparin; oxygen,106,https://clinicaltrials.gov/show/NCT04380818,None
4260,NCT04380870,ClinicalTrials.gov,2020-05-05,2020-04-11,True,Center for Integrated Care,Recruiting,Not Applicable,Observational,United States,Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,500,https://clinicaltrials.gov/show/NCT04380870,None
4261,NCT04380896,ClinicalTrials.gov,2020-05-04,2020-04-27,True,Great Ormond Street Hospital for Children NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 Staff Testing of Antibody Responses Study (Co-Stars),Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04380896,None
4262,NCT04380909,ClinicalTrials.gov,2020-05-07,2020-05-06,True,University of Bern,Recruiting,Not Applicable,Interventional,Switzerland,ROCO - Self-help for People With Psychological Distress Due to the Covid-19 Situation,Other (psych),Psychological,Psychological,80,https://clinicaltrials.gov/show/NCT04380909,None
4263,NCT04380935,ClinicalTrials.gov,2020-05-04,2020-05-18,False,Indonesia University,Recruiting,Phase 2/Phase 3,Interventional,Indonesia,Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04380935,None
4264,NCT04380961,ClinicalTrials.gov,2020-05-07,2020-04-24,True,Janssen Pharmaceutical,Recruiting,Phase 2,Interventional,"Russian Federation, Argentina, Mexico, Brazil, United States, South Africa, Spain",A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19,Drug,Sirukumab,Sirukumab,270,https://clinicaltrials.gov/show/NCT04380961,None
4265,NCT04380987,ClinicalTrials.gov,2020-04-30,2020-05-04,False,Luxembourg Institute of Health,Recruiting,Not Applicable,Observational,Luxembourg,Luxembourg Cohort of Positive Patients for COVID-19: a Stratification Study to Predict Patient Prognosis,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04380987,None
4266,NCT04381000,ClinicalTrials.gov,2020-05-07,2020-04-01,True,Clinical Exercise Physiology and Rehabilitation Reasearch Laboratory,Not Recruiting,Not Applicable,Interventional,Greece,Quarantine and Telerehabilitation in Chronic Pain Patients During COVID-19 Pandemic.,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,170,https://clinicaltrials.gov/show/NCT04381000,None
4267,NCT04381052,ClinicalTrials.gov,2020-05-06,2020-05-01,True,Columbia University,Not Recruiting,Phase 2,Interventional,United States,Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection,Drug,Clazakizumab,Clazakizumab,30,https://clinicaltrials.gov/show/NCT04381052,None
4268,NCT04381273,ClinicalTrials.gov,2020-05-06,2020-05-08,False,Heidelberg University,Recruiting,Not Applicable,Observational,Germany,Oral Health and Psychosocial Factors During the Covid-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04381273,None
4269,NCT04381286,ClinicalTrials.gov,2020-04-23,2019-04-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Transpulmonary Driving Pressure in ARDS COVID19 Patients,Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04381286,None
4270,NCT04381312,ClinicalTrials.gov,2020-04-10,2020-04-09,True,"University Hospital, Grenoble",Recruiting,Not Applicable,Observational,France,Direct and Indirect Impact of COVID-19 In Older Populations,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04381312,None
4271,NCT04381338,ClinicalTrials.gov,2020-05-04,2020-05-10,False,University of Padova,Not Recruiting,Not Applicable,Interventional,Italy,Rehabilitation for People With COVID-19 in ICU,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,92,https://clinicaltrials.gov/show/NCT04381338,None
4272,NCT04381351,ClinicalTrials.gov,2020-05-07,2020-04-16,True,Heinrich-Heine University,Recruiting,Not Applicable,Observational,Germany,Noncoding RNAs in COVID-19 and COVID-19 Related Kidney Dysfunction,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04381351,None
4273,NCT04381364,ClinicalTrials.gov,2020-05-07,2020-05-29,True,Dr. Ola Blennow,Recruiting,Phase 2,Interventional,Sweden,Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19),Drug,Ciclesonide,Ciclesonide,446,https://clinicaltrials.gov/show/NCT04381364,EUCTR2020-001928-34
4274,NCT04381377,ClinicalTrials.gov,2020-05-07,2020-04-29,True,NPO Petrovax,Recruiting,Phase 2/Phase 3,Interventional,Russian Federation,Efficacy and Safety of PolyoxidoniumÂ® in Hospitalized Patients With Coronavirus Disease COVID-19,Drug,Azoximer bromide,Azoximer bromide,394,https://clinicaltrials.gov/show/NCT04381377,None
4275,NCT04381819,ClinicalTrials.gov,2020-05-04,2020-03-02,True,Oslo University Hospital,Recruiting,Not Applicable,Observational,Norway,"Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of COVID-19",Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04381819,None
4276,NCT04381845,ClinicalTrials.gov,2020-05-06,2020-12-10,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,No Country Given,Immunity and Infections in the Psychiatric Population,Clinical Presentation (Epidemiology),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04381845,None
4277,NCT04381858,ClinicalTrials.gov,2020-05-06,2020-05-06,False,Centenario Hospital Miguel Hidalgo,Not Recruiting,Phase 3,Interventional,Mexico,Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia,ATMP,Plasma vs. Immunoglobulin,Plasma; Immunoglobulin,196,https://clinicaltrials.gov/show/NCT04381858,None
4278,NCT04381871,ClinicalTrials.gov,2020-05-08,2020-06-01,False,Al-Neelain University,Not Recruiting,Phase 2/Phase 3,Interventional,Sudan,Potential Role of Gum Arabic as Immunomodulatory Agent Among COVID 19 Patients,Drug,Gum Arabic,Gum Arabic,110,https://clinicaltrials.gov/show/NCT04381871,None
4279,NCT04381884,ClinicalTrials.gov,2020-05-05,2020-05-18,False,Laboratorio Elea,Not Recruiting,Phase 2,Interventional,Argentina,Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19,Drug,Ivermectin,Ivermectin,45,https://clinicaltrials.gov/show/NCT04381884,None
4280,NCT04381923,ClinicalTrials.gov,2020-05-07,2021-02-15,False,University of Pennsylvania,Not Recruiting,Not Applicable,Interventional,United States,COVIDNOCHE Trial (HFNO Versus CPAP Helmet) in COVID-19 Pneumonia,Drug,Oxygen,Oxygen,200,https://clinicaltrials.gov/show/NCT04381923,None
4281,NCT04381962,ClinicalTrials.gov,2020-05-07,2020-05-29,True,University of Oxford,Recruiting,Phase 3,Interventional,United Kingdom,A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2),Drug,Azithromycin,Azithromycin,800,https://clinicaltrials.gov/show/NCT04381962,EUCTR2020-001740-26
4282,NCT04381988,ClinicalTrials.gov,2020-05-08,2020-05-07,True,Memorial Sloan Kettering Cancer Center,Recruiting,Phase 2,Interventional,United States,A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy,Drug,Hydroxychloroquine,Hydroxychloroquine,132,https://clinicaltrials.gov/show/NCT04381988,None
4283,NCT04382040,ClinicalTrials.gov,2020-05-07,2020-05-08,False,MGC Pharmaceuticals,Recruiting,Phase 2,Interventional,"India, Israel","A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19",Drug,Artemisinin + Curcumin + Frankincense + Vitamin C,Artemisinin; Curcumin; Frankincense; Vitamin C,50,https://clinicaltrials.gov/show/NCT04382040,None
4284,NCT04382066,ClinicalTrials.gov,2020-05-07,2020-05-12,False,PharmaMar,Not Recruiting,Phase 1,Interventional,Spain,Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19,Drug,Plitidepsin,Plitidepsin,46,https://clinicaltrials.gov/show/NCT04382066,None
4285,NCT04382092,ClinicalTrials.gov,2020-05-06,2020-03-23,True,"University Clinic, UCLouvain",Not Recruiting,Not Applicable,Interventional,Belgium,Co-infection Management in COVID-19 Critically Ill,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,32,https://clinicaltrials.gov/show/NCT04382092,None
4286,NCT04382131,ClinicalTrials.gov,2020-05-08,2020-06-23,False,University of Edinburgh,Recruiting,Not Applicable,Interventional,United Kingdom,Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19),Procedure,Nasal irrigation,Nasal irrigation,405,https://clinicaltrials.gov/show/NCT04382131,None
4287,NCT04382196,ClinicalTrials.gov,2020-05-08,2020-04-17,True,"University Hospital, Ghent",Not Recruiting,Not Applicable,Observational,Belgium,Impact of COVID-19 on Mental Health of Health Care Workers,Other (psych),No Intervention,No Intervention,497,https://clinicaltrials.gov/show/NCT04382196,None
4288,NCT04382235,ClinicalTrials.gov,2020-05-05,2020-03-26,True,University of Milano Bicocca,Not Recruiting,Not Applicable,Observational,Italy,Non-invasive Ventilatory Support of Patients Affected by COVID-19,Other (physical),Mechanical ventilation,Mechanical ventilation,900,https://clinicaltrials.gov/show/NCT04382235,None
4289,NCT04382391,ClinicalTrials.gov,2020-04-14,2020-05-08,False,Allegheny Singer Research Institute,Recruiting,Not Applicable,Interventional,United States,Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms,Other (device),Vagus nerve stimulation,Vagus nerve stimulation,20,https://clinicaltrials.gov/show/NCT04382391,None
4290,NCT04382417,ClinicalTrials.gov,2020-05-04,2020-03-26,True,Region Västmanland,Not Recruiting,Not Applicable,Observational,Sweden,Prospective Observational Cohort Study of Critically Ill Patients With Covid-19 in Sweden,Clinical Presentation,No Intervention,No Intervention,57,https://clinicaltrials.gov/show/NCT04382417,None
4291,NCT04382469,ClinicalTrials.gov,2020-05-05,2020-02-01,True,Alexandria University,Not Recruiting,Not Applicable,Observational,Egypt,Egyptian Initial Experience About 2019 Novel Corona Virus: Study of 48 Patients in Alexandria-Egypt Using Chest CT,Clinical Presentation,No Intervention,No Intervention,48,https://clinicaltrials.gov/show/NCT04382469,None
4292,NCT04382495,ClinicalTrials.gov,2020-05-08,2020-06-15,False,El Zaitoun Specialized Hospital,Not Recruiting,Not Applicable,Observational,Egypt,The Impact of COVID-19 Pandemic on Cancer Care,Health System,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04382495,None
4293,NCT04382508,ClinicalTrials.gov,2020-05-06,2020-03-22,True,University Hospital Southampton NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults.,Clinical Presentation,No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04382508,None
4294,NCT04382534,ClinicalTrials.gov,2020-04-26,2020-03-10,True,Peking University Third Hospital,Recruiting,Not Applicable,Observational,China,A Cross-sectional and Cohort Study of COVID-19 Patients With Post - Discharge Dysfunction,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04382534,None
4295,NCT04382547,ClinicalTrials.gov,2020-05-08,2020-05-11,False,Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus,Recruiting,Phase 1/Phase 2,Interventional,Belarus,Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells,ATMP,Cells (mesenchymal),Cells (mesenchymal),40,https://clinicaltrials.gov/show/NCT04382547,None
4296,NCT04382560,ClinicalTrials.gov,2020-05-05,2020-05-02,True,University of Parma,Not Recruiting,Not Applicable,Interventional,Italy,Coping Strategies and Responsiveness to a Brief Online Intervention During COVID-19 Pandemic,Other (psych),Psychological,Psychological,69,https://clinicaltrials.gov/show/NCT04382560,None
4297,NCT04382586,ClinicalTrials.gov,2020-05-07,2020-07-06,False,BeiGene,Recruiting,Phase 2,Interventional,"United States, Brazil",Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants,Drug,Zanubrutinib,Zanubrutinib,52,https://clinicaltrials.gov/show/NCT04382586,None
4298,NCT04382625,ClinicalTrials.gov,2020-04-14,2020-10-01,False,Kootenai Health,Not Recruiting,Phase 4,Interventional,United States,Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial,Drug,Hydroxychloroquine,Hydroxychloroquine,120,https://clinicaltrials.gov/show/NCT04382625,None
4299,NCT04382729,ClinicalTrials.gov,2020-05-08,2020-04-17,True,University of Turin,Recruiting,Not Applicable,Interventional,Italy,Neuromuscular Electrical Stimulation in Patients With COVID19 Associated Pneumonia,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,80,https://clinicaltrials.gov/show/NCT04382729,None
4300,NCT04382755,ClinicalTrials.gov,2020-05-07,2020-05-22,False,"University Hospital, Ghent",Recruiting,Phase 2,Interventional,Belgium,ZilucoplanÂ® in Improving Oxygenation and Short- and Long-term Outcome of COVID-19 Patients With Acute Hypoxic Respiratory Failure,Drug,Zilucoplan,Zilucoplan,81,https://clinicaltrials.gov/show/NCT04382755,None
4301,NCT04382768,ClinicalTrials.gov,2020-05-06,2020-05-01,True,Química Luar,Recruiting,Not Applicable,Interventional,Argentina,Inhaled Ibuprofen to Treat COVID-19,Drug,Ibuprofen,Ibuprofen,40,https://clinicaltrials.gov/show/NCT04382768,None
4302,NCT04382781,ClinicalTrials.gov,2020-05-06,2020-05-01,True,Spanish Network for Research in Infectious Diseases,Recruiting,Not Applicable,Observational,Spain,Immunosupressive Treatment in COVID-19 Patients,Drug,Immunosupressives,Immunosupressives,500,https://clinicaltrials.gov/show/NCT04382781,None
4303,NCT04382794,ClinicalTrials.gov,2020-05-08,2020-05-14,False,University of Milan,Not Recruiting,Not Applicable,Observational,Italy,Sitagliptin Treatment in Diabetic COVID-19 Positive Patients,Drug,Sitagliptin,Sitagliptin,338,https://clinicaltrials.gov/show/NCT04382794,None
4304,NCT04382950,ClinicalTrials.gov,2020-05-08,2020-07-01,False,Kafrelsheikh University,Not Recruiting,Phase 1,Interventional,No Country Given,Combination of Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP and Isotretinoin Could be Promising COVID-19 Infection- and Lung Injury Preventing Drug Better Than Recombinant Human ACE2,Drug,ACE enzyme + retonic acid,ACE enzyme + retonic acid,24,https://clinicaltrials.gov/show/NCT04382950,None
4305,NCT04383002,ClinicalTrials.gov,2020-05-01,2020-09-02,False,"University Health Network, Toronto",Recruiting,Phase 1,Interventional,Canada,High Dose Inhaled Nitric Oxide for COVID-19 (ICU Patients),Drug,Nitric Oxide,Nitric Oxide,20,https://clinicaltrials.gov/show/NCT04383002,None
4306,NCT04383444,ClinicalTrials.gov,2020-05-09,2020-07-07,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Not Applicable,Observational,United States,Surveillance of Individuals Following SARS-CoV-2 Exposure,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1050,https://clinicaltrials.gov/show/NCT04383444,None
4307,NCT04383470,ClinicalTrials.gov,2020-04-27,2020-04-26,True,University of Padova,Recruiting,Not Applicable,Observational,Greece,Collaborative Outcomes Study on Health and Functioning During Infection Times During COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,100000,https://clinicaltrials.gov/show/NCT04383470,None
4308,NCT04383535,ClinicalTrials.gov,2020-05-06,2020-05-15,False,Hospital Italiano de Buenos Aires,Not Recruiting,Not Applicable,Interventional,Argentina,Convalescent Plasma and Placebo for the Treatment of COVID-19 Severe Pneumonia,ATMP,Plasma,Plasma,333,https://clinicaltrials.gov/show/NCT04383535,None
4309,NCT04383548,ClinicalTrials.gov,2020-04-17,2020-06-01,False,Assiut University,Not Recruiting,Not Applicable,Interventional,No Country Given,Clinical Study for Efficacy of Anti-Corona VS2 Immunoglobulins Prepared From COVID19 Convalescent Plasma Prepared by VIPS Mini-Pool IVIG Medical Devices in Prevention of SARS-CoV-2 Infection in High Risk Groups as Well as Treatment of Early Cases of COVID19 Patients,ATMP,Immunoglobulin,Immunoglobulin,100,https://clinicaltrials.gov/show/NCT04383548,None
4310,NCT04383574,ClinicalTrials.gov,2020-05-09,2020-05-22,False,"Sinovac Research and Development Co., Ltd.",Not Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19),ATMP,Vaccine,Vaccine,422,https://clinicaltrials.gov/show/NCT04383574,None
4311,NCT04383587,ClinicalTrials.gov,2020-05-07,2020-05-06,True,Mayo Clinic,Not Recruiting,Not Applicable,Interventional,United States,Seroprevalence of SARS CoV 2 Antibodies in Previously Undiagnosed Healthcare Workers,Clinical Presentation (Epidemiology),No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04383587,None
4312,NCT04383613,ClinicalTrials.gov,2020-05-05,2020-05-15,False,"St. Michael's Hospital, Toronto",Recruiting,Not Applicable,Interventional,Canada,Prone Positioning for Patients on General Medical Wards With COVID19,Procedure,Positioning,Positioning,350,https://clinicaltrials.gov/show/NCT04383613,None
4313,NCT04383626,ClinicalTrials.gov,2020-05-10,2020-03-02,True,Cairo University,Not Recruiting,Not Applicable,Observational,Egypt,Fear Among Dentists During COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,216,https://clinicaltrials.gov/show/NCT04383626,None
4314,NCT04383652,ClinicalTrials.gov,2020-05-07,2020-05-06,True,Kirby Institute,Recruiting,Not Applicable,Observational,Australia,Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales,Clinical Presentation (Epidemiology),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04383652,None
4315,NCT04383678,ClinicalTrials.gov,2020-05-07,2020-03-01,True,Helsinki University Central Hospital,Recruiting,Not Applicable,Observational,"Sweden, Germany, Italy, France, United Kingdom, Finland",Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome,Drug,Oxygen,Oxygen,200,https://clinicaltrials.gov/show/NCT04383678,None
4316,NCT04383717,ClinicalTrials.gov,2020-05-04,2020-05-05,False,Cairo University,Not Recruiting,Phase 3,Interventional,No Country Given,Levamisole and Isoprinosine in the Treatment of COVID19: A Proposed Therapeutic Trial,Drug,Levamisole + Isoprinosine vs. Azithromycin + Hydroxychloroquine,Levamisole; Isoprinosine; Azithromycin; Hydroxychloroquine,60,https://clinicaltrials.gov/show/NCT04383717,None
4317,NCT04383730,ClinicalTrials.gov,2020-05-08,2020-06-26,False,"University Hospital, Clermont-Ferrand",Recruiting,Not Applicable,Observational,"Germany, France, United States, Switzerland, Spain",Inhaled Sedation in COVID-19-related Acute Respiratory Distress Syndrome (ISCA): an International Research Data Study in the Recent Context of Widespread Disease Resulting From the 2019 (SARS-CoV2) Coronavirus Pandemics (COVID-19),Drug,Sedation,Sedation,400,https://clinicaltrials.gov/show/NCT04383730,None
4318,NCT04383886,ClinicalTrials.gov,2020-05-08,2020-04-18,True,Hospices Civils de Lyon,Recruiting,Not Applicable,Observational,France,Evaluation of Emergency Department (ED) Staff Stress Level During COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04383886,None
4319,NCT04383899,ClinicalTrials.gov,2020-05-07,2020-09-30,False,"University Hospital, Bordeaux",Recruiting,Not Applicable,Observational,France,Role of Ibuprofen and Other Medicines on Severity of Coronavirus Disease 2019,Drug,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04383899,None
4320,NCT04384029,ClinicalTrials.gov,2020-04-20,2020-03-24,True,Francois Mach,Not Recruiting,Not Applicable,Observational,Switzerland,The Geneva Covid-19 CVD Study,Clinical Presentation,No Intervention,No Intervention,7000,https://clinicaltrials.gov/show/NCT04384029,None
4321,NCT04384042,ClinicalTrials.gov,2020-05-10,2020-05-01,True,Hospital Sultanah Bahiyah,Not Recruiting,Not Applicable,Observational,Malaysia,Malaysian COVID-19 Anosmia Study (Phase 2) - A Nationwide Multicentre Case-Control Study,Clinical Presentation,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04384042,None
4322,NCT04384055,ClinicalTrials.gov,2020-05-08,2020-03-21,True,Stanford University,Recruiting,Not Applicable,Observational,United States,Predicting Outcomes for Covid-19 Using Sonography,Prognosis,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04384055,None
4323,NCT04384250,ClinicalTrials.gov,2020-05-10,2020-05-10,False,Mansoura University,Recruiting,Not Applicable,Observational,Egypt,Genetic Basis of COVID-19 Infection,Genomics,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04384250,None
4324,NCT04384380,ClinicalTrials.gov,2020-04-07,2020-04-01,True,Taoyuan General Hospital,Not Recruiting,Not Applicable,Interventional,Taiwan,Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,33,https://clinicaltrials.gov/show/NCT04384380,None
4325,NCT04384406,ClinicalTrials.gov,2020-05-10,2020-04-01,True,"University Hospital, Montpellier",Not Recruiting,Not Applicable,Observational,France,COVID-19 Outbreak Consequences for Outpatients Followed in PRM,Health System,No Intervention,No Intervention,467,https://clinicaltrials.gov/show/NCT04384406,None
4326,NCT04384419,ClinicalTrials.gov,2020-05-05,2020-05-29,False,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,"Death Number Perception in Depression, Anxiety, and Schizoypal Personnality in General Population (Covid-19 Pandemic)",Other (psych),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04384419,None
4327,NCT04384458,ClinicalTrials.gov,2020-05-08,2020-07-20,False,Federal University of Ceara,Recruiting,Not Applicable,Interventional,Brazil,Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis,Drug (Chemoprophylaxis),Hydroxychloroquine + Zinc,Hydroxychloroquine; Zinc,400,https://clinicaltrials.gov/show/NCT04384458,None
4328,NCT04384471,ClinicalTrials.gov,2020-05-01,2020-04-29,True,McGill University,Recruiting,Not Applicable,Observational,Canada,Covid-19 Pandemic: Patients' Experience in T1D,Other,No Intervention,No Intervention,384,https://clinicaltrials.gov/show/NCT04384471,None
4329,NCT04384497,ClinicalTrials.gov,2020-05-07,2020-05-07,False,Joakim Dillner,Recruiting,Phase 1/Phase 2,Interventional,Sweden,Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study,ATMP,Plasma,Plasma,50,https://clinicaltrials.gov/show/NCT04384497,None
4330,NCT04384549,ClinicalTrials.gov,2020-05-06,2020-05-20,True,Assistance Publique – Hôpitaux de Paris,Recruiting,Phase 3,Interventional,France,Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care Workers,ATMP,Vaccine,Vaccine,1120,https://clinicaltrials.gov/show/NCT04384549,EUCTR2020-001678-31
4331,NCT04384588,ClinicalTrials.gov,2020-04-29,2020-04-07,True,Fundacion Arturo Lopez Perez,Recruiting,Phase 2/Phase 3,Interventional,Chile,COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID),ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04384588,None
4332,NCT04384614,ClinicalTrials.gov,2020-05-09,2020-05-15,False,Direction des Soins de Santé de Base,Not Recruiting,Not Applicable,Observational,Tunisia,Covid-19 In Tunisia: An Observational Cross-Sectional Registry Study,Clinical Presentation (Epidemiology),No Intervention,No Intervention,0,https://clinicaltrials.gov/show/NCT04384614,None
4333,NCT04384705,ClinicalTrials.gov,2020-05-06,2020-06-17,False,CHU de la Réunion,Recruiting,Not Applicable,Observational,France,HDL Target of CoViD19 ? Analysis on the Caregivers of the Reunion University Hospital,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04384705,None
4334,NCT04384731,ClinicalTrials.gov,2020-05-07,2020-05-29,False,Dr. Christophe Lenclud,Recruiting,Phase 2,Interventional,France,CurosurfÂ® in Adult Acute Respiratory Distress Syndrome Due to COVID-19,Drug,Poractant alfa,Poractant alfa,20,https://clinicaltrials.gov/show/NCT04384731,None
4335,NCT04384887,ClinicalTrials.gov,2020-05-11,2020-04-25,True,Kanuni Sultan Suleyman Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,"""Investigation of the Relationship Between New Coronary Virus Disease (COVID-19) and Anxiety and Depressive Symptoms in Pregnant Women""",Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04384887,None
4336,NCT04384900,ClinicalTrials.gov,2020-05-11,2020-05-11,False,"Copenhagen University Hospital, North Zealand",Recruiting,Not Applicable,Interventional,Denmark,Accelerated Prone Position Ventilation of Patients With COVID-19,Procedure,Positioning,Positioning,150,https://clinicaltrials.gov/show/NCT04384900,None
4337,NCT04384926,ClinicalTrials.gov,2020-05-11,2020-03-30,True,University of Birmingham,Recruiting,Not Applicable,Observational,Spain,Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic Crisis,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04384926,None
4338,NCT04384965,ClinicalTrials.gov,2020-05-08,2020-05-12,False,Centre for Addiction and Mental Health,Recruiting,Not Applicable,Interventional,Canada,Accelerated iTBS for Depressed Patients During the COVID-19 Pandemic,Other (psych),Electroconvulsive Therapy,Electroconvulsive Therapy,200,https://clinicaltrials.gov/show/NCT04384965,None
4339,NCT04385004,ClinicalTrials.gov,2020-05-08,2020-04-27,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,"Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in ICU",Clinical Presentation,No Intervention,No Intervention,320,https://clinicaltrials.gov/show/NCT04385004,None
4340,NCT04385017,ClinicalTrials.gov,2020-05-10,2020-05-11,False,CHU de Nice,Recruiting,Not Applicable,Interventional,France,Role of Inflammasomes in COVID-19 Disease,Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04385017,None
4341,NCT04385043,ClinicalTrials.gov,2020-05-04,2020-05-01,True,University of Catanzaro,Recruiting,Phase 2/Phase 3,Interventional,Italy,Hyperimmune Plasma in Patients With COVID-19 Severe Infection,ATMP,Plasma,Plasma,400,https://clinicaltrials.gov/show/NCT04385043,None
4342,NCT04385069,ClinicalTrials.gov,2020-04-20,2020-04-16,True,"University College, London",Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 Hyperinflammation Syndrome (COV-HI): Protocol for a Rapidly Executed Cohort Study,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04385069,None
4343,NCT04385095,ClinicalTrials.gov,2020-04-24,2020-03-16,False,Synairgen Research Limited,Recruiting,Phase 2,Interventional,United Kingdom,Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection,Drug,Interferon beta,Interferon beta,820,https://clinicaltrials.gov/show/NCT04385095,EUCTR2020-001023-14; ISRCTN14241621
4344,NCT04385108,ClinicalTrials.gov,2020-05-05,2020-03-04,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Interventional,France,Predictive Immune Biomarkers for COVID-19 Pathogenesis,Clinical Presentation,No Intervention,No Intervention,170,https://clinicaltrials.gov/show/NCT04385108,None
4345,NCT04385121,ClinicalTrials.gov,2020-04-16,2020-04-16,False,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Psychological Impact of the Hospitalization of a Family Member in Intensive Care for Covid-19 Infection,Other (psych),No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04385121,None
4346,NCT04385147,ClinicalTrials.gov,2020-05-11,2020-05-18,False,Al-Azhar University,Not Recruiting,Not Applicable,Observational,"Egypt, Germany, Singapore, Peru, United States",Advanced Endoscopy During COVID-19,Clinical Presentation,No Intervention,No Intervention,670,https://clinicaltrials.gov/show/NCT04385147,None
4347,NCT04385160,ClinicalTrials.gov,2020-05-11,2020-05-13,False,Fondazione per la Ricerca Ospedale Maggiore,Recruiting,Not Applicable,Observational,"Denmark, Germany, Italy, France, Poland, United Kingdom, United States, Spain",Myeloproliferative Neoplasms (MPN) and COVID-19,Clinical Presentation,No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04385160,None
4348,NCT04385186,ClinicalTrials.gov,2020-05-06,2020-06-20,False,"National Blood Center Foundation, Hemolife",Not Recruiting,Phase 2,Interventional,Colombia,Inactivated Convalescent Plasma as a Therapeutic Alternative in Patients CoViD-19,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04385186,None
4349,NCT04385199,ClinicalTrials.gov,2020-05-09,2020-05-04,True,Henry Ford Health System,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma for Patients With COVID-19,ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04385199,None
4350,NCT04385212,ClinicalTrials.gov,2020-04-29,2020-03-13,True,"University Hospital, Geneva",Not Recruiting,Not Applicable,Observational,Switzerland,Outcomes in Hospitalized Older Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,230,https://clinicaltrials.gov/show/NCT04385212,None
4351,NCT04385238,ClinicalTrials.gov,2020-05-10,2020-05-15,False,Pregistry,Not Recruiting,Not Applicable,Observational,United States,Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,7000,https://clinicaltrials.gov/show/NCT04385238,None
4352,NCT04385251,ClinicalTrials.gov,2020-05-08,2020-06-18,False,University of Minnesota,Recruiting,Not Applicable,Observational,"United Kingdom, United States, Denmark, Argentina",International SARS-CoV-2 (COVID-19) Infection Observational Study,Clinical Presentation,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04385251,None
4353,NCT04385264,ClinicalTrials.gov,2020-04-21,2020-05-12,False,University of Lausanne,Not Recruiting,Phase 2/Phase 3,Interventional,Switzerland,#StayHome: Early Hydroxychloroquine to Reduce Secondary Hospitalisation and Household Transmission in COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,800,https://clinicaltrials.gov/show/NCT04385264,None
4354,NCT04385576,ClinicalTrials.gov,2020-04-28,2020-05-15,False,University of Malaya,Recruiting,Not Applicable,Interventional,Malaysia,"Taiwan ""Aerosol Box"" Versus UMMC ""Intubation Box""",Other (physical),Mechanical ventilation,Mechanical ventilation,30,https://clinicaltrials.gov/show/NCT04385576,None
4355,NCT04385771,ClinicalTrials.gov,2020-04-19,2020-09-01,False,Dr. Alexander Supady,Recruiting,Not Applicable,Interventional,Germany,Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation,Other (device),Cytokine Adsorber,Cytokine Adsorber,80,https://clinicaltrials.gov/show/NCT04385771,None
4356,NCT04385810,ClinicalTrials.gov,2020-04-29,2020-04-27,True,Fondation Ophtalmologique Adolphe de Rothschild,Not Recruiting,Not Applicable,Interventional,France,Description of Ophthalmologic Injuries in Intensive Care During the SARS-CoV2 Epidemic - COVID19,Clinical Presentation,No Intervention,No Intervention,23,https://clinicaltrials.gov/show/NCT04385810,None
4357,NCT04385823,ClinicalTrials.gov,2020-05-11,2020-03-01,True,Assistance Publique – Hôpitaux de Paris (Louis Mourier),Not Recruiting,Not Applicable,Observational,France,Use of High Flow Nasal Cannula Oxygen and Covid-19 Acute Hypoxemic Respiratory Failure,Drug,Oxygen,Oxygen,62,https://clinicaltrials.gov/show/NCT04385823,None
4358,NCT04385849,ClinicalTrials.gov,2020-05-07,2020-06-01,False,"ImmunityBio, Inc.",Not Recruiting,Phase 1,Interventional,No Country Given,Study of the Safety of Therapeutic Treatment With an Immunomodulatory Agent (N-803) in Adults With COVID-19,Drug,N-803,N-803,30,https://clinicaltrials.gov/show/NCT04385849,None
4359,NCT04385901,ClinicalTrials.gov,2020-05-06,2020-05-19,False,University of Missouri-Columbia,Recruiting,Not Applicable,Interventional,United States,Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,72,https://clinicaltrials.gov/show/NCT04385901,None
4360,NCT04385914,ClinicalTrials.gov,2020-05-11,2020-05-01,True,Atlantic Health System,Not Recruiting,Not Applicable,Observational,No Country Given,Demographics and Outcomes of COVID 19 in Pregnancy at a Community Based Hospital,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04385914,None
4361,NCT04385940,ClinicalTrials.gov,2020-05-08,2020-06-01,False,University of Alberta,Not Recruiting,Phase 3,Interventional,No Country Given,Vitamin D and COVID-19 Management,Drug,Vitamin D,Vitamin D,64,https://clinicaltrials.gov/show/NCT04385940,None
4362,NCT04386044,ClinicalTrials.gov,2020-05-10,2020-06-01,False,Tameside General Hospital,Not Recruiting,Not Applicable,Observational,United Kingdom,Investigating the Role of Vitamin D in the Morbidity of COVID-19 Patients,Drug,Vitamin D,Vitamin D,1000,https://clinicaltrials.gov/show/NCT04386044,None
4363,NCT04386070,ClinicalTrials.gov,2020-04-30,2020-11-15,True,University of Birmingham,Not Recruiting,Phase 3,Interventional,No Country Given,Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19,Drug,Lopinavir/ritonavir vs. Hydroxychloroquine vs. Lopinavir/ritonavir + Hydroxychloroquine,Lopinavir/ritonavir; Hydroxychloroquine,6400,https://clinicaltrials.gov/show/NCT04386070,EUCTR2020-001448-24
4364,NCT04386083,ClinicalTrials.gov,2020-05-04,2020-06-10,False,University of the Philippines,Recruiting,Not Applicable,Observational,Philippines,Neurologic Manifestations of COVID-19,Clinical Presentation,No Intervention,No Intervention,1342,https://clinicaltrials.gov/show/NCT04386083,None
4365,NCT04386109,ClinicalTrials.gov,2020-04-15,2020-04-01,True,University of Oxford,Recruiting,Not Applicable,Observational,United Kingdom,Neonatal Complications of Coronavirus Disease (COVID-19),Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04386109,None
4366,NCT04386239,ClinicalTrials.gov,2020-05-07,2020-05-01,True,ASST Fatebenefratelli Sacco,Not Recruiting,Phase 1,Interventional,No Country Given,Study on the Use of Sarilumab in Patients With COVID-19 Infection,Drug,Sarilumab,Sarilumab,40,https://clinicaltrials.gov/show/NCT04386239,None
4367,NCT04386265,ClinicalTrials.gov,2020-05-11,2020-04-15,True,"SerenaGroup, Inc.",Recruiting,Not Applicable,Observational,"Poland, United States",Compassionate Use of Hyperbaric Oxygen Therapy,Drug,Oxygen,Oxygen,100,https://clinicaltrials.gov/show/NCT04386265,None
4368,NCT04386291,ClinicalTrials.gov,2020-05-11,2020-05-25,False,"Research Foundation for Mental Hygiene, Inc.",Recruiting,Not Applicable,Interventional,United States,Meditation and Kundalini Yoga for Heightened Anxiety Related to COVID-19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,360,https://clinicaltrials.gov/show/NCT04386291,None
4369,NCT04386369,ClinicalTrials.gov,2020-04-14,2020-04-15,False,CHU de Nancy,Not Recruiting,Not Applicable,Observational,France,Evaluation of Airway Pressure Release Ventilation in COVID-19 ARDS,Other (physical),Mechanical ventilation,Mechanical ventilation,17,https://clinicaltrials.gov/show/NCT04386369,None
4370,NCT04386395,ClinicalTrials.gov,2020-05-06,2020-03-30,True,CHU de Nancy,Not Recruiting,Not Applicable,Observational,France,Immune Changes in Severe COVID-19 Pulmonary Infections,Clinical Presentation,No Intervention,No Intervention,15,https://clinicaltrials.gov/show/NCT04386395,None
4371,NCT04386447,ClinicalTrials.gov,2020-05-12,2020-09-01,False,AOU di Parma,Not Recruiting,Phase 2,Interventional,"France, Italy",Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19,Drug,Oxytocin,Oxytocin,145,https://clinicaltrials.gov/show/NCT04386447,None
4372,NCT04386460,ClinicalTrials.gov,2020-05-12,2020-05-11,True,CHU de Nice,Recruiting,Not Applicable,Observational,France,Covid-19 and Prevention of Malnutrition After Confinement by Dentists,Other,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04386460,None
4373,NCT04386512,ClinicalTrials.gov,2020-05-12,2020-05-15,False,Versailles Hospital,Not Recruiting,Not Applicable,Observational,France,Clinical Epidemiology and Characteristics Of Covid-19 Cases Occurred In A Lymphoma Setting In The First Epidemic Phase (LymphoCov1),Clinical Presentation (Epidemiology),No Intervention,No Intervention,89,https://clinicaltrials.gov/show/NCT04386512,None
4374,NCT04386564,ClinicalTrials.gov,2020-05-11,2020-05-15,False,I.M. Sechenov First Moscow State Medical University,Not Recruiting,Not Applicable,Observational,Russian Federation,Kidney Injury Severity and COVID-19,Clinical Presentation,No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04386564,None
4375,NCT04386668,ClinicalTrials.gov,2020-05-12,2020-05-26,False,"University College, London",Not Recruiting,Not Applicable,Interventional,United Kingdom,Let It Out (LIO) and COVID19: Testing an Online Emotional Disclosure-based Intervention During the COVID19 Pandemic,Other (psych),Psychological,Psychological,80,https://clinicaltrials.gov/show/NCT04386668,None
4376,NCT04386694,ClinicalTrials.gov,2020-05-08,2020-05-18,False,University of Nove de Julho,Not Recruiting,Not Applicable,Interventional,Brazil,Photobiomodulation Therapy Combined With Static Magnetic Field in Patients With COVID-19,Other,Photobiomodulation therapy + static magnetic field,Photobiomodulation therapy; static magnetic field,30,https://clinicaltrials.gov/show/NCT04386694,None
4377,NCT04386720,ClinicalTrials.gov,2020-05-11,2020-05-25,False,"University Hospital, Bordeaux",Recruiting,Not Applicable,Observational,France,Measurement of Airway Opening Pressure (AOP) in Patients With Acute Respiratory Distress Syndrom and With or Without Covid 19.,Other,Other,Other,20,https://clinicaltrials.gov/show/NCT04386720,None
4378,NCT04386759,ClinicalTrials.gov,2020-04-30,2020-05-01,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,COVID-19 Infection in Healthcare Workers,Clinical Presentation (Epidemiology),No Intervention,No Intervention,6000,https://clinicaltrials.gov/show/NCT04386759,None
4379,NCT04386850,ClinicalTrials.gov,2020-05-11,2020-04-14,True,Tehran University of Medical Sciences,Recruiting,Phase 2/Phase 3,Interventional,Iran,Oral 25-hydroxyvitamin D3 and COVID-19,Drug,Vitamin D,Vitamin D,1500,https://clinicaltrials.gov/show/NCT04386850,IRCT20200401046909N1; IRCT20200401046909N2
4380,NCT04387214,ClinicalTrials.gov,2020-05-12,2020-04-13,True,South Valley University,Not Recruiting,Not Applicable,Observational,Egypt,COVID-19 Pandemic and Academic Performance of Veterinary Students,Other,No Intervention,No Intervention,1426,https://clinicaltrials.gov/show/NCT04387214,None
4381,NCT04387240,ClinicalTrials.gov,2020-05-12,2020-12-01,False,Princess Nourah Bint Abdulrahman University,Not Recruiting,Phase 2,Interventional,Saudi Arabia,Evaluating the Efficacy of Artesunate in Adults With Mild Symptoms of COVID-19,Drug,Artesunate,Artesunate,22,https://clinicaltrials.gov/show/NCT04387240,None
4382,NCT04387253,ClinicalTrials.gov,2020-05-12,2020-05-23,False,Poitiers University Hospital,Recruiting,Not Applicable,Interventional,France,Study of Late Fetal Loss in Poitou-Charentes. GYNE-COVID,Clinical Presentation,No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04387253,None
4383,NCT04387279,ClinicalTrials.gov,2020-05-12,2020-04-24,True,Keimyung University Dongsan Medical Center,Recruiting,Not Applicable,Observational,South Korea,The Impact of COVID-19 on the Health Care Utilization of Inflammatory Bowel Disease,Other,No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04387279,None
4384,NCT04387292,ClinicalTrials.gov,2020-05-12,2020-09-07,False,Fondation Ophtalmologique Adolphe de Rothschild,Recruiting,Not Applicable,Interventional,France,Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04387292,None
4385,NCT04387409,ClinicalTrials.gov,2020-05-11,2020-05-25,False,Vakzine Projekt Management GmbH,Not Recruiting,Phase 3,Interventional,Germany,Study to Assess VPM1002 in Reducing Healthcare Professionals' Absenteeism in COVID-19 Pandemic,Drug,VPM1002,VPM1002,59,https://clinicaltrials.gov/show/NCT04387409,None
4386,NCT04387643,ClinicalTrials.gov,2020-05-13,2020-03-01,True,Aarogyam UK,Not Recruiting,Not Applicable,Observational,India,Protecting Health Care Workers During the COVID-19 Outbreak,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,52,https://clinicaltrials.gov/show/NCT04387643,None
4387,NCT04387760,ClinicalTrials.gov,2020-05-09,2020-08-11,False,Royal College of Surgeons in Ireland - Medical University of Bahrain,Recruiting,Phase 2,Interventional,Bahrain,Favipiravir vs Hydroxychloroquine in COVID -19,Drug,Hydroxychloroquine vs. Favipiravir,Hydroxychloroquine; Favipiravir,150,https://clinicaltrials.gov/show/NCT04387760,None
4388,NCT04387786,ClinicalTrials.gov,2020-05-11,2020-03-31,True,Feinstein Institute for Medical Research,Not Recruiting,Not Applicable,Observational,United States,Dornase Alfa Administered to Patients With COVID-19 (DACOVID),Drug,Dornase alfa,Dornase alfa,5,https://clinicaltrials.gov/show/NCT04387786,None
4389,NCT04387799,ClinicalTrials.gov,2020-05-13,2020-05-13,False,Catholic University of the Sacred Heart,Not Recruiting,Not Applicable,Observational,Italy,Determinants of COVID-19 Pneumonia (MC-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,520,https://clinicaltrials.gov/show/NCT04387799,None
4390,NCT04387838,ClinicalTrials.gov,2020-05-13,2020-05-14,False,Direction Centrale du Service de Sant des Armes,Recruiting,Not Applicable,Observational,France,Study of the SARS-COV-2 (COVID-19) Serological Profile of an Army Training Hospital Staff,Clinical Presentation (Epidemiology),No Intervention,No Intervention,900,https://clinicaltrials.gov/show/NCT04387838,None
4391,NCT04387890,ClinicalTrials.gov,2020-05-13,2020-06-01,False,Hospital Italiano de Buenos Aires,Not Recruiting,Not Applicable,Observational,No Country Given,Serologic Surveillance for SARS-CoV-2 (COVID-19) in a Prospective Cohort of Health Care Workers,Clinical Presentation (Epidemiology),No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04387890,None
4392,NCT04387929,ClinicalTrials.gov,2020-05-13,2020-05-04,True,Istituto Clinico Humanitas,Recruiting,Not Applicable,Observational,Italy,Detection of Anti-COVID-19 Antibody Levels in an Hospital Population,Clinical Presentation (Epidemiology),No Intervention,No Intervention,6000,https://clinicaltrials.gov/show/NCT04387929,None
4393,NCT04387955,ClinicalTrials.gov,2020-04-29,2020-04-30,False,Poitiers University Hospital,Recruiting,Not Applicable,Interventional,France,Analysis of Chilblains pROfile During coVID-19 Epidemic (ACROVID),Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04387955,None
4394,NCT04388410,ClinicalTrials.gov,2020-05-12,2020-08-25,False,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,Recruiting,Phase 2/Phase 3,Interventional,Mexico,Safety and Efficacy of Convalescent Plasma Transfusion for Patients With COVID-19,ATMP,Plasma,Plasma,410,https://clinicaltrials.gov/show/NCT04388410,None
4395,NCT04388436,ClinicalTrials.gov,2020-05-11,2020-05-11,False,Mansoura University,Not Recruiting,Not Applicable,Observational,Egypt,Post Covid-19 Cardiopulmonary and Immunological Changes,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04388436,None
4396,NCT04388579,ClinicalTrials.gov,2020-05-12,2020-03-20,True,University of Lisbon,Not Recruiting,Not Applicable,Observational,Portugal,Screening Patients for a Strategic Shift to Pulmonary Telerehabilitation Because of COVID-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,100,https://clinicaltrials.gov/show/NCT04388579,None
4397,NCT04388605,ClinicalTrials.gov,2020-05-07,2020-04-21,True,"University of California, San Francisco",Recruiting,Not Applicable,Observational,United States,Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic,Clinical Presentation,No Intervention,No Intervention,11000,https://clinicaltrials.gov/show/NCT04388605,None
4398,NCT04388618,ClinicalTrials.gov,2020-05-13,2020-06-15,False,Princess Nourah Bint Abdulrahman University,Recruiting,Not Applicable,Observational,Saudi Arabia,Investigating Anosmia and Ageusia in COVID-19 Adult Patients in Saudi Arabia,Clinical Presentation,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04388618,None
4399,NCT04388631,ClinicalTrials.gov,2020-05-12,2020-05-10,True,"Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology",Recruiting,Not Applicable,Observational,China,Detection Rate of SARS-CoV-2 in Male Genitourinary System and Its Impact on Male Reproductive Health.,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04388631,None
4400,NCT04388644,ClinicalTrials.gov,2020-05-12,2020-02-20,True,Taipei City Hospital,Recruiting,Not Applicable,Observational,Taiwan,Survey of Satisfaction on Traditional Chinese Medicine Jing-Guan-Fang (JGF) for COVID-19 Prevention,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,https://clinicaltrials.gov/show/NCT04388644,None
4401,NCT04388657,ClinicalTrials.gov,2020-05-13,2020-05-01,True,Ramsay Générale de Santé,Recruiting,Not Applicable,Observational,France,"COVID-19, bLOod Coagulation and Thrombosis",Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04388657,None
4402,NCT04388670,ClinicalTrials.gov,2020-05-12,2020-02-22,True,Policlinico Hospital,Recruiting,Not Applicable,Observational,Italy,Epidemiological and Clinical Characteristics of Critically Ill Patients With COVID-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04388670,None
4403,NCT04388683,ClinicalTrials.gov,2020-05-13,2020-05-12,True,Tufts Medical Center,Recruiting,Phase 2,Interventional,United States,Inhaled Nitric Oxide for Preventing Progression in COVID-19,Drug,Nitric Oxide,Nitric Oxide,42,https://clinicaltrials.gov/show/NCT04388683,None
4404,NCT04388709,ClinicalTrials.gov,2020-05-12,2020-09-01,False,Icahn School of Medicine at Mount Sinai,Not Recruiting,Phase 2,Interventional,United States,Interferon Lambda Therapy for COVID-19,Drug,Interferon lambda,Interferon lambda,66,https://clinicaltrials.gov/show/NCT04388709,None
4405,NCT04388813,ClinicalTrials.gov,2020-05-04,2020-05-28,False,Verily Life Sciences LLC,Recruiting,Not Applicable,Observational,United States,Predictors of Severe COVID-19 Outcomes,Prognosis,No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04388813,None
4406,NCT04389294,ClinicalTrials.gov,2020-05-08,2020-05-05,True,"Hospital for Special Surgery, New York",Recruiting,Not Applicable,Interventional,United States,HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists,Clinical Presentation (Epidemiology),No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04389294,None
4407,NCT04389320,ClinicalTrials.gov,2020-05-11,2020-03-15,True,Assiut University,Not Recruiting,Not Applicable,Observational,Egypt,Antimalarial and Covid 19 in Rheumatoid Arthritis,Drug,Hydroxychloroquine,Hydroxychloroquine,60,https://clinicaltrials.gov/show/NCT04389320,None
4408,NCT04389333,ClinicalTrials.gov,2020-05-09,2020-03-26,True,Changhai Hospital,Not Recruiting,Not Applicable,Interventional,China,Feasibility of Non-contact Magnetically-controlled Capsule Endoscopy During COVID-19 Pandemic,Other,Other,Other,40,https://clinicaltrials.gov/show/NCT04389333,None
4409,NCT04389359,ClinicalTrials.gov,2020-05-12,2020-09-01,True,Cambridge University Hospitals NHS Foundation Trust,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,PROphylaxis for paTiEnts at Risk of COVID-19 infecTion,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1500,https://clinicaltrials.gov/show/NCT04389359,EUCTR2020-004144-28; ISRCTN88057279
4410,NCT04389372,ClinicalTrials.gov,2020-05-05,2020-03-15,True,Fondazione IRCCS Istituto Neurologico Carlo Besta,Recruiting,Not Applicable,Interventional,Italy,"Effectiveness and Acceptability of MINDFULNESS by Smartphone, for Patients With Chronic Migraine and Medication Overuse",Other (psych),Psychological,Psychological,50,https://clinicaltrials.gov/show/NCT04389372,None
4411,NCT04389385,ClinicalTrials.gov,2020-05-12,2020-05-01,True,TC Erciyes University,Not Recruiting,Phase 1,Interventional,Turkey,COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo),ATMP,Exosomes,Exosomes,60,https://clinicaltrials.gov/show/NCT04389385,None
4412,NCT04389411,ClinicalTrials.gov,2020-05-13,2020-10-01,False,McGill University,Not Recruiting,Phase 3,Interventional,No Country Given,The COvid-19 Symptom MOntelukast Trial,Drug,Montelukast,Montelukast,600,https://clinicaltrials.gov/show/NCT04389411,None
4413,NCT04389450,ClinicalTrials.gov,2020-05-14,2020-10-01,False,Pluristem Ltd.,Recruiting,Phase 2,Interventional,"United States, Israel","Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19",ATMP,Cells (mesenchymal),Cells (mesenchymal),140,https://clinicaltrials.gov/show/NCT04389450,None
4414,NCT04389463,ClinicalTrials.gov,2020-05-14,2020-05-11,True,Nantes University Hospital,Recruiting,Not Applicable,Observational,France,Patient Outcome of Cardiac Surgery During the COVID-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,350,https://clinicaltrials.gov/show/NCT04389463,None
4415,NCT04389476,ClinicalTrials.gov,2020-05-14,2020-06-15,False,Kaohsiung Kai-Suan Psychiatric Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,The Impact and Coping Strategy of COVID-19 Among Taiwan Society and Medical and Nursing Institutes,Other (psych),No Intervention,No Intervention,2500,https://clinicaltrials.gov/show/NCT04389476,None
4416,NCT04389489,ClinicalTrials.gov,2020-05-14,2020-05-14,False,Kanuni Sultan Suleyman Training and Research Hospital,Recruiting,Not Applicable,Observational,Turkey,Postpartum Sexual Function in Pregnant Women With COVID-19,Other (psych),No Intervention,No Intervention,140,https://clinicaltrials.gov/show/NCT04389489,None
4417,NCT04389515,ClinicalTrials.gov,2020-05-14,2020-05-14,False,Kanuni Sultan Suleyman Training and Research Hospital,Recruiting,Not Applicable,Observational,Turkey,"Postoperative Recovery Index, Patient Expectations and Satisfaction With Prenatal Care Instrument in Pregnant Patients With COVID-19",Clinical Presentation,No Intervention,No Intervention,75,https://clinicaltrials.gov/show/NCT04389515,None
4418,NCT04389554,ClinicalTrials.gov,2020-05-14,2020-05-14,False,Kanuni Sultan Suleyman Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,D-dimer Levels in Pregnant With COVID-19,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04389554,None
4419,NCT04389567,ClinicalTrials.gov,2020-05-13,2020-05-12,True,Northwell Health,Not Recruiting,Not Applicable,Observational,United States,Famotidine Outpatient COVID-19 Treatment Study,Drug,Famotidine,Famotidine,10,https://clinicaltrials.gov/show/NCT04389567,None
4420,NCT04389580,ClinicalTrials.gov,2020-05-12,2020-06-01,False,Kafrelsheikh University,Not Recruiting,Phase 2,Interventional,No Country Given,Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome Coronavirus,Drug,Isotretinoin + Tamoxifen,Isotretinoin; Tamoxifen,160,https://clinicaltrials.gov/show/NCT04389580,None
4421,NCT04389645,ClinicalTrials.gov,2020-05-13,2020-04-07,True,MeMed Diagnostics Ltd.,Not Recruiting,Not Applicable,Observational,Israel,Interferon Gamma Induced Protein 10 (IP-10) in a Clinical Decision Support Protocol in COVID-19 Patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,52,https://clinicaltrials.gov/show/NCT04389645,None
4422,NCT04389658,ClinicalTrials.gov,2020-05-14,2020-05-07,True,Igenomix,Not Recruiting,Not Applicable,Observational,Spain,Contagiousness and Immunogenicity Status of COVID-19 in Asymptomatic Population (COVID-19 CONDITION),Clinical Presentation,No Intervention,No Intervention,1526,https://clinicaltrials.gov/show/NCT04389658,None
4423,NCT04389671,ClinicalTrials.gov,2020-05-13,2020-10-01,False,Windtree Therapeutics,Not Recruiting,Phase 1/Phase 2,Interventional,United States,The Safety and Preliminary Efficacy of Lucinactant in Adults With COVID-19,Drug,Lucinactant,Lucinactant,30,https://clinicaltrials.gov/show/NCT04389671,None
4424,NCT04389684,ClinicalTrials.gov,2020-05-14,2020-05-27,False,Poitiers University Hospital,Recruiting,Not Applicable,Observational,France,Clinical and Psycho-social Impact of COVID-19 Related Confinement on Patients With Digestive Tumors,Other (psych),No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04389684,None
4425,NCT04389710,ClinicalTrials.gov,2020-04-27,2020-04-15,True,Thomas Jefferson University,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma for the Treatment of COVID-19,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04389710,None
4426,NCT04389801,ClinicalTrials.gov,2020-05-13,2020-06-01,False,Hesham Al-Inany,Not Recruiting,Phase 4,Interventional,No Country Given,Use of Desferal for Prevention of ARDS in Hospitalised Cases Documented With Covid 19 Infection,Drug,Deferoxamine,Deferoxamine,200,https://clinicaltrials.gov/show/NCT04389801,None
4427,NCT04389840,ClinicalTrials.gov,2020-05-13,2020-06-03,False,Chimerix,Recruiting,Phase 2/Phase 3,Interventional,United States,Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure,Drug,Heparin,Heparin,524,https://clinicaltrials.gov/show/NCT04389840,None
4428,NCT04389944,ClinicalTrials.gov,2020-05-12,2020-03-31,True,"University Hospital, Basel",Not Recruiting,Not Applicable,Interventional,Switzerland,Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19,ATMP,Plasma,Plasma,15,https://clinicaltrials.gov/show/NCT04389944,None
4429,NCT04389996,ClinicalTrials.gov,2020-05-12,2020-05-14,False,Odense University Hospital,Not Recruiting,Not Applicable,Observational,Denmark,COVID-19 Pandemic Impact on Patients With Cancer - a Danish Survey,Clinical Presentation,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04389996,None
4430,NCT04390022,ClinicalTrials.gov,2020-05-07,2020-07-31,False,Clínica Universidad de Navarra,Not Recruiting,Phase 2,Interventional,Spain,Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial,Drug,Ivermectin,Ivermectin,24,https://clinicaltrials.gov/show/NCT04390022,None
4431,NCT04390061,ClinicalTrials.gov,2020-05-13,2020-06-01,True,Universit Politecnica delle Marche,Not Recruiting,Phase 2,Interventional,No Country Given,TOFAcitinib Plus Hydroxycloroquine vs Hydroxycloroquine in Patients With COVID-19 Interstitial Pneumonia,Drug,Tofacitinib + Hydroxycloroquine vs. Hydroxycloroquine,Tofacitinib; Hydroxycloroquine,116,https://clinicaltrials.gov/show/NCT04390061,EUCTR2020-002035-30
4432,NCT04390074,ClinicalTrials.gov,2020-05-14,2020-05-27,False,Uppsala University,Not Recruiting,Not Applicable,Observational,Sweden,COVID-19 in the Swedish ICU-cohort: Risk Factors of Critical Care Admission and Intensive Care Mortality,Clinical Presentation (Epidemiology),No Intervention,No Intervention,9905,https://clinicaltrials.gov/show/NCT04390074,None
4433,NCT04390126,ClinicalTrials.gov,2020-05-14,2020-04-20,True,CHU Dijon,Not Recruiting,Not Applicable,Observational,France,COVID-19 Related Lockdown Effects On Chronic Diseases,Other,Other,Other,1200,https://clinicaltrials.gov/show/NCT04390126,None
4434,NCT04390139,ClinicalTrials.gov,2020-05-07,2020-05-13,False,Banc de Sang i Teixits,Recruiting,Phase 1/Phase 2,Interventional,Spain,Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04390139,None
4435,NCT04390152,ClinicalTrials.gov,2020-05-12,2020-09-01,False,BioXcellerator,Not Recruiting,Phase 1/Phase 2,Interventional,Colombia,Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19,ATMP,Cells (mesenchymal),Cells (mesenchymal),40,https://clinicaltrials.gov/show/NCT04390152,None
4436,NCT04390165,ClinicalTrials.gov,2020-05-10,2020-05-01,True,Hospital Sultanah Bahiyah,Not Recruiting,Not Applicable,Observational,Malaysia,Malaysian COVID-19 Anosmia Study (Phase 1) - A Nationwide Multicentre Cross-Sectional Study,Clinical Presentation,No Intervention,No Intervention,760,https://clinicaltrials.gov/show/NCT04390165,None
4437,NCT04390178,ClinicalTrials.gov,2020-04-10,2020-04-10,False,Joakim Dillner,Not Recruiting,Phase 1/Phase 2,Interventional,Sweden,Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19),ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04390178,None
4438,NCT04390191,ClinicalTrials.gov,2020-05-12,2020-05-07,True,Icahn School of Medicine at Mount Sinai,Recruiting,Not Applicable,Interventional,United States,Early CPAP in COVID-19 Confirmed or Suspected Patients,Other (device),CPAP,CPAP,200,https://clinicaltrials.gov/show/NCT04390191,None
4439,NCT04390217,ClinicalTrials.gov,2020-05-13,2020-10-31,False,"Leading BioSciences, Inc",Not Recruiting,Phase 2,Interventional,No Country Given,LB1148 for Pulmonary Dysfunction Associated With COVID-19 Pneumonia,Drug,LB1148,LB1148,120,https://clinicaltrials.gov/show/NCT04390217,None
4440,NCT04390269,ClinicalTrials.gov,2020-05-12,2020-09-10,False,Mansoura University,Not Recruiting,Not Applicable,Observational,Egypt,Immunogenetics Predictors With COVID-19,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04390269,None
4441,NCT04390412,ClinicalTrials.gov,2020-05-13,2020-05-04,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 1/Phase 2,Interventional,Iran,Low Dose Radiotherapy in COVID-19 Pneumonia,Other,Radiation,Radiation,5,https://clinicaltrials.gov/show/NCT04390412,IRCT20200509047366N1
4442,NCT04390464,ClinicalTrials.gov,2020-05-08,2020-05-08,True,Cambridge University Hospitals NHS Foundation Trust,Recruiting,Phase 4,Interventional,United Kingdom,mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R),Drug,Ravulizumab vs. Baricitinib,Ravulizumab; Baricitinib,1167,https://clinicaltrials.gov/show/NCT04390464,EUCTR2020-001354-22; ISRCTN11188345
4443,NCT04390477,ClinicalTrials.gov,2020-05-07,2020-05-04,True,Bioithas SL,Recruiting,Not Applicable,Interventional,Spain,Study to Evaluate the Effect of a Probiotic in COVID-19,Supplement,Probiotics,Probiotics,40,https://clinicaltrials.gov/show/NCT04390477,None
4444,NCT04390503,ClinicalTrials.gov,2020-05-14,2020-05-01,True,Columbia University,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma for COVID-19 Close Contacts,ATMP,Plasma,Plasma,200,https://clinicaltrials.gov/show/NCT04390503,None
4445,NCT04390516,ClinicalTrials.gov,2020-05-14,2020-03-24,True,Dascena,Not Recruiting,Not Applicable,Interventional,United States,Respiratory Decompensation and Model for the Triage of COVID-19 Patients,Prognosis,No Intervention,No Intervention,197,https://clinicaltrials.gov/show/NCT04390516,None
4446,NCT04390555,ClinicalTrials.gov,2020-05-06,2020-04-30,True,University of Zurich,Recruiting,Not Applicable,Observational,Switzerland,The Global PCHF-COVICAV Registry,Clinical Presentation,No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04390555,None
4447,NCT04390594,ClinicalTrials.gov,2020-05-14,2020-08-13,False,Institut Pasteur,Recruiting,Phase 3,Interventional,Senegal,Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal,Drug,Hydroxychloroquine vs. Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,186,https://clinicaltrials.gov/show/NCT04390594,None
4448,NCT04391101,ClinicalTrials.gov,2020-05-08,2020-06-01,False,Hospital San Vicente Fundación,Not Recruiting,Phase 3,Interventional,Colombia,Convalescent Plasma for the Treatment of Severe SARS-CoV-2 (COVID-19),ATMP,Plasma,Plasma,231,https://clinicaltrials.gov/show/NCT04391101,None
4449,NCT04391127,ClinicalTrials.gov,2020-05-12,2020-05-04,True,Centenario Hospital Miguel Hidalgo,Not Recruiting,Phase 3,Interventional,Mexico,Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection,Drug,Hydroxychloroquine vs. Ivermectin,Hydroxychloroquine; Ivermectin,108,https://clinicaltrials.gov/show/NCT04391127,None
4450,NCT04391140,ClinicalTrials.gov,2020-05-10,2020-05-13,False,Vall d'Hebron Research Institute (VHIR),Recruiting,Not Applicable,Interventional,Spain,Prone Positioning and High-flow Nasal Cannula in COVID-19 Induced ARDS,Procedure,Positioning,Positioning,248,https://clinicaltrials.gov/show/NCT04391140,None
4451,NCT04391166,ClinicalTrials.gov,2020-05-15,2020-05-20,False,Vanderbilt University,Not Recruiting,Not Applicable,Observational,United States,Validity of at Home Visual Acuity Measurements for Telemedicine During Corona Virus (COVID-19) Pandemic,Telehealth,Telehealth,Telehealth,150,https://clinicaltrials.gov/show/NCT04391166,None
4452,NCT04391179,ClinicalTrials.gov,2020-05-15,2020-05-31,False,University of Michigan,Recruiting,Phase 2,Interventional,United States,Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19,Drug,Dipyridamole,Dipyridamole,80,https://clinicaltrials.gov/show/NCT04391179,None
4453,NCT04391309,ClinicalTrials.gov,2020-05-14,2020-07-01,False,Implicit Bioscience,Not Recruiting,Phase 2,Interventional,United States,IC14 (Anti-CD14) Treatment in Patients With SARS-CoV-2 (COVID-19),Drug,IC14,IC14,300,https://clinicaltrials.gov/show/NCT04391309,None
4454,NCT04391400,ClinicalTrials.gov,2020-05-14,2020-06-01,False,"Invivoscribe, Inc.",Not Recruiting,Not Applicable,Observational,No Country Given,"The Use of Peripheral Blood Specimens From Patients Suspected of Having SARS-CoV-2 Infections in Research Studies Intended to Support the Development of COVID-19 Detection Methods, Treatments, and/or Vaccines",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,https://clinicaltrials.gov/show/NCT04391400,None
4455,NCT04391686,ClinicalTrials.gov,2020-05-15,2020-07-03,False,Centre Hospitalier Arras,Recruiting,Not Applicable,Observational,France,Resting Energy Expenditure of the COronaVirus (COVID19) Patient in Reanimation Context,Clinical Presentation,No Intervention,No Intervention,90,https://clinicaltrials.gov/show/NCT04391686,None
4456,NCT04391712,ClinicalTrials.gov,2020-05-04,2020-04-30,True,Lowell General Hospital,Not Recruiting,Phase 2,Interventional,United States,Photobiomodulation Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease,Other (device),Cold Laser Therapy,Cold Laser Therapy,10,https://clinicaltrials.gov/show/NCT04391712,None
4457,NCT04391738,ClinicalTrials.gov,2020-05-14,2020-02-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,France,Association Between BMI and COVID-19,Clinical Presentation,No Intervention,No Intervention,1200,https://clinicaltrials.gov/show/NCT04391738,None
4458,NCT04391829,ClinicalTrials.gov,2020-05-13,2020-08-31,False,UZ Brussel,Recruiting,Not Applicable,Interventional,Belgium,Detection of SARS-CoV-2 in Semen of COVID-19 Positive Males,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04391829,None
4459,NCT04391881,ClinicalTrials.gov,2020-05-14,2020-05-30,False,Cairo University,Recruiting,Not Applicable,Observational,Egypt,Oral Manifestation of COVID 19 Patient: A Cross Sectional Study on Egyptian Population,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04391881,None
4460,NCT04391920,ClinicalTrials.gov,2020-05-12,2020-08-28,False,"CytoSorbents, Inc",Recruiting,Not Applicable,Observational,United States,Registry of CytoSorb Therapy in COVID-19 ICU Patients,Other (device),Cytokine Adsorber,Cytokine Adsorber,500,https://clinicaltrials.gov/show/NCT04391920,None
4461,NCT04391946,ClinicalTrials.gov,2020-05-13,2020-03-14,True,French Innovative Leukemia Organisation,Recruiting,Not Applicable,Observational,France,Observatory of Patients With Chronic Lymphocytic Leukemia / Lymphocytic Lymphoma or Waldenstrom Disease Infected With COVID-19,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04391946,None
4462,NCT04392089,ClinicalTrials.gov,2020-05-14,2020-05-01,True,"Copenhagen University Hospital, Hvidovre",Recruiting,Not Applicable,Observational,Denmark,Effects of Cardiovascular and Pulmonary Optimization on Cerebral Oxygenation in COVID-19 Patients With Severe ARDS,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04392089,None
4463,NCT04392115,ClinicalTrials.gov,2020-05-15,2020-06-15,False,Ottawa Hospital Research Institute,Not Recruiting,Not Applicable,Interventional,No Country Given,The PREPARE for COVID Trial,Other (exercise),Exercise,Exercise,372,https://clinicaltrials.gov/show/NCT04392115,None
4464,NCT04392128,ClinicalTrials.gov,2020-05-15,2020-09-02,False,Institut de Cancérologie Strasbourg Europe (ICANS),Not Recruiting,Phase 2,Interventional,France,Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE),Drug,Hydroxychloroquine vs. Azithromycin,Hydroxychloroquine; Azithromycin,0,https://clinicaltrials.gov/show/NCT04392128,None
4465,NCT04392141,ClinicalTrials.gov,2020-05-15,2020-04-01,False,Kermanshah University of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,Iran,Colchicine Plus Phenolic Monoterpenes to Treat COVID-19,Drug,Colchicine + Phenolic Monoterpenes,Colchicine; Phenolic Monoterpenes,200,https://clinicaltrials.gov/show/NCT04392141,IRCT20150623022884N3
4466,NCT04392219,ClinicalTrials.gov,2020-04-29,2020-04-10,True,Ridgeback Biotherapeutics,Not Recruiting,Phase 1,Interventional,"United Kingdom, United States","COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in Healthy Volunteers",Drug,EIDD-2801,EIDD-2801,130,https://clinicaltrials.gov/show/NCT04392219,None
4467,NCT04392232,ClinicalTrials.gov,2020-05-15,2020-05-05,True,TriHealth Inc.,Recruiting,Phase 2,Interventional,United States,A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04392232,None
4468,NCT04392245,ClinicalTrials.gov,2020-05-15,2020-04-15,True,Società Italiana di Chirurgia Colo-Rettale,Not Recruiting,Not Applicable,Observational,Italy,Proctologic Practice and Covid-19,Health System,No Intervention,No Intervention,1050,https://clinicaltrials.gov/show/NCT04392245,None
4469,NCT04392323,ClinicalTrials.gov,2020-05-15,2020-05-13,True,Northwell Health,Recruiting,Not Applicable,Interventional,United States,Incidence of COVID-19 Test Conversion in Post-surgical Patients,Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04392323,None
4470,NCT04392388,ClinicalTrials.gov,2020-05-15,2020-05-01,True,INSERM,Recruiting,Not Applicable,Observational,France,"Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis",Other,No Intervention,No Intervention,110000,https://clinicaltrials.gov/show/NCT04392388,None
4471,NCT04392401,ClinicalTrials.gov,2020-05-13,2020-05-11,True,Hospices Civils de Lyon,Recruiting,Not Applicable,Observational,France,COVID-19 - Study of the Kinetics of the Immune Response During the Intensive Care Unit Stay in Adult Patients Infected With SARS-CoV-2: Multicentric Non Interventional Study,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04392401,None
4472,NCT04392414,ClinicalTrials.gov,2020-05-13,2020-05-01,True,"Federal Research Clinical Center of Federal Medical & Biological Agency, Russia",Not Recruiting,Phase 2,Interventional,Russian Federation,Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04392414,None
4473,NCT04392427,ClinicalTrials.gov,2020-05-12,2020-10-01,False,Mansoura University,Not Recruiting,Phase 3,Interventional,Egypt,New Antiviral Drugs for Treatment of COVID-19,Drug,Nitazoxanide + Ribavirin + Ivermectin,Nitazoxanide; Ribavirin; Ivermectin,100,https://clinicaltrials.gov/show/NCT04392427,None
4474,NCT04392453,ClinicalTrials.gov,2020-05-15,2020-05-01,True,Fondazione Don Carlo Gnocchi Onlus,Not Recruiting,Not Applicable,Interventional,No Country Given,Upper Limb Robotic Rehabilitation During COVID-19 Outbreak,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,40,https://clinicaltrials.gov/show/NCT04392453,None
4475,NCT04392713,ClinicalTrials.gov,2020-05-05,2020-04-15,True,"Combined Military Hospital, Pakistan",Recruiting,Not Applicable,Interventional,Pakistan,Efficacy of Ivermectin in COVID-19,Drug,Ivermectin,Ivermectin,100,https://clinicaltrials.gov/show/NCT04392713,None
4476,NCT04392778,ClinicalTrials.gov,2020-04-25,2020-04-01,True,SBu Dr. Sadi Konuk Egitim ve Arastirma Hastanesi,Recruiting,Phase 1/Phase 2,Interventional,Turkey,Clinical Use of Stem Cells for the Treatment of Covid-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04392778,None
4477,NCT04392869,ClinicalTrials.gov,2020-05-09,2019-10-23,True,University of Granada,Not Recruiting,Not Applicable,Interventional,Spain,The Effects of Mindfulness-based Training in Undergraduate Students of Translation and Interpreting,Other (psych),Psychological,Psychological,75,https://clinicaltrials.gov/show/NCT04392869,None
4478,NCT04392973,ClinicalTrials.gov,2020-05-10,2020-05-21,False,King Abdullah International Medical Research Center,Recruiting,Not Applicable,Interventional,Saudi Arabia,FAvipiravir and HydroxyChloroquine Combination Therapy,Drug,Favipiravir + Hydroxychloroquine,Favipiravir; Hydroxychloroquine,520,https://clinicaltrials.gov/show/NCT04392973,None
4479,NCT04393038,ClinicalTrials.gov,2020-05-18,2020-05-01,True,Abivax S.A.,Recruiting,Phase 2/Phase 3,Interventional,"Germany, Italy, France, Belgium, Mexico, Brazil, United Kingdom, Spain",ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19,Drug,ABX464,ABX464,1034,https://clinicaltrials.gov/show/NCT04393038,PER-069-20; EUCTR2020-001673-75
4480,NCT04393051,ClinicalTrials.gov,2020-05-16,2020-05-20,False,AOU Pisana,Not Recruiting,Phase 2,Interventional,Italy,Baricitinib Compared to Standard Therapy in Patients With COVID-19,Drug,Baricitinib,Baricitinib,126,https://clinicaltrials.gov/show/NCT04393051,None
4481,NCT04393077,ClinicalTrials.gov,2020-05-11,2020-05-10,True,Istanbul Saglik Bilimleri University,Not Recruiting,Not Applicable,Interventional,Turkey,Emotional Freedom Technique (EFT) Effect on Nurses,Other (psych),Psychological,Psychological,80,https://clinicaltrials.gov/show/NCT04393077,None
4482,NCT04393142,ClinicalTrials.gov,2020-04-26,2020-05-05,False,Hospital Universitario Dr. Jose E. Gonzalez,Recruiting,Not Applicable,Observational,Mexico,Serologic Testing of Household Contacts of Confirmed Cases of COVID-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,92,https://clinicaltrials.gov/show/NCT04393142,None
4483,NCT04393233,ClinicalTrials.gov,2020-04-22,2020-04-23,False,"University Hospital, Brest",Recruiting,Not Applicable,Observational,France,Drug Management of Rheumatoid Arthritis in Covid-19 Context : Impact on Therapeutic De-escalation,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04393233,None
4484,NCT04393246,ClinicalTrials.gov,2020-05-16,2020-07-03,False,Cambridge University Hospitals NHS Foundation Trust,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Experimental Drugs and Mechanisms,Drug,EDP1815 vs. Ambrisentan + Dapagliflozin,EDP1815; Ambrisentan; Dapagliflozin,1407,https://clinicaltrials.gov/show/NCT04393246,None
4485,NCT04393311,ClinicalTrials.gov,2020-05-15,2020-12-01,False,Stanford University,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Ulinastatin for the Treatment of COVID-19 in Hospitalized Patients,Drug,Ulinastatin,Ulinastatin,160,https://clinicaltrials.gov/show/NCT04393311,None
4486,NCT04393324,ClinicalTrials.gov,2020-05-17,2020-04-24,True,"Hospital San Carlos, Madrid",Recruiting,Not Applicable,Observational,Spain,The Critical Care Response to the COVID-19 Pandemic in Madrid,Health System,No Intervention,No Intervention,2500,https://clinicaltrials.gov/show/NCT04393324,None
4487,NCT04393402,ClinicalTrials.gov,2020-05-15,2020-03-20,True,CHU de Nice,Recruiting,Not Applicable,Observational,France,Lung Ultrasound Score in Covid 19 Infectious Disease in Critical Care (LUS-COVID19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,14,https://clinicaltrials.gov/show/NCT04393402,None
4488,NCT04393415,ClinicalTrials.gov,2020-05-15,2020-05-25,False,Aljazeera Hospital,Recruiting,Not Applicable,Interventional,Egypt,Using PRP and Cord Blood in Treatment of Covid -19,ATMP,Cells (stem cells),Cells (stem cells),100,https://clinicaltrials.gov/show/NCT04393415,None
4489,NCT04393428,ClinicalTrials.gov,2020-05-14,2020-03-01,True,"University Hospital, Montpellier",Not Recruiting,Not Applicable,Observational,France,Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19),Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04393428,None
4490,NCT04393558,ClinicalTrials.gov,2020-05-16,2020-04-20,True,Shirley Ryan AbilityLab,Recruiting,Not Applicable,Observational,United States,Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms,Other (device),Biosensors,Biosensors,100,https://clinicaltrials.gov/show/NCT04393558,None
4491,NCT04393636,ClinicalTrials.gov,2020-05-11,2020-06-05,False,Academic Hospital Maastricht,Recruiting,Not Applicable,Interventional,Netherlands,Digital Cardiac Counseling Trial: DCC Trial,Other (software),eHealth,eHealth,394,https://clinicaltrials.gov/show/NCT04393636,None
4492,NCT04393649,ClinicalTrials.gov,2020-05-13,2020-04-20,True,Jewish General Hospital,Recruiting,Not Applicable,Observational,Canada,First Level Socio-geriatric Evaluation: ESOGER Databank,Other,No Intervention,No Intervention,20000,https://clinicaltrials.gov/show/NCT04393649,None
4493,NCT04393727,ClinicalTrials.gov,2020-05-16,2020-05-01,True,AOU Pisana,Not Recruiting,Phase 2,Interventional,Italy,Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19,ATMP,Plasma,Plasma,1,https://clinicaltrials.gov/show/NCT04393727,None
4494,NCT04393792,ClinicalTrials.gov,2020-05-18,2020-05-01,True,Hampshire Hospitals NHS Foundation Trust,Recruiting,Phase 1,Interventional,United Kingdom,SINUS WASH Pilot Study in Adults Testing Positive for COVID-19,Drug,Povidone Iodine,Povidone Iodine,40,https://clinicaltrials.gov/show/NCT04393792,EUCTR2020-001721-31
4495,NCT04393805,ClinicalTrials.gov,2020-05-16,2020-06-01,False,Quovadis Associazione,Recruiting,Not Applicable,Observational,Italy,Heparins for Thromboprophylaxis in COVID-19 Patients: HETHICO Study in Veneto,Drug,Heparin,Heparin,877,https://clinicaltrials.gov/show/NCT04393805,None
4496,NCT04393818,ClinicalTrials.gov,2020-05-18,2020-05-05,True,Fundació d'investigació Sanitària de les Illes Balears,Not Recruiting,Phase 3,Interventional,Spain,Mobile Phone Based Intervention to Protect Mental Health in Healthcare Workers at Frontline Against COVID19,Other (psych),Psychological,Psychological,560,https://clinicaltrials.gov/show/NCT04393818,None
4497,NCT04393948,ClinicalTrials.gov,2020-05-15,2020-06-01,False,Brigham and Women's Hospital,Recruiting,Not Applicable,Interventional,United States,Lung Irradiation for COVID-19 Pneumonia,Other,Radiation,Radiation,48,https://clinicaltrials.gov/show/NCT04393948,None
4498,NCT04393961,ClinicalTrials.gov,2020-04-24,2020-04-05,True,ProofPilot,Recruiting,Not Applicable,Interventional,United States,At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,600,https://clinicaltrials.gov/show/NCT04393961,None
4499,NCT04393974,ClinicalTrials.gov,2020-05-18,2020-03-24,True,Imperial College London,Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 and Cancer Patients,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04393974,None
4500,NCT04394000,ClinicalTrials.gov,2020-05-16,2020-05-04,True,Jessa Hospital,Not Recruiting,Not Applicable,Observational,Belgium,Impact of an Intensified Thromboprofylaxis Protocol in COVID-19,Drug,Heparin,Heparin,72,https://clinicaltrials.gov/show/NCT04394000,None
4501,NCT04394013,ClinicalTrials.gov,2020-05-18,2020-08-26,False,Monash University Malaysia,Recruiting,Not Applicable,Interventional,Malaysia,A Web-Based Gentle Body Stretching to Alleviate Loneliness and Improve Mental Fitness During COVID-19 Isolation Period,Other (psych),Psychological,Psychological,70,https://clinicaltrials.gov/show/NCT04394013,None
4502,NCT04394026,ClinicalTrials.gov,2020-05-15,2020-04-16,True,Francesco De Cobelli,Recruiting,Not Applicable,Observational,Italy,Imaging Feature of SARS-CoV2 Infection,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04394026,None
4503,NCT04394039,ClinicalTrials.gov,2020-05-13,2020-06-01,False,"National University, Singapore",Not Recruiting,Not Applicable,Interventional,Singapore,Post-Pandemic Perception of Public Space in Singapore,Other,No Intervention,No Intervention,34,https://clinicaltrials.gov/show/NCT04394039,None
4504,NCT04394078,ClinicalTrials.gov,2020-05-18,2020-05-06,True,Okan University,Not Recruiting,Not Applicable,Observational,Turkey,Impact of COVID-19 Pandemic on Depression and Quality of Life,Other (psych),No Intervention,No Intervention,543,https://clinicaltrials.gov/show/NCT04394078,None
4505,NCT04394117,ClinicalTrials.gov,2020-05-18,2020-06-19,False,The George Institute for Global Health,Recruiting,Phase 4,Interventional,Australia,Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease,Drug,ARBs,ARBs,605,https://clinicaltrials.gov/show/NCT04394117,None
4506,NCT04394169,ClinicalTrials.gov,2020-05-13,2020-05-25,False,Hospital Clinic of Barcelona,Recruiting,Not Applicable,Interventional,Spain,Early Care Program for the Management of Post-ICU Syndrome and Chronic Pain After COVID-19 Infection.,Other,Other,Other,102,https://clinicaltrials.gov/show/NCT04394169,None
4507,NCT04394182,ClinicalTrials.gov,2020-05-15,2020-04-21,True,Fundación Genesiscare,Recruiting,Not Applicable,Interventional,Spain,Ultra Low Doses of Therapy With Radiation Applicated to COVID-19,Other,"Radiation (with Lopinavir/ritonavir, Hydroxychloroquine, Azithromycin, Piperacillin/tazobactam, Heparin, Corticosteroids, Tocilizumab)",Radiation; Lopinavir/ritonavir; Hydroxychloroquine; Azithromycin; Piperacillin/tazobactam; Heparin; Methylprednisolone; Tocilizumab,15,https://clinicaltrials.gov/show/NCT04394182,None
4508,NCT04394195,ClinicalTrials.gov,2020-05-16,2020-03-25,True,CHU de Reims,Recruiting,Not Applicable,Observational,France,sFlt1: a Biomarker of Organ Dysfunction in Critically-ill Patients With COVID-19?,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04394195,None
4509,NCT04394208,ClinicalTrials.gov,2020-05-15,2020-08-16,False,Cairo University,Recruiting,Phase 3,Interventional,Egypt,Silymarin in COVID-19 Pneumonia,Drug,Silymarin,Silymarin,50,https://clinicaltrials.gov/show/NCT04394208,None
4510,NCT04394377,ClinicalTrials.gov,2020-05-08,2020-06-21,False,Brazilian Clinical Research Institute,Recruiting,Phase 4,Interventional,Brazil,Full Anticoagulation Versus Prophylaxis in COVID-19: COALIZAO ACTION Trial,Drug,Rivaroxaban + Heparin,Rivaroxaban; Heparin,600,https://clinicaltrials.gov/show/NCT04394377,None
4511,NCT04394390,ClinicalTrials.gov,2020-05-18,2020-05-01,True,Bursa City Hospital,Recruiting,Not Applicable,Observational,Turkey,Do Vitamin D Levels Really Correlated With Disease Severity in COVID-19 Patients?,Drug,Vitamin D,Vitamin D,100,https://clinicaltrials.gov/show/NCT04394390,None
4512,NCT04394403,ClinicalTrials.gov,2020-05-13,2020-05-14,False,Hebrew University of Jerusalem,Recruiting,Not Applicable,Interventional,Israel,Pilot Internet-based Self-Help Program for Managing Corona (COVID-19) Stress,Other (psych),Psychological,Psychological,120,https://clinicaltrials.gov/show/NCT04394403,None
4513,NCT04394416,ClinicalTrials.gov,2020-05-08,2020-06-02,False,"University of Maryland, Baltimore",Recruiting,Phase 3,Interventional,United States,Trial of Imatinib for Hospitalized Adults With COVID-19,Drug,Imatinib,Imatinib,204,https://clinicaltrials.gov/show/NCT04394416,None
4514,NCT04394429,ClinicalTrials.gov,2020-05-18,2020-04-24,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Endotracheal Tube Obstruction in Covid-19 Patients Requiring Mechanical Ventilation,Clinical Presentation,No Intervention,No Intervention,184,https://clinicaltrials.gov/show/NCT04394429,None
4515,NCT04394442,ClinicalTrials.gov,2020-05-17,2020-03-21,True,Samah Lutfy,Recruiting,Phase 2,Interventional,Saudi Arabia,Hydroxychloroquine in COVID-19 Patients,Drug,Hydroxychloroquine,Hydroxychloroquine,200,https://clinicaltrials.gov/show/NCT04394442,None
4516,NCT04394455,ClinicalTrials.gov,2020-05-03,2020-06-30,False,Universidad Nacional Autónoma de Honduras,Recruiting,Not Applicable,Interventional,Honduras,Brief Cognitive Behavioral Therapy Versus Crisis Intervention Therapy Through Telepsychiatry on Psychiatric Symptoms,Other (psych),Psychological,Psychological,236,https://clinicaltrials.gov/show/NCT04394455,None
4517,NCT04394793,ClinicalTrials.gov,2020-05-17,2020-06-13,False,All India Institute of Medical Sciences,Not Recruiting,Not Applicable,Interventional,India,Low Dose Radiation Therapy for Covid-19 Pneumonia,Other,Radiation,Radiation,10,https://clinicaltrials.gov/show/NCT04394793,None
4518,NCT04395105,ClinicalTrials.gov,2020-05-16,2020-05-21,False,Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno,Recruiting,Phase 3,Interventional,Argentina,"Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial",Drug,Corticosteroids,Dexamethasone,284,https://clinicaltrials.gov/show/NCT04395105,None
4519,NCT04395144,ClinicalTrials.gov,2020-05-15,2020-05-15,False,Hôpital de Verdun,Recruiting,Not Applicable,Interventional,Canada,COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss,Procedure,Positioning,Positioning,346,https://clinicaltrials.gov/show/NCT04395144,None
4520,NCT04395170,ClinicalTrials.gov,2020-05-15,2020-09-01,False,Lifefactors Zona Franca,Not Recruiting,Phase 2/Phase 3,Interventional,Colombia,Convalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19.,ATMP,Plasma vs. Immunoglobulin,Plasma; Immunoglobulin,75,https://clinicaltrials.gov/show/NCT04395170,None
4521,NCT04395300,ClinicalTrials.gov,2020-05-19,2020-03-30,True,Assiut University,Not Recruiting,Not Applicable,Observational,Egypt,Sleep Quality in Healthcare Personnel During COVID-19,Other (psych),No Intervention,No Intervention,143,https://clinicaltrials.gov/show/NCT04395300,None
4522,NCT04395391,ClinicalTrials.gov,2020-05-19,2020-05-18,True,Exact Sciences Corporation,Not Recruiting,Not Applicable,Observational,United States,Home Usability Study of the SARS-CoV-2 (COVID-19) Test,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,30,https://clinicaltrials.gov/show/NCT04395391,None
4523,NCT04395430,ClinicalTrials.gov,2020-02-03,2020-09-01,False,KK Women's and Children's Hospital,Not Recruiting,Not Applicable,Interventional,No Country Given,A Novel School-clinic-community Online Model of Child Obesity Treatment in Singapore During COVID-19,Other (exercise),Exercise,Exercise,40,https://clinicaltrials.gov/show/NCT04395430,None
4524,NCT04395456,ClinicalTrials.gov,2020-05-19,2020-07-01,False,Amyndas Pharmaceuticals S.A.,Not Recruiting,Phase 2,Interventional,No Country Given,A Phase 2 Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE),Drug,AMY-101,AMY-101,144,https://clinicaltrials.gov/show/NCT04395456,None
4525,NCT04395482,ClinicalTrials.gov,2020-05-18,2020-05-07,True,University of Milano Bicocca,Recruiting,Not Applicable,Observational,"San Marino, Italy",Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04395482,None
4526,NCT04395508,ClinicalTrials.gov,2020-05-15,2017-06-27,True,"Genentech, Inc.",Not Recruiting,Not Applicable,Expanded Access,United States,An Expanded Access Study to Provide at Home Subcutaneous Administration of Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Patients With HER2-Positive Breast Cancer During the COVID-19 Pandemic,Not relevant,Not relevant,Not relevant,Not Available,https://clinicaltrials.gov/show/NCT04395508,None
4527,NCT04395599,ClinicalTrials.gov,2020-05-19,2020-05-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Interventional,No Country Given,Risk of Air Contamination During Visceral Surgery in COVID19 Patients,Other,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04395599,None
4528,NCT04395664,ClinicalTrials.gov,2020-05-19,2020-04-16,True,"Copenhagen University Hospital, Herlev and Gentofte Hospital",Not Recruiting,Not Applicable,Observational,Denmark,Arrhythmias in Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04395664,None
4529,NCT04395716,ClinicalTrials.gov,2020-05-19,2020-07-01,False,ProgenaBiome,Not Recruiting,Phase 1,Interventional,United States,A Study of ResCureâ„¢ to Treat COVID-19 Infection,Drug,Unspecified Therapy,Unspecified Therapy,50,https://clinicaltrials.gov/show/NCT04395716,None
4530,NCT04395742,ClinicalTrials.gov,2020-05-14,2020-05-01,True,Poitiers University Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,"1,3,7-Trimethylxanthine as a Treatment of COVID-19: Results of a Controlled Study",Clinical Presentation,No Intervention,No Intervention,93,https://clinicaltrials.gov/show/NCT04395742,None
4531,NCT04395755,ClinicalTrials.gov,2020-05-19,2020-04-01,True,Ospedale Policlinico San Martino,Not Recruiting,Not Applicable,Observational,Italy,Impact of COVID-19 on Psychological Status in Case of IVF Interrupted or Postponed,Other (psych),No Intervention,No Intervention,503,https://clinicaltrials.gov/show/NCT04395755,None
4532,NCT04395768,ClinicalTrials.gov,2020-05-18,2020-09-09,False,"National Institute of Integrative Medicine, Australia",Recruiting,Phase 2,Interventional,Australia,International ALLIANCE Study of Therapies to Prevent Progression of COVID-19,Drug,Vitamin C + Hydroxychloroquine + Azithromycin + Zinc + Vitamin D + Vitamin B vs. Hydroxychloroquine + Azithromycin + Zinc + Vitamin D + Vitamin B ,Vitamin C; Hydroxychloroquine; Azithromycin; Zinc; Vitamin D; Vitamin B,200,https://clinicaltrials.gov/show/NCT04395768,None
4533,NCT04395781,ClinicalTrials.gov,2020-05-18,2020-05-18,False,KK Women's and Children's Hospital,Recruiting,Not Applicable,Observational,"Malaysia, Pakistan, Japan, India, Singapore, China, Indonesia",Pediatric Acute and Critical Care COVID-19 Registry of Asia,Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04395781,None
4534,NCT04395794,ClinicalTrials.gov,2020-05-19,2020-05-07,True,Meshalkin Research Institute of Pathology of Circulation,Recruiting,Not Applicable,Observational,Russian Federation,SARS-CoV-2 Disguise Study,Clinical Presentation (Epidemiology),No Intervention,No Intervention,900,https://clinicaltrials.gov/show/NCT04395794,None
4535,NCT04395807,ClinicalTrials.gov,2020-05-18,2020-06-03,False,Lund University,Recruiting,Not Applicable,Interventional,Sweden,Helmet CPAP Versus HFNC in COVID-19,Other (device),CPAP vs. Nasal cannula,CPAP; Nasal cannula,120,https://clinicaltrials.gov/show/NCT04395807,None
4536,NCT04395833,ClinicalTrials.gov,2020-05-15,2020-04-07,True,"University Hospital, Brest",Not Recruiting,Not Applicable,Observational,France,National Survey on the Lockdown of Children With Disabilities,Other,No Intervention,No Intervention,2500,https://clinicaltrials.gov/show/NCT04395833,None
4537,NCT04395859,ClinicalTrials.gov,2020-05-18,2020-05-27,False,Fondation Ophtalmologique Adolphe de Rothschild,Recruiting,Not Applicable,Observational,France,Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents,Clinical Presentation,No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04395859,None
4538,NCT04395872,ClinicalTrials.gov,2020-05-08,2020-05-28,False,Daegu Catholic University Medical Center,Not Recruiting,Not Applicable,Observational,No Country Given,Psychiatric Consultation for COVID-19 Patients,Other (psych),Psychological,Psychological,54,https://clinicaltrials.gov/show/NCT04395872,None
4539,NCT04395885,ClinicalTrials.gov,2020-05-19,2020-06-01,False,Assiut University,Not Recruiting,Not Applicable,Observational,Egypt,Sexual Function During COVID 19 Pandemic,Other (psych),No Intervention,No Intervention,306,https://clinicaltrials.gov/show/NCT04395885,None
4540,NCT04395924,ClinicalTrials.gov,2020-05-19,2020-05-05,True,Centre Hospitalier Régional d'Orleans,Recruiting,Not Applicable,Observational,France,Maternal-foetal Transmission of SARS-Cov-2,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04395924,None
4541,NCT04395976,ClinicalTrials.gov,2020-05-19,2020-06-10,False,British Ayurvedic Medical Council,Not Recruiting,Not Applicable,Interventional,United Kingdom,Ayurveda as Prophylaxis for Suspected COVID-19 Patients,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,120,https://clinicaltrials.gov/show/NCT04395976,None
4542,NCT04396067,ClinicalTrials.gov,2020-05-18,2020-10-01,False,Kafrelsheikh University,Not Recruiting,Phase 2,Interventional,No Country Given,Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative Treatment,Drug,Retinoic acid,Retinoic acid,360,https://clinicaltrials.gov/show/NCT04396067,None
4543,NCT04396106,ClinicalTrials.gov,2020-05-16,2020-05-26,True,"Atea Pharmaceuticals, Inc.",Recruiting,Phase 2,Interventional,"South Africa, Belgium, Brazil, United States, Moldova, Republic of, Ukraine, Romania",Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19),Drug,AT-527,AT-527,190,https://clinicaltrials.gov/show/NCT04396106,EUCTR2020-002869-34
4544,NCT04396197,ClinicalTrials.gov,2020-05-17,2020-03-01,True,University Hospital Birmingham NHS Foundation Trust,Not Recruiting,Not Applicable,Observational,United Kingdom,Physical Activity Levels in COVID-19 Patients Admitted to Intensive Care,Other (exercise),No Intervention,No Intervention,92,https://clinicaltrials.gov/show/NCT04396197,None
4545,NCT04396210,ClinicalTrials.gov,2020-05-18,2020-05-14,True,"University Hospital, Ghent",Not Recruiting,Not Applicable,Observational,Belgium,Patients Perspectives on Discontinuation of Their Fertility Treatment Due to the COVID-19 Pandemic,Other,No Intervention,No Intervention,389,https://clinicaltrials.gov/show/NCT04396210,None
4546,NCT04396314,ClinicalTrials.gov,2020-05-15,2021-01-01,False,University of Lleida,Not Recruiting,Not Applicable,Interventional,No Country Given,Effectiveness of Basic Body Awareness Therapy in Post-traumatic Stress Disorders: A Randomized Clinical Trial,Other (psych),Psychological,Psychological,54,https://clinicaltrials.gov/show/NCT04396314,None
4547,NCT04396353,ClinicalTrials.gov,2020-05-18,2020-06-04,False,University of São Paulo General Hospital,Not Recruiting,Not Applicable,Observational,Brazil,EXercise TRAining and Sedentary Lifestyle on Clinical Outcomes in Patients With COVID-19,Other (exercise),Exercise,Exercise,1574,https://clinicaltrials.gov/show/NCT04396353,None
4548,NCT04396600,ClinicalTrials.gov,2020-04-23,2020-06-08,False,University of Minnesota,Recruiting,Not Applicable,Observational,United States,The Professional Peer Resilience Initiative,Other (psych),Psychological,Psychological,1200,https://clinicaltrials.gov/show/NCT04396600,None
4549,NCT04397172,ClinicalTrials.gov,2020-05-20,2020-04-09,True,"University Hospital, Bern",Recruiting,Not Applicable,Observational,Switzerland,Intensive Care Associated Complications and Outcome of Acute Respiratory Distress Syndrome Due to COVID-19,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04397172,None
4550,NCT04397237,ClinicalTrials.gov,2020-05-19,2020-05-01,True,Pitié-Salpêtrière Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in Europe,Clinical Presentation (Epidemiology),No Intervention,No Intervention,3600,https://clinicaltrials.gov/show/NCT04397237,None
4551,NCT04397328,ClinicalTrials.gov,2020-05-13,2020-05-19,False,Lawson Health Research Institute,Not Recruiting,Phase 3,Interventional,No Country Given,COVID-19 PEP- High-risk Individuals in Long-term and Specialized Care - Canada,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,336,https://clinicaltrials.gov/show/NCT04397328,None
4552,NCT04397380,ClinicalTrials.gov,2020-05-16,2020-05-20,False,NHS Greater Glasgow and Clyde,Not Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 Thales Thermography Triage : Thermal Camera Feasibility Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04397380,None
4553,NCT04397471,ClinicalTrials.gov,2020-05-13,2020-05-01,True,University of Cambridge,Not Recruiting,Not Applicable,Observational,United Kingdom,A Study to Collect Bone Marrow for Process Development and Production of BM-MSC to Treat Severe COVID19 Pneumonitis,ATMP,Cells (mesenchymal),Cells (mesenchymal),10,https://clinicaltrials.gov/show/NCT04397471,None
4554,NCT04397497,ClinicalTrials.gov,2020-05-20,2020-05-22,False,IRCCS Ospedale San Raffaele,Not Recruiting,Phase 2,Interventional,Italy,Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19),Drug,Mavrilimumab,Mavrilimumab,50,https://clinicaltrials.gov/show/NCT04397497,None
4555,NCT04397523,ClinicalTrials.gov,2020-05-20,2020-04-30,True,Institute for Transfusion Medicine of RNM,Recruiting,Not Applicable,Interventional,North Macedonia,Efficacy and Safety of COVID-19 Convalescent Plasma,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04397523,None
4556,NCT04397562,ClinicalTrials.gov,2020-05-19,2020-04-29,True,Biocad,Not Recruiting,Phase 3,Interventional,Russian Federation,A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19,Drug,Levilimab,Levilimab,206,https://clinicaltrials.gov/show/NCT04397562,None
4557,NCT04397575,ClinicalTrials.gov,2020-05-13,2020-04-03,True,Federation Francophone de Cancerologie Digestive,Not Recruiting,Not Applicable,Observational,France,The GCO-002 CACOVID-19 Cohort: a French Nationwide Multicenter Study of COVID-19 Infected Cancer Patients,Clinical Presentation,No Intervention,No Intervention,1509,https://clinicaltrials.gov/show/NCT04397575,None
4558,NCT04397588,ClinicalTrials.gov,2020-05-19,2020-04-21,True,Rennes University Hospital,Recruiting,Not Applicable,Observational,France,Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19,Other,Oxygen,Oxygen,300,https://clinicaltrials.gov/show/NCT04397588,None
4559,NCT04397614,ClinicalTrials.gov,2020-05-20,2020-07-22,False,University of Oklahoma,Recruiting,Not Applicable,Observational,United States,Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer Patients,Other (software),eHealth,eHealth,500,https://clinicaltrials.gov/show/NCT04397614,None
4560,NCT04397666,ClinicalTrials.gov,2020-05-20,2020-05-15,True,Versailles Hospital,Recruiting,Not Applicable,Interventional,France,RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,68,https://clinicaltrials.gov/show/NCT04397666,None
4561,NCT04397692,ClinicalTrials.gov,2020-05-19,2020-06-13,False,Beyond Air Inc.,Recruiting,Not Applicable,Interventional,United States,Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial),Drug,Nitric Oxide,Nitric Oxide,20,https://clinicaltrials.gov/show/NCT04397692,None
4562,NCT04397705,ClinicalTrials.gov,2020-05-20,2020-06-01,False,The Christie NHS Foundation Trust,Not Recruiting,Phase 1,Interventional,United Kingdom,Remote Monitoring of Cancer Patients With Suspected Covid-19,Other (device),Biosensors,Biosensors,30,https://clinicaltrials.gov/show/NCT04397705,None
4563,NCT04397796,ClinicalTrials.gov,2020-05-18,2020-08-03,False,"NantKwest, Inc.",Recruiting,Phase 1,Interventional,United States,Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation,ATMP,Cells (mesenchymal),Cells (mesenchymal),45,https://clinicaltrials.gov/show/NCT04397796,None
4564,NCT04397822,ClinicalTrials.gov,2020-05-19,2020-04-16,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Observational,France,COVID-19 : Study of INFLAmmasome and PLAtelets Functions,Clinical Presentation,No Intervention,No Intervention,110,https://clinicaltrials.gov/show/NCT04397822,None
4565,NCT04397835,ClinicalTrials.gov,2020-04-21,2020-04-17,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Observational,France,Psychological Impact of COVID-19 Quarantine and Worsening of Cardiovascular Risk in the French General Population,Other (psych),No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04397835,None
4566,NCT04397848,ClinicalTrials.gov,2020-05-19,2020-05-14,True,"University Health Network, Toronto",Not Recruiting,Not Applicable,Observational,Canada,Mental Health Outcomes in Healthcare Workers During COVID-19,Other (psych),No Intervention,No Intervention,3852,https://clinicaltrials.gov/show/NCT04397848,None
4567,NCT04397900,ClinicalTrials.gov,2020-05-19,2020-04-09,True,"TScan Therapeutics, Inc.",Recruiting,Not Applicable,Observational,United States,Blood Collection Study From COVID-19 Convalescents Previously Hospitalized to Identify Immunogenic Viral Epitopes,Clinical Presentation,No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04397900,None
4568,NCT04397939,ClinicalTrials.gov,2020-05-19,2020-05-08,True,Icahn School of Medicine at Mount Sinai,Recruiting,Not Applicable,Observational,United States,Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04397939,None
4569,NCT04398004,ClinicalTrials.gov,2020-05-17,2020-05-06,True,Hellenic Institute for the Study of Sepsis,Not Recruiting,Phase 2,Interventional,Greece,Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early,Drug,Clarithromycin,Clarithromycin,90,https://clinicaltrials.gov/show/NCT04398004,EUCTR2020-001882-36
4570,NCT04398043,ClinicalTrials.gov,2020-05-19,2020-05-15,True,Hospital de Clínicas José de San Martín,Not Recruiting,Not Applicable,Observational,No Country Given,SARS-CoV 2 in Personal Protective Equipment,Other,No Intervention,No Intervention,16,https://clinicaltrials.gov/show/NCT04398043,None
4571,NCT04398147,ClinicalTrials.gov,2020-05-18,2020-08-01,False,CanSino Biologics Inc.,Not Recruiting,Phase 1/Phase 2,Interventional,Canada,Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Canada,ATMP,Vaccine,Vaccine,696,https://clinicaltrials.gov/show/NCT04398147,None
4572,NCT04398264,ClinicalTrials.gov,2020-05-20,2020-07-22,False,Inova Health System,Recruiting,Not Applicable,Observational,United States,Characteristics of COVID-19 Infection Among PREGnant Women,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04398264,None
4573,NCT04398277,ClinicalTrials.gov,2020-05-20,2020-05-01,True,Kent State University,Recruiting,Not Applicable,Interventional,United States,A Daily Coping Toolkit for Medical Personnel and First-Responders During COVID-19 Pandemic,Other (psych),Psychological,Psychological,1000,https://clinicaltrials.gov/show/NCT04398277,None
4574,NCT04398290,ClinicalTrials.gov,2020-05-20,2020-12-01,False,Roger Alvarez,Not Recruiting,Phase 2,Interventional,United States,iNOPulse for COVID-19,Drug,Nitric Oxide,Nitric Oxide,0,https://clinicaltrials.gov/show/NCT04398290,None
4575,NCT04398303,ClinicalTrials.gov,2020-05-20,2020-05-01,True,Aspire Health Science,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,ACT-20 in Patients With Severe COVID-19 Pneumonia,Drug,ACT-20,ACT-20,70,https://clinicaltrials.gov/show/NCT04398303,None
4576,NCT04399005,ClinicalTrials.gov,2020-05-19,2020-05-25,False,The First Affiliated Hospital of Zhejiang Chinese Medical University,Not Recruiting,Not Applicable,Interventional,China,The Efficacy Comparing Daily and After-each-case Room Disinfection.,Other,Other,Other,240,https://clinicaltrials.gov/show/NCT04399005,None
4577,NCT04399109,ClinicalTrials.gov,2020-05-21,2020-05-20,True,Dr. Sze-Yuan Ooi,Recruiting,Not Applicable,Interventional,Australia,Evaluation of a Remote Monitoring Smartphone Application and Care Model of COVID-19 Patients in the Community (ReCOVER),Other (software),eHealth,eHealth,2000,https://clinicaltrials.gov/show/NCT04399109,None
4578,NCT04399252,ClinicalTrials.gov,2020-05-19,2020-06-24,False,Duke University,Recruiting,Not Applicable,Interventional,United States,Effect of Lactobacillus on the Microbiome of Household Contacts Exposed to COVID-19,Supplement,Lactobaciltus rhamnosus,Lactobaciltus rhamnosus,1000,https://clinicaltrials.gov/show/NCT04399252,None
4579,NCT04399317,ClinicalTrials.gov,2020-05-18,2020-05-28,False,Hamad Medical Corporation,Recruiting,Not Applicable,Interventional,Qatar,Flow Controlled Ventilation in ARDS Associated With COVID-19,Other (physical),Mechanical ventilation,Mechanical ventilation,20,https://clinicaltrials.gov/show/NCT04399317,None
4580,NCT04399356,ClinicalTrials.gov,2020-05-19,2020-10-01,False,Tufts Medical Center,Recruiting,Phase 2,Interventional,United States,Niclosamide for Mild to Moderate COVID-19,Drug,Niclosamide,Niclosamide,100,https://clinicaltrials.gov/show/NCT04399356,None
4581,NCT04399603,ClinicalTrials.gov,2020-05-19,2020-05-18,True,Imperial College London,Not Recruiting,Not Applicable,Observational,United Kingdom,Mechanisms of Multi-organ Failure in COVID-19,Clinical Presentation,No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04399603,None
4582,NCT04399681,ClinicalTrials.gov,2020-05-21,2020-05-10,True,Kanuni Sultan Suleyman Training and Research Hospital,Recruiting,Not Applicable,Interventional,Turkey,The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04399681,None
4583,NCT04399733,ClinicalTrials.gov,2020-05-21,2021-02-01,False,Future Genetics Limited,Not Recruiting,Not Applicable,Observational,United Kingdom,EMPOWER - BAME vs COVID,Genomics,No Intervention,No Intervention,12800,https://clinicaltrials.gov/show/NCT04399733,None
4584,NCT04399746,ClinicalTrials.gov,2020-05-19,2020-03-15,True,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado,Recruiting,Not Applicable,Interventional,Mexico,Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19,Drug,Ivermectin + Azithromycin + Cholecalciferol,Ivermectin; Azithromycin; Cholecalciferol,30,https://clinicaltrials.gov/show/NCT04399746,None
4585,NCT04399798,ClinicalTrials.gov,2020-05-13,2020-05-15,False,IRCCS Policlinico San Matteo,Not Recruiting,Phase 2,Interventional,No Country Given,Baricitinib for coRona Virus pnEumonia (COVID-19): a THerapeutic Trial,Drug,Baricitinib,Baricitinib,13,https://clinicaltrials.gov/show/NCT04399798,None
4586,NCT04399889,ClinicalTrials.gov,2020-05-21,2020-06-18,False,"Joanne Kurtzberg, MD",Recruiting,Phase 1/Phase 2,Interventional,United States,hCT-MSCs for COVID19 ARDS,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04399889,None
4587,NCT04399967,ClinicalTrials.gov,2020-05-19,2020-06-13,False,University of Hong Kong,Recruiting,Not Applicable,Interventional,China,"COVID-19 Brief Advice and Chat-based Support for Smoking Cessation Via ""Quit to Win"" Contest 2020",Other,Other,Other,842,https://clinicaltrials.gov/show/NCT04399967,None
4588,NCT04399980,ClinicalTrials.gov,2020-05-21,2020-05-20,True,The Cleveland Clinic,Not Recruiting,Phase 2,Interventional,United States,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation,Drug,Mavrilimumab,Mavrilimumab,30,https://clinicaltrials.gov/show/NCT04399980,None
4589,NCT04400006,ClinicalTrials.gov,2020-05-21,2020-05-06,True,Marmara University,Not Recruiting,Not Applicable,Observational,Turkey,Ozone Therapy in the Prevention of COVID-19 Infection,Drug,Ozone,Ozone,71,https://clinicaltrials.gov/show/NCT04400006,None
4590,NCT04400019,ClinicalTrials.gov,2020-05-20,2020-09-01,False,University of Malaga,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1930,https://clinicaltrials.gov/show/NCT04400019,None
4591,NCT04400032,ClinicalTrials.gov,2020-04-27,2020-05-15,False,Ottawa Hospital Research Institute,Recruiting,Phase 1,Interventional,Canada,Cellular Immuno-Therapy for COVID-19 Acute Respiratory Distress Syndrome - Vanguard,ATMP,Cells (mesenchymal),Cells (mesenchymal),9,https://clinicaltrials.gov/show/NCT04400032,None
4592,NCT04400058,ClinicalTrials.gov,2020-05-21,2020-06-01,False,Octapharma,Recruiting,Phase 3,Interventional,United States,Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression,ATMP,Immunoglobulin,Immunoglobulin,208,https://clinicaltrials.gov/show/NCT04400058,None
4593,NCT04400279,ClinicalTrials.gov,2020-05-21,2020-06-01,False,University of British Columbia,Not Recruiting,Not Applicable,Interventional,Canada,The COVID-19 Pandemic and Exercise Study,Other (exercise),Exercise,Exercise,334,https://clinicaltrials.gov/show/NCT04400279,None
4594,NCT04400305,ClinicalTrials.gov,2020-05-21,2020-05-20,True,University of Victoria,Recruiting,Not Applicable,Interventional,Canada,"""Increasing Physical Activity in Canadian Adults Affected by COVID-19 Social Distancing Restrictions: A Feasibility Trial of an Online Intervention""",Other (software),eHealth,eHealth,40,https://clinicaltrials.gov/show/NCT04400305,None
4595,NCT04400448,ClinicalTrials.gov,2020-05-14,2020-06-01,False,Fundación para el Fomento de la Investigación Sanitaria y Biomedica de la Comunitat Valenciana,Not Recruiting,Not Applicable,Observational,No Country Given,Acceptance of Telemedicine During the COVID-19 Pandemic,Telehealth,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04400448,None
4596,NCT04400461,ClinicalTrials.gov,2020-05-20,2020-05-15,True,Fundación para la Investigación Biomédica Hospital Ramón y Cajal,Recruiting,Not Applicable,Observational,Spain,Short-term Physical Function Outcomes in Severe COVID-19 Patients Admitted to ICU for Invasive Mechanical Ventilation,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04400461,None
4597,NCT04400799,ClinicalTrials.gov,2020-05-15,2020-06-15,False,University of Zurich,Recruiting,Phase 3,Interventional,Switzerland,Enoxaparin for Primary Thromboprophylaxis in Ambulatory Patients With COVID-19,Drug,Heparin,Heparin,1000,https://clinicaltrials.gov/show/NCT04400799,None
4598,NCT04400812,ClinicalTrials.gov,2020-05-20,2020-05-19,True,Zagazig University,Recruiting,Not Applicable,Observational,Egypt,Attitude and Perception Towards COVID-19 Pandemic,Other,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04400812,None
4599,NCT04400877,ClinicalTrials.gov,2020-05-22,2020-06-08,False,"University Hospital, Linköping",Not Recruiting,Not Applicable,Observational,Sweden,Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,7795,https://clinicaltrials.gov/show/NCT04400877,None
4600,NCT04400890,ClinicalTrials.gov,2020-05-22,2020-09-12,False,Dr. Marvin McCreary,Recruiting,Phase 2,Interventional,United States,Randomized Proof-of-Concept Trial to Evaluate the Safety and Explore the Effectiveness of a Plant Polyphenol for COVID-19,Drug,Resveratrol,Resveratrol,200,https://clinicaltrials.gov/show/NCT04400890,None
4601,NCT04400929,ClinicalTrials.gov,2020-05-08,2020-06-02,False,Singapore General Hospital,Recruiting,Phase 2,Interventional,Singapore,Using GM-CSF as a Host Directed Therapeutic Against COVID-19,Drug,Sargramostim,Sargramostim,30,https://clinicaltrials.gov/show/NCT04400929,None
4602,NCT04401033,ClinicalTrials.gov,2020-05-21,2020-05-11,True,Hospital Universitario Río Hortega,Not Recruiting,Not Applicable,Observational,Spain,Increased Risk of SARS-CoronaVirus-2 (SARS-CoV-2) Infection Associated With Endoscopy (DECORE Study),Other,No Intervention,No Intervention,450,https://clinicaltrials.gov/show/NCT04401033,None
4603,NCT04401046,ClinicalTrials.gov,2020-05-22,2020-05-20,True,Institut Paoli-Calmettes,Recruiting,Not Applicable,Interventional,France,COVID-19 and Reorganisation of Cancer Patient Care: Self- Evaluation of Potential Post-traumatic Stress Disorder,Other (psych),No Intervention,No Intervention,4000,https://clinicaltrials.gov/show/NCT04401046,None
4604,NCT04401072,ClinicalTrials.gov,2020-05-22,2020-04-24,True,Damanhour University,Recruiting,Not Applicable,Observational,Egypt,Attitude of Egyptian Population Toward COVID 19 in Ramadan,Other,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04401072,None
4605,NCT04401085,ClinicalTrials.gov,2020-05-21,2020-04-23,True,Institute of Health Information and Statistics of the Czech Republic,Not Recruiting,Not Applicable,Observational,Czech Republic,COVID-19: Herd Immunity Study in the Czech Republic,Clinical Presentation (Epidemiology),No Intervention,No Intervention,27000,https://clinicaltrials.gov/show/NCT04401085,None
4606,NCT04401098,ClinicalTrials.gov,2020-05-22,2020-05-02,True,Damanhour University,Recruiting,Not Applicable,Observational,Egypt,Changing Of Egyptian Population Behaviour Towards COVID 19 Outbreak,Other,No Intervention,No Intervention,700,https://clinicaltrials.gov/show/NCT04401098,None
4607,NCT04401111,ClinicalTrials.gov,2020-05-22,2020-06-16,False,CHU de Nice,Recruiting,Not Applicable,Observational,France,One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU),Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04401111,None
4608,NCT04401124,ClinicalTrials.gov,2020-05-22,2020-05-25,False,Beijing Friendship Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Status of Management of Surgery in Beijing During COVID-19,Health System,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04401124,None
4609,NCT04401150,ClinicalTrials.gov,2020-05-21,2020-08-14,False,University of Sherbrooke,Recruiting,Phase 3,Interventional,Canada,Lessening Organ Dysfunction With VITamin C - COVID-19,Drug,Vitamin C,Vitamin C,800,https://clinicaltrials.gov/show/NCT04401150,None
4610,NCT04401163,ClinicalTrials.gov,2020-05-12,2020-05-01,True,Aarhus University,Not Recruiting,Not Applicable,Observational,Denmark,Long-term Pulmonary Outcomes After Infection With Sars-CoV-2,Clinical Presentation,No Intervention,No Intervention,180,https://clinicaltrials.gov/show/NCT04401163,None
4611,NCT04401202,ClinicalTrials.gov,2020-05-21,2020-05-21,False,King Abdulaziz University,Recruiting,Phase 2,Interventional,Saudi Arabia,Nigella Sativa in COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,200,https://clinicaltrials.gov/show/NCT04401202,None
4612,NCT04401228,ClinicalTrials.gov,2020-05-21,2020-03-01,True,Clinique Saint Pierre Ottignies,Not Recruiting,Not Applicable,Observational,Belgium,Predictive Models for Intensive Care Admission and Death of COVID-19,Prognosis,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04401228,None
4613,NCT04401241,ClinicalTrials.gov,2020-05-18,2020-02-01,True,Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida,Not Recruiting,Not Applicable,Observational,Monaco,How Routine Biomarkers and Blood Leucocytes Count Can Assist Diagnosis of COVID-19 in Emergency Department,Clinical Presentation,No Intervention,No Intervention,257,https://clinicaltrials.gov/show/NCT04401241,None
4614,NCT04401254,ClinicalTrials.gov,2020-05-07,2020-07-01,False,Australian and New Zealand Intensive Care Research Centre,Recruiting,Not Applicable,Observational,Australia,Recovery of Patients From COVID-19 After Critical Illness,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04401254,None
4615,NCT04401371,ClinicalTrials.gov,2020-05-21,2020-05-01,True,Cairo University,Not Recruiting,Not Applicable,Observational,Egypt,Distance Learning for Dental Student During COVID-19 Pandemic,Other,No Intervention,No Intervention,418,https://clinicaltrials.gov/show/NCT04401371,None
4616,NCT04401410,ClinicalTrials.gov,2020-05-21,2020-11-04,False,Baylor University,Recruiting,Phase 1,Interventional,United States,Anti-SARS Cov-2 T Cell Infusions for COVID 19,ATMP,Cells (T),Cells (T),58,https://clinicaltrials.gov/show/NCT04401410,None
4617,NCT04401423,ClinicalTrials.gov,2020-05-21,2020-08-01,False,Columbia University,Recruiting,Phase 2,Interventional,United States,TXA127 for the Treatment of Severe COVID-19,Drug,TXA127,TXA127,100,https://clinicaltrials.gov/show/NCT04401423,None
4618,NCT04401436,ClinicalTrials.gov,2020-05-22,2020-05-22,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Not Applicable,Observational,United States,COVID-19 Associated Lymphopenia Pathogenesis Study in Blood (CALYPSO),Clinical Presentation,No Intervention,No Intervention,175,https://clinicaltrials.gov/show/NCT04401436,None
4619,NCT04401475,ClinicalTrials.gov,2020-05-21,2020-09-01,False,Edesa Biotech Inc.,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients With Moderate to Severe COVID-19",Drug,EB05,EB05,865,https://clinicaltrials.gov/show/NCT04401475,None
4620,NCT04401527,ClinicalTrials.gov,2020-05-21,2020-07-22,False,Hope Pharmaceuticals,Not Recruiting,Phase 2,Interventional,United States,Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite,Drug,Sodium Nitrite,Sodium Nitrite,0,https://clinicaltrials.gov/show/NCT04401527,None
4621,NCT04401540,ClinicalTrials.gov,2020-05-22,2020-05-01,True,Recep Tayyip Erdogan University Training and Research Hospital,Recruiting,Not Applicable,Observational,Turkey,Characteristics of Neonatal Covid-19 in Turkey,Clinical Presentation,No Intervention,No Intervention,90,https://clinicaltrials.gov/show/NCT04401540,None
4622,NCT04401644,ClinicalTrials.gov,2020-05-15,2020-06-01,False,Somerset NHS Foundation Trust,Not Recruiting,Not Applicable,Interventional,United Kingdom,COVID-19: Laser Interferometry for Rapid Single Coronavirus Detection,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,250,https://clinicaltrials.gov/show/NCT04401644,None
4623,NCT04402060,ClinicalTrials.gov,2020-05-22,2020-05-28,False,"Apellis Pharmaceuticals, Inc.",Recruiting,Phase 1/Phase 2,Interventional,"United States, Brazil",A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19,Drug,APL-9,APL-9,66,https://clinicaltrials.gov/show/NCT04402060,None
4624,NCT04402203,ClinicalTrials.gov,2020-05-19,2020-05-01,True,Bangladesh Medical Research Council (BMRC),Recruiting,Phase 2/Phase 3,Interventional,Bangladesh,Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh,Drug,Favipiravir,Favipiravir,50,https://clinicaltrials.gov/show/NCT04402203,None
4625,NCT04402229,ClinicalTrials.gov,2020-05-21,2020-05-12,True,Versailles Hospital,Not Recruiting,Not Applicable,Observational,France,Psychological Impact of the Covid-19 Pandemic on Student Nurses,Other (psych),No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04402229,None
4626,NCT04402814,ClinicalTrials.gov,2020-05-22,2020-05-05,True,Dr. Fadi Haddad,Recruiting,Not Applicable,Observational,United States,IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With the Standard Method of COVID19 Testing.,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,90,https://clinicaltrials.gov/show/NCT04402814,None
4627,NCT04402827,ClinicalTrials.gov,2020-05-23,2020-08-01,False,Asociación para el Estudio de las Enfermedades Infecciosas,Recruiting,Not Applicable,Observational,Spain,Different Susceptibility to SARS CoV-2 Infection Among Health Care Workers Highly Exposed to COVID-19.,Clinical Presentation,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04402827,None
4628,NCT04402840,ClinicalTrials.gov,2020-05-22,2020-04-24,True,West Virginia University,Recruiting,Not Applicable,Interventional,United States,Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS),Procedure,Stellate Ganglion Block,Stellate Ganglion Block,5,https://clinicaltrials.gov/show/NCT04402840,None
4629,NCT04402866,ClinicalTrials.gov,2020-05-22,2020-06-24,True,Theravance Biopharma,Recruiting,Phase 2,Interventional,"United Kingdom, Moldova, Republic of, Ukraine, Romania",TD-0903 for ALI Associated With COVID-19,Drug,TD-0903,TD-0903,222,https://clinicaltrials.gov/show/NCT04402866,EUCTR2020-001807-18
4630,NCT04402879,ClinicalTrials.gov,2020-05-22,2020-11-10,False,University of Calgary,Recruiting,Not Applicable,Interventional,Canada,CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals,Procedure,Positioning,Positioning,596,https://clinicaltrials.gov/show/NCT04402879,None
4631,NCT04402892,ClinicalTrials.gov,2020-05-19,2020-06-01,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19: SARS-CoV-2 Specific Memory B and T-CD4+ Cells,Clinical Presentation,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04402892,None
4632,NCT04402905,ClinicalTrials.gov,2020-05-20,2020-06-15,False,Centre de Recherches et d'Études Surla Pathologie Tropicale,Recruiting,Not Applicable,Observational,France,"Observational Study in Diagnosed Patients COVID-19, Supported on an Outpatient Basis. (COVID-PSL)",Clinical Presentation,No Intervention,No Intervention,450,https://clinicaltrials.gov/show/NCT04402905,None
4633,NCT04402918,ClinicalTrials.gov,2020-05-18,2020-05-17,True,CHU de Besançon,Recruiting,Not Applicable,Interventional,France,Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy,Clinical Presentation,No Intervention,No Intervention,160,https://clinicaltrials.gov/show/NCT04402918,None
4634,NCT04402944,ClinicalTrials.gov,2020-05-12,2020-07-05,False,Boston Children's Hospital,Recruiting,Phase 2,Interventional,United States,Pulmozyme to Improve COVID-19 ARDS Outcomes,Drug,Dornase alfa,Dornase alfa,60,https://clinicaltrials.gov/show/NCT04402944,None
4635,NCT04403009,ClinicalTrials.gov,2020-04-21,2020-02-01,True,The First Affiliated Hospital of Guangzhou Medical University,Recruiting,Not Applicable,Observational,China,The Clinical Difference Between the Nonfatal Patients and the Fatal Patients With Severe COVID-19,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04403009,None
4636,NCT04403035,ClinicalTrials.gov,2020-05-21,2020-05-10,True,Ascension South East Michigan,Recruiting,Not Applicable,Observational,United States,Comparison of the ID NOW and Accula Point-of-Care Assays for Detection of COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04403035,None
4637,NCT04403061,ClinicalTrials.gov,2020-05-23,2020-05-22,True,Asociación para el Estudio de las Enfermedades Infecciosas,Recruiting,Not Applicable,Observational,Spain,Th1/Th2/Th17/TREG and TLRs Activation/KIR for COVID 19 Prediction of Outcome,Prognosis,No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04403061,None
4638,NCT04403100,ClinicalTrials.gov,2020-05-23,2020-06-03,False,Cardresearch,Recruiting,Phase 3,Interventional,Brazil,"Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: ""The Hope Coalition - 1""",Drug,Hydroxychloroquine + Lopinavir/ritonavir vs. Hydroxychloroquine vs. Lopinavir/ritonavir,Hydroxychloroquine; Lopinavir/ritonavir,1968,https://clinicaltrials.gov/show/NCT04403100,None
4639,NCT04403243,ClinicalTrials.gov,2020-05-20,2020-05-08,True,Lomonosov Moscow State University Medical Research and Educational Center,Recruiting,Phase 2,Interventional,Russian Federation,COLchicine Versus Ruxolitinib and Secukinumab In Open Prospective Randomized Trial,Drug,Colchicine vs. Ruxolitinib vs. Secukinumab,Colchicine; Ruxolitinib; Secukinumab,70,https://clinicaltrials.gov/show/NCT04403243,None
4640,NCT04403269,ClinicalTrials.gov,2020-05-18,2020-05-05,True,Versailles Hospital,Recruiting,Phase 2,Interventional,France,"NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER, COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE",ATMP,Immunoglobulin,Immunoglobulin,35,https://clinicaltrials.gov/show/NCT04403269,None
4641,NCT04403438,ClinicalTrials.gov,2020-05-23,2020-04-01,True,Istanbul University,Recruiting,Not Applicable,Observational,Turkey,Familial Mediterranean Fever and BehÃ§et: Analysis Before and After Covid19 Pandemic,Clinical Presentation,No Intervention,No Intervention,45,https://clinicaltrials.gov/show/NCT04403438,None
4642,NCT04403477,ClinicalTrials.gov,2020-05-20,2020-05-20,False,Bangabandhu Sheikh Mujib Medical University,Recruiting,Phase 2,Interventional,Bangladesh,Convalescent Plasma Therapy in Severe COVID-19 Infection,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04403477,None
4643,NCT04403555,ClinicalTrials.gov,2020-05-23,2020-06-01,False,Tanta University,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Ivermectin and Doxycycine in COVID-19 Treatment,Drug,Ivermectin + Doxycycine vs. Chloroquine,Ivermectin; Doxycycline; Chloroquine,200,https://clinicaltrials.gov/show/NCT04403555,None
4644,NCT04403581,ClinicalTrials.gov,2020-05-19,2020-05-01,True,Ain Shams University,Not Recruiting,Not Applicable,Observational,No Country Given,"Egyptian Doctors Stresses, Knowledge and Attitude During COVID-19 Pandemic",Other (psych),No Intervention,No Intervention,384,https://clinicaltrials.gov/show/NCT04403581,None
4645,NCT04403607,ClinicalTrials.gov,2020-05-20,2020-05-22,False,NHS Greater Glasgow and Clyde,Recruiting,Not Applicable,Observational,United Kingdom,Cardiac Imaging in SARS-CoV-2 (COVID-19),Clinical Presentation,No Intervention,No Intervention,180,https://clinicaltrials.gov/show/NCT04403607,None
4646,NCT04403646,ClinicalTrials.gov,2020-05-22,2020-06-01,False,Hospital de Clínicas José de San Martín,Not Recruiting,Not Applicable,Interventional,No Country Given,Tannin Specific Natural Extract for COVID-19 Infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,140,https://clinicaltrials.gov/show/NCT04403646,None
4647,NCT04403672,ClinicalTrials.gov,2020-05-24,2020-05-18,True,Bangladesh Medical Research Council (BMRC),Recruiting,Not Applicable,Observational,Bangladesh,Performance Evaluation of RealDetectâ„¢ COVID-19 RT-PCR Kit for the Detection of SARS-CoV-2 Virus,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,120,https://clinicaltrials.gov/show/NCT04403672,None
4648,NCT04403685,ClinicalTrials.gov,2020-05-24,2020-05-08,True,Beneficência Portuguesa de São Paulo,Not Recruiting,Phase 3,Interventional,Brazil,Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers,Drug,Tocilizumab,Tocilizumab,129,https://clinicaltrials.gov/show/NCT04403685,None
4649,NCT04403828,ClinicalTrials.gov,2020-05-24,2020-05-20,True,Fayoum University,Not Recruiting,Not Applicable,Observational,Egypt,Impact of COVID-19 on Personal Protection Among Dentist in Egypt,Other,No Intervention,No Intervention,323,https://clinicaltrials.gov/show/NCT04403828,None
4650,NCT04403906,ClinicalTrials.gov,2020-05-21,2020-06-01,False,Somerset NHS Foundation Trust,Not Recruiting,Not Applicable,Interventional,United Kingdom,Somerset and South Essex Coronavirus Antigen Testing,Clinical Presentation (Epidemiology),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04403906,None
4651,NCT04403932,ClinicalTrials.gov,2020-05-24,2020-04-17,True,"Hospital San Carlos, Madrid",Recruiting,Not Applicable,Observational,Spain,Increased Risk of Severe Coronavirus Disease 2019 in Patients With Vitamin D Deficiency,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04403932,None
4652,NCT04404062,ClinicalTrials.gov,2020-05-22,2020-03-16,True,Richmond Pharmacology Limited,Not Recruiting,Not Applicable,Observational,United Kingdom,Validation of COVID-19 Tests,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,https://clinicaltrials.gov/show/NCT04404062,None
4653,NCT04404179,ClinicalTrials.gov,2020-05-24,2020-03-27,True,"Services Institute of Medical Sciences, Pakistan",Not Recruiting,Not Applicable,Observational,Pakistan,Setting up a COVID-19 Care Facility at a Prison in Pakistan,Other,No Intervention,No Intervention,69,https://clinicaltrials.gov/show/NCT04404179,None
4654,NCT04404192,ClinicalTrials.gov,2020-05-21,2020-11-01,False,"VistaGen Therapeutics, Inc.",Not Recruiting,Phase 2,Interventional,United States,PH94B in the Treatment of Adjustment Disorder With Anxiety,Other (psych),PH94B,PH94B,30,https://clinicaltrials.gov/show/NCT04404192,None
4655,NCT04404218,ClinicalTrials.gov,2020-05-24,2020-08-04,False,"University Health Network, Toronto",Recruiting,Phase 2,Interventional,Canada,The AÃ§aÃ­ Berry COVID-19 Anti-Inflammation Trial,Supplement,Acai Berry,Acai Berry,480,https://clinicaltrials.gov/show/NCT04404218,None
4656,NCT04404244,ClinicalTrials.gov,2020-05-25,2020-01-01,True,Fatma Soliman Elsayed Ebeid,Recruiting,Not Applicable,Observational,Egypt,Extraordinary Measures for Egyptian Children With Hemato-Oncological Disorders During COVID-19 Pandemic,Other,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04404244,None
4657,NCT04404270,ClinicalTrials.gov,2020-05-25,2020-05-26,False,Direction Centrale du Service de Sant des Armes,Recruiting,Not Applicable,Observational,France,Study of SARS-CoV2 Virus (COVID-19) Seroprevalence in the Population of Creil Air Force Base (BA110),Clinical Presentation (Epidemiology),No Intervention,No Intervention,2500,https://clinicaltrials.gov/show/NCT04404270,None
4658,NCT04404426,ClinicalTrials.gov,2020-05-22,2020-11-02,False,Rennes University Hospital,Recruiting,Not Applicable,Interventional,France,CACOLAC : Citrulline Administration in the Hospital Patient in Intensive Care for COVID-19 Acute Respiratory Distress Syndrome,Drug,Citrulline,Citrulline,100,https://clinicaltrials.gov/show/NCT04404426,None
4659,NCT04404608,ClinicalTrials.gov,2020-05-23,2020-06-01,False,Dr. Medhat Khafagy,Not Recruiting,Not Applicable,Observational,No Country Given,Etiology of Lymphopenia in Covid19 Infection,Clinical Presentation,No Intervention,No Intervention,90,https://clinicaltrials.gov/show/NCT04404608,None
4660,NCT04405076,ClinicalTrials.gov,2020-05-13,2020-05-29,False,"ModernaTX, Inc.",Not Recruiting,Phase 2,Interventional,United States,"Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older",ATMP,Vaccine,Vaccine,600,https://clinicaltrials.gov/show/NCT04405076,None
4661,NCT04405102,ClinicalTrials.gov,2020-05-26,2020-09-16,False,Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec,Recruiting,Phase 2,Interventional,Canada,COVID-19 Ozanimod Intervention Study,Drug,Ozanimod,Ozanimod,48,https://clinicaltrials.gov/show/NCT04405102,None
4662,NCT04405232,ClinicalTrials.gov,2020-05-26,2020-05-25,True,Imperial College London,Recruiting,Not Applicable,Observational,United Kingdom,Coagulopathy in COVID19 - A Multi-Centre Observational Study in UK,Clinical Presentation,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04405232,None
4663,NCT04405271,ClinicalTrials.gov,2020-05-26,2020-07-31,False,Hospital Italiano de Buenos Aires,Not Recruiting,Phase 3,Interventional,Argentina,TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study),Drug (Chemoprophylaxis),Emtricitabine + Tenofovir alafenamide,Emtricitabine; Tenofovir alafenamide,1378,https://clinicaltrials.gov/show/NCT04405271,None
4664,NCT04405284,ClinicalTrials.gov,2020-05-26,2020-06-04,False,Helwan University,Not Recruiting,Not Applicable,Observational,Egypt,The Use of Disinfectants Among Women in Egypt and the Toxicity by Bleach During the Coronavirus Lock-down.,Other,No Intervention,No Intervention,425,https://clinicaltrials.gov/show/NCT04405284,None
4665,NCT04405310,ClinicalTrials.gov,2020-05-26,2020-05-20,True,Grupo Mexicano para el Estudio de la Medicina Intensiva,Recruiting,Phase 2,Interventional,Mexico,Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial,ATMP,Plasma,Plasma,80,https://clinicaltrials.gov/show/NCT04405310,None
4666,NCT04405362,ClinicalTrials.gov,2020-05-18,2020-05-01,True,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Consequences of the QUARANTINE Relating to the COvid-19 Epidemic on the Mental Health of the Patients Followed in PSYchiatry,Other (psych),No Intervention,No Intervention,753,https://clinicaltrials.gov/show/NCT04405362,None
4667,NCT04405466,ClinicalTrials.gov,2020-05-19,2020-04-22,True,Miltenyi Biomedicine GmbH,Recruiting,Not Applicable,Observational,Germany,A Study to Assess the Feasibility of Screening for SARS-CoV-2 Among Healthy Workers,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,https://clinicaltrials.gov/show/NCT04405466,None
4668,NCT04405492,ClinicalTrials.gov,2020-05-19,2020-05-25,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,No Country Given,"Evaluation of Rapid Diagnostic Solutions, Serological and Molecular Tests for COVID-19",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1210,https://clinicaltrials.gov/show/NCT04405492,None
4669,NCT04405544,ClinicalTrials.gov,2020-05-26,2020-05-22,True,Ministry of Health of Russia,Not Recruiting,Not Applicable,Interventional,Russian Federation,Determination of Acute Encephalopathy Predictors in Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,51,https://clinicaltrials.gov/show/NCT04405544,None
4670,NCT04405726,ClinicalTrials.gov,2020-05-25,2020-03-27,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Prognostic Factors of COVID19,Prognosis,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04405726,None
4671,NCT04405869,ClinicalTrials.gov,2020-05-25,2020-04-29,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Thromboembolic Events in Severe COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04405869,None
4672,NCT04405908,ClinicalTrials.gov,2020-05-25,2020-06-19,False,Clover Biopharmaceuticals,Recruiting,Phase 1,Interventional,Australia,SCB-2019 as COVID-19 Vaccine,ATMP,Vaccine,Vaccine,150,https://clinicaltrials.gov/show/NCT04405908,None
4673,NCT04405921,ClinicalTrials.gov,2020-05-26,2020-07-01,False,Centre Hôpital Universitaire Farhat Hached,Not Recruiting,Phase 3,Interventional,Tunisia,"Hydroxychloroquine, Azithromycin in the Treatment of Covid-19",Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Hydroxychloroquine; Azithromycin,200,https://clinicaltrials.gov/show/NCT04405921,None
4674,NCT04405934,ClinicalTrials.gov,2020-05-07,2020-07-01,False,"University College, London",Not Recruiting,Not Applicable,Interventional,No Country Given,COG-UK Project Hospital-Onset COVID-19 Infections Study,Genomics,Genomics,Genomics,2000,https://clinicaltrials.gov/show/NCT04405934,None
4675,NCT04405973,ClinicalTrials.gov,2020-05-25,2020-05-19,True,Dr. Alexander Supady,Not Recruiting,Not Applicable,Observational,Germany,Clinical Scores for Outcome Prediction in Patients With Severe COVID-19 Pneumonia Requiring ECMO,Prognosis,No Intervention,No Intervention,133,https://clinicaltrials.gov/show/NCT04405973,None
4676,NCT04405986,ClinicalTrials.gov,2020-05-08,2020-05-19,False,"University Hospital, Bordeaux",Recruiting,Not Applicable,Interventional,France,Exploring Brain Damages After COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,38,https://clinicaltrials.gov/show/NCT04405986,None
4677,NCT04405999,ClinicalTrials.gov,2020-05-18,2020-05-14,True,"Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health",Not Recruiting,Phase 4,Interventional,Russian Federation,Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease,Drug (Chemoprophylaxis),Bromhexine hydrochloride,Bromhexine hydrochloride,50,https://clinicaltrials.gov/show/NCT04405999,None
4678,NCT04406038,ClinicalTrials.gov,2020-05-26,2020-05-27,False,European University at St. Petersburg,Not Recruiting,Not Applicable,Observational,Russian Federation,"Study of the Spread of COVID-19 in Saint Petersburg, Russia",Clinical Presentation (Epidemiology),No Intervention,No Intervention,1038,https://clinicaltrials.gov/show/NCT04406038,None
4679,NCT04406064,ClinicalTrials.gov,2020-05-26,2021-01-01,False,"Children's Hospital Medical Center, Cincinnati",Not Recruiting,Phase 2,Interventional,United States,Viral Specific T-cells for Treatment of COVID-19,ATMP,Cells (T),Cells (T),100,https://clinicaltrials.gov/show/NCT04406064,None
4680,NCT04406090,ClinicalTrials.gov,2020-05-26,2020-04-01,True,"University Hospital, Montpellier",Not Recruiting,Not Applicable,Observational,France,Endovascular Thrombectomy in COVID-19 Infected Patients,Procedure,Mechanical Trombectomy,Mechanical Trombectomy,50,https://clinicaltrials.gov/show/NCT04406090,None
4681,NCT04406181,ClinicalTrials.gov,2020-04-28,2020-05-18,False,UZ Brussel,Recruiting,Not Applicable,Interventional,Belgium,Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04406181,None
4682,NCT04406233,ClinicalTrials.gov,2020-05-23,2020-05-23,False,University of São Paulo,Recruiting,Not Applicable,Observational,Brazil,Muscle Mass and Strength as Predictors of Time to Discharge in Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,176,https://clinicaltrials.gov/show/NCT04406233,None
4683,NCT04406246,ClinicalTrials.gov,2020-05-24,2020-05-21,True,Materno-Perinatal Hospital of the State of Mexico,Recruiting,Phase 4,Interventional,Mexico,Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide,Drug,Nitazoxanide,Nitazoxanide,150,https://clinicaltrials.gov/show/NCT04406246,None
4684,NCT04406324,ClinicalTrials.gov,2020-05-13,2020-06-01,False,"University Hospital, Grenoble",Recruiting,Not Applicable,Observational,France,COVID-19: Respiratory and Sleep Follow-up,Other,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04406324,None
4685,NCT04406389,ClinicalTrials.gov,2020-05-26,2020-10-13,False,Weill Medical College of Cornell University,Recruiting,Phase 4,Interventional,United States,Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial),Drug,"Heparin, Fondapariniux, Argatroban",Heparin; Fondapariniux; Argatroban,186,https://clinicaltrials.gov/show/NCT04406389,None
4686,NCT04406493,ClinicalTrials.gov,2020-05-23,2020-04-28,True,Hillel Yaffe Medical Center,Recruiting,Not Applicable,Interventional,Israel,Monitoring COVID-19 Patients' Lung Fluid Using Impedance Technique,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://clinicaltrials.gov/show/NCT04406493,None
4687,NCT04406532,ClinicalTrials.gov,2020-05-22,2021-01-20,False,Albert Einstein College of Medicine,Not Recruiting,Not Applicable,Interventional,No Country Given,Home-Based Covid-19 Rehabilitation Program,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,100,https://clinicaltrials.gov/show/NCT04406532,None
4688,NCT04406545,ClinicalTrials.gov,2020-05-23,2020-05-15,True,"National Institute of Cardiology, Laranjeiras, Brazil",Recruiting,Not Applicable,Observational,Brazil,Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of COVID-19.,Clinical Presentation,No Intervention,No Intervention,25,https://clinicaltrials.gov/show/NCT04406545,None
4689,NCT04406558,ClinicalTrials.gov,2020-05-24,2020-05-27,False,Centre Hospitalier Intercommunal Creteil,Recruiting,Not Applicable,Observational,France,Psychological Impact of the Health Measures Generated by the COVID19 in Adolescents,Other (psych),No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04406558,None
4690,NCT04406571,ClinicalTrials.gov,2020-05-27,2020-04-01,True,CHU de Reims,Recruiting,Not Applicable,Observational,France,Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer,Health System,No Intervention,No Intervention,700,https://clinicaltrials.gov/show/NCT04406571,None
4691,NCT04406688,ClinicalTrials.gov,2020-05-18,2020-05-25,False,"University Hospital, Muenster",Not Recruiting,Not Applicable,Observational,Germany,Prediction of Acute Kidney Injury in Patients With COVID-19,Prognosis,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04406688,None
4692,NCT04406844,ClinicalTrials.gov,2020-05-25,2020-05-09,True,Max Healthcare Insititute Limited,Recruiting,Not Applicable,Observational,India,Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04406844,None
4693,NCT04407117,ClinicalTrials.gov,2020-05-27,2017-03-23,True,Dr. Claus Anders Bertelsen,Not Recruiting,Not Applicable,Observational,Denmark,Appendicitis During the National Lockdown During the COVID-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,6000000,https://clinicaltrials.gov/show/NCT04407117,None
4694,NCT04407143,ClinicalTrials.gov,2020-05-25,2020-04-15,True,Fundacin GECP,Recruiting,Not Applicable,Observational,Spain,Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,128,https://clinicaltrials.gov/show/NCT04407143,None
4695,NCT04407156,ClinicalTrials.gov,2020-05-06,2020-06-01,False,University Hospitals of Derby and Burton NHS Foundation Trust,Not Recruiting,Not Applicable,Observational,United Kingdom,Epidemiology of Acute Kidney Injury in COVID19 Disease in United Kingdom,Clinical Presentation,No Intervention,No Intervention,724,https://clinicaltrials.gov/show/NCT04407156,None
4696,NCT04407169,ClinicalTrials.gov,2020-04-14,2020-06-01,False,CHU de Nancy,Not Recruiting,Not Applicable,Observational,France,Prevalence of Critical Forms of CoVid-19 in Patients With Chronic Respiratory Disease,Clinical Presentation (Epidemiology),No Intervention,No Intervention,617,https://clinicaltrials.gov/show/NCT04407169,None
4697,NCT04407182,ClinicalTrials.gov,2020-05-25,2020-05-04,True,Catalysis SL,Recruiting,Phase 2,Interventional,Ecuador,Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19,Supplement,Viusid + Asbrip,Viusid + Asbrip,80,https://clinicaltrials.gov/show/NCT04407182,None
4698,NCT04407195,ClinicalTrials.gov,2020-05-27,2020-06-01,False,Northeastern University,Not Recruiting,Not Applicable,Observational,United States,COVID-19 and Mental Health,Other (psych),No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04407195,None
4699,NCT04407208,ClinicalTrials.gov,2020-05-16,2020-05-01,True,Biofarma,Not Recruiting,Phase 1,Interventional,Indonesia,Convalescent Plasma Therapy in Patients With COVID-19,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04407208,None
4700,NCT04407221,ClinicalTrials.gov,2020-05-03,2020-06-01,False,Vastra Gotaland Region,Not Recruiting,Not Applicable,Observational,Sweden,COVID-19 Research in Organ Transplant Recipients,Other,No Intervention,No Intervention,1100,https://clinicaltrials.gov/show/NCT04407221,None
4701,NCT04407260,ClinicalTrials.gov,2020-05-27,2020-03-06,True,Northwell Health,Not Recruiting,Not Applicable,Observational,United States,"The Use of Oxygen Hoods as Compared to Conventional High-flow Oxygen Delivery Systems, the Effects on Oxygenation, Mechanical Ventilation and Mortality Rates in Hypoxic Patients With COVID-19. A Prospective Controlled Cohort Study.",Other (device),Hood,Hood,136,https://clinicaltrials.gov/show/NCT04407260,None
4702,NCT04407273,ClinicalTrials.gov,2020-05-27,2020-05-14,True,Institut d'Investigació Sanitària Pere Virgili,Not Recruiting,Not Applicable,Observational,Spain,STATIN THERAPY AND COVID-19 INFECTION,Drug,Statins,Statins,1200,https://clinicaltrials.gov/show/NCT04407273,None
4703,NCT04407299,ClinicalTrials.gov,2020-05-23,2020-04-20,True,Cairo University,Not Recruiting,Not Applicable,Observational,Egypt,COVID-19 Impact on Rheumatic Patients,Other,No Intervention,No Intervention,360,https://clinicaltrials.gov/show/NCT04407299,None
4704,NCT04407390,ClinicalTrials.gov,2020-05-22,2020-06-01,False,University of Copenhagen,Recruiting,Phase 2,Interventional,Denmark,Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly,Supplement,Nicotinamide riboside,Nicotinamide riboside,100,https://clinicaltrials.gov/show/NCT04407390,None
4705,NCT04407429,ClinicalTrials.gov,2020-05-27,2020-05-27,False,Medical University of Vienna,Recruiting,Not Applicable,Observational,Austria,Vienna Versus SARS-CoV-2 Virus Study,Clinical Presentation (Epidemiology),No Intervention,No Intervention,12000,https://clinicaltrials.gov/show/NCT04407429,None
4706,NCT04407468,ClinicalTrials.gov,2020-05-27,2020-05-01,True,Hospital General San Juan del Rio,Not Recruiting,Not Applicable,Observational,Mexico,Awake Prone Positioning and Oxygen Therapy in Patients With COVID-19,Procedure,Positioning,Positioning,827,https://clinicaltrials.gov/show/NCT04407468,None
4707,NCT04407494,ClinicalTrials.gov,2020-05-27,2020-03-01,True,"University Hospital, Montpellier",Not Recruiting,Not Applicable,Observational,France,Diagnostic Value of Patient - Reported and Clinically Verified Olfactory Disorders (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,809,https://clinicaltrials.gov/show/NCT04407494,None
4708,NCT04407507,ClinicalTrials.gov,2020-05-27,2020-06-01,False,Investigacion Biomedica para el Desarrollo de Farmacos S.A. de C.V.,Not Recruiting,Phase 2,Interventional,No Country Given,"Efficacy, Safety and Tolerability of Ivermectin in Subjects Infected With SARS-CoV-2 With or Without Symptoms",Drug,Ivermectin,Ivermectin,66,https://clinicaltrials.gov/show/NCT04407507,None
4709,NCT04407533,ClinicalTrials.gov,2020-05-27,2020-05-25,True,McGill University,Recruiting,Not Applicable,Observational,Canada,Dietary Intake and Eating Habits During the COVID-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,1920,https://clinicaltrials.gov/show/NCT04407533,None
4710,NCT04407546,ClinicalTrials.gov,2020-05-27,2020-05-27,False,Jonsson Comprehensive Cancer Center,Recruiting,Not Applicable,Observational,United States,Role of Children in Transmission of COVID-19 to Immunocompromised Patients,Clinical Presentation (Epidemiology),No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04407546,None
4711,NCT04407559,ClinicalTrials.gov,2020-05-27,2020-05-01,True,"University Hospital, Montpellier",Not Recruiting,Not Applicable,Observational,France,COVID-SErology in Rheumatoid Arthritis (COVID-19),Clinical Presentation (Epidemiology),No Intervention,No Intervention,216,https://clinicaltrials.gov/show/NCT04407559,None
4712,NCT04407572,ClinicalTrials.gov,2020-05-27,2020-04-20,True,Kanuni Sultan Suleyman Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,Evaluation of the Relationship Between Zinc Vitamin D and b12 Levels in the Covid-19 Positive Pregnant Women,Clinical Presentation,No Intervention,No Intervention,44,https://clinicaltrials.gov/show/NCT04407572,None
4713,NCT04407585,ClinicalTrials.gov,2020-05-27,2020-06-01,False,King's College London,Recruiting,Not Applicable,Observational,United Kingdom,Testing the Accuracy of a Digital Test to Diagnose Covid-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000000,https://clinicaltrials.gov/show/NCT04407585,None
4714,NCT04407598,ClinicalTrials.gov,2020-05-27,2020-05-01,True,University of Leicester,Not Recruiting,Not Applicable,Observational,United Kingdom,COPD in the Time of COVID-19,Clinical Presentation,No Intervention,No Intervention,160,https://clinicaltrials.gov/show/NCT04407598,None
4715,NCT04407663,ClinicalTrials.gov,2020-05-27,2020-03-03,True,"University of Campania ""Luigi Vanvitelli""",Not Recruiting,Not Applicable,Observational,Italy,"Outpatient Clinic in Obesity Care During COVID-19 Outbreak: Physically Far, Virtually Near",Telehealth,Telehealth,Telehealth,138,https://clinicaltrials.gov/show/NCT04407663,None
4716,NCT04407689,ClinicalTrials.gov,2020-05-27,2020-06-08,False,Revimmune,Recruiting,Phase 2,Interventional,France,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort,Drug,Interleukin-7,Interleukin-7,48,https://clinicaltrials.gov/show/NCT04407689,None
4717,NCT04407923,ClinicalTrials.gov,2020-05-28,2020-05-25,True,"University Hospital, Brest",Recruiting,Not Applicable,Observational,France,Drug Management of Juvenile Idiopathic Arthritis in Covid-19 Context : Impact on Therapeutical Managment,Other,Other,Other,150,https://clinicaltrials.gov/show/NCT04407923,None
4718,NCT04408001,ClinicalTrials.gov,2020-05-28,2020-06-04,False,Direction Centrale du Service de Sant des Armes,Recruiting,Not Applicable,Observational,France,Study of Kinetics and Efficacy of the Immune Response Against COVID-19 Among Hospital Staff,Clinical Presentation,No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04408001,None
4719,NCT04408014,ClinicalTrials.gov,2020-05-22,2020-06-01,False,Butantan Institute,Not Recruiting,Not Applicable,Observational,No Country Given,Seroepidemiological Study of SARS-CoV-2 (COVID-19) Infection in Population Subgroups in the State of SÃ£o Paulo,Clinical Presentation (Epidemiology),No Intervention,No Intervention,18901,https://clinicaltrials.gov/show/NCT04408014,None
4720,NCT04408027,ClinicalTrials.gov,2020-05-26,2020-06-01,False,The Hospital for Sick Children,Not Recruiting,Not Applicable,Interventional,Canada,Mental Health Support for SickKids Children and Families During COVID-19 Using Established eHealth Interventions,Other (psych),Psychological,Psychological,20,https://clinicaltrials.gov/show/NCT04408027,None
4721,NCT04408040,ClinicalTrials.gov,2020-05-15,2020-07-14,False,"Northside Hospital, Inc.",Recruiting,Phase 2,Interventional,United States,Use of Convalescent Plasma for COVID-19,ATMP,Plasma,Plasma,700,https://clinicaltrials.gov/show/NCT04408040,None
4722,NCT04408066,ClinicalTrials.gov,2020-04-30,2020-04-30,False,LumiraDx UK Limited,Recruiting,Not Applicable,Interventional,United Kingdom,COVID-19: A POC Test Under Research & Evaluation,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,2000,https://clinicaltrials.gov/show/NCT04408066,None
4723,NCT04408131,ClinicalTrials.gov,2020-05-28,2020-05-28,False,Assistance Publique – Hôpitaux de Marseille,Recruiting,Not Applicable,Interventional,France,Morbi-mortality by COVID-19 Among Homeless People in Marseille: a Cohort Study,Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04408131,None
4724,NCT04408157,ClinicalTrials.gov,2020-05-26,2020-05-20,True,King's College London,Recruiting,Not Applicable,Interventional,United Kingdom,A Research Study to Evaluate the Benefits of a Self-management Booklet to Promote Wellbeing During the COVID-19 Pandemic,Other (psych),Psychological,Psychological,548,https://clinicaltrials.gov/show/NCT04408157,None
4725,NCT04408170,ClinicalTrials.gov,2020-05-26,2020-06-19,True,Manchester University NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,https://clinicaltrials.gov/show/NCT04408170,ISRCTN86124626
4726,NCT04408196,ClinicalTrials.gov,2020-05-21,2020-05-26,False,Fondazione Don Carlo Gnocchi Onlus,Recruiting,Not Applicable,Observational,Italy,QoL and the Emotional-affective Sphere o in Rehabilitation Setting During COVID-19 Quarantine,Other (psych),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04408196,None
4727,NCT04408209,ClinicalTrials.gov,2020-05-25,2020-04-23,True,National and Kapodistrian University of Athens,Recruiting,Not Applicable,Interventional,Greece,Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04408209,None
4728,NCT04408222,ClinicalTrials.gov,2020-05-25,2020-04-16,True,Columbia University,Not Recruiting,Not Applicable,Observational,United States,Awake Proning in COVID-19 Patients With Hypoxemic Respiratory Failure,Procedure,Positioning,Positioning,29,https://clinicaltrials.gov/show/NCT04408222,None
4729,NCT04408235,ClinicalTrials.gov,2020-05-26,2020-06-01,True,AOU di Modena,Not Recruiting,Phase 3,Interventional,Italy,High Versus Low LMWH Dosages in Hospitalized Patients With Severe COVID-19 Pneumonia and Coagulopathy,Drug,Heparin,Heparin,300,https://clinicaltrials.gov/show/NCT04408235,EUCTR2020-001972-13
4730,NCT04408287,ClinicalTrials.gov,2020-05-20,2020-09-15,False,Lawson Health Research Institute,Not Recruiting,Not Applicable,Interventional,Canada,Improving Activity Engagement Among Persons With SCI During COVID-19,Other (exercise),Exercise,Exercise,50,https://clinicaltrials.gov/show/NCT04408287,None
4731,NCT04408326,ClinicalTrials.gov,2020-05-27,2020-06-01,False,Guy's and St Thomas' NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,Efficacy and Safety of Angiotensin II Use in Coronavirus Disease(COVID)-19 Patients With Acute Respiratory Distress Syndrome,Drug,Angiotensin II vs. Interleukin-1,Angiotensin II; Interleukin-1,50,https://clinicaltrials.gov/show/NCT04408326,None
4732,NCT04408339,ClinicalTrials.gov,2020-05-19,2020-04-15,True,"University Hospital, Hamburg-Eppendorf",Recruiting,Not Applicable,Observational,Germany,COVID-19 in Cancer Patients: Evaluation of Clinical Course and Impact on Oncological Care Including Biobanking,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04408339,None
4733,NCT04408378,ClinicalTrials.gov,2020-05-27,2020-06-05,False,Gaziosmanpasa Taksim Research and Education Hospital,Recruiting,Not Applicable,Observational,Turkey,Change in the Ratio of Mean Platelet Volume (MPV) to Platellet(PLT) in Covid-19 Pneumonia Patients,Clinical Presentation,No Intervention,No Intervention,156,https://clinicaltrials.gov/show/NCT04408378,None
4734,NCT04408391,ClinicalTrials.gov,2020-05-26,2020-05-20,True,CHU de Nimes,Not Recruiting,Not Applicable,Observational,France,Brain MRI Imaging in Patients With SARS-Cov2 (COVID-19) Infection With or Without Anosmia,Clinical Presentation,No Intervention,No Intervention,0,https://clinicaltrials.gov/show/NCT04408391,None
4735,NCT04408456,ClinicalTrials.gov,2020-05-24,2020-03-01,True,Postgraduate Institute of Medical Education and Research,Not Recruiting,Phase 3,Interventional,India,Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,325,https://clinicaltrials.gov/show/NCT04408456,None
4736,NCT04409184,ClinicalTrials.gov,2020-05-28,2020-08-14,False,Medical College of Wisconsin,Not Recruiting,Not Applicable,Observational,No Country Given,Whole Blood Collection From Individuals in the Convalescent Phase of SARS-CoV-2 Infection,Clinical Presentation,No Intervention,No Intervention,0,https://clinicaltrials.gov/show/NCT04409184,None
4737,NCT04409197,ClinicalTrials.gov,2020-05-18,2020-05-08,True,"University Hospital, Grenoble",Not Recruiting,Not Applicable,Observational,France,"Evaluation of Changes in Weight, Sleep, and Other Psycho-behavioural Parameters During Covid-19 Confinement in Subjects Monitored by the RNPC Network",Clinical Presentation,No Intervention,No Intervention,4789,https://clinicaltrials.gov/show/NCT04409197,None
4738,NCT04409249,ClinicalTrials.gov,2020-05-28,2020-03-15,True,Kanuni Sultan Suleyman Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,Prognosis in Pregnant With COVID-19,Prognosis,No Intervention,No Intervention,155,https://clinicaltrials.gov/show/NCT04409249,None
4739,NCT04409262,ClinicalTrials.gov,2020-05-28,2020-06-16,False,Roche,Recruiting,Phase 3,Interventional,"Russian Federation, France, Brazil, United States, Spain",A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia,Drug,Tocilizumab + Remdesivir vs. Remdesivir,Tocilizumab; Remdesivir,500,https://clinicaltrials.gov/show/NCT04409262,None
4740,NCT04409483,ClinicalTrials.gov,2020-05-28,2020-06-01,False,Epicentre,Not Recruiting,Phase 3,Interventional,No Country Given,Evaluation of Additional Treatments for COVID-19: a Randomized Trial in Niger,Drug,Lopinavir/ritonavir,Lopinavir/ritonavir,0,https://clinicaltrials.gov/show/NCT04409483,None
4741,NCT04409496,ClinicalTrials.gov,2020-05-26,2020-06-02,False,University of Hong Kong,Not Recruiting,Not Applicable,Interventional,Hong Kong,Chat-based Support for Preventing Smoking Relapse,Other,Other,Other,108,https://clinicaltrials.gov/show/NCT04409496,None
4742,NCT04409509,ClinicalTrials.gov,2020-05-28,2020-07-01,False,CSL Behring,Recruiting,Phase 2,Interventional,United States,Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19),Drug,Garadacimab,Garadacimab,124,https://clinicaltrials.gov/show/NCT04409509,None
4743,NCT04409522,ClinicalTrials.gov,2020-05-28,2020-05-12,True,Mohammad Sadegh Bagheri Baghdasht,Recruiting,Not Applicable,Interventional,Iran,Evaluation of Therapeutic Effects of Melatonin by Inhibition of NLRP3 Inflammasome in COVID19 Patients,Drug,Melatonin,Melatonin,55,https://clinicaltrials.gov/show/NCT04409522,None
4744,NCT04409535,ClinicalTrials.gov,2020-05-11,2020-05-07,True,University of New Mexico,Not Recruiting,Not Applicable,Observational,United States,Effects of the COVID-19 Health Emergency on Biopsychosocial Health,Other (psych),No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04409535,None
4745,NCT04409574,ClinicalTrials.gov,2020-05-28,2020-06-01,False,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,COVID 19 Viral Clearance Among the Infected Healthcare Workers In Assiut University Hospitals,Clinical Presentation,No Intervention,No Intervention,31,https://clinicaltrials.gov/show/NCT04409574,None
4746,NCT04409821,ClinicalTrials.gov,2020-05-22,2020-06-01,False,"Rigshospitalet, Denmark",Not Recruiting,Not Applicable,Interventional,No Country Given,Tele-based Psychological Emotional Support for Informal CARegivers of COVID-19 Patients in Intensive Care,Telehealth,Telehealth,Telehealth,50,https://clinicaltrials.gov/show/NCT04409821,None
4747,NCT04409834,ClinicalTrials.gov,2020-05-28,2020-08-05,False,The TIMI Study Group,Recruiting,Phase 4,Interventional,United States,Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial,Drug,Heparin,Heparin,750,https://clinicaltrials.gov/show/NCT04409834,None
4748,NCT04409847,ClinicalTrials.gov,2020-05-22,2020-06-01,False,NHS Greater Glasgow and Clyde,Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 Blood Pressure Endothelium Interaction Study (OBELIX),Clinical Presentation,No Intervention,No Intervention,70,https://clinicaltrials.gov/show/NCT04409847,None
4749,NCT04409873,ClinicalTrials.gov,2020-05-28,2020-12-07,False,"University of California, San Francisco",Not Recruiting,Phase 2,Interventional,United States,Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19),Drug,Mouthwash,Mouthwash,150,https://clinicaltrials.gov/show/NCT04409873,None
4750,NCT04409886,ClinicalTrials.gov,2020-05-27,2020-06-01,False,Maimonides Medical Center,Not Recruiting,Not Applicable,Interventional,No Country Given,Hyperbaric Oxygen Therapy in Non-ventilated COVID-19 Patients,Drug,Oxygen,Oxygen,30,https://clinicaltrials.gov/show/NCT04409886,None
4751,NCT04409899,ClinicalTrials.gov,2020-05-26,2020-03-20,True,Fundacio Puigvert,Not Recruiting,Not Applicable,Observational,Spain,The Utility of Enhanced Pre and Post-surgical Work-out to Prevent the Spread of COVID-19 in a Large Urology Department,Other (exercise),Exercise,Exercise,300,https://clinicaltrials.gov/show/NCT04409899,None
4752,NCT04409925,ClinicalTrials.gov,2020-05-13,2020-11-01,False,McGill University,Not Recruiting,Phase 1,Interventional,No Country Given,DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1),Drug,rhDNase I,rhDNase I,25,https://clinicaltrials.gov/show/NCT04409925,None
4753,NCT04409951,ClinicalTrials.gov,2020-05-22,2020-11-01,False,Damanhour University,Not Recruiting,Not Applicable,Observational,Egypt,Pharmacy Education During Covid-19 Outbreak,Other,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04409951,None
4754,NCT04410016,ClinicalTrials.gov,2020-05-22,2020-05-25,False,University of Nottingham,Recruiting,Not Applicable,Interventional,United Kingdom,Evaluation of Staff COVID-19 Wellbeing Centres in a Healthcare Workplace: COVID-WELL Study,Other (psych),Psychological,Psychological,45,https://clinicaltrials.gov/show/NCT04410016,None
4755,NCT04410107,ClinicalTrials.gov,2020-05-25,2020-05-15,True,Federal University of Rio Grande do Sul,Recruiting,Not Applicable,Observational,Brazil,"Lung Function, Exercise Capacity and Health-Related Quality of Life After Severe COVID-19",Clinical Presentation,No Intervention,No Intervention,134,https://clinicaltrials.gov/show/NCT04410107,None
4756,NCT04410159,ClinicalTrials.gov,2020-05-27,2020-06-22,False,Universiti Sains Islam Malaysia,Not Recruiting,Phase 2,Interventional,Malaysia,Povidone-Iodine Vs Essential Oil Vs Tap Water Gargling For COVID-19 Patients,Drug,Povidone Iodine vs. Essential Oil,Povidone Iodine; Essential Oil,20,https://clinicaltrials.gov/show/NCT04410159,None
4757,NCT04410263,ClinicalTrials.gov,2020-05-18,2020-04-09,True,University of Zurich,Recruiting,Not Applicable,Observational,Switzerland,Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches,ATMP,Intestinal microbiome,Intestinal microbiome,300,https://clinicaltrials.gov/show/NCT04410263,None
4758,NCT04410328,ClinicalTrials.gov,2020-05-28,2020-10-21,False,Rutgers University,Recruiting,Phase 3,Interventional,United States,Aggrenox To Treat Acute Covid-19,Drug,Dipyridamole,Dipyridamole,132,https://clinicaltrials.gov/show/NCT04410328,None
4759,NCT04410458,ClinicalTrials.gov,2020-05-29,2020-05-31,False,Guangzhou Blood Center,Recruiting,Not Applicable,Interventional,China,Recruit Blood Donors Via SMS During Epidemic of COVID-19 (Repeat Trial),Other,Other,Other,506517,https://clinicaltrials.gov/show/NCT04410458,None
4760,NCT04410471,ClinicalTrials.gov,2020-05-29,2020-05-29,False,Magdalena Salcedo,Recruiting,Not Applicable,Observational,Spain,Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients After COVID-19 in Comparison With Immunocompetent Patients,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04410471,None
4761,NCT04410484,ClinicalTrials.gov,2020-05-29,2020-05-22,True,Hull University Teaching Hospitals NHS Trust,Not Recruiting,Not Applicable,Observational,United Kingdom,PREPARE-IBD: Physician Responses to Disease Flares and Patient Adaptation in Relation to Events in Inflammatory Bowel Disease During COVID-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04410484,None
4762,NCT04410510,ClinicalTrials.gov,2020-05-27,2020-09-30,False,Hospital Universitario San Ignacio,Recruiting,Phase 2/Phase 3,Interventional,Colombia,P2Et Extract in the Symptomatic Treatment of Subjects With COVID-19,Drug,P2Et,P2Et,100,https://clinicaltrials.gov/show/NCT04410510,None
4763,NCT04410536,ClinicalTrials.gov,2020-05-25,2020-06-15,False,Fondazione IRCCS Istituto Neurologico Carlo Besta,Recruiting,Not Applicable,Interventional,Italy,Home Detox in Medication Overuse Headache (MOH) During Covid-19 Emergency,Other,Other,Other,25,https://clinicaltrials.gov/show/NCT04410536,None
4764,NCT04410549,ClinicalTrials.gov,2020-05-21,2020-06-01,False,IRCCS Ospedale San Raffaele,Recruiting,Not Applicable,Interventional,"Brazil, Italy",Pulmonary Optical Coherence Tomography in COVID-19 Patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,10,https://clinicaltrials.gov/show/NCT04410549,None
4765,NCT04410562,ClinicalTrials.gov,2020-05-26,2020-05-13,True,Barcelona Institute for Global Health,Recruiting,Phase 3,Interventional,Spain,Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy,Drug,Hydroxychloroquine,Hydroxychloroquine,714,https://clinicaltrials.gov/show/NCT04410562,EUCTR2020-001587-29
4766,NCT04410692,ClinicalTrials.gov,2020-05-27,2020-05-15,True,"National University, Singapore",Not Recruiting,Not Applicable,Interventional,Singapore,Can the Prediction Market Improve Predictions of COVID-19?,Other,Other,Other,560,https://clinicaltrials.gov/show/NCT04410692,None
4767,NCT04410718,ClinicalTrials.gov,2020-05-05,2020-04-20,True,Steno Diabetes Center Copenhagen,Recruiting,Not Applicable,Observational,Denmark,Glycaemia and Cardiac Function in Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04410718,None
4768,NCT04410835,ClinicalTrials.gov,2020-05-14,2020-04-28,True,Medical University of Graz,Recruiting,Not Applicable,Observational,Austria,Psychological Impact of the Corona Virus (SARS-CoV-2) and COVID-19 Pandemic in Individuals With Psychiatric Disorders,Other (psych),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04410835,None
4769,NCT04410939,ClinicalTrials.gov,2020-05-22,2020-04-10,True,Istanbul Medipol University Hospital,Not Recruiting,Not Applicable,Observational,Turkey,COVID-19 PCR Test Results in Asymptomatic Pregnants,Clinical Presentation (Epidemiology),No Intervention,No Intervention,179,https://clinicaltrials.gov/show/NCT04410939,None
4770,NCT04411147,ClinicalTrials.gov,2020-05-30,2020-06-17,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Not Applicable,Observational,United States,A Longitudinal Study of COVID-19 Sequelae and Immunity,Clinical Presentation,No Intervention,No Intervention,900,https://clinicaltrials.gov/show/NCT04411147,None
4771,NCT04411433,ClinicalTrials.gov,2020-05-23,2020-05-08,True,"Ministry of Health, Turkey",Recruiting,Phase 3,Interventional,Turkey,Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19,Drug,Favipiravir vs. Favipiravir + Hydroxychloroquine vs. Favipiravir + Azithromycin vs. Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine,Favipiravir; Azithromycin; Hydroxychloroquine,1000,https://clinicaltrials.gov/show/NCT04411433,None
4772,NCT04411446,ClinicalTrials.gov,2020-05-26,2020-08-11,False,Vitamin D Study Group,Recruiting,Phase 4,Interventional,Argentina,Cholecalciferol to Improve the Outcomes of COVID-19 Patients,Drug,Vitamin D,Vitamin D,1264,https://clinicaltrials.gov/show/NCT04411446,None
4773,NCT04411459,ClinicalTrials.gov,2020-05-29,2020-02-01,True,Azienda Unita Sanitaria Locale di Bologna,Not Recruiting,Not Applicable,Observational,Italy,Risk Factors for Prolonged Invasive Mechanical Ventilation in COVID-19 Acute Respiratory Distress Syndrome,Clinical Presentation,No Intervention,No Intervention,470,https://clinicaltrials.gov/show/NCT04411459,None
4774,NCT04411511,ClinicalTrials.gov,2020-05-20,2020-05-06,True,Academic Hospital Maastricht,Recruiting,Not Applicable,Observational,Netherlands,"COVID-19, Obesity and Lifestyle in Children",Clinical Presentation,No Intervention,No Intervention,4000,https://clinicaltrials.gov/show/NCT04411511,None
4775,NCT04411563,ClinicalTrials.gov,2020-05-25,2020-05-21,True,Bakırköy Dr. Sadi Konuk Research And Training Hospital,Recruiting,Not Applicable,Observational,Turkey,Epigenetic Tools as Prognostic Predictors in Covid19,Prognosis,No Intervention,No Intervention,105,https://clinicaltrials.gov/show/NCT04411563,None
4776,NCT04411576,ClinicalTrials.gov,2020-05-26,2020-04-23,True,Karolinska University Hospital,Recruiting,Not Applicable,Observational,Sweden,Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare,Clinical Presentation (Epidemiology),No Intervention,No Intervention,40000,https://clinicaltrials.gov/show/NCT04411576,None
4777,NCT04411602,ClinicalTrials.gov,2020-05-22,2020-04-07,True,Ascension South East Michigan,Recruiting,Phase 1,Interventional,United States,Feasibility Study of Anti-SARS-CoV-2 Plasma Transfusions in COVID-19 Patients With SRD,ATMP,Plasma,Plasma,90,https://clinicaltrials.gov/show/NCT04411602,None
4778,NCT04411628,ClinicalTrials.gov,2020-05-29,2020-05-28,True,Eli Lilly and Company,Not Recruiting,Phase 1,Interventional,United States,A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19,Drug,LY3819253,LY3819253,24,https://clinicaltrials.gov/show/NCT04411628,None
4779,NCT04411667,ClinicalTrials.gov,2020-05-29,2020-04-28,True,Dr. George Sakoulas,Not Recruiting,Phase 4,Interventional,United States,Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19,ATMP,Immunoglobulin,Immunoglobulin,34,https://clinicaltrials.gov/show/NCT04411667,None
4780,NCT04411784,ClinicalTrials.gov,2020-05-29,2020-05-20,True,Hull University Teaching Hospitals NHS Trust,Not Recruiting,Not Applicable,Observational,United Kingdom,"PROTECT-ASUC: Covid-19 Pandemic Response Of assessmenT, EndosCopy and Treatment in Acute Severe Ulcerative Colitis",Other,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04411784,None
4781,NCT04412018,ClinicalTrials.gov,2020-05-29,2020-06-04,False,Canadian Medical and Surgical Knowledge Translation Research Group,Recruiting,Phase 2,Interventional,Canada,An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19,Drug,Icosapent ethyl,Icosapent ethyl,100,https://clinicaltrials.gov/show/NCT04412018,None
4782,NCT04412031,ClinicalTrials.gov,2020-05-29,2019-11-11,True,Hospices Civils de Lyon,Not Recruiting,Not Applicable,Observational,France,Prediction of Unfavourable Outcome in Newly Covid-19 Hospitalized Patient,Clinical Presentation,No Intervention,No Intervention,802,https://clinicaltrials.gov/show/NCT04412031,None
4783,NCT04412057,ClinicalTrials.gov,2020-05-29,2020-06-09,False,Aevi Genomic Medicine,Recruiting,Phase 2,Interventional,United States,Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury,Drug,CERC-002,CERC-002,82,https://clinicaltrials.gov/show/NCT04412057,None
4784,NCT04412239,ClinicalTrials.gov,2020-05-30,2020-04-20,True,Health Science Center of Xi'an Jiaotong University,Recruiting,Not Applicable,Interventional,Pakistan,To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic,Telehealth,Telehealth,Telehealth,200,https://clinicaltrials.gov/show/NCT04412239,None
4785,NCT04412252,ClinicalTrials.gov,2020-05-30,2020-07-06,False,Pfizer,Not Recruiting,Phase 2,Interventional,United States,Safety and Efficacy of Tofacitinib in Hospitalized Participants With COVID-19 Pneumonia Who Are Receiving Standard of Care Therapy,Drug,Tofacitinib,Tofacitinib,0,https://clinicaltrials.gov/show/NCT04412252,None
4786,NCT04412265,ClinicalTrials.gov,2020-05-30,2020-04-16,True,University of Milano Bicocca,Recruiting,Not Applicable,Observational,Italy,Frailty in Elderly Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04412265,None
4787,NCT04412278,ClinicalTrials.gov,2020-05-30,2020-06-01,False,Okan University,Not Recruiting,Not Applicable,Observational,Turkey,Impact of COVID-19 Pandemic on Perceived Exercise Benefits and Barriers,Other (exercise),No Intervention,No Intervention,392,https://clinicaltrials.gov/show/NCT04412278,None
4788,NCT04412291,ClinicalTrials.gov,2020-06-01,2020-06-11,True,Karolinska University Hospital,Recruiting,Phase 2,Interventional,Sweden,"A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study",Drug,Anakinra vs. Tocilizumab,Anakinra; Tocilizumab,120,https://clinicaltrials.gov/show/NCT04412291,EUCTR2020-001748-24
4789,NCT04412304,ClinicalTrials.gov,2020-05-30,2020-03-06,True,Karolinska Institutet,Not Recruiting,Not Applicable,Observational,Sweden,Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients,Drug,Anticoagulants,Anticoagulants,166,https://clinicaltrials.gov/show/NCT04412304,None
4790,NCT04412317,ClinicalTrials.gov,2020-05-30,2020-06-03,False,Centre Hospitalier Intercommunal Creteil,Recruiting,Not Applicable,Observational,France,Use of PCR-Sars-CoV-2 in Children,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,600,https://clinicaltrials.gov/show/NCT04412317,None
4791,NCT04412330,ClinicalTrials.gov,2020-05-12,2020-05-01,True,University of Kentucky,Recruiting,Not Applicable,Interventional,United States,Optimizing Outcomes With Physical Therapy Treatment for IndividuALs Surviving an ICU Admission for Covid-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,20,https://clinicaltrials.gov/show/NCT04412330,None
4792,NCT04412343,ClinicalTrials.gov,2020-05-29,2020-05-23,True,University of British Columbia,Not Recruiting,Not Applicable,Interventional,Canada,The Seniors COvid-19 Pandemic and Exercise Study,Other (exercise),Exercise,Exercise,241,https://clinicaltrials.gov/show/NCT04412343,None
4793,NCT04412356,ClinicalTrials.gov,2020-05-24,2020-06-04,False,Sahlgrenska University Hospital,Recruiting,Not Applicable,Interventional,Sweden,Timing of Tracheotomy in Covid-19 Patients,Other,No Intervention,No Intervention,180,https://clinicaltrials.gov/show/NCT04412356,None
4794,NCT04412369,ClinicalTrials.gov,2020-05-27,2020-06-01,False,University of Cambridge,Not Recruiting,Not Applicable,Observational,United Kingdom,Multi-modality Imaging & Immunophenotyping of COVID-19 Related Myocardial Injury,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04412369,None
4795,NCT04412382,ClinicalTrials.gov,2020-05-26,2020-06-01,False,AOUI Verona,Recruiting,Not Applicable,Observational,Italy,Covid-19: Possible Role of Neutrophil Extracellular Traps,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04412382,None
4796,NCT04412395,ClinicalTrials.gov,2020-05-15,2020-06-01,False,"National Research Center, Egypt",Not Recruiting,Phase 2,Interventional,Egypt,Clinical Assessment of Oral Lactoferrin as a Safe Antiviral and Immunoregulatory in Treating COVID-19 Disease,Supplement,Lactoferrin,Lactoferrin,516,https://clinicaltrials.gov/show/NCT04412395,None
4797,NCT04412460,ClinicalTrials.gov,2020-05-20,2020-03-20,True,"University Hospital, Tübingen",Recruiting,Not Applicable,Observational,Germany,Echocardiography in Patients With Covid-19,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04412460,None
4798,NCT04412473,ClinicalTrials.gov,2020-05-27,2020-04-30,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,COVID-19 Respiratory Distress and Antithrombotic Drugs in Subject's Habits,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04412473,None
4799,NCT04412486,ClinicalTrials.gov,2020-05-28,2020-06-01,False,Dr. Gailen D. Marshall Jr.,Recruiting,Phase 1,Interventional,United States,COVID-19 Convalescent Plasma (CCP) Transfusion,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04412486,None
4800,NCT04412538,ClinicalTrials.gov,2020-05-21,2020-05-15,True,Chinese Academy of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19,ATMP,Vaccine,Vaccine,942,https://clinicaltrials.gov/show/NCT04412538,None
4801,NCT04412551,ClinicalTrials.gov,2020-06-01,2020-05-20,True,"Dalarna County Council, Sweden",Recruiting,Not Applicable,Observational,Sweden,Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04412551,None
4802,NCT04412655,ClinicalTrials.gov,2020-06-01,2020-05-05,True,"Universit degli Studi del Piemonte Orientale ""Amedeo Avogadro""",Not Recruiting,Not Applicable,Observational,Italy,Primary Angioplasty for STEMI During COVID-19 Pandemic (ISACS-STEMI COVID-19) Registry,Other,No Intervention,No Intervention,6609,https://clinicaltrials.gov/show/NCT04412655,None
4803,NCT04412668,ClinicalTrials.gov,2020-06-01,2020-06-12,False,"aTyr Pharma, Inc.",Not Recruiting,Phase 2,Interventional,"United States, Puerto Rico",Study to Evaluate the Safety and Efficacy of ATYR1923 In Patients With Severe Pneumonia Related to COVID-19,Drug,ATYR1923,ATYR1923,30,https://clinicaltrials.gov/show/NCT04412668,None
4804,NCT04412746,ClinicalTrials.gov,2020-06-01,2020-04-01,True,University of Tlemcen,Recruiting,Not Applicable,Observational,Algeria,Covid-19 and Diabetes in West of Algeria,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04412746,None
4805,NCT04412772,ClinicalTrials.gov,2020-06-01,2020-06-12,False,Queen's Medical Centre,Recruiting,Phase 3,Interventional,United States,Trial of Tocilizumab for Treatment of Severe COVID-19: ARCHITECTS,Drug,Tocilizumab,Tocilizumab,300,https://clinicaltrials.gov/show/NCT04412772,None
4806,NCT04412785,ClinicalTrials.gov,2020-06-01,2020-06-30,False,University of Pennsylvania,Recruiting,Phase 1,Interventional,United States,Cyclosporine in Patients With Moderate COVID-19,Drug,Cyclosporine,Cyclosporine,20,https://clinicaltrials.gov/show/NCT04412785,None
4807,NCT04413006,ClinicalTrials.gov,2020-05-21,2020-05-25,False,University of Manitoba,Recruiting,Not Applicable,Interventional,Canada,Self-compassion for Chronic Pain Virtual Group Treatment Program,Other (psych),Psychological,Psychological,28,https://clinicaltrials.gov/show/NCT04413006,None
4808,NCT04413045,ClinicalTrials.gov,2020-06-01,2020-05-20,True,Assiut University,Not Recruiting,Not Applicable,Observational,Egypt,"Novel COVID-19, A National Analysis",Clinical Presentation (Epidemiology),No Intervention,No Intervention,61,https://clinicaltrials.gov/show/NCT04413045,None
4809,NCT04413058,ClinicalTrials.gov,2020-05-27,2020-04-10,True,Haydarpasa Numune Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,Menstrual Cycle Characteristics of Healthcare Professionals,Other,No Intervention,No Intervention,260,https://clinicaltrials.gov/show/NCT04413058,None
4810,NCT04413071,ClinicalTrials.gov,2020-05-23,2020-05-25,False,AORTICA Group,Not Recruiting,Not Applicable,Observational,Spain,Cardiac COVID-19 Health Care Workers,Clinical Presentation,No Intervention,No Intervention,142,https://clinicaltrials.gov/show/NCT04413071,None
4811,NCT04413435,ClinicalTrials.gov,2020-05-25,2020-10-30,False,Nevsehir Public Hospital,Recruiting,Not Applicable,Observational,Turkey,Clinical Characteristics of Critically Ill Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,105,https://clinicaltrials.gov/show/NCT04413435,None
4812,NCT04413747,ClinicalTrials.gov,2020-05-29,2020-08-15,False,Health Ricerca E Sviluppo S.r.l.,Not Recruiting,Not Applicable,Interventional,Italy,Yoga Pranayama Adjuvant to Treat Burden COVID-19,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,1000,https://clinicaltrials.gov/show/NCT04413747,None
4813,NCT04413838,ClinicalTrials.gov,2020-06-02,2020-06-15,False,Hospices Civils de Lyon,Not Recruiting,Phase 2,Interventional,France,Efficiency and Security of NIVOLUMAB Therapy in Obese Individuals With COVID-19(COrona VIrus Disease) Infection,Drug,Nivolumab,Nivolumab,120,https://clinicaltrials.gov/show/NCT04413838,None
4814,NCT04413864,ClinicalTrials.gov,2020-04-21,2020-04-24,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Interventional,France,Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19,Drug,Dexmedetomidine,Dexmedetomidine,50,https://clinicaltrials.gov/show/NCT04413864,None
4815,NCT04413877,ClinicalTrials.gov,2020-05-25,2020-10-01,False,University of Liège,Not Recruiting,Not Applicable,Observational,No Country Given,Implementation of the Integrated Care of Older People App and ICOPE Monitor in Primary Care (ICOPE),Other (software),eHealth,eHealth,600,https://clinicaltrials.gov/show/NCT04413877,None
4816,NCT04413955,ClinicalTrials.gov,2020-05-19,2020-06-01,False,"Children's Hospital Medical Center, Cincinnati",Recruiting,Not Applicable,Observational,United States,Registry of SeraphÂ®-100 MicrobindÂ® Affinity Blood Filter for COVID-19 Under EUA,Other (device),Blood filter,Blood filter,100,https://clinicaltrials.gov/show/NCT04413955,None
4817,NCT04413968,ClinicalTrials.gov,2020-06-02,2020-06-02,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,"COVID-19 Infection and Transmission in Exposed, Confined and Community-based Infants",Clinical Presentation (Epidemiology),No Intervention,No Intervention,600,https://clinicaltrials.gov/show/NCT04413968,None
4818,NCT04414059,ClinicalTrials.gov,2020-06-01,2021-03-01,False,Elsan,Not Recruiting,Not Applicable,Observational,France,Protein Electrophoresis as a Tool for Complications Prediction in COVID-19 Hospitalised Patients,Prognosis,No Intervention,No Intervention,155,https://clinicaltrials.gov/show/NCT04414059,None
4819,NCT04414098,ClinicalTrials.gov,2020-05-29,2020-06-01,False,Marcelo Iastrebner,Not Recruiting,Phase 2,Interventional,No Country Given,Ruxolitinib in the Treatment of Covid-19,Drug,Ruxolitinib,Ruxolitinib,100,https://clinicaltrials.gov/show/NCT04414098,None
4820,NCT04414124,ClinicalTrials.gov,2020-06-01,2020-07-02,False,Kaleido Biosciences,Recruiting,Not Applicable,Interventional,United States,A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19,Drug,KB109,KB109,400,https://clinicaltrials.gov/show/NCT04414124,None
4821,NCT04414293,ClinicalTrials.gov,2020-06-01,2020-10-01,False,Hospital Provincial de Castellón,Not Recruiting,Not Applicable,Interventional,Spain,Low Dose Pulmonary Irradiation in Patients With COVID-19 Infection of Bad Prognosis,Other,Radiation,Radiation,41,https://clinicaltrials.gov/show/NCT04414293,None
4822,NCT04414371,ClinicalTrials.gov,2020-05-31,2020-05-20,True,Rutgers University,Recruiting,Not Applicable,Interventional,United States,Tools for Wellbeing COVID-19 National Study of Undergraduate Students,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,200,https://clinicaltrials.gov/show/NCT04414371,None
4823,NCT04414410,ClinicalTrials.gov,2020-05-27,2020-05-12,True,CHU Ambroise Paré,Recruiting,Not Applicable,Observational,France,Echocardiography in Critically-ill Patients With COVID-19 Pneumonia,Clinical Presentation,No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04414410,None
4824,NCT04414618,ClinicalTrials.gov,2020-05-26,2020-07-02,False,RedHill Biopharma Limited,Not Recruiting,Phase 2,Interventional,"United States, Israel",A Study of Opaganib in Coronavirus Disease 2019 Pneumonia,Drug,Opaganib,Opaganib,40,https://clinicaltrials.gov/show/NCT04414618,None
4825,NCT04414657,ClinicalTrials.gov,2020-06-02,2020-04-09,True,Regina Grossmann,Recruiting,Not Applicable,Observational,Switzerland,USZ BioResource COVID,Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04414657,None
4826,NCT04414904,ClinicalTrials.gov,2020-05-29,2020-06-10,False,Imperial College London,Not Recruiting,Not Applicable,Observational,United Kingdom,Determining the Reproductive Health of Men Post-COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,0,https://clinicaltrials.gov/show/NCT04414904,None
4827,NCT04415060,ClinicalTrials.gov,2020-06-02,2020-06-15,False,Sunnybrook Health Sciences Centre,Recruiting,Phase 3,Interventional,Canada,SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival,Drug,Isoflurane + Sevoflurane,Isoflurane; Sevoflurane,752,https://clinicaltrials.gov/show/NCT04415060,None
4828,NCT04415073,ClinicalTrials.gov,2020-05-29,2020-05-30,False,Syndax Pharmaceuticals,Not Recruiting,Phase 2,Interventional,United States,A Phase 2 Study to Evaluate Axatilimab for Hospitalized Patients With Respiratory Involvement Secondary to COVID-19,Drug,Axatilimab,Axatilimab,186,https://clinicaltrials.gov/show/NCT04415073,None
4829,NCT04415086,ClinicalTrials.gov,2020-06-01,2020-06-01,False,University of São Paulo General Hospital,Recruiting,Phase 2,Interventional,Brazil,Treatment of Patients With COVID-19 With Convalescent Plasma,ATMP,Plasma,Plasma,120,https://clinicaltrials.gov/show/NCT04415086,None
4830,NCT04415359,ClinicalTrials.gov,2020-05-29,2020-05-20,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Evaluation of the Evolution of Pregnancies in the First Trimester Following MAR Management During a COVD-19 Pandemic Period,Clinical Presentation,No Intervention,No Intervention,700,https://clinicaltrials.gov/show/NCT04415359,None
4831,NCT04415879,ClinicalTrials.gov,2020-06-01,2020-06-01,False,The Cleveland Clinic,Not Recruiting,Not Applicable,Interventional,United States,Effects of a N95 Respirator vs Cloth Mask on Exercise Capacity During Treadmill Exercise.,Other (device),Masks,Masks,20,https://clinicaltrials.gov/show/NCT04415879,None
4832,NCT04416009,ClinicalTrials.gov,2020-06-01,2020-07-05,False,Gaziosmanpasa Taksim Research and Education Hospital,Recruiting,Not Applicable,Observational,Turkey,Extracellular Water in Covid 19 Pneumonia,Clinical Presentation,No Intervention,No Intervention,52,https://clinicaltrials.gov/show/NCT04416009,None
4833,NCT04416048,ClinicalTrials.gov,2020-06-02,2020-08-01,True,Charité University,Not Recruiting,Phase 3,Interventional,Germany,Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19,Drug,Rivaroxaban,Rivaroxaban,400,https://clinicaltrials.gov/show/NCT04416048,EUCTR2020-002282-33
4834,NCT04416061,ClinicalTrials.gov,2020-06-01,2020-05-25,True,Hong Kong Sanatorium & Hospital,Not Recruiting,Not Applicable,Observational,Hong Kong,The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,2500,https://clinicaltrials.gov/show/NCT04416061,None
4835,NCT04416113,ClinicalTrials.gov,2020-05-24,2020-08-01,False,Cairo University,Not Recruiting,Not Applicable,Interventional,No Country Given,Photodynamic Therapy for the Treatment of COVID-19,Other,Photodynamic Therapy,Photodynamic Therapy,60,https://clinicaltrials.gov/show/NCT04416113,None
4836,NCT04416139,ClinicalTrials.gov,2020-05-30,2020-05-01,True,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,Recruiting,Phase 2,Interventional,Mexico,Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),10,https://clinicaltrials.gov/show/NCT04416139,None
4837,NCT04416256,ClinicalTrials.gov,2020-05-29,2020-02-01,True,Paris Translational Research Center for Organ Transplantation,Recruiting,Not Applicable,Observational,France,COVID-19 Pandemic and Worldwide Organ Procurement,Health System,No Intervention,No Intervention,230000,https://clinicaltrials.gov/show/NCT04416256,None
4838,NCT04416308,ClinicalTrials.gov,2020-05-27,2020-05-29,False,Rennes University Hospital,Recruiting,Not Applicable,Interventional,France,COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB),Clinical Presentation (Epidemiology),No Intervention,No Intervention,13000,https://clinicaltrials.gov/show/NCT04416308,None
4839,NCT04416334,ClinicalTrials.gov,2020-06-03,2020-08-19,False,Instituto de Investigacin Marqus de Valdecilla,Recruiting,Phase 3,Interventional,Spain,PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 60 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS,Drug,Colchicine,Colchicine,954,https://clinicaltrials.gov/show/NCT04416334,None
4840,NCT04416347,ClinicalTrials.gov,2020-05-06,2020-06-15,False,St. George's University Hospitals NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,COVID19 Clinical Predictors and Outcome,Clinical Presentation,No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04416347,None
4841,NCT04416360,ClinicalTrials.gov,2020-05-19,2020-05-05,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Interventional,France,Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak,Other (psych),No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04416360,None
4842,NCT04416373,ClinicalTrials.gov,2020-05-29,2020-03-22,True,University Nova de Lisboa,Recruiting,Not Applicable,Observational,Portugal,COVID-19 and Pregnancy Outcomes,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04416373,None
4843,NCT04416399,ClinicalTrials.gov,2020-06-03,2020-07-16,False,University of Oxford,Recruiting,Phase 2,Interventional,United Kingdom,STerOids in COVID-19 Study,Drug,Corticosteroids,Budesonide,478,https://clinicaltrials.gov/show/NCT04416399,None
4844,NCT04416438,ClinicalTrials.gov,2020-06-03,2020-05-18,True,French Innovative Leukemia Organisation,Recruiting,Not Applicable,Observational,France,COVID-19 Epidemic and Patients With Myeloproliferative Neoplasias,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04416438,None
4845,NCT04416464,ClinicalTrials.gov,2020-06-03,2020-06-15,False,University of Porto,Not Recruiting,Not Applicable,Observational,Portugal,Quality of Life and Patient-centered Outcomes After ICU Admission for COVID-19,Clinical Presentation,No Intervention,No Intervention,230,https://clinicaltrials.gov/show/NCT04416464,None
4846,NCT04416893,ClinicalTrials.gov,2020-06-02,2020-06-07,False,Centre Hospitalier Intercommunal Creteil,Not Recruiting,Not Applicable,Observational,No Country Given,Part 2 on the Study Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children (COVILLE2 ),Clinical Presentation (Epidemiology),No Intervention,No Intervention,630,https://clinicaltrials.gov/show/NCT04416893,None
4847,NCT04416919,ClinicalTrials.gov,2020-05-13,2020-07-15,False,University of Oklahoma,Recruiting,Not Applicable,Interventional,United States,Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment,Other (device),Masks,Masks,20,https://clinicaltrials.gov/show/NCT04416919,None
4848,NCT04417257,ClinicalTrials.gov,2020-05-28,2020-06-29,False,Laurent Pharmaceuticals Inc.,Recruiting,Phase 2,Interventional,"United States, Canada",Study of LAU-7b for the Treatment of COVID-19 Disease in Adults,Drug,LAU-7b,LAU-7b,240,https://clinicaltrials.gov/show/NCT04417257,None
4849,NCT04417270,ClinicalTrials.gov,2020-06-01,2020-06-12,False,Northwell Health,Recruiting,Not Applicable,Interventional,United States,Reliability of the Freestyle Libre CGM in the Inpatient Setting During the COVID-19 Surge,Other (device),Biosensors,Biosensors,50,https://clinicaltrials.gov/show/NCT04417270,None
4850,NCT04417335,ClinicalTrials.gov,2020-05-25,2020-04-16,True,Radboud University,Not Recruiting,Phase 4,Interventional,Netherlands,Reducing COVID-19 Related Hospital Admission in Elderly by BCG Vaccination,ATMP,Vaccine,Vaccine,2014,https://clinicaltrials.gov/show/NCT04417335,EUCTR2020-001591-15; NL8547
4851,NCT04417374,ClinicalTrials.gov,2020-06-03,2020-05-01,True,"University Hospital, Montpellier",Not Recruiting,Not Applicable,Observational,France,"Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in the Context COVID-19",Clinical Presentation,No Intervention,No Intervention,94,https://clinicaltrials.gov/show/NCT04417374,None
4852,NCT04418128,ClinicalTrials.gov,2020-06-03,2020-06-10,False,Gyeongsang National University Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Clinical Efficacy of Nafamostat Mesylate for COVID-19 Pneumonia,Drug,Nafamostat Mesylate,Nafamostat Mesylate,84,https://clinicaltrials.gov/show/NCT04418128,None
4853,NCT04418193,ClinicalTrials.gov,2020-06-02,2020-04-06,True,Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida,Recruiting,Not Applicable,Observational,Monaco,Patient Preference Trial for COVID-19 (PPT-COVID),Drug,Hydroxychloroquine vs. Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,100,https://clinicaltrials.gov/show/NCT04418193,None
4854,NCT04418206,ClinicalTrials.gov,2020-05-18,2020-06-01,False,CHU de Nice,Recruiting,Not Applicable,Interventional,France,Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04418206,None
4855,NCT04418245,ClinicalTrials.gov,2020-06-04,2020-03-01,True,CHU de Nimes,Not Recruiting,Not Applicable,Observational,"France, Martinique",CT Biomarkers Identification by Artificial Intelligence for COVID-19 Prognosis,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,https://clinicaltrials.gov/show/NCT04418245,None
4856,NCT04418284,ClinicalTrials.gov,2020-06-03,2020-06-05,False,South Valley University,Recruiting,Not Applicable,Observational,Egypt,Online Learning of Veterinary Anatomy During COVID-19 Pandemic,Other,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04418284,None
4857,NCT04418375,ClinicalTrials.gov,2020-06-02,2020-06-08,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Observational,France,Establishment of a Biological Collection During COVID-19 Serological Screening in APHP Professionals (COVID-HOP),Clinical Presentation (Epidemiology),No Intervention,No Intervention,4000,https://clinicaltrials.gov/show/NCT04418375,None
4858,NCT04418505,ClinicalTrials.gov,2020-06-03,2020-09-02,False,Vielight Inc.,Recruiting,Not Applicable,Interventional,"United States, Canada",Vielight RX Plus for the Treatment of COVID-19 Respiratory Symptoms,Other,Photobiomodulation,Photobiomodulation,280,https://clinicaltrials.gov/show/NCT04418505,None
4859,NCT04418518,ClinicalTrials.gov,2020-06-03,2020-06-24,False,Weill Medical College of Cornell University,Recruiting,Phase 3,Interventional,United States,A Trial of CONvalescent Plasma for Hospitalized Adults With Acute COVID-19 Respiratory Illness,ATMP,Plasma,Plasma,1200,https://clinicaltrials.gov/show/NCT04418518,None
4860,NCT04418531,ClinicalTrials.gov,2020-06-03,2020-06-01,True,Piero Luigi Ruggenenti,Not Recruiting,Not Applicable,Interventional,Italy,Convalescent Antibodies Infusion in COVID 19 Patients,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04418531,None
4861,NCT04418544,ClinicalTrials.gov,2020-06-01,2020-06-01,False,Soniphi LLC,Recruiting,Not Applicable,Observational,United States,Vocal Feature Analysis Algorithm for COVID-19 Detection,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,400,https://clinicaltrials.gov/show/NCT04418544,None
4862,NCT04418557,ClinicalTrials.gov,2020-06-03,2020-04-28,True,University Hospitals Cleveland Medical Center,Recruiting,Not Applicable,Observational,United States,COVID-19 and Obstetric Transmission,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04418557,None
4863,NCT04418609,ClinicalTrials.gov,2020-05-28,2020-05-01,True,Emanuela Keller,Recruiting,Not Applicable,Observational,Switzerland,Neuro-COVID-19: Neurological Complications of COVID-19,Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04418609,None
4864,NCT04418947,ClinicalTrials.gov,2020-05-29,2020-06-15,False,University of Pennsylvania,Not Recruiting,Not Applicable,Interventional,United States,Project Resurgence Communication Trial,Other,Other,Other,11120,https://clinicaltrials.gov/show/NCT04418947,None
4865,NCT04419025,ClinicalTrials.gov,2020-06-03,2020-09-23,False,Cambridge Health Alliance,Recruiting,Phase 4,Interventional,United States,Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease,Drug,N-acetylcysteine,N-acetylcysteine,200,https://clinicaltrials.gov/show/NCT04419025,None
4866,NCT04419064,ClinicalTrials.gov,2020-06-02,2019-01-01,True,University of Pittsburgh,Not Recruiting,Not Applicable,Observational,United States,Confirmation of Ventilation and Intubation by Determination With Ultrasonography,Other,No Intervention,No Intervention,118,https://clinicaltrials.gov/show/NCT04419064,None
4867,NCT04419545,ClinicalTrials.gov,2020-06-04,2020-03-24,True,AOU Città della Salute e della Scienza di Torino,Recruiting,Not Applicable,Observational,Italy,Covid Radiographic Images Data-set for A.I,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,2500,https://clinicaltrials.gov/show/NCT04419545,None
4868,NCT04419571,ClinicalTrials.gov,2020-06-04,2020-03-23,True,"Barking, Havering and Redbridge University Hospitals NHS Trust",Not Recruiting,Not Applicable,Observational,United Kingdom,Outcomes in Emergency Laparotomies During COVID-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,94,https://clinicaltrials.gov/show/NCT04419571,None
4869,NCT04419623,ClinicalTrials.gov,2020-06-03,2020-07-09,True,"Telios Pharma, Inc.",Recruiting,Phase 1/Phase 2,Interventional,United States,A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer,Drug,TL-895,TL-895,146,https://clinicaltrials.gov/show/NCT04419623,PER-042-20; EUCTR2020-002259-39
4870,NCT04420247,ClinicalTrials.gov,2020-06-02,2020-04-16,True,Centro de Estudos e Pesquisa em Emergências Médicas e Terapia Intensiva (CEPETI),Not Recruiting,Phase 3,Interventional,Brazil,Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19,Drug,Chloroquine or Hydroxychloroquine,Chloroquine; Hydroxychloroquine,142,https://clinicaltrials.gov/show/NCT04420247,None
4871,NCT04420260,ClinicalTrials.gov,2020-05-25,2020-07-01,False,Unidad de Investigación Genética Molecular,Not Recruiting,Not Applicable,Interventional,No Country Given,Primary Prevention of Infection by COVID-19 in Health Providers,Drug (Chemoprophylaxis),"Oropharygeal spray, Immunostimulant",Oropharygeal spray; Immunostimulant,300,https://clinicaltrials.gov/show/NCT04420260,None
4872,NCT04420273,ClinicalTrials.gov,2020-06-03,2020-07-02,False,Northwestern University,Not Recruiting,Not Applicable,Interventional,United States,Targeted Melanoma Detection With Skin Self-Examination During COVID-19 Restricted Physician Access,Other,Other,Other,1000,https://clinicaltrials.gov/show/NCT04420273,None
4873,NCT04420286,ClinicalTrials.gov,2020-06-05,2020-05-06,True,CHU de Nimes,Recruiting,Not Applicable,Observational,France,Study of the Increase in ICU Beds Capacity During COVID-19 Pandemic in France,Health System,No Intervention,No Intervention,9000,https://clinicaltrials.gov/show/NCT04420286,None
4874,NCT04420299,ClinicalTrials.gov,2020-06-05,2020-06-04,False,Fundación de Investigación HM Hospita​les​,Recruiting,Phase 2,Interventional,Spain,Clinical Trial on the Efficacy and Safety of Bemiparin in Patients Hospitalized Because of COVID-19,Drug,Bemiparin,Bemiparin,120,https://clinicaltrials.gov/show/NCT04420299,EUCTR2020-001548-24
4875,NCT04420312,ClinicalTrials.gov,2020-06-05,2020-03-01,True,Groupe Hospitalier Paris Saint-Joseph,Not Recruiting,Not Applicable,Observational,France,Prevalence and Characteristics of Pulmonary Embolism on COVID-19 Patients Presenting Respiratory Symptoms,Clinical Presentation,No Intervention,No Intervention,1024,https://clinicaltrials.gov/show/NCT04420312,None
4876,NCT04420338,ClinicalTrials.gov,2020-06-05,2020-06-05,False,Assistance Publique – Hôpitaux de Marseille,Recruiting,Not Applicable,Interventional,France,"SeroCOVIDial Study: Assessment of COVID-19 Seroconversion in Patients on Chronic Hemodialysis and in Their Caregivers, a Cohort Study",Clinical Presentation (Epidemiology),No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04420338,None
4877,NCT04420364,ClinicalTrials.gov,2020-06-04,2020-07-01,False,Brigham and Women's Hospital,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Maintenance Versus Reduction of Immunosuppression for Renal Transplant Patients Hospitalized With COVID-19 Disease,Other,Immunosupression,Immunosupression,50,https://clinicaltrials.gov/show/NCT04420364,None
4878,NCT04420390,ClinicalTrials.gov,2020-05-14,2020-05-01,True,"Hospital San Carlos, Madrid",Recruiting,Not Applicable,Interventional,Spain,Low Dose Radiotherapy for COVID-19 Pneumonitis,Other,Radiation,Radiation,41,https://clinicaltrials.gov/show/NCT04420390,None
4879,NCT04420416,ClinicalTrials.gov,2020-06-04,2020-04-01,True,Instituto Mexicano del Seguro Social,Recruiting,Not Applicable,Observational,Mexico,Mental Health and Academic Performance in COVID-19,Other (psych),No Intervention,No Intervention,720,https://clinicaltrials.gov/show/NCT04420416,None
4880,NCT04420468,ClinicalTrials.gov,2020-06-05,2020-06-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,Descriptive and Retrospective Analysis of Acute Myocarditis Associated With Pandemic COVID-19 in Children,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04420468,None
4881,NCT04420637,ClinicalTrials.gov,2020-06-04,2020-06-15,False,Medical University of Graz,Recruiting,Not Applicable,Observational,Austria,Impact of the Covid-19 Pandemic on Gastrointestinal and Liver Diseases,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04420637,None
4882,NCT04420676,ClinicalTrials.gov,2020-06-04,2020-09-24,False,Medical University of Graz,Recruiting,Not Applicable,Interventional,Austria,Synbiotic Therapy of Gastrointestinal Symptoms During Covid-19 Infection,Supplement,Probiotics,Probiotics,108,https://clinicaltrials.gov/show/NCT04420676,None
4883,NCT04420741,ClinicalTrials.gov,2020-06-04,2020-06-15,True,Par Johansson,Recruiting,Phase 2,Interventional,Denmark,Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory Failure,Drug,Ilopros,Ilopros,80,https://clinicaltrials.gov/show/NCT04420741,EUCTR2020-001296-33
4884,NCT04420806,ClinicalTrials.gov,2020-06-05,2020-03-14,True,University of Erlangen-Nornberg Medical School,Not Recruiting,Not Applicable,Interventional,Germany,Effects of COVID-19 Lockdown in Exercising Early Postmenopausal Women,Other (exercise),Exercise,Exercise,21,https://clinicaltrials.gov/show/NCT04420806,None
4885,NCT04420988,ClinicalTrials.gov,2020-05-06,2020-10-14,False,Rutgers University,Not Recruiting,Not Applicable,Expanded Access,United States,Investigational COVID-19 Convalescent Plasma Infusion for Severely or Life-threateningly Ill COVID-19 Patients,ATMP,Plasma,Plasma,Not Available,https://clinicaltrials.gov/show/NCT04420988,None
4886,NCT04421391,ClinicalTrials.gov,2020-06-04,2020-06-08,False,Therapeutic Solutions International,Recruiting,Not Applicable,Interventional,United States,QuadraMune(TM) for Prevention of COVID-19,Supplement,Nutritional Supplement,Nutritional Supplement,500,https://clinicaltrials.gov/show/NCT04421391,None
4887,NCT04421404,ClinicalTrials.gov,2020-06-03,2020-06-09,False,Dr. Priscilla Hsue,Not Recruiting,Phase 2,Interventional,United States,Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients,ATMP,Plasma,Plasma,50,https://clinicaltrials.gov/show/NCT04421404,None
4888,NCT04421508,ClinicalTrials.gov,2020-06-05,2020-07-12,False,Bellerophon Pulse Technologies,Not Recruiting,Phase 3,Interventional,United States,A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19,Drug,Nitric Oxide,Nitric Oxide,500,https://clinicaltrials.gov/show/NCT04421508,None
4889,NCT04421534,ClinicalTrials.gov,2020-06-05,2020-06-01,True,Cairo University,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Utility of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19,Drug,Lactoferrin,Lactoferrin,150,https://clinicaltrials.gov/show/NCT04421534,None
4890,NCT04421612,ClinicalTrials.gov,2020-06-04,2020-04-02,True,Haukeland University Hospital,Recruiting,Not Applicable,Interventional,Norway,Coping With 2020 - No Health Without Mental Health,Other (psych),Psychological,Psychological,400,https://clinicaltrials.gov/show/NCT04421612,None
4891,NCT04421625,ClinicalTrials.gov,2020-05-18,2020-06-15,False,Institut de Cancérologie de l'Ouest,Recruiting,Not Applicable,Interventional,France,Patients and Health Staff of Cancer Centres During the Covid-19 Pandemic,Clinical Presentation (Epidemiology),No Intervention,No Intervention,12000,https://clinicaltrials.gov/show/NCT04421625,None
4892,NCT04421664,ClinicalTrials.gov,2020-06-05,2020-03-25,True,McGill University,Not Recruiting,Phase 3,Interventional,"United States, Canada",Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada),Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,70,https://clinicaltrials.gov/show/NCT04421664,None
4893,NCT04422340,ClinicalTrials.gov,2020-06-08,2020-04-01,True,Hospices Civils de Lyon,Recruiting,Not Applicable,Observational,France,Senior-COVID-Rea Multicentric Survey,Clinical Presentation,No Intervention,No Intervention,185,https://clinicaltrials.gov/show/NCT04422340,None
4894,NCT04422353,ClinicalTrials.gov,2020-06-07,2020-05-01,True,Federal University of Rio Grande do Sul,Recruiting,Not Applicable,Interventional,Brazil,Video Dance Class and Unsupervised Physical Activity During Covid-19 Pandemic in People With Parkinson's Disease,Other (exercise),Exercise,Exercise,60,https://clinicaltrials.gov/show/NCT04422353,None
4895,NCT04422379,ClinicalTrials.gov,2020-06-07,2020-06-07,False,Max Healthcare Insititute Limited,Not Recruiting,Not Applicable,Observational,India,COVID-19 and Liver Injury in Patients With or Without Underlying Liver Disease: A Multi-centre Retrospective-prospective Observational Study,Clinical Presentation,No Intervention,No Intervention,314,https://clinicaltrials.gov/show/NCT04422379,None
4896,NCT04422418,ClinicalTrials.gov,2020-06-03,2020-07-01,False,Khalifa University for Science and Technology,Recruiting,Not Applicable,Observational,United Arab Emirates,Impact of Burnout on Cardiovascular and Immune Biomarkers in Healthcare Professionals - Covid-19 Pandemic in Abu Dhabi,Other (psych),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04422418,None
4897,NCT04422444,ClinicalTrials.gov,2020-06-04,2020-06-01,True,Corporació Sanitària Parc Taulí ,Recruiting,Not Applicable,Observational,Spain,Post Intensive Care Syndrome in COVID19 Patients,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04422444,None
4898,NCT04422470,ClinicalTrials.gov,2020-06-08,2020-06-22,False,"National Research Center for Hematology, Russia",Recruiting,Not Applicable,Observational,Russian Federation,Registry of Patients With Hematologic Disease and COVID-19 in Russia,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04422470,None
4899,NCT04422509,ClinicalTrials.gov,2020-06-03,2020-10-03,False,Radboud University,Recruiting,Phase 1/Phase 2,Interventional,Netherlands,Lanadelumab for Treatment of COVID-19 Disease,Drug,Lanadelumab,Lanadelumab,80,https://clinicaltrials.gov/show/NCT04422509,None
4900,NCT04422522,ClinicalTrials.gov,2020-06-07,2020-03-15,True,Al-Azhar University,Not Recruiting,Not Applicable,Observational,Egypt,Fibromyalgia During the COVID-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,45,https://clinicaltrials.gov/show/NCT04422522,None
4901,NCT04422535,ClinicalTrials.gov,2020-06-03,2020-05-29,True,Matilde Zaballos,Recruiting,Not Applicable,Observational,Spain,Effects on the Qt Interval of COVID-19 Coronavirus Infection,Clinical Presentation,No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04422535,None
4902,NCT04422561,ClinicalTrials.gov,2020-06-06,2020-05-31,True,Zagazig University,Not Recruiting,Phase 2/Phase 3,Interventional,Egypt,Prophylactic Ivermectin in COVID-19 Contacts,Drug (Chemoprophylaxis),Ivermectin,Ivermectin,340,https://clinicaltrials.gov/show/NCT04422561,None
4903,NCT04422574,ClinicalTrials.gov,2020-06-08,2020-05-01,True,"University Hospital, Montpellier",Not Recruiting,Not Applicable,Observational,France,COVID 19 Serology in Pulmonologists,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,97,https://clinicaltrials.gov/show/NCT04422574,None
4904,NCT04422587,ClinicalTrials.gov,2020-06-05,2020-03-13,True,"University Hospital, Toulouse",Not Recruiting,Not Applicable,Observational,France,Evaluation of the COVID-19 Infection Response in Patients Admitted to the Emergency Department for Dyspnea,Clinical Presentation,No Intervention,No Intervention,1860,https://clinicaltrials.gov/show/NCT04422587,None
4905,NCT04422613,ClinicalTrials.gov,2020-06-05,2020-05-28,True,"University Hospital, Toulouse",Not Recruiting,Not Applicable,Interventional,France,Characterization of Persistent Pulmonary Abnormalities Following COVID-19 Pneumonia,Clinical Presentation,No Intervention,No Intervention,73,https://clinicaltrials.gov/show/NCT04422613,None
4906,NCT04422626,ClinicalTrials.gov,2020-06-06,2020-07-01,False,University of Pecs,Not Recruiting,Not Applicable,Observational,No Country Given,Data Analysis of the Cytokine Adsorption Treatment on Coronavirus Disease-19 (COVID-19) Patients With Respiratory Failure,Other (device),Cytokine Adsorber,Cytokine Adsorber,42,https://clinicaltrials.gov/show/NCT04422626,None
4907,NCT04422678,ClinicalTrials.gov,2020-06-05,2020-06-01,True,Alexandria University,Not Recruiting,Phase 3,Interventional,No Country Given,The Safety & Efficacy of Imatinib for the Treatment of SARS-COV-2 Induced Pneumonia,Drug,Imatinib,Imatinib,30,https://clinicaltrials.gov/show/NCT04422678,None
4908,NCT04422691,ClinicalTrials.gov,2020-06-05,2020-07-01,False,St. Olavs Hospital,Recruiting,Not Applicable,Observational,Norway,Ultrasonography in Norwegian Emergency Department Patients With Suspected Covid-19 Infection,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04422691,None
4909,NCT04422769,ClinicalTrials.gov,2020-06-04,2020-05-22,True,Washington University in St. Louis,Recruiting,Not Applicable,Observational,United States,Needs of Persons With Spinal Cord Injury (SCI),Other,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04422769,None
4910,NCT04422873,ClinicalTrials.gov,2020-06-04,2020-06-03,True,University of Portsmouth,Recruiting,Not Applicable,Observational,United Kingdom,The Impact of COVID-19 on Dialysis Users,Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04422873,None
4911,NCT04422977,ClinicalTrials.gov,2020-06-05,2020-06-08,False,Centre Hospitalier Saint Joseph Saint Luc de Lyon,Not Recruiting,Not Applicable,Interventional,No Country Given,Serological Study of the Exposure of Personnel to Sars-cov-2,Clinical Presentation (Epidemiology),No Intervention,No Intervention,900,https://clinicaltrials.gov/show/NCT04422977,None
4912,NCT04423003,ClinicalTrials.gov,2020-06-08,2020-03-01,True,"University Hospital, Tübingen",Not Recruiting,Not Applicable,Observational,Germany,Endoscopic Interventions in Patients With COVID-19,Procedure,Endoscopy,Endoscopy,10,https://clinicaltrials.gov/show/NCT04423003,None
4913,NCT04423042,ClinicalTrials.gov,2020-06-05,2020-07-30,False,University of Calgary,Not Recruiting,Phase 3,Interventional,No Country Given,Tocilizumab in Coronavirus-19 Positive Patients,Drug,Tocilizumab,Tocilizumab,30,https://clinicaltrials.gov/show/NCT04423042,None
4914,NCT04423289,ClinicalTrials.gov,2020-06-06,2020-03-31,True,Vall d'Hebron Research Institute (VHIR),Not Recruiting,Not Applicable,Interventional,Spain,Telematic Monitoring Through a Mobile Application of Patients With COVID-19,Other (software),eHealth,eHealth,150,https://clinicaltrials.gov/show/NCT04423289,None
4915,NCT04423315,ClinicalTrials.gov,2020-06-05,2020-06-08,False,Nisantasi University,Not Recruiting,Not Applicable,Observational,Turkey,Thrombosis Risk Assessment and Clinical Presentation of Covid-19 Pneumonia,Clinical Presentation,No Intervention,No Intervention,70,https://clinicaltrials.gov/show/NCT04423315,None
4916,NCT04423640,ClinicalTrials.gov,2020-05-27,2020-04-15,True,"Coordinación de Investigación en Salud, Mexico",Recruiting,Not Applicable,Observational,Mexico,Analysis of the Inflammatory Response and the Development of Humoral and Cellular Immunity in Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04423640,None
4917,NCT04423692,ClinicalTrials.gov,2020-06-07,2020-06-01,True,Aljazeera Hospital,Recruiting,Not Applicable,Observational,Egypt,Knowledge About Covid-19 Infection in Pregnant Women,Other,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04423692,None
4918,NCT04423770,ClinicalTrials.gov,2020-06-08,2020-06-08,False,American Dental Association,Not Recruiting,Not Applicable,Observational,United States,COVID-19 Related Health and Infection Control Practices Among Dentists,Other,No Intervention,No Intervention,4000,https://clinicaltrials.gov/show/NCT04423770,None
4919,NCT04423861,ClinicalTrials.gov,2020-06-08,2020-12-01,False,Azidus Brasil,Not Recruiting,Phase 3,Interventional,No Country Given,Efficacy and Safety of Nitazoxanide 600 mg BID Versus Placebo for the Treatment of Hospitalized Patients With COVID-19,Drug,Nitazoxanide,Nitazoxanide,380,https://clinicaltrials.gov/show/NCT04423861,None
4920,NCT04423978,ClinicalTrials.gov,2020-06-08,2020-05-04,True,Azienda Unita Sanitaria Locale Reggio Emilia,Not Recruiting,Not Applicable,Observational,Italy,Implications of Covid-19 on the Lifestyle Changes,Other,No Intervention,No Intervention,1826,https://clinicaltrials.gov/show/NCT04423978,None
4921,NCT04423991,ClinicalTrials.gov,2020-06-08,2020-03-10,True,Dascena,Not Recruiting,Not Applicable,Interventional,United States,Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning,Other (software),Machine Learning,Machine Learning,290,https://clinicaltrials.gov/show/NCT04423991,None
4922,NCT04424004,ClinicalTrials.gov,2020-06-08,2020-06-09,False,Duke University,Not Recruiting,Not Applicable,Observational,United States,MURDOCK Cabarrus County COVID-19 Prevalence and Immunity (C3PI) Study,Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04424004,None
4923,NCT04424017,ClinicalTrials.gov,2020-06-08,2020-06-07,True,Egyptian Center for Research and Regenerative Medicine,Recruiting,Not Applicable,Observational,Egypt,Sero-prevalence of Coronavirus Disease 2019 (COVID-19) in Healthcare Workers,Clinical Presentation (Epidemiology),No Intervention,No Intervention,726,https://clinicaltrials.gov/show/NCT04424017,None
4924,NCT04424056,ClinicalTrials.gov,2020-06-08,2020-09-01,False,Assistance Publique – Hôpitaux de Marseille,Not Recruiting,Phase 3,Interventional,France,"A Trial Using ANAKINRA, TOCILIZUMAB Alone or in Association With RUXOLITINIB in Severe Stage 2b and 3 of COVID19-associated Disease",Drug,Anakinra + Ruxolitinib vs. Tocilizumab + Ruxolitinib,Anakinra; Ruxolitinib; Tocilizumab,216,https://clinicaltrials.gov/show/NCT04424056,None
4925,NCT04424082,ClinicalTrials.gov,2020-06-07,2020-06-09,False,Karolinska Institutet,Recruiting,Not Applicable,Interventional,Sweden,External Dead Space in Ventilated COVID-19 Patients,Other (physical),Mechanical ventilation,Mechanical ventilation,40,https://clinicaltrials.gov/show/NCT04424082,None
4926,NCT04424134,ClinicalTrials.gov,2020-05-27,2020-05-16,True,Lomonosov Moscow State University Medical Research and Educational Center,Recruiting,Phase 3,Interventional,Russian Federation,BromhexIne And Spironolactone For Coron?VirUs Infection Requiring HospiTalization,Drug,Bromhexine + Spironolactone,Bromhexine; Spironolactone,80,https://clinicaltrials.gov/show/NCT04424134,None
4927,NCT04424446,ClinicalTrials.gov,2020-06-09,2020-07-13,False,National Institutes of Health Clinical Center (CC),Recruiting,Not Applicable,Observational,United States,Saliva as Source of Detection for SARS-CoV-2,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,5000,https://clinicaltrials.gov/show/NCT04424446,None
4928,NCT04424771,ClinicalTrials.gov,2020-06-07,2020-03-01,True,Piazza della Vittoria 14 Studio Medico - Ginecologia e Ostetricia,Not Recruiting,Not Applicable,Observational,Italy,Post-traumatic Stress Disease in Health Workers During COVID-19 Pandemia,Other (psych),No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04424771,None
4929,NCT04424797,ClinicalTrials.gov,2020-06-05,2020-07-13,False,Poudre Valley Health System,Recruiting,Not Applicable,Interventional,United States,Prone Positioning on Admission for Hospitalized COVID-19 Pneumonia Protocol,Procedure,Positioning,Positioning,100,https://clinicaltrials.gov/show/NCT04424797,None
4930,NCT04424836,ClinicalTrials.gov,2020-06-07,2020-05-15,True,Sisli Hamidiye Etfal Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,HFNC Treatment in COVID-19 Pneumonia,Other (device),Nasal cannula,Nasal cannula,43,https://clinicaltrials.gov/show/NCT04424836,None
4931,NCT04424849,ClinicalTrials.gov,2020-06-08,2020-03-15,True,Tepecik Training and Research Hospital,Recruiting,Not Applicable,Observational,Turkey,Thorax Computed Tomography Severity Score and Outcome in COVID-19 Patients,Prognosis,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04424849,None
4932,NCT04424901,ClinicalTrials.gov,2020-05-29,2020-05-03,True,UConn Health,Recruiting,Phase 2,Interventional,United States,Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19,Drug,Dipyridamole,Dipyridamole,100,https://clinicaltrials.gov/show/NCT04424901,None
4933,NCT04424940,ClinicalTrials.gov,2020-05-20,2020-09-01,False,University of Kinshasa,Not Recruiting,Not Applicable,Observational,Democratic Republic of Congo,COVID-19 Lessons Learned: the Outcome of TOMEKAÂ® Project is to Teach,Other,No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04424940,None
4934,NCT04424992,ClinicalTrials.gov,2020-06-04,2020-02-23,True,University of Milano Bicocca,Not Recruiting,Not Applicable,Observational,Italy,The Natural History of Hospitalized COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,1433,https://clinicaltrials.gov/show/NCT04424992,None
4935,NCT04425005,ClinicalTrials.gov,2020-06-08,2020-05-10,True,University of São Paulo,Recruiting,Not Applicable,Interventional,Brazil,Home-based Exercise Training During Covid-19 Pandemic in Post-bariatric,Other (exercise),Exercise,Exercise,70,https://clinicaltrials.gov/show/NCT04425005,None
4936,NCT04425044,ClinicalTrials.gov,2020-06-09,2020-04-12,True,Aarogyam UK,Not Recruiting,Not Applicable,Observational,India,AiM Covid Self Monitoring,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,https://clinicaltrials.gov/show/NCT04425044,None
4937,NCT04425213,ClinicalTrials.gov,2020-05-28,2020-05-12,True,CHU de Nancy,Not Recruiting,Not Applicable,Observational,France,Obesity and Mortality of Critically Ill Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04425213,None
4938,NCT04425252,ClinicalTrials.gov,2020-06-09,2020-06-25,False,"Clear Creek Bio, Inc.",Recruiting,Phase 1/Phase 2,Interventional,United States,Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19,Drug,Brequinar,Brequinar,24,https://clinicaltrials.gov/show/NCT04425252,None
4939,NCT04425317,ClinicalTrials.gov,2020-05-27,2020-06-24,False,CRG UZ Brussel,Recruiting,Not Applicable,Interventional,Belgium,Detection of SARS-CoV-2 in Follicular Fluid and Cumulus-oocyte-complexes in COVID-19 Patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,20,https://clinicaltrials.gov/show/NCT04425317,None
4940,NCT04425382,ClinicalTrials.gov,2020-05-21,2020-03-01,True,Hamad Medical Corporation,Recruiting,Not Applicable,Observational,Qatar,Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19 Pneumonia in Qatar,Drug,Darunavir/Cobicistat vs. Lopinavir/Ritonavir,Darunavir/Cobicistat; Lopinavir/Ritonavir,200,https://clinicaltrials.gov/show/NCT04425382,None
4941,NCT04425460,ClinicalTrials.gov,2020-05-28,2020-06-01,False,Zhejiang Hisun Pharmaceutical Co. Ltd.,Not Recruiting,Phase 3,Interventional,"China, Germany, Romania","A Multi-center,Randomized,Double-blind,Placebo-controlled,Phase 3 Study Evaluating Favipiravir in Treatment of COVID19",Drug,Favipiravir,Favipiravir,256,https://clinicaltrials.gov/show/NCT04425460,None
4942,NCT04425499,ClinicalTrials.gov,2020-06-08,2020-06-01,True,University of Montreal,Not Recruiting,Not Applicable,Interventional,No Country Given,A Gamified Network for Surgical Education During COVID-19: A Randomized Controlled Trial,Other,Other,Other,60,https://clinicaltrials.gov/show/NCT04425499,None
4943,NCT04425538,ClinicalTrials.gov,2020-06-08,2020-06-01,True,Tufts Medical Center,Recruiting,Phase 2,Interventional,United States,A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).,Drug,Infliximab,Infliximab,17,https://clinicaltrials.gov/show/NCT04425538,None
4944,NCT04425616,ClinicalTrials.gov,2020-06-03,2020-05-29,True,University Hospital Southampton NHS Foundation Trust,Recruiting,Not Applicable,Interventional,United Kingdom,SafeFit Trial: Virtual Clinics to Deliver Universal Interventions in People With Cancer,Other,Welfare,Welfare,1100,https://clinicaltrials.gov/show/NCT04425616,None
4945,NCT04425707,ClinicalTrials.gov,2020-06-08,2020-06-09,False,"Ministry of Health and Population, Egypt",Recruiting,Not Applicable,Interventional,Egypt,Ivermectin In Treatment of COVID 19 Patients,Drug,Ivermectin,Ivermectin,100,https://clinicaltrials.gov/show/NCT04425707,None
4946,NCT04425720,ClinicalTrials.gov,2020-06-02,2020-09-01,False,Montefiore Medical Center,Recruiting,Not Applicable,Interventional,United States,Use of Remote Monitoring for COVID-19 Patient,Other (device),Biosensors,Biosensors,300,https://clinicaltrials.gov/show/NCT04425720,None
4947,NCT04425733,ClinicalTrials.gov,2020-06-08,2020-07-07,False,Merck Sharp & Dohme Corp.,Not Recruiting,Phase 1,Interventional,No Country Given,MK-5475 in Participants With Hypoxemia Due to COVID-19 Pneumonia (MK-5475-009),Drug,MK-5475,MK-5475,0,https://clinicaltrials.gov/show/NCT04425733,None
4948,NCT04425759,ClinicalTrials.gov,2020-06-08,2020-06-08,False,Hospital de Mataró,Recruiting,Not Applicable,Observational,Spain,Prevalence and Risk Factors of SARS-CoV-2 Antibody Responses (COVID-19),Clinical Presentation,No Intervention,No Intervention,2400,https://clinicaltrials.gov/show/NCT04425759,None
4949,NCT04425772,ClinicalTrials.gov,2020-05-09,2020-06-12,False,"HeNan Sincere Biotech Co., Ltd",Not Recruiting,Not Applicable,Interventional,No Country Given,A Clinical Trial for Azvudine in the Treatment of Novel Coronavirus Pneumonia (COVID-19),Drug,Azvudine,Azvudine,342,https://clinicaltrials.gov/show/NCT04425772,None
4950,NCT04425837,ClinicalTrials.gov,2020-05-29,2020-07-01,False,Fundación Santa Fe de Bogotá,Not Recruiting,Phase 2/Phase 3,Interventional,Colombia,Effectiveness and Safety of Convalescent Plasma in Patients With High-risk COVID-19,ATMP,Plasma,Plasma,236,https://clinicaltrials.gov/show/NCT04425837,None
4951,NCT04425850,ClinicalTrials.gov,2020-06-08,2020-06-01,True,Eurnekian Public Hospital,Not Recruiting,Not Applicable,Observational,Argentina,USEFULNESS of Topic Ivermectin and Carrageenan to Prevent Contagion of Covid 19,Drug,Ivermectin + Carrageenan,Ivermectin; Carrageenan,229,https://clinicaltrials.gov/show/NCT04425850,None
4952,NCT04425863,ClinicalTrials.gov,2020-06-08,2020-05-01,True,Eurnekian Public Hospital,Not Recruiting,Not Applicable,Observational,Argentina,"Ivermectin, Aspirin, Dexamethasone and Enoxaparin as Treatment of Covid 19",Drug,"Ivermectin, Aspirin, Dexamethasone, Enoxaparin",Ivermectin; Aspirin; Dexamethasone; Enoxaparin,167,https://clinicaltrials.gov/show/NCT04425863,None
4953,NCT04425889,ClinicalTrials.gov,2020-06-06,2020-05-05,True,Hospital Universitario Dr. Jose E. Gonzalez,Not Recruiting,Not Applicable,Observational,Mexico,COVID-19 Antibodies Among Healthcare Workers,Clinical Presentation (Epidemiology),No Intervention,No Intervention,156,https://clinicaltrials.gov/show/NCT04425889,None
4954,NCT04425915,ClinicalTrials.gov,2020-06-07,2020-06-14,False,"Institute of Liver and Biliary Sciences, India",Recruiting,Phase 3,Interventional,India,Efficacy of Convalescent Plasma Therapy in Patients With COVID-19,ATMP,Plasma,Plasma,400,https://clinicaltrials.gov/show/NCT04425915,None
4955,NCT04426006,ClinicalTrials.gov,2020-06-09,2020-06-01,True,Institut Bergonié,Not Recruiting,Not Applicable,Interventional,France,Serological Response to SARS-Cov-2 Virus in Personnel of the Institut BergoniÃ© in the Context of the COVID-19 Pandemic,Clinical Presentation (Epidemiology),No Intervention,No Intervention,550,https://clinicaltrials.gov/show/NCT04426006,None
4956,NCT04426071,ClinicalTrials.gov,2020-05-28,2020-06-01,False,Lawson Health Research Institute,Not Recruiting,Not Applicable,Observational,Canada,The Impact of a Societal Lockdown on Those With Spinal Cord and Brain Injuries,Other,No Intervention,No Intervention,142,https://clinicaltrials.gov/show/NCT04426071,None
4957,NCT04426084,ClinicalTrials.gov,2020-06-09,2020-03-01,True,Karolinska Institutet,Not Recruiting,Not Applicable,Observational,Sweden,Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study,Clinical Presentation,No Intervention,No Intervention,22784,https://clinicaltrials.gov/show/NCT04426084,None
4958,NCT04426253,ClinicalTrials.gov,2020-06-09,2020-06-05,True,Szeged University,Not Recruiting,Not Applicable,Observational,Hungary,"Identification of Genetic Factors Determining Disease Course in the New Type of Coronavirus Infection, COVID-19",Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04426253,None
4959,NCT04426266,ClinicalTrials.gov,2020-06-08,2020-05-01,True,Szeged University,Not Recruiting,Not Applicable,Observational,Hungary,Psychological Effects of the COVID-19 Pandemic on the Hungarian Adult Population,Other (psych),No Intervention,No Intervention,441,https://clinicaltrials.gov/show/NCT04426266,None
4960,NCT04426292,ClinicalTrials.gov,2020-06-08,2020-05-12,True,UZ Brussel,Recruiting,Not Applicable,Interventional,Belgium,SARS-COV-2 Seroprevalence and Seroconversion Among Employees of the Universitair Ziekenhuis Brussel During the 2020 COVID-19 Outbreak,Clinical Presentation (Epidemiology),No Intervention,No Intervention,3500,https://clinicaltrials.gov/show/NCT04426292,None
4961,NCT04426305,ClinicalTrials.gov,2020-06-03,2020-05-21,True,University of Ghent,Recruiting,Not Applicable,Interventional,Belgium,Community Health Workers Against COVID19,Other (psych),Psychological,Psychological,140,https://clinicaltrials.gov/show/NCT04426305,None
4962,NCT04426318,ClinicalTrials.gov,2020-06-09,2020-06-14,False,"University of Wisconsin, Madison",Recruiting,Not Applicable,Interventional,United States,COVID-19 and the Healthy Minds Program for Educators,Other (psych),Psychological,Psychological,800,https://clinicaltrials.gov/show/NCT04426318,None
4963,NCT04426344,ClinicalTrials.gov,2020-06-03,2020-10-01,False,Washington University in St. Louis,Not Recruiting,Not Applicable,Interventional,United States,Core Warming of COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,0,https://clinicaltrials.gov/show/NCT04426344,None
4964,NCT04426695,ClinicalTrials.gov,2020-06-08,2020-06-10,True,Regeneron Pharmaceuticals,Recruiting,Phase 1/Phase 2,Interventional,"Chile, Brazil, United States, Moldova, Republic of, Romania","Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19",Drug,REGN10933 vs. REGN10987,REGN10933; REGN10987,2970,https://clinicaltrials.gov/show/NCT04426695,EUCTR2020-002537-15
4965,NCT04427098,ClinicalTrials.gov,2020-05-29,2020-05-22,False,AOU di Bologna Policlinico S.Orsola-Malpighi,Recruiting,Phase 2,Interventional,Italy,Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients,Drug,Enoxaparin,Enoxaparin,300,https://clinicaltrials.gov/show/NCT04427098,EUCTR2020-001308-40
4966,NCT04427137,ClinicalTrials.gov,2020-06-10,2020-06-09,True,Centre for Addiction and Mental Health,Recruiting,Not Applicable,Interventional,Canada,Accelerated LFR for Bipolar Patients During the COVID-19 Pandemic,Other (psych),Electroconvulsive Therapy,Electroconvulsive Therapy,50,https://clinicaltrials.gov/show/NCT04427137,None
4967,NCT04427176,ClinicalTrials.gov,2020-06-10,2020-04-29,True,CHU de Saint Etienne,Not Recruiting,Not Applicable,Observational,France,Evaluation of ARFC Masks Equipped With CF5 Filter in the Care Unit to Allow a Wider Distribution of FFP2 Masks (Covid-19).,Other (device),Masks,Masks,15,https://clinicaltrials.gov/show/NCT04427176,None
4968,NCT04427254,ClinicalTrials.gov,2020-05-26,2021-01-01,False,Fondation Ophtalmologique Adolphe de Rothschild,Not Recruiting,Not Applicable,Interventional,France,Study of the Sars-Cov2 Neuroinvasiveness - COVID19,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04427254,None
4969,NCT04427267,ClinicalTrials.gov,2020-06-10,2020-06-03,True,"Federal State Budgetary Scientific Institution, Izmerov Research Institute of Occupational Health",Not Recruiting,Not Applicable,Observational,Russian Federation,Assessment of Thermal Condition of Health Workers Who Use Personal Protective Equipment From Biological Hazards During Their Work With COVID-19 Patients,Other,PPE,PPE,6,https://clinicaltrials.gov/show/NCT04427267,None
4970,NCT04427280,ClinicalTrials.gov,2020-05-21,2020-05-26,False,Royal Marsden NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,60,https://clinicaltrials.gov/show/NCT04427280,None
4971,NCT04427332,ClinicalTrials.gov,2020-06-10,2020-06-11,False,University of Milano Bicocca,Recruiting,Not Applicable,Observational,Italy,Smell and Taste Disorders in COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04427332,None
4972,NCT04427345,ClinicalTrials.gov,2020-06-04,2020-04-30,True,University of Milano Bicocca,Recruiting,Not Applicable,Observational,Italy,Predictive Factors COVID-19 Patients,Prognosis,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04427345,None
4973,NCT04427358,ClinicalTrials.gov,2020-06-10,2020-05-07,True,"University Hospital, Strasbourg",Not Recruiting,Not Applicable,Observational,France,RT-PCR SARS-CoV-2 at 1 Month of COVID-19 Infection in the Geriatric Population,Clinical Presentation (Epidemiology),No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04427358,None
4974,NCT04427566,ClinicalTrials.gov,2020-06-05,2020-07-23,False,Ohio State University Comprehensive Cancer Center,Recruiting,Phase 2,Interventional,United States,Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise,Other,Radiation,Radiation,24,https://clinicaltrials.gov/show/NCT04427566,None
4975,NCT04427631,ClinicalTrials.gov,2020-06-03,2020-06-22,False,Cambridgeshire Community Services NHS Trust,Not Recruiting,Not Applicable,Interventional,United Kingdom,Exploring Interventions for Glue Ear During Covid-19,Other,Other,Other,20,https://clinicaltrials.gov/show/NCT04427631,None
4976,NCT04427735,ClinicalTrials.gov,2020-06-09,2019-01-24,True,Beijing Friendship Hospital,Recruiting,Not Applicable,Observational,China,Effect of Covid-19 Epidemic on Primary PCI in Patients With STEMI,Health System,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04427735,None
4977,NCT04427813,ClinicalTrials.gov,2020-06-09,2020-06-11,False,Aljazeera Hospital,Not Recruiting,Not Applicable,Observational,Egypt,Sexual Health and Problems During the Covid -19 Infection,Other,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04427813,None
4978,NCT04427865,ClinicalTrials.gov,2020-06-10,2020-07-01,False,Cairo University,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Utility of Lactoferrin as a Preventive Agent for Healthcare Workers Exposed to COVID-19,Drug (Chemoprophylaxis),Lactoferrin,Lactoferrin,200,https://clinicaltrials.gov/show/NCT04427865,None
4979,NCT04427878,ClinicalTrials.gov,2020-06-10,2020-07-01,False,CHU de Nice,Not Recruiting,Not Applicable,Interventional,France,Is Adipose Tissue a Reservoir for SARS-Cov2 Spread in Covid-19 Patients?,Clinical Presentation,No Intervention,No Intervention,5,https://clinicaltrials.gov/show/NCT04427878,None
4980,NCT04428008,ClinicalTrials.gov,2020-06-07,2020-09-01,False,Inova Health System,Not Recruiting,Phase 2,Interventional,No Country Given,Thymosin Alpha 1 to Prevent COVID-19 Infection in Elderly Renal Dialysis Patients,Drug,Thymalfasin,Thymalfasin,240,https://clinicaltrials.gov/show/NCT04428008,None
4981,NCT04428021,ClinicalTrials.gov,2020-06-07,2020-06-15,False,AOU Città della Salute e della Scienza di Torino,Recruiting,Phase 2,Interventional,Italy,Standard or Convalescent Plasma in Patients With Recent Onset of COVID-19 Respiratory Failure,ATMP,Plasma,Plasma,180,https://clinicaltrials.gov/show/NCT04428021,None
4982,NCT04428073,ClinicalTrials.gov,2020-06-08,2020-07-01,False,GeneCure Biotechnologies,Not Recruiting,Phase 1,Interventional,No Country Given,Therapeutic Vaccine Trial of COVID-19 for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection,ATMP,Vaccine,Vaccine,32,https://clinicaltrials.gov/show/NCT04428073,None
4983,NCT04428099,ClinicalTrials.gov,2020-06-09,2020-01-13,True,University of the Balearic Islands,Recruiting,Not Applicable,Interventional,Spain,Healthy Lifestyle Promotion as Adjunctive Teletherapy for Treatment-resistant Major Depression,Telehealth,Telehealth,Telehealth,186,https://clinicaltrials.gov/show/NCT04428099,None
4984,NCT04428268,ClinicalTrials.gov,2020-04-26,2020-03-10,True,Hospital Universitario Dr. Jose E. Gonzalez,Recruiting,Phase 2,Interventional,Mexico,Chloroquine + Losartan Compared to Chloroquine Alone for the Treatment of COVID-19 Pneumonia,Drug,Chloroquine vs. Chloroquine + Losartan,Chloroquine; Losartan,20,https://clinicaltrials.gov/show/NCT04428268,None
4985,NCT04428801,ClinicalTrials.gov,2020-04-08,2021-01-10,False,Celltex Therapeutics Corporation,Not Recruiting,Phase 2,Interventional,No Country Given,Autologous Adipose-derived Stem Cells (AdMSCs) for COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),200,https://clinicaltrials.gov/show/NCT04428801,None
4986,NCT04429334,ClinicalTrials.gov,2020-05-29,2020-08-01,False,Inotrem,Not Recruiting,Phase 2,Interventional,France,"Safety, Tolerability and Efficacy of Nangibotide in Mechanically Ventilated Patients With COVID-19 and Features of Systemic Inflammation",Drug,Nangibotide,Nangibotide,60,https://clinicaltrials.gov/show/NCT04429334,None
4987,NCT04429477,ClinicalTrials.gov,2020-06-09,2020-05-01,True,University of São Paulo,Not Recruiting,Not Applicable,Observational,Brazil,Cerebral Compliance Impairment in COVID-19,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04429477,None
4988,NCT04429529,ClinicalTrials.gov,2020-06-09,2020-06-09,False,Tychan Pte Ltd.,Not Recruiting,Phase 1,Interventional,Singapore,"Safety of TY027, a Treatment for COVID-19, in Humans",Drug,TY027,TY027,32,https://clinicaltrials.gov/show/NCT04429529,None
4989,NCT04429555,ClinicalTrials.gov,2020-06-09,2020-11-01,False,MediciNova,Not Recruiting,Phase 2,Interventional,No Country Given,"Efficacy, Safety, Tolerability, and Biomarkers of MN-166 (Ibudilast) in Patients Hospitalized With COVID-19 and at Risk for ARDS",Drug,Ibudilast,Ibudilast,40,https://clinicaltrials.gov/show/NCT04429555,None
4990,NCT04429594,ClinicalTrials.gov,2020-06-10,2020-07-28,False,CHU de Nice,Recruiting,Not Applicable,Interventional,France,Study of the Incidence of SARS-CoV-2 Infection (COVID-19),Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04429594,None
4991,NCT04429620,ClinicalTrials.gov,2020-06-10,2020-05-30,True,Szeged University,Recruiting,Not Applicable,Observational,Hungary,Prospective Assay for SARS-CoV-2 (COVID-19) Antibody Detection Indirectly by Immunofluorescence: SARS-CoV2 IIF Method,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04429620,None
4992,NCT04429711,ClinicalTrials.gov,2020-05-24,2020-05-12,True,Sheba Medical Center,Recruiting,Not Applicable,Interventional,Israel,Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19,Drug,Ivermectin,Ivermectin,100,https://clinicaltrials.gov/show/NCT04429711,None
4993,NCT04429724,ClinicalTrials.gov,2020-06-10,2020-07-06,False,Tourcoing Hospital,Recruiting,Not Applicable,Interventional,France,Health Professional Exposure Assessment to Covid-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,6000,https://clinicaltrials.gov/show/NCT04429724,None
4994,NCT04429763,ClinicalTrials.gov,2020-06-10,2020-07-01,False,Trustem,Not Recruiting,Phase 2,Interventional,No Country Given,Safety and Efficacy of Mesenchymal Stem Cells in the Management of Severe COVID-19 Pneumonia,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04429763,None
4995,NCT04429815,ClinicalTrials.gov,2020-06-11,2020-07-01,False,CHU de Nancy,Not Recruiting,Not Applicable,Observational,No Country Given,Impact of Smoking and Nicotine on the Risk of Being Infected With COVID-19,Clinical Presentation,No Intervention,No Intervention,489,https://clinicaltrials.gov/show/NCT04429815,None
4996,NCT04429828,ClinicalTrials.gov,2020-06-11,2020-06-13,False,University of Nottingham,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 Psychological Wellbeing for Healthcare Students,Other (psych),Psychological,Psychological,45,https://clinicaltrials.gov/show/NCT04429828,None
4997,NCT04429854,ClinicalTrials.gov,2020-06-09,2020-05-02,True,UZ Leuven,Recruiting,Phase 2,Interventional,Belgium,Donated Antibodies Working Against nCoV,ATMP,Plasma,Plasma,483,https://clinicaltrials.gov/show/NCT04429854,None
4998,NCT04429867,ClinicalTrials.gov,2020-06-10,2020-05-07,True,WellStar Health System,Not Recruiting,Phase 4,Interventional,United States,Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease,Drug,Hydroxychloroquine,Hydroxychloroquine,700,https://clinicaltrials.gov/show/NCT04429867,None
4999,NCT04430049,ClinicalTrials.gov,2020-06-10,2020-06-22,False,"University Hospital, Clermont-Ferrand",Not Recruiting,Not Applicable,Observational,France,"Impact of Covid-19 Restrictive Measure on Anxiety, Depression and PTSD for Relatives of ICU Patients",Other (psych),No Intervention,No Intervention,240,https://clinicaltrials.gov/show/NCT04430049,None
5000,NCT04430062,ClinicalTrials.gov,2020-06-11,2020-05-01,True,Azienda Socio Sanitaria Territoriale di Lodi,Not Recruiting,Not Applicable,Observational,Italy,Short-term Outcome of Covid-19 Surgical Patients: Case-series of a High-risk Area Community Hospital,Other,No Intervention,No Intervention,14,https://clinicaltrials.gov/show/NCT04430062,None
5001,NCT04430322,ClinicalTrials.gov,2020-06-11,2020-03-01,True,Centre Hospitalier Régional Metz-Thionville,Recruiting,Not Applicable,Observational,France,Covid-19 at the Regional Medical Center Metz-Thionville: a Descriptive Study,Prognosis,No Intervention,No Intervention,330,https://clinicaltrials.gov/show/NCT04430322,None
5002,NCT04430374,ClinicalTrials.gov,2020-06-11,2020-06-02,True,Hamad Medical Corporation,Recruiting,Not Applicable,Observational,Qatar,Registry for a Cardiovascular Patient Who COVID-19 Infection in Qatar and Gulf,Clinical Presentation (Epidemiology),No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04430374,None
5003,NCT04430608,ClinicalTrials.gov,2020-05-26,2020-05-25,True,"Copenhagen University Hospital, North Zealand",Recruiting,Not Applicable,Interventional,Denmark,Remote Continues Glucose Monitoring During the COVID-19 Pandemic in Quarantined Hospitalized Patients,Other (device),Biosensors,Biosensors,72,https://clinicaltrials.gov/show/NCT04430608,None
5004,NCT04431180,ClinicalTrials.gov,2020-06-12,2020-06-13,False,Guangzhou Blood Center,Recruiting,Not Applicable,Interventional,China,Recruit Blood Donors Via SMS During Epidemic of COVID-19 #Second Repeat Trial#,Other,Other,Other,403535,https://clinicaltrials.gov/show/NCT04431180,None
5005,NCT04431284,ClinicalTrials.gov,2020-06-10,2020-06-16,False,Hospices Civils de Lyon,Recruiting,Not Applicable,Observational,France,Impact of COVID-19 Lockdown on Obesity and Eating Behaviors,Other,No Intervention,No Intervention,46,https://clinicaltrials.gov/show/NCT04431284,None
5006,NCT04431310,ClinicalTrials.gov,2020-05-11,2020-03-27,True,"Copenhagen University Hospital, North Zealand",Recruiting,Not Applicable,Observational,Denmark,Seroconversion Among Staff at a Large Acute Care Hospital in Denmark During the COVID-19 Pandemic,Clinical Presentation (Epidemiology),No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04431310,None
5007,NCT04431466,ClinicalTrials.gov,2020-06-10,2020-07-01,False,Federal University of São Carlos,Recruiting,Phase 2,Interventional,Brazil,A Study to Compare the Efficacy and Safety of Different Doses of Ivermectin for COVID-19,Drug,Ivermectin,Ivermectin,64,https://clinicaltrials.gov/show/NCT04431466,None
5008,NCT04431869,ClinicalTrials.gov,2020-06-11,2020-08-18,False,"University of Colorado, Denver",Recruiting,Not Applicable,Observational,United States,In-Utero Vascular Accidents in Neonates From COVID-19 Infected Mothers,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04431869,None
5009,NCT04431908,ClinicalTrials.gov,2020-06-12,2020-06-15,False,Yale University,Recruiting,Not Applicable,Observational,United States,Validation of a Rapid Quantitative Test for Loss of Smell in COVID-19 Subjects,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,250,https://clinicaltrials.gov/show/NCT04431908,None
5010,NCT04432051,ClinicalTrials.gov,2020-06-11,2020-05-26,True,Gaziosmanpasa Taksim Research and Education Hospital,Recruiting,Not Applicable,Interventional,Turkey,The Use of Lung Ultrasonography in COVID-19 Patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04432051,None
5011,NCT04432103,ClinicalTrials.gov,2020-06-12,2020-06-19,False,Centro Medico ABC,Not Recruiting,Phase 3,Interventional,No Country Given,Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma,ATMP,Plasma,Plasma,36,https://clinicaltrials.gov/show/NCT04432103,None
5012,NCT04432272,ClinicalTrials.gov,2020-06-12,2020-07-16,False,William Beaumont Hospitals,Recruiting,Phase 2,Interventional,United States,ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS),ATMP,Plasma,Plasma,500,https://clinicaltrials.gov/show/NCT04432272,None
5013,NCT04432324,ClinicalTrials.gov,2020-06-12,2020-06-02,True,"Grifols, S.A.",Recruiting,Phase 2,Interventional,Spain,Study to Evaluate the Safety and Efficacy of High Dose IVIG in Hospitalized Participants With Coronavirus Disease (COVID-19),ATMP,Immunoglobulin,Immunoglobulin,100,https://clinicaltrials.gov/show/NCT04432324,EUCTR2020-001696-32
5014,NCT04432350,ClinicalTrials.gov,2020-06-12,2020-06-15,False,Tabula Rasa HealthCare,Not Recruiting,Not Applicable,Observational,No Country Given,Assessment of Mortality Rates in SARS-CoV-2 Infected Populations Treated With Repurposed Medications,Drug,Unspecified,Unspecified,50000,https://clinicaltrials.gov/show/NCT04432350,None
5015,NCT04432766,ClinicalTrials.gov,2020-06-12,2020-10-20,False,Bio-Thera Solutions,Not Recruiting,Phase 1/Phase 2,Interventional,United States,A Phase 1/2 Study to Assess Safety and Efficacy of BAT2020 in Hospitalized COVID-19 Patients,Drug,BAT2020,BAT2020,174,https://clinicaltrials.gov/show/NCT04432766,None
5016,NCT04432779,ClinicalTrials.gov,2020-06-15,2020-06-25,False,CHU St. Pierre,Not Recruiting,Not Applicable,Observational,Belgium,Impact of COVID-19 Infection During Pregnancy on Newborns and Young Children,Clinical Presentation,No Intervention,No Intervention,3000,https://clinicaltrials.gov/show/NCT04432779,None
5017,NCT04432805,ClinicalTrials.gov,2020-06-15,2020-06-15,False,Assistance Publique – Hôpitaux de Marseille,Recruiting,Not Applicable,Interventional,France,Descriptive and Evaluation Study of the Use of Pulmonary Ultrasound in the Initial Management of Pregnant Women in the Context of COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,160,https://clinicaltrials.gov/show/NCT04432805,None
5018,NCT04432922,ClinicalTrials.gov,2020-06-15,2020-11-01,False,Centre Hospitalier Intercommunal Creteil,Recruiting,Not Applicable,Observational,France,"Perceptions, Representations and Experiences of Septic Isolation of Hospitalized Patients for COVID-19 Infection",Other (psych),No Intervention,No Intervention,15,https://clinicaltrials.gov/show/NCT04432922,None
5019,NCT04432948,ClinicalTrials.gov,2020-06-14,2020-05-15,True,General and Maternity Hospital of Athens Elena Venizelou,Recruiting,Not Applicable,Observational,Greece,Maternal Psychological Implications of Covid-19 Pandemic and Possible Effect on Anaesthetic Management.,Other (psych),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04432948,None
5020,NCT04432961,ClinicalTrials.gov,2020-06-15,2020-07-01,False,Cambridge University Hospitals NHS Foundation Trust,Not Recruiting,Not Applicable,Observational,No Country Given,Natural Language Processing (NLP) Analysis of Free Text Notes to Investigate Coronavirus (COVID-19),Other (software),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04432961,None
5021,NCT04432987,ClinicalTrials.gov,2020-06-15,2020-05-25,True,Acibadem University,Recruiting,Phase 2,Interventional,Turkey,Dornase Alpha for the Treatment of COVID-19,Drug,Dornase alfa,Dornase alfa,60,https://clinicaltrials.gov/show/NCT04432987,None
5022,NCT04433000,ClinicalTrials.gov,2020-06-12,2020-03-15,True,University of Siena,Recruiting,Not Applicable,Observational,Italy,Reliability of a Pocket Sized Ultrasound Scanner in the Evaluation Covid-19 Pneumonia,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,34,https://clinicaltrials.gov/show/NCT04433000,None
5023,NCT04433013,ClinicalTrials.gov,2020-06-14,2020-07-01,False,Nanyang Technological University,Not Recruiting,Phase 3,Interventional,No Country Given,A Randomized Controlled Trial Assessing the Efficacy of Lianhua Qingwen as an Adjuvant Treatment in Patients With Mild Symptoms of COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,300,https://clinicaltrials.gov/show/NCT04433013,None
5024,NCT04433026,ClinicalTrials.gov,2020-06-14,2020-08-01,False,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,"BNP, Serum Troponin and D-dimer as Risk Factors in Patients With COVID-19",Clinical Presentation,No Intervention,No Intervention,90,https://clinicaltrials.gov/show/NCT04433026,None
5025,NCT04433039,ClinicalTrials.gov,2020-06-14,2020-05-22,True,Alexandria University,Not Recruiting,Not Applicable,Observational,Egypt,COVID19 Versus H1N1: Radiological Challenge During Next Influenza Season Rising,Clinical Presentation,No Intervention,No Intervention,130,https://clinicaltrials.gov/show/NCT04433039,None
5026,NCT04433078,ClinicalTrials.gov,2020-06-10,2020-06-22,False,Temple University,Recruiting,Phase 2,Interventional,United States,RepurpoSing Old Drugs TO SuppRess a Modern Threat: COVID-19 STORM,Drug,Doxycycline,Doxycycline,20,https://clinicaltrials.gov/show/NCT04433078,None
5027,NCT04433260,ClinicalTrials.gov,2020-06-09,2020-07-25,False,Queen Mary University of London,Recruiting,Not Applicable,Observational,United Kingdom,COVID19 and Physical and Emotional Wellbeing of HCP,Other (psych),No Intervention,No Intervention,1050,https://clinicaltrials.gov/show/NCT04433260,None
5028,NCT04433286,ClinicalTrials.gov,2020-06-10,2020-06-15,False,Mansoura University,Not Recruiting,Not Applicable,Observational,Egypt,COVID-19 - Implications on Surgeons' Burnout and Career Satisfaction,Other (psych),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04433286,None
5029,NCT04433312,ClinicalTrials.gov,2020-06-10,2020-07-01,False,Mansoura University,Not Recruiting,Not Applicable,Observational,Egypt,Impact of Cancellation of Non-urgent Surgical Cases on Patients During the COVID-19 Pandemic,Health System,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04433312,None
5030,NCT04433325,ClinicalTrials.gov,2020-06-12,2020-06-01,True,Rennes University Hospital,Not Recruiting,Not Applicable,Observational,France,COVID-19 Critically Ill Patients' Evolution After Medical Transport by Train From Paris Intensive Care Units to West of France Intensive Care Units,Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04433325,None
5031,NCT04433364,ClinicalTrials.gov,2020-06-15,2020-06-02,True,Sahlgrenska University Hospital,Recruiting,Not Applicable,Observational,Sweden,COPE - COVID-19 in Pregnancy and Early Childhood,Clinical Presentation,No Intervention,No Intervention,1200,https://clinicaltrials.gov/show/NCT04433364,None
5032,NCT04433754,ClinicalTrials.gov,2020-06-12,2020-03-01,True,Usak University,Not Recruiting,Not Applicable,Observational,Turkey,The Development of Pancreatic Injury in the Course of Severe Acute Respiratory Syndrome Coronavirus 2 Infection,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04433754,None
5033,NCT04433871,ClinicalTrials.gov,2020-04-24,2020-04-27,False,"University Hospital, Caen",Recruiting,Not Applicable,Observational,France,COVID-19 in Pediatric Oncology and Hematology Centers in France,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04433871,None
5034,NCT04433910,ClinicalTrials.gov,2020-05-06,2020-08-30,True,Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen,Recruiting,Phase 2,Interventional,Germany,A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19,ATMP,Plasma,Plasma,106,https://clinicaltrials.gov/show/NCT04433910,EUCTR2020-001310-38
5035,NCT04433949,ClinicalTrials.gov,2020-06-12,2020-06-12,False,Emory University,Recruiting,Phase 3,Interventional,United States,Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19,Other,Radiation,Radiation,52,https://clinicaltrials.gov/show/NCT04433949,None
5036,NCT04433988,ClinicalTrials.gov,2020-06-13,2020-12-13,False,Sadat City University,Not Recruiting,Phase 1/Phase 2,Interventional,Egypt,Efficacy of Pentoxifylline as Add on Therapy in COVID19 Patients,Drug,Pentoxifylline,Pentoxifylline,200,https://clinicaltrials.gov/show/NCT04433988,None
5037,NCT04434014,ClinicalTrials.gov,2020-06-06,2020-06-08,False,October University for Modern Sciences and Arts,Recruiting,Not Applicable,Observational,Egypt,Proper Nutrition And Its Relation To Oral Diseases In Covid -19 Era,Other,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04434014,None
5038,NCT04434118,ClinicalTrials.gov,2020-06-13,2020-03-20,True,Sadat City University,Recruiting,Not Applicable,Observational,Egypt,Anti-rheumatic Drug Use and Risk of COVID-19 Infection in Rheumatoid Arthritis Patients,Drug,"Hydroxychloroqine, Methotrexate, Glucocorticoids, Leflunomide, Sulphasalazine",Hydroxychloroqine; Methotrexate; Glucocorticoids; Leflunomide; Sulphasalazine,600,https://clinicaltrials.gov/show/NCT04434118,None
5039,NCT04434131,ClinicalTrials.gov,2020-06-09,2020-04-28,True,University of New Mexico,Recruiting,Phase 2,Interventional,United States,Treatment With Investigational Convalescent Plasma and Measure Antibody Levels in Patients Hospitalized With COVID-19,ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04434131,None
5040,NCT04434144,ClinicalTrials.gov,2020-06-09,2020-05-02,True,Upazila Health & Family Planning Officer's Office (UHFPO),Not Recruiting,Not Applicable,Observational,Bangladesh,A Comparative Study on Ivermectin and Hydroxychloroquine on the COVID19 Patients in Bangladesh,Drug,Ivermectin + Doxycycline vs. Hydroxychloroquine + Azithromycin,Ivermectin; Doxycycline; Hydroxychloroquine; Azithromycin,116,https://clinicaltrials.gov/show/NCT04434144,None
5041,NCT04434157,ClinicalTrials.gov,2020-06-12,2020-03-28,True,Hospital Regional de Alta Especialidad de Ixtapaluca,Not Recruiting,Not Applicable,Observational,Mexico,Association of the Neutrophil/Lymphocyte Ratio With Clinical Complications and Mortality in COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,221,https://clinicaltrials.gov/show/NCT04434157,None
5042,NCT04434248,ClinicalTrials.gov,2020-06-13,2020-04-23,True,Chromis LLC,Not Recruiting,Phase 2/Phase 3,Interventional,Russian Federation,An Adaptive Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19,Drug,Favipiravir,Favipiravir,330,https://clinicaltrials.gov/show/NCT04434248,None
5043,NCT04434261,ClinicalTrials.gov,2020-06-15,2020-05-11,True,Instituto Brasileiro de Controle do Câncer,Not Recruiting,Not Applicable,Observational,Brazil,Oncological Surgery in Times of COVID-19: Effectiveness of Preoperative Screening for Sars-Cov-2,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1500,https://clinicaltrials.gov/show/NCT04434261,None
5044,NCT04434417,ClinicalTrials.gov,2020-06-09,2020-04-15,True,European Institute of Oncology,Recruiting,Not Applicable,Observational,Italy,Validation of an Immunochromatographic Assay for IgG/IgM Antibodies to 2019- nCoV,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,https://clinicaltrials.gov/show/NCT04434417,None
5045,NCT04435015,ClinicalTrials.gov,2020-06-16,2021-02-01,False,Yale University,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications,Drug,Camostat Mesilate,Camostat Mesilate,200,https://clinicaltrials.gov/show/NCT04435015,None
5046,NCT04435028,ClinicalTrials.gov,2020-06-15,2019-01-14,True,Horus University,Not Recruiting,Not Applicable,Observational,Egypt,Ketotifen: as a Cardioprotective Agent in Breast Cancer Patients Receiving Anthracycline-containing Chemotherapy,Drug,Ketotifen,Ketotifen,111,https://clinicaltrials.gov/show/NCT04435028,None
5047,NCT04435041,ClinicalTrials.gov,2020-06-16,2020-06-01,True,University of Oxford,Not Recruiting,Not Applicable,Observational,United Kingdom,Remote-by-Default Care in the COVID-19 Pandemic,Telehealth,Telehealth,Telehealth,1,https://clinicaltrials.gov/show/NCT04435041,None
5048,NCT04435080,ClinicalTrials.gov,2020-06-15,2020-03-15,True,Koç University,Not Recruiting,Not Applicable,Observational,Turkey,Physical Rehabilitation in ICU in ARDS Patients With COVID-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,35,https://clinicaltrials.gov/show/NCT04435080,None
5049,NCT04435106,ClinicalTrials.gov,2020-05-26,2020-04-03,True,Shaare Zedek Medical Center,Not Recruiting,Not Applicable,Observational,Israel,Compassionate Use of Opaganib in Patients With Coronavirus Disease 2019 (COVID-19),Drug,Opaganib,Opaganib,23,https://clinicaltrials.gov/show/NCT04435106,None
5050,NCT04435119,ClinicalTrials.gov,2020-06-12,2020-03-15,True,"University Hospital, Angers",Not Recruiting,Not Applicable,Observational,France,Covid-19 and Vitamin D in Nursing-home,Drug,Vitamin D,Vitamin D,96,https://clinicaltrials.gov/show/NCT04435119,None
5051,NCT04435184,ClinicalTrials.gov,2020-06-16,2020-07-09,False,Johns Hopkins University,Recruiting,Phase 2,Interventional,United States,Crizanlizumab for Treating COVID-19 Vasculopathy,Drug,Crizanlizumab,Crizanlizumab,40,https://clinicaltrials.gov/show/NCT04435184,None
5052,NCT04435223,ClinicalTrials.gov,2020-06-16,2020-04-07,True,CHU Dijon,Not Recruiting,Not Applicable,Observational,France,Lipid Metabolism in COVID-19 Severe Pneumonia Compared With Severe Pneumonia Caused by Other Pathogen,Clinical Presentation,No Intervention,No Intervention,62,https://clinicaltrials.gov/show/NCT04435223,None
5053,NCT04435275,ClinicalTrials.gov,2020-06-09,2020-06-30,False,"University Health Network, Toronto",Not Recruiting,Not Applicable,Interventional,No Country Given,Virtual Assistant for COVID-19 PPE,Telehealth,Telehealth,Telehealth,50,https://clinicaltrials.gov/show/NCT04435275,None
5054,NCT04435314,ClinicalTrials.gov,2020-06-08,2020-06-01,True,Azidus Brasil,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19,Drug,Nitazoxanide,Nitazoxanide,200,https://clinicaltrials.gov/show/NCT04435314,None
5055,NCT04435327,ClinicalTrials.gov,2020-06-12,2020-08-17,False,University of Milano Bicocca,Recruiting,Not Applicable,Observational,Italy,Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19),Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04435327,None
5056,NCT04435353,ClinicalTrials.gov,2020-06-14,2020-03-22,True,Astana Medical University,Recruiting,Not Applicable,Interventional,Kazakhstan,Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19,Other,Vibroacoustic Therapy,Vibroacoustic Therapy,200,https://clinicaltrials.gov/show/NCT04435353,None
5057,NCT04435457,ClinicalTrials.gov,2020-06-02,2020-09-01,False,University of Texas Southwestern Medical Center,Recruiting,Not Applicable,Observational,United States,Cardiovascular Implications of COVID-19,Clinical Presentation,No Intervention,No Intervention,70,https://clinicaltrials.gov/show/NCT04435457,None
5058,NCT04435522,ClinicalTrials.gov,2020-06-15,2020-09-21,False,Rhode Island Hospital,Recruiting,Phase 1,Interventional,United States,Maraviroc in Patients With Moderate and Severe COVID-19,Drug,Maraviroc,Maraviroc,16,https://clinicaltrials.gov/show/NCT04435522,None
5059,NCT04435587,ClinicalTrials.gov,2020-06-15,2020-07-01,False,Mahidol University,Not Recruiting,Phase 4,Interventional,Thailand,Ivermectin vs Combined Hydroxychloroquine and Antiretroviral Drugs (ART) Among Asymptomatic COVID-19 Infection,Drug,Ivermectin vs. Hydroxychloroquine + Darunavir/ritonavir,Ivermectin; Hydroxychloroquine; Darunavir/ritonavir,80,https://clinicaltrials.gov/show/NCT04435587,None
5060,NCT04435717,ClinicalTrials.gov,2020-06-11,2020-05-04,True,Hospital Universitario Ramón y Cajal,Recruiting,Phase 2,Interventional,Spain,Efficacy of Tocilizumab in Modifying the Inflammatory Parameters of Patients With COVID-19 (COVITOZ-01),Drug,Tocilizumab,Tocilizumab,78,https://clinicaltrials.gov/show/NCT04435717,None
5061,NCT04435795,ClinicalTrials.gov,2020-06-16,2020-09-14,False,McGill University,Recruiting,Phase 2/Phase 3,Interventional,Canada,Inhaled Ciclesonide for Outpatients With COVID19,Drug,Ciclesonide,Ciclesonide,454,https://clinicaltrials.gov/show/NCT04435795,None
5062,NCT04435808,ClinicalTrials.gov,2020-06-04,2020-04-14,True,University of New Mexico,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,1,https://clinicaltrials.gov/show/NCT04435808,None
5063,NCT04436276,ClinicalTrials.gov,2020-06-15,2020-07-15,True,Janssen Pharmaceutical,Recruiting,Phase 1/Phase 2,Interventional,"United States, Belgium",A Study of Ad26.COV2.S in Adults (COVID-19),ATMP,Vaccine,Vaccine,1045,https://clinicaltrials.gov/show/NCT04436276,EUCTR2020-001483-28
5064,NCT04436458,ClinicalTrials.gov,2020-06-16,2020-12-01,False,"First Wave Bio, Inc.",Not Recruiting,Phase 2,Interventional,No Country Given,Niclosamide In Moderate COVID-19,Drug,Niclosamide,Niclosamide,100,https://clinicaltrials.gov/show/NCT04436458,None
5065,NCT04436471,ClinicalTrials.gov,2020-06-16,2020-06-17,False,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",Not Recruiting,Phase 1/Phase 2,Interventional,Russian Federation,"An Open Study of the Safety, Tolerability and Immunogenicity of the Drug ""Gam-COVID-Vac"" Vaccine Against COVID-19",ATMP,Vaccine,Vaccine,38,https://clinicaltrials.gov/show/NCT04436471,None
5066,NCT04437121,ClinicalTrials.gov,2020-06-15,2020-04-30,True,University of Thessaly,Not Recruiting,Not Applicable,Observational,Greece,Dietary and Lifestyle Habits During the Pandemic of COVID-19 in Greece,Other,No Intervention,No Intervention,397,https://clinicaltrials.gov/show/NCT04437121,None
5067,NCT04437342,ClinicalTrials.gov,2020-06-15,2020-06-30,False,General and Maternity Hospital of Athens Elena Venizelou,Not Recruiting,Not Applicable,Observational,Greece,Postpartum Depression in the Covid-19 Pandemic and the Impact of Anaesthesia,Other (psych),No Intervention,No Intervention,330,https://clinicaltrials.gov/show/NCT04437342,None
5068,NCT04437693,ClinicalTrials.gov,2020-06-17,2020-08-31,False,Hamad Medical Corporation,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,500,https://clinicaltrials.gov/show/NCT04437693,None
5069,NCT04437706,ClinicalTrials.gov,2020-06-17,2020-12-15,False,Duke University,Not Recruiting,Not Applicable,Observational,United States,Network-Targeted Strategies for Efficient Community SARS-CoV-2 (COVID-19) Sampling,Clinical Presentation (Epidemiology),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04437706,None
5070,NCT04437719,ClinicalTrials.gov,2020-06-17,2020-06-29,False,Groupe Hospitalier Paris Saint-Joseph,Recruiting,Not Applicable,Interventional,France,"Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group for a Period of 6 Months During the COVID-19 Pandemic",Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04437719,None
5071,NCT04437823,ClinicalTrials.gov,2020-06-17,2020-06-01,True,Jinnah Hospital,Recruiting,Phase 2,Interventional,Pakistan,Efficacy of Intravenous Infusions of Stem Cells in the Treatment of COVID-19 Patients,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04437823,None
5072,NCT04437875,ClinicalTrials.gov,2020-06-16,2020-06-17,False,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",Not Recruiting,Phase 1/Phase 2,Interventional,Russian Federation,"An Open Study of the Safety, Tolerability and Immunogenicity of ""Gam-COVID-Vac Lyo"" Vaccine Against COVID-19",ATMP,Vaccine,Vaccine,38,https://clinicaltrials.gov/show/NCT04437875,None
5073,NCT04437901,ClinicalTrials.gov,2020-05-28,2020-06-01,False,Hospital Clinic of Barcelona,Not Recruiting,Not Applicable,Observational,"Italy, Belgium, Netherlands, United Kingdom, Spain",COVIDAR - Arrhythmias in COVID-19,Clinical Presentation,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04437901,None
5074,NCT04437940,ClinicalTrials.gov,2020-06-17,2020-06-15,True,Acibadem University,Recruiting,Not Applicable,Observational,Turkey,Evaluation of Vaginal Fluid for Covid-19 Positivity in Women With Positive Nasofarengeal Covid-19 Test,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,35,https://clinicaltrials.gov/show/NCT04437940,None
5075,NCT04438057,ClinicalTrials.gov,2020-06-17,2020-08-12,False,Metro Infectious Disease Consultants,Recruiting,Phase 2,Interventional,United States,Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19,ATMP,Plasma,Plasma,150,https://clinicaltrials.gov/show/NCT04438057,None
5076,NCT04438070,ClinicalTrials.gov,2020-06-17,2020-04-10,True,St. Joseph's Healthcare Hamilton,Recruiting,Not Applicable,Interventional,Canada,COVID Screening Strategies in Homeless Shelters,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,400,https://clinicaltrials.gov/show/NCT04438070,None
5077,NCT04438239,ClinicalTrials.gov,2020-06-10,2020-06-30,False,Azienda Unita Sanitaria Locale Reggio Emilia,Recruiting,Not Applicable,Observational,Italy,Rehabilitation Needs After COVID-19 Hospital Treatment,Other (physio),No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04438239,None
5078,NCT04438629,ClinicalTrials.gov,2020-06-16,2020-03-26,True,AOUI Verona,Recruiting,Not Applicable,Observational,Italy,Evaluation of Immune Response in COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04438629,None
5079,NCT04438694,ClinicalTrials.gov,2020-06-16,2020-06-01,True,Cairo University,Recruiting,Phase 1/Phase 2,Interventional,Egypt,Assessment of the Effect of Convalescent Plasma Therapy in Patients With Life-threatening COVID19 Infection,ATMP,Plasma,Plasma,67,https://clinicaltrials.gov/show/NCT04438694,None
5080,NCT04438837,ClinicalTrials.gov,2020-06-18,2020-07-01,False,Rambam Health Care Campus,Not Recruiting,Not Applicable,Interventional,Israel,Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,582,https://clinicaltrials.gov/show/NCT04438837,None
5081,NCT04438850,ClinicalTrials.gov,2020-04-10,2020-07-31,False,IRCCS Don Calabria Ospedale Sacro Cuore,Recruiting,Phase 2,Interventional,"Spain, Italy",COVidIVERmectin: Ivermectin for Treatment of Covid-19,Drug,Ivermectin,Ivermectin,102,https://clinicaltrials.gov/show/NCT04438850,None
5082,NCT04438863,ClinicalTrials.gov,2020-06-17,2020-08-08,False,Sheba Medical Center,Recruiting,Not Applicable,Observational,Israel,Daily Home Spirometry for Early Detection of Pulmonary Complications in Patients With COVID19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,90,https://clinicaltrials.gov/show/NCT04438863,None
5083,NCT04438941,ClinicalTrials.gov,2020-06-17,2020-03-25,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Contribution of a Prone Team in Intensive Care During the Covid-19 Epidemic,Procedure,Positioning,Positioning,100,https://clinicaltrials.gov/show/NCT04438941,None
5084,NCT04438954,ClinicalTrials.gov,2020-06-17,2020-05-05,True,Ankara Yildirim Beyazit University,Not Recruiting,Not Applicable,Observational,Turkey,"Investigation of Fatigue, Physical Activity, Sleep Quality and Anxiety Levels",Other (psych),No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04438954,None
5085,NCT04438967,ClinicalTrials.gov,2020-06-15,2020-06-16,False,Miro Health,Recruiting,Not Applicable,Observational,United States,Brain Health in the Time of COVID-19,Clinical Presentation,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04438967,None
5086,NCT04438980,ClinicalTrials.gov,2020-06-18,2020-05-15,True,Fundación Miguel Servet,Recruiting,Phase 3,Interventional,Spain,Glucocorticoids in COVID-19 (CORTIVID),Drug,Corticosteroids,Methylprednisolone,72,https://clinicaltrials.gov/show/NCT04438980,EUCTR2020-001827-15
5087,NCT04438993,ClinicalTrials.gov,2020-06-18,2020-05-29,True,NHS Lanarkshire,Recruiting,Not Applicable,Observational,United Kingdom,The COVID-19 Disease and CARdiac Events Study,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04438993,None
5088,NCT04439006,ClinicalTrials.gov,2020-06-17,2020-07-22,False,Jennifer Woyach,Recruiting,Phase 2,Interventional,United States,Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization,Drug,Ibrutinib,Ibrutinib,72,https://clinicaltrials.gov/show/NCT04439006,None
5089,NCT04439045,ClinicalTrials.gov,2020-06-03,2020-06-24,False,"University Health Network, Toronto",Recruiting,Phase 3,Interventional,Canada,Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and Severity,Drug,VPM1002,VPM1002,3626,https://clinicaltrials.gov/show/NCT04439045,None
5090,NCT04439071,ClinicalTrials.gov,2020-06-17,2020-07-09,True,PTC Therapeutics,Recruiting,Phase 2/Phase 3,Interventional,"Spain, United States, Australia, Brazil",A Study to Evaluate Efficacy and Safety of PTC299 in Hospitalized Participants With Coronavirus (COVID-19),Drug,PTC299,PTC299,380,https://clinicaltrials.gov/show/NCT04439071,EUCTR2020-001872-13
5091,NCT04439084,ClinicalTrials.gov,2020-06-17,2020-03-06,True,Stanford University,Recruiting,Not Applicable,Observational,United States,COVID-19 in Patients With Chronic Liver Diseases,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04439084,None
5092,NCT04439825,ClinicalTrials.gov,2020-06-18,2020-07-15,False,DeNova Research,Not Recruiting,Phase 1,Interventional,United States,Impact of Botox Treatment Into the Upper One Third of the Face an Area on Mood and Self -Appearance Satisfaction,Drug,Botulinum Neurotoxin,Botulinum Neurotoxin,45,https://clinicaltrials.gov/show/NCT04439825,None
5093,NCT04440098,ClinicalTrials.gov,2020-06-18,2020-04-22,True,University of Miami,Not Recruiting,Not Applicable,Observational,United States,Isolated During COVID-19: Effects of COVID-19's Social Restrictions on Loneliness and Psychosocial Symptomatology,Other (psych),No Intervention,No Intervention,1008,https://clinicaltrials.gov/show/NCT04440098,None
5094,NCT04441372,ClinicalTrials.gov,2020-06-17,2020-10-01,False,"Medecins Sans Frontieres, Spain",Not Recruiting,Not Applicable,Observational,Bangladesh,Prognostication of Oxygen Requirement in Non-severe SARS-CoV-2 Infection,Prognosis,No Intervention,No Intervention,1200,https://clinicaltrials.gov/show/NCT04441372,None
5095,NCT04441385,ClinicalTrials.gov,2020-06-18,2020-06-26,True,Hospital Universitario Infanta Leonor,Recruiting,Phase 2,Interventional,Spain,Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19).,Drug,Maraviroc,Maraviroc,200,https://clinicaltrials.gov/show/NCT04441385,EUCTR2020-002011-21
5096,NCT04441398,ClinicalTrials.gov,2020-06-18,2020-07-01,False,Azidus Brasil,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Efficacy and Safety of Nitazoxanide 600 mg to Treat Mild Ambulatory COVID-19 Patients,Drug,Nitazoxanide,Nitazoxanide,300,https://clinicaltrials.gov/show/NCT04441398,None
5097,NCT04441424,ClinicalTrials.gov,2020-06-12,2020-04-03,True,Alkarkh Health Directorate-Baghdad,Not Recruiting,Not Applicable,Interventional,Iraq,Convalescent Plasma Therapy on Critically-ill Novel Coronavirus (COVID-19) Patients,ATMP (+ Drug),Plasma + Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Azithromycin,Plasma; Hydroxychloroquine; Azithromycin,49,https://clinicaltrials.gov/show/NCT04441424,None
5098,NCT04441476,ClinicalTrials.gov,2020-06-17,2020-04-21,True,CHU Dijon,Not Recruiting,Not Applicable,Observational,France,Ethical and Psychological Support for Health Care Professions in Intensive Care Units in the COVID19 Pandemic Context: Adequacy With Needs and Psychological Impact Crisis and Post-crisis,Other (psych),No Intervention,No Intervention,3000,https://clinicaltrials.gov/show/NCT04441476,None
5099,NCT04441489,ClinicalTrials.gov,2020-06-16,2020-03-27,True,Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida,Not Recruiting,Not Applicable,Observational,Monaco,Assessment of Lung Inflammation With FDG PET/CT in COVID-19,Clinical Presentation,No Intervention,No Intervention,13,https://clinicaltrials.gov/show/NCT04441489,None
5100,NCT04441502,ClinicalTrials.gov,2020-06-12,2020-03-30,True,IRCCS Policlinico San Donato,Recruiting,Not Applicable,Observational,Italy,Identification of Predictors for the Evolution of COVID-19 Related Pneumonia by Transcriptomic and Seroproteomic,Clinical Presentation,No Intervention,No Intervention,240,https://clinicaltrials.gov/show/NCT04441502,None
5101,NCT04441632,ClinicalTrials.gov,2020-06-18,2020-06-15,True,Cedars-Sinai Medical Center,Not Recruiting,Not Applicable,Interventional,United States,Effect of Positive Attitudes on Behavior and Wellness,Other (psych),Psychological,Psychological,24,https://clinicaltrials.gov/show/NCT04441632,None
5102,NCT04441684,ClinicalTrials.gov,2020-05-20,2020-04-17,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Interventional,France,"Seroprevalence of SARS-CoV-2 in Strasbourg University Hospital, Strasbourg, France (COVID-19)",Clinical Presentation (Epidemiology),No Intervention,No Intervention,1800,https://clinicaltrials.gov/show/NCT04441684,None
5103,NCT04441814,ClinicalTrials.gov,2020-06-18,2019-07-23,True,Fondazione IRCCS Istituto Nazionale dei Tumori,Recruiting,Not Applicable,Observational,Italy,FOUND - Ancillary Study to Smile Protocol NCT03654105,Clinical Presentation,No Intervention,No Intervention,960,https://clinicaltrials.gov/show/NCT04441814,None
5104,NCT04441918,ClinicalTrials.gov,2020-06-06,2020-06-05,True,"Shanghai Junshi Bioscience Co., Ltd.",Recruiting,Phase 1,Interventional,China,"Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects",Drug,JS016,JS016,40,https://clinicaltrials.gov/show/NCT04441918,None
5105,NCT04441996,ClinicalTrials.gov,2020-06-19,2020-07-17,False,Emory University,Recruiting,Phase 4,Interventional,United States,Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04441996,None
5106,NCT04442048,ClinicalTrials.gov,2020-06-19,2020-06-25,False,Canadian Cancer Trials Group,Recruiting,Phase 3,Interventional,Canada,Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure,Drug,IMM-101,IMM-101,1500,https://clinicaltrials.gov/show/NCT04442048,None
5107,NCT04442152,ClinicalTrials.gov,2020-06-19,2020-06-01,True,Promundo,Recruiting,Not Applicable,Interventional,Rwanda,Impact of COVID-19 on Family Dynamics on Bandebereho Study Participants,Other,Other,Other,1000,https://clinicaltrials.gov/show/NCT04442152,None
5108,NCT04442165,ClinicalTrials.gov,2020-06-16,2020-07-15,False,Institute of Tropical Medicine,Not Recruiting,Not Applicable,Observational,No Country Given,Characterising Transmission of SARS-CoV-2 in a Peri-urban Population in Mozambique,Clinical Presentation (Epidemiology),No Intervention,No Intervention,15393,https://clinicaltrials.gov/show/NCT04442165,None
5109,NCT04442178,ClinicalTrials.gov,2020-06-19,2020-09-15,False,Revimmune,Recruiting,Phase 2,Interventional,United States,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I ),Drug,Interleukin-7,Interleukin-7,48,https://clinicaltrials.gov/show/NCT04442178,None
5110,NCT04442191,ClinicalTrials.gov,2020-05-11,2020-05-05,True,"University of Illinois, Chicago",Recruiting,Phase 2,Interventional,United States,Convalescent Plasma as a Possible Treatment for COVID-19,ATMP,Plasma,Plasma,50,https://clinicaltrials.gov/show/NCT04442191,None
5111,NCT04442204,ClinicalTrials.gov,2020-06-19,2020-06-22,False,University of Oslo,Not Recruiting,Not Applicable,Observational,No Country Given,Predictors and Mechanisms of Depression and Anxiety During the COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,4000,https://clinicaltrials.gov/show/NCT04442204,None
5112,NCT04442217,ClinicalTrials.gov,2020-06-19,2020-06-22,False,University of Oslo,Not Recruiting,Not Applicable,Observational,No Country Given,Factors Associated With Adherence to Hygiene-related Behaviors and Viral Mitigation Protocols During the COVID-19 Pandemic,Other,Other,Other,4000,https://clinicaltrials.gov/show/NCT04442217,None
5113,NCT04442243,ClinicalTrials.gov,2020-06-19,2020-06-22,False,University of Oslo,Not Recruiting,Not Applicable,Observational,No Country Given,PTSD Symptoms Among Health Workers and Public Service Providers After the COVID-19 Outbreak: A 3 Month Follow up,Other (psych),No Intervention,No Intervention,889,https://clinicaltrials.gov/show/NCT04442243,None
5114,NCT04442282,ClinicalTrials.gov,2020-06-19,2020-06-22,False,University of Oslo,Not Recruiting,Not Applicable,Observational,No Country Given,Difficulties in Emotion-regulation and Interpersonal Problems During and After the COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,5041,https://clinicaltrials.gov/show/NCT04442282,None
5115,NCT04442308,ClinicalTrials.gov,2020-06-19,2020-06-22,False,University of Oslo,Not Recruiting,Not Applicable,Observational,No Country Given,Parental Stress After the Covid-19 Pandemic,Other (psych),No Intervention,No Intervention,1440,https://clinicaltrials.gov/show/NCT04442308,None
5116,NCT04442360,ClinicalTrials.gov,2020-06-19,2020-06-22,False,University of Oslo,Not Recruiting,Not Applicable,Observational,No Country Given,The Impact of Information Sources on Mental Health During the COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,4000,https://clinicaltrials.gov/show/NCT04442360,None
5117,NCT04442386,ClinicalTrials.gov,2020-06-19,2020-06-22,False,University of Oslo,Not Recruiting,Not Applicable,Observational,No Country Given,Parental Burnout During the COVID-19 Pandemic: Risk Factors and Predictors,Other (psych),No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04442386,None
5118,NCT04442958,ClinicalTrials.gov,2020-06-17,2020-05-15,True,Bagcilar Training and Research Hospital,Not Recruiting,Not Applicable,Interventional,Turkey,Effectiveness of Convalescent Immune Plasma Therapy,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04442958,None
5119,NCT04443075,ClinicalTrials.gov,2020-06-03,2020-06-24,False,The First Affiliated Hospital Xi'an Jiaotong University,Recruiting,Not Applicable,Observational,China,Alterations of Gut Microbiome in the Frontline Medical Staff Under the Stress,Clinical Presentation,No Intervention,No Intervention,180,https://clinicaltrials.gov/show/NCT04443075,None
5120,NCT04443140,ClinicalTrials.gov,2020-06-21,2020-03-15,True,Zeynep Kamil Maternity and Pediatric Research and Training Hospital,Not Recruiting,Not Applicable,Observational,Turkey,Preeclampsia-like Syndrome Induced by COVID-19: Is it a Real Public Health Issue in Pregnancy During the Pandemic?,Clinical Presentation,No Intervention,No Intervention,131,https://clinicaltrials.gov/show/NCT04443140,None
5121,NCT04443179,ClinicalTrials.gov,2020-06-19,2013-04-05,True,King's College London,Recruiting,Not Applicable,Observational,United Kingdom,Brain Imaging in Babies Study,Clinical Presentation,No Intervention,No Intervention,790,https://clinicaltrials.gov/show/NCT04443179,None
5122,NCT04443270,ClinicalTrials.gov,2020-06-17,2020-07-27,False,Centro Médico Nacional 20 de Noviembre,Not Recruiting,Phase 1,Interventional,Mexico,Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients,Other (Chemoprophylaxis),Chloroquine,Chloroquine,200,https://clinicaltrials.gov/show/NCT04443270,None
5123,NCT04443361,ClinicalTrials.gov,2020-06-19,2020-06-22,False,University of Oslo,Not Recruiting,Not Applicable,Observational,No Country Given,Insomnia After the COVID-19 Pandemic,Other,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04443361,None
5124,NCT04443673,ClinicalTrials.gov,2020-06-18,2020-08-20,False,Instituto Nacional de Enfermedades Respiratorias,Recruiting,Not Applicable,Interventional,Mexico,Glycine Supplement for Severe COVID-19,Supplement,Glycine,Glycine,82,https://clinicaltrials.gov/show/NCT04443673,None
5125,NCT04443699,ClinicalTrials.gov,2020-06-19,2020-06-22,False,University of Oslo,Not Recruiting,Not Applicable,Observational,No Country Given,Predictors of Mental Well-being During the COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,4000,https://clinicaltrials.gov/show/NCT04443699,None
5126,NCT04443712,ClinicalTrials.gov,2020-06-16,2020-05-29,True,Samia Girgis,Recruiting,Not Applicable,Observational,Egypt,Screening for Patients Admitted to Ain-Shams University Hospitals for SARS-COV-2 (COVID19),Clinical Presentation (Epidemiology),No Intervention,No Intervention,1900,https://clinicaltrials.gov/show/NCT04443712,None
5127,NCT04443725,ClinicalTrials.gov,2020-06-20,2020-07-01,False,Cairo University,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Efficacy and Safety of Anti HCV Drugs in the Treatment of COVID-19,Drug,Hydroxychloroquine + Sofosbuvir + Daclatasvir,Hydroxychloroquine; Sofosbuvir; Daclatasvir,100,https://clinicaltrials.gov/show/NCT04443725,None
5128,NCT04443764,ClinicalTrials.gov,2020-06-19,2020-06-22,False,University of Oslo,Not Recruiting,Not Applicable,Observational,No Country Given,Status and Predictors of Mental Health Symptoms Among Migrants and Refugees During the COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,287,https://clinicaltrials.gov/show/NCT04443764,None
5129,NCT04443803,ClinicalTrials.gov,2020-06-19,2020-07-01,False,Randy Loftus,Not Recruiting,Not Applicable,Observational,No Country Given,Characterizing the Perioperative Epidemiology of SARS-CoV-2 (COVID-19) Spread for Quality Improvement of Perioperative Infection Control Program,Clinical Presentation (Epidemiology),No Intervention,No Intervention,9,https://clinicaltrials.gov/show/NCT04443803,None
5130,NCT04443868,ClinicalTrials.gov,2020-06-20,2021-01-01,False,Sanotize Research and Development corp.,Not Recruiting,Phase 2,Interventional,No Country Given,Nitric Oxide Releasing Solution to Treat and Prevent Exacerbation of Mild COVID-19 Infection,Drug,Nitric Oxide,Nitric Oxide,50,https://clinicaltrials.gov/show/NCT04443868,None
5131,NCT04443881,ClinicalTrials.gov,2020-06-18,2020-05-08,True,Fundación Miguel Servet,Recruiting,Phase 2/Phase 3,Interventional,Spain,Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS),Drug,Anakinra,Anakinra,180,https://clinicaltrials.gov/show/NCT04443881,None
5132,NCT04444115,ClinicalTrials.gov,2020-06-20,2020-06-22,False,Modum Bad,Not Recruiting,Not Applicable,Observational,No Country Given,Loneliness During Strict and Lifted Social Distancing Protocols Against the COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,10084,https://clinicaltrials.gov/show/NCT04444115,None
5133,NCT04444271,ClinicalTrials.gov,2020-05-27,2020-05-01,True,Dr. Zaineb Akram,Recruiting,Phase 2,Interventional,Pakistan,Mesenchymal Stem Cell Infusion for COVID-19 Infection,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04444271,None
5134,NCT04444297,ClinicalTrials.gov,2020-06-20,2020-07-31,False,NHS Greater Glasgow and Clyde,Not Recruiting,Not Applicable,Interventional,United Kingdom,3D Telemedicine During COVID-19: Non-clinical Validation,Telehealth,Telehealth,Telehealth,40,https://clinicaltrials.gov/show/NCT04444297,None
5135,NCT04444310,ClinicalTrials.gov,2020-06-19,2020-06-15,True,Assiut University,Not Recruiting,Not Applicable,Observational,Egypt,Antibody Responses in Contacts of COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04444310,None
5136,NCT04444323,ClinicalTrials.gov,2020-06-20,2020-09-01,False,NHS Greater Glasgow and Clyde,Not Recruiting,Not Applicable,Interventional,United Kingdom,3D Telemedicine During COVID-19: Cohort Study,Telehealth,Telehealth,Telehealth,50,https://clinicaltrials.gov/show/NCT04444323,None
5137,NCT04444336,ClinicalTrials.gov,2020-06-21,2020-06-22,False,University of Oslo,Not Recruiting,Not Applicable,Observational,No Country Given,Information Sources and Their Relationship to Depressive and Anxiety Symptoms During the COVID-19 Pandemic: A Network Study,Other (psych),No Intervention,No Intervention,4000,https://clinicaltrials.gov/show/NCT04444336,None
5138,NCT04444401,ClinicalTrials.gov,2020-06-22,2020-06-15,True,European Institute of Oncology,Recruiting,Not Applicable,Observational,Italy,Registry on NEN Patients and COVID-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04444401,None
5139,NCT04444531,ClinicalTrials.gov,2020-06-22,2020-03-20,True,Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta,Not Recruiting,Not Applicable,Observational,Spain,Ozone Therapy and Coronavirus Disease of 2019 (COVID-19) Pneumonia,Clinical Presentation,No Intervention,No Intervention,18,https://clinicaltrials.gov/show/NCT04444531,None
5140,NCT04444557,ClinicalTrials.gov,2020-06-21,2020-04-17,True,Sisli Hamidiye Etfal Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,Effect of COvid-19 on Mental Health in Syrian and Turkish Maintenance HemoDialysis Patients: COST-HD Study,Other (psych),No Intervention,No Intervention,97,https://clinicaltrials.gov/show/NCT04444557,None
5141,NCT04444596,ClinicalTrials.gov,2020-06-18,2020-06-17,True,Medical University Innsbruck,Recruiting,Not Applicable,Interventional,Austria,Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04444596,None
5142,NCT04444609,ClinicalTrials.gov,2020-06-16,2020-06-18,False,Imperial College London,Recruiting,Not Applicable,Observational,United Kingdom,PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort,Clinical Presentation,No Intervention,No Intervention,230,https://clinicaltrials.gov/show/NCT04444609,None
5143,NCT04444661,ClinicalTrials.gov,2020-06-19,2020-06-10,True,University of Erlangen-Nornberg Medical School,Not Recruiting,Not Applicable,Observational,Germany,Effects of COVID-19 Induced Deconditioning After Long-term High Intensity Resistance Exercise,Other,No Intervention,No Intervention,21,https://clinicaltrials.gov/show/NCT04444661,None
5144,NCT04444674,ClinicalTrials.gov,2020-06-15,2020-06-24,False,University of Oxford,Not Recruiting,Phase 1/Phase 2,Interventional,South Africa,COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infection,ATMP,Vaccine,Vaccine,2130,https://clinicaltrials.gov/show/NCT04444674,None
5145,NCT04444687,ClinicalTrials.gov,2020-06-15,2020-08-01,False,"University Hospital, Basel",Not Recruiting,Not Applicable,Observational,No Country Given,COVID 19: Is SARS-CoV-2 Contaminating Surgical Aerosols From Laparoscopy and Open Abdominal Surgery?,Other,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04444687,None
5146,NCT04444700,ClinicalTrials.gov,2020-06-22,2020-07-04,False,University of São Paulo General Hospital,Recruiting,Phase 3,Interventional,Brazil,A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic,Drug,Heparin,Heparin,462,https://clinicaltrials.gov/show/NCT04444700,None
5147,NCT04444713,ClinicalTrials.gov,2020-06-20,2020-06-22,False,Modum Bad,Not Recruiting,Not Applicable,Observational,No Country Given,Do Network Centrality Predict Overall Depression Symptom Reduction With Lifting of Social Distancing Protocols?,Other (psych),No Intervention,No Intervention,10084,https://clinicaltrials.gov/show/NCT04444713,None
5148,NCT04445207,ClinicalTrials.gov,2020-06-20,2020-06-22,False,Jonathan Gerber,Not Recruiting,Not Applicable,Expanded Access,United States,Experimental Expanded Access Treatment With Convalescent Plasma for the Treatment of Patients With COVID-19,ATMP,Plasma,Plasma,Not Available,https://clinicaltrials.gov/show/NCT04445207,None
5149,NCT04445220,ClinicalTrials.gov,2020-06-22,2020-11-19,False,"Sentien Biotechnologies, Inc.",Recruiting,Phase 1/Phase 2,Interventional,United States,A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy,ATMP,Cells (mesenchymal),Cells (mesenchymal),22,https://clinicaltrials.gov/show/NCT04445220,None
5150,NCT04445246,ClinicalTrials.gov,2020-06-09,2020-05-23,True,Hamad Medical Corporation,Recruiting,Phase 2,Interventional,Qatar,Inhaled Iloprost for Suspected COVID-19 Respiratory Failure,Drug,Iloprost,Iloprost,40,https://clinicaltrials.gov/show/NCT04445246,None
5151,NCT04445259,ClinicalTrials.gov,2020-05-27,2020-06-20,False,Guy's and St Thomas' NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 and High Risk of Acute Kidney Injury,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04445259,None
5152,NCT04445272,ClinicalTrials.gov,2020-06-13,2020-05-22,True,Fundación SEIMC-GESIDA,Recruiting,Phase 2,Interventional,Spain,Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia,Drug,Tocilizumab,Tocilizumab,500,https://clinicaltrials.gov/show/NCT04445272,None
5153,NCT04445285,ClinicalTrials.gov,2020-06-22,2020-04-28,True,Jon Simmons,Recruiting,Phase 2,Interventional,United States,Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure,Drug,Dornase alpha,Dornase alpha,44,https://clinicaltrials.gov/show/NCT04445285,None
5154,NCT04445311,ClinicalTrials.gov,2020-06-19,2020-05-31,True,Zagazig University,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Ivermectin in Treatment of COVID-19,Drug,Ivermectin,Ivermectin,100,https://clinicaltrials.gov/show/NCT04445311,None
5155,NCT04445324,ClinicalTrials.gov,2020-06-22,2020-08-25,False,Centre de Recherche de l'Institut Universitaire en Santé Mentale de Montréal,Not Recruiting,Not Applicable,Interventional,Canada,Effects of Online and Recovery-oriented Peer Support Groups Facilitated by Peer Support Workers in Times of COVID-19,Other (psych),Psychological,Psychological,30,https://clinicaltrials.gov/show/NCT04445324,None
5156,NCT04445337,ClinicalTrials.gov,2020-06-09,2020-07-01,False,University of Nebraska,Not Recruiting,Not Applicable,Interventional,No Country Given,Stellate Ganglion Blockade in COVID-19 Positive Patients,Clinical Presentation,No Intervention,No Intervention,10,https://clinicaltrials.gov/show/NCT04445337,None
5157,NCT04445376,ClinicalTrials.gov,2020-06-22,2020-07-03,False,Government College University Faisalabad,Not Recruiting,Not Applicable,Interventional,Pakistan,Effect of Physical Therapy Exercises on Cardiorespiratory Fitness Level in COVID19 Patients After Recovery.,Other (exercise),Exercise,Exercise,20,https://clinicaltrials.gov/show/NCT04445376,None
5158,NCT04445389,ClinicalTrials.gov,2020-06-19,2020-06-17,True,"Genexine, Inc.",Recruiting,Phase 1/Phase 2,Interventional,South Korea,"Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults",ATMP,Vaccine,Vaccine,210,https://clinicaltrials.gov/show/NCT04445389,None
5159,NCT04445402,ClinicalTrials.gov,2020-06-22,2020-04-30,True,Columbia University,Recruiting,Not Applicable,Observational,United States,Pediatrics HOT COVID-19 Database in NY Tristate,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04445402,None
5160,NCT04445415,ClinicalTrials.gov,2020-06-18,2020-07-01,False,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,Diagnostic Value of New COVID-19 Antibodies Testing Among Laboratory Healthcare Workers,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,250,https://clinicaltrials.gov/show/NCT04445415,None
5161,NCT04445428,ClinicalTrials.gov,2020-06-22,2020-07-15,False,Bandim Health Project,Recruiting,Phase 4,Interventional,Guinea-Bissau,OPV as Potential Protection Against COVID-19,ATMP,Vaccine,Vaccine,3400,https://clinicaltrials.gov/show/NCT04445428,None
5162,NCT04445441,ClinicalTrials.gov,2020-06-22,2020-04-24,True,Centre Muraz,Recruiting,Not Applicable,Observational,Burkina Faso,An Observational Study to Assess the Protocol for the COVID-19 Treatment in Burkina Faso,Other,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04445441,None
5163,NCT04445454,ClinicalTrials.gov,2020-06-19,2020-06-12,True,University of Liège,Recruiting,Phase 1/Phase 2,Interventional,Belgium,Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04445454,None
5164,NCT04445467,ClinicalTrials.gov,2020-06-22,2020-08-01,False,Bayside Health,Recruiting,Phase 2,Interventional,Australia,An Adaptive Clinical Trial of Antivirals for COVID-19 Infection,Drug,Favipiravir,Favipiravir,190,https://clinicaltrials.gov/show/NCT04445467,None
5165,NCT04445493,ClinicalTrials.gov,2020-06-18,2020-10-01,False,"MindRhythm, Inc.",Not Recruiting,Not Applicable,Observational,No Country Given,EPISODE-PS-COVID: hEad Pulse for Ischemic StrOke DEtection Prehospital Study During the COVID-19 Pandemic ( EPISODEPSCOVID ),Other,Other,Other,250,https://clinicaltrials.gov/show/NCT04445493,None
5166,NCT04445506,ClinicalTrials.gov,2020-06-19,2020-04-01,True,The Miriam Hospital,Not Recruiting,Not Applicable,Observational,United States,Short Term Corticosteroids in SARS-CoV2 Patients,Drug,Corticosteroids,Dexamethasone,50,https://clinicaltrials.gov/show/NCT04445506,None
5167,NCT04445597,ClinicalTrials.gov,2020-06-22,2020-05-07,True,UZ Leuven,Recruiting,Not Applicable,Interventional,Belgium,ANalyzing Olfactory Dysfunction Mechanisms In COVID-19,Clinical Presentation,No Intervention,No Intervention,90,https://clinicaltrials.gov/show/NCT04445597,None
5168,NCT04445610,ClinicalTrials.gov,2020-06-23,2020-07-01,False,Ain Shams University,Not Recruiting,Not Applicable,Observational,Egypt,Measles Vaccine: Is There a Protective Role in COVID 19 Pandemic?,ATMP,Vaccine,Vaccine,60,https://clinicaltrials.gov/show/NCT04445610,None
5169,NCT04445623,ClinicalTrials.gov,2020-06-04,2020-07-01,False,AOUI Verona,Not Recruiting,Phase 3,Interventional,Italy,Prasugrel in Severe COVID-19 Pneumonia,Drug,Prasugrel,Prasugrel,128,https://clinicaltrials.gov/show/NCT04445623,None
5170,NCT04445870,ClinicalTrials.gov,2020-06-23,2020-05-01,True,CHU de Reims,Recruiting,Not Applicable,Observational,France,Oncology Care Pathway's Modifications Impact During COVID-19 Pandemic : the ONCOCARE-COV Study,Health System,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04445870,None
5171,NCT04445935,ClinicalTrials.gov,2020-06-23,2020-06-28,False,Hamad Medical Corporation,Recruiting,Phase 4,Interventional,Qatar,Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial,Drug,Bivalirudin,Bivalirudin,100,https://clinicaltrials.gov/show/NCT04445935,None
5172,NCT04445961,ClinicalTrials.gov,2020-06-22,2020-05-01,True,I.M. Sechenov First Moscow State Medical University,Not Recruiting,Not Applicable,Observational,Russian Federation,Respiratory Mechanics and Gas Exchange in Patients With COVID-19 and Hypoxemic Acute Respiratory Failure,Clinical Presentation,No Intervention,No Intervention,117,https://clinicaltrials.gov/show/NCT04445961,None
5173,NCT04446065,ClinicalTrials.gov,2020-06-23,2020-09-30,False,MELISA Institute Genomics & Proteomics Research SpA,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,PrevifenonÂ® as Chemoprophylaxis of COVID-19 in Health Workers,Drug (Chemoprophylaxis),Epigallocatechin gallate,Epigallocatechin gallate,524,https://clinicaltrials.gov/show/NCT04446065,None
5174,NCT04446104,ClinicalTrials.gov,2020-05-11,2020-05-13,False,"National University Hospital, Singapore",Not Recruiting,Phase 3,Interventional,Singapore,A Preventive Treatment for Migrant Workers at High-risk of COVID-19,Drug (Chemoprophylaxis),Hydroxychloroquine vs. Ivermectin vs. Zinc + Vitamin C vs. Povidone Iodine vs. Vitamin C,Hydroxychloroquine; Ivermectin; Zinc; Vitamin C; Povidone Iodine,4257,https://clinicaltrials.gov/show/NCT04446104,None
5175,NCT04446169,ClinicalTrials.gov,2020-06-20,2020-06-27,False,University of Florence,Not Recruiting,Not Applicable,Observational,Italy,COVID-19 (SARS-CoV-2) in Urine and Semen,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,43,https://clinicaltrials.gov/show/NCT04446169,None
5176,NCT04446286,ClinicalTrials.gov,2020-06-23,2020-06-18,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Bicentric Study on the Use of ECMO-VV or VA for Severe ARDS Associated With Covid-19,Drug,Oxygen,Oxygen,50,https://clinicaltrials.gov/show/NCT04446286,None
5177,NCT04446338,ClinicalTrials.gov,2020-06-22,2020-05-13,True,"University Hospital, Tübingen",Recruiting,Not Applicable,Observational,Germany,Immune Status SARS-CoV-2 in a Sample of a Tertiary Eye Health Centre,Clinical Presentation (Epidemiology),No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04446338,None
5178,NCT04446377,ClinicalTrials.gov,2020-06-23,2020-07-15,False,"AI Therapeutics, Inc.",Recruiting,Phase 2,Interventional,United States,A Study of LAM-002A for the Prevention of Progression of COVID-19,Drug,Apilimod Dimesylate,Apilimod Dimesylate,142,https://clinicaltrials.gov/show/NCT04446377,None
5179,NCT04447131,ClinicalTrials.gov,2020-06-17,2020-04-29,True,University of São Paulo,Recruiting,Not Applicable,Observational,Brazil,Effect of COVID-19 on Platelet Aggregation,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04447131,None
5180,NCT04447144,ClinicalTrials.gov,2020-06-23,2020-06-01,True,Cairo University,Recruiting,Not Applicable,Observational,Egypt,"Nutritional Habits, and Coronavirus Disease 2019 (COVID-19) Outcome",Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04447144,None
5181,NCT04447209,ClinicalTrials.gov,2020-06-17,2020-06-06,True,University of Malaya,Recruiting,Not Applicable,Observational,Malaysia,Dietary Diversity of Young Children During CoVID-19 Outbreak: A Longitudinal Study,Other,Other,Other,300,https://clinicaltrials.gov/show/NCT04447209,None
5182,NCT04447222,ClinicalTrials.gov,2020-06-11,2020-05-12,True,M.D. Anderson Cancer Center,Recruiting,Not Applicable,Observational,United States,Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors,Other (psych),No Intervention,No Intervention,1242,https://clinicaltrials.gov/show/NCT04447222,None
5183,NCT04447235,ClinicalTrials.gov,2020-06-22,2020-07-23,False,Instituto do Câncer do Estado de São Paulo,Recruiting,Phase 2,Interventional,Brazil,Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection,Drug,Ivermectin + Losartan,Ivermectin; Losartan,176,https://clinicaltrials.gov/show/NCT04447235,None
5184,NCT04447469,ClinicalTrials.gov,2020-06-23,2020-07-27,False,"Kiniksa Pharmaceuticals, Ltd.",Recruiting,Phase 2/Phase 3,Interventional,"Chile, Brazil, Peru, United States, South Africa",Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation,Drug,Mavrilimumab,Mavrilimumab,573,https://clinicaltrials.gov/show/NCT04447469,None
5185,NCT04447495,ClinicalTrials.gov,2020-06-23,2020-07-01,False,Medical College of Wisconsin,Not Recruiting,Not Applicable,Observational,No Country Given,Self-sampling for the Study of COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,https://clinicaltrials.gov/show/NCT04447495,None
5186,NCT04447638,ClinicalTrials.gov,2020-06-24,2020-03-20,True,Çanakkale Onsekiz Mart University,Not Recruiting,Not Applicable,Observational,Turkey,Percutaneous Tracheostomy With COVID-19,Procedure,Tracheostomy,Tracheostomy,24,https://clinicaltrials.gov/show/NCT04447638,None
5187,NCT04447781,ClinicalTrials.gov,2020-06-16,2020-07-15,False,International Vaccine Institute,Recruiting,Phase 1/Phase 2,Interventional,South Korea,"Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19",ATMP,Vaccine,Vaccine,160,https://clinicaltrials.gov/show/NCT04447781,None
5188,NCT04447833,ClinicalTrials.gov,2020-06-20,2020-06-17,True,Uppsala University,Recruiting,Phase 1,Interventional,Sweden,Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome,ATMP,Cells (mesenchymal),Cells (mesenchymal),9,https://clinicaltrials.gov/show/NCT04447833,None
5189,NCT04448119,ClinicalTrials.gov,2020-06-24,2020-10-16,False,Appili Therapeutics Inc.,Recruiting,Phase 2,Interventional,Canada,Control of COVID-19 Outbreaks in Long Term Care,Drug,Favipiravir,Favipiravir,760,https://clinicaltrials.gov/show/NCT04448119,None
5190,NCT04448145,ClinicalTrials.gov,2020-06-24,2020-03-26,True,Columbia University,Recruiting,Not Applicable,Observational,United States,Determinants of SARS-COV2 (COVID-19) Persistence After Convalescence,Clinical Presentation,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04448145,None
5191,NCT04448405,ClinicalTrials.gov,2020-06-19,2020-06-18,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Covid-19 Lockdown and Deviant Sexual Fantasies,Other (psych),No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04448405,None
5192,NCT04448418,ClinicalTrials.gov,2020-06-01,2020-05-20,True,Unità Operativa Complessa Ostetricia e Ginecologia,Not Recruiting,Not Applicable,Observational,Italy,The Impact of COVID-19 Outbreak on Trans-population's Health in Italy,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04448418,None
5193,NCT04448704,ClinicalTrials.gov,2020-06-25,2020-06-22,True,Yale-NUS College,Recruiting,Not Applicable,Observational,Singapore,Understanding the Mental Health of Migrant Workers During the COVID-19 Outbreak,Other (psych),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04448704,None
5194,NCT04448717,ClinicalTrials.gov,2020-06-18,2020-06-16,True,University of Zurich,Recruiting,Not Applicable,Observational,Switzerland,Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children,Clinical Presentation (Epidemiology),No Intervention,No Intervention,8000,https://clinicaltrials.gov/show/NCT04448717,None
5195,NCT04448743,ClinicalTrials.gov,2020-06-22,2020-06-01,True,"University Hospital, Strasbourg",Not Recruiting,Not Applicable,Observational,No Country Given,Role of Microparticles in Covid-19 Infection,Clinical Presentation,No Intervention,No Intervention,175,https://clinicaltrials.gov/show/NCT04448743,None
5196,NCT04448756,ClinicalTrials.gov,2020-06-25,2020-07-29,False,Merck KGaA,Recruiting,Phase 2,Interventional,"United States, Brazil",M5049 Study in Participants With Coronavirus Disease 2019 (COVID-19) Pneumonia,Drug,M5049,M5049,150,https://clinicaltrials.gov/show/NCT04448756,None
5197,NCT04448769,ClinicalTrials.gov,2020-06-23,2020-06-26,False,CHU de Nancy,Not Recruiting,Not Applicable,Interventional,France,Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19),Clinical Presentation (Epidemiology),No Intervention,No Intervention,2006,https://clinicaltrials.gov/show/NCT04448769,None
5198,NCT04448782,ClinicalTrials.gov,2020-06-17,2020-03-09,True,Corporació Sanitària Parc Taulí ,Not Recruiting,Not Applicable,Observational,Spain,Characterization of Reverse Triggering and Other Asynchronies in COVID-19 Patients Under Invasive Mechanical Ventilation,Clinical Presentation,No Intervention,No Intervention,32,https://clinicaltrials.gov/show/NCT04448782,None
5199,NCT04449042,ClinicalTrials.gov,2020-06-22,2020-04-01,True,Boston Children's Hospital,Recruiting,Not Applicable,Observational,United States,The PAWS-COVID-19 (Pediatric AirWay complicationS COVID-19) Registry,Clinical Presentation,No Intervention,No Intervention,15000,https://clinicaltrials.gov/show/NCT04449042,None
5200,NCT04449081,ClinicalTrials.gov,2020-06-25,2020-04-25,True,Melaka Manipal Medical College,Not Recruiting,Not Applicable,Observational,Malaysia,"Knowledge, Attitude and Practice of Dental Students About COVID-19",Other,No Intervention,No Intervention,215,https://clinicaltrials.gov/show/NCT04449081,None
5201,NCT04449094,ClinicalTrials.gov,2020-06-25,2020-02-28,True,CHU de Nice,Not Recruiting,Not Applicable,Observational,France,Emergence of the COVID 19 Epidemic in the City of Nice,Clinical Presentation (Epidemiology),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04449094,None
5202,NCT04449276,ClinicalTrials.gov,2020-06-18,2020-06-18,False,CureVac AG,Recruiting,Phase 1,Interventional,"Belgium, Germany","A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults",ATMP,Vaccine,Vaccine,284,https://clinicaltrials.gov/show/NCT04449276,None
5203,NCT04449380,ClinicalTrials.gov,2020-06-23,2020-11-02,False,Emanuele Bosi,Recruiting,Phase 2,Interventional,Italy,Clinical Study for the Treatment With Interferon-ÃŸ-1a (IFNÃŸ-1a) of COVID-19 Patients,Drug,Interferon beta,Interferon beta,126,https://clinicaltrials.gov/show/NCT04449380,None
5204,NCT04449588,ClinicalTrials.gov,2020-06-26,2020-07-23,False,"Staidson (Beijing) Biopharmaceuticals Co., Ltd",Recruiting,Phase 2/Phase 3,Interventional,"China, Indonesia",Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS,Drug,BDB-001,BDB-001,368,https://clinicaltrials.gov/show/NCT04449588,None
5205,NCT04449627,ClinicalTrials.gov,2020-06-11,2020-08-31,False,Royal Free Hospital NHS Foundation Trust,Not Recruiting,Not Applicable,Observational,No Country Given,Psychological Impact of Admission With Covid-19 During the SARS-CoV-2 Pandemic: Naturalistic Cohort Study With a Digital Intervention,Other (psych),Psychological,Psychological,125,https://clinicaltrials.gov/show/NCT04449627,None
5206,NCT04449718,ClinicalTrials.gov,2020-06-16,2020-06-01,True,University of São Paulo,Not Recruiting,Not Applicable,Interventional,Brazil,Vitamin D Supplementation in Patients With COVID-19,Drug,Vitamin D,Vitamin D,240,https://clinicaltrials.gov/show/NCT04449718,None
5207,NCT04449731,ClinicalTrials.gov,2020-06-23,2020-03-20,True,University of Granada,Recruiting,Not Applicable,Observational,Spain,Changes in Dietary Behaviours During the COVID-19 Outbreak Confinement in the Adult Population (COVIDiet_Int),Other,No Intervention,No Intervention,30000,https://clinicaltrials.gov/show/NCT04449731,None
5208,NCT04449783,ClinicalTrials.gov,2020-06-23,2020-06-25,False,Liverpool University Hospitals NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,Preoperative Shielding and N/T RT-PCR Swabbing for Elective Cancer Surgery,Procedure,Shielding + Swabbing,Shielding; Swabbing,150,https://clinicaltrials.gov/show/NCT04449783,None
5209,NCT04449965,ClinicalTrials.gov,2020-06-24,2020-07-01,False,"St. Paul's Hospital, Canada",Not Recruiting,Phase 1,Interventional,No Country Given,Povidone-Iodine Rinses in the Management of COVID-19,Drug,Povidone Iodine,Povidone Iodine,81,https://clinicaltrials.gov/show/NCT04449965,None
5210,NCT04449978,ClinicalTrials.gov,2020-06-23,2020-04-09,True,The Hospital for Sick Children,Recruiting,Not Applicable,Observational,Canada,TARGet Kids! COVID-19 Study of Children and Families,Clinical Presentation,No Intervention,No Intervention,1082,https://clinicaltrials.gov/show/NCT04449978,None
5211,NCT04450004,ClinicalTrials.gov,2020-06-18,2020-07-10,False,Medicago,Not Recruiting,Phase 1,Interventional,Canada,"Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years.",ATMP,Vaccine,Vaccine,180,https://clinicaltrials.gov/show/NCT04450004,None
5212,NCT04450017,ClinicalTrials.gov,2020-06-23,2020-04-06,True,"Federal Research Clinical Center of Federal Medical & Biological Agency, Russia",Recruiting,Not Applicable,Observational,Russian Federation,Clinical Features of Severe Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04450017,None
5213,NCT04450277,ClinicalTrials.gov,2020-06-25,2020-04-01,True,Khoo Teck Puat Hospital,Not Recruiting,Not Applicable,Observational,Singapore,Delivery of Protocolised Emergency Surgical Care During COVID-19 Pandemic,Procedure,Other,Other,15,https://clinicaltrials.gov/show/NCT04450277,None
5214,NCT04451174,ClinicalTrials.gov,2020-06-26,2020-06-23,True,University of Chile,Recruiting,Phase 3,Interventional,Chile,Early Use of Corticosteroids in Non-critical Patients With COVID-19 Pneumonia,Drug,Corticosteroids,Prednisone,184,https://clinicaltrials.gov/show/NCT04451174,None
5215,NCT04451239,ClinicalTrials.gov,2020-06-28,2020-06-30,False,Ameera Gamal Abdelhameed,Not Recruiting,Not Applicable,Interventional,Kuwait,Topical Steroids and Cyclosporin-A for COVID-19 Keratoconjunctivitis,Drug,Corticosteroids + Cyclosporine,Prednisolone + Cyclosporine,12,https://clinicaltrials.gov/show/NCT04451239,None
5216,NCT04451291,ClinicalTrials.gov,2020-06-26,2020-08-24,False,"University Health Network, Toronto",Not Recruiting,Not Applicable,Interventional,Canada,Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure,ATMP,Cells (decidual stromal),Cells (decidual stromal),20,https://clinicaltrials.gov/show/NCT04451291,None
5217,NCT04451317,ClinicalTrials.gov,2020-06-26,2020-06-12,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Observational,France,Physical Activity Following the Containment Period Imposed by the COVID-19 Pandemic in Patients,Other (exercise),No Intervention,No Intervention,600,https://clinicaltrials.gov/show/NCT04451317,None
5218,NCT04451577,ClinicalTrials.gov,2020-06-25,2020-06-01,True,Istituto Clinico Humanitas,Recruiting,Not Applicable,Observational,Italy,"Epidemiologic, Clinical, Molecular Characteristics of Hospital Employees With or Without Covid-19 Infection",Clinical Presentation,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04451577,None
5219,NCT04451694,ClinicalTrials.gov,2020-06-15,2020-04-01,True,CHU de Nancy,Recruiting,Not Applicable,Observational,France,Nutritional Follow up After Hospital Discharge for Coronavirus Disease-19,Other (nutrition),Nutrition,Nutrition,800,https://clinicaltrials.gov/show/NCT04451694,None
5220,NCT04451889,ClinicalTrials.gov,2020-06-29,2020-08-01,False,"Federal Research Clinical Center of Federal Medical & Biological Agency, Russia",Recruiting,Not Applicable,Interventional,Russian Federation,Probe-based Confocal Laser Endomicroscopy in Critically Ill COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,15,https://clinicaltrials.gov/show/NCT04451889,None
5221,NCT04451902,ClinicalTrials.gov,2020-06-23,2020-06-30,False,Imagine Institute,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 and Rare Skin Diseases European Observational Study During an Epidemic,Clinical Presentation,No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04451902,None
5222,NCT04451993,ClinicalTrials.gov,2020-06-26,2020-06-25,True,Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital,Recruiting,Not Applicable,Observational,Turkey,Physical Activity Level in Patients With OSAS During Covid-19 Pandemic,Other (exercise),No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04451993,None
5223,NCT04452097,ClinicalTrials.gov,2020-06-28,2021-02-01,False,Baylx Inc.,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS,ATMP,Cells (mesenchymal),Cells (mesenchymal),39,https://clinicaltrials.gov/show/NCT04452097,None
5224,NCT04452422,ClinicalTrials.gov,2020-06-23,2020-06-23,False,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Deep Venous Thrombosis in Non-severe COVID-19 Patients Hospitalized for a Neurovascular Pathology,Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04452422,None
5225,NCT04452435,ClinicalTrials.gov,2020-06-29,2020-07-21,True,Vicore Pharma AB,Not Recruiting,Phase 2,Interventional,"United Kingdom, India",Safety and Efficacy of C21 in Subjects With COVID-19,Drug,C21,C21,106,https://clinicaltrials.gov/show/NCT04452435,EUCTR2020-001502-38
5226,NCT04452474,ClinicalTrials.gov,2020-06-25,2020-06-30,False,"R-Pharm International, LLC",Not Recruiting,Phase 2/Phase 3,Interventional,United States,Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).,Drug,Olokizumab,Olokizumab,376,https://clinicaltrials.gov/show/NCT04452474,None
5227,NCT04452487,ClinicalTrials.gov,2020-06-23,2020-06-01,True,"University Hospital, Clermont-Ferrand",Recruiting,Not Applicable,Observational,France,Study of the Consequences of Infection on Compliance of Modalities of Decisions of Limitations and Stops of Treatments (COVID-19-LAT),Other,No Intervention,No Intervention,2500,https://clinicaltrials.gov/show/NCT04452487,None
5228,NCT04452565,ClinicalTrials.gov,2020-06-26,2020-10-15,False,"NeuroActiva, Inc.",Recruiting,Phase 2/Phase 3,Interventional,United States,"NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection",Drug,NA-831 vs. NA-831 + Atazanavir vs. NA-831 + Corticosteroids vs. Atazanavir + Corticosteroids,NA-831; Dexamethasone; Atazanavir,525,https://clinicaltrials.gov/show/NCT04452565,None
5229,NCT04452604,ClinicalTrials.gov,2020-06-18,2020-08-01,False,French Innovative Leukemia Organisation,Not Recruiting,Not Applicable,Observational,No Country Given,Multicentric Registry of Patients With Acute Leukemia Infected by COVID-19,Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04452604,None
5230,NCT04452617,ClinicalTrials.gov,2020-06-26,2020-03-19,True,Institut Mutualiste Montsouris,Not Recruiting,Not Applicable,Observational,France,Safety of Short-term Hydroxychloroquine Plus Azithromycin Treatment in Critically Ill Patients With Severe COVID-19,Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,40,https://clinicaltrials.gov/show/NCT04452617,None
5231,NCT04452630,ClinicalTrials.gov,2020-06-26,2020-06-23,True,Assistance Publique – Hôpitaux de Marseille,Recruiting,Not Applicable,Observational,France,Cardiovascular Consequences After COVID-19,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04452630,None
5232,NCT04452643,ClinicalTrials.gov,2020-06-26,2020-10-01,False,Inmunotek S.L.,Not Recruiting,Phase 3,Interventional,Mexico,Efficacy of BACMUNE (MV130) in the Prevention of Disease Due to COVID-19 Infection in Healthcare Personnel,Drug (Chemoprophylaxis),Bacteria,Bacteria,0,https://clinicaltrials.gov/show/NCT04452643,None
5233,NCT04452669,ClinicalTrials.gov,2020-06-29,2020-08-15,False,Aerogen Pharma Limited,Not Recruiting,Phase 2,Interventional,United States,VentaProst in Subjects With COVID-19 Requiring Mechanical Ventilation,Drug,Epoprostenol,Epoprostenol,20,https://clinicaltrials.gov/show/NCT04452669,None
5234,NCT04452682,ClinicalTrials.gov,2020-06-21,2020-05-25,True,Mansoura University,Not Recruiting,Not Applicable,Observational,Egypt,The Impact of COVID-19 Pandemic on Critical Limb Threatening Ischemia and Emergency Vascular Practice,Clinical Presentation,No Intervention,No Intervention,998,https://clinicaltrials.gov/show/NCT04452682,None
5235,NCT04452695,ClinicalTrials.gov,2020-06-29,2020-03-10,True,Brigham and Women's Hospital,Recruiting,Not Applicable,Observational,United States,Acceptability of Telehealth Triage Using Robotic Systems in COVID-19,Telehealth,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04452695,None
5236,NCT04452708,ClinicalTrials.gov,2020-06-29,2020-06-11,True,Chinese University of Hong Kong,Recruiting,Not Applicable,Observational,Hong Kong,HFNC and NIV for COVID-19 Complicated by Respiratory Failure,Other (device),Nasal cannula vs. noninvasice ventilation,Nasal cannula; noninvasice ventilation,15,https://clinicaltrials.gov/show/NCT04452708,None
5237,NCT04452773,ClinicalTrials.gov,2020-06-25,2020-07-14,False,Reig Jofre Group,Recruiting,Not Applicable,Interventional,Spain,Clinical Trial to Evaluate the Efficacy of Food Supplement ManremycÂ® Against SARS- COV-2 Infection (COVID-19) in Healthcare Workers,Supplement,Nutritional Supplement,Nutritional Supplement,315,https://clinicaltrials.gov/show/NCT04452773,None
5238,NCT04452799,ClinicalTrials.gov,2020-06-29,2020-07-01,False,Tanta University,Not Recruiting,Phase 1,Interventional,No Country Given,Hesperidin and Diosmin for Treatment of COVID-19,Drug,Hesperidin + Diosmin,Hesperidin; Diosmin,100,https://clinicaltrials.gov/show/NCT04452799,None
5239,NCT04452812,ClinicalTrials.gov,2020-06-29,2020-07-06,False,Universidad Autónoma de Coahuila,Not Recruiting,Phase 1/Phase 2,Interventional,Mexico,Statistical and Epidemiological Study Based on the Use of Convalescent Plasma for the Management of Patients With COVID-19,ATMP,Plasma,Plasma,15,https://clinicaltrials.gov/show/NCT04452812,None
5240,NCT04452942,ClinicalTrials.gov,2020-06-27,2020-07-01,False,EicOsis Human Health Inc.,Not Recruiting,Not Applicable,Observational,United States,Cytokine and Eicosanoid Mediators in Coronavirus Disease 2019 (COVID-19),Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04452942,None
5241,NCT04453280,ClinicalTrials.gov,2020-06-30,2020-05-18,True,Institute of Health Information and Statistics of the Czech Republic,Not Recruiting,Not Applicable,Observational,Czech Republic,Antibody Detection in COVID-19 Cured Patients (SARS-CoV-2-CZ-Immunity),Clinical Presentation (Epidemiology),No Intervention,No Intervention,695,https://clinicaltrials.gov/show/NCT04453280,None
5242,NCT04453371,ClinicalTrials.gov,2020-06-26,2020-10-15,False,Negovsky Reanimatology Research Institute,Not Recruiting,Phase 3,Interventional,No Country Given,Impact of Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (COVID-19),Drug,Tissue plasminogen activator,Tissue plasminogen activator,50,https://clinicaltrials.gov/show/NCT04453371,None
5243,NCT04453475,ClinicalTrials.gov,2020-06-29,2020-07-01,False,Jacobs University Bremen gGmbH,Recruiting,Not Applicable,Interventional,Germany,Feasibility and Benefits of Digital Services During the COVID19 Pandemic,Other,Other,Other,1230,https://clinicaltrials.gov/show/NCT04453475,None
5244,NCT04453488,ClinicalTrials.gov,2020-06-30,2020-07-30,False,Fundació Institut Germans Trias i Pujol,Not Recruiting,Phase 3,Interventional,Spain,Clinical Trial to Evaluate the Efficacy of RUTIÂ® Against SARS-COV-2 Infection (COVID-19) in Healthcare Workers,ATMP,Vaccine,Vaccine,315,https://clinicaltrials.gov/show/NCT04453488,None
5245,NCT04453501,ClinicalTrials.gov,2020-06-25,2020-03-02,True,Centre d'Investigation Clinique et Technologique 805,Not Recruiting,Not Applicable,Observational,France,Anti Infective Agents Impact in COVID-19 Pneumonia,Drug,Azithromycin vs. Azithormycin + Hydroxychloroquine,Azithormycin; Hydroxychloroquine,132,https://clinicaltrials.gov/show/NCT04453501,None
5246,NCT04453514,ClinicalTrials.gov,2020-06-30,2020-07-21,False,National University of Natural Medicine,Recruiting,Not Applicable,Interventional,United States,Feasibility of a Brief Trauma-informed Yoga Intervention for Anxiety During the Coronavirus Disease (COVID-19) Pandemic,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,200,https://clinicaltrials.gov/show/NCT04453514,None
5247,NCT04453527,ClinicalTrials.gov,2020-06-25,2020-05-28,True,Portsmouth Hospitals NHS Trust,Recruiting,Not Applicable,Observational,United Kingdom,The CASCADE Study - Measures of Complement Activation and Inflammation in Patients With Covid-19,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04453527,None
5248,NCT04453540,ClinicalTrials.gov,2020-06-30,2020-07-01,False,CHU de Nancy,Not Recruiting,Not Applicable,Observational,No Country Given,FilmArray and Management of ICU Patients With Pneumonia in the Covid-19 Context,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,150,https://clinicaltrials.gov/show/NCT04453540,None
5249,NCT04453553,ClinicalTrials.gov,2020-06-29,2020-07-02,False,Queen Mary University of London,Not Recruiting,Not Applicable,Interventional,United Kingdom,CICERO- A Care Home Study of COVID-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04453553,None
5250,NCT04453566,ClinicalTrials.gov,2020-06-29,2020-05-27,True,Uskudar University,Recruiting,Not Applicable,Observational,Turkey,"Effect of COVID-19 Pandemic on Perceived Stress, Anxiety, Mood, and Training Quality in Elite Athletes.",Other (psych),No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04453566,None
5251,NCT04453579,ClinicalTrials.gov,2020-06-29,2020-03-09,True,University of Rome Tor Vergata,Not Recruiting,Not Applicable,Observational,Italy,"Bariatric Surgery During Lockdown, Impact of COVID-19 on Physical and Mental Health",Other,No Intervention,No Intervention,116,https://clinicaltrials.gov/show/NCT04453579,None
5252,NCT04453657,ClinicalTrials.gov,2020-06-26,2020-12-01,False,Johns Hopkins University,Recruiting,Not Applicable,Interventional,United States,"Tele-Wellness Supported App for Family Child Care Home Providers and Families to Promote Health, Family Engagement, and School Readiness Amid COVID-19",Other (psych),Psychological,Psychological,270,https://clinicaltrials.gov/show/NCT04453657,None
5253,NCT04453670,ClinicalTrials.gov,2020-05-15,2020-03-10,True,University of Versailles,Not Recruiting,Not Applicable,Observational,France,Neuropathology in Adults Intensive Care Unit Patients With COVID 19,Clinical Presentation,No Intervention,No Intervention,7,https://clinicaltrials.gov/show/NCT04453670,None
5254,NCT04453748,ClinicalTrials.gov,2020-05-21,2020-06-08,False,Silesian Centre for Heart Diseases,Recruiting,Not Applicable,Observational,Poland,"The Assessment of the Prevalence, Clinical Course and Treatment of COVID-19 Complications",Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04453748,None
5255,NCT04453774,ClinicalTrials.gov,2020-05-06,2020-10-16,False,"University Health Network, Toronto",Not Recruiting,Not Applicable,Interventional,Canada,At Home Monitoring for Patients With Covid19,Other (device),Remote monitoring,Remote monitoring,1000,https://clinicaltrials.gov/show/NCT04453774,None
5256,NCT04453852,ClinicalTrials.gov,2020-06-03,2020-06-30,False,Vaxine Pty Ltd,Recruiting,Phase 1,Interventional,Australia,Monovalent Recombinant COVID19 Vaccine,ATMP,Vaccine,Vaccine,40,https://clinicaltrials.gov/show/NCT04453852,None
5257,NCT04453891,ClinicalTrials.gov,2020-06-29,2020-07-15,False,Nguyen Thu Ngan Trinh,Not Recruiting,Not Applicable,Observational,No Country Given,Hexoskin Feasibility Study With COVID-19 Patients,Other (device),Biosensors,Biosensors,16,https://clinicaltrials.gov/show/NCT04453891,None
5258,NCT04453969,ClinicalTrials.gov,2020-06-29,2020-05-24,True,Deborah O'Connor,Recruiting,Not Applicable,Observational,Canada,Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1a,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04453969,None
5259,NCT04453982,ClinicalTrials.gov,2020-06-29,2020-06-21,True,Deborah O'Connor,Recruiting,Not Applicable,Observational,Canada,Is COVID-19 Transmitted Through Human Milk? Implications for Breastfeeding and Human Milk Banking-Study 1b,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04453982,None
5260,NCT04454307,ClinicalTrials.gov,2020-06-29,2020-07-01,False,Tanta University,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Safety and Efficacy of Tramadol in COVID-19 Egyptian Patients,Drug,Tramadol,Tramadol,100,https://clinicaltrials.gov/show/NCT04454307,None
5261,NCT04454333,ClinicalTrials.gov,2020-06-30,2020-06-03,True,Sisli Hamidiye Etfal Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,COVID-19 in Pain Perspective,Clinical Presentation,No Intervention,No Intervention,466,https://clinicaltrials.gov/show/NCT04454333,None
5262,NCT04454372,ClinicalTrials.gov,2020-06-29,2020-07-15,False,Hospital Sao Domingos,Not Recruiting,Not Applicable,Observational,No Country Given,Clinical Characteristics and Outcomes of 187 Critically Ill Patients With Coronavirus Disease 2019 (COVID-19),Clinical Presentation,No Intervention,No Intervention,187,https://clinicaltrials.gov/show/NCT04454372,None
5263,NCT04454398,ClinicalTrials.gov,2020-06-30,2020-09-17,False,"Sorrento Therapeutics, Inc.",Recruiting,Phase 1,Interventional,United States,Study to Evaluate STI-1499 (COVI-GUARD) in Patients With Moderate COVID-19,Drug,STI-1499,STI-1499,33,https://clinicaltrials.gov/show/NCT04454398,None
5264,NCT04454606,ClinicalTrials.gov,2020-06-26,2020-05-01,True,Bangkok Metropolitan Administration Medical College; Vajira Hospital,Not Recruiting,Not Applicable,Interventional,Thailand,The New Silicone N99 Half-Piece Respirator,Other (device),Mask,Mask,43,https://clinicaltrials.gov/show/NCT04454606,None
5265,NCT04455243,ClinicalTrials.gov,2020-07-01,2020-08-01,True,Dr. Tariq Alhawassi,Not Recruiting,Phase 3,Interventional,No Country Given,Inflammatory Regulation Effect of NAC on COVID-19 Treatment,Drug,N-acetyl cysteine,N-acetyl cysteine,1180,https://clinicaltrials.gov/show/NCT04455243,ISRCTN60069084
5266,NCT04455308,ClinicalTrials.gov,2020-06-30,2020-07-21,False,Rennes University Hospital,Not Recruiting,Not Applicable,Interventional,France,COVID-19 and Chilblains,Clinical Presentation,No Intervention,No Intervention,269,https://clinicaltrials.gov/show/NCT04455308,None
5267,NCT04455347,ClinicalTrials.gov,2020-07-01,2020-06-15,True,Imagine Institute,Recruiting,Not Applicable,Observational,France,Cardiac and Thoracic Imaging in Pediatric Patients With Evidence of Systemic Inflammation COVID19 Linked,Clinical Presentation,No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04455347,None
5268,NCT04455360,ClinicalTrials.gov,2020-06-26,2020-10-01,False,University Hospital Southampton NHS Foundation Trust,Recruiting,Not Applicable,Interventional,United Kingdom,Early EMDR Following Covid-19 Critical Illness: A Feasibility Trial,Other,Other,Other,26,https://clinicaltrials.gov/show/NCT04455360,None
5269,NCT04455451,ClinicalTrials.gov,2020-07-01,2020-08-06,False,"University Hospital, Tübingen",Recruiting,Not Applicable,Observational,Germany,Intensive Care Therapy of Covid-19 Disease in Germany,Clinical Presentation (Epidemiology),No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04455451,None
5270,NCT04455958,ClinicalTrials.gov,2020-07-01,2020-11-01,False,Oregon Health and Science University,Not Recruiting,Phase 2,Interventional,United States,Lopinavir/Ritonavir for the Treatment of COVID-19 Positive Patients With Cancer and Immune Suppression in the Last Year,Drug,Lopinavir/ritonavir,Lopinavir/ritonavir,75,https://clinicaltrials.gov/show/NCT04455958,None
5271,NCT04456010,ClinicalTrials.gov,2020-06-15,2020-06-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,COVID-19 in ART: Perception and Experience,Other,No Intervention,No Intervention,600,https://clinicaltrials.gov/show/NCT04456010,None
5272,NCT04456036,ClinicalTrials.gov,2020-06-30,2020-07-01,False,Universit Politecnica delle Marche,Recruiting,Not Applicable,Observational,Italy,Rehabilitation Needs and Functional Recovery in Covid-19 Acute and Post-acute Care,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,100,https://clinicaltrials.gov/show/NCT04456036,None
5273,NCT04456049,ClinicalTrials.gov,2020-07-01,2020-07-01,False,Ricardo Pereira Mestre,Not Recruiting,Phase 2,Interventional,Switzerland,Randomized Open Label Phase II Study to Evaluate the Efficacy of Enzalutamide in High Risk Male Outpatients With COVID-19,Drug,Enzalutamide,Enzalutamide,90,https://clinicaltrials.gov/show/NCT04456049,None
5274,NCT04456062,ClinicalTrials.gov,2020-06-30,2020-08-04,False,Sunnybrook Health Sciences Centre,Recruiting,Not Applicable,Interventional,Canada,Using Caring Contacts to Reduce Psychiatric Morbidity Following Hospitalization During the COVID-19 Pandemic,Other (psych),Psychological,Psychological,150,https://clinicaltrials.gov/show/NCT04456062,None
5275,NCT04456075,ClinicalTrials.gov,2020-06-29,2020-04-01,True,Heidelberg University,Recruiting,Not Applicable,Observational,Germany,Risk Prediction and Therapy Monitoring in Patients With SARS-Cov-2 Infection / COVID 19,Prognosis,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04456075,None
5276,NCT04456088,ClinicalTrials.gov,2020-07-01,2020-07-15,False,Beyond Air Inc.,Not Recruiting,Phase 2,Interventional,No Country Given,Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (CANADA Trial),Drug,Nitric Oxide,Nitric Oxide,50,https://clinicaltrials.gov/show/NCT04456088,None
5277,NCT04456101,ClinicalTrials.gov,2020-06-30,2020-06-19,True,"Wuhan Union Hospital, China",Recruiting,Not Applicable,Observational,China,"Study on the Recovery of Pulmonary Function, Chest CT, Hematologic, and Immune & Inflammatory Conditions in COVID-19 Rehabilitation Patients",Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,240,https://clinicaltrials.gov/show/NCT04456101,None
5278,NCT04456153,ClinicalTrials.gov,2020-06-30,2020-07-22,False,University of Texas Southwestern Medical Center,Recruiting,Phase 2,Interventional,United States,Atovaquone for Treatment of COVID-19,Drug,Atovaquone,Atovaquone,60,https://clinicaltrials.gov/show/NCT04456153,None
5279,NCT04456361,ClinicalTrials.gov,2020-06-23,2020-04-16,True,Instituto de Medicina Regenerativa,Not Recruiting,Phase 1,Interventional,Mexico,Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),9,https://clinicaltrials.gov/show/NCT04456361,None
5280,NCT04456413,ClinicalTrials.gov,2020-06-30,2020-11-06,False,Hackensack Meridian Health,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma as Treatment for Subjects With Early COVID-19 Infection,ATMP,Plasma,Plasma,306,https://clinicaltrials.gov/show/NCT04456413,None
5281,NCT04456426,ClinicalTrials.gov,2020-05-29,2020-07-01,False,Hospital Departamental de Villavicencio,Not Recruiting,Not Applicable,Observational,No Country Given,"Characteristics of Patients and Healthcare Workers With COVID-19 in Meta State, Colombia",Clinical Presentation,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04456426,None
5282,NCT04456439,ClinicalTrials.gov,2020-06-29,2020-07-01,False,Mesoblast International,Not Recruiting,Not Applicable,Expanded Access,No Country Given,"Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)",ATMP (+ Drug),Cells (mesenchymal) + Corticosteroids + Diphenhydramine,Cells (mesenchymal); Hydrocortisone; Diphenhydramine,Not Available,https://clinicaltrials.gov/show/NCT04456439,None
5283,NCT04456452,ClinicalTrials.gov,2020-06-30,2020-07-27,False,Ampio Pharmaceuticals. Inc.,Not Recruiting,Phase 1,Interventional,United States,Study of Ampion for the Treatment of Adult COVID-19 Patients Requiring Oxygen Supplementation,Drug,Human serum albumin,Human serum albumin,10,https://clinicaltrials.gov/show/NCT04456452,None
5284,NCT04456556,ClinicalTrials.gov,2020-06-30,2020-04-27,True,Minia University,Not Recruiting,Not Applicable,Observational,Egypt,Combined Endophthalmitis and Orbital Cellulitis in Patients With Novel Coronavirus Disease (COVID-19),Clinical Presentation,No Intervention,No Intervention,5,https://clinicaltrials.gov/show/NCT04456556,None
5285,NCT04456933,ClinicalTrials.gov,2020-06-30,2020-06-29,True,Corporació Sanitària Parc Taulí ,Recruiting,Not Applicable,Observational,Spain,Intracorporeal Anastomosis in Laparoscopic Left Colectomy. Cohort Comparative Study,Procedure,Surgical technique,Surgical technique,148,https://clinicaltrials.gov/show/NCT04456933,None
5286,NCT04457349,ClinicalTrials.gov,2020-06-30,2020-07-25,False,Alexandria University,Recruiting,Not Applicable,Interventional,Egypt,Therapeutic Plasma Exchange in Resistant Cytokine Storm of COVID 19,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04457349,None
5287,NCT04457388,ClinicalTrials.gov,2020-06-30,2020-03-25,True,Aarogyam UK,Not Recruiting,Not Applicable,Interventional,United Kingdom,Tele-Yoga Therapy for Chronic Pain,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,18,https://clinicaltrials.gov/show/NCT04457388,None
5288,NCT04457505,ClinicalTrials.gov,2020-07-01,2020-05-08,True,Centro de Investigación Biomédica en Red (Ciber),Recruiting,Not Applicable,Observational,Spain,One Year Follow-ups of Patients Admitted to Spanish Intensive Care Units Due to COVID-19,Clinical Presentation,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04457505,None
5289,NCT04457570,ClinicalTrials.gov,2020-07-02,2020-06-15,True,Hospices Civils de Lyon,Recruiting,Not Applicable,Observational,France,Excess Risk of Morbi-mortality Due to COVID-19 in Patients With Cancer,Clinical Presentation (Epidemiology),No Intervention,No Intervention,600,https://clinicaltrials.gov/show/NCT04457570,None
5290,NCT04457609,ClinicalTrials.gov,2020-05-27,2020-07-01,False,Indonesia University,Recruiting,Phase 1,Interventional,Indonesia,Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients,ATMP (+ Drug),Cells (mesenchymal) + Oseltamivir + Azithromycin vs. Oseltamivir + Azithromycin,Cells (mesenchymal); Oseltamivir; Azithromycin,40,https://clinicaltrials.gov/show/NCT04457609,None
5291,NCT04457726,ClinicalTrials.gov,2020-07-02,2020-07-01,True,KK Women's and Children's Hospital,Recruiting,Phase 1/Phase 2,Interventional,Singapore,Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19,ATMP,Cells (T),Cells (T),18,https://clinicaltrials.gov/show/NCT04457726,None
5292,NCT04457817,ClinicalTrials.gov,2020-06-24,2020-12-01,False,"University of Colorado, Denver",Not Recruiting,Not Applicable,Interventional,No Country Given,Compensatory Reserve Index (CRI) for Management of COVID-19,Other (device),Compensatory Reserve Index (CRI) Management,Compensatory Reserve Index (CRI) Management,100,https://clinicaltrials.gov/show/NCT04457817,None
5293,NCT04458246,ClinicalTrials.gov,2020-07-01,2020-07-01,False,University of São Paulo,Recruiting,Not Applicable,Interventional,Brazil,Home-based Aerobic Training Among Adolescents With Chronic Diseases During COVID-19 Pandemic,Other (exercise),Exercise,Exercise,140,https://clinicaltrials.gov/show/NCT04458246,None
5294,NCT04458298,ClinicalTrials.gov,2020-06-29,2020-07-01,False,"Orpheris, Inc.",Recruiting,Phase 2,Interventional,United States,A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients,Drug,Dendrimer N-acetyl-cysteine,Dendrimer N-acetyl-cysteine,24,https://clinicaltrials.gov/show/NCT04458298,None
5295,NCT04458337,ClinicalTrials.gov,2020-06-26,2020-03-13,True,Centre Hospitalier de l'Université de Montréal ,Recruiting,Not Applicable,Observational,Canada,SURgical Outcomes in COvid Patients - the SUROCO Multicenter Cohort Study (COVID-19),Clinical Presentation,No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04458337,None
5296,NCT04458363,ClinicalTrials.gov,2020-06-25,2020-07-01,False,Emory University,Recruiting,Phase 1,Interventional,United States,Convalescent Plasma in Pediatric COVID-19,ATMP,Plasma,Plasma,50,https://clinicaltrials.gov/show/NCT04458363,None
5297,NCT04458519,ClinicalTrials.gov,2020-07-01,2020-07-16,False,Centre Hospitalier de l'Université de Montréal ,Recruiting,Not Applicable,Interventional,Canada,Efficacy of Intranasal Probiotic Treatment to Reduce Severity of Symptoms in COVID19 Infection,Supplement,Probiotics,Probiotics,40,https://clinicaltrials.gov/show/NCT04458519,None
5298,NCT04458948,ClinicalTrials.gov,2020-06-09,2020-03-24,True,University of New Mexico,Not Recruiting,Phase 2,Interventional,United States,Open Label Non-comparative Trial of the Combination of Hydroxychloroquine and Azithromycin in the Treatment of Hospitalized Patients,Drug,Hydroxychloroquine + Azithromycin,Hydroxychloroquine; Azithromycin,10000,https://clinicaltrials.gov/show/NCT04458948,None
5299,NCT04459247,ClinicalTrials.gov,2020-07-03,2020-06-15,True,Postgraduate Institute of Medical Education and Research,Not Recruiting,Not Applicable,Interventional,India,"Short Term, High Dose Vitamin D Supplementation for COVID-19",Drug,Vitamin D,Vitamin D,30,https://clinicaltrials.gov/show/NCT04459247,None
5300,NCT04459286,ClinicalTrials.gov,2020-07-03,2020-10-09,True,Obafemi Awolowo University,Recruiting,Phase 2,Interventional,Nigeria,The Nitazoxanide Plus Atazanavir for COVID-19 Study,Drug,Nitazoxanide + Atazanavir/ritonavir,Nitazoxanide; Atazanavir/ritonavir,98,https://clinicaltrials.gov/show/NCT04459286,PACTR202008855701534
5301,NCT04459312,ClinicalTrials.gov,2020-07-03,2020-06-01,True,Heinrich-Heine University,Recruiting,Not Applicable,Observational,Germany,National Covid-19 Surveillance Physicians,Clinical Presentation (Epidemiology),No Intervention,No Intervention,600,https://clinicaltrials.gov/show/NCT04459312,None
5302,NCT04459325,ClinicalTrials.gov,2020-07-03,2020-06-01,True,AO Generium,Not Recruiting,Phase 3,Interventional,Russian Federation,TigeraseÂ® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19,Drug,Tigerase,Tigerase,100,https://clinicaltrials.gov/show/NCT04459325,None
5303,NCT04459351,ClinicalTrials.gov,2020-06-18,2020-06-19,False,Chelsea and Westminster Hospital NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,PHenotyping patiENts Admitted to Hospital With cOvid-19 Infection and idenTifYing Prognostic markErs,Prognosis,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04459351,None
5304,NCT04459364,ClinicalTrials.gov,2020-07-03,2020-06-01,True,Attgeno AB,Recruiting,Not Applicable,Observational,Sweden,The Prevalence of Pulmonary Hypertension in Patients With COVID-19.,Clinical Presentation,No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04459364,None
5305,NCT04459390,ClinicalTrials.gov,2020-07-05,2020-07-20,False,Assiut University,Recruiting,Not Applicable,Observational,Egypt,Association of Comorbidities With COVID19,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04459390,None
5306,NCT04459403,ClinicalTrials.gov,2020-07-02,2020-06-08,True,Cairo University,Recruiting,Not Applicable,Observational,Egypt,Psychiatric Disturbances and COVID-19 Infection,Other (psych),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04459403,None
5307,NCT04459455,ClinicalTrials.gov,2020-06-29,2020-08-19,False,Stony Brook University,Not Recruiting,Not Applicable,Interventional,United States,"Project H-COVID: Evaluating Hyper-Brief, Online Materials During the COVID-19 Pandemic",Other,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04459455,None
5308,NCT04459520,ClinicalTrials.gov,2020-07-05,2020-07-23,False,"University of California, Los Angeles",Not Recruiting,Not Applicable,Interventional,United States,Effect of Availability of COVID-19 Testing on Choice to Isolate and Socially Distance,Other,No Intervention,No Intervention,1400,https://clinicaltrials.gov/show/NCT04459520,None
5309,NCT04459533,ClinicalTrials.gov,2020-06-22,2020-06-01,True,Hospices Civils de Lyon,Not Recruiting,Not Applicable,Observational,France,Sparing in Neuromuscular Blockade in COVID 19 ICU,Clinical Presentation,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04459533,None
5310,NCT04459637,ClinicalTrials.gov,2020-06-25,2020-07-01,False,Peking University First Hospital,Not Recruiting,Not Applicable,Observational,China,COVID-19 Surveillance Based on Smart Wearable Device,Other (device),Biosensors,Biosensors,200,https://clinicaltrials.gov/show/NCT04459637,None
5311,NCT04459676,ClinicalTrials.gov,2020-07-03,2020-07-31,False,Angion Biomedica Corp,Recruiting,Phase 2,Interventional,Brazil,Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia,Drug,ANG-3777,ANG-3777,100,https://clinicaltrials.gov/show/NCT04459676,None
5312,NCT04459689,ClinicalTrials.gov,2020-07-02,2020-03-15,True,Imagine Institute,Recruiting,Not Applicable,Observational,France,COVID-19 in PID Survey,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04459689,None
5313,NCT04459702,ClinicalTrials.gov,2020-06-25,2020-07-01,False,ProgenaBiome,Not Recruiting,Phase 2,Interventional,United States,A Study of Combination Therapies to Treat COVID-19 Infection,Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine + Azithromycin + Lopinavir/ritonavir,Hydroxychloroquine; Azithromycin; Lopinavir/ritonavir,200,https://clinicaltrials.gov/show/NCT04459702,None
5314,NCT04459819,ClinicalTrials.gov,2020-06-27,2020-03-01,True,Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,Recruiting,Not Applicable,Observational,Italy,Respiratory Physiotherapy in Severe COVID-19 Patients,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,80,https://clinicaltrials.gov/show/NCT04459819,None
5315,NCT04459962,ClinicalTrials.gov,2020-07-03,2020-06-29,True,Ancon Technologies Ltd,Recruiting,Not Applicable,Interventional,United Kingdom,Covid-19 Breath Test,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,250,https://clinicaltrials.gov/show/NCT04459962,None
5316,NCT04459975,ClinicalTrials.gov,2020-06-12,2020-04-01,True,Hospices Civils de Lyon,Recruiting,Not Applicable,Observational,France,Acute Kidney Injury and Renal Outcomes for COVID-19 Patients in Intensive Care Units,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04459975,None
5317,NCT04460014,ClinicalTrials.gov,2020-07-06,2020-09-30,False,Karolinska Institutet,Recruiting,Not Applicable,Interventional,Sweden,Simple Cognitive Task Intervention After Trauma During COVID-19 In Hospital Staff EKUT-P RCT,Other (psych),Psychological,Psychological,164,https://clinicaltrials.gov/show/NCT04460014,None
5318,NCT04460027,ClinicalTrials.gov,2020-07-01,2020-06-22,True,Athena Robinson,Recruiting,Phase 1,Interventional,United States,W-SUDs for COVID-19,Other (psych),Psychological,Psychological,160,https://clinicaltrials.gov/show/NCT04460027,None
5319,NCT04460105,ClinicalTrials.gov,2020-06-30,2020-10-31,False,Shire,Not Recruiting,Phase 1,Interventional,United States,Lanadelumab in Participants Hospitalized With COVID-19 Pneumonia,Drug,Lanadelumab,Lanadelumab,0,https://clinicaltrials.gov/show/NCT04460105,None
5320,NCT04460170,ClinicalTrials.gov,2020-06-29,2020-07-01,False,University Medical Center Groningen,Recruiting,Not Applicable,Observational,Netherlands,COVID-19 Follow up Intensive Care Studies,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04460170,None
5321,NCT04460183,ClinicalTrials.gov,2020-07-03,2020-07-29,False,Thirty Respiratory Limited,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,A Study to Assess Efficacy and Safety of RESP301 Plus Standard of Care (SOC) Compared to SOC Alone in Hospitalized Participants With COVID-19,Drug,Nitric Oxide,Nitric Oxide,300,https://clinicaltrials.gov/show/NCT04460183,None
5322,NCT04460196,ClinicalTrials.gov,2020-07-06,2020-07-08,False,"University Hospital, Angers",Not Recruiting,Not Applicable,Observational,France,Healthcare Renunciation During the Confinement Period in Connection With the COVID-19 Epidemic in Adult Emergency Departments,Health System,No Intervention,No Intervention,900,https://clinicaltrials.gov/show/NCT04460196,None
5323,NCT04460274,ClinicalTrials.gov,2020-07-03,2019-12-31,True,Turkish Ministry of Health Izmir Teaching Hospital,Not Recruiting,Not Applicable,Observational,Turkey,Forecast Number of Covid-19 Cases Worldwide,Other,No Intervention,No Intervention,7882471,https://clinicaltrials.gov/show/NCT04460274,None
5324,NCT04460469,ClinicalTrials.gov,2020-07-04,2020-07-01,True,Cairo University,Recruiting,Not Applicable,Observational,Egypt,Anxiety Level and Oral Hygiene Practice in Dental Students During Covid-19 Pandemic,Other (psych),No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04460469,None
5325,NCT04460534,ClinicalTrials.gov,2020-07-02,2020-05-07,True,GCS Ramsay Sant pour l'Enseignement et la Recherche,Recruiting,Not Applicable,Interventional,France,Detection of COVID-19 (SARS-CoV-2) in the Semen of COVID+ Patients (Positive RT-PCR on a Nasopharyngeal Swab),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04460534,None
5326,NCT04460547,ClinicalTrials.gov,2020-07-03,2020-07-25,False,Qassim University,Not Recruiting,Not Applicable,Observational,No Country Given,Worldwide Trends on COVID-19 Research After the Declaration of COVID-19 Pandemic,Drug (ATMP),"Plasma, Hydroxychloroquine, DAS181, Ivermectin, Interferon beta",Plasma; Hydroxychloroquine; DAS181; Ivermectin; Interferon beta,200,https://clinicaltrials.gov/show/NCT04460547,None
5327,NCT04460599,ClinicalTrials.gov,2020-07-06,2020-03-08,True,Centre d'Investigation Clinique et Technologique 805,Recruiting,Not Applicable,Observational,France,Neurological Features During COVID19,Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04460599,None
5328,NCT04460638,ClinicalTrials.gov,2020-07-06,2020-07-23,False,Direction Centrale du Service de Sant des Armes,Recruiting,Not Applicable,Observational,France,SARS-CoV2 (COVID-19) Diagnosis in Human Saliva by MALDI-TOF MS Profiling,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,600,https://clinicaltrials.gov/show/NCT04460638,None
5329,NCT04460651,ClinicalTrials.gov,2020-07-02,2020-08-14,False,Estudios Clínicos Latino América,Recruiting,Phase 3,Interventional,Argentina,PREPARE-IT. Prevention of COVID19 With EPA in Healthcare Providers at Risk - Intervention Trial,Drug,Icosapent ethyl,Icosapent ethyl,2000,https://clinicaltrials.gov/show/NCT04460651,None
5330,NCT04460664,ClinicalTrials.gov,2020-06-30,2020-08-14,False,HemoSonics LLC,Recruiting,Not Applicable,Observational,United States,Coagulation Changes Associated With COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04460664,None
5331,NCT04460677,ClinicalTrials.gov,2020-07-06,2020-08-12,False,Rutgers University,Recruiting,Not Applicable,Interventional,United States,ASD (Autism Spectrum Disorder) Telehealth for Distress Related to COVID-19,Telehealth,Telehealth,Telehealth,80,https://clinicaltrials.gov/show/NCT04460677,None
5332,NCT04460690,ClinicalTrials.gov,2020-07-06,2020-07-13,False,"University of Wisconsin, Madison",Recruiting,Not Applicable,Interventional,United States,"Rapid, Onsite COVID-19 Detection",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,10000,https://clinicaltrials.gov/show/NCT04460690,None
5333,NCT04460703,ClinicalTrials.gov,2020-07-02,2020-07-03,False,Yale University,Not Recruiting,Not Applicable,Interventional,United States,"COVID-19 Vaccine Messaging, Part 1",Other,Other,Other,4000,https://clinicaltrials.gov/show/NCT04460703,None
5334,NCT04461340,ClinicalTrials.gov,2020-07-04,2020-08-15,False,Alexandria University,Recruiting,Phase 2,Interventional,Egypt,Efficacy and Safety of Sirolimus in COVID-19 Infection,Drug,Sirolimus,Sirolimus,40,https://clinicaltrials.gov/show/NCT04461340,None
5335,NCT04461379,ClinicalTrials.gov,2020-07-02,2020-07-21,False,Hospital Universitario Dr. Jose E. Gonzalez,Not Recruiting,Phase 3,Interventional,Mexico,"Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare Workers",ATMP,Vaccine,Vaccine,908,https://clinicaltrials.gov/show/NCT04461379,None
5336,NCT04461925,ClinicalTrials.gov,2020-07-01,2020-05-02,True,Institute of Cell Therapy,Recruiting,Phase 1/Phase 2,Interventional,Ukraine,Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04461925,None
5337,NCT04462120,ClinicalTrials.gov,2020-06-19,2020-06-16,True,Assiut University,Not Recruiting,Not Applicable,Observational,Egypt,IL-12RB and TNF-alpha Gene Polymorphism and Susceptibility and Progress of Covid-19 SARS-CoV-2: A Case Control Study,Genomics,Genomics,Genomics,100,https://clinicaltrials.gov/show/NCT04462120,None
5338,NCT04462367,ClinicalTrials.gov,2020-06-23,2020-07-01,False,Instituto Materno Infantil Professor Fernando Figueira,Not Recruiting,Not Applicable,Observational,Brazil,Northeast COVID-19 and Pregnancy Study Group,Clinical Presentation,No Intervention,No Intervention,180,https://clinicaltrials.gov/show/NCT04462367,None
5339,NCT04462393,ClinicalTrials.gov,2020-07-06,2020-03-06,True,Linkoeping University,Not Recruiting,Not Applicable,Observational,Sweden,Characteristics and Outcomes of Patients Admitted to Swedish Intensive Care Units for COVID-19,Clinical Presentation,No Intervention,No Intervention,1563,https://clinicaltrials.gov/show/NCT04462393,None
5340,NCT04462627,ClinicalTrials.gov,2020-07-07,2020-04-14,True,Hanane El Kenz,Recruiting,Not Applicable,Interventional,Belgium,Reduction of COVID 19 Transmission to Health Care Professionals,Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04462627,None
5341,NCT04462757,ClinicalTrials.gov,2020-06-12,2020-05-28,True,University of Manchester,Not Recruiting,Phase 2,Interventional,United Kingdom,SCIL-1Ra in COVID-19 Feasibility & PK/PD,Drug,Anakinra,Anakinra,5,https://clinicaltrials.gov/show/NCT04462757,EUCTR2020-001636-95
5342,NCT04462783,ClinicalTrials.gov,2020-07-07,2020-12-01,False,University of Michigan,Not Recruiting,Not Applicable,Interventional,No Country Given,Emergency Department (ED) Self-Monitoring Pilot COVID-19,Other,Other,Other,200,https://clinicaltrials.gov/show/NCT04462783,None
5343,NCT04462848,ClinicalTrials.gov,2020-06-30,2020-08-01,False,"University of California, Los Angeles",Not Recruiting,Phase 1,Interventional,United States,Covid-19 Convalescent Plasma as Prevention and Treatment for Children With Underlying Medical Conditions,ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04462848,None
5344,NCT04463004,ClinicalTrials.gov,2020-07-07,2020-09-02,False,Virginia Commonwealth University,Recruiting,Phase 2,Interventional,United States,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation,Drug,Mavrilimumab,Mavrilimumab,60,https://clinicaltrials.gov/show/NCT04463004,None
5345,NCT04463264,ClinicalTrials.gov,2020-06-26,2020-06-26,False,Laboratorios Roemmers,Recruiting,Phase 2/Phase 3,Interventional,Argentina,Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19),Drug,Nitazoxanide,Nitazoxanide,135,https://clinicaltrials.gov/show/NCT04463264,None
5346,NCT04463420,ClinicalTrials.gov,2020-07-04,2020-08-15,True,Baqiyatallah Medical Sciences University,Recruiting,Not Applicable,Interventional,Iran,Safety and Efficacy of PHR 160 Spray on the Outcomes of Patients With COVID-19,Drug,PHR160,PHR160,224,https://clinicaltrials.gov/show/NCT04463420,IRCT20200731048257N1
5347,NCT04463433,ClinicalTrials.gov,2020-04-12,2020-02-01,True,Beijing Normal University,Recruiting,Not Applicable,Interventional,China,Psychological Intervention for Parent-child Relationship and Couple Relationship Under COVID-19 in China,Other (psych),Psychological,Psychological,300,https://clinicaltrials.gov/show/NCT04463433,None
5348,NCT04463472,ClinicalTrials.gov,2020-07-08,2020-06-29,True,"AnGes, Inc.",Not Recruiting,Phase 1/Phase 2,Interventional,Japan,Study of COVID-19 DNA Vaccine (AG0301-COVID19),ATMP,Vaccine,Vaccine,30,https://clinicaltrials.gov/show/NCT04463472,None
5349,NCT04463628,ClinicalTrials.gov,2020-06-29,2020-05-15,True,Centre Hospitalier Intercommunal Creteil,Recruiting,Not Applicable,Observational,France,"Impacts of the Covid-19 Epidemic and Associated Lockdown Measures on the Management, Health and Behaviors of Cystic Fibrosis Patients During the 2020 Epidemic",Other,No Intervention,No Intervention,1200,https://clinicaltrials.gov/show/NCT04463628,None
5350,NCT04463706,ClinicalTrials.gov,2020-07-06,2020-06-01,True,Hospital Galdakao-Usansolo,Recruiting,Not Applicable,Observational,Spain,COVID19 Severity Prediction and Health Services Research Evaluation,Prognosis,No Intervention,No Intervention,20000,https://clinicaltrials.gov/show/NCT04463706,None
5351,NCT04463758,ClinicalTrials.gov,2020-07-08,2020-05-11,True,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Observational,France,Covid-19 in Pregnancy: a French Population-based Cohort of Women and Newborns,Clinical Presentation,No Intervention,No Intervention,3060,https://clinicaltrials.gov/show/NCT04463758,None
5352,NCT04463823,ClinicalTrials.gov,2020-07-03,2020-07-06,False,Oslo University Hospital,Not Recruiting,Not Applicable,Observational,Norway,"""NORPLASMA"" Covid-19 Convalescent Plasma Treatment Monitoring Study",ATMP,Plasma,Plasma,500,https://clinicaltrials.gov/show/NCT04463823,None
5353,NCT04463849,ClinicalTrials.gov,2020-07-02,2020-06-30,True,University of Milan,Recruiting,Not Applicable,Interventional,Italy,Effects of COVID-19 Infection on Beta-cell Function in Euglycemic Patients,Clinical Presentation,No Intervention,No Intervention,24,https://clinicaltrials.gov/show/NCT04463849,None
5354,NCT04463862,ClinicalTrials.gov,2020-07-08,2020-06-04,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,"France, Belgium",COVID - AirPollution,Clinical Presentation,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04463862,None
5355,NCT04464395,ClinicalTrials.gov,2020-07-07,2020-07-01,True,"Corvus Pharmaceuticals, Inc.",Recruiting,Phase 1,Interventional,United States,Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 Patients,Drug,CPI-006,CPI-006,60,https://clinicaltrials.gov/show/NCT04464395,None
5356,NCT04464408,ClinicalTrials.gov,2020-06-28,2020-07-23,False,King Abdullah International Medical Research Center,Recruiting,Phase 2/Phase 3,Interventional,Saudi Arabia,Favipiravir Therapy in Adults With Mild COVID-19,Drug,Favipiravir,Favipiravir,576,https://clinicaltrials.gov/show/NCT04464408,None
5357,NCT04464460,ClinicalTrials.gov,2020-07-08,2020-09-25,False,Takeda,Not Recruiting,Phase 1,Interventional,No Country Given,"A Study to Evaluate the Safety, Pharmacokinetics (PK), and Efficacy of TAK-671 for the Treatment of Coronavirus Disease (COVID) 2019 in Adults",Not relevant,Not relevant,Not relevant,0,https://clinicaltrials.gov/show/NCT04464460,None
5358,NCT04464486,ClinicalTrials.gov,2020-06-26,2020-04-21,True,University of Utah,Recruiting,Not Applicable,Interventional,United States,Remote COVID-19 Symptom Tracking for Cancer Patients at Home During the Pandemic,Other (device),Biosensors,Biosensors,300,https://clinicaltrials.gov/show/NCT04464486,None
5359,NCT04465058,ClinicalTrials.gov,2020-07-08,2020-07-08,False,Assiut University,Recruiting,Not Applicable,Observational,Egypt,Characteristics of Critically Ill COVID 19 Patients,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04465058,None
5360,NCT04465474,ClinicalTrials.gov,2020-07-03,2020-05-01,True,Chinese University of Hong Kong,Recruiting,Not Applicable,Observational,"Hong Kong, China, Spain","Coronavirus Disease 2019 (COVID-19) During Pregnancy: Prevalence of Seroconversion, Effect on Maternal and Perinatal Outcomes and Risk of Vertical Transmission (COVID-MAP)",Clinical Presentation (Epidemiology),No Intervention,No Intervention,3000,https://clinicaltrials.gov/show/NCT04465474,None
5361,NCT04465513,ClinicalTrials.gov,2020-07-08,2020-08-31,False,Hofseth Biocare ASA,Not Recruiting,Not Applicable,Interventional,Canada,Investigation of Safety and Efficacy of CARDIO Softgels in Former Smokers and Asthma Patients With COVID-19 Infection,Supplement,Nutritional Supplement,Nutritional Supplement,100,https://clinicaltrials.gov/show/NCT04465513,None
5362,NCT04465552,ClinicalTrials.gov,2020-07-09,2020-07-10,False,Kansas City Heart Rhythm Research Foundation,Recruiting,Not Applicable,Observational,United States,Arrhythmic Manifestations and Management in Hospitalized COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,750,https://clinicaltrials.gov/show/NCT04465552,None
5363,NCT04465604,ClinicalTrials.gov,2020-07-02,2020-07-01,True,King Faisal Specialist Hospital & Research Center,Recruiting,Not Applicable,Interventional,Saudi Arabia,Hypertonic Saline for COVID-19 Symptoms,Other (device),Masks + Saline,Masks; Saline,50,https://clinicaltrials.gov/show/NCT04465604,None
5364,NCT04465656,ClinicalTrials.gov,2020-06-30,2020-07-07,False,"Hospital St. Joseph, Marseille",Recruiting,Not Applicable,Observational,France,Registry of the Evolution of Diagnosed and/or Hospitalized Patients for Pulmonary Embolism During the Covid-19 Pandemic,Clinical Presentation (Epidemiology),No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04465656,None
5365,NCT04465695,ClinicalTrials.gov,2020-07-09,2020-07-14,False,University of Hong Kong,Recruiting,Phase 2,Interventional,China,Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19,Drug,Interferon beta + Colfazimine vs. Colfazimine,Interferon beta; Colfazimine,81,https://clinicaltrials.gov/show/NCT04465695,None
5366,NCT04465981,ClinicalTrials.gov,2020-07-07,2020-07-01,True,INanoBio Inc.,Recruiting,Not Applicable,Observational,United States,Investigation of Antibody and Immune Responses to SARS-CoV-2 Proteins,Clinical Presentation,No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04465981,None
5367,NCT04466098,ClinicalTrials.gov,2020-07-08,2020-07-30,False,University of Minnesota,Recruiting,Phase 2,Interventional,United States,Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19),ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04466098,None
5368,NCT04466280,ClinicalTrials.gov,2020-07-09,2020-07-15,False,Baqiyatallah Medical Sciences University,Recruiting,Not Applicable,Interventional,Iran,"Efficacy and Safety of Mucoadhesive Sustained Release, Mucodentol, in Comparison With Hydroxychloroquine to Prevent COVID-19",Drug,Hydroxychloroquine vs. Dentol Gel,Hydroxychloroquine; Dentol Gel,180,https://clinicaltrials.gov/show/NCT04466280,None
5369,NCT04466306,ClinicalTrials.gov,2020-06-24,2020-04-15,True,Children's Healthcare of Atlanta,Recruiting,Not Applicable,Observational,"Japan, Israel, Canada, United Kingdom, United States, Serbia, Spain",Pediatric Acute Kidney Injury in COVID-19,Clinical Presentation,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04466306,None
5370,NCT04466371,ClinicalTrials.gov,2020-07-07,2020-10-15,False,Misr International University,Not Recruiting,Not Applicable,Observational,No Country Given,Perceptions of Undergraduate Students and Teaching Staff on Online Teaching,Other,No Intervention,No Intervention,9209,https://clinicaltrials.gov/show/NCT04466371,None
5371,NCT04466462,ClinicalTrials.gov,2020-07-08,2020-05-26,True,Fundació Lluita contra la SIDA,Not Recruiting,Not Applicable,Observational,Spain,Cross-sectional Study of COVID-19 Infection in Hospital Health Personnel,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04466462,None
5372,NCT04466540,ClinicalTrials.gov,2020-07-03,2020-05-12,True,Hospital Alemo Oswaldo Cruz,Recruiting,Phase 4,Interventional,Brazil,Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19),Drug,Hydroxychloroquine,Hydroxychloroquine,1300,https://clinicaltrials.gov/show/NCT04466540,None
5373,NCT04466605,ClinicalTrials.gov,2020-07-09,2020-03-30,True,Aarogyam UK,Not Recruiting,Not Applicable,Interventional,India,Effect of Tele-Yoga Therapy on Patients With Chronic Musculoskeletal Pain During Covid-19 Lockdown,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,64,https://clinicaltrials.gov/show/NCT04466605,None
5374,NCT04466644,ClinicalTrials.gov,2020-07-09,2020-06-08,True,Igenomix,Not Recruiting,Not Applicable,Observational,United States,COVID-19: A Prevalence Study of Two ART Centres After the Pandemic Lockdown in the USA (COVID-19 Free Clinics),Clinical Presentation (Epidemiology),No Intervention,No Intervention,340,https://clinicaltrials.gov/show/NCT04466644,None
5375,NCT04466657,ClinicalTrials.gov,2020-07-09,2020-11-01,False,Obafemi Awolowo University,Not Recruiting,Not Applicable,Interventional,Nigeria,Antioxidant Therapy for COVID-19 Study,Supplement,Nutritional Supplement,Nutritional Supplement,90,https://clinicaltrials.gov/show/NCT04466657,None
5376,NCT04466670,ClinicalTrials.gov,2020-07-08,2020-07-08,False,University of São Paulo General Hospital,Recruiting,Phase 3,Interventional,Brazil,Hemostasis in COVID-19: an Adaptive Clinical Trial,Drug,"Heparin, Aspirin, Enoxaparin",Heparin; Aspirin; Enoxaparin,310,https://clinicaltrials.gov/show/NCT04466670,None
5377,NCT04466683,ClinicalTrials.gov,2020-06-20,2020-08-28,False,Ohio State University Comprehensive Cancer Center,Recruiting,Phase 2,Interventional,United States,Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia,Other,Radiation,Radiation,100,https://clinicaltrials.gov/show/NCT04466683,None
5378,NCT04466800,ClinicalTrials.gov,2020-07-09,2020-07-30,False,Rennes University Hospital,Recruiting,Not Applicable,Interventional,France,Functional and Respiratory Rehabilitation and Nutritional Care of COVID-19 Patients (RECOVER-19),Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,160,https://clinicaltrials.gov/show/NCT04466800,None
5379,NCT04466839,ClinicalTrials.gov,2020-06-23,2020-07-02,False,"University Hospital, Toulouse",Recruiting,Not Applicable,Observational,France,Evaluation of the Containment Impact Linked to the Covid-19 Pandemic in a Population of Parkinson Patients,Other,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04466839,None
5380,NCT04467008,ClinicalTrials.gov,2020-07-09,2020-07-15,False,CHU Ambroise Paré,Not Recruiting,Not Applicable,Observational,France,Covid-19 Rapid Diagnostic Tests on Blood Drop,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,113,https://clinicaltrials.gov/show/NCT04467008,None
5381,NCT04467047,ClinicalTrials.gov,2020-07-07,2020-07-25,False,Hospital de Clinicas de Porto Alegre,Not Recruiting,Phase 1,Interventional,No Country Given,Safety and Feasibility of Allogenic MSC in the Treatment of COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),10,https://clinicaltrials.gov/show/NCT04467047,None
5382,NCT04467086,ClinicalTrials.gov,2020-06-30,2020-12-01,False,Ottawa Hospital Research Institute,Not Recruiting,Phase 3,Interventional,No Country Given,Propranolol as an Anxiolytic to Reduce the Use of Sedatives From Critically-ill Adults Receiving Mechanical Ventilation,Drug,Propranolol Hydrochloride,Propranolol Hydrochloride,108,https://clinicaltrials.gov/show/NCT04467086,None
5383,NCT04467112,ClinicalTrials.gov,2020-06-30,2020-07-30,False,Owlstone Ltd,Recruiting,Not Applicable,Observational,United Kingdom,Non Inferiority Trial for Detection of nCOVID-19 Through Analysis of Exhaled Breath Aerosols,Other (device),Masks,Masks,100,https://clinicaltrials.gov/show/NCT04467112,None
5384,NCT04467151,ClinicalTrials.gov,2020-07-09,2020-10-01,False,Kashif Khan,Not Recruiting,Phase 2,Interventional,United States,"Administration of Anti-SARS-CoV-2 Convalescent Plasma in Hospitalized, Non-ICU Patients With COVID-19",ATMP,Plasma,Plasma,0,https://clinicaltrials.gov/show/NCT04467151,None
5385,NCT04467840,ClinicalTrials.gov,2020-07-09,2020-08-21,False,RedHill Biopharma Limited,Recruiting,Phase 2/Phase 3,Interventional,"Mexico, Russian Federation, Israel, Brazil","Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia",Drug,Opaganib,Opaganib,270,https://clinicaltrials.gov/show/NCT04467840,None
5386,NCT04467918,ClinicalTrials.gov,2020-07-03,2020-07-06,False,University of São Paulo,Not Recruiting,Phase 2/Phase 3,Interventional,Brazil,CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms,Drug,Cannabidiol,Cannabidiol,100,https://clinicaltrials.gov/show/NCT04467918,None
5387,NCT04467931,ClinicalTrials.gov,2020-07-06,2020-01-19,True,University of Utah,Not Recruiting,Not Applicable,Observational,United States,ACEI or ARB and COVID-19 Severity and Mortality in US Veterans,Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,10000,https://clinicaltrials.gov/show/NCT04467931,None
5388,NCT04468009,ClinicalTrials.gov,2020-07-09,2020-06-25,True,Hospital de Infecciosas Francisco Javier Muñiz,Recruiting,Phase 2,Interventional,Argentina,Treatment of Critically Ill Patients With Covid-19 With Convalescent Plasma,ATMP,Plasma,Plasma,36,https://clinicaltrials.gov/show/NCT04468009,None
5389,NCT04468035,ClinicalTrials.gov,2020-07-10,2020-06-01,True,Groupe Hospitalier Paris Saint-Joseph,Recruiting,Not Applicable,Observational,France,Early Cognitive Assessment and Evolutionary Monitoring of Patients With Severe ARDS on COVID-19 Pneumonia Requiring Mechanical Ventilation,Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04468035,None
5390,NCT04468087,ClinicalTrials.gov,2020-07-03,2020-12-01,False,Hospital do Coração,Not Recruiting,Phase 2/Phase 3,Interventional,Brazil,Antiviral Agents Against COVID-19 Infection,Drug,Atazanavir vs. Daclatasvir vs. Sofusbuvir vs. Favipiravir,Atazanavir; Daclatasvir; Sofusbuvir; Favipiravir,1005,https://clinicaltrials.gov/show/NCT04468087,None
5391,NCT04468139,ClinicalTrials.gov,2020-07-05,2020-06-20,True,"Ministry of Health, Saudi Arabia",Recruiting,Phase 4,Interventional,Saudi Arabia,"The Study of Quadruple Therapy Zinc, Quercetin, Bromelain and Vitamin C on the Clinical Outcomes of Patients Infected With COVID-19",Drug,Quercetin + Bromelain + Zinc + Vitamin C,Quercetin; Bromelain; Zinc; Vitamin C,60,https://clinicaltrials.gov/show/NCT04468139,None
5392,NCT04468217,ClinicalTrials.gov,2020-07-09,2020-06-02,True,Neurognos,Recruiting,Not Applicable,Observational,Chile,Evaluation of an Alternative Method of Obtaining Viral RNA for the Detection of SARS-CoV-2 Virus Using PCR,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,150,https://clinicaltrials.gov/show/NCT04468217,None
5393,NCT04468256,ClinicalTrials.gov,2020-07-09,2020-07-26,False,Imperial College London,Recruiting,Not Applicable,Observational,United Kingdom,The Heart Hive COVID-19 Study,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04468256,None
5394,NCT04468308,ClinicalTrials.gov,2020-06-22,2020-09-08,False,Medical University Innsbruck,Recruiting,Not Applicable,Observational,Austria,VRQOL in Cataract Patients During the COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,116,https://clinicaltrials.gov/show/NCT04468308,None
5395,NCT04468386,ClinicalTrials.gov,2020-07-08,2020-07-07,True,Biomerica,Not Recruiting,Not Applicable,Observational,United States,Specimen Collection Study Protocol,Clinical Presentation (Epidemiology),No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04468386,None
5396,NCT04468412,ClinicalTrials.gov,2020-07-09,2020-07-14,False,Radboud University,Not Recruiting,Not Applicable,Observational,Netherlands,Influence of COVID-19 on Vascular Endothelial Function,Clinical Presentation,No Intervention,No Intervention,203,https://clinicaltrials.gov/show/NCT04468412,None
5397,NCT04468646,ClinicalTrials.gov,2020-07-07,2020-06-15,True,Dr. Fridoon Jawad Ahmad,Recruiting,Phase 3,Interventional,Pakistan,To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients,Drug,NK-1R antagonist,NK-1R antagonist,100,https://clinicaltrials.gov/show/NCT04468646,None
5398,NCT04468802,ClinicalTrials.gov,2020-07-09,2020-02-01,True,Kanuni Sultan Suleyman Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,Do Childhood Measles and DTaP Vaccination Decrease the Mortality Rate Caused by COVID-19 in OECD Countries?,ATMP,Vaccine,Vaccine,32,https://clinicaltrials.gov/show/NCT04468802,None
5399,NCT04468893,ClinicalTrials.gov,2020-07-10,2020-05-20,True,Universidad Internacional de Valencia,Recruiting,Not Applicable,Interventional,Mexico,Online Positive Psychology Intervention for Depression and Anxiety Due to COVID-19,Other (psych),Psychological,Psychological,128,https://clinicaltrials.gov/show/NCT04468893,None
5400,NCT04468958,ClinicalTrials.gov,2020-07-08,2020-08-05,False,"SAb Biotherapeutics, Inc.",Recruiting,Phase 1,Interventional,United States,"Safety, Tolerability, and Pharmacokinetics of SAB-185 in Healthy Participants",Drug,SAB-185,SAB-185,28,https://clinicaltrials.gov/show/NCT04468958,None
5401,NCT04468971,ClinicalTrials.gov,2020-07-10,2020-09-29,False,"Cellenkos, Inc.",Recruiting,Phase 1,Interventional,United States,REgulatory T Cell infuSion fOr Lung Injury Due to COVID-19 PnEumonia,Drug,CK0802,CK0802,45,https://clinicaltrials.gov/show/NCT04468971,None
5402,NCT04469114,ClinicalTrials.gov,2020-07-10,2020-09-16,False,Hospital Israelita Albert Einstein,Recruiting,Phase 2,Interventional,Brazil,Tofacitinib in Hospitalized Patients With COVID-19 Pneumonia,Drug,Tofacitinib,Tofacitinib,260,https://clinicaltrials.gov/show/NCT04469114,None
5403,NCT04469153,ClinicalTrials.gov,2020-06-29,2020-06-29,False,Hospices Civils de Lyon,Recruiting,Not Applicable,Observational,France,Interest of the Dosage of Ferritin / Glycosylated Ferritin in COVID-19,Clinical Presentation,No Intervention,No Intervention,57,https://clinicaltrials.gov/show/NCT04469153,None
5404,NCT04469179,ClinicalTrials.gov,2020-07-08,2020-08-20,False,"SAb Biotherapeutics, Inc.",Recruiting,Phase 1,Interventional,United States,"Safety, Tolerability, and Pharmacokinetics of SAB-185 in Ambulatory Participants With COVID-19",Drug,SAB-185,SAB-185,21,https://clinicaltrials.gov/show/NCT04469179,None
5405,NCT04469621,ClinicalTrials.gov,2020-06-28,2020-07-17,False,Sanofi,Not Recruiting,Phase 1,Interventional,"Chile, Russian Federation, Argentina, Mexico, Brazil",A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19,Drug,SAR443122,SAR443122,68,https://clinicaltrials.gov/show/NCT04469621,None
5406,NCT04469634,ClinicalTrials.gov,2020-07-13,2020-07-31,False,Institute of Tropical Medicine,Not Recruiting,Not Applicable,Interventional,Belgium,Are SARS-CoV-2 Specific Antibodies a Correlate for Protection?,Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04469634,None
5407,NCT04469647,ClinicalTrials.gov,2020-07-13,2020-07-19,False,Johns Hopkins Aramco Healthcare,Recruiting,Not Applicable,Observational,Saudi Arabia,COVID 19 Seroprevalence Amongst Healthcare Workers in JHAH,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1200,https://clinicaltrials.gov/show/NCT04469647,None
5408,NCT04469660,ClinicalTrials.gov,2020-07-13,2020-05-18,True,Max Healthcare Insititute Limited,Recruiting,Not Applicable,Observational,India,Impact of COVID-19 Pandemic on the Psychological Wellbeing of Healthcare Professionals in India,Other (psych),No Intervention,No Intervention,1300,https://clinicaltrials.gov/show/NCT04469660,None
5409,NCT04470258,ClinicalTrials.gov,2020-06-10,2020-08-02,False,Escola de Saúde Pública do Ceará,Recruiting,Not Applicable,Interventional,Brazil,Elmo Respiratory Support Project - COVID-19,Other,Respiratory support,Respiratory support,10,https://clinicaltrials.gov/show/NCT04470258,None
5410,NCT04470297,ClinicalTrials.gov,2020-07-12,2020-09-01,False,Associação Fundo de Incentivo à Pesquisa,Not Recruiting,Phase 2,Interventional,No Country Given,Melatonin Agonist on Hospitalized Patients With Confirmed or Suspected COVID-19,Drug,Ramelteon,Ramelteon,100,https://clinicaltrials.gov/show/NCT04470297,None
5411,NCT04470323,ClinicalTrials.gov,2020-07-12,2020-07-22,False,Assiut University,Recruiting,Not Applicable,Observational,Egypt,Functional Exhaustion of T Cells in COVID19 Patients,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04470323,None
5412,NCT04470414,ClinicalTrials.gov,2020-07-12,2020-08-01,False,Assiut University,Not Recruiting,Not Applicable,Observational,Egypt,COVID-19 IgG Antibodies in the Serum of Recovered Patients,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04470414,None
5413,NCT04470427,ClinicalTrials.gov,2020-07-11,2020-07-27,False,"ModernaTX, Inc.",Not Recruiting,Phase 3,Interventional,United States,"A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19",ATMP,Vaccine,Vaccine,30000,https://clinicaltrials.gov/show/NCT04470427,None
5414,NCT04470531,ClinicalTrials.gov,2020-07-11,2020-07-12,False,Bangabandhu Sheikh Mujib Medical University,Recruiting,Phase 2,Interventional,Bangladesh,Role of Co-trimoxazole in Severe COVID-19 Patients,Drug,Co-trimoxazole,Co-trimoxazole,94,https://clinicaltrials.gov/show/NCT04470531,None
5415,NCT04470544,ClinicalTrials.gov,2020-07-09,2020-07-28,False,Alan Bryce,Recruiting,Phase 2,Interventional,United States,Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19,Drug,Camostat Mesilate,Camostat Mesilate,264,https://clinicaltrials.gov/show/NCT04470544,None
5416,NCT04470557,ClinicalTrials.gov,2020-07-11,2020-07-15,False,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,Relation Between Lab Finding and COVID-19 Severity,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04470557,None
5417,NCT04470583,ClinicalTrials.gov,2020-07-13,2020-10-09,False,Chelsea and Westminster Hospital NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,Evaluating Clinical Parameters of COVID-19 in Pregnancy,Clinical Presentation,No Intervention,No Intervention,116,https://clinicaltrials.gov/show/NCT04470583,None
5418,NCT04470609,ClinicalTrials.gov,2020-07-13,2020-07-10,True,Chinese Academy of Medical Sciences,Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 in People Aged ?60 Years,ATMP,Vaccine,Vaccine,471,https://clinicaltrials.gov/show/NCT04470609,None
5419,NCT04470622,ClinicalTrials.gov,2020-07-13,2020-07-20,False,Heron Therapeutics,Recruiting,Phase 2,Interventional,"United States, Puerto Rico",Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1),Drug,Aprepitan,Aprepitan,100,https://clinicaltrials.gov/show/NCT04470622,None
5420,NCT04470648,ClinicalTrials.gov,2020-07-12,2020-07-01,True,INSERM,Not Recruiting,Not Applicable,Observational,France,COVID-19 Infection at Samusocial in Paris: Descriptive and Serological Survey,Clinical Presentation (Epidemiology),No Intervention,No Intervention,220,https://clinicaltrials.gov/show/NCT04470648,None
5421,NCT04470739,ClinicalTrials.gov,2020-07-12,2020-05-30,True,Kanuni Sultan Suleyman Training and Research Hospital,Recruiting,Not Applicable,Interventional,Turkey,Is Thymus Size of Infants Who Born to COVID-19 Positive Mothers Associated With Neonatal Morbidities?,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04470739,None
5422,NCT04470999,ClinicalTrials.gov,2020-07-09,2020-04-15,True,Dr. Serhat Gumrukcu,Recruiting,Not Applicable,Interventional,United States,Changes in Cellular Immune Profile During COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,25,https://clinicaltrials.gov/show/NCT04470999,None
5423,NCT04471051,ClinicalTrials.gov,2020-07-13,2020-04-30,True,"University of Colorado, Denver",Recruiting,Not Applicable,Observational,United States,An Observational Cohort Trial of Outcomes and Antibody Responses Following Treatment With COVID19 Convalescent Plasma in Hospitalized COVID-19 Patients,ATMP,Plasma,Plasma,150,https://clinicaltrials.gov/show/NCT04471051,None
5424,NCT04471519,ClinicalTrials.gov,2020-07-11,2020-07-13,False,Bharat Biotech International Limited,Not Recruiting,Phase 1/Phase 2,Interventional,India,Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers,ATMP,Vaccine,Vaccine,755,https://clinicaltrials.gov/show/NCT04471519,None
5425,NCT04471636,ClinicalTrials.gov,2020-07-09,2020-09-18,False,Ludwig Maximilian University of Munich,Recruiting,Not Applicable,Interventional,Germany,Telemedicine in Outpatient Covid-19 Patients,Telehealth,Telehealth,Telehealth,600,https://clinicaltrials.gov/show/NCT04471636,None
5426,NCT04471649,ClinicalTrials.gov,2020-07-07,2020-06-15,True,Tanta University,Recruiting,Not Applicable,Observational,Egypt,Hydroxy Chloroquine and Covid in RA Patients,Drug,Hydroxychloroquine,Hydroxychloroquine,80,https://clinicaltrials.gov/show/NCT04471649,None
5427,NCT04471701,ClinicalTrials.gov,2020-07-14,2020-04-13,True,"Institute of Biomedical Technologies-National Research Council, Italy",Recruiting,Not Applicable,Observational,Italy,Italian Web-based Cross-sectional Survey on COVID-19,Clinical Presentation,No Intervention,No Intervention,200000,https://clinicaltrials.gov/show/NCT04471701,None
5428,NCT04471766,ClinicalTrials.gov,2020-07-14,2020-07-20,False,Bandim Health Project,Recruiting,Not Applicable,Interventional,Guinea-Bissau,Locally Produced Cloth Face Mask and COVID-19 Like Illness Prevention,Other (device),Masks,Masks,66000,https://clinicaltrials.gov/show/NCT04471766,None
5429,NCT04471831,ClinicalTrials.gov,2020-07-07,2020-07-13,False,"University of Lagos, Nigeria",Not Recruiting,Not Applicable,Interventional,No Country Given,"Physiotherapy as a Complimentary Treatment in Reducing Viral-Load, Complications, Death, Expedite Discharge and Improve Quality of Life, Exercise Endurance and Capacity in Stroke Survivors With CoViD-19: A Clinical-Controlled Study",Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,30,https://clinicaltrials.gov/show/NCT04471831,None
5430,NCT04472013,ClinicalTrials.gov,2020-07-14,2020-08-12,False,"University Hospital, Basel",Recruiting,Not Applicable,Observational,Switzerland,"Systematic Assessment of SARS-CoV-2 Neurotropic Capacity in Modestly and Critically Ill Patients, and Patients Who Died From COVID-19",Clinical Presentation (Epidemiology),No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04472013,None
5431,NCT04472052,ClinicalTrials.gov,2020-07-10,2020-03-16,True,"University Hospital, Tübingen",Not Recruiting,Not Applicable,Observational,Germany,Frequency of Perforated Appendicitis in Times of COVID-19,Other,No Intervention,No Intervention,143,https://clinicaltrials.gov/show/NCT04472052,None
5432,NCT04472078,ClinicalTrials.gov,2020-07-12,2020-06-10,True,Hospital Italiano de Buenos Aires,Not Recruiting,Not Applicable,Observational,Argentina,"Seroprevalence of Coronavirus Disease 2019 (COVID-19) Antibodies in a Vulnerable Neighbourhood, Buenos Aries Argentina",Clinical Presentation (Epidemiology),No Intervention,No Intervention,873,https://clinicaltrials.gov/show/NCT04472078,None
5433,NCT04472494,ClinicalTrials.gov,2020-07-14,2020-08-24,False,Bristol-Myers Squibb,Recruiting,Phase 2,Interventional,"United States, Puerto Rico",Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise,Drug,Abatacept,Abatacept,129,https://clinicaltrials.gov/show/NCT04472494,None
5434,NCT04472559,ClinicalTrials.gov,2020-07-13,2020-12-25,False,"University of California, Los Angeles",Not Recruiting,Not Applicable,Interventional,No Country Given,Acupressure for COVID-19 Related Quality of Life and Stress,Other,Other,Other,200,https://clinicaltrials.gov/show/NCT04472559,None
5435,NCT04472572,ClinicalTrials.gov,2020-07-14,2020-12-25,False,Hackensack Meridian Health,Not Recruiting,Not Applicable,Expanded Access,United States,Expanded Access to Convalescent Plasma for Treatment of COVID-19,ATMP,Plasma,Plasma,Not Available,https://clinicaltrials.gov/show/NCT04472572,None
5436,NCT04472585,ClinicalTrials.gov,2020-07-14,2020-07-14,False,Sohaib Ashraf,Recruiting,Phase 1/Phase 2,Interventional,Pakistan,Efficacy of Subcutaneous Ivermectin With or Without Zinc and Nigella Sativa in COVID-19 Patients,Drug,Ivermectin vs. Ivermectin + Zinc vs. Ivermectin + Nigella Sativa,Zinc; Ivermectin; Nigella Sativa,40,https://clinicaltrials.gov/show/NCT04472585,None
5437,NCT04472611,ClinicalTrials.gov,2020-07-14,2020-08-01,False,Yale University,Not Recruiting,Phase 3,Interventional,United States,Colchicine/Statins for the Prevention of COVID-19 Complications (COLSTAT) Trial,Drug,Colchicine + Rosuvastatin,Colchicine; Rosuvastatin,466,https://clinicaltrials.gov/show/NCT04472611,None
5438,NCT04472793,ClinicalTrials.gov,2020-06-03,2020-05-11,True,"Children's Hospital Medical Center, Cincinnati",Recruiting,Not Applicable,Observational,United States,Repeated Employee Testing for Understanding Our Recovery to Normal,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04472793,None
5439,NCT04473053,ClinicalTrials.gov,2020-07-09,2020-07-03,True,University of Edinburgh,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,Rapid Experimental Medicine for COVID-19,Drug,Nafamostat Mesilate vs. TD139,Nafamostat Mesilate; TD139,60,https://clinicaltrials.gov/show/NCT04473053,EUCTR2020-002230-32; ISRCTN14212905
5440,NCT04473105,ClinicalTrials.gov,2020-05-20,2020-05-01,True,Nottingham University Hospitals NHS Trust,Recruiting,Not Applicable,Observational,United Kingdom,Optimising Resource Allocation Via Prediction of Outcomes for Covid-19,Prognosis,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04473105,None
5441,NCT04473118,ClinicalTrials.gov,2020-07-15,2020-07-11,True,Hamad Medical Corporation,Recruiting,Not Applicable,Observational,Qatar,Assessment of Mental Health in Healthcare Workers Exposed to COVID-19 Patients,Clinical Presentation (Epidemiology),No Intervention,No Intervention,25000,https://clinicaltrials.gov/show/NCT04473118,None
5442,NCT04473131,ClinicalTrials.gov,2020-07-15,2020-04-27,True,Hamad Medical Corporation,Recruiting,Not Applicable,Observational,Qatar,Immune Profiling of COVID19-patients Admitted to ICU,Clinical Presentation (Epidemiology),No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04473131,None
5443,NCT04473157,ClinicalTrials.gov,2020-07-15,2020-07-01,True,Ain Shams University,Recruiting,Not Applicable,Observational,Egypt,COVID-19 in Patients With Anosmia in Egypt,Clinical Presentation (Epidemiology),No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04473157,None
5444,NCT04473170,ClinicalTrials.gov,2020-07-14,2020-04-04,True,Abu Dhabi Stem Cells Center,Not Recruiting,Phase 1/Phase 2,Interventional,United Arab Emirates,Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19,ATMP,Cells (Non-Hematopoietic Peripheral),Cells (Non-Hematopoietic Peripheral),146,https://clinicaltrials.gov/show/NCT04473170,None
5445,NCT04473183,ClinicalTrials.gov,2020-07-14,2020-07-21,False,University of Minnesota,Recruiting,Not Applicable,Observational,United States,Epidemiologic Assessment of SARS-CoV-2 (COVID-19) Prevalence in Minnesota,Clinical Presentation (Epidemiology),No Intervention,No Intervention,3000,https://clinicaltrials.gov/show/NCT04473183,None
5446,NCT04473248,ClinicalTrials.gov,2020-07-14,2020-06-28,True,Spartan Bioscience Inc.,Not Recruiting,Not Applicable,Interventional,Canada,Spartan COVID-19 System: Evaluation of Clinical Sample Collection,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,27,https://clinicaltrials.gov/show/NCT04473248,None
5447,NCT04473261,ClinicalTrials.gov,2020-07-14,2020-07-14,False,Sohaib Ashraf,Recruiting,Phase 1/Phase 2,Interventional,Pakistan,Efficacy of Iodine Complex Against COVID-19 Patients,Drug,Iodine Complex,Iodine Complex,30,https://clinicaltrials.gov/show/NCT04473261,None
5448,NCT04473352,ClinicalTrials.gov,2020-06-18,2020-09-01,False,Federal University of Ceara,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 Detection Tests in Different Body Fluids,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,80,https://clinicaltrials.gov/show/NCT04473352,None
5449,NCT04473365,ClinicalTrials.gov,2020-07-11,2020-07-20,False,Mekelle University,Recruiting,Not Applicable,Observational,Ethiopia,Rapid Diagnostic Profiling of SARS-CoV-2 (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,186,https://clinicaltrials.gov/show/NCT04473365,None
5450,NCT04473547,ClinicalTrials.gov,2020-07-14,2020-07-15,False,Mansoura University,Recruiting,Not Applicable,Observational,Egypt,COVID 19 Preventive Measures Among Mansoura Nursing Students,Other,No Intervention,No Intervention,215,https://clinicaltrials.gov/show/NCT04473547,None
5451,NCT04473599,ClinicalTrials.gov,2020-07-13,2020-04-17,True,"University of California, Berkeley",Recruiting,Not Applicable,Interventional,United States,Stay Well at Home: a Text-messaging Study Social Distancing,Other,Health Education,Health Education,200,https://clinicaltrials.gov/show/NCT04473599,None
5452,NCT04473898,ClinicalTrials.gov,2020-07-14,2020-06-19,True,KTO Karatay University,Recruiting,Not Applicable,Interventional,Turkey,Telerehabilitation After Coronavirus,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,36,https://clinicaltrials.gov/show/NCT04473898,None
5453,NCT04474067,ClinicalTrials.gov,2020-07-15,2020-06-28,True,Hadassah Medical Organization,Recruiting,Not Applicable,Observational,Israel,COVID-19 - Cytokine Storm,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04474067,None
5454,NCT04474080,ClinicalTrials.gov,2020-07-08,2021-01-15,False,St. Joseph's Healthcare Hamilton,Not Recruiting,Not Applicable,Interventional,Canada,Reducing Burnout Among Frontline Healthcare Workers During COVID-19,Other (psych),Psychological,Psychological,1080,https://clinicaltrials.gov/show/NCT04474080,None
5455,NCT04474236,ClinicalTrials.gov,2020-07-07,2020-05-27,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Observational,France,Lung Ultrasound for COVID-19 Initial Triage and Monitoring,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,148,https://clinicaltrials.gov/show/NCT04474236,None
5456,NCT04474249,ClinicalTrials.gov,2020-06-29,2020-06-25,True,Uppsala University,Recruiting,Not Applicable,Observational,Sweden,Follow-up of Critical COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04474249,None
5457,NCT04474288,ClinicalTrials.gov,2020-07-15,2020-07-16,False,Bassett Healthcare,Recruiting,Not Applicable,Observational,United States,The COVID-19 PUI Reality Check (CPRC) Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,400,https://clinicaltrials.gov/show/NCT04474288,None
5458,NCT04474301,ClinicalTrials.gov,2020-07-14,2020-06-11,True,M.D. Anderson Cancer Center,Recruiting,Not Applicable,Observational,United States,Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,1152,https://clinicaltrials.gov/show/NCT04474301,None
5459,NCT04474340,ClinicalTrials.gov,2020-07-15,2020-05-21,True,"Ministry of Health, Kuwait",Recruiting,Phase 1,Interventional,Kuwait,COVID-19 Convalescent Plasma Treatment in SARS-CoV-2 Infected Patients,ATMP,Plasma,Plasma,300,https://clinicaltrials.gov/show/NCT04474340,None
5460,NCT04474444,ClinicalTrials.gov,2020-07-12,2019-03-23,True,University of Lincoln,Recruiting,Not Applicable,Observational,United Kingdom,Ambulance Calls for Substance Use and Alcohol in a Pandemic (ASAP),Health System,No Intervention,No Intervention,55000,https://clinicaltrials.gov/show/NCT04474444,None
5461,NCT04474457,ClinicalTrials.gov,2020-07-15,2020-06-11,True,"Ministry of Health, Turkey",Recruiting,Not Applicable,Observational,Turkey,Efficacy and Safety of Favipiravir in the Treatment of COVID-19 Patients Over 15 Years of Age,Drug,Favipiravir,Favipiravir,1000,https://clinicaltrials.gov/show/NCT04474457,None
5462,NCT04474483,ClinicalTrials.gov,2020-05-15,2020-11-06,False,State University of New York at Buffalo,Recruiting,Phase 2,Interventional,United States,Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19,Drug,Melatonin,Melatonin,30,https://clinicaltrials.gov/show/NCT04474483,None
5463,NCT04474496,ClinicalTrials.gov,2020-07-10,2020-07-27,False,University of Arkansas,Recruiting,Not Applicable,Observational,United States,Impact of COVID-19 on Marshallese Communities in the U.S.,Other,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04474496,None
5464,NCT04475068,ClinicalTrials.gov,2020-07-14,2020-07-17,False,Hospital Nacional Edgardo Rebagliati Martins,Recruiting,Not Applicable,Observational,Peru,Postural Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Infection,Procedure,Positioning,Positioning,12,https://clinicaltrials.gov/show/NCT04475068,None
5465,NCT04475081,ClinicalTrials.gov,2020-07-14,2020-08-17,False,Louisiana State University Health Sciences Center in New Orleans,Not Recruiting,Phase 3,Interventional,No Country Given,Use of a Live Attenuated Vaccine as an Immune-based Preventive Against COVID-19-associated Sepsis,ATMP,Vaccine,Vaccine,60,https://clinicaltrials.gov/show/NCT04475081,None
5466,NCT04475107,ClinicalTrials.gov,2020-07-14,2020-07-09,True,Shin Poong Pharmaceutical Co. Ltd.,Recruiting,Phase 2,Interventional,South Korea,The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients,Drug,Pyronaridine-Artesunate,Pyronaridine-Artesunate,76,https://clinicaltrials.gov/show/NCT04475107,None
5467,NCT04475120,ClinicalTrials.gov,2020-07-16,2020-04-15,True,University of Rome Tor Vergata,Not Recruiting,Phase 2/Phase 3,Interventional,Italy,Efficacy and Safety of Liposomal Lactoferrin in COVID-19 Patients With Mild-to-Moderate Disease and in COVID-19 Asymptomatic Patients,Drug,Liposomal lactoferrin,Liposomal lactoferrin,60,https://clinicaltrials.gov/show/NCT04475120,None
5468,NCT04475185,ClinicalTrials.gov,2020-07-15,2020-07-20,False,Nantes University Hospital,Recruiting,Not Applicable,Interventional,France,Safety and Effectiveness Assessment of the MakAir Artificial Ventilator,Other (physical),Mechanical ventilation,Mechanical ventilation,117,https://clinicaltrials.gov/show/NCT04475185,None
5469,NCT04475211,ClinicalTrials.gov,2020-07-10,2020-08-10,False,"University Hospital, Lille",Recruiting,Not Applicable,Observational,France,LILLE COVID RESEARCH NETWORK (Covid-19),Prognosis,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04475211,None
5470,NCT04475302,ClinicalTrials.gov,2020-07-16,2020-07-01,True,"Tuberculosis Research Centre, India",Recruiting,Phase 3,Interventional,India,BCG Vaccine in Reducing Morbidity and Mortality in Elderly Individuals in COVID-19 Hotspots,ATMP,Vaccine,Vaccine,2175,https://clinicaltrials.gov/show/NCT04475302,None
5471,NCT04475471,ClinicalTrials.gov,2020-07-01,2020-06-11,True,Public Health Foundation of India,Recruiting,Not Applicable,Observational,"Ghana, Bosnia and Herzegovina, India, Iran, Argentina, Sudan",WORLD HEART FEDERATION (WHF) COVID-19 and Cardiovascular Disease Survey,Clinical Presentation,No Intervention,No Intervention,5200,https://clinicaltrials.gov/show/NCT04475471,None
5472,NCT04475484,ClinicalTrials.gov,2020-07-06,2020-06-10,True,Hospices Civils de Lyon,Recruiting,Not Applicable,Observational,France,Online Survey on Psychological Impact of COVID-19 Epidemic on School-age Children,Other (psych),No Intervention,No Intervention,30000,https://clinicaltrials.gov/show/NCT04475484,None
5473,NCT04475562,ClinicalTrials.gov,2020-07-15,2020-04-06,True,Academic Hospital Maastricht,Not Recruiting,Not Applicable,Interventional,Netherlands,Can the Electronic Nose Smell COVID-19?,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,219,https://clinicaltrials.gov/show/NCT04475562,None
5474,NCT04475575,ClinicalTrials.gov,2020-07-15,2020-04-06,True,Academic Hospital Maastricht,Not Recruiting,Not Applicable,Interventional,Netherlands,Can the Electronic Nose Smell COVID-19 Antibodies?,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,222,https://clinicaltrials.gov/show/NCT04475575,None
5475,NCT04475588,ClinicalTrials.gov,2020-07-16,2020-05-01,True,Biocon Limited,Not Recruiting,Phase 2,Interventional,India,Efficacy and Safety of Itolizumab in COVID-19 Complications,Drug,Itolizumab vs. Hydroxychloroquine,Itolizumab; Hydroxychloroquine,30,https://clinicaltrials.gov/show/NCT04475588,None
5476,NCT04475601,ClinicalTrials.gov,2020-06-08,2020-07-15,False,Andreas Josefsson,Recruiting,Phase 2,Interventional,Sweden,Enzalutamide Treatment in COVID-19,Drug,Enzalutamide,Enzalutamide,500,https://clinicaltrials.gov/show/NCT04475601,None
5477,NCT04475913,ClinicalTrials.gov,2020-07-14,2018-07-11,True,October University for Modern Sciences and Arts,Not Recruiting,Not Applicable,Interventional,Egypt,Digital vs Analog Impression in Cases of All-on-4 - Prosthesis,Other,Other,Other,56,https://clinicaltrials.gov/show/NCT04475913,None
5478,NCT04475991,ClinicalTrials.gov,2020-07-15,2020-11-01,False,Hospital General de México Dr. Eduardo Liceaga,Not Recruiting,Phase 2,Interventional,Mexico,Safety and Efficacy of Maraviroc and/or Favipiravir With Standard Therapy in Severe COVID-19 Adults,Drug,"Maraviroc vs. Favipiravir vs. Maraviroc + Favipiravir (w/ or w/o Enoxaparin, hydroxychloroquine, chloroquine, azithormycin)",Maraviroc; Favipiravir; Enoxaparin; hydroxychloroquine; chloroquine; azithormycin,100,https://clinicaltrials.gov/show/NCT04475991,None
5479,NCT04476589,ClinicalTrials.gov,2020-07-16,2020-07-01,True,Massachusetts General Hospital,Recruiting,Not Applicable,Observational,United States,Prognostication of Recovery in Early Disorders of Consciousness After COVID-19,Prognosis,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04476589,None
5480,NCT04476602,ClinicalTrials.gov,2020-07-16,2020-04-27,True,Northwell Health,Recruiting,Not Applicable,Observational,United States,Ambulatory Management of Moderate to High Risk COVID-19 (SARS-CoV-2) Patients - The Coronavirus Related Outpatient Work Navigators (CROWN) Protocol,Health System,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04476602,None
5481,NCT04476667,ClinicalTrials.gov,2020-07-13,2020-06-15,True,Queen's University,Recruiting,Not Applicable,Interventional,Canada,"Online Delivery of Psychotherapy, Tailored to Patients' Suffering From Mental Health Problems Due to COVID-19",Other (psych),Psychological,Psychological,80,https://clinicaltrials.gov/show/NCT04476667,None
5482,NCT04476680,ClinicalTrials.gov,2020-07-16,2020-09-01,False,Royal Centre for Defence Medicine,Not Recruiting,Not Applicable,Interventional,United Kingdom,Reducing Asymptomatic Infection With Vitamin D in Coronavirus Disease,Drug,Vitamin D,Vitamin D,4400,https://clinicaltrials.gov/show/NCT04476680,None
5483,NCT04476706,ClinicalTrials.gov,2020-07-16,2018-10-01,True,Novartis Pharmaceuticals,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Canakinumab MAP in COVID-19 Pneumonia With CRS,Drug,Canakinumab,Canakinumab,Not Available,https://clinicaltrials.gov/show/NCT04476706,None
5484,NCT04476823,ClinicalTrials.gov,2020-07-16,2020-03-15,True,CHU de Nice,Not Recruiting,Not Applicable,Observational,France,European Pathology Laboratories and COVID-19,Health System,No Intervention,No Intervention,71,https://clinicaltrials.gov/show/NCT04476823,None
5485,NCT04476888,ClinicalTrials.gov,2020-07-16,2020-04-26,True,Aga Khan University,Recruiting,Not Applicable,Interventional,Pakistan,Convalescent Plasma Treatment in COVID-19,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04476888,None
5486,NCT04476914,ClinicalTrials.gov,2020-07-09,2020-06-29,True,"University of Colorado, Denver",Recruiting,Not Applicable,Observational,United States,Stress Related Disorders in Family Members of COVID-19 Patients Admitted to the ICU,Other (psych),No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04476914,None
5487,NCT04476927,ClinicalTrials.gov,2020-06-16,2020-08-01,False,Nanose Medical Ltd.,Not Recruiting,Not Applicable,Interventional,No Country Given,Detection of COVID-19 Subjects Using DiaNose Exhalation Test,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,300,https://clinicaltrials.gov/show/NCT04476927,None
5488,NCT04476940,ClinicalTrials.gov,2020-07-13,2020-09-01,False,Meharry Medical College,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Breastfeeding Guideline for African-Americans,Other,Health Education,Health Education,200,https://clinicaltrials.gov/show/NCT04476940,None
5489,NCT04476953,ClinicalTrials.gov,2020-07-15,2020-08-03,False,Mayo Clinic,Recruiting,Phase 2,Interventional,United States,COVID-FISETIN: Pilot in Covid-19 of Fisetin to Alleviate Dysfunction and Inflammation,Drug,Fisetin,Fisetin,70,https://clinicaltrials.gov/show/NCT04476953,None
5490,NCT04476979,ClinicalTrials.gov,2020-07-16,2020-07-16,True,Assistance Publique – Hôpitaux de Paris,Recruiting,Phase 2,Interventional,French Guiana,Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19,Drug,Tocilizumab + Dexamethasone vs. Dexamethasone,Tocilizumab; Dexamethasone,120,https://clinicaltrials.gov/show/NCT04476979,EUCTR2020-001246-18
5491,NCT04476992,ClinicalTrials.gov,2020-07-16,2020-07-24,False,"Federal State Budgetary Scientific Institution, Research Institute of Cardiology",Not Recruiting,Phase 1/Phase 2,Interventional,Russian Federation,Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement,Drug,Nitric Oxide,Nitric Oxide,20,https://clinicaltrials.gov/show/NCT04476992,None
5492,NCT04477083,ClinicalTrials.gov,2020-07-14,2020-07-15,False,Mansoura University,Not Recruiting,Not Applicable,Interventional,Egypt,"Development and Validation of ""Ready-to-Use"" Inhalable Forms of Hydroxychloroquine for Treatment of COVID-19",Drug,Hydroxychloroquine,Hydroxychloroquine,40,https://clinicaltrials.gov/show/NCT04477083,None
5493,NCT04477473,ClinicalTrials.gov,2020-07-17,2020-06-30,True,"University Hospital, Geneva",Recruiting,Not Applicable,Observational,Switzerland,Perceived Impact of the COVID-19 Pandemic on Medical Management and Symptoms in a High Risk Group,Other,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04477473,None
5494,NCT04477642,ClinicalTrials.gov,2020-04-22,2020-08-01,False,Beth Israel Deaconess Medical Center,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Abatacept for Patients With COVID-19 and Respiratory Distress,Drug,Abatacept,Abatacept,0,https://clinicaltrials.gov/show/NCT04477642,None
5495,NCT04477655,ClinicalTrials.gov,2020-07-15,2020-05-03,True,Hospital Civil de Guadalajara,Recruiting,Not Applicable,Interventional,Mexico,Prone Positioning in Non-intubated Patients With COVID-19 Associated Acute Respiratory Failure,Procedure,Positioning,Positioning,200,https://clinicaltrials.gov/show/NCT04477655,None
5496,NCT04477668,ClinicalTrials.gov,2020-07-09,2020-10-01,False,King Abdullah International Medical Research Center,Not Recruiting,Not Applicable,Interventional,Saudi Arabia,Helmet Non-Invasive Ventilation for COVID-19 Patients,Other (physical),Mechanical ventilation,Mechanical ventilation,320,https://clinicaltrials.gov/show/NCT04477668,None
5497,NCT04477889,ClinicalTrials.gov,2020-07-17,2020-06-20,True,Methodist Health System,Recruiting,Not Applicable,Observational,United States,Methodist Health System COVID-19 Patient Registry,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04477889,None
5498,NCT04477902,ClinicalTrials.gov,2020-07-16,2020-07-01,True,Altura,Recruiting,Not Applicable,Observational,United States,Long-Term Experience and Health Effects of COVID-19,Clinical Presentation,No Intervention,No Intervention,50000,https://clinicaltrials.gov/show/NCT04477902,None
5499,NCT04477954,ClinicalTrials.gov,2020-07-16,2020-07-06,True,La Asociación Argentina de Medicina Hiperbárica e Investigación (AAMHEI),Recruiting,Phase 2,Interventional,Argentina,Hyperbaric Oxygen as an Adjuvant Treatment for Patients With Covid-19 Severe Hypoxemia,Drug,Oxygen,Oxygen,80,https://clinicaltrials.gov/show/NCT04477954,None
5500,NCT04477993,ClinicalTrials.gov,2020-07-13,2020-07-17,False,Vanderson Geraldo Rocha,Recruiting,Phase 2/Phase 3,Interventional,Brazil,Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19,Drug,Ruxolitinib,Ruxolitinib,200,https://clinicaltrials.gov/show/NCT04477993,None
5501,NCT04478019,ClinicalTrials.gov,2020-07-15,2020-07-07,True,"University of Wisconsin, Madison",Recruiting,Phase 1,Interventional,United States,SHIELD Study: Using Naso-oropharyngeal Antiseptic Decolonization to Reduce COVID-19 Viral Shedding,Drug,Povidone Iodine,Povidone Iodine,94,https://clinicaltrials.gov/show/NCT04478019,None
5502,NCT04478071,ClinicalTrials.gov,2020-07-15,2020-08-22,False,"University of Texas Health Science Center, Houston",Recruiting,Phase 2,Interventional,United States,Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19),Drug,Vadadustat,Vadadustat,300,https://clinicaltrials.gov/show/NCT04478071,None
5503,NCT04478539,ClinicalTrials.gov,2020-07-14,2020-06-01,True,Zan Mitrev Clinic,Recruiting,Not Applicable,Interventional,North Macedonia,Extracorporeal Blood Purification as a Treatment Modality for COVID-19,Other (physical),Blood purification,Blood purification,35,https://clinicaltrials.gov/show/NCT04478539,None
5504,NCT04479124,ClinicalTrials.gov,2020-07-19,2020-03-10,True,Kanuni Sultan Suleyman Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,The Impact of COVID-19 Pandemic to Trauma Patients in Emergency Department: A Multicenter Experience of Istanbul,Health System,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04479124,None
5505,NCT04479137,ClinicalTrials.gov,2020-07-18,2020-03-10,True,Kanuni Sultan Suleyman Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,Possible Predictors of Mortality Based on COVID-19 for Patients Under 50 Years Old: A Multi-Center Experience of Istanbul,Prognosis,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04479137,None
5506,NCT04479150,ClinicalTrials.gov,2020-07-19,2020-03-01,True,Hospital Universitari de Bellvitge,Recruiting,Not Applicable,Observational,Spain,Complications and Mortality Following Emergency Digestive Surgery During the COVID-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,3000,https://clinicaltrials.gov/show/NCT04479150,None
5507,NCT04479163,ClinicalTrials.gov,2020-06-29,2020-06-04,True,Fundación Infant,Not Recruiting,Not Applicable,Interventional,Argentina,Prevention of Severe Covid-19 in Infected Elderly by Early Administration of Convalescent Plasma With High-titers of Antibody Against SARS-CoV2,ATMP,Plasma,Plasma,165,https://clinicaltrials.gov/show/NCT04479163,None
5508,NCT04479202,ClinicalTrials.gov,2020-05-13,2020-02-08,True,Chinese Medical Association,Not Recruiting,Phase 4,Interventional,China,The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,76,https://clinicaltrials.gov/show/NCT04479202,None
5509,NCT04479280,ClinicalTrials.gov,2020-07-19,2020-07-20,False,Assiut University,Not Recruiting,Not Applicable,Observational,Egypt,Evaluation of Coagulopathy in Critically Ill COVID-19 Patients.,Clinical Presentation,No Intervention,No Intervention,70,https://clinicaltrials.gov/show/NCT04479280,None
5510,NCT04479293,ClinicalTrials.gov,2020-07-19,2020-07-01,True,Assiut University,Recruiting,Not Applicable,Observational,Egypt,Post COVID-19 Functional Status in Egypt,Clinical Presentation,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04479293,None
5511,NCT04479319,ClinicalTrials.gov,2020-07-16,2020-08-01,False,Ankara University,Not Recruiting,Not Applicable,Observational,No Country Given,Decision Support System Algorithm for COVID-19 Diagnosis,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,10000,https://clinicaltrials.gov/show/NCT04479319,None
5512,NCT04479332,ClinicalTrials.gov,2020-07-16,2020-08-01,False,National Taiwan University Hospital,Not Recruiting,Not Applicable,Interventional,No Country Given,The Change of Critical Patient Managements and Subsequent Influences Under Epidemic of Coronavirus Disease 19 (COVID-19),Health System,No Intervention,No Intervention,334,https://clinicaltrials.gov/show/NCT04479332,None
5513,NCT04479345,ClinicalTrials.gov,2020-07-20,2020-07-01,True,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,"Knowledge, Attitude and Practice of Gastrointestinal Endoscopists Toward PPE in COVID-19 Era",Other,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04479345,None
5514,NCT04479358,ClinicalTrials.gov,2020-07-13,2020-09-10,False,University of Chicago,Recruiting,Phase 2,Interventional,United States,Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19,Drug,Tocilizumab,Tocilizumab,332,https://clinicaltrials.gov/show/NCT04479358,None
5515,NCT04479488,ClinicalTrials.gov,2020-07-13,2020-07-27,False,Hospital Israelita Albert Einstein,Recruiting,Not Applicable,Observational,Brazil,Brazilian Registry for Clinical Presentation of Individuals With COVID-19 (SARS-Brazil),Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04479488,None
5516,NCT04479540,ClinicalTrials.gov,2020-07-06,2020-05-26,True,Hôpital Foch,Recruiting,Not Applicable,Interventional,France,Assessment of the Risk of Pulmonary Embolism and Coagulation Profile in Patients With COVID-19 Lung Disease,Clinical Presentation,No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04479540,None
5517,NCT04479982,ClinicalTrials.gov,2020-07-17,2020-09-24,False,Assiut University,Recruiting,Not Applicable,Observational,Egypt,Microbial Infection and AMR in Hospitalized Patients With Covid 19,Clinical Presentation,No Intervention,No Intervention,70,https://clinicaltrials.gov/show/NCT04479982,None
5518,NCT04480034,ClinicalTrials.gov,2020-07-15,2020-07-15,False,University of Roma La Sapienza,Recruiting,Not Applicable,Observational,Italy,Obesity Surgery During 2020 Italian Pandemic,Health System,No Intervention,No Intervention,1600,https://clinicaltrials.gov/show/NCT04480034,None
5519,NCT04480060,ClinicalTrials.gov,2020-07-18,2020-03-10,True,Kanuni Sultan Suleyman Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,Experience of an Emergency Intensive Care Unit During COVID-19 Pandemic,Health System,No Intervention,No Intervention,100000,https://clinicaltrials.gov/show/NCT04480060,None
5520,NCT04480112,ClinicalTrials.gov,2020-07-19,2020-06-02,True,Boston University,Recruiting,Not Applicable,Interventional,United States,Impact of Covid-19 on Frequent Social Interaction Through Communication Technologies in the Cognitive Status of Socially-isolated Older Adults,Other,Other,Other,150,https://clinicaltrials.gov/show/NCT04480112,None
5521,NCT04480138,ClinicalTrials.gov,2020-07-20,2020-08-11,False,Cadila Healthcare Ltd,Recruiting,Phase 2,Interventional,Mexico,Pegylated Interferon - a2b With SARSCoV- 2 (COVID-19),Drug,Interferon alpha,Interferon alpha,40,https://clinicaltrials.gov/show/NCT04480138,None
5522,NCT04480333,ClinicalTrials.gov,2020-07-13,2020-09-15,False,"NeuroActiva, Inc.",Recruiting,Phase 1,Interventional,United States,"Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831",Drug,Remdesivir,Remdesivir,45,https://clinicaltrials.gov/show/NCT04480333,None
5523,NCT04480398,ClinicalTrials.gov,2020-07-18,2020-05-12,True,Aarogyam UK,Not Recruiting,Not Applicable,Observational,India,Efficacy and Safety of Guduchi Ghan Vati for Covid-19 Asymptomatic Patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,91,https://clinicaltrials.gov/show/NCT04480398,None
5524,NCT04480411,ClinicalTrials.gov,2020-07-17,2021-01-01,False,Stanford University,Not Recruiting,Not Applicable,Interventional,United States,Use of Technology and Telemedicine to Improve Quality of Care in COVID 19 Patients,Telehealth,Telehealth,Telehealth,50,https://clinicaltrials.gov/show/NCT04480411,None
5525,NCT04480424,ClinicalTrials.gov,2020-07-20,2020-09-17,False,"Grifols, S.A.",Recruiting,Phase 2,Interventional,United States,Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19),ATMP,Immunoglobulin,Immunoglobulin,100,https://clinicaltrials.gov/show/NCT04480424,None
5526,NCT04480515,ClinicalTrials.gov,2020-07-17,2020-03-11,True,Kanuni Sultan Suleyman Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,Does COVID-19 Pandemic Reduce In-hospital Mortality?,Health System,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04480515,None
5527,NCT04480580,ClinicalTrials.gov,2020-07-20,2020-03-30,True,University of Cagliari,Not Recruiting,Not Applicable,Observational,Italy,Seroprevalence of SARS-Cov-2 in the Setting of a Non-dedicated COVID-19 Hospital in a Low CoV-2 Incidence Area: Implications for Surgery,Clinical Presentation (Epidemiology),No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04480580,None
5528,NCT04480593,ClinicalTrials.gov,2020-07-12,2020-06-02,True,D'Or Institute for Research and Education,Not Recruiting,Phase 2/Phase 3,Interventional,Brazil,The Use of Brazilian Green Propolis Extract (EPP-AF) in Patients Affected by COVID-19.,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,https://clinicaltrials.gov/show/NCT04480593,None
5529,NCT04480606,ClinicalTrials.gov,2020-07-16,2020-08-01,False,Istinye University,Not Recruiting,Not Applicable,Interventional,No Country Given,Evaluation of the Physical Activity Level of the Elderly in Social Isolation,Other (exercise),Exercise,Exercise,88,https://clinicaltrials.gov/show/NCT04480606,None
5530,NCT04480632,ClinicalTrials.gov,2020-07-17,2020-08-01,False,Fundación Cardiovascular de Colombia,Not Recruiting,Phase 2,Interventional,Colombia,Therapeutic Plasmapheresis in Critically Ill Adult Patients With COVID-19 Confirmed Diagnosis,ATMP,Plasma,Plasma,44,https://clinicaltrials.gov/show/NCT04480632,None
5531,NCT04481360,ClinicalTrials.gov,2020-07-11,2020-08-01,False,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,Evaluation of Clinical Characteristics and Outcome of COVID19 Pneumonia in Assiut University Hospital,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04481360,None
5532,NCT04481477,ClinicalTrials.gov,2020-07-21,2020-09-01,False,Corporació Sanitària Parc Taulí ,Not Recruiting,Not Applicable,Observational,Spain,Results of Emotional Support Activities During Hospital Admission With a Diagnosis of COVID19,Other (psych),Psychological,Psychological,450,https://clinicaltrials.gov/show/NCT04481477,None
5533,NCT04481516,ClinicalTrials.gov,2020-07-01,2020-07-01,False,Doncaster & Bassetlaw Hospitals NHS Trust,Recruiting,Not Applicable,Observational,United Kingdom,Yoga in NHS Health Care Workers With COVID-19 Related Stress,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,30,https://clinicaltrials.gov/show/NCT04481516,None
5534,NCT04481529,ClinicalTrials.gov,2020-07-20,2020-08-15,False,"University Hospital, Limoges",Not Recruiting,Not Applicable,Observational,France,COVID-19 Serological Status of Hospital Staff Working or Not in the COVID-19 Sector,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04481529,None
5535,NCT04481620,ClinicalTrials.gov,2020-07-20,2020-08-31,False,"University Hospital, Bordeaux",Recruiting,Not Applicable,Observational,France,"Development and Validation of a Prediction Model for the Transition From Mild to Moderate Form of COVID-19, Using Data From Chest CT",Prognosis,No Intervention,No Intervention,1315,https://clinicaltrials.gov/show/NCT04481620,None
5536,NCT04481633,ClinicalTrials.gov,2020-07-21,2020-09-09,False,"University Hospital, Toulouse",Recruiting,Not Applicable,Interventional,France,Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,800,https://clinicaltrials.gov/show/NCT04481633,None
5537,NCT04481646,ClinicalTrials.gov,2020-07-21,2020-06-12,True,University of Leicester,Recruiting,Not Applicable,Observational,United Kingdom,Novel Face Mask Sampling for COVID-19: A Diagnostic and Public Health Tool,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,630,https://clinicaltrials.gov/show/NCT04481646,None
5538,NCT04481685,ClinicalTrials.gov,2020-07-15,2020-07-20,False,University of Kansas Medical Center,Recruiting,Phase 2,Interventional,United States,"A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19)",Drug,ATI-450,ATI-450,36,https://clinicaltrials.gov/show/NCT04481685,None
5539,NCT04482023,ClinicalTrials.gov,2020-07-21,2020-09-01,False,Corporació Sanitària Parc Taulí ,Not Recruiting,Not Applicable,Observational,Spain,Emotional Support and Stress Management in Patients Diagnosed With COVID-19,Other (psych),Psychological,Psychological,150,https://clinicaltrials.gov/show/NCT04482023,None
5540,NCT04482205,ClinicalTrials.gov,2020-07-21,2020-03-16,True,Aga Khan University,Not Recruiting,Not Applicable,Observational,Pakistan,Covid -19 Pandemic: Economic Burden on Patients Operated for Traumatic Close Fractures,Other,No Intervention,No Intervention,840,https://clinicaltrials.gov/show/NCT04482205,None
5541,NCT04482361,ClinicalTrials.gov,2020-07-20,2020-07-01,True,Ministerio de Salud de la Ciudad de Buenos Aires,Not Recruiting,Not Applicable,Observational,No Country Given,SERO-EPIDEMIOLOGY OF SARS-COV2 INFECTION IN THE AUTONOMOUS CITY OF BUENOS AIRES,Clinical Presentation (Epidemiology),No Intervention,No Intervention,5400,https://clinicaltrials.gov/show/NCT04482361,None
5542,NCT04482387,ClinicalTrials.gov,2020-07-17,2020-07-24,False,Cambridge University Hospitals NHS Foundation Trust,Not Recruiting,Not Applicable,Interventional,United Kingdom,DigiVis: Self-testing Vision App for Telephone Consultations,Telehealth,Telehealth,Telehealth,250,https://clinicaltrials.gov/show/NCT04482387,None
5543,NCT04482595,ClinicalTrials.gov,2020-07-17,2020-11-11,False,Humanetics Corporation,Recruiting,Phase 2,Interventional,United States,BIO 300 Oral Suspension in Discharged COVID-19 Patients,Drug,Genistein,Genistein,66,https://clinicaltrials.gov/show/NCT04482595,None
5544,NCT04482621,ClinicalTrials.gov,2020-07-21,2020-09-14,False,Johns Hopkins University,Recruiting,Phase 2,Interventional,United States,Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial,Drug,Decitabine,Decitabine,40,https://clinicaltrials.gov/show/NCT04482621,None
5545,NCT04482634,ClinicalTrials.gov,2020-07-21,2020-09-01,False,Koç University,Recruiting,Not Applicable,Interventional,Turkey,Tele-rehabilitation Versus Home Exercise Program in COVID-19,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,122,https://clinicaltrials.gov/show/NCT04482634,None
5546,NCT04482647,ClinicalTrials.gov,2020-07-21,2020-06-17,True,M.D. Anderson Cancer Center,Recruiting,Phase 1,Interventional,United States,Breathing Techniques and Meditation for Health Care Workers During COVID-19 Pandemic,Other (psych),Psychological,Psychological,50,https://clinicaltrials.gov/show/NCT04482647,None
5547,NCT04482673,ClinicalTrials.gov,2020-07-01,2020-07-31,False,Medical University of South Carolina,Recruiting,Phase 4,Interventional,United States,Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection,Drug (Chemoprophylaxis),Vitamin D,Vitamin D,140,https://clinicaltrials.gov/show/NCT04482673,None
5548,NCT04482699,ClinicalTrials.gov,2020-07-20,2020-12-30,False,Rapa Therapeutics LLC,Not Recruiting,Phase 1/Phase 2,Interventional,United States,RAPA-501-Allo Off-the-Shelf Therapy of COVID-19,ATMP,Cells (Allogeneic),Cells (Allogeneic),88,https://clinicaltrials.gov/show/NCT04482699,None
5549,NCT04482712,ClinicalTrials.gov,2020-07-21,2021-01-01,False,"University of Texas Health Science Center, San Antonio",Not Recruiting,Phase 1/Phase 2,Interventional,United States,Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDS,Drug,Sirolimus,Sirolimus,20,https://clinicaltrials.gov/show/NCT04482712,None
5550,NCT04483375,ClinicalTrials.gov,2020-07-17,2020-07-24,False,Sinocelltech Ltd.,Recruiting,Phase 1,Interventional,China,"Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects",Drug,SCTA01,SCTA01,33,https://clinicaltrials.gov/show/NCT04483375,None
5551,NCT04483622,ClinicalTrials.gov,2020-07-21,2020-06-12,True,Sohag University,Recruiting,Not Applicable,Observational,Egypt,Immunoglobulin G Antibody Immune Response Profile Following Infection With SARS-CoV-2 in COVID-19 Egyptian Patients,Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04483622,None
5552,NCT04483635,ClinicalTrials.gov,2020-06-29,2020-11-30,False,St. Justine's Hospital,Not Recruiting,Phase 3,Interventional,Canada,PRevention of COVID-19 With Oral Vitamin D Supplemental Therapy in Essential healthCare Teams,Drug,Vitamin D,Vitamin D,2414,https://clinicaltrials.gov/show/NCT04483635,None
5553,NCT04483752,ClinicalTrials.gov,2020-07-21,2020-06-08,True,Centre Chirurgical Marie Lannelongue,Recruiting,Not Applicable,Interventional,France,Predicting the Progression to Chronic Fibrosis of Lung Lesions Related to Covid-19 Infection From Chest CT Images,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04483752,None
5554,NCT04483830,ClinicalTrials.gov,2020-07-22,2020-06-05,True,CLINEDEM,Not Recruiting,Phase 2/Phase 3,Interventional,Mexico,Suloexide in the Treatment of Early Stages of COVID-19,Drug,Suloexide,Suloexide,243,https://clinicaltrials.gov/show/NCT04483830,None
5555,NCT04483908,ClinicalTrials.gov,2020-07-22,2020-04-10,True,"University Hospital, Basel",Recruiting,Not Applicable,Observational,Switzerland,COVID-19 in Baselland: Investigation and Validation of Serological Diagnostic Assays and Epidemiological Study of Sars-CoV-2 Specific Antibody Responses,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,550,https://clinicaltrials.gov/show/NCT04483908,None
5556,NCT04483960,ClinicalTrials.gov,2020-07-22,2020-07-28,False,University of Melbourne,Recruiting,Phase 3,Interventional,Australia,"Australasian COVID-19 Trial (ASCOT): An International Multi-Centre Randomised Clinical Trial to Assess the Clinical, Virological and Immunological Outcomes in Patients Diagnosed With SARS-CoV-2 Infection (COVID-19)",Drug (+ ATMP),Lopinavir/ritonavir vs. Hydroxychloroquine + Lopinavir/ritonavir vs. Plasma,Hydroxychloroquine; Lopinavir/ritonavir; Plasma,2400,https://clinicaltrials.gov/show/NCT04483960,None
5557,NCT04483973,ClinicalTrials.gov,2020-07-13,2020-12-01,False,"Sound Pharmaceuticals, Incorporated",Not Recruiting,Phase 2,Interventional,No Country Given,SPI-1005 Treatment in Severe COVID-19 Patients,Drug,Ebselen,Ebselen,60,https://clinicaltrials.gov/show/NCT04483973,None
5558,NCT04484025,ClinicalTrials.gov,2020-07-13,2020-12-01,False,"Sound Pharmaceuticals, Incorporated",Not Recruiting,Phase 2,Interventional,No Country Given,SPI-1005 Treatment in Moderate COVID-19 Patients,Drug,Ebselen,Ebselen,60,https://clinicaltrials.gov/show/NCT04484025,None
5559,NCT04484207,ClinicalTrials.gov,2020-07-21,2020-07-06,True,"Research Foundation for Mental Hygiene, Inc.",Recruiting,Not Applicable,Interventional,United States,Addressing COVID-19 Mental Health Problems Among US Veterans,Other (psych),Psychological,Psychological,200,https://clinicaltrials.gov/show/NCT04484207,None
5560,NCT04484493,ClinicalTrials.gov,2020-07-22,2020-08-08,False,Benha University,Not Recruiting,Phase 3,Interventional,Egypt,Corticosteroid Nasal Spray in COVID-19 Anosmia,Drug,Corticosteroids,momentasone furatenasal,100,https://clinicaltrials.gov/show/NCT04484493,None
5561,NCT04484545,ClinicalTrials.gov,2020-07-22,2020-04-01,True,Glasgow Royal Infirmary,Not Recruiting,Not Applicable,Observational,United Kingdom,Prognostic Factors in Patients Admitted to an Urban Teaching Hospital With COVID-19 Infection,Prognosis,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04484545,None
5562,NCT04484597,ClinicalTrials.gov,2020-07-14,2020-03-15,True,Port Said University,Recruiting,Not Applicable,Observational,Egypt,Predictors of COVID-19 Infection and Disease Progression,Prognosis,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04484597,None
5563,NCT04485130,ClinicalTrials.gov,2020-07-22,2020-12-01,False,"University of California, San Francisco",Not Recruiting,Phase 2,Interventional,United States,DISulfiram for COvid-19 (DISCO) Trial,Drug,Disulfiram,Disulfiram,60,https://clinicaltrials.gov/show/NCT04485130,None
5564,NCT04485169,ClinicalTrials.gov,2020-07-21,2020-04-01,True,UNICEF,Not Recruiting,Not Applicable,Interventional,Pakistan,Therapeutic Plasma Exchange for Coronavirus Disease-2019 Triggered Cytokine Release Storm;,ATMP,Plasma,Plasma,280,https://clinicaltrials.gov/show/NCT04485169,None
5565,NCT04485338,ClinicalTrials.gov,2020-07-23,2020-08-01,False,UMC Amsterdam,Not Recruiting,Not Applicable,Observational,No Country Given,Chest Radiography in COVID-19 Patients,Prognosis,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04485338,None
5566,NCT04485351,ClinicalTrials.gov,2020-07-02,2020-07-01,True,CHU de Nancy,Recruiting,Not Applicable,Observational,France,Assessing the Impact of the COVID-19 Lockdown on Metabolic Control and Access to Health Care in Patients With Diabetes,Health System,No Intervention,No Intervention,700,https://clinicaltrials.gov/show/NCT04485351,None
5567,NCT04485364,ClinicalTrials.gov,2020-07-23,2020-04-14,True,Groupe Hospitalier Paris Saint-Joseph,Not Recruiting,Not Applicable,Observational,France,Place of Circulating Biomarkers and Respiratory Eicosanoids in the Prognosis of Severe Forms of Covid-19 Pneumonia,Prognosis,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04485364,None
5568,NCT04485429,ClinicalTrials.gov,2020-07-20,2020-07-20,False,D'Or Institute for Research and Education,Recruiting,Phase 3,Interventional,Brazil,Efficacy Assessment of Methylprednisolone and Heparin in Patients With COVID-19 Pneumonia,Drug,Corticosteroids vs. Heparin vs. Corticosteroids + Heparin,Methylprednisolone; Heparin,268,https://clinicaltrials.gov/show/NCT04485429,None
5569,NCT04486001,ClinicalTrials.gov,2020-07-22,2020-12-15,False,"Sorrento Therapeutics, Inc.",Not Recruiting,Phase 1,Interventional,United States,Study of Intravenous Administration of Allogeneic Adipose Stem Cells for COVID-19,ATMP,Cells (Allogeneic adipose),Cells (Allogeneic adipose),20,https://clinicaltrials.gov/show/NCT04486001,None
5570,NCT04486144,ClinicalTrials.gov,2020-07-20,2020-05-20,True,HealthQuilt,Recruiting,Not Applicable,Interventional,United States,Impact Nerium Oleander on Symptoms and Mortality: A Feasibility Study,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,https://clinicaltrials.gov/show/NCT04486144,None
5571,NCT04486313,ClinicalTrials.gov,2020-07-23,2020-08-13,False,Romark Laboratories L.C.,Recruiting,Phase 3,Interventional,United States,Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19,Drug,Nitazoxanide,Nitazoxanide,800,https://clinicaltrials.gov/show/NCT04486313,None
5572,NCT04486404,ClinicalTrials.gov,2020-07-23,2020-04-01,True,Universidad Miguel Hernández de Elche,Recruiting,Not Applicable,Observational,"Ecuador, Colombia, Chile, Argentina, Spain","Needs, Perceptions and Acute Stress of Healtcare Workers Caring for COVID-19 Patients in South America",Other,No Intervention,No Intervention,2500,https://clinicaltrials.gov/show/NCT04486404,None
5573,NCT04486417,ClinicalTrials.gov,2020-07-22,2020-06-01,True,University of Roma La Sapienza,Recruiting,Not Applicable,Observational,Italy,Feasibility of a Telematics Pre-operative Assessment in a Bariatric Surgery During Covid-19,Other,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04486417,None
5574,NCT04486482,ClinicalTrials.gov,2020-07-23,2020-07-01,True,Kaleido Biosciences,Recruiting,Not Applicable,Interventional,United States,A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function,Drug,KB109,KB109,50,https://clinicaltrials.gov/show/NCT04486482,None
5575,NCT04486508,ClinicalTrials.gov,2020-07-22,2020-07-30,False,Rajaie Cardiovascular Medical and Research Center,Recruiting,Phase 3,Interventional,Iran,Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19,Drug,Enoxaparin or heparin vs. Atorvastatin,Enoxaparin; heparin; Atorvastatin,600,https://clinicaltrials.gov/show/NCT04486508,None
5576,NCT04486729,ClinicalTrials.gov,2020-07-21,2020-07-01,True,Sanatorio Anchorena San Martin,Recruiting,Not Applicable,Observational,Argentina,Respiratory Mechanics and Gas Exchange Characteristics in Patient With SARS-CoV-2,Clinical Presentation,No Intervention,No Intervention,15,https://clinicaltrials.gov/show/NCT04486729,None
5577,NCT04487119,ClinicalTrials.gov,2020-07-24,2020-08-12,False,Benha University,Not Recruiting,Not Applicable,Observational,Egypt,Hematology and Clinical Picture in Pediatric COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,29,https://clinicaltrials.gov/show/NCT04487119,None
5578,NCT04487171,ClinicalTrials.gov,2020-07-24,2020-07-21,True,CHU de Amiens,Recruiting,Not Applicable,Interventional,France,Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic,Other (psych),No Intervention,No Intervention,248,https://clinicaltrials.gov/show/NCT04487171,None
5579,NCT04487197,ClinicalTrials.gov,2020-07-24,2020-07-15,True,Antonio Secchi,Recruiting,Not Applicable,Observational,Italy,"SARS-CoV2 (COVID-19) Seroepidemiological Transplanted Subjects (Kidney, Kidney-pancreas, Pancreas, Langerhans Islets)",Clinical Presentation (Epidemiology),No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04487197,None
5580,NCT04487210,ClinicalTrials.gov,2020-07-22,2020-10-07,False,Medigen Vaccine Biologics Corp.,Recruiting,Phase 1,Interventional,Taiwan,A Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 Against COVID-19,Drug,MVC-COV1901,MVC-COV1901,45,https://clinicaltrials.gov/show/NCT04487210,None
5581,NCT04487444,ClinicalTrials.gov,2020-07-22,2020-09-10,False,Rhode Island Hospital,Recruiting,Phase 2,Interventional,United States,Thymalfasin (Thymosin Alpha 1) to Treat COVID-19 Infection,Drug,Thymosin alpha,Thymosin alpha,80,https://clinicaltrials.gov/show/NCT04487444,None
5582,NCT04487574,ClinicalTrials.gov,2020-07-22,2020-07-25,False,RSV Therapeutics LLC,Not Recruiting,Phase 3,Interventional,Russian Federation,A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19,Drug,XC221,XC221,118,https://clinicaltrials.gov/show/NCT04487574,None
5583,NCT04487639,ClinicalTrials.gov,2020-07-21,2020-07-10,True,"University Hospital, Clermont-Ferrand",Recruiting,Not Applicable,Interventional,France,Presence of SARS-CoV-2 in Semen: Impact on Fertility Preservation in Male Oncological Patients ?,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,250,https://clinicaltrials.gov/show/NCT04487639,None
5584,NCT04487665,ClinicalTrials.gov,2020-07-21,2020-09-15,False,Cairo University,Not Recruiting,Not Applicable,Observational,No Country Given,Oral Manifestations of Coronavirus Disease 2019(COVID-19) :a Multicentre Study,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04487665,None
5585,NCT04487769,ClinicalTrials.gov,2020-07-24,2020-06-01,True,UMC Amsterdam,Recruiting,Not Applicable,Observational,Netherlands,Lung Ultrasound in COVID-19 Patients,Prognosis,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04487769,None
5586,NCT04487873,ClinicalTrials.gov,2020-07-23,2020-07-23,False,Hacettepe University,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 Phobia in Patients With Bronchiectasis During Covid-19 Pandemic,Other (psych),No Intervention,No Intervention,28,https://clinicaltrials.gov/show/NCT04487873,None
5587,NCT04487886,ClinicalTrials.gov,2020-07-23,2020-08-01,False,Emory University,Not Recruiting,Phase 2,Interventional,United States,Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19),Drug,Duvelisib,Duvelisib,80,https://clinicaltrials.gov/show/NCT04487886,None
5588,NCT04487951,ClinicalTrials.gov,2020-07-24,2020-07-01,True,Cairo University,Recruiting,Not Applicable,Observational,Egypt,N-terminal Pro B-type Natriuretic Peptide and Vitamin D Levels as Prognostic Markers in COVID-19 Pneumonia,Prognosis,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04487951,None
5589,NCT04487964,ClinicalTrials.gov,2020-07-24,2020-01-01,True,Egyptian Biomedical Research Network,Recruiting,Not Applicable,Interventional,Egypt,Complementary Intervention for COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,70,https://clinicaltrials.gov/show/NCT04487964,None
5590,NCT04487977,ClinicalTrials.gov,2020-07-23,2020-04-22,True,Spanish Society of Anesthesia and Critical Care (SEDAR),Recruiting,Not Applicable,Observational,Spain,Survey on COVID-19 Airway Management,Other,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04487977,None
5591,NCT04487990,ClinicalTrials.gov,2020-07-23,2020-06-29,True,University of São Paulo General Hospital,Recruiting,Not Applicable,Interventional,Brazil,CoV-Hep Study: Regional Anticoagulation Modalities in Continuous Venous Venous Hemodialysis in Patients With COVID-19,Drug,Heparin,Heparin,90,https://clinicaltrials.gov/show/NCT04487990,None
5592,NCT04488081,ClinicalTrials.gov,2020-07-14,2020-07-31,False,QuantumLeap Healthcare Collaborative,Recruiting,Phase 2,Interventional,United States,I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients,Drug,"Remdesivir, Cenicriviroc, Icatibant, Razuprotafib, Apremilast",Remdesivir; Cenicriviroc; Icatibant; Razuprotafib; Apremilast,1500,https://clinicaltrials.gov/show/NCT04488081,None
5593,NCT04488471,ClinicalTrials.gov,2020-07-24,2020-06-30,True,Sheffield Teaching Hospitals NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,Impact of Isolation in Patients With IBD During the COVID-19 Crisis,Other,No Intervention,No Intervention,232,https://clinicaltrials.gov/show/NCT04488471,None
5594,NCT04488484,ClinicalTrials.gov,2020-07-20,2020-07-01,True,Groupe Hospitalier Paris Saint-Joseph,Not Recruiting,Not Applicable,Interventional,France,Medical and Serological Follow-up of the Staff of the Paris Saint-Joseph Hospital Group Infected With Severe Acute Respiratory Syndrome Coronavirus 2.,Clinical Presentation (Epidemiology),No Intervention,No Intervention,450,https://clinicaltrials.gov/show/NCT04488484,None
5595,NCT04488510,ClinicalTrials.gov,2020-07-23,2020-05-06,True,Groupe Hospitalier Paris Saint-Joseph,Not Recruiting,Not Applicable,Observational,France,Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia:,Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04488510,None
5596,NCT04488549,ClinicalTrials.gov,2020-07-23,2020-05-20,True,Treviso Regional Hospital,Not Recruiting,Not Applicable,Observational,Italy,Delayed Colorectal Cancer Care During Coronavirus Disease (COVID-19) Pandemic (DECOR-19),Other,No Intervention,No Intervention,1051,https://clinicaltrials.gov/show/NCT04488549,None
5597,NCT04488562,ClinicalTrials.gov,2020-06-02,2020-05-08,True,Erasmus Medical Center,Recruiting,Not Applicable,Observational,Netherlands,Home Monitoring and Evaluation After Admission for COVID-19 in the Netherlands,Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04488562,None
5598,NCT04488575,ClinicalTrials.gov,2020-07-23,2020-08-26,False,"Evelo Biosciences, Inc.",Recruiting,Phase 2,Interventional,United States,Safety and Efficacy of EDP1815 in the Treatment of Patients Hospitalized With COVID-19 Infection,Drug,EDP1815,EDP1815,60,https://clinicaltrials.gov/show/NCT04488575,None
5599,NCT04488588,ClinicalTrials.gov,2020-07-24,2020-03-15,True,Assiut University,Not Recruiting,Not Applicable,Observational,Egypt,Survival and 30-days Hospital Outcome in COVID-19 Patients in Upper Egypt,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1064,https://clinicaltrials.gov/show/NCT04488588,None
5600,NCT04488796,ClinicalTrials.gov,2020-07-22,2020-09-07,False,"Western University, Canada",Recruiting,Not Applicable,Interventional,Canada,STAND UP to SARS-CoV-2 (COVID-19): Using Behavioural Economics to Reduce Sedentary Behaviour in At-home Office Workers,Other,Other,Other,145,https://clinicaltrials.gov/show/NCT04488796,None
5601,NCT04489446,ClinicalTrials.gov,2020-07-25,2020-08-19,False,Andrés Bello National University,Recruiting,Phase 1/Phase 2,Interventional,Chile,Sildenafil in COVID-19,Drug,Sildenafil,Sildenafil,40,https://clinicaltrials.gov/show/NCT04489446,None
5602,NCT04489628,ClinicalTrials.gov,2020-07-24,2020-08-01,False,University Hospitals Cleveland Medical Center,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Tele-health Enabled Clinical Trial for COVID-19,Drug,Vitamin D,Vitamin D,110,https://clinicaltrials.gov/show/NCT04489628,None
5603,NCT04490200,ClinicalTrials.gov,2020-07-19,2020-11-30,False,University of Brasilia,Not Recruiting,Not Applicable,Interventional,No Country Given,Effectiveness of a Novel Respirator With Chitosan Nanoparticles,Other (device),Masks,Masks,1000,https://clinicaltrials.gov/show/NCT04490200,None
5604,NCT04490239,ClinicalTrials.gov,2020-07-20,2020-10-09,False,Joshua Sharp,Not Recruiting,Phase 1,Interventional,United States,Intranasal Heparin Tolerability Study,Drug,Heparin,Heparin,6,https://clinicaltrials.gov/show/NCT04490239,None
5605,NCT04490278,ClinicalTrials.gov,2020-07-23,2020-09-29,False,Washington University in St. Louis,Recruiting,Not Applicable,Interventional,United States,CoV-PICS: A Virtual Post-ICU Clinic,Telehealth,Telehealth,Telehealth,80,https://clinicaltrials.gov/show/NCT04490278,None
5606,NCT04490486,ClinicalTrials.gov,2020-07-27,2021-03-01,False,Joshua M Hare,Not Recruiting,Phase 1,Interventional,United States,Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),21,https://clinicaltrials.gov/show/NCT04490486,None
5607,NCT04490772,ClinicalTrials.gov,2020-07-20,2020-07-01,True,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,Characteristics and Outcomes of Gastrointestinal Manifestations of COVID-19,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04490772,None
5608,NCT04490811,ClinicalTrials.gov,2020-06-20,2020-04-09,True,Hôpital Necker-Enfants Malades,Recruiting,Not Applicable,Observational,France,Seroprevalence and Immunoprotection Against COVID-19 in Parisian Children,Clinical Presentation (Epidemiology),No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04490811,None
5609,NCT04490824,ClinicalTrials.gov,2020-07-27,2020-10-01,False,Institute of Progressive Medicine,Recruiting,Not Applicable,Interventional,United States,Inhalation of KELEA Excellerated Water in Covid-19 Infected Individuals,Drug,Excellerated Water,Excellerated Water,100,https://clinicaltrials.gov/show/NCT04490824,None
5610,NCT04490837,ClinicalTrials.gov,2020-05-15,2020-06-22,False,Corporació Sanitària Parc Taulí ,Not Recruiting,Not Applicable,Observational,Spain,Rapid Diagnostic Test for COVID-19 Based on Antibody Detection (YCOVID),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,3500,https://clinicaltrials.gov/show/NCT04490837,None
5611,NCT04490850,ClinicalTrials.gov,2020-07-28,2020-07-15,True,Institut Pasteur,Recruiting,Not Applicable,Interventional,French Guiana,COVID-19 Seroprevalence Study in French Guiana,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04490850,None
5612,NCT04491071,ClinicalTrials.gov,2020-07-27,2020-09-01,False,CHU de Saint Etienne,Not Recruiting,Not Applicable,Observational,"United Kingdom, France",Stress Induced by the COVID-19 Pandemic and Nonconfinement: Study of Anxiety Factors and Potential Effects on Immunity.,Other (psych),No Intervention,No Intervention,405,https://clinicaltrials.gov/show/NCT04491071,None
5613,NCT04491201,ClinicalTrials.gov,2020-07-27,2020-07-27,False,Lei Li,Recruiting,Not Applicable,Observational,China,National Survey of the Impact of COVID-19 Pandemics,Other,No Intervention,No Intervention,6000,https://clinicaltrials.gov/show/NCT04491201,None
5614,NCT04491214,ClinicalTrials.gov,2020-07-20,2020-07-24,False,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Post ICU Follow up in Patients With Severe SARS-CoV-2 Infection (Covid-19),Clinical Presentation,No Intervention,No Intervention,131,https://clinicaltrials.gov/show/NCT04491214,None
5615,NCT04491227,ClinicalTrials.gov,2020-07-24,2020-05-05,True,"University of California, San Diego",Recruiting,Not Applicable,Observational,"Bolivia, Chile, India, Canada, United Kingdom, United States",Global Assessment of Acute and Chronic Kidney Disease Incidence and Outcomes in Patients With COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04491227,None
5616,NCT04491240,ClinicalTrials.gov,2020-07-27,2020-07-20,True,Samara Regional Medical Center Dinasty,Not Recruiting,Phase 1/Phase 2,Interventional,Russian Federation,Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia.,Procedure,Exosome Inhalation,Exosome Inhalation,30,https://clinicaltrials.gov/show/NCT04491240,None
5617,NCT04491292,ClinicalTrials.gov,2020-07-28,2020-05-18,True,M.D. Anderson Cancer Center,Recruiting,Not Applicable,Observational,United States,Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce,Other (psych),No Intervention,No Intervention,20000,https://clinicaltrials.gov/show/NCT04491292,None
5618,NCT04491318,ClinicalTrials.gov,2020-07-27,2020-07-01,True,Investigacion en Hemofilia y Fisioterapia,Recruiting,Not Applicable,Observational,Spain,COVID-19 Quarantine on Musculoskeletal Status in Hemophilia,Other,No Intervention,No Intervention,27,https://clinicaltrials.gov/show/NCT04491318,None
5619,NCT04491994,ClinicalTrials.gov,2020-07-28,2020-04-10,True,UNICEF,Not Recruiting,Phase 3,Interventional,Pakistan,Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression,Other,Hydroxychloroquine,Hydroxychloroquine,540,https://clinicaltrials.gov/show/NCT04491994,None
5620,NCT04492189,ClinicalTrials.gov,2020-04-19,2020-04-01,True,"University Hospital, Montpellier",Not Recruiting,Not Applicable,Observational,France,Containment Measures and Eating Disorders,Other,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04492189,None
5621,NCT04492202,ClinicalTrials.gov,2020-07-28,2020-08-01,False,Istinye University,Not Recruiting,Not Applicable,Observational,No Country Given,"Knowledge, Attitudes, and Practices Towards COVID-19 Among Health Care Professionals Among Healthcare Professionals",Other,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04492202,None
5622,NCT04492228,ClinicalTrials.gov,2020-07-25,2020-09-01,False,Ospedale Policlinico San Martino,Recruiting,Not Applicable,Interventional,Italy,Eucaloric Ketogenic Diet in COVID-19 Cytokine Storm Syndrome,Other (nutrition),Nutrition,Nutrition,100,https://clinicaltrials.gov/show/NCT04492228,None
5623,NCT04492254,ClinicalTrials.gov,2020-07-22,2020-07-01,False,Thrombosis Research Institute,Not Recruiting,Phase 3,Interventional,No Country Given,Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients,Drug,Enoxaparin,Enoxaparin,1370,https://clinicaltrials.gov/show/NCT04492254,EUCTR2020-003125-39
5624,NCT04492267,ClinicalTrials.gov,2020-07-23,2020-07-07,True,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Inflammatory Bowel Disease (IBD) and Covid-19 Infection,Clinical Presentation,No Intervention,No Intervention,700,https://clinicaltrials.gov/show/NCT04492267,None
5625,NCT04492358,ClinicalTrials.gov,2020-07-28,2020-10-22,False,Maria Joyera Rodriguez,Recruiting,Phase 2/Phase 3,Interventional,Spain,"Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population, Admitted to a Geriatric Hospital Unit or in a Transicional Care Center",Drug,Colchicine + Prednisone,Colchicine; Prednisone,144,https://clinicaltrials.gov/show/NCT04492358,None
5626,NCT04492371,ClinicalTrials.gov,2020-07-28,2020-07-01,True,European Myeloma Network,Recruiting,Not Applicable,Observational,"Greece, Germany, Italy, Belgium, Netherlands, United Kingdom, Austria, Czech Republic",COVID-19 Infection and Multiple Myeloma,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04492371,None
5627,NCT04492384,ClinicalTrials.gov,2020-07-27,2020-06-11,True,Eurasian Association of Therapists,Recruiting,Not Applicable,Observational,Russian Federation,Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients,Clinical Presentation,No Intervention,No Intervention,3500,https://clinicaltrials.gov/show/NCT04492384,None
5628,NCT04492410,ClinicalTrials.gov,2020-07-28,2020-07-21,True,Centre Antoine Lacassagne,Recruiting,Not Applicable,Interventional,France,COVID-19 Infection Screening in Cancer Patients (NEOSCREENCOVID),Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04492410,None
5629,NCT04492501,ClinicalTrials.gov,2020-07-28,2020-04-01,True,UNICEF,Not Recruiting,Not Applicable,Interventional,Pakistan,Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan,ATMP (+Drug),"Plasma, Cells (mesenchymal), Tocilizumab, Remdesivir",Plasma; Cells (mesenchymal); Tocilizumab; Remdesivir,600,https://clinicaltrials.gov/show/NCT04492501,None
5630,NCT04492514,ClinicalTrials.gov,2020-07-28,2020-05-20,True,Kristin Hudock,Recruiting,Phase 2,Interventional,United States,Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflation,Drug,Mavrilimumab,Mavrilimumab,60,https://clinicaltrials.gov/show/NCT04492514,None
5631,NCT04492527,ClinicalTrials.gov,2020-07-28,2020-07-28,False,University of British Columbia,Recruiting,Not Applicable,Interventional,Canada,Student-delivered Telehealth Program for COVID-19 Education and Health Promotion,Telehealth,Telehealth,Telehealth,75,https://clinicaltrials.gov/show/NCT04492527,None
5632,NCT04492865,ClinicalTrials.gov,2020-07-25,2020-07-30,False,Assiut University,Not Recruiting,Not Applicable,Observational,Egypt,MSCT Chest in Suspected COVID-19 Patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,150,https://clinicaltrials.gov/show/NCT04492865,None
5633,NCT04492891,ClinicalTrials.gov,2020-07-20,2020-11-23,False,"Bryan Burt, MD",Recruiting,Phase 2,Interventional,United States,Cyclosporine For The Treatment Of COVID-19(+),Drug,Cyclosporine,Cyclosporine,75,https://clinicaltrials.gov/show/NCT04492891,None
5634,NCT04492904,ClinicalTrials.gov,2020-07-27,2020-07-23,True,"Clinical Nutrition Research Centre, Singapore",Recruiting,Not Applicable,Observational,Singapore,Singapore COVID-19 Chemosensory Tracking (SCCT) Study,Clinical Presentation,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04492904,None
5635,NCT04492943,ClinicalTrials.gov,2020-04-24,2020-04-20,True,Massachusetts General Hospital,Not Recruiting,Not Applicable,Observational,United States,To Observe Whether Isoflurane Can Treat COVID-19 Patients,Drug,Isoflurane,Isoflurane,35,https://clinicaltrials.gov/show/NCT04492943,None
5636,NCT04493242,ClinicalTrials.gov,2020-07-29,2020-09-01,False,"Direct Biologics, LLC",Not Recruiting,Phase 2,Interventional,No Country Given,Extracellular Vesicle Infusion Therapy for Severe COVID-19,Drug,DB-001,DB-001,60,https://clinicaltrials.gov/show/NCT04493242,None
5637,NCT04493268,ClinicalTrials.gov,2020-07-28,2020-03-07,True,Hospital Nacional Profesor Alejandro Posadas,Not Recruiting,Not Applicable,Observational,Argentina,HYPONATREMIA IN COVID-19 PATIENTS,Clinical Presentation,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04493268,None
5638,NCT04493294,ClinicalTrials.gov,2020-07-29,2020-11-01,False,International Geriatric Radiotherapy Group,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Low Dose Whole Lung Radiotherapy for Older Patients With COVID-19 Pneumonitis,Other,Radiation,Radiation,500,https://clinicaltrials.gov/show/NCT04493294,None
5639,NCT04493307,ClinicalTrials.gov,2020-06-25,2020-06-30,False,LifeBridge Health,Recruiting,Not Applicable,Observational,United States,The Evaluation of Hemostasis in Hospitalized COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04493307,None
5640,NCT04493359,ClinicalTrials.gov,2020-07-29,2020-07-25,True,University of São Paulo,Recruiting,Phase 2/Phase 3,Interventional,Brazil,Switch of Renin-Angiotensin System Inhibitors in Patients With Covid-19,Drug,Renin-angiotensin system inhibitors,Renin-angiotensin system inhibitors,240,https://clinicaltrials.gov/show/NCT04493359,None
5641,NCT04494204,ClinicalTrials.gov,2020-07-28,2020-08-07,False,Puneet Mittal,Recruiting,Phase 2/Phase 3,Interventional,India,Effect of a Combination of Treatment of Reginmune Capsule and Immunofree Tablets in the Treatment of Mild to Moderate COVID-19 Patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,100,https://clinicaltrials.gov/show/NCT04494204,None
5642,NCT04494386,ClinicalTrials.gov,2020-07-24,2020-07-23,True,"Restem, LLC.",Recruiting,Phase 1/Phase 2,Interventional,United States,Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS,ATMP,Cells (ULSC),Cells (ULSC),60,https://clinicaltrials.gov/show/NCT04494386,None
5643,NCT04494399,ClinicalTrials.gov,2020-07-28,2020-07-29,False,University of Hong Kong,Recruiting,Phase 2,Interventional,Hong Kong,IFN Beta-1b and Ribavirin for Covid-19,Drug,Interferon beta + Ribavirin,Interferon beta; Ribavirin,96,https://clinicaltrials.gov/show/NCT04494399,None
5644,NCT04494646,ClinicalTrials.gov,2020-07-29,2020-09-08,False,NYU Langone Health,Recruiting,Phase 2/Phase 3,Interventional,United States,BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19),Drug,Bardoxolone methyl,Bardoxolone methyl,440,https://clinicaltrials.gov/show/NCT04494646,None
5645,NCT04494724,ClinicalTrials.gov,2020-07-21,2020-07-13,True,The Methodist Hospital System,Recruiting,Phase 2,Interventional,United States,Clazakizumab vs. Placebo - COVID-19 Infection,Drug,Clazakizumab,Clazakizumab,60,https://clinicaltrials.gov/show/NCT04494724,None
5646,NCT04494776,ClinicalTrials.gov,2020-07-16,2020-05-21,True,Helio Tedesco Silva Junior,Recruiting,Not Applicable,Observational,Brazil,SARS-COV-2 Infection in Kidney Transplant Recipients: a Brazilian Multicenter Study,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04494776,None
5647,NCT04494867,ClinicalTrials.gov,2020-07-29,2020-08-19,False,Sharp HealthCare,Recruiting,Not Applicable,Interventional,United States,Core Warming in COVID-19 Patients Undergoing Mechanical Ventilation,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04494867,None
5648,NCT04494893,ClinicalTrials.gov,2020-07-29,2020-04-24,True,Adaptive Biotechnologies,Recruiting,Not Applicable,Observational,United States,ImmuneRACE - Immune Response Action to COVID-19 Events,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04494893,None
5649,NCT04494984,ClinicalTrials.gov,2020-07-29,2020-07-27,True,Inmunova S.A.,Not Recruiting,Phase 2/Phase 3,Interventional,Argentina,"A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.",Drug,INM005,INM005,242,https://clinicaltrials.gov/show/NCT04494984,None
5650,NCT04495101,ClinicalTrials.gov,2020-07-28,2020-07-29,True,"Grifols, S.A.",Recruiting,Phase 2,Interventional,Spain,Study to Evaluate the Safety and Efficacy of Prolastin in Hospitalized Subjects With COVID-19,Drug,Prolastin,Prolastin,100,https://clinicaltrials.gov/show/NCT04495101,EUCTR2020-001953-36
5651,NCT04495543,ClinicalTrials.gov,2020-07-23,2020-08-01,False,"St. Michael's Hospital, Toronto",Not Recruiting,Not Applicable,Interventional,Canada,Mitigating Suicide Risk With Single Session 'Brief Skills for Safer Living',Other (psych),Psychological,Psychological,75,https://clinicaltrials.gov/show/NCT04495543,None
5652,NCT04495764,ClinicalTrials.gov,2020-07-22,2020-07-20,True,Davita Clinical Research,Not Recruiting,Not Applicable,Observational,United States,Registry of Sustained Immunity to COVID-19 Among ESKD Patients,Clinical Presentation,No Intervention,No Intervention,2504,https://clinicaltrials.gov/show/NCT04495764,None
5653,NCT04495803,ClinicalTrials.gov,2020-07-30,2020-08-10,False,St. Joseph's Healthcare Hamilton,Not Recruiting,Not Applicable,Interventional,No Country Given,Augmented CBGT for Perinatal Anxiety During a Global Pandemic (COVID-19),Other (psych),Psychological,Psychological,120,https://clinicaltrials.gov/show/NCT04495803,None
5654,NCT04495816,ClinicalTrials.gov,2020-07-30,2020-07-15,True,Icahn School of Medicine at Mount Sinai,Recruiting,Phase 2,Interventional,United States,COVID-19 Anosmia Study,Drug,Omega 3,Omega 3,126,https://clinicaltrials.gov/show/NCT04495816,None
5655,NCT04495842,ClinicalTrials.gov,2020-07-30,2020-10-01,False,Franklin School of Integrative Health Sciences,Recruiting,Not Applicable,Interventional,United States,The Effect of Aromatherapy on COVID-19-induced Anxiety,Other,Aromatherapy,Aromatherapy,65,https://clinicaltrials.gov/show/NCT04495842,None
5656,NCT04495907,ClinicalTrials.gov,2020-07-30,2020-08-06,False,Davita Clinical Research,Recruiting,Not Applicable,Observational,United States,COVID-19 Progression in End-Stage Kidney Disease,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04495907,None
5657,NCT04495933,ClinicalTrials.gov,2020-07-13,2020-07-13,True,University of Queensland,Recruiting,Phase 1,Interventional,Australia,"A Study on the Safety, Tolerability and Immune Response of SARS-CoV-2 Sclamp (COVID-19) Vaccine in Healthy Adults",ATMP,Vaccine,Vaccine,216,https://clinicaltrials.gov/show/NCT04495933,ACTRN12620000674932; ISRCTN51232965
5658,NCT04496076,ClinicalTrials.gov,2020-07-13,2020-04-02,True,University of Pittsburgh,Recruiting,Not Applicable,Observational,United States,COVID-19 Brain Injury,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04496076,None
5659,NCT04496128,ClinicalTrials.gov,2020-07-13,2020-04-13,True,University of Pittsburgh,Recruiting,Not Applicable,Observational,United States,COVID19 Neurological Manifestation,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04496128,None
5660,NCT04496141,ClinicalTrials.gov,2020-07-30,2020-07-27,True,Hong Kong Sanatorium & Hospital,Not Recruiting,Not Applicable,Observational,Hong Kong,Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,70,https://clinicaltrials.gov/show/NCT04496141,None
5661,NCT04496245,ClinicalTrials.gov,2020-07-26,2020-08-24,False,University of Queensland,Recruiting,Phase 3,Interventional,Australia,Reducing Acute Severe Respiratory Events in Health Care Workers During the Covid-19 Pandemic With OM85,Drug,OM85,OM85,1000,https://clinicaltrials.gov/show/NCT04496245,None
5662,NCT04496869,ClinicalTrials.gov,2020-06-15,2020-07-01,False,Hospices Civils de Lyon,Not Recruiting,Not Applicable,Observational,France,Psychological Impact of COVID19 Among Women Undergoing Infertility Treatment,Other (psych),No Intervention,No Intervention,600,https://clinicaltrials.gov/show/NCT04496869,None
5663,NCT04497194,ClinicalTrials.gov,2020-05-18,2020-03-01,True,AOUI Verona,Recruiting,Not Applicable,Observational,Italy,Registry of COVID-19 Patients at AOUI Verona,Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04497194,None
5664,NCT04497246,ClinicalTrials.gov,2020-08-03,2020-05-29,True,Murielle Surquin,Recruiting,Not Applicable,Observational,Belgium,"Psychological Impact, Mental Health and Sleep Disorder Among Patients Hospitalized and Health Care Workers During the 2019 Coronavirus Outbreak (COVID-19)",Other (psych),No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04497246,None
5665,NCT04497272,ClinicalTrials.gov,2020-08-03,2020-08-07,False,CHU de Nice,Recruiting,Not Applicable,Interventional,France,Assesment of the Metabolomic Signature in COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04497272,None
5666,NCT04497298,ClinicalTrials.gov,2020-07-31,2020-08-10,False,Institut Pasteur,Recruiting,Phase 1,Interventional,"France, Belgium",Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine,ATMP,Vaccine,Vaccine,90,https://clinicaltrials.gov/show/NCT04497298,None
5667,NCT04497311,ClinicalTrials.gov,2020-07-31,2020-06-15,True,Universidad de Guanajuato,Recruiting,Not Applicable,Observational,Mexico,Tomographic Findings in COVID-19 and Influenza,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04497311,None
5668,NCT04497324,ClinicalTrials.gov,2020-07-31,2020-08-20,True,Universidad Peruana Cayetano Heredia,Not Recruiting,Phase 2,Interventional,Peru,PERUCONPLASMA: Evaluating the Use of Convalescent Plasma as Management of COVID-19,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04497324,PER-016-20
5669,NCT04497389,ClinicalTrials.gov,2020-06-09,2020-10-28,False,University of Utah,Recruiting,Phase 1/Phase 2,Interventional,United States,Safety and Feasibility of Amniotic Fluid as a Treatment for COVID-19 Patients,ATMP,Human Amniotic Fluid,Human Amniotic Fluid,60,https://clinicaltrials.gov/show/NCT04497389,None
5670,NCT04497402,ClinicalTrials.gov,2020-07-31,2020-09-01,False,University of Roma La Sapienza,Recruiting,Not Applicable,Observational,Italy,Sex-Informed Data in the COVID-19 Pandemic.,Clinical Presentation,No Intervention,No Intervention,88,https://clinicaltrials.gov/show/NCT04497402,None
5671,NCT04497415,ClinicalTrials.gov,2020-08-02,2020-10-21,False,"Research Foundation for Mental Hygiene, Inc.",Recruiting,Not Applicable,Interventional,United States,The COVID-19 and Healthcare Workers: An Active Intervention,Other,Other,Other,1200,https://clinicaltrials.gov/show/NCT04497415,None
5672,NCT04497441,ClinicalTrials.gov,2020-08-01,2020-06-10,True,Qassim University,Recruiting,Not Applicable,Observational,Saudi Arabia,Netizens' Perception of COVID-19 Information & Information Sources.,Other,No Intervention,No Intervention,385,https://clinicaltrials.gov/show/NCT04497441,None
5673,NCT04497454,ClinicalTrials.gov,2020-07-31,2020-05-08,True,University of São Paulo General Hospital,Recruiting,Not Applicable,Interventional,Brazil,Mechanical Ventilation Strategy for Coronavirus Disease 2019 (COVID-19),Other (physical),Mechanical ventilation,Mechanical ventilation,128,https://clinicaltrials.gov/show/NCT04497454,None
5674,NCT04497467,ClinicalTrials.gov,2020-08-02,2020-08-01,True,National Taiwan University Hospital,Recruiting,Not Applicable,Observational,Taiwan,Changes in Out-patient Visits in Taiwan During the Time of Global COVID-19 Pandemic,Health System,No Intervention,No Intervention,1200000,https://clinicaltrials.gov/show/NCT04497467,None
5675,NCT04497519,ClinicalTrials.gov,2020-07-27,2020-09-15,False,University Medical Center Groningen,Not Recruiting,Phase 1,Interventional,Netherlands,Local Tolerability and Pharmacokinetic Evaluation of Cyclops Dry Powder Hydroxychloroquine Inhalation in Healthy Volunteers,Drug,Hydroxychloroquine,Hydroxychloroquine,12,https://clinicaltrials.gov/show/NCT04497519,None
5676,NCT04497610,ClinicalTrials.gov,2020-08-02,2020-08-04,False,Instituto Costarricense de Investigaciones Clínicas (ICIC),Not Recruiting,Not Applicable,Observational,Costa Rica,SARS-CoV-2 (COVID-19) Detection Using the Breath Analizer TeraSystem,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,https://clinicaltrials.gov/show/NCT04497610,None
5677,NCT04497623,ClinicalTrials.gov,2020-07-27,2020-07-28,False,Fundación Neumológica Colombiana,Not Recruiting,Not Applicable,Interventional,Colombia,"Clinical Evaluation of Ventilador Innovation Product in Colombia in the SARS COVID 19 Pandemic, Unisabana Herons.",Other (physical),Mechanical ventilation,Mechanical ventilation,5,https://clinicaltrials.gov/show/NCT04497623,None
5678,NCT04497636,ClinicalTrials.gov,2020-08-01,2020-07-03,True,Pontificia Universidad Católica de Chile,Recruiting,Not Applicable,Observational,Chile,Mental Health Impact of the COVID-19 Pandemic Among Migrants in Chile,Other (psych),No Intervention,No Intervention,1092,https://clinicaltrials.gov/show/NCT04497636,None
5679,NCT04497779,ClinicalTrials.gov,2020-06-29,2020-07-13,False,City of Hope Medical Center,Recruiting,Not Applicable,Observational,United States,Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma,Clinical Presentation,No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04497779,None
5680,NCT04497818,ClinicalTrials.gov,2020-08-01,2020-06-16,True,Qassim University,Not Recruiting,Not Applicable,Observational,Saudi Arabia,Correlation Fear of COVID-19 & Dental Treatment Anxiety,Other (psych),No Intervention,No Intervention,385,https://clinicaltrials.gov/show/NCT04497818,None
5681,NCT04497922,ClinicalTrials.gov,2020-07-30,2020-08-20,False,Brigham and Women's Hospital,Not Recruiting,Not Applicable,Interventional,United States,Virtual White Boards for Patient Satisfaction,Other,Other,Other,100,https://clinicaltrials.gov/show/NCT04497922,None
5682,NCT04497987,ClinicalTrials.gov,2020-07-31,2020-08-02,False,Eli Lilly and Company,Recruiting,Phase 3,Interventional,United States,A Study of LY3819253 (LY-CoV555) in Preventing SARS-CoV-2 Infection and COVID-19 in Nursing Home Residents and Staff,Drug (Chemoprophylaxis),LY3819253,LY3819253,2400,https://clinicaltrials.gov/show/NCT04497987,None
5683,NCT04498065,ClinicalTrials.gov,2020-08-03,2020-03-01,True,CHU Dijon,Not Recruiting,Not Applicable,Observational,France,MYocardial DOmmages Related to COVID-19,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04498065,None
5684,NCT04498091,ClinicalTrials.gov,2020-08-03,2020-03-15,True,CHU Dijon,Not Recruiting,Not Applicable,Observational,France,EPIdemiological Approaches to the Cardiovascular Consequences of COVID-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,35,https://clinicaltrials.gov/show/NCT04498091,None
5685,NCT04498273,ClinicalTrials.gov,2020-08-03,2020-09-07,False,Frank C Sciurba,Recruiting,Phase 3,Interventional,United States,COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80,Drug,Apixaban,Apixaban,7000,https://clinicaltrials.gov/show/NCT04498273,None
5686,NCT04498286,ClinicalTrials.gov,2020-08-03,2020-08-06,False,Zoe van Kempen,Recruiting,Not Applicable,Observational,Netherlands,COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients,Clinical Presentation,No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04498286,None
5687,NCT04498299,ClinicalTrials.gov,2020-07-31,2020-09-01,False,Miguel Ayala Leon,Recruiting,Not Applicable,Observational,Mexico,Stress Echocardiography in Patients Recovery From Mild COVID-19 Illness,Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04498299,None
5688,NCT04498325,ClinicalTrials.gov,2020-07-30,2020-12-31,False,Washington University in St. Louis,Not Recruiting,Phase 1,Interventional,United States,"Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Increase Lymphocyte Counts and Enhance Immune Clearance of SARS-CoV-2 (COVID-19)",Drug,NT-I7,NT-I7,42,https://clinicaltrials.gov/show/NCT04498325,None
5689,NCT04498377,ClinicalTrials.gov,2020-07-31,2020-10-09,False,Generon (Shanghai) Corporation Ltd.,Recruiting,Phase 2,Interventional,United States,Study of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19,Drug,F-652,F-652,38,https://clinicaltrials.gov/show/NCT04498377,None
5690,NCT04498416,ClinicalTrials.gov,2020-07-31,2020-04-27,True,Fondation Lenval,Recruiting,Not Applicable,Observational,France,CoCo-20: a Longitudinal Follow-up Study of the French Paediatric Population During and After the Coronavirus Pandemic COVID-19,Clinical Presentation,No Intervention,No Intervention,70,https://clinicaltrials.gov/show/NCT04498416,None
5691,NCT04498442,ClinicalTrials.gov,2020-08-03,2020-05-22,True,Beth Israel Deaconess Medical Center,Recruiting,Not Applicable,Interventional,United States,"A Study on Prevalence, Protection and Recovery From COVID-19 in Seasoned Yoga Practitioners in Comparison to Age and Gender Matched Controls",Clinical Presentation (Epidemiology),No Intervention,No Intervention,30000,https://clinicaltrials.gov/show/NCT04498442,None
5692,NCT04498507,ClinicalTrials.gov,2020-08-01,2020-04-16,True,University of Liège,Not Recruiting,Not Applicable,Observational,Belgium,Psychosocial Outcomes in Families of COVID-19 ICU Patients,Other (psych),No Intervention,No Intervention,39,https://clinicaltrials.gov/show/NCT04498507,None
5693,NCT04498546,ClinicalTrials.gov,2020-07-27,2020-07-20,True,KTO Karatay University,Recruiting,Not Applicable,Observational,Turkey,Mask Usage and Exercise During the COVID-19 Pandemic,Other (exercise),Exercise,Exercise,60,https://clinicaltrials.gov/show/NCT04498546,None
5694,NCT04498936,ClinicalTrials.gov,2020-04-14,2020-07-15,False,Assiut University,Not Recruiting,Phase 4,Interventional,Egypt,Sofosbuvir/Ledipasvir and Nitazoxanide for Treatment of COVID-19,Drug,Sofosbuvir + Ledipasvir vs. Nitazoxanide,Sofosbuvir; Ledipasvir; Nitazoxanide,240,https://clinicaltrials.gov/show/NCT04498936,None
5695,NCT04499300,ClinicalTrials.gov,2020-08-03,2020-06-09,True,Murielle Surquin,Recruiting,Not Applicable,Observational,Belgium,Elderly Patients and COVID-19 Infection: a Cohort of Fifty Patients Over Ninety Years of Age,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04499300,None
5696,NCT04499313,ClinicalTrials.gov,2020-07-27,2020-08-02,False,Chattogram General Hospital,Recruiting,Phase 3,Interventional,Bangladesh,Dexamethasone Vs Methylprednisolone for the Treatment of Patients With ARDS Caused by COVID-19,Drug,Corticosteroids,Dexamethasone; Methylprednisolone,60,https://clinicaltrials.gov/show/NCT04499313,None
5697,NCT04499378,ClinicalTrials.gov,2020-08-03,2020-08-15,False,Universidad de Guanajuato,Not Recruiting,Not Applicable,Observational,No Country Given,Tomographic Findings in COVID-19 and Influenza H1N1,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04499378,None
5698,NCT04499391,ClinicalTrials.gov,2020-07-31,2020-12-12,False,Milton S. Hershey Medical Center,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 Project ECHO in Nursing Homes,Telehealth,Telehealth,Telehealth,100,https://clinicaltrials.gov/show/NCT04499391,None
5699,NCT04499677,ClinicalTrials.gov,2020-06-16,2020-09-24,False,"University College, London",Recruiting,Phase 2,Interventional,United Kingdom,FLARE: Favipiravir +/- Lopinavir: A RCT of Early Antivirals,Drug,Favipiravir + Lopinavir/ritonavir vs. Favipiravir vs. Lopinavir/ritonavir,Favipiravir; Lopinavir/ritonavir,240,https://clinicaltrials.gov/show/NCT04499677,None
5700,NCT04500067,ClinicalTrials.gov,2020-07-15,2020-05-07,True,Biopharma Plasma LLC,Not Recruiting,Phase 3,Interventional,Ukraine,"Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment",ATMP,Immunoglobulin,Immunoglobulin,76,https://clinicaltrials.gov/show/NCT04500067,None
5701,NCT04500132,ClinicalTrials.gov,2020-08-04,2020-05-28,True,Enzychem Lifesciences Corporation,Recruiting,Phase 2,Interventional,South Korea,To Evaluate Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia,Drug,EC-18,EC-18,60,https://clinicaltrials.gov/show/NCT04500132,None
5702,NCT04500366,ClinicalTrials.gov,2020-07-31,2020-08-26,False,McMaster University,Recruiting,Not Applicable,Interventional,Canada,GERAS Frailty Rehabilitation at Home During COVID-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,70,https://clinicaltrials.gov/show/NCT04500366,None
5703,NCT04500418,ClinicalTrials.gov,2020-08-04,2020-08-25,True,Charité University,Recruiting,Phase 2,Interventional,Germany,CharitÃ© Trial of Cenicriviroc (CVC) Treatment for COVID-19 Patients,Drug,Cenicriviroc,Cenicriviroc,183,https://clinicaltrials.gov/show/NCT04500418,EUCTR2020-001493-29
5704,NCT04500600,ClinicalTrials.gov,2020-07-24,2020-06-11,True,M.D. Anderson Cancer Center,Recruiting,Not Applicable,Observational,United States,Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,50000,https://clinicaltrials.gov/show/NCT04500600,None
5705,NCT04500626,ClinicalTrials.gov,2020-07-31,2020-10-01,False,Ottawa Hospital Research Institute,Not Recruiting,Phase 2/Phase 3,Interventional,Canada,Hyperbaric Versus Normobaric Oxygen Therapy for COVID-19 Patients,Drug,Oxygen,Oxygen,234,https://clinicaltrials.gov/show/NCT04500626,None
5706,NCT04500639,ClinicalTrials.gov,2020-08-04,2020-07-23,True,University of Alberta,Recruiting,Not Applicable,Observational,Canada,Over-the-counter Medications & COVID-19,Drug,Other,Other,14000,https://clinicaltrials.gov/show/NCT04500639,None
5707,NCT04500652,ClinicalTrials.gov,2020-07-24,2020-06-27,True,Dokuz Eylul University,Recruiting,Not Applicable,Observational,Turkey,Mental Health Status and Related Factors Among Physical Medicine & Rehabilitation Physicians in the Covid-19 Pandemic,Other (psych),No Intervention,No Intervention,310,https://clinicaltrials.gov/show/NCT04500652,None
5708,NCT04501172,ClinicalTrials.gov,2020-07-25,2020-06-25,True,Democritus University of Thrace,Not Recruiting,Not Applicable,Observational,Greece,Impact of Spectacles on Compliance to Mask-wearing Directives,Other,No Intervention,No Intervention,1214,https://clinicaltrials.gov/show/NCT04501172,None
5709,NCT04501445,ClinicalTrials.gov,2020-08-04,2020-09-14,False,Rush University Medical Center,Recruiting,Not Applicable,Interventional,United States,Psychological Symptoms and Families of COVID-19 Patients,Other (psych),No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04501445,None
5710,NCT04501458,ClinicalTrials.gov,2020-08-05,2020-05-18,True,Surgical Systems Research Group,Recruiting,Not Applicable,Interventional,Kenya,Western Kenya Integrated COVID-19 Response,Health System,Health System,Health System,200000,https://clinicaltrials.gov/show/NCT04501458,None
5711,NCT04501783,ClinicalTrials.gov,2020-08-05,2020-05-20,True,"R-Pharm International, LLC",Not Recruiting,Phase 3,Interventional,Russian Federation,Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19,Drug,Favipiravir,Favipiravir,168,https://clinicaltrials.gov/show/NCT04501783,None
5712,NCT04501796,ClinicalTrials.gov,2020-07-27,2020-08-01,False,NeoImmuneTech,Recruiting,Phase 1,Interventional,United States,A Trial of NT-I7 in COVID-19 (SPESELPIS),Drug,NT-I7,NT-I7,30,https://clinicaltrials.gov/show/NCT04501796,None
5713,NCT04501822,ClinicalTrials.gov,2020-07-28,2020-07-19,True,Tomsk National Research Medical Center of the Russian Academy of Sciences,Recruiting,Not Applicable,Observational,Russian Federation,One-year Cardiac Follow-up of Patients With COVID-19 Pneumonia,Clinical Presentation,No Intervention,No Intervention,380,https://clinicaltrials.gov/show/NCT04501822,None
5714,NCT04501965,ClinicalTrials.gov,2020-08-03,2020-06-01,True,Institute for Research and Development of Medicinal and Food Plants of Guinea,Recruiting,Phase 2,Interventional,Guinea,Phytomedicines Versus Hydroxychloroquine as an Add on Therapy to Azythromycin in Asymptomatic Covid-19 Patients,Drug,Hydroxychloroquine + Azithromycin vs. Quinquina-Stevia + Azythromycin vs. 4Plants + Azythromycin,Hydroxychloroquine; Azithromycin; Quinquina-Stevia; 4Plants,231,https://clinicaltrials.gov/show/NCT04501965,None
5715,NCT04501978,ClinicalTrials.gov,2020-08-03,2020-08-04,False,National Institute of Allergy and Infectious Diseases (NIAID),Not Recruiting,Phase 3,Interventional,"Singapore, United States, Denmark, Spain",ACTIV-3: Therapeutics for Inpatients With COVID-19,Drug,LY3819253,LY3819253,10000,https://clinicaltrials.gov/show/NCT04501978,None
5716,NCT04501991,ClinicalTrials.gov,2020-08-05,2020-03-11,True,University of Pisa,Not Recruiting,Not Applicable,Observational,Italy,Short-term Impact of COVID-19 Lockdown on Metabolic Control of Type 2 Diabetes,Clinical Presentation,No Intervention,No Intervention,114,https://clinicaltrials.gov/show/NCT04501991,None
5717,NCT04502056,ClinicalTrials.gov,2020-08-02,2020-07-31,True,"National Bureau of Economic Research, Inc.",Not Recruiting,Not Applicable,Interventional,United States,Covid-19 Messaging to Underserved Communities - 2nd Experiment,Other,Other,Other,20000,https://clinicaltrials.gov/show/NCT04502056,None
5718,NCT04502069,ClinicalTrials.gov,2020-07-10,2020-08-01,False,RedHill Biopharma Limited,Not Recruiting,Phase 1/Phase 2,Interventional,Israel,Treatment of COVID-19 With Opaganib in Patients With Pneumonia Requiring Oxygen,Drug,Opaganib,Opaganib,0,https://clinicaltrials.gov/show/NCT04502069,None
5719,NCT04502108,ClinicalTrials.gov,2020-08-05,2020-04-01,True,Slavko Rogan,Recruiting,Not Applicable,Observational,Switzerland,Behavior During and After COVID-19 Crisis,Other,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04502108,None
5720,NCT04502342,ClinicalTrials.gov,2020-08-04,2020-06-01,True,Institute for Research and Development of Medicinal and Food Plants of Guinea,Recruiting,Phase 2,Interventional,Guinea,"Add on to Azythromycine, Phytomedicine and/or Antimalarial Drug vs Hydroxychloroquine in Uncomplicated COVID-19 Patients",Drug,Hydroxychloroquine + Azithromycin vs. Cospherunate + Azithromycin vs. Cospherunate + Phytomedicine + Azithromycin,Hydroxychloroquine; Azithromycin; Cospherunate; Phytomedicine,30,https://clinicaltrials.gov/show/NCT04502342,None
5721,NCT04502433,ClinicalTrials.gov,2020-08-03,2020-09-01,True,Chiesi Farmaceutici,Not Recruiting,Phase 2,Interventional,No Country Given,Poractant Alfa - Curosurf and SARS-COV-19 ARDS (Covid-19),Drug,Poractant alfa,Poractant alfa,85,https://clinicaltrials.gov/show/NCT04502433,EUCTR2020-002632-75
5722,NCT04502472,ClinicalTrials.gov,2020-08-04,2020-06-06,True,Inova Health Care Services,Recruiting,Phase 2/Phase 3,Interventional,United States,Open-label Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma,ATMP,Plasma,Plasma,200,https://clinicaltrials.gov/show/NCT04502472,None
5723,NCT04502667,ClinicalTrials.gov,2020-08-04,2020-07-15,True,"Coordinación de Investigación en Salud, Mexico",Recruiting,Phase 3,Interventional,Mexico,Efficacy of Vitamin D Treatment in Pediatric Patients Hospitalized by COVID-19,Drug,Vitamin D,Vitamin D,40,https://clinicaltrials.gov/show/NCT04502667,None
5724,NCT04503057,ClinicalTrials.gov,2020-08-03,2020-05-01,True,Lund University Hospital,Recruiting,Not Applicable,Observational,Sweden,Exhaled Breath Particles as a Clinical Indicator for Lung Injury and Acute Respiratory Distress Syndrome (ARDS),Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04503057,None
5725,NCT04503434,ClinicalTrials.gov,2020-06-11,2020-05-15,True,Hospital Clinic of Barcelona,Not Recruiting,Not Applicable,Observational,Spain,Patients' Experiences in a Medicalized Hotel for COVID-19 Acute Care Support,Other,No Intervention,No Intervention,517,https://clinicaltrials.gov/show/NCT04503434,None
5726,NCT04503447,ClinicalTrials.gov,2020-08-04,2020-08-01,True,Institute of Tropical Medicine,Not Recruiting,Not Applicable,Observational,Belgium,COVID-19 Seroprevalence Study in ITM Staff,Clinical Presentation (Epidemiology),No Intervention,No Intervention,330,https://clinicaltrials.gov/show/NCT04503447,None
5727,NCT04503525,ClinicalTrials.gov,2020-08-04,2020-05-25,True,Lille Catholic University,Recruiting,Not Applicable,Observational,France,Nutritional Assessment of Hospitalized Patients With COVID-19,Other (nutrition),No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04503525,None
5728,NCT04504240,ClinicalTrials.gov,2020-08-06,2020-08-01,True,Chattogram General Hospital,Recruiting,Phase 3,Interventional,Bangladesh,Role of Famotidine in the Symptomatic Improvement of COVID-19 Patients,Drug,Famotidine,Famotidine,200,https://clinicaltrials.gov/show/NCT04504240,None
5729,NCT04504877,ClinicalTrials.gov,2020-08-04,2020-06-16,True,University of São Paulo,Not Recruiting,Phase 2/Phase 3,Interventional,Brazil,Burnout and Distress preventiOn With caNnabidiol in Front-line Health Care workerS deAling wIth COVID-19,Other (psych),Cannabidiol,Cannabidiol,120,https://clinicaltrials.gov/show/NCT04504877,None
5730,NCT04505098,ClinicalTrials.gov,2020-08-05,2020-08-07,False,Kaiser Permanente,Recruiting,Phase 4,Interventional,United States,A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults,Drug,Icosapent ethyl,Icosapent ethyl,16500,https://clinicaltrials.gov/show/NCT04505098,None
5731,NCT04505592,ClinicalTrials.gov,2020-08-06,2020-09-25,False,Hooman Poor,Recruiting,Phase 2,Interventional,United States,Tenecteplase in Patients With COVID-19,Drug,Tenecteplase,Tenecteplase,60,https://clinicaltrials.gov/show/NCT04505592,None
5732,NCT04505605,ClinicalTrials.gov,2020-07-31,2020-05-14,True,Groupe Hospitalier Paris Saint-Joseph,Not Recruiting,Not Applicable,Observational,France,Study of a Possible Respiratory Degradation Prognosis Caused by Biomarkers in Severe Forms of COVID-19 Pneumonia,Prognosis,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04505605,None
5733,NCT04505631,ClinicalTrials.gov,2020-08-03,2020-06-10,True,Groupe Hospitalier de la Region de Mulhouse et Sud Alsace,Recruiting,Not Applicable,Observational,France,Follow-up of Respiratory Sequelae of Hospitalized Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04505631,None
5734,NCT04505709,ClinicalTrials.gov,2020-08-07,2020-08-01,True,Instituto de Investigación Sanitaria Fundación Jiménez Díaz,Recruiting,Not Applicable,Observational,Spain,"Clinical, Immunological, Genomic, Virological and Bioethical Actors of COVID-19",Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04505709,None
5735,NCT04505761,ClinicalTrials.gov,2020-07-03,2020-08-01,False,Radboud University,Recruiting,Not Applicable,Interventional,Netherlands,"The Usability, Feasibility, and Tolerability of Virtual Reality for Rehabilitation From COVID-19",Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,40,https://clinicaltrials.gov/show/NCT04505761,None
5736,NCT04505774,ClinicalTrials.gov,2020-08-06,2020-09-04,False,Dr. Matthew Neal,Recruiting,Phase 4,Interventional,United States,Anti-thrombotics for Adults Hospitalized With COVID-19 (ACTIV-4),Drug,Heparin,Heparin,2000,https://clinicaltrials.gov/show/NCT04505774,None
5737,NCT04506229,ClinicalTrials.gov,2020-08-07,2020-08-20,False,Texas Cardiac Arrhythmia Research Foundation,Recruiting,Not Applicable,Observational,United States,Genetic Mechanisms Underlying SARS-CoV-2 Infection and the Impact of COVID-19 on Cognitive Function,Genomics,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04506229,None
5738,NCT04506515,ClinicalTrials.gov,2020-08-03,2020-04-09,True,Hospital General Universitari de València,Not Recruiting,Not Applicable,Observational,Spain,Psychological Impact of COVID-19 Pandemic in Healthcare Workers,Other (psych),No Intervention,No Intervention,3000,https://clinicaltrials.gov/show/NCT04506515,None
5739,NCT04506528,ClinicalTrials.gov,2020-08-07,2020-08-10,False,"University of Wisconsin, Madison",Recruiting,Not Applicable,Observational,United States,The C3I COVID-19 Project,Clinical Presentation (Epidemiology),No Intervention,No Intervention,170000,https://clinicaltrials.gov/show/NCT04506528,None
5740,NCT04506632,ClinicalTrials.gov,2020-07-21,2020-06-02,True,Sheffield Teaching Hospitals NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,Burden for STaff Working in the NHS,Health System,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04506632,None
5741,NCT04507230,ClinicalTrials.gov,2020-08-07,2020-08-07,False,Assiut University,Recruiting,Not Applicable,Observational,Egypt,COVID-19 Associated Coagulopathy in Egypt,Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04507230,None
5742,NCT04507256,ClinicalTrials.gov,2020-08-07,2020-08-18,False,AstraZeneca,Not Recruiting,Phase 1,Interventional,United Kingdom,AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19,Drug,AZD7442,AZD7442,60,https://clinicaltrials.gov/show/NCT04507256,None
5743,NCT04507282,ClinicalTrials.gov,2020-08-07,2020-05-15,True,Bursa Postgraduate Hospital,Not Recruiting,Not Applicable,Observational,Turkey,Eosinophil and Anticoagulation in COVID-19 Patients,Drug,Heparin,Heparin,80,https://clinicaltrials.gov/show/NCT04507282,None
5744,NCT04507867,ClinicalTrials.gov,2020-08-06,2020-08-01,True,Anáhuac University,Not Recruiting,Not Applicable,Interventional,No Country Given,Effect of a Nss to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III,Other (nutrition),Nutrition,Nutrition,240,https://clinicaltrials.gov/show/NCT04507867,None
5745,NCT04507893,ClinicalTrials.gov,2020-08-05,2020-03-15,True,University of Palermo,Recruiting,Not Applicable,Observational,Italy,Comparison Between Positive and Negative COVID-19 Pneumonia,Clinical Presentation,No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04507893,None
5746,NCT04508075,ClinicalTrials.gov,2020-08-07,2020-08-10,False,PT Bio Farma,Recruiting,Phase 3,Interventional,Indonesia,"Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine",ATMP,Vaccine,Vaccine,1620,https://clinicaltrials.gov/show/NCT04508075,None
5747,NCT04508439,ClinicalTrials.gov,2020-08-05,2020-06-20,True,Hospital Regional de Alta Especialidad de Ixtapaluca,Recruiting,Not Applicable,Interventional,Mexico,Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection,Drug,Enoxaparin,Enoxaparin,130,https://clinicaltrials.gov/show/NCT04508439,None
5748,NCT04508556,ClinicalTrials.gov,2020-08-07,2020-09-01,False,Owlstone Ltd,Not Recruiting,Not Applicable,Observational,No Country Given,Performance Assessment of SARS-CoV-2 Detection Breath Biopsy - SARS-CoV-2 Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,https://clinicaltrials.gov/show/NCT04508556,None
5749,NCT04508712,ClinicalTrials.gov,2020-08-08,2020-08-10,False,RenJi Hospital,Recruiting,Not Applicable,Observational,China,Long-term Outcomes in Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,900,https://clinicaltrials.gov/show/NCT04508712,None
5750,NCT04508777,ClinicalTrials.gov,2020-08-10,2020-09-09,False,University of Pennsylvania,Recruiting,Not Applicable,Observational,United States,COVID SAFE: COVID-19 Screening Assessment for Exposure,Clinical Presentation (Epidemiology),No Intervention,No Intervention,600,https://clinicaltrials.gov/show/NCT04508777,None
5751,NCT04508868,ClinicalTrials.gov,2020-08-10,2020-08-17,False,Uppsala University,Recruiting,Not Applicable,Interventional,Sweden,Treatment of Depressive Symptoms in Older Individuals in Isolation During Covid-19,Other (psych),Psychological,Psychological,154,https://clinicaltrials.gov/show/NCT04508868,None
5752,NCT04508920,ClinicalTrials.gov,2020-08-07,2019-05-15,True,"Centro en Insuficiencia Cardiaca, Mexico",Recruiting,Not Applicable,Observational,Mexico,A Survey to Assess Effects of Covid-19 on Cardiovascular Patients,Clinical Presentation,No Intervention,No Intervention,76,https://clinicaltrials.gov/show/NCT04508920,None
5753,NCT04508933,ClinicalTrials.gov,2020-08-08,2020-09-01,False,Istanbul University-Cerrahpasa,Not Recruiting,Not Applicable,Observational,Turkey,"Comparison of Extra Vascular Lung Water Index in Covid-19 ARDS and ""Typical""ARDS Patients",Clinical Presentation,No Intervention,No Intervention,10,https://clinicaltrials.gov/show/NCT04508933,None
5754,NCT04508959,ClinicalTrials.gov,2020-08-10,2020-04-15,True,McMaster University,Recruiting,Not Applicable,Observational,Canada,The McMaster Multi-Regional COVID-19 Hospital Case Registry,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04508959,None
5755,NCT04508972,ClinicalTrials.gov,2020-08-10,2020-07-01,True,McGill University,Recruiting,Not Applicable,Observational,Canada,The VOICE-COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04508972,None
5756,NCT04508985,ClinicalTrials.gov,2020-08-10,2020-09-01,False,McGill University,Not Recruiting,Not Applicable,Interventional,No Country Given,The McGill RAAS-COVID-19 Trial,Drug,RAAS inhibitor,RAAS inhibitor,40,https://clinicaltrials.gov/show/NCT04508985,None
5757,NCT04509713,ClinicalTrials.gov,2020-08-06,2020-07-02,True,London School of Hygiene and Tropical Medicine,Recruiting,Not Applicable,Observational,United Kingdom,Canine COVID-19 Detection,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,16250,https://clinicaltrials.gov/show/NCT04509713,None
5758,NCT04509752,ClinicalTrials.gov,2020-08-11,2020-08-20,False,Hacettepe University,Not Recruiting,Not Applicable,Observational,Turkey,Dysphagia Management During COVID-19 Pandemic,Other,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04509752,None
5759,NCT04509947,ClinicalTrials.gov,2020-08-11,2020-08-11,False,Janssen Pharmaceutical,Recruiting,Phase 1,Interventional,Japan,A Study of Ad26.COV2.S in Adults (COVID-19),ATMP,Vaccine,Vaccine,250,https://clinicaltrials.gov/show/NCT04509947,None
5760,NCT04509986,ClinicalTrials.gov,2020-08-11,2020-10-01,False,University of Birmingham,Not Recruiting,Not Applicable,Observational,No Country Given,GlobalSurg-CovidSurg Week,Health System,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04509986,None
5761,NCT04510012,ClinicalTrials.gov,2020-08-10,2020-03-05,True,"University Hospital, Bern",Recruiting,Not Applicable,Observational,Switzerland,Characterizing the Immune Response and Neuronal Damage in COVID-19,Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04510012,None
5762,NCT04510025,ClinicalTrials.gov,2020-07-14,2020-05-13,True,University of Oxford,Recruiting,Not Applicable,Observational,United Kingdom,Capturing MultiORgan Effects of COVID-19,Clinical Presentation,No Intervention,No Intervention,616,https://clinicaltrials.gov/show/NCT04510025,None
5763,NCT04510038,ClinicalTrials.gov,2020-08-10,2020-09-01,False,Miami Cardiac and Vascular Institute,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Colchicine vs Current Standard of Care in Hospitalized Patients With COVID-19 and Cardiac Injury,Drug,Colchicine,Colchicine,75,https://clinicaltrials.gov/show/NCT04510038,None
5764,NCT04510194,ClinicalTrials.gov,2020-08-07,2020-11-01,False,University of Minnesota,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,MET-Covid -- Outpatient Metformin Use for Covid-19.,Drug,Metformin,Metformin,70,https://clinicaltrials.gov/show/NCT04510194,None
5765,NCT04510207,ClinicalTrials.gov,2020-08-03,2020-07-16,True,China National Biotec Group Co. Ltd,Recruiting,Phase 3,Interventional,"Bahrain, Egypt, Jordan, United Arab Emirates","A Study to Evaluate The Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Population Aged 18 Years Old and Above",ATMP,Vaccine,Vaccine,45000,https://clinicaltrials.gov/show/NCT04510207,None
5766,NCT04510233,ClinicalTrials.gov,2020-08-10,2020-09-01,False,Tanta University,Not Recruiting,Phase 2,Interventional,No Country Given,Ivermectin Nasal Spray for COVID19 Patients,Drug,Ivermectin,Ivermectin,60,https://clinicaltrials.gov/show/NCT04510233,None
5767,NCT04510402,ClinicalTrials.gov,2020-08-10,2020-08-01,True,Brigham and Women's Hospital,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Phase I/II Trial of Povidone-iodine (PVP-I) Nasal Swab For Preventing COVID-19 Spread in Healthy Subjects,Drug,Povidine iodine,Povidine iodine,50,https://clinicaltrials.gov/show/NCT04510402,None
5768,NCT04510441,ClinicalTrials.gov,2020-08-07,2020-05-26,True,Imperial College London,Recruiting,Not Applicable,Observational,United Kingdom,Artificial Intelligence-assisted Diagnosis and Prognostication in COVID-19 Using Electrocardiograms,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,2000,https://clinicaltrials.gov/show/NCT04510441,None
5769,NCT04510454,ClinicalTrials.gov,2020-08-11,2020-09-01,False,Centre Leon Berard,Not Recruiting,Not Applicable,Interventional,No Country Given,Evaluation of a ddPCR Technology for the SARS-CoV-2 Detection in Symptomatic Patients With Suspicion of COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04510454,None
5770,NCT04510467,ClinicalTrials.gov,2020-08-11,2021-01-01,False,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Mental Health Consequences of COVID19 Infection in the French RMD Cohort,Other (psych),No Intervention,No Intervention,1313,https://clinicaltrials.gov/show/NCT04510467,None
5771,NCT04510493,ClinicalTrials.gov,2020-08-11,2020-10-23,False,"University Hospital, Basel",Recruiting,Phase 3,Interventional,Switzerland,Canakinumab in Patients With COVID-19 and Type 2 Diabetes,Drug,Canakinumab,Canakinumab,116,https://clinicaltrials.gov/show/NCT04510493,None
5772,NCT04510519,ClinicalTrials.gov,2020-08-07,2020-09-01,False,"Kintsugi Mindful Wellness, Inc.",Not Recruiting,Not Applicable,Observational,No Country Given,Scaling Mental Healthcare in COVID-19 With Voice Biomarkers,Other (psych),No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04510519,None
5773,NCT04510623,ClinicalTrials.gov,2020-08-11,2020-03-17,True,University of British Columbia,Recruiting,Not Applicable,Observational,Canada,Host Response Mediators in Coronavirus (COVID-19) Infection,Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,500,https://clinicaltrials.gov/show/NCT04510623,None
5774,NCT04510662,ClinicalTrials.gov,2020-08-11,2020-08-01,True,Abraham Edgar Gracia-Ramos,Recruiting,Phase 2,Interventional,Mexico,Telmisartan in Respiratory Failure Due to COVID-19,Drug,Telmisartan,Telmisartan,60,https://clinicaltrials.gov/show/NCT04510662,None
5775,NCT04511429,ClinicalTrials.gov,2020-07-24,2020-06-30,True,D'Or Institute for Research and Education,Recruiting,Not Applicable,Observational,Brazil,COVID-19 in Immunosuppressed Children,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04511429,None
5776,NCT04511650,ClinicalTrials.gov,2020-08-07,2020-10-21,False,Aerpio Therapeutics,Recruiting,Phase 2,Interventional,United States,"A Study to Evaluate the Safety and Efficacy of Razuprotafib, a Novel Tie 2 Activator, in Hospitalized Subjects With Moderate to Severe Coronavirus Disease 2019 (COVID-19)",Drug,Razuprotafib,Razuprotafib,180,https://clinicaltrials.gov/show/NCT04511650,None
5777,NCT04511780,ClinicalTrials.gov,2020-08-12,2020-09-01,False,CHU de Nimes,Not Recruiting,Not Applicable,Observational,France,Psychological Impact of COVID-19 Outbreak on Caregivers,Other (psych),No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04511780,None
5778,NCT04511819,ClinicalTrials.gov,2020-08-08,2020-08-28,False,Fulcrum Therapeutics,Recruiting,Phase 3,Interventional,"United States, Mexico, Brazil",Losmapimod Safety and Efficacy in COVID-19,Drug,Losmapimod,Losmapimod,410,https://clinicaltrials.gov/show/NCT04511819,None
5779,NCT04511923,ClinicalTrials.gov,2020-08-10,2020-09-01,False,University College Hospital Galway,Not Recruiting,Phase 1/Phase 2,Interventional,Ireland,Nebulised Heparin to Reduce COVID-19 Induced Acute Lung Injury,Drug,Heparin,Heparin,40,https://clinicaltrials.gov/show/NCT04511923,None
5780,NCT04511949,ClinicalTrials.gov,2020-08-12,2020-07-12,True,Centre de Recherches et d'Études Surla Pathologie Tropicale,Recruiting,Not Applicable,Interventional,France,COVID-19: Epidemiological Study of the Spread of SARS-CoV-2 in the Household of a Person Who Has Had a COVID-19 Disease,Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04511949,None
5781,NCT04511962,ClinicalTrials.gov,2020-08-05,2020-08-12,False,Hull University Teaching Hospitals NHS Trust,Not Recruiting,Not Applicable,Observational,United Kingdom,"Feasibility, of Tele-rehabilitation Following COVID-19",Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,40,https://clinicaltrials.gov/show/NCT04511962,None
5782,NCT04512027,ClinicalTrials.gov,2020-08-11,2020-09-15,True,Composite Interceptive Med Science,Not Recruiting,Not Applicable,Interventional,India,Prolectin-M in COVID-19 Patients Having Mild to Moderate Symptoms Not Requiring Oxygen Support.,Drug,Protectin-M,Protectin-M,10,https://clinicaltrials.gov/show/NCT04512027,CTRI/2020/09/027833
5783,NCT04512079,ClinicalTrials.gov,2020-08-11,2020-09-08,True,Valentin Fuster,Recruiting,Phase 4,Interventional,United States,FREEDOM COVID-19 Anticoagulation Strategy,Drug,Apixaban vs. Enoxaparin,Apixaban; Enoxaparin,3600,https://clinicaltrials.gov/show/NCT04512079,CTRI/2020/11/029345
5784,NCT04512118,ClinicalTrials.gov,2020-08-12,2020-03-15,True,CHU de Nancy,Not Recruiting,Not Applicable,Observational,France,CT Abnormalities Evocative of Lung Infection Are Associated With Lower 18F-FDG Uptake in Confirmed COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,22,https://clinicaltrials.gov/show/NCT04512118,None
5785,NCT04512300,ClinicalTrials.gov,2020-08-12,2020-06-15,True,Cairo University,Not Recruiting,Not Applicable,Observational,Egypt,Parental Attitude Toward Children Dental Treatment During COVID-19 Pandemic,Other,No Intervention,No Intervention,267,https://clinicaltrials.gov/show/NCT04512300,None
5786,NCT04513158,ClinicalTrials.gov,2020-08-06,2020-08-14,False,Dr. Joseph M. Flynn,Recruiting,Phase 2,Interventional,United States,Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04513158,None
5787,NCT04513184,ClinicalTrials.gov,2020-08-12,2020-07-14,True,Edda Sciutto Conde,Recruiting,Phase 2,Interventional,Mexico,Randomized Clinical Trial of Intranasal Dexamethasone as an Adjuvant in Patients With COVID-19,Drug,Corticosteroids,Dexamthasone,60,https://clinicaltrials.gov/show/NCT04513184,None
5788,NCT04513210,ClinicalTrials.gov,2020-08-11,2020-10-10,False,Jagiellonian University,Recruiting,Not Applicable,Observational,Poland,Reliability of Standardized Protocol of Ultrasound of the Lungs in Prediction of Severity of Covid-19 Infection,Prognosis,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04513210,None
5789,NCT04513314,ClinicalTrials.gov,2020-08-12,2021-11-01,False,University of Miami,Not Recruiting,Phase 4,Interventional,United States,Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium,Drug,Valporate vs. Valporate + Quetiapine,Valporate; Quetiapine,20,https://clinicaltrials.gov/show/NCT04513314,None
5790,NCT04513470,ClinicalTrials.gov,2020-08-10,2020-08-01,True,Hadassah Medical Organization,Not Recruiting,Phase 1,Interventional,Israel,Allocetra-OTS in COVID-19,ATMP,Cells (mononuclear),Cells (mononuclear),5,https://clinicaltrials.gov/show/NCT04513470,None
5791,NCT04513496,ClinicalTrials.gov,2020-08-04,2020-09-01,False,Fundación IBIS,Not Recruiting,Not Applicable,Observational,No Country Given,Telemedicine in HIV Care in Buenos Aires,Other,No Intervention,No Intervention,4000,https://clinicaltrials.gov/show/NCT04513496,None
5792,NCT04513561,ClinicalTrials.gov,2020-08-11,2020-12-01,False,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Evaluation of the Impact of Lock Down and End of Lock Down on the Management of Patients With Inflammatory and Dysimmune Diseases Followed in the Context of IMMINeNT FHU and COVID-19,Other,No Intervention,No Intervention,4500,https://clinicaltrials.gov/show/NCT04513561,None
5793,NCT04513847,ClinicalTrials.gov,2020-08-12,2020-08-13,False,Dermatrials Research,Not Recruiting,Not Applicable,Observational,Canada,PsoVac: Educational Needs re Vaccines for Biologic Patients With Psoriasis,Other,No Intervention,No Intervention,661,https://clinicaltrials.gov/show/NCT04513847,None
5794,NCT04513964,ClinicalTrials.gov,2020-08-13,2020-11-01,False,Groupe Hospitalier Paris Saint-Joseph,Not Recruiting,Not Applicable,Observational,France,Impact of COVID-19 on the Benefit of Cardiac Rehabilitation,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,60,https://clinicaltrials.gov/show/NCT04513964,None
5795,NCT04513990,ClinicalTrials.gov,2020-06-05,2020-04-09,True,M.D. Anderson Cancer Center,Recruiting,Not Applicable,Interventional,United States,Novel Point-of-Care Diagnostic Test for SARS-CoV-2 (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1500,https://clinicaltrials.gov/show/NCT04513990,None
5796,NCT04514003,ClinicalTrials.gov,2020-08-13,2020-07-01,True,Sykehuset Telemark,Recruiting,Not Applicable,Observational,Norway,The Corona and COVID-19 Study in Telemark and Agder,Clinical Presentation,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04514003,None
5797,NCT04514016,ClinicalTrials.gov,2020-08-13,2020-08-12,True,University of Miami,Recruiting,Not Applicable,Observational,United States,Cross Sectional CFAR HIV/COVID Study,Clinical Presentation (Epidemiology),No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04514016,None
5798,NCT04514302,ClinicalTrials.gov,2020-08-12,2020-10-20,False,Hospital San Jose Tec de Monterrey,Not Recruiting,Phase 1/Phase 2,Interventional,Mexico,Safety and Efficacy of Anti-SARS-CoV-2 Equine Antibody Fragments (INOSARS) for Hospitalized Patients With COVID-19,ATMP,Immunoglobulin,Immunoglobulin,51,https://clinicaltrials.gov/show/NCT04514302,None
5799,NCT04514627,ClinicalTrials.gov,2020-07-08,2020-07-13,False,"University of California, Los Angeles",Recruiting,Not Applicable,Interventional,United States,Neuromodulation With Percutaneous Electrical Nerve Field Stimulation for Adults With COVID-19,Other (device),Vagus nerve stimulation,Vagus nerve stimulation,100,https://clinicaltrials.gov/show/NCT04514627,None
5800,NCT04514705,ClinicalTrials.gov,2020-08-11,2020-08-11,False,Universidade Metodista de Piracicaba,Recruiting,Not Applicable,Interventional,Brazil,Characteristics in Post Covid-19 Patients,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04514705,None
5801,NCT04514874,ClinicalTrials.gov,2020-08-14,2020-09-01,False,Direction Centrale du Service de Sant des Armes,Recruiting,Not Applicable,Observational,France,Assessment of the Prevalence and the Impact of the COVID-19 Epidemic in the French Flight Crew in 2020,Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04514874,None
5802,NCT04514900,ClinicalTrials.gov,2020-07-20,2020-09-23,False,University of South Carolina,Not Recruiting,Not Applicable,Interventional,United States,Exploring Optimal Treatment Components for Contactless Online Group-based Behavioral Weight Loss Program,Other,Other,Other,120,https://clinicaltrials.gov/show/NCT04514900,None
5803,NCT04515108,ClinicalTrials.gov,2020-08-14,2020-03-10,True,Ankara City Hospital Bilkent,Not Recruiting,Not Applicable,Observational,Turkey,Perinatal Outcomes and Hematologic Parameters in COVID-19 Pregnancies,Clinical Presentation,No Intervention,No Intervention,108,https://clinicaltrials.gov/show/NCT04515108,None
5804,NCT04515147,ClinicalTrials.gov,2020-08-13,2020-09-28,False,CureVac AG,Recruiting,Phase 2,Interventional,"Peru, Panama","A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19",ATMP,Vaccine,Vaccine,660,https://clinicaltrials.gov/show/NCT04515147,None
5805,NCT04515199,ClinicalTrials.gov,2020-08-07,2020-07-01,True,Cairo University,Recruiting,Not Applicable,Observational,Egypt,Home Management of Adult Egyptian Mild COVID-19 Cases,Telehealth,Telehealth,Telehealth,400,https://clinicaltrials.gov/show/NCT04515199,None
5806,NCT04515225,ClinicalTrials.gov,2020-08-13,2020-09-15,False,"University Hospital, Strasbourg",Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 Prevalence in HIV-infected Patients,Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04515225,None
5807,NCT04516486,ClinicalTrials.gov,2020-06-23,2020-03-09,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,Coronavirus Studied by Metagenomics in ARDS COVID-19 Patients,Genomics,No Intervention,No Intervention,180,https://clinicaltrials.gov/show/NCT04516486,None
5808,NCT04516512,ClinicalTrials.gov,2020-08-17,2020-09-01,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,No Country Given,Assessment of SARS-CoV-2 Seroprevalence in Detention,Clinical Presentation (Epidemiology),No Intervention,No Intervention,2500,https://clinicaltrials.gov/show/NCT04516512,None
5809,NCT04516564,ClinicalTrials.gov,2020-08-13,2020-09-01,False,Akesobio Australia Pty Ltd,Recruiting,Phase 1,Interventional,New Zealand,"A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects",Drug,AK119,AK119,32,https://clinicaltrials.gov/show/NCT04516564,None
5810,NCT04516668,ClinicalTrials.gov,2020-08-17,2020-11-01,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,No Country Given,Effect of Tele-consultation in Addition With Psychiatric Follow-up During COVID-19 in Women Who Have Medical History of Post-partum Depression,Telehealth,Telehealth + Psychological,Telehealth; Psychological,250,https://clinicaltrials.gov/show/NCT04516668,None
5811,NCT04516759,ClinicalTrials.gov,2020-08-14,2020-08-12,True,St. George Street Capital Ltd,Recruiting,Phase 2,Interventional,United Kingdom,AZD1656 in Diabetic Patients Hospitalised With Suspected or Confirmed COVID-19,Drug,AZD1656,AZD1656,150,https://clinicaltrials.gov/show/NCT04516759,EUCTR2020-002211-21
5812,NCT04516811,ClinicalTrials.gov,2020-08-12,2020-09-21,False,South African National Blood Service,Recruiting,Phase 3,Interventional,South Africa,Therapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19,ATMP,Plasma,Plasma,600,https://clinicaltrials.gov/show/NCT04516811,None
5813,NCT04516824,ClinicalTrials.gov,2020-08-16,2020-03-19,True,Ghurki Trust and Teaching Hospital,Not Recruiting,Not Applicable,Observational,Pakistan,Experience of Orthopaedic and Spine Center Pakistan During COVID-19,Other,No Intervention,No Intervention,2160,https://clinicaltrials.gov/show/NCT04516824,None
5814,NCT04516837,ClinicalTrials.gov,2020-08-16,2020-08-31,False,Peking University People's Hospital,Recruiting,Phase 2,Interventional,China,Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19),Drug,Eltrombopag,Eltrombopag,120,https://clinicaltrials.gov/show/NCT04516837,None
5815,NCT04516850,ClinicalTrials.gov,2020-08-16,2020-09-01,False,Ricardo Pereira Mestre,Not Recruiting,Not Applicable,Observational,Switzerland,HSD3B1 Gene Polymorphisms With Outcomes in SARS-CoV-2 Infected Patients,Genomics,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04516850,None
5816,NCT04516915,ClinicalTrials.gov,2020-08-10,2020-06-15,True,University Hospitals Coventry and Warwickshire NHS Trust,Recruiting,Phase 2,Interventional,United Kingdom,IMU-838 and Oseltamivir in the Treatment of COVID-19,Drug,IMU-838 vs. IMU-838 + Oseltamivir,IMU-838; Oseltamivir,120,https://clinicaltrials.gov/show/NCT04516915,None
5817,NCT04516928,ClinicalTrials.gov,2020-08-14,2020-09-21,False,Direction Centrale du Service de Sant des Armes,Recruiting,Not Applicable,Observational,France,Study of SARS-CoV2 Virus (COVID-19) Seroprevalence Among Lyon-Bron Military Health Schools Personnel,Clinical Presentation (Epidemiology),No Intervention,No Intervention,950,https://clinicaltrials.gov/show/NCT04516928,None
5818,NCT04516941,ClinicalTrials.gov,2020-08-05,2020-10-01,False,"University Hospital, Bern",Not Recruiting,Phase 3,Interventional,Switzerland,CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19,Drug,Edoxaban vs. Colchicine vs. Edoxaban + Colchicine,Edoxaban; Colchicine,420,https://clinicaltrials.gov/show/NCT04516941,None
5819,NCT04516954,ClinicalTrials.gov,2020-08-17,2020-08-01,True,Vinmec Research Institute of Stem Cell and Gene Technology,Recruiting,Phase 1,Interventional,Vietnam,Convalescent Plasma for COVID-19 Patients,ATMP,Plasma,Plasma,10,https://clinicaltrials.gov/show/NCT04516954,None
5820,NCT04517006,ClinicalTrials.gov,2020-08-14,2021-01-01,False,University of Toronto,Not Recruiting,Not Applicable,Interventional,No Country Given,Prosocial Behavior Can Safeguard Mental Health and Foster Emotional Well-being During the COVID-19 Pandemic,Other (psych),Psychological,Psychological,1542,https://clinicaltrials.gov/show/NCT04517006,None
5821,NCT04517123,ClinicalTrials.gov,2020-08-14,2020-09-01,False,Johns Hopkins University,Recruiting,Not Applicable,Interventional,United States,"Prone Position and Respiratory Outcomes in Non-Intubated COVID-19 PatiEnts The ""PRONE"" Study",Procedure,Positioning,Positioning,100,https://clinicaltrials.gov/show/NCT04517123,None
5822,NCT04517136,ClinicalTrials.gov,2020-08-15,2020-09-14,False,Direction Centrale du Service de Sant des Armes,Recruiting,Not Applicable,Observational,France,Impact of Perceived Control on Operational Strain: a Study of COVID-19 Pandemic Caregivers and Military Personnel on Operational Missions,Other (psych),No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04517136,None
5823,NCT04517162,ClinicalTrials.gov,2020-08-14,2020-08-19,False,Janette Furuzawa Carballeda,Recruiting,Phase 1,Interventional,Mexico,Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients,Drug,Collagen-Polyvinylpyrrolidone,Collagen-Polyvinylpyrrolidone,90,https://clinicaltrials.gov/show/NCT04517162,None
5824,NCT04517188,ClinicalTrials.gov,2020-08-15,2020-10-15,False,Halodine LLC,Not Recruiting,Phase 4,Interventional,No Country Given,Halodine Nasal Antiseptic in Patients With COVID-19,Drug,Povidone Iodine,Povidone Iodine,40,https://clinicaltrials.gov/show/NCT04517188,None
5825,NCT04517422,ClinicalTrials.gov,2020-08-16,2020-08-19,False,"AB Biotics, SA",Recruiting,Not Applicable,Interventional,Mexico,Efficacy of L. Plantarum and P. Acidilactici in Adults With SARS-CoV-2 and COVID-19,Supplement,Probiotics,Probiotics,300,https://clinicaltrials.gov/show/NCT04517422,None
5826,NCT04517630,ClinicalTrials.gov,2020-08-15,2020-06-01,True,Instituto Nacional de Enfermedades Respiratorias,Recruiting,Not Applicable,Observational,Mexico,Renal Biomarkers in AKI and COVID-19,Clinical Presentation,No Intervention,No Intervention,90,https://clinicaltrials.gov/show/NCT04517630,None
5827,NCT04517682,ClinicalTrials.gov,2020-05-19,2020-05-21,False,Ambry Genetics,Recruiting,Not Applicable,Observational,United States,COVID-19 and SARS-CoV-2 Detection in Saliva,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,300,https://clinicaltrials.gov/show/NCT04517682,None
5828,NCT04517695,ClinicalTrials.gov,2020-08-14,2020-08-01,True,NYU Langone Health,Recruiting,Not Applicable,Observational,United States,Blood Volume Assessment in COVID-19 ICU Patients - BVAC19,Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04517695,None
5829,NCT04518514,ClinicalTrials.gov,2020-07-28,2020-04-20,True,RWTH Aachen University,Recruiting,Not Applicable,Interventional,Germany,Telemedical Risk Assessment and Preoperative Evaluation (TAPE),Telehealth,Telehealth,Telehealth,100,https://clinicaltrials.gov/show/NCT04518514,None
5830,NCT04518735,ClinicalTrials.gov,2020-08-18,2020-04-01,True,Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau,Not Recruiting,Not Applicable,Observational,Spain,Evolution of COVID-19 in Anticoagulated or Antiaggregated Patients (CORONA Study),Drug,Antithrombotic Therapy,Antithrombotic Therapy,1707,https://clinicaltrials.gov/show/NCT04518735,None
5831,NCT04518969,ClinicalTrials.gov,2020-04-25,2020-05-03,False,Dr. David de Bels,Recruiting,Not Applicable,Interventional,Belgium,Determination of the Hemoadsorption Impact as Adjunctive Treatment Upon the Support Therapy of COVID-19,Other (device),Cytokine Adsorber,Cytokine Adsorber,24,https://clinicaltrials.gov/show/NCT04518969,None
5832,NCT04519034,ClinicalTrials.gov,2020-08-03,2020-09-01,False,Guy's and St Thomas' NHS Foundation Trust,Not Recruiting,Not Applicable,Observational,United Kingdom,Vitamin D Status and Immune-inflammatory Status in Different UK Populations With COVID-19 Infection,Drug,Vitamin D,Vitamin D,27000,https://clinicaltrials.gov/show/NCT04519034,None
5833,NCT04519125,ClinicalTrials.gov,2020-08-18,2020-08-30,False,Hospital Universitario San Ignacio,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Daily Regimen of Tenofovir/Emtricitabine as Prevention for COVID-19 in Health Care Personnel in Colombia,Drug (Chemoprophylaxis),Tenofovir + Emtricitabine,Tenofovir; Emtricitabine,950,https://clinicaltrials.gov/show/NCT04519125,None
5834,NCT04519216,ClinicalTrials.gov,2020-08-12,2020-07-31,True,"University of California, Davis",Recruiting,Not Applicable,Interventional,United States,Breastfeeding Education in the Time of COVID-19,Other,Other,Other,39,https://clinicaltrials.gov/show/NCT04519216,None
5835,NCT04519255,ClinicalTrials.gov,2020-08-18,2020-07-01,True,The Fifth Affiliated Hospital of Sun Yat-Sen University,Not Recruiting,Not Applicable,Observational,China,Study for Quantitative Analysis of the Recovered COVID-19 Patients by <Sup>18<Sup>F-FDG-PET/CT,Clinical Presentation,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04519255,None
5836,NCT04519307,ClinicalTrials.gov,2020-08-18,2020-03-01,True,Dr. Behcet Uz,Not Recruiting,Not Applicable,Observational,Turkey,Evaluation of Newborns Presenting With Suspected COVID 19,Clinical Presentation,No Intervention,No Intervention,72,https://clinicaltrials.gov/show/NCT04519307,None
5837,NCT04519320,ClinicalTrials.gov,2020-08-18,2020-05-18,True,CHU de Besançon,Recruiting,Not Applicable,Interventional,France,Medium and Long Term Follow-up of COVID-19 Infected Patients: Research and Characterization of Pulmonary Sequelae,Clinical Presentation,No Intervention,No Intervention,140,https://clinicaltrials.gov/show/NCT04519320,None
5838,NCT04519372,ClinicalTrials.gov,2020-08-17,2020-04-01,True,"University Hospital, Basel",Not Recruiting,Not Applicable,Observational,Switzerland,SARS-CoV-2 /COVID-19 Admission Screening in a University Hospital Setting,Clinical Presentation (Epidemiology),No Intervention,No Intervention,4099,https://clinicaltrials.gov/show/NCT04519372,None
5839,NCT04519385,ClinicalTrials.gov,2020-08-17,2020-03-01,True,South Valley University,Not Recruiting,Not Applicable,Interventional,Egypt,Toclizumam Versus Dexamethasone in Severe Covid-19 Cases,Drug,Tocilizumab vs. Dexamethasone,Tocilizumab; Dexamethasone,69,https://clinicaltrials.gov/show/NCT04519385,None
5840,NCT04519398,ClinicalTrials.gov,2020-08-18,2020-08-18,False,Grigore T. Popa University of Medicine and Pharmacy,Recruiting,Not Applicable,Observational,Romania,Investigating the Involvement of ACE and Angiotensinogen Genes' Polymorphism Along With Other Thrombophilic Genotypes in Severe Forms of COVID-19 With/Without Thrombotic Events,Genomics,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04519398,None
5841,NCT04519411,ClinicalTrials.gov,2020-08-18,2020-05-21,True,Mayo Clinic,Recruiting,Not Applicable,Interventional,United States,Transpulmonary Pressure Measurements in Intubated Children With Covid-19 Respiratory Failure,Other (physical),Mechanical ventilation,Mechanical ventilation,10,https://clinicaltrials.gov/show/NCT04519411,None
5842,NCT04519424,ClinicalTrials.gov,2020-08-18,2020-09-01,False,CSL Behring,Not Recruiting,Phase 2,Interventional,United States,CSL324 in COVID-19,Drug,CSL324,CSL324,0,https://clinicaltrials.gov/show/NCT04519424,None
5843,NCT04519502,ClinicalTrials.gov,2020-08-18,2020-06-23,True,George Washington University,Recruiting,Not Applicable,Observational,United States,Maternal Morbidity and Mortality During the COVID-19 Pandemic,Other,No Intervention,No Intervention,26400,https://clinicaltrials.gov/show/NCT04519502,None
5844,NCT04520191,ClinicalTrials.gov,2020-08-17,2020-09-01,False,University of New Mexico,Not Recruiting,Not Applicable,Observational,No Country Given,Home-based Kidney Care in Native Americans of New Mexico (HBKC) - Enhancement,Other,No Intervention,No Intervention,529,https://clinicaltrials.gov/show/NCT04520191,None
5845,NCT04520620,ClinicalTrials.gov,2020-07-22,2020-05-02,True,CHU de Saint Etienne,Not Recruiting,Phase 4,Interventional,France,Concentration-effect Relationship of Enoxaparin for Thromboembolic Prevention,Drug,Enoxaparin,Enoxaparin,0,https://clinicaltrials.gov/show/NCT04520620,EUCTR2020-001823-15
5846,NCT04520880,ClinicalTrials.gov,2020-07-21,2020-08-01,False,Dammam University,Not Recruiting,Not Applicable,Observational,Saudi Arabia,Antibodies Responses to COVID-19 Infection in Hospitalized Patients,Clinical Presentation,No Intervention,No Intervention,158,https://clinicaltrials.gov/show/NCT04520880,None
5847,NCT04521010,ClinicalTrials.gov,2020-08-13,2020-01-01,True,Poznan University of Medical Sciences,Not Recruiting,Not Applicable,Observational,Poland,Staff Absenteeism and Delivery of Healthcare Services During the COVID-19 Pandemic,Health System,No Intervention,No Intervention,700,https://clinicaltrials.gov/show/NCT04521010,None
5848,NCT04521036,ClinicalTrials.gov,2020-08-18,2020-12-01,False,Vinmec Research Institute of Stem Cell and Gene Technology,Not Recruiting,Phase 1/Phase 2,Interventional,Vietnam,Convalescent Plasma for COVID-19 Patients (CPCP),ATMP,Plasma,Plasma,44,https://clinicaltrials.gov/show/NCT04521036,None
5849,NCT04521296,ClinicalTrials.gov,2020-07-07,2020-08-01,False,Daewoong Pharmaceutical Co.,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo,Drug,DWJ1248,DWJ1248,90,https://clinicaltrials.gov/show/NCT04521296,None
5850,NCT04521309,ClinicalTrials.gov,2020-05-07,2020-06-19,False,Dow University of Health Sciences,Recruiting,Phase 1,Interventional,Pakistan,SARS-CoV-2 Antibodies Based IVIG Therapy for COVID-19 Patients,ATMP,Immunoglobulin,Immunoglobulin,50,https://clinicaltrials.gov/show/NCT04521309,None
5851,NCT04521322,ClinicalTrials.gov,2020-08-19,2020-07-24,True,Ariel Dogliotti,Recruiting,Phase 4,Interventional,Argentina,Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Prophylaxis of COVID-19 Disease in Health Personnel Dedicated to Patients Care With COVID-19 Disease,Drug (Chemoprophylaxis),Iota-Carrageenan,Iota-Carrageenan,400,https://clinicaltrials.gov/show/NCT04521322,None
5852,NCT04521400,ClinicalTrials.gov,2020-08-18,2020-08-20,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 2,Interventional,No Country Given,"the Investigation Into Beneficial Effects of High-dose Interferon Beta 1-a, Compared to Low-dose Interferon Beta 1-a in Moderate to Severe Covid-19",Drug,Interferon beta + Lopinavir/ritonavir,Interferon beta; Lopinavir/ritonavir,100,https://clinicaltrials.gov/show/NCT04521400,None
5853,NCT04522037,ClinicalTrials.gov,2020-07-06,2020-06-01,True,Hospices Civils de Lyon,Recruiting,Not Applicable,Observational,France,Measurement of the Efficacy of MORPHINE in the Early Management of Dyspnea in COVID-19 Positive Patients,Drug,Morphine,Morphine,200,https://clinicaltrials.gov/show/NCT04522037,None
5854,NCT04522076,ClinicalTrials.gov,2020-08-18,2020-04-06,True,National Research Center for Preventive Medicine,Not Recruiting,Not Applicable,Observational,Russian Federation,Prospective Hospital Registry of Patients With Suspected or Confirmed Coronavirus Infection (COVID-19) and Community-acquired Pneumonia,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1124,https://clinicaltrials.gov/show/NCT04522076,None
5855,NCT04522089,ClinicalTrials.gov,2020-08-12,2020-08-24,False,Adimmune Corporation,Recruiting,Phase 1,Interventional,Taiwan,A Study to Evaluate the Safety and Immunogenicity of COVID-19 (AdimrSC-2f) Vaccine,ATMP,Vaccine,Vaccine,70,https://clinicaltrials.gov/show/NCT04522089,None
5856,NCT04522128,ClinicalTrials.gov,2020-05-12,2020-05-22,False,University of Manchester,Recruiting,Not Applicable,Interventional,United Kingdom,Does Quality of Life Decline During the COVID-19 Pandemic and Can we Change Behaviour to Improve Poor Quality of Life?,Other (psych),Psychological,Psychological,969,https://clinicaltrials.gov/show/NCT04522128,None
5857,NCT04522310,ClinicalTrials.gov,2020-07-17,2020-05-20,True,Centre Hospitalier de Lens,Recruiting,Not Applicable,Observational,France,ProAdrenomedullin Assessment of Multi-Organ Failure in COvid-19 Sepsis,Clinical Presentation,No Intervention,No Intervention,183,https://clinicaltrials.gov/show/NCT04522310,None
5858,NCT04522466,ClinicalTrials.gov,2020-08-19,2020-04-03,True,CHU de Saint Etienne,Not Recruiting,Phase 3,Interventional,France,Evaluation of the Pharmacokinetics and Pharmacodynamics of Hydroxychloroquine in COVID-19 Intensive Care Unit Patients,Drug,Hydroxychloroquine,Hydroxychloroquine,7,https://clinicaltrials.gov/show/NCT04522466,EUCTR2020-001281-11
5859,NCT04522492,ClinicalTrials.gov,2020-08-07,2020-08-11,False,Hospital de Clinicas de Porto Alegre,Recruiting,Not Applicable,Interventional,Brazil,Impact of COVID-19 on Mental Health of Patients With Skin Picking,Other (psych),Psychological,Psychological,20,https://clinicaltrials.gov/show/NCT04522492,None
5860,NCT04522817,ClinicalTrials.gov,2020-08-20,2020-10-05,False,"Caladrius Biosciences, Inc.",Recruiting,Phase 1,Interventional,United States,CLBS119 for Repair of COVID-19 Induced Pulmonary Damage,Drug,CLBS119,CLBS119,12,https://clinicaltrials.gov/show/NCT04522817,None
5861,NCT04522830,ClinicalTrials.gov,2020-08-18,2020-07-30,True,"Beech Tree Labs, Inc.",Recruiting,Phase 2,Interventional,United States,A Study in Adults to Test the Effects of Low Dose Thimerosal on Symptoms of COVID-19,Drug,Thimerosal,Thimerosal,40,https://clinicaltrials.gov/show/NCT04522830,None
5862,NCT04522986,ClinicalTrials.gov,2020-08-20,2020-09-01,False,"Rohto Pharmaceutical Co., Ltd.",Not Recruiting,Phase 1,Interventional,Japan,An Exploratory Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection,ATMP,Cells (mesenchymal),Cells (mesenchymal),6,https://clinicaltrials.gov/show/NCT04522986,None
5863,NCT04523012,ClinicalTrials.gov,2020-08-20,2020-07-01,True,Centre de Recherches et d'Études Surla Pathologie Tropicale,Recruiting,Not Applicable,Observational,France,COVID-19 and HIV Patients,Clinical Presentation (Epidemiology),No Intervention,No Intervention,2200,https://clinicaltrials.gov/show/NCT04523012,None
5864,NCT04523051,ClinicalTrials.gov,2020-08-20,2020-04-01,True,Centre Hospitalier Régional Metz-Thionville,Recruiting,Not Applicable,Observational,France,Rehabilitation After Admission in Intensive Care Unit for COVID-19,Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04523051,None
5865,NCT04523090,ClinicalTrials.gov,2020-08-20,2020-08-27,False,University of Cape Town,Recruiting,Phase 2/Phase 3,Interventional,South Africa,Catalysing the Containment of COVID-19,Drug,Nitazoxanide,Nitazoxanide,960,https://clinicaltrials.gov/show/NCT04523090,None
5866,NCT04523246,ClinicalTrials.gov,2020-08-20,2020-09-01,False,Barbara Carlson,Recruiting,Phase 1,Interventional,United States,Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents,ATMP,Vaccine,Vaccine,250,https://clinicaltrials.gov/show/NCT04523246,None
5867,NCT04523831,ClinicalTrials.gov,2020-08-19,2020-06-01,True,Dhaka Medical College,Not Recruiting,Phase 3,Interventional,Bangladesh,Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection,Drug,Ivermectin + Doxycycline,Ivermectin; Doxycycline,400,https://clinicaltrials.gov/show/NCT04523831,None
5868,NCT04524052,ClinicalTrials.gov,2020-08-19,2020-08-01,True,Daewoong Pharmaceutical Co.,Not Recruiting,Phase 1,Interventional,No Country Given,"To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19",Drug,DWRX2003,DWRX2003,32,https://clinicaltrials.gov/show/NCT04524052,None
5869,NCT04524156,ClinicalTrials.gov,2020-04-30,2020-10-04,False,Erasme University Hospital,Not Recruiting,Not Applicable,Interventional,Belgium,COVID-19 : Transcutaneous pO2 and pCO2 as Predictive Factors for Acute Respiratory Destress Syndrome in Patients Affected With SARS-Cov-2,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04524156,None
5870,NCT04524234,ClinicalTrials.gov,2020-08-21,2020-04-20,True,Sahlgrenska University Hospital,Not Recruiting,Not Applicable,Observational,Sweden,Cardiac Dysfunction in Critically Ill Patients Infected With COVID-19,Clinical Presentation,No Intervention,No Intervention,133,https://clinicaltrials.gov/show/NCT04524234,None
5871,NCT04524507,ClinicalTrials.gov,2020-08-21,2020-08-27,False,"University of North Carolina, Chapel Hill",Recruiting,Phase 2,Interventional,United States,COVID-19 Antibody Plasma Research Study in Hospitalized Patients,ATMP,Plasma,Plasma,56,https://clinicaltrials.gov/show/NCT04524507,None
5872,NCT04524520,ClinicalTrials.gov,2020-08-19,2020-05-05,True,Western Sussex Hospitals NHS Trust,Recruiting,Not Applicable,Observational,United Kingdom,"COVID19-OR (SARS-CoV-2): Observation,Risk & Recovery",Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04524520,None
5873,NCT04524598,ClinicalTrials.gov,2020-08-20,2020-07-20,True,"Limbix Health, Inc.",Recruiting,Not Applicable,Interventional,United States,A CBT-based Mobile Intervention as First Line Treatment for Adolescent Depression During COVID-19,Other (psych),Psychological,Psychological,410,https://clinicaltrials.gov/show/NCT04524598,None
5874,NCT04524663,ClinicalTrials.gov,2020-04-10,2020-11-01,False,Stanford University,Not Recruiting,Phase 2,Interventional,United States,Oral Camostat Compared With Standard Supportive Care in Mild-Moderate COVID-19 Patients,Drug,Camostat Mesilate,Camostat Mesilate,120,https://clinicaltrials.gov/show/NCT04524663,None
5875,NCT04524754,ClinicalTrials.gov,2020-08-21,2020-07-11,True,Ain Shams University,Recruiting,Not Applicable,Observational,Egypt,Prevalence and Outcomes of Olfactory and Gustatory Dysfunctions in Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,218,https://clinicaltrials.gov/show/NCT04524754,None
5876,NCT04524962,ClinicalTrials.gov,2020-08-19,2020-09-15,False,Cartesian Therapeutics,Recruiting,Phase 1/Phase 2,Interventional,United States,Study of Descartes-30 in Acute Respiratory Distress Syndrome,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04524962,None
5877,NCT04525287,ClinicalTrials.gov,2020-08-20,2020-02-20,True,"Second Affiliated Hospital, School of Medicine, Zhejiang University",Recruiting,Not Applicable,Observational,China,Prediction Models for Diagnosis and Prognosis of Severe COVID-19,Prognosis,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04525287,None
5878,NCT04525378,ClinicalTrials.gov,2020-07-31,2020-07-01,True,D'Or Institute for Research and Education,Recruiting,Phase 1,Interventional,Brazil,MSC-based Therapy in COVID-19-associated Acute Respiratory Distress Syndrome,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04525378,None
5879,NCT04525404,ClinicalTrials.gov,2020-08-17,2020-11-12,False,University of Alberta,Recruiting,Not Applicable,Observational,Canada,MOIST Study: Multi-Organ Imaging With Serial Testing in COVID-19 Infected Patients,Clinical Presentation,No Intervention,No Intervention,228,https://clinicaltrials.gov/show/NCT04525404,None
5880,NCT04525417,ClinicalTrials.gov,2020-08-21,2020-04-25,True,Groupe d’Etude sur le Risque d’Expositiondes Soignants aux agents infectieux (GERES),Recruiting,Not Applicable,Interventional,France,Rapid Screening Test for Covid-19 Antibodies in Healthcare Workers,Clinical Presentation (Epidemiology),No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04525417,None
5881,NCT04525443,ClinicalTrials.gov,2020-08-21,2020-06-03,True,"Hospital San Carlos, Madrid",Recruiting,Not Applicable,Observational,"United States, Spain",Endothelial Function and COVID-19,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04525443,None
5882,NCT04525716,ClinicalTrials.gov,2020-08-21,2020-03-01,True,Karolinska Institutet,Recruiting,Not Applicable,Observational,Sweden,The Effect of Covid-19 on Patient Outcomes Among Operated Patients,Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04525716,None
5883,NCT04525742,ClinicalTrials.gov,2020-06-28,2020-07-05,False,Gaziosmanpasa Taksim Research and Education Hospital,Not Recruiting,Not Applicable,Interventional,Turkey,COVID-19 Pandemic and Parents of Disabled Children,Other,No Intervention,No Intervention,309,https://clinicaltrials.gov/show/NCT04525742,None
5884,NCT04525820,ClinicalTrials.gov,2020-08-17,2020-12-01,False,Dr. Jorg Leuppi,Not Recruiting,Not Applicable,Interventional,Switzerland,"High Dose Vitamin-D Substitution in Patients With COVID-19: a Randomized Controlled, Multi Center Study",Drug,Vitamin D,Vitamin D,80,https://clinicaltrials.gov/show/NCT04525820,None
5885,NCT04525911,ClinicalTrials.gov,2020-08-19,2020-08-26,False,Hôpital Européen Marseille,Recruiting,Not Applicable,Observational,France,Assessment of Long-term Impact Post COVID-19 for Patients and Health Care Professionals of the European Hospital,Clinical Presentation,No Intervention,No Intervention,258,https://clinicaltrials.gov/show/NCT04525911,None
5886,NCT04526054,ClinicalTrials.gov,2020-08-03,2020-09-03,False,Hôpital Foch,Recruiting,Not Applicable,Interventional,France,Morphological Abnormalities of the Olfactory Bulb on MRI and Olfactometry in Anosmic Versus Normosmic COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04526054,None
5887,NCT04526145,ClinicalTrials.gov,2020-08-10,2020-09-14,False,Ohio State University,Not Recruiting,Not Applicable,Interventional,No Country Given,OUR Stress/ Emotion Management for Black/African American Women With Hypertension,Other (psych),Psychological,Psychological,30,https://clinicaltrials.gov/show/NCT04526145,None
5888,NCT04526405,ClinicalTrials.gov,2020-08-06,2020-07-14,True,University of Milano Bicocca,Not Recruiting,Not Applicable,Observational,Italy,Frequency of COVID-19 Antibodies in Patients With Hereditary Hematological Diseases,Clinical Presentation (Epidemiology),No Intervention,No Intervention,63,https://clinicaltrials.gov/show/NCT04526405,None
5889,NCT04526717,ClinicalTrials.gov,2020-07-30,2020-12-01,False,Joseah Bio,Not Recruiting,Phase 1,Interventional,No Country Given,Heat Shock Protein Inhibitor- MPT0B640 for COVID-19 Infection,Drug,MPT0B640,MPT0B640,15,https://clinicaltrials.gov/show/NCT04526717,None
5890,NCT04526769,ClinicalTrials.gov,2020-08-21,2020-09-01,False,University of Minnesota,Not Recruiting,Not Applicable,Observational,United States,Detecting SARS-CoV-2 in Tears,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,30,https://clinicaltrials.gov/show/NCT04526769,None
5891,NCT04526821,ClinicalTrials.gov,2020-08-21,2020-09-01,False,Universidad Peruana Cayetano Heredia,Not Recruiting,Phase 2,Interventional,Peru,Lactoferrin for Prevention of COVID-19 in Health Care Workers,Drug (Chemoprophylaxis),Lactoferrin,Lactoferrin,336,https://clinicaltrials.gov/show/NCT04526821,None
5892,NCT04526912,ClinicalTrials.gov,2020-08-21,2020-08-28,False,Viela Bio,Recruiting,Phase 1,Interventional,United States,Treatment and Prevention of Acute Lung Injury (ALI) in Patients With COVID-19 Infection,Drug,VIB7734,VIB7734,48,https://clinicaltrials.gov/show/NCT04526912,None
5893,NCT04526977,ClinicalTrials.gov,2020-08-22,2020-09-01,False,Asociación para el Estudio de las Enfermedades Infecciosas,Not Recruiting,Not Applicable,Observational,No Country Given,Differences in Immune Response Among HIV-1-infected Individuals With Previous or Current COVID-19 (CoVIHDis).,Clinical Presentation,No Intervention,No Intervention,90,https://clinicaltrials.gov/show/NCT04526977,None
5894,NCT04527133,ClinicalTrials.gov,2020-08-24,2020-06-11,True,Aviron LLC,Not Recruiting,Not Applicable,Interventional,Russian Federation,An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19,Drug,Aprotinin,Aprotinin,30,https://clinicaltrials.gov/show/NCT04527133,None
5895,NCT04527198,ClinicalTrials.gov,2020-06-02,2020-09-01,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,Brainstem Dysfunction in COVID-19 Critically Ill Patients: a Prospective Observational Study,Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04527198,None
5896,NCT04527211,ClinicalTrials.gov,2020-08-24,2020-09-07,False,Javeriana University,Not Recruiting,Phase 3,Interventional,Colombia,Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel,Drug,Ivermectin,Ivermectin,550,https://clinicaltrials.gov/show/NCT04527211,None
5897,NCT04527224,ClinicalTrials.gov,2020-08-21,2020-12-01,False,Nature Cell Co. Ltd.,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 Pneumonia,ATMP,Cells (mesenchymal),Cells (mesenchymal),10,https://clinicaltrials.gov/show/NCT04527224,None
5898,NCT04527315,ClinicalTrials.gov,2020-08-24,2020-07-17,True,NYU Langone Health,Recruiting,Not Applicable,Observational,United States,COVID-19 Survivorship Registry,Clinical Presentation (Epidemiology),No Intervention,No Intervention,350,https://clinicaltrials.gov/show/NCT04527315,None
5899,NCT04527354,ClinicalTrials.gov,2020-08-24,2020-09-08,False,Pharmenterprise LLC,Not Recruiting,Phase 2,Interventional,Russian Federation,Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia,Drug,Treamid,Treamid,60,https://clinicaltrials.gov/show/NCT04527354,None
5900,NCT04527432,ClinicalTrials.gov,2020-08-24,2020-11-01,False,The Royal Wolverhampton Hospitals NHS Trust,Not Recruiting,Not Applicable,Interventional,United Kingdom,COVID-19 Health Professional Impact Study,Clinical Presentation (Epidemiology),No Intervention,No Intervention,3000,https://clinicaltrials.gov/show/NCT04527432,None
5901,NCT04527458,ClinicalTrials.gov,2020-08-24,2020-02-24,True,University of Edinburgh,Not Recruiting,Not Applicable,Observational,United Kingdom,Case Fatalities in Hospitalised COVID-19 Patients in the UK,Clinical Presentation (Epidemiology),No Intervention,No Intervention,70000,https://clinicaltrials.gov/show/NCT04527458,None
5902,NCT04527497,ClinicalTrials.gov,2020-08-20,2020-08-01,True,Wissenschaftliches Institut Bethanien e.V,Recruiting,Not Applicable,Observational,Germany,Clinical Course and Treatment of COVID-19 Inpatients in Hospital,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04527497,None
5903,NCT04527562,ClinicalTrials.gov,2020-08-25,2020-07-14,True,Dhaka Medical College,Recruiting,Not Applicable,Interventional,Bangladesh,Colchicine in Moderate Symptomatic COVID-19 Patients,Drug,Colchicine,Colchicine,300,https://clinicaltrials.gov/show/NCT04527562,None
5904,NCT04527575,ClinicalTrials.gov,2020-08-11,2020-07-27,True,State Research Center of Virology and Biotechnology (VECTOR),Not Recruiting,Phase 1/Phase 2,Interventional,Russian Federation,"Study of the Safety, Reactogenicity and Immunogenicity of ""EpiVacCorona"" Vaccine for the Prevention of COVID-19",ATMP,Vaccine,Vaccine,100,https://clinicaltrials.gov/show/NCT04527575,None
5905,NCT04527601,ClinicalTrials.gov,2020-08-25,2020-08-21,True,"Rigshospitalet, Denmark",Not Recruiting,Not Applicable,Observational,Denmark,Extremely Premature Births During the Peak of the COVID-19 Pandemic: an International Study of the Active SafeBoosC III Departments,Other,No Intervention,No Intervention,885,https://clinicaltrials.gov/show/NCT04527601,None
5906,NCT04527614,ClinicalTrials.gov,2020-08-18,2020-09-24,False,Sciensano,Recruiting,Not Applicable,Interventional,Belgium,Influence of Prior Infection With COVID-19 on Occurrence of Influenza-like Illness or Acute Respiratory Infection,Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04527614,None
5907,NCT04528329,ClinicalTrials.gov,2020-08-24,2020-08-30,False,ClinAmygate,Recruiting,Phase 4,Interventional,Egypt,Anosmia and / or Ageusia and Early Corticosteroid Use,Drug,Corticosteroids,Dexamthasone,300,https://clinicaltrials.gov/show/NCT04528329,None
5908,NCT04528368,ClinicalTrials.gov,2020-08-19,2020-08-18,True,D'Or Institute for Research and Education,Recruiting,Phase 2,Interventional,Brazil,Convalescent Plasma for Treating Patients With COVID-19 Pneumonia Without Indication of Ventilatory Support,ATMP,Plasma,Plasma,60,https://clinicaltrials.gov/show/NCT04528368,None
5909,NCT04528641,ClinicalTrials.gov,2020-08-19,2020-08-10,True,ReiThera Srl,Recruiting,Phase 1,Interventional,Italy,GRAd-COV2 Vaccine Against COVID-19,ATMP,Vaccine,Vaccine,90,https://clinicaltrials.gov/show/NCT04528641,None
5910,NCT04528667,ClinicalTrials.gov,2020-08-20,2020-12-01,False,"Sorrento Therapeutics, Inc.",Not Recruiting,Phase 2,Interventional,No Country Given,Study of the Safety and Efficacy of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized Due to COVID-19,Drug,Abivertinib Maleate,Abivertinib Maleate,400,https://clinicaltrials.gov/show/NCT04528667,None
5911,NCT04528771,ClinicalTrials.gov,2020-08-25,2020-10-31,False,Robert Schilz,Not Recruiting,Phase 1,Interventional,United States,S-Nitrosylation Therapy of COVID-19,Drug,S-Nitrosylation,S-Nitrosylation,21,https://clinicaltrials.gov/show/NCT04528771,None
5912,NCT04528888,ClinicalTrials.gov,2020-08-21,2020-09-01,False,Massimo Girardis,Not Recruiting,Phase 3,Interventional,No Country Given,Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection,Drug,Enoxaparin vs. Enoxaparin + Corticosteroids vs. Corticosteroids + Heparin,Methylprednisolone; Heparin; Enoxaparin,210,https://clinicaltrials.gov/show/NCT04528888,None
5913,NCT04528901,ClinicalTrials.gov,2020-08-25,2020-09-01,False,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Study of seroPREvalence Vis-Ã -vis SARS-CoV2 and Correlation With Clinical Forms of COVID-19 in Patients Followed in Pneumology in the Cluster Area of the Grand-Est Region (Strasbourg University Hospital),Clinical Presentation (Epidemiology),No Intervention,No Intervention,1080,https://clinicaltrials.gov/show/NCT04528901,None
5914,NCT04528927,ClinicalTrials.gov,2020-05-06,2020-05-15,False,Abderrahmane Mami Hospital,Not Recruiting,Phase 3,Interventional,Tunisia,"Evaluation of the Efficacy and Safety of Treatments for Patients Hospitalized for COVID-19 Infection Without Signs of Acute Respiratory Failure, in Tunisia",Not relevant,Not relevant,Not relevant,0,https://clinicaltrials.gov/show/NCT04528927,None
5915,NCT04529408,ClinicalTrials.gov,2020-08-26,2020-08-26,False,Imperial College London,Recruiting,Not Applicable,Observational,United Kingdom,EARSATS-19: In-ear Measurement of Blood Oxygen Saturation in COVID-19 Follow up,Clinical Presentation,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04529408,None
5916,NCT04529421,ClinicalTrials.gov,2020-08-25,2020-09-01,False,Oslo Metropolitan University,Not Recruiting,Not Applicable,Observational,Norway,Assocation Between In-person Instruction and COVID-19 Risk,Other,Other,Other,70000,https://clinicaltrials.gov/show/NCT04529421,None
5917,NCT04529447,ClinicalTrials.gov,2020-08-26,2020-06-10,True,Jaseng Hospital of Korean Medicine,Not Recruiting,Not Applicable,Observational,South Korea,Response of Korean Medicine Hospital to COVID-19,Health System,No Intervention,No Intervention,485,https://clinicaltrials.gov/show/NCT04529447,None
5918,NCT04529460,ClinicalTrials.gov,2020-08-26,2020-09-01,False,Royal Free Hospital NHS Foundation Trust,Not Recruiting,Not Applicable,Observational,No Country Given,Healthy Volunteer COVID-19 Antibody Testing Study,Clinical Presentation (Epidemiology),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04529460,None
5919,NCT04529499,ClinicalTrials.gov,2020-08-19,2020-08-20,False,Dr. Reddy's Laboratories Limited,Recruiting,Phase 3,Interventional,Kuwait,Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients,Drug,Favipiravir,Favipiravir,780,https://clinicaltrials.gov/show/NCT04529499,None
5920,NCT04529525,ClinicalTrials.gov,2020-08-21,2020-08-19,True,Instituto de Cardiología de Corrientes,Recruiting,Phase 2/Phase 3,Interventional,Argentina,Ivermectin to Prevent Hospitalizations in COVID-19,Drug,Ivermectin,Ivermectin,500,https://clinicaltrials.gov/show/NCT04529525,None
5921,NCT04530357,ClinicalTrials.gov,2020-08-26,2020-09-19,False,Research Institute for Biological Safety Problems,Not Recruiting,Phase 1/Phase 2,Interventional,Kazakhstan,"Reactogenicity, Safety and Immunogenicity of QazCovid-inÂ® COVID-19 Vaccine",ATMP,Vaccine,Vaccine,244,https://clinicaltrials.gov/show/NCT04530357,None
5922,NCT04530370,ClinicalTrials.gov,2020-08-26,2020-05-29,True,South Valley University,Recruiting,Phase 1,Interventional,Egypt,Efficacy and Safety of Recovered Covid 19 Plasma Transfusion to Covid 19 Severly Ill Patients,ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04530370,None
5923,NCT04530396,ClinicalTrials.gov,2020-08-25,2020-09-07,False,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",Recruiting,Phase 3,Interventional,Russian Federation,"Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19",ATMP,Vaccine,Vaccine,40000,https://clinicaltrials.gov/show/NCT04530396,None
5924,NCT04530409,ClinicalTrials.gov,2020-08-24,2020-08-26,False,ClinAmygate,Recruiting,Phase 4,Interventional,Egypt,Timing of Corticosteroids in COVID-19,Drug,Corticosteroids,Dexamthasone,450,https://clinicaltrials.gov/show/NCT04530409,None
5925,NCT04530422,ClinicalTrials.gov,2020-08-26,2020-04-15,True,Almaza Military Fever Hospital,Not Recruiting,Phase 3,Interventional,Egypt,Efficacy of Sofosbuvir Plus Ledipasvir in Egyptian Patients With COVID-19 Compared to Standard Treatment,Drug,Sofosbuvir + Ledipasvir vs. Oseltamivir + Hydroxychloroquine + Azithromycin,Sofosbuvir; Ledipasvir; Oseltamivir; Hydroxychloroquine; Azithromycin,250,https://clinicaltrials.gov/show/NCT04530422,None
5926,NCT04530435,ClinicalTrials.gov,2020-08-25,2020-10-06,False,"Copenhagen University Hospital, Bispebjerg",Recruiting,Not Applicable,Interventional,Denmark,PEP Flute-selfcare in COVID-19,Other (device),Positive Expiratory Pressure flute,Positive Expiratory Pressure flute,400,https://clinicaltrials.gov/show/NCT04530435,None
5927,NCT04530448,ClinicalTrials.gov,2020-08-20,2020-10-05,False,West Virginia University,Recruiting,Phase 4,Interventional,United States,Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization,Drug,Sodium bicarbonate,Sodium bicarbonate,40,https://clinicaltrials.gov/show/NCT04530448,None
5928,NCT04530461,ClinicalTrials.gov,2020-08-26,2020-06-01,True,Faida Agili,Recruiting,Not Applicable,Observational,Tunisia,Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04530461,None
5929,NCT04530474,ClinicalTrials.gov,2020-08-26,2020-10-01,False,Temple University,Not Recruiting,Phase 3,Interventional,United States,Outpatient Use of Ivermectin in COVID-19,Drug,Ivermectin,Ivermectin,200,https://clinicaltrials.gov/show/NCT04530474,None
5930,NCT04530539,ClinicalTrials.gov,2020-08-26,2020-09-18,False,Lancaster General Hospital,Not Recruiting,Not Applicable,Interventional,United States,The Effect of Melatonin and Vitamin C on COVID-19,Drug,Melatonin vs. Vitamin C,Melatonin; Vitamin C,150,https://clinicaltrials.gov/show/NCT04530539,None
5931,NCT04530578,ClinicalTrials.gov,2020-08-17,2020-06-01,True,"Clinica San Camilo, Argentina",Recruiting,Phase 4,Interventional,Argentina,Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19,Drug,Heparin,Heparin,200,https://clinicaltrials.gov/show/NCT04530578,None
5932,NCT04530604,ClinicalTrials.gov,2020-08-25,2020-10-01,False,Gregory Yanik,Recruiting,Phase 1,Interventional,United States,Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS),Drug,Defibrotide,Defibrotide,12,https://clinicaltrials.gov/show/NCT04530604,None
5933,NCT04530617,ClinicalTrials.gov,2020-08-26,2020-10-05,False,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,Recruiting,Phase 2,Interventional,Mexico,Camostat and Artemisia Annua vs Placebo in COVID-19 Outpatients,Drug,Camostat Mesilate vs. Artemisia,Camostat Mesilate; Artemisia,360,https://clinicaltrials.gov/show/NCT04530617,None
5934,NCT04530656,ClinicalTrials.gov,2020-08-27,2020-08-28,False,Jiangsu Provincial Center for Disease Control and Prevention,Not Recruiting,Phase 1,Interventional,China,Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell),ATMP,Vaccine,Vaccine,168,https://clinicaltrials.gov/show/NCT04530656,None
5935,NCT04530682,ClinicalTrials.gov,2020-07-27,2020-10-20,False,"University Hospital, Montpellier",Not Recruiting,Not Applicable,Observational,France,COVID-19 in Rheumatic Inflammatory Diseases Under Immuno-suppressive Drugs,Clinical Presentation,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04530682,None
5936,NCT04531111,ClinicalTrials.gov,2020-08-25,2020-07-07,True,Ain Shams University,Recruiting,Not Applicable,Observational,Egypt,Glycemic Control Among Children and Adolescents With Type 1 Diabetes During COVID-19 Pandemic in Egypt,Other,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04531111,None
5937,NCT04531202,ClinicalTrials.gov,2020-08-26,2020-03-02,True,D'Or Institute for Research and Education,Recruiting,Not Applicable,Observational,Brazil,CORE Study COVID-19,Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04531202,None
5938,NCT04531254,ClinicalTrials.gov,2020-08-24,2020-08-10,True,The Hospital for Sick Children,Not Recruiting,Not Applicable,Observational,Canada,Back to School COVID-19 Simulation Study,Other,Other,Other,240,https://clinicaltrials.gov/show/NCT04531254,None
5939,NCT04531319,ClinicalTrials.gov,2020-08-27,2020-08-15,True,Istanbul Training and Research Hospital,Recruiting,Not Applicable,Observational,Turkey,Immune Cell Subgroups in Covid 19 Patients,Clinical Presentation,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04531319,None
5940,NCT04531345,ClinicalTrials.gov,2020-08-27,2020-09-01,False,Istanbul Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,Cytokine Status of Covid-19 Patients,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04531345,None
5941,NCT04531501,ClinicalTrials.gov,2020-08-26,2020-06-29,True,Chronomics Limited,Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 Saliva Test Research Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,400,https://clinicaltrials.gov/show/NCT04531501,None
5942,NCT04531618,ClinicalTrials.gov,2020-08-19,2020-08-13,True,Columbia University,Recruiting,Not Applicable,Interventional,United States,Mother-infant Bonding During COVID-19,Other,Other,Other,280,https://clinicaltrials.gov/show/NCT04531618,None
5943,NCT04531735,ClinicalTrials.gov,2020-08-19,2020-03-01,True,Dr. Behcet Uz,Not Recruiting,Not Applicable,Observational,Turkey,Respiratory Syncytial Virus Infection May be More Dangerous in Neonate,Clinical Presentation,No Intervention,No Intervention,28,https://clinicaltrials.gov/show/NCT04531735,None
5944,NCT04531748,ClinicalTrials.gov,2020-08-27,2020-12-01,False,Dr. Reena Mehra,Not Recruiting,Phase 2,Interventional,No Country Given,Selective Estrogen Modulation and Melatonin in Early COVID-19,Drug,Toremifene + Melatonin vs. Melatonin,Toremifene; Melatonin,390,https://clinicaltrials.gov/show/NCT04531748,None
5945,NCT04531774,ClinicalTrials.gov,2020-08-26,2020-08-28,False,Naser Morina,Recruiting,Not Applicable,Interventional,Switzerland,RECHARGE: A Brief Psychological Intervention to Build Resilience in Healthcare Workers During COVID-19,Other (psych),Psychological,Psychological,160,https://clinicaltrials.gov/show/NCT04531774,None
5946,NCT04532294,ClinicalTrials.gov,2020-08-27,2020-09-08,False,BeiGene,Recruiting,Phase 1,Interventional,Australia,"Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants",ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04532294,None
5947,NCT04532372,ClinicalTrials.gov,2020-08-25,2020-09-18,False,City of Hope Medical Center,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy,Drug,Leflunomide,Leflunomide,30,https://clinicaltrials.gov/show/NCT04532372,None
5948,NCT04532411,ClinicalTrials.gov,2020-08-25,2020-03-01,True,Massachusetts General Hospital,Not Recruiting,Not Applicable,Observational,United States,COVID-19 Testing Sample Acquisition Throughput and Efficiency,Other,Other,Other,25000,https://clinicaltrials.gov/show/NCT04532411,None
5949,NCT04532554,ClinicalTrials.gov,2020-08-24,2020-10-26,False,ClinAmygate,Not Recruiting,Phase 4,Interventional,Egypt,Growth Hormone in Obese Cases With Covid-19,Clinical Presentation,No Intervention,No Intervention,0,https://clinicaltrials.gov/show/NCT04532554,None
5950,NCT04532632,ClinicalTrials.gov,2020-08-28,2020-09-01,False,Pinar Ay Sayin,Not Recruiting,Not Applicable,Observational,Turkey,Taste and Smell Impairment in Critically Ill COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04532632,None
5951,NCT04532931,ClinicalTrials.gov,2020-08-26,2020-09-03,False,Shin Poong Pharmaceutical Co. Ltd.,Recruiting,Phase 2,Interventional,South Africa,COVID-19 Treatment in South Africa,Drug,Artesunate-Amodiaquine vs. Pyronaridine-Artesunate vs. Favipiravir + Nitazoxanide vs. Sofosbuvir/daclatasvir,Artesunate-Amodiaquine; Pyronaridine-Artesunate; Favipiravir; Nitazoxanide; Sofosbuvir/daclatasvir,250,https://clinicaltrials.gov/show/NCT04532931,None
5952,NCT04533048,ClinicalTrials.gov,2020-08-22,2020-08-07,True,"Mabwell (Shanghai) Bioscience Co., Ltd.",Not Recruiting,Phase 1,Interventional,China,A Clinical Study to Evaluate MW33 Injection,Drug,MW33,MW33,42,https://clinicaltrials.gov/show/NCT04533048,None
5953,NCT04533347,ClinicalTrials.gov,2020-08-28,2020-10-01,False,60 Degrees Pharmaceuticals LLC,Not Recruiting,Phase 2,Interventional,No Country Given,A Double-blind Placebo-controlled Study to Assess the Efficacy and Safety of Oral Tafenoquine Versus Placebo in Patients With Mild to Moderate COVID-19 Disease,Drug,Tafenoquine,Tafenoquine,275,https://clinicaltrials.gov/show/NCT04533347,None
5954,NCT04533360,ClinicalTrials.gov,2020-08-28,2020-09-28,False,Kingman Regional Medical Center,Recruiting,Not Applicable,Observational,United States,Prevalence of COVID-19 Antibodies Kingman AZ,Clinical Presentation (Epidemiology),No Intervention,No Intervention,3000,https://clinicaltrials.gov/show/NCT04533360,None
5955,NCT04533399,ClinicalTrials.gov,2020-08-28,2020-08-17,True,Novavax,Recruiting,Phase 2,Interventional,South Africa,A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults,ATMP,Vaccine,Vaccine,4400,https://clinicaltrials.gov/show/NCT04533399,None
5956,NCT04534400,ClinicalTrials.gov,2020-08-26,2020-09-01,False,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,Automated Quantification of Radiologic Pulmonary Alteration During Acute Respiratory Failure,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04534400,None
5957,NCT04534478,ClinicalTrials.gov,2020-08-31,2020-09-07,False,Vall d'Hebron Research Institute (VHIR),Not Recruiting,Phase 4,Interventional,No Country Given,Oral Prednisone Regimens to Optimize the Therapeutic Strategy in Patients With Organizing Pneumonia Post-COVID-19,Drug,Prednisone,Prednisone,120,https://clinicaltrials.gov/show/NCT04534478,None
5958,NCT04534569,ClinicalTrials.gov,2020-08-30,2020-09-04,False,NMC Specialty Hospital,Not Recruiting,Not Applicable,Observational,United Arab Emirates,Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF),Other,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04534569,None
5959,NCT04534595,ClinicalTrials.gov,2020-08-31,2019-04-30,True,"St. Michael's Hospital, Toronto",Recruiting,Not Applicable,Observational,Canada,Data Collection on the Model Schools Pediatric Health Initiative at 5 SBHC Sites: COVID-19 Questionnaire,Other,No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04534595,None
5960,NCT04534608,ClinicalTrials.gov,2020-08-31,2020-05-11,True,"University Hospital, Hamburg-Eppendorf",Not Recruiting,Not Applicable,Observational,Germany,COVID-19 Child Health Investigation of Latent Disease in Hamburg,Clinical Presentation (Epidemiology),No Intervention,No Intervention,6000,https://clinicaltrials.gov/show/NCT04534608,None
5961,NCT04534621,ClinicalTrials.gov,2020-08-25,2020-08-26,False,Trate - Tratamentos Especializados,Not Recruiting,Not Applicable,Observational,No Country Given,How Brazilian Chiropractors Are Facing the COVID-19 Pandemic,Health System,No Intervention,No Intervention,948,https://clinicaltrials.gov/show/NCT04534621,None
5962,NCT04534673,ClinicalTrials.gov,2020-04-20,2020-08-05,False,Soroka University Medical Center,Recruiting,Phase 2,Interventional,Israel,Pegylated Interferon Lambda for Treatment of COVID-19 Infection,Drug,Interferon lambda,Interferon lambda,40,https://clinicaltrials.gov/show/NCT04534673,None
5963,NCT04534712,ClinicalTrials.gov,2020-08-30,2020-09-01,False,Postgraduate Institute of Medical Education and Research,Not Recruiting,Not Applicable,Observational,India,Lymphocyte - Monocyte Ratio As An Independent Predictor For Progression Of Illness In Patients With Covid-19,Prognosis,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04534712,None
5964,NCT04534725,ClinicalTrials.gov,2020-08-30,2020-11-01,False,Peter MacCallum Cancer Centre,Not Recruiting,Phase 3,Interventional,No Country Given,COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial;,Drug,"Interferon alpha, Selinexor, Lenzilumab",Interferon alpha; Selinexor; Lenzilumab,2282,https://clinicaltrials.gov/show/NCT04534725,None
5965,NCT04534790,ClinicalTrials.gov,2020-08-05,2020-07-24,True,Instituto Mexicano del Seguro Social,Recruiting,Not Applicable,Interventional,Mexico,Anti-inflammatory Effect of Low-Dose Whole-Lung Radiation for COVID-19 Pneumonia,Other,Radiation,Radiation,30,https://clinicaltrials.gov/show/NCT04534790,None
5966,NCT04534803,ClinicalTrials.gov,2020-08-21,2020-09-01,False,Harvard University,Not Recruiting,Phase 3,Interventional,No Country Given,BCG Against Covid-19 for Prevention and Amelioration of Severity Trial (BAC to the PAST),ATMP,Vaccine,Vaccine,2100,https://clinicaltrials.gov/show/NCT04534803,None
5967,NCT04535063,ClinicalTrials.gov,2020-08-29,2020-04-18,True,Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno,Recruiting,Phase 3,Interventional,Argentina,Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia,ATMP,Plasma,Plasma,200,https://clinicaltrials.gov/show/NCT04535063,None
5968,NCT04535128,ClinicalTrials.gov,2020-08-29,2020-03-24,True,Brigham and Women's Hospital,Recruiting,Not Applicable,Observational,United States,"COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications",Clinical Presentation,No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04535128,None
5969,NCT04535154,ClinicalTrials.gov,2020-08-29,2020-03-31,True,"University Hospital, Akershus",Not Recruiting,Not Applicable,Observational,Norway,Patient-reported Outcomes and Lung Function After Hospitalization for COVID-19,Clinical Presentation,No Intervention,No Intervention,264,https://clinicaltrials.gov/show/NCT04535154,None
5970,NCT04535167,ClinicalTrials.gov,2020-08-21,2020-09-09,False,Pfizer,Recruiting,Phase 1,Interventional,United States,"First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending Dose And Extended Infusion of PF 07304814 In Hospitalized Participants With COVID-19.",Drug,PF-07304814,PF-07304814,56,https://clinicaltrials.gov/show/NCT04535167,None
5971,NCT04535297,ClinicalTrials.gov,2020-08-31,2020-05-10,True,University of Haifa,Not Recruiting,Not Applicable,Observational,Israel,Consequences of the COVID-19 Lockdown on Health and Well-being of Patients With Parkinson Disease and Post-stroke,Other,Other,Other,198,https://clinicaltrials.gov/show/NCT04535297,None
5972,NCT04535674,ClinicalTrials.gov,2020-08-31,2020-10-09,False,Apogenix AG,Recruiting,Phase 2,Interventional,"Russian Federation, Spain",Asunercept in Patients With Severe COVID-19,Drug,Asunercept,Asunercept,400,https://clinicaltrials.gov/show/NCT04535674,None
5973,NCT04535700,ClinicalTrials.gov,2020-08-27,2020-09-18,False,Fundación para la Investigación Biomédica Hospital Ramón y Cajal,Recruiting,Phase 4,Interventional,Spain,Clinical Trial of Pioglitazone Treatment in Patients With Type 2 Diabetes Mellitus and Covid-19,Drug,Pioglitazone,Pioglitazone,76,https://clinicaltrials.gov/show/NCT04535700,None
5974,NCT04535778,ClinicalTrials.gov,2020-08-12,2020-09-28,False,King's College London,Not Recruiting,Not Applicable,Interventional,United Kingdom,COMPASS Study: an Online Cognitive-behavioural Therapy (CBT) Program Treating Anxiety and Low Mood in Long-term Conditions During the COVID-19 Pandemic,Other (psych),Psychological,Psychological,200,https://clinicaltrials.gov/show/NCT04535778,None
5975,NCT04535791,ClinicalTrials.gov,2020-07-30,2020-07-15,True,"Coordinación de Investigación en Salud, Mexico",Recruiting,Phase 3,Interventional,Mexico,Efficacy of Vitamin D Supplementation to Prevent the Risk of Acquiring COVID-19 in Healthcare Workers,Drug (Chemoprophylaxis),Vitamin D,Vitamin D,400,https://clinicaltrials.gov/show/NCT04535791,None
5976,NCT04535856,ClinicalTrials.gov,2020-08-28,2020-10-26,False,Ina-Respond,Not Recruiting,Phase 1,Interventional,Indonesia,Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients,ATMP,Cells (mesenchymal),Cells (mesenchymal),9,https://clinicaltrials.gov/show/NCT04535856,None
5977,NCT04535869,ClinicalTrials.gov,2020-08-28,2020-09-04,False,Mansoura University,Not Recruiting,Phase 3,Interventional,Egypt,Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19),Drug,Sofosbuvir/daclatasvir,Sofosbuvir/daclatasvir,50,https://clinicaltrials.gov/show/NCT04535869,None
5978,NCT04536051,ClinicalTrials.gov,2020-09-01,2020-06-02,True,University of Oxford,Recruiting,Phase 3,Interventional,Brazil,A Study of a Candidate COVID-19 Vaccine (COV003),ATMP,Vaccine,Vaccine,10300,https://clinicaltrials.gov/show/NCT04536051,None
5979,NCT04536090,ClinicalTrials.gov,2020-08-31,2020-11-01,False,Institut de Recherches Cliniques de Montréal (IRCM),Not Recruiting,Phase 2,Interventional,No Country Given,Study of Isoquercetin (IQC-950AN) Plus Standard of Care Versus Standard of Care Only for the Treatment of COVID-19,Drug,Isoquercetin,Isoquercetin,150,https://clinicaltrials.gov/show/NCT04536090,None
5980,NCT04536285,ClinicalTrials.gov,2020-08-27,2020-05-01,True,Ain Shams University,Not Recruiting,Not Applicable,Observational,Egypt,Hospitalized Children and Adolescent Patients With Type 1 Diabetes During the COVID-19 Pandemic in Egypt,Clinical Presentation,No Intervention,No Intervention,36,https://clinicaltrials.gov/show/NCT04536285,None
5981,NCT04536298,ClinicalTrials.gov,2020-08-27,2020-12-01,False,Brigham and Women's Hospital,Not Recruiting,Phase 3,Interventional,United States,Vitamin D and COVID-19 Trial,Drug,Vitamin D,Vitamin D,2700,https://clinicaltrials.gov/show/NCT04536298,None
5982,NCT04536350,ClinicalTrials.gov,2020-08-21,2021-01-01,False,Dr. Jorg Leuppi,Not Recruiting,Phase 1,Interventional,Switzerland,Inhaled Aviptadil for the Prevention of COVID-19 Related ARDS,Drug,Aviptadil,Aviptadil,80,https://clinicaltrials.gov/show/NCT04536350,None
5983,NCT04536363,ClinicalTrials.gov,2020-08-29,2020-10-01,False,Alonso Vera Torres,Not Recruiting,Phase 2,Interventional,No Country Given,Cri Analog PG1 Effectiveness and Safety in Covid-19,Drug,Prostaglandin E1,Prostaglandin E1,284,https://clinicaltrials.gov/show/NCT04536363,None
5984,NCT04536441,ClinicalTrials.gov,2020-08-26,2020-04-01,True,University Tunku Abdul Rahman,Not Recruiting,Not Applicable,Interventional,Malaysia,Ultra-brief Online Mindfulness-based Intervention During COVID-19 Movement Control Order,Other (psych),Psychological,Psychological,161,https://clinicaltrials.gov/show/NCT04536441,None
5985,NCT04536935,ClinicalTrials.gov,2020-08-22,2020-09-01,False,University of Washington,Not Recruiting,Not Applicable,Interventional,No Country Given,Mobile Mental Health Apps for Suicide Prevention,Other (psych),Psychological,Psychological,2000,https://clinicaltrials.gov/show/NCT04536935,None
5986,NCT04537117,ClinicalTrials.gov,2020-09-02,2020-04-20,True,Fayoum University,Not Recruiting,Not Applicable,Observational,Egypt,"Knowledge, Attitudes and Clinical Practices of Pediatric Dentists Regarding Covid-19",Other,No Intervention,No Intervention,202,https://clinicaltrials.gov/show/NCT04537117,None
5987,NCT04537130,ClinicalTrials.gov,2020-09-02,2020-12-01,False,Instituto Oncologico Dr Rosell,Not Recruiting,Phase 1,Interventional,Spain,Vaccination of Ex-acute COVID-19 Patients With Fibrosing Lung Syndrome at Discharge,ATMP,Vaccine,Vaccine,40,https://clinicaltrials.gov/show/NCT04537130,None
5988,NCT04537208,ClinicalTrials.gov,2020-09-02,2020-09-03,False,Sanofi,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older,ATMP,Vaccine,Vaccine,440,https://clinicaltrials.gov/show/NCT04537208,None
5989,NCT04537299,ClinicalTrials.gov,2020-09-01,2020-12-01,False,Mayo Clinic,Not Recruiting,Phase 2,Interventional,United States,COVID-FIS: Pilot in COVID-19 (SARS-CoV-2) of Fisetin in Older Adults in Nursing Homes,Drug,Fisetin,Fisetin,150,https://clinicaltrials.gov/show/NCT04537299,None
5990,NCT04537338,ClinicalTrials.gov,2020-08-27,2020-09-14,False,Agencia Costarricense de Investigaciones Biomedicas,Not Recruiting,Not Applicable,Observational,No Country Given,Evaluation of the Immune Response to SARS-CoV-2 Among Patients With Covid-19 in Costa Rica,Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04537338,None
5991,NCT04537351,ClinicalTrials.gov,2020-08-25,2020-08-24,True,Cynata Therapeutics Limited,Recruiting,Phase 1/Phase 2,Interventional,Australia,The MEseNchymal coviD-19 Trial: a Pilot Study to Investigate Early Efficacy of MSCs in Adults With COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),24,https://clinicaltrials.gov/show/NCT04537351,None
5992,NCT04537559,ClinicalTrials.gov,2020-08-27,2020-03-01,True,"University Hospital, Geneva",Recruiting,Not Applicable,Observational,Switzerland,Impact of COVID-19 Outbreak on Non-COVID-19 Patients,Health System,No Intervention,No Intervention,40000,https://clinicaltrials.gov/show/NCT04537559,None
5993,NCT04537572,ClinicalTrials.gov,2020-09-01,2020-09-01,False,Salveo Diagnostics,Not Recruiting,Not Applicable,Interventional,No Country Given,A Comparison of Sample Collection Methods for SARS-COV-2 Antibody Testing,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,300,https://clinicaltrials.gov/show/NCT04537572,None
5994,NCT04537585,ClinicalTrials.gov,2020-08-29,2020-11-01,False,Dr. Guyguy K Tshima,Not Recruiting,Not Applicable,Interventional,Democratic Republic of Congo,"COVID-19: Collecting Measurements of Renin-angiotensin-system Markers, Such as Angiotensin-2 and Angiotensin 1-7",Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04537585,None
5995,NCT04537650,ClinicalTrials.gov,2020-09-01,2020-11-15,False,"University Health Network, Toronto",Not Recruiting,Not Applicable,Observational,"United States, Canada",Swallowing Impairment After COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,75,https://clinicaltrials.gov/show/NCT04537650,None
5996,NCT04537663,ClinicalTrials.gov,2020-08-28,2020-08-25,True,UMC Utrecht,Recruiting,Phase 4,Interventional,Netherlands,Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults,ATMP,Vaccine,Vaccine,5200,https://clinicaltrials.gov/show/NCT04537663,None
5997,NCT04537806,ClinicalTrials.gov,2020-09-01,2020-11-01,False,Sage Therapeutics,Not Recruiting,Phase 3,Interventional,No Country Given,A Study of Brexanolone for Acute Respiratory Distress Syndrome Due to COVID-19,Drug,Brexanolone,Brexanolone,100,https://clinicaltrials.gov/show/NCT04537806,None
5998,NCT04537858,ClinicalTrials.gov,2020-08-29,2020-06-18,True,University of São Paulo,Not Recruiting,Not Applicable,Interventional,Brazil,Virtual Reality Therapy Influence on Heart Rate Variability of Inpatients With COVID-19,Other,Virtual Reality,Virtual Reality,50,https://clinicaltrials.gov/show/NCT04537858,None
5999,NCT04537949,ClinicalTrials.gov,2020-09-02,2020-09-09,True,Biontech SE,Recruiting,Phase 1/Phase 2,Interventional,Germany,A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults,ATMP,Vaccine,Vaccine,120,https://clinicaltrials.gov/show/NCT04537949,EUCTR2020-003267-26
6000,NCT04537962,ClinicalTrials.gov,2020-07-14,2020-06-11,True,Hospital Israelita Albert Einstein,Recruiting,Not Applicable,Interventional,Brazil,"Evaluationof the Load of SARS-CoV-2 Virus in Oral Cavity, Oropharinge and Saliva of Patients With Covid-19 After Disinfection With Oral Antimicrobial Solutions: a Pilot Study",Drug,Mouthwash,Mouthwash,70,https://clinicaltrials.gov/show/NCT04537962,None
6001,NCT04538456,ClinicalTrials.gov,2020-09-01,2020-09-01,False,The Christie NHS Foundation Trust,Not Recruiting,Not Applicable,Observational,No Country Given,Impact of COVID-19 on Lung Cancer Patients,Other,No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04538456,None
6002,NCT04538469,ClinicalTrials.gov,2020-09-01,2020-09-01,False,University of Glasgow,Not Recruiting,Not Applicable,Observational,No Country Given,"Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff",Health System,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04538469,None
6003,NCT04538586,ClinicalTrials.gov,2020-09-03,2020-05-01,True,"University Hospital, Clermont-Ferrand",Recruiting,Not Applicable,Observational,France,"Influence of the COVId-19 Pandemic on STRESS, and Screening Procedures (COVISTRESS Screening)",Other,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04538586,None
6004,NCT04539275,ClinicalTrials.gov,2020-08-27,2020-11-16,False,VA Office of Research and Development,Recruiting,Phase 3,Interventional,United States,COVID-19 (VA CURES-1),ATMP,Plasma,Plasma,702,https://clinicaltrials.gov/show/NCT04539275,None
6005,NCT04539626,ClinicalTrials.gov,2020-09-03,2020-10-01,False,Centro Médico Nacional 20 de Noviembre,Not Recruiting,Not Applicable,Interventional,No Country Given,Estrogen Therapy in Non-severe COVID-19 Patients,Drug,Estrogen,Estrogen,60,https://clinicaltrials.gov/show/NCT04539626,None
6006,NCT04539795,ClinicalTrials.gov,2020-09-03,2020-11-01,False,University of Alabama at Birmingham,Recruiting,Phase 1/Phase 2,Interventional,United States,COVID-19 Study of Safety and Tolerability of Alvelestat,Drug,Alvelestat,Alvelestat,15,https://clinicaltrials.gov/show/NCT04539795,None
6007,NCT04539821,ClinicalTrials.gov,2020-09-03,2020-10-01,False,VA Office of Research and Development,Recruiting,Not Applicable,Interventional,United States,Virtual Pain Care Management (COVID-19),Telehealth,Telehealth,Telehealth,60,https://clinicaltrials.gov/show/NCT04539821,None
6008,NCT04539834,ClinicalTrials.gov,2020-09-01,2020-05-01,True,Zagazig University,Not Recruiting,Not Applicable,Observational,Egypt,Electrolyte State in Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,52,https://clinicaltrials.gov/show/NCT04539834,None
6009,NCT04539873,ClinicalTrials.gov,2020-08-29,2020-11-30,False,Fundacion Universitaria de Ciencias de la Salud,Not Recruiting,Phase 3,Interventional,Colombia,Impact of Colchicine in Hospitalized Colombian Patients With COVID-19,Drug,Colchicine,Colchicine,128,https://clinicaltrials.gov/show/NCT04539873,None
6010,NCT04540029,ClinicalTrials.gov,2020-09-02,2020-05-06,True,"IRCCS National Neurological Institute ""C. Mondino"" Foundation",Recruiting,Not Applicable,Observational,Italy,Measuring Outcomes of Maternal COVID-19-related Prenatal Exposure,Clinical Presentation,No Intervention,No Intervention,600,https://clinicaltrials.gov/show/NCT04540029,None
6011,NCT04540185,ClinicalTrials.gov,2020-09-04,2020-11-01,False,"NeuroActiva, Inc.",Recruiting,Phase 3,Interventional,"United States, New Zealand",A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19,ATMP (+ drug),Vaccine + NA-831 vs Vaccine vs. NA-831,Vaccine; NA-831,3600,https://clinicaltrials.gov/show/NCT04540185,None
6012,NCT04540393,ClinicalTrials.gov,2020-08-26,2020-09-02,False,AstraZeneca,Not Recruiting,Phase 3,Interventional,Russian Federation,AZD1222 Vaccine for the Prevention of COVID-19,ATMP,Vaccine,Vaccine,100,https://clinicaltrials.gov/show/NCT04540393,None
6013,NCT04540406,ClinicalTrials.gov,2020-09-03,2020-10-01,False,Notitia Biotechnologies Company,Not Recruiting,Phase 2,Interventional,United States,NBT-NM108 as an Early Treatment of Suspected or Confirmed COVID-19 in Patients With Prediabetes or Type 2 Diabetes,Drug,NBT-NM108,NBT-NM108,100,https://clinicaltrials.gov/show/NCT04540406,None
6014,NCT04540419,ClinicalTrials.gov,2020-08-17,2020-09-11,False,NPO Petrovax,Not Recruiting,Phase 3,Interventional,Russian Federation,Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Against COVID-19,ATMP,Vaccine,Vaccine,500,https://clinicaltrials.gov/show/NCT04540419,None
6015,NCT04540484,ClinicalTrials.gov,2020-09-03,2020-08-26,True,Advocate Health Care,Recruiting,Not Applicable,Observational,United States,COVID-19 IgG Formation in Physicians at ALGH and Their Household Members,Clinical Presentation,No Intervention,No Intervention,900,https://clinicaltrials.gov/show/NCT04540484,None
6016,NCT04540926,ClinicalTrials.gov,2020-09-02,2020-09-01,True,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado,Not Recruiting,Phase 1/Phase 2,Interventional,Mexico,Cyclosporine A Plus Low-steroid Treatment in COVID-19 Pneumonia,Drug,Cyclosporine,Cyclosporine,200,https://clinicaltrials.gov/show/NCT04540926,None
6017,NCT04540939,ClinicalTrials.gov,2020-09-04,2020-10-19,False,University of Michigan,Recruiting,Not Applicable,Interventional,United States,Neural Mechanisms of Mindfulness-based Cognitive Therapy (MBCT) for Posttraumatic Stress Disorder (PTSD) - COVID Related Substudy,Other (psych),Psychological,Psychological,60,https://clinicaltrials.gov/show/NCT04540939,None
6018,NCT04541472,ClinicalTrials.gov,2020-09-07,2020-05-01,True,"University Hospital, Clermont-Ferrand",Recruiting,Not Applicable,Observational,France,Influence of the COVId-19 Pandemic on the STRESS of Dental Surgeons (COVISTRESS - Dental Surgery),Other (psych),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04541472,None
6019,NCT04541485,ClinicalTrials.gov,2020-09-07,2020-10-06,False,Daewoong Pharmaceutical Co.,Not Recruiting,Phase 1,Interventional,No Country Given,"To Evaluate Safety, Tolerability and Pharmacodynamics of DWRX2003 Against COVID-19 (in Philippines)",Drug,DWRX2003,DWRX2003,40,https://clinicaltrials.gov/show/NCT04541485,None
6020,NCT04541979,ClinicalTrials.gov,2020-06-05,2020-06-04,True,Region Skåne,Recruiting,Phase 2,Interventional,Sweden,Aerosoliserat DNase for Treatment of Respiratory Failure in Severe COVID-19,Drug,Aerosolized DNase I,Aerosolized DNase I,100,https://clinicaltrials.gov/show/NCT04541979,None
6021,NCT04542031,ClinicalTrials.gov,2020-09-07,2020-10-01,False,The Royal Wolverhampton Hospitals NHS Trust,Not Recruiting,Not Applicable,Interventional,United Kingdom,COVID-19 in a Single Large UK Rheumatology Centre and Impact on QOL,Other,No Intervention,No Intervention,7911,https://clinicaltrials.gov/show/NCT04542031,None
6022,NCT04542044,ClinicalTrials.gov,2020-09-02,2020-04-02,True,"University Hospital, Geneva",Not Recruiting,Not Applicable,Observational,Switzerland,Evaluation of the Safety and Outcomes of Outpatient Management With Mild to Moderate COVID-19 Pneumonia,Other,Other,Other,40,https://clinicaltrials.gov/show/NCT04542044,None
6023,NCT04542083,ClinicalTrials.gov,2020-09-04,2020-12-01,False,"University Hospital, Montpellier",Not Recruiting,Not Applicable,Observational,France,"Covid-19, Acute Myocardial Infarctions and Strokes in France",Health System,No Intervention,No Intervention,4000,https://clinicaltrials.gov/show/NCT04542083,None
6024,NCT04542122,ClinicalTrials.gov,2020-08-31,2020-09-03,False,"University Hospital, Caen",Not Recruiting,Not Applicable,Interventional,No Country Given,Moral Judgements and Choices of Caregivers in the Time of COVID-19 Pandemic,Other,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04542122,None
6025,NCT04542200,ClinicalTrials.gov,2020-09-08,2021-01-01,False,Northwell Health,Recruiting,Not Applicable,Observational,United States,Workforce Serosurveillance to Track Long-term Modifications to COVID-19 Exposure Due to Factors in the Built Environment,Clinical Presentation (Epidemiology),No Intervention,No Intervention,70812,https://clinicaltrials.gov/show/NCT04542200,None
6026,NCT04542213,ClinicalTrials.gov,2020-09-03,2020-08-01,True,Hospital Regional de Alta Especialidad del Bajio,Recruiting,Phase 3,Interventional,Mexico,Dipeptidyl Peptidase-4 Inhibitor (DPP4i) for the Control of Hyperglycemia in Patients With COVID-19,Drug,Linagliptin,Linagliptin,28,https://clinicaltrials.gov/show/NCT04542213,None
6027,NCT04542330,ClinicalTrials.gov,2020-09-07,2020-09-15,False,Bandim Health Project,Recruiting,Phase 3,Interventional,Denmark,Using BCG to Protect Senior Citizens During the COVID-19 Pandemic,ATMP,Vaccine,Vaccine,1900,https://clinicaltrials.gov/show/NCT04542330,None
6028,NCT04542343,ClinicalTrials.gov,2020-09-03,2020-10-01,False,Charles Drew University of Medicine and Science,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 Risk Reduction Among African American Parishioners,Other,Other,Other,265,https://clinicaltrials.gov/show/NCT04542343,None
6029,NCT04542395,ClinicalTrials.gov,2020-09-03,2020-12-01,False,Charles Drew University of Medicine and Science,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-2019 Testing and Vaccination Among African American and Latinx Public Housing Residents,Other,Other,Other,310,https://clinicaltrials.gov/show/NCT04542395,None
6030,NCT04542408,ClinicalTrials.gov,2020-09-06,2020-11-12,False,"University Hospital, Hamburg-Eppendorf",Recruiting,Phase 3,Interventional,Germany,Hamburg Edoxaban for Anticoagulation in COVID-19 Study,Drug,Edoxaban or Heparin,Edoxaban; Heparin,172,https://clinicaltrials.gov/show/NCT04542408,None
6031,NCT04542421,ClinicalTrials.gov,2020-09-04,2020-07-01,True,"University of Colorado, Denver",Recruiting,Not Applicable,Interventional,United States,Lung Ultrasound Implementation in the Management of Patients Hospitalized With COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,90,https://clinicaltrials.gov/show/NCT04542421,None
6032,NCT04542434,ClinicalTrials.gov,2020-09-04,2020-11-01,False,"First Wave Bio, Inc.",Not Recruiting,Phase 2,Interventional,No Country Given,Niclosamide in COVID-19,Drug,Niclosamide,Niclosamide,148,https://clinicaltrials.gov/show/NCT04542434,None
6033,NCT04542447,ClinicalTrials.gov,2020-09-06,2020-09-01,True,NatureCeuticals Sdn Bhd,Recruiting,Phase 1,Interventional,India,To Evaluate Safety and Efficacy of Nuvastatic as an Immunomodulator Adjuvant Therapy in COVID-19 Patients.,Drug,Nuvastatic,Nuvastatic,10,https://clinicaltrials.gov/show/NCT04542447,None
6034,NCT04542512,ClinicalTrials.gov,2020-09-06,2020-10-01,False,Poissy-Saint Germain Hospital,Recruiting,Not Applicable,Observational,France,Risk Factors for Necrotic Cholecystitis During COVID-19 Pandemic.,Clinical Presentation,No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04542512,None
6035,NCT04542694,ClinicalTrials.gov,2020-09-04,2020-05-21,True,"Promomed, LLC",Not Recruiting,Phase 3,Interventional,Russian Federation,Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19,Drug,Favipiravir,Favipiravir,200,https://clinicaltrials.gov/show/NCT04542694,None
6036,NCT04542850,ClinicalTrials.gov,2020-08-16,2020-11-01,False,Royal College of Surgeons in Ireland - Medical University of Bahrain,Not Recruiting,Not Applicable,Interventional,Bahrain,"Pilot Study to Evaluate the Safety, Tolerability, and Efficacy of 5-ALA-Phosphate + SFC in Subjects With COVID-19",Supplement,5-ALA-Phosphate + SFC (5-ALA + SFC),5-ALA-Phosphate; SFC (5-ALA + SFC),40,https://clinicaltrials.gov/show/NCT04542850,None
6037,NCT04542876,ClinicalTrials.gov,2020-09-08,2020-05-01,True,Aarogyam UK,Not Recruiting,Not Applicable,Interventional,India,Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,46,https://clinicaltrials.gov/show/NCT04542876,None
6038,NCT04542915,ClinicalTrials.gov,2020-09-08,2020-09-01,True,American Dental Association,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19-Related Health and Practices Among Dental Hygienists,Health System,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04542915,None
6039,NCT04542941,ClinicalTrials.gov,2020-08-31,2020-06-16,True,Makerere University,Not Recruiting,Not Applicable,Interventional,Uganda,Assessment of Safety and Efficacy of CCP,ATMP,Plasma,Plasma,136,https://clinicaltrials.gov/show/NCT04542941,None
6040,NCT04542954,ClinicalTrials.gov,2020-09-07,2020-03-01,True,Hamid Al-Essa Organ Transplant Center,Not Recruiting,Not Applicable,Observational,Kuwait,Optimized Management of Covid-19 Positive Kidney Transplant Recipients: Single Center Experience From the Middle East,Health System,No Intervention,No Intervention,104,https://clinicaltrials.gov/show/NCT04542954,None
6041,NCT04542967,ClinicalTrials.gov,2020-09-04,2020-06-23,True,Hospital Central Militar,Recruiting,Phase 2,Interventional,Mexico,Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 Disease,ATMP,Plasma,Plasma,150,https://clinicaltrials.gov/show/NCT04542967,None
6042,NCT04542980,ClinicalTrials.gov,2020-04-13,2020-09-15,False,Namida Lab,Not Recruiting,Not Applicable,Observational,No Country Given,Qualitative Evaluation of Tear Fluid and Blood for Auto Antibodies Produced in Response to COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04542980,None
6043,NCT04542993,ClinicalTrials.gov,2020-09-08,2020-09-08,False,Swedish Medical Center,Recruiting,Phase 2,Interventional,United States,Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy,Drug,Zinc,Zinc,60,https://clinicaltrials.gov/show/NCT04542993,None
6044,NCT04543006,ClinicalTrials.gov,2020-09-08,2020-09-08,False,"University Hospital, Grenoble",Not Recruiting,Not Applicable,Interventional,No Country Given,Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,170,https://clinicaltrials.gov/show/NCT04543006,None
6045,NCT04543760,ClinicalTrials.gov,2020-09-08,2020-10-01,False,"Hospital St. Joseph, Marseille",Recruiting,Not Applicable,Interventional,France,Effect of Prone Positioning Combined With High Flow Oxygen Therapy on Oxygenation During Acute Respiratory Failure Due to COVID-19,Procedure,Positioning,Positioning,18,https://clinicaltrials.gov/show/NCT04543760,None
6046,NCT04544033,ClinicalTrials.gov,2020-09-05,2020-09-15,False,Tanta University,Recruiting,Not Applicable,Observational,Egypt,IL- 6 Gene (174G/C) Single Nucleotide Polymorphism as an Indicator of COVID-19 Severity in Egyptian Patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,120,https://clinicaltrials.gov/show/NCT04544033,None
6047,NCT04544072,ClinicalTrials.gov,2020-08-15,2020-05-01,True,UZ Brussel,Recruiting,Not Applicable,Observational,Belgium,Analysis of the Quality and Quantity of Antibiotic Prescriptions for Bacterial Respiratory Tract Superinfection in Patients Hospitalized in COVID-19 Wards,Clinical Presentation,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04544072,None
6048,NCT04544150,ClinicalTrials.gov,2020-09-08,2020-06-01,True,Assiut University,Not Recruiting,Not Applicable,Observational,Egypt,Gastrointestinal Manifestations Among Patients With COVID19,Clinical Presentation,No Intervention,No Intervention,220,https://clinicaltrials.gov/show/NCT04544150,None
6049,NCT04544176,ClinicalTrials.gov,2020-09-09,2020-01-01,True,Nottingham University Hospitals NHS Trust,Not Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 Risk From Attending Outpatient Appointments,Health System,No Intervention,No Intervention,34000,https://clinicaltrials.gov/show/NCT04544176,None
6050,NCT04544605,ClinicalTrials.gov,2020-09-03,2020-09-07,False,Hong Kong Baptist University,Recruiting,Not Applicable,Observational,China,Special Chinese Medicine Out-patient Programme for Discharged COVID-19 Patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,150,https://clinicaltrials.gov/show/NCT04544605,None
6051,NCT04544878,ClinicalTrials.gov,2020-09-03,2020-03-26,True,Bicetre Hospital,Recruiting,Not Applicable,Observational,France,Pediatric Intensive Care and COVID-19,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04544878,None
6052,NCT04544891,ClinicalTrials.gov,2020-09-09,2020-10-01,False,CHU de Nancy,Not Recruiting,Not Applicable,Observational,France,TREM-1 Pathway Activation in COVID-19,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04544891,None
6053,NCT04545008,ClinicalTrials.gov,2020-09-01,2020-09-01,False,Prisma Health-Upstate,Not Recruiting,Phase 1,Interventional,No Country Given,Trial of Famotidine & N-Acetyl Cysteine for Outpatients With COVID-19,Drug,Famotidine vs. N-Acetyl vs. Famotidine + N-Acetyl,Famotidine; N-Acetyl,42,https://clinicaltrials.gov/show/NCT04545008,None
6054,NCT04545047,ClinicalTrials.gov,2020-09-09,2020-08-07,True,VA Office of Research and Development,Not Recruiting,Not Applicable,Observational,United States,Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19,ATMP,Plasma,Plasma,4000,https://clinicaltrials.gov/show/NCT04545047,None
6055,NCT04545242,ClinicalTrials.gov,2020-09-05,2020-10-07,False,Dr. Negrin University Hospital,Not Recruiting,Phase 4,Interventional,Spain,Efficacy of DEXamethasone in Patients With Acute Hypoxemic REspiratory Failure Caused by INfEctions,Drug,Corticosteroids,Dexamethasone,980,https://clinicaltrials.gov/show/NCT04545242,None
6056,NCT04545541,ClinicalTrials.gov,2020-09-05,2020-11-01,False,Australian National University,Recruiting,Phase 2/Phase 3,Interventional,United States,Nebulised Heparin in Patients With Severe COVID-19,Drug,Heparin,Heparin,202,https://clinicaltrials.gov/show/NCT04545541,None
6057,NCT04545749,ClinicalTrials.gov,2020-09-02,2020-09-25,False,"United Biomedical Inc., Asia",Recruiting,Phase 1,Interventional,Taiwan,"A Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine",ATMP,Vaccine,Vaccine,60,https://clinicaltrials.gov/show/NCT04545749,None
6058,NCT04546191,ClinicalTrials.gov,2020-09-10,2020-07-01,True,Landspitali University Hospital,Not Recruiting,Not Applicable,Observational,Iceland,Symptoms and Wellbeing of People Infected With Covid-19 Virus in Iceland,Clinical Presentation,No Intervention,No Intervention,1580,https://clinicaltrials.gov/show/NCT04546191,None
6059,NCT04546737,ClinicalTrials.gov,2020-09-10,2020-09-08,True,CHU de Amiens,Recruiting,Not Applicable,Interventional,France,"Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients",Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04546737,None
6060,NCT04546776,ClinicalTrials.gov,2020-09-09,2020-09-08,True,Quadram Institute Bioscience,Recruiting,Not Applicable,Observational,United Kingdom,COVID-19 Persistence in Stool,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04546776,None
6061,NCT04546841,ClinicalTrials.gov,2020-08-26,2020-11-27,False,"University Hospital, Tübingen",Recruiting,Phase 1,Interventional,Germany,Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults,ATMP,Vaccine,Vaccine,36,https://clinicaltrials.gov/show/NCT04546841,None
6062,NCT04547114,ClinicalTrials.gov,2020-09-11,2020-09-14,False,Klinikum Bayreuth GmbH,Recruiting,Not Applicable,Observational,Germany,Breath Analysis for SARS-CoV-2 in Infected and Healthy Subjects,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04547114,None
6063,NCT04547127,ClinicalTrials.gov,2020-09-10,2020-04-29,True,"Grifols, S.A.",Recruiting,Phase 2,Interventional,Spain,A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19),ATMP,Plasma,Plasma,200,https://clinicaltrials.gov/show/NCT04547127,None
6064,NCT04547140,ClinicalTrials.gov,2020-09-10,2020-11-01,False,"Grifols, S.A.",Recruiting,Phase 2,Interventional,United States,Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19),ATMP,Alpha-1-proteinase inhibitor,Alpha-1-proteinase inhibitor,100,https://clinicaltrials.gov/show/NCT04547140,None
6065,NCT04547218,ClinicalTrials.gov,2020-09-11,2020-06-22,True,University of Malaya,Recruiting,Not Applicable,Observational,Malaysia,Study on Incidence of Elective Surgery Postponed During COVID-19 Pandemic in Geriatric Population,Health System,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04547218,None
6066,NCT04547257,ClinicalTrials.gov,2020-04-29,2020-12-15,False,ExThera Medical Europe BV,Not Recruiting,Not Applicable,Interventional,Netherlands,Safety & Performance Evaluation of Seraph 100 in Treatment of Pts With COVID-19,Other (device),Blood filter,Blood filter,42,https://clinicaltrials.gov/show/NCT04547257,None
6067,NCT04547283,ClinicalTrials.gov,2020-09-09,2020-06-14,True,Atrium Health,Recruiting,Not Applicable,Interventional,United States,Awake-Prone Positioning Strategy for Hypoxic Patients With COVID-19,Procedure,Positioning,Positioning,40,https://clinicaltrials.gov/show/NCT04547283,None
6068,NCT04547634,ClinicalTrials.gov,2020-08-17,2020-07-01,True,University of Malaga,Recruiting,Not Applicable,Interventional,Spain,Telerehabilitation in Oncology Patients,Telehealth,Physio & Rehabilitation,Physio & Rehabilitation,30,https://clinicaltrials.gov/show/NCT04547634,None
6069,NCT04547660,ClinicalTrials.gov,2020-09-09,2020-07-16,True,Hospital de Clinicas de Porto Alegre,Recruiting,Phase 3,Interventional,Brazil,Convalescent Plasma for Severe COVID-19 Patients,ATMP,Plasma,Plasma,160,https://clinicaltrials.gov/show/NCT04547660,None
6070,NCT04548492,ClinicalTrials.gov,2020-09-11,2020-09-14,False,Ain Shams University,Not Recruiting,Not Applicable,Observational,No Country Given,The Validity of Modern Mobile Applications in Management of COVID-19 Home Isolation Patients: a Survey for Health Care Professionals,Other,No Intervention,No Intervention,175,https://clinicaltrials.gov/show/NCT04548492,None
6071,NCT04548505,ClinicalTrials.gov,2020-09-11,2020-10-01,False,Direction Centrale du Service de Sant des Armes,Not Recruiting,Not Applicable,Observational,France,Recovery of Exertion Ability Following COVID-19 Infection in Military Staff,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04548505,None
6072,NCT04548531,ClinicalTrials.gov,2020-09-09,2020-09-10,False,Massachusetts General Hospital,Recruiting,Not Applicable,Interventional,United States,Engaging Patients in Colon Cancer Screening Decisions During COVID-19,Health System,No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04548531,None
6073,NCT04548544,ClinicalTrials.gov,2020-09-11,2019-10-18,True,"University of California, San Francisco",Not Recruiting,Not Applicable,Interventional,United States,A Randomized Controlled Feasibility Study of Emotional Well-being of Adolescents Undergoing a Mindfulness Training During COVID-19,Other (psych),Psychological,Psychological,21,https://clinicaltrials.gov/show/NCT04548544,None
6074,NCT04548557,ClinicalTrials.gov,2020-09-07,2020-09-15,False,University of Health Sciences Lahore,Not Recruiting,Phase 3,Interventional,Pakistan,Intravenous Immunoglobulins for the Treatment of Covid-19 Patients: a Clinical Trial,ATMP,Immunoglobulin,Immunoglobulin,60,https://clinicaltrials.gov/show/NCT04548557,None
6075,NCT04548895,ClinicalTrials.gov,2020-09-10,2020-09-01,True,"Health Stream Analytics, LLC",Not Recruiting,Not Applicable,Observational,No Country Given,Non-invasive Biometric Monitoring in Nursing Homes to Fight COVID-19,Other (device),Biosensors,Biosensors,30,https://clinicaltrials.gov/show/NCT04548895,None
6076,NCT04548908,ClinicalTrials.gov,2020-09-07,2020-08-03,True,Centre Hospitalier Sud Essonne,Recruiting,Not Applicable,Observational,France,Prevalence Of COVID-19 Among Health-workers in a French General Hospital,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1300,https://clinicaltrials.gov/show/NCT04548908,None
6077,NCT04548934,ClinicalTrials.gov,2020-09-02,2020-09-13,False,Institute of Mountain Emergency Medicine,Not Recruiting,Not Applicable,Interventional,No Country Given,Effect of Wearing Personal Protective Equipment (PPE) on CPR Quality in Times of the COVID-19-pandemic,Other,Other,Other,28,https://clinicaltrials.gov/show/NCT04548934,None
6078,NCT04549337,ClinicalTrials.gov,2020-09-09,2020-09-25,False,"Rigshospitalet, Denmark",Recruiting,Not Applicable,Interventional,Denmark,Feasibility and Safety of High-intensity Exercise Training in Patients Surviving COVID-19,Other (exercise),Exercise,Exercise,10,https://clinicaltrials.gov/show/NCT04549337,None
6079,NCT04549350,ClinicalTrials.gov,2020-09-08,2020-05-19,True,Zagazig University,Not Recruiting,Not Applicable,Observational,Egypt,Sleep Quality Among HCWs,Other,No Intervention,No Intervention,217,https://clinicaltrials.gov/show/NCT04549350,None
6080,NCT04549376,ClinicalTrials.gov,2020-09-11,2020-07-01,True,"Pi Research Consultancy Center, Bangladesh",Recruiting,Phase 2,Interventional,Bangladesh,Virucidal Effect of Povidone Iodine on COVID-19 In-Vivo,Drug,Povidone Iodine,Povidone Iodine,200,https://clinicaltrials.gov/show/NCT04549376,None
6081,NCT04549636,ClinicalTrials.gov,2020-08-28,2020-09-18,False,McMaster University,Recruiting,Not Applicable,Observational,Canada,COVID-19 Related Lung Ventilation and Perfusion Injury,Other (physical),Mechanical ventilation,Mechanical ventilation,92,https://clinicaltrials.gov/show/NCT04549636,None
6082,NCT04549831,ClinicalTrials.gov,2020-09-11,2020-04-08,True,University of Siena,Recruiting,Not Applicable,Observational,Italy,Genetic Bases of COVID-19 Clinical Variability,Genomics,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04549831,None
6083,NCT04550312,ClinicalTrials.gov,2020-09-13,2020-09-01,True,The First Affiliated Hospital of Nanjing Medical University,Recruiting,Not Applicable,Observational,China,The Impact of Lifestyle Changes on Non-COVID Deaths,Other,Other,Other,80000,https://clinicaltrials.gov/show/NCT04550312,None
6084,NCT04550325,ClinicalTrials.gov,2020-09-10,2020-08-05,True,"Kamada, Ltd.",Recruiting,Phase 1/Phase 2,Interventional,Israel,"Safety, PK and PD of Kamada Anti-SARS-CoV-2 in COVID-19",ATMP,Immunoglobulin,Immunoglobulin,12,https://clinicaltrials.gov/show/NCT04550325,None
6085,NCT04550338,ClinicalTrials.gov,2020-09-13,2020-12-01,False,University of Alabama at Birmingham,Not Recruiting,Phase 3,Interventional,No Country Given,Antiviral Effects of TXA as a Preventative Treatment Following COVID-19 Exposure,Drug,Tranexamic acid,Tranexamic acid,100,https://clinicaltrials.gov/show/NCT04550338,None
6086,NCT04550390,ClinicalTrials.gov,2020-09-14,2020-09-15,False,Direction Centrale du Service de Sant des Armes,Recruiting,Not Applicable,Observational,France,Study of the Analytical Performance of Different Salivary Self-collection Methods for the Detection of COVID-19.,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,2400,https://clinicaltrials.gov/show/NCT04550390,None
6087,NCT04550403,ClinicalTrials.gov,2020-09-10,2020-07-30,True,AOU di Parma,Recruiting,Not Applicable,Observational,Italy,Clinical Phenotype and Outcomes of Inpatients With COVID-19 and Diabetes,Clinical Presentation,No Intervention,No Intervention,700,https://clinicaltrials.gov/show/NCT04550403,None
6088,NCT04551274,ClinicalTrials.gov,2020-09-01,2020-10-01,False,Simon Fraser University,Not Recruiting,Not Applicable,Interventional,Canada,Music Therapy in Frontline Healthcare Workers,Other (psych),Psychological,Psychological,20,https://clinicaltrials.gov/show/NCT04551274,None
6089,NCT04551339,ClinicalTrials.gov,2020-09-09,2020-09-28,False,Mayo Clinic,Recruiting,Not Applicable,Interventional,United States,Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19,Drug,Zinc,Zinc,4500,https://clinicaltrials.gov/show/NCT04551339,None
6090,NCT04551378,ClinicalTrials.gov,2020-09-15,2020-07-13,True,M.D. Anderson Cancer Center,Recruiting,Not Applicable,Observational,United States,The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors,Other,No Intervention,No Intervention,600,https://clinicaltrials.gov/show/NCT04551378,None
6091,NCT04551547,ClinicalTrials.gov,2020-09-15,2020-10-31,False,"Sinovac Research and Development Co., Ltd.",Recruiting,Phase 1/Phase 2,Interventional,China,Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of COVID-19,ATMP,Vaccine,Vaccine,552,https://clinicaltrials.gov/show/NCT04551547,None
6092,NCT04551690,ClinicalTrials.gov,2020-07-28,2020-04-15,True,"Hospital San Juan de Dios, Santiago",Not Recruiting,Not Applicable,Observational,Chile,Prevalence of COVID-19 (Coronavirus Disease 19) in Pregnant Women on Labor in a Public Hospital in Chile (COroNavirus diSease Covid-19 pandEmic iN ChilE),Clinical Presentation (Epidemiology),No Intervention,No Intervention,720,https://clinicaltrials.gov/show/NCT04551690,None
6093,NCT04551755,ClinicalTrials.gov,2020-09-03,2020-09-01,True,Bangladesh Medical Research Council (BMRC),Not Recruiting,Phase 2,Interventional,No Country Given,Safety and Efficacy of Ivermectin and Doxycycline in Treatment of Covid-19,Drug,Ivermectin + Doxycycline,Ivermectin; Doxycycline,188,https://clinicaltrials.gov/show/NCT04551755,None
6094,NCT04551768,ClinicalTrials.gov,2020-09-15,2020-11-01,False,"Bausch Health Americas, Inc.",Not Recruiting,Phase 1,Interventional,No Country Given,Study to Evaluate the Safety and Efficacy of VIRAZOLEÂ® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19,Drug,Virazole,Virazole,50,https://clinicaltrials.gov/show/NCT04551768,None
6095,NCT04551781,ClinicalTrials.gov,2020-09-13,2020-04-01,True,South Valley University,Not Recruiting,Not Applicable,Interventional,Egypt,Short Term Low Dose Corticosteroids for Management of Post covid19 Pulmonary Fibrosis,Drug,Corticosteroids,Prednisone,450,https://clinicaltrials.gov/show/NCT04551781,None
6096,NCT04551898,ClinicalTrials.gov,2020-09-10,2020-10-30,False,BeiGene,Not Recruiting,Phase 2,Interventional,No Country Given,Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19),Drug,BGB-DXP593,BGB-DXP593,180,https://clinicaltrials.gov/show/NCT04551898,None
6097,NCT04551911,ClinicalTrials.gov,2020-09-15,2020-10-26,False,"OPKO Health, Inc.",Recruiting,Phase 2,Interventional,United States,Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19,Drug,CTAP101,CTAP101,160,https://clinicaltrials.gov/show/NCT04551911,None
6098,NCT04552340,ClinicalTrials.gov,2020-09-08,2020-03-16,True,Istituto Clinico Humanitas,Recruiting,Not Applicable,Observational,Italy,"Epidemiologic, Clinical and Molecular Characteristics of Patients With Acute Respiratory Failure Affected by 2019-NCOV.",Clinical Presentation,No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04552340,None
6099,NCT04552392,ClinicalTrials.gov,2020-09-15,2020-09-20,False,Lohia Hospital,Not Recruiting,Not Applicable,Observational,India,Psychological Impact of Institutional Quarantine as a Precautionary Measure Against COVID-19,Other (psych),No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04552392,None
6100,NCT04552483,ClinicalTrials.gov,2020-09-09,2020-06-08,True,Universidade Federal do Rio de Janeiro,Not Recruiting,Phase 2,Interventional,Brazil,Effects of Early Use of Nitazoxanide in Patients With COVID-19,Drug,Nitazoxanide,Nitazoxanide,392,https://clinicaltrials.gov/show/NCT04552483,None
6101,NCT04552951,ClinicalTrials.gov,2020-05-21,2020-04-04,True,Fundación para la Investigación y la Innovación Biosanitaria del Principado de Asturias (FINBA),Recruiting,Phase 4,Interventional,Spain,Effect of Vitamin D on Morbidity and Mortality of the COVID-19,Drug,Vitamin D,Vitamin D,80,https://clinicaltrials.gov/show/NCT04552951,None
6102,NCT04553575,ClinicalTrials.gov,2020-09-15,2020-09-25,False,CHU de Reims,Recruiting,Not Applicable,Observational,France,CoViD-19 Patient in Reims University Hospital in March to April 2020,Clinical Presentation (Epidemiology),No Intervention,No Intervention,499,https://clinicaltrials.gov/show/NCT04553575,None
6103,NCT04553705,ClinicalTrials.gov,2020-09-15,2020-09-20,False,Beni-Suef University,Recruiting,Phase 2/Phase 3,Interventional,Saudi Arabia,"Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19)",Drug,"Omega 3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice",Omega 3; Nigella Sativa; Indian Costus; Quinine; Anise Seed; Deglycyrrhizinated Licorice,200,https://clinicaltrials.gov/show/NCT04553705,None
6104,NCT04554251,ClinicalTrials.gov,2020-09-06,2020-09-01,True,Assiut University,Recruiting,Not Applicable,Observational,Egypt,Global Impact of COVID-19 on Pulmonology Special Units,Health System,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04554251,None
6105,NCT04554264,ClinicalTrials.gov,2020-09-02,2020-09-01,True,CHU de Amiens,Recruiting,Not Applicable,Interventional,France,Complicated Grief in ICU in the Aftermath of COVID-19,Other (psych),No Intervention,No Intervention,160,https://clinicaltrials.gov/show/NCT04554264,None
6106,NCT04554433,ClinicalTrials.gov,2020-09-17,2020-12-01,False,Mansoura University,Not Recruiting,Phase 3,Interventional,No Country Given,New Treatment for COVID-19 Using Ethanol Vapor Inhalation .,Drug,Ethanol + Aspirin,Ethanol; Aspirin,80,https://clinicaltrials.gov/show/NCT04554433,None
6107,NCT04554979,ClinicalTrials.gov,2020-09-12,2020-06-01,True,Cairo University,Not Recruiting,Not Applicable,Observational,Egypt,COVID-19 Disease Duration and GIT Manifestations. A New Disease Severity Classification. An Egyptian Experience,Clinical Presentation,No Intervention,No Intervention,199,https://clinicaltrials.gov/show/NCT04554979,None
6108,NCT04554992,ClinicalTrials.gov,2020-08-26,2020-03-20,True,The Methodist Hospital System,Not Recruiting,Phase 1,Interventional,United States,Convalescent Plasma for the Treatment of COVID-19 (Coronavirus Disease 2019),ATMP,Plasma,Plasma,350,https://clinicaltrials.gov/show/NCT04554992,None
6109,NCT04555005,ClinicalTrials.gov,2020-06-11,2020-03-10,True,Instituto de Investigación Hospital Universitario La Paz,Not Recruiting,Not Applicable,Interventional,Spain,Mindfulness-based Crisis Intervention for COVID-19 Frontline Healthcare Workers During COVID-19,Other (psych),Psychological,Psychological,1000,https://clinicaltrials.gov/show/NCT04555005,None
6110,NCT04555109,ClinicalTrials.gov,2020-09-17,2020-06-30,True,The Hospital for Sick Children,Recruiting,Not Applicable,Observational,Canada,Convalescent Plasma for COVID-19 Research Donor Study,ATMP,Plasma,Plasma,1000,https://clinicaltrials.gov/show/NCT04555109,None
6111,NCT04555122,ClinicalTrials.gov,2020-04-29,2020-09-29,False,"University of California, Irvine",Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Ad Intervention,Other,Other,Other,52500,https://clinicaltrials.gov/show/NCT04555122,None
6112,NCT04555148,ClinicalTrials.gov,2020-09-16,2020-09-20,False,Green Cross Corporation,Recruiting,Phase 2,Interventional,South Korea,COVIDIG (COVID-19 Hyper-ImmunoGlobulin),ATMP,Immunoglobulin,Immunoglobulin,60,https://clinicaltrials.gov/show/NCT04555148,None
6113,NCT04555187,ClinicalTrials.gov,2020-09-16,2020-06-08,True,Oregon Health and Science University,Not Recruiting,Not Applicable,Observational,United States,Cardiovascular Risk Stratification in Covid-19,Prognosis,No Intervention,No Intervention,60000,https://clinicaltrials.gov/show/NCT04555187,None
6114,NCT04555213,ClinicalTrials.gov,2020-09-16,2020-09-30,False,Noxopharm Limited,Recruiting,Phase 1,Interventional,"Moldova, Republic of",A Dose Escalation and Dose Expansion Study of NOX66 in the Treatment of COVID-19,Drug,NOX66,NOX66,40,https://clinicaltrials.gov/show/NCT04555213,None
6115,NCT04555954,ClinicalTrials.gov,2020-09-14,2020-04-11,True,Pamukkale University,Not Recruiting,Not Applicable,Observational,Turkey,Determining the Physical Activity Level of Healthy Adults During Pandemic,Other,No Intervention,No Intervention,205,https://clinicaltrials.gov/show/NCT04555954,None
6116,NCT04556318,ClinicalTrials.gov,2020-09-18,2020-09-23,False,B. Braun Melsungen AG,Recruiting,Not Applicable,Observational,Germany,Identification of Differences in Breath Components Detected With IMS in Patients Tested on SARS-CoV-2 (COVID-19),Clinical Presentation,No Intervention,No Intervention,392,https://clinicaltrials.gov/show/NCT04556318,None
6117,NCT04556513,ClinicalTrials.gov,2020-09-16,2020-09-18,False,CHU Dijon,Recruiting,Not Applicable,Observational,France,Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status,Other,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04556513,None
6118,NCT04556565,ClinicalTrials.gov,2020-09-10,2020-05-08,True,Jordi Alonso,Recruiting,Not Applicable,Observational,Spain,MIND/COVID-19: Mental Health Impact and NeeDs Associated With COVID-19: a Comprehensive National Evaluation in Spain,Other (psych),No Intervention,No Intervention,16000,https://clinicaltrials.gov/show/NCT04556565,None
6119,NCT04556604,ClinicalTrials.gov,2020-09-18,2020-04-10,True,Medway Primary Care Trust,Not Recruiting,Not Applicable,Observational,United Kingdom,Surgical Consent During the COVID-19 Pandemic,Health System,No Intervention,No Intervention,45,https://clinicaltrials.gov/show/NCT04556604,None
6120,NCT04556630,ClinicalTrials.gov,2020-09-18,2020-10-01,False,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,Experience of Lock Down Related to the Covid-19 Epidemic and Its Impact on the Project of Parenthood,Other,No Intervention,No Intervention,360,https://clinicaltrials.gov/show/NCT04556630,None
6121,NCT04556864,ClinicalTrials.gov,2020-09-12,2020-10-01,False,Juan Victor Lorente,Not Recruiting,Not Applicable,Observational,Spain,Hemodynamic Impact on Critical Care Patients With Lung Damage Secondary to COVID-19,Clinical Presentation,No Intervention,No Intervention,67,https://clinicaltrials.gov/show/NCT04556864,None
6122,NCT04557046,ClinicalTrials.gov,2020-09-17,2020-06-26,True,LumiraDx UK Limited,Recruiting,Not Applicable,Interventional,United States,Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,400,https://clinicaltrials.gov/show/NCT04557046,None
6123,NCT04557241,ClinicalTrials.gov,2020-09-16,2020-10-01,False,Indiana University,Not Recruiting,Not Applicable,Interventional,No Country Given,Brief Informational Intervention for COVID-19 Misinformation Prophylaxis,Other,Other,Other,1000,https://clinicaltrials.gov/show/NCT04557241,None
6124,NCT04557358,ClinicalTrials.gov,2020-09-16,2020-07-01,True,National Institute of Medical Sciences and Nutrition,Recruiting,Not Applicable,Observational,Mexico,Impact in the Medical Care Among the Rheumatic Diseases Patients in a Tertiary Hospital in MÃ©xico During the COVID-19 Pandemic,Health System,No Intervention,No Intervention,346,https://clinicaltrials.gov/show/NCT04557358,None
6125,NCT04557605,ClinicalTrials.gov,2020-09-09,2020-09-14,False,University of Saskatchewan,Not Recruiting,Not Applicable,Interventional,Canada,Effects of a Face Mask on Oxygenation During Exercise,Other,Other,Other,14,https://clinicaltrials.gov/show/NCT04557605,None
6126,NCT04558021,ClinicalTrials.gov,2020-09-18,2020-10-08,False,Imuneks Farma ilac San. Tic. A.S.,Recruiting,Phase 3,Interventional,Turkey,A Study To Evaluate The Efficacy And Safety Of a Novel Niclosamide Suspension Formulation For COVID-19,Drug,Niclosamide,Niclosamide,200,https://clinicaltrials.gov/show/NCT04558021,None
6127,NCT04558125,ClinicalTrials.gov,2020-09-19,2020-09-08,True,Cedars-Sinai Medical Center,Not Recruiting,Phase 4,Interventional,United States,Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism,Drug,Tenecteplase,Tenecteplase,45,https://clinicaltrials.gov/show/NCT04558125,None
6128,NCT04558203,ClinicalTrials.gov,2020-09-19,2020-09-22,False,ClinAmygate,Recruiting,Not Applicable,Observational,Egypt,"The Relationship Between COVID-19 and Autoimmune Diseases, Lessons From Practice",Clinical Presentation,No Intervention,No Intervention,450,https://clinicaltrials.gov/show/NCT04558203,None
6129,NCT04558307,ClinicalTrials.gov,2020-09-18,2020-06-03,True,Mayo Clinic,Recruiting,Not Applicable,Observational,United States,Feasibility of Rapid COVID-19 Testing in Disadvantaged Populations,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,https://clinicaltrials.gov/show/NCT04558307,None
6130,NCT04558320,ClinicalTrials.gov,2020-09-19,2020-07-02,True,University of Rochester,Recruiting,Not Applicable,Observational,United States,COVID-19 and Lactating Mothers,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04558320,None
6131,NCT04558385,ClinicalTrials.gov,2020-09-20,2020-07-01,True,Lahore General Hospital,Not Recruiting,Not Applicable,Observational,Pakistan,Seroconversion in COVID-19 Recovered Population,Clinical Presentation (Epidemiology),No Intervention,No Intervention,275,https://clinicaltrials.gov/show/NCT04558385,None
6132,NCT04558411,ClinicalTrials.gov,2020-09-20,2020-09-12,True,Rutgers University,Recruiting,Not Applicable,Interventional,United States,"Pilot Study of a Brief, Scaleable Intervention for Coronavirus (COVID-19) Mental Health Sequelae in College Students",Other (psych),Psychological,Psychological,150,https://clinicaltrials.gov/show/NCT04558411,None
6133,NCT04558424,ClinicalTrials.gov,2020-09-21,2020-10-01,False,Bangabandhu Sheikh Mujib Medical University,Not Recruiting,Not Applicable,Interventional,Bangladesh,"RCT,Double Blind, Placebo to Evaluate the Effect of Zinc and Ascorbic Acid Supplementation in COVID-19 Positive Hospitalized Patients in BSMMU",Drug,Zinc + Vitamin C,Zinc; Vitamin C,50,https://clinicaltrials.gov/show/NCT04558424,None
6134,NCT04558437,ClinicalTrials.gov,2020-06-10,2020-06-12,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Observational,France,"COVID-Impact ""Psychological IMPACT of Covid-19 on AP-HP Staff""",Other (psych),No Intervention,No Intervention,20000,https://clinicaltrials.gov/show/NCT04558437,None
6135,NCT04558450,ClinicalTrials.gov,2020-08-31,2020-09-01,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN),Clinical Presentation,No Intervention,No Intervention,360,https://clinicaltrials.gov/show/NCT04558450,None
6136,NCT04558463,ClinicalTrials.gov,2020-09-03,2020-04-16,True,Indonesia University,Recruiting,Phase 3,Interventional,Indonesia,The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19,Drug,Favipiravir vs. Oseltamivir,Favipiravir; Oseltamivir,100,https://clinicaltrials.gov/show/NCT04558463,None
6137,NCT04558476,ClinicalTrials.gov,2020-09-14,2020-09-01,True,University of Liège,Recruiting,Phase 2,Interventional,Belgium,Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical Ventilation,ATMP,Plasma,Plasma,500,https://clinicaltrials.gov/show/NCT04558476,None
6138,NCT04558645,ClinicalTrials.gov,2020-09-18,2020-09-18,False,Gazi University,Recruiting,Not Applicable,Observational,Turkey,Evaluation of Physical Activity and Quality of Life of Patients With Type 1 Diabetes Mellitus During the Covid-19 Pandemic,Other,No Intervention,No Intervention,70,https://clinicaltrials.gov/show/NCT04558645,None
6139,NCT04558749,ClinicalTrials.gov,2020-09-18,2020-10-01,False,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,Anxiety and Depression Among Pregnant Women During COVID-19 Pandemic,Other (psych),No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04558749,None
6140,NCT04558996,ClinicalTrials.gov,2020-09-18,2020-03-01,True,Puerta de Hierro University Hospital,Recruiting,Not Applicable,Observational,Spain,Spanish Registry of Pregnant Women With COVID-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,3000,https://clinicaltrials.gov/show/NCT04558996,None
6141,NCT04559009,ClinicalTrials.gov,2020-09-21,2020-10-15,False,Atrium Health,Recruiting,Not Applicable,Observational,United States,COVID-19 Amyotrophic Lateral Sclerosis (ALS) Registry,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04559009,None
6142,NCT04559035,ClinicalTrials.gov,2020-09-21,2020-09-24,False,Augusta University,Recruiting,Not Applicable,Interventional,United States,Nasal Irrigation to Reduce COVID-19 Morbidity,Procedure,Nasal Irrigation,Nasal Irrigation,200,https://clinicaltrials.gov/show/NCT04559035,None
6143,NCT04559074,ClinicalTrials.gov,2020-08-26,2020-10-23,False,Queen Mary University of London,Recruiting,Phase 4,Interventional,United Kingdom,Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension- Pilot Study for Remote Medical Management of Hypertension During the COVID-19 Pandemic,Telehealth,Telehealth,Telehealth,1000,https://clinicaltrials.gov/show/NCT04559074,None
6144,NCT04559100,ClinicalTrials.gov,2020-09-17,2020-11-21,False,Fundacion Clinica Valle del Lili,Not Recruiting,Not Applicable,Observational,No Country Given,Long-term Characterization of Patients With Severe/Critical Infection by COVID-19 Virus,Clinical Presentation,No Intervention,No Intervention,112,https://clinicaltrials.gov/show/NCT04559100,None
6145,NCT04559542,ClinicalTrials.gov,2020-08-25,2020-09-10,False,Norwegian School of Sport Sciences,Recruiting,Not Applicable,Observational,Norway,"Body Weight Regulation, Disordered Eating Behaviour, and Experiences of Sexual Harassment in Female Martial Art Athletes",Not relevant,Not relevant,Not relevant,200,https://clinicaltrials.gov/show/NCT04559542,None
6146,NCT04560231,ClinicalTrials.gov,2020-07-11,2020-06-01,True,Lahore General Hospital,Recruiting,Phase 1,Interventional,Pakistan,Remdesivir in COVID-19 Lahore General Hospital,Drug,Remdesivir,Remdesivir,30,https://clinicaltrials.gov/show/NCT04560231,None
6147,NCT04560413,ClinicalTrials.gov,2020-09-20,2020-06-01,True,Fatih Sultan Mehmet Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,"Depression, Anxiety and SARS-CoV-2 (Covid-19) Phobia in Post-stroke Patients",Other (psych),No Intervention,No Intervention,77,https://clinicaltrials.gov/show/NCT04560413,None
6148,NCT04560530,ClinicalTrials.gov,2020-09-22,2020-03-01,True,Tanta University,Not Recruiting,Not Applicable,Observational,Saudi Arabia,The Role of CT Chest Scan in the Pre-anesthetic Assessment of Suspected or Confirmed COVID -19 Patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,76,https://clinicaltrials.gov/show/NCT04560530,None
6149,NCT04560855,ClinicalTrials.gov,2020-09-17,2020-09-14,True,Withings,Recruiting,Not Applicable,Observational,France,Secure Self-monitoring Through a Combination of Connected Objects: Implementation in COVID-19 Patients Monitored at Home,Other (device),Biosensors,Biosensors,400,https://clinicaltrials.gov/show/NCT04560855,None
6150,NCT04560881,ClinicalTrials.gov,2020-09-16,2020-09-16,False,Laboratorio Elea,Not Recruiting,Phase 3,Interventional,Argentina,"Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)",ATMP,Vaccine,Vaccine,3000,https://clinicaltrials.gov/show/NCT04560881,None
6151,NCT04561024,ClinicalTrials.gov,2020-09-22,2020-03-01,True,"Ensemble Group Holdings, LLC",Not Recruiting,Not Applicable,Observational,Hong Kong,Evaluation of a COVID-19 Pneumonia CXR AI Detection Algorithm,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,4000,https://clinicaltrials.gov/show/NCT04561024,None
6152,NCT04561063,ClinicalTrials.gov,2020-09-21,2020-12-01,False,"University of Witwatersrand, South Africa",Not Recruiting,Phase 2,Interventional,South Africa,COVID-19 Prophylaxis South Africa (COVER HCW),Drug (Chemoprophylaxis),Nitazoxanide vs. Sofosbuvir/daclatasvir,Nitazoxanide; Sofosbuvir/daclatasvir,1950,https://clinicaltrials.gov/show/NCT04561063,None
6153,NCT04561076,ClinicalTrials.gov,2020-09-07,2020-12-09,False,Hengenix Biotech Inc,Not Recruiting,Phase 1,Interventional,No Country Given,Evaluate Safety and Pharmacokinetics of HLX70 in Healthy Adult Volunteers,Drug,HLX70,HLX70,24,https://clinicaltrials.gov/show/NCT04561076,None
6154,NCT04561089,ClinicalTrials.gov,2020-09-21,2020-07-13,True,"Illumina, Inc.",Recruiting,Not Applicable,Observational,United States,Evaluation of the COVIDSeq Test in Saliva Specimens From Illumina Personnel,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,2000,https://clinicaltrials.gov/show/NCT04561089,None
6155,NCT04561102,ClinicalTrials.gov,2020-09-21,2020-09-11,True,"Illumina, Inc.",Recruiting,Not Applicable,Observational,United States,Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From an Asymptomatic Population,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,2500,https://clinicaltrials.gov/show/NCT04561102,None
6156,NCT04561141,ClinicalTrials.gov,2020-09-22,2020-12-01,False,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,Post Covid Syndrome: Clinical Pattern and Functional Assessment,Clinical Presentation,No Intervention,No Intervention,85,https://clinicaltrials.gov/show/NCT04561141,None
6157,NCT04561154,ClinicalTrials.gov,2020-09-09,2020-06-11,True,Centre Hospitalier le Mans,Recruiting,Not Applicable,Interventional,France,Identifying Functional and Psycho-social Complaints After Hospitalization for SARS-CoV-2 Infection( COVID 19)- REPERCOV,Other (psych),No Intervention,No Intervention,134,https://clinicaltrials.gov/show/NCT04561154,None
6158,NCT04561180,ClinicalTrials.gov,2020-09-22,2020-12-01,False,"Evergreen Therapeutics, Inc.",Not Recruiting,Phase 2,Interventional,No Country Given,Study to Evaluate the Efficacy and Safety of EG-HPCP-03a Compared to DEX in Patients With COVID-19 Pneumonia,Drug,EG-HPCP-03a + Corticosteroids,EG-HPCP-03a; Dexamethasone,96,https://clinicaltrials.gov/show/NCT04561180,None
6159,NCT04561193,ClinicalTrials.gov,2020-09-22,2020-05-30,True,Methodist Health System,Recruiting,Not Applicable,Observational,United States,Investigation of Subsequent and Co-infections Associated With SARS-CoV-2 (COVID-19),Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04561193,None
6160,NCT04561219,ClinicalTrials.gov,2020-09-22,2020-04-19,True,Universidade Federal do Rio de Janeiro,Not Recruiting,Phase 2,Interventional,Brazil,Nitazoxanide Therapy for Patients With COVID-19 Pneumonia,Drug,Nitazoxanide,Nitazoxanide,500,https://clinicaltrials.gov/show/NCT04561219,None
6161,NCT04562246,ClinicalTrials.gov,2020-09-22,2020-08-14,True,Henry Ford Health System,Recruiting,Not Applicable,Observational,United States,SARS-CoV-2 IgG and IgM Serologic Assays,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,https://clinicaltrials.gov/show/NCT04562246,None
6162,NCT04562285,ClinicalTrials.gov,2020-09-22,2020-06-23,True,Henry Ford Health System,Recruiting,Not Applicable,Observational,United States,Sustained Immunity to SARS-CoV-2,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,https://clinicaltrials.gov/show/NCT04562285,None
6163,NCT04563065,ClinicalTrials.gov,2020-09-19,2020-08-01,True,Universidad Politécnica de Madrid,Recruiting,Not Applicable,Interventional,Spain,Active Pregnancy Against COVID-19,Other (exercise),Exercise,Exercise,280,https://clinicaltrials.gov/show/NCT04563065,None
6164,NCT04563156,ClinicalTrials.gov,2020-09-23,2020-06-23,True,University of São Paulo General Hospital,Recruiting,Not Applicable,Observational,Brazil,Follow-up and Rehabilitation of Survivors of Severe Coronavirus Disease 2019 (COVID-19) Infection,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,100,https://clinicaltrials.gov/show/NCT04563156,None
6165,NCT04563208,ClinicalTrials.gov,2020-09-21,2020-12-01,False,"University of Witwatersrand, South Africa",Not Recruiting,Phase 2,Interventional,South Africa,Study of Oral Administration of Ribavirin and Nitazoxamide Versus Placebo in COVID-19,Drug,Ribavirin + Nitazoxanide,Ribavirin; Nitazoxanide,40,https://clinicaltrials.gov/show/NCT04563208,None
6166,NCT04563247,ClinicalTrials.gov,2020-09-20,2020-07-01,True,Lahore General Hospital,Not Recruiting,Not Applicable,Observational,Pakistan,Seroprevalence of SARS-CoV-2 in Asymptomatic Frontline COVID-19 HCWs,Clinical Presentation (Epidemiology),No Intervention,No Intervention,700,https://clinicaltrials.gov/show/NCT04563247,None
6167,NCT04563442,ClinicalTrials.gov,2020-09-23,2020-10-15,False,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,Comorbidities And Complications Associated With Covid-19 Infection,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04563442,None
6168,NCT04563650,ClinicalTrials.gov,2020-09-18,2020-09-18,False,CHU de Amiens,Recruiting,Not Applicable,Interventional,France,COVID-19 Serology and Immunosenescence,Clinical Presentation (Epidemiology),No Intervention,No Intervention,330,https://clinicaltrials.gov/show/NCT04563650,None
6169,NCT04563676,ClinicalTrials.gov,2020-09-23,2020-09-22,True,CHU de Amiens,Recruiting,Not Applicable,Interventional,France,Physiopathology and Sequelae of COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04563676,None
6170,NCT04563689,ClinicalTrials.gov,2020-09-22,2020-06-18,True,Dentaid SL,Not Recruiting,Not Applicable,Interventional,Colombia,Pilot Study to Evaluate Effect of CHX0.12/CPC 0.05 of SARS-CoV-2 Viral Load in COVID-19 Patients,Drug,Mouthwash,Mouthwash,23,https://clinicaltrials.gov/show/NCT04563689,None
6171,NCT04563702,ClinicalTrials.gov,2020-09-21,2020-09-21,False,Vaxart,Not Recruiting,Phase 1,Interventional,United States,Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults,ATMP,Vaccine,Vaccine,35,https://clinicaltrials.gov/show/NCT04563702,None
6172,NCT04564040,ClinicalTrials.gov,2020-08-27,2020-10-12,False,AstraZeneca,Recruiting,Phase 1,Interventional,Germany,A Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for Rabeprazole,Drug,Acalabrutinib,Acalabrutinib,40,https://clinicaltrials.gov/show/NCT04564040,None
6173,NCT04564287,ClinicalTrials.gov,2020-09-24,2020-10-28,False,National Institute of Neurological Disorders and Stroke (NINDS),Recruiting,Not Applicable,Observational,United States,An Observational Study of Neurologic Function After COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04564287,None
6174,NCT04565106,ClinicalTrials.gov,2020-09-24,2020-04-15,True,"Copenhagen University Hospital, Hvidovre",Not Recruiting,Not Applicable,Observational,Denmark,Automatic Oxygen Titration With O2maticÂ® to Patients Admitted With COVID-19 and Hypoxemic Respiratory Failure,Drug,Oxygen,Oxygen,16,https://clinicaltrials.gov/show/NCT04565106,None
6175,NCT04565249,ClinicalTrials.gov,2020-09-15,2020-10-22,False,"Pliant Therapeutics, Inc.",Recruiting,Phase 2,Interventional,United States,"Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19",Drug,PLN-74809,PLN-74809,36,https://clinicaltrials.gov/show/NCT04565249,None
6176,NCT04565379,ClinicalTrials.gov,2020-09-23,2020-09-25,False,Shaperon,Recruiting,Phase 2,Interventional,Romania,Clinical Trial to Investigate the Efficacy and Safety of NuSepinÂ® in COVID-19 Pneumonia Patients,ATMP,Cells (mesenchymal),Cells (mesenchymal),60,https://clinicaltrials.gov/show/NCT04565379,None
6177,NCT04565392,ClinicalTrials.gov,2020-09-21,2020-12-01,False,drpykessupplements.com,Not Recruiting,Phase 4,Interventional,United States,Study of Famotidine With Vitamins C and D for Pandemic Coronavirus,Drug,Famotidine,Famotidine,216,https://clinicaltrials.gov/show/NCT04565392,None
6178,NCT04565509,ClinicalTrials.gov,2020-09-24,2020-11-20,False,Washington University in St. Louis,Recruiting,Not Applicable,Interventional,United States,Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 Pandemic,Other,Other,Other,2500,https://clinicaltrials.gov/show/NCT04565509,None
6179,NCT04565522,ClinicalTrials.gov,2020-09-23,2020-09-21,True,Dr. Simeone Andrulli,Not Recruiting,Not Applicable,Observational,Italy,Transmission of COVID-19 Virus Among Patients and Staff in Dialysis Centers,Clinical Presentation (Epidemiology),No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04565522,None
6180,NCT04565665,ClinicalTrials.gov,2020-09-22,2020-07-29,True,M.D. Anderson Cancer Center,Recruiting,Phase 1,Interventional,United States,Cord Blood-Derived Mesenchymal Stem Cells for the Treatment of COVID-19 Related Acute Respiratory Distress Syndrome,ATMP,Cells (mesenchymal),Cells (mesenchymal),70,https://clinicaltrials.gov/show/NCT04565665,None
6181,NCT04565782,ClinicalTrials.gov,2020-09-22,2020-09-15,True,Assiut University,Recruiting,Not Applicable,Observational,Egypt,Corona Virus Infection Among Liver Transplant Recipients,Clinical Presentation (Epidemiology),No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04565782,None
6182,NCT04566276,ClinicalTrials.gov,2020-09-15,2021-01-01,False,Chulalongkorn University,Not Recruiting,Phase 1,Interventional,Thailand,ChulaCov19 mRNA Vaccine in Healthy Adults,ATMP,Vaccine,Vaccine,96,https://clinicaltrials.gov/show/NCT04566276,None
6183,NCT04566770,ClinicalTrials.gov,2020-09-22,2020-09-24,False,CanSino Biologics Inc.,Recruiting,Phase 2,Interventional,China,A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector),ATMP,Vaccine,Vaccine,481,https://clinicaltrials.gov/show/NCT04566770,None
6184,NCT04566965,ClinicalTrials.gov,2020-09-24,2020-08-18,True,"Children's Hospital Medical Center, Cincinnati",Recruiting,Not Applicable,Observational,United States,Serology to Covid for Recording Exposures and Evaluating Needs,Clinical Presentation (Epidemiology),No Intervention,No Intervention,230,https://clinicaltrials.gov/show/NCT04566965,None
6185,NCT04567173,ClinicalTrials.gov,2020-09-24,2020-09-21,True,University of the Philippines,Recruiting,Phase 2/Phase 3,Interventional,Philippines,Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients With COVID-19,ATMP,Plasma,Plasma,136,https://clinicaltrials.gov/show/NCT04567173,None
6186,NCT04567576,ClinicalTrials.gov,2020-09-24,2020-10-01,False,Fundación Santa Fe de Bogotá,Not Recruiting,Not Applicable,Observational,No Country Given,Predictive Factors for COVID-19 in Rheumatology,Prognosis,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04567576,None
6187,NCT04567810,ClinicalTrials.gov,2020-09-18,2020-09-18,False,Stanford University,Recruiting,Phase 1,Interventional,Australia,"Safety, Tolerability, and Pharmacokinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY) (COVID-19)",ATMP,Immunoglobulin,Immunoglobulin,48,https://clinicaltrials.gov/show/NCT04567810,None
6188,NCT04567836,ClinicalTrials.gov,2020-09-22,2020-06-01,True,University of Milano Bicocca,Recruiting,Not Applicable,Observational,Italy,Screening of Health-care Workers in an University Hospital for SARS-CoV-2,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,3000,https://clinicaltrials.gov/show/NCT04567836,None
6189,NCT04567927,ClinicalTrials.gov,2020-09-18,2020-03-03,True,Chiesa Alessandro Felice,Not Recruiting,Not Applicable,Observational,Switzerland,Prevalence and Risk Factors for Venous Thromboembolic Events in Critically Ill Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04567927,None
6190,NCT04567953,ClinicalTrials.gov,2020-09-25,2020-07-28,True,Paradigm Laboratories LLC,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Tests With Saliva Specimens,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,2000,https://clinicaltrials.gov/show/NCT04567953,None
6191,NCT04567979,ClinicalTrials.gov,2020-09-25,2020-06-11,True,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,Not Recruiting,Not Applicable,Observational,Mexico,Prospective Determination of COVID-19 Infection Rate in a Chemotherapy Unit in Mexico.,Clinical Presentation (Epidemiology),No Intervention,No Intervention,149,https://clinicaltrials.gov/show/NCT04567979,None
6192,NCT04568005,ClinicalTrials.gov,2020-09-25,2020-06-01,True,Fatih Sultan Mehmet Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,Evaluation of Lymphedema Patients Status During Covid-19 Pandemic,Other,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04568005,None
6193,NCT04568018,ClinicalTrials.gov,2020-09-18,2020-07-03,True,Biosurf LLC.,Recruiting,Not Applicable,Observational,Russian Federation,Surfactant-BL in Adult Acute Respiratory Distress Syndrome Due to COVID-19,Drug,Surfactant-BL,Surfactant-BL,120,https://clinicaltrials.gov/show/NCT04568018,None
6194,NCT04568044,ClinicalTrials.gov,2020-09-23,2020-09-16,True,Imperial College London,Recruiting,Not Applicable,Observational,United Kingdom,Evaluation of Humoral Immunity Following COVID-19 in Pregnancy,Clinical Presentation (Epidemiology),No Intervention,No Intervention,96,https://clinicaltrials.gov/show/NCT04568044,None
6195,NCT04568096,ClinicalTrials.gov,2020-09-26,2020-11-01,False,Kafrelsheikh University,Not Recruiting,Phase 2,Interventional,No Country Given,Combination of Chemopreventive Agents (All- Trans Retinoic Acid and Tamoxifen) as Potential Treatment for the Lung Complication of COVID-19,Drug,Retinoic acid + Tamoxifen,Retinoic acid; Tamoxifen,160,https://clinicaltrials.gov/show/NCT04568096,None
6196,NCT04568135,ClinicalTrials.gov,2020-09-18,2020-10-31,False,Siyan Clinical Corporation,Not Recruiting,Not Applicable,Observational,No Country Given,A Survey Study to Assess the Impact of the COVID-19 Pandemic on Participants With Pre-Existing Mental Health Diagnosis,Other (psych),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04568135,None
6197,NCT04568148,ClinicalTrials.gov,2020-04-15,2020-04-15,False,University of Kansas Medical Center,Recruiting,Not Applicable,Observational,United States,COVID-19 Biorepository,Clinical Presentation (Epidemiology),No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04568148,None
6198,NCT04568356,ClinicalTrials.gov,2020-09-27,2020-04-24,True,"E25Bio, Inc.",Not Recruiting,Not Applicable,Interventional,United States,A Clinical Evaluation of COVID-19 Rapid Point of Care Antigen Tests,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04568356,None
6199,NCT04568421,ClinicalTrials.gov,2020-09-23,2020-08-18,True,Sociedad Argentina de Reumatologia,Recruiting,Not Applicable,Observational,Argentina,Argentinian Registry of Patients With Rheumatic Diseases and COVID-19 Infection,Clinical Presentation (Epidemiology),No Intervention,No Intervention,3000,https://clinicaltrials.gov/show/NCT04568421,None
6200,NCT04568499,ClinicalTrials.gov,2020-09-24,2020-10-01,False,Johns Hopkins University,Not Recruiting,Not Applicable,Observational,No Country Given,"Presenting Nutrition Characteristics, Comorbidities and Outcomes of COVID-19 in African Humanitarian Settings",Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04568499,None
6201,NCT04568525,ClinicalTrials.gov,2020-09-23,2020-07-01,True,Kyrgyz State Medical Academy,Not Recruiting,Not Applicable,Interventional,Kyrgyzstan,Passive Microwave Radiometry (MWR) and AI for COVID-19 Complications Early Diagnostics of Lungs,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,195,https://clinicaltrials.gov/show/NCT04568525,None
6202,NCT04568551,ClinicalTrials.gov,2020-09-24,2020-10-01,False,Martin Luther University Halle-Wittenberg,Recruiting,Not Applicable,Observational,Germany,"COVID-19-associated Anxiety of Pregnant Women for Anomalies, Stillbirth and Preterm Labor",Other (psych),No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04568551,None
6203,NCT04568655,ClinicalTrials.gov,2020-09-28,2020-02-01,True,The First Affiliated Hospital of Guangzhou Medical University,Not Recruiting,Not Applicable,Observational,China,The Noninvasive Ventilation to COVID-19 Patients,Other (physical),Mechanical ventilation,Mechanical ventilation,23,https://clinicaltrials.gov/show/NCT04568655,None
6204,NCT04568707,ClinicalTrials.gov,2020-08-31,2020-10-15,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES),Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04568707,None
6205,NCT04568811,ClinicalTrials.gov,2020-09-28,2020-09-26,True,Jiangsu Provincial Center for Disease Control and Prevention,Not Recruiting,Phase 1,Interventional,China,The Phase I Clinical Trial of Booster Vaccination of Adenovirus Type-5 Vectored COVID-19 Vaccine,ATMP,Vaccine,Vaccine,89,https://clinicaltrials.gov/show/NCT04568811,None
6206,NCT04568850,ClinicalTrials.gov,2020-09-21,2020-07-01,True,Lahore General Hospital,Not Recruiting,Not Applicable,Observational,Pakistan,Waxing and Waning of Serum SARS CoV-2-IgG Level in COVID-19 Exposed Population,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04568850,None
6207,NCT04568863,ClinicalTrials.gov,2020-09-28,2020-06-20,True,Pharmamel S.L.,Recruiting,Phase 2,Interventional,Spain,Efficacy of Intravenous Melatonin on Mortality in Adult Patients Admitted to the Intensive Care Unit With COVID-19,Drug,Melatonin,Melatonin,18,https://clinicaltrials.gov/show/NCT04568863,None
6208,NCT04568876,ClinicalTrials.gov,2020-09-24,2020-10-23,False,Epitech Group SpA,Recruiting,Phase 4,Interventional,Italy,Micronized and Ultramicronized Palmitoylethanolamide in COVID-19 Patients,Drug,Palmitoylethanolamide,Palmitoylethanolamide,40,https://clinicaltrials.gov/show/NCT04568876,None
6209,NCT04568889,ClinicalTrials.gov,2020-09-24,2020-09-28,False,Harvard University,Not Recruiting,Not Applicable,Interventional,No Country Given,Minnesota COVID-19 Testing Project,Other,Other,Other,1000,https://clinicaltrials.gov/show/NCT04568889,None
6210,NCT04569188,ClinicalTrials.gov,2020-09-04,2020-05-15,True,Azienda Socio Sanitaria Territoriale di Mantova,Not Recruiting,Phase 2,Interventional,Italy,Convalescent Plasma in COVID-19 Elderly Patients,ATMP,Plasma,Plasma,21,https://clinicaltrials.gov/show/NCT04569188,None
6211,NCT04569227,ClinicalTrials.gov,2020-09-28,2020-11-16,False,Enzychem Lifesciences Corporation,Not Recruiting,Phase 2,Interventional,No Country Given,Prevention of COVID-19 Infection to Severe Pneumonia or ARDS,Drug (Chemoprophylaxis),EC-18,EC-18,60,https://clinicaltrials.gov/show/NCT04569227,None
6212,NCT04569266,ClinicalTrials.gov,2020-09-10,2020-08-07,True,Groupe Hospitalier Paris Saint-Joseph,Recruiting,Not Applicable,Interventional,France,Effectiveness of an Exercise Re-training Program on Dyspnea in Patients After Acute Respiratory Distress Syndrome Secondary to Severe COVID-19 Pneumonia in Post-ICU,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,200,https://clinicaltrials.gov/show/NCT04569266,None
6213,NCT04569292,ClinicalTrials.gov,2020-09-16,2020-01-01,True,Ospedale Andrea Tortora di Pagani,Recruiting,Not Applicable,Observational,Italy,COVID-19 Infection in Cancer Pantients,Clinical Presentation (Epidemiology),No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04569292,None
6214,NCT04569344,ClinicalTrials.gov,2020-09-25,2020-01-01,True,"University of California, San Francisco",Recruiting,Not Applicable,Observational,United States,COVID-19 and Venous Thromboembolism Risk,Clinical Presentation,No Intervention,No Intervention,40000,https://clinicaltrials.gov/show/NCT04569344,None
6215,NCT04569383,ClinicalTrials.gov,2020-09-21,2020-10-05,False,"University Hospital, Hamburg-Eppendorf",Recruiting,Phase 1,Interventional,Germany,"Safety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S Against COVID-19",ATMP,Vaccine,Vaccine,30,https://clinicaltrials.gov/show/NCT04569383,None
6216,NCT04569825,ClinicalTrials.gov,2020-09-29,2020-08-01,True,University of Anbar,Recruiting,Phase 1,Interventional,Iraq,Effect of Nasal Steroid in the Treatment of Anosmia Due to COVID-19 Disease,Drug,Ophtamesone,Ophtamesone,250,https://clinicaltrials.gov/show/NCT04569825,None
6217,NCT04569851,ClinicalTrials.gov,2020-04-11,2020-01-01,True,Medsavana,Recruiting,Not Applicable,Observational,Spain,Clinical Characteristics and Prognostic Factors of Patients With COVID-19 (Coronavirus Disease 2019),Clinical Presentation,No Intervention,No Intervention,100000,https://clinicaltrials.gov/show/NCT04569851,None
6218,NCT04569877,ClinicalTrials.gov,2020-09-25,2020-09-24,True,University of Giessen,Recruiting,Phase 2,Interventional,Germany,GM-CSF Inhalation to Prevent ARDS in COVID-19 Pneumonia,Drug,Molgramostim,Molgramostim,238,https://clinicaltrials.gov/show/NCT04569877,EUCTR2020-001654-21
6219,NCT04570202,ClinicalTrials.gov,2020-09-28,2020-11-20,False,CHU de Tours,Recruiting,Not Applicable,Interventional,France,Health cAre woRkers exposeD to COVID-19,Other (psych),Psychological,Psychological,900,https://clinicaltrials.gov/show/NCT04570202,None
6220,NCT04570254,ClinicalTrials.gov,2020-09-26,2020-08-19,True,Unidad Temporal COVID-19 en Centro Citibanamex,Not Recruiting,Not Applicable,Interventional,Mexico,Antioxidants as Adjuvant Therapy to Standard Therapy in Patients With COVID-19,Drug,Vitamin C + Vitamin E + Melatonin + N-acetyl cysteine + Pentoxifylline,Vitamin C; Vitamin E; Melatonin; N-acetyl cysteine; Pentoxifylline,11,https://clinicaltrials.gov/show/NCT04570254,None
6221,NCT04570384,ClinicalTrials.gov,2020-09-17,2020-10-15,False,"Asklepion Pharmaceuticals, LLC",Recruiting,Phase 2,Interventional,United States,Intravenous L-Citrulline to Delay and Potentially Prevent the Need for Invasive Mechanical Ventilation for Acute Hypoxemic Respiratory Failure in Patients With COVID-19 (SARS-CoV-2) Illness,Drug,L-Citrulline,L-Citrulline,60,https://clinicaltrials.gov/show/NCT04570384,None
6222,NCT04570397,ClinicalTrials.gov,2020-09-29,2020-11-01,False,Brigham and Women's Hospital,Not Recruiting,Phase 3,Interventional,United States,Ravulizumab and COVID-19,Drug,Ravulizumab,Ravulizumab,32,https://clinicaltrials.gov/show/NCT04570397,None
6223,NCT04570449,ClinicalTrials.gov,2020-09-29,2020-09-01,True,Milton S. Hershey Medical Center,Not Recruiting,Phase 1,Interventional,United States,Pilot Randomized Controlled Trial: Fluoxetine to Reduce Hospitalization From COVID-19 Infection (FloR COVID-19),Drug,Fluoxetine,Fluoxetine,40,https://clinicaltrials.gov/show/NCT04570449,None
6224,NCT04570462,ClinicalTrials.gov,2020-07-21,2020-05-18,True,Northwell Health,Recruiting,Not Applicable,Interventional,United States,Mild Hypothermia for COVID-19 ARDS,Other (device),Cooling Machine,Cooling Machine,20,https://clinicaltrials.gov/show/NCT04570462,None
6225,NCT04570488,ClinicalTrials.gov,2020-09-25,2020-05-15,True,NYU Langone Health,Recruiting,Not Applicable,Interventional,United States,Predicting Favorable Outcomes in Hospitalized Covid-19 Patients,Prognosis,No Intervention,No Intervention,1200,https://clinicaltrials.gov/show/NCT04570488,None
6226,NCT04570501,ClinicalTrials.gov,2020-09-28,2021-01-01,False,Stanford University,Not Recruiting,Phase 1/Phase 2,Interventional,United States,Angiotensin (1-7) for the Treatment of COVID-19 in Hospitalized Patients,Drug,Angiotensin,Angiotensin,160,https://clinicaltrials.gov/show/NCT04570501,None
6227,NCT04570982,ClinicalTrials.gov,2020-07-24,2020-07-30,False,Dr. Pradip Gyanwali,Recruiting,Not Applicable,Observational,Nepal,Clinical Protocol for Convalescent Plasma and Remdesivir Therapy in Nepal,ATMP,Plasma,Plasma,200,https://clinicaltrials.gov/show/NCT04570982,None
6228,NCT04572360,ClinicalTrials.gov,2020-09-27,2020-10-01,False,Hong Kong Baptist University,Not Recruiting,Not Applicable,Interventional,Hong Kong,Cardiorespiratory Exercise & Chinese Medicine for Rehabilitation of Discharged Coronavirus Disease (COVID-19) Patients,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,172,https://clinicaltrials.gov/show/NCT04572360,None
6229,NCT04572399,ClinicalTrials.gov,2020-09-28,2020-10-30,False,Cedars-Sinai Medical Center,Recruiting,Not Applicable,Interventional,United States,UVA Light Device to Treat COVID-19,Other,Ultraviolet Therapy,Ultraviolet Therapy,5,https://clinicaltrials.gov/show/NCT04572399,None
6230,NCT04572412,ClinicalTrials.gov,2020-09-29,2020-10-01,False,Lancashire Teaching Hospitals NHS Foundation Trust,Not Recruiting,Not Applicable,Interventional,United Kingdom,Low Dose Lung Radiotherapy to Treat COVID-19 Pneumonia,Other,Radiation,Radiation,13,https://clinicaltrials.gov/show/NCT04572412,None
6231,NCT04572438,ClinicalTrials.gov,2020-09-29,2020-08-01,True,"University College, London",Recruiting,Not Applicable,Observational,United Kingdom,A Cohort Study of Mechanically Ventilated COVID-19 Patients Undergoing Tracheostomy,Procedure,Tracheostomy,Tracheostomy,2500,https://clinicaltrials.gov/show/NCT04572438,None
6232,NCT04573153,ClinicalTrials.gov,2020-09-30,2020-09-21,True,ScandiBio Therapeutics AB,Recruiting,Phase 2/Phase 3,Interventional,Turkey,Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients,Drug,Hydroxychloroquine + N-acetyl cysteine + L-carnitine tartrate + nicotinamide riboside + serine vs. Hydroxychloroquine,Hydroxychloroquine; N-acetyl cysteine; L-carnitine tartrate; nicotinamide riboside; serine,400,https://clinicaltrials.gov/show/NCT04573153,None
6233,NCT04573270,ClinicalTrials.gov,2020-09-23,2020-04-24,True,Thomas Advanced Medical LLC,Not Recruiting,Phase 1,Interventional,United States,Mesenchymal Stem Cells for the Treatment of COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),40,https://clinicaltrials.gov/show/NCT04573270,None
6234,NCT04573322,ClinicalTrials.gov,2020-09-29,2020-09-10,True,Diffusion Pharmaceuticals Inc,Recruiting,Phase 1/Phase 2,Interventional,Romania,Safety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected Subjects,Drug,Trans Sodium Crocetinate,Trans Sodium Crocetinate,224,https://clinicaltrials.gov/show/NCT04573322,None
6235,NCT04573335,ClinicalTrials.gov,2020-09-29,2020-06-01,True,"Services Institute of Medical Sciences, Pakistan",Not Recruiting,Not Applicable,Observational,Pakistan,Diabetes Outcomes in COVID-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,1282,https://clinicaltrials.gov/show/NCT04573335,None
6236,NCT04573348,ClinicalTrials.gov,2020-09-30,2020-10-14,False,Savicell Diagnostics Ltd,Recruiting,Not Applicable,Observational,Israel,T Cells Response to SARS COV 2 Peptides,Clinical Presentation,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04573348,None
6237,NCT04573361,ClinicalTrials.gov,2020-09-29,2020-05-02,True,Real Centro Universitario Maria Cristina,Not Recruiting,Not Applicable,Interventional,Spain,Access to Chiropractic Care During the COVID-19 Healthcare Emergency in Spain,Health System,No Intervention,No Intervention,723,https://clinicaltrials.gov/show/NCT04573361,None
6238,NCT04573634,ClinicalTrials.gov,2020-09-30,2020-05-15,True,Jill M Kolesar,Recruiting,Not Applicable,Observational,United States,A Registry Study of COVID-19 Serologic and Virologic Testing to Accelerate Recovery and Transition,Clinical Presentation (Epidemiology),No Intervention,No Intervention,960,https://clinicaltrials.gov/show/NCT04573634,None
6239,NCT04573764,ClinicalTrials.gov,2020-10-01,2020-10-01,False,Steno Diabetes Center Copenhagen,Not Recruiting,Not Applicable,Interventional,No Country Given,Acute Effects of Oral Ketone Ester on Cardiac Function in Patients With COVID-19,Supplement,"D-beta-hydroxybutyrate-(R)-1,3 butanediol monoester","D-beta-hydroxybutyrate-(R)-1,3 butanediol monoester",12,https://clinicaltrials.gov/show/NCT04573764,None
6240,NCT04573855,ClinicalTrials.gov,2020-09-30,2020-12-01,False,D'Or Institute for Research and Education,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,TREATMENT WITH ANTI-SARS-COV-2 IMMUNOGLOBULIN IN PATIENTS WITH COVID-19,ATMP,Immunoglobulin,Immunoglobulin,41,https://clinicaltrials.gov/show/NCT04573855,None
6241,NCT04573868,ClinicalTrials.gov,2020-09-30,2020-03-01,True,Hospitales Universitarios Virgen del Rocio,Recruiting,Not Applicable,Observational,Spain,"National Study ""AEC COVID-19""",Health System,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04573868,None
6242,NCT04574050,ClinicalTrials.gov,2020-09-28,2020-12-03,False,King's College Hospital NHS Foundation Trust,Not Recruiting,Not Applicable,Interventional,No Country Given,SELF-BREATHE RCT for Chronic Breathlessness,Other,Other,Other,40,https://clinicaltrials.gov/show/NCT04574050,None
6243,NCT04574219,ClinicalTrials.gov,2020-09-24,2020-10-01,False,"Children's Hospital Medical Center, Cincinnati",Not Recruiting,Not Applicable,Interventional,"United States, Canada",Virtual Parental Presence on Induction,Not relevant,Not relevant,Not relevant,184,https://clinicaltrials.gov/show/NCT04574219,None
6244,NCT04574765,ClinicalTrials.gov,2020-09-28,2020-04-16,True,"University Health Network, Toronto",Recruiting,Not Applicable,Observational,Canada,A Research Platform to Screen Healthcare Workers,Clinical Presentation (Epidemiology),No Intervention,No Intervention,100000,https://clinicaltrials.gov/show/NCT04574765,None
6245,NCT04574869,ClinicalTrials.gov,2020-09-16,2020-10-01,False,"ReAlta Life Sciences, Inc.",Not Recruiting,Phase 1,Interventional,United States,A Study of RLS-0071 in Patients With Acute Lung Injury Due to COVID-19 Pneumonia in Early Respiratory Failure,Drug,RLS-0071,RLS-0071,42,https://clinicaltrials.gov/show/NCT04574869,None
6246,NCT04575168,ClinicalTrials.gov,2020-10-01,2020-10-30,False,Spartan Bioscience Inc.,Recruiting,Not Applicable,Observational,United States,Clinical Study Spartan COVID-19 V2 System,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04575168,None
6247,NCT04575532,ClinicalTrials.gov,2020-10-01,2020-10-05,False,"physIQ, Inc.",Recruiting,Not Applicable,Observational,United States,Detection of COVID-19 Decompensation,Prognosis,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04575532,None
6248,NCT04575545,ClinicalTrials.gov,2020-10-02,2020-10-01,True,Hôpital Européen Marseille,Not Recruiting,Not Applicable,Observational,France,Prevalence of COVID-19 Infection in a Cohort of Patients Infected by the HIV and Patients Taking PrEP,Clinical Presentation (Epidemiology),No Intervention,No Intervention,600,https://clinicaltrials.gov/show/NCT04575545,None
6249,NCT04575558,ClinicalTrials.gov,2020-05-18,2020-06-30,False,Latin American Cooperative Oncology Group,Not Recruiting,Phase 2,Interventional,Brazil,HOPE: A Trial of Hydroxichloroquine Plus Azithromycin in High Risk COVID-19,Not relevant,Not relevant,Not relevant,0,https://clinicaltrials.gov/show/NCT04575558,None
6250,NCT04575571,ClinicalTrials.gov,2020-09-24,2020-04-29,True,Laval University,Recruiting,Not Applicable,Observational,Canada,MAVIPAN: My Life and the COVID-19 Pandemic,Other,No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04575571,None
6251,NCT04576299,ClinicalTrials.gov,2020-09-28,2020-09-01,True,Universidad Miguel Hernández de Elche,Not Recruiting,Not Applicable,Observational,"Chile, Spain, Ecuador, Colombia",Health Care Workers' Perception of Patient Safety During COVID-19 Pandemic,Health System,No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04576299,None
6252,NCT04576312,ClinicalTrials.gov,2020-09-28,2020-06-29,True,UNION therapeutics,Recruiting,Phase 1,Interventional,Denmark,Study to Assess the Safety of Ascending Doses of UNI911 INHALATION in Healthy Volunteers in Preparation for Evaluation in Adults With COVID-19,Drug,UNI911,UNI911,44,https://clinicaltrials.gov/show/NCT04576312,None
6253,NCT04576351,ClinicalTrials.gov,2020-09-10,2020-09-01,True,Oslo University Hospital,Recruiting,Not Applicable,Observational,Norway,The Norwegian Study of Nervous System Manifestations and Sequelae After COVID-19,Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04576351,None
6254,NCT04576728,ClinicalTrials.gov,2020-09-24,2020-10-06,False,Biotest,Recruiting,Phase 2,Interventional,Spain,Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19,Drug,Trimodulin,Trimodulin,164,https://clinicaltrials.gov/show/NCT04576728,None
6255,NCT04577105,ClinicalTrials.gov,2020-10-02,2020-04-01,True,Instituto Nacional de Cardiologia Ignacio Chavez,Not Recruiting,Not Applicable,Observational,Mexico,Risk Factors and Computed Tomography Findings in COVID-19.,Clinical Presentation,No Intervention,No Intervention,233,https://clinicaltrials.gov/show/NCT04577105,None
6256,NCT04577235,ClinicalTrials.gov,2020-09-29,2020-06-05,True,Gaziosmanpasa Taksim Research and Education Hospital,Not Recruiting,Not Applicable,Interventional,Turkey,Correlation Between Thoracic Ultrasound and Thorax Computed Tomography Scores.,Clinical Presentation,No Intervention,No Intervention,29,https://clinicaltrials.gov/show/NCT04577235,None
6257,NCT04577378,ClinicalTrials.gov,2020-04-13,2020-10-20,False,Kafrelsheikh University,Not Recruiting,Phase 2,Interventional,Egypt,Efficacy and Safety of Drug Combination Therapy of Isotretinoin and Some Antifungal Drugs as A Potential Aerosol Therapy for COVID-19 : An Innovative Therapeutic Approach COVID-19,Drug,Isotretinoin + Itraconazole vs. Isotretinoin,Isotretinoin; Itraconazole,45,https://clinicaltrials.gov/show/NCT04577378,None
6258,NCT04577534,ClinicalTrials.gov,2020-09-03,2020-08-14,True,Jarmo Oksi,Recruiting,Phase 3,Interventional,Finland,COVID-19: Salvage TOcilizumab as a Rescue Measure,Drug,Tocilizumab,Tocilizumab,90,https://clinicaltrials.gov/show/NCT04577534,EUCTR2020-002039-31
6259,NCT04578158,ClinicalTrials.gov,2020-10-06,2020-10-29,False,Liaquat University of Medical & Health Sciences,Recruiting,Phase 2,Interventional,Pakistan,Trial to Study the Adjuvant Benefits of Quercetin Phytosome in Patients With COVID-19,Supplement,Quercetin Phytosome,Quercetin Phytosome,200,https://clinicaltrials.gov/show/NCT04578158,None
6260,NCT04578197,ClinicalTrials.gov,2020-09-02,2020-08-18,True,Karolinska University Hospital,Recruiting,Not Applicable,Observational,Sweden,NeuroCovid - a Study of Intensive Care-requiring Covid-19 Patients,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04578197,None
6261,NCT04578210,ClinicalTrials.gov,2020-10-01,2020-09-04,True,Instituto de Investigación Hospital Universitario La Paz,Recruiting,Phase 1/Phase 2,Interventional,Spain,Safety Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in COVID-19 pnEumonia or Lymphopenia,ATMP,Cells (T) vs. Cells (NK),Cells (T); Cells (NK),58,https://clinicaltrials.gov/show/NCT04578210,None
6262,NCT04578236,ClinicalTrials.gov,2020-10-04,2020-11-01,False,Kafrelsheikh University,Not Recruiting,Phase 2,Interventional,No Country Given,"Efficacy of Aerosol Combination Therapy of 13 Cis Retinoic Acid and Captopril for Treating Covid-19 Patients Via Indirect Inhibition of Transmembrane Protease, Serine 2 (TMPRSS2)",Drug,Retinoic acid + Captopril,Retinoic acid; Captopril,360,https://clinicaltrials.gov/show/NCT04578236,None
6263,NCT04578509,ClinicalTrials.gov,2020-09-21,2020-10-01,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Observational,France,Evaluation of a Screening Program for SARS-CoV-2 Infection in the General Population Based on the Use of New Detection Approaches or for Diagnostic Orientation on Saliva,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,2750,https://clinicaltrials.gov/show/NCT04578509,None
6264,NCT04579289,ClinicalTrials.gov,2020-10-01,2020-06-15,True,Rennes University Hospital,Not Recruiting,Not Applicable,Observational,France,Managerial and Environmental Risk for COVID 19 in French Long Term Care Institutions,Clinical Presentation,No Intervention,No Intervention,230,https://clinicaltrials.gov/show/NCT04579289,None
6265,NCT04579458,ClinicalTrials.gov,2020-10-06,2020-11-16,False,Vanderbilt University,Recruiting,Not Applicable,Observational,United States,Assessment of COVID-19 in Tearfilm,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04579458,None
6266,NCT04579471,ClinicalTrials.gov,2020-10-06,2020-07-01,True,UZ Leuven,Recruiting,Not Applicable,Observational,Belgium,Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study,Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04579471,None
6267,NCT04579549,ClinicalTrials.gov,2020-10-06,2020-09-29,True,"University of Wisconsin, Madison",Recruiting,Not Applicable,Interventional,United States,Repeat Testing for SARS-CoV-2,Clinical Presentation (Epidemiology),No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04579549,None
6268,NCT04579562,ClinicalTrials.gov,2020-10-06,2020-11-01,False,University Hospitals of Derby and Burton NHS Foundation Trust,Not Recruiting,Not Applicable,Observational,No Country Given,Regional COVID Epidemiology in England (RECEDE),Clinical Presentation (Epidemiology),No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04579562,None
6269,NCT04579588,ClinicalTrials.gov,2020-10-06,2020-10-29,False,Stanford University,Recruiting,Not Applicable,Observational,United States,Understanding Immunity to the Flu Vaccine in COVID-19 Patients,ATMP,Vaccine,Vaccine,100,https://clinicaltrials.gov/show/NCT04579588,None
6270,NCT04579627,ClinicalTrials.gov,2020-10-06,2020-05-14,True,Royal Cornwall Hospitals NHS Trust,Not Recruiting,Not Applicable,Observational,United Kingdom,"Facial Hair, PPE and COVID-19",Other,No Intervention,No Intervention,358,https://clinicaltrials.gov/show/NCT04579627,None
6271,NCT04579640,ClinicalTrials.gov,2020-10-06,2020-10-27,False,Queen Mary University of London,Not Recruiting,Phase 3,Interventional,United Kingdom,Trial of Vitamin D to Reduce Risk and Severity of COVID-19 and Other Acute Respiratory Infections,Drug,Vitamin D,Vitamin D,6200,https://clinicaltrials.gov/show/NCT04579640,None
6272,NCT04581018,ClinicalTrials.gov,2020-08-11,2020-08-13,False,Siew Chien NG,Recruiting,Not Applicable,Interventional,Hong Kong,An Evaluation of a Synbiotic Formula for Patients With COVID-19 Infection,Supplement,Nutritional Supplement,Nutritional Supplement,50,https://clinicaltrials.gov/show/NCT04581018,None
6273,NCT04581031,ClinicalTrials.gov,2020-05-04,2020-07-11,False,The Christie NHS Foundation Trust,Recruiting,Not Applicable,Interventional,United Kingdom,COntinuous Signs Monitoring In Covid-19 Patients,Other (device),Biosensors,Biosensors,60,https://clinicaltrials.gov/show/NCT04581031,None
6274,NCT04581044,ClinicalTrials.gov,2020-10-06,2020-09-17,True,Cairo University,Not Recruiting,Not Applicable,Observational,Egypt,Impact of COVID-19 on Psoriasis Practice,Health System,No Intervention,No Intervention,197,https://clinicaltrials.gov/show/NCT04581044,None
6275,NCT04581070,ClinicalTrials.gov,2020-05-29,2020-04-29,True,Cancer Trials Ireland,Not Recruiting,Not Applicable,Observational,Ireland,"The COVID-IYON Study - Study Examining Data Pertaining to Clinical Outcomes and Organisational Responses to the 2020 SARS-CoV-2 Pandemic""",Clinical Presentation,No Intervention,No Intervention,4,https://clinicaltrials.gov/show/NCT04581070,None
6276,NCT04581083,ClinicalTrials.gov,2020-10-07,2020-10-08,False,Hunter College of City University of New York,Recruiting,Not Applicable,Observational,Bolivia,"Validation of Laboratory Techniques, Strategies, and Types of Samples for Epidemiological Control in the Covid-19 Pandemic",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,30,https://clinicaltrials.gov/show/NCT04581083,None
6277,NCT04581096,ClinicalTrials.gov,2020-10-07,2020-10-02,True,Hospital General Universitari de València,Recruiting,Not Applicable,Observational,Spain,Mapping COVID-19 Spread in a Tertiary Hospital,Clinical Presentation (Epidemiology),No Intervention,No Intervention,3000,https://clinicaltrials.gov/show/NCT04581096,None
6278,NCT04581135,ClinicalTrials.gov,2020-09-17,2020-05-01,True,"University Hospital, Bern",Recruiting,Not Applicable,Observational,Switzerland,Study to Investigate Long-term Pulmonary and Extrapulmonary Effects of COVID-19,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04581135,None
6279,NCT04581148,ClinicalTrials.gov,2020-10-03,2020-10-05,False,University of Erlangen-Nornberg Medical School,Not Recruiting,Not Applicable,Observational,No Country Given,SARS-CoV2 Antibodies in Pediatric Patients (COVID-19),Clinical Presentation (Epidemiology),No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04581148,None
6280,NCT04581161,ClinicalTrials.gov,2020-08-19,2020-08-28,False,Hill-Rom,Recruiting,Not Applicable,Interventional,United States,Proportional Open Ventilation (POV) Device and Its Efficacy in Managing Acute Respiratory Failure in COVID-19 Patients,Other (physical),Mechanical ventilation,Mechanical ventilation,10,https://clinicaltrials.gov/show/NCT04581161,None
6281,NCT04581187,ClinicalTrials.gov,2020-09-30,2020-10-01,False,Gruppo Italiano Malattie Ematologiche dell'adulto (GIMEMA),Not Recruiting,Not Applicable,Observational,No Country Given,An Online-platform to Improve Patient-centered Care During the COVID-19 Pandemic: a GIMEMA Surveillance Program in Hematologic Malignancies,Health System,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04581187,None
6282,NCT04581200,ClinicalTrials.gov,2020-10-04,2020-12-01,False,Duke University,Not Recruiting,Not Applicable,Interventional,United States,Lift Mobile Mindfulness for COVID-19 Distress Symptoms,Other (psych),Psychological,Psychological,300,https://clinicaltrials.gov/show/NCT04581200,None
6283,NCT04581291,ClinicalTrials.gov,2020-10-04,2020-01-01,True,Istanbul Gelisim University,Not Recruiting,Not Applicable,Interventional,Turkey,The Effect of Aerobic Exercise on Immune Biomarkers and Symptoms Severity and Progression in Patients With COVID-19: A Pilot Randomized Control Trial,Other (exercise),Exercise,Exercise,30,https://clinicaltrials.gov/show/NCT04581291,None
6284,NCT04581577,ClinicalTrials.gov,2020-09-29,2020-09-11,True,Royal Brompton and Harefield NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,Perceptions of the Clinical and Psychosocial Impact of Covid-19 in Patients With Neuromuscular and Neurological Disorders,Other (psych),No Intervention,No Intervention,75,https://clinicaltrials.gov/show/NCT04581577,None
6285,NCT04581746,ClinicalTrials.gov,2020-09-22,2020-10-01,False,Tourcoing Hospital,Not Recruiting,Not Applicable,Interventional,France,Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2),Other,No Intervention,No Intervention,1800,https://clinicaltrials.gov/show/NCT04581746,None
6286,NCT04581811,ClinicalTrials.gov,2020-10-07,2020-11-10,False,University of Alabama at Birmingham,Recruiting,Not Applicable,Interventional,United States,Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome (ARDS),Procedure,Positioning,Positioning,52,https://clinicaltrials.gov/show/NCT04581811,None
6287,NCT04581863,ClinicalTrials.gov,2020-10-07,2020-12-05,False,University of Pennsylvania,Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 Watch + COVID-19 Pulse,Other (device),Biosensors,Biosensors,850,https://clinicaltrials.gov/show/NCT04581863,None
6288,NCT04581889,ClinicalTrials.gov,2020-10-07,2020-07-02,True,"University Hospital, Tübingen",Recruiting,Not Applicable,Observational,Germany,Prevalence of Antibodies Against SARS-CoV-2 Virus That Causes COVID-19 in TÃ¼bingen Children,Clinical Presentation (Epidemiology),No Intervention,No Intervention,2380,https://clinicaltrials.gov/show/NCT04581889,None
6289,NCT04581915,ClinicalTrials.gov,2020-09-16,2020-09-08,True,Fatima Mayat,Recruiting,Phase 2/Phase 3,Interventional,South Africa,PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19,Drug,Triazavirin,Triazavirin,420,https://clinicaltrials.gov/show/NCT04581915,None
6290,NCT04581928,ClinicalTrials.gov,2020-10-06,2020-10-10,False,ClinAmygate,Recruiting,Not Applicable,Observational,Egypt,Patients Reactions Towards Their Diagnosis as Having COVID-19,Other,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04581928,None
6291,NCT04581954,ClinicalTrials.gov,2020-10-05,2020-10-02,True,Imperial College London,Recruiting,Phase 1/Phase 2,Interventional,United Kingdom,Inflammatory Signal Inhibitors for COVID-19 (MATIS),Drug,Fostamatinib vs. Ruxolitinib,Fostamatinib; Ruxolitinib,456,https://clinicaltrials.gov/show/NCT04581954,EUCTR2020-001750-22
6292,NCT04582201,ClinicalTrials.gov,2020-10-06,2020-09-21,True,"AgenTus Therapeutics, Inc.",Recruiting,Phase 1,Interventional,United States,An Experiment to Evaluate the Safety of agenT-797 in COVID-19 Patients With Severe Difficulty Breathing.,Drug,agenT-797,agenT-797,55,https://clinicaltrials.gov/show/NCT04582201,None
6293,NCT04582214,ClinicalTrials.gov,2020-10-06,2020-09-28,True,Hill-Rom,Recruiting,Not Applicable,Interventional,United States,Oscillation and Lung Expansion Therapy in Patients With COVID-19,Other (physical),Mechanical ventilation,Mechanical ventilation,30,https://clinicaltrials.gov/show/NCT04582214,None
6294,NCT04582266,ClinicalTrials.gov,2020-10-08,2020-10-15,False,International Maternal Pediatric Adolescent AIDS Clinical Trials Group,Not Recruiting,Not Applicable,Observational,"United States, Puerto Rico",PK and Safety of Remdesivir for Treatment of COVID-19 in Pregnant and Non-Pregnant Women in the US,Drug,Remdesivir,Remdesivir,40,https://clinicaltrials.gov/show/NCT04582266,None
6295,NCT04582318,ClinicalTrials.gov,2020-10-07,2020-11-08,False,"NGM Biopharmaceuticals, Inc",Recruiting,Phase 1/Phase 2,Interventional,Australia,"A Phase 1/2 Study to Assess the Safety, Tolerability and Pharmacokinetics of NGM621 in Healthy Subjects, and to Assess the Safety, PK and Efficacy in Subjects With Moderate to Severe ARDS Caused by COVID-19",Drug,NGM621,NGM621,48,https://clinicaltrials.gov/show/NCT04582318,None
6296,NCT04582331,ClinicalTrials.gov,2020-10-07,2020-09-10,True,Sonde Health,Recruiting,Not Applicable,Observational,"United States, India",Improving Real-time COVID-19 Monitoring Through Smartphone Voice Analysis,Other (software),eHealth,eHealth,300,https://clinicaltrials.gov/show/NCT04582331,None
6297,NCT04582344,ClinicalTrials.gov,2020-10-01,2020-09-14,True,Health Institutes of Turkey,Recruiting,Phase 3,Interventional,Turkey,Clinical Trial For SARS-CoV-2 Vaccine (COVID-19),ATMP,Vaccine,Vaccine,13000,https://clinicaltrials.gov/show/NCT04582344,None
6298,NCT04583228,ClinicalTrials.gov,2020-09-25,2020-11-30,False,Hengenix Biotech Inc,Not Recruiting,Phase 1,Interventional,No Country Given,"Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of HLX71 (Recombinant Human Angiotensin-converting Enzyme 2-Fc Fusion Protein for COVID-19) in Healthy Adult Subjects",Drug,ACE enzyme,ACE enzyme,40,https://clinicaltrials.gov/show/NCT04583228,None
6299,NCT04583293,ClinicalTrials.gov,2020-10-06,2020-11-01,False,University Hospitals of Derby and Burton NHS Foundation Trust,Not Recruiting,Not Applicable,Observational,No Country Given,Acute kIDnEy Injury in coviD-19,Clinical Presentation,No Intervention,No Intervention,220,https://clinicaltrials.gov/show/NCT04583293,None
6300,NCT04583306,ClinicalTrials.gov,2020-10-09,2020-06-01,True,Fondazione Don Carlo Gnocchi Onlus,Recruiting,Not Applicable,Observational,Italy,The Salivary Raman COVID-19 Fingerprint,Clinical Presentation,No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04583306,None
6301,NCT04583319,ClinicalTrials.gov,2020-09-30,2020-10-01,False,Firalis SA,Recruiting,Not Applicable,Observational,Turkey,"Validation of a Rapid, Non-invasive Point-of-care IVD Test for Diagnosis of SARS-COV-2 (COVID-19) Infection",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,160,https://clinicaltrials.gov/show/NCT04583319,None
6302,NCT04583345,ClinicalTrials.gov,2020-10-09,2020-06-01,True,Ebru Calik Kutukcu,Recruiting,Not Applicable,Observational,Turkey,Physical Activity Levels of Hypertensive and Healthy Individuals Under Social Isolation During the COVID-19 Pandemic,Other (exercise),No Intervention,No Intervention,32,https://clinicaltrials.gov/show/NCT04583345,None
6303,NCT04583410,ClinicalTrials.gov,2020-09-28,2020-10-22,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Phase 3,Interventional,France,Efficacy of Nicotine in Preventing COVID-19 Infection in Caregivers,Drug,Nicotine,Nicotine,1633,https://clinicaltrials.gov/show/NCT04583410,None
6304,NCT04583449,ClinicalTrials.gov,2020-10-02,2020-08-19,True,University of East London,Recruiting,Not Applicable,Interventional,United Kingdom,Mental Imagery to Increase Face Covering Use in UK-based Public Places During the COVID-19 Pandemic,Other,Other,Other,250,https://clinicaltrials.gov/show/NCT04583449,None
6305,NCT04583566,ClinicalTrials.gov,2020-10-07,2020-10-04,True,Tanta University,Recruiting,Not Applicable,Observational,Egypt,"Differential Expression of Cytokines, Transcriptome and miRNA in Coronavirus Disease 2019 (COVID-19) Egyptian's Patients",Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04583566,None
6306,NCT04583761,ClinicalTrials.gov,2020-10-05,2020-10-12,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,No Country Given,Tobacco and Nicotine Consumption and the Risk of Acquisition of Coronavirus Disease 2019 (COVID-19),Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04583761,None
6307,NCT04583865,ClinicalTrials.gov,2020-10-07,2020-10-07,False,"University Hospital, Toulouse",Not Recruiting,Not Applicable,Observational,France,Feasibility and Quality of TeleConsultation in Pediatric Anesthesia,Telehealth,Telehealth,Telehealth,400,https://clinicaltrials.gov/show/NCT04583865,None
6308,NCT04584411,ClinicalTrials.gov,2020-09-09,2020-11-01,False,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,Patterns of Arrhythmias and Conduction Block in COVID-19 Patients and Its Relation to Myocardial Injury Detected by Cardiac Magnetic Resonance,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04584411,None
6309,NCT04584424,ClinicalTrials.gov,2020-09-22,2020-10-30,False,Ethiopian Public Health Institute,Not Recruiting,Not Applicable,Observational,Ethiopia,Prognostic Factors and Outcomes of COVID-19 Cases in Ethiopia,Prognosis,No Intervention,No Intervention,6390,https://clinicaltrials.gov/show/NCT04584424,None
6310,NCT04584437,ClinicalTrials.gov,2020-10-09,2020-10-30,False,GAAD Medical Research Institute Inc.,Not Recruiting,Not Applicable,Interventional,Canada,Treatment of Covid-19 Using Infrared and/or Vitamin C,Other,Infrared Energy + Vitamin C,Infrared Energy; Vitamin C,400,https://clinicaltrials.gov/show/NCT04584437,None
6311,NCT04584450,ClinicalTrials.gov,2020-10-09,2020-09-02,True,Hacettepe University,Recruiting,Not Applicable,Observational,Turkey,Investigation of Validity and Reliability of Post-COVID-19 Functional Status Scale,Other,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04584450,None
6312,NCT04584541,ClinicalTrials.gov,2020-06-10,2020-06-11,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Interventional,France,SarS-Cov-2 Viral Infection (COVID-19) in Patients With Chronic Inflammatory Rheumatism,Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04584541,None
6313,NCT04584580,ClinicalTrials.gov,2020-10-06,2020-08-01,True,Ain Shams University,Recruiting,Phase 4,Interventional,Egypt,D-dimer Adjusted Versus Therapeutic Dose Low-molecular-weight Heparin in Patients With COVID-19 Pneumonia,Drug,Heparin,Heparin,50,https://clinicaltrials.gov/show/NCT04584580,None
6314,NCT04584593,ClinicalTrials.gov,2020-10-12,2020-10-02,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Interventional,France,Pilot Study to Detect SARS-CoV-2 Virus in Sperm,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://clinicaltrials.gov/show/NCT04584593,None
6315,NCT04584606,ClinicalTrials.gov,2020-10-06,2020-06-27,True,Ain Shams University,Recruiting,Not Applicable,Observational,Egypt,Ain Shams University Experience: Clinical Determinants of Hospitalized COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04584606,None
6316,NCT04584671,ClinicalTrials.gov,2020-10-07,2020-12-01,False,"Western University, Canada",Not Recruiting,Not Applicable,Observational,Canada,Lung Structure-Function In Survivors of Mild and Severe COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04584671,None
6317,NCT04584684,ClinicalTrials.gov,2020-10-09,2020-12-01,False,"University of North Carolina, Chapel Hill",Not Recruiting,Phase 2,Interventional,United States,Mouth Rinses for Inactivation of COVID-19,Drug,Hydrogen Peroxide vs. Chlorhexidine Gluconate vs. Ethanol vs. Povidone iodide vs. Cetylpyridinium Chloride,Hydrogen Peroxide; Chlorhexidine Gluconate; Ethanol; Povidone iodide; Cetylpyridinium Chloride,480,https://clinicaltrials.gov/show/NCT04584684,None
6318,NCT04584697,ClinicalTrials.gov,2020-10-07,2020-12-01,False,"Sorrento Therapeutics, Inc.",Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,"Study to Evaluate the Safety, Pharmacokinetics and Efficacy of STI-2020 (COVI-AMGâ„¢) in Outpatients With COVID-19",Drug,STI-2020,STI-2020,50,https://clinicaltrials.gov/show/NCT04584697,None
6319,NCT04584710,ClinicalTrials.gov,2020-10-08,2020-10-13,False,Restorbio Inc.,Recruiting,Phase 2,Interventional,United States,A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults,Drug,RTB101,RTB101,60,https://clinicaltrials.gov/show/NCT04584710,None
6320,NCT04585945,ClinicalTrials.gov,2020-09-17,2020-08-04,True,Prisma Health-Upstate,Recruiting,Not Applicable,Observational,United States,Pregnancy Outcomes During the Pandemic: Using Placental Pathology and Gene Expression to Understand Fetal Risk,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04585945,None
6321,NCT04586114,ClinicalTrials.gov,2020-10-08,2020-03-01,True,CHU de Nancy,Not Recruiting,Not Applicable,Observational,France,Effect of Corticosteroid Treatment on Prognosis in ARDS Secondary to Covid-19,Drug,Corticosteroids,Corticosteroids,200,https://clinicaltrials.gov/show/NCT04586114,None
6322,NCT04586140,ClinicalTrials.gov,2020-10-12,2020-11-09,False,Groupe Hospitalier Paris Saint-Joseph,Not Recruiting,Not Applicable,Observational,France,Operation of the GHPSJ Clinical Ethical Reflection Assistance Group During the COVID-19 Period,Health System,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04586140,None
6323,NCT04586153,ClinicalTrials.gov,2020-10-12,2020-12-30,False,Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Study to Assess the Effect of Meplazumab on COVID-19,Drug,Meplazumab,Meplazumab,456,https://clinicaltrials.gov/show/NCT04586153,None
6324,NCT04586413,ClinicalTrials.gov,2020-10-07,2020-10-07,False,Medialis Ltd.,Recruiting,Not Applicable,Observational,United Kingdom,Post Acute COVID-19 Quality of Life (PAC-19QoL) Tool Development and Patient Registry (PAC-19QoLReg),Other,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04586413,None
6325,NCT04587219,ClinicalTrials.gov,2020-10-13,2020-10-22,False,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",Not Recruiting,Phase 2,Interventional,Russian Federation,"The Study of ""Gam-COVID-Vac"" Vaccine Against COVID-19 With the Participation of Volunteers of 60 y.o and Older",ATMP,Vaccine,Vaccine,110,https://clinicaltrials.gov/show/NCT04587219,None
6326,NCT04587245,ClinicalTrials.gov,2020-10-07,2020-10-01,True,"ND Sciences, LLC",Recruiting,Not Applicable,Observational,United States,The Provider Insurance Revenue Study in Healthcare Providers in the United States of America,Health System,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04587245,None
6327,NCT04587258,ClinicalTrials.gov,2020-10-08,2020-08-28,True,Rhode Island Hospital,Recruiting,Not Applicable,Observational,United States,Improving Cancer Screening and Prevention During the COVID-19 Pandemic in Underserved Populations of Rhode Island,Other,Other,Other,100,https://clinicaltrials.gov/show/NCT04587258,None
6328,NCT04587323,ClinicalTrials.gov,2020-09-22,2020-05-22,True,University of Alabama at Birmingham,Recruiting,Not Applicable,Observational,United States,VEGF and sFlt-1 Levels in the Pathogenesis and Severity of COVID-19 Disease,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04587323,None
6329,NCT04587375,ClinicalTrials.gov,2020-06-18,2020-03-01,True,"University Hospital, Montpellier",Not Recruiting,Not Applicable,Observational,France,Diagnosis of Endocrine Dysfunctions in Covid-19,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04587375,None
6330,NCT04587414,ClinicalTrials.gov,2020-09-08,2019-03-06,True,UKK Institute,Not Recruiting,Not Applicable,Interventional,Finland,eHealth Intervention on Physical Activity for Type 2 Diabetics - Frustrated by COVID-19,Other (software),eHealth,eHealth,122,https://clinicaltrials.gov/show/NCT04587414,None
6331,NCT04587921,ClinicalTrials.gov,2020-08-18,2020-06-22,True,University of São Paulo General Hospital,Recruiting,Not Applicable,Interventional,Brazil,Feasibility and Impact of Remote Oximetry in Patients Hospitalized With Covid-19,Other (device),Biosensors,Biosensors,90,https://clinicaltrials.gov/show/NCT04587921,None
6332,NCT04588415,ClinicalTrials.gov,2020-10-08,2020-11-01,False,Ottawa Hospital Research Institute,Not Recruiting,Not Applicable,Interventional,No Country Given,Supporting Family Members With Severe Grief Reaction During the COVID-19 Pandemic,Other (psych),Psychological,Psychological,200,https://clinicaltrials.gov/show/NCT04588415,None
6333,NCT04588441,ClinicalTrials.gov,2020-10-13,2020-12-01,False,University of Florida,Not Recruiting,Phase 2,Interventional,No Country Given,The ARCTIC Trial: Aerosolized Inhaled Adenosine Treatment in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by COVID-19,Drug,Adenosine,Adenosine,30,https://clinicaltrials.gov/show/NCT04588441,None
6334,NCT04588480,ClinicalTrials.gov,2020-10-14,2020-10-21,True,Biontech SE,Not Recruiting,Phase 1/Phase 2,Interventional,Japan,"Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults",ATMP,Vaccine,Vaccine,160,https://clinicaltrials.gov/show/NCT04588480,JPRN-jRCT2071200045
6335,NCT04588909,ClinicalTrials.gov,2020-10-14,2020-03-23,True,Sheri Kashmir Institute of Medical Sciences,Not Recruiting,Not Applicable,Observational,India,Outcomes of Elective Colorectal Cancer Surgery During COVID 19 Pandemic: Implications for Cancer Care Policy,Health System,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04588909,None
6336,NCT04589104,ClinicalTrials.gov,2020-10-12,2020-05-26,True,Duke University,Not Recruiting,Not Applicable,Interventional,United States,Expressive Writing for COVID-19 Resilience,Other (psych),Psychological,Psychological,63,https://clinicaltrials.gov/show/NCT04589104,None
6337,NCT04589117,ClinicalTrials.gov,2020-10-12,2020-05-27,True,Duke University,Not Recruiting,Not Applicable,Interventional,United States,Expressive Writing for COVID-19 Resilience for Parents,Other (psych),Psychological,Psychological,11,https://clinicaltrials.gov/show/NCT04589117,None
6338,NCT04589936,ClinicalTrials.gov,2020-10-06,2020-09-03,True,Cambridge University Hospitals NHS Foundation Trust,Recruiting,Not Applicable,Interventional,United Kingdom,Prone Position to Improve Oxygenation in COVID-19 Patients Outside Critical Care,Procedure,Positioning,Positioning,56,https://clinicaltrials.gov/show/NCT04589936,None
6339,NCT04589949,ClinicalTrials.gov,2020-10-12,2020-10-12,False,Erasmus Medical Center,Recruiting,Phase 3,Interventional,Netherlands,Early Convalescent Plasma Therapy for High-risk Patients With COVID-19 in Primary Care (the CoV-Early Study),ATMP,Plasma,Plasma,690,https://clinicaltrials.gov/show/NCT04589949,None
6340,NCT04590053,ClinicalTrials.gov,2020-10-15,2020-10-20,False,Hadassah Medical Organization,Recruiting,Phase 2,Interventional,Israel,"Allocetra-OTS in COVID-19, Phase II",Drug,Allocetra-OTS,Allocetra-OTS,24,https://clinicaltrials.gov/show/NCT04590053,None
6341,NCT04590170,ClinicalTrials.gov,2020-10-05,2020-10-15,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,French Cohort of COVID-19 Patients With Post-intensive Care Syndrome,Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04590170,None
6342,NCT04590209,ClinicalTrials.gov,2020-10-05,2020-10-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,Clinical and Mechanistic Study of Patients (With COVID-19 or Not) With a Recent Acrosyndrome,Clinical Presentation,No Intervention,No Intervention,25,https://clinicaltrials.gov/show/NCT04590209,None
6343,NCT04590222,ClinicalTrials.gov,2020-10-09,2020-11-01,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,Impact of a Monoamine Oxidase Inhibitor on the Phenotype of Blood Mononucleated Cells in Patients With COVID-19,Drug,Phenelzine,Phenelzine,80,https://clinicaltrials.gov/show/NCT04590222,None
6344,NCT04590261,ClinicalTrials.gov,2020-10-15,2020-11-01,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,No Country Given,Myeloid Cells in Patients With Covid-19 Pneumonia,Clinical Presentation,No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04590261,None
6345,NCT04590274,ClinicalTrials.gov,2020-10-07,2020-11-01,False,International Brain Research Foundation,Not Recruiting,Phase 1,Interventional,No Country Given,Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),Drug,Hydroxychloroquine + Azithromycin + Zinc + Vitamin C + Vitamin D + N-acetyl cysteine + Elderberry + Quercetin,Hydroxychloroquine; Azithromycin; Zinc; Vitamin C; Vitamin D; N-acetyl cysteine; Elderberry; Quercetin,5000,https://clinicaltrials.gov/show/NCT04590274,None
6346,NCT04590352,ClinicalTrials.gov,2020-08-27,2020-03-26,True,Radboud University,Not Recruiting,Not Applicable,Observational,Netherlands,Mucosal Immunity Against SARS-CoV-2 Infection in COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,187,https://clinicaltrials.gov/show/NCT04590352,None
6347,NCT04590365,ClinicalTrials.gov,2020-05-28,2020-12-20,False,Swansea University,Not Recruiting,Not Applicable,Interventional,No Country Given,Iota-carrageenan Nasal Spray COVID-19 Prophylaxis for Healthcare Professionals,Drug (Chemoprophylaxis),Carrageenan,Carrageenan,480,https://clinicaltrials.gov/show/NCT04590365,None
6348,NCT04590378,ClinicalTrials.gov,2020-10-14,2020-03-01,True,Usak University,Recruiting,Not Applicable,Observational,Turkey,Pulmonary Embolism and COVID-19,Clinical Presentation,No Intervention,No Intervention,600,https://clinicaltrials.gov/show/NCT04590378,None
6349,NCT04590430,ClinicalTrials.gov,2020-10-08,2020-10-01,True,HiFiBiO Therapeutics,Recruiting,Phase 1,Interventional,United States,"Study to Assess the Safety, Tolerability, and Pharmacokinetics of HFB30132A Against COVID-19 in Healthy Adults",Drug,HFB30132A,HFB30132A,24,https://clinicaltrials.gov/show/NCT04590430,None
6350,NCT04590469,ClinicalTrials.gov,2020-10-13,2020-11-20,False,University of Exeter,Not Recruiting,Not Applicable,Interventional,No Country Given,Improving Wellbeing and Health for Care Home Residents During COVID-19,Other,Other,Other,2880,https://clinicaltrials.gov/show/NCT04590469,None
6351,NCT04590586,ClinicalTrials.gov,2020-10-14,2020-11-30,False,Amgen,Not Recruiting,Phase 3,Interventional,No Country Given,Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients,Drug,Apremilast,Apremilast,700,https://clinicaltrials.gov/show/NCT04590586,None
6352,NCT04591015,ClinicalTrials.gov,2020-10-05,2020-12-01,False,Scripps Whittier Diabetes Institute,Not Recruiting,Phase 3,Interventional,No Country Given,Dulce Digital-COVID Aware (DD-CA) Discharge Texting Platform for US/Mexico Border Hispanics With Diabetes + COVID-19,Other,Other,Other,172,https://clinicaltrials.gov/show/NCT04591015,None
6353,NCT04591158,ClinicalTrials.gov,2020-09-15,2020-09-15,False,Bridge to Health Medical and Dental USA,Recruiting,Not Applicable,Interventional,Canada,COVID-19 and Lung Ultrasound Utility,Telehealth,Telehealth,Telehealth,100,https://clinicaltrials.gov/show/NCT04591158,None
6354,NCT04591184,ClinicalTrials.gov,2020-09-23,2020-12-01,False,Entos Pharmaceuticals Inc.,Not Recruiting,Phase 1,Interventional,No Country Given,A Clinical Trial of a Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults,ATMP,Vaccine,Vaccine,72,https://clinicaltrials.gov/show/NCT04591184,None
6355,NCT04591210,ClinicalTrials.gov,2020-10-06,2020-10-30,False,Ottawa Heart Institute Research Corporation,Not Recruiting,Phase 3,Interventional,Canada,The COVID-RASi Trial (COVID-19),Drug,ACE inhibitors or ARBs,ACE inhibitors; ARBs,1155,https://clinicaltrials.gov/show/NCT04591210,None
6356,NCT04591600,ClinicalTrials.gov,2020-10-15,2020-07-01,True,Alkarkh Health Directorate-Baghdad,Not Recruiting,Phase 1/Phase 2,Interventional,Iraq,Effectiveness of Ivermectin and Doxycycline on COVID-19 Patients,Drug,Ivermectin + Doxycyline,Ivermectin; Doxycyline,140,https://clinicaltrials.gov/show/NCT04591600,None
6357,NCT04591613,ClinicalTrials.gov,2020-10-10,2020-10-01,True,Tourcoing Hospital,Not Recruiting,Not Applicable,Interventional,"France, French Guiana",Late Clinical Events Associated With COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04591613,None
6358,NCT04591704,ClinicalTrials.gov,2020-10-16,2020-03-20,True,Usak University,Recruiting,Not Applicable,Observational,Turkey,The Effect of Diabetes Mellitus on the Prognosis of Patients With COVID-19,Prognosis,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04591704,None
6359,NCT04591717,ClinicalTrials.gov,2020-10-13,2020-10-19,False,"ImmunityBio, Inc.",Recruiting,Phase 1,Interventional,United States,Study of the Safety of Prophylactic Vaccination With 2nd Generation E1/E2B/E3-Deleted Adenoviral-COVID-19 in Normal Healthy Volunteers,ATMP,Vaccine,Vaccine,35,https://clinicaltrials.gov/show/NCT04591717,None
6360,NCT04591873,ClinicalTrials.gov,2020-09-23,2020-10-10,False,National Taiwan University Hospital,Not Recruiting,Not Applicable,Observational,Taiwan,Using Telemedicine to Optimize Teamwork and Infection Control of Critical and Highly-infectious Patients in an Emergency Department,Telehealth,Telehealth,Telehealth,100,https://clinicaltrials.gov/show/NCT04591873,None
6361,NCT04592055,ClinicalTrials.gov,2020-10-16,2020-03-20,True,Usak University,Recruiting,Not Applicable,Observational,Turkey,The Effect of COVID-19 on Diabetes Mellitus,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04592055,None
6362,NCT04592354,ClinicalTrials.gov,2020-10-15,2020-10-15,False,Terra Biological LLC,Recruiting,Not Applicable,Interventional,United States,Anhydrous Enol-Oxaloacetate (AEO) on Improving Fatigue in Post-COVID-19 Survivors,Supplement,Oxaloacetate,Oxaloacetate,40,https://clinicaltrials.gov/show/NCT04592354,None
6363,NCT04592510,ClinicalTrials.gov,2020-10-16,2021-02-01,False,Cairo University,Not Recruiting,Not Applicable,Observational,No Country Given,Impact of COVID-19 on Pediatric Dental Practice In Egypt.,Health System,No Intervention,No Intervention,290,https://clinicaltrials.gov/show/NCT04592510,None
6364,NCT04592705,ClinicalTrials.gov,2020-10-07,2020-09-11,True,Larkin Community Hospital,Recruiting,Phase 1,Interventional,United States,Measurement of IL-6 and Secondary Inflammatory Markers Before and After Therapeutic Plasma Exchange (TPE) in Hospitalized Patients,Other (device),Plasma exchange,Plasma exchange,10,https://clinicaltrials.gov/show/NCT04592705,None
6365,NCT04592835,ClinicalTrials.gov,2020-10-07,2020-10-19,False,Daewoong Pharmaceutical Co.,Not Recruiting,Phase 1,Interventional,No Country Given,"To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003",Drug,DWRX2003,DWRX2003,24,https://clinicaltrials.gov/show/NCT04592835,None
6366,NCT04593069,ClinicalTrials.gov,2020-10-12,2020-10-07,True,East Limburg Hospital,Recruiting,Not Applicable,Interventional,Belgium,The COGCOV Study in ICU Patients,Clinical Presentation,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04593069,None
6367,NCT04593433,ClinicalTrials.gov,2020-10-13,2021-01-04,False,Jewish General Hospital,Not Recruiting,Not Applicable,Interventional,Canada,A 3-month Cycle of Virtual Guided Tours to Promote Health in Older Community Members in a Context of COVID-19 Induced Social Isolation: a Pilot Study,Other,Other,Other,40,https://clinicaltrials.gov/show/NCT04593433,None
6368,NCT04593641,ClinicalTrials.gov,2020-10-05,2020-09-04,True,Celltrion,Not Recruiting,Phase 1,Interventional,South Korea,"This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19)",Drug,CT-P59,CT-P59,18,https://clinicaltrials.gov/show/NCT04593641,None
6369,NCT04593654,ClinicalTrials.gov,2020-10-16,2020-03-01,True,Karolinska Institutet,Not Recruiting,Not Applicable,Observational,Sweden,Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients,Drug,"Tinzaparin, dalteparin",tinzaparin; dalteparin,257,https://clinicaltrials.gov/show/NCT04593654,None
6370,NCT04593940,ClinicalTrials.gov,2020-09-23,2020-10-15,False,Daniel Benjamin,Recruiting,Phase 3,Interventional,United States,Immune Modulators for Treating COVID-19,Drug,Infliximab + Remdesivir vs. Abatacept + Remdesivir vs.  Remdesivir,Infliximab; Remdesivir; Abatacept,2160,https://clinicaltrials.gov/show/NCT04593940,None
6371,NCT04594278,ClinicalTrials.gov,2020-10-18,2020-11-01,False,"University Health Network, Toronto",Not Recruiting,Not Applicable,Interventional,No Country Given,COVID-19 Burnout Study,Other (psych),Psychological,Psychological,100,https://clinicaltrials.gov/show/NCT04594278,None
6372,NCT04594291,ClinicalTrials.gov,2020-09-28,2020-10-07,False,University Hospitals of Derby and Burton NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,MRI Changes of Acute Kidney Injury in COVID-19,Clinical Presentation,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04594291,None
6373,NCT04594330,ClinicalTrials.gov,2020-10-05,2020-06-01,True,Gadjah Mada University,Recruiting,Phase 2,Interventional,Indonesia,Virgin Coconut Oil (VCO) as a Potential Adjuvant Therapy in COVID-19 Patients,Drug,Coconut oil,Coconut oil,60,https://clinicaltrials.gov/show/NCT04594330,None
6374,NCT04594343,ClinicalTrials.gov,2020-10-18,2020-11-20,False,ETICA,Recruiting,Phase 2,Interventional,Brazil,Clinical Study to Evaluate the Effects of Disulfiram in Patients With Moderate COVID-19,Drug,Disulfiram,Disulfiram,200,https://clinicaltrials.gov/show/NCT04594343,None
6375,NCT04594356,ClinicalTrials.gov,2020-10-19,2020-11-19,False,Groupe Hospitalier Paris Saint-Joseph,Not Recruiting,Not Applicable,Observational,France,"Assessment of Netosis During COVID-19, Under Treatment With Anakinra, an Interleukin-1 Receptor Antagonist",Drug,Anakinra,Anakinra,126,https://clinicaltrials.gov/show/NCT04594356,None
6376,NCT04594395,ClinicalTrials.gov,2020-10-17,2021-01-31,False,National Institute of Allergy and Infectious Diseases (NIAID),Not Recruiting,Not Applicable,Observational,Cambodia,Defining the COVID-19 Immunity Denominator in the Mekong: a Cross-Sectional Seroprevalence Study of SARS-CoV-2 in HealthyVolunteers,Clinical Presentation (Epidemiology),No Intervention,No Intervention,2700,https://clinicaltrials.gov/show/NCT04594395,None
6377,NCT04594460,ClinicalTrials.gov,2020-10-19,2020-10-31,False,Guangzhou Institute of Respiratory Disease,Not Recruiting,Not Applicable,Interventional,China,Hydrogen-oxygen Gas Mixture Inhalation in Patients With Convalescent Coronavirus Disease 2019 (COVID-19),Drug,Hydrogen + Oxygen,Hydrogen; Oxygen,198,https://clinicaltrials.gov/show/NCT04594460,None
6378,NCT04594525,ClinicalTrials.gov,2020-10-12,2020-11-01,False,Hamad Medical Corporation,Not Recruiting,Not Applicable,Interventional,No Country Given,Maternal Telemental Health Interventions in Response to Covid-19*,Other (psych),Psychological,Psychological,58,https://clinicaltrials.gov/show/NCT04594525,None
6379,NCT04594668,ClinicalTrials.gov,2020-10-07,2020-04-24,True,Aarhus University,Recruiting,Phase 2,Interventional,Denmark,Senicapoc in COVID-19 Patients With Severe Respiratory Insufficiency,Drug,Senicapoc,Senicapoc,46,https://clinicaltrials.gov/show/NCT04594668,None
6380,NCT04595084,ClinicalTrials.gov,2020-10-19,2020-11-01,False,Cambridge Health Alliance,Not Recruiting,Not Applicable,Interventional,No Country Given,Remotely Delivered Programs Targeting COVID-19 Stress-Related Depression and Substance Use,Other (psych),Psychological,Psychological,240,https://clinicaltrials.gov/show/NCT04595084,None
6381,NCT04595097,ClinicalTrials.gov,2020-10-19,2020-11-01,False,Escola Superior de Ciencias da Saude,Not Recruiting,Not Applicable,Interventional,Brazil,Inspiratory Muscle Training in COVID-19 Patients,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,120,https://clinicaltrials.gov/show/NCT04595097,None
6382,NCT04595110,ClinicalTrials.gov,2020-09-14,2020-03-25,True,Anna Falanga,Recruiting,Not Applicable,Observational,Italy,Hemostatic Profile in Patients Affected by COVID-19,Clinical Presentation,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04595110,None
6383,NCT04595123,ClinicalTrials.gov,2020-10-06,2020-06-15,True,University of Minho,Recruiting,Not Applicable,Observational,"Portugal, Spain, Albania, Greece, Chile, Israel, Cyprus, Malta, France, Turkey, Brazil, United Kingdom, Bulgaria",Impact of COVID-19 Pandemic in Perinatal Mental Health (RISEUP-PPD-COVID-19),Other (psych),No Intervention,No Intervention,3900,https://clinicaltrials.gov/show/NCT04595123,None
6384,NCT04595136,ClinicalTrials.gov,2020-10-15,2020-11-02,False,United Medical Specialties,Not Recruiting,Phase 1/Phase 2,Interventional,Colombia,Study to Evaluate the Efficacy of COVID19-0001-USR in Patients With Mild/or Moderate COVID-19 Infection in Outpatient,Drug,COVID19-0001-USR,COVID19-0001-USR,60,https://clinicaltrials.gov/show/NCT04595136,None
6385,NCT04595175,ClinicalTrials.gov,2020-06-10,2020-06-10,False,Dr. Brian Tiffany,Recruiting,Not Applicable,Observational,United States,Changes in Seroprevalence and Wellness Over Time in Healthcare Workers (CONSERVE-HCW),Clinical Presentation (Epidemiology),No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04595175,None
6386,NCT04595240,ClinicalTrials.gov,2020-10-14,2020-05-01,True,Assiut University,Not Recruiting,Not Applicable,Observational,Egypt,Semen Analysis Changes in Covid-19 Positivepatients,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04595240,None
6387,NCT04595695,ClinicalTrials.gov,2020-10-14,2020-09-03,True,"University of North Carolina, Chapel Hill",Recruiting,Not Applicable,Interventional,United States,The Effect of Clear Masks in Improving Patient Relationships,Other (device),Masks,Masks,100,https://clinicaltrials.gov/show/NCT04595695,None
6388,NCT04595903,ClinicalTrials.gov,2020-10-08,2020-10-01,True,Aethlon Medical Inc.,Not Recruiting,Not Applicable,Interventional,United States,Treatment of SARS-CoV-2 Virus Disease (COVID-19) in Humans With HemopurifierÂ® Device,Other (device),Blood filter,Blood filter,40,https://clinicaltrials.gov/show/NCT04595903,None
6389,NCT04596085,ClinicalTrials.gov,2020-10-19,2020-09-16,True,"The Herb, Inc",Recruiting,Not Applicable,Interventional,India,"Study to Evaluate Efficacy and Safety of ""VIRACIDE"" IN THE MANAGEMENT OF CORONA VIRUS DISEASE 2019 (COVID-19)",Drug,Viracide,Viracide,124,https://clinicaltrials.gov/show/NCT04596085,None
6390,NCT04596098,ClinicalTrials.gov,2020-07-30,2020-04-30,True,"University Hospital, Grenoble",Recruiting,Not Applicable,Observational,France,Immune Responses to COVID-19; Isolation of Neutralizing Antibodies for Therapeutics and Vaccine.,Clinical Presentation,No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04596098,None
6391,NCT04596579,ClinicalTrials.gov,2020-10-16,2020-10-09,True,H. Lee Moffitt Cancer Center and Research Institute,Recruiting,Not Applicable,Observational,United States,SARS-CoV-2 (COVID-19) Immune Surveillance Among a Population Based Sample of Adults in Florida,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1200,https://clinicaltrials.gov/show/NCT04596579,None
6392,NCT04596657,ClinicalTrials.gov,2020-10-15,2020-10-27,False,The Cooper Health System,Recruiting,Not Applicable,Interventional,United States,Vitamin D3 Supplementation to Prevent Respiratory Tract Infections,Drug,Vitamin D,Vitamin D,2099,https://clinicaltrials.gov/show/NCT04596657,None
6393,NCT04596839,ClinicalTrials.gov,2020-10-20,2020-09-04,True,Dr. Alimur Reza,Recruiting,Not Applicable,Interventional,Bangladesh,Antiviral Activity and Safety of Remdesivir in Bangladeshi Patients With Severe Coronavirus Disease (COVID-19),Drug,Remdesivir,Remdesivir,60,https://clinicaltrials.gov/show/NCT04596839,None
6394,NCT04596943,ClinicalTrials.gov,2020-10-20,2020-10-15,True,Radboud University,Recruiting,Not Applicable,Observational,Netherlands,RGD PET/CT Imaging in COVID-19 Patients,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,10,https://clinicaltrials.gov/show/NCT04596943,None
6395,NCT04597034,ClinicalTrials.gov,2020-10-03,2020-10-02,True,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,Recruiting,Not Applicable,Interventional,Mexico,Efficacy and Safety of a Highly Selective Semipermeable Membrane (AN-69 Oxiris) vs (Standard AN-69) in COVID-19,Other (device),Membrane,Membrane,35,https://clinicaltrials.gov/show/NCT04597034,None
6396,NCT04597047,ClinicalTrials.gov,2020-10-19,2020-08-20,True,LumiraDx UK Limited,Recruiting,Not Applicable,Interventional,United States,Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04597047,None
6397,NCT04597216,ClinicalTrials.gov,2020-10-13,2020-10-15,False,"University Hospital, Grenoble",Recruiting,Not Applicable,Interventional,France,Exploration of Feasability of Blood and Saliva Proteomic Analysis Through Harvesting by Silica Matrix (NanoDx-CoV-19),Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04597216,None
6398,NCT04597242,ClinicalTrials.gov,2020-10-20,2020-09-28,True,ContraFect,Not Recruiting,Not Applicable,Expanded Access,United States,Expanded Access Study of Exebacase in COVID-19 Patients With Persistent MRSA Bacteremia,Drug,Exebacase,Exebacase,Not Available,https://clinicaltrials.gov/show/NCT04597242,None
6399,NCT04597736,ClinicalTrials.gov,2020-10-02,2020-11-01,False,"University Hospital, Clermont-Ferrand",Not Recruiting,Not Applicable,Interventional,France,Relationship Between Biological Profiles and Clinical Evolutions Within the Same Cluster COVID-19 (COVIDCOLLECT),Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04597736,None
6400,NCT04597775,ClinicalTrials.gov,2020-10-18,2020-10-27,False,"Regional Center for Disease Control and Prevention, Jordan",Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Chemoprevention Clinical Trial of COVID-19: Hydroxychloroquine Post Exposure Prophylaxis,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,93,https://clinicaltrials.gov/show/NCT04597775,None
6401,NCT04597853,ClinicalTrials.gov,2020-10-19,2020-10-20,False,University of Zurich,Not Recruiting,Not Applicable,Observational,No Country Given,Assessment of Lung Mechanics in COVID-19 Acute Respiratory Distress Syndrome,Clinical Presentation,No Intervention,No Intervention,25,https://clinicaltrials.gov/show/NCT04597853,None
6402,NCT04598256,ClinicalTrials.gov,2020-10-21,2020-06-01,True,Tepecik Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,Endoscopic Procedures of Children in the Normalization Process of Covid-19 Pandemic,Other,No Intervention,No Intervention,77,https://clinicaltrials.gov/show/NCT04598256,None
6403,NCT04598334,ClinicalTrials.gov,2020-10-21,2020-10-01,True,"International Centre for Diarrhoeal Disease Research, Bangladesh",Not Recruiting,Not Applicable,Observational,Bangladesh,Cytokine Storm Among Bangladeshi Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,75,https://clinicaltrials.gov/show/NCT04598334,None
6404,NCT04598347,ClinicalTrials.gov,2020-10-21,2020-08-08,True,Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau,Recruiting,Not Applicable,Observational,Spain,Evaluation of the Possible Vertical Transmission of SARS-CoV-2 Through Study of Amniotic Fluid and Chorionic Villi of Affected Pregnant Women for the COVID-19,Clinical Presentation,No Intervention,No Intervention,225,https://clinicaltrials.gov/show/NCT04598347,None
6405,NCT04598581,ClinicalTrials.gov,2020-10-20,2020-11-02,False,"University Hospital, Basel",Recruiting,Not Applicable,Interventional,Switzerland,"Low Dose Radiation Therapy for Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2), COVID-19",Other,Radiation,Radiation,22,https://clinicaltrials.gov/show/NCT04598581,None
6406,NCT04598594,ClinicalTrials.gov,2020-10-15,2020-11-01,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Phase 3,Interventional,France,Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Intensive Care Unit Patients,Drug,Nicotine,Nicotine,220,https://clinicaltrials.gov/show/NCT04598594,None
6407,NCT04598620,ClinicalTrials.gov,2020-10-21,2020-09-19,True,Inger Lise Gade,Recruiting,Not Applicable,Observational,Denmark,Non-invasive Prognostication of COVID-19 Patients by Use of Biomarkers in Exhaled Breath Condensate,Prognosis,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04598620,None
6408,NCT04598763,ClinicalTrials.gov,2020-10-15,2020-07-01,True,CHU de Nancy,Recruiting,Not Applicable,Interventional,France,Evaluation of Two Methods of Olfactory Rehabilitation in Post-viral Loss of Smell: Classic and Intensive,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,80,https://clinicaltrials.gov/show/NCT04598763,None
6409,NCT04599959,ClinicalTrials.gov,2020-10-22,2020-10-26,False,Boehringer Ingelheim,Recruiting,Not Applicable,Interventional,Mexico,COVID-19 Tests: Nasopharyngeal Swab vs Saliva Collected With SalivetteÂ® Cortisol for Viral RNA Sampling for RT-qPCR,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,80,https://clinicaltrials.gov/show/NCT04599959,None
6410,NCT04599998,ClinicalTrials.gov,2020-10-19,2020-10-15,True,Koç University Hospital,Recruiting,Not Applicable,Observational,Turkey,Long-term Follow-up Findings of Inpatients for COVID-19 Pneumonia,Clinical Presentation,No Intervention,No Intervention,37,https://clinicaltrials.gov/show/NCT04599998,None
6411,NCT04600141,ClinicalTrials.gov,2020-10-22,2020-10-20,True,University of São Paulo,Not Recruiting,Phase 3,Interventional,No Country Given,Clinical Efficacy of Heparin and Tocilizumab in Patients With Severe COVID-19 Infection: a Randomized Clinical Trial,Drug,Heparin + Tocilizumab,Heparin; Tocilizumab,308,https://clinicaltrials.gov/show/NCT04600141,None
6412,NCT04600440,ClinicalTrials.gov,2020-10-20,2020-04-25,True,Skåne University Hospital,Recruiting,Not Applicable,Interventional,Sweden,Convalescent Plasma in the Treatment of Covid-19,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04600440,None
6413,NCT04600713,ClinicalTrials.gov,2020-10-09,2021-01-01,False,Vastra Gotaland Region,Not Recruiting,Not Applicable,Interventional,No Country Given,Physiotherapist-led Exercise Within Cardiac Rehabilitation and Paroxysmal Atrial Fibrillation and COVID-19.,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,180,https://clinicaltrials.gov/show/NCT04600713,None
6414,NCT04600895,ClinicalTrials.gov,2020-09-15,2020-11-01,False,Appili Therapeutics Inc.,Not Recruiting,Phase 3,Interventional,No Country Given,The Prevent Severe COVID-19 (PRESECO) Study,Drug,Favipiravir,Favipiravir,826,https://clinicaltrials.gov/show/NCT04600895,None
6415,NCT04600999,ClinicalTrials.gov,2020-10-08,2020-10-07,True,University of Pecs,Recruiting,Phase 3,Interventional,Hungary,Clinical Trial of Favipiravir Treatment of Patients With COVID-19,Drug,Favipiravir,Favipiravir,150,https://clinicaltrials.gov/show/NCT04600999,None
6416,NCT04601012,ClinicalTrials.gov,2020-10-22,2020-09-20,True,Federico II University,Not Recruiting,Not Applicable,Observational,Italy,OCTA Study: Retinal Vascular Changes in SARS-CoV-2 Patients,Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04601012,None
6417,NCT04601090,ClinicalTrials.gov,2020-10-15,2020-09-16,True,Oslo University Hospital,Recruiting,Not Applicable,Observational,Norway,Survival Rates and Longterm Outcomes After COVID-19,Clinical Presentation,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04601090,None
6418,NCT04601415,ClinicalTrials.gov,2020-08-26,2021-02-01,False,Imperial College London,Not Recruiting,Not Applicable,Observational,No Country Given,Point of Care Artificial Intelligence Tool for Heart Failure Diagnosis,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1500,https://clinicaltrials.gov/show/NCT04601415,None
6419,NCT04602000,ClinicalTrials.gov,2020-10-18,2020-09-25,True,Celltrion,Recruiting,Phase 2/Phase 3,Interventional,South Korea,To Evaluate the Safety and Efficacy of CT-P59 in Patients With Mild to Moderate Syptoms of Severe Acute Respiratory Syndrome COVID-19,Drug,CT-P59,CT-P59,1020,https://clinicaltrials.gov/show/NCT04602000,None
6420,NCT04602260,ClinicalTrials.gov,2020-09-03,2020-06-09,True,McMaster University,Recruiting,Not Applicable,Observational,Canada,Functional Recovery of Hospitalised Patients With COVID-19: The COREG Extension Study,Clinical Presentation,No Intervention,No Intervention,211,https://clinicaltrials.gov/show/NCT04602260,None
6421,NCT04602286,ClinicalTrials.gov,2020-10-19,2020-10-28,False,University of Queensland,Recruiting,Not Applicable,Interventional,Australia,How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Pain Sample),Other (psych),Psychological,Psychological,292,https://clinicaltrials.gov/show/NCT04602286,None
6422,NCT04602312,ClinicalTrials.gov,2020-10-19,2020-10-28,False,University of Queensland,Recruiting,Not Applicable,Interventional,Australia,How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Healthy Sample),Other (psych),Psychological,Psychological,624,https://clinicaltrials.gov/show/NCT04602312,None
6423,NCT04602442,ClinicalTrials.gov,2020-10-21,2020-10-01,True,Olga Tyumina,Recruiting,Phase 2,Interventional,Russian Federation,Safety and Efficiency of Method of Exosome Inhalation in COVID-19 Associated Pneumonia,Drug,Exosome,Exosome,90,https://clinicaltrials.gov/show/NCT04602442,None
6424,NCT04602481,ClinicalTrials.gov,2020-10-23,2020-05-31,True,University of Bern,Recruiting,Not Applicable,Observational,Switzerland,COVID-19 in People With Primary Ciliary Dyskinesia,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04602481,None
6425,NCT04602637,ClinicalTrials.gov,2020-10-22,2019-12-15,True,Kine Kinesiologia Deportiva y Funcional,Not Recruiting,Not Applicable,Observational,Argentina,Training Load Management in Three Professional Tennis Players During COVID-19 Lockdown: a Case Series Study,Other,Other,Other,3,https://clinicaltrials.gov/show/NCT04602637,None
6426,NCT04602832,ClinicalTrials.gov,2020-10-23,2020-10-14,True,University of British Columbia,Recruiting,Not Applicable,Interventional,Canada,Enduring Happiness and Continued Self-Enhancement (ENHANCE) for COVID-19,Other (psych),No Intervention,No Intervention,350,https://clinicaltrials.gov/show/NCT04602832,None
6427,NCT04602871,ClinicalTrials.gov,2020-10-21,2020-07-03,True,Scentech Medical Technologies Ltd,Recruiting,Not Applicable,Interventional,Israel,Early Detection of COVID-19 Using Breath Analysis - Feasibility Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,108,https://clinicaltrials.gov/show/NCT04602871,None
6428,NCT04602884,ClinicalTrials.gov,2020-10-21,2020-09-22,True,Scentech Medical Technologies Ltd,Not Recruiting,Not Applicable,Interventional,Israel,Early Detection of COVID-19 Using Breath Analysis,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://clinicaltrials.gov/show/NCT04602884,None
6429,NCT04602949,ClinicalTrials.gov,2020-10-21,2020-11-12,False,Scentech Medical Technologies Ltd,Not Recruiting,Not Applicable,Interventional,Israel,Detection of COVID-19 Using Breath Analysis - Validation Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,4000,https://clinicaltrials.gov/show/NCT04602949,None
6430,NCT04603079,ClinicalTrials.gov,2020-10-19,2020-11-01,False,Forman Christian College,Not Recruiting,Not Applicable,Interventional,No Country Given,Nurse Leadership for Hospital Infection Control,Health System,Other,Other,200,https://clinicaltrials.gov/show/NCT04603079,None
6431,NCT04603105,ClinicalTrials.gov,2020-10-09,2020-10-31,False,The Clatterbridge Cancer Centre NHS Foundation Trust,Not Recruiting,Not Applicable,Observational,No Country Given,CCP Cancer UK Companion Study,Clinical Presentation,No Intervention,No Intervention,9000,https://clinicaltrials.gov/show/NCT04603105,None
6432,NCT04603651,ClinicalTrials.gov,2020-10-23,2020-03-04,True,Eli Lilly and Company,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Expanded Access Program to Provide Bamlanivimab (LY3819253) for the Treatment of COVID-19,Drug,Bamlanivimab,Bamlanivimab,Not Available,https://clinicaltrials.gov/show/NCT04603651,None
6433,NCT04603664,ClinicalTrials.gov,2020-10-17,2020-10-30,False,Ain Shams University,Recruiting,Not Applicable,Observational,Egypt,Role of NGAL and Cystatin C in Prediction of Acute Kidney Injury Covid-19 Infection,Clinical Presentation,No Intervention,No Intervention,88,https://clinicaltrials.gov/show/NCT04603664,None
6434,NCT04603677,ClinicalTrials.gov,2020-10-25,2020-07-08,True,Colorado State University,Recruiting,Not Applicable,Observational,United States,Northern Colorado COVID-19 Biobank,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04603677,None
6435,NCT04603729,ClinicalTrials.gov,2020-10-21,2020-05-30,True,Fatima Memorial Hospital,Not Recruiting,Phase 3,Interventional,Pakistan,Comparison of Efficacy of Dexamethasone and Methylprednisolone in Moderate to Severe Covid 19 Disease,Drug,Corticosteroids,Dexamethasone; Methylprednisolone,100,https://clinicaltrials.gov/show/NCT04603729,None
6436,NCT04603742,ClinicalTrials.gov,2020-10-21,2020-11-01,False,Weill Medical College of Cornell University,Not Recruiting,Phase 2,Interventional,United States,"Anakinra, COVID-19, Cytokine Storm",Drug,Anakinra,Anakinra,100,https://clinicaltrials.gov/show/NCT04603742,None
6437,NCT04603755,ClinicalTrials.gov,2020-10-24,2020-10-26,False,Direction Centrale du Service de Sant des Armes,Recruiting,Not Applicable,Observational,France,Electrical Impedance Tomography: Collapse in Dependent Areas as a Predictor of Response to Prone Position Ventilation in COVID-19 Acute Respiratory Distress Syndrome,Other (device),Electrical Impedance tomography,Electrical Impedance tomography,15,https://clinicaltrials.gov/show/NCT04603755,None
6438,NCT04603794,ClinicalTrials.gov,2020-10-21,2020-10-01,True,Ohio State University,Recruiting,Phase 4,Interventional,United States,Efficacy of Mouthwash in Reducing Salivary Carriage of COVID-19,Drug,Povidone iodine + Chlorhexidine Gluconate + Hydrogen Peroxide,Povidone iodine; Chlorhexidine Gluconate; Hydrogen Peroxide,60,https://clinicaltrials.gov/show/NCT04603794,None
6439,NCT04603924,ClinicalTrials.gov,2020-10-20,2020-10-07,True,ANA Therapeutics,Recruiting,Phase 2/Phase 3,Interventional,United States,Study of Niclosamide in Moderate Hospitalized Coronavirus-19 (COVID-19) Patients,Drug,Niclosamide,Niclosamide,436,https://clinicaltrials.gov/show/NCT04603924,None
6440,NCT04603963,ClinicalTrials.gov,2020-10-25,2020-06-01,True,Elaine Cristina Pereira,Not Recruiting,Not Applicable,Interventional,Brazil,Inspiratory Muscle Training in Patients With COVID-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,55,https://clinicaltrials.gov/show/NCT04603963,None
6441,NCT04604080,ClinicalTrials.gov,2020-10-25,2020-11-01,False,Islamia University of Bahawalpur,Not Recruiting,Not Applicable,Observational,Pakistan,Post-COVID-19 Epidemic Depression Assessment in Adults in South Punjab Pakistan,Other (psych),No Intervention,No Intervention,390,https://clinicaltrials.gov/show/NCT04604080,None
6442,NCT04604119,ClinicalTrials.gov,2020-10-25,2020-05-01,True,Sisli Hamidiye Etfal Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,Anxiety and Burnout in Anesthetists and Intensive Care Unit Nurses During Covid-19 Pandemic,Health System,No Intervention,No Intervention,104,https://clinicaltrials.gov/show/NCT04604119,None
6443,NCT04604223,ClinicalTrials.gov,2020-10-26,2020-11-15,False,Dasman Diabetes Institute,Not Recruiting,Phase 4,Interventional,No Country Given,Effect of Pioglitazone on T2DM Patients With COVID-19,Drug,Pioglitazone,Pioglitazone,1506,https://clinicaltrials.gov/show/NCT04604223,None
6444,NCT04604249,ClinicalTrials.gov,2020-10-25,2020-10-26,False,Centre d'Expertise sur l'Altitude EXALT,Recruiting,Not Applicable,Observational,Peru,Prevalence of COVID-19 in High Altitude : Insights From the Highest City of the World,Clinical Presentation (Epidemiology),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04604249,None
6445,NCT04604327,ClinicalTrials.gov,2020-10-23,2020-10-26,False,Clínica Universidad de Navarra,Recruiting,Phase 3,Interventional,Spain,Comparison of Two Different Doses of Bemiparin in COVID-19,Drug,Bemiparin,Bemiparin,164,https://clinicaltrials.gov/show/NCT04604327,None
6446,NCT04604678,ClinicalTrials.gov,2020-10-26,2020-11-01,False,AgelessRx,Not Recruiting,Phase 2,Interventional,United States,Pilot Study Into the Use of Metformin and LDN for Patients With COVID-19,Drug,Metformin + Naltrexone,Metformin; Naltrexone,80,https://clinicaltrials.gov/show/NCT04604678,None
6447,NCT04604704,ClinicalTrials.gov,2020-10-26,2020-11-01,False,AgelessRx,Not Recruiting,Phase 2,Interventional,United States,Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome,Drug,Naltrexone + NAD+,Naltrexone; NAD+,60,https://clinicaltrials.gov/show/NCT04604704,None
6448,NCT04604743,ClinicalTrials.gov,2020-10-25,2021-01-01,False,University of Alabama at Birmingham,Not Recruiting,Not Applicable,Interventional,United States,Clinic-based HPV and COVID-19 Vaccine Promoting Intervention for AfAm Adolescents in Alabama,Other,Other,Other,4,https://clinicaltrials.gov/show/NCT04604743,None
6449,NCT04604769,ClinicalTrials.gov,2020-04-27,2019-06-26,True,University of Liège,Not Recruiting,Not Applicable,Observational,Belgium,Perceived Stress Among ICU Medical Staff During COVID-19 Crisis,Other (psych),No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04604769,None
6450,NCT04604977,ClinicalTrials.gov,2020-10-20,2020-09-15,True,Fondazione IRCCS Istituto Neurologico Carlo Besta,Recruiting,Not Applicable,Interventional,Italy,Feasibility and Effectiveness of Home-behavioral Program for Adolescents With Migraine,Other (psych),Psychological,Psychological,25,https://clinicaltrials.gov/show/NCT04604977,None
6451,NCT04605692,ClinicalTrials.gov,2020-10-26,2020-03-09,True,Akdeniz University,Not Recruiting,Not Applicable,Observational,Turkey,Evaluation of Occupational Burnout and Stress Among Dentists in Covid-19 Pandemic,Other (psych),No Intervention,No Intervention,706,https://clinicaltrials.gov/show/NCT04605692,None
6452,NCT04605757,ClinicalTrials.gov,2020-10-11,2020-07-30,True,AOU di Bologna Policlinico S.Orsola-Malpighi,Recruiting,Not Applicable,Observational,Italy,Long-term Evolution of Pulmonary Involvement of Novel SARS-COV-2 Infection (COVID-19): Follow the Covid Study,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04605757,None
6453,NCT04605887,ClinicalTrials.gov,2020-10-27,2020-11-01,False,Rambam Health Care Campus,Not Recruiting,Phase 2,Interventional,Israel,Angiotensin 1-7 as a Therapy in the Treatment of COVID-19,Drug,Angiotensin 1-7,Angiotensin 1-7,120,https://clinicaltrials.gov/show/NCT04605887,None
6454,NCT04605926,ClinicalTrials.gov,2020-10-21,2020-11-01,False,Equillium,Not Recruiting,Phase 3,Interventional,Colombia,A Study to Evaluate the Efficacy and Safety of Itolizumab in Subjects Hospitalized With COVID-19,Drug,Itolizumab,Itolizumab,800,https://clinicaltrials.gov/show/NCT04605926,None
6455,NCT04605952,ClinicalTrials.gov,2020-10-23,2020-07-01,True,Tata Main Hospital,Not Recruiting,Not Applicable,Observational,India,Study to Find the Percentage of Cases Retaining COVID-19 IgG Antibodies 45-65 After They Have Tested Positive,Clinical Presentation,No Intervention,No Intervention,201,https://clinicaltrials.gov/show/NCT04605952,None
6456,NCT04606069,ClinicalTrials.gov,2020-10-26,2020-11-01,False,"University of Maryland, Baltimore",Not Recruiting,Phase 1/Phase 2,Interventional,United States,Treat COVID-19 Patients With Regadenoson,Drug,Regadenoson,Regadenoson,40,https://clinicaltrials.gov/show/NCT04606069,None
6457,NCT04606498,ClinicalTrials.gov,2020-10-26,2020-11-20,False,Henry M. Jackson Foundation for the Advancement of Military Medicine,Not Recruiting,Not Applicable,Observational,United States,Blood Purification With Seraph 100 Microbind Affinity Blood Filter for Treatment of Severe COVID19 Observational Study,Other (device),Blood filter,Blood filter,200,https://clinicaltrials.gov/show/NCT04606498,None
6458,NCT04606563,ClinicalTrials.gov,2020-10-27,2020-10-09,True,University of British Columbia,Recruiting,Phase 3,Interventional,"Japan, France, Canada, Belgium, United States, Spain",Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan on Outcomes of Coronavirus Infection?,Drug,Losartan,Losartan,1372,https://clinicaltrials.gov/show/NCT04606563,None
6459,NCT04606732,ClinicalTrials.gov,2020-10-27,2020-09-20,True,University of Bologna,Recruiting,Not Applicable,Observational,Italy,CardioVascular Disease Progression and Prognosis in COVID-19,Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04606732,None
6460,NCT04607915,ClinicalTrials.gov,2020-07-30,2020-11-30,False,Centre for Addiction and Mental Health,Not Recruiting,Not Applicable,Interventional,No Country Given,Technology-enabled Collaborative Care for Diabetes Management During COVID-19,Telehealth,Telehealth,Telehealth,30,https://clinicaltrials.gov/show/NCT04607915,None
6461,NCT04607928,ClinicalTrials.gov,2020-10-28,2020-08-01,True,Institut d'Investigacio Biomedica de Bellvitge,Recruiting,Phase 2,Interventional,Spain,Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis COVID-19,Drug,Pirfenidone,Pirfenidone,148,https://clinicaltrials.gov/show/NCT04607928,None
6462,NCT04607941,ClinicalTrials.gov,2020-10-20,2020-10-27,False,Institut Pasteur,Recruiting,Not Applicable,Observational,France,"Study of Socio-demographic Factors, Behaviors and Practices Associated With Infection With SARS-CoV-2 Responsible for COVID-19",Clinical Presentation (Epidemiology),No Intervention,No Intervention,57720,https://clinicaltrials.gov/show/NCT04607941,None
6463,NCT04608214,ClinicalTrials.gov,2020-10-12,2020-11-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,Evaluation of Alisporivir for the Treatment of Hospitalised Patients With Infections Due to SARS-CoV-2 (COVID-19),Drug,Alisporivir,Alisporivir,100,https://clinicaltrials.gov/show/NCT04608214,EUCTR2020-002295-13
6464,NCT04608305,ClinicalTrials.gov,2020-10-26,2020-10-28,False,Israel Institute for Biological Research (IIBR),Recruiting,Phase 1/Phase 2,Interventional,Israel,"Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine",ATMP,Vaccine,Vaccine,1040,https://clinicaltrials.gov/show/NCT04608305,None
6465,NCT04608383,ClinicalTrials.gov,2020-10-23,2020-11-01,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,Laparoscopy and COVID-19 Contamination,Other,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04608383,None
6466,NCT04609332,ClinicalTrials.gov,2020-10-23,2020-11-10,False,University of Chile,Recruiting,Not Applicable,Observational,Chile,Endothelial Damage and Angiogenesis Biomarkers During COVID-19,Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04609332,None
6467,NCT04609371,ClinicalTrials.gov,2020-10-19,2020-10-21,False,"St. Mary's Research Center, Canada",Recruiting,Not Applicable,Interventional,Canada,PanDirect: Self-care Tools and Telephone Coaching for Depression and Anxiety During Pandemics,Other (psych),Psychological,Psychological,176,https://clinicaltrials.gov/show/NCT04609371,None
6468,NCT04609423,ClinicalTrials.gov,2020-10-22,2020-11-10,False,Oslo University Hospital,Recruiting,Phase 4,Interventional,Norway,Cod Liver Oil for Covid-19 Prevention Study,Supplement,Cod liver oil,Cod liver oil,80000,https://clinicaltrials.gov/show/NCT04609423,None
6469,NCT04609462,ClinicalTrials.gov,2020-09-24,2020-08-11,True,Fundacion Clinica Valle del Lili,Recruiting,Not Applicable,Interventional,Colombia,High-Flow Nasal Cannula in Severe COVID-19 With Acute Hypoxemic Respiratory Failure.,Other (device),Nasal cannula,Nasal cannula,196,https://clinicaltrials.gov/show/NCT04609462,None
6470,NCT04609488,ClinicalTrials.gov,2020-10-28,2020-11-01,False,Zealand University Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Surfactant Levels in the Lungs of COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04609488,None
6471,NCT04609501,ClinicalTrials.gov,2020-10-22,2020-06-01,True,Hillel Yaffe Medical Center,Not Recruiting,Not Applicable,Observational,Israel,"Delivery During Covid-19 Pandemic: Implications for Obstetrics, Maternal Psychopathology, and Mother-Infant Relationship",Other,No Intervention,No Intervention,440,https://clinicaltrials.gov/show/NCT04609501,None
6472,NCT04609722,ClinicalTrials.gov,2020-10-26,2020-07-01,True,Adiyaman University Research Hospital,Recruiting,Not Applicable,Interventional,Turkey,Effect of Solution-Focused Support Program on Anxiety Levels of Parents During the COVID-19 Pandemic,Other (psych),Psychological,Psychological,60,https://clinicaltrials.gov/show/NCT04609722,None
6473,NCT04609774,ClinicalTrials.gov,2020-10-27,2020-05-08,True,Hospital Italiano de Buenos Aires,Not Recruiting,Not Applicable,Observational,Argentina,Aerosol Transmission of Severe Acute Respiratory Syndrome Coronavirus of Coronavirus Disease 2019,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,8,https://clinicaltrials.gov/show/NCT04609774,None
6474,NCT04609839,ClinicalTrials.gov,2020-10-26,2020-10-27,False,"University Hospital, Strasbourg",Recruiting,Not Applicable,Observational,France,FOLLOW-UP OF PATIENTS WITH COVID-19.,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04609839,None
6475,NCT04609865,ClinicalTrials.gov,2020-10-23,2020-11-04,False,"University Hospital, Strasbourg",Not Recruiting,Phase 3,Interventional,No Country Given,Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 Pandemia,Drug,Lidocaine,Lidocaine,100,https://clinicaltrials.gov/show/NCT04609865,None
6476,NCT04610138,ClinicalTrials.gov,2020-10-28,2020-12-01,False,Clene Nanomedicine,Not Recruiting,Phase 2,Interventional,No Country Given,Study of ZnAg Liquid Solution to Treat COVID-19 Symptomatic Participants,Drug,Zinc + Silver,Zinc; Silver,238,https://clinicaltrials.gov/show/NCT04610138,None
6477,NCT04610489,ClinicalTrials.gov,2020-10-27,2020-11-01,False,Carilion Clinic,Not Recruiting,Not Applicable,Interventional,No Country Given,Diagnostic Performance of an Antigen Test for SARS-CoV-2 Infection (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,800,https://clinicaltrials.gov/show/NCT04610489,None
6478,NCT04610502,ClinicalTrials.gov,2020-09-15,2020-09-06,True,Caja Costarricense de Seguro Social,Not Recruiting,Phase 2,Interventional,Costa Rica,Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients,ATMP,Immunoglobulin,Immunoglobulin,26,https://clinicaltrials.gov/show/NCT04610502,None
6479,NCT04610515,ClinicalTrials.gov,2020-10-28,2020-11-14,False,Rush University Medical Center,Not Recruiting,Not Applicable,Observational,United States,Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE),Clinical Presentation,No Intervention,No Intervention,4800,https://clinicaltrials.gov/show/NCT04610515,None
6480,NCT04610541,ClinicalTrials.gov,2020-10-11,2020-10-12,False,University of Pecs,Not Recruiting,Phase 3,Interventional,Hungary,REMdesivir-HU Clinical Study and Severe Covid-19 Patients,Drug,Remdesivir,Remdesivir,2000,https://clinicaltrials.gov/show/NCT04610541,None
6481,NCT04610554,ClinicalTrials.gov,2020-10-29,2020-05-14,True,IRCCS Azienda Ospedaliera Universitaria San Martino ,Not Recruiting,Not Applicable,Observational,Italy,Lung Diffusing Capacity for Nitric Oxide and Carbon Monoxide Early After Mild-to-severe COVID-19,Clinical Presentation,No Intervention,No Intervention,74,https://clinicaltrials.gov/show/NCT04610554,None
6482,NCT04610567,ClinicalTrials.gov,2020-10-24,2020-10-27,False,University of São Paulo General Hospital,Recruiting,Phase 1/Phase 2,Interventional,Brazil,Treatment of Patients With Mild Coronavirus-19 (COVID-19) Disease With Methotrexate Associated to LDL Like Nanoparticles (Nano-COVID19),Drug,Methotrexate,Methotrexate,100,https://clinicaltrials.gov/show/NCT04610567,None
6483,NCT04610801,ClinicalTrials.gov,2020-10-26,2020-08-08,True,Larkin Community Hospital,Recruiting,Phase 3,Interventional,United States,Evaluation of the Efficacy of Xylitol Nasal Spray Against SARS-CoV-2,Drug,Xylitol,Xylitol,200,https://clinicaltrials.gov/show/NCT04610801,None
6484,NCT04611243,ClinicalTrials.gov,2020-06-29,2020-05-22,True,Chinese University of Hong Kong,Recruiting,Not Applicable,Observational,Hong Kong,"Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19",Clinical Presentation,No Intervention,No Intervention,80,https://clinicaltrials.gov/show/NCT04611243,None
6485,NCT04611256,ClinicalTrials.gov,2020-10-29,2020-08-01,True,Hospital Regional Lic. Adolfo López Mateos,Recruiting,Phase 1,Interventional,Mexico,Mesenchymal Stem Cells in Patients Diagnosed With COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04611256,None
6486,NCT04611269,ClinicalTrials.gov,2020-10-29,2020-03-20,True,Argentinian Intensive Care Society,Not Recruiting,Not Applicable,Observational,Argentina,Clinical Characteristics and Outcomes of Patients With COVID-19 on Mechanical Ventilation in Argentina,Clinical Presentation,No Intervention,No Intervention,950,https://clinicaltrials.gov/show/NCT04611269,None
6487,NCT04611399,ClinicalTrials.gov,2020-10-08,2020-11-01,False,Fondazione IRCCS Istituto Neurologico Carlo Besta,Not Recruiting,Not Applicable,Interventional,Italy,MIND-VR: Virtual Reality for COVID-19 Operators' Psychological Support,Other (psych),Psychological,Psychological,90,https://clinicaltrials.gov/show/NCT04611399,None
6488,NCT04611425,ClinicalTrials.gov,2020-10-07,2020-11-01,False,Nantes University Hospital,Not Recruiting,Phase 2,Interventional,France,"REmimazolam Infusion in the Context of Hypnotic Shortage in the Critical Care Unit During the Pandemic of COVID-19, the REHSCU Study",Drug,Remimazolam,Remimazolam,30,https://clinicaltrials.gov/show/NCT04611425,None
6489,NCT04611802,ClinicalTrials.gov,2020-10-30,2020-11-01,False,Novavax,Not Recruiting,Phase 3,Interventional,"United States, Mexico, Puerto Rico","A Study Looking at the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults at Risk for SARS-CoV-2",ATMP,Vaccine,Vaccine,30000,https://clinicaltrials.gov/show/NCT04611802,None
6490,NCT04611841,ClinicalTrials.gov,2020-09-26,2020-07-21,True,Federal Research and Clinical Center of Physical-Chemical Medicine,Recruiting,Not Applicable,Observational,Russian Federation,Medical-biological Research of the Pathogenesis of COVID-19 Disease Caused by SARS-CoV-2,Clinical Presentation,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04611841,None
6491,NCT04612972,ClinicalTrials.gov,2020-08-18,2020-09-10,False,Universidad Peruana Cayetano Heredia,Recruiting,Phase 3,Interventional,Peru,"Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) in Healthy Adult Population In Peru",ATMP,Vaccine,Vaccine,6000,https://clinicaltrials.gov/show/NCT04612972,None
6492,NCT04613050,ClinicalTrials.gov,2020-10-30,2020-07-02,True,Cairo University,Recruiting,Not Applicable,Interventional,Egypt,Effect of Respiratory Versus Aerobic Training on Respiratory and Immunity Efficiency in Recovered COVID- 19 Patients,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,80,https://clinicaltrials.gov/show/NCT04613050,None
6493,NCT04613271,ClinicalTrials.gov,2020-10-25,2020-10-15,True,Ina-Respond,Recruiting,Phase 3,Interventional,Indonesia,Efficacy and Safety of Favipiravir in Covid-19 Patients in Indonesia,Drug,Favipiravir vs. Favipiravir + Azithromycin,Favipiravir; Azithromycin,210,https://clinicaltrials.gov/show/NCT04613271,None
6494,NCT04613297,ClinicalTrials.gov,2020-11-02,2020-10-19,True,Hôpital Foch,Recruiting,Not Applicable,Interventional,France,HLA-G Immuno-Inhibitor Checkpoint Study in Patients With COVID-19 Infection: Molecular and Cellular Assessment,Clinical Presentation,No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04613297,None
6495,NCT04613310,ClinicalTrials.gov,2020-10-26,2020-09-25,True,University of Lausanne,Recruiting,Not Applicable,Interventional,Switzerland,PCR and Rapid Diagnostic Test on Saliva and Nasopharyngeal Swabs for the Detection of SARS-CoV-2 (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1250,https://clinicaltrials.gov/show/NCT04613310,None
6496,NCT04613739,ClinicalTrials.gov,2020-10-29,2020-11-02,False,Harvard Pilgrim Health Care,Not Recruiting,Not Applicable,Interventional,No Country Given,Asthma in Families Facing Out-of-pocket Requirements Due to COVID-19,Other,No Intervention,No Intervention,430,https://clinicaltrials.gov/show/NCT04613739,None
6497,NCT04613817,ClinicalTrials.gov,2020-10-30,2020-11-20,False,Sciensano,Not Recruiting,Not Applicable,Observational,No Country Given,Sero-prevalence COVID-19 Among Belgian Children,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1640,https://clinicaltrials.gov/show/NCT04613817,None
6498,NCT04613986,ClinicalTrials.gov,2020-11-02,2020-12-01,False,University of Zurich,Not Recruiting,Not Applicable,Interventional,No Country Given,Therapeutic Plasma Exchange as an Adjunctive Strategy to Treat Coagulopathy and Inflammation in Severe Covid-19,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04613986,None
6499,NCT04614012,ClinicalTrials.gov,2020-11-02,2020-07-02,True,Anna Falanga,Recruiting,Not Applicable,Interventional,Italy,Hyperimmune Plasma for Patients With COVID-19,ATMP,Plasma,Plasma,100,https://clinicaltrials.gov/show/NCT04614012,None
6500,NCT04614025,ClinicalTrials.gov,2020-11-02,2020-11-01,True,Pluristem Ltd.,Recruiting,Phase 2,Interventional,"Israel, Germany",Open-label Multicenter Study to Evaluate the Efficacy of PLX-PAD for the Treatment of COVID-19,ATMP,Cells (Stromal),Cells (Stromal),40,https://clinicaltrials.gov/show/NCT04614025,None
6501,NCT04614883,ClinicalTrials.gov,2020-11-02,2020-10-21,True,Hôpital Foch,Recruiting,Not Applicable,Interventional,France,Analysis of Volatile Organic Compounds in Exhaled Air and in Sweat in the Context of Suspicion of COVID-19 Infection,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04614883,None
6502,NCT04615000,ClinicalTrials.gov,2020-11-03,2020-10-29,True,"University Hospital, Ghent",Recruiting,Not Applicable,Observational,Belgium,SeroCovid<19: A Prospective Covid-19 Seroconversion Study in a Tertiary Pediatric Patient Cohort,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04615000,None
6503,NCT04615026,ClinicalTrials.gov,2020-11-03,2020-11-04,False,"University Hospital, Augsburg",Recruiting,Not Applicable,Observational,Germany,Prevalence of Thrombosis in COVID-Patients,Clinical Presentation (Epidemiology),No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04615026,None
6504,NCT04615052,ClinicalTrials.gov,2020-10-29,2020-09-26,True,University of São Paulo,Recruiting,Not Applicable,Interventional,Brazil,Home-based Exercise in COVID-19 Survivors,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,60,https://clinicaltrials.gov/show/NCT04615052,None
6505,NCT04615195,ClinicalTrials.gov,2020-11-03,2020-06-10,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Observational,France,Effect of COVID19-related COntainment in ChildreN,Other (psych),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04615195,None
6506,NCT04615208,ClinicalTrials.gov,2020-11-02,2020-11-15,False,University of Manitoba,Not Recruiting,Not Applicable,Observational,No Country Given,Screening for COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04615208,None
6507,NCT04615390,ClinicalTrials.gov,2020-10-29,2020-03-30,True,"University Hospital, Ferrara",Recruiting,Not Applicable,Observational,Italy,Recovery Profiles in Patients With SARS-CoV-2 Outcomes Undergoing Rehabilitation,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,200,https://clinicaltrials.gov/show/NCT04615390,None
6508,NCT04615416,ClinicalTrials.gov,2020-10-26,2020-05-01,True,Columbia University,Recruiting,Not Applicable,Interventional,United States,Emotion Regulation Training Via Telehealth During the COVID-19 Pandemic,Other (psych),Psychological,Psychological,100,https://clinicaltrials.gov/show/NCT04615416,None
6509,NCT04615429,ClinicalTrials.gov,2020-10-25,2020-09-15,True,Cristina Avendaño-Solá,Recruiting,Phase 2,Interventional,Spain,Clinical Trial to Assess the Efficacy of MSC in Patients With ARDS Due to COVID-19,ATMP,Cells (mesenchymal),Cells (mesenchymal),20,https://clinicaltrials.gov/show/NCT04615429,EUCTR2020-002193-27
6510,NCT04615676,ClinicalTrials.gov,2020-11-03,2020-04-27,True,"University Hospital, Toulouse",Not Recruiting,Not Applicable,Observational,France,Prospective Evaluation of the Predictive Criteria of Severity for Respiratory Infection Due to COVID-19 Virus,Prognosis,No Intervention,No Intervention,4734,https://clinicaltrials.gov/show/NCT04615676,None
6511,NCT04615728,ClinicalTrials.gov,2020-11-02,2019-11-01,True,Cambridge University Hospitals NHS Foundation Trust,Not Recruiting,Not Applicable,Observational,United Kingdom,MANAGEMENT OF APPENDICITIS DURING THE COVID-19 PANDEMIC,Health System,No Intervention,No Intervention,207,https://clinicaltrials.gov/show/NCT04615728,None
6512,NCT04615741,ClinicalTrials.gov,2020-10-29,2020-11-01,False,University of Lethbridge,Recruiting,Not Applicable,Interventional,Canada,Finding Wellness in the Pandemic,Other (psych),Psychological,Psychological,200,https://clinicaltrials.gov/show/NCT04615741,None
6513,NCT04615871,ClinicalTrials.gov,2020-10-29,2020-11-30,False,Vladimir Dzavik,Not Recruiting,Phase 2,Interventional,"United Kingdom, Canada, Mexico, Brazil",Semaglutide to Reduce Myocardial Injury in PATIents With COVID-19,Drug,Semaglutide,Semaglutide,400,https://clinicaltrials.gov/show/NCT04615871,None
6514,NCT04615936,ClinicalTrials.gov,2020-11-02,2020-07-10,True,Sunnybrook Health Sciences Centre,Recruiting,Not Applicable,Interventional,Canada,Nasal Photodisinfection COVID Proof of Concept Study,Drug,Methylene Blue,Methylene Blue,100,https://clinicaltrials.gov/show/NCT04615936,None
6515,NCT04615949,ClinicalTrials.gov,2020-11-02,2020-12-01,False,Cardiol Therapeutics Inc.,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors,Drug,Cannabidiol,Cannabidiol,422,https://clinicaltrials.gov/show/NCT04615949,None
6516,NCT04615975,ClinicalTrials.gov,2020-10-31,2020-11-01,False,University of Padova,Recruiting,Not Applicable,Interventional,Italy,Ketogenic Diet as Protective Factor During COVID-19,Other (nutrition),Nutrition,Nutrition,28,https://clinicaltrials.gov/show/NCT04615975,None
6517,NCT04616001,ClinicalTrials.gov,2020-11-02,2020-11-01,True,Sharp HealthCare,Not Recruiting,Phase 4,Interventional,United States,IVIG in Patients With Severe COVID-19 Requiring Mechanical Ventilation,ATMP,Immunoglobulin,Immunoglobulin,10,https://clinicaltrials.gov/show/NCT04616001,None
6518,NCT04616846,ClinicalTrials.gov,2020-11-02,2020-08-04,True,Centre Antoine Lacassagne,Recruiting,Not Applicable,Interventional,"Monaco, France",Thromboembolic Risk Screening in Patients With Cancer and COVID-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04616846,None
6519,NCT04616950,ClinicalTrials.gov,2020-11-04,2020-12-01,False,Groupe Hospitalier Paris Saint-Joseph,Not Recruiting,Not Applicable,Observational,No Country Given,Impact of the COVID-19 Epidemic on the Hospital Journey of Patients With Cancer of the Digestive System,Health System,No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04616950,None
6520,NCT04616976,ClinicalTrials.gov,2020-11-01,2020-01-01,True,"Southeast University, China",Not Recruiting,Not Applicable,Observational,China,COVID-19 With Convalescent Plasma,ATMP,Plasma,Plasma,78,https://clinicaltrials.gov/show/NCT04616976,None
6521,NCT04616989,ClinicalTrials.gov,2020-10-20,2020-11-01,False,Makerere University,Not Recruiting,Not Applicable,Interventional,No Country Given,Mental Health in Communities Affected by COVID-19 in Uganda,Other (psych),No Intervention,No Intervention,840,https://clinicaltrials.gov/show/NCT04616989,None
6522,NCT04617119,ClinicalTrials.gov,2020-10-28,2020-11-01,False,Dr. Jassim Alghaith,Not Recruiting,Not Applicable,Interventional,Kuwait,The Effects of Multi-modality Physiotherapy in Delaying or Preventing COVID-19 Patient From Admitting to ICU,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,38,https://clinicaltrials.gov/show/NCT04617119,None
6523,NCT04617262,ClinicalTrials.gov,2020-11-02,2020-11-01,True,The New School,Not Recruiting,Not Applicable,Interventional,No Country Given,Pilot Feasibility Study of Remote Problem Management Plus for Adults Affected by COVID-19,Other (psych),Psychological,Psychological,100,https://clinicaltrials.gov/show/NCT04617262,None
6524,NCT04617483,ClinicalTrials.gov,2020-11-04,2020-10-31,True,"Sinovac Research and Development Co., Ltd.",Recruiting,Phase 3,Interventional,China,"Study of the Commercial Scale SARS-CoV-2 Vaccine Against the Pilot Scale Among Adults, and Bridging Study of the Immunogenicity in Elderly Against That in Adults",ATMP,Vaccine,Vaccine,1040,https://clinicaltrials.gov/show/NCT04617483,None
6525,NCT04617535,ClinicalTrials.gov,2020-11-02,2021-01-01,False,Regeneron Pharmaceuticals,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Compassionate Use of REGN-COV2 for the Treatment of COVID-19,Drug,REGN10933+REGN10987,REGN10933; REGN10987,Not Available,https://clinicaltrials.gov/show/NCT04617535,None
6526,NCT04618042,ClinicalTrials.gov,2020-10-23,2020-11-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Phase 2,Interventional,France,FX06 to Rescue Acute Respiratory Distress Syndrome During Covid-19 Pneumonia,Drug,FX06,FX06,50,https://clinicaltrials.gov/show/NCT04618042,EUCTR2020-002056-20
6527,NCT04618341,ClinicalTrials.gov,2020-10-28,2020-03-30,True,Revival Active,Not Recruiting,Not Applicable,Observational,United Kingdom,A Clinical Study of Online Active Play Program With Adolescents,Other (psych),Psychological,Psychological,32,https://clinicaltrials.gov/show/NCT04618341,None
6528,NCT04618796,ClinicalTrials.gov,2020-11-02,2021-04-01,False,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,Effect of COVID-19 Pandemic on Vaccination Compliance,ATMP,Vaccine,Vaccine,100,https://clinicaltrials.gov/show/NCT04618796,None
6529,NCT04618835,ClinicalTrials.gov,2020-10-31,2020-11-03,False,Betsi Cadwaladr University Health Board,Recruiting,Not Applicable,Observational,United Kingdom,Physical Activity a Vital Sign? 40 Steps to Safety Test for Patients With COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,https://clinicaltrials.gov/show/NCT04618835,None
6530,NCT04618861,ClinicalTrials.gov,2020-11-03,2020-10-13,True,Kafkas University,Not Recruiting,Not Applicable,Observational,Turkey,Surfactant Protein D Levels in Covid-19 Infection: Case-Control Study,Clinical Presentation,No Intervention,No Intervention,127,https://clinicaltrials.gov/show/NCT04618861,None
6531,NCT04619290,ClinicalTrials.gov,2020-11-04,2020-10-12,True,Hospital Regional Lic. Adolfo López Mateos,Recruiting,Phase 1,Interventional,Mexico,Outpatient Treatment With CoVid-19 With Prexablu,Drug,Methylene Blue,Methylene Blue,46,https://clinicaltrials.gov/show/NCT04619290,None
6532,NCT04619368,ClinicalTrials.gov,2020-11-03,2020-07-27,True,"University Hospital, Toulouse",Recruiting,Not Applicable,Observational,France,Post-intensive Care Follow-up of Patients Hospitalized for an Acute Respiratory Distress Syndrome Caused by COVID-19,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04619368,None
6533,NCT04619407,ClinicalTrials.gov,2020-11-04,2020-11-04,False,University of Greifswald,Recruiting,Not Applicable,Observational,Germany,"Screening for COVID-19 in Teachers, Childcare Educators, Pupils and Preschoolers",Clinical Presentation (Epidemiology),No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04619407,None
6534,NCT04619576,ClinicalTrials.gov,2020-11-05,2020-06-01,True,"University Hospital, Clermont-Ferrand",Recruiting,Not Applicable,Observational,France,Influence of the COVId-19 Pandemic on STRESS of Occupational Health Workers,Other (psych),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04619576,None
6535,NCT04619628,ClinicalTrials.gov,2020-11-05,2020-12-01,False,"Codagenix, Inc",Not Recruiting,Phase 1,Interventional,United Kingdom,"Safety and Immunogenicity of COVI-VAC, a Live Attenuated Vaccine Against COVID-19",ATMP,Vaccine,Vaccine,48,https://clinicaltrials.gov/show/NCT04619628,None
6536,NCT04619680,ClinicalTrials.gov,2020-11-05,2020-11-01,True,Icahn School of Medicine at Mount Sinai,Recruiting,Phase 4,Interventional,United States,The Study Will Evaluate the Use of Nintedanib in Slowing Lung Fibrosis in Patients With Pulmonary Infiltrates Related to COVID-19,Drug,Nintedanib,Nintedanib,120,https://clinicaltrials.gov/show/NCT04619680,None
6537,NCT04619706,ClinicalTrials.gov,2020-11-05,2020-11-15,False,"FSD Pharma, Inc.",Not Recruiting,Phase 2,Interventional,No Country Given,Ultramicronized Palmitoylethanolamide (PEA) Treatment in Hospitalized Participants With COVID-19,Drug,Palmitoylethanolamide,Palmitoylethanolamide,350,https://clinicaltrials.gov/show/NCT04619706,None
6538,NCT04619719,ClinicalTrials.gov,2020-11-05,2020-11-16,False,NYU Langone Health,Not Recruiting,Not Applicable,Interventional,United States,Hyperbaric Oxygen for COVID-19 Patients With Moderate to Severe Respiratory Distress,Drug,Oxygen,Oxygen,600,https://clinicaltrials.gov/show/NCT04619719,None
6539,NCT04620798,ClinicalTrials.gov,2020-11-04,2020-09-14,True,Indiana University,Not Recruiting,Not Applicable,Interventional,United States,Longitudinal COVID-19 Antibody Testing in Indiana University Undergraduate Students,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1700,https://clinicaltrials.gov/show/NCT04620798,None
6540,NCT04621058,ClinicalTrials.gov,2020-11-06,2020-11-09,False,Bioaraba Health Research Institute,Recruiting,Phase 3,Interventional,Spain,Efficacy of Vitamin D Treatment in Mortality Reduction Due to COVID-19.,Drug,Vitamin D,Vitamin D,108,https://clinicaltrials.gov/show/NCT04621058,None
6541,NCT04621071,ClinicalTrials.gov,2020-11-05,2020-11-16,False,University of Sherbrooke,Not Recruiting,Not Applicable,Interventional,Canada,Efficacy of Probiotics in Reducing Duration and Symptoms of COVID-19,Supplement,Probiotics,Probiotics,84,https://clinicaltrials.gov/show/NCT04621071,None
6542,NCT04621084,ClinicalTrials.gov,2020-11-05,2020-04-01,True,"University Hospital, Clermont-Ferrand",Recruiting,Not Applicable,Observational,France,Influence of the COVId-19 Pandemic on STRESS and Eating Habits,Other (psych),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04621084,None
6543,NCT04621123,ClinicalTrials.gov,2020-11-04,2020-10-30,True,Fundació Lluita contra la SIDA,Recruiting,Phase 2,Interventional,Spain,Plasma for Early Treatment in Non-hospitalised Mild or Moderate COVID-19 Patients,ATMP,Plasma,Plasma,474,https://clinicaltrials.gov/show/NCT04621123,None
6544,NCT04621149,ClinicalTrials.gov,2020-11-05,2020-11-09,False,"Profact, Inc.",Not Recruiting,Phase 2,Interventional,No Country Given,An Outpatient Study Investigating Non-prescription Treatments for COVID-19,Supplement,Chlorine dioxide; zinc acetate; famotidine; lactoferrin; green tea extract,Chlorine dioxide; zinc acetate; famotidine; lactoferrin; green tea extract,120,https://clinicaltrials.gov/show/NCT04621149,None
6545,NCT04621214,ClinicalTrials.gov,2020-11-04,2020-03-21,True,University of Lahore,Not Recruiting,Not Applicable,Observational,Pakistan,Innovation of Audio-Visual Triage System in Combating the Spread of COVID-19 Infection and Its Efficacy: A Novel Strategy,Other (device),Audio-Visual Triage System,Audio-Visual Triage System,60,https://clinicaltrials.gov/show/NCT04621214,None
6546,NCT04621461,ClinicalTrials.gov,2020-11-06,2020-11-01,True,"St. Francis Hospital, New York",Not Recruiting,Phase 4,Interventional,United States,"Hydroxychloroquine, Azithromycin and Zinc for the Treatment of COVID-19 in the Outpatient Setting",Drug,Zinc,Zinc,750,https://clinicaltrials.gov/show/NCT04621461,None
6547,NCT04621903,ClinicalTrials.gov,2020-11-06,2020-10-08,True,Aarogyam UK,Not Recruiting,Not Applicable,Interventional,United Kingdom,A Pilot Study on Efficacy and Safety of Ayurveda Combination in Patients With Mild-to-Moderate COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,26,https://clinicaltrials.gov/show/NCT04621903,None
6548,NCT04622332,ClinicalTrials.gov,2020-11-03,2020-12-15,False,"Sironax USA, Inc.",Not Recruiting,Phase 1,Interventional,No Country Given,A Pilot Study to Assess Safety and Efficacy of SIR1-365 in Patients With Severe COVID-19,Drug,SIR1-365,SIR1-365,60,https://clinicaltrials.gov/show/NCT04622332,None
6549,NCT04622748,ClinicalTrials.gov,2020-09-06,2020-07-10,True,"National Institute on Drug Dependence, China",Recruiting,Not Applicable,Observational,China,Neurocognitive Functions of Recovered COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,160,https://clinicaltrials.gov/show/NCT04622748,None
6550,NCT04622826,ClinicalTrials.gov,2020-11-04,2020-05-15,True,Azienda Unita Sanitaria Locale Toscana Nord Ovest,Recruiting,Phase 2,Interventional,Italy,plasmApuane CoV-2 : Efficacy and Safety of Immune Covid-19 Plasma in Covid-19 Pneumonia in Non ITU Patients,ATMP,Plasma,Plasma,50,https://clinicaltrials.gov/show/NCT04622826,None
6551,NCT04622865,ClinicalTrials.gov,2020-11-09,2020-06-01,True,AB Science,Recruiting,Phase 2,Interventional,France,Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19,Drug,Masitinib + Isoquercetin,Masitinib; Isoquercetin,200,https://clinicaltrials.gov/show/NCT04622865,EUCTR2020-001635-27
6552,NCT04622891,ClinicalTrials.gov,2020-11-06,2020-04-01,True,South Valley University,Not Recruiting,Not Applicable,Interventional,Egypt,Clarithromycin Versus Azithromycin in Treatment of Mild COVID-19 Infection,Drug,Clarithromycin vs. Azithromycin,Clarithromycin; Azithromycin,300,https://clinicaltrials.gov/show/NCT04622891,None
6553,NCT04623021,ClinicalTrials.gov,2020-11-05,2020-09-25,True,Chong Kun Dang Pharmaceutical,Recruiting,Phase 2,Interventional,Russian Federation,A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia,Drug,Nafamostat Mesilate,Nafamostat Mesilate,100,https://clinicaltrials.gov/show/NCT04623021,None
6554,NCT04623047,ClinicalTrials.gov,2020-11-09,2020-04-02,True,Duke University,Recruiting,Not Applicable,Observational,United States,Using Smart Watches to Detect and Monitor COVID-19,Other (device),Biosensors,Biosensors,100000,https://clinicaltrials.gov/show/NCT04623047,None
6555,NCT04623138,ClinicalTrials.gov,2020-10-30,2020-11-01,False,Evidation Health,Not Recruiting,Not Applicable,Observational,No Country Given,A Virtual Prospective Study Exploring Activity Trackers and COVID-19 Infections,Other (device),Biosensors,Biosensors,950,https://clinicaltrials.gov/show/NCT04623138,None
6556,NCT04623177,ClinicalTrials.gov,2020-11-02,2020-03-01,True,Instituto de Investigación Sanitaria La Fe,Not Recruiting,Not Applicable,Observational,Spain,Thromboprophylaxis for Patients in ICU With COVID-19,Drug,Heparin,Heparin,950,https://clinicaltrials.gov/show/NCT04623177,None
6557,NCT04623255,ClinicalTrials.gov,2020-06-11,2020-10-16,False,"University College, London",Recruiting,Phase 2,Interventional,United Kingdom,Randomised Study of Plasma Exchange in Severe COVID-19,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04623255,None
6558,NCT04623346,ClinicalTrials.gov,2020-11-07,2020-03-11,True,Dr. Cemil Tascioglu,Not Recruiting,Not Applicable,Observational,Turkey,Orthopaedic Conservative Treatment in the Time of Covid-19 Pandemic,Other,No Intervention,No Intervention,262,https://clinicaltrials.gov/show/NCT04623346,None
6559,NCT04623385,ClinicalTrials.gov,2020-11-08,2020-11-01,True,Kafrelsheikh University,Not Recruiting,Phase 4,Interventional,No Country Given,Clinical Role of Testosterone and Dihydrotestosterone and Which of Them Should be Inhibited in COVID-19 Patients - A Double-edged Sword?,Drug,retinoic acid + testosterone,retinoic acid; testosterone,1000,https://clinicaltrials.gov/show/NCT04623385,None
6560,NCT04623619,ClinicalTrials.gov,2020-11-09,2020-12-15,False,AOU Policlinico Paolo Giaccone Palermo,Not Recruiting,Not Applicable,Interventional,No Country Given,Efficacy and Safety of Acetyl L-Carnitine in COVID-19 Patients With Mild-to-Moderate Disease,Drug,Acetyl L-Carnitine,Acetyl L-Carnitine,100,https://clinicaltrials.gov/show/NCT04623619,None
6561,NCT04623671,ClinicalTrials.gov,2020-10-07,2020-11-15,False,Capricor Inc.,Recruiting,Phase 2,Interventional,United States,Intravenous Infusion of CAP-1002 in Patients With COVID-19,Drug,CAP-1002,CAP-1002,60,https://clinicaltrials.gov/show/NCT04623671,None
6562,NCT04623697,ClinicalTrials.gov,2020-11-09,2020-11-01,True,Hospital of South West Jutland,Recruiting,Not Applicable,Observational,Denmark,Covid-19 Infection and New Onset Type 1 Diabetes,Clinical Presentation,No Intervention,No Intervention,600,https://clinicaltrials.gov/show/NCT04623697,None
6563,NCT04624048,ClinicalTrials.gov,2020-11-08,2020-12-04,False,University of Salamanca,Not Recruiting,Not Applicable,Observational,No Country Given,Exercise Influence on COVID-19,Other (exercise),No Intervention,No Intervention,30000,https://clinicaltrials.gov/show/NCT04624048,None
6564,NCT04624503,ClinicalTrials.gov,2020-10-17,2020-10-01,True,"Humanitas Hospital, Italy",Recruiting,Not Applicable,Observational,Italy,Prognostic and Clinical Impact of Cardiovascular Involvement in Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04624503,None
6565,NCT04624997,ClinicalTrials.gov,2020-06-17,2020-06-08,True,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Observational,France,Coagulopathy and Vasculopathy Assessment as a Predictor of the Severity of SARS-CoV-2 / COVID-19 Infection,Prognosis,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04624997,None
6566,NCT04625036,ClinicalTrials.gov,2020-10-30,2020-05-30,True,ICS Maugeri,Recruiting,Not Applicable,Observational,Italy,NO-mediated Vascular Function in Covid-19 Patient,Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04625036,None
6567,NCT04625075,ClinicalTrials.gov,2020-11-09,2020-06-10,True,University of Edinburgh,Recruiting,Not Applicable,Observational,United Kingdom,Manganese-Enhanced Magnetic Resonance Imaging of MyOcardial injuRY in COVID 19 (COVID-19),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,40,https://clinicaltrials.gov/show/NCT04625075,None
6568,NCT04625114,ClinicalTrials.gov,2020-11-05,2020-11-04,True,"University Hospital, Ghent",Recruiting,Phase 2,Interventional,Belgium,The Potential of Oral Camostat in Early COVID-19 Disease in an Ambulatory Setting to Reduce Viral Load and Disease Burden,Drug,Camostat Mesilate,Camostat Mesilate,150,https://clinicaltrials.gov/show/NCT04625114,None
6569,NCT04625218,ClinicalTrials.gov,2020-11-10,2021-01-01,False,"University Hospital, Toulouse",Not Recruiting,Not Applicable,Observational,No Country Given,Hydroxychloroquine for the Treatment of SARS-CoV2 (COVID 19) : Pharmacokinetic Study,Drug,Hydroxychloroquine,Hydroxychloroquine,40,https://clinicaltrials.gov/show/NCT04625218,None
6570,NCT04625257,ClinicalTrials.gov,2020-11-10,2020-10-24,True,"University Hospital, Basel",Recruiting,Not Applicable,Observational,Switzerland,"COVID-19 in Baselland: Validation of Simple and Accurate Tests for COVID-19 Detection, Monitoring and Tracing (ACCURATE-BL-COVID-19)",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,3000,https://clinicaltrials.gov/show/NCT04625257,None
6571,NCT04625296,ClinicalTrials.gov,2020-11-10,2020-09-17,True,Assistance Publique – Hôpitaux de Paris,Recruiting,Not Applicable,Observational,France,Behaviour and Experience of Communities Healthcare Professionals Facing the SARS CoV-2 (COVID-19) Epidemic,Health System,No Intervention,No Intervention,75,https://clinicaltrials.gov/show/NCT04625296,None
6572,NCT04625738,ClinicalTrials.gov,2020-11-04,2020-11-06,False,CHU de Nancy,Not Recruiting,Phase 2,Interventional,No Country Given,Efficacy of Infusions of MSC From Wharton Jelly in the SARS-Cov-2 (COVID-19) Related Acute Respiratory Distress Syndrome,ATMP,Cells (mesenchymal),Cells (mesenchymal),30,https://clinicaltrials.gov/show/NCT04625738,None
6573,NCT04625985,ClinicalTrials.gov,2020-10-23,2020-07-14,True,Laboratorios Silanes,Recruiting,Phase 2,Interventional,Mexico,"Metformin Glycinate, Treatment of Patients With COVID-19 and Severe Acute Respiratory Syndrome Secondary to SARS-CoV-2.",Drug,Metformin,Metformin Glycinate,20,https://clinicaltrials.gov/show/NCT04625985,None
6574,NCT04626050,ClinicalTrials.gov,2020-11-10,2020-11-01,True,Weill Medical College of Cornell University,Not Recruiting,Not Applicable,Interventional,United States,"General Psychological Distress, PTSD, and Co-Morbidities in Healthcare Workers Consequent to COVID-19",Other (psych),No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04626050,None
6575,NCT04626076,ClinicalTrials.gov,2020-11-10,2020-08-13,True,Certara,Recruiting,Not Applicable,Observational,Pakistan,International Registry of Healthcare Workers Exposed to COVID-19 Patients,Clinical Presentation (Epidemiology),No Intervention,No Intervention,10000,https://clinicaltrials.gov/show/NCT04626076,None
6576,NCT04626089,ClinicalTrials.gov,2020-10-23,2020-11-30,False,Laboratorios Silanes,Not Recruiting,Phase 2,Interventional,Mexico,"Metformin Glycinate in Patients With MS or DM2 , Hospitalized With COVID-19 and SARS Secondary to SARS-CoV-2",Drug,Metformin,Metformin Glycinate,20,https://clinicaltrials.gov/show/NCT04626089,None
6577,NCT04627194,ClinicalTrials.gov,2020-11-06,2020-02-20,True,Semey State Medical University,Not Recruiting,Not Applicable,Observational,Kazakhstan,Characteristics of COVID-19 Patients in Kazakhstan in Early 2020,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04627194,None
6578,NCT04627233,ClinicalTrials.gov,2020-11-06,2020-12-20,False,Shahid Beheshti University of Medical Sciences,Not Recruiting,Phase 1,Interventional,Iran,Ezrin Peptide (HEP-1) for Treatment of Coronavirus Disease (COVID-19) Infection,Drug,Ezrin Peptide,Ezrin Peptide,20,https://clinicaltrials.gov/show/NCT04627233,None
6579,NCT04627467,ClinicalTrials.gov,2020-10-30,2020-03-28,True,Fundacion Clinica Valle del Lili,Not Recruiting,Phase 2,Interventional,Colombia,Prevention With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19) (TS-COVID),Drug (Chemoprophylaxis),Chloroquine,Chloroquine,3217,https://clinicaltrials.gov/show/NCT04627467,None
6580,NCT04627519,ClinicalTrials.gov,2020-11-10,2020-12-01,False,Padjadjaran University,Not Recruiting,Phase 2,Interventional,No Country Given,Effectiveness and Safety of Rhea Health ToneÂ® as add-on Therapy for COVID-19 in Hospitalized Adults in Indonesia,Supplement,Rhea Health Tone,Rhea Health Tone,69,https://clinicaltrials.gov/show/NCT04627519,None
6581,NCT04627584,ClinicalTrials.gov,2020-11-12,2020-11-01,True,"Mabwell (Shanghai) Bioscience Co., Ltd.",Not Recruiting,Phase 2,Interventional,No Country Given,A Phase 2 Clinical Trial of MW33 Injection in Patients With COVID-19,Drug,MW33 injection,MW33 injection,150,https://clinicaltrials.gov/show/NCT04627584,None
6582,NCT04627623,ClinicalTrials.gov,2020-11-12,2020-06-22,True,Medical University of Silesia,Recruiting,Not Applicable,Observational,Poland,Prevalence and Risk Factors of COVID-19 in the Upper Silesian Agglomeration,Clinical Presentation (Epidemiology),No Intervention,No Intervention,6000,https://clinicaltrials.gov/show/NCT04627623,None
6583,NCT04627675,ClinicalTrials.gov,2020-11-06,2020-12-01,False,Providence Health & Services,Not Recruiting,Phase 1,Interventional,United States,CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2),ATMP,Vaccine,Vaccine,36,https://clinicaltrials.gov/show/NCT04627675,None
6584,NCT04628000,ClinicalTrials.gov,2020-11-11,2020-10-27,True,Parkview Medical Center,Recruiting,Not Applicable,Observational,United States,Baseline Vitamin D Deficiency and COVID-19 Disease Severity,Drug,Vitamin D,Vitamin D,50,https://clinicaltrials.gov/show/NCT04628000,None
6585,NCT04628039,ClinicalTrials.gov,2020-11-09,2021-11-01,False,VA Office of Research and Development,Not Recruiting,Not Applicable,Interventional,United States,"Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs",Clinical Presentation,No Intervention,No Intervention,506,https://clinicaltrials.gov/show/NCT04628039,None
6586,NCT04628104,ClinicalTrials.gov,2020-11-12,2021-01-01,False,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,CMR Findings in COVID-19 Patients Presenting With Myocardial Infarction,Clinical Presentation,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04628104,None
6587,NCT04628143,ClinicalTrials.gov,2020-11-10,2020-11-20,False,Chong Kun Dang Pharmaceutical,Not Recruiting,Phase 2,Interventional,No Country Given,A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia,Drug,Nafamostat Mesilate,Nafamostat Mesilate,100,https://clinicaltrials.gov/show/NCT04628143,None
6588,NCT04628195,ClinicalTrials.gov,2020-11-10,2020-04-01,True,Pontificia Universidad Católica de Chile,Not Recruiting,Not Applicable,Observational,Chile,Cardiac Performance in Mechanically Ventilated COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04628195,None
6589,NCT04628637,ClinicalTrials.gov,2020-11-10,2020-04-16,True,Kafkas University,Not Recruiting,Not Applicable,Observational,Turkey,High GRP78 Levels in Covid-19 Infection: A Case-Control Study,Clinical Presentation,No Intervention,No Intervention,144,https://clinicaltrials.gov/show/NCT04628637,None
6590,NCT04629001,ClinicalTrials.gov,2020-11-12,2020-09-01,True,Assiut University,Not Recruiting,Not Applicable,Observational,Egypt,Effect of Covid-19 on Outcomes of Pregnancy,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04629001,None
6591,NCT04629105,ClinicalTrials.gov,2020-09-29,2020-07-24,True,Longeveron LLC,Recruiting,Phase 1,Interventional,United States,Regenerative Medicine for COVID-19 and Flu-Elicited ARDS Using Longeveron Mesenchymal Stem Cells (LMSCs) (RECOVER),ATMP,Cells (mesenchymal),Cells (mesenchymal),70,https://clinicaltrials.gov/show/NCT04629105,None
6592,NCT04629157,ClinicalTrials.gov,2020-11-04,2020-11-05,False,Alder Hey Children's NHS Foundation Trust,Recruiting,Not Applicable,Interventional,United Kingdom,The LAVA (Lateral Flow Antigen Validation and Applicability) Study for COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,400,https://clinicaltrials.gov/show/NCT04629157,None
6593,NCT04629183,ClinicalTrials.gov,2020-11-13,2020-11-01,True,AOU Città della Salute e della Scienza di Torino,Recruiting,Not Applicable,Observational,Italy,Risk Stratification of COVID-19 Patients Discharged From the Emergency Department,Clinical Presentation,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04629183,None
6594,NCT04629222,ClinicalTrials.gov,2020-11-13,2020-03-11,True,Pierre Yves Marie,Not Recruiting,Not Applicable,Observational,France,Tracheobronchitis in Respiratory Involvement on the Lung SPECT/CT Images of COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,10,https://clinicaltrials.gov/show/NCT04629222,None
6595,NCT04629638,ClinicalTrials.gov,2020-11-12,2020-08-01,True,Kanuni Sultan Suleyman Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,Maternal Attachment and Depression Anxiety Score Evaluation in COVID-19 Positive Pregnant Women,Other (psych),No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04629638,None
6596,NCT04629703,ClinicalTrials.gov,2020-11-13,2020-12-01,False,Rigel Pharmaceuticals,Not Recruiting,Phase 3,Interventional,No Country Given,"Double-Blind, Randomized, Placebo-Controlled, Adaptive Design, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects",Drug,Fostamatinib,Fostamatinib,308,https://clinicaltrials.gov/show/NCT04629703,None
6597,NCT04629755,ClinicalTrials.gov,2020-11-09,2020-04-04,True,University of Washington,Not Recruiting,Not Applicable,Interventional,United States,A Smartphone Intervention for Relational and Mental Well Being,Other (psych),Psychological,Psychological,1765,https://clinicaltrials.gov/show/NCT04629755,None
6598,NCT04629989,ClinicalTrials.gov,2020-11-13,2020-11-13,False,"University Clinic, UCLouvain",Recruiting,Not Applicable,Interventional,Belgium,Comparison of the Surgical Facemask With the Double-trunk Mask on Oxygenation in COVID-19,Other (device),Masks,Masks,27,https://clinicaltrials.gov/show/NCT04629989,None
6599,NCT04630015,ClinicalTrials.gov,2020-11-13,2020-08-31,True,"University of California, San Francisco",Recruiting,Not Applicable,Observational,United States,Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth,Other (psych),Psychological,Psychological,250,https://clinicaltrials.gov/show/NCT04630015,None
6600,NCT04630054,ClinicalTrials.gov,2020-11-13,2020-11-15,False,Yale University,Recruiting,Not Applicable,Interventional,Bangladesh,Face Masks to Reduce COVID-19 in Bangladesh,Other (device),Masks,Masks,450000,https://clinicaltrials.gov/show/NCT04630054,None
6601,NCT04631172,ClinicalTrials.gov,2020-11-14,2020-05-01,True,Selcuk University,Not Recruiting,Not Applicable,Observational,Turkey,Covid-19 Anxiety and Phobia Levels of the Parents,Other (psych),Psychological,Psychological,150,https://clinicaltrials.gov/show/NCT04631172,None
6602,NCT04631367,ClinicalTrials.gov,2020-11-13,2021-02-01,False,University of Toronto,Not Recruiting,Not Applicable,Interventional,No Country Given,mHealth Intervention for Increasing COVID-19 Prevention Practices With Urban Refugee and Displaced Youth in Uganda,Other (software),eHealth,eHealth,404,https://clinicaltrials.gov/show/NCT04631367,None
6603,NCT04631380,ClinicalTrials.gov,2020-08-04,2020-08-01,True,Hospital do Coração,Recruiting,Not Applicable,Interventional,Brazil,Prayer in Commbate to Corona Virus - Covid -19,Other,Other,Other,200,https://clinicaltrials.gov/show/NCT04631380,None
6604,NCT04631497,ClinicalTrials.gov,2020-11-09,2020-07-01,True,Jagiellonian University,Recruiting,Not Applicable,Observational,Poland,"Assessment of Stress, Depression and Anxiety in Healthcare Caring for Patients With COVID-19",Other (psych),Psychological,Psychological,100,https://clinicaltrials.gov/show/NCT04631497,None
6605,NCT04631536,ClinicalTrials.gov,2020-10-28,2020-11-10,False,Lebanese American University Medical Center,Not Recruiting,Phase 1,Interventional,No Country Given,Managing Endothelial Dysfunction in COVID-19 : A Randomized Controlled Trial at LAUMC,Drug,Atorvostatin,Atorvostatin,80,https://clinicaltrials.gov/show/NCT04631536,None
6606,NCT04631666,ClinicalTrials.gov,2020-11-05,2020-11-23,False,University of Cologne,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,COVID-19 - Administration of the SARS-CoV-2-Neutralizing Monoclonal Antibody DZIF-10c (Infusion),Drug,DZIF-10c,DZIF-10c,69,https://clinicaltrials.gov/show/NCT04631666,None
6607,NCT04631705,ClinicalTrials.gov,2020-11-10,2020-11-23,False,University of Cologne,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,COVID-19 - Administration of the SARS-CoV-2-Neutralizing Monoclonal Antibody DZIF-10c (Inhalation),Drug,DZIF-10c,DZIF-10c,69,https://clinicaltrials.gov/show/NCT04631705,None
6608,NCT04631861,ClinicalTrials.gov,2020-11-14,2014-01-01,True,Wonju Severance Christian Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Physical Activity and the Risk of COVID-19 Infection and Mortality,Prognosis,No Intervention,No Intervention,132069,https://clinicaltrials.gov/show/NCT04631861,None
6609,NCT04632043,ClinicalTrials.gov,2020-11-15,2020-11-18,False,Evangelismos Hospital,Not Recruiting,Not Applicable,Interventional,Greece,Early Versus Delayed Intubation of Patients With COVID-19,Other (physical),Mechanical ventilation,Mechanical ventilation,80,https://clinicaltrials.gov/show/NCT04632043,None
6610,NCT04632082,ClinicalTrials.gov,2020-11-05,2020-11-05,False,Hospital de Clinicas de Porto Alegre,Recruiting,Not Applicable,Interventional,Brazil,Telepsychoeducation for the Prevention of Emotional Distress in Professionals and Students From Essential Services in the Context of COVID-19,Other (psych),Psychological,Psychological,2200,https://clinicaltrials.gov/show/NCT04632082,None
6611,NCT04632173,ClinicalTrials.gov,2020-11-15,2020-12-01,False,Hellenic Cooperative Oncology Group,Not Recruiting,Not Applicable,Observational,No Country Given,Head and Neck cancERs International cOviD-19 collabOraTion,Other,No Intervention,No Intervention,750,https://clinicaltrials.gov/show/NCT04632173,None
6612,NCT04632355,ClinicalTrials.gov,2020-11-13,2020-12-01,False,Fondazione Don Carlo Gnocchi Onlus,Not Recruiting,Not Applicable,Observational,Italy,Musculoskeletal Pain in Patients With Covid-19 Who Have Hospital Care,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04632355,None
6613,NCT04632368,ClinicalTrials.gov,2020-11-11,2020-11-01,True,Duke University,Not Recruiting,Not Applicable,Interventional,No Country Given,Targeting the Health Care Provider (HCP) Burnout Crisis During the COVID-19 Pandemic,Traditional Medicine (Other),Traditional Medicine,Traditional Medicine,80,https://clinicaltrials.gov/show/NCT04632368,None
6614,NCT04632381,ClinicalTrials.gov,2020-11-12,2020-11-16,False,Effector Therapeutics,Not Recruiting,Phase 1,Interventional,No Country Given,Intravenous Zotatifin in Adults With Mild or Moderate COVID-19,Drug,Zotatifin,Zotatifin,36,https://clinicaltrials.gov/show/NCT04632381,None
6615,NCT04632602,ClinicalTrials.gov,2020-11-16,2020-04-04,True,Assistance Publique – Hôpitaux de Marseille,Recruiting,Not Applicable,Interventional,France,Awake Prone Position to Reduce Ventilation Inhomogeneity in COVID-19 Acute Respiratory Failure,Procedure,Positioning,Positioning,20,https://clinicaltrials.gov/show/NCT04632602,None
6616,NCT04632615,ClinicalTrials.gov,2020-11-12,2020-05-22,True,IRCCS Istituto Ortopedico Galeazzi,Recruiting,Not Applicable,Observational,Italy,Sleep Behaviour in Athletes During Home Confinement Due to the Covid-19 Outbreak,Other,No Intervention,No Intervention,230,https://clinicaltrials.gov/show/NCT04632615,None
6617,NCT04632706,ClinicalTrials.gov,2020-10-26,2020-09-22,True,MedinCell S.A,Recruiting,Phase 1,Interventional,United Kingdom,Exploratory Ph I Trial of the Active IMP in Healthy Volunteers in Relation to COVID-19,Drug,Ivermectin,Ivermectin,24,https://clinicaltrials.gov/show/NCT04632706,None
6618,NCT04632719,ClinicalTrials.gov,2020-11-14,2020-11-08,True,University of São Paulo,Recruiting,Not Applicable,Interventional,Brazil,The MentalPlusÂ® for Assessment and Rehabilitation of Cognitive Function After Remission of the Symptoms of COVID-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,200,https://clinicaltrials.gov/show/NCT04632719,None
6619,NCT04632732,ClinicalTrials.gov,2020-11-03,2020-10-26,True,University of Sherbrooke,Recruiting,Not Applicable,Observational,Canada,Apelin; ACE2 and Biomarkers of Alveolar-capillary Permeability in SARS-cov-2 (COVID-19).,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,140,https://clinicaltrials.gov/show/NCT04632732,None
6620,NCT04633772,ClinicalTrials.gov,2020-11-06,2020-08-05,True,Erasme University Hospital,Recruiting,Phase 1/Phase 2,Interventional,Brazil,Use of Angiotensin-(1-7) in COVID-19,Drug,Angiotensin (1-7),Angiotensin (1-7),130,https://clinicaltrials.gov/show/NCT04633772,RBR-35734p
6621,NCT04633915,ClinicalTrials.gov,2020-11-15,2020-11-01,True,"Saint Petersburg State University, Russia",Not Recruiting,Not Applicable,Observational,Russian Federation,Antibody Response in Hemodialysis and Non-dialysis Patients Diagnosed With COVID-19.,Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04633915,None
6622,NCT04633941,ClinicalTrials.gov,2020-11-12,2020-06-01,True,Singapore General Hospital,Not Recruiting,Not Applicable,Observational,Singapore,Impact of Social Distancing on Bariatric Versus Non-Surgical Obese Patients During COVID-19 Pandemic,Other,No Intervention,No Intervention,272,https://clinicaltrials.gov/show/NCT04633941,None
6623,NCT04633980,ClinicalTrials.gov,2020-11-16,2020-12-01,False,"University Hospital, Grenoble",Not Recruiting,Phase 1,Interventional,No Country Given,Hydrogen Therapy in Patients With Moderate Covid-19,Drug,Hydrogen,Hydrogen,10,https://clinicaltrials.gov/show/NCT04633980,None
6624,NCT04634214,ClinicalTrials.gov,2020-11-15,2020-11-16,False,India Diabetes Research Foundation; Dr. A. Ramachandran's Diabetes Hospitals,Not Recruiting,Not Applicable,Observational,India,The Severity of COVID 19 in Diabetes and Non-diabetes Patients,Clinical Presentation,No Intervention,No Intervention,1050,https://clinicaltrials.gov/show/NCT04634214,None
6625,NCT04634370,ClinicalTrials.gov,2020-11-16,2021-01-02,False,Hospital de Clinicas de Porto Alegre,Not Recruiting,Phase 1,Interventional,Brazil,Fase I Clinical Trial on NK Cells for COVID-19,ATMP,Cells (NK),Cells (NK),24,https://clinicaltrials.gov/show/NCT04634370,None
6626,NCT04634422,ClinicalTrials.gov,2020-11-14,2020-11-16,False,Wladimir Szpirt,Not Recruiting,Not Applicable,Interventional,No Country Given,Plasma Exchange (PLEX) and Convalescent Plasma (CCP) in COVID-19 Patients With Multiorgan Failure,ATMP,Plasma,Plasma,220,https://clinicaltrials.gov/show/NCT04634422,None
6627,NCT04634799,ClinicalTrials.gov,2020-11-17,2020-11-16,True,Northwestern University,Recruiting,Phase 1/Phase 2,Interventional,United States,Study To antagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19,Drug,TM5614,TM5614,80,https://clinicaltrials.gov/show/NCT04634799,None
6628,NCT04635241,ClinicalTrials.gov,2020-11-14,2020-06-01,True,Australian National University,Recruiting,Phase 2/Phase 3,Interventional,"Egypt, Argentina",Inhaled Heparin for Hospitalised COVID-19 Patients,Drug,Heparin,Heparin,656,https://clinicaltrials.gov/show/NCT04635241,None
6629,NCT04635592,ClinicalTrials.gov,2020-11-17,2020-11-01,True,UMC Ljubljana,Not Recruiting,Not Applicable,Observational,Slovenia,Serological Diagnostics of COVID-19 in Health Care Workers,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,300,https://clinicaltrials.gov/show/NCT04635592,None
6630,NCT04635605,ClinicalTrials.gov,2020-09-28,2020-11-01,False,Fondazione Epatocentro Ticino,Not Recruiting,Phase 2,Interventional,Switzerland,Methylene Blue Treatment of COVID-19,Drug,Methylene Blue,Methylene Blue,64,https://clinicaltrials.gov/show/NCT04635605,None
6631,NCT04635618,ClinicalTrials.gov,2020-11-05,2020-11-05,False,Hospital de Clinicas de Porto Alegre,Recruiting,Not Applicable,Interventional,Brazil,Psychotherapy Strategies for the Treatment of Professionals and Students From Essential Services With High Levels of Emotional Distress in the Context of COVID-19,Other (psych),Psychological,Psychological,999,https://clinicaltrials.gov/show/NCT04635618,None
6632,NCT04635787,ClinicalTrials.gov,2020-11-13,2020-11-05,True,Northwestern University,Recruiting,Not Applicable,Observational,United States,Vital Sensor Monitors for CV19 Detection,Other (device),Biosensors,Biosensors,300,https://clinicaltrials.gov/show/NCT04635787,None
6633,NCT04635813,ClinicalTrials.gov,2020-11-17,2020-03-10,True,University of Cagliari,Not Recruiting,Not Applicable,Observational,Italy,The Impact of COVID-19 Pandemic on Thyroid Surgery in Italy: Results From a Nation-wide Multicentric Study,Other,No Intervention,No Intervention,3800,https://clinicaltrials.gov/show/NCT04635813,None
6634,NCT04635943,ClinicalTrials.gov,2020-11-09,2020-08-28,True,Universidad Peruana Cayetano Heredia,Recruiting,Phase 2,Interventional,Peru,Randomized Phase IIA Clinical Trial to Evaluate the Efficacy of Ivermectin to Obtain Negative PCR Results in Patients With Early Phase COVID-19,Drug,Ivermectin,Ivermectin,68,https://clinicaltrials.gov/show/NCT04635943,None
6635,NCT04636021,ClinicalTrials.gov,2020-11-13,2020-08-01,True,Pinnacle Health Cardiovascular Institute,Recruiting,Not Applicable,Observational,United States,Restoring Non-Emergent Cardiovascular Care in the Peri- COVID-19 Era,Other,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04636021,None
6636,NCT04636086,ClinicalTrials.gov,2020-11-17,2020-11-12,True,University of Liège,Recruiting,Phase 4,Interventional,Belgium,Effect of Vitamin D on Hospitalized Adults With COVID-19 Infection,Drug,Vitamin D,Vitamin D,100,https://clinicaltrials.gov/show/NCT04636086,None
6637,NCT04636203,ClinicalTrials.gov,2020-11-17,2020-12-15,False,Neuromed IRCCS,Not Recruiting,Not Applicable,Observational,No Country Given,Burden of COVID-19 Infection in Populations With High or Low Risk of Infection,Clinical Presentation (Epidemiology),No Intervention,No Intervention,3500,https://clinicaltrials.gov/show/NCT04636203,None
6638,NCT04636294,ClinicalTrials.gov,2020-11-18,2020-08-01,True,Jessa Hospital,Not Recruiting,Not Applicable,Observational,Belgium,Borderline COVID-19 PCR Test Result,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,30000,https://clinicaltrials.gov/show/NCT04636294,None
6639,NCT04636320,ClinicalTrials.gov,2020-11-18,2020-06-13,True,"University Hospital, Bordeaux",Recruiting,Not Applicable,Interventional,France,Prevalence of Myocardial Scars on CMR After COVID-19 Infection,Clinical Presentation,No Intervention,No Intervention,240,https://clinicaltrials.gov/show/NCT04636320,None
6640,NCT04636333,ClinicalTrials.gov,2020-11-17,2020-10-30,True,Jiangsu Provincial Center for Disease Control and Prevention,Recruiting,Phase 1,Interventional,China,Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell),ATMP,Vaccine,Vaccine,216,https://clinicaltrials.gov/show/NCT04636333,None
6641,NCT04636554,ClinicalTrials.gov,2020-11-09,2018-04-30,True,"Adaptive Phage Therapeutics, Inc.",Not Recruiting,Not Applicable,Expanded Access,No Country Given,Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/Septicemia,Drug,Phage Therapy,Phage Therapy,Not Available,https://clinicaltrials.gov/show/NCT04636554,None
6642,NCT04636671,ClinicalTrials.gov,2020-11-18,2020-11-25,False,University of Trieste,Not Recruiting,Phase 3,Interventional,No Country Given,Methylprednisolone vs. Dexamethasone in COVID-19 Pneumonia (MEDEAS RCT),Drug,Corticosteroids,Methylprednisolone; Dexamethasone,680,https://clinicaltrials.gov/show/NCT04636671,None
6643,NCT04636697,ClinicalTrials.gov,2020-11-12,2020-11-19,False,Medicago,Recruiting,Phase 2/Phase 3,Interventional,Canada,Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults,ATMP,Vaccine,Vaccine,30612,https://clinicaltrials.gov/show/NCT04636697,None
6644,NCT04637295,ClinicalTrials.gov,2020-11-17,2020-12-01,False,University of Nebraska,Not Recruiting,Not Applicable,Observational,No Country Given,"Perceptions, Experiences, and Activity in CancEr Survivors During COVID-19",Other,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04637295,None
6645,NCT04637828,ClinicalTrials.gov,2020-11-17,2020-11-18,False,Genoscience Pharma,Recruiting,Phase 2,Interventional,France,A Study to Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection,Drug,GNS561,GNS561,178,https://clinicaltrials.gov/show/NCT04637828,None
6646,NCT04637893,ClinicalTrials.gov,2020-11-18,2020-12-16,False,Istituto Clinico Humanitas,Not Recruiting,Not Applicable,Observational,No Country Given,The Impact of Covid-19 Pandemic on Colorectal Cancer Prevention Due to Delays in Diagnosis: a Global Study,Other,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04637893,None
6647,NCT04637906,ClinicalTrials.gov,2020-11-18,2020-11-18,False,"University of Campania ""Luigi Vanvitelli""",Not Recruiting,Not Applicable,Interventional,No Country Given,Short and Long-term Effects of Adding Oral L-arginine to Standard Therapy in Patients With COVID-19 (SARS-CoV-2),Supplement,L-arginine,L-arginine,290,https://clinicaltrials.gov/show/NCT04637906,None
6648,NCT04638634,ClinicalTrials.gov,2020-11-19,2020-12-01,False,CSL Behring,Not Recruiting,Phase 1,Interventional,No Country Given,"Pharmacokinetics, Safety, and Tolerability of CSL760, an Anti- COVID-19 Hyperimmune Intravenous Immunoglobulin, in Healthy Adult Subjects",ATMP,Immunoglobulin,Immunoglobulin,24,https://clinicaltrials.gov/show/NCT04638634,None
6649,NCT04638842,ClinicalTrials.gov,2020-11-19,2020-12-15,False,Universidad Internacional de Valencia,Not Recruiting,Not Applicable,Interventional,Mexico,Online Multi-component Psychological Intervention for Prevention of Grief Disorder Due to COVID-19,Other (psych),Psychological,Psychological,42,https://clinicaltrials.gov/show/NCT04638842,None
6650,NCT04639349,ClinicalTrials.gov,2020-11-19,2020-11-19,False,Cairo University,Recruiting,Not Applicable,Interventional,Egypt,Effect of Home Exercise Activity on Cortisol and Depression in COPD During the Pandemic COVID,Other (exercise),Exercise,Exercise,40,https://clinicaltrials.gov/show/NCT04639349,None
6651,NCT04639375,ClinicalTrials.gov,2020-11-16,2020-11-15,True,E-MO Biology Inc,Recruiting,Phase 4,Interventional,United States,Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19),ATMP,Vaccine,Vaccine,25,https://clinicaltrials.gov/show/NCT04639375,None
6652,NCT04639427,ClinicalTrials.gov,2020-11-19,2020-11-01,True,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,Benefits of Using a Transparent Visor to Replace the Face Mask in Speech Therapy Rehabilitation of Oral-Linguo-Facial Praxies in the Context of COVID-19: a Series of Cases,Other (device),Visor,Visor,4,https://clinicaltrials.gov/show/NCT04639427,None
6653,NCT04639440,ClinicalTrials.gov,2020-10-28,2020-11-23,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Observational,France,Impact of Adipose Tissue in COVID-19,Clinical Presentation,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04639440,None
6654,NCT04640181,ClinicalTrials.gov,2020-11-19,2020-12-01,False,St. David's HealthCare,Not Recruiting,Phase 2,Interventional,No Country Given,Factor Xa Inhibitor Versus Standard of Care Heparin in Hospitalized Patients With COVID-19 (XACT),Drug,Enoxaparin vs. Rivaroxaban,Enoxaparin; Rivaroxaban,150,https://clinicaltrials.gov/show/NCT04640181,None
6655,NCT04640233,ClinicalTrials.gov,2020-11-17,2020-12-01,True,Dr. Reddy's Laboratories Limited,Not Recruiting,Phase 2/Phase 3,Interventional,India,Clinical Trial to Assess Safety and Immunogenicity of Gam-COVID-Vac Combined Vector Vaccine for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-?ov-2) Infection,ATMP,Vaccine,Vaccine,1600,https://clinicaltrials.gov/show/NCT04640233,CTRI/2020/11/029234
6656,NCT04640402,ClinicalTrials.gov,2020-11-19,2020-11-17,True,Jiangsu Provincial Center for Disease Control and Prevention,Recruiting,Phase 2,Interventional,China,A Phase ? Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells),ATMP,Vaccine,Vaccine,960,https://clinicaltrials.gov/show/NCT04640402,None
6657,NCT04640428,ClinicalTrials.gov,2020-11-20,2020-12-01,False,King's College Hospital NHS Foundation Trust,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 Stroke Apical Lung Examination Study - A Multi-centre Prospective Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,https://clinicaltrials.gov/show/NCT04640428,None
6658,NCT04641182,ClinicalTrials.gov,2020-09-12,2020-07-06,True,Pontificia Universidad Católica de Chile,Not Recruiting,Not Applicable,Observational,Chile,Prone Position for Nonintubated Patients With COVID-19 and Hypoxemic Respiratory Failure,Procedure,Positioning,Positioning,66,https://clinicaltrials.gov/show/NCT04641182,None
6659,NCT04641195,ClinicalTrials.gov,2020-11-19,2020-12-07,False,Harvard University,Not Recruiting,Phase 3,Interventional,India,Vitamin D and Zinc Supplementation for Improving Treatment Outcomes Among COVID-19 Patients in India,Drug,Vitamin D vs. Zinc vs. Vitamin D + Zinc,Vitamin D; Zinc,700,https://clinicaltrials.gov/show/NCT04641195,None
6660,NCT04641481,ClinicalTrials.gov,2020-11-09,2020-11-25,False,Bharat Biotech International Limited,Recruiting,Phase 3,Interventional,India,An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers,ATMP,Vaccine,Vaccine,25800,https://clinicaltrials.gov/show/NCT04641481,None
6661,NCT04641806,ClinicalTrials.gov,2020-11-20,2020-12-15,False,Versailles Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Clinical and Immunological Evolution of Covid-19 Occurring in a Context of Non-Hodgkin Lymphoma,Clinical Presentation,No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04641806,None
6662,NCT04641988,ClinicalTrials.gov,2020-11-23,2020-02-01,True,"University Hospital, Montpellier",Not Recruiting,Not Applicable,Observational,France,Cardiac Biomarkers and Mortality in Critically Ill Patients With SARS-CoV-2 (COVID-19),Clinical Presentation,No Intervention,No Intervention,111,https://clinicaltrials.gov/show/NCT04641988,None
6663,NCT04642014,ClinicalTrials.gov,2020-11-23,2020-12-01,False,Wroclaw Medical University,Not Recruiting,Not Applicable,Interventional,Poland,Application of Convalescent Plasma in the Treatment of SARS CoV-2 Disease (COVID-19) With Evaluation of Therapy Effectiveness,ATMP,Plasma,Plasma,500,https://clinicaltrials.gov/show/NCT04642014,None
6664,NCT04642040,ClinicalTrials.gov,2020-11-21,2020-06-30,True,Sisli Hamidiye Etfal Training and Research Hospital,Recruiting,Not Applicable,Interventional,Turkey,Effectiveness of Pulmonary Rehabilitation Program in Patients With SARS-CoV-2 Pneumonia,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,100,https://clinicaltrials.gov/show/NCT04642040,None
6665,NCT04642196,ClinicalTrials.gov,2020-11-22,2020-05-02,True,"University Hospital, Linköping",Not Recruiting,Not Applicable,Observational,Sweden,COVID-19 in Home Healthcare,Clinical Presentation,No Intervention,No Intervention,155,https://clinicaltrials.gov/show/NCT04642196,None
6666,NCT04642326,ClinicalTrials.gov,2020-11-16,2020-06-26,True,Rd Global Araştırma Geliştirme Sağlık İlaç,Not Recruiting,Not Applicable,Interventional,Turkey,Study Investigating the Effects of UVC Beam and Laser Beam Therapy According to Standard Therapy in Patients With Covid-19 Diagnosis,Other (device),UVC Therapy,UVC Therapy,50,https://clinicaltrials.gov/show/NCT04642326,None
6667,NCT04642339,ClinicalTrials.gov,2020-11-16,2020-11-01,True,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",Not Recruiting,Phase 3,Interventional,No Country Given,"Clinical Trial of the Immunogenicity, Safety, and Efficacy of the Gam-COVID-Vac Vaccine Against COVID-19 in Venezuela",ATMP,Vaccine,Vaccine,2000,https://clinicaltrials.gov/show/NCT04642339,None
6668,NCT04642703,ClinicalTrials.gov,2020-11-18,2020-03-03,True,University of Chile,Recruiting,Not Applicable,Observational,Chile,Mortality in Patients With Severe COVID-19 Pneumonia Who Underwent Tracheostomy,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04642703,None
6669,NCT04642950,ClinicalTrials.gov,2020-11-19,2020-11-24,False,Nobelpharma,Not Recruiting,Phase 2/Phase 3,Interventional,Japan,A Phase II/III Study of Sargramostim,Drug,Sargramostim,Sargramostim,60,https://clinicaltrials.gov/show/NCT04642950,None
6670,NCT04643054,ClinicalTrials.gov,2020-11-22,2020-12-01,False,AOU Policlinico Paolo Giaccone Palermo,Not Recruiting,Not Applicable,Interventional,Italy,Efficacy and Safety of Ovotransferrin in COVID-19 Patients,Supplement,Ovotransferrin,Ovotransferrin,100,https://clinicaltrials.gov/show/NCT04643054,None
6671,NCT04643444,ClinicalTrials.gov,2020-11-19,2021-01-01,False,University of Bern,Not Recruiting,Not Applicable,Observational,Switzerland,Police COVID-19 Serosurvey,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04643444,None
6672,NCT04643522,ClinicalTrials.gov,2020-11-24,2020-01-07,True,Ankara City Hospital Bilkent,Not Recruiting,Not Applicable,Observational,Turkey,Semen Parameters and COVID-19 in Infertile Men,Clinical Presentation,No Intervention,No Intervention,21,https://clinicaltrials.gov/show/NCT04643522,None
6673,NCT04643548,ClinicalTrials.gov,2020-11-16,2020-10-13,True,"University Hospital, Clermont-Ferrand",Recruiting,Not Applicable,Observational,France,WHO Covid 19 - Neurological Abnormalities in SARS-CoV-2 ICU Patients,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04643548,None
6674,NCT04643561,ClinicalTrials.gov,2020-11-24,2020-11-01,True,Hadassah Medical Organization,Not Recruiting,Phase 1/Phase 2,Interventional,Israel,Using Travelan to Boost Immune Response in Vitro to COVID-19,Supplement,Travelan,Travelan,5,https://clinicaltrials.gov/show/NCT04643561,None
6675,NCT04643691,ClinicalTrials.gov,2020-11-24,2020-09-11,True,Assistance Publique – Hôpitaux de Marseille,Recruiting,Phase 2,Interventional,France,Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS,Drug,Losartan + Spironolactone,Losartan; Spironolactone,90,https://clinicaltrials.gov/show/NCT04643691,EUCTR2020-001766-11
6676,NCT04643860,ClinicalTrials.gov,2020-11-24,2020-12-01,False,Neuromed IRCCS,Not Recruiting,Not Applicable,Observational,Italy,Differential Leucocyte Count and Covid-19 Diagnosis,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04643860,None
6677,NCT04643964,ClinicalTrials.gov,2020-11-12,2020-11-01,True,Ohio State University,Recruiting,Not Applicable,Interventional,United States,Brief Video Interventions for Depression,Other (psych),Psychological,Psychological,501,https://clinicaltrials.gov/show/NCT04643964,None
6678,NCT04644120,ClinicalTrials.gov,2020-11-23,2020-11-27,False,AbbVie,Not Recruiting,Phase 1,Interventional,United States,Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 Moves Through the Body of Adult Participants Hospitalized With Coronavirus Disease 2019 (COVID-19),Drug,ABBV-47D11,ABBV-47D11,24,https://clinicaltrials.gov/show/NCT04644120,None
6679,NCT04644146,ClinicalTrials.gov,2020-11-19,2020-12-01,False,Hospices Civils de Lyon,Recruiting,Not Applicable,Observational,France,Genetic Predisposition to Severe Forms of COVID-19 (SARS-CoV2 Infection),Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04644146,None
6680,NCT04644159,ClinicalTrials.gov,2020-11-18,2020-11-13,True,Institut Pasteur,Recruiting,Not Applicable,Observational,France,"Longitudinal Follow-up of a Population Cohort in a French City With High SARS-CoV-2 Circulation, in Early 2020 [COVID-19]",Clinical Presentation (Epidemiology),No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04644159,None
6681,NCT04644172,ClinicalTrials.gov,2020-11-23,2020-11-01,True,University of Alabama at Birmingham,Recruiting,Phase 1/Phase 2,Interventional,United States,Improving Thinking in Everyday Life After Covid-19,Other,Other,Other,40,https://clinicaltrials.gov/show/NCT04644172,None
6682,NCT04644185,ClinicalTrials.gov,2020-11-22,2021-02-10,False,Sinocelltech Ltd.,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,The Efficacy and Safety of SCTA01 in Hospitalized Patients With Severe COVID-19,Drug,SCTA01,SCTA01,795,https://clinicaltrials.gov/show/NCT04644185,None
6683,NCT04644198,ClinicalTrials.gov,2020-11-18,2020-12-01,False,The University of The West Indies,Not Recruiting,Phase 2,Interventional,Jamaica,Convalescent Plasma Transfusion in Severe COVID-19 Patients in Jamaica,ATMP,Plasma,Plasma,30,https://clinicaltrials.gov/show/NCT04644198,None
6684,NCT04644276,ClinicalTrials.gov,2020-11-18,2020-11-17,True,Philips Clinical & Medical Affairs Global,Not Recruiting,Not Applicable,Interventional,United States,Mask Adhesive Institutional Study,Other (device),Masks,Masks,30,https://clinicaltrials.gov/show/NCT04644276,None
6685,NCT04644302,ClinicalTrials.gov,2020-11-24,2020-02-01,True,"University Hospital, Hradec Kralove",Recruiting,Not Applicable,Observational,Czech Republic,Circulatory Coherence in COVID-19 and Non-COVID-19 Patients With Sepsis,Clinical Presentation,No Intervention,No Intervention,25,https://clinicaltrials.gov/show/NCT04644302,None
6686,NCT04644328,ClinicalTrials.gov,2020-11-13,2020-11-14,False,"National Bureau of Economic Research, Inc.",Not Recruiting,Not Applicable,Interventional,United States,The Doctors for Coronavirus Prevention Project Thanksgiving Messaging Campaign,Other,Other,Other,20000000,https://clinicaltrials.gov/show/NCT04644328,None
6687,NCT04644341,ClinicalTrials.gov,2020-11-14,2020-12-01,False,University of Manitoba,Not Recruiting,Not Applicable,Observational,No Country Given,Tele-monitoring of COVID-19 Survivors for Long-Term Impacts,Telehealth,Telehealth,Telehealth,20,https://clinicaltrials.gov/show/NCT04644341,None
6688,NCT04644705,ClinicalTrials.gov,2020-11-02,2020-11-02,False,Charité University,Recruiting,Phase 1,Interventional,Germany,Safety and Pharmacokinetics of a Novel Niclosamide Solution in Combination With Camostat,Drug,Niclosamide + Camostat Mesilate,Niclosamide' Camostat Mesilate,28,https://clinicaltrials.gov/show/NCT04644705,None
6689,NCT04645368,ClinicalTrials.gov,2020-11-20,2020-07-01,True,NPO Petrovax,Recruiting,Not Applicable,Observational,Russian Federation,"Study of Longidaze in the Prevention & Treatment of Pulmonary Fibrosis, Interstitial Lung Diseases Caused by COVID-19",Drug,bovhyarulonidase azoximer,bovhyarulonidase azoximer,160,https://clinicaltrials.gov/show/NCT04645368,None
6690,NCT04645407,ClinicalTrials.gov,2020-02-15,2020-02-01,True,ShuGuang Hospital,Not Recruiting,Phase 4,Interventional,China,Effects of Fuzheng Huayu Tablets on COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,66,https://clinicaltrials.gov/show/NCT04645407,None
6691,NCT04645433,ClinicalTrials.gov,2020-11-07,2020-03-15,True,Sisli Hamidiye Etfal Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,Effect of Favipiravir on Mortality in Patients With COVID-19 at a Tertiary Center Intensive Care Unit,Drug,Favipiravir,Favipiravir,100,https://clinicaltrials.gov/show/NCT04645433,None
6692,NCT04645498,ClinicalTrials.gov,2020-11-25,2021-01-01,False,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 and Hereditary Metabolic Diseases,Clinical Presentation,No Intervention,No Intervention,77,https://clinicaltrials.gov/show/NCT04645498,None
6693,NCT04645563,ClinicalTrials.gov,2020-11-20,2020-03-11,True,Kafkas University,Not Recruiting,Not Applicable,Observational,Turkey,Using Whatsapp for the Consultation,Other (software),eHealth,eHealth,144,https://clinicaltrials.gov/show/NCT04645563,None
6694,NCT04646031,ClinicalTrials.gov,2020-11-24,2020-05-20,True,"Tasly Pharmaceuticals, Inc.",Not Recruiting,Not Applicable,Expanded Access,United States,Expanded Access to T89 for Treatment Use in Intermediate-size Patients Population With COVID-19,Drug,T89,T89,Not Available,https://clinicaltrials.gov/show/NCT04646031,None
6695,NCT04646044,ClinicalTrials.gov,2020-11-14,2020-11-13,True,Nektar Therapeutics,Recruiting,Phase 1,Interventional,United States,A Placebo Controlled Trial of Bempegaldesleukin (BEMPEG; NKTR-214) With Standard of Care in Patients With Mild COVID-19,Drug,Bempegaldesleukin,Bempegaldesleukin,30,https://clinicaltrials.gov/show/NCT04646044,None
6696,NCT04646109,ClinicalTrials.gov,2020-11-15,2020-05-11,True,Afyonkarahisar Health Sciences University,Not Recruiting,Phase 3,Interventional,Turkey,Ivermectin for Severe COVID-19 Management,Drug,Ivermectin,Ivermectin,60,https://clinicaltrials.gov/show/NCT04646109,None
6697,NCT04646525,ClinicalTrials.gov,2020-11-05,2020-10-01,True,Selcuk University,Recruiting,Not Applicable,Observational,Turkey,The Relationship Between Covid-19 Infection in Pediatric Patients and Secondary Lymphoid Organs,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04646525,None
6698,NCT04646551,ClinicalTrials.gov,2020-11-26,2020-12-01,False,Assiut University,Not Recruiting,Not Applicable,Observational,No Country Given,Covid-19 Risk Factors and Pattern Between Healthcare Workers,Clinical Presentation (Epidemiology),No Intervention,No Intervention,165,https://clinicaltrials.gov/show/NCT04646551,None
6699,NCT04646590,ClinicalTrials.gov,2020-11-25,2020-12-01,False,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",Not Recruiting,Phase 3,Interventional,China,A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19,ATMP,Vaccine,Vaccine,29000,https://clinicaltrials.gov/show/NCT04646590,None
6700,NCT04646642,ClinicalTrials.gov,2020-11-25,2020-12-01,False,David Grant U.S. Air Force Medical Center,Not Recruiting,Not Applicable,Observational,No Country Given,"Psychological Health, Coping Strategies and Preferences of Military COVID-19 Deployers",Other (psych),Psychological,Psychological,160,https://clinicaltrials.gov/show/NCT04646642,None
6701,NCT04646655,ClinicalTrials.gov,2020-11-22,2020-07-27,True,ASST Fatebenefratelli Sacco,Recruiting,Phase 3,Interventional,Italy,Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19,Drug,Enoxaparin,Enoxaparin,300,https://clinicaltrials.gov/show/NCT04646655,None
6702,NCT04647305,ClinicalTrials.gov,2020-11-24,2020-12-01,False,"University of Los Andes, Columbia",Not Recruiting,Not Applicable,Interventional,No Country Given,Effectiveness and Adherence to Closed Face Shields to Prevent COVID-19 Transmission,Other (device),Face shield vs. Masks,Face shield; Masks,233,https://clinicaltrials.gov/show/NCT04647305,None
6703,NCT04647604,ClinicalTrials.gov,2020-06-12,2020-06-23,True,Karolinska University Hospital,Recruiting,Phase 2,Interventional,Sweden,Resolving Inflammatory Storm in COVID-19 Patients by Omega-3 Polyunsaturated Fatty Acids -,Drug,Omega 3,Omega 3,40,https://clinicaltrials.gov/show/NCT04647604,EUCTR2020-002293-28
6704,NCT04647656,ClinicalTrials.gov,2020-11-29,2021-01-01,False,Assaf-Harofeh Medical Center,Not Recruiting,Not Applicable,Interventional,Israel,Hyperbaric Oxygen Therapy for Post-COVID-19 Syndrome,Drug,Oxygen,Oxygen,70,https://clinicaltrials.gov/show/NCT04647656,None
6705,NCT04647734,ClinicalTrials.gov,2020-11-25,2021-01-01,False,"Rigshospitalet, Denmark",Not Recruiting,Not Applicable,Interventional,Denmark,The Protective Potential of Exercise Training on the Cardiopulmonary Morbidity After COVID-19,Other (exercise),Exercise,Exercise,40,https://clinicaltrials.gov/show/NCT04647734,None
6706,NCT04648410,ClinicalTrials.gov,2020-11-26,2021-01-01,False,Brno University Hospital,Not Recruiting,Not Applicable,Observational,Czech Republic,Corticosteroids in Severe COVID-19(ASAP-C Study),Drug,Corticosteroids,Corticosteroids,2000,https://clinicaltrials.gov/show/NCT04648410,None
6707,NCT04648709,ClinicalTrials.gov,2020-11-27,2020-12-01,False,CHU de Saint Etienne,Not Recruiting,Not Applicable,Observational,France,Evaluation and Longitudinal Follow-up of Biomarkers Predictive of Severe Forms of COVID-19,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04648709,None
6708,NCT03648372,ClinicalTrials.gov,2018-08-24,2018-10-01,False,"Millennium Pharmaceuticals, Inc.",Recruiting,Phase 1/Phase 2,Interventional,United States,"A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics (PK) of TAK-981 in Adult Participants With Advanced or Metastatic Solid Tumors or Relapsed/Refractory Hematologic Malignancies and in a Subset With Coronavirus Disease 2019 (COVID-19)",Not relevant,Not relevant,Not relevant,242,https://clinicaltrials.gov/show/NCT03648372,None
6709,NCT03944447,ClinicalTrials.gov,2019-05-03,2018-12-01,True,"OMNI Medical Services, LLC",Recruiting,Phase 2,Interventional,United States,Outcomes Mandate National Integration With Cannabis as Medicine for Prevention and Treatment of COVID-19,Not relevant,Not relevant,Not relevant,200000,https://clinicaltrials.gov/show/NCT03944447,None
6710,NCT04169542,ClinicalTrials.gov,2019-11-18,2019-05-21,True,M.D. Anderson Cancer Center,Recruiting,Not Applicable,Observational,United States,"Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery",Not relevant,Not relevant,Not relevant,600,https://clinicaltrials.gov/show/NCT04169542,None
6711,NCT04280705,ClinicalTrials.gov,2020-02-20,2020-02-21,True,National Institute of Allergy and Infectious Diseases (NIAID),Not Recruiting,Phase 3,Interventional,"Denmark, Greece, South Korea, Japan, Germany, Singapore, Mexico, United Kingdom, United States, Spain",Adaptive COVID-19 Treatment Trial (ACTT),Drug,Remdesivir,Remdesivir,1062,https://clinicaltrials.gov/show/NCT04280705,EUCTR2020-001052-18; JPRN-jRCT2031190264; ISRCTN13035264
6712,NCT04283461,ClinicalTrials.gov,2020-02-21,2020-03-16,False,National Institute of Allergy and Infectious Diseases (NIAID),Not Recruiting,Phase 1,Interventional,United States,Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19),ATMP,Vaccine,Vaccine,120,https://clinicaltrials.gov/show/NCT04283461,None
6713,NCT04304690,ClinicalTrials.gov,2020-03-09,2020-03-16,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,France,"COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic",Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04304690,None
6714,NCT04312009,ClinicalTrials.gov,2020-03-13,2020-04-13,False,University of Minnesota,Recruiting,Phase 2,Interventional,United States,Losartan for Patients With COVID-19 Requiring Hospitalization,Drug,ARB (Losartan),ARB (Losartan),200,https://clinicaltrials.gov/show/NCT04312009,None
6715,NCT04324021,ClinicalTrials.gov,2020-03-25,2020-04-02,True,Swedish Orphan Biovitrum,Not Recruiting,Phase 2/Phase 3,Interventional,"United States, Italy",Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection.,Drug,Emapalumab + Anakinra,Emapalumab; anakinra,16,https://clinicaltrials.gov/show/NCT04324021,EUCTR2020-001167-93
6716,NCT04326920,ClinicalTrials.gov,2020-03-24,2020-03-24,True,"University Hospital, Ghent",Not Recruiting,Phase 4,Interventional,"Belgium, Italy",Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC),Drug,Sargramostim,Sargramostim,80,https://clinicaltrials.gov/show/NCT04326920,EUCTR2020-001254-22
6717,NCT04327505,ClinicalTrials.gov,2020-03-25,2020-06-03,True,Karolinska Institutet,Recruiting,Phase 2/Phase 3,Interventional,"Sweden, Germany, Romania",Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19,Drug,Oxygen,Oxygen,200,https://clinicaltrials.gov/show/NCT04327505,EUCTR2020-001349-37; DRKS00021626
6718,NCT04329923,ClinicalTrials.gov,2020-03-30,2020-04-09,False,"Ravi Amaravadi, MD",Not Recruiting,Phase 2,Interventional,United States,The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine),Drug,Hydroxychloroquine,Hydroxychloroquine,173,https://clinicaltrials.gov/show/NCT04329923,None
6719,NCT04330638,ClinicalTrials.gov,2020-03-31,2020-04-03,False,"University Hospital, Ghent",Not Recruiting,Phase 3,Interventional,Belgium,Treatment of COVID-19 Patients With Anti-interleukin Drugs,Drug,Anakinta + Siltuximab vs. Tocilizumab + Anakinra vs. Tocilizumab vs. Siltuximab vs. Anakinra,Anakinra; Siltuximab; Tocilizumab,342,https://clinicaltrials.gov/show/NCT04330638,None
6720,NCT04332107,ClinicalTrials.gov,2020-03-30,2020-05-22,False,Thomas M. Lietman,Recruiting,Phase 3,Interventional,United States,Azithromycin for COVID-19 Treatment in Outpatients Nationwide,Drug,Azithromycin,Azithromycin,2271,https://clinicaltrials.gov/show/NCT04332107,None
6721,NCT04333420,ClinicalTrials.gov,2020-04-01,2020-03-31,True,InflaRx GmbH,Recruiting,Phase 2/Phase 3,Interventional,"Germany, Netherlands","Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia",Drug,IFX-1,IFX-1,390,https://clinicaltrials.gov/show/NCT04333420,EUCTR2020-001335-28
6722,NCT04333472,ClinicalTrials.gov,2020-04-01,2021-01-06,False,Can-Fite BioPharma,Not Recruiting,Phase 2,Interventional,Israel,Piclidenoson for Treatment of COVID-19,Drug,Piclidenoson,Piclidenoson,40,https://clinicaltrials.gov/show/NCT04333472,None
6723,NCT04333914,ClinicalTrials.gov,2020-04-01,2020-04-15,True,Centre Leon Berard,Recruiting,Phase 2,Interventional,France,Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection,Drug,Chloroquine + Nivolumab + Tocilizumab,Chloroquine; Nivolumab; Tocilizumab,219,https://clinicaltrials.gov/show/NCT04333914,EUCTR2020-001373-70
6724,NCT04339426,ClinicalTrials.gov,2020-04-07,2020-04-20,False,HonorHealth Research Institute,Recruiting,Phase 2,Interventional,United States,Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection,Drug,Atovaquone + azithromycin,Atovaquone; azithromycin,25,https://clinicaltrials.gov/show/NCT04339426,None
6725,NCT04341116,ClinicalTrials.gov,2020-04-04,2020-04-11,False,I-Mab Biopharma Co. Ltd.,Recruiting,Phase 2/Phase 3,Interventional,United States,Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19),Drug,TJ003234,TJ003234,384,https://clinicaltrials.gov/show/NCT04341116,None
6726,NCT04341441,ClinicalTrials.gov,2020-04-07,2020-04-07,False,Henry Ford Health System,Recruiting,Phase 3,Interventional,United States,Will Hydroxychloroquine Impede or Prevent COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,3000,https://clinicaltrials.gov/show/NCT04341441,None
6727,NCT04343755,ClinicalTrials.gov,2020-04-08,2020-04-09,False,Hackensack Meridian Health,Not Recruiting,Phase 2,Interventional,United States,Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection,ATMP,Plasma,Plasma,52,https://clinicaltrials.gov/show/NCT04343755,None
6728,NCT04343976,ClinicalTrials.gov,2020-04-09,2020-06-22,False,Raymond Chung,Recruiting,Phase 2,Interventional,United States,Pegylated Interferon Lambda Treatment for COVID-19,Drug,Interferon lambda,Interferon lambda,20,https://clinicaltrials.gov/show/NCT04343976,None
6729,NCT04344184,ClinicalTrials.gov,2020-04-09,2021-01-01,False,Virginia Commonwealth University,Not Recruiting,Phase 2,Interventional,United States,SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI),Drug,Vitamin C,Vitamin C,60,https://clinicaltrials.gov/show/NCT04344184,None
6730,NCT04344587,ClinicalTrials.gov,2020-04-08,2020-04-23,False,Boston University,Recruiting,Not Applicable,Interventional,"United States, Spain",Awake Prone Position for Early Hypoxemia in COVID-19,Procedure,Positioning,Positioning,560,https://clinicaltrials.gov/show/NCT04344587,None
6731,NCT04344977,ClinicalTrials.gov,2020-04-13,2020-06-01,False,National Institute of Allergy and Infectious Diseases (NIAID),Not Recruiting,Not Applicable,Observational,"United States, United States Minor Outlying Islands",Collection of Anti-SARS-CoV-2 Immune Plasma,ATMP,Plasma,Plasma Collection,1500,https://clinicaltrials.gov/show/NCT04344977,None
6732,NCT04345419,ClinicalTrials.gov,2020-04-11,2020-06-16,False,Tanta University,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Remdesivir vs Chloroquine in Coronavirus Disease,Drug,Chloroquine vs. Favipiravir vs. Nitazoxanide vs. Ivermectin vs. Niclosamide,Chloroquine; Favipiravir; Nitazoxanide; Ivermectin; Niclosamide,120,https://clinicaltrials.gov/show/NCT04345419,None
6733,NCT04347174,ClinicalTrials.gov,2020-03-31,2020-04-30,True,Cadila Pharnmaceuticals,Recruiting,Not Applicable,Interventional,India,A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients,Drug,Mycobacterium,Mycobacterium,300,https://clinicaltrials.gov/show/NCT04347174,CTRI/2020/04/024846
6734,NCT04348240,ClinicalTrials.gov,2020-04-15,2020-04-16,False,National Institute of Dental and Craniofacial Research (NIDCR),Recruiting,Not Applicable,Observational,United States,Transmissibility and Viral Load of SARS-CoV-2 in Oral Secretions,Clinical Presentation,No Intervention,No Intervention,90,https://clinicaltrials.gov/show/NCT04348240,None
6735,NCT04348864,ClinicalTrials.gov,2020-04-13,2020-04-16,False,Neuroganics LLC,Recruiting,Not Applicable,Interventional,United States,COVID-19 Diagnostic Self-testing Using Virtual Point-of-care,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04348864,None
6736,NCT04350073,ClinicalTrials.gov,2020-04-14,2020-04-20,False,Duke University,Recruiting,Not Applicable,Observational,United States,Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID),Clinical Presentation,No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04350073,None
6737,NCT04351243,ClinicalTrials.gov,2020-04-15,2020-04-12,True,Kinevant Sciences GmbH,Not Recruiting,Phase 2,Interventional,United States,A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE),Drug,Grimsilumab,Grimsilumab,227,https://clinicaltrials.gov/show/NCT04351243,None
6738,NCT04351399,ClinicalTrials.gov,2020-04-14,2020-04-27,False,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,France,Psychological Impact of Quarantine in Rheumatoid Arthritis Patient During COVID-19 Outbreak,Other (psych),No Intervention,No Intervention,318,https://clinicaltrials.gov/show/NCT04351399,None
6739,NCT04351633,ClinicalTrials.gov,2020-04-15,2020-04-23,False,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,France,Psychological Impact of Quarantine in Osteoporosis Patient During COVID-19 Outbreak,Other (psych),No Intervention,No Intervention,52,https://clinicaltrials.gov/show/NCT04351633,None
6740,NCT04351802,ClinicalTrials.gov,2020-04-16,2020-05-11,False,University Hospital Plymouth NHS Trust,Recruiting,Not Applicable,Observational,United Kingdom,CORonavirus (COVID-19) Diagnostic Lung UltraSound Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,180,https://clinicaltrials.gov/show/NCT04351802,None
6741,NCT04351854,ClinicalTrials.gov,2020-04-16,2020-04-20,False,University of Cologne,Recruiting,Not Applicable,Observational,Germany,Registry for Clinical Presentation and Management of Patients With COVID-19 in the Emergency Room,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04351854,None
6742,NCT04353011,ClinicalTrials.gov,2020-04-15,2020-04-20,False,"University Hospital, Lille",Not Recruiting,Not Applicable,Observational,France,Psychological Impact of Quarantine in Chronic Pain Patient During COVID-19 Outbreak,Other (psych),No Intervention,No Intervention,312,https://clinicaltrials.gov/show/NCT04353011,None
6743,NCT04353336,ClinicalTrials.gov,2020-04-15,2020-03-23,True,Tanta University,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment,Drug,Chloroquine,Chloroquine,200,https://clinicaltrials.gov/show/NCT04353336,None
6744,NCT04355364,ClinicalTrials.gov,2020-04-15,2020-04-21,False,Fondation Ophtalmologique Adolphe de Rothschild,Recruiting,Phase 3,Interventional,France,Efficacy and Safety of aerosolizedDornase Alfa Administration in Patients With COVID19 Induced ARDS (COVIDORNASE),Drug,Dornase alfa,Dornase alfa,100,https://clinicaltrials.gov/show/NCT04355364,None
6745,NCT04355676,ClinicalTrials.gov,2020-04-17,2020-04-30,False,Karyopharm Therapeutics Inc,Not Recruiting,Phase 2,Interventional,No Country Given,Evaluation of Activity and Safety of Two Regimens of Low Dose Oral Selinexor in Participants With Moderate or Severe COVID-19,Drug,Selinexor,Selinexor,0,https://clinicaltrials.gov/show/NCT04355676,None
6746,NCT04355767,ClinicalTrials.gov,2020-04-17,2020-08-11,False,Stanford University,Recruiting,Phase 3,Interventional,United States,Convalescent Plasma in Outpatients With COVID-19,ATMP,Plasma,Plasma,600,https://clinicaltrials.gov/show/NCT04355767,None
6747,NCT04355962,ClinicalTrials.gov,2020-03-26,2020-04-23,False,University of Zurich,Recruiting,Phase 3,Interventional,Switzerland,Sevoflurane in COVID-19 ARDS (SevCov),Drug,Sevoflurane,Sevoflurane,64,https://clinicaltrials.gov/show/NCT04355962,None
6748,NCT04356950,ClinicalTrials.gov,2020-04-16,2020-04-28,False,CHU de Nimes,Recruiting,Not Applicable,Observational,France,Analysis of the Coagulopathy Developed by COVID-19 Infected Patients,Clinical Presentation,No Intervention,No Intervention,175,https://clinicaltrials.gov/show/NCT04356950,None
6749,NCT04359797,ClinicalTrials.gov,2020-04-20,2020-04-27,False,Vanderbilt University,Recruiting,Not Applicable,Interventional,United States,COVID-19 Patient Positioning Pragmatic Trial,Procedure,Positioning,Positioning,500,https://clinicaltrials.gov/show/NCT04359797,None
6750,NCT04360096,ClinicalTrials.gov,2020-04-21,2021-01-10,False,"NeuroRx, Inc.",Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,Inhaled Aviptadil for the Treatment of Moderate and Severe COVID-19,Drug,Aviptadil,Aviptadil,288,https://clinicaltrials.gov/show/NCT04360096,None
6751,NCT04361396,ClinicalTrials.gov,2020-04-22,2020-06-16,False,Centre Hospitalier René Dubos,Recruiting,Not Applicable,Interventional,France,Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04361396,None
6752,NCT04362176,ClinicalTrials.gov,2020-04-21,2020-04-24,False,Vanderbilt University,Recruiting,Phase 3,Interventional,United States,Passive Immunity Trial for Our Nation to Treat COVID-19 in Hospitalized Adults,ATMP,Plasma,Plasma,1000,https://clinicaltrials.gov/show/NCT04362176,None
6753,NCT04362813,ClinicalTrials.gov,2020-04-24,2020-04-30,True,Novartis Pharmaceuticals,Not Recruiting,Phase 3,Interventional,"Russian Federation, Germany, Italy, France, United Kingdom, United States, Spain, Hungary",Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia,Drug,Canakinumab,Canakinumab,451,https://clinicaltrials.gov/show/NCT04362813,EUCTR2020-001370-30
6754,NCT04362995,ClinicalTrials.gov,2020-04-22,2020-04-23,False,St. Jude Children's Research Hospital,Recruiting,Not Applicable,Observational,United States,St. Jude Tracking of Viral and Host Factors Associated With COVID-19,Clinical Presentation,No Intervention,No Intervention,1517,https://clinicaltrials.gov/show/NCT04362995,None
6755,NCT04363593,ClinicalTrials.gov,2020-04-24,2020-05-04,False,Centre Hospitalier de Cornouaille,Not Recruiting,Not Applicable,Interventional,France,Serology COVID-19 From the Cornwall Hospital Union,Clinical Presentation (Epidemiology),No Intervention,No Intervention,2587,https://clinicaltrials.gov/show/NCT04363593,None
6756,NCT04365257,ClinicalTrials.gov,2020-04-24,2020-05-13,False,Johns Hopkins University,Recruiting,Phase 2,Interventional,United States,Prazosin to Prevent COVID-19 (PREVENT-COVID Trial),Drug,Prazosin,Prazosin,220,https://clinicaltrials.gov/show/NCT04365257,None
6757,NCT04366154,ClinicalTrials.gov,2020-04-16,2020-04-15,True,Centre Francois Baclesse,Not Recruiting,Not Applicable,Observational,France,Impact of the COVID-19 Infectious Epidemic on the Management of Oncology and Onco-hematology Patients and on the Psychological Consequences for Patients and Caregivers,Other (psych),No Intervention,No Intervention,809,https://clinicaltrials.gov/show/NCT04366154,None
6758,NCT04368000,ClinicalTrials.gov,2020-04-24,2020-04-29,False,University of Utah,Not Recruiting,Not Applicable,Interventional,United States,Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization,Procedure,Positioning,Positioning,30,https://clinicaltrials.gov/show/NCT04368000,None
6759,NCT04368338,ClinicalTrials.gov,2020-04-28,2020-04-28,False,CHU de Amiens,Recruiting,Not Applicable,Observational,France,Lung Ultrasound to Diagnose COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04368338,None
6760,NCT04369469,ClinicalTrials.gov,2020-04-28,2020-05-11,True,Alexion Pharmaceuticals,Recruiting,Phase 3,Interventional,"Japan, France, United Kingdom, United States, Spain",Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia,Drug,Ravulizumab,Ravulizumab,270,https://clinicaltrials.gov/show/NCT04369469,JPRN-jRCT2031200126
6761,NCT04369599,ClinicalTrials.gov,2020-04-28,2020-08-11,False,Emory University,Not Recruiting,Not Applicable,Interventional,United States,Trans Thoracic Manipulation of Ventilation/Perfusion: the V/Q Vest for COVID-19,Other (device),Thoracic Manipulation Vest,Thoracic Manipulation Vest,24,https://clinicaltrials.gov/show/NCT04369599,None
6762,NCT04370262,ClinicalTrials.gov,2020-04-27,2020-04-07,True,Northwell Health,Not Recruiting,Phase 3,Interventional,United States,Multi-site Adaptive Trials for COVID-19,Drug,Hydroxychloroquine + Famotidine vs. Hydroxychloroquine,Hydroxychloroquine; Famotidine,233,https://clinicaltrials.gov/show/NCT04370262,None
6763,NCT04370782,ClinicalTrials.gov,2020-04-26,2020-04-28,False,"St. Francis Hospital, New York",Not Recruiting,Phase 4,Interventional,United States,Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting,Drug,Hydroxychloroquine + Azithromycin + Zinc vs. Hydroxychloroquine + Doxycycline + Zinc,Hydroxychloroquine; Azithromycin; Zinc; Doxycycline,18,https://clinicaltrials.gov/show/NCT04370782,None
6764,NCT04371432,ClinicalTrials.gov,2020-04-29,2020-12-17,False,National Human Genome Research Institute (NHGRI),Recruiting,Not Applicable,Observational,United States,Genetics of COVID-19 Susceptibility and Manifestations,Genomics,No Intervention,No Intervention,2500,https://clinicaltrials.gov/show/NCT04371432,None
6765,NCT04371640,ClinicalTrials.gov,2020-04-28,2020-07-06,False,Walter K. Kraft,Not Recruiting,Phase 1,Interventional,United States,Sirolimus in COVID-19 Phase 1,Drug,Sirolimus,Sirolimus,0,https://clinicaltrials.gov/show/NCT04371640,None
6766,NCT04373759,ClinicalTrials.gov,2020-04-30,2020-05-02,False,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer,Not Recruiting,Not Applicable,Observational,"France, Martinique",Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs,Clinical Presentation,No Intervention,No Intervention,186,https://clinicaltrials.gov/show/NCT04373759,None
6767,NCT04374279,ClinicalTrials.gov,2020-05-04,2021-01-04,False,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Not Recruiting,Phase 2,Interventional,United States,Trial to Promote Recovery From COVID-19 With Endocrine Therapy,Drug,Bicalutamide vs. Ivermectin,Bicalutamide; Ivermectin,60,https://clinicaltrials.gov/show/NCT04374279,None
6768,NCT04377100,ClinicalTrials.gov,2020-05-05,2020-12-17,False,National Institute of Mental Health (NIMH),Recruiting,Not Applicable,Interventional,United States,Impact on Anxiety and Motivation of COVID-19 and Predictors of Individual Responses,Other (psych),No Intervention,No Intervention,3000,https://clinicaltrials.gov/show/NCT04377100,None
6769,NCT04378452,ClinicalTrials.gov,2020-04-15,2020-03-31,True,Fundació Institut Germans Trias i Pujol,Not Recruiting,Not Applicable,Observational,Spain,Assessment of the Psycho-social Impact of COVID-19 Outbreak,Other (psych),No Intervention,No Intervention,56442,https://clinicaltrials.gov/show/NCT04378452,None
6770,NCT04380688,ClinicalTrials.gov,2020-05-07,2020-06-13,False,AstraZeneca,Not Recruiting,Phase 2,Interventional,United States,Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.,Drug,Acalabrutinib,Acalabrutinib,62,https://clinicaltrials.gov/show/NCT04380688,None
6771,NCT04380779,ClinicalTrials.gov,2020-05-07,2020-04-13,True,Manuel Monreal,Not Recruiting,Not Applicable,Observational,Spain,Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses,Clinical Presentation,No Intervention,No Intervention,2430,https://clinicaltrials.gov/show/NCT04380779,None
6772,NCT04380792,ClinicalTrials.gov,2020-05-07,2020-04-13,True,Manuel Monreal,Not Recruiting,Not Applicable,Observational,Spain,Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital,Clinical Presentation,No Intervention,No Intervention,2497,https://clinicaltrials.gov/show/NCT04380792,None
6773,NCT04381013,ClinicalTrials.gov,2020-05-07,2021-03-01,False,Stanford University,Not Recruiting,Not Applicable,Interventional,United States,Emergency Ventilator Splitting Between Two or More Patients (COVID-19),Other (device),Other,Other,4,https://clinicaltrials.gov/show/NCT04381013,None
6774,NCT04382651,ClinicalTrials.gov,2020-05-08,2020-06-07,False,Novartis Pharmaceuticals,Recruiting,Phase 2,Interventional,United States,Study of Efficacy and Safety of MAS825 in Patients With COVID-19,Drug,MAS825,MAS825,120,https://clinicaltrials.gov/show/NCT04382651,None
6775,NCT04382846,ClinicalTrials.gov,2020-05-07,2020-05-08,False,Tanta University,Recruiting,Phase 3,Interventional,Egypt,Novel Regimens in COVID-19 Treatment,Drug,Nitazoxanide + Azithromycin vs. Ivermectin + Chloroquine vs. Ivermectin + Nitazoxanide vs. Nitazoxanide + Ivermectin + Azithromycin,Nitazoxanide + Ivermectin + Azithromycin + Chloroquine,160,https://clinicaltrials.gov/show/NCT04382846,None
6776,NCT04382924,ClinicalTrials.gov,2020-05-08,2020-08-05,False,Algernon Pharmaceuticals,Not Recruiting,Phase 2/Phase 3,Interventional,"Romania, United States, Australia, Philippines",Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized Patient With Confirmed COVID-19 Disease,Drug,Ifenprodil,Ifenprodil,682,https://clinicaltrials.gov/show/NCT04382924,None
6777,NCT04383457,ClinicalTrials.gov,2020-05-04,2020-06-15,False,Vastra Gotaland Region,Not Recruiting,Not Applicable,Observational,Sweden,Covid-19 Triage Using Camera-based AI,Other (device),Other,Other,214,https://clinicaltrials.gov/show/NCT04383457,None
6778,NCT04384445,ClinicalTrials.gov,2020-05-09,2020-09-08,False,Organicell Regenerative Medicine,Recruiting,Phase 1/Phase 2,Interventional,United States,Zofin (Organicell Flow) for Patients With COVID-19,ATMP,Exosomes,Exosomes,20,https://clinicaltrials.gov/show/NCT04384445,None
6779,NCT04385797,ClinicalTrials.gov,2020-05-07,2020-05-04,True,Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS),Not Recruiting,Not Applicable,Observational,Spain,Cognitive Outcomes During COVID-19 confiNemeNt in Elderly and Their Caregivers Using Technologies for DEMentia,Other (psych),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04385797,None
6780,NCT04386252,ClinicalTrials.gov,2020-05-11,2021-02-01,False,"Aivita Biomedical, Inc.",Not Recruiting,Phase 1/Phase 2,Interventional,United States,Phase I-II Trial of Dendritic Cell Vaccine to Prevent COVID-19 in Adults,ATMP,Vaccine,Vaccine,175,https://clinicaltrials.gov/show/NCT04386252,None
6781,NCT04386551,ClinicalTrials.gov,2020-05-11,2020-05-06,True,CHU de Amiens,Not Recruiting,Not Applicable,Observational,France,Detection of COVID-19 in Saliva Collection,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,501,https://clinicaltrials.gov/show/NCT04386551,None
6782,NCT04386616,ClinicalTrials.gov,2020-05-11,2020-06-02,True,"Genentech, Inc.",Not Recruiting,Phase 2,Interventional,"Spain, United States, Mexico, Brazil",A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia,Drug,Astegolimab vs. UTTR1147A,Astegolimab; UTTR1147A,410,https://clinicaltrials.gov/show/NCT04386616,EUCTR2020-002713-17
6783,NCT04387656,ClinicalTrials.gov,2020-05-13,2020-05-21,False,National Cancer Institute (NCI),Recruiting,Not Applicable,Observational,"United States, Canada, Puerto Rico","NCI COVID-19 in Cancer Patients, NCCAPS Study",Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04387656,None
6784,NCT04387968,ClinicalTrials.gov,2020-05-12,2020-08-24,False,Raphael Serreau,Recruiting,Not Applicable,Observational,France,"Epidemiological Study of the Covid-19 Presto Test - The ""COVIDOR"" Study",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,5000,https://clinicaltrials.gov/show/NCT04387968,None
6785,NCT04388527,ClinicalTrials.gov,2020-05-04,2020-04-30,True,University of Pennsylvania,Recruiting,Phase 1,Interventional,United States,COVID-19 Convalescent Plasma for Mechanically Ventilated Population,ATMP,Plasma,Plasma,50,https://clinicaltrials.gov/show/NCT04388527,None
6786,NCT04388826,ClinicalTrials.gov,2020-05-13,2020-06-18,False,Veru Inc.,Recruiting,Phase 2,Interventional,United States,COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111,Drug,Veru-111,Veru-111,40,https://clinicaltrials.gov/show/NCT04388826,None
6787,NCT04391816,ClinicalTrials.gov,2020-05-15,2020-12-17,False,National Institute on Alcohol Abuse and Alcoholism (NIAAA),Recruiting,Not Applicable,Observational,United States,COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study,Other,No Intervention,No Intervention,700,https://clinicaltrials.gov/show/NCT04391816,None
6788,NCT04393155,ClinicalTrials.gov,2020-05-06,2020-04-16,True,University of Vermont,Recruiting,Not Applicable,Observational,United States,Longitudinal COVID-19 Cohort Study,Clinical Presentation (Epidemiology),No Intervention,No Intervention,225,https://clinicaltrials.gov/show/NCT04393155,None
6789,NCT04394104,ClinicalTrials.gov,2020-05-15,2020-05-27,False,Rutgers University,Not Recruiting,Not Applicable,Observational,United States,COVID-19 Wellness Survey,Other (psych),No Intervention,No Intervention,593,https://clinicaltrials.gov/show/NCT04394104,None
6790,NCT04394884,ClinicalTrials.gov,2020-05-19,2020-12-17,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Not Applicable,Observational,United States,Pathogenesis of BTK-mediated Hyper-Inflammatory Responses in COVID-19 (RESPOND),Clinical Presentation,No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04394884,None
6791,NCT04395911,ClinicalTrials.gov,2020-05-17,2020-09-10,False,SeaStar Medical,Recruiting,Not Applicable,Interventional,United States,Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections,Other (device),Selective Cytopheretic Device,Selective Cytopheretic Device,30,https://clinicaltrials.gov/show/NCT04395911,None
6792,NCT04397510,ClinicalTrials.gov,2020-05-19,2020-06-01,False,Frederick Health,Recruiting,Phase 4,Interventional,United States,Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury,Drug,Heparin,Heparin,50,https://clinicaltrials.gov/show/NCT04397510,None
6793,NCT04397718,ClinicalTrials.gov,2020-05-14,2020-07-06,False,VA Office of Research and Development,Recruiting,Phase 2,Interventional,United States,Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization,Drug,Degarelix,Degarelix,198,https://clinicaltrials.gov/show/NCT04397718,None
6794,NCT04397757,ClinicalTrials.gov,2020-05-19,2020-05-13,True,University of Pennsylvania,Recruiting,Phase 1,Interventional,United States,COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2.,ATMP,Plasma,Plasma,80,https://clinicaltrials.gov/show/NCT04397757,None
6795,NCT04401293,ClinicalTrials.gov,2020-05-20,2020-04-26,True,Northwell Health,Recruiting,Phase 3,Interventional,United States,Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients,Drug,Heparin,Heparin,308,https://clinicaltrials.gov/show/NCT04401293,None
6796,NCT04401449,ClinicalTrials.gov,2020-05-22,2020-05-20,True,National Institutes of Health Clinical Center (CC),Recruiting,Not Applicable,Observational,United States,Cardiopulmonary Inflammation and Multi-System Imaging During the Clinical Course of COVID-19 Infection in Asymptomatic and Symptomatic Persons,Clinical Presentation,No Intervention,No Intervention,180,https://clinicaltrials.gov/show/NCT04401449,None
6797,NCT04402853,ClinicalTrials.gov,2020-05-22,2020-02-01,True,Università degli Studi dell'Insubria,Not Recruiting,Not Applicable,Observational,Italy,SARS Cov-2 in Conjunctival Secretion in COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04402853,None
6798,NCT04402957,ClinicalTrials.gov,2020-05-12,2020-10-14,False,Arch Biopartners Inc.,Recruiting,Phase 2,Interventional,"United States, Turkey",LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19),Drug,LSALT peptide,LSALT peptide,60,https://clinicaltrials.gov/show/NCT04402957,None
6799,NCT04402983,ClinicalTrials.gov,2020-05-22,2020-05-27,False,Istanbul Medipol University Hospital,Not Recruiting,Not Applicable,Interventional,Turkey,The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,34,https://clinicaltrials.gov/show/NCT04402983,None
6800,NCT04403386,ClinicalTrials.gov,2020-05-23,2020-06-01,False,National Institute of Environmental Health Sciences (NIEHS),Recruiting,Not Applicable,Observational,United States,"Prospective Natural History Study of Smoking, Immune Cell Profiles, Epigenetics and COVID-19",Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04403386,None
6801,NCT04403880,ClinicalTrials.gov,2020-05-22,2020-05-13,True,HIV Vaccine Trials Network,Recruiting,Not Applicable,Observational,"Zimbabwe, Mozambique, Tanzania, Zambia, Peru, United States, South Africa, Malawi",Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,727,https://clinicaltrials.gov/show/NCT04403880,None
6802,NCT04404361,ClinicalTrials.gov,2020-05-22,2020-05-22,False,CTI BioPharma,Recruiting,Phase 3,Interventional,United States,PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer,Drug,Pacritinib,Pacritinib,364,https://clinicaltrials.gov/show/NCT04404361,None
6803,NCT04405570,ClinicalTrials.gov,2020-05-26,2020-06-16,False,Ridgeback Biotherapeutics,Recruiting,Phase 2,Interventional,United States,"A Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19",Drug,EIDD-2801,EIDD-2801,204,https://clinicaltrials.gov/show/NCT04405570,None
6804,NCT04405739,ClinicalTrials.gov,2020-05-26,2020-06-16,False,Ridgeback Biotherapeutics,Recruiting,Phase 2,Interventional,United States,The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID),Drug,EIDD-2801,EIDD-2801,80,https://clinicaltrials.gov/show/NCT04405739,None
6805,NCT04405843,ClinicalTrials.gov,2020-05-23,2020-07-14,False,Centro de Estudios en Infectología Pediátrica,Not Recruiting,Phase 2/Phase 3,Interventional,Colombia,Efficacy of Ivermectin in Adult Patients With Early Stages of COVID-19 (EPIC Trial),Drug,Ivermectin,Ivermectin,476,https://clinicaltrials.gov/show/NCT04405843,None
6806,NCT04407130,ClinicalTrials.gov,2020-05-17,2020-06-16,False,"International Centre for Diarrhoeal Disease Research, Bangladesh",Recruiting,Phase 2,Interventional,Bangladesh,Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection.,Drug,Ivermectin + Doxycycline vs. Ivermectin,Ivermectin; Doxycycline,72,https://clinicaltrials.gov/show/NCT04407130,None
6807,NCT04407286,ClinicalTrials.gov,2020-05-19,2020-05-19,False,Arizona State University,Not Recruiting,Phase 1,Interventional,United States,Vitamin D Testing and Treatment for COVID 19,Drug,Vitamin D,Vitamin D,41,https://clinicaltrials.gov/show/NCT04407286,None
6808,NCT04408183,ClinicalTrials.gov,2020-05-22,2020-06-01,False,"GeneOne Life Science, Inc.",Recruiting,Phase 2,Interventional,United States,GLS-1200 Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19) in Health Care Personnel,Drug (Chemoprophylaxis),GLS-1200,GLS-1200,225,https://clinicaltrials.gov/show/NCT04408183,None
6809,NCT04408248,ClinicalTrials.gov,2020-05-27,2020-08-20,False,Guy's and St Thomas' NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,AKI Biomarkers in Coronavirus(COVID)-19,Clinical Presentation,No Intervention,No Intervention,30,https://clinicaltrials.gov/show/NCT04408248,None
6810,NCT04408365,ClinicalTrials.gov,2020-05-27,2020-08-05,False,Guy's and St Thomas' NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,"Endothelial Function, Inflammation and Organ Dysfunction in COVID-19",Clinical Presentation,No Intervention,No Intervention,82,https://clinicaltrials.gov/show/NCT04408365,None
6811,NCT04409327,ClinicalTrials.gov,2020-05-28,2020-07-11,False,Restorbio Inc.,Not Recruiting,Phase 2,Interventional,United States,Phase 2 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes,Drug,RTB101,RTB101,36,https://clinicaltrials.gov/show/NCT04409327,None
6812,NCT04409743,ClinicalTrials.gov,2020-05-28,2020-06-07,False,Stanford University,Recruiting,Not Applicable,Interventional,United States,Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic,Telehealth,Telehealth,Telehealth,50,https://clinicaltrials.gov/show/NCT04409743,None
6813,NCT04410354,ClinicalTrials.gov,2020-04-28,2020-06-16,False,"ViralClear Pharmaceuticals, Inc.",Not Recruiting,Phase 2,Interventional,United States,Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19,Drug,Merimepodib + Remdesivir vs. Remdesivir,Merimepodib; Remdesivir,44,https://clinicaltrials.gov/show/NCT04410354,None
6814,NCT04411680,ClinicalTrials.gov,2020-05-29,2020-08-18,False,"Partner Therapeutics, Inc.",Recruiting,Phase 2,Interventional,United States,Study of Sargramostim in Patients With COVID-19,Drug,Sargramostim,Sargramostim,60,https://clinicaltrials.gov/show/NCT04411680,None
6815,NCT04412226,ClinicalTrials.gov,2020-05-31,2020-06-10,False,Derince Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,Effect of Using Barrier Devices for Intubation in COVID-19 Patients,Other (device),Barrier,Barrier,13,https://clinicaltrials.gov/show/NCT04412226,None
6816,NCT04414631,ClinicalTrials.gov,2020-05-19,2020-08-06,False,"University Hospital, Basel",Recruiting,Phase 2,Interventional,Switzerland,Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19,Drug,Conestat alfa,Conestat alfa,120,https://clinicaltrials.gov/show/NCT04414631,None
6817,NCT04415151,ClinicalTrials.gov,2020-06-02,2020-07-29,False,Yale University,Not Recruiting,Phase 2,Interventional,United States,Tofacitinib for Treatment of Moderate COVID-19,Drug,Tofacitinib,Tofacitinib,60,https://clinicaltrials.gov/show/NCT04415151,None
6818,NCT04416100,ClinicalTrials.gov,2020-05-26,2020-04-29,True,Medical University Innsbruck,Recruiting,Not Applicable,Observational,Austria,Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19),Clinical Presentation,No Intervention,No Intervention,130,https://clinicaltrials.gov/show/NCT04416100,None
6819,NCT04417673,ClinicalTrials.gov,2020-06-04,2020-12-17,False,National Human Genome Research Institute (NHGRI),Not Recruiting,Not Applicable,Observational,United States,Living With Sickle Cell Disease in the COVID-19 Pandemic,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04417673,None
6820,NCT04419610,ClinicalTrials.gov,2020-04-16,2020-10-09,False,Imperial College London,Recruiting,Phase 1,Interventional,United Kingdom,RAS and Coagulopathy in COVID19,Drug,TRV027,TRV027,60,https://clinicaltrials.gov/show/NCT04419610,None
6821,NCT04419870,ClinicalTrials.gov,2020-06-05,2020-12-17,False,National Human Genome Research Institute (NHGRI),Recruiting,Not Applicable,Observational,United States,"Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity During the COVID19 Pandemic",Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04419870,None
6822,NCT04420182,ClinicalTrials.gov,2020-05-29,2020-08-17,False,Lawson Health Research Institute,Recruiting,Not Applicable,Interventional,Canada,COVID-19 Virtual Care at Home,Other (software),eHealth,eHealth,2000,https://clinicaltrials.gov/show/NCT04420182,None
6823,NCT04421027,ClinicalTrials.gov,2020-06-05,2019-09-07,False,Eli Lilly and Company,Recruiting,Phase 3,Interventional,"South Korea, Japan, India, Germany, Russian Federation, Italy, Argentina, Mexico, Brazil, Puerto Rico, United Kingdom, United States, Spain",A Study of Baricitinib (LY3009104) in Participants With COVID-19,Drug,Baricitinib,Baricitinib,1400,https://clinicaltrials.gov/show/NCT04421027,EUCTR2020-001517-21
6824,NCT04424355,ClinicalTrials.gov,2020-06-05,2020-05-19,True,Department of Health Care of Moscow,Recruiting,Not Applicable,Observational,Russian Federation,Magnetic Resonance Imaging to Detect Signs of Viral Pneumonia in Patients With Coronavirus Infection.,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,115,https://clinicaltrials.gov/show/NCT04424355,None
6825,NCT04425629,ClinicalTrials.gov,2020-06-08,2020-06-16,True,Regeneron Pharmaceuticals,Recruiting,Phase 1/Phase 2,Interventional,"United States, Romania","Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult Patients With COVID-19",Drug,REGN10933 + REGN10987,REGN10933; REGN10987,2104,https://clinicaltrials.gov/show/NCT04425629,EUCTR2020-003690-21
6826,NCT04426201,ClinicalTrials.gov,2020-06-09,2020-12-20,False,Revimmune,Not Recruiting,Phase 2,Interventional,No Country Given,InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O ),Drug,Interleukin-7,Interleukin-7,48,https://clinicaltrials.gov/show/NCT04426201,None
6827,NCT04426279,ClinicalTrials.gov,2020-06-09,2020-08-18,False,"University Hospital, Lille",Recruiting,Not Applicable,Observational,France,Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With Immunosuppressants,Clinical Presentation,No Intervention,No Intervention,1500,https://clinicaltrials.gov/show/NCT04426279,None
6828,NCT04427501,ClinicalTrials.gov,2020-06-09,2020-06-17,False,Eli Lilly and Company,Recruiting,Phase 2,Interventional,"United States, Puerto Rico",A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness,Drug,LY3819253,LY3819253,1200,https://clinicaltrials.gov/show/NCT04427501,None
6829,NCT04431297,ClinicalTrials.gov,2020-06-12,2021-01-01,False,Icahn School of Medicine at Mount Sinai,Not Recruiting,Not Applicable,Interventional,United States,Virtual Mindfulness Rounds in the Time of COVID-19 Pandemic,Other (psych),Psychological,Psychological,30,https://clinicaltrials.gov/show/NCT04431297,None
6830,NCT04431414,ClinicalTrials.gov,2020-06-09,2020-07-20,False,COVID-19 Prevention Network,Recruiting,Not Applicable,Observational,"Kenya, Botswana, Zimbabwe, Mozambique, Tanzania, Zambia, Argentina, Mexico, Brazil, Peru, United States, South Africa, Malawi",A Study of Immune Responses to the Virus That Causes COVID-19,Clinical Presentation,No Intervention,No Intervention,800,https://clinicaltrials.gov/show/NCT04431414,None
6831,NCT04431453,ClinicalTrials.gov,2020-06-08,2020-07-21,True,Gilead Sciences,Recruiting,Phase 2/Phase 3,Interventional,"United Kingdom, United States, Spain, Italy","Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734â„¢) in Participants From Birth to < 18 Years of Age With Coronavirus Disease 2019 (COVID-19)",Drug,Remdesivir,Remdesivir,52,https://clinicaltrials.gov/show/NCT04431453,EUCTR2020-001803-17
6832,NCT04431856,ClinicalTrials.gov,2020-06-12,2020-05-15,True,University of Miami,Not Recruiting,Not Applicable,Interventional,United States,CO-PARENT: COVID-19 - Parent Action in Response to Emotions and Needs for Treatment,Other (psych),Psychological,Psychological,80,https://clinicaltrials.gov/show/NCT04431856,None
6833,NCT04432298,ClinicalTrials.gov,2020-06-12,2020-06-20,False,FibroGen,Recruiting,Phase 2,Interventional,United States,"Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Patients With Acute COVID-19 Disease",Drug,Pamrevlumab,Pamrevlumab,130,https://clinicaltrials.gov/show/NCT04432298,None
6834,NCT04432870,ClinicalTrials.gov,2020-06-12,2020-06-09,True,Massachusetts General Hospital,Recruiting,Not Applicable,Observational,United States,Patients' Preferences About Rescheduling Colonoscopies Delayed Due to COVID-19: Cross Sectional Study,Health System,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04432870,None
6835,NCT04433546,ClinicalTrials.gov,2020-05-28,2020-07-15,False,PhaseBio Pharmaceuticals Inc.,Not Recruiting,Phase 2,Interventional,United States,"Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).",Drug,PB1046,PB1046,54,https://clinicaltrials.gov/show/NCT04433546,None
6836,NCT04435379,ClinicalTrials.gov,2020-06-16,2020-06-18,True,Vakzine Projekt Management GmbH,Recruiting,Phase 3,Interventional,Germany,Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 Pandemic,Drug,VPM1002,VPM1002,2038,https://clinicaltrials.gov/show/NCT04435379,EUCTR2020-001675-33
6837,NCT04436484,ClinicalTrials.gov,2020-06-12,2020-04-29,True,University Hospital Plymouth NHS Trust,Recruiting,Not Applicable,Observational,United Kingdom,Immune Biomarkers of Outcome From COVID-19,Clinical Presentation,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04436484,None
6838,NCT04440007,ClinicalTrials.gov,2020-06-17,2020-10-09,False,"Sorrento Therapeutics, Inc.",Recruiting,Phase 2,Interventional,United States,Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized With COVID-19,Drug,Abivertinib,Abivertinib,80,https://clinicaltrials.gov/show/NCT04440007,None
6839,NCT04441710,ClinicalTrials.gov,2020-06-18,2020-10-27,False,Hospices Civils de Lyon,Recruiting,Not Applicable,Observational,France,Caregiver Serological Monitoring Extended Secondarily to Patients With the SARS-CoV-2 Coronavirus,Clinical Presentation (Epidemiology),No Intervention,No Intervention,2500,https://clinicaltrials.gov/show/NCT04441710,None
6840,NCT04442230,ClinicalTrials.gov,2020-06-17,2020-10-10,False,"Altimmune, Inc.",Recruiting,Phase 2,Interventional,United States,NasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19),ATMP,Vaccine,Vaccine,96,https://clinicaltrials.gov/show/NCT04442230,None
6841,NCT04445194,ClinicalTrials.gov,2020-06-16,2020-06-22,False,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",Not Recruiting,Phase 1,Interventional,China,Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine,ATMP,Vaccine,Vaccine,50,https://clinicaltrials.gov/show/NCT04445194,None
6842,NCT04445233,ClinicalTrials.gov,2020-06-22,2020-04-29,True,"University of North Carolina, Chapel Hill",Not Recruiting,Not Applicable,Observational,United States,COVID-19 Household Transmission Study,Clinical Presentation (Epidemiology),No Intervention,No Intervention,315,https://clinicaltrials.gov/show/NCT04445233,None
6843,NCT04446429,ClinicalTrials.gov,2020-06-22,2020-07-02,False,"Applied Biology, Inc.",Recruiting,Not Applicable,Interventional,Brazil,Anti-Androgen Treatment for COVID-19,Drug,Ivermectin + Azythromycin + Dutasteride vs. Ivermectin + Azythromycin,Ivermectin; Azythromycin; Dutasteride,381,https://clinicaltrials.gov/show/NCT04446429,None
6844,NCT04447534,ClinicalTrials.gov,2020-06-23,2020-06-23,False,Tanta University,Recruiting,Phase 3,Interventional,Egypt,Zinc With Chloroquine/Hydroxychloroquine in Treatment of COVID-19,Drug,Chloroquine + Zinc vs. Chloroquine,Chloroquine; Zinc,200,https://clinicaltrials.gov/show/NCT04447534,None
6845,NCT04453384,ClinicalTrials.gov,2020-06-22,2020-09-01,False,Nantes University Hospital,Recruiting,Phase 2,Interventional,France,Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia,Drug,XAV-19,XAV-19,414,https://clinicaltrials.gov/show/NCT04453384,None
6846,NCT04453839,ClinicalTrials.gov,2020-06-27,2020-09-01,False,"NeuroRx, Inc.",Not Recruiting,Not Applicable,Expanded Access,United States,RLF-100 (Aviptadil) Intermediate Population Expanded Access Protocol (SAMICARE),Drug,Aviptadil,Aviptadil,Not Available,https://clinicaltrials.gov/show/NCT04453839,None
6847,NCT04455815,ClinicalTrials.gov,2020-06-25,2020-09-25,False,Cancer Research UK,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,A Trial Looking at the Use of Camostat to Reduce Progression of Symptoms of Coronavirus (COVID-19) in People Who Have Tested Positive But Are Able to Stay at Home,Drug,Camostat Mesilate,Camostat Mesilate,389,https://clinicaltrials.gov/show/NCT04455815,None
6848,NCT04456595,ClinicalTrials.gov,2020-06-30,2020-07-21,False,Butantan Institute,Recruiting,Phase 3,Interventional,Brazil,Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals,ATMP,Vaccine,Vaccine,13060,https://clinicaltrials.gov/show/NCT04456595,None
6849,NCT04460443,ClinicalTrials.gov,2020-07-04,2020-08-01,False,Tanta University,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Sofosbuvir in Treatment of COVID 19,Drug,Sofosbuvir + Ribavirin vs. Sofosbuvir,Sofosbuvir; Ribavirin,60,https://clinicaltrials.gov/show/NCT04460443,None
6850,NCT04463602,ClinicalTrials.gov,2020-07-07,2020-07-25,False,Cadila Healthcare Ltd,Not Recruiting,Phase 2,Interventional,Mexico,Desidustat in the Management of COVID-19 Patients,Drug,Desidustat,Desidustat,24,https://clinicaltrials.gov/show/NCT04463602,None
6851,NCT04466085,ClinicalTrials.gov,2020-07-08,2020-07-12,False,"Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.",Not Recruiting,Phase 2,Interventional,China,Clinical Study of Recombinant Novel Coronavirus Vaccine,ATMP,Vaccine,Vaccine,900,https://clinicaltrials.gov/show/NCT04466085,None
6852,NCT04466241,ClinicalTrials.gov,2020-07-06,2020-11-27,False,Inserm-ANRS,Recruiting,Phase 2/Phase 3,Interventional,Cote d'Ivoire,Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial,Drug,Lopinavir/ritonavir vs. Lopinavir/ritonavir + Telmisartan vs. Lopinavir/ritonavir + Atorvastatin,Telmisartan; Lopinavir/ritonavir; Atorvastatin,294,https://clinicaltrials.gov/show/NCT04466241,None
6853,NCT04466982,ClinicalTrials.gov,2020-07-09,2020-07-02,True,Cambridge University Hospitals NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection,Clinical Presentation,No Intervention,No Intervention,90,https://clinicaltrials.gov/show/NCT04466982,None
6854,NCT04468789,ClinicalTrials.gov,2020-07-08,2021-04-01,False,Boston University,Not Recruiting,Not Applicable,Observational,South Africa,Evaluation of Six-month HIV Treatment Dispensing in South Africa,Other,Other,Other,150945,https://clinicaltrials.gov/show/NCT04468789,None
6855,NCT04469491,ClinicalTrials.gov,2020-07-13,2020-09-20,False,CHU de Amiens,Not Recruiting,Phase 2,Interventional,France,Treatment of COVID-19 by Nebulization of Inteferon Beta 1b Efficiency and Safety Study,Drug,Interferon,Interferon,60,https://clinicaltrials.gov/show/NCT04469491,None
6856,NCT04472728,ClinicalTrials.gov,2020-07-06,2020-06-16,True,Biophytis S.A.,Recruiting,Phase 2/Phase 3,Interventional,"France, Belgium, Puerto Rico, Brazil, United States",Testing the Efficacy and Safety of BIO101 for the Prevention of Respiratory Deterioration in COVID-19 Patients,Drug,BIO101,BIO101,310,https://clinicaltrials.gov/show/NCT04472728,None
6857,NCT04473690,ClinicalTrials.gov,2020-07-14,2020-12-28,False,"Kentucky BioProcessing, Inc.",Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers,ATMP,Vaccine,Vaccine,180,https://clinicaltrials.gov/show/NCT04473690,None
6858,NCT04476745,ClinicalTrials.gov,2020-07-16,2020-10-05,False,Applied Science Private University,Recruiting,Not Applicable,Interventional,Jordan,The Effect of D3 on Selected Cytokines Involved in Cytokine Storm in the Covid-19 Uninfected Jordanian People,Drug,Vitamin D,Vitamin D,100,https://clinicaltrials.gov/show/NCT04476745,None
6859,NCT04477213,ClinicalTrials.gov,2020-07-17,2021-01-15,False,NMC Specialty Hospital,Not Recruiting,Not Applicable,Observational,No Country Given,Risk Profiling of the Occupational Exposure of COVID-19 to Healthcare Workers.,Clinical Presentation,No Intervention,No Intervention,600,https://clinicaltrials.gov/show/NCT04477213,None
6860,NCT04479631,ClinicalTrials.gov,2020-07-14,2020-07-12,True,Brii Biosciences Limited,Not Recruiting,Phase 1,Interventional,China,"Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-196",Drug,BRII-196,BRII-196,16,https://clinicaltrials.gov/show/NCT04479631,None
6861,NCT04479644,ClinicalTrials.gov,2020-07-14,2020-07-13,True,Brii Biosciences Limited,Not Recruiting,Phase 1,Interventional,China,"Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-198",Drug,BRII-196,BRII-196,17,https://clinicaltrials.gov/show/NCT04479644,None
6862,NCT04482686,ClinicalTrials.gov,2020-07-21,2020-12-09,False,ProgenaBiome,Recruiting,Phase 2,Interventional,United States,Trial of Combination Therapy to Treat COVID-19 Infection,Drug,Ivermectin + Doxycycline + Zinc + Vitamin D + Vitamin C vs. Zinc + Vitamin D + Vitamin C,Ivermectin; Doxycycline; Zinc; Vitamin D; Vitamin C,300,https://clinicaltrials.gov/show/NCT04482686,None
6863,NCT04483271,ClinicalTrials.gov,2020-07-18,2020-10-02,False,Applied Science Private University,Recruiting,Not Applicable,Interventional,Jordan,The Effect of Omega-3 on Selected Cytokines Involved in Cytokine Storm,Drug,Omega 3,Omega 3,100,https://clinicaltrials.gov/show/NCT04483271,None
6864,NCT04487691,ClinicalTrials.gov,2020-07-23,2020-12-08,False,"Regenexx, LLC",Recruiting,Not Applicable,Interventional,United States,Nebulized PL for Post-COVID-19 Syndrome,Drug,Platelet Lysate,Platelet Lysate,40,https://clinicaltrials.gov/show/NCT04487691,None
6865,NCT04490174,ClinicalTrials.gov,2020-07-28,2020-08-24,False,National Institute of Environmental Health Sciences (NIEHS),Recruiting,Not Applicable,Observational,United States,Serological Surveillance for COVID-19 in Central North Carolina,Clinical Presentation (Epidemiology),No Intervention,No Intervention,2500,https://clinicaltrials.gov/show/NCT04490174,None
6866,NCT04492449,ClinicalTrials.gov,2020-07-20,2021-01-01,False,University of São Paulo,Not Recruiting,Not Applicable,Observational,No Country Given,"Evaluation of Systemic and Oral Conditions of Pregnant Women and Their Babies, With Exposure to COVID-19 Infection",Clinical Presentation,No Intervention,No Intervention,260,https://clinicaltrials.gov/show/NCT04492449,None
6867,NCT04492475,ClinicalTrials.gov,2020-07-28,2020-08-04,False,National Institute of Allergy and Infectious Diseases (NIAID),Not Recruiting,Phase 3,Interventional,"South Korea, Japan, Singapore, Mexico, United States",Adaptive COVID-19 Treatment Trial 3 (ACTT-3),Drug,Interferon beta + Remdesivir vs. Remdesivir,Interferon beta; Remdesivir,969,https://clinicaltrials.gov/show/NCT04492475,None
6868,NCT04497649,ClinicalTrials.gov,2020-08-01,2020-07-01,True,Tanta University,Recruiting,Phase 2/Phase 3,Interventional,Egypt,Sofosbuvir Containing Regimens in Treatment of COVID 19 Patients,Drug,"Sofosbuvir, Daclatsavir, Ribavirin, Ledipasvir",Sofosbuvir; Daclatsavir; Ribavirin; Ledipasvir,100,https://clinicaltrials.gov/show/NCT04497649,None
6869,NCT04497948,ClinicalTrials.gov,2020-06-16,2020-09-21,False,Acerta Pharma B.V.,Not Recruiting,Phase 1,Interventional,"United States, Brazil",Acalabrutinib Study With Best Supportive Care in Participants Hospitalized With COVID-19,Drug,Acalabrutinib,Acalabrutinib,8,https://clinicaltrials.gov/show/NCT04497948,None
6870,NCT04498247,ClinicalTrials.gov,2020-08-03,2020-08-27,False,Merck Sharp & Dohme Corp.,Not Recruiting,Phase 1/Phase 2,Interventional,"United States, Belgium, Austria","A Study to Assess Safety, Tolerability, and Immunogenicity of V591 (COVID-19 Vaccine) in Healthy Participants (V591-001)",ATMP,Vaccine,Vaccine,260,https://clinicaltrials.gov/show/NCT04498247,None
6871,NCT04501432,ClinicalTrials.gov,2020-07-29,2020-07-14,True,Ludwig Boltzmann Institute for Digital Health and Prevention,Not Recruiting,Not Applicable,Observational,Austria,Cardiac Rehabilitation and Ongoing Physical Activity During COVID-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,27,https://clinicaltrials.gov/show/NCT04501432,None
6872,NCT04501952,ClinicalTrials.gov,2020-08-05,2020-09-18,True,Gilead Sciences,Recruiting,Phase 3,Interventional,"United States, Denmark",Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734â„¢) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting,Drug,Remdesivir,Remdesivir,1264,https://clinicaltrials.gov/show/NCT04501952,EUCTR2020-003510-12
6873,NCT04504032,ClinicalTrials.gov,2020-08-05,2020-09-02,False,Bill & Melinda Gates Medical Research Institute,Recruiting,Phase 2,Interventional,United States,A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19),Drug,Rivaroxaban,Rivaroxaban,600,https://clinicaltrials.gov/show/NCT04504032,None
6874,NCT04504734,ClinicalTrials.gov,2020-08-04,2020-11-27,False,"Revive Therapeutics, Ltd.",Recruiting,Phase 3,Interventional,United States,Bucillamine in Treatment of Patients With COVID-19,Drug,Bucillamine,Bucillamine,1000,https://clinicaltrials.gov/show/NCT04504734,None
6875,NCT04505722,ClinicalTrials.gov,2020-07-31,2020-09-07,True,Janssen Pharmaceutical,Recruiting,Phase 3,Interventional,"Colombia, Philippines, Chile, Argentina, Mexico, Brazil, Peru, United States, South Africa, Ukraine",A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants,ATMP,Vaccine,Vaccine,60000,https://clinicaltrials.gov/show/NCT04505722,PER-048-20
6876,NCT04506268,ClinicalTrials.gov,2020-08-07,2020-09-09,False,University of Pennsylvania,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 SAFE Enrollment,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1200,https://clinicaltrials.gov/show/NCT04506268,None
6877,NCT04508023,ClinicalTrials.gov,2020-08-10,2020-08-13,False,Janssen Pharmaceutical,Recruiting,Phase 3,Interventional,United States,"A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection",Drug,Rivaroxaban,Rivaroxaban,4000,https://clinicaltrials.gov/show/NCT04508023,None
6878,NCT04509999,ClinicalTrials.gov,2020-08-07,2020-10-26,False,University of Florida,Recruiting,Phase 3,Interventional,United States,Bicalutamide to Block TMPRSS2 in Males With COVID-19 Infection,Drug,Bicalutamide,Bicalutamide,100,https://clinicaltrials.gov/show/NCT04509999,None
6879,NCT04516746,ClinicalTrials.gov,2020-08-17,2020-08-28,True,AstraZeneca,Recruiting,Phase 3,Interventional,"Colombia, Chile, Argentina, Peru, United States","Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults",ATMP,Vaccine,Vaccine,40000,https://clinicaltrials.gov/show/NCT04516746,PER-059-20
6880,NCT04517396,ClinicalTrials.gov,2020-08-17,2020-08-18,False,University of Pennsylvania,Recruiting,Phase 2,Interventional,United States,FEnofibRate as a Metabolic INtervention for COVID-19,Drug,Fenofibrate,Fenofibrate,300,https://clinicaltrials.gov/show/NCT04517396,None
6881,NCT04518410,ClinicalTrials.gov,2020-08-17,2020-08-19,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Phase 2/Phase 3,Interventional,"United States, Puerto Rico",ACTIV-2: A Study for Outpatients With COVID-19,Drug,LY3819253,LY3819253,2000,https://clinicaltrials.gov/show/NCT04518410,None
6882,NCT04519437,ClinicalTrials.gov,2020-07-24,2020-07-26,False,Regeneron Pharmaceuticals,Not Recruiting,Phase 1,Interventional,United States,"Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19",Drug,REGN10933 + REGN10987,REGN10933; REGN10987,974,https://clinicaltrials.gov/show/NCT04519437,None
6883,NCT04521088,ClinicalTrials.gov,2020-07-02,2020-07-02,False,Wissenschaftliches Institut Bethanien e.V,Recruiting,Not Applicable,Observational,Germany,Epidemiological Analysis of Ambulant Patients in a COVID-19 Outpatient Clinic,Clinical Presentation (Epidemiology),No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04521088,None
6884,NCT04523181,ClinicalTrials.gov,2020-08-19,2020-10-08,False,Golden Biotechnology Corporation,Recruiting,Phase 2,Interventional,United States,Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients,Drug,Antroquinonol,Antroquinonol,174,https://clinicaltrials.gov/show/NCT04523181,None
6885,NCT04524715,ClinicalTrials.gov,2020-08-19,2021-03-31,False,Ward Photonics LLC,Not Recruiting,Not Applicable,Interventional,United States,LLLT Treatment of Lung Inflammation in COVID-19,Other (device),Low-Level Laser Therapy,Low-Level Laser Therapy,64,https://clinicaltrials.gov/show/NCT04524715,None
6886,NCT04526990,ClinicalTrials.gov,2020-08-22,2020-09-15,False,CanSino Biologics Inc.,Recruiting,Phase 3,Interventional,"Chile, Pakistan, Russian Federation, Argentina, Mexico",Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above,ATMP,Vaccine,Vaccine,40000,https://clinicaltrials.gov/show/NCT04526990,None
6887,NCT04527081,ClinicalTrials.gov,2020-08-24,2020-08-31,False,"AnGes, Inc.",Not Recruiting,Phase 1/Phase 2,Interventional,Japan,Study of COVID-19 DNA Vaccine (AG0302-COVID19),ATMP,Vaccine,Vaccine,30,https://clinicaltrials.gov/show/NCT04527081,None
6888,NCT04527471,ClinicalTrials.gov,2020-08-06,2020-09-04,False,Verona Pharma Inc,Recruiting,Phase 2,Interventional,United States,Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19,Drug,Ensifentrine,Ensifentrine,45,https://clinicaltrials.gov/show/NCT04527471,None
6889,NCT04530136,ClinicalTrials.gov,2020-08-26,2020-11-30,False,Pharming Technologies B.V.,Recruiting,Phase 2,Interventional,United States,Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19,Drug,Ruconest,Ruconest,120,https://clinicaltrials.gov/show/NCT04530136,None
6890,NCT04530500,ClinicalTrials.gov,2020-08-26,2020-08-13,True,"University of California, Irvine",Recruiting,Not Applicable,Observational,United States,COVID-19 In-vitro Diagnostic Test and Androgen Receptor Gene Expression,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04530500,None
6891,NCT04535453,ClinicalTrials.gov,2020-08-27,2020-08-28,True,Janssen Pharmaceutical,Recruiting,Phase 2,Interventional,"Canada, Germany, Spain, Netherlands",A Study to Evaluate a Range of Dose Levels and Vaccination Intervals of Ad26.COV2.S in Healthy Adults and Adolescents,ATMP,Vaccine,Vaccine,1210,https://clinicaltrials.gov/show/NCT04535453,EUCTR2020-002584-63
6892,NCT04536376,ClinicalTrials.gov,2020-08-26,2021-01-01,False,Mayo Clinic,Not Recruiting,Not Applicable,Interventional,No Country Given,First Responder Resiliency Program During COVID-19,Other,No Intervention,No Intervention,10,https://clinicaltrials.gov/show/NCT04536376,None
6893,NCT04537975,ClinicalTrials.gov,2020-08-25,2020-09-15,False,SeaStar Medical,Not Recruiting,Not Applicable,Interventional,No Country Given,C2Rx Hemofiltration Treatment in Severe or Critically Ill Adults With COVID-19,Other (device),Blood filter,Blood filter,0,https://clinicaltrials.gov/show/NCT04537975,None
6894,NCT04539262,ClinicalTrials.gov,2020-08-26,2020-09-14,False,Gilead Sciences,Recruiting,Phase 1/Phase 2,Interventional,United States,"Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation",Drug,Remdesivir,Remdesivir,282,https://clinicaltrials.gov/show/NCT04539262,None
6895,NCT04540120,ClinicalTrials.gov,2020-08-13,2020-09-25,False,Olatec Therapeutics LLC,Recruiting,Phase 2,Interventional,"United States, Switzerland",Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome,Drug,Dapansutrile,Dapansutrile,80,https://clinicaltrials.gov/show/NCT04540120,None
6896,NCT04542226,ClinicalTrials.gov,2020-09-08,2020-03-31,True,NPO Petrovax,Not Recruiting,Not Applicable,Observational,"Belarus, Russian Federation",Observational Open Study of Polyoxidonium in Hospitalized Patients With COVID-19,Drug,Polyoxidonium,Polyoxidonium,81,https://clinicaltrials.gov/show/NCT04542226,None
6897,NCT04545060,ClinicalTrials.gov,2020-09-04,2020-08-27,True,"Vir Biotechnology, Inc.",Recruiting,Phase 2/Phase 3,Interventional,"Spain, Chile, France, Canada, Brazil, United Kingdom, Peru, United States, Austria",VIR-7831 for the Early Treatment of COVID-19 in Outpatients,Drug,VIR-7831,VIR-7831,1360,https://clinicaltrials.gov/show/NCT04545060,None
6898,NCT04546581,ClinicalTrials.gov,2020-09-08,2020-10-08,True,University of Minnesota,Recruiting,Phase 3,Interventional,"Denmark, Nigeria, Greece, Japan, Argentina, United Kingdom, United States, Spain",Inpatient Treatment With Anti-Coronavirus Immunoglobulin (ITAC),ATMP (+ Drug),Immunoglobulin + Remdesivir vs. Remdesivir,Immunoglobulin; Remdesivir,500,https://clinicaltrials.gov/show/NCT04546581,EUCTR2020-002542-16; JPRN-jRCT2031200174
6899,NCT04549922,ClinicalTrials.gov,2020-09-09,2020-10-22,False,Hospital do Coração,Not Recruiting,Phase 2,Interventional,Brazil,Antisense Therapy to Block the Kallikrein-kinin Pathway in COVID-19,Drug,ISIS 721744,ISIS 721744,111,https://clinicaltrials.gov/show/NCT04549922,None
6900,NCT04552366,ClinicalTrials.gov,2020-09-15,2020-09-29,False,"Insitute of Biotechnology, Academy of Military Medical Sciences, PLA of China",Not Recruiting,Phase 1,Interventional,China,A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults,ATMP,Vaccine,Vaccine,149,https://clinicaltrials.gov/show/NCT04552366,None
6901,NCT04552379,ClinicalTrials.gov,2020-08-21,2020-12-01,False,Pontificia Universidad Católica de Chile,Recruiting,Phase 3,Interventional,Chile,The Containing Coronavirus Disease 19 (COVID-19) Trial,Drug,Interferon beta,Interferon beta,1240,https://clinicaltrials.gov/show/NCT04552379,None
6902,NCT04553055,ClinicalTrials.gov,2020-09-15,2020-07-20,True,Beni-Suef University,Not Recruiting,Not Applicable,Observational,Egypt,Antibiotic Misuse During COVID-19 Pandemic,Health System,No Intervention,No Intervention,413,https://clinicaltrials.gov/show/NCT04553055,None
6903,NCT04555096,ClinicalTrials.gov,2020-09-16,2020-09-09,True,"Galera Therapeutics, Inc.",Recruiting,Phase 2,Interventional,United States,A Trial of GC4419 in Patients With Critical Illness Due to COVID-19,Drug,GC4419,GC4419,50,https://clinicaltrials.gov/show/NCT04555096,None
6904,NCT04556149,ClinicalTrials.gov,2020-05-23,2020-10-01,False,"Level 42 AI, Inc.",Recruiting,Not Applicable,Observational,United States,"imPulseâ„¢ Una Full-spectrum, Over Clothing E-stethoscope",Other (device),e-stethoscope,e-stethoscope,30,https://clinicaltrials.gov/show/NCT04556149,None
6905,NCT04558372,ClinicalTrials.gov,2020-09-20,2020-04-01,True,Gadjah Mada University,Recruiting,Not Applicable,Interventional,Indonesia,Genosvid Diagnostic Test for Early Detection of COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1543,https://clinicaltrials.gov/show/NCT04558372,None
6906,NCT04559113,ClinicalTrials.gov,2020-09-15,2020-05-01,True,Lahore General Hospital,Recruiting,Not Applicable,Interventional,Pakistan,Methylprednisolone in COVID-19 Patients (Methyl19LGH),Drug,Corticosteroids,Methylprednisolone,200,https://clinicaltrials.gov/show/NCT04559113,None
6907,NCT04560205,ClinicalTrials.gov,2020-07-11,2020-05-01,True,Lahore General Hospital,Recruiting,Phase 1,Interventional,Pakistan,Tocilizumab in COVID-19 Lahore General Hospital,Drug,Tocilizumab,Tocilizumab,50,https://clinicaltrials.gov/show/NCT04560205,None
6908,NCT04560257,ClinicalTrials.gov,2020-07-13,2020-05-01,True,Lahore General Hospital,Recruiting,Not Applicable,Interventional,Pakistan,High Flow Nasal Cannula HFNC In Covid-19 Patients,Other (device),Nasal cannula,Nasal cannula,30,https://clinicaltrials.gov/show/NCT04560257,None
6909,NCT04560608,ClinicalTrials.gov,2020-09-08,2020-03-15,True,"University Hospital, Angers",Recruiting,Not Applicable,Observational,France,"Elucidating the Symptomatic, Explanatory and Prognostic Characteristics of GERIAtric Patients Hospitalized for COVID-19",Clinical Presentation,No Intervention,No Intervention,255,https://clinicaltrials.gov/show/NCT04560608,None
6910,NCT04564274,ClinicalTrials.gov,2020-09-24,2020-12-17,False,"National Heart, Lung, and Blood Institute (NHLBI)",Recruiting,Not Applicable,Observational,United States,COV2Base-A Rare Disease by COVID Study,Clinical Presentation,No Intervention,No Intervention,120000,https://clinicaltrials.gov/show/NCT04564274,None
6911,NCT04564716,ClinicalTrials.gov,2020-09-24,2020-09-28,False,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",Not Recruiting,Phase 3,Interventional,Belarus,"Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus",ATMP,Vaccine,Vaccine,100,https://clinicaltrials.gov/show/NCT04564716,None
6912,NCT04565067,ClinicalTrials.gov,2020-09-24,2020-12-17,False,National Institute on Aging (NIA),Recruiting,Not Applicable,Observational,United States,Identification and Characterization of SARS-CoV-2 Specific CD8 T Cells in Humans,Clinical Presentation,No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04565067,None
6913,NCT04565080,ClinicalTrials.gov,2020-09-24,2020-12-17,False,National Institute of Neurological Disorders and Stroke (NINDS),Recruiting,Not Applicable,Observational,United States,Clinical Correlates of COVID-19 Pandemic in Patients With Functional Movement Disorder (FMD) and Parkinson's Disease (PD),Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04565080,None
6914,NCT04565197,ClinicalTrials.gov,2020-09-24,2020-05-01,True,Lahore General Hospital,Not Recruiting,Phase 1,Interventional,Pakistan,Convalescent Plasma Therapy for COVID-19 Patients,ATMP,Plasma,Plasma,20,https://clinicaltrials.gov/show/NCT04565197,None
6915,NCT04568031,ClinicalTrials.gov,2020-08-21,2020-08-23,False,AstraZeneca,Not Recruiting,Phase 1/Phase 2,Interventional,Japan,Study of AZD1222 for the Prevention of COVID-19 in Japan,Drug (Chemoprophylaxis),AZD1222,AZD1222,256,https://clinicaltrials.gov/show/NCT04568031,None
6916,NCT04568122,ClinicalTrials.gov,2020-09-25,2020-11-20,False,Stanford University,Recruiting,Not Applicable,Interventional,United States,"Rapid Turnaround, Home-based Saliva Testing for COVID-19",Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,3015,https://clinicaltrials.gov/show/NCT04568122,None
6917,NCT04569786,ClinicalTrials.gov,2020-09-24,2020-10-29,False,Merck Sharp & Dohme Corp.,Recruiting,Phase 1,Interventional,United States,Dose Ranging Trial to Assess Safety and Immunogenicity of V590 (COVID-19 Vaccine) in Healthy Adults (V590-001),ATMP,Vaccine,Vaccine,252,https://clinicaltrials.gov/show/NCT04569786,None
6918,NCT04570189,ClinicalTrials.gov,2020-09-17,2020-10-01,False,AusculSciences Canada Inc.,Recruiting,Not Applicable,Observational,Canada,"Evaluating Auscul-X, a Touch Free Digital Stethoscope",Other (device),Digital stethoscope,Digital stethoscope,40,https://clinicaltrials.gov/show/NCT04570189,None
6919,NCT04575038,ClinicalTrials.gov,2020-10-01,2020-11-19,False,"Clear Creek Bio, Inc.",Recruiting,Phase 2,Interventional,United States,CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19,Drug,Brequinar,Brequinar,100,https://clinicaltrials.gov/show/NCT04575038,None
6920,NCT04575584,ClinicalTrials.gov,2020-09-30,2020-10-19,True,Merck Sharp & Dohme Corp.,Recruiting,Phase 2/Phase 3,Interventional,"Colombia, South Korea, Chile, Israel, Russian Federation, France, Poland, Brazil, United Kingdom, United States, South Africa, Ukraine, Spain",Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001),Drug,Molnupiravir,Molnupiravir,1300,https://clinicaltrials.gov/show/NCT04575584,EUCTR2020-003367-26
6921,NCT04575610,ClinicalTrials.gov,2020-08-05,2020-11-30,False,Yale University,Recruiting,Phase 2,Interventional,United States,IRAK4 Inhibition in Treatment of COVID-19 With ARDS (I-RAMIC),Drug,PF-06650833,PF-06650833,68,https://clinicaltrials.gov/show/NCT04575610,None
6922,NCT04578132,ClinicalTrials.gov,2020-10-06,2020-11-24,False,Spanish Oncology Genito-Urinary Group,Recruiting,Not Applicable,Observational,Spain,Description of the Population With Genitourinary Tumors and COVID-19,Clinical Presentation,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04578132,None
6923,NCT04579393,ClinicalTrials.gov,2020-10-06,2020-10-08,False,"National Heart, Lung, and Blood Institute (NHLBI)",Recruiting,Phase 2,Interventional,United States,Fostamatinib for Hospitalized Adults With COVID-19,Drug,Fostamatinib,Fostamatinib,80,https://clinicaltrials.gov/show/NCT04579393,None
6924,NCT04582903,ClinicalTrials.gov,2020-10-09,2020-12-17,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Not Applicable,Observational,United States,Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04582903,None
6925,NCT04583189,ClinicalTrials.gov,2020-10-01,2020-10-01,False,Centre Hospitalier Intercommunal Creteil,Not Recruiting,Not Applicable,Interventional,France,Evaluation of the Performance of the Covid-19 Ag BSS Rapid Antigenic Test in Symptomatic Children in a Pediatric Emergency Department,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,https://clinicaltrials.gov/show/NCT04583189,None
6926,NCT04583592,ClinicalTrials.gov,2020-10-07,2020-11-09,False,Sagent Pharmaceuticals Inc.,Recruiting,Phase 2,Interventional,United States,Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID-19 (CAMELOT),Drug,Camostat Mesilate,Camostat Mesilate,300,https://clinicaltrials.gov/show/NCT04583592,None
6927,NCT04583956,ClinicalTrials.gov,2020-10-09,2020-10-14,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Phase 2,Interventional,United States,ACTIV-5 / Big Effect Trial (BET-A) for the Treatment of COVID-19,Drug,Risankizumab + Remdesivir vs. Remdesivir,Risankizumab; Remdesivir,200,https://clinicaltrials.gov/show/NCT04583956,None
6928,NCT04583969,ClinicalTrials.gov,2020-10-09,2020-10-19,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Phase 2,Interventional,United States,ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19,Drug,Lenzilumab + Remdesivir vs. Remdesivir,Lenzilumab; Remdesivir,200,https://clinicaltrials.gov/show/NCT04583969,None
6929,NCT04583982,ClinicalTrials.gov,2020-10-07,2020-10-09,False,Adaptive Biotechnologies,Recruiting,Not Applicable,Observational,United States,ImmuneSenseâ„¢ COVID-19 Study,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,125,https://clinicaltrials.gov/show/NCT04583982,None
6930,NCT04584567,ClinicalTrials.gov,2020-10-06,2020-11-20,False,Hedi Gharsallah,Recruiting,Phase 3,Interventional,Tunisia,"OD-doxy-PNV-COV Old Drug "" DOXY "" for Prevention of New Virus Virus OD-doxy-PNV",Drug,Doxycyclin,Doxycyclin,1100,https://clinicaltrials.gov/show/NCT04584567,None
6931,NCT04584658,ClinicalTrials.gov,2020-10-10,2020-09-15,True,Cambridge University Hospitals NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19) Infection (DYADS Study),Clinical Presentation,No Intervention,No Intervention,36,https://clinicaltrials.gov/show/NCT04584658,None
6932,NCT04588363,ClinicalTrials.gov,2020-10-12,2020-11-19,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Not Applicable,Observational,United States,COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C (PRISM),Clinical Presentation,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04588363,None
6933,NCT04588792,ClinicalTrials.gov,2020-10-14,2020-12-11,False,Queen's University,Recruiting,Phase 2/Phase 3,Interventional,Canada,Furosemide as Supportive Therapy for COVID-19 Respiratory Failure,Drug,Furosemide,Furosemide,640,https://clinicaltrials.gov/show/NCT04588792,None
6934,NCT04590794,ClinicalTrials.gov,2020-10-14,2020-10-11,True,University of Thessaly,Recruiting,Not Applicable,Observational,Greece,SuPAR in Adult Patients With Covid-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,500,https://clinicaltrials.gov/show/NCT04590794,None
6935,NCT04592549,ClinicalTrials.gov,2020-10-12,2020-12-04,False,Ology Bioservices,Recruiting,Phase 1,Interventional,United States,"This is a Phase 1 Clinical Trial to Evaluate the Safety, Pharmacokinetics, and Immunogenicity of ADM03820, a Monoclonal Antibody Cocktail Being Tested for the Treatment and Prevention of COVID-19",Drug,ADM03820,ADM03820,40,https://clinicaltrials.gov/show/NCT04592549,None
6936,NCT04595773,ClinicalTrials.gov,2020-10-20,2020-12-17,False,National Institutes of Health Clinical Center (CC),Not Recruiting,Phase 1/Phase 2,Interventional,United States,"COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE)",Other (exercise),Exercise,Exercise,90,https://clinicaltrials.gov/show/NCT04595773,None
6937,NCT04601077,ClinicalTrials.gov,2020-10-21,2020-11-01,False,Nitric Oxide Innovations LLC,Recruiting,Phase 1/Phase 2,Interventional,United States,The Evaluation of Nitric Oxide Generating Lozenges on Outcome in Newly Diagnosed COVID-19 Patient of African Americans,Drug,Nitric Oxide,Nitric Oxide,100,https://clinicaltrials.gov/show/NCT04601077,None
6938,NCT04602351,ClinicalTrials.gov,2020-10-21,2021-01-15,False,NMC Specialty Hospital,Not Recruiting,Not Applicable,Observational,United Arab Emirates,Communication in ICU During COVID-19,Other,No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04602351,None
6939,NCT04602507,ClinicalTrials.gov,2020-10-22,2020-12-07,False,CES University,Recruiting,Phase 2,Interventional,Colombia,Ivermectin in Adults With Severe COVID-19.,Drug,Ivermectin,Ivermectin,100,https://clinicaltrials.gov/show/NCT04602507,None
6940,NCT04603690,ClinicalTrials.gov,2020-10-24,2020-12-15,False,Liaquat University of Medical & Health Sciences,Not Recruiting,Phase 3,Interventional,No Country Given,Study to Investigate the Benefits of Colchicine in Patients With COVID-19,Drug,Colchicine,Colchicine,0,https://clinicaltrials.gov/show/NCT04603690,None
6941,NCT04603781,ClinicalTrials.gov,2020-10-03,2020-12-04,False,"University of Texas, Austin",Recruiting,Phase 2/Phase 3,Interventional,United States,CBD Oil for Reducing Emotional Impact of COVID-19,Drug,CBD Oil,CBD Oil,120,https://clinicaltrials.gov/show/NCT04603781,None
6942,NCT04604184,ClinicalTrials.gov,2020-10-26,2020-11-03,False,Boehringer Ingelheim,Recruiting,Phase 2,Interventional,United States,ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19,Drug,BI 764198,BI 764198,90,https://clinicaltrials.gov/show/NCT04604184,None
6943,NCT04605588,ClinicalTrials.gov,2020-10-26,2020-12-02,False,Rutgers University,Recruiting,Phase 2,Interventional,United States,A Triple Combination Antiviral Coronavirus Therapy (TriACT) for COVID-19,Drug,Nitazoxanide + Ribavirin + Hydroxychloroquine,itazoxanide; Ribavirin; Hydroxychloroquine,70,https://clinicaltrials.gov/show/NCT04605588,None
6944,NCT04605965,ClinicalTrials.gov,2020-08-12,2020-06-09,True,Tulane University,Recruiting,Not Applicable,Observational,United States,WEAICOR: Wearables to Investigate the Long Term Cardiovascular and Behavioral Impacts of COVID-19,Other (device),Biosensors,Biosensors,100,https://clinicaltrials.gov/show/NCT04605965,None
6945,NCT04606407,ClinicalTrials.gov,2020-10-22,2020-11-25,False,Beyond Air Inc.,Recruiting,Not Applicable,Interventional,Israel,Inhaled NO for the Treatment of Viral Pneumonia in Adults,Drug,Nitric Oxide,Nitric Oxide,90,https://clinicaltrials.gov/show/NCT04606407,None
6946,NCT04606784,ClinicalTrials.gov,2020-10-27,2020-10-28,False,Ampio Pharmaceuticals. Inc.,Recruiting,Phase 1,Interventional,United States,Study of Nebulized Ampion for the Treatment of Adult COVID-19 Patients With Respiratory Distress,Drug,Ampion,Ampion,40,https://clinicaltrials.gov/show/NCT04606784,None
6947,NCT04608097,ClinicalTrials.gov,2020-10-28,2020-10-28,False,Uppsala University,Recruiting,Not Applicable,Interventional,Sweden,Understanding Reactions to Emotional Material in the Media During COVID-19,Other,Other,Other,66,https://clinicaltrials.gov/show/NCT04608097,None
6948,NCT04608201,ClinicalTrials.gov,2020-10-23,2020-12-09,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Phase 3,Interventional,France,Evaluation of the Efficacy of Nicotine Patches in SARS-CoV2 (COVID-19) Infection in Hospitalized Patients,Drug,Nicotine,Nicotine,220,https://clinicaltrials.gov/show/NCT04608201,None
6949,NCT04608266,ClinicalTrials.gov,2020-10-28,2020-12-03,False,Assistance Publique – Hôpitaux de Paris,Recruiting,Phase 3,Interventional,France,CAMOVID : Evaluation of Efficacy and Safety of Camostat Mesylate for the Treatment of SARS-CoV-2 Infection - COVID-19 in Ambulatory Adult Patients,Drug,Camostat Mesilate,Camostat Mesilate,596,https://clinicaltrials.gov/show/NCT04608266,None
6950,NCT04609969,ClinicalTrials.gov,2020-10-28,2020-10-13,True,Centre Hospitalier Régional d'Orleans,Not Recruiting,Not Applicable,Interventional,France,Diagnostic Performance Evaluation of a Novel SARS-CoV-2 (COVID-19) Antigen Detection Test,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://clinicaltrials.gov/show/NCT04609969,None
6951,NCT04613245,ClinicalTrials.gov,2020-10-29,2020-05-01,True,Cairo University,Recruiting,Not Applicable,Observational,Egypt,Health-Related Quality of Life of Patients With Asthma During the Pandemic of COVID-19,Other,No Intervention,No Intervention,400,https://clinicaltrials.gov/show/NCT04613245,None
6952,NCT04614844,ClinicalTrials.gov,2020-11-02,2020-12-15,False,Yale University,Not Recruiting,Not Applicable,Interventional,United States,COVID-19 Responsive Intervention: Systems Improvement Simulations (CRI:SIS),Other (psych),Psychological,Psychological,84,https://clinicaltrials.gov/show/NCT04614844,None
6953,NCT04619693,ClinicalTrials.gov,2020-11-02,2020-11-18,False,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Biomarkers for Dexamethasone Response in Sars-Cov-2 / COVID-19 Pneumonia,Drug,Corticosteroids,Dexamethasone,100,https://clinicaltrials.gov/show/NCT04619693,None
6954,NCT04625725,ClinicalTrials.gov,2020-11-10,2020-11-21,True,AstraZeneca,Recruiting,Phase 3,Interventional,"France, Belgium, United Kingdom, United States, Spain","Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.",Drug (Chemoprophylaxis),AZD1061,AZD1061,5000,https://clinicaltrials.gov/show/NCT04625725,EUCTR2020-004356-16
6955,NCT04625972,ClinicalTrials.gov,2020-11-10,2020-12-02,True,AstraZeneca,Recruiting,Phase 3,Interventional,"United Kingdom, United States","Phase III Double-blind, Placebo-controlled Study of AZD7442 for Post- Exposure Prophylaxis of COVID-19 in Adults",Drug (Chemoprophylaxis),AZD1061,AZD1061,1125,https://clinicaltrials.gov/show/NCT04625972,EUCTR2020-004719-28
6956,NCT04628208,ClinicalTrials.gov,2020-11-12,2020-11-17,False,Spartan Bioscience Inc.,Recruiting,Not Applicable,Observational,Canada,Clinical Study Spartan COVID-19 V2 System (Canada Alternate),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,60,https://clinicaltrials.gov/show/NCT04628208,None
6957,NCT04632537,ClinicalTrials.gov,2020-11-04,2020-12-07,False,Henry M. Jackson Foundation for the Advancement of Military Medicine,Recruiting,Phase 3,Interventional,United States,BCG Vaccination to Prevent COVID-19,ATMP,Vaccine,Vaccine,550,https://clinicaltrials.gov/show/NCT04632537,None
6958,NCT04634318,ClinicalTrials.gov,2020-11-17,2020-12-10,False,Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer,Recruiting,Not Applicable,Interventional,France,Organization of Pulmonary Rehabilitation of Post-COVID-19 Patient With Sequelae (REHABCOVID),Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,118,https://clinicaltrials.gov/show/NCT04634318,None
6959,NCT04634409,ClinicalTrials.gov,2020-11-17,2020-10-29,True,Eli Lilly and Company,Recruiting,Phase 2,Interventional,"United States, Puerto Rico",A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness,Drug,LY3819253 + LY3832479 vs. LY3819253,LY3819253; LY3832479,500,https://clinicaltrials.gov/show/NCT04634409,None
6960,NCT04634903,ClinicalTrials.gov,2020-11-11,2020-11-19,False,Stony Brook University,Not Recruiting,Not Applicable,Interventional,United States,"Testing Scalable, Single-Session Interventions for Adolescent Depression in the Context of COVID-19",Other (psych),Psychological,Psychological,2409,https://clinicaltrials.gov/show/NCT04634903,None
6961,NCT04636034,ClinicalTrials.gov,2020-11-18,2020-12-01,False,University Hospital Bispebjerg and Frederiksberg,Not Recruiting,Phase 3,Interventional,Denmark,The Effect of Ganglion Sphenopalatine Block Versus Placebo on Persistent Headache Following COVID-19 Infection,Procedure,Sphenopalatine Ganglion Block,Sphenopalatine Ganglion Block,60,https://clinicaltrials.gov/show/NCT04636034,None
6962,NCT04637867,ClinicalTrials.gov,2020-11-16,2020-11-23,False,Hospices Civils de Lyon,Recruiting,Not Applicable,Interventional,France,COVID-19 - Multicentre Study on Nosocomial Transmission of SARS-CoV-2 Virus: an Ancillary Study (NOSO-COR IMMUNO),Clinical Presentation (Epidemiology),No Intervention,No Intervention,200,https://clinicaltrials.gov/show/NCT04637867,None
6963,NCT04638673,ClinicalTrials.gov,2020-11-18,2020-11-19,False,Medical University of South Carolina,Recruiting,Phase 2,Interventional,United States,NeuroCovid Rehab and Recovery Related to COVID-19 Diagnosis,Other (device),vagus nerve stimulation,vagus nerve stimulation,30,https://clinicaltrials.gov/show/NCT04638673,None
6964,NCT04639466,ClinicalTrials.gov,2020-11-04,2020-12-23,False,City of Hope Medical Center,Recruiting,Phase 1,Interventional,United States,"A Synthetic MVA-based SARS-CoV-2 Vaccine, COH04S1, for the Prevention of COVID-19",ATMP,Vaccine,Vaccine,129,https://clinicaltrials.gov/show/NCT04639466,None
6965,NCT04640038,ClinicalTrials.gov,2020-11-19,2020-12-01,False,Children's Hospital of Philadelphia,Recruiting,Phase 3,Interventional,United States,Contrast Enhanced Ultrasound in COVID-19,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,30,https://clinicaltrials.gov/show/NCT04640038,None
6966,NCT04640168,ClinicalTrials.gov,2020-11-19,2020-11-24,False,National Institute of Allergy and Infectious Diseases (NIAID),Recruiting,Phase 3,Interventional,United States,Adaptive COVID-19 Treatment Trial 4 (ACTT-4),Drug,Baricitinib + Remdesivir vs. Remdesivir + Corticosteroids,Baricitinib; Remdesivir; Dexamethasone,1500,https://clinicaltrials.gov/show/NCT04640168,None
6967,NCT04640194,ClinicalTrials.gov,2020-11-20,2020-12-07,True,Boehringer Ingelheim,Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,A Study to Test Whether Different Doses of Alteplase Help People With Severe Breathing Problems Because of COVID-19,Drug,Alteplase,Alteplase,270,https://clinicaltrials.gov/show/NCT04640194,EUCTR2020-002913-16
6968,NCT04641858,ClinicalTrials.gov,2020-11-22,2020-12-03,False,University of Southern Denmark,Recruiting,Phase 4,Interventional,"Mozambique, Cape Verde, Guinea-Bissau",BCG to Reduce Absenteeism Among Health Care Workers During the COVID-19 Pandemic,ATMP,Vaccine,Vaccine,1050,https://clinicaltrials.gov/show/NCT04641858,None
6969,NCT04642638,ClinicalTrials.gov,2020-11-23,2020-11-30,False,Inovio Pharmaceuticals,Recruiting,Phase 2/Phase 3,Interventional,United States,"Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Healthy Seronegative Adults at High Risk of SARS-CoV-2 Exposure",Drug,INO-4800,INO-4800,6578,https://clinicaltrials.gov/show/NCT04642638,None
6970,NCT04643678,ClinicalTrials.gov,2020-11-24,2020-10-30,True,Hamad Medical Corporation,Recruiting,Phase 2/Phase 3,Interventional,Qatar,Anakinra in the Management of COVID-19 Infection,Drug,Anakinra,Anakinra,80,https://clinicaltrials.gov/show/NCT04643678,None
6971,NCT04646239,ClinicalTrials.gov,2020-11-20,2020-12-01,False,Washington University in St. Louis,Not Recruiting,Not Applicable,Observational,No Country Given,Biomarkers of Trained Immunity Following MMR Vaccination,Not relevant,Not relevant,Not relevant,80,https://clinicaltrials.gov/show/NCT04646239,None
6972,NCT04646603,ClinicalTrials.gov,2020-11-24,2021-01-05,False,Medical University Innsbruck,Not Recruiting,Phase 1/Phase 2,Interventional,No Country Given,MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients,Drug,MRG-001,MRG-001,12,https://clinicaltrials.gov/show/NCT04646603,None
6973,NCT04646616,ClinicalTrials.gov,2020-11-25,2021-01-06,False,Drexel University,Not Recruiting,Not Applicable,Interventional,United States,CRISOL Contigo: a Multi-level Intervention to Reduce the Disproportionate Toll of COVID-19 Among Latino Communities in Philadelphia.,Other,Other,Other,800,https://clinicaltrials.gov/show/NCT04646616,None
6974,NCT04647682,ClinicalTrials.gov,2020-10-29,2020-11-01,False,"University Hospital, Toulouse",Recruiting,Not Applicable,Observational,France,Physical Activity Program Implementation in Hospitalized Positive Covid-19 Older Adults,Other (exercise),Exercise,Exercise,30,https://clinicaltrials.gov/show/NCT04647682,None
6975,NCT04647695,ClinicalTrials.gov,2020-11-27,2020-11-20,True,University of Hong Kong,Recruiting,Phase 2,Interventional,Hong Kong,IFN-beta 1b and Remdesivir for COVID19,Drug,Interferon beta + Remdesivir vs. Remdesivir,Interferon beta; Remdesivir,100,https://clinicaltrials.gov/show/NCT04647695,None
6976,NCT04647747,ClinicalTrials.gov,2020-11-27,2020-11-30,False,Østfold Hospital Trust,Not Recruiting,Not Applicable,Interventional,No Country Given,Silent Hypoxia and Awake Proning in COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04647747,None
6977,NCT04647994,ClinicalTrials.gov,2020-11-23,2020-09-21,True,University of São Paulo General Hospital,Recruiting,Not Applicable,Observational,Brazil,Exploratory Study: COVID-19 and Pregnancy,Clinical Presentation (Epidemiology),No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04647994,None
6978,NCT04648800,ClinicalTrials.gov,2020-10-18,2020-07-07,True,Hanna Czajka,Recruiting,Phase 3,Interventional,Poland,Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland,ATMP,Vaccine,Vaccine,1000,https://clinicaltrials.gov/show/NCT04648800,EUCTR2020-002111-22
6979,NCT04649086,ClinicalTrials.gov,2020-09-29,2020-06-05,True,"University Hospital, Clermont-Ferrand",Recruiting,Not Applicable,Interventional,France,Muscular Rehabilitation by Eccentric Exercise After Severe COVID-19 Infection,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,120,https://clinicaltrials.gov/show/NCT04649086,None
6980,NCT04649151,ClinicalTrials.gov,2020-11-30,2020-11-30,False,"ModernaTX, Inc.",Not Recruiting,Phase 2/Phase 3,Interventional,United States,"A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19",ATMP,Vaccine,Vaccine,3000,https://clinicaltrials.gov/show/NCT04649151,None
6981,NCT04649320,ClinicalTrials.gov,2020-11-30,2020-11-23,True,Medical University Innsbruck,Recruiting,Not Applicable,Observational,Austria,Perception of the COVID-19 Pandemic in Patients With Haematological or Solid Neoplasias,Other,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04649320,None
6982,NCT04649333,ClinicalTrials.gov,2020-11-30,2020-06-15,True,Medical University Innsbruck,Not Recruiting,Not Applicable,Observational,Austria,COVID-19 and Sports - an Online Survey on the Impact of the Pandemic and Possible Preventive Measures,Other,No Intervention,No Intervention,1336,https://clinicaltrials.gov/show/NCT04649333,None
6983,NCT04649424,ClinicalTrials.gov,2020-11-27,2020-12-01,False,Orthopaedic Innovation Centre,Not Recruiting,Not Applicable,Interventional,Canada,COVID-19 Nasal Swab Trial,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,72,https://clinicaltrials.gov/show/NCT04649424,None
6984,NCT04649515,ClinicalTrials.gov,2020-11-26,2020-12-04,False,Tychan Pte Ltd.,Recruiting,Phase 3,Interventional,Singapore,"Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans",Drug,TY027,TY027,1305,https://clinicaltrials.gov/show/NCT04649515,None
6985,NCT04649658,ClinicalTrials.gov,2020-11-30,2020-03-01,True,University of Modena and Reggio Emilia,Not Recruiting,Not Applicable,Observational,Italy,Pronation in COVID-19 Patients Undergoing Non Invasive Respiratory Support,Procedure,Positioning,Positioning,93,https://clinicaltrials.gov/show/NCT04649658,None
6986,NCT04649736,ClinicalTrials.gov,2020-11-30,2020-10-26,True,Universidad Peruana Cayetano Heredia,Recruiting,Not Applicable,Interventional,Peru,Home-based Respiratory Physiotherapy and Telephone-Based Psychological Support in Severe COVID-19 Patients,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,108,https://clinicaltrials.gov/show/NCT04649736,None
6987,NCT04649775,ClinicalTrials.gov,2020-10-14,2020-12-04,False,Duke University,Not Recruiting,Not Applicable,Interventional,No Country Given,AirFLO2 Treatment for Hypoxia and/or Tachypnea in Patients With COVID-19,Drug,Oxygen,Oxygen,50,https://clinicaltrials.gov/show/NCT04649775,None
6988,NCT04649827,ClinicalTrials.gov,2020-11-26,2020-04-02,True,Escola de Saúde Pública do Ceará,Recruiting,Not Applicable,Observational,Brazil,A Clinical Trial for Hospitalized Patients With COVID-19 in CearÃ¡: ResCOVID Study,Clinical Presentation,No Intervention,No Intervention,3000,https://clinicaltrials.gov/show/NCT04649827,None
6989,NCT04649840,ClinicalTrials.gov,2020-12-01,2020-10-01,True,Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus,Recruiting,Not Applicable,Observational,Belarus,Estimation of Dynamics of Humoral and Cellular Immunity in COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04649840,None
6990,NCT04649879,ClinicalTrials.gov,2020-12-01,2020-12-03,False,Joakim Dillner,Not Recruiting,Phase 2/Phase 3,Interventional,Sweden,Convalescent Plasma for Treatment of COVID-19: An Open Randomised Controlled Trial,ATMP,Plasma,Plasma,920,https://clinicaltrials.gov/show/NCT04649879,None
6991,NCT04649918,ClinicalTrials.gov,2020-11-25,2020-11-25,False,Schön Klinik Berchtesgadener Land,Recruiting,Not Applicable,Observational,Germany,Short and Medium-term Effects of Pulmonary Rehabilitation in Mild to Critical Post-acute COVID-19,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,50,https://clinicaltrials.gov/show/NCT04649918,None
6992,NCT04649931,ClinicalTrials.gov,2020-11-25,2020-12-01,False,B. Braun Melsungen AG,Not Recruiting,Not Applicable,Observational,Germany,Differences in Exhaled Breath by Using Ion Mobility Spectrometry (IMS) in Subjects Tested for SARS-CoV-2 Infection (COVID-19 Disease),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,400,https://clinicaltrials.gov/show/NCT04649931,None
6993,NCT04649944,ClinicalTrials.gov,2020-11-26,2020-12-05,False,University of Milan,Not Recruiting,Not Applicable,Observational,Italy,Serological Profile of Children and Young Adolescents With at Least One COVID-19 Diagnosed Family Member,Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04649944,None
6994,NCT04649957,ClinicalTrials.gov,2020-12-01,2021-01-04,False,University of Derby,Not Recruiting,Not Applicable,Observational,United Kingdom,Profiling Recovery of Those Discharged Into the Community With COVID-19,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04649957,None
6995,NCT04649996,ClinicalTrials.gov,2020-12-01,2020-09-01,True,University of Milano Bicocca,Not Recruiting,Not Applicable,Observational,Italy,Variation in Acute Appendicitis During COVID-19 Pandemic in Italy,Other,No Intervention,No Intervention,532,https://clinicaltrials.gov/show/NCT04649996,None
6996,NCT04650035,ClinicalTrials.gov,2020-12-01,2020-11-01,True,Yarmouk University,Not Recruiting,Not Applicable,Observational,Jordan,The Impact of COVID-19 on Surgical Practice in Jordan During the Second Outbreak,Other,No Intervention,No Intervention,60,https://clinicaltrials.gov/show/NCT04650035,None
6997,NCT04650087,ClinicalTrials.gov,2020-11-30,2020-12-01,False,Dr. Thomas Ortel,Not Recruiting,Phase 3,Interventional,No Country Given,COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis,Drug,Apixaban,Apixaban,5320,https://clinicaltrials.gov/show/NCT04650087,None
6998,NCT04650178,ClinicalTrials.gov,2020-08-19,2020-05-26,True,M.D. Anderson Cancer Center,Recruiting,Not Applicable,Observational,United States,Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials,Other (psych),No Intervention,No Intervention,274,https://clinicaltrials.gov/show/NCT04650178,None
6999,NCT04650191,ClinicalTrials.gov,2020-11-30,2020-03-01,True,Milton S. Hershey Medical Center,Recruiting,Not Applicable,Observational,United States,Surfactant Protein Genetic Variants in COVID-19 Infection,Genomics,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04650191,None
7000,NCT04651374,ClinicalTrials.gov,2020-11-27,2020-12-01,False,Lawson Health Research Institute,Not Recruiting,Not Applicable,Interventional,Canada,COVID-19 And Geko Evaluation: The CAGE Study,Other (device),Geko device,Geko device,40,https://clinicaltrials.gov/show/NCT04651374,None
7001,NCT04651387,ClinicalTrials.gov,2020-12-01,2021-01-01,False,Neuromed IRCCS,Not Recruiting,Not Applicable,Interventional,No Country Given,Efficacy and Safety of Ozonised Oil (HOO) in COVID-19 Patients,Supplement,Ozonised Oil,Ozonised Oil,74,https://clinicaltrials.gov/show/NCT04651387,None
7002,NCT04651400,ClinicalTrials.gov,2020-11-19,2020-10-19,True,Octapharma,Recruiting,Not Applicable,Observational,"France, Austria, Germany","Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 Infection",Drug,Antithrombin III,Antithrombin III,300,https://clinicaltrials.gov/show/NCT04651400,None
7003,NCT04651413,ClinicalTrials.gov,2020-12-02,2020-11-24,True,University Hospitals of North Midlands NHS Trust,Recruiting,Not Applicable,Observational,United Kingdom,PCR Cycle Threshold Values and COVID-19 Outcomes,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,800,https://clinicaltrials.gov/show/NCT04651413,None
7004,NCT04651790,ClinicalTrials.gov,2020-11-20,2020-11-27,False,Pontificia Universidad Católica de Chile,Recruiting,Phase 3,Interventional,Chile,"Efficacy, Safety, and Immunogenicity of an Inactivated Vaccine Against COVID-19 in High Infection Risk Adults",ATMP,Vaccine,Vaccine,2300,https://clinicaltrials.gov/show/NCT04651790,None
7005,NCT04652102,ClinicalTrials.gov,2020-12-01,2020-11-30,True,CureVac AG,Not Recruiting,Phase 2/Phase 3,Interventional,Germany,A Study to Determine the Safety and Efficacy of SARS-CoV-2 mRNA Vaccine CVnCoV in Adults,ATMP,Vaccine,Vaccine,36500,https://clinicaltrials.gov/show/NCT04652102,EUCTR2020-003998-22
7006,NCT04652115,ClinicalTrials.gov,2020-12-01,2021-01-01,False,Brigham and Women's Hospital,Not Recruiting,Phase 2,Interventional,United States,A Single-Arm Safety and Feasibility Study of Defibrotide for the Treatment of Severe COVID-19,Drug,Defibrotide,Defibrotide,42,https://clinicaltrials.gov/show/NCT04652115,None
7007,NCT04652505,ClinicalTrials.gov,2020-09-11,2020-07-13,True,M.D. Anderson Cancer Center,Recruiting,Not Applicable,Observational,United States,"Effect of the COVID-19 Public Health Crisis on the Mental Health and Physical Well-Being of Cancer Patients, the Coping With COVID Study",Other (psych),No Intervention,No Intervention,700,https://clinicaltrials.gov/show/NCT04652505,None
7008,NCT04652518,ClinicalTrials.gov,2020-12-02,2020-12-01,True,PureTech,Not Recruiting,Phase 2,Interventional,"United States, Romania",LYT-100 in Post-acute COVID-19 Respiratory Disease,Drug,LYT-100,LYT-100,168,https://clinicaltrials.gov/show/NCT04652518,None
7009,NCT04652596,ClinicalTrials.gov,2020-11-30,2021-01-01,False,Boston Medical Center,Not Recruiting,Not Applicable,Interventional,United States,Reducing Food Insecurity During COVID-19,Other,Other,Other,250,https://clinicaltrials.gov/show/NCT04652596,None
7010,NCT04652648,ClinicalTrials.gov,2020-12-02,2020-05-27,True,Bryn Mawr Hospital,Not Recruiting,Phase 4,Interventional,United States,Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,54,https://clinicaltrials.gov/show/NCT04652648,None
7011,NCT04652674,ClinicalTrials.gov,2020-12-02,2020-09-28,True,Cedars-Sinai Medical Center,Recruiting,Not Applicable,Interventional,United States,Impact of Postoperative Telemedicine Visit vs In-person Visit on Patient Satisfaction During the COVID-19 Pandemic: A Prospective Randomized Trial,Telehealth,Telehealth,Telehealth,70,https://clinicaltrials.gov/show/NCT04652674,None
7012,NCT04652765,ClinicalTrials.gov,2020-12-02,2021-01-01,False,Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins,Not Recruiting,Phase 1,Interventional,United States,Camostat With Bicalutamide for COVID-19,Drug,Camostat Mesilate + Bicalutamide vs. Camostat Mesilate,Camostat Mesilate; Bicalutamide,60,https://clinicaltrials.gov/show/NCT04652765,None
7013,NCT04653727,ClinicalTrials.gov,2020-11-23,2020-12-01,False,Charité University,Not Recruiting,Not Applicable,Observational,Germany,Effects of Integrative Medicine on Infectious Respiratory Diseases Including COVID-19,Other,No Intervention,No Intervention,3000,https://clinicaltrials.gov/show/NCT04653727,None
7014,NCT04653831,ClinicalTrials.gov,2020-10-27,2020-11-08,False,Soroka University Medical Center,Recruiting,Not Applicable,Interventional,Israel,Treatment With Pirfenidone for COVID-19 Related Severe ARDS,Drug,Pirfenidone,Pirfenidone,100,https://clinicaltrials.gov/show/NCT04653831,None
7015,NCT04653844,ClinicalTrials.gov,2020-12-03,2020-02-01,True,"University Hospital, Montpellier",Not Recruiting,Not Applicable,Observational,France,RT-PCR Database Analysis for COVID-19 Infections and Re-infection,Clinical Presentation (Epidemiology),No Intervention,No Intervention,7000000,https://clinicaltrials.gov/show/NCT04653844,None
7016,NCT04653857,ClinicalTrials.gov,2020-12-03,2020-04-01,True,"University Hospital, Montpellier",Not Recruiting,Not Applicable,Observational,France,Cardiac Assessment After Covid-19 Disease in Elite Altheltic Population,Clinical Presentation,No Intervention,No Intervention,250,https://clinicaltrials.gov/show/NCT04653857,None
7017,NCT04654325,ClinicalTrials.gov,2020-11-30,2020-12-01,False,Assistance Publique – Hôpitaux de Paris,Not Recruiting,Not Applicable,Interventional,No Country Given,Prevalence of SARS-CoV-2 Genome in Tears of Asymptomatic and Moderately Symptomatic COVID-19 Patients,Clinical Presentation,No Intervention,No Intervention,1280,https://clinicaltrials.gov/show/NCT04654325,None
7018,NCT04654416,ClinicalTrials.gov,2020-12-02,2020-03-20,True,Grupo Quirónsalud,Not Recruiting,Not Applicable,Observational,Colombia,Clinical Outcome of Patients With COVID-19 Pneumonia Treated With Corticosteroids and Colchicine,Drug,Corticosteroids vs Corticosteroids + Colchicine,Corticosteroids; Colchicine,301,https://clinicaltrials.gov/show/NCT04654416,None
7019,NCT04654442,ClinicalTrials.gov,2020-12-03,2020-12-15,False,"University Hospital, Grenoble",Not Recruiting,Not Applicable,Observational,France,Feasibility and Analytic Performance of TestNPass (IVDMD) for CoViD-19 Diagnosis on Saliva Sample,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,60,https://clinicaltrials.gov/show/NCT04654442,None
7020,NCT04654481,ClinicalTrials.gov,2020-12-03,2020-12-01,True,Icahn School of Medicine at Mount Sinai,Recruiting,Not Applicable,Interventional,United States,Study of AffloVest in At-Risk Respiratory Patients During COVID-19 Pandemic,Other (device),high frequency chest wall oscillation,high frequency chest wall oscillation,30,https://clinicaltrials.gov/show/NCT04654481,None
7021,NCT04655521,ClinicalTrials.gov,2020-12-02,2020-12-02,False,Saarland University,Recruiting,Not Applicable,Observational,Germany,Dynamics of the Immune Response to COVID-19 / Infection by SARS-CoV-2,Clinical Presentation,No Intervention,No Intervention,300,https://clinicaltrials.gov/show/NCT04655521,None
7022,NCT04655586,ClinicalTrials.gov,2020-12-02,2020-12-04,False,"ARCA Biopharma, Inc.",Not Recruiting,Phase 2/Phase 3,Interventional,No Country Given,"Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19",Drug,rNAPc2 vs. Heparin,rNAPc2; Heparin,100,https://clinicaltrials.gov/show/NCT04655586,None
7023,NCT04655612,ClinicalTrials.gov,2020-12-03,2020-12-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Seroprevalence Study of CoV-2-SARS (COVID-19) Infection in Patients With Chronic Inflammatory Rheumatic Diseases,Clinical Presentation (Epidemiology),No Intervention,No Intervention,5000,https://clinicaltrials.gov/show/NCT04655612,None
7024,NCT04655625,ClinicalTrials.gov,2020-11-26,2020-11-23,True,"AnGes, Inc.",Recruiting,Phase 2/Phase 3,Interventional,Japan,Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19),ATMP,Vaccine,Vaccine,500,https://clinicaltrials.gov/show/NCT04655625,JPRN-jRCT2051200088
7025,NCT04655638,ClinicalTrials.gov,2020-12-03,2021-01-10,False,AOU Policlinico Paolo Giaccone Palermo,Not Recruiting,Not Applicable,Interventional,Italy,HFNT vs. COT in COVID-19,Other (device),Nasal cannula,Nasal cannula,364,https://clinicaltrials.gov/show/NCT04655638,None
7026,NCT04655716,ClinicalTrials.gov,2020-12-04,2021-02-01,False,Guy's and St Thomas' NHS Foundation Trust,Not Recruiting,Phase 3,Interventional,No Country Given,Urine Alkalinisation to Prevent AKI in COVID-19,Drug,Sodium bicarbonate,Sodium bicarbonate,80,https://clinicaltrials.gov/show/NCT04655716,None
7027,NCT04656444,ClinicalTrials.gov,2020-12-04,2020-12-01,True,Fondation Lenval,Not Recruiting,Not Applicable,Observational,France,Parental Compliance After Telephone Triage Advice During and After Confinement During the COVID Epidemic in France,Other,Other,Other,250,https://clinicaltrials.gov/show/NCT04656444,None
7028,NCT04656613,ClinicalTrials.gov,2020-11-30,2020-12-01,False,"Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation",Not Recruiting,Phase 3,Interventional,No Country Given,A Phase III Clinical Trial of the Immunogenicity and Safety of the Gam-COVID-Vac Vaccine Against COVID-19 in the UAE,ATMP,Vaccine,Vaccine,1000,https://clinicaltrials.gov/show/NCT04656613,None
7029,NCT04656626,ClinicalTrials.gov,2020-12-04,2020-07-07,True,Imam Abdulrahman Bin Faisal University,Not Recruiting,Not Applicable,Interventional,Saudi Arabia,Brief Mindfulness Based Intervention to Improve Psychological Wellbeing,Other (psych),Psychological,Psychological,146,https://clinicaltrials.gov/show/NCT04656626,None
7030,NCT04656691,ClinicalTrials.gov,2020-12-04,2020-12-01,True,Dr. Daniel Griffin,Not Recruiting,Phase 4,Interventional,No Country Given,At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19,Drug,Bamlanivimab,Bamlanivimab,7500,https://clinicaltrials.gov/show/NCT04656691,None
7031,NCT04657263,ClinicalTrials.gov,2020-12-07,2020-11-01,True,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Impact of the COVID-19 Pandemic on Vaccination,Other,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04657263,None
7032,NCT04657406,ClinicalTrials.gov,2020-12-03,2019-06-01,True,Organicell Regenerative Medicine,Not Recruiting,Not Applicable,Expanded Access,No Country Given,Expanded Access to ZofinTM (OrganicellTM Flow) for Patients With COVID-19,ATMP,Human amniotic fluid derived product,Human amniotic fluid derived product,Not Available,https://clinicaltrials.gov/show/NCT04657406,None
7033,NCT04657419,ClinicalTrials.gov,2020-12-07,2020-12-05,True,"University Hospital, Bordeaux",Not Recruiting,Not Applicable,Observational,No Country Given,Fatigue and Sleep in Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,720,https://clinicaltrials.gov/show/NCT04657419,None
7034,NCT04657445,ClinicalTrials.gov,2020-12-06,2020-11-17,True,"University Hospital, Ioannina",Recruiting,Not Applicable,Observational,Greece,"EFFECT OF COVID-19 DISEASE IN SMELL AND TASTE OF PATIENTS WITH MILD, MODERATE OR SEVERE SYMPTOMATOLOGY",Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04657445,None
7035,NCT04657458,ClinicalTrials.gov,2020-12-07,2020-11-17,True,"Direct Biologics, LLC",Not Recruiting,Not Applicable,Expanded Access,No Country Given,Expanded Access Protocol on Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicle Infusion Treatment for Patients With COVID-19 Associated ARDS,ATMP,Cells (mesenchymal),Cells (mesenchymal),Not Available,https://clinicaltrials.gov/show/NCT04657458,None
7036,NCT04657484,ClinicalTrials.gov,2020-12-05,2020-12-10,False,Postgraduate Institute of Medical Education and Research,Recruiting,Not Applicable,Interventional,India,Comparison of Two Corticosteroid Regimens for Post-COVID Diffuse Lung Disease,Drug,Corticosteroids,Prednisolone,100,https://clinicaltrials.gov/show/NCT04657484,None
7037,NCT04657497,ClinicalTrials.gov,2020-11-09,2020-11-09,False,Ono Pharmaceutical Co. Ltd,Recruiting,Phase 3,Interventional,Japan,A Study of FOY-305 in Patients With SARS-Cov-2 Infection (COVID-19),Drug,FOY-305,FOY-305,110,https://clinicaltrials.gov/show/NCT04657497,None
7038,NCT04657510,ClinicalTrials.gov,2020-11-14,2020-11-14,False,IRCCS Istituto Ortopedico Galeazzi,Recruiting,Not Applicable,Observational,Italy,Femoral frACturEs and COVID-19.,Other,No Intervention,No Intervention,140,https://clinicaltrials.gov/show/NCT04657510,None
7039,NCT04657809,ClinicalTrials.gov,2020-12-02,2020-12-01,True,Soad Ali,Not Recruiting,Phase 2,Interventional,Egypt,Clinical Assessment of Insulin Fast Dissolving Film in Treatment of Post Infection Anosmia,Drug,Insulin,Insulin,40,https://clinicaltrials.gov/show/NCT04657809,None
7040,NCT04658121,ClinicalTrials.gov,2020-11-19,2020-12-15,False,COVID-19 Prevention Network,Not Recruiting,Not Applicable,Observational,"United States, Puerto Rico",SARS-CoV-2/COVID-19 PREVALENCE STUDY,Clinical Presentation (Epidemiology),No Intervention,No Intervention,3920,https://clinicaltrials.gov/show/NCT04658121,None
7041,NCT04658433,ClinicalTrials.gov,2020-12-05,2020-12-05,False,Applied Science Private University,Recruiting,Not Applicable,Interventional,Jordan,The Effect of Omega -3 Supplements on the Serum Levels of ACE/ACE2 Ratio as a Potential Key in Cardiovascular Disease and COVID-19; A Randomized Clinical Trial in the Covid-19 Uninfected Jordanian People,Drug,Omega 3,Omega 3,100,https://clinicaltrials.gov/show/NCT04658433,None
7042,NCT04658979,ClinicalTrials.gov,2020-12-02,2020-12-01,True,Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec,Recruiting,Not Applicable,Interventional,Canada,Pulmonary TELE-REHABilitation Program : Feasibility and Safety Study,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,30,https://clinicaltrials.gov/show/NCT04658979,None
7043,NCT04659109,ClinicalTrials.gov,2020-11-30,2020-12-01,True,Acticor Biotech,Not Recruiting,Phase 2,Interventional,No Country Given,Glenzocimab in SARS-Cov-2 Acute Respiratory DistrEss syNdrome Related to COVID-19,Drug,Glenzocimab,Glenzocimab,60,https://clinicaltrials.gov/show/NCT04659109,EUCTR2020-002733-15
7044,NCT04659122,ClinicalTrials.gov,2020-12-04,2021-01-01,False,"Airway Therapeutics, Inc.",Not Recruiting,Phase 1,Interventional,No Country Given,A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection,Drug,AT-100,AT-100,9,https://clinicaltrials.gov/show/NCT04659122,None
7045,NCT04659135,ClinicalTrials.gov,2020-11-30,2020-04-19,True,American Society of Clinical Oncology,Recruiting,Not Applicable,Observational,United States,ASCO Survey on COVID-19 in Oncology (ASCO) Registry,Clinical Presentation,No Intervention,No Intervention,2000,https://clinicaltrials.gov/show/NCT04659135,None
7046,NCT04659187,ClinicalTrials.gov,2020-12-08,2020-03-26,True,Asklepios Proresearch,Recruiting,Not Applicable,Observational,Germany,CORONA Germany- Clinical Outcome and Risk in Hospitalized COVID-19 Patients - A Registry From Germany,Clinical Presentation,No Intervention,No Intervention,4000,https://clinicaltrials.gov/show/NCT04659187,None
7047,NCT04659200,ClinicalTrials.gov,2020-12-07,2020-09-01,True,Bezmialem Vakif University,Recruiting,Not Applicable,Observational,Turkey,Thyroid Function Tests and Status of Thyroid Autoantibodies in Covid-19 Patients,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04659200,None
7048,NCT04659239,ClinicalTrials.gov,2020-12-05,2020-12-01,True,Chinese Academy of Medical Sciences,Not Recruiting,Phase 3,Interventional,"Malaysia, Brazil","The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19",ATMP,Vaccine,Vaccine,34020,https://clinicaltrials.gov/show/NCT04659239,None
7049,NCT04659252,ClinicalTrials.gov,2020-12-08,2021-01-15,False,"Institute of Cancer Research, United Kingdom",Not Recruiting,Not Applicable,Observational,No Country Given,CORONADO (Circulating tumOur pROtein quaNtification cApillary blooD cOvid),Clinical Presentation,No Intervention,No Intervention,70,https://clinicaltrials.gov/show/NCT04659252,None
7050,NCT04659304,ClinicalTrials.gov,2020-12-07,2021-03-01,False,Enlivex Therapeutics Ltd.,Not Recruiting,Phase 1,Interventional,No Country Given,"Study Evaluating Safety, Tolerability and Efficacy of Allocetra-OTS in Patients With COVID-19",ATMP,Cells (allogenic),Cells (allogenic),50,https://clinicaltrials.gov/show/NCT04659304,None
7051,NCT04659356,ClinicalTrials.gov,2020-12-08,2020-09-01,True,Nantes University Hospital,Recruiting,Not Applicable,Observational,France,NOSOcomial COVID-19 in ICU (NOSOCOVID),Clinical Presentation,No Intervention,No Intervention,600,https://clinicaltrials.gov/show/NCT04659356,None
7052,NCT04659460,ClinicalTrials.gov,2020-07-03,2020-12-15,False,"St. Michael's Hospital, Toronto",Not Recruiting,Not Applicable,Interventional,No Country Given,RIC as an Adjunct Therapy for Severe COVID-19 Disease: a Prospective Randomized Pilot Study,Other (device),Remote Ischemic Conditioning,Remote Ischemic Conditioning,30,https://clinicaltrials.gov/show/NCT04659460,None
7053,NCT04659473,ClinicalTrials.gov,2020-12-08,2020-12-09,False,University of Salamanca,Not Recruiting,Not Applicable,Observational,Spain,Spanish Survey on Third Wave of COVID-19,Other,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04659473,None
7054,NCT04659486,ClinicalTrials.gov,2020-12-01,2020-09-24,True,University of São Paulo,Recruiting,Not Applicable,Interventional,Brazil,Adolescents With COVID-19/MIS-C at HCFMUSP,Other (exercise),Exercise,Exercise,100,https://clinicaltrials.gov/show/NCT04659486,None
7055,NCT04659707,ClinicalTrials.gov,2020-12-07,2021-01-01,False,University of Kansas Medical Center,Not Recruiting,Phase 1,Interventional,No Country Given,Hyperpolarized 129Xe MRI of Survivors of COVID-19,Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04659707,None
7056,NCT04659746,ClinicalTrials.gov,2020-12-07,2020-12-09,False,Universidad Autónoma de Encarnación,Not Recruiting,Not Applicable,Interventional,Paraguay,MejoraCare-Paraguay: mHealth Solution for Chronic Patients During the COVID-19 Outbreak in Paraguay,Other (software),eHealth,eHealth,96,https://clinicaltrials.gov/show/NCT04659746,None
7057,NCT04659759,ClinicalTrials.gov,2020-12-07,2020-11-17,True,Thomas Jefferson University,Recruiting,Not Applicable,Observational,United States,"COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes",Clinical Presentation,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04659759,None
7058,NCT04659772,ClinicalTrials.gov,2020-12-07,2020-12-01,True,Ayan Sen,Recruiting,Phase 2,Interventional,United States,A Study to Evaluate Clazakizumab in Patients With Life-threatening COVID-19 Infection,Drug,Clazakizumab,Clazakizumab,30,https://clinicaltrials.gov/show/NCT04659772,None
7059,NCT04659876,ClinicalTrials.gov,2020-12-08,2020-03-22,True,Istanbul Saglik Bilimleri University,Not Recruiting,Not Applicable,Observational,Turkey,Factors Affecting Mortality in Critical Patients Admitted to Intensive Care Unit Due to COVID 19,Clinical Presentation (Epidemiology),No Intervention,No Intervention,445,https://clinicaltrials.gov/show/NCT04659876,None
7060,NCT04659889,ClinicalTrials.gov,2020-12-07,2020-12-01,True,HCA International Limited,Recruiting,Not Applicable,Observational,United Kingdom,Clinical and Haematological Phenotypes in Long COVID,Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04659889,None
7061,NCT04659928,ClinicalTrials.gov,2020-11-30,2020-12-01,False,"University of Texas Health Science Center, Houston",Not Recruiting,Phase 4,Interventional,United States,Evaluation of Aerosol in a Dental Clinic,Other,No Intervention,No Intervention,50,https://clinicaltrials.gov/show/NCT04659928,None
7062,NCT04659941,ClinicalTrials.gov,2020-12-08,2020-10-01,True,Universidade Federal do Rio de Janeiro,Recruiting,Phase 2,Interventional,Brazil,Use of BCG Vaccine as a Preventive Measure for COVID-19 in Health Care Workers,ATMP,Vaccine,Vaccine,1000,https://clinicaltrials.gov/show/NCT04659941,None
7063,NCT04660422,ClinicalTrials.gov,2020-12-03,2021-02-01,False,Dana-Farber Cancer Institute,Recruiting,Not Applicable,Observational,United States,Advance Care Planning: Communicating With Outpatients for Vital Informed Decision,Telehealth,Telehealth,Telehealth,13150,https://clinicaltrials.gov/show/NCT04660422,None
7064,NCT04661410,ClinicalTrials.gov,2020-12-07,2020-12-01,True,Drexel University,Recruiting,Not Applicable,Interventional,United States,Reward Re-Training: A New Treatment to Address Reward Imbalance During the COVID-19 Pandemic,Other,Other,Other,60,https://clinicaltrials.gov/show/NCT04661410,None
7065,NCT04661423,ClinicalTrials.gov,2020-12-07,2021-01-01,False,IHU Strasbourg,Not Recruiting,Not Applicable,Interventional,France,Use of RDS MultiSenseÂ® in Post-ICU Patients in the COVID-19 Era,Other (device),Biosensors,Biosensors,60,https://clinicaltrials.gov/show/NCT04661423,None
7066,NCT04661462,ClinicalTrials.gov,2020-09-29,2020-09-30,False,Medical University Innsbruck,Recruiting,Not Applicable,Observational,Austria,Health After Covid-19 in Tyrol,Clinical Presentation,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04661462,None
7067,NCT04661527,ClinicalTrials.gov,2020-09-10,2020-04-22,True,Clínica Universidad de Navarra,Recruiting,Phase 2,Interventional,Spain,Sarilumab Treatment In cytoKinE Storm Caused by Infection With COVID-19,Drug,Sarilumab,Sarilumab,60,https://clinicaltrials.gov/show/NCT04661527,EUCTR2020-001255-40
7068,NCT04661540,ClinicalTrials.gov,2020-12-04,2020-12-01,True,"CalciMedica, Inc.",Not Recruiting,Phase 2,Interventional,United States,A Study of Auxora in Patients With Critical COVID-19 Pneumonia,Drug,CM4620-IE,CM4620-IE,36,https://clinicaltrials.gov/show/NCT04661540,None
7069,NCT04661631,ClinicalTrials.gov,2020-12-07,2020-05-08,True,Fundacion Clinica Valle del Lili,Recruiting,Not Applicable,Observational,Colombia,Surgery and Lung Ultrasound in SARS-CoV-2 Infection,Clinical Presentation,No Intervention,No Intervention,451,https://clinicaltrials.gov/show/NCT04661631,None
7070,NCT04661657,ClinicalTrials.gov,2020-12-08,2020-12-01,True,Columbia University,Not Recruiting,Not Applicable,Observational,United States,COvid-19 LongitUdinal Multiethnic BioImaging Assessment of CARDiovascular Sequelae Registry,Other,No Intervention,No Intervention,70,https://clinicaltrials.gov/show/NCT04661657,None
7071,NCT04661813,ClinicalTrials.gov,2020-10-29,2021-02-01,False,Case Western Reserve University,Not Recruiting,Not Applicable,Interventional,United States,Assess and Adapt to the Impact of COVID-19 on CVD Self-Management and Prevention Care in Adults Living With HIV,Other,Other,Other,75,https://clinicaltrials.gov/show/NCT04661813,None
7072,NCT04661839,ClinicalTrials.gov,2020-12-09,2020-12-01,True,Emergent BioSolutions,Recruiting,Phase 1,Interventional,United States,Phase 1 Study to Evaluate Safety and Pharmacokinetics of COVID-HIGIV Administered as a Single Dose or a Repeat Dose in Healthy Adults,ATMP,Immunoglobulin,Immunoglobulin,56,https://clinicaltrials.gov/show/NCT04661839,None
7073,NCT04661930,ClinicalTrials.gov,2020-12-09,2020-12-13,False,Hebrew University of Jerusalem,Recruiting,Phase 3,Interventional,Israel,Fenofibrate for Patients With COVID-19 Requiring Hospitalization,Drug,Fenofibrate,Fenofibrate,50,https://clinicaltrials.gov/show/NCT04661930,None
7074,NCT04662021,ClinicalTrials.gov,2020-12-04,2020-12-10,False,Cairo University,Recruiting,Not Applicable,Interventional,Egypt,Aerobic Training Versus Cognitive Behavioral Therapy in Management of Anxiety,Other (psych),Psychological,Psychological,40,https://clinicaltrials.gov/show/NCT04662021,None
7075,NCT04662060,ClinicalTrials.gov,2020-12-08,2021-01-01,False,Stanford University,Not Recruiting,Phase 2,Interventional,United States,COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Acebilustat Sub-Protocol,Drug,Acebilustat,Acebilustat,120,https://clinicaltrials.gov/show/NCT04662060,None
7076,NCT04662073,ClinicalTrials.gov,2020-12-08,2021-01-01,False,Stanford University,Not Recruiting,Phase 2,Interventional,United States,COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Camostat Sub-Protocol,Drug,Camostat Mesilate,Camostat Mesilate,120,https://clinicaltrials.gov/show/NCT04662073,None
7077,NCT04662086,ClinicalTrials.gov,2020-12-08,2021-01-01,False,Stanford University,Not Recruiting,Phase 2,Interventional,United States,COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol,Drug,Acebilustat vs. Camostat Mesilate,Acebilustat; Camostat Mesilate,240,https://clinicaltrials.gov/show/NCT04662086,None
7078,NCT04662437,ClinicalTrials.gov,2020-12-08,2020-09-10,True,Bezmialem Vakif University,Not Recruiting,Not Applicable,Observational,Turkey,The Status of Parathyroid Hormone Secretion in Covid-19 Patients,Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04662437,None
7079,NCT04662671,ClinicalTrials.gov,2020-12-09,2020-11-18,True,EmitBio Inc.,Recruiting,Phase 1/Phase 2,Interventional,United States,"Phase I/II Randomized, Dose Escalation Study to Evaluate the Safety and Antiviral Activity of the RD-X19 Device in SARS-CoV-2 Infected Individuals With Uncomplicated COVID-19",Other (device),RD-X19,RD-X19,60,https://clinicaltrials.gov/show/NCT04662671,None
7080,NCT04662684,ClinicalTrials.gov,2020-12-08,2020-10-16,True,Science Valley Research Institute,Recruiting,Phase 3,Interventional,Brazil,Medically Ill Hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis With Rivaroxaban ThErapy: The MICHELLE Trial,Drug,Rivaroxaban,Rivaroxaban,320,https://clinicaltrials.gov/show/NCT04662684,None
7081,NCT04662697,ClinicalTrials.gov,2020-12-09,2020-12-11,False,Medicago,Not Recruiting,Phase 2,Interventional,No Country Given,Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults (USA),ATMP,Vaccine,Vaccine,918,https://clinicaltrials.gov/show/NCT04662697,None
7082,NCT04663555,ClinicalTrials.gov,2020-12-09,2021-01-01,False,Brno University Hospital,Not Recruiting,Phase 4,Interventional,Czech Republic,Effect of Two Different Doses of Dexamethasone in Patients With ARDS and COVID-19,Drug,Corticosteroids,Dexamethasone,300,https://clinicaltrials.gov/show/NCT04663555,None
7083,NCT04663594,ClinicalTrials.gov,2020-11-27,2020-12-04,False,University of Oxford,Not Recruiting,Not Applicable,Interventional,No Country Given,Online Culture for Mental Health in People Aged 16-24,Other (psych),Psychological,Psychological,400,https://clinicaltrials.gov/show/NCT04663594,None
7084,NCT04663659,ClinicalTrials.gov,2020-12-10,2020-03-15,True,Sisli Hamidiye Etfal Training and Research Hospital,Not Recruiting,Not Applicable,Observational,Turkey,The Effect of Diabetes Mellitus on Mortality of Patients With COVID-19,Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04663659,None
7085,NCT04663737,ClinicalTrials.gov,2020-12-01,2020-12-03,False,Dr. Chris Recknor,Recruiting,Phase 2,Interventional,United States,"Evaluating Safety, Pharmacokinetics and Clinical Benefit of Silmitasertib (CX-4945) in Subjects With Moderate COVID-19",Drug,Silmitasertib,Silmitasertib,20,https://clinicaltrials.gov/show/NCT04663737,None
7086,NCT04663776,ClinicalTrials.gov,2020-12-05,2020-11-04,True,Boston Children's Hospital,Recruiting,Not Applicable,Observational,United States,Wide Scale Monitoring for Acute Respiratory Infection Using a Mobile-Based Study Platform,Other (software),eHealth,eHealth,100000,https://clinicaltrials.gov/show/NCT04663776,None
7087,NCT04663906,ClinicalTrials.gov,2020-12-10,2021-01-15,False,University of Aberdeen,Not Recruiting,Not Applicable,Observational,No Country Given,Oral Isotretinoin and Covid-19 Infection,Drug,Isotretinoin,Isotretinoin,300,https://clinicaltrials.gov/show/NCT04663906,None
7088,NCT04663945,ClinicalTrials.gov,2020-12-08,2020-12-15,False,"University of Colorado, Denver",Not Recruiting,Not Applicable,Interventional,No Country Given,Predictors of Recovery and the App-Facilitated Tele-Rehabilitation (AFTER) Program for COVID-19 Survivors,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,45,https://clinicaltrials.gov/show/NCT04663945,None
7089,NCT04664010,ClinicalTrials.gov,2020-12-07,2020-02-06,True,Xi'an International Medical Center Hospital,Not Recruiting,Not Applicable,Interventional,China,Efficacy and Safety of High-dose Vitamin C Combined With Chinese Medicine Against Coronavirus Pneumonia (COVID-19),Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,60,https://clinicaltrials.gov/show/NCT04664010,None
7090,NCT04664023,ClinicalTrials.gov,2020-12-03,2020-12-09,False,Poitiers University Hospital,Recruiting,Not Applicable,Observational,France,"Description of Immunologic, Enzymatic and Metabolic Biomarkers Associated to the Severity of COVID-19 (SARS-CoV-2) and Its Resolution",Clinical Presentation,No Intervention,No Intervention,120,https://clinicaltrials.gov/show/NCT04664023,None
7091,NCT04664049,ClinicalTrials.gov,2020-12-04,2020-12-20,False,"National Research Institute of Chinese Medicine, Ministry of Health and Welfare",Not Recruiting,Not Applicable,Observational,No Country Given,The Outcomes of NRICM101 on SARS-COV-2 (COVID-19) Infection,Supplement,NRICM101,NRICM101,51000,https://clinicaltrials.gov/show/NCT04664049,None
7092,NCT04664075,ClinicalTrials.gov,2020-12-01,2020-12-07,False,Imperial College London,Not Recruiting,Not Applicable,Observational,United Kingdom,Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19),Prognosis,No Intervention,No Intervention,100,https://clinicaltrials.gov/show/NCT04664075,None
7093,NCT04664101,ClinicalTrials.gov,2020-12-10,2021-01-01,False,Duke University,Not Recruiting,Not Applicable,Interventional,United States,"REmotely Monitored, Mobile Health Supported High Intensity Interval Training for Survivors of COVID-19",Other (exercise),Exercise,Exercise,30,https://clinicaltrials.gov/show/NCT04664101,None
7094,NCT04664296,ClinicalTrials.gov,2020-12-10,2021-01-01,False,Hospices Civils de Lyon,Not Recruiting,Not Applicable,Observational,No Country Given,COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults (Dyn3CEA_Nosocor),Clinical Presentation (Epidemiology),No Intervention,No Intervention,75,https://clinicaltrials.gov/show/NCT04664296,None
7095,NCT04664309,ClinicalTrials.gov,2020-12-09,2021-01-01,False,Stanford University,Not Recruiting,Not Applicable,Observational,United States,Understanding Immunity to the COVID-19 Vaccines,ATMP,Vaccine,Vaccine,1000,https://clinicaltrials.gov/show/NCT04664309,None
7096,NCT04665115,ClinicalTrials.gov,2020-12-10,2020-12-31,False,Academic and Community Cancer Research United,Not Recruiting,Phase 2,Interventional,United States,Ibrutinib for the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease 2019 (COVID-19),Drug,Ibrutinib,Ibrutinib,134,https://clinicaltrials.gov/show/NCT04665115,None
7097,NCT04665193,ClinicalTrials.gov,2020-12-08,2020-11-23,True,University of British Columbia,Recruiting,Not Applicable,Interventional,Canada,An Approach to Screening for COVID-19 at Vancouver Airport,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,900,https://clinicaltrials.gov/show/NCT04665193,None
7098,NCT04665245,ClinicalTrials.gov,2020-12-10,2020-12-01,True,University of Iowa,Not Recruiting,Not Applicable,Observational,United States,Symptom-Based Markers for COVID Transmission,Clinical Presentation,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04665245,None
7099,NCT04665258,ClinicalTrials.gov,2020-12-10,2020-12-14,False,University of Miami,Recruiting,Not Applicable,Observational,United States,COVID-19 Vaccine and Impact on Fertility Study,ATMP,Vaccine,Vaccine,60,https://clinicaltrials.gov/show/NCT04665258,None
7100,NCT04665752,ClinicalTrials.gov,2020-12-11,2020-12-17,False,National Eye Institute (NEI),Recruiting,Not Applicable,Observational,United States,"Ocular Findings and Viral Persistence in Ocular Fluids in COVID-19 Survivors, a Natural History, Observational Study",Clinical Presentation,No Intervention,No Intervention,150,https://clinicaltrials.gov/show/NCT04665752,None
7101,NCT04665778,ClinicalTrials.gov,2020-12-07,2020-12-04,True,CHU de Amiens,Recruiting,Not Applicable,Observational,France,Prediction of the Patient Pathway in Emergency Room in an Exceptional Sanitary Situation,Health system,No Intervention,No Intervention,1516,https://clinicaltrials.gov/show/NCT04665778,None
7102,NCT04665960,ClinicalTrials.gov,2020-12-09,2021-01-15,False,NMC Specialty Hospital,Not Recruiting,Not Applicable,Observational,United Arab Emirates,Infection Control for SARS-CoV-2,Other,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04665960,None
7103,NCT04666012,ClinicalTrials.gov,2020-12-10,2021-01-01,False,"Cellid Co., Ltd.",Not Recruiting,Phase 1/Phase 2,Interventional,South Korea,Safety and Immunogenicity Study of AdCLD-CoV19: A COVID-19 Preventive Vaccine in Healthy Volunteers,ATMP,Vaccine,Vaccine,150,https://clinicaltrials.gov/show/NCT04666012,None
7104,NCT04666025,ClinicalTrials.gov,2020-12-10,2020-09-23,True,City of Hope Medical Center,Recruiting,Not Applicable,Observational,United States,SARS-CoV-2 Donor-Recipient Immunity Transfer,ATMP,Cells (hematopoietic),Cells (hematopoietic),36,https://clinicaltrials.gov/show/NCT04666025,None
7105,NCT04666064,ClinicalTrials.gov,2020-12-11,2020-12-10,True,CHU de Amiens,Recruiting,Not Applicable,Observational,France,Validation of COVILUS Score in Patients Suspected of COVID-19 Infection in the Emergency Room,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,100,https://clinicaltrials.gov/show/NCT04666064,None
7106,NCT04666116,ClinicalTrials.gov,2020-04-25,2020-04-01,True,Hospital de Sagunto,Recruiting,Not Applicable,Interventional,Spain,Changes in Viral Load in COVID-19 After Probiotics,Supplement,Probiotics,Probiotics,96,https://clinicaltrials.gov/show/NCT04666116,None
7107,NCT04666207,ClinicalTrials.gov,2020-11-08,2020-05-25,True,"Rigshospitalet, Denmark",Recruiting,Not Applicable,Observational,Denmark,"Viral Shedding, Symptoms and Exposure of SARS-CoV-2 in Non-hospitalized Children With COVID-19",Clinical Presentation,No Intervention,No Intervention,20,https://clinicaltrials.gov/show/NCT04666207,None
7108,NCT04666233,ClinicalTrials.gov,2020-12-11,2021-01-01,False,University Hospital Padova,Not Recruiting,Not Applicable,Interventional,No Country Given,Personal Protective Equipment for the Prevention of SARS-Cov-2 During Neonatal Resuscitation,Other (device),PPE,PPE,48,https://clinicaltrials.gov/show/NCT04666233,None
7109,NCT04666246,ClinicalTrials.gov,2020-12-11,2020-03-01,True,University of Modena and Reggio Emilia,Recruiting,Not Applicable,Observational,Italy,Inspiratory Effort in COVID-19,Clinical Presentation,No Intervention,No Intervention,40,https://clinicaltrials.gov/show/NCT04666246,None
7110,NCT04666285,ClinicalTrials.gov,2020-10-15,2020-12-01,False,University of Southampton,Not Recruiting,Not Applicable,Observational,United Kingdom,Southampton Women's Survey COVID-19 Study,Other,No Intervention,No Intervention,1000,https://clinicaltrials.gov/show/NCT04666285,None
7111,NCT04666311,ClinicalTrials.gov,2020-12-07,2020-12-01,True,Klaus Reither,Not Recruiting,Not Applicable,Observational,"South Africa, Lesotho",Diagnostic Accuracy of CAD4TB and C-reactive Protein Assay as Triage Tests for Pulmonary Tuberculosis,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1400,https://clinicaltrials.gov/show/NCT04666311,None
7112,NCT04666441,ClinicalTrials.gov,2020-12-10,2020-12-15,False,Regeneron Pharmaceuticals,Not Recruiting,Phase 2,Interventional,United States,A Study to Assess the Virologic Efficacy of REGN10933+REGN10987 Across Different Dose Regimens in Adult Outpatients With SARS-CoV-2 Infection,Drug,REGN10933 + REGN10987,REGN10933; REGN10987,1400,https://clinicaltrials.gov/show/NCT04666441,None
7113,NCT04666493,ClinicalTrials.gov,2020-12-11,2020-12-04,True,Evdokia Anagnostou,Recruiting,Not Applicable,Interventional,Canada,Adapting Anxiety Intervention for Youth With Autism for Rapid Response to COVID-19,Other (psych),Psychological,Psychological,100,https://clinicaltrials.gov/show/NCT04666493,None
7114,NCT04666558,ClinicalTrials.gov,2020-11-30,2020-11-30,False,University of Alberta,Recruiting,Not Applicable,Interventional,Canada,Heal-Me Personalized Online Nutrition and Exercise Routines,Other (exercise),Exercise,Exercise,216,https://clinicaltrials.gov/show/NCT04666558,None
7115,NCT04666753,ClinicalTrials.gov,2020-12-11,2020-07-02,True,Fagron Iberica S.A.U.,Not Recruiting,Not Applicable,Observational,Spain,Retrospective Study of ImmunoFormulation for COVID-19,Supplement,ImmunoFormulation,ImmunoFormulation,40,https://clinicaltrials.gov/show/NCT04666753,None
7116,NCT04666779,ClinicalTrials.gov,2020-12-11,2020-12-14,False,Real Centro Universitario Maria Cristina,Not Recruiting,Not Applicable,Observational,Spain,Access to Chiropractic Care During the COVID-19 Pandemic,Other,No Intervention,No Intervention,500,https://clinicaltrials.gov/show/NCT04666779,None
7117,NCT04667247,ClinicalTrials.gov,2020-12-03,2020-12-03,False,Gordon Saxe,Recruiting,Phase 1/Phase 2,Interventional,United States,Mushroom-based Product for COVID-19,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,66,https://clinicaltrials.gov/show/NCT04667247,None
7118,NCT04667286,ClinicalTrials.gov,2020-12-11,2020-12-30,False,AOU di Bologna Policlinico S.Orsola-Malpighi,Not Recruiting,Not Applicable,Interventional,No Country Given,Awake Pronation for Covid-19 Treatment,Procedure,Positioning,Positioning,100,https://clinicaltrials.gov/show/NCT04667286,None
7119,NCT04667442,ClinicalTrials.gov,2020-12-10,2020-12-01,True,Nanomix,Recruiting,Not Applicable,Observational,United States,Investigational Performance Evaluation of the Nanomix eLabÂ® COVID-19 Rapid Antigen Panel With Samples From COVID-19 Positive and Negative Human Subjects,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,60,https://clinicaltrials.gov/show/NCT04667442,None
7120,ISRCTN14159936,ISRCTN,2020-12-14,2020-01-03,True,King's College Hospital NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,Change in disability in activities of daily living over time among adults with advanced respiratory disease during the COVID-19 pandemic,Other,No Intervention,No Intervention,120,http://isrctn.com/ISRCTN14159936,None
7121,ISRCTN27106947,ISRCTN,2020-12-07,2020-08-09,True,University of Liverpool,Recruiting,Phase 1/Phase 2,Interventional,"United Kingdom, South Africa",A study to assess several different treatments that may be useful for patients with COVID-19,Drug,EIDD-2801,EIDD-2801,180,http://isrctn.com/ISRCTN27106947,EUCTR2020-001860-27
7122,ISRCTN11713182,ISRCTN,2020-12-02,2020-12-21,True,University of Oxford,Recruiting,Not Applicable,Interventional,United Kingdom,Testing the effectiveness of almitrine bismesylate in the treatment of COVID-19,Drug,Almitrine Bimesylate,Almitrine Bimesylate,116,http://isrctn.com/ISRCTN11713182,EUCTR2020-002567-57
7123,ISRCTN12735607,ISRCTN,2020-12-02,2020-01-10,True,University College Dublin,Recruiting,Not Applicable,Observational,Ireland,Exploring the role of virtual reality in midwifery education: a prospective study,Not relevant,Not relevant,Not relevant,40,http://isrctn.com/ISRCTN12735607,None
7124,ISRCTN19845486,ISRCTN,2020-12-02,2020-01-07,True,University College Dublin,Recruiting,Not Applicable,Interventional,Ireland,"VR Baby, a virtual reality learning environment - does it help medical students to learn about complex topics in obstetrics and gynaecology?",Not relevant,Not relevant,Not relevant,40,http://isrctn.com/ISRCTN19845486,None
7125,ISRCTN77689525,ISRCTN,2020-12-02,2020-08-25,True,Stellenbosch University,Recruiting,Not Applicable,Interventional,"Tanzania, Uganda, Zambia","Sharing Stories: A digital intervention for caregivers with young children in the COVID-19 era to promote child social, emotional and language development, responsive parenting and parental mental wellbeing in Zambia, Tanzania, and Uganda",Other (psych),Psychological,Psychological,720,http://isrctn.com/ISRCTN77689525,None
7126,ISRCTN33037282,ISRCTN,2020-11-27,2020-11-06,True,Grupo Quirónsalud,Not Recruiting,Not Applicable,Observational,Colombia,Comparing two medications (dexamethasone and methylprednisolone high dose) for the treatment of pneumonia in patients with COVID-19,Drug,Corticosteroids,Dexamethasone; Methylprednisolone,213,http://isrctn.com/ISRCTN33037282,None
7127,ISRCTN77941736,ISRCTN,2020-11-23,2020-11-14,True,University of Oxford,Recruiting,Not Applicable,Interventional,United Kingdom,Coping during COVID-19: Peer-delivered training to improve adolescent wellbeing,Other (psych),Psychological,Psychological,120,http://isrctn.com/ISRCTN77941736,None
7128,ISRCTN12833010,ISRCTN,2020-11-12,2020-11-16,False,University Hospital Lewisham,Recruiting,Not Applicable,Observational,United Kingdom,A study of parents' views and motivations on presenting to their local paediatric emergency department during the coronavirus pandemic (COVID-19),Other,No Intervention,No Intervention,165,http://isrctn.com/ISRCTN12833010,None
7129,ISRCTN15019599,ISRCTN,2020-11-10,2021-04-01,False,Clatterbridge Cancer Centre NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,CCP Cancer UK Study. Companion study to educate and inform practice and guidelines regarding COVID-19 infection in cancer patients,Other,Other,Other,9000,http://isrctn.com/ISRCTN15019599,None
7130,ISRCTN10989132,ISRCTN,2020-11-06,2021-01-02,False,University of Bristol,Recruiting,Not Applicable,Interventional,United Kingdom,ASK: Improving access to kidney transplantation,Not relevant,Not relevant,Not relevant,60,http://isrctn.com/ISRCTN10989132,None
7131,ISRCTN18172749,ISRCTN,2020-10-30,2020-11-23,False,Bradford Teaching Hospitals NHS Foundation Trust,Recruiting,Not Applicable,Observational,United Kingdom,"Lessons from the frontline: the impact of redeployment during COVID-19 on nurse wellbeing, performance and retention",Health System,No Intervention,No Intervention,93,http://isrctn.com/ISRCTN18172749,None
7132,ISRCTN89951424,ISRCTN,2020-06-11,2020-06-15,False,University of Oxford,Recruiting,Phase 3,Interventional,Brazil,A phase III study to investigate a vaccine against COVID-19,ATMP,Vaccine,Vaccine,10300,http://isrctn.com/ISRCTN89951424,None
7133,ISRCTN59048638,ISRCTN,2020-06-04,2020-06-15,False,CLINEDEM,Not Recruiting,Not Applicable,Interventional,Mexico,Sulodexide in the treatment of COVID-19,Drug,Sulodexide,Sulodexide,200,http://isrctn.com/ISRCTN59048638,None
7134,ISRCTN28342533,ISRCTN,2020-05-04,2020-03-26,True,Sheffield Teaching Hospitals NHS Foundation Trust,Not Recruiting,Not Applicable,Observational,United Kingdom,Evaluation of COVID-19 assessment in emergency departments and ambulance services,Clinical Presentation,No Intervention,No Intervention,20000,http://isrctn.com/ISRCTN28342533,None
7135,ISRCTN37530113,ISRCTN,2020-01-31,2017-04-09,True,Central Norway Regional Health Authority,Recruiting,Not Applicable,Interventional,Norway,Enhanced cognitive behavioral therapy for children and adolescents with obsessive compulsive disorder: an open trial,Other (psych),Psychological,Psychological,70,http://isrctn.com/ISRCTN37530113,None
7136,ACTRN12620000417987,ANZCTR,2020-03-30,2020-03-04,True,Australian Defence Force Malaria and Infectious Disease Institute,Not Recruiting,Phase 4,Interventional,Australia,Chloroquine Chemorophylaxis Countermeasure against COVID-19,Drug,Chloroquine,Chloroquine,680,https://anzctr.org.au/ACTRN12620000417987.aspx,None
7137,ACTRN12620000555954,ANZCTR,2020-05-11,2020-06-15,False,UNSW Sydney,Not Recruiting,Not Applicable,Interventional,Australia,"Randomised controlled trial of an app-based intervention, Anchored, to support the mental health of Australians recently unemployed due to COVID-19.",Other (psych),Psychological,Psychological,780,https://anzctr.org.au/ACTRN12620000555954.aspx,None
7138,ACTRN12620000501943,ANZCTR,2020-04-22,2020-05-20,False,Walter and Eliza Hall Institute of Medical Research,Recruiting,Phase 2/Phase 3,Interventional,Australia,COVID-19 prophylaxis with hydroxychloroquine in Front-line Health and Allied-Health Care Workers: The COVID-SHIELD Trial,Drug (Chemoprophylaxis),Hydroxychloroquine,Hydroxychloroquine,650,https://anzctr.org.au/ACTRN12620000501943.aspx,None
7139,ACTRN12620000636954,ANZCTR,2020-05-29,2020-07-23,False,South Western Sydney Local Health District,Recruiting,Not Applicable,Interventional,Australia,COACHING FOR COVID-19: A Pilot Study Investigating the Effectiveness of Coaching on Psychological Outcomes in Hospital-Based Senior Doctors,Other (psych),Psychological,Psychological,35,https://anzctr.org.au/ACTRN12620000636954.aspx,None
7140,ACTRN12620001308987,ANZCTR,2020-12-04,2020-09-12,True,Accelagen Pty Ltd,Not Recruiting,Phase 1/Phase 2,Interventional,Australia,"A Phase 1/2 randomized, placebo-controlled, multi-centre study to evaluate the safety and immunogenicity of a novel Receptor Binding Domain (RBD) COVID-19 Vaccine in Healthy Adults",ARMP,Vaccine,Vaccine,255,https://anzctr.org.au/ACTRN12620001308987.aspx,None
7141,ChiCTR2000038672,ChiCTR,2020-09-27,2020-11-05,False,Beijing Ditan Hospital,Not Recruiting,Phase 1,Interventional,China,"A single-site, single-arm,open Phase I Study to Evaluate the Safety,tolerability and pharmacokinetic of CD24Fc in healthy adults",Drug,CD24Fc,CD24Fc,12,http://www.chictr.org.cn/showproj.aspx?proj=59313,None
7142,ChiCTR2000038343,ChiCTR,2020-09-19,2020-10-01,False,The Third Affiliated Hospital of Beijing University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Evaluation of primary preventive measures in populations at high risk for novel coronavirus pneumonia (COVID-19) sequelae osteonecrosis of the femoral head -- a prospective randomized controlled trial,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=61668,None
7143,ChiCTR2000038333,ChiCTR,2020-09-18,2020-10-01,False,The Third Affiliated Hospital of Beijing University of Traditional Chinese Medicine,Recruiting,Not Applicable,Interventional,China,Study on Screening and prevention of osteonecrosis of the femoral head during novel coronavirus pneumonia (COVID-19) recovery,Traditional Medicine (Drug),Traditional Medicine,Traditional Medicine,120,http://www.chictr.org.cn/showproj.aspx?proj=61769,None
7144,EUCTR2020-003368-24-DE,EU Clinical Trials Register,2020-09-25,2020-07-12,True,Merck Sharp & Dohme Corp.,Authorised,Phase 2/Phase 3,Interventional,"Sweden, Colombia, Philippines, Chile, Israel, Russian Federation, Italy, Germany, France, Canada, Mexico, Brazil, United Kingdom, United States, South Africa, Ukraine, Spain",MK-4482 Ph 2/3 Study in Non-Hospitalized Participants with COVID-19,Drug,MK-4482,MK-4482,1450,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-003368-24,None
7145,EUCTR2020-002502-75-DE,EU Clinical Trials Register,2020-06-26,2020-11-26,False,"University Hospital, Tübingen",Authorised,Phase 2,Interventional,Germany,Covid-19 Vaccination Trial,ATMP,Vaccine,Vaccine,36,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-002502-75,None
7146,EUCTR2020-001632-10-DE,EU Clinical Trials Register,2020-04-20,2020-04-05,True,"University Hospital, Heidelberg",Authorised,Phase 2,Interventional,Germany,A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease,ATMP,Plasma,Plasma,174,https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-001632-10,None
7147,NL8536,Netherlands Trial Register,2020-04-15,2020-04-28,False,Zuyderland Medical Centre,Recruiting,Not Applicable,Observational,Netherlands,Neurological Manifestations of COVID-19 and Indications of an Association with Respiratory Failure,Clinical Presentation,No Intervention,No Intervention,285,https://trialregister.nl/trial/8536,None
7148,NL8512,Netherlands Trial Register,2020-04-02,2020-03-18,True,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,"The use of ACE2 receptor increasing medication at hospital admission and
mortality rates in COVID-19 patiÃ«nts 
",Drug,ACE inhibitors,ACE inhibitors,400,https://trialregister.nl/trial/8512,None
7149,NL8520,Netherlands Trial Register,2020-04-12,2020-04-14,False,UMC Utrecht,Not Recruiting,Not Applicable,Observational,Netherlands,SARS-CoV-2 Observational Study,Clinical Presentation,No Intervention,No Intervention,600,https://trialregister.nl/trial/8520,None
7150,NL8551,Netherlands Trial Register,2020-04-23,2020-04-23,False,Zuyderland Medical Centre,Recruiting,Not Applicable,Observational,Netherlands,Covid High-intensity Immunosuppression in Cytokine release syndrome,Drug,Corticosteroids + Tocilizumab,Methylprednisolone; Tocilizumab,160,https://trialregister.nl/trial/8551,None
7151,NL8501,Netherlands Trial Register,2020-04-01,2020-03-23,True,Interactive Studios,Recruiting,Not Applicable,Observational,Netherlands,"Using eHealth to support COVID-19 education, self-assessment and symptom tracking.",Other (software),eHealth,eHealth,2000,https://trialregister.nl/trial/8501,None
7152,NL8522,Netherlands Trial Register,2020-04-12,2020-08-04,False,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,The Digital Doc in the Emergency Department: The solution for patient care in the Covid-19 pandemic?,Telehealth,Telehealth,Telehealth,50,https://trialregister.nl/trial/8522,None
7153,NL8523,Netherlands Trial Register,2020-04-13,2020-04-26,False,UMC Utrecht,Not Recruiting,Not Applicable,Interventional,Netherlands,Volatile Anaesthetics in COVID-19 â€“ a pilot study,Drug,Isoflurane,Isoflurane,20,https://trialregister.nl/trial/8523,None
7154,NL8562,Netherlands Trial Register,2020-04-21,2020-01-04,True,None (investigator initiated study),Not Recruiting,Not Applicable,Observational,Netherlands,Bioelectric Impedance Analysis in COVID-19 positive patients. A prospective prevalence study,Clinical Presentation,No Intervention,No Intervention,50,https://trialregister.nl/trial/8562,None
7155,NL8563,Netherlands Trial Register,2020-04-22,2020-04-22,False,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,Patientâ€™s knowledge And behavior oN the COVID-19 disease and as DEterMInants of Contamination,Other,No Intervention,No Intervention,170,https://trialregister.nl/trial/8563,None
7156,NL8570,Netherlands Trial Register,2020-04-29,2020-10-05,False,Franciscus Gasthuis & Vlietland Group,Not Recruiting,Not Applicable,Observational,Netherlands,COVID-19 infections in health care workers,Clinical Presentation,No Intervention,No Intervention,300,https://trialregister.nl/trial/8570,None
7157,NL8529,Netherlands Trial Register,2020-04-14,2020-01-05,True,MCC Omnes (Sittard),Not Recruiting,Not Applicable,Observational,Netherlands,General practice cooperative COVID-19 centre Urmond,Health System,No Intervention,No Intervention,2000,https://trialregister.nl/trial/8529,None
7158,NL8572,Netherlands Trial Register,2020-04-30,2020-04-19,True,University Medical Center Groningen,Recruiting,Not Applicable,Observational,Netherlands,Prevalence of asymptomatic deep vein thrombosis in admitted COVID-19 patients,Clinical Presentation,No Intervention,No Intervention,100,https://trialregister.nl/trial/8572,None
7159,NL8575,Netherlands Trial Register,2020-05-02,2020-01-05,True,Hans van Goudoever,Recruiting,Not Applicable,Observational,Netherlands,COVID MILK,Clinical Presentation,No Intervention,No Intervention,60,https://trialregister.nl/trial/8575,None
7160,NL8576,Netherlands Trial Register,2020-04-20,2020-04-20,False,Franciscus Gasthuis & Vlietland,Not Recruiting,Not Applicable,Observational,Netherlands,Effect van COVID-19 op kwaliteit van leven bij astma,Other (psych),No Intervention,No Intervention,80,https://trialregister.nl/trial/8576,None
7161,NL8521,Netherlands Trial Register,2020-04-13,2020-08-05,False,UMC Amsterdam,Not Recruiting,Not Applicable,Interventional,Netherlands,Continuous positive airway pressure in severe Covid-19 pneumonia,Drug,Oxygen,Oxygen,13,https://trialregister.nl/trial/8521,None
7162,NL8580,Netherlands Trial Register,2020-04-28,2020-04-28,False,No Sponsor Name Given,Recruiting,Not Applicable,Unknown,Netherlands,Metabolic syndrome And Severity of Covid-19,Clinical Presentation,No Intervention,No Intervention,100,https://trialregister.nl/trial/8580,None
7163,NL8531,Netherlands Trial Register,2020-04-08,2020-12-04,False,Stichting Steun Emma,Recruiting,Not Applicable,Observational,Netherlands,Humoral responses to SARS-CoV-2 infection in children,Clinical Presentation,No Intervention,No Intervention,420,https://trialregister.nl/trial/8531,None
7164,NL8578,Netherlands Trial Register,2020-05-02,2020-07-13,False,Rode Kruis Ziekenhuis Beverwijk,Not Recruiting,Not Applicable,Interventional,Netherlands,Alkaline phosphatase for reducing systemic inflammatory response syndrome (SIRS) in patients with Sars-CoV-2 infection and acute respiratory insufficiency (COVID 19),Drug,Alkaline phosphatase,Alkaline phosphatase,124,https://trialregister.nl/trial/8578,None
7165,NL8577,Netherlands Trial Register,2020-05-06,2020-05-15,False,Academic Hospital Maastricht,Not Recruiting,Not Applicable,Interventional,Netherlands,Digital Cardiac Counseling Trial: DCC Trial,Other (software),eHealth,eHealth,394,https://trialregister.nl/trial/8577,None
7166,NL8587,Netherlands Trial Register,2020-05-06,2020-07-05,False,CIRO,Recruiting,Not Applicable,Observational,Netherlands,Quality of life in COVID-19 survivors,Other (psych),No Intervention,No Intervention,500,https://trialregister.nl/trial/8587,None
7167,NL8589,Netherlands Trial Register,2020-05-07,2020-04-23,True,Dr. L.G. Visser,Recruiting,Not Applicable,Observational,Netherlands,Biomarker-based Early Anti-inflammatory Therapy for severe COVID-19,Clinical Presentation,No Intervention,No Intervention,250,https://trialregister.nl/trial/8589,None
7168,NL8528,Netherlands Trial Register,2020-04-15,2020-04-22,False,UMC Utrecht,Not Recruiting,Not Applicable,Observational,Netherlands,Control of COVID-19 in hospitals,Clinical Presentation (Epidemiology),No Intervention,No Intervention,2000,https://trialregister.nl/trial/8528,None
7169,NL8535,Netherlands Trial Register,2020-04-15,2020-03-30,True,CIRO,Recruiting,Not Applicable,Observational,Netherlands,Functional status and health status in COVID-19 patients pre and post rehabilitation,Other (physio),Physio & Rehabilitation,Physio & Rehabilitation,30,https://trialregister.nl/trial/8535,None
7170,NL8513,Netherlands Trial Register,2020-04-07,2020-04-13,False,Reade Research BV,Recruiting,Not Applicable,Observational,Netherlands,COVID-19 in rheumatic patients: a prospective cohort study,Clinical Presentation,No Intervention,No Intervention,8000,https://trialregister.nl/trial/8513,None
7171,NL8609,Netherlands Trial Register,2020-05-11,2020-05-25,False,Radboud University Medical Centre,Not Recruiting,Not Applicable,Interventional,Netherlands,Enhancing the BCG-induced trained immunity response by addition of bisphosphonate or MMR vaccine: a possible preventive approach against COVID-19 (BCG-PLUS),ATMP,Vaccine,Vaccine,100,https://trialregister.nl/trial/8609,None
7172,NL8613,Netherlands Trial Register,2020-05-12,2020-03-23,True,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,Serial measurements in COVID-19-induced acute respiratory disease to unravel heterogeneity of the disease course: design of the Maastricht Intensive Care COVID cohort; MaastrICCht.,Clinical Presentation,No Intervention,No Intervention,250,https://trialregister.nl/trial/8613,None
7173,NL8543,Netherlands Trial Register,2020-04-18,2020-04-14,True,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,COVID19 ultrasound triage,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://trialregister.nl/trial/8543,None
7174,NL8544,Netherlands Trial Register,2020-04-18,2020-04-18,False,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,COVID19 ultrasound diagnosis,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://trialregister.nl/trial/8544,None
7175,NL8625,Netherlands Trial Register,2020-05-15,2020-05-15,False,UMC Utrecht,Recruiting,Not Applicable,Observational,Netherlands,Hocus POCUS: a tool for increasing the efficiency of diagnosing venous thromboembolic disease in critically ill COVID-19 patients?,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,50,https://trialregister.nl/trial/8625,None
7176,NL8627,Netherlands Trial Register,2020-05-18,2020-01-03,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,Netherlands,Association of BMI with COVID-19 incidence and severity,Clinical Presentation,No Intervention,No Intervention,200,https://trialregister.nl/trial/8627,None
7177,NL8633,Netherlands Trial Register,2020-05-13,2020-05-13,False,Leiden University Medical Center,Recruiting,Not Applicable,Interventional,Netherlands,"A randomized, double blinded clinical trial of convalescent plasma compared to standard plasma for treatment of hospitalized non-ICU patients with COVID-19 infections",ATMP,Plasma,Plasma,430,https://trialregister.nl/trial/8633,None
7178,NL8645,Netherlands Trial Register,2020-05-19,2020-03-23,True,UMC Amsterdam,Recruiting,Not Applicable,Observational,Netherlands,Sero-surveillance SARS-CoV-2,Clinical Presentation (Epidemiology),No Intervention,No Intervention,800,https://trialregister.nl/trial/8645,None
7179,NL8668,Netherlands Trial Register,2020-05-28,2020-05-28,False,Academic Hospital Maastricht,Not Recruiting,Not Applicable,Observational,Netherlands,Lifestyle of pregnant women during COVID-19 pandemic,Other,No Intervention,No Intervention,20,https://trialregister.nl/trial/8668,None
7180,NL8473,Netherlands Trial Register,2020-03-23,2020-03-23,False,National Institute for Public Health and the Environment (RIVM),Recruiting,Not Applicable,Observational,Netherlands,Immunity against SARS-CoV-2 in Dutch population,Clinical Presentation,No Intervention,No Intervention,7000,https://trialregister.nl/trial/8473,None
7181,NL8526,Netherlands Trial Register,2020-04-14,2020-04-26,False,Zuyderland Medical Centre,Not Recruiting,Not Applicable,Observational,Netherlands,Neuroinvasion in COVID-19,Clinical Presentation,No Intervention,No Intervention,10,https://trialregister.nl/trial/8526,None
7182,NL8685,Netherlands Trial Register,2020-05-10,2020-05-18,False,KNVB,Recruiting,Not Applicable,Observational,Netherlands,COVID-19 in professional soccer players (COPROS study),Clinical Presentation (Epidemiology),No Intervention,No Intervention,140,https://trialregister.nl/trial/8685,None
7183,NL8694,Netherlands Trial Register,2020-06-10,2020-04-17,True,Leiden University Medical Center,Recruiting,Not Applicable,Observational,Netherlands,Prospective diagnosis of Covid-19 Ã¯nfectionusing exhaled breath analysis by electronic nose,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://trialregister.nl/trial/8694,None
7184,NL8710,Netherlands Trial Register,2020-06-12,2020-01-07,True,Erasmus MC,Not Recruiting,Not Applicable,Observational,Netherlands,"COVID-19 Follow-up care paths and Long-term Outcomes Within the Dutch health care system: a combined rehabilitation, pulmonary, and intensive care perspective",Clinical Presentation,No Intervention,No Intervention,335,https://trialregister.nl/trial/8710,None
7185,NL8714,Netherlands Trial Register,2020-06-12,2020-01-08,True,ZonMw,Not Recruiting,Not Applicable,Observational,Netherlands,"The impact of COVID-19 among illiterate people and people with a mild intellectual disabilities: preventative measures, (mental) health and support needs",Other (psych),No Intervention,No Intervention,1000,https://trialregister.nl/trial/8714,None
7186,NL8726,Netherlands Trial Register,2020-06-23,2020-01-06,True,CHDR,Recruiting,Not Applicable,Interventional,Netherlands,Effect of hydroxychloroquine treatment on the general immunocompetence,Drug,Hydroxychloroquine,Hydroxychloroquine,40,https://trialregister.nl/trial/8726,None
7187,NL8729,Netherlands Trial Register,2020-06-26,2020-01-08,True,UMC Utrecht,Not Recruiting,Not Applicable,Observational,Netherlands,Primary care Research on Outcomes of COVID-19,Clinical Presentation,No Intervention,No Intervention,274,https://trialregister.nl/trial/8729,None
7188,NL8735,Netherlands Trial Register,2020-06-16,2020-06-16,False,UMC Amsterdam,Not Recruiting,Not Applicable,Observational,Netherlands,Risk of infection with SARS-CoV-2 amongst physicians,Clinical Presentation (Epidemiology),No Intervention,No Intervention,3000,https://trialregister.nl/trial/8735,None
7189,NL8490,Netherlands Trial Register,2020-03-31,2020-12-04,False,UMC Utrecht,Not Recruiting,Not Applicable,Interventional,Netherlands,"An open label randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID-19
",Drug,Chloroquine vs. hydroxychloroquine,Chloroquine; hydroxychloroquine,950,https://trialregister.nl/trial/8490,None
7190,NL8538,Netherlands Trial Register,2020-04-17,2020-04-17,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Interventional,Netherlands,Sleep position related to hospital length of stay in admitted COVID-19 patients,Procedure,Positioning,Positioning,342,https://trialregister.nl/trial/8538,None
7191,NL8765,Netherlands Trial Register,2020-07-07,2020-07-07,False,Radboud University Medical Centre,Recruiting,Not Applicable,Observational,Netherlands,"PULmonary DAMage after hospitalization for acute COvid-19 (PULDAMCO), an exploratory prospective cohort study",Clinical Presentation,No Intervention,No Intervention,150,https://trialregister.nl/trial/8765,None
7192,NL8787,Netherlands Trial Register,2020-07-21,2020-01-06,True,Leiden University Medical Center,Recruiting,Not Applicable,Interventional,Netherlands,COVID-VTE follow-up study,Clinical Presentation,No Intervention,No Intervention,400,https://trialregister.nl/trial/8787,None
7193,NL8775,Netherlands Trial Register,2020-07-13,2020-07-13,False,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,Postcorona care,Clinical Presentation,No Intervention,No Intervention,90,https://trialregister.nl/trial/8775,None
7194,NL8818,Netherlands Trial Register,2020-08-03,2020-07-29,True,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,Preparations of Dutch Emergency Departments for the SARS-COV-2 outbreak,Health System,No Intervention,No Intervention,84,https://trialregister.nl/trial/8818,None
7195,NL8821,Netherlands Trial Register,2020-08-07,2020-10-08,False,ISA Pharmaceuticals,Not Recruiting,Not Applicable,Observational,Netherlands,In vitro characterization of the immune response of recovered COVID-19 patients and healthy controls to SARS-CoV-2,Clinical Presentation,No Intervention,No Intervention,14,https://trialregister.nl/trial/8821,None
7196,NL8477,Netherlands Trial Register,2020-03-20,2020-03-20,False,UMC Utrecht,Not Recruiting,Not Applicable,Interventional,Netherlands,BCG vaccination for healthcare workers in SARS-CoV-2 pandemic,ATMP,Vaccine,Vaccine,1500,https://trialregister.nl/trial/8477,None
7197,NL8835,Netherlands Trial Register,2020-08-14,2020-06-29,True,Erasmus Medical Center,Recruiting,Not Applicable,Interventional,Netherlands,"Intensive Care Unit specific Virtual Reality (ICU-VR) to improve psychological impairments in survivors of COVID-19; a multicentre, randomised controlled trial.",Other (psych),Psychological,Psychological,80,https://trialregister.nl/trial/8835,None
7198,NL8836,Netherlands Trial Register,2020-08-14,2020-08-14,False,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,"Registry of COvid 19 survivors for FItness, exercise impairment and exercise Training (COFIT)",Clinical Presentation,No Intervention,No Intervention,200,https://trialregister.nl/trial/8836,None
7199,NL8837,Netherlands Trial Register,2020-08-14,2020-08-31,False,Academic Hospital Maastricht,Recruiting,Not Applicable,Observational,Netherlands,"TRACE ll Retrospective: Outcome in patients undergoing (postponed) surgery during the COVID-19 pandemic
",Other,No Intervention,No Intervention,14000,https://trialregister.nl/trial/8837,None
7200,NL8842,Netherlands Trial Register,2020-08-18,2020-09-04,False,Drs. Sasja Duijff & Eva Potharst,Recruiting,Not Applicable,Interventional,Netherlands,Online Communities,Other (psych),Psychological,Psychological,50,https://trialregister.nl/trial/8842,None
7201,NL8841,Netherlands Trial Register,2020-08-17,2020-01-09,True,Academic Hospital Maastricht,Not Recruiting,Not Applicable,Observational,Netherlands,TRACE ll Prospective study: Outcome in patients undergoing postponed elective surgery during the COVID-19 pandemic,Other,No Intervention,No Intervention,2500,https://trialregister.nl/trial/8841,None
7202,NL8705,Netherlands Trial Register,2020-06-04,2020-04-06,True,CIRO,Recruiting,Not Applicable,Observational,Netherlands,Quality of life in patients with suspected COVID-19,Other (psych),No Intervention,No Intervention,10000,https://trialregister.nl/trial/8705,None
7203,NL8882,Netherlands Trial Register,2020-09-07,2020-05-28,True,Franciscus Gasthuis & Vlietland Group,Not Recruiting,Not Applicable,Observational,Netherlands,The psychological well-being and health-related quality of life of patients admitted to the hospital with COVID-19.,Other (psych),Psychological,Psychological,250,https://trialregister.nl/trial/8882,None
7204,NL8903,Netherlands Trial Register,2020-09-15,2020-09-15,False,Reade Research BV,Recruiting,Not Applicable,Interventional,Netherlands,A diet for the treatment of gout,Not relevant,Not relevant,Not relevant,30,https://trialregister.nl/trial/8903,None
7205,NL8706,Netherlands Trial Register,2020-06-09,2020-01-06,True,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,Extracorporeal membrane oxygenation in patients with coronavirus disease 2019,Drug,Oxygen,Oxygen,200,https://trialregister.nl/trial/8706,None
7206,NTR5191,Netherlands Trial Register,2015-05-18,2015-01-09,True,KU Leuven,Not Recruiting,Not Applicable,Interventional,Netherlands,"Self-sizing Radiofrequency Ablation balloon
for eradication of Barrett's esophagus: a
randomized trial comparing three different
treatment regimens",Not relevant,Not relevant,Not relevant,108,https://trialregister.nl/trial/5059,None
7207,NL8922,Netherlands Trial Register,2020-09-23,2020-01-10,True,Sint Maartenskliniek,Not Recruiting,Not Applicable,Interventional,Netherlands,"COntinuation Versus Interruption of Immunomodulating Drugs in case of an Infectious disease in IMID patients (COVID I2 study), with special attention for COVID 19: a pragmatic, explorative randomized controlled trial",Drug,Immunomodulatory agents,Immunomodulatory agents,2200,https://trialregister.nl/trial/8922,None
7208,NL8926,Netherlands Trial Register,2020-09-11,2020-01-10,True,UMC Amsterdam,Not Recruiting,Not Applicable,Observational,Netherlands,"Clinical features of COVID-19 in Pediatric Patients, long term effects
",Clinical Presentation,No Intervention,No Intervention,120,https://trialregister.nl/trial/8926,None
7209,NL8947,Netherlands Trial Register,2020-10-04,2020-05-10,True,UMC Amsterdam,Recruiting,Not Applicable,Interventional,Netherlands,ReCOVer: Cognitive Behavioural Therapy for post-COVID-19 fatigue,Other (psych),Psychological,Psychological,114,https://trialregister.nl/trial/8947,None
7210,NL8993,Netherlands Trial Register,2020-10-21,2020-01-07,True,Utrecht University,Recruiting,Not Applicable,Interventional,Netherlands,Online cognitive behavioral therapy for distress in people who lost a loved one during the corona pandemic: A randomized waitlist-controlled trial,Other (psych),Psychological,Psychological,52,https://trialregister.nl/trial/8993,None
7211,NL9007,Netherlands Trial Register,2020-10-29,2020-09-06,True,W. Cahn,Recruiting,Not Applicable,Interventional,Netherlands,"Exercise via videoconferencing for people with severe mental illness during covid-19 times, a feasibility study",Other,Other,Other,70,https://trialregister.nl/trial/9007,None
7212,NL9019,Netherlands Trial Register,2020-10-23,2020-10-23,False,Máxima Medisch Centrum,Not Recruiting,Not Applicable,Interventional,Netherlands,Effect of Iodine treatment in patiÃ«nts with COVID-19 disease,Drug,Potassium Iodine,Potassium Iodine,200,https://trialregister.nl/trial/9019,None
7213,NL9018,Netherlands Trial Register,2020-10-19,2020-09-26,True,Amphia Hospital Breda,Recruiting,Not Applicable,Observational,Netherlands,Performance evaluation of a sars-cov-2 rapid antigentest: test performance in the community in the netherlands,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,1000,https://trialregister.nl/trial/9018,None
7214,NL9045,Netherlands Trial Register,2020-11-12,2020-03-11,True,Leyden Laboratories B.V.,Not Recruiting,Not Applicable,Observational,Netherlands,Healthy volunteers blood sampling,Other,No Intervention,No Intervention,20,https://trialregister.nl/trial/9045,None
7215,NL9053,Netherlands Trial Register,2020-11-17,2020-09-11,True,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,Evolution of diaphragm and abdominal muscle thickness in ventilated COVID-19 patients,Clinical Presentation,No Intervention,No Intervention,40,https://trialregister.nl/trial/9053,None
7216,NL8954,Netherlands Trial Register,2020-10-06,2020-01-11,True,UMC Utrecht,Recruiting,Not Applicable,Interventional,Netherlands,A randomised controlled pilot trial investigating the feasibility of monitoring patients with or at risk for cardiovascular disease who have symptoms suspected of COVID-19 by pulse oximetry at home,Other,Other,Other,50,https://trialregister.nl/trial/8954,None
7217,NL9063,Netherlands Trial Register,2020-11-18,2020-11-22,False,SHARP,Not Recruiting,Not Applicable,Observational,Netherlands,COVID-19 pandemic impact on severe asthma patients care in Europe,Other,No Intervention,No Intervention,900,https://trialregister.nl/trial/9063,None
7218,NL9067,Netherlands Trial Register,2020-11-27,2020-01-12,True,No Sponsor Name Given,Not Recruiting,Not Applicable,Observational,Netherlands,"High-Flow Nasal Cannula for severe COVID-19, a multicentre prospective cohort study",Other (device),Nasal cannula,Nasal cannula,200,https://trialregister.nl/trial/9067,None
7219,NL9082,Netherlands Trial Register,2020-11-30,2021-01-01,False,Franciscus Gasthuis & Vlietland Group,Not Recruiting,Not Applicable,Observational,Netherlands,Serum Amyloid A as a prognostic marker for disease severity and mortality in COVID-19,Prognosis,No Intervention,No Intervention,400,https://trialregister.nl/trial/9082,None
7220,NL9081,Netherlands Trial Register,2020-11-30,2021-11-01,False,No Sponsor Name Given,Not Recruiting,Not Applicable,Interventional,Netherlands,Early@home,Telehealth,Telehealth,Telehealth,100,https://trialregister.nl/trial/9081,None
7221,NL9093,Netherlands Trial Register,2020-12-04,2020-01-06,True,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,Pulmonary and fitness characteristics of COVID-19 patients with persistent dyspnea and / or reduced exercise capacity,Clinical Presentation,No Intervention,No Intervention,100,https://trialregister.nl/trial/9093,None
7222,NL8460,Netherlands Trial Register,2020-03-16,2020-03-16,False,No Sponsor Name Given,Recruiting,Not Applicable,Observational,Netherlands,Biomarkers for prognosis in critically ill COVID-19 patients : a prospective cohort study,Prognosis,No Intervention,No Intervention,100,https://trialregister.nl/trial/8460,None
7223,NL8483,Netherlands Trial Register,2020-03-26,2020-03-16,True,Fred Foundation; Noaber Foundation,Recruiting,Not Applicable,Interventional,Netherlands,A weapon against COVID-19: (Social) media and influencers,Other,Other,Other,17000,https://trialregister.nl/trial/8483,None
7224,NL8485,Netherlands Trial Register,2020-03-27,2020-03-27,False,Máxima Medisch Centrum,Not Recruiting,Not Applicable,Observational,Netherlands,COVID-19 during pregnancy: a prospective observational cohort,Clinical Presentation,No Intervention,No Intervention,20,https://trialregister.nl/trial/8485,None
7225,NL8497,Netherlands Trial Register,2020-03-31,2020-03-15,True,Radboud University Medical Centre,Recruiting,Not Applicable,Observational,Netherlands,Lung ultrasound vs CT scan in COVID-19 disease,Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,200,https://trialregister.nl/trial/8497,None
7226,NL8498,Netherlands Trial Register,2020-03-31,2020-03-15,True,Radboud University Medical Centre,Recruiting,Not Applicable,Observational,Netherlands,Lung ultrasound (LUS) as a tool to determine the clinical course in COVID-19 patients,Clinical Presentation,No Intervention,No Intervention,20,https://trialregister.nl/trial/8498,None
7227,NCT04323527,ClinicalTrials.gov,2020-03-13,2020-03-23,False,Fundação de Medicina Tropical Dr. Heitor Vieira Dourado,Recruiting,Phase 2,Interventional,Brazil,Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 (CloroCOVID19),Drug,Chloroquine,Chloroquine,440,https://clinicaltrials.gov/ct2/show/NCT04323527,None
7228,NCT04335552,ClinicalTrials.gov,2020-04-03,2020-04-17,False,Duke University,Recruiting,Phase 2,Interventional,United States,"Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection",Drug,Hydroxychloroquine + Azithromycin vs. Hydroxychloroquine vs. Azithormycin,Hydroxychloroquine; Azithromycin,500,https://clinicaltrials.gov/ct2/show/NCT04335552,None
7229,NCT04341727,ClinicalTrials.gov,2020-04-04,2020-04-04,False,Washington University in St. Louis,Recruiting,Phase 3,Interventional,United States,"Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection (WU352)",Drug,Hydroxychloroquine vs. Hydroxychloroquine + Azithromycin vs. Chloroquine vs. Chloroquine + Azithormycin,Hydroxychloroquine; Chloroquine; Azithormycin,500,https://clinicaltrials.gov/ct2/show/NCT04341727,None
7230,NCT04337424,ClinicalTrials.gov,2020-04-05,2020-04-13,False,"University Hospital, Montpellier",Recruiting,Not Applicable,Observational,France,Evaluation of Quickly Diagnostic Saliva Tests for SARS-CoV-2 (EasyCoV),Diagnostics,Diagnostic Test or Assessment,Diagnostic Test or Assessment,180,https://clinicaltrials.gov/ct2/show/NCT04337424,None
7231,NCT04381936,ClinicalTrials.gov,2020-05-07,2020-03-19,True,University of Oxford,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,Randomized Evaluation of COVID-19 Therapy,Drug (+ ATMP),"Lopinavir/ritonavir, Corticosteroids, hydroxychloroquine, azithromycin, tocilizumab, Plasma, REGN10933+REGN10987, Aspirin",Lopinavir/ritonavir; dexamethasone; hydrocortisone; methylprednisolone; hydroxychloroquine; azithromycin; tocilizumab; Plasma; REGN10933; REGN10987; Aspirin,12000,https://clinicaltrials.gov/ct2/show/NCT04381936,EUCTR2020-001113-21; ISRCTN50189673
7232,NCT04370067,ClinicalTrials.gov,2020-04-28,2020-05-01,False,Semmelweis University,Recruiting,Not Applicable,Observational,Hungary,HUNgarian COronaVirus Disease-19 Epidemiological Research,Clinical Presentation (Epidemiology),No Intervention,No Intervention,11200,https://clinicaltrials.gov/ct2/show/NCT04370067,None
7233,RBR-3cbs3w,REBEC,2020-04-08,2020-04-10,False,EMS Pharmaceuticals,Not Recruiting,Phase 3,Interventional,Brazil,"Randomized, pragmatic, double-blind, placebo-controlled clinical study, evaluation of Hydroxychloroquine for prevention of hospitalizations and respiratory complications in outpatients with confirmed or probable diagnosis of COVID-19",Drug,Hydroxychloroquine,Hydroxychloroquine,1300,http://www.ensaiosclinicos.gov.br/rg/RBR-3cbs3w/,None
7234,NCT04356495,ClinicalTrials.gov,2020-04-11,2020-07-01,False,"University Hospital, Bordeaux",Recruiting,Phase 3,Interventional,France,Treatments to Decrease the Risk of Hospitalization or Death in Elderly Outpatients With Symptomatic SARS-CoV-2 Infection (COVID-19),Drug,Hydroxychloroquine vs. Imatinib vs. Favipiravir vs. Telmisartan vs. Vitamins,Hydroxychloroquine; Imatinib; Favipiravir; Telmisartan; Vitamins,1057,https://clinicaltrials.gov/show/NCT04356495,EUCTR2020-001435-27
7235,NCT04448054,ClinicalTrials.gov,2020-06-23,2020-05-20,True,Fondation Ophtalmologique Adolphe de Rothschild,Recruiting,Not Applicable,Observational,France,"Imaging Covid Involvement of Leptomeninges, Olfactory and Limbic Areas",Clinical Presentation,No Intervention,No Intervention,100,https://clinicaltrials.gov/ct2/show/NCT04448054,None
7236,NCT04342221,ClinicalTrials.gov,2020-04-08,2020-03-29,True,"University Hospital, Tübingen",Recruiting,Phase 3,Interventional,Germany,Hydroxychloroquine for COVID-19,Drug,Hydroxychloroquine,Hydroxychloroquine,220,https://clinicaltrials.gov/ct2/show/NCT04342221,EUCTR2020-001224-33
7237,ISRCTN40580903,ISRCTN,2020-05-15,2020-05-16,False,University of Birmingham,Recruiting,Phase 2,Interventional,United Kingdom,Which treatment could lessen the severity of a coronavirus infection when compared with usual care in an NHS setting?,Drug,Gemtuzumab Ozogamicin,Gemtuzumab Ozogamicin,588,http://isrctn.com/ISRCTN40580903,EUCTR2020-001684-89
7238,NCT04401579,ClinicalTrials.gov,2020-05-22,2020-05-08,False,National Institute of Allergy and Infectious Diseases (NIAID),Not Recruiting,Phase 3,Interventional,"Singapore, South Korea, Mexico, Japan, United States",Adaptive COVID-19 Treatment Trial 2 (ACTT-2),Drug,Baricitinib + Remdesivir vs. Remdesivir,Baricitinib; Remdesivir,1034,https://clinicaltrials.gov/ct2/show/NCT04401579,JPRN-jRCT2031200035
7239,NCT04414267,ClinicalTrials.gov,2020-06-01,2020-05-26,True,Hellenic Institute for the Study of Sepsis,Recruiting,Phase 4,Interventional,Greece,Bacillus Calmette-gu‚àö¬©rin Vaccination to Prevent COVID-19,ATMP,Vaccine,Vaccine,900,https://clinicaltrials.gov/ct2/show/NCT04414267,EUCTR2020-002448-21
7240,NCT04451083,ClinicalTrials.gov,2020-06-21,2020-07-01,False,Ono Pharmaceutical Co. Ltd,Recruiting,Phase 1,Interventional,Japan,Multiple-dose Study of FOY-305 in Japanese Healthy Adult Male Subjects,Drug,Camostat Mesilate,Camostat Mesilate,14,https://clinicaltrials.gov/ct2/show/NCT04451083,JPRN-JapicCTI-205326
7241,NCT04382053,ClinicalTrials.gov,2020-05-08,2020-05-27,True,Novartis Pharmaceuticals,Recruiting,Phase 2,Interventional,"Denmark, Hungary, Germany, Netherlands, Spain",Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia,Drug,DFV890,DFV890,120,https://clinicaltrials.gov/ct2/show/NCT04382053,EUCTR2020-001870-32
7242,NCT04376684,ClinicalTrials.gov,2020-05-04,2020-05-28,False,GlaxoSmithKline,Recruiting,Phase 2,Interventional,"United Kingdom, Spain, United States, Netherlands, Japan, France, Poland",Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease,Drug,Otilimab,Otilimab,800,https://clinicaltrials.gov/show/NCT04376684,EUCTR2020-001759-42
7243,NCT04400838,ClinicalTrials.gov,2020-05-12,2020-05-28,False,University of Oxford,Recruiting,Phase 2/Phase 3,Interventional,United Kingdom,Investigating a Vaccine Against COVID-19,ATMP,Vaccine,Vaccine,12330,https://clinicaltrials.gov/ct2/show/NCT04400838,EUCTR2020-001228-32; ISRCTN90906759
7244,NCT04425031,ClinicalTrials.gov,2020-06-05,2020-08-25,False,Aalborg University Hospital,Recruiting,Phase 4,Interventional,Denmark,Handling Oxygenation Targets in COVID-19 (HOT-COVID),Drug,Oxygen,Oxygen,780,https://clinicaltrials.gov/ct2/show/NCT04425031,EUCTR2017-000632-34
7245,NCT04362137,ClinicalTrials.gov,2020-04-22,2020-05-02,False,Novartis Pharmaceuticals,Not Recruiting,Phase 3,Interventional,"United States, Argentina, Brazil, Colombia, France, Germany, Mexico, Peru, Russian Federation, Spain, Turkey, United Kingdom","Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID) (RUXCOVID)",Drug,Ruxolitinib,Ruxolitinib,432,https://clinicaltrials.gov/ct2/show/NCT04362137,EUCTR2020-001662-11; PER-030-20
7246,NCT04346199,ClinicalTrials.gov,2020-04-09,2020-06-12,False,AstraZeneca,Not Recruiting,Phase 2,Interventional,"Argentina, Brazil, Chile, France, Germany, India, Italy, Mexico, Peru, Russian Federation, South Africa, Spain, Turkey",Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19. (CALAVI),Drug,Acalabrutinib,Acalabrutinib,163,https://clinicaltrials.gov/ct2/show/NCT04346199,PER-018-20; EUCTR2020-001644-25
7247,NCT04340544,ClinicalTrials.gov,2020-04-03,2020-04-22,False,"University Hospital, Tübingen",Not Recruiting,Phase 2,Interventional,Germany,Hydroxychloroquine for the Treatment of Mild COVID-19 Disease (COMIHY),Drug,Hydroxychloroquine,Hydroxychloroquine,17,https://clinicaltrials.gov/ct2/show/NCT04340544,EUCTR2020-001512-26
7248,ISRCTN30564012,ISRCTN,2020-05-20,2020-05-20,True,University of Dundee,Recruiting,Phase 3,Interventional,United Kingdom,STOP-COVID19: Superiority Trial Of Protease inhibition in COVID-19 (coronavirus infection),Drug,Brensocatib,Brensocatib,300,https://www.isrctn.com/ISRCTN30564012,EUCTR2020-001643-13
7249,NCT04575597,ClinicalTrials.gov,2020-09-30,2020-10-19,False,Merck Sharp & Dohme Corp.,Recruiting,Phase 2/Phase 3,Interventional,"Israel, United States, United Kingdom",Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002),Drug,Molnupiravir,Molnupiravir,1450,https://clinicaltrials.gov/ct2/show/NCT04575597,EUCTR2020-003368-24
7250,NCT04583995,ClinicalTrials.gov,2020-10-09,2020-09-28,True,Novavax,Recruiting,Phase 3,Interventional,United Kingdom,"A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom",ATMP,Vaccine,Vaccine,15000,https://clinicaltrials.gov/ct2/show/NCT04583995,EUCTR2020-004123-16
7251,NCT04614948,ClinicalTrials.gov,2020-11-03,2020-11-06,False,Janssen Pharmaceutical,Not Recruiting,Phase 3,Interventional,"United States, Germany, Spain, South Africa, United Kingdom, Philippines, Colombia, France, Belgium",A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults,ATMP,Vaccine,Vaccine,30000,https://clinicaltrials.gov/ct2/show/NCT04614948,EUCTR2020-003643-29; ISRCTN14722499
7252,NCT04509973 ,ClinicalTrials.gov,2020-08-11,2020-08-27,False,Scandinavian Critical Care Trials Group,Recruiting,Phase 3,Interventional,"India, Denmark, Switzerland, Sweden",Higher vs. Lower Doses of Dexamethasone for COVID-19 and Severe Hypoxia,Not relevant,Not relevant,Not relevant,1000,https://clinicaltrials.gov/ct2/show/NCT04509973,EUCTR2020-003363-25; CTRI/2020/10/028731
7253,NCT04452318,ClinicalTrials.gov,2020-06-26,2020-07-13,False,Regeneron Pharmaceuticals,Recruiting,Phase 3,Interventional,"United States, Romania, Moldova",Study Assessing the Efficacy and Safety of Anti-Spike SARS CoV-2 Monoclonal Antibodies for Prevention of SARS CoV-2 Infection Asymptomatic in Healthy Adults and Adolescents Who Are Household Contacts to an Individual With a Positive SARS-CoV-2 RT-PCR Assay,Drug,REGN10933 + REGN10987,REGN10933 + REGN10987,2000,https://clinicaltrials.gov/ct2/show/NCT04452318,EUCTR2020-003654-71
